{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "2bb7e138-a76e-4ec4-b3d3-b145875f3f62",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import numpy as np\n",
    "from matplotlib import pyplot as plt\n",
    "from brendapyrser import BRENDA\n",
    "\n",
    "dataFile = \"/mnt/c/Users/nikbu/OneDrive/Desktop/TreeSAPP519/brenda_2025_1.txt\"\n",
    "brenda = BRENDA(dataFile)\n",
    "\n",
    "BRENDA_KMs = np.array(\n",
    "    [v for r in brenda.reactions for v in r.KMvalues.get_values()]\n",
    ")\n",
    "\n",
    "values = BRENDA_KMs[(BRENDA_KMs < 1000) & (BRENDA_KMs >= 0)]\n",
    "\n",
    "plt.hist(values, bins=50)\n",
    "plt.title(f\"Median KM value: {np.median(values)}\")\n",
    "plt.xlabel(\"Km (mM)\")\n",
    "plt.ylabel(\"Frequency\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "786d63c9-4f84-40f9-8307-8a51beb51c85",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['KIvalues',\n",
       " 'KKMvalues',\n",
       " 'KMvalues',\n",
       " 'Kcatvalues',\n",
       " 'PH',\n",
       " '_Reaction__ec_number',\n",
       " '_Reaction__eval_range_value',\n",
       " '_Reaction__extractDataField',\n",
       " '_Reaction__extractReactionMechanismInfo',\n",
       " '_Reaction__extractRegexPattern',\n",
       " '_Reaction__extractTempOrPHData',\n",
       " '_Reaction__getBinomialNames',\n",
       " '_Reaction__getDataLines',\n",
       " '_Reaction__getDictOfEnzymeActuators',\n",
       " '_Reaction__getDictOfEnzymeProperties',\n",
       " '_Reaction__getFullReferences',\n",
       " '_Reaction__mechanism_str',\n",
       " '_Reaction__name',\n",
       " '_Reaction__proteins',\n",
       " '_Reaction__reaction_data',\n",
       " '_Reaction__reaction_type',\n",
       " '_Reaction__references',\n",
       " '_Reaction__removeTabs',\n",
       " '_Reaction__splitSpeciesFromProteinID',\n",
       " '_Reaction__systematic_name',\n",
       " '__class__',\n",
       " '__delattr__',\n",
       " '__dict__',\n",
       " '__dir__',\n",
       " '__doc__',\n",
       " '__eq__',\n",
       " '__format__',\n",
       " '__ge__',\n",
       " '__getattribute__',\n",
       " '__getstate__',\n",
       " '__gt__',\n",
       " '__hash__',\n",
       " '__init__',\n",
       " '__init_subclass__',\n",
       " '__le__',\n",
       " '__lt__',\n",
       " '__module__',\n",
       " '__ne__',\n",
       " '__new__',\n",
       " '__reduce__',\n",
       " '__reduce_ex__',\n",
       " '__repr__',\n",
       " '__setattr__',\n",
       " '__sizeof__',\n",
       " '__str__',\n",
       " '__subclasshook__',\n",
       " '__weakref__',\n",
       " '_repr_html_',\n",
       " 'activators',\n",
       " 'cofactors',\n",
       " 'ec_number',\n",
       " 'extractDataLineInfo',\n",
       " 'getReferencesDict',\n",
       " 'getSpeciesDict',\n",
       " 'inhibitors',\n",
       " 'mechanism',\n",
       " 'metals',\n",
       " 'name',\n",
       " 'organisms',\n",
       " 'printReactionSummary',\n",
       " 'proteins',\n",
       " 'reaction_str',\n",
       " 'reaction_type',\n",
       " 'references',\n",
       " 'specificActivities',\n",
       " 'substratesAndProducts',\n",
       " 'summary',\n",
       " 'systematic_name',\n",
       " 'temperature']"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dir(brenda.reactions[0])\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "898204c5-59a6-4f9f-b61b-f2bb53d3719e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Minimum and maximum pH optima in database: 1.0 to 14.0\n"
     ]
    }
   ],
   "source": [
    "ph_raw = [v for r in brenda.reactions for v in r.PH.get_values()]\n",
    "ph_values = [float(p) for p in ph_raw if isinstance(p, (int, float))]\n",
    "ph_values = np.array(ph_values)\n",
    "ph_values = ph_values[(ph_values >= 1) & (ph_values <= 14)]\n",
    "\n",
    "plt.hist(ph_values, bins=28)\n",
    "plt.title(f\"Median pH optimum: {np.median(ph_values):.2f}\")\n",
    "plt.xlabel(\"pH\")\n",
    "plt.ylabel(\"Frequency\")\n",
    "plt.show()\n",
    "\n",
    "print(f\"Minimum and maximum pH optima in database: {ph_values.min()} to {ph_values.max()}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "13e6e45a-b9d7-444a-ac0b-633bc25096be",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[<brendapyrser.parser.Reaction at 0x7f623fdb80e0>]"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "r = [rxn for rxn in brenda.reactions if rxn.ec_number == \"4.2.1.1\"]\n",
    "r"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "2da63c63-dc27-4ce4-aa78-ca5ef3caa940",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "EC: 4.2.1.1\n",
      "Name: Carbonic anhydrase\n",
      "Systematic Name: carbonic acid hydro-lyase (carbon-dioxide-forming)\n",
      "Reaction Type: ['elimination', 'addition', 'hydration (#14# of CO2 <77>)', 'dehydration\\n\\nSOURCE_TISSUE\\nST\\t#1,14,31,102,107,111,118,120,124,133,141,168,169,171,200,201,209,210# \\n\\tmore (#102# no CA activity in blood <128>; #133# no CA XIII transcript \\n\\tdetected in liver <118>; #111# unlike isoenzyme TCAb, isoenzyme TCAc \\n\\tlacks tissue specificity and may be expressed in the cytoplasm of all \\n\\tcells <150>; #141# CA2 transcripts are equally abundant in all organs \\n\\texamined <189>; #107# heart, liver and muscle have negligible levels of \\n\\tcytoplasmic carbonic anhydrase activity <182>; #133# no expression in \\n\\ttestis <175>; #14# the normal mucosa adjacent to the tumors also does \\n\\tnot display expression of carbonic anhydrase IX <217>; #14# CAIX is \\n\\toverexpressed in many types of cancer, including breast cancer, but is \\n\\tmost frequently absent in corresponding normal tissues <291>; #14# \\n\\tcancer-associated cell, isozymes IX and XII <299>; #168,169# expression \\n\\tpatterns of isozymes LjCAA1 and LjCAA2 by in situ hybridization, both \\n\\tare expressed in nodule inner cortical cells, vascular bundles and \\n\\tcentral tissue, overview <292>; #31# real-time RT-PCR analysis reveals \\n\\tthe temporal expression pattern of genes cah-1, cah-2, cah-3, cah-4, \\n\\tcah-5, and cah-6 <310>; #1# the concentration of CA-II in the \\n\\terythrocytes of WL-chicken is much higher than that in erythrocytes \\n\\tfrom Araucana-chicken <285>; #118# CA XIV is highly expressed in all \\n\\tparts of the central nervous system and to a lesser extent in adult \\n\\tliver, heart, small intestine, colon, kidney, urinary bladder and \\n\\tskeletal muscle <381>; #120# human carbonic anhydrase IX (hCA IX) is a \\n\\ttumour-associated enzyme overexpressed in several malignant human \\n\\ttumours <364>; #200# immunohistochemic analysis of enzyme distribution \\n\\tin zebrafish tissues, quantitative expression analysis of ca6 mRNA in \\n\\twild-type and the ca6 morphant zebrafish at different stages of \\n\\tdevelopment <399>; #171# immunohistochemic analysis using monoclonal \\n\\tantibody against CP3, mAb CP3, detailed overview. No CAIII is detected \\n\\tby CP3 in mouse heart and bladder smooth muscle, or in extensor \\n\\tdigitorum longus muscle <370>; #124# isozyme human CA II is \\n\\tubiquitously-expressed <396>; #210# quantitative and semiquantitative \\n\\tRT-PCR expression analysis and in situ hybridization <373>; #201# the \\n\\tDDCA is localized apically in certain epithelial cells near the base of \\n\\tthe ctenidial filament and the epithelial cells surrounding the \\n\\ttertiary water channels. No or very poor expression in inner mantle, \\n\\tfoot muscle, byssal muscle, heart, hepatopancreas, and kidney of \\n\\tTridacna squamosa kept in darkness for 12 h, immunofluorescent tissue \\n\\tdistribution analysis <371>; #201# the outer mantle, which contains the \\n\\thighest density of tertiary tubules and exosymbiont zooxanthellae, \\n\\tdisplays high level of CA2-like expression, and CA2-like is localized \\n\\tto the tubule epithelial cells. Cloning of CA2 homolog (CA2-like) from \\n\\tthe fleshy and colorful outer mantle as well as the thin and whitish \\n\\tinner mantle of Tridacna squamosa to determine its cellular and \\n\\tsubcellular localization. Immunofluorescent enzyme localization study \\n\\t<401>; #209# the protein sequence of the enzyme contains a signal \\n\\tpeptide composed of 19 amino acid residues (MVVATVILLLACAAVSNCV). \\n\\tQuantitative RT-PCR expression analysis and in-situ hybridization in \\n\\tmussel tissues, overview <372>) \\n\\t<118,128,150,175,182,189,217,285,291,292,299,310,364,370,371,372,373,\\n\\t381,396,399,401>\\nST\\t#1,15,16,18,19,21,36,46,112,224,225,226,234# muscle (#112# low activity \\n\\t<147>; #15,18,19# skeletal muscle <3,13,68>; #15# slow-fibre type and \\n\\tfast-fibre type. Slow-fibre type muscle contains carbonic anhydrase I, \\n\\tII and III. Fast-fibre type muscle contains carbonic anhydrase I and II \\n\\t<13>; #1,21# carbonic anhydrase A <22>; #15# carbonic anhydrase IV \\n\\t<45>; #19# carbonic anhydrase III <18>; #19# white muscle and red \\n\\tmuscle <68>; #224# isoform CAb is highly expressed in muscle <422>) \\n\\t<3,4,5,12,13,18,22,45,68,147,422,424>\\nST\\t#1,21,92,102,104,167,200,224,225,226# intestine (#1,21# carbonic \\n\\tanhydrase B and C <22>; #200# very low expression level of isozyme \\n\\tpentraxin-carbonic anhydrase <399>) <22,128,300,399,422>\\nST\\t#1,5,8,14,15,18,19,21,29,36,37,46,57,58,66,67,70,72,74,107,109,111,112,\\n\\t120,121,122,124,127,193,221# erythrocyte (#112# high activity <147>; \\n\\t#1,21# carbonic anhydrase B and C <22>; #19# anhydrase I and II <18>; \\n\\t#21# contain a single high-activity carbonic anhydrase <40>; #46# 5 \\n\\tisozymes of the low activity B type <37>; #70# two enzyme forms <32>; \\n\\t#46# carbonic anhydrase C2, differs from the usual C1 form by having a \\n\\tCys replacement for Arg at residue 180 <25>; #36# low activity \\n\\tisoenzyme carbonic anhydrase I <27>; #14# carbonic anhydrase H differs \\n\\tfrom carbonic anhydrase C in having an Asp rather than Asn at a \\n\\tposition 9 residues removed from the COOH-terminal end of the molecule \\n\\t<38>; #36# contains only the high activity isoenzyme carbonic anhydrase \\n\\tII <27>; #15# contains 2 major forms of enzyme: high-activity type and \\n\\tlow-activity type <23>; #112# induction of anemia causes 30-60fold \\n\\tincrease in anaemic animals <150>; #37# carbonic anhydrase activity is \\n\\tsensitive to zinc and copper inputs from the environment. Carbonic \\n\\tanhydrase activity is increased by zinc or iron in the range of lower \\n\\tZn or Fe additions, and is inhibited by zinc or iron for the higher Zn \\n\\tor Fe additions. Carbonic anhydrase activity is inhibited by copper at \\n\\ta very low Cu addition level <166>; #107# high exprerssion <182>; #1# \\n\\tdevelopmental expression profile of CA-II in erythrocytes of male and \\n\\tfemale chicken, age-related changes of CA-II levels in erythrocytes, \\n\\toverview <285>; #221# about 90% of the CA activity in erythrocytes is \\n\\tdue to the high activity CA II-like isoform, 10% are due to a low \\n\\tactivity CA XIII isozyme <366>; #221# erythrocyte isoform CA XIII. \\n\\tAbout 90% of the CA activity in erythrocytes is due to a high activity \\n\\tCA II-like isoform, 10% are due to the low activity CA XIII isozyme \\n\\t<366>; #193# purified bovine erythrocyte CA-II <357>) \\n\\t<9,16,18,19,22,23,25,27,29,30,32,34,37,38,40,61,74,95,96,100,127,146,\\n\\t147,148,150,166,173,179,182,209,225,226,285,304,308,353,357,366,378,379,\\n\\t380,386,400,414,416>\\nST\\t#1,5,8,36# cecum (#5,8,36# mucosa <19,27>; #36# low activity isoenzyme \\n\\tcarbonic anhydrase I <27>; #1# carbonic anhydrase appears within 2 days \\n\\tof birth <22>) <19,22,27>\\nST\\t#118# Mueller cell <381>\\nST\\t#118# urinary bladder <381>\\nST\\t#12# epididymis (#12# corpus and cauda <314>) <314>\\nST\\t#12# hepatocyte (#12# carbonic anhydrase XIV <175>) <175>\\nST\\t#12# hippocampus <157>\\nST\\t#12# retina (#12# CA XIV is highly expressed on both the basal and \\n\\tapical surfaces of the pigmented epithelial cells of the retina, \\n\\tcarbonic anhydrase XIV <175>) <159,175>\\nST\\t#12,118# central nervous system <157,381>\\nST\\t#12,118# glial cell (#12# carbonic anhydrase XIV <175>) <175,381>\\nST\\t#12,118# retinal pigment epithelium <159,381>\\nST\\t#12,118,133,171# skeletal muscle (#12,118# carbonic anhydrase XIV \\n\\t<175>; #171# tibial anterior musle and soleus muscle, broad expression \\n\\tof CAIII in mouse skeletal muscles. Postnatal downregulation and \\n\\treexpression of CAIII in adult tibial anterior muscle <370>) \\n\\t<118,175,370,381>\\nST\\t#12,14# spermatozoon <314>\\nST\\t#12,14,15,18,118,133,167# lung (#14# carbonic anhydrase IV <45,53>; \\n\\t#12# Balb/c lung carbonic anhydrase IV <52>; #12,118# carbonic \\n\\tanhydrase XIV <175>) <11,45,52,53,118,120,122,123,126,175,300>\\nST\\t#12,14,15,21,29,92,102,104,107,112,118,133,167,170,171,172,200,219# \\n\\tkidney (#112# low activity <147>; #29# cortex <15>; #14# carbonic \\n\\tanhydrase IV <53,70>; #15# contains carbonic anhydrase type I and II \\n\\t<13>; #15# contains one high-activity form <23>; #172# carbonic \\n\\tanhydrase XV <139>; #118# carbonic anhydrase XIV <175>; #133# expressed \\n\\tin cortical and medullary ducts, carbonic anhydrase XIII <175>; #14# in \\n\\tboth renal cortex and medulla the strongest expression is confined to \\n\\tthe collecting ducts and weak expression can be found in the \\n\\tglomerulus, carbonic anhydrase XIII <175>; #12# renal cortex has higher \\n\\texpression than renal medulla <175>; #12# strongest expression of CA \\n\\tXIV is detected in the cortex region, where it is restricted to the \\n\\tproximal tubules of S1 and S2 segments, carbonic anhydrase XIV <175>; \\n\\t#14# kidney expresses only the longer isoform of carbonic anhydrase XII \\n\\t<236>; #12# apical and basal plasma membrane of proximal tubuli <314>) \\n\\t<13,15,17,23,28,46,53,70,118,119,128,139,147,175,182,232,236,300,314,\\n\\t368,381,399>\\nST\\t#12,14,15,21,36,58,80,98,118,167,171,200,210# liver (#15# carbonic \\n\\tanhydrase IV <45>; #36# low activity isoenzyme carbonic anhydrase I \\n\\t<27>; #15# contains carbonic anhydrase I, II and III. Male livers \\n\\tcontain about 5times more carbonic anhydrase II than females <13>; #14# \\n\\tcarbonic anhydrase III is absent from human liver <13>; #14# Caplan-1 \\n\\tcell line, which is derived from a liver metastasis of pancreatic \\n\\tadenocarcinoma <58>; #12,118# carbonic anhydrase XIV <175>; #14# \\n\\tpredominant expression in the liver of males <234>; #210# the \\n\\tpufferfish CA VI is highly expressed in liver tissue <373>; #200# very \\n\\tlow expression level of isozyme pentraxin-carbonic anhydrase <399>) \\n\\t<13,17,27,45,58,108,175,234,246,300,306,370,373,381,399>\\nST\\t#12,14,15,21,58,107,118,133,172,200# brain (#15# carbonic anhydrase IV \\n\\t<45>; #172# carbonic anhydrase XV <139>; #133# carbonic anhydrase XIII \\n\\t<175>; #12,118# carbonic anhydrase XIV <175>; #12,118# neuronal \\n\\tmembrane, carbonic anhydrase XIV <175>; #14# isozyme CA II <268>; #200# \\n\\thighest expression level of isozyme pentraxin-carbonic anhydrase <399>) \\n\\t<17,45,118,139,157,159,175,182,199,268,399,430>\\nST\\t#12,15,107,112,118,133,167,200,224,225,226# heart (#112# low activity \\n\\t<147>; #15# contains carbonic anhydrase I, II and III <13>; #12,118# \\n\\tcarbonic anhydrase XIV <175>; #200# very low expression level of \\n\\tisozyme pentraxin-carbonic anhydrase <399>) \\n\\t<13,118,146,147,175,300,381,399,422>\\nST\\t#120# solid cancer cell (#120# isoform hCA IX is not usually expressed \\n\\tin healthy tissues but is found in over 30 kinds of solid tumor cancers \\n\\tto date <352>) <352>\\nST\\t#124# neuron <396>\\nST\\t#125,200# pancreas (#200# very low expression level of isozyme \\n\\tpentraxin-carbonic anhydrase <399>) <167,399>\\nST\\t#126# bone (#126# cytosolic peripheral isoenzyme <176>; #126# inner \\n\\tperipheral isoenzyme <176>; #126# integral peripheral isoenzyme <176>; \\n\\t#126# outer peripheral isoenzyme <176>) <176>\\nST\\t#127# placenta <93>\\nST\\t#127# vitreous chamber (#127# elevated levels of extracellular carbonic \\n\\tanhydrase-I (CA-I) in vitreous from individuals with diabetic \\n\\tretinopathy, suggesting that retinal hemorrhage and erythrocyte lysis \\n\\tcontribute to the diabetic vitreous proteome <186>) <186>\\nST\\t#133# cerebellum (#133# carbonic anhydrase XIII <175>) <175>\\nST\\t#133# oligodendrocyte (#133# carbonic anhydrase XIII <175>) <175>\\nST\\t#133# telencephalon (#133# carbonic anhydrase XIII <175>) <175>\\nST\\t#133,211# embryo (#211# Pl-can temporal and spatial expression \\n\\tprofiles, analyzed throughout embryo development by comparative \\n\\tquantitative PCR and whole-mount in situ hybridization (WMISH), shows \\n\\tthat Pl-can mRNA is specifically expressed in the primary mesenchyme \\n\\tcells of the embryo and levels increase along with the growth of the \\n\\tembryonic skeleton, reaching a peak at the pluteus stage <395>) \\n\\t<118,395>\\nST\\t#14# astrocytoma cell (#14# isozyme CA XII is commonly expressed in \\n\\tdiffuse astrocytomas <236>) <236>\\nST\\t#14# blood serum (#14# activity of carbonic anhydrase is significantly \\n\\tlower in patients with renal cell carcinoma than in controls <406>) \\n\\t<406>\\nST\\t#14# Caki-1 cell <236>\\nST\\t#14# CCF-STTG1 cell <236>\\nST\\t#14# colorectal mucosa (#14# neoplastic, carbonic anhydrase XIII <175>) \\n\\t<175>\\nST\\t#14# enterocyte (#14# in every segment of the gut, carbonic anhydrase \\n\\tXIII <175>) <118,175>\\nST\\t#14# gastrointestinal tract (#14# CA XIII is found mainly in surface \\n\\tepithelial cells of the body and antrum segments. carbonic anhydrase \\n\\tXIII <175>) <175>\\nST\\t#14# gut (#14# enterocytes, carbonic anhydrase XIII <175>) <175>\\nST\\t#14# hepatoma cell line <234>\\nST\\t#14# leukocyte <118>\\nST\\t#14# MDA-MB-231 cell (#14# CAIX is localized in lipid rafts <291>; #14# \\n\\tthe effect of zinc on the activity of CAIX in MDA-MB-231 breast cancer \\n\\tcells and membrane ghosts derived from these cells is examined. In \\n\\tneither setting any significant elevation of CAIX activity is measured \\n\\t<326>) <267,291,326>\\nST\\t#14# non-small cell lung cancer cell <233>\\nST\\t#14# oral squamous cell carcinoma cell <217>\\nST\\t#14# ovary <118>\\nST\\t#14# pancreatic adenocarcinoma cell line (#14# Caplan-1 cell line, \\n\\twhich is derived from a liver metastasis of pancreatic adenocarcinoma \\n\\t<58>) <57,58>\\nST\\t#14# pancreatic cell line <245>\\nST\\t#14# platelet <8>\\nST\\t#14# prostate <118>\\nST\\t#14# semen (#14# carbonic anhydrase XIII <175>) <175>\\nST\\t#14# serous acinar cell (#14# carbonic anhydrase XIII <175>) <175>\\nST\\t#14# submandibular gland (#14# carbonic anhydrase XIII <175>) <175>\\nST\\t#14# T-47D cell <267>\\nST\\t#14# thymus <118>\\nST\\t#14# U-373MG cell <236>\\nST\\t#14# U-87MG cell <236>\\nST\\t#14# umbilical vein endothelial cell line (#14# umbilical vein \\n\\tendothelial cell line EA-hv926 <57>) <57>\\nST\\t#14# umbilical vein endothelium (#14# cell line EA-hv926 <57>) <57>\\nST\\t#14# uterine cervix (#14# carbonic anhydrase XIII <175>) <175>\\nST\\t#14,118# small intestine <118,381>\\nST\\t#14,118,133# colon (#133# carbonic anhydrase XIII <175>; #14# colon \\n\\texpresses only the longer isoform of carbonic anhydrase XII <236>) \\n\\t<118,175,236,381>\\nST\\t#14,15,131# milk (#14# eight times higher in colostrum than in mature \\n\\tmilk <134>) <134,445>\\nST\\t#14,15,131# saliva <2,7,134,445>\\nST\\t#14,15,133,172# testis (#15# contains carbonic anhydrase I, II and III \\n\\t<13>; #172# carbonic anhydrase XV <139>) <13,118,139>\\nST\\t#14,15,36,112,133,167,200# spleen (#112# low activity <147>; #36# low \\n\\tactivity isoenzyme carbonic anhydrase I <27>; #15# carbonic anhydrase \\n\\tIV not detected <45>; #200# very low expression level of isozyme \\n\\tpentraxin-carbonic anhydrase <399>) <27,45,118,147,300,399>\\nST\\t#14,15,58,92,104# blood (#15# lysate contains carbonic anhydrase I, II \\n\\tand III <13>) <13,96,100,127,128>\\nST\\t#14,18# gastric mucosa (#14# low expression, carbonic anhydrase XIII \\n\\t<175>) <60,175>\\nST\\t#14,201# epithelial cell (#14# of the duct, carbonic anhydrase XIII \\n\\t<175>; #201# at apical membrane of some epithelial cells surrounding \\n\\tthe tertiary water channels and to a lesser extent at the apical \\n\\tmembrane of some epithelial apical immunofluorescence epithelial cells \\n\\tas compared with the control <371>) <175,371>\\nST\\t#140,141,142# flower (#141# carbonic anhydrase 2 <189>; #142# carbonic \\n\\tanhydrase 3 <189>; #140# low transcript level, carbonic anhydrase 1 \\n\\t<189>) <189>\\nST\\t#148# shell (#148# acid-soluble matrix of the nacreous layer <213>) \\n\\t<213>\\nST\\t#15# brown adipose tissue (#15# contains carbonic anhydrase I, III and \\n\\tIII <13>) <13>\\nST\\t#15# extensor digitorum longus (#15# fast limb muscle, high activity of \\n\\tisoenzyme CA3, message levels of isoenzyme CA2 and CA4 are higher in \\n\\textraocular muscle than in extensor digitorum longus, expression of \\n\\tisoenzyme CA5 is equivalent in extraocular muscle and extensor \\n\\tdigitorum longus <154>) <154>\\nST\\t#15# extraocular muscle (#15# isoenzyme CA3 is depressed, message \\n\\tlevels of isoenzyme CA2 and CA4 are higher in extraocular muscle than \\n\\tin extensor digitorum longus, expression of isoenzyme CA5 is equivalent \\n\\tin extraocular muscle and extensor digitorum longus <154>) <154>\\nST\\t#15# mammary gland <134>\\nST\\t#15,171# white adipose tissue (#15# contains carbonic anhydrase I, III \\n\\tand III <13>) <13,370>\\nST\\t#171# renal proximal tubule <232>\\nST\\t#171# urine <232>\\nST\\t#176# culture condition:methanol-grown cell (#176# the expression of \\n\\tthe gene encoding CamH is substantially greater in acetate-grown cells \\n\\tthan in methanol- or trimethylamine-grown cells <320>) <320>\\nST\\t#176# culture condition:trimethylamine-grown cell (#176# the expression \\n\\tof the gene encoding CamH is substantially greater in acetate-grown \\n\\tcells than in methanol- or trimethylamine-grown cells <320>) <320>\\nST\\t#18# bone marrow <248>\\nST\\t#18# corneal endothelial cell <218>\\nST\\t#18,145,193# commercial preparation (#145# thermostable enzyme <354>) \\n\\t<309,354,356,400>\\nST\\t#19# myocyte (#19# neonatal <144>) <144>\\nST\\t#194,201,209# mantle (#209# expression in the posterior mantle pallial \\n\\t(pMP) is significantly higher than that in the anterior mantle pallial \\n\\t(aMP), and expression is low in the mantle center (MC). Expression in \\n\\tthe aMP, pMP and MC is significantly higher in purple mussels compared \\n\\twith that in white mussels <372>) <371,372,389,391,401>\\nST\\t#195# gametocyte <388>\\nST\\t#2,3,4,7,22,23,24,25,26,33,47,60,69,136,140,141,142,173,213# leaf \\n\\t(#141# carbonic anhydrase 2 <189>; #142# carbonic anhydrase 3. CA3 gene \\n\\ttranscripts are the most abundant CA transcripts in the leaf tissues of \\n\\tall plants examined, being at least 50 times more plentiful than either \\n\\tCA1 or CA2 mRNAs. CA3 gene expression is at least 1000 times greater in \\n\\tleaves than in roots or flowers <189>; #136# during the period of \\n\\tmaximal growth (February-May), maximal activity of carbonic anhydrase \\n\\tis observed in fully expanded and illuminated leaves <193>; #140# low \\n\\ttranscript level, carbonic anhydrase 1. Levels of CA1 mRNA are highest \\n\\tin leaves, albeit about 100fold lower than the levels of CA3 \\n\\ttranscripts in these organs <189>) \\n\\t<21,26,31,39,56,136,155,189,193,212,345,400>\\nST\\t#2,3,4,7,23,25,33,60,69,168,169# root nodule (#3# over 99% of the \\n\\tnodule enzyme is located outside the bacteroids <31>; #168,169# inner \\n\\tcortical cells, both genes encoding LjCAA1 and LjCAA2 code for nodule \\n\\tenhanced carbonic anhydrase isoforms, which are induced early during \\n\\tnodule development, overview <292>) <31,292>\\nST\\t#200# egg (#200# very low expression level of isozyme \\n\\tpentraxin-carbonic anhydrase <399>) <399>\\nST\\t#200# fin (#200# high expression level of isozyme pentraxin-carbonic \\n\\tanhydrase <399>) <399>\\nST\\t#200# skin (#200# very low expression level of isozyme \\n\\tpentraxin-carbonic anhydrase <399>) <399>\\nST\\t#200# swim bladder (#200# very low expression level of isozyme \\n\\tpentraxin-carbonic anhydrase <399>) <399>\\nST\\t#200# tail <399>\\nST\\t#201# ctenidium (#201# DDCA is expressed predominantly in the ctenidium \\n\\t<371>) <371>\\nST\\t#201# renal tubule epithelium <401>\\nST\\t#209# epidermis (#209# in-situ hybridization shows that the HcCA3 is \\n\\texpressed in both inside and outside epidermal cells <372>) <372>\\nST\\t#21# parotid gland <1,17>\\nST\\t#211# gastrula <395>\\nST\\t#211# pluteus <395>\\nST\\t#214,215,216,217# cell suspension culture <402>\\nST\\t#214,215,216,217# rosette leaf <402>\\nST\\t#224,225,226# hemocyte <422>\\nST\\t#23# cotyledon <75>\\nST\\t#26# seedling <243>\\nST\\t#26# shoot (#26# functional carbonic anhydrase genes are more strongly \\n\\texpressed in green tissue, but strong expression is also found in roots \\n\\tfor alphaCA2 <188>; #26# functional carbonic anhydrase genes are more \\n\\tstrongly expressed in green tissue, but strong expression is also found \\n\\tin roots for betaCA3, betaCA6 <188>) <188>\\nST\\t#26,140,141,142# root (#141# carbonic anhydrase 2 is the most abundant \\n\\tcarbonic anhydrase transcript in roots <189>; #142# carbonic anhydrase \\n\\t3 <189>; #26# functional carbonic anhydrase genes are more strongly \\n\\texpressed in green tissue, but strong expression is also found in roots \\n\\tfor alphaCA2 <188>; #26# functional carbonic anhydrase genes are more \\n\\tstrongly expressed in green tissue, but strong expression is also found \\n\\tin roots for betaCA3 and betaCA6 <188>; #140# very low transcript \\n\\tlevel, carbonic anhydrase 1 <189>) <188,189>\\nST\\t#38# spermatheca <390>\\nST\\t#39,76# larva (#39# midgut <165>) <143,165>\\nST\\t#39,84,113,114,115,116,117# midgut (#39,84,113,114,115,116,117# \\n\\tpreferentially associated with the posterior midgut in both males and \\n\\tfemales <151>; #39# of larva <165>) <151,165>\\nST\\t#42# antennal gland <214>\\nST\\t#42# epipodite <214>\\nST\\t#42,64,72,75,92,102,104,107,111,112,137,138,143,144,200,222,224,225,\\n\\t226# gill (#72# pavement cells forming the gill epithelial surface \\n\\tlayer, mucous cells, pillar cells bordering the vascular channels of \\n\\tthe secondary lamellae, chloride cells, mitochondria-rich cells located \\n\\tin the primary epithelium, interlamellar regions, bases of the \\n\\tsecondary lamellae <61>; #107# high expression <182>; #112# \\n\\tintermediate activity <147>; #75# carbonic anhydrase activity is low \\n\\tand uniform across gills in shrimp acclimated to osmolarity of 30 ppt, \\n\\tbut carbonic anhydrase activity increases in all gils after exposure to \\n\\tboth low and high salinities. Anterior gills have the largest increases \\n\\tin carbonic anhydrase activity, and levels of increase are \\n\\tapproximately the same for low and high salinity exposure. Induction of \\n\\tbranchial carbonic anhydrase appears to be functionally important in \\n\\tboth hyper- and hypo-osmotic regulations of hemolymph osmotic \\n\\tconcentrations <174>; #138# expression of the cytoplasmic isoform in \\n\\tthe posterior gill (CasCAc) undergoes a significantly greater degree of \\n\\tup-regulation after exposure to low salinity (15p.p.t.) as compared to \\n\\thigh salinity. CasCAc has the largest scope of induction (100fold) \\n\\treported for any transportrelated protein in the gill <183>; #137# the \\n\\tmembrane associated isoform CasCAg is present in much higher levels of \\n\\tmRNA expression in both anterior and posterior gills in crabs \\n\\tacclimated to high salinity (35p.p.t.) compared to crabs acclimated to \\n\\tlow salinity <183>; #226# isoform CAg is most abundantly in gills \\n\\t<422>; #225# isoforms CAc is most abundantly in gills <422>) \\n\\t<61,66,128,147,150,173,174,182,183,191,214,377,399,422,426>\\nST\\t#5# colonic mucosa (#5# isoenzyme specific for mucus of colon. Human \\n\\tmucus CA differs from cytosolic CAI and CAII, membrane-bound CAIV, and \\n\\tthe secreted CAVI of saliva <152>) <152>\\nST\\t#5# inner ear (#5# membraneous lateral wall, stria vascularis, spiral \\n\\tligament, spiral prominence, outer sulcus <24>) <24>\\nST\\t#5,14# ileum (#5# mucosa <19>; #14# carbonic anhydrase XIII <175>) \\n\\t<19,175>\\nST\\t#5,14# jejunum (#5# mucosa <19>; #14# carbonic anhydrase XIII <175>) \\n\\t<19,175>\\nST\\t#5,8# gall bladder (#5# mucosa <19>) <19>\\nST\\t#5,8# right colon mucosa <19>\\nST\\t#5,8,18,21# stomach (#5,8# gastric mucosa <19>) <17,19,149>\\nST\\t#58# lens <177>\\nST\\t#77# digestive gland <269>\\nST\\t#8# choroid plexus <19>\\nST\\t#8# glia <19>\\nST\\t#8# rumen epithelium <19>\\nST\\t#8,118# eye (#8# retina, lens, ciliary body <19>) <19,381>\\nST\\t#8,14# uterine endometrium (#14# carbonic anhydrase XIII <175>) <19,175>\\nST\\t#8,15# prostate gland (#15# contains carbonic anhydrase I, II and III \\n\\t<13>) <13,19>\\nST\\t#8,15# salivary gland <19,134>\\nST\\t#96# gametophyte <423>\\nST\\t#99,176# culture condition:acetate-grown cell (#176# the expression of \\n\\tthe gene encoding CamH is substantially greater in acetate-grown cells \\n\\tthan in methanol- or trimethylamine-grown cells <320>) <160,320>\\n\\nLOCALIZATION\\nLO\\t#10,12,43,81,118,119,120,127,210# extracellular (#12,118# carbonic \\n\\tanhydrase XIV <175>; #12# murine sperm possesses extracellular isozyme \\n\\tCA IV that is transferred to the sperm surface as the sperm pass \\n\\tthrough the epididymis, the transfer takes place in the corpus \\n\\tepididymidis <314>; #119,120# extracellular membrane-bound <365>; #210# \\n\\tthe isozyme VI is secreted <373>) \\n\\t<72,142,158,159,175,186,282,314,365,373>\\nLO\\t#10,23,26# thylakoid (#10# thylakoid lumen <244>; #23# membrane. \\n\\tActivity of photosystem 1 membranes if calculated on chlorophyll basis \\n\\tis much higher than the activity of photosystem 2 membranes <163>; #23# \\n\\tcomplexed with rubisco on the outer surface of thylakoids <212>) \\n\\t<163,187,212,244,345>\\nLO\\t#10,41,192,236# periplasm (#10# carbonic anhydrase 1 and 2 <62>) \\n\\t<62,145,239,429>\\nLO\\t#12,100# cell surface (#12# murine sperm possesses extracellular \\n\\tisozyme CA IV that is transferred to the sperm surface as the sperm \\n\\tpass through the epididymis, the transfer takes place in the corpus \\n\\tepididymidis <314>) <161,314>\\nLO\\t#12,118# axon (#12,118# carbonic anhydrase XIV <175>) <175>\\nLO\\t#12,14,18,29,64,107,118,119,120,124,137,170,172,201# membrane (#14# \\n\\tintegral membrane protein <79>; #14,29,170# bound <15,46,70>; #12,107# \\n\\tbound to <146,159>; #18# associated <11>; #14# carbonic anhydrase IV is \\n\\tassociated with a lipid or a glycolipid membrane fraction <57>; #64# \\n\\tthe enzyme is anchored to membrane surface by a \\n\\tphosphatidylinositol-glycan linkage <66>; #14# at least half of the \\n\\tcarbonic anhydrase IV in lung and kidney is anchored to membranes by \\n\\tphosphatidylinositol-glycan linkages <53>; #14# carbonic anhydrase IV \\n\\tis detected in the apical membrane of polarized cells <58>; #12,14,120# \\n\\ttransmembrane protein <119,223,251>; #14# transmembrane enzyme <236>; \\n\\t#172# glycosylphosphatidylinositol-anchored membrane protein <139>; \\n\\t#119# membrane protein overexpressed in certain cancer tumor cells \\n\\t<135>; #14# transmembrane glycoprotein with an active extracellular CA \\n\\tdomain <133>; #14# transmembrane isozyme IX <131>; #14# transmembrane \\n\\ttumor-associated isozyme IX <132>; #137# isoenzyme CasCAg <183>; #18# \\n\\tCAIV is localized exclusively to the apical membrane <218>; #14# \\n\\tisozyme carbonic anhydrase IV <203>; #124# isoform CA IX is a \\n\\ttransmembrane enzyme <254>; #14# isoforms CA XIV, CA IX and CA XII are \\n\\ttransmembrane proteins <271>; #14# transmembrane isozymes CA IX and CA \\n\\tXI <296>; #14# transmembrane isozymes hCA IX and hCA XII <294>; #14# \\n\\ttransmembrane isozymes IX and XII <299>; #120# CA IX is a transmembrane \\n\\tprotein, where the extracellular region consists of the catalytic CA \\n\\tdomain and the proteoglycan-like (PG) domain <364>; #118# CA XIV is a \\n\\tmembrane-associated glycoprotein <381>; #119,120# extracellular \\n\\tmembrane-bound <365>; #201# membrane-bound, at apical membrane of some \\n\\tepithelial cells surrounding the tertiary water channels and to a \\n\\tlesser extent at the apical membrane of some epithelial apical \\n\\timmunofluorescence epithelial cells as compared with the control. \\n\\tPresence of two transmembrane regions in the DDCA <371>) \\n\\t<11,15,46,53,57,58,66,70,79,119,131,132,133,135,139,146,159,183,203,218,\\n\\t223,230,236,251,253,254,267,271,294,296,299,364,365,371,381,401,437>\\nLO\\t#12,14,26,82,100,120# plasma membrane (#26# betaCA4 is targeted to the \\n\\tplasma membrane <188>; #82# the enzyme is associated exclusively with \\n\\tthe plasma membrane <242>; #12# apical and basal plasma membrane of \\n\\tproximal tubuli <314>; #14# CAIX is the only membrane-associated \\n\\tcarbonic anhydrase inMDA-MB-231 cells. EGF induces CAIX translocation \\n\\tto lipid rafts <291>) <137,188,242,280,291,314>\\nLO\\t#14,15# cytoplasmic membrane (#14# CA9 is expressed along the \\n\\tcytoplasmic membrane of tumor cells <217>) <45,217>\\nLO\\t#14,18,24,26,57,92,102,104,109,112,119,121,124,125,126,127,128,132,133,\\n\\t141,142,178# cytosol (#24# 13% of the activity <56>; #119# cytosolic \\n\\tisozyme CA II <135>; #14# isozymes I and II <132,299>; #26# betaCA2 and \\n\\tbetaCA3 are targeted to the cytosol <188>; #142# carbonic anhydrase 3 \\n\\t<189>; #14,133# carbonic anhydrase XIII <175>; #14# isozyme carbonic \\n\\tanhydrase III <203>; #14,124# isoforms CA I and CA II \\n\\t<254,258,261,271>; #14# cytosolic isozymes hCA I and hCA II <294>; #14# \\n\\tcytosolic isozymes hCA I and II <295>; #14# cytosolic isozymes hCA I, \\n\\thCA II, and hCA VII <311>; #14# cytosolic isozymes hCA I, II, III, VII \\n\\tand XIII <302>; #14# isozymes CA I and CA II <296>; #14# isozymes \\n\\tcarbonic anhydrase I and II <304>) \\n\\t<56,101,128,131,132,135,147,149,167,175,176,188,189,203,209,227,247,254,\\n\\t255,258,261,268,271,294,295,296,299,301,302,304,311,337,365,387,418,437>\\nLO\\t#14,24,73# intracellular <54,56,314>\\nLO\\t#14,48,102,107,138,143,194,221# cytoplasm (#138# isoenzyme CasCAc \\n\\t<183>) <6,28,173,182,183,191,366,391>\\nLO\\t#15,18,29# microsome (#18# association of the enzyme with light \\n\\tmicrosomal membranes is dependent on pH, being lower at neutral or \\n\\talkaline pH. 2 Enzyme forms: a loosely-membrane-associated enzyme and a \\n\\tfirmly-membrane-associated enzyme <60>) <15,45,60,120,122,123,126>\\nLO\\t#15,19# sarcolemma (#19# associated with <68>; #15# in extensor \\n\\tdigitorum longus. Extraocular muscle has very low sarcolemmal or \\n\\tcytosolic carbonic anhydrase activity <154>) <68,154>\\nLO\\t#19# sarcoplasmic reticulum (#19# associated with <68>) <68>\\nLO\\t#218# thylakoid lumen (#218# alpha-type CA (CrCAH3) locates in the \\n\\tthylakoid lumen <403>) <403>\\nLO\\t#23,24,26,47,79,140,173,174,213# chloroplast (#23# membrane <155>; #24# \\n\\t87% of the activity in the cell <56>; #47# isoenzyme I <26>; #79# the \\n\\tsoluble PtCA1 is targeted to the stroma by the bipartite sequence of \\n\\tPre46AA (N-terminal presequence of 46 amino acids that does not exist \\n\\tin the mature PtCA1) <156>; #26# betaCA1 and betaCA5 are targeted to \\n\\tthe chloroplast <188>; #140# in vitro import assays shows CA1 is \\n\\timported into isolated chloroplast of Pisum sativum <189>; #174# CA1 \\n\\tbut not CA2 is localized in the chloroplast <240>) \\n\\t<26,56,65,75,136,155,156,188,189,240,243,400>\\nLO\\t#26# thylakoid membrane <345>\\nLO\\t#26,106# plastid <243,419>\\nLO\\t#49,61,108,203,204,220# carboxysome (#49# CsoSCA exists within the \\n\\tcarboxysome shell either as a homodimer or as extended filaments <180>; \\n\\t#61# enzyme shows activity only in carboxysomal fraction <346>; \\n\\t#203,204# beta-carboxysome <355>) <178,180,281,346,355,361>\\nLO\\t#54,78,79,88,89,90,151,152,153,154,155,156,157,158,159,160,161# soluble \\n\\t<238>\\nLO\\t#6,10,14,26,96,106,129,130,179,214,215,216,217# mitochondrion (#26# \\n\\tbetaCA6 is targeted to the mitochondria <188>; #14,129,130# isoforms CA \\n\\tVA and CA VB <258,261>; #179# contain N-terminal signal peptide for \\n\\ttranslocation into mitochondria <337>) \\n\\t<43,188,258,261,303,337,349,402,419,423>\\nLO\\t#6,18,201,203,204,218# more (#18# outer peripheral, inner peripheral or \\n\\tintegral localization <149>; #6# subcellular localization study, \\n\\toverview <303>; #203,204# CcaAs recruitment to the carboxysome relies \\n\\tupon interacting with CcmM by aligning their mutual three-fold symmetry \\n\\taxes <355>; #218# enzyme CrCAH3 is associated with photosystem II, PSII \\n\\t<403>; #201# the signal peptide (residue 1-22) is predicted to be \\n\\textracellular, and the GPI anchor is predicted to be Ala576 located \\n\\tnear the 3 end of the second CA domain <371>) <149,303,355,371,403>\\n\\nNATURAL_SUBSTRATE_PRODUCT\\nNSP\\t#10,12,14,15,18,19,26,39,55,76,84,107,113,114,115,116,117,124,127,139,\\n\\t140,141,142,170,171,205,206,207,220# more = ? (#14# carbonic anhydrase \\n\\tI, II and III are constitutive enzymes <57>; #10# carbonic anhydrase 2 \\n\\tis induced by high CO2 concentration, carbonic anhydrase 1 is induced \\n\\tby low and high CO2 concentration <62>; #14# carbonic anhydrase IV is \\n\\tpossibly responsible for HCO3- secretion, the cytoplasmic form of \\n\\tcarbonic anhydrase II is believed to play a role in pH regulation near \\n\\tapical ionic channels of the near apical carbonic anhydrase IV <58>; \\n\\t#10# the enzyme is induced by low CO2 conditions, the enzyme probably \\n\\thas an important role in adaption of this algal cell to low CO2 \\n\\tconditions. A possible role for the mitochondrial enzyme might be to \\n\\tfunction as a pH stabilizer to prevent alkalinization of the \\n\\tmitochondrial matrix at the onset of photorespiration. The enzyme could \\n\\talso be involved in the diffusion and transport of inorganic carbon \\n\\tspecies within the mitochondrial matrix as well as their efflux <43>; \\n\\t#170# the enzyme is involved in various physiological processess such \\n\\tas acid-base balance and transport of CO2 and ions <46>; #55# inducible \\n\\tby low levels of CO2 <55>; #15# carbonic anhydrase does not influence \\n\\tthe fast contractile kinetics characteristic of the extraocular muscles \\n\\t<154>; #12# carbonic anhydrase IV mediates buffering in the \\n\\textracellular space in central nervous system <157>; #12# carbonic \\n\\tanhydrase XIV may facilitate CO2 removal from neural retina and \\n\\tmodulate photoreceptor function <159>; #12# carbonic anhydrase XIV \\n\\tmediates buffering in the extracellular space in central nervous system \\n\\t<157>; #10# external carbonic anhydrase enables algal cells to utilize \\n\\tHCO3- as inorganic carbon source in case that CO2 is limited externally \\n\\tto the plasma membrane <142>; #76# in mortality bioassays, carbonic \\n\\tanhydrase protects Tribolium castaneum from the toxicity of COS but has \\n\\tthe opposite effect on COS toxicity. With CS2, carbonic anhydrase has a \\n\\tvery minor role, neither facilitating, nor protecting against toxicity \\n\\t<143>; #39,84,113,114,115,116,117# the enzyme might play a key role in \\n\\tmaintenance of midgut pH <151>; #19# the Na+/H+ antiporter NHE1 is the \\n\\tmajor exporter of protons by skeletal muscle in recovery from a period \\n\\tof anoxia. It is essential for functioning carbonic anhydrase to be \\n\\tattached to NHE1 to activate it <144>; #140# carbonic anhydrase 1 \\n\\tcarries out nonphotosynthetic functions, including lipid biosynthesis \\n\\tand antioxidant activity <189>; #141# carbonic anhydrase 2 provides \\n\\tbicarbonate for anapleurotic reactions involving nonphotosynthetic \\n\\tforms of phosphoenol pyruvate carboxylase in the cytosol of cells in \\n\\tboth photosynthetic and nongreen tissues <189>; #142# carbonic \\n\\tanhydrase 3 is responsible for catalyzing the first step in the C4 \\n\\tpathway in the mesophyll cell cytosol <189>; #124# carbonic anhydrase \\n\\tII increases the activity of the human electrogenic Na+/HCO3- \\n\\tcotransporter <181>; #127# extracellular carbonic anhydrase mediates \\n\\themorrhagic retinal and cerebral vascular permeability through \\n\\tprekallikrein activation <186>; #26# other carbonic anhydrase isoforms \\n\\tthan the well-characterized betaCA1 may contribute to the CO2 transfer \\n\\tin the cell to the catalytic site of ribulose 1,5-bisphosphate \\n\\tcarboxylase/oxygenase <188>; #26# other carbonic anhydrase isoforms \\n\\tthan the well-characterized betaCA1 may contribute to the CO2 transfer \\n\\tin the cell to the catalytic site of ribulose 15-bisphosphate \\n\\tcarboxylase/oxygenase <188>; #107# rn the erythrocyte, carbonic \\n\\tanhydrase is necessary to facilitate the transport of carbon dioxide \\n\\tout of the body <182>; #139# that carbonic anhydrase domain in \\n\\talcyonarian is involved in the calcification process <185>; #18# BCA II \\n\\twhen incubated under mildly denaturing condition of GdnHCl \\n\\tconcentration of 1.5 M and a pH of 3.5 (slightly below its isoelectric \\n\\tpoint), forms ordered aggregates that are characteristically distinct \\n\\tfrom amorphous aggregates <198>; #171# the renal carbonic anhydrase \\n\\ttype III plays a role in proximal tubule dysfunction <232>; #207# \\n\\tenzyme SazCA is highly active in the CO2 hydration reaction <360>; \\n\\t#206# the enzyme has a medium-low catalytic activity for the \\n\\tphysiologic reaction of CO2 hydration to bicarbonate and protons <358>; \\n\\t#220# the enzyme has significant catalytic activity for the physiologic \\n\\treaction, CO2 hydration to bicarbonate and protons <361>; #205# the \\n\\tenzyme shows a significant catalytic activity for the physiologic \\n\\treaction of CO2 hydration to bicarbonate and protons <359>) \\n\\t<43,46,55,57,58,62,142,143,144,151,154,157,159,181,182,185,186,188,189,\\n\\t198,232,358,359,360,361>\\nNSP\\t#10,12,14,15,18,19,26,39,55,76,84,107,113,114,115,116,117,124,127,139,\\n\\t140,141,142,170,171,205,206,207,220# more = ? (#14# carbonic anhydrase \\n\\tI, II and III are constitutive enzymes <57>; #10# carbonic anhydrase 2 \\n\\tis induced by high CO2 concentration, carbonic anhydrase 1 is induced \\n\\tby low and high CO2 concentration <62>; #14# carbonic anhydrase IV is \\n\\tpossibly responsible for HCO3- secretion, the cytoplasmic form of \\n\\tcarbonic anhydrase II is believed to play a role in pH regulation near \\n\\tapical ionic channels of the near apical carbonic anhydrase IV <58>; \\n\\t#10# the enzyme is induced by low CO2 conditions, the enzyme probably \\n\\thas an important role in adaption of this algal cell to low CO2 \\n\\tconditions. A possible role for the mitochondrial enzyme might be to \\n\\tfunction as a pH stabilizer to prevent alkalinization of the \\n\\tmitochondrial matrix at the onset of photorespiration. The enzyme could \\n\\talso be involved in the diffusion and transport of inorganic carbon \\n\\tspecies within the mitochondrial matrix as well as their efflux <43>; \\n\\t#170# the enzyme is involved in various physiological processess such \\n\\tas acid-base balance and transport of CO2 and ions <46>; #55# inducible \\n\\tby low levels of CO2 <55>; #15# carbonic anhydrase does not influence \\n\\tthe fast contractile kinetics characteristic of the extraocular muscles \\n\\t<154>; #12# carbonic anhydrase IV mediates buffering in the \\n\\textracellular space in central nervous system <157>; #12# carbonic \\n\\tanhydrase XIV may facilitate CO2 removal from neural retina and \\n\\tmodulate photoreceptor function <159>; #12# carbonic anhydrase XIV \\n\\tmediates buffering in the extracellular space in central nervous system \\n\\t<157>; #10# external carbonic anhydrase enables algal cells to utilize \\n\\tHCO3- as inorganic carbon source in case that CO2 is limited externally \\n\\tto the plasma membrane <142>; #76# in mortality bioassays, carbonic \\n\\tanhydrase protects Tribolium castaneum from the toxicity of COS but has \\n\\tthe opposite effect on COS toxicity. With CS2, carbonic anhydrase has a \\n\\tvery minor role, neither facilitating, nor protecting against toxicity \\n\\t<143>; #39,84,113,114,115,116,117# the enzyme might play a key role in \\n\\tmaintenance of midgut pH <151>; #19# the Na+/H+ antiporter NHE1 is the \\n\\tmajor exporter of protons by skeletal muscle in recovery from a period \\n\\tof anoxia. It is essential for functioning carbonic anhydrase to be \\n\\tattached to NHE1 to activate it <144>; #140# carbonic anhydrase 1 \\n\\tcarries out nonphotosynthetic functions, including lipid biosynthesis \\n\\tand antioxidant activity <189>; #141# carbonic anhydrase 2 provides \\n\\tbicarbonate for anapleurotic reactions involving nonphotosynthetic \\n\\tforms of phosphoenol pyruvate carboxylase in the cytosol of cells in \\n\\tboth photosynthetic and nongreen tissues <189>; #142# carbonic \\n\\tanhydrase 3 is responsible for catalyzing the first step in the C4 \\n\\tpathway in the mesophyll cell cytosol <189>; #124# carbonic anhydrase \\n\\tII increases the activity of the human electrogenic Na+/HCO3- \\n\\tcotransporter <181>; #127# extracellular carbonic anhydrase mediates \\n\\themorrhagic retinal and cerebral vascular permeability through \\n\\tprekallikrein activation <186>; #26# other carbonic anhydrase isoforms \\n\\tthan the well-characterized betaCA1 may contribute to the CO2 transfer \\n\\tin the cell to the catalytic site of ribulose 1,5-bisphosphate \\n\\tcarboxylase/oxygenase <188>; #26# other carbonic anhydrase isoforms \\n\\tthan the well-characterized betaCA1 may contribute to the CO2 transfer \\n\\tin the cell to the catalytic site of ribulose 15-bisphosphate \\n\\tcarboxylase/oxygenase <188>; #107# rn the erythrocyte, carbonic \\n\\tanhydrase is necessary to facilitate the transport of carbon dioxide \\n\\tout of the body <182>; #139# that carbonic anhydrase domain in \\n\\talcyonarian is involved in the calcification process <185>; #18# BCA II \\n\\twhen incubated under mildly denaturing condition of GdnHCl \\n\\tconcentration of 1.5 M and a pH of 3.5 (slightly below its isoelectric \\n\\tpoint), forms ordered aggregates that are characteristically distinct \\n\\tfrom amorphous aggregates <198>; #171# the renal carbonic anhydrase \\n\\ttype III plays a role in proximal tubule dysfunction <232>; #207# \\n\\tenzyme SazCA is highly active in the CO2 hydration reaction <360>; \\n\\t#206# the enzyme has a medium-low catalytic activity for the \\n\\tphysiologic reaction of CO2 hydration to bicarbonate and protons <358>; \\n\\t#220# the enzyme has significant catalytic activity for the physiologic \\n\\treaction, CO2 hydration to bicarbonate and protons <361>; #205# the \\n\\tenzyme shows a significant catalytic activity for the physiologic \\n\\treaction of CO2 hydration to bicarbonate and protons <359>) \\n\\t<43,46,55,57,58,62,142,143,144,151,154,157,159,181,182,185,186,188,189,\\n\\t198,232,358,359,360,361>\\nNSP\\t#14,17,18,28,41,58,85,94,96,97,106,118,120,124,127,129,130,131,132,144,\\n\\t147,165,191,192,197,205,206,207,220,222,223,224,225,226,227,228,229,230,\\n\\t231,232,233,234,235,236,237,238# CO2 + H2O = H2CO3 (#41# periplasmic \\n\\talpha-carbonic anhydrase activity of Helicobacter pylori is essential \\n\\tfor acid acclimation <145>) \\n\\t<145,195,199,209,210,248,250,254,255,258,259,261,263,283,327,358,359,\\n\\t360,361,374,377,381,407,408,411,414,415,416,418,419,420,422,423,424,425,\\n\\t426,427,428,429,430,434,435,436,437,438,439,440,441,442,443,444,445,446>\\nNSP\\t#14,17,18,28,41,58,85,94,96,97,106,118,120,124,127,129,130,131,132,144,\\n\\t147,165,191,192,197,205,206,207,220,222,223,224,225,226,227,228,229,230,\\n\\t231,232,233,234,235,236,237,238# CO2 + H2O = H2CO3 (#41# periplasmic \\n\\talpha-carbonic anhydrase activity of Helicobacter pylori is essential \\n\\tfor acid acclimation <145>) {r} \\n\\t<145,195,199,209,210,248,250,254,255,258,259,261,263,283,327,358,359,\\n\\t360,361,374,377,381,407,408,411,414,415,416,418,419,420,422,423,424,425,\\n\\t426,427,428,429,430,434,435,436,437,438,439,440,441,442,443,444,445,446>\\nNSP\\t#6,9,12,14,15,17,18,20,21,23,26,28,30,31,34,38,41,43,49,56,58,62,81,83,\\n\\t85,88,91,92,94,96,97,98,99,100,101,102,103,104,105,106,118,119,120,122,\\n\\t124,127,128,129,131,132,133,144,145,147,162,166,167,171,173,181,184,185,\\n\\t186,187,188,189,190,191,192,193,194,195,196,197,198,199,200,201,202,203,\\n\\t204,205,206,207,208,209,210,211,212,213,214,215,216,217,218,219,221,222,\\n\\t223,224,225,226,227,228,229,230,231,232,233,234,235,236,237,238# H2CO3 \\n\\t= CO2 + H2O (#14# essential physiological function is to catalyze the \\n\\thydration of carbon dioxide and the backreaction, the dehydration of \\n\\tbicarbonate <111>; #173# plays a role in the hypersensitive defense \\n\\tresponse <136>; #18# plays a role in various physiological functions, \\n\\tincluding interconversion between CO2 and HCO3- in intermediary \\n\\tmetabolism, facilitated diffusion of CO2, pH homeostasis and ion \\n\\ttransport <74>; #49# CsoSCA converts HCO3- to CO2 for use in carbon \\n\\tfixation by ribulose-bisphosphate carboxylase/oxygenase <180>) {r} \\n\\t<71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,\\n\\t94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,\\n\\t113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,\\n\\t131,132,133,134,135,136,137,138,180,286,287,288,289,290,297,298,299,300,\\n\\t303,304,305,307,308,310,311,312,349,350,351,352,353,354,355,356,357,358,\\n\\t359,360,362,363,364,365,366,367,368,369,370,371,372,373,374,375,376,377,\\n\\t378,379,380,381,382,383,384,385,386,387,388,389,390,391,392,393,394,395,\\n\\t396,397,398,399,400,401,402,403,404,405,407,408,411,414,415,416,418,419,\\n\\t420,422,423,424,425,426,427,428,429,430,434,435,436,437,438,439,440,441,\\n\\t442,443,444,445,446>\\nNSP\\t#6,9,12,14,15,17,18,20,21,23,26,28,30,31,34,38,41,43,49,56,58,62,81,83,\\n\\t85,88,91,92,94,96,97,98,99,100,101,102,103,104,105,106,118,119,120,122,\\n\\t124,127,128,129,131,132,133,144,145,147,162,166,167,171,173,181,184,185,\\n\\t186,187,188,189,190,191,192,193,194,195,196,197,198,199,200,201,202,203,\\n\\t204,205,206,207,208,209,210,211,212,213,214,215,216,217,218,219,221,222,\\n\\t223,224,225,226,227,228,229,230,231,232,233,234,235,236,237,238# H2CO3 \\n\\t= CO2 + H2O (#14# essential physiological function is to catalyze the \\n\\thydration of carbon dioxide and the backreaction, the dehydration of \\n\\tbicarbonate <111>; #173# plays a role in the hypersensitive defense \\n\\tresponse <136>; #18# plays a role in various physiological functions, \\n\\tincluding interconversion between CO2 and HCO3- in intermediary \\n\\tmetabolism, facilitated diffusion of CO2, pH homeostasis and ion \\n\\ttransport <74>; #49# CsoSCA converts HCO3- to CO2 for use in carbon \\n\\tfixation by ribulose-bisphosphate carboxylase/oxygenase <180>) \\n\\t<71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,\\n\\t94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,\\n\\t113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,\\n\\t131,132,133,134,135,136,137,138,180,286,287,288,289,290,297,298,299,300,\\n\\t303,304,305,307,308,310,311,312,349,350,351,352,353,354,355,356,357,358,\\n\\t359,360,362,363,364,365,366,367,368,369,370,371,372,373,374,375,376,377,\\n\\t378,379,380,381,382,383,384,385,386,387,388,389,390,391,392,393,394,395,\\n\\t396,397,398,399,400,401,402,403,404,405,407,408,411,414,415,416,418,419,\\n\\t420,422,423,424,425,426,427,428,429,430,434,435,436,437,438,439,440,441,\\n\\t442,443,444,445,446>\\n\\nSUBSTRATE_PRODUCT\\nSP\\t#1,10,12,14,15,16,18,19,20,21,22,26,29,30,36,38,39,49,55,62,67,71,76,80,\\n\\t84,91,106,107,113,114,115,116,117,118,120,122,124,127,128,129,139,140,\\n\\t141,142,166,170,171,181,183,185,188,191,193,194,197,198,199,203,204,205,\\n\\t206,207,208,211,212,219,220,221,222,233# more = ? (#1,14,30,67# \\n\\testerase activity with p-nitrophenyl acetate <16,34,44,49>; #16# \\n\\tacetate esterase activity <4>; #16,29,36# p-nitrophenyl phosphatase \\n\\t<4,27>; #62# no esterase activity <51>; #29,36# esterase activity with \\n\\tumbelliferone acetate <27>; #29,36# esterase activity with fluorescein \\n\\tdiacetate, erythrocyte carbonic anhydrase II, no activity with cat \\n\\tcaecum enzyme and erythrocyte carbonic anhydrase I <27>; #10,71# weak \\n\\testerase activity with p-nitrophenyl acetate <14,35>; #22# CO2/HCO3- \\n\\texchange <69>; #106,233# no activity with 4-nitrophenyl acetate <419>; \\n\\t#20# no esterase activity detected with p-phenylacetate as the \\n\\tsubstrate <112>; #14# carbonic anhydrase I, II and III are constitutive \\n\\tenzymes <57>; #10# carbonic anhydrase 2 is induced by high CO2 \\n\\tconcentration, carbonic anhydrase 1 is induced by low and high CO2 \\n\\tconcentration <62>; #14# carbonic anhydrase IV is possibly responsible \\n\\tfor HCO3- secretion, the cytoplasmic form of carbonic anhydrase II is \\n\\tbelieved to play a role in pH regulation near apical ionic channels of \\n\\tthe near apical carbonic anhydrase IV <58>; #10# the enzyme is induced \\n\\tby low CO2 conditions, the enzyme probably has an important role in \\n\\tadaption of this algal cell to low CO2 conditions. A possible role for \\n\\tthe mitochondrial enzyme might be to function as a pH stabilizer to \\n\\tprevent alkalinization of the mitochondrial matrix at the onset of \\n\\tphotorespiration. The enzyme could also be involved in the diffusion \\n\\tand transport of inorganic carbon species within the mitochondrial \\n\\tmatrix as well as their efflux <43>; #170# the enzyme is involved in \\n\\tvarious physiological processess such as acid-base balance and \\n\\ttransport of CO2 and ions <46>; #55# inducible by low levels of CO2 \\n\\t<55>; #15# carbonic anhydrase does not influence the fast contractile \\n\\tkinetics characteristic of the extraocular muscles <154>; #12# carbonic \\n\\tanhydrase IV mediates buffering in the extracellular space in central \\n\\tnervous system <157>; #12# carbonic anhydrase XIV may facilitate CO2 \\n\\tremoval from neural retina and modulate photoreceptor function <159>; \\n\\t#12# carbonic anhydrase XIV mediates buffering in the extracellular \\n\\tspace in central nervous system <157>; #10# external carbonic anhydrase \\n\\tenables algal cells to utilize HCO3- as inorganic carbon source in case \\n\\tthat CO2 is limited externally to the plasma membrane <142>; #76# in \\n\\tmortality bioassays, carbonic anhydrase protects Tribolium castaneum \\n\\tfrom the toxicity of COS but has the opposite effect on COS toxicity. \\n\\tWith CS2, carbonic anhydrase has a very minor role, neither \\n\\tfacilitating, nor protecting against toxicity <143>; \\n\\t#39,84,113,114,115,116,117# the enzyme might play a key role in \\n\\tmaintenance of midgut pH <151>; #19# the Na+/H+ antiporter NHE1 is the \\n\\tmajor exporter of protons by skeletal muscle in recovery from a period \\n\\tof anoxia. It is essential for functioning carbonic anhydrase to be \\n\\tattached to NHE1 to activate it <144>; #140# carbonic anhydrase 1 \\n\\tcarries out nonphotosynthetic functions, including lipid biosynthesis \\n\\tand antioxidant activity <189>; #141# carbonic anhydrase 2 provides \\n\\tbicarbonate for anapleurotic reactions involving nonphotosynthetic \\n\\tforms of phosphoenol pyruvate carboxylase in the cytosol of cells in \\n\\tboth photosynthetic and nongreen tissues <189>; #142# carbonic \\n\\tanhydrase 3 is responsible for catalyzing the first step in the C4 \\n\\tpathway in the mesophyll cell cytosol <189>; #124# carbonic anhydrase \\n\\tII increases the activity of the human electrogenic Na+/HCO3- \\n\\tcotransporter <181>; #127# extracellular carbonic anhydrase mediates \\n\\themorrhagic retinal and cerebral vascular permeability through \\n\\tprekallikrein activation <186>; #26# other carbonic anhydrase isoforms \\n\\tthan the well-characterized betaCA1 may contribute to the CO2 transfer \\n\\tin the cell to the catalytic site of ribulose 1,5-bisphosphate \\n\\tcarboxylase/oxygenase <188>; #26# other carbonic anhydrase isoforms \\n\\tthan the well-characterized betaCA1 may contribute to the CO2 transfer \\n\\tin the cell to the catalytic site of ribulose 15-bisphosphate \\n\\tcarboxylase/oxygenase <188>; #107# rn the erythrocyte, carbonic \\n\\tanhydrase is necessary to facilitate the transport of carbon dioxide \\n\\tout of the body <182>; #139# that carbonic anhydrase domain in \\n\\talcyonarian is involved in the calcification process <185>; #49# \\n\\trCsoSCA exhibits no detectable esterase activity when assayed \\n\\tspectrophotometrically with 4-nitrophenylacetate as a substrate <178>; \\n\\t#18# BCA II when incubated under mildly denaturing condition of GdnHCl \\n\\tconcentration of 1.5 M and a pH of 3.5 (slightly below its isoelectric \\n\\tpoint), forms ordered aggregates that are characteristically distinct \\n\\tfrom amorphous aggregates <198>; #171# the renal carbonic anhydrase \\n\\ttype III plays a role in proximal tubule dysfunction <232>; #122# the \\n\\tenzyme shows esterase activity with 4-nitrophenyl acetate <308>; #14# \\n\\tthe enzyme also shows esterase activity in 4-nitrophenylacetate \\n\\thydrolysis <287,290>; #80# the enzyme also shows esterase activity with \\n\\t4-nitrophenylacetate as substrate <306>; #14# the enzyme shows esterase \\n\\tassay with 4-nitrophenyl acetate as substrate <304>; #166# type II \\n\\tbeta-carbonic anhydrases have a characteristic triad of non-catalytic \\n\\tresidues, i.e. Trp39, Arg64, and Tyr181 in HICA, about 8 A away from \\n\\tthe active site zinc ion that can bind bicarbonate ion. The studied \\n\\tanion binding site along the dimerization interface of HICA is an \\n\\tescort site that represents an intermediate along the ingress/egress \\n\\troute of bicarbonate ion to/from the allosteric binding site, overview. \\n\\tThe mechanism of sulfate activation of HICA is the result of sulfate \\n\\tion competing for bicarbonate at this escort site, preventing passage \\n\\tof bicarbonate from bulk solution to its allosteric site. The \\n\\tnoncatalytic bicarbonate ion is a negative allosteric effector that \\n\\tstabilizes an inactive, T-state conformation of the enzyme, where Asp44 \\n\\tdisplaces the catalytically essential zinc-bound water. Type II \\n\\tbeta-CAs can also adopt an active, R-state conformation in which Asp44 \\n\\tpairs with Arg46, allowing the coordination of the catalytically \\n\\tessential water molecule to the active site zinc ion. The noncatalytic \\n\\tbicarbonate ion stabilizes the inactive T state. The steric bulk of the \\n\\tVal47 side chain displaces bicarbonate from the allosteric binding site \\n\\tin the R state, and thus provides the necessary steric coupling \\n\\tmechanism between the bicarbonate binding and the adopted allosteric \\n\\tstate <289>; #183# the enzmye shows esterase activity with \\n\\t4-nitrophenyl phosphate <325>; #207# enzyme SazCA is highly active in \\n\\tthe CO2 hydration reaction <360>; #206# the enzyme has a medium-low \\n\\tcatalytic activity for the physiologic reaction of CO2 hydration to \\n\\tbicarbonate and protons <358>; #220# the enzyme has significant \\n\\tcatalytic activity for the physiologic reaction, CO2 hydration to \\n\\tbicarbonate and protons <361>; #205# the enzyme shows a significant \\n\\tcatalytic activity for the physiologic reaction of CO2 hydration to \\n\\tbicarbonate and protons <359>; #129# 4-nitrophenyl acetate is used as \\n\\tthe substrate to measure the activity of enzyme CAVA <349>; #194# \\n\\t4-nitrophenylacetate is used as activity assay substrate <391>; #211# \\n\\tactivity measurement by colorimetric reaction with P-nitrophenyl \\n\\tacetate as substrate <395>; #221# assay using the delta pH method at \\n\\t4C <366>; #204# CcaA-CcmM interactions, overview <355>; #120,124# \\n\\tdetermination of enzyme esterase activity using p-nitrophenyl acetate \\n\\tas substrate. Presence of D2O reduces catalysis, but does not change \\n\\thow it proceeds <352>; #222# enzyme activity assay using the enzymes \\n\\testerase activity with 4-nitrophenyl acetate as substrate <377>; #193# \\n\\tenzyme activity assay with 4-nitrophenyl acetate as substrate using the \\n\\tenzymes esterase activity <357>; #191# enzyme activity measurement by \\n\\tdetermining the enzymes CO2 hydration activity and esterase activity \\n\\twith substrate 4-nitrophenyl acetate. The recombinant enzyme lacking \\n\\tthe signal peptide can efficiently catalyze the hydration of CO2, \\n\\tprecipitating CaCO3 as calcite in the presence of Ca2+ <404>; #127# \\n\\tenzyme activity measurement by determining the enzymes esterase \\n\\tactivity with substrate 4-nitrophenyl acetate <405>; #212# enzyme \\n\\tactivity measurement by stopped-flow CO2 hydrase assay <398>; #124# \\n\\tenzyme activity measurements determining CO2-hydratase activity or \\n\\tdetermining esterase activity with 4-nitrophenyl acetate as substrate \\n\\t<378>; #127# enzyme activity measurements determining CO2-hydratase \\n\\tactivity or determining esterase activity with 4-nitrophenylacetate as \\n\\tsubstrate <378>; #219# enzyme assay with 4-nitrophenyl acetate as \\n\\tsubstrate <368>; #21# enzyme esterase activity assay using \\n\\tp-nitrophenyl acetate as substrate <380>; #21# enzyme esterase activity \\n\\tassay using p-nitrophenylacetate as substrate <379>; #199# enzyme TweCA \\n\\thas no esterase activity with 4-nitrophenyl acetate as substrate, \\n\\tmeasurement of CO2 hydration reaction for determination of enzyme \\n\\tactivity by stopped-flow pH-based assay with bromothymol blue as \\n\\tindicator <382>; #91# esterase activity assay with 4-nitrophenyl \\n\\tacetate as substrate and measurement of CO2 hydration reaction for \\n\\tdetermination of enzyme activity <385>; #124# esterase activity assay \\n\\twith 4-nitrophenyl acetate as substrate for determination of activity \\n\\tof wild-type and mutant enzymes <397>; #197# mineralization of CO2 \\n\\tusing recombinant BhCA leads to accelerated precipitation of CaCO3 in \\n\\tcalcite form. Recombinant BhCA also functions as an efficient virtual \\n\\tperoxidase when Zn2+ is substituted with Mn2+ <374>; #120,124,127,128# \\n\\tpH-based enzyme activity detection <369>; #203# protein/protein-binding \\n\\tanalysis with recombinant enzyme variants CcaA220 and CcaA274 using \\n\\tsurface plasmon resonance. CcaA-CcmM interactions, overview <355>; \\n\\t#118# reactivity of the purified CA XIV is determined by following the \\n\\tCO2 hydration using the stopped-flow technique <381>; #208# recombinant \\n\\tengineered enzyme ASCA exhibits esterase activity with 4-nitrophenyl \\n\\tacetate and can promote CO2 absorption in an alkaline solvent required \\n\\tfor efficient carbon capture. Recombinant mASCA is capable of \\n\\tcatalyzing the conversion of CO2 to CaCO3 (calcite form) in the \\n\\tpresence of Ca2+. The CO2 hydration activity is determined by \\n\\tmonitoring the time required for the pH of the assay solution to change \\n\\tfrom 8.3 to 7.0 and using the formula [[(t0 - tc)/tc]/protein(mg)] \\n\\t[Wilbur-Anderson units (WAU) per mg of protein] <363>; #198# stopped \\n\\tflow CO2 hydrase assay method <384>; #188# stopped-flow enzyme assay \\n\\t<376>; #14# the carbonic anhydrase enzyme activity is measured by the \\n\\tpH change of 0.02 M Tris buffer. The reaction is initiated by the \\n\\taddition of substrate and the time needed for the pH of the reaction \\n\\tmixture to drop from pH 8.3 to pH 6.3 is recorded <353>; #185# the \\n\\tenzyme also presents esterase activity <376>; #197# the enzyme \\n\\teffectively sequesters CO2 into calcite form of CaCO3 <367>; #38# the \\n\\tenzyme is also active in an esterase assay with 4-nitrophenylacetate as \\n\\tsubstrate <390>; #220# the enzyme is highly active in the CO2 hydration \\n\\treaction <361>; #181# the enzyme shows very high activity compared to \\n\\tother carbonic anhydrases, it has also esterase activity <376>) \\n\\t<4,14,16,27,34,35,43,44,46,49,50,51,55,57,58,62,69,112,142,143,144,151,\\n\\t154,157,159,178,181,182,185,186,188,189,198,232,287,289,290,304,306,308,\\n\\t325,349,352,353,355,357,358,359,360,361,363,366,367,368,369,374,376,377,\\n\\t378,379,380,381,382,384,385,390,391,395,397,398,404,405,419>\\nSP\\t#1,10,12,14,15,16,18,19,20,21,22,26,29,30,36,38,39,49,55,62,67,71,76,80,\\n\\t84,91,106,107,113,114,115,116,117,118,120,122,124,127,128,129,139,140,\\n\\t141,142,166,170,171,181,183,185,188,191,193,194,197,198,199,203,204,205,\\n\\t206,207,208,211,212,219,220,221,222,233# more = ? (#1,14,30,67# \\n\\testerase activity with p-nitrophenyl acetate <16,34,44,49>; #16# \\n\\tacetate esterase activity <4>; #16,29,36# p-nitrophenyl phosphatase \\n\\t<4,27>; #62# no esterase activity <51>; #29,36# esterase activity with \\n\\tumbelliferone acetate <27>; #29,36# esterase activity with fluorescein \\n\\tdiacetate, erythrocyte carbonic anhydrase II, no activity with cat \\n\\tcaecum enzyme and erythrocyte carbonic anhydrase I <27>; #10,71# weak \\n\\testerase activity with p-nitrophenyl acetate <14,35>; #22# CO2/HCO3- \\n\\texchange <69>; #106,233# no activity with 4-nitrophenyl acetate <419>; \\n\\t#20# no esterase activity detected with p-phenylacetate as the \\n\\tsubstrate <112>; #14# carbonic anhydrase I, II and III are constitutive \\n\\tenzymes <57>; #10# carbonic anhydrase 2 is induced by high CO2 \\n\\tconcentration, carbonic anhydrase 1 is induced by low and high CO2 \\n\\tconcentration <62>; #14# carbonic anhydrase IV is possibly responsible \\n\\tfor HCO3- secretion, the cytoplasmic form of carbonic anhydrase II is \\n\\tbelieved to play a role in pH regulation near apical ionic channels of \\n\\tthe near apical carbonic anhydrase IV <58>; #10# the enzyme is induced \\n\\tby low CO2 conditions, the enzyme probably has an important role in \\n\\tadaption of this algal cell to low CO2 conditions. A possible role for \\n\\tthe mitochondrial enzyme might be to function as a pH stabilizer to \\n\\tprevent alkalinization of the mitochondrial matrix at the onset of \\n\\tphotorespiration. The enzyme could also be involved in the diffusion \\n\\tand transport of inorganic carbon species within the mitochondrial \\n\\tmatrix as well as their efflux <43>; #170# the enzyme is involved in \\n\\tvarious physiological processess such as acid-base balance and \\n\\ttransport of CO2 and ions <46>; #55# inducible by low levels of CO2 \\n\\t<55>; #15# carbonic anhydrase does not influence the fast contractile \\n\\tkinetics characteristic of the extraocular muscles <154>; #12# carbonic \\n\\tanhydrase IV mediates buffering in the extracellular space in central \\n\\tnervous system <157>; #12# carbonic anhydrase XIV may facilitate CO2 \\n\\tremoval from neural retina and modulate photoreceptor function <159>; \\n\\t#12# carbonic anhydrase XIV mediates buffering in the extracellular \\n\\tspace in central nervous system <157>; #10# external carbonic anhydrase \\n\\tenables algal cells to utilize HCO3- as inorganic carbon source in case \\n\\tthat CO2 is limited externally to the plasma membrane <142>; #76# in \\n\\tmortality bioassays, carbonic anhydrase protects Tribolium castaneum \\n\\tfrom the toxicity of COS but has the opposite effect on COS toxicity. \\n\\tWith CS2, carbonic anhydrase has a very minor role, neither \\n\\tfacilitating, nor protecting against toxicity <143>; \\n\\t#39,84,113,114,115,116,117# the enzyme might play a key role in \\n\\tmaintenance of midgut pH <151>; #19# the Na+/H+ antiporter NHE1 is the \\n\\tmajor exporter of protons by skeletal muscle in recovery from a period \\n\\tof anoxia. It is essential for functioning carbonic anhydrase to be \\n\\tattached to NHE1 to activate it <144>; #140# carbonic anhydrase 1 \\n\\tcarries out nonphotosynthetic functions, including lipid biosynthesis \\n\\tand antioxidant activity <189>; #141# carbonic anhydrase 2 provides \\n\\tbicarbonate for anapleurotic reactions involving nonphotosynthetic \\n\\tforms of phosphoenol pyruvate carboxylase in the cytosol of cells in \\n\\tboth photosynthetic and nongreen tissues <189>; #142# carbonic \\n\\tanhydrase 3 is responsible for catalyzing the first step in the C4 \\n\\tpathway in the mesophyll cell cytosol <189>; #124# carbonic anhydrase \\n\\tII increases the activity of the human electrogenic Na+/HCO3- \\n\\tcotransporter <181>; #127# extracellular carbonic anhydrase mediates \\n\\themorrhagic retinal and cerebral vascular permeability through \\n\\tprekallikrein activation <186>; #26# other carbonic anhydrase isoforms \\n\\tthan the well-characterized betaCA1 may contribute to the CO2 transfer \\n\\tin the cell to the catalytic site of ribulose 1,5-bisphosphate \\n\\tcarboxylase/oxygenase <188>; #26# other carbonic anhydrase isoforms \\n\\tthan the well-characterized betaCA1 may contribute to the CO2 transfer \\n\\tin the cell to the catalytic site of ribulose 15-bisphosphate \\n\\tcarboxylase/oxygenase <188>; #107# rn the erythrocyte, carbonic \\n\\tanhydrase is necessary to facilitate the transport of carbon dioxide \\n\\tout of the body <182>; #139# that carbonic anhydrase domain in \\n\\talcyonarian is involved in the calcification process <185>; #49# \\n\\trCsoSCA exhibits no detectable esterase activity when assayed \\n\\tspectrophotometrically with 4-nitrophenylacetate as a substrate <178>; \\n\\t#18# BCA II when incubated under mildly denaturing condition of GdnHCl \\n\\tconcentration of 1.5 M and a pH of 3.5 (slightly below its isoelectric \\n\\tpoint), forms ordered aggregates that are characteristically distinct \\n\\tfrom amorphous aggregates <198>; #171# the renal carbonic anhydrase \\n\\ttype III plays a role in proximal tubule dysfunction <232>; #122# the \\n\\tenzyme shows esterase activity with 4-nitrophenyl acetate <308>; #14# \\n\\tthe enzyme also shows esterase activity in 4-nitrophenylacetate \\n\\thydrolysis <287,290>; #80# the enzyme also shows esterase activity with \\n\\t4-nitrophenylacetate as substrate <306>; #14# the enzyme shows esterase \\n\\tassay with 4-nitrophenyl acetate as substrate <304>; #166# type II \\n\\tbeta-carbonic anhydrases have a characteristic triad of non-catalytic \\n\\tresidues, i.e. Trp39, Arg64, and Tyr181 in HICA, about 8 A away from \\n\\tthe active site zinc ion that can bind bicarbonate ion. The studied \\n\\tanion binding site along the dimerization interface of HICA is an \\n\\tescort site that represents an intermediate along the ingress/egress \\n\\troute of bicarbonate ion to/from the allosteric binding site, overview. \\n\\tThe mechanism of sulfate activation of HICA is the result of sulfate \\n\\tion competing for bicarbonate at this escort site, preventing passage \\n\\tof bicarbonate from bulk solution to its allosteric site. The \\n\\tnoncatalytic bicarbonate ion is a negative allosteric effector that \\n\\tstabilizes an inactive, T-state conformation of the enzyme, where Asp44 \\n\\tdisplaces the catalytically essential zinc-bound water. Type II \\n\\tbeta-CAs can also adopt an active, R-state conformation in which Asp44 \\n\\tpairs with Arg46, allowing the coordination of the catalytically \\n\\tessential water molecule to the active site zinc ion. The noncatalytic \\n\\tbicarbonate ion stabilizes the inactive T state. The steric bulk of the \\n\\tVal47 side chain displaces bicarbonate from the allosteric binding site \\n\\tin the R state, and thus provides the necessary steric coupling \\n\\tmechanism between the bicarbonate binding and the adopted allosteric \\n\\tstate <289>; #183# the enzmye shows esterase activity with \\n\\t4-nitrophenyl phosphate <325>; #207# enzyme SazCA is highly active in \\n\\tthe CO2 hydration reaction <360>; #206# the enzyme has a medium-low \\n\\tcatalytic activity for the physiologic reaction of CO2 hydration to \\n\\tbicarbonate and protons <358>; #220# the enzyme has significant \\n\\tcatalytic activity for the physiologic reaction, CO2 hydration to \\n\\tbicarbonate and protons <361>; #205# the enzyme shows a significant \\n\\tcatalytic activity for the physiologic reaction of CO2 hydration to \\n\\tbicarbonate and protons <359>; #129# 4-nitrophenyl acetate is used as \\n\\tthe substrate to measure the activity of enzyme CAVA <349>; #194# \\n\\t4-nitrophenylacetate is used as activity assay substrate <391>; #211# \\n\\tactivity measurement by colorimetric reaction with P-nitrophenyl \\n\\tacetate as substrate <395>; #221# assay using the delta pH method at \\n\\t4C <366>; #204# CcaA-CcmM interactions, overview <355>; #120,124# \\n\\tdetermination of enzyme esterase activity using p-nitrophenyl acetate \\n\\tas substrate. Presence of D2O reduces catalysis, but does not change \\n\\thow it proceeds <352>; #222# enzyme activity assay using the enzymes \\n\\testerase activity with 4-nitrophenyl acetate as substrate <377>; #193# \\n\\tenzyme activity assay with 4-nitrophenyl acetate as substrate using the \\n\\tenzymes esterase activity <357>; #191# enzyme activity measurement by \\n\\tdetermining the enzymes CO2 hydration activity and esterase activity \\n\\twith substrate 4-nitrophenyl acetate. The recombinant enzyme lacking \\n\\tthe signal peptide can efficiently catalyze the hydration of CO2, \\n\\tprecipitating CaCO3 as calcite in the presence of Ca2+ <404>; #127# \\n\\tenzyme activity measurement by determining the enzymes esterase \\n\\tactivity with substrate 4-nitrophenyl acetate <405>; #212# enzyme \\n\\tactivity measurement by stopped-flow CO2 hydrase assay <398>; #124# \\n\\tenzyme activity measurements determining CO2-hydratase activity or \\n\\tdetermining esterase activity with 4-nitrophenyl acetate as substrate \\n\\t<378>; #127# enzyme activity measurements determining CO2-hydratase \\n\\tactivity or determining esterase activity with 4-nitrophenylacetate as \\n\\tsubstrate <378>; #219# enzyme assay with 4-nitrophenyl acetate as \\n\\tsubstrate <368>; #21# enzyme esterase activity assay using \\n\\tp-nitrophenyl acetate as substrate <380>; #21# enzyme esterase activity \\n\\tassay using p-nitrophenylacetate as substrate <379>; #199# enzyme TweCA \\n\\thas no esterase activity with 4-nitrophenyl acetate as substrate, \\n\\tmeasurement of CO2 hydration reaction for determination of enzyme \\n\\tactivity by stopped-flow pH-based assay with bromothymol blue as \\n\\tindicator <382>; #91# esterase activity assay with 4-nitrophenyl \\n\\tacetate as substrate and measurement of CO2 hydration reaction for \\n\\tdetermination of enzyme activity <385>; #124# esterase activity assay \\n\\twith 4-nitrophenyl acetate as substrate for determination of activity \\n\\tof wild-type and mutant enzymes <397>; #197# mineralization of CO2 \\n\\tusing recombinant BhCA leads to accelerated precipitation of CaCO3 in \\n\\tcalcite form. Recombinant BhCA also functions as an efficient virtual \\n\\tperoxidase when Zn2+ is substituted with Mn2+ <374>; #120,124,127,128# \\n\\tpH-based enzyme activity detection <369>; #203# protein/protein-binding \\n\\tanalysis with recombinant enzyme variants CcaA220 and CcaA274 using \\n\\tsurface plasmon resonance. CcaA-CcmM interactions, overview <355>; \\n\\t#118# reactivity of the purified CA XIV is determined by following the \\n\\tCO2 hydration using the stopped-flow technique <381>; #208# recombinant \\n\\tengineered enzyme ASCA exhibits esterase activity with 4-nitrophenyl \\n\\tacetate and can promote CO2 absorption in an alkaline solvent required \\n\\tfor efficient carbon capture. Recombinant mASCA is capable of \\n\\tcatalyzing the conversion of CO2 to CaCO3 (calcite form) in the \\n\\tpresence of Ca2+. The CO2 hydration activity is determined by \\n\\tmonitoring the time required for the pH of the assay solution to change \\n\\tfrom 8.3 to 7.0 and using the formula [[(t0 - tc)/tc]/protein(mg)] \\n\\t[Wilbur-Anderson units (WAU) per mg of protein] <363>; #198# stopped \\n\\tflow CO2 hydrase assay method <384>; #188# stopped-flow enzyme assay \\n\\t<376>; #14# the carbonic anhydrase enzyme activity is measured by the \\n\\tpH change of 0.02 M Tris buffer. The reaction is initiated by the \\n\\taddition of substrate and the time needed for the pH of the reaction \\n\\tmixture to drop from pH 8.3 to pH 6.3 is recorded <353>; #185# the \\n\\tenzyme also presents esterase activity <376>; #197# the enzyme \\n\\teffectively sequesters CO2 into calcite form of CaCO3 <367>; #38# the \\n\\tenzyme is also active in an esterase assay with 4-nitrophenylacetate as \\n\\tsubstrate <390>; #220# the enzyme is highly active in the CO2 hydration \\n\\treaction <361>; #181# the enzyme shows very high activity compared to \\n\\tother carbonic anhydrases, it has also esterase activity <376>) \\n\\t<4,14,16,27,34,35,43,44,46,49,50,51,55,57,58,62,69,112,142,143,144,151,\\n\\t154,157,159,178,181,182,185,186,188,189,198,232,287,289,290,304,306,308,\\n\\t325,349,352,353,355,357,358,359,360,361,363,366,367,368,369,374,376,377,\\n\\t378,379,380,381,382,384,385,390,391,395,397,398,404,405,419>\\nSP\\t#1,2,3,4,5,7,8,10,11,12,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,\\n\\t30,32,33,35,36,38,40,41,42,43,44,46,47,48,49,51,52,53,54,55,57,58,59,60,\\n\\t61,62,63,64,65,66,67,68,69,70,71,72,73,74,77,78,79,82,85,86,87,88,89,90,\\n\\t91,94,96,97,99,106,108,109,110,111,112,118,119,120,121,123,124,125,127,\\n\\t128,129,130,131,132,133,136,144,146,147,148,150,151,152,153,154,155,156,\\n\\t157,158,159,160,161,162,163,164,165,170,172,175,176,177,178,179,180,181,\\n\\t182,184,191,192,195,196,197,198,199,203,205,206,207,220,222,223,224,225,\\n\\t226,227,228,229,230,231,232,233,234,235,236,237,238# CO2 + H2O = H2CO3 \\n\\t(#14# among the seven known isozymes carbonic anhydrase III is the \\n\\tleast efficient in catalytic hydration of CO2 <67>; #41# periplasmic \\n\\talpha-carbonic anhydrase activity of Helicobacter pylori is essential \\n\\tfor acid acclimation <145>; #124# roles for residues 7, 62, and 67 in \\n\\tfinetuning the properties of His64 for optimal proton transfer in \\n\\tcatalysis <162>; #177# kinetics of SspCA is characterized in terms of \\n\\tfirst order CO2 hydration rate according to a procedure based on CO2 \\n\\tabsorption tests in a stirred cell apparatus <336>) \\n\\t<1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,\\n\\t27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,\\n\\t51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,141,142,145,\\n\\t147,148,150,155,162,163,167,171,172,178,184,190,193,194,195,196,197,199,\\n\\t200,201,202,204,206,207,208,209,210,211,212,213,214,215,218,219,220,221,\\n\\t222,223,224,225,227,228,229,230,231,233,234,235,236,237,238,239,241,242,\\n\\t243,244,245,247,248,249,250,251,252,253,254,255,256,257,258,259,260,261,\\n\\t262,263,264,265,266,267,268,269,270,271,272,273,274,275,276,277,278,279,\\n\\t280,281,282,283,315,317,320,321,323,326,327,328,329,330,331,332,334,336,\\n\\t337,338,339,340,341,342,343,345,346,347,348,355,358,359,360,361,362,374,\\n\\t377,381,382,383,384,385,390,404,407,408,411,413,414,415,416,418,419,420,\\n\\t421,422,423,424,425,426,427,428,429,430,434,435,436,437,438,439,440,441,\\n\\t442,443,444,445,446>\\nSP\\t#1,2,3,4,5,7,8,10,11,12,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,\\n\\t30,32,33,35,36,38,40,41,42,43,44,46,47,48,49,51,52,53,54,55,57,58,59,60,\\n\\t61,62,63,64,65,66,67,68,69,70,71,72,73,74,77,78,79,82,85,86,87,88,89,90,\\n\\t91,94,96,97,99,106,108,109,110,111,112,118,119,120,121,123,124,125,127,\\n\\t128,129,130,131,132,133,136,144,146,147,148,150,151,152,153,154,155,156,\\n\\t157,158,159,160,161,162,163,164,165,170,172,175,176,177,178,179,180,181,\\n\\t182,184,191,192,195,196,197,198,199,203,205,206,207,220,222,223,224,225,\\n\\t226,227,228,229,230,231,232,233,234,235,236,237,238# CO2 + H2O = H2CO3 \\n\\t(#14# among the seven known isozymes carbonic anhydrase III is the \\n\\tleast efficient in catalytic hydration of CO2 <67>; #41# periplasmic \\n\\talpha-carbonic anhydrase activity of Helicobacter pylori is essential \\n\\tfor acid acclimation <145>; #124# roles for residues 7, 62, and 67 in \\n\\tfinetuning the properties of His64 for optimal proton transfer in \\n\\tcatalysis <162>; #177# kinetics of SspCA is characterized in terms of \\n\\tfirst order CO2 hydration rate according to a procedure based on CO2 \\n\\tabsorption tests in a stirred cell apparatus <336>) {r} \\n\\t<1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,\\n\\t27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,\\n\\t51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,141,142,145,\\n\\t147,148,150,155,162,163,167,171,172,178,184,190,193,194,195,196,197,199,\\n\\t200,201,202,204,206,207,208,209,210,211,212,213,214,215,218,219,220,221,\\n\\t222,223,224,225,227,228,229,230,231,233,234,235,236,237,238,239,241,242,\\n\\t243,244,245,247,248,249,250,251,252,253,254,255,256,257,258,259,260,261,\\n\\t262,263,264,265,266,267,268,269,270,271,272,273,274,275,276,277,278,279,\\n\\t280,281,282,283,315,317,320,321,323,326,327,328,329,330,331,332,334,336,\\n\\t337,338,339,340,341,342,343,345,346,347,348,355,358,359,360,361,362,374,\\n\\t377,381,382,383,384,385,390,404,407,408,411,413,414,415,416,418,419,420,\\n\\t421,422,423,424,425,426,427,428,429,430,434,435,436,437,438,439,440,441,\\n\\t442,443,444,445,446>\\nSP\\t#11,14,18,21,30,41,43,58,76,94,100,124,126,127,132,232,234# \\n\\t4-nitrophenyl acetate + H2O = 4-nitrophenol + acetate (#232# the enzyme \\n\\tshows minimal esterase activity <411>) {r} \\n\\t<93,98,101,105,107,121,122,123,124,125,126,131,133,137,143,149,176,177,\\n\\t195,200,209,248,264,282,324,333,411,414,418,424,425>\\nSP\\t#11,14,18,21,30,41,43,58,76,94,100,124,126,127,132,232,234# \\n\\t4-nitrophenyl acetate + H2O = 4-nitrophenol + acetate (#232# the enzyme \\n\\tshows minimal esterase activity <411>) \\n\\t<93,98,101,105,107,121,122,123,124,125,126,131,133,137,143,149,176,177,\\n\\t195,200,209,248,264,282,324,333,411,414,418,424,425>\\nSP\\t#14# 4-nitrophenyl phosphate + H2O = 4-nitrophenol + phosphate <200>\\nSP\\t#14# 4-nitrophenyl sulfate + H2O = 4-nitrophenol + sulfate <200>\\nSP\\t#14# 4-nitrophenyl propionate + H2O = 4-nitrophenol + propionate <105>\\nSP\\t#14# 3-nitrophenyl acetate + H2O = 3-nitrophenol + acetate <105>\\nSP\\t#14,41,191,223,230,237# 2-nitrophenyl acetate + H2O = 2-nitrophenol + \\n\\tacetate <98,105,416,420,428,440,441>\\nSP\\t#14,41,191,223,230,237# 2-nitrophenyl acetate + H2O = 2-nitrophenol + \\n\\tacetate {r} <98,105,416,420,428,440,441>\\nSP\\t#18,76# COS + H2O = CO2 + H2S <143>\\nSP\\t#18,76# CS2 + 2 H2O = CO2 + 2 H2S <143>\\nSP\\t#45# p-nitrophenyl acetate + H2O = p-nitrophenol + acetate <205>\\nSP\\t#6,9,12,14,15,17,18,20,21,22,23,24,26,28,30,31,34,38,41,43,49,56,58,62,\\n\\t81,83,85,88,91,92,94,96,97,98,99,100,101,102,103,104,105,106,118,119,\\n\\t120,122,124,127,128,129,131,132,133,144,145,147,162,166,167,171,173,181,\\n\\t184,185,186,187,188,189,190,191,192,193,194,195,196,197,198,199,200,201,\\n\\t202,203,204,205,206,207,208,209,210,211,212,213,214,215,216,217,218,219,\\n\\t220,221,222,223,224,225,226,227,228,229,230,231,232,233,234,235,236,237,\\n\\t238# H2CO3 = CO2 + H2O (#14# essential physiological function is to \\n\\tcatalyze the hydration of carbon dioxide and the backreaction, the \\n\\tdehydration of bicarbonate <111>; #173# plays a role in the \\n\\thypersensitive defense response <136>; #18# plays a role in various \\n\\tphysiological functions, including interconversion between CO2 and \\n\\tHCO3- in intermediary metabolism, facilitated diffusion of CO2, pH \\n\\thomeostasis and ion transport <74>; #49# CsoSCA converts HCO3- to CO2 \\n\\tfor use in carbon fixation by ribulose-bisphosphate \\n\\tcarboxylase/oxygenase <180>; #166# bicarbonate binding mode and binding \\n\\tstructure, overview <289>; #14# the proton transfer from a zinc-bound \\n\\twater molecule to the proton shuttle His64, along a hydrogen-bonded \\n\\twater network, limits the reaction velocity of CO2 hydration. The side \\n\\tchain of His64 occupies two conformations in wild-type HCA II, pointing \\n\\tinward toward the zinc or outward toward bulk solvent. The enzyme shows \\n\\ta significant extension of the effective active site of HCA II from the \\n\\tzinc-bound water at the base of the conical cavity in the enzyme to \\n\\tLys170 near the rim of the cavity <290>) {r} \\n\\t<28,50,56,69,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,\\n\\t90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,\\n\\t110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,\\n\\t128,129,130,131,132,133,134,135,136,137,138,158,161,180,286,287,288,289,\\n\\t290,297,298,299,300,303,304,305,307,308,310,311,312,349,350,351,352,353,\\n\\t354,355,356,357,358,359,360,361,362,363,364,365,366,367,368,369,370,371,\\n\\t372,373,374,375,376,377,378,379,380,381,382,383,384,385,386,387,388,389,\\n\\t390,391,392,393,394,395,396,397,398,399,400,401,402,403,404,405,407,408,\\n\\t411,414,415,416,418,419,420,422,423,424,425,426,427,428,429,430,434,435,\\n\\t436,437,438,439,440,441,442,443,444,445,446>\\nSP\\t#6,9,12,14,15,17,18,20,21,22,23,24,26,28,30,31,34,38,41,43,49,56,58,62,\\n\\t81,83,85,88,91,92,94,96,97,98,99,100,101,102,103,104,105,106,118,119,\\n\\t120,122,124,127,128,129,131,132,133,144,145,147,162,166,167,171,173,181,\\n\\t184,185,186,187,188,189,190,191,192,193,194,195,196,197,198,199,200,201,\\n\\t202,203,204,205,206,207,208,209,210,211,212,213,214,215,216,217,218,219,\\n\\t220,221,222,223,224,225,226,227,228,229,230,231,232,233,234,235,236,237,\\n\\t238# H2CO3 = CO2 + H2O (#14# essential physiological function is to \\n\\tcatalyze the hydration of carbon dioxide and the backreaction, the \\n\\tdehydration of bicarbonate <111>; #173# plays a role in the \\n\\thypersensitive defense response <136>; #18# plays a role in various \\n\\tphysiological functions, including interconversion between CO2 and \\n\\tHCO3- in intermediary metabolism, facilitated diffusion of CO2, pH \\n\\thomeostasis and ion transport <74>; #49# CsoSCA converts HCO3- to CO2 \\n\\tfor use in carbon fixation by ribulose-bisphosphate \\n\\tcarboxylase/oxygenase <180>; #166# bicarbonate binding mode and binding \\n\\tstructure, overview <289>; #14# the proton transfer from a zinc-bound \\n\\twater molecule to the proton shuttle His64, along a hydrogen-bonded \\n\\twater network, limits the reaction velocity of CO2 hydration. The side \\n\\tchain of His64 occupies two conformations in wild-type HCA II, pointing \\n\\tinward toward the zinc or outward toward bulk solvent. The enzyme shows \\n\\ta significant extension of the effective active site of HCA II from the \\n\\tzinc-bound water at the base of the conical cavity in the enzyme to \\n\\tLys170 near the rim of the cavity <290>) \\n\\t<28,50,56,69,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,\\n\\t90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,\\n\\t110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,\\n\\t128,129,130,131,132,133,134,135,136,137,138,158,161,180,286,287,288,289,\\n\\t290,297,298,299,300,303,304,305,307,308,310,311,312,349,350,351,352,353,\\n\\t354,355,356,357,358,359,360,361,362,363,364,365,366,367,368,369,370,371,\\n\\t372,373,374,375,376,377,378,379,380,381,382,383,384,385,386,387,388,389,\\n\\t390,391,392,393,394,395,396,397,398,399,400,401,402,403,404,405,407,408,\\n\\t411,414,415,416,418,419,420,422,423,424,425,426,427,428,429,430,434,435,\\n\\t436,437,438,439,440,441,442,443,444,445,446>\\nSP\\t#61# carbonylsulfide + H2O = ? <346>\\n\\nTURNOVER_NUMBER\\nTN\\t#1,14,18,22,29,62,99,107,118,122,133,177# -999 {more}  (#22# influence \\n\\tof buffer composition and pH on the turnover-number <20>; #18# \\n\\tinfluence of pH-value and buffer composition and the native enzyme and \\n\\ton an activated derivative with modified thiol groups <42>; #122# \\n\\t20.3/s with 4-nitrophenyl acetate, pH 9.0, 30C, esterase activity \\n\\t<308>; #99# kinetic constants of apoenzyme reconstituted with Zn2+, \\n\\tCo2+, Cu2+, Mn2+, Ni2+, Cd2+, or Fe2+ <321>; #62# the \\n\\tFe2+-reconstituted enzyme produced in Escherichia coli and purified \\n\\tanaerobically contains iron with effective kcat and kcat/Km values \\n\\texceeding the values for Zn2+-reconstituted enzyme <321>; #177# first \\n\\torder kinetic constant at 25C is 9160000 L/(mol s) <336>) \\n\\t<15,20,34,42,70,175,182,308,321,336>\\nTN\\t#100# 39400 {H2CO3}  (#100# pH 6.8, in absence of NaCl <161>) <161>\\nTN\\t#100# 41600 {H2CO3}  (#100# pH 6.8, 0.1 M NaCl <161>) <161>\\nTN\\t#100# 45000 {H2CO3}  (#100# pH 6.8, 0.5 M NaCl <161>) <161>\\nTN\\t#102# 66700 {CO2}  (#102# pH 8.5, 0C <128>) <128>\\nTN\\t#102# 66670 {CO2}  (#102# pH 8.5, 0C <128>) <128>\\nTN\\t#104# 55000 {CO2}  (#104# pH 8.5, 0C <128>) <128>\\nTN\\t#109# 49000 {CO2}  <147>\\nTN\\t#112# 302800 {CO2}  <150>\\nTN\\t#12# 0.039 {CO2}  (#12# pH 9.0, 25C, mutant \\n\\tR94H/E92Q/I121V/I143V/I200T <106>) <106>\\nTN\\t#12# 0.012 {CO2}  (#12# pH 9.0, 25C, mutant R94H <106>) <106>\\nTN\\t#12# 190000 {HCO3-}  <50>\\nTN\\t#12# 400000 {CO2}  (#12# acrolein-modified enzyme <50>) <50>\\nTN\\t#12# 450000 {CO2}  (#12# truncated form of carbonic anhydrase VII \\n\\tlacking the amino-terminal 23 residues of recombinant enzyme <50>) <50>\\nTN\\t#12# 0.038 {CO2}  (#12# pH 9.0, 25C, mutant R94H/E92Q/I143V/I200T \\n\\t<106>) <106>\\nTN\\t#12# 0.023 {CO2}  (#12# pH 9.0, 25C, mutant R94H/E92Q <106>) <106>\\nTN\\t#12# 0.034 {CO2}  (#12# pH 9.0, 25C, mutant R94H/E92Q/I121V <106>) \\n\\t<106>\\nTN\\t#12# 0.046 {CO2}  (#12# pH 9.0, 25C, mutant R94H/E92Q/I200T <106>) \\n\\t<106>\\nTN\\t#12# 0.019 {CO2}  (#12# pH 9.0, 25C, mutant R94H/E92Q/I143V <106>) \\n\\t<106>\\nTN\\t#12# 83000 {CO2}  (#12# isoform carbonic anhydrase XIII, at pH 7.4 and \\n\\t25C <200>) <200>\\nTN\\t#12,14,30# 18300 {CO2}  (#12# carbonic anhydrase IV, pH above 9 <52>; \\n\\t#14# pH-independent turnover <70>) <49,52,70>\\nTN\\t#12,17# 940000 {CO2}  (#12# carbonic anhydrase VII <50>; #17# at 20C, \\n\\tpH 8.3 in 20 mM Tris buffer and 20 mM NaClO4- <207>; #17# pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <305>) <50,207,210,305>\\nTN\\t#12,172# 470000 {CO2}  (#172# at 20C and pH 7.5 <230>; #12# at pH 7.5 \\n\\tand 20C <201>) <201,215,230>\\nTN\\t#120# 11000000 {CO2}  (#120# recombinant CA IX catalytic domain \\n\\texpressed in Sf9 cells, in the presence of 0.05 mM Mg2+ <223>) <223>\\nTN\\t#120# 3800000 {CO2}  (#120# recombinant CA IX catalytic domain \\n\\texpressed in Escherichia coli <223>; #120# recombinant CA IX catalytic \\n\\tdomain expressed in Sf9 cells, in the absence of Zn2+ <223>) <223>\\nTN\\t#120# 4200000 {CO2}  (#120# recombinant CA IX catalytic domain \\n\\texpressed in Sf9 cells, in the presence of 0.05 mM Zn2+ <223>) <223>\\nTN\\t#120# 1100000 {CO2}  (#120# recombinant extracellular domain of CA IX \\n\\texpressed in Sf9 cells, in the absence of Zn2+ <223>) <223>\\nTN\\t#120# 25000000 {CO2}  (#120# recombinant CA IX catalytic domain \\n\\texpressed in Sf9 cells, in the presence of 0.05 mM Mn2+ <223>; #120# \\n\\trecombinant CA IX catalytic domain expressed in Sf9 cells, in the \\n\\tpresence of Zn2+ <223>) <223>\\nTN\\t#120# 12000000 {CO2}  (#120# recombinant CA IX catalytic domain \\n\\texpressed in Sf9 cells, in the presence of 0.05 mM Co2+ <223>) <223>\\nTN\\t#121,125# 22000 {CO2}  (#125# 25C, mutant enzyme F198L/C183S/C188S \\n\\t<140>) <140,147>\\nTN\\t#123# 935000 {CO2}  (#123# pH 7.5, 20C <343>) <343>\\nTN\\t#124# 1400000 {H2CO3}  (#124# pH 7.5, 20C <376>) <376>\\nTN\\t#124,205# 600000 {CO2}  (#205# pH 8.3, 22C <359>; #124# isoform CA II \\n\\tmutant A65T/N67Q/F130Y/V134Q/L203T, at pH 7.5 and 23C <446>; #124# \\n\\twild type isoform CA II, at pH 7.5 and 23C <446>) <359,446>\\nTN\\t#131# 190000 {CO2}  (#131# wild type isoform CA IV, at pH 7.5 and 23C \\n\\t<446>) <446>\\nTN\\t#131# 330000 {CO2}  (#131# saliva isoform CA VI, at pH 7.5, temperature \\n\\tnot specified in the publication <445>) <445>\\nTN\\t#131# 230000 {CO2}  (#131# milk isoform CA VI, at pH 7.5, temperature \\n\\tnot specified in the publication <445>) <445>\\nTN\\t#14# 117 {CO2}  (#14# pH 6.3, MES buffer, wild-type carbonic anhydrase \\n\\tI <44>) <44>\\nTN\\t#14# 433 {CO2}  (#14# pH 8.8, TAPS buffer, wild-type carbonic anhydrase \\n\\tI <44>) <44>\\nTN\\t#14# 4000 {CO2}  (#14# pH 8.94, 1,2-dimethylimidazole buffer, carbonic \\n\\tanhydrase II mutant T200H <44>) <44>\\nTN\\t#14# 250 {CO2}  (#14# pH 6.28, MES buffer, carbonic anhydrase I mutant \\n\\tH67N <44>) <44>\\nTN\\t#14# 85 {CO2}  (#14# pH 6.28, MES buffer, carbonic anhydrase I mutant \\n\\tV62N,H67N,H200T <44>) <44>\\nTN\\t#14# 217 {CO2}  (#14# pH 6.28, MES buffer, carbonic anhydrase I mutant \\n\\tV62N <44>; #14# pH 6.3, MES buffer <44>) <44>\\nTN\\t#14# 233 {CO2}  (#14# pH 8.88, TAPS buffer, carbonic anhydrase I mutant \\n\\tH200T <44>) <44>\\nTN\\t#14# 883 {CO2}  (#14# pH 7.23, 1-methylimidazole buffer, carbonic \\n\\tanhydrase I mutant H67N <44>) <44>\\nTN\\t#14# 1180 {CO2}  (#14# pH 8.98, TAPS buffer, carbonic anhydrase I \\n\\tmutant V62N and carbonic anhydrase I mutant H67N <44>) <44>\\nTN\\t#14# 1380 {CO2}  (#14# pH 7.21, 1-methylimidazole buffer, carbonic \\n\\tanhydrase I mutant H200T <44>) <44>\\nTN\\t#14# 1400 {CO2}  (#14# pH 8.98, TAPS buffer, carbonic anhydrase I \\n\\tmutant V62N,H67N,H200T <44>) <44>\\nTN\\t#14# 1470 {CO2}  (#14# pH 8.88, TAPS buffer, carbonic anhydrase I \\n\\tmutant V62N,H67N <44>) <44>\\nTN\\t#14# 2830 {CO2}  (#14# pH 8.75, 1,2-dimethylimidazole buffer, carbonic \\n\\tanhydrase I mutant H67N <44>) <44>\\nTN\\t#14# 3500 {CO2}  (#14# pH 8.77, 1,2-dimethylimidazole buffer, wild-type \\n\\tcarbonic anhydrase I <44>; #14# pH 8.72, 1,2-dimethylimidazole buffer, \\n\\tcarbonic anhydrase I mutant V62B, H67B <44>) <44>\\nTN\\t#14# 3670 {CO2}  (#14# pH 7.23, 1-methylimidazolebuffer, carbonic \\n\\tanhydrase I mutant V62N,H67N,H200T <44>) <44>\\nTN\\t#14# 5500 {CO2}  (#14# pH 8.95, 1,2-dimethylimidazole buffer, carbonic \\n\\tanhydrase I mutant H200T <44>) <44>\\nTN\\t#14# 8170 {CO2}  (#14# pH 8.94, 1,2-dimethylimidazole buffer, carbonic \\n\\tanhydrase II mutant N62V <44>) <44>\\nTN\\t#14# 8500 {CO2}  (#14# pH 8.75, 1,2-dimethylimidazole buffer, carbonic \\n\\tanhydrase I mutant V62N,H67N,H200T <44>) <44>\\nTN\\t#14# 15200 {CO2}  (#14# pH 8.7, 1,2-dimethylimidazole buffer, carbonic \\n\\tanhydrase II <44>) <44>\\nTN\\t#14# 28300 {CO2}  (#14# pH 8.94, 1,2-dimethylimidazole buffer, carbonic \\n\\tanhydrase II mutant N67H <44>) <44>\\nTN\\t#14# 0.0004 {CO2}  (#14# pH 7.5, 25C, wild-type CA XII <133>) <133>\\nTN\\t#14# 0.0000005 {CO2}  (#14# mutant V143A, pH 8.3, 25C <327>) <327>\\nTN\\t#14# 200000 {CO2}  (#14# isoform carbonic anhydrase I, at pH 7.4 and \\n\\t25C <200>) <200>\\nTN\\t#14# 0.000001 {CO2}  (#14# wild-type, pH 8.3, 25C <327>) <327>\\nTN\\t#14# 150000 {CO2}  (#14# isoform carbonic anhydrase XIII, at pH 7.4 and \\n\\t25C <200>) <200,215,247>\\nTN\\t#14# 29500 {H2CO3}  (#14# without NaCl <158>) <158>\\nTN\\t#14# 28700 {H2CO3}  (#14# 0.1 M NaCl <158>) <158>\\nTN\\t#14# 1400000 {CO2}  (#14# pH 7.5, 20C, wild-type <332>; #14# isoform \\n\\tcarbonic anhydrase II, at pH 7.4 and 25C <200>; #14# native isozyme \\n\\tcarbonic anhydrase II, in 10 mM HEPES, 0.1 M Na2SO4, pH 7.5 <211>; #14# \\n\\tpH 7.5, 20C, mutant N67I <332>) <200,211,332>\\nTN\\t#14# 1000000 {CO2}  (#14# pH 7.5, 20C, mutant Q92V <332>) <332>\\nTN\\t#14# 1500000 {CO2}  (#14# pH 7.5, 20C, mutant L204S <332>) <332>\\nTN\\t#14# 0.0000007 {CO2}  (#14# mutant V143I, pH 8.3, 25C <327>) <327>\\nTN\\t#14# 0.0000011 {CO2}  (#14# mutant V143L, pH 8.3, 25C <327>) <327>\\nTN\\t#14,20,125,179# 13000 {CO2}  (#125# at 20C and pH 7.5 <227>; #20# pH \\n\\t8.5, 25C, wild-type, imidazole buffer <114>; #14# isoform carbonic \\n\\tanhydrase III, at pH 7.4 and 25C <200>; #179# 20C, pH 8.3 <337>) \\n\\t<114,200,227,337>\\nTN\\t#14,36,125# 2000 {CO2}  (#36# pH 6-8 <5>; #14# pH 8.95, \\n\\t1,2-dimethylimidazole buffer, carbonic anhydrase I mutant V62N <44>; \\n\\t#125# 25C, mutant enzyme C183S/C188S <140>) <5,44,140>\\nTN\\t#14,62# 16700 {CO2}  (#14# pH 8.9, TAPS buffer, carbonic anhydrase II \\n\\t<44>; #62# pH 7.5, 25C, wild-type, D2O <86>) <44,86>\\nTN\\t#14,62# 800 {CO2}  (#14# pH 7.21, 1-methylimidazole buffer, wild-type \\n\\tcarbonic anhydrase I <44>; #62# pH 7.5, 25C, variant E84A, 50 mM \\n\\tMOPS-Ac buffer <86>) <44,86>\\nTN\\t#14,88,199# 130000 {CO2}  (#88# pH 7.5, 20C <334>; #199# measured with \\n\\thydration of CO2 activity assay, pH 7.5-8.3, 0C <382>) <8,334,382>\\nTN\\t#14,97,195,230# 380000 {CO2}  (#230# at pH 7.5 and 20C <440>; #14# \\n\\tEscherichia coli recombinant enzyme <251>; #195# pH 7.5, 22C, long \\n\\tenzyme form PfCAdom, CO2 hydration reaction <362>; #97# at pH 8.3, \\n\\ttemperature not specified in the publication <439>) <251,362,439,440>\\nTN\\t#147# 920000 {CO2}  (#147# in the presence of 0.01 mM L-Trp, at 25C \\n\\tand pH 7.5 <262>) <262>\\nTN\\t#147# 340000 {CO2}  (#147# in the absence of L-Trp and D-Trp, at 25C \\n\\tand pH 7.5 <262>) <262>\\nTN\\t#147,162# 640000 {CO2}  (#162# at 20C, pH 8.3 in 20 mM Tris-HCl buffer \\n\\tand 20 mM NaCl <257>; #162# in 10-20 mM Tris, pH 8.3, 10-20 mM NaCl \\n\\t<277>; #147# in the presence of 0.01 mM D-Trp, at 25C and pH 7.5 \\n\\t<262>) <257,262,277>\\nTN\\t#15# 58300 {CO2}  <7>\\nTN\\t#150# 310000 {CO2}  (#150# at 20C and pH 7.5 in 10 mM HEPES buffer \\n\\t<222>) <222>\\nTN\\t#162# 64000 {CO2}  (#162# isozyme bsCAI, pH 8.3, temperature not \\n\\tspecified in the publication <298>) <298>\\nTN\\t#164# 813600 {CO2}  (#164# recombinant enzyme, at 4C in a HEPES/NaOH, \\n\\tpH 7.5 <273>) <273>\\nTN\\t#164# 121500 {H2CO3}  (#164# recombinant enzyme, at 4C in a MES/KOH pH \\n\\t6.3 buffer <273>) <273>\\nTN\\t#176# 0.0052 {CO2}  (#176# pH 7.5, 25C, enzyme cultured with \\n\\tsupplemental iron <320>) <320>\\nTN\\t#176# 0.000493 {CO2}  (#176# pH 7.5, 25C, enzyme cultured with \\n\\tsupplemental zinc <320>) <320>\\nTN\\t#178# 12000 {CO2}  (#178# 20C, pH 8.3 <337>) <337>\\nTN\\t#18# 41 {COS}  (#18# pH 8-9, 25C <143>) <143>\\nTN\\t#18# 0.0005 {CS2}  <143>\\nTN\\t#180# 900000 {CO2}  (#180# pH 7.5, 20C <331>) <331>\\nTN\\t#181# 4400000 {H2CO3}  (#181# pH 7.5, 20C <376>) <376>\\nTN\\t#181# 15000000 {CO2}  (#181# pH 7.5, 25C, 10 microM L-Phe <328>) <328>\\nTN\\t#181# 33000000 {CO2}  (#181# pH 7.5, 25C, 10 microM D-Phe <328>) <328>\\nTN\\t#181,207# 4400000 {CO2}  (#181# pH 7.5, 25C, without activator <328>; \\n\\t#207# pH 7.5, 20C, recombinant His-tagged enzyme <360>) <328,360>\\nTN\\t#182# 860000 {CO2}  (#182# pH 8.3, 20C <342>) <342>\\nTN\\t#185# 935000 {H2CO3}  (#185# pH 7.5, 20C <376>) <376>\\nTN\\t#188# 17000 {H2CO3}  (#188# pH 8.5, 25C <376>) <376>\\nTN\\t#19# 4170 {CO2}  (#19# enzyme from red muscle sarcolemmal membranes \\n\\t<68>) <68>\\nTN\\t#19# 6170 {CO2}  (#19# enzyme from white muscle sarcoplasmic reticulum \\n\\t<68>) <68>\\nTN\\t#19# 3830 {CO2}  (#19# enzyme from red muscle sarcoplasmic reticulum \\n\\t<68>) <68>\\nTN\\t#19# 9000 {CO2}  (#19# enzyme from white muscle sarcolemmal membranes \\n\\t<68>) <68>\\nTN\\t#191# 320000 {CO2}  (#191# pH 7.8, 25C, recombinant enzyme <404>) <404>\\nTN\\t#191# 320000 {H2CO3}  (#191# pH 7.5, 20C <376>) <376>\\nTN\\t#192# 1600000 {H2CO3}  (#192# pH 7.5, 20C <376>) <376>\\nTN\\t#194# 420000 {CO2}  (#194# CO2 hydration, pH 8.3, 22C, recombinant \\n\\tenzyme <389>) <389>\\nTN\\t#195# 140000 {H2CO3}  (#195# truncated mutant PfCA1, pH 8.3, 22C \\n\\t<388>) <388>\\nTN\\t#195# 380000 {H2CO3}  (#195# enzyme PfCAdom, pH 8.3, 22C <388>) <388>\\nTN\\t#195,206# 140000 {CO2}  (#206# pH 8.3, 20C <358>; #195# pH 7.5, 22C, \\n\\ttruncated form PfCA1, CO2 hydration reaction <362>) <358,362>\\nTN\\t#196# 280000 {CO2}  (#196# pH 8.3, 22C, recombinant His-tagged enzyme \\n\\t<383>) <383>\\nTN\\t#198# 480000 {CO2}  (#198# pH 8.3, 20C, recombinant His-tagged enzyme \\n\\t<384>) <384>\\nTN\\t#20# 30 {CO2}  (#20# pH 8.5, 25C, mutant R36A, imidazole buffer <114>) \\n\\t<114>\\nTN\\t#20# 92 {CO2}  (#20# pH 8.5, 25C, mutant R36K <114>) <114>\\nTN\\t#20# 46 {CO2}  (#20# pH 8.5, 25C, mutant R36A <114>) <114>\\nTN\\t#20# 1100 {CO2}  (#20# pH 8.5, 25C, mutant D34A, MOPS buffer <114>) \\n\\t<114>\\nTN\\t#20# 24 {CO2}  (#20# pH 8.5, 25C, mutant R36A, MOPS buffer <114>) <114>\\nTN\\t#20# 1500 {CO2}  (#20# pH 8.5, 25C, mutant D34A/R36A, imidazole buffer \\n\\t<114>) <114>\\nTN\\t#20# 260 {CO2}  (#20# pH 8.5, 25C, mutant D34A/R36A, MOPS buffer \\n\\t<114>) <114>\\nTN\\t#20# 4200 {CO2}  (#20# pH 8.5, 25C, mutant D34A <114>) <114>\\nTN\\t#20# 3600 {CO2}  (#20# pH 8.5, 25C, mutant D34E <114>) <114>\\nTN\\t#20# 9100 {CO2}  (#20# pH 8.5, 25C, mutant D34A, imidazole buffer \\n\\t<114>) <114>\\nTN\\t#20# 24000 {CO2}  (#20# pH 8.5, 25C, wild-type <114>) <114>\\nTN\\t#20,112# 17000 {CO2}  (#20# pH 8.5, 25C <112>) <112,147>\\nTN\\t#20,162# 11000 {CO2}  (#20# pH 8.5, 25C, wild-type, MOPS buffer <114>; \\n\\t#162# isozyme bsCAII, pH 8.3, temperature not specified in the \\n\\tpublication <298>) <114,298>\\nTN\\t#20,99# 520 {CO2}  (#99# pH 7.5, 37C, variant R59C <94>; #20# pH 8.5, \\n\\t25C, mutant D34A/R36A <114>) <94,114>\\nTN\\t#200# 890000 {H2CO3}  (#200# carbonate dehydratase activity, \\n\\trecombinant enzyme, pH and temperature not specified in the publication \\n\\t<399>) <399>\\nTN\\t#203# 3340 {CO2}  (#203# recombinant full-length CcaA274 enzyme, pH \\n\\t7.5, 25C, CO2 hydration reaction <355>) <355>\\nTN\\t#203# 13700 {CO2}  (#203# recombinant full-length CcaA274 enzyme, pH \\n\\t9.5, 25C, CO2 hydration reaction <355>) <355>\\nTN\\t#203# 31000 {CO2}  (#203# recombinant truncated CcaA220 enzyme, pH 9.5, \\n\\t25C, CO2 hydration reaction <355>) <355>\\nTN\\t#219# 688 {H2CO3}  (#219# pH 9.0, 40C <368>) <368>\\nTN\\t#221# 13000 {H2CO3}  (#221# pH not specified in the publication, 4C, \\n\\tassay using the delta pH method <366>) <366>\\nTN\\t#228# 570000 {CO2}  (#228# at pH 8.3 and 25C <436>) <436>\\nTN\\t#229# 490000 {CO2}  (#229# at pH 7.5 and 25C <434>) <434>\\nTN\\t#23# 6.08 {CO2}  (#23# pH 8.8, 25C, mutant H208A <75>; #23# pH 8.8, \\n\\t25C, wild-type <75>) <75>\\nTN\\t#23# 0.05 {CO2}  (#23# pH 6.2, 25C, mutant H208A <75>) <75>\\nTN\\t#23# 0.74 {CO2}  (#23# pH 8.8, 25C, wild-type <75>) <75>\\nTN\\t#23# 0.28 {CO2}  (#23# pH 7.3, 25C, mutant H208A <75>) <75>\\nTN\\t#23# 0.31 {CO2}  (#23# pH 7.3, 25C, wild-type <75>) <75>\\nTN\\t#23# 0.135 {CO2}  (#23# pH 6.2, 25C, wild-type <75>) <75>\\nTN\\t#23# 1.36 {CO2}  (#23# pH 8.8, 25C, mutant H208A <75>) <75>\\nTN\\t#26# 0.32 {CO2}  <76>\\nTN\\t#28# 670000 {CO2}  (#28# at pH 8.3 and 25C <443>) <443>\\nTN\\t#31# 685000 {CO2}  (#31# purified recombinant CAH-4a, pH 7.5, 4C \\n\\t<310>) <310>\\nTN\\t#32# 430000 {CO2}  (#32# at 20C, pH 8.3, in 20 mM Tris-HCl and 20 mM \\n\\tNaCl <276>) <276>\\nTN\\t#32,53# 390000 {CO2}  (#53# at 20C, pH 8.3 in 20 mM Tris buffer and 20 \\n\\tmM NaClO4 <204>; #32# at 20C and pH 8.3, in 20 mM Tris-HCl buffer and \\n\\t20 mM NaCl <275>; #53# Can2, at 25C, pH 8.3 in 20 mM Tris buffer and \\n\\t20 mM NaClO4 <260>) <204,260,275>\\nTN\\t#35# 1210000 {CO2}  (#35# pH 7.5, 20C <342>) <342>\\nTN\\t#36# 10000 {CO2}  (#36# above pH 8 <5>) <5>\\nTN\\t#40# 800000 {CO2}  (#40# at 20C, pH 8.3 in 20 mM Tris buffer and 20 mM \\n\\tNaClO4 <204>; #40# CaNce103, at 25C, pH 8.3 in 20 mM Tris buffer and \\n\\t20 mM NaClO4 <260>) <204,260>\\nTN\\t#40# 2010000 {CO2}  (#40# CaNce103, at 25C, pH 8.3 in 20 mM Tris \\n\\tbuffer and 20 mM NaClO4, in the presence of 0.01 mM histamine <260>) \\n\\t<260>\\nTN\\t#41# 240000 {CO2}  (#41# pH 8.9, 25C <98>) <98>\\nTN\\t#49# 46000 {HCO3-}  (#49# pH 7.0, rCsoSCA <178>) <178>\\nTN\\t#49,111# 89000 {CO2}  (#49# rCsoSCA <178>) <150,178>\\nTN\\t#51,238# 110000 {CO2}  (#238# at pH 8.3 and 20C <438>) <190,438>\\nTN\\t#52# 15000 {CO2}  (#52# pH not specified in the publication, 25C \\n\\t<338>) <338>\\nTN\\t#53# 680000 {CO2}  (#53# Can2, at 25C, pH 8.3 in 20 mM Tris buffer and \\n\\t20 mM NaClO4, in the presence of 0.01 mM histamine <260>) <260>\\nTN\\t#57# 26000 {CO2}  <147>\\nTN\\t#59# 1300000 {CO2}  (#59# pH 7.5, 20C <339>) <339>\\nTN\\t#6,220# 950000 {CO2}  (#220# pH 7.5, 20C <361>; #6# pH 8.3, 20C \\n\\t<303>) <303,361>\\nTN\\t#61,99# 20000 {CO2}  (#99# pH 7.5, 37C, variant R59E, without \\n\\tguanidine hydrochloride <94>; #61# pH 8, 25C <346>) <94,346>\\nTN\\t#62# 1300 {CO2}  (#62# pH 7.5, 25C, variant E84Q, 50 mM MOPS buffer \\n\\t<86>) <86>\\nTN\\t#62# 1080 {CO2}  (#62# pH 7.5, 25C, variant E84S, 50 mM MOPS buffer \\n\\t<86>) <86>\\nTN\\t#62# 720 {CO2}  (#62# pH 7.5, 25C, variant E84C and E62A, 50 mM MOPS \\n\\tbuffer <86>) <86>\\nTN\\t#62# 47 {CO2}  (#62# pH 7.5, 25C, variant E62Y, 50 mM MOPS buffer \\n\\t<86>) <86>\\nTN\\t#62# 210 {CO2}  (#62# pH 7.5, 25C, variant E62A/E84A, 50 mM MOPS \\n\\tbuffer <86>) <86>\\nTN\\t#62# 1070 {CO2}  (#62# pH 7.5, 25C, variant E62A, 50 mM IMID buffer \\n\\t<86>) <86>\\nTN\\t#62# 860 {CO2}  (#62# pH 7.5, 25C, variant E62T, 50 mM MOPS buffer \\n\\t<86>) <86>\\nTN\\t#62# 410 {CO2}  (#62# pH 7.5, 25C, variant E62Q, 50 mM MOPS buffer \\n\\t<86>) <86>\\nTN\\t#62# 910 {CO2}  (#62# pH 7.5, 25C, variant E62C, 50 mM MOPS buffer \\n\\t<86>) <86>\\nTN\\t#62# 510 {CO2}  (#62# pH 7.5, 25C, variant E84Y, 50 mM MOPS buffer \\n\\t<86>) <86>\\nTN\\t#62# 340 {CO2}  (#62# pH 7.5, 25C, variant E62A, 50 mM MOPS-Ac buffer \\n\\t<86>) <86>\\nTN\\t#62# 1050 {CO2}  (#62# pH 7.5, 25C, variant E62H, 50 mM MOPS buffer \\n\\t<86>) <86>\\nTN\\t#62# 29100 {CO2}  (#62# pH 7.5, 25C, variant E89A, 50 mM MOPS buffer \\n\\t<86>) <86>\\nTN\\t#62# 1900 {CO2}  (#62# pH 7.5, 25C, variant E84K, 50 mM MOPS buffer \\n\\t<86>) <86>\\nTN\\t#62# 0.00061 {CO2}  (#62# pH 5.5-7.5, 25C, Zn-Cam <81>) <81>\\nTN\\t#62# 870 {CO2}  (#62# pH 7.5, 25C, variant E84A, 50 mM MOPS buffer \\n\\t<86>) <86>\\nTN\\t#62# 4700 {CO2}  (#62# pH 7.5, 25C, variant E62D/E84D, 50 mM MOPS \\n\\tbuffer <86>) <86>\\nTN\\t#62# 7100 {CO2}  (#62# pH 5.7-9.5, 25C, wild-type <86>) <86>\\nTN\\t#62# 9300 {CO2}  (#62# pH 6.5, 25C, wild-type, D2O <86>) <86>\\nTN\\t#62# 9500 {CO2}  (#62# pH 7.5, 25C, variant E84H, 50 mM MOPS buffer \\n\\t<86>) <86>\\nTN\\t#62# 16800 {CO2}  (#62# pH 7.5, 25C, variant E62D, 50 mM MOPS buffer \\n\\t<86>) <86>\\nTN\\t#62# 18600 {CO2}  (#62# pH 6.5, 25C, wild-type <86>) <86>\\nTN\\t#62# 21000 {CO2}  (#62# pH 7.5, 25C, variant E84D, 50 mM MOPS buffer \\n\\t<86>) <86>\\nTN\\t#62# 22600 {CO2}  (#62# pH 8.5, 25C, wild-type, D2O <86>) <86>\\nTN\\t#62# 24700 {CO2}  (#62# pH 7.5, 25C, wild-type, 50 mM MOPS-Ac buffer \\n\\t<86>) <86>\\nTN\\t#62# 26500 {CO2}  (#62# pH 7.5, 25C, variant E88A, 50 mM MOPS buffer \\n\\t<86>) <86>\\nTN\\t#62# 35100 {CO2}  (#62# pH 7.5, 25C, variant E84A, 50 mM IMID buffer \\n\\t<86>) <86>\\nTN\\t#62# 56800 {CO2}  (#62# pH 7.5, 25C, wild-type, 50 mM MOPS buffer \\n\\t<86>) <86>\\nTN\\t#62# 58900 {CO2}  (#62# pH 8.5, 25C, wild-type <86>) <86>\\nTN\\t#62# 71900 {CO2}  (#62# pH 7.5, 25C, wild-type, 50 mM IMID buffer \\n\\t<86>) <86>\\nTN\\t#62# 0.00104 {CO2}  (#62# pH 5.5-7.5, 25C, Co-Cam <81>) <81>\\nTN\\t#62# 68000 {H2CO3}  (#62# pH 7.5, 25C, recombinant enzyme expressed \\n\\tfrom Escherichia coli and aerobically purified <376>) <376>\\nTN\\t#62# 231000 {H2CO3}  (#62# pH 7.5, 25C, recombinant enzyme expressed \\n\\tfrom Methanosarcina acetivorans and anaerobically purified <376>) <376>\\nTN\\t#62# 243000 {H2CO3}  (#62# pH 7.5, 25C, recombinant enzyme expressed \\n\\tfrom Escherichia coli and anaerobically purified <376>) <376>\\nTN\\t#63,194# 410000 {CO2}  (#63# pH 8.3, 20C <330>; #194# CO2 hydration, \\n\\tpH 8.3, 22C, native enzyme <389>) <330,389>\\nTN\\t#65# 823000 {CO2}  (#65# pH 7.5, 20C <341>) <341>\\nTN\\t#68# 2670 {CO2}  (#68# pH 6.6, MES buffer <63>) <63>\\nTN\\t#68# 3000 {CO2}  (#68# pH 8.8, TAPS buffer <63>) <63>\\nTN\\t#74,122# 1200000 {CO2}  (#74# pH 7.5, 20C <148>; #122# pH 7.4, 30C, \\n\\tCO2 hydration activity <308>) <148,308>\\nTN\\t#81# 38300 {H2CO3}  (#81# without NaCl <158>) <158>\\nTN\\t#81# 44600 {H2CO3}  (#81# 0.1 M NaCl <158>) <158>\\nTN\\t#81# 41200 {H2CO3}  (#81# 0.25 M NaCl <158>) <158>\\nTN\\t#81# 39100 {H2CO3}  (#81# 0.5 M NaCl <158>) <158>\\nTN\\t#85# 986000 {CO2}  (#85# at pH 7.5 and 37C <408>) <408>\\nTN\\t#86# 380000 {histamine}  (#86# at 25C, pH 8.3 in 20 mM Tris buffer and \\n\\t20 mM NaClO4 <256>) <256>\\nTN\\t#86# 1070000 {histamine}  (#86# at 25C, pH 8.3 in 20 mM Tris buffer \\n\\tand 20 mM NaClO4, in the presence of 0.01 mM histamine <256>) <256>\\nTN\\t#87# 120000 {CO2}  (#87# pH 7.5, 20C <329>) <329>\\nTN\\t#88# 150 {CO2}  (#88# pH 7.9, temperature not specified in the \\n\\tpublication, the activities depended on culture conditions, ranging \\n\\tbetween 20/sec and 150/sec <347>) <347>\\nTN\\t#90# 200 {CO2}  (#90# pH 7.9, temperature not specified in the \\n\\tpublication, the activities depended on culture conditions, ranging \\n\\tbetween 80/sec and 200/sec <347>) <347>\\nTN\\t#92# 25000 {CO2}  (#92# pH 8.5, 0C <128>) <128>\\nTN\\t#94# 80.56 {4-nitrophenyl acetate}  (#94# at pH 7.5 and 35C <425>) \\n\\t<425>\\nTN\\t#99# 2-8 {CO2}  (#99# pH 7.5, 37C, variant R59A, 100 mM urea <94>) <94>\\nTN\\t#99# 110 {CO2}  (#99# pH 7.5, 37C, variant R59A, 100 mM imidazole \\n\\t<94>) <94>\\nTN\\t#99# 42 {CO2}  (#99# pH 7.5, 37C, variant R59H, without guanidine \\n\\thydrochloride <94>) <94>\\nTN\\t#99# 67 {CO2}  (#99# pH 7.5, 37C, variant R59E, without guanidine \\n\\thydrochloride <94>) <94>\\nTN\\t#99# 70 {CO2}  (#99# pH 7.5, 37C, variant R59A <94>) <94>\\nTN\\t#99# 10 {CO2}  (#99# pH 7.5, 37C, variant R59Q, without guanidine \\n\\thydrochloride <94>) <94>\\nTN\\t#99# 160 {CO2}  (#99# pH 7.5, 37C, variant R59A, 100 mM ethylamine \\n\\t<94>) <94>\\nTN\\t#99# 12 {CO2}  (#99# pH 7.5, 37C, variant R59A, 100 mM \\n\\t1.3-diaminoguanidine, variant R59H plus 100 mM guanidine hydrochloride \\n\\t<94>) <94>\\nTN\\t#99# 13 {CO2}  (#99# pH 7.5, 37C, variant R59M, without guanidine \\n\\thydrochloride <94>) <94>\\nTN\\t#99# 350 {CO2}  (#99# pH 7.5, 37C, variant R59A, 100 mM aminoguanidine \\n\\t<94>) <94>\\nTN\\t#99# 310 {CO2}  (#99# pH 7.5, 37C, variant R59C, 100 mM ethylguanidine \\n\\t<94>) <94>\\nTN\\t#99# 990 {CO2}  (#99# pH 7.5, 37C, variant R59C, 100 mM \\n\\tmethylguanidine <94>) <94>\\nTN\\t#99# 320 {CO2}  (#99# pH 7.5, 37C, variant R59C, 100 mM aminoguanidine \\n\\t<94>) <94>\\nTN\\t#99# 159 {CO2}  (#99# pH 7.5, 37C, variant R59M, 100 mM guanidine \\n\\thydrochloride <94>) <94>\\nTN\\t#99# 2250 {CO2}  (#99# pH 7.5, 37C, variant R59A, 150 mM guanidine \\n\\t<94>) <94>\\nTN\\t#99# 6500 {CO2}  (#99# 25C, pH 7.5, mutant enzyme W19F <315>) <315>\\nTN\\t#99# 2700 {CO2}  (#99# pH 7.5, 37C, variant R59A, 50 mM guanidine \\n\\t<94>) <94>\\nTN\\t#99# 627 {CO2}  (#99# pH 7.5, 37C, variant R59Q, 100 mM guanidine \\n\\thydrochloride <94>) <94>\\nTN\\t#99# 2170 {CO2}  (#99# pH 7.5, 37C, variant R59C, 100 mM guanidine \\n\\t<94>) <94>\\nTN\\t#99# 2740 {CO2}  (#99# pH 7.5, 37C, variant R59K, 100 mM guanidine \\n\\thydrochloride <94>) <94>\\nTN\\t#99# 3270 {CO2}  (#99# pH 7.5, 37C, variant R59A, 100 mM guanidine \\n\\t<94>) <94>\\nTN\\t#99# 4720 {CO2}  (#99# pH 7.5, 37C, variant R59K, without guanidine \\n\\thydrochloride <94>) <94>\\nTN\\t#99# 5690 {CO2}  (#99# pH 7.5, 37C, variant R59A, 100 mM \\n\\tmethylguanidine <94>) <94>\\nTN\\t#99# 7140 {CO2}  (#99# pH 7.5, 37C, variant R59A, 100 mM \\n\\tethylguanidine <94>) <94>\\nTN\\t#99# 22900 {CO2}  (#99# pH 7.5, 37C, wild-type, 100 mM guanidine \\n\\thydrochloride <94>) <94>\\nTN\\t#99# 62900 {CO2}  (#99# pH 7.5, 37C, wild-type, without guanidine \\n\\thydrochloride <94>) <94>\\nTN\\t#99# 32400 {CO2}  (#99# 25C, pH 7.5, wild-type enzyme <315>) <315>\\nTN\\t#99# 5800 {CO2}  (#99# 25C, pH 7.5, mutant enzyme W19N <315>) <315>\\nTN\\t#99# 2701 {CO2}  (#99# pH 7.5, 37C, variant R59A, 50 mM guanidine \\n\\t<94>) <94>\\nTN\\t#99# 7900 {CO2}  (#99# 25C, pH 7.5, mutant enzyme W19A <315>) <315>\\nTN\\t#99# 95000 {CO2}  (#99# 25C, pH 7.5, mutant enzyme Y200A <315>) <315>\\nTN\\t#99# 79300 {CO2}  (#99# 25C, pH 7.5, mutant enzyme Y200S <315>) <315>\\nTN\\t#99# 120100 {CO2}  (#99# 25C, pH 7.5, mutant enzyme Y200F <315>) <315>\\n\\nKM_VALUE\\nKM\\t#100# 45 {H2CO3}  (#100# pH 6.8, 0.5 M NaCl <161>) <161>\\nKM\\t#100# 37.1 {H2CO3}  (#100# pH 6.8, 0.1 M NaCl <161>) <161>\\nKM\\t#100# 37.3 {H2CO3}  (#100# pH 6.8, in absence of NaCl <161>) <161>\\nKM\\t#102# 10.41 {CO2}  (#102# pH 8.5, 0C <128>) <128>\\nKM\\t#104# 11.04 {CO2}  (#104# pH 8.5, 0C <128>) <128>\\nKM\\t#109# 16 {CO2}  <147>\\nKM\\t#11# 9.09 {4-nitrophenyl acetate}  (#11# in 0.1 M Tris-HCl buffer, pH \\n\\t8.3, and 37C <264>) <264>\\nKM\\t#111# 8.72 {CO2}  <150>\\nKM\\t#112# 12.1 {CO2}  <147>\\nKM\\t#112# 23.26 {CO2}  <150>\\nKM\\t#12# 5.6 {CO2}  (#12# pH 9.0, 25C, mutant R94H/E92Q/I143V/I200T <106>) \\n\\t<106>\\nKM\\t#12# 5.9 {CO2}  (#12# pH 9.0, 25C, mutant R94H/E92Q/I143V <106>) <106>\\nKM\\t#12,14# 15 {CO2}  (#14# pH 7.23, 1-methylimidazole buffer, carbonic \\n\\tanhydrase I mutant H67N <44>; #12# pH 9.0, 25C, mutant R94H/E92Q/I200T \\n\\t<106>) <44,106>\\nKM\\t#12,14# 13 {CO2}  (#12# pH 9.0, 25C, mutant R94H/E92Q/I121V <106>; \\n\\t#14# isoform CA II, at 25C in 0.01 M HEPES buffer pH 7.4, in the \\n\\tabsence of timolol <252>) <106,252>\\nKM\\t#12,14# 19 {CO2}  (#12# pH 9.0, 25C, mutant R94H <106>; #14# isoform \\n\\tCA I, at 25C in 0.01 M HEPES buffer pH 7.4, in the absence of timolol \\n\\t<252>) <106,252>\\nKM\\t#12,172# 14.2 {CO2}  (#172# at 20C and pH 7.5 <230>; #12# at pH 7.5 \\n\\tand 20C <201>) <201,230>\\nKM\\t#12,19# 1.6 {CO2}  (#19# enzyme from white muscle sarcoplasmic \\n\\treticulum <68>; #12# pH 9.0, 25C, mutant R94H/E92Q/I121V/I143V/I200T \\n\\t<106>) <68,106>\\nKM\\t#12,62,99# 19.3 {CO2}  (#62# pH 7.5, 25C, variant E89A, 50 mM MOPS \\n\\tbuffer <86>; #99# pH 7.5, 37C, variant R59E, 100 mM guanidine \\n\\thydrochloride <94>; #12# isoform carbonic anhydrase XIII, at pH 7.4 and \\n\\t25C <200>) <86,94,200>\\nKM\\t#120# 7.3 {CO2}  (#120# recombinant CA IX catalytic domain expressed in \\n\\tSf9 cells, in the presence of 0.05 mM Co2+ <223>; #120# recombinant CA \\n\\tIX catalytic domain expressed in Sf9 cells, in the presence of 0.05 mM \\n\\tMg2+ <223>; #120# recombinant CA IX catalytic domain expressed in Sf9 \\n\\tcells, in the presence of 0.05 mM Mn2+ <223>; #120# recombinant CA IX \\n\\tcatalytic domain expressed in Sf9 cells, in the presence of Zn2+ <223>) \\n\\t<223>\\nKM\\t#122# 10.9 {CO2}  (#122# pH 7.4, 30C, CO2 hydration activity <308>) \\n\\t<308>\\nKM\\t#123# 0.0158 {CO2}  (#123# pH 7.5, 20C <343>) <343>\\nKM\\t#126# 6.8 {p-nitrophenyl acetate}  (#126# cytosolic isoenzyme <176>) \\n\\t<176>\\nKM\\t#126# 3.86 {p-nitrophenyl acetate}  (#126# integral isoenzyme <176>) \\n\\t<176>\\nKM\\t#126# 4.83 {p-nitrophenyl acetate}  (#126# outer peripheral isoenzyme \\n\\t<176>) <176>\\nKM\\t#126# 4.525 {p-nitrophenyl acetate}  (#126# inner peripheral isoenzyme \\n\\t<176>) <176>\\nKM\\t#136# 15.2 {CO2}  <193>\\nKM\\t#14# 0.31 {CO2}  (#14# pH 8.95, 1,2-dimethylimidazole buffer, carbonic \\n\\tanhydrase I mutant H200T <44>) <44>\\nKM\\t#14# 0.012 {CO2}  (#14# isoform CA II, in the presence of 4.5 mM \\n\\ttimolol, at 25C in 0.01 M HEPES buffer (pH 7.4) <252>) <252>\\nKM\\t#14# 0.013 {CO2}  (#14# isoform CA II, in the presence of 2.0 mM \\n\\ttimolol, at 25C in 0.01 M HEPES buffer (pH 7.4) <252>) <252>\\nKM\\t#14# 0.02 {CO2}  (#14# isoform CA I, in the presence of 1.5 or 3.0 mM \\n\\ttimolol, at 25C in 0.01 M HEPES buffer (pH 7.4) <252>) <252>\\nKM\\t#14# 1 {CO2}  <8>\\nKM\\t#14# 5.3 {CO2}  (#14# pH 8.77, 1,2-dimethylimidazole buffer, wild-type \\n\\tcarbonic anhydrase I <44>) <44>\\nKM\\t#14# 7.1 {CO2}  (#14# pH 8.95, 1,2-dimethylimidazole buffer, carbonic \\n\\tanhydrase I mutant V62N <44>) <44>\\nKM\\t#14# 2.3 {CO2}  (#14# pH 8.98, TAPS buffer, carbonic anhydrase I mutant \\n\\tV62N,H67N, H200T <44>) <44>\\nKM\\t#14# 2.8 {CO2}  (#14# pH 8.94, 1,2-dimethylimidazole buffer, carbonic \\n\\tanhydrase II mutant N62V <44>) <44>\\nKM\\t#14# 14 {CO2}  (#14# pH 8.75, 1,2-dimethylimidazole buffer, carbonic \\n\\tanhydrase I mutant V62N,H67N,H200T <44>; #14# pH 8.94, \\n\\t1,2-dimethylimidazole buffer, carbonic anhydrase II mutant N67HV <44>; \\n\\t#14# 25C, pH 7.05, high activity carbonic anhydrase <19>) <19,44>\\nKM\\t#14# 26 {HCO3-}  (#14# carbonic anhydrase IV <70>) <70>\\nKM\\t#14# 3.9 {CO2}  (#14# pH 8.94, 1,2-dimethylimidazole buffer, carbonic \\n\\tanhydrase II mutant T200H <44>) <44>\\nKM\\t#14# 2.6 {CO2}  (#14# erythrocytes, carbonic anhydrase B <28>) <28>\\nKM\\t#14# 69 {CO2}  (#14# pH 6.28, MES buffer, carbonic anhydrase I mutant \\n\\tV62N <44>) <44>\\nKM\\t#14# 11.9 {CO2}  (#14# erythrocytes, carbonic anhydrase C <28>) <28>\\nKM\\t#14# 37 {HCO3-}  (#14# carbonic anhydrase II <70>) <70>\\nKM\\t#14# 6.6 {CO2}  (#14# pH 8.75, 1,2-dimethylimidazole buffer, carbonic \\n\\tanhydrase I mutant H67N <44>) <44>\\nKM\\t#14# 9.3 {CO2}  (#14# pH 7.5, 20C, wild-type <332>; #14# isoform \\n\\tcarbonic anhydrase II, at pH 7.4 and 25C <200>; #14# native isozyme \\n\\tcarbonic anhydrase II, in 10 mM HEPES, 0.1 M Na2SO4, pH 7.5 <211>; #14# \\n\\tpH 7.5, 20C, mutant L204S <332>) <200,211,332>\\nKM\\t#14# 46 {CO2}  (#14# pH 6.28, MES buffer, carbonic anhydrase I mutant \\n\\tH67N <44>) <44>\\nKM\\t#14# 52 {CO2}  (#14# isoform carbonic anhydrase III, at pH 7.4 and 25C \\n\\t<200>) <200>\\nKM\\t#14# 19.7 {H2CO3}  (#14# without NaCl <158>) <158>\\nKM\\t#14# 9.7 {CO2}  (#14# pH 8.9, TAPS buffer, carbonic anhydrase II <44>) \\n\\t<44>\\nKM\\t#14# 13.4 {CO2}  (#14# kidney enzyme <28>) <28>\\nKM\\t#14# 48.4 {H2CO3}  (#14# erythrocytes, carbonic anhydrase B <28>) <28>\\nKM\\t#14# 54.6 {H2CO3}  (#14# kidney enzyme <28>) <28>\\nKM\\t#14# 73.8 {H2CO3}  (#14# erythrocyte, carbonic anhydrase C <28>) <28>\\nKM\\t#14# 2.94 {4-nitrophenyl acetate}  (#14# pH 7.8, 25C, hCA II, 25 mM \\n\\thydroxyurea <101>) <101>\\nKM\\t#14# 15.4 {4-nitrophenyl acetate}  (#14# pH 7.8, 25C, hCA I <101>) \\n\\t<101>\\nKM\\t#14# 13.8 {CO2}  (#14# isoform carbonic anhydrase XIII, at pH 7.4 and \\n\\t25C <200>) <200,247>\\nKM\\t#14# 2.92 {4-nitrophenyl acetate}  (#14# pH 7.8, 25C, hCA II <101>) \\n\\t<101>\\nKM\\t#14# 15.3 {4-nitrophenyl acetate}  (#14# pH 7.8, 25C, hCA I, 25 mM \\n\\thydroxyurea <101>) <101>\\nKM\\t#14# 80.1 {H2CO3}  (#14# 0.1 M NaCl <158>) <158>\\nKM\\t#14# 3.025 {4-nitrophenyl acetate}  (#14# isoform carbonic anhydrase I, \\n\\tat pH 7.4 and 25C <200>) <200>\\nKM\\t#14# 30.53 {4-nitrophenyl acetate}  (#14# isoform carbonic anhydrase \\n\\tII, at pH 7.4 and 25C <200>) <200>\\nKM\\t#14# 0.935 {4-nitrophenyl phosphate}  (#14# isoform carbonic anhydrase \\n\\tI, at pH 7.4 and 25C <200>) <200>\\nKM\\t#14# 2.195 {4-nitrophenyl phosphate}  (#14# isoform carbonic anhydrase \\n\\tII, at pH 7.4 and 25C <200>) <200>\\nKM\\t#14,120# 6.9 {CO2}  (#120# recombinant CA IX catalytic domain expressed \\n\\tin Escherichia coli <223>; #14# Escherichia coli recombinant enzyme \\n\\t<251>) <223,251>\\nKM\\t#14,15,18,53,68# 9 {CO2}  (#15# 25C, pH 7.0, low activity carbonic \\n\\tanhydrase <19>; #18# 0.5C, pH 7.1, high activity carbonic anhydrase \\n\\t<19>; #68# pH 6.6, MES buffer <63>; #14# 25C, pH 7.0, high activity \\n\\tcarbonic anhydrase <19>; #53# Can2, at 25C, pH 8.3 in 20 mM Tris \\n\\tbuffer and 20 mM NaClO4 <260>; #14# pH 7.5, 20C, mutant N67I <332>) \\n\\t<3,19,63,260,332>\\nKM\\t#14,180# 4 {CO2}  (#14# pH 8.88, TAPS buffer, carbonic anhydrase I \\n\\tmutant V62N,H67N <44>; #14# 25C, pH 7.0, low activity carbonic \\n\\tanhydrase <19>; #180# pH 7.5, 20C <331>; #14# isoform carbonic \\n\\tanhydrase I, at pH 7.4 and 25C <200>) <19,44,200,331>\\nKM\\t#14,19# 2.4 {CO2}  (#14# pH 7.21, 1-methylimidazole buffer, carbonic \\n\\tanhydrase I mutant H200T <44>; #14# pH 8.98, TAPS buffer, carbonic \\n\\tanhydrase I mutant H67B <44>) <44,68>\\nKM\\t#14,19,20# 3.6 {CO2}  (#19# enzyme from red muscle sarcolemmal \\n\\tmembranes <68>; #14# pH 6.28, MES buffer, carbonic anhydrase I mutant \\n\\tV62N,H67N,H200T <44>; #14# pH 7.21, 1-methylimidazole buffer, wild-type \\n\\tcarbonic anhydrase I <44>; #20# pH 8.5, 25C, mutant D34A <114>) \\n\\t<44,68,114>\\nKM\\t#14,20# 3.5 {CO2}  (#14# pH 8.98, TAPS buffer, carbonic anhydrase I \\n\\tmutant V62N <44>; #20# pH 8.5, 25C, mutant D34A, MOPS buffer <114>) \\n\\t<44,114>\\nKM\\t#14,20# 9.2 {CO2}  (#20# pH 8.5, 25C, mutant D34A/R36A, MOPS buffer \\n\\t<114>; #14# pH 7.5, 20C, mutant Q92V <332>) <114,332>\\nKM\\t#14,24,62# 9.4 {CO2}  (#24# chloroplastic isoenzyme <56>; #14# pH 8.72, \\n\\t1,2-dimethyimidazole buffer, carbonic anhydrase I mutant V62N,H67N \\n\\t<44>; #62# pH 7.5, 25C, variant E62A, 50 mM IMID buffer <86>) \\n\\t<44,56,86>\\nKM\\t#14,27# 8 {CO2}  (#14# 0C, pH 7.0, high activity carbonic anhydrase \\n\\t<19>; #27# 25C, pH 7.07, high activity carbonic anhydrase <19>; #14# \\n\\tcarbonic anhydrase II <70>) <19,70>\\nKM\\t#14,28,120# 7.5 {CO2}  (#14# pH 7.23, 1-methylimidazolebuffer, carbonic \\n\\tanhydrase I mutant V62N,H67N,H200T <44>; #28# at pH 8.3 and 25C <443>; \\n\\t#120# recombinant CA IX catalytic domain expressed in Sf9 cells, in the \\n\\tpresence of 0.05 mM Zn2+ <223>; #120# recombinant extracellular domain \\n\\tof CA IX expressed in Sf9 cells, in the absence of Zn2+ <223>) \\n\\t<44,223,443>\\nKM\\t#14,62# 8.8 {CO2}  (#14# pH 8.7, 1,2-dimethylimidazole buffer, carbonic \\n\\tanhydrase II <44>; #62# pH 7.5, 25C, variant E84A, 50 mM IMID buffer \\n\\t<86>) <44,86>\\nKM\\t#14,62,68,176# 3 {CO2}  (#68# pH 8.8, TAPS buffer <63>; #14# 25C, pH \\n\\t7.05, low activity carbonic anhydrase <19>; #62# pH 7.5, 25C, variant \\n\\tE62Y, 50 mM MOPS buffer <86>; #176# pH 7.5, 25C, enzyme cultured with \\n\\tsupplemental iron <320>) <19,63,86,320>\\nKM\\t#15# 11 {CO2}  (#15# 0C, pH 7.0, high activity carbonic anhydrase \\n\\t<19>) <19>\\nKM\\t#15,20# 4.2 {CO2}  (#20# pH 8.5, 25C, wild-type, imidazole buffer \\n\\t<114>) <7,114>\\nKM\\t#16# 83 {CO2}  <4>\\nKM\\t#164# 31.73 {CO2}  (#164# recombinant enzyme, at 4C in a HEPES/NaOH, \\n\\tpH 7.5 <273>) <273>\\nKM\\t#164# 112.7 {H2CO3}  (#164# recombinant enzyme, at 4C in a MES/KOH pH \\n\\t6.3 buffer <273>) <273>\\nKM\\t#177# 26 {CO2}  (#177# Vmax: 7100 WAU/mg protein, pH 7.6, 0C <340>) \\n\\t<340>\\nKM\\t#18# 0.625 {4-nitrophenyl acetate}  (#18# pH 7.4, 20C, outer \\n\\tperipheral isoenzyme <149>) <149>\\nKM\\t#18# 12 {CO2}  (#18# 25C, pH 7.0, high activity carbonic anhydrase \\n\\t<19>) <19>\\nKM\\t#18# 1.1 {4-nitrophenyl acetate}  (#18# pH 9, 25C, Vmax: 2.84 \\n\\tmicromol/min/mg <324>) <324>\\nKM\\t#18# 1.86 {COS}  (#18# pH 8-9, 25C <143>) <143>\\nKM\\t#18# 21 {CO2}  (#18# 25C, pH 7.2, low activity carbonic anhydrase \\n\\t<19>) <19>\\nKM\\t#18# 0.785 {4-nitrophenyl acetate}  (#18# pH 7.4, 20C, inner \\n\\tperipheral isoenzyme <149>) <149>\\nKM\\t#18# 0.541 {4-nitrophenyl acetate}  (#18# pH 7.4, 20C, cytosolic \\n\\tisoenzyme <149>) <149>\\nKM\\t#18# 0.862 {4-nitrophenyl acetate}  (#18# pH 7.4, 20C, integral \\n\\tisoenzyme <149>) <149>\\nKM\\t#18# 0.002409 {4-nitrophenyl acetate}  (#18# at pH 7.0 and 20C <248>) \\n\\t<248>\\nKM\\t#19# 6 {CO2}  (#19# 0C, pH 7.0, high activity carbonic anhydrase <19>) \\n\\t<19>\\nKM\\t#19# 27 {CO2}  (#19# 0C, pH 7.0, low activity carbonic anhydrase <19>) \\n\\t<19>\\nKM\\t#191# 10.8 {CO2}  (#191# pH 7.8, 25C, recombinant enzyme <404>) <404>\\nKM\\t#20# 1.8 {CO2}  (#20# pH 8.5, 25C, mutant D34E <114>) <114>\\nKM\\t#20# 5.8 {CO2}  (#20# pH 8.5, 25C, mutant D34A/R36A, imidazole buffer \\n\\t<114>) <114>\\nKM\\t#20# 2.7 {CO2}  (#20# pH 8.5, 25C, wild-type, MOPS buffer <114>) <114>\\nKM\\t#20# 7.2 {CO2}  (#20# pH 8.5, 25C, mutant R36K <114>) <114>\\nKM\\t#20# 47.1 {CO2}  (#20# pH 8.5, 25C, mutant R36A, imidazole buffer \\n\\t<114>) <114>\\nKM\\t#20# 15.3 {CO2}  (#20# pH 8.5, 25C, mutant D34A, imidazole buffer \\n\\t<114>) <114>\\nKM\\t#20# 35.3 {CO2}  (#20# pH 8.5, 25C, mutant R36A, MOPS buffer <114>) \\n\\t<114>\\nKM\\t#20# 36.2 {CO2}  (#20# pH 8.5, 25C, mutant R36A <114>) <114>\\nKM\\t#20,62# 2.9 {CO2}  (#20# pH 8.5, 25C <112>; #62# pH 7.5, 25C, variant \\n\\tE62A/E84A, 50 mM MOPS buffer <86>; #20# pH 8.5, 25C, wild-type <114>) \\n\\t<86,112,114>\\nKM\\t#200# 6.5 {H2CO3}  (#200# carbonate dehydratase activity, recombinant \\n\\tenzyme, pH and temperature not specified in the publication <399>) <399>\\nKM\\t#205# 4700 {CO2}  (#205# pH 8.3, 22C <359>) <359>\\nKM\\t#21# 0.01787 {4-nitrophenyl acetate}  (#21# Vmax: 0.168 micromol/min, \\n\\tpH 8.5, 35C <333>) <333>\\nKM\\t#219# 0.434 {H2CO3}  (#219# pH 9.0, 40C <368>) <368>\\nKM\\t#221# 21.5 {H2CO3}  (#221# pH not specified in the publication, 4C, \\n\\tassay using the delta pH method <366>) <366>\\nKM\\t#23# 30 {HCO3-}  <39>\\nKM\\t#237# 10.1 {CO2}  (#237# at pH 8.3 and 25C <428>) <428>\\nKM\\t#30,62# 20 {CO2}  (#62# pH 8.5, 25C, wild-type, H2O <86>) <49,86>\\nKM\\t#35,182# 8.1 {CO2}  (#35# pH 7.5, 20C <342>; #182# pH 8.3, 20C <342>) \\n\\t<342>\\nKM\\t#40# 8.2 {CO2}  (#40# CaNce103, at 25C, pH 8.3 in 20 mM Tris buffer \\n\\tand 20 mM NaClO4 <260>) <260>\\nKM\\t#41# 17 {CO2}  (#41# pH 8.9, 25C <98>) <98>\\nKM\\t#48# 80 {CO2}  <6>\\nKM\\t#49# 9.3 {HCO3-}  (#49# rCsoSCA <178>) <178>\\nKM\\t#49,62# 3.2 {CO2}  (#62# pH 7.5, 25C, variant E84H, 50 mM MOPS buffer \\n\\t<86>; #49# rCsoSCA <178>) <86,178>\\nKM\\t#5,12,14# 22 {CO2}  (#14# carbonic anhydrase IV <70>; #5# 0C, pH 7.2, \\n\\tlow activity carbonic anhydrase <19>; #12# pH 9.0, 25C, mutant \\n\\tR94H/E92Q <106>) <19,70,106>\\nKM\\t#5,14,24# 10 {CO2}  (#14# pH 8.95, 1,2-dimethylimidazole buffer, \\n\\tcarbonic anhydrase I mutant H200T <44>; #24# cytosolic isoenzyme <56>; \\n\\t#5# 0C, pH 7.2, high activity carbonic anhydrase <19>) <19,44,56>\\nKM\\t#52,176# 3.1 {CO2}  (#52# pH not specified in the publication, 25C \\n\\t<338>; #176# pH 7.5, 25C, enzyme cultured with supplemental zinc \\n\\t<320>) <320,338>\\nKM\\t#57,118# 7.9 {CO2}  (#118# pH 7.5, 25C, recombinant enzyme <381>) \\n\\t<147,381>\\nKM\\t#58# 5.1 {4-nitrophenyl acetate}  <177>\\nKM\\t#62# 0.8 {CO2}  (#62# pH 7.5, 25C, variant E84A, 50 mM MOPS-Ac buffer \\n\\t<86>) <86>\\nKM\\t#62# 1.4 {CO2}  (#62# pH 7.5, 25C, variant E62Q, 50 mM MOPS buffer \\n\\t<86>) <86>\\nKM\\t#62# 1.2 {CO2}  (#62# pH 7.5, 25C, variant E84Q, 50 mM MOPS buffer \\n\\t<86>) <86>\\nKM\\t#62# 1.5 {CO2}  (#62# pH 7.5, 25C, variant E84A and E84K, 50 mM MOPS \\n\\tbuffer <86>) <86>\\nKM\\t#62# 2.5 {CO2}  (#62# pH 7.5, 25C, variant E62T, 50 mM MOPS buffer \\n\\t<86>) <86>\\nKM\\t#62# 2.1 {CO2}  (#62# pH 7.5, 25C, variant E84S and E84Y, 50 mM MOPS \\n\\tbuffer <86>) <86>\\nKM\\t#62# 1.1 {CO2}  (#62# pH 7.5, 25C, variant E84C, 50 mM MOPS buffer \\n\\t<86>) <86>\\nKM\\t#62# 5.4 {CO2}  (#62# pH 7.5, 25C, variant E62D/E84D, 50 mM MOPS \\n\\tbuffer <86>) <86>\\nKM\\t#62# 3.8 {CO2}  (#62# pH 7.5, 25C, variant E62C, 50 mM MOPS buffer \\n\\t<86>) <86>\\nKM\\t#62# 7.6 {CO2}  (#62# pH 7.5, 25C, variant E62H, 50 mM MOPS buffer \\n\\t<86>) <86>\\nKM\\t#62# 14.7 {CO2}  (#62# pH 7.5, 25C, wild-type, D2O <86>) <86>\\nKM\\t#62# 12.6 {CO2}  (#62# pH 8.5, 25C, wild-type, D2O <86>) <86>\\nKM\\t#62# 5.5 {CO2}  (#62# pH 7.5, 25C, variant E62A, 50 mM MOPS-Ac buffer \\n\\t<86>) <86>\\nKM\\t#62# 28.5 {CO2}  (#62# pH 6.5, 25C, wild-type <86>) <86>\\nKM\\t#62# 44.1 {CO2}  (#62# pH 7.5, 25C, wild-type, 50 mM IMID buffer <86>) \\n\\t<86>\\nKM\\t#62# 23.8 {CO2}  (#62# pH 6.5, 25C, wild-type, D2O <86>) <86>\\nKM\\t#62# 27.8 {CO2}  (#62# pH 7.5, 25C, wild-type, 50 mM MOPS buffer <86>) \\n\\t<86>\\nKM\\t#62# 16.9 {CO2}  (#62# pH 7.5, 25C, variant E88A, 50 mM MOPS buffer \\n\\t<86>) <86>\\nKM\\t#62# 22.5 {CO2}  (#62# pH 7.5, 25C, wild-type, 50 mM MOPS-Ac buffer \\n\\t<86>) <86>\\nKM\\t#62# 18.1 {CO2}  (#62# pH 7.5, 25C, variant E84D, 50 mM MOPS buffer \\n\\t<86>) <86>\\nKM\\t#62,121# 18.8 {CO2}  (#62# pH 7.5, 25C, variant E62D, 50 mM MOPS \\n\\tbuffer <86>) <86,147>\\nKM\\t#62,99# 6.5 {CO2}  (#62# pH 7.5, 25C, variant E62A, 50 mM MOPS buffer \\n\\t<86>; #99# pH 7.5, 37C, variant R59C, 100 mM ethylguanidine <94>) \\n\\t<86,94>\\nKM\\t#65,99# 11.7 {CO2}  (#65# pH 7.5, 20C <341>; #99# pH 7.5, 37C, \\n\\tvariant R59A, 150 mM guanidine <94>) <94,341>\\nKM\\t#66# 2.67 {CO2}  <9>\\nKM\\t#81# 32.2 {H2CO3}  (#81# 0.25 M NaCl <158>) <158>\\nKM\\t#81# 33.4 {H2CO3}  (#81# 0.5 M NaCl <158>) <158>\\nKM\\t#81# 28.7 {H2CO3}  (#81# without NaCl <158>) <158>\\nKM\\t#81# 30.1 {H2CO3}  (#81# 0.1 M NaCl <158>) <158>\\nKM\\t#85,120# 7 {CO2}  (#120# recombinant CA IX catalytic domain expressed \\n\\tin Sf9 cells, in the absence of Zn2+ <223>; #85# at pH 7.5 and 37C \\n\\t<408>) <223,408>\\nKM\\t#86# 7.9 {histamine}  (#86# at 25C, pH 8.3 in 20 mM Tris buffer and 20 \\n\\tmM NaClO4 <256>) <256>\\nKM\\t#88# 0.087 {CO2}  (#88# pH 7.9, temperature not specified in the \\n\\tpublication <347>) <347>\\nKM\\t#9,15,18,21,22,29,80,99,120,122,124,127,145,166,168,169,181,185,191,192,\\n\\t194,198,202,203,204,219,222# -999 {more}  (#124,185,191,192# kinetics \\n\\t<376>; #22# influence of pH and buffer composition on Km-values <33>; \\n\\t#18# influence of pH-value and buffer composition on Km-value on native \\n\\tenzyme and on an activated derivative with modified thiol groups <42>; \\n\\t#22# influence of buffer composition and pH on the Km-value <20>; \\n\\t#168,169# Michaelis-Menten kinetics, overview <292>; #166# steady-state \\n\\tkinetics, overview <289>; #80# kinetics of the esterase activity with \\n\\t4-nitrophenylacetate as substrate <306>; #122# Km is 4.0 mM with \\n\\t4-nitrophenyl acetate, pH 9.0, 30C, esterase activity <308>; #9# \\n\\tsteady-state kinetic analysis of the Co2+-substituted enzyme, overview \\n\\t<288>; #99# kinetic constants of apoenzyme reconstituted with Zn2+, \\n\\tCo2+, Cu2+, Mn2+, Ni2+, Cd2+, or Fe2+ <321>; #202# during the second \\n\\tcatalytic stage, the zinc-bound 18O-labeled hydroxide is protonated, \\n\\tforming H2 18O, which is then released into solution, 18O-exchange \\n\\tkinetic analysis, overview <350>; #145# intrinsic second order kinetic \\n\\tconstant kcat/KM for the CO2 hydration reaction catalyzed by the \\n\\timmobilized CA <354>; #124# kinetic and thermodynamic analysis, \\n\\tmolecular modelling, overview <351>; #222# kinetics of 4-nitrophenyl \\n\\tacetate hydrolysis reaction <377>; #127# kinetics of free and \\n\\timmobilized enzymes with esterase activity on substrate 4-nitrophenyl \\n\\tacetate <405>; #181# kinetics, stopped-flow assay method <376>; #219# \\n\\tLineweaver-Burk kinetic plots <368>; #21# Lineweaver-Burk kinetics \\n\\t<380>; #120,124# steady-state kinetics and isotope effects of \\n\\trecombinant enzyme variants, overview <352>; #198# stopped flow CO2 \\n\\thydrase assay method <384>; #203,204# stopped-flow spectrophotometric \\n\\tkinetic analysis <355>; #120# stopped-flow spectrophotometric \\n\\tmeasurements <364>; #194# stopped-flow technique, kinetic analysis \\n\\t<391>; #194# the recombinant MgaCA shows a very similar kinetic \\n\\tfeatures when compared to those of the native enzyme (MgaCA) <389>) \\n\\t<15,20,23,33,42,288,289,292,306,308,321,350,351,352,354,355,364,368,376,\\n\\t377,380,384,389,391,405>\\nKM\\t#92# 21.72 {CO2}  (#92# pH 8.5, 0C <128>) <128>\\nKM\\t#94# 5.12 {4-nitrophenyl acetate}  (#94# at pH 7.5 and 35C <425>) <425>\\nKM\\t#97# 39.7 {CO2}  (#97# at pH 8.3, temperature not specified in the \\n\\tpublication <439>) <439>\\nKM\\t#99# 25 {CO2}  (#99# pH 7.5, 37C, variant R59H, without guanidine \\n\\thydrochloride <94>) <94>\\nKM\\t#99# 34 {CO2}  (#99# pH 7.5, 37C, variant R59A, 100 mM imidazole <94>) \\n\\t<94>\\nKM\\t#99# 17.3 {CO2}  (#99# pH 7.5, 37C, variant R59C, 100 mM \\n\\tmethylguanidine, variant R59Q, 100 mM guanidine hydrochloride <94>) <94>\\nKM\\t#99# 15.7 {CO2}  (#99# pH 7.5, 37C, variant R59A <94>) <94>\\nKM\\t#99# 17.1 {CO2}  (#99# pH 7.5, 37C, variant R59A, 100 mM guanidine \\n\\t<94>) <94>\\nKM\\t#99# 12.8 {CO2}  (#99# pH 7.5, 37C, variant R59A, 100 mM \\n\\t1.3-diaminoguanidine <94>) <94>\\nKM\\t#99# 26.2 {CO2}  (#99# pH 7.5, 37C, variant R59A, 100 mM urea <94>) \\n\\t<94>\\nKM\\t#99# 6.09 {CO2}  (#99# pH 7.5, 37C, variant R59H, 100 mM guanidine \\n\\thydrochloride <94>) <94>\\nKM\\t#99# 14.5 {CO2}  (#99# pH 7.5, 37C, variant R59A, 50 mM guanidine \\n\\t<94>) <94>\\nKM\\t#99# 47.6 {CO2}  (#99# pH 7.5, 37C, variant R59C, 100 mM \\n\\taminoguanidine <94>) <94>\\nKM\\t#99# 16.7 {CO2}  (#99# pH 7.5, 37C, 100 mM guanidine hydrochloride \\n\\t<94>) <94>\\nKM\\t#99# 12.2 {CO2}  (#99# pH 7.5, 37C, variant R59A, 100 mM \\n\\tmethylguanidine <94>) <94>\\nKM\\t#99# 16.2 {CO2}  (#99# pH 7.5, 37C, variant R59A, 100 mM \\n\\tethylguanidine <94>) <94>\\nKM\\t#99# 21.8 {CO2}  (#99# pH 7.5, 37C, wild-type, without guanidine \\n\\thydrochloride <94>) <94>\\nKM\\t#99# 13.6 {CO2}  (#99# pH 7.5, 37C, variant R59C, 100 mM guanidine \\n\\t<94>) <94>\\nKM\\t#99# 16.3 {CO2}  (#99# pH 7.5, 37C, variant R59K, 100 mM guanidine \\n\\thydrochloride <94>) <94>\\nKM\\t#99# 19.1 {CO2}  (#99# pH 7.5, 37C, variant R59K, 100 mM guanidine \\n\\thydrochloride <94>) <94>\\nKM\\t#99# 33.4 {CO2}  (#99# pH 7.5, 37C, variant R59K, without guanidine \\n\\thydrochloride <94>) <94>\\nKM\\t#99# 43.3 {CO2}  (#99# pH 7.5, 37C, variant R59M, without guanidine \\n\\thydrochloride <94>) <94>\\nKM\\t#99# 9.45 {CO2}  (#99# pH 7.5, 37C, variant R59A, 100 mM \\n\\taminoguanidine <94>) <94>\\nKM\\t#99# 25.4 {CO2}  (#99# pH 7.5, 37C, variant R59A, 100 mM ethylamine \\n\\t<94>) <94>\\nKM\\t#99# 33.9 {CO2}  (#99# pH 7.5, 37C, variant R59Q, without guanidine \\n\\thydrochloride <94>) <94>\\nKM\\t#99# 34.2 {CO2}  (#99# pH 7.5, 37C, variant R59C <94>) <94>\\nKM\\t#99# 51.4 {CO2}  (#99# pH 7.5, 37C, variant R59E, without guanidine \\n\\thydrochloride <94>) <94>\\n\\nPH_OPTIMUM\\nPHO\\t#120# 6.5 <280>\\nPHO\\t#126# 7.5-10 (#126# cytosolic isoenzyme <176>; #126# inner peripheral \\n\\tisoenzyme <176>) <176>\\nPHO\\t#126# 7.5-11 (#126# outer peripheral isoenzyme <176>) <176>\\nPHO\\t#14# 7.2 <79>\\nPHO\\t#14# -999 (#14# esterase activity assay at pH 7.4 <304>) <304>\\nPHO\\t#14# 7.8-8.5 (#14# mutant H64A <110>) <110>\\nPHO\\t#14,122,124,127,191,193# 7.4 (#14,122,124,127,193# assay at \\n\\t<308,326,357,392>; #191# esterase assay at <404>; #124,127# esterase \\n\\tactivity assay at with 4-nitrophenylacetate as substrate <378>) \\n\\t<308,326,357,378,392,404>\\nPHO\\t#14,124,177# 7.6 (#14,124,177# assay at <301,323,340>; #14# hydration \\n\\tof CO2 <133>) <133,301,323,340>\\nPHO\\t#14,21,31,48,59,62,63,80,88,91,94,118,119,120,124,126,127,128,167,168,\\n\\t169,176,181,185,191,192,195,207# 7.5 \\n\\t(#14,31,59,62,63,88,118,119,120,124,127,128,167,176,181,185,191,192,195,\\n\\t207# assay at \\n\\t<299,300,310,311,320,328,330,332,334,339,360,362,364,369,375,376,381,\\n\\t387,393>; #126# integral isoenzyme <176>; #168,169# CO2 hydration assay \\n\\tat <292>; #80# optimum pH for the esterase activity with \\n\\t4-nitrophenylacetate as substrate <306>) \\n\\t<6,176,292,299,300,306,310,311,320,328,330,332,334,339,360,362,364,369,\\n\\t375,376,380,381,385,387,393,425>\\nPHO\\t#14,58,203# 9.5 (#14# CA II mutant H64A <97>; #14# hydrolysis of \\n\\t4-nitrophenyl acetate <133>; #58# 0.025 M boric acid buffer <177>; \\n\\t#203# assay at, CO2 hydration reaction <355>) <97,133,177,355>\\nPHO\\t#168,169# 6.3 (#168,169# bicarbonate dehydration assay at <292>) <292>\\nPHO\\t#18,124,231# 7 <87,117,248,442>\\nPHO\\t#18,58,90,219,234# 9 (#18# assay at <324>; #58# in 1 M Tris-SO4 at 4C \\n\\t<199>; #58# in 1 M Tris-SO4 buffer <246>) <199,241,246,324,368,424>\\nPHO\\t#191# 7.8-8.3 (#191# assay at, the pH drops during the CO2 hydration \\n\\treaction to pH 6.2 <404>) <404>\\nPHO\\t#199# 7.5-8.3 (#199# assay at <382>) <382>\\nPHO\\t#21,58,124,188# 8.5 (#124,188# assay at <376,397>; #58# in 1 M Tris-SO4 \\n\\tbuffer at 4C <246>) <246,333,376,397>\\nPHO\\t#211# 8.2 (#211# assay at <395>) <395>\\nPHO\\t#218# 6-6.5 <403>\\nPHO\\t#26# 8.4 (#26# assay at <345>) <345>\\nPHO\\t#41# 8.8 <98>\\nPHO\\t#6,11,14,18,34,43,83,162,177,194,195,196,197,198,205,206,212# 8.3 \\n\\t(#6,14,18,34,43,83,162,177,194,195,196,197,198,205,206,212# assay at \\n\\t<298,303,307,309,327,336,358,359,374,383,384,388,389,391,398>; #197# \\n\\tassay at, initial pH value, the value drops to pH 7.3 during the \\n\\treaction <367>; #14# assay at, starting pH value <353>) \\n\\t<264,298,303,307,309,327,336,353,358,359,367,374,383,384,388,389,391,\\n\\t398>\\nPHO\\t#88,90# 7.9 (#88,90# assay at <347>) <347>\\nPHO\\t#9,14,43,61,127,129,132,208,222,235# 8 (#127# immobilized enzyme <405>; \\n\\t#14,61,129# assay at <287,346,349>; #9# and above <288>) \\n\\t<282,287,288,346,349,363,377,405,418,427>\\nPHO\\t#99# 7.8 <110>\\n\\nPH_RANGE\\nPHR\\t#101# 5.5-7.5 <113>\\nPHR\\t#12# 6-9 <106>\\nPHR\\t#124,197,208# 6-11 (#197# activity range <367>; #208# activity range, \\n\\testerase activity of recombinant enzyme <363>) <286,363,367>\\nPHR\\t#14# 4.5-9.5 (#14# hydrolysis of 4-nitrophenyl acetate <133>) <133>\\nPHR\\t#14# 5.7-9.5 (#14# CA II mutant H64A <97>) <97>\\nPHR\\t#14# 5.6-9.8 (#14# hydration of CO2 <133>) <133>\\nPHR\\t#14,124# -999 (#124# change in metal coordination from tetrahedral at \\n\\tpH 11.0 to a coordination consistent with a mixed population of both \\n\\ttetrahedral and penta-coordinate at pH 8.5 to an octahedral geometry \\n\\tcharacteristic of the oxidized enzyme Co(III)-HCA II at pH 6.0 <286>; \\n\\t#14# pH profiles for the hydration of CO2 catalyzed by wild-type HCA II \\n\\tand mutant Y7I HCA II, overview <287>) <286,287>\\nPHR\\t#14,30,124# 5-9 <79,87,107,117>\\nPHR\\t#178,179# 8.3 (#178,179# assay at <337>) <337>\\nPHR\\t#18# 3-8 <248>\\nPHR\\t#183# 10-11 (#183# more than 80% of enzymatic activity retained even \\n\\tafter 24 h at 4C <325>) <325>\\nPHR\\t#191# 4-10 (#191# activity range, recombinant enzyme <404>) <404>\\nPHR\\t#20# 6.4-9 <114>\\nPHR\\t#207# 7-9 (#207# both free and microcrystalline cellulose-immobilized \\n\\tenzymes show optimal activity between pH 7.0 and 9.0 <444>) <444>\\nPHR\\t#21,231# 5-10 (#21# activity range, profile overview <380>; #231# the \\n\\tenzyme is stable over a wide pH range (pH 5.0-9.0), but is rapidly \\n\\tinactivated below pH 5.0 or above pH 10.0 <442>) <380,442>\\nPHR\\t#219# 8.5-10 (#219# narrow pH range, profile overview <368>) <368>\\nPHR\\t#234# 8-10 (#234# the enzyme is highly active between pH 8.0 and 10 \\n\\t<424>) <424>\\nPHR\\t#41# 6.2-9 <98>\\nPHR\\t#49# 6.5-8.5 (#49# CO2 hydration increases over a pH range from 6.5 to \\n\\t8.5 <178>) <178>\\nPHR\\t#49# 6-7.5 (#49# kcat for dehydration increases over the pH range of \\n\\t6.0 to 7.5 <178>) <178>\\nPHR\\t#61# 8-9.5 (#61# optimal pH <346>) <346>\\nPHR\\t#88# 7.5-8.4 (#88# enzyme activity increases linearly with pH <347>) \\n\\t<347>\\nPHR\\t#9# 6.5-10.5 (#9# pH profile, pH-dependent changes in the absorption \\n\\tspectrum of Co-HICA including an increase in molar absorptivity and a \\n\\tred shift of a 580 nm peak with decreasing pH, correlate with the \\n\\tpH-dependence of kcat/Km, overview <288>) <288>\\nPHR\\t#90# 7.8-8.6 (#90# enzyme activity increases linearly with pH <347>) \\n\\t<347>\\nPHR\\t#99# 7.2-9 <110>\\n\\nSPECIFIC_ACTIVITY\\nSA\\t#1,5,10,14,16,18,20,21,23,24,29,34,36,38,43,47,48,51,58,62,70,71,83,91,\\n\\t99,100,124,173,219,222# -999.0 (#173# specific activity 300 dpm hr-1 \\n\\tmicrogram-1 <136>; #20# specific activity 39.0 U/mg, one unit = \\n\\t(t0-t)/t, where t0 is the time for the uncatalyzed reaction and t is \\n\\tthe time of the catalyzed reaction <112>; #100# specific activity 393 \\n\\tU/mg, enzyme units are defined as Wilbur-Anderson (WA) units <137>; \\n\\t#58# specific activity 422.5 EU/mg protein <127>; #14# specific \\n\\tactivity CA-I 0.67 U/mg, specific activity CA-II 1.7 U/mg <96>; #62# \\n\\tspecific activity Cam 720 units/mg, apo-Cam 20 units/mg, Co-Cam 2020 \\n\\tunits/mg, Zn-Cam 910 units/mg, one unit = (t0-t)/t where t0 is the time \\n\\tfor the uncatalyzed reaction and t is the time for the catalyzed \\n\\treaction <81>; #58# enzyme from lysate shows a specific activity of \\n\\t1.77 EU/mg, the 1280fold purified enzyme shows a specific activity of \\n\\t2275 EU/mg <199>; #10# the recombinant CAH7 protein has a specific \\n\\tactivity of 3.1 Wilbur Anderson units/mg, while the recombinant CAH8 \\n\\tprotein has an activity of 4.2 Wilbur Anderson units/mg <239>; #43# the \\n\\tcrude supernatant displays a specific activity of 2.44 U/mg, the \\n\\t4.52fold purified enzyme shows a specific activity of 11.03 U/mg, at \\n\\t25C <282>; #34,43,83# activities of purified enzyme immobilized on \\n\\tdifferent matrices, overview <307>; #1# isozyme CA-II from erythrocytes \\n\\tis 7.8fold more active than CA-I <285>; #21# 11626 EU/mg, purified \\n\\tenzyme, pH 7.4, 25C, p-nitrophenylacetate substrate <379>; #38# 175 \\n\\tEU/mg protein activity in CO2 hydration reaction, purified native \\n\\tenzyme, pH and temperature not specified in the publication <390>; #91# \\n\\t600 EU/mg protein, purified native enzyme, pH 7.5, 20C <385>; #21# \\n\\t6681.57 EU/mg, purified enzyme, pH 7.4, 25C, p-nitrophenyl acetate \\n\\tsubstrate <380>; #124# esterase activity measurements of wild-type and \\n\\tmutant enzymes, pH 8.5, substrate 4-nitrophenyl acetate <397>; #222# \\n\\tpurified native enzyme, specific activity 4130.4 EU/mg of protein \\n\\t<377>; #219# the purified enzyme from kidney has a specific activity of \\n\\t603.77 EU/mg <368>) \\n\\t<2,3,4,6,11,14,24,26,27,32,35,39,51,56,81,96,112,127,136,137,149,160,\\n\\t190,199,239,282,285,307,368,377,379,380,385,390,397>\\nSA\\t#100# 0.161 <137>\\nSA\\t#102# 52410.0 <128>\\nSA\\t#104# 25780.0 <128>\\nSA\\t#109# 529.1 <147>\\nSA\\t#11# 1.62 (#11# crude extract, using 4-nitrophenyl acetate as \\n\\tsubstrate, at pH 8.3 and 37C <264>) <264>\\nSA\\t#11# 737.8 (#11# after 456.6fold purification, using 4-nitrophenyl \\n\\tacetate as substrate, at pH 8.3 and 37C <264>) <264>\\nSA\\t#112# 984.2 <147>\\nSA\\t#121# 455.4 <147>\\nSA\\t#122# 26970.0 (#122# purified native enzyme, pH 7.4, 30C <308>) <308>\\nSA\\t#132# 0.33 (#132# lysate, at pH 8.0, temperature not specified in the \\n\\tpublication <418>) <418>\\nSA\\t#132# 7.02 (#132# isoform CA VII, after 21.07fold purification, at pH \\n\\t8.0, temperature not specified in the publication <418>) <418>\\nSA\\t#164# 285000.0 (#164# reverse reaction of bicarbonate dehydration at \\n\\t4C in a MES/KOH pH 6.3 buffer <273>) <273>\\nSA\\t#164# 1914000.0 (#164# forward reaction of CO2 dehydration at 4C in a \\n\\tHEPES/NaOH, pH 7.5 <273>) <273>\\nSA\\t#18# 0.052 (#18# crude homogenate, at 20C <248>) <248>\\nSA\\t#18# 74.6 (#18# purified enzyme, pH 8.3, 4C <309>) <309>\\nSA\\t#18# 7.843 (#18# after 150.82fold purification, at 20C <248>) <248>\\nSA\\t#23# 14.5 <155>\\nSA\\t#34# 61.0 (#34# purified enzyme, pH 8.3, 4C <307,309>) <307,309>\\nSA\\t#43# 70.6 (#43# purified enzyme, pH 8.3, 4C <307,309>) <307,309>\\nSA\\t#50# 75.2 (#50# in vivo activity with supply of compressed air to the \\n\\tcell cultures, pH not specified in the publication, temperature not \\n\\tspecified in the publication <313>) <313>\\nSA\\t#50# 9.96 (#50# in vivo activity with supply of compressed air with \\n\\tadded 5% CO2 to the cell cultures, pH not specified in the publication, \\n\\ttemperature not specified in the publication <313>) <313>\\nSA\\t#50# 62.32 (#50# in vivo activity with supply of compressed air to the \\n\\tcell cultures, pH 9.0, with addition of HCO3-, pH not specified in the \\n\\tpublication, temperature not specified in the publication <313>) <313>\\nSA\\t#57# 375.3 <147>\\nSA\\t#58# 16.7 <177>\\nSA\\t#80# 751.7 (#80# purified enzyme, esterase activity with \\n\\t4-nitrophenylacetate as substrate, pH 7.5, 25C <306>) <306>\\nSA\\t#83# 66.5 (#83# purified enzyme, pH 8.3, 4C <307,309>) <307,309>\\nSA\\t#92# 7313.0 <128>\\n\\nTEMPERATURE_OPTIMUM\\nTO\\t#102# 24 <191>\\nTO\\t#105# 65-75 <113>\\nTO\\t#11,14,197,235# 37 (#14,197# assay at <353,374>) <264,353,374,427>\\nTO\\t#124# 42.5 (#124# mutant M4 <397>) <397>\\nTO\\t#124# 67.5 (#124# wild-type enzyme <397>) <397>\\nTO\\t#124# 66.5 (#124# mutant M1 <397>) <397>\\nTO\\t#124,132# 50 (#124# mutants M2 and M3 <397>) <397,418>\\nTO\\t#126# 60 (#126# integral isoenzyme <176>) <176>\\nTO\\t#126# 10-20 (#126# outer peripheral isoenzyme <176>) <176>\\nTO\\t#14# -999 (#14# esterase activity assay at 25C <304>) <304>\\nTO\\t#14# 16 (#14# assay at <326>) <326>\\nTO\\t#14,119,124,127,128,194,195,196,205,208,231# 22 \\n\\t(#14,119,124,127,128,194,195,196,205# assay at room temperature \\n\\t<299,359,362,383,387,388,389,391,393>; #208# CO2 hydration assay at \\n\\troom temperature <363>; #124,127# esterase activity assay at room \\n\\ttemperature with 4-nitrophenyl acetate as substrate <378>) \\n\\t<299,359,362,363,378,383,387,388,389,391,393,442>\\nTO\\t#177,185# 95 (#177# optimum temperature <340>) <340,376>\\nTO\\t#177,199# 0 (#177,199# assay at <340,382>) <340,382>\\nTO\\t#18,21,43,94,222# 35 <248,282,333,377,425>\\nTO\\t#18,31,34,43,83,168,169,197# 4 (#18,31,34,43,83,168,169,197# assay at \\n\\t<292,307,309,310,367>) <292,307,309,310,367>\\nTO\\t#181# 80 <376>\\nTO\\t#191# 35-45 (#191# CA-catalyzed sequestration of CO2 hydration, assay \\n\\tat <404>) <404>\\nTO\\t#191# 0-4 (#191# esterase assay at <404>) <404>\\nTO\\t#20,183# 65 (#183# only 34% of residual activity compared to 25C \\n\\t<325>) <112,325>\\nTO\\t#21,122,126,234# 30 (#122# assay at <308>; #126# cytosolic isoenzyme \\n\\t<176>; #126# inner peripheral isoenzyme <176>) <176,308,380,424>\\nTO\\t#58# 23 <177>\\nTO\\t#58,219# 40 <246,368>\\nTO\\t#6,14,20,59,63,88,91,99,124,167,178,179,191,192,198,206,207,218# 20 \\n\\t(#6,14,20,59,63,88,99,124,167,178,179,191,192,198,206,207,218# assay at \\n\\t<300,303,316,317,318,330,332,334,337,339,358,360,376,384,403>) \\n\\t<300,303,316,317,318,330,332,334,337,339,358,360,376,384,385,403>\\nTO\\t#62# 55 (#62# 15 min, stable <51>) <51>\\nTO\\t#9,14,18,52,61,62,80,118,120,124,127,128,129,166,176,177,181,183,188,\\n\\t191,193,203,204,208,212# 25 (#127# immobilized enzyme <405>; \\n\\t#9,14,18,52,61,62,118,120,124,127,128,129,166,176,177,181,188,193,203,\\n\\t204,212# assay at \\n\\t<287,288,289,301,311,320,324,327,328,336,338,346,349,355,357,364,369,\\n\\t375,376,381,398>; #80# optimum temperature for the esterase activity \\n\\twith 4-nitrophenylacetate as substrate <306>; #191# CO2hydration \\n\\treaction, assay at <404>; #208# esterase activity assay at, p-NPA \\n\\thydrolysis <363>) \\n\\t<287,288,289,301,306,311,320,324,325,327,328,336,338,346,349,355,357,\\n\\t363,364,369,375,376,381,398,404,405>\\n\\nTEMPERATURE_RANGE\\nTR\\t#102# 13-30 (#102# 13C: about 40% of maximal activity, 30C: about 85% \\n\\tof maximal activity <191>) <191>\\nTR\\t#18# 20-70 <248>\\nTR\\t#181# 0-100 (#181# esterase and CO2 hydration activity, activity range \\n\\t<376>) <376>\\nTR\\t#208# 10-60 (#208# activity range, esterase activity of recombinant \\n\\tenzyme <363>) <363>\\nTR\\t#21# 0-60 (#21# activity range, profile overview <380>) <380>\\nTR\\t#231# 22-50 (#231# the enzyme retains more than 70% of its initial \\n\\tactivity after incubation at temperatures up to 40C, it retains 30% \\n\\tactivity after 50C treatment, and activity is almost negligible after \\n\\texposure to temperatures above 50C <442>) <442>\\nTR\\t#234# 20-40 (#234# the enzyme is highly active between 20 and 40C \\n\\t<424>) <424>\\nTR\\t#58# 15-30 (#58# 15C: about 35% of maximal activity, 30C: about 80% \\n\\tof maximal activity <177>) <177>\\nTR\\t#61# 25-35 (#61# optimal temperature <346>) <346>\\nTR\\t#80# 5-70 (#80# assay range <306>) <306>\\n\\nACTIVATING_COMPOUND\\nAC\\t#10# 2-mercaptoethanol (#10# increases the activity of isozyme CAH7 by \\n\\t69% but has no effect on the activity of isozyme CAH8 <239>) <239>\\nAC\\t#124# phenylalanine (#124# enzyme bound structure, PDB ID 2FMG <396>) \\n\\t<396>\\nAC\\t#124# histidine (#124# enzyme bound structure, PDB ID 2ABE <396>) <396>\\nAC\\t#124# 4-methylimidazole (#124# enzyme bound structure, PDB ID 4HEY \\n\\t<396>) <396>\\nAC\\t#124# \\n\\t(2S)-2-amino-3-(1H-imidazol-4-yl)-N\\'-(naphthalen-2-\\n\\tylsulfonyl)propanehydrazide hydrochloride <254>\\nAC\\t#124# \\n\\t(2S)-2-amino-3-(1H-imidazol-4-yl)-N\\'-[(4-\\n\\tiodophenyl)sulfonyl]propanehydrazide hydrochloride (#124# submicromolar \\n\\tactivator of isoform CA II, but shows much higher affinities for \\n\\tisoforms CA I and IX <254>) <254>\\nAC\\t#124# \\n\\t(2S)-2-amino-3-(1H-imidazol-4-yl)-N\\'-[(4-\\n\\tmethoxyphenyl)sulfonyl]propanehydrazide hydrochloride <254>\\nAC\\t#124# \\n\\t(2S)-2-amino-3-(1H-imidazol-4-yl)-N\\'-[(4-\\n\\tmethylphenyl)sulfonyl]propanehydrazide hydrochloride (#124# effective \\n\\tCA IX activator <254>) <254>\\nAC\\t#124# \\n\\t(2S)-2-amino-3-(1H-imidazol-4-yl)-N\\'-[(4-\\n\\tnitrophenyl)sulfonyl]propanehydrazide hydrochloride (#124# effective CA \\n\\tIX activator <254>) <254>\\nAC\\t#124# \\n\\t(2S)-2-amino-3-(1H-imidazol-4-yl)-N\\'-\\n\\t[(pentafluorophenyl)sulfonyl]propanehydrazide hydrochloride <254>\\nAC\\t#124# \\n\\t(2S)-2-amino-3-(1H-imidazol-4-yl)-N\\'-[[4-\\n\\t(trifluoromethyl)phenyl]sulfonyl]propanehydrazide hydrochloride <254>\\nAC\\t#124# \\n\\t(2S)-2-amino-N\\'-(biphenyl-4-ylsulfonyl)-3-(1H-imidazol-4-\\n\\tyl)propanehydrazide hydrochloride <254>\\nAC\\t#124# \\n\\t(2S)-2-amino-N\\'-[(4-bromophenyl)sulfonyl]-3-(1H-imidazol-4-\\n\\tyl)propanehydrazide hydrochloride (#124# effective CA IX activator \\n\\t<254>) <254>\\nAC\\t#124# \\n\\t(2S)-2-amino-N\\'-[(4-chlorophenyl)sulfonyl]-3-(1H-imidazol-4-\\n\\tyl)propanehydrazide hydrochloride <254>\\nAC\\t#124# \\n\\t(2S)-2-amino-N\\'-[(4-cyanophenyl)sulfonyl]-3-(1H-imidazol-4-\\n\\tyl)propanehydrazide hydrochloride <254>\\nAC\\t#124# \\n\\t(2S)-2-amino-N\\'-[(4-fluorophenyl)sulfonyl]-3-(1H-imidazol-4-\\n\\tyl)propanehydrazide hydrochloride (#124# effective CA IX activator \\n\\t<254>) <254>\\nAC\\t#124# \\n\\t(2S)-2-amino-N\\'-[(4-tert-butylphenyl)sulfonyl]-3-(1H-imidazol-4-\\n\\tyl)propanehydrazide hydrochloride <254>\\nAC\\t#124# CAA12i (#124# carbonic anhydrase activator 12i, enzyme binding \\n\\tstructure determination and analysis, the location of the imidazole \\n\\tmoiety in both conformations of CAA12i flips between two small \\n\\thydrophobic cavities flanking Phe131. This movement may be analogous to \\n\\tthe movement observed with His64 as it performs its proton-shuttling \\n\\tfunction. Conformation A may represent the in conformation of His64, as \\n\\tthis position forms an extension of the proton wire network. In \\n\\tconformation B, the CAA12i tail moiety is extended away from the proton \\n\\tnetwork, and this may be analogous to the out conformation of His64. \\n\\tOverall, the crystal structure of this CAA12i ligand indicates possible \\n\\ttransient motion that may be essential to its activation function \\n\\t<396>) <396>\\nAC\\t#14# phosphate (#14# below 20 mM, activates <70>) <70>\\nAC\\t#14# Cl- (#14# below 20 mM, activates <70>) <70>\\nAC\\t#14# Br- (#14# below 20 mM, activates <70>) <70>\\nAC\\t#14# sertraline (#14# strong enzyme activator <430>) <430>\\nAC\\t#14# citalopram (#14# strong enzyme activator <430>) <430>\\nAC\\t#14# aminoethyl-piperazine/morpholine (#14# carbonic anhydrase III is \\n\\tefficiently activated by aminoethyl-piperazine/morpholine <203>) <203>\\nAC\\t#14# timolol (#14# the formal name is \\n\\t(2S)-1-[(1,1-dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,\\n\\t5-thiadiazol-3-yl]oxy]-2-propanol, timolol noncompetitively activates \\n\\tcarbonic anhydrases I and II activities, timolol increases the value of \\n\\tVmax but does not influence the value of Km <252>) <252>\\nAC\\t#14# tert-butyl [2-(2,5-dichloro-1H-imidazol-4-yl)ethyl]carbamate <295>\\nAC\\t#14# tert-butyl [2-(2,5-dibromo-1H-imidazol-4-yl)ethyl]carbamate <295>\\nAC\\t#14# tert-butyl [2-(2,5-diiodo-1H-imidazol-4-yl)ethyl]carbamate <295>\\nAC\\t#14# tert-butyl [2-(5-chloro-1H-imidazol-4-yl)ethyl]carbamate <295>\\nAC\\t#14# tert-butyl [2-(5-bromo-1H-imidazol-4-yl)ethyl]carbamate <295>\\nAC\\t#14# tert-butyl [2-(5-iodo-1H-imidazol-4-yl)ethyl]carbamate <295>\\nAC\\t#14# 2-(2,5-dichloro-1H-imidazol-4-yl)ethanamine <295>\\nAC\\t#14# 2-(2,5-dibromo-1H-imidazol-4-yl)ethanamine <295>\\nAC\\t#14# 2-(2,5-diiodo-1H-imidazol-4-yl)ethanamine <295>\\nAC\\t#14# 2-(5-chloro-1H-imidazol-4-yl)ethanamine <295>\\nAC\\t#14# 2-(5-bromo-1H-imidazol-4-yl)ethanamine <295>\\nAC\\t#14# 2-(5-iodo-1H-imidazol-4-yl)ethanamine <295>\\nAC\\t#14# 1-[2-(1H-imidazol-4-yl)-ethyl]-2,6-dimethyl-4-phenylpyridinium \\n\\thexafluorophosphate <311>\\nAC\\t#14# 1-[2-(1H-imidazol-4-yl)-ethyl]-2,6-diethyl-4-phenylpyridinium \\n\\thexafluorophosphate <311>\\nAC\\t#14# 1-[2-(1H-imidazol-4-yl)-ethyl]-2,6-di-n-propyl-4-phenylpyridinium \\n\\thexafluorophosphate <311>\\nAC\\t#14# \\n\\t1-[2-(1H-imidazol-4-yl)-ethyl]-2,6-di-iso-propyl-4-phenylpyridinium \\n\\thexafluorophosphate <311>\\nAC\\t#14# 1-[2-(1H-imidazol-4-yl)-ethyl]-2,6-di-n-butyl-4-phenylpyridinium \\n\\thexafluorophosphate <311>\\nAC\\t#14# 1-[2-(1H-imidazol-4-yl)-ethyl]-2,4,6-trimethylpyridinium \\n\\thexafluorophosphate <311>\\nAC\\t#14# 1-[2-(1H-imidazol-4-yl)-ethyl]-2,6-diethyl-4-methylpyridinium \\n\\thexafluorophosphate <311>\\nAC\\t#14# 1-[2-(1H-imidazol-4-yl)-ethyl]-2,6-di-n-propyl-4-methylpyridinium \\n\\thexafluorophosphate <311>\\nAC\\t#14# \\n\\t1-[2-(1H-imidazol-4-yl)-ethyl]-2,6-di-iso-propyl-4-methylpyridinium \\n\\thexafluorophosphate <311>\\nAC\\t#14# 1-[2-(1H-imidazol-4-yl)-ethyl]-2,6-di-n-butyl-4-methylpyridinium \\n\\thexafluorophosphate <311>\\nAC\\t#14# 1-[2-(1H-imidazol-4-yl)-ethyl]-2-ethyl-4,6-dimethylpyridinium \\n\\thexafluorophosphate <311>\\nAC\\t#14# 1-[2-(1H-imidazol-4-yl)-ethyl]-2-n-propyl-4,6-dimethylpyridinium \\n\\thexafluorophosphate <311>\\nAC\\t#14# 1-[2-(1H-imidazol-4-yl)-ethyl]-2-iso-propyl-4,6-dimethylpyridinium \\n\\thexafluorophosphate <311>\\nAC\\t#14# 1-[2-(1H-imidazol-4-yl)-ethyl]-2-n-butyl -4,6 -dimethylpyridinium \\n\\thexafluorophosphate <311>\\nAC\\t#14# 1-[2-(1H-imidazol-4-yl)-ethyl]-2,3,4,6-tetramethylpyridinium \\n\\thexafluorophosphate <311>\\nAC\\t#14# 1-[2-(1H-imidazol-4-yl)-ethyl]-2-methyl-4,6-diphenylpyridinium \\n\\thexafluorophosphate <311>\\nAC\\t#14# 1-[2-(1H-imidazol-4-yl)-ethyl]-2-ethyl-4,6-diphenylpyridinium \\n\\thexafluorophosphate <311>\\nAC\\t#14# 1-[2-(1H-imidazol-4-yl)-ethyl]-2-n-propyl-4,6-diphenylpyridinium \\n\\thexafluorophosphate <311>\\nAC\\t#14# 1-[2-(1H-imidazol-4-yl)-ethyl]-2-iso-propyl-4,6-diphenylpyridinium \\n\\thexafluorophosphate <311>\\nAC\\t#14# 1-[2-(1H-imidazol-4-yl)-ethyl]-2-n-butyl-4,6-diphenylpyridinium \\n\\thexafluorophosphate <311>\\nAC\\t#14# 1-[2-(1H-imidazol-4-yl)-ethyl]-2,4-dimethyl-6-phenylpyridinium \\n\\thexafluorophosphate <311>\\nAC\\t#14# 1-[2-(1H-imidazol-4-yl)-ethyl]-2,6-diphenyl-4-methylpyridinium \\n\\thexafluorophosphate <311>\\nAC\\t#14# \\n\\t1-[2-(1H-imidazol-4-yl)-ethyl]-2,6-dimethyl-3,5-(nonane-1,\\n\\t9-diyl)pyridinium hexafluorophosphate <311>\\nAC\\t#14# \\n\\t4-[2-(4-dimethylaminophenyl)-vinyl]-1-[2-(1H-imidazol-4-yl)ethyl]-2,\\n\\t6-di-isopropylpyridinium hexafluorophosphate <311>\\nAC\\t#14# fuoxetine (#14# strong enzyme activator <430>) <430>\\nAC\\t#14,17,20,40,53,62,86,147,181# L-adrenaline (#86# activation constant \\n\\tof 0.0108 mM <256>; #147# activation constant of 0.047 mM <262>; #181# \\n\\tmoderate activator <328>) <203,206,256,260,262,305,328>\\nAC\\t#14,17,42,120,124,149,150,171# more (#42# carbonic anhydrase mRNA and \\n\\tenzyme activity are significantly increased in shrimp gills at 24 h \\n\\tafter hypo-osmotic stress <214>; #171# lack of proximal tubule CIC-5 is \\n\\tassociated with CAIII induction <232>; #150# the carbonic anhydrase \\n\\tgene is expressed 2fold more during the dark than the light <222>; \\n\\t#149# the external carbonic anhydrase is activated by hydration, \\n\\tespecially at low pH, the increase is modest (1.6fold) and transitory, \\n\\tif the pH of the hydration medium is set at 8. Relatively high internal \\n\\tcarbonic anhydrase activity is present in the dry colonies, at pH 6, no \\n\\tappreciable variation is observed during subsequent dehydration, \\n\\twhereas, at pH 8.0, dehydration induces a recovery of the intracellular \\n\\tcarbonic anhydrase activity, the presence of light does not affect \\n\\tinternal carbonic anhydrase activity during dehydration at either pH \\n\\t<216>; #14# activating effects on the cytosolic isozymes hCA I, hCA II, \\n\\tand hCA VII, competitive steady-state activation kinetics of the \\n\\tpyridinium histamine derivatives, KA values, overview <311>; #14# Ka \\n\\tvalues of activators of isozymes hCA I and hCA II, overview <295>; #17# \\n\\tL-adrenaline and some piperazines incorporating aminoethyl moieties \\n\\twere the most effective scCA activators <305>; #120# addition of the PG \\n\\tdomain of iszyme CA IX to the catalytic CA-domain increases the \\n\\tcatalytic activity by about 63% <364>; #124# proposed mechanism of CA \\n\\tenzyme activation by the compounds <396>) \\n\\t<214,216,222,232,295,305,311,364,396>\\nAC\\t#14,20,40,53,62,86,124,147# histamine (#86# activation constant of \\n\\t0.0274 mM <256>; #147# activation constant of 0.12 mM <262>; #124# \\n\\tenzyme bound structure, PDB ID 1AVN <396>) \\n\\t<203,206,256,260,262,295,311,396>\\nAC\\t#14,20,40,53,62,86,124,147,181# L-His (#147# activation constant of \\n\\t0.028 mM <262>; #86# activation constant of 0.037 mM <256>; #181# \\n\\tmoderate activator <328>) <203,206,254,256,260,262,328>\\nAC\\t#14,20,40,53,62,86,147# 4-amino-L-phenylalanine (#14# carbonic \\n\\tanhydrase IV is efficiently activated by 4-amino-L-phenylalanine <203>; \\n\\t#147# activation constant of 0.0101 mM <262>; #86# activation constant \\n\\tof 0.0316 mM <256>) <203,206,256,260,262>\\nAC\\t#14,20,40,53,62,86,147# 1-(2-aminoethyl)-piperazine (#62# effectively \\n\\tactivates Zn-gamma-class carbonic anhydrase <206>; #147# activation \\n\\tconstant of 0.0115 mM <262>; #86# activation constant of 0.0149 mM \\n\\t<256>) <203,206,256,260,262>\\nAC\\t#14,20,40,53,62,86,147# 4-(2-aminoethyl)-morpholine (#14# carbonic \\n\\tanhydrase IV is efficiently activated by 4-(2-aminoethyl)-morpholine \\n\\t<203>; #86# activation constant of 0.0101 mM <256>; #147# activation \\n\\tconstant of 0.064 mM <262>) <203,206,256,260,262>\\nAC\\t#14,20,40,53,62,86,147# 2-pyridyl-methylamine (#86# activation constant \\n\\tof 0.015 mM <256>; #147# activation constant of 0.126 mM <262>) \\n\\t<203,206,256,260,262>\\nAC\\t#14,20,40,53,62,86,147,181# L-Phe (#86# activation constant of 0.0241 \\n\\tmM <256>; #147# activation constant of 0.034 mM <262>; #181# moderate \\n\\tactivator <328>) <203,206,256,260,262,328>\\nAC\\t#14,20,40,53,62,86,147,181# L-Tyr (#20# effective beta-class carbonic \\n\\tanhydrase activator <206>; #147# activation constant of 0.031 mM <262>; \\n\\t#86# best activator, activation constant of 0.0095 mM <256>; #181# \\n\\tmoderate activator <328>) <203,206,256,260,262,328>\\nAC\\t#14,20,40,53,62,86,147,181# L-Trp (#147# activation constant of 0.00321 \\n\\tmM <262>; #86# activation constant of 0.0228 mM <256>; #53# best Can2 \\n\\tactivator <260>; #181# high activator <328>) <203,206,256,260,262,328>\\nAC\\t#14,20,40,53,62,86,147,181# serotonin (#14# carbonic anhydrases III and \\n\\tIV are efficiently activated by serotinin <203>; #86# activation \\n\\tconstant of 0.0167 mM <256>; #147# activation constant of 0.056 mM \\n\\t<262>; #181# high activator <328>) <203,206,256,260,262,328>\\nAC\\t#14,20,40,53,62,86,147,181# D-Phe (#20# effective beta-class carbonic \\n\\tanhydrase activator <206>; #86# activation constant of 0.0157 mM <256>; \\n\\t#147# activation constant of 0.021 mM <262>; #53# micromolar affinity \\n\\tfor Can2 <260>; #40# micromolar affinity for CANce103 <260>; #181# high \\n\\tactivator <328>) <203,206,256,260,262,328>\\nAC\\t#14,20,40,53,62,86,147,181# D-Trp (#86# activation constant of 0.0121 \\n\\tmM <256>; #147# activation constant of 0.019 mM <262>; #181# high \\n\\tactivator <328>) <203,206,256,260,262,328>\\nAC\\t#14,20,40,53,62,86,147,181# D-His (#14# carbonic anhydrase III is \\n\\tefficiently activated by D-His <203>; #86# activation constant of \\n\\t0.0212 mM <256>; #147# activation constant of 0.026 mM <262>; #181# \\n\\tmoderate activator <328>) <203,206,256,260,262,328>\\nAC\\t#14,20,40,53,62,86,181# dopamine (#86# activation constant of 0.0276 mM \\n\\t<256>; #181# high activator <328>) <203,206,256,260,328>\\nAC\\t#14,40,53,86,147# D-Dopa (#86# activation constant of 0.0151 mM <256>; \\n\\t#147# activation constant of 0.089 mM <262>; #40# best activator of \\n\\tCaNce103 <260>; #147# best activator, with an activation constant of \\n\\t0.00018 mM <262>) <203,256,260,262>\\nAC\\t#14,40,53,86,147# 2-(2-aminoethyl)pyridine (#86# activation constant of \\n\\t0.0163 mM <256>; #147# activation constant of 0.107 mM <262>) \\n\\t<203,256,260,262>\\nAC\\t#14,40,53,86,147,181# L-Dopa (#147# activation constant of 0.015 mM \\n\\t<262>; #86# activation constant of 0.0233 mM <256>; #40# best activator \\n\\tof CaNce103 <260>; #181# high activator <328>) <203,256,260,262,328>\\nAC\\t#144# arsenic (V) oxide <426>\\nAC\\t#176# H2O2 (#176# the enzyme loses activity when it was exposed to 3% \\n\\tH2O2 <320>) <320>\\nAC\\t#176# imidazole (#176# addition of 50 mM imidazole to the assay buffer \\n\\tincreases the kcat of the enzyme more than 4fold <320>) <320>\\nAC\\t#176# air (#176# the enzyme loses activity when it was exposed to air \\n\\t<320>) <320>\\nAC\\t#18# SO32- (#18# activates <48>) <48>\\nAC\\t#18# HPO42- (#18# activates <48>) <48>\\nAC\\t#20,62# L-3,4-dihydroxyphenylalanine <206>\\nAC\\t#20,62# D-3,4-dihydroxyphenylalanine <206>\\nAC\\t#20,62,181# 2-pyridylmethylamine (#62# effectively activates \\n\\tZn-gamma-class carbonic anhydrase <206>; #181# moderate activator \\n\\t<328>) <206,328>\\nAC\\t#207# Na2CO3 (#207# about 170% activity at 1 M <444>) <444>\\nAC\\t#207# NaOH (#207# about 180% activity at 10 mM <444>) <444>\\nAC\\t#207# K2CO3 (#207# about 150% activity at 1 M <444>) <444>\\nAC\\t#207# N-methyldiethanolamine (#207# about 190% activity at 2 M <444>) \\n\\t<444>\\nAC\\t#23# acetazolamide (#23# increases carbonic anhydrase activity of \\n\\tphotosystem 2 membranes at concentrations lower than 0.001 mM and \\n\\tsuppresses this activity only at higher concentrations. Carbonic \\n\\tanhydrase activity of photosystem 1 membranes is suppressed <163>) <163>\\nAC\\t#24# Reducing agent (#24# required <56>) <56>\\nAC\\t#50# N2 (#50# increases the growth rate of the cells and the enzyme \\n\\tactivity <313>) <313>\\nAC\\t#50# Phosphorus (#50# increases the growth rate of the cells and the \\n\\tenzyme activity <313>) <313>\\nAC\\t#61# Diamide <346>\\nAC\\t#86# D-Tyr (#86# best activator, activation constant of 0.0071 mM \\n\\t<256>) <256>\\n\\nINHIBITORS\\nIN\\t#1# 1,3-diacetylbenzimidazole-2-thione <285>\\nIN\\t#1# 1,3-diacetyl-1H-benzo[d]imidazol-2(3H)-one (#1# 10% inhibition \\n\\t<285>) <285>\\nIN\\t#1# 1-(3-ethyl-1,2-dihydro-2-thioxobenzo[d]imidazole-1-yl)ethanone <285>\\nIN\\t#1# 1-(3-acetyl-1,2-dihydro-2-thioxobenzo[d]imidazol-1-yl)hexan-1-one \\n\\t<285>\\nIN\\t#1# 1,3-dihydro-2H-benzimidazole-2-thione <285>\\nIN\\t#1# 1-ethyl-1H-benzo[d]imidazole-2(3H)-thione (#1# 28% inhibition \\n\\t<285>) <285>\\nIN\\t#1# 1-(2-thioxo-1H-benzo[d]imidazol-1-yl)ethanone <285>\\nIN\\t#1# 1-(2-thioxo-1H-benzo[d]imidazol-1-yl)propan-1one <285>\\nIN\\t#1# 1-(2-Tthioxo-1H-benzo[d]imidazol-1-yl)butan-1-one <285>\\nIN\\t#1# 1-(2-thioxo-1H-benzo[d]imidazol-1-yl)hexan-1-one <285>\\nIN\\t#1# 1-(2-thioxo-1H-benzo[d]imidazol-1-yl)-3-phenylpropan-1-one <285>\\nIN\\t#1# (3-chlorophenyl)(2-thioxo-1H-benzo[d]imidazol-1-yl)methanone <285>\\nIN\\t#1# 1,3-benzoxazole-2(3H)-thione <285>\\nIN\\t#1# methyl 2-sulfanylbenzo[d]oxazole-5-carboxylate (#1# 27% inhibition \\n\\t<285>) <285>\\nIN\\t#1# 1-(2-thioxobenzo[d]oxazol-3(2H)-yl)ethanone <285>\\nIN\\t#1# 1-(2-thioxobenzo[d]oxazol-3(2H)-yl)propan-1-one <285>\\nIN\\t#1# 1-(2-thioxobenzo[d]oxazol-3(2H)-yl)hexan-1-one <285>\\nIN\\t#1# 1-(2-thioxobenzo[d]oxazol-3(2H)-yl)decan-1-one <285>\\nIN\\t#1# 1-(2-thioxobenzo[d]oxazol-3(2H)-yl)hexadecan-1-one <285>\\nIN\\t#1# 2-phenyl-1-(2-thioxobenzo[d]oxazol-3(2H)-yl)ethanone <285>\\nIN\\t#1# 3-phenyl-1-(2-thioxobenzo[d]oxazol-3(2H)-yl)propan-1-one <285>\\nIN\\t#1# 4-phenyl-1-(2-thioxobenzo[d]oxazol-3(2H)-yl)butan-1-one <285>\\nIN\\t#1# (E)-3-phenyl-1-(2-thioxobenzo[d]oxazol-3(2H)-yl)prop-2-en-1-one \\n\\t(#1# 36% inhibition <285>) <285>\\nIN\\t#1# 3-cyclohexyl-1-(2-thioxobenzo[d]oxazol-3(2H)-yl)propan-1-one <285>\\nIN\\t#1# 2-phenoxy-1-(2-thioxobenzo[d]oxazol-3(2H)-yl)ethanone <285>\\nIN\\t#1# benzyl 2-thioxobenzo[d]oxazol-3(2H)-carboxylate <285>\\nIN\\t#1# \\n\\tmethyl-3-(3-phenylpropanoyl)-2,\\n\\t3-dihydro-2-thioxobenzo[d]oxazole-5-carboxylate <285>\\nIN\\t#1# 3-acetylbenzo[d]oxazol-2(3H)-one <285>\\nIN\\t#1# 3-hexanoylbenzo[d]oxazol-2(3H)-one <285>\\nIN\\t#1# 3-ethylbenzo[d]oxazole-2(3H)-thione (#1# 17% inhibition <285>) <285>\\nIN\\t#1,23,66# PCMB (#23# 0.25 mM, complete inhibition after 10 min <39>; \\n\\t#66# reversible with 5 mM dithiothreitol <9>) <9,34,39>\\nIN\\t#1,5,10,11,12,14,17,18,19,20,21,23,24,26,28,29,32,35,40,43,44,45,47,48,\\n\\t51,53,54,58,59,62,63,67,71,72,73,74,78,79,82,85,87,88,89,90,92,97,99,\\n\\t100,102,104,107,111,112,118,119,120,122,123,124,125,126,127,128,129,130,\\n\\t131,132,133,134,135,147,150,151,152,153,154,155,156,157,158,159,160,161,\\n\\t162,167,172,175,178,179,185,191,194,195,196,197,198,200,205,206,207,208,\\n\\t218,220,222,229,230,231,237,238# acetazolamide (#18# weak <3>; #122# \\n\\tstrong inhibition <308>; #191# competitive inhibitor <441>; #1# \\n\\tcarbonic anhydrase A is 100times less sensitive than carbonic anhydrase \\n\\tC <22>; #1# carbonic anhydrase A is completely inhibited at 1 mM, \\n\\tcarbonic anhydrase C is completely inhibited at 0.01 mM <22>; #18# 100 \\n\\tmM, the firmly-membrane-associated activity is less sensitive to \\n\\tinhibition than the loosely-membrane associated enzyme <60>; #1# \\n\\tinhibits CO2 hydration and esterase activity <34>; #73# 0.001 mM , 50% \\n\\tinhibition <54>; #5# complete inhibition above 0.01 mM <24>; #47# \\n\\tisoenzyme I <26>; #18# uncompetitive inhibitor <248>; #197# strong \\n\\tinhibition at 5 mM <374>; #99# IC50: 0.4 mM <160>; #102# noncompetitive \\n\\treversible inhibitor <128>; #100# IC50: 97 nM <161>; #133# carbonic \\n\\tanhydrase XIII <175>; #126# cytosolic isoenzyme <176>; #23# increases \\n\\tcarbonic anhydrase activity of photosystem 2 membranes at \\n\\tconcentrations lower than 0.001 mM and suppresses this activity only at \\n\\thigher concentrations. Carbonic anhydrase activity of photosystem 1 \\n\\tmembranes is suppressed <163>; #126# inner peripheral isoenzyme <176>; \\n\\t#126# integral isoenzyme <176>; #99# isoenzyme gammaCA <169>; #127# \\n\\tisoenzyme hCA I <169>; #124# isoenzyme hCA II <169>; #125# isoenzyme \\n\\thCA III <169>; #128# isoenzyme hCA IV <169>; #120# isoenzyme hCA IX \\n\\t<169>; #129# isoenzyme hCA VA <169>; #130# isoenzyme hCA VB <169>; \\n\\t#131# isoenzyme hCA VI <169>; #132# isoenzyme hCA VII <169>; #119# \\n\\tisoenzyme hCA XII <169>; #118# isoenzyme hCA XIV <169>; #134# isoenzyme \\n\\thpalphaCA <169>; #135# isoenzyme hpbetaCA <169>; #133# isoenzyme mCA \\n\\tXIII <169>; #126# outer peripheral isoenzyme <176>; #82# a \\n\\tnon-membrane-permeable carbonic anhydrase inhibitor <242>; #150# highly \\n\\tinhibited by acetazolamide, i.e. \\n\\t5-acetamido-1,3,4-thiadiazole-2-sulfonamide <222>; \\n\\t#12,14,17,53,120,124,127,131,162# i.e. \\n\\t5-acetamido-1,3,4-thiadiazole-2-sulfonamide <200,204,207,257,386,445>; \\n\\t#124# promiscuous inhibitor of all isozymes except CA III <229>; #17# \\n\\tshows effective carbonic anhydrase inhibitory activity <210>; #14# \\n\\tsystemic carbonic anhydrase inhibitor <228>; #11# 62% residual activity \\n\\tat 1 mM <264>; #32# effective, submicromolar inhibition <276>; #26# at \\n\\t0.5 mM inhibition of the cabonic anhydrase activity of the high \\n\\tmolecular mass protein and stimulation of activity of the low molecular \\n\\tmass carrier in the PSII-membranes. At 0.5 mM acetazolamide moderately \\n\\tinhibits the carbonic anhydrase activity of PSI membranes <345>; \\n\\t#88,90# at very low CO2 concentrations enzyme inhibition reduces \\n\\tphotosynthesis <347>; #200# 5-acetamido-1,3,4-thiadiazole-2-sulfonamide \\n\\t<399>; #195# 5-acetamido-1,3,4-thiadiazole-2-sulfonamide, AAZ <362>; \\n\\t#120,124,127# AAZ, a sulfonamide inhibitor <369>; #208# about 70% \\n\\tinhibition at 1 mM <363>; #207# AZM, strong inhibitor <360>; #218# \\n\\tbinding structure analysis, overview. Each unit cell is comprised of \\n\\tfour dimers of CrCAH3 <403>; #196# inhibits the CO2 hydrase activity of \\n\\tPgiCAb <383>; #205,206# sulfonamide CA inhibitor (CAI) <358,359>; #194# \\n\\tthe recombinant MgaCA shows a very similar acetazolamide inhibition \\n\\tfeatures when compared to those of the native enzyme (MgaCA) <389>; \\n\\t#231# potent inhibitor, complete inhibition at 0.005 mM <442>) \\n\\t<2,3,6,11,14,15,16,17,22,24,26,34,35,39,41,47,50,51,53,54,56,59,60,61,\\n\\t68,75,79,96,102,118,120,127,128,131,132,133,135,141,143,146,148,150,153,\\n\\t160,161,163,169,175,176,182,184,190,196,200,201,202,204,205,207,208,210,\\n\\t211,222,223,226,228,229,230,238,239,242,247,248,255,257,258,259,261,264,\\n\\t268,270,271,272,274,275,276,277,278,282,296,297,298,300,301,302,304,308,\\n\\t318,329,330,337,339,342,343,345,347,358,359,360,361,362,363,365,369,374,\\n\\t376,377,383,384,386,387,388,389,391,393,399,403,408,409,410,412,414,415,\\n\\t416,417,428,430,431,432,433,434,437,438,439,440,441,442,443,445>\\nIN\\t#10,11,18,21,34,43,80,83,191,197,219,234# Pb2+ (#21# uncompetitive \\n\\tinhibition <380>; #11# 33% residual activity at 1 mM <264>; #43# 46.6% \\n\\tresidual activity at 1 mM <282>; #80# competitive, moderate inhibition \\n\\tof carbonic anhydrase esterase activity <306>; #197# inhibits by 30% at \\n\\t5 mM <374>; #234# uncompetive inhibition <424>) \\n\\t<142,264,282,306,309,368,374,380,404,424>\\nIN\\t#10,12,13,14,18,19,23,24,26,29,61,71# ethoxyzolamide (#23# effectively \\n\\tsuppresses the carbonic anhydrase activity of photosystem 2 membranes. \\n\\tCarbonic anhydrase activity of PS1 membranes is suppressed alike by \\n\\tboth inhibitors <163>) <8,15,35,47,50,52,56,68,143,163,239,335,345,346>\\nIN\\t#10,12,17,20,40,43,44,49,53,62,99,125,133,147,167,208# azide (#17# weak \\n\\tinhibition <207>; #125# best inhibitor <227>; #99# IC50: 3.4 mM <160>; \\n\\t#133# carbonic anhydrase XIII <175>; #12# shows low micromolar \\n\\tinhibition against CA XV <253>; #208# about 30% inhibition at 1 mM \\n\\t<363>; #62# weak inhibitor of the Zn(II)-substituted enzyme <316>) \\n\\t<112,160,175,178,204,207,208,227,239,253,272,282,300,316,363>\\nIN\\t#10,12,17,40,43,53,62,99,125,133,167# cyanide (#17# weak inhibition \\n\\t<207>; #125# best inhibitor <227>; #53# weak inhibitor <204>; #40# \\n\\tpotent inhibitor <204>; #99# IC50: 0.31 mM <160>; #167# high inhibition \\n\\t<300>; #133# carbonic anhydrase XIII <175>; #12# shows low micromolar \\n\\tinhibition against CA XV <253>) \\n\\t<160,175,204,207,227,239,253,282,300,316>\\nIN\\t#10,21,22,58,80,107,122,144,191,197,219,221,234# Cu2+ (#122# weak \\n\\tinhibition <308>; #21,58# uncompetitive inhibition <246,380>; #58# \\n\\tcopper inhibits noncompetitively <199>; #80# competitive, very strong \\n\\tinhibition of carbonic anhydrase esterase activity <306>; #197# \\n\\tinhibitits by 80-100% at 5 mM <367>; #197# inhibits completely at 5 mM, \\n\\t66% inhibition at 1 mM <374>; #234# uncompetive inhibition <424>) \\n\\t<69,142,146,199,246,306,308,366,367,368,374,380,404,424,426>\\nIN\\t#10,22,58,62,80,106,122,197,233# Zn2+ (#122# weak inhibition <308>; \\n\\t#58# competitive inhibition <246>; #58# zinc inhibits uncompetitively \\n\\t<199>; #80# competitive, strong inhibition of carbonic anhydrase \\n\\testerase activity <306>; #62# the enzyme binds three catalytic Zn2+ \\n\\tions at symmetry-related subunit interfaces. Zinc binding drives the \\n\\tfolding and association of the homotrimeric enzyme <322>; #197# \\n\\tinhibits by 95% at 5 mM <374>; #106,233# the addition of 2 mM Zn2+ \\n\\tnegatively affects the enzyme activity <419>) \\n\\t<69,142,199,246,306,308,322,374,419>\\nIN\\t#11,14,15,18,20,21,29,43,48,58,62,71,74,92,99,102,104,118,119,120,126,\\n\\t162,208# sulfanilamide (#58# noncompetitive <177>; #18# uncompetitive \\n\\tinhibitor <248>; #102# noncompetitive reversible inhibitor <128>; #18# \\n\\tuncompetitive inhibition of outer peripheral, cytosolic, inner \\n\\tperipheral and integral isoenzyme <149>; #126# integral isoenzyme \\n\\t<176>; #126# outer peripheral isoenzyme <176>; #162# quite weak CA 1 \\n\\tinhibitor <257>; #208# about 70% inhibition at 1 mM <363>) \\n\\t<2,6,7,15,23,35,51,53,124,128,141,148,149,160,176,177,248,257,261,264,\\n\\t268,282,296,318,333,363>\\nIN\\t#11,18,21,22,23,34,43,80,83,181,191,197,234# Hg2+ (#11# complete \\n\\tinhibition at 1 mM <264>; #21# uncompetitive inhibition <380>; #43# \\n\\t40.9% residual activity at 1 mM <282>; #80# competitive, strong \\n\\tinhibition of carbonic anhydrase esterase activity <306>; #197# \\n\\tinhibitits by 80-100% at 5 mM <367>; #197# inhibits completely at 5 mM, \\n\\t78% inhibition at 1 mM <374>; #234# uncompetive inhibition <424>) \\n\\t<39,69,264,282,306,309,367,374,380,404,421,424>\\nIN\\t#11,18,34,43,83# Ca2+ (#11# 72% residual activity at 1 mM <264>; \\n\\t#18,34,43,83# 25% inhibition at 0.2 mM <309>) <264,309>\\nIN\\t#11,43,197# EDTA (#11# complete inhibition at 1 mM <264>; #43# 71.49% \\n\\tresidual activity at 1 mM <282>) <264,282,374>\\nIN\\t#11,94# Mn2+ (#11# 73% residual activity at 1 mM <264>) <264,425>\\nIN\\t#110,118,120,124,125,127,128,129,130,131,132,133# \\n\\t2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide (#127# isoenzyme \\n\\thCA I <171>; #124# isoenzyme hCA II <171>; #125# isoenzyme hCA III \\n\\t<171>; #128# isoenzyme hCA IV <171>; #120# isoenzyme hCA IX <171>; \\n\\t#129# isoenzyme hCA VA <171>; #130# isoenzyme hCA VB <171>; #131# \\n\\tisoenzyme hCA VI <171>; #132# isoenzyme hCA VII <171>; #110# isoenzyme \\n\\thCA XII <171>; #118# isoenzyme hCA XIV catalytic domain <171>; #133# \\n\\tisoenzyme mCA XIII <171>; #124# efficient inhibitor of only isozymes CA \\n\\tI and II <229>) <171,229>\\nIN\\t#118# \\n\\t3-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]-2,5,\\n\\t6-trifluoro-4-(2-phenylethanesulfonyl)benzene-1-sulfonamide <381>\\nIN\\t#118# \\n\\t3-(benzylamino)-2,5,\\n\\t6-trifluoro-4-(2-hydroxyethanesulfonyl)benzene-1-sulfonamide <381>\\nIN\\t#118# \\n\\t3-[[(3,4-dimethoxyphenyl)methyl]amino]-2,5,\\n\\t6-trifluoro-4-(2-hydroxyethanesulfonyl)benzene-1-sulfonamide <381>\\nIN\\t#118# \\n\\t3-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]-2,5,\\n\\t6-trifluoro-4-(2-hydroxyethanesulfonyl)benzene-1-sulfonamide <381>\\nIN\\t#118# \\n\\t2,3,6-trifluoro-4-(2-hydroxyethanesulfonyl)-5-[[(1S)-1,2,3,\\n\\t4-tetrahydronaphthalen-1-yl]amino]benzene-1-sulfonamide <381>\\nIN\\t#118,119,120# 4-aminoethylbenzenesulfonamide <141>\\nIN\\t#118,119,120,124,125,127,128,129,130,131,132,133# \\n\\t2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide (#127# \\n\\tisoenzyme hCA I <172>; #124# isoenzyme hCA II <172>; #125# isoenzyme \\n\\thCA III <172>; #128# isoenzyme hCA IV <172>; #120# isoenzyme hCA IX \\n\\t<172>; #129# isoenzyme hCA VA <172>; #130# isoenzyme hCA VB <172>; \\n\\t#131# isoenzyme hCA VI <172>; #132# isoenzyme hCA VII <172>; #119# \\n\\tisoenzyme hCA XII <172>; #118# isoenzyme hCA XIV <172>; #133# isoenzyme \\n\\tmCA XIII <172>) <172>\\nIN\\t#118,119,120,124,125,127,128,129,130,131,132,133,167,228# \\n\\thydrochlorothiazide (#127# isoenzyme hCA I <169>; #124# isoenzyme hCA \\n\\tII <169>; #125# isoenzyme hCA III <169>; #128# isoenzyme hCA IV <169>; \\n\\t#120# isoenzyme hCA IX <169>; #129# isoenzyme hCA VA <169>; #130# \\n\\tisoenzyme hCA VB <169>; #131# isoenzyme hCA VI <169>; #132# isoenzyme \\n\\thCA VII <169>; #119# isoenzyme hCA XII <169>; #118# isoenzyme hCA XIV \\n\\t<169>; #133# isoenzyme mCA XIII <169>) <169,300,436>\\nIN\\t#118,119,120,133# homosulfanilamide (#133# carbonic anhydrase XIII \\n\\t<175>) <141,175>\\nIN\\t#118,124,131# trifluoromethanesulfonamide (#118# U-shaped pH-dependence \\n\\tof the Gibbs energy of binding, the affinity is greatest in the near \\n\\tneutral pH region and diminished towards both the acidic and alkaline \\n\\tregions <381>) <381,446>\\nIN\\t#118,131# \\n\\t2,3,5,6-tetrafluoro-4-(2-phenylethanesulfonyl)benzene-1-sulfonamide \\n\\t(#131# VD11-10 <446>) <381,446>\\nIN\\t#119,120,124,127# N-hydroxysulfamide (#127# isoenzyme hCA I <168>; \\n\\t#120# isoenzyme hCA IX <168>; #119# isoenzyme hCA XII <168>; #124# the \\n\\tinhibitor coordinates to the active site zinc ion by the ionized \\n\\tprimary amino group, participating in an extended network of hydrogen \\n\\tbonds with amino acid residues Thr199, Thr200 and two water molecules, \\n\\tisoenzyme hCA II <168>) <168>\\nIN\\t#119,120,124,127# 4-phenylbenzene-1-sulfonamide <365>\\nIN\\t#119,120,124,127# 4-(2-methylphenyl)benzene-1-sulfonamide <365>\\nIN\\t#119,120,124,127# 4-(3-formylphenyl)benzene-1-sulfonamide <365>\\nIN\\t#119,120,124,127# 4-(3-quinolinyl)benzene-1-sulfonamide <365>\\nIN\\t#119,120,124,127# [[(eta5-C5H4)-CH=N-N(H)-C6H4-4-SO2NH2]]re(CO)3 <437>\\nIN\\t#119,120,124,127# [[(eta5-C5H4)-C(CH3)=N-N(H)-C6H4-4-SO2NH2]]re(CO)3 \\n\\t<437>\\nIN\\t#119,120,124,127# [[(eta5-C5H4)-CH=N-N(H)-C6H4-4-SO2NH2]]Mn(CO)3 <437>\\nIN\\t#119,120,124,127# [[(eta5-C5H4)-C(CH3)=N-N(H)-C6H4-4-SO2NH2]]Mn(CO)3 \\n\\t<437>\\nIN\\t#119,120,124,127# [[(eta5-C5H4)-CH=N-N(H)-C6H4-4-SO2NH2]]FeCp <437>\\nIN\\t#119,120,124,127# [[(eta5-C5H4)-C(CH3)=N-N(H)-C6H4-4-SO2NH2]]FeCp <437>\\nIN\\t#119,127# tert-butyl \\n\\t(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate \\n\\t<387>\\nIN\\t#12# paracetamol <201>\\nIN\\t#12# clioquinol <201>\\nIN\\t#12# benzene-1,4-diol <201>\\nIN\\t#12# 2,5-difluorophenol <201>\\nIN\\t#12# 3,5-difluorophenol <201>\\nIN\\t#12# 4-hydroxybenzoic acid <201>\\nIN\\t#12# 4-Aminophenol <201>\\nIN\\t#12# 4-Hydroxybenzonitrile <201>\\nIN\\t#12,124# EMD 486019 (#124# EMD 486019 acts as a strong inhibitor of \\n\\tisozymes carbonic anhydrase II, VB, VII, IX, XII, and XIV <202>) <202>\\nIN\\t#12,124# 667-coumate <202>\\nIN\\t#12,127# benzene-1,2-diol (#127# inhibition of isozyme hCA I <392>) \\n\\t<201,392>\\nIN\\t#12,127# benzene-1,3-diol (#127# inhibition of isozyme hCA I <392>) \\n\\t<201,392>\\nIN\\t#12,14,120,124,127# phenol (#127# inhibition of isozyme hCA I <392>; \\n\\t#124# inhibition of isozyme hCA II <392>) <201,261,299,386,392>\\nIN\\t#12,14,120,124,127# salicylic acid (#14# noncompetitive inhibition of \\n\\tisozymes carbonic anhydrase I and II <209>) <201,209,386>\\nIN\\t#12,14,17,18,19,29,32,53,85,124,125,131,147,162,167,172,228# \\n\\tbenzolamide (#18# apical CAIV is inhibited by about 20% by 0.01 mM \\n\\tbenzolamide <218>; #17# shows effective carbonic anhydrase inhibitory \\n\\tactivity <210>) \\n\\t<15,68,120,157,167,184,196,210,218,230,231,259,275,276,277,300,408,436>\\nIN\\t#12,14,17,18,20,28,34,40,43,44,53,62,83,124,125,133,147,167,208# \\n\\tnitrate (#133# weak, carbonic anhydrase XIII <175>; #62# good inhibitor \\n\\tof the Co(II)-substituted enzyme <316>; #208# about 70% inhibition at 1 \\n\\tmM <363>; #124# mutants M3 and M4 are more resistent against inhibition \\n\\tby nitrate compared to wild-type and mutants M1 and M2 <397>; #28# low \\n\\tmillimolar inhibitor <443>) \\n\\t<101,112,175,204,207,208,227,253,272,282,300,309,316,363,397,443>\\nIN\\t#12,14,17,18,20,28,40,42,45,53,62,80,85,91,99,106,118,119,120,124,127,\\n\\t128,132,162,167,191,193,195,203,205,206,212,213,220,222,233,238# more \\n\\t(#12,118# overview <175>; #18# dianionic inhibitors depress the rate of \\n\\tH+ transfer during turnover by stabilizing the protonated from of Lys64 \\n\\t<48>; #14# insensitive to bromopyruvate <2>; #106,233# not inhibited by \\n\\tEDTA <419>; #53# Can2 is not inhibited by perchlorate <204>; #14# \\n\\tNaClO4 is not inhibitory <228>; #14# not inhibited by acetazolamide \\n\\t<234>; #17# not inhibited by perchlorate <207>; #45# not inhibited by \\n\\tquinine, qinghausu, and chloroquine <205>; #40# perchlorate is not an \\n\\tinhibitor in concentrations up to 200 mM <204>; #42# the epipodites and \\n\\tantennal gland display decreased levels of mRNA expression and stable \\n\\tenzyme activity at 24 h after hypo-osmotic stress <214>; #12# isoform \\n\\tCA XV is not inhibited by tetrafluoroborate <253>; #14# an additional \\n\\t3-fluoro substituent on the 4-amino-benzenesulfonamide scaffold of \\n\\tinhibitors alters the inhibition profiles against the cytosolic \\n\\tisozymes hCA I, II, III, VII and XIII, interaction analysis, overview. \\n\\tThe binding differences render the inhibitors more isozyme-specific. \\n\\tDocking studies, overview <302>; #162# best bsCA II inhibitors are some \\n\\tglycosylated sulfanilamides, aliphatic sulfamates, and halogenated \\n\\tsulfanilamides <298>; #17# bromide, iodide and sulfamide, are the best \\n\\tanion inhibitors, with Ki values of 0.0087-0.0108 mM. \\n\\tBenzenesulfonamides substituted in 2-, 4- and 3,4-positions with amino, \\n\\talkyl, halogeno and hydroxyalkyl moieties have Ki values in the range \\n\\tof 0.000976-0.01845 mM. Better inhibition with Ki values in the range \\n\\tof 154-654 nM is observed for benzenesulfonamides incorporating \\n\\taminoalkyl/carboxyalkyl moieties or halogenosulfanilamides, \\n\\tbenzene-1,3-disulfonamides, simple heterocyclic sulfonamides and \\n\\tsulfanilyl-sulfonamides. The clinically used sulfonamides/sulfamates, \\n\\te.g. acetazolamide, ethoxzolamide, methazolamide, dorzolamide, \\n\\ttopiramate, celecoxib, generally show effective scCA inhibitory \\n\\tactivity, with Ki values in the range of 82.6-133 nM, overview <305>; \\n\\t#14# carbonic anhydrases are inhibited by sulfonamides, inorganic \\n\\tanions, phenols, coumarins (acting as prodrugs) and polyamines. \\n\\tDevelopment of hydroxy-, methoxy-substituted benzoic acids as well as \\n\\tdi-, tri-methoxy benzenes as submicromolar-low micromolar inhibitors of \\n\\tcarbonic anhydrase isozymes, molecular docking and inhibition \\n\\tmechanism, overview <299>; #14# development and synthesis of a series \\n\\tof compounds incorporating regioisomeric \\n\\tphenylethynylbenzenesulfonamide moieties, analysis of potential as \\n\\tinhibitors of the four human isozymes, hCA I, hCA II, hCA IX, and hCA \\n\\tXII. The position of the sulfamoyl group with respect to the alkyne \\n\\tfunctionality, and the nature of the moieties substituting the second \\n\\taromatic ring are the principal structural features influencing CA \\n\\tinhibition. The para-sulfamoyl-substituted derivatives are effective \\n\\tinhibitors of CA IX and XII, the meta-substituted regioisomers of CA I, \\n\\tX and XII, whereas the ortho-substituted sulfonamides ae weak \\n\\tinhibitors of CA I, II and IX, but inhibit ignificantly CA XII, \\n\\tstructure-activity relationship study, overview <296>; #14# \\n\\tN-beta-glycosyl sulfamides are selective inhibitors of the \\n\\tcancer-associated carbonic anhydrase isoforms IX and XII <294>; #167# \\n\\tno inhibition by perchlorate <300>; #124# no inhibition of HCA II by \\n\\tcitrate and no conformational changes of amino-acid side chains as a \\n\\tresult of the use of citrate at pH 6.0-11.0 <286>; #14# some natural \\n\\tphenols show effective hCA II inhibitory effects, in the same range as \\n\\tthe clinically used sulfonamide acetazolamide, and might be used as \\n\\tleads for generating enzyme inhibitors possibly targeting other CA \\n\\tisozymes <304>; #14# synthesis of \\n\\t2-[(p-toluenesulfonamido)-N-yl]-l,3,4-thiadiazole-5-sulfonamide \\n\\tinhibitors, inhibitory potencies versus isozymes CAII, docking study, \\n\\toverview <301>; #14# synthesis of two series of disubstituted coumarins \\n\\tincorporating ether and acetyl/propionyl moieties in positions 6,7 and \\n\\t7,8 of the heterocyclic ring. The compounds are very weak or \\n\\tineffective as inhibitors of the housekeeping, offtarget isozymes CA I \\n\\tand CA II. The 6,7-disubstituted series show ineffective inhibition \\n\\talso for the transmembrane tumor-associated isoforms CA IX and XII, \\n\\twhereas the corresponding isomeric 7,8-disubstituted coumarins show \\n\\tnanomolar/subnanomolar inhibition of CA IX/XII, overview. No inhibition \\n\\tby 12 and 13 <293>; #80# the inhibitory metals might be dangerous at \\n\\tlow micromolar concentrations for fish carbonic anhydrase enzymes \\n\\t<306>; #20# fluoride, chloride, and sulfate do not inhibit the enzyme \\n\\tappreciably <317>; #99# fluoride, chloride, and sulfate do not inhibit \\n\\tthe Zn2+-substituted enzyme and the Co2+-substituted enzyme appreciably \\n\\t<316>; #62# Zn(II)- and Co(II)-substituted enzymes show a very \\n\\tdifferent behavior against anion inhibitors.The best Zn-Cam anion \\n\\tinhibitors are hydrogen sulfide and cyanate whereas thiocyanate, azide, \\n\\tcarbonate, nitrite, and hydrogensulfite are weaker inhibitors. The \\n\\tinhibition of the Zn(II)-substituted enzyme by sulfide is puzzling \\n\\tsince Cam is proposed to be located outside the cytoplasmic membrane \\n\\twhere it is exposed to high levels of sulfide in the anaerobic \\n\\tenvironments. The best inhibitors of the Co(II)-substituted enzyme is \\n\\tcarbonate, followed by nitrate and hydrogencarbonate. Fluoride, \\n\\tchloride, and sulfate do not inhibit either Zn(II)- or \\n\\tCo(II)-substituted enzyme appreciably up to concentrations of 200 mM. \\n\\tThis lack of inhibition may represent an adaptation to marine \\n\\tenvironments high in chloride and sulfate <316>; #120,124,127,128# \\n\\t2-benzylpiperazine is a scaffold for potent human carbonic anhydrase \\n\\tinhibitors, compounds synthesis, enzyme inhibition, and \\n\\tenantioselectivity, overview <369>; #118# \\n\\t3-[[(3,4-dimethoxyphenyl)methyl]amino]-2,5,\\n\\t6-trifluoro-4-(2-hydroxyethanesulfonyl)benzene-1-sulfonamide does not \\n\\texhibit selectivity for CA XIV <381>; #193# antimony(III) complexes \\n\\tinhibit alpha-carbonic anhydrase isozyme II from bovine erythrocytes. \\n\\tNo inhibition by 5 <400>; #213# antimony(III) complexes inhibit \\n\\tglutathione reductase activity of chloroplast, and a number of them \\n\\talso exhibit good inhibitory efficiency against the photosynthetic and \\n\\tcarbonic anhydrase activity of Pisum sativum photosystem II <400>; \\n\\t#127# benzothiazole derivative inhibitor synthesis, overview <387>; \\n\\t#124# benzothiazole derivative inhibitor synthesis, overview. No \\n\\tinhibition by benzyl \\n\\t(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate,\\n\\t tert-butyl \\n\\t(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate,\\n\\t (S)-tert-butyl \\n\\t(1-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-\\n\\t2-yl)carbamate, (S)-tert-butyl \\n\\t(1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxo-3-phenylpropan-\\n\\t2-yl)carbamate, benzyl \\n\\t(2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, \\n\\ttert-butyl \\n\\t(2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-carbamate, \\n\\t(S)-benzyl \\n\\t(1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, \\n\\t(S)-tert-butyl \\n\\t(1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, \\n\\t(S)-tert-butyl \\n\\t(1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-\\n\\tyl)carbamate, and \\n\\t(S)-2-(2-ammoniopropanamido)-4-methylbenzo[d]thiazol-3-ium \\n\\tdi-2,2,2-trifluoroacetate <387>; #128# benzothiazole derivative \\n\\tinhibitor synthesis, overview. No inhibition by benzyl \\n\\t(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate,\\n\\t tert-butyl \\n\\t(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate,\\n\\t (S)-tert-butyl \\n\\t(1-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-\\n\\t2-yl)carbamate, benzyl \\n\\t(2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate,\\n\\t tert-butyl \\n\\t(2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate,\\n\\t (S)-benzyl \\n\\t(1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxopropan-2-\\n\\tyl)carbamate, (S)-tert-butyl \\n\\t(1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxo-3-phenylpropan-\\n\\t2-yl)carbamate, benzyl \\n\\t(2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, \\n\\ttert-butyl \\n\\t(2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-carbamate, \\n\\t(S)-benzyl \\n\\t(1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, \\n\\t(S)-tert-butyl \\n\\t(1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, \\n\\t(S)-tert-butyl \\n\\t(1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-\\n\\tyl)carbamate, and \\n\\t(S)-2-(2-ammoniopropanamido)-4-methylbenzo[d]thiazol-3-ium \\n\\tdi-2,2,2-trifluoroacetate <387>; #193# carbohydrazones as another class \\n\\tof carbonic anhydrase inhibitors, synthesis, kinetics, and ligand \\n\\tdocking studies, overview. Single crystal X-ray diffraction, structural \\n\\tcoordinates of bovine carbonic anhydrase (PDB ID 1V9E) is used for \\n\\tdocking of carbohydrazone compounds, three-dimensional structure \\n\\tanalysis. No inhibition by \\n\\tN,N-bis[(E)-(4-chlorophenyl)methylidene]carbonic dihydrazide, \\n\\tN,N-bis[(E)-(2-fluorophenyl)methylidene]carbonic dihydrazide, \\n\\tN,N-bis[(E)-phenylmethylidene]carbonic dihydrazide, \\n\\tN,N-bis[(E)-(2-hydroxyphenyl)methylidene]carbonic dihydrazide, \\n\\tN,N-bis[(E)-(3-hydroxyphenyl)methylidene]carbonic dihydrazide, \\n\\tN,N-bis[(E)-(4-hydroxyphenyl)methylidene]carbonic dihydrazide, \\n\\tN,N-bis[(E)-(2,3-dihydroxyphenyl)methylidene]carbonic dihydrazide, \\n\\tN,N-bis[(E)-(2,5-dihydroxyphenyl)methylidene]carbonic dihydrazide, \\n\\tN,N-bis[(E)-(5-bromo-2-hydroxyphenyl)methylidene]carbonic dihydrazide, \\n\\tN,N-bis[(E)-(2,4,6-trihydroxyphenyl)methylidene]carbonicdihydrazide, \\n\\tN,N-bis[(E)-(2,3,4-trihydroxyphenyl)methylidene]carbonic dihydrazide, \\n\\tN,N-bis[(E)-(2-methoxyphenyl)methylidene]carbonic dihydrazide, \\n\\tN,N-bis[(E)-(3-methoxyphenyl)methylidene]carbonic dihydrazide, \\n\\tN,N-bis[(E)-(4-methoxyphenyl)methylidene]carbonic dihydrazide, \\n\\tN,N-bis[(E)-(2-hydroxy-5-methoxyphenyl)methylidene]carbonic \\n\\tdihydrazide, \\n\\tN,N-bis[(E)-(2-hydroxy-3-methoxyphenyl)methylidene]carbonic \\n\\tdihydrazide, N,N-bis[(E)-(3-ethoxy-2-hydroxyphenyl)methylidene]carbonic \\n\\tdihydrazide, and N,N-bis[(E)-(3,4-dimethoxyphenyl)methylidene]carbonic \\n\\tdihydrazide <357>; #120# development and synthesis of a class of CA IX \\n\\tinhibitors that comprise a sulfamate as the zinc binding group, a \\n\\tvariable linker, and a carbohydrate tail moiety <394>; #220# fluoride, \\n\\tsulfate, perchlorate and tetrafluoroborate do not inhibit appreciably \\n\\tNcoCA, whereas the other halides, pseudohalides, bicarbonate, nitrate, \\n\\tnitrite and many complex inorganic anions cause inhibition in the \\n\\tmillimolar range <361>; #212# inhibitor molecular docking simulations \\n\\tusing the three-dimensional structure of the thiocyanate-bound Mtb \\n\\tRv1248 enzyme, PDB ID 1YLK, binding structures, overview <398>; #212# \\n\\tinhibitor molecular docking simulations using the three-dimensional \\n\\tstructure of the thiocyanate-bound Mtb Rv3588c enzyme, PDB ID 2A5V, \\n\\tbinding structures, overview <398>; #127# inhibitor synthesis and \\n\\tisozyme in silico docking study using enzyme structure, PDB ID 2FW4, \\n\\tmodeling <386>; #120# inhibitor synthesis and isozyme in silico docking \\n\\tstudy using enzyme structure, PDB ID 3IAI, modeling. No inhibition by \\n\\tpyrogallol <386>; #124# inhibitor synthesis and isozyme in silico \\n\\tdocking study using enzyme structure, PDB ID 5AML, modeling <386>; \\n\\t#119# inhibitor synthesis, overview. No inhibition by benzyl \\n\\t(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate,\\n\\t (S)-tert-butyl \\n\\t(1-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-\\n\\t2-yl)carbamate, benzyl \\n\\t(2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate,\\n\\t tert-butyl \\n\\t(2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate,\\n\\t (S)-benzyl \\n\\t(1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxopropan-2-\\n\\tyl)carbamate, (S)-tert-butyl \\n\\t(1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxo-3-phenylpropan-\\n\\t2-yl)carbamate, benzyl \\n\\t(2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate, \\n\\ttert-butyl \\n\\t(2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-carbamate, \\n\\t(S)-benzyl \\n\\t(1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, \\n\\t(S)-tert-butyl \\n\\t(1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate, \\n\\t(S)-tert-butyl \\n\\t(1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-\\n\\tyl)carbamate, and \\n\\t(S)-2-(2-ammoniopropanamido)-4-methylbenzo[d]thiazol-3-ium \\n\\tdi-2,2,2-trifluoroacetate <387>; #127# isozyme hCA I is inhibited by \\n\\tflavonoids, poor inhibition by pelargonin <378>; #124# isozyme hCA II \\n\\tis inhibited by flavonoids, poor inhibition by pelargonin <378>; #206# \\n\\tno inhibition by fluoride, iodide, chloride, azide, sulfate, P2O74-, \\n\\tV2O74-, ReO4-, chlorate, tetrafluoroborate, PF6-, and CF3SO3- <358>; \\n\\t#205# perchlorate, tetrafluoroborate, azide, fluoride, and bromide are \\n\\tnot inhibitory for the enzyme <359>; #120,124# presence of D2O reduces \\n\\tcatalysis, but does not change how it proceeds <352>; #124,127# some \\n\\turacil derivatives have carbonic anhydrase inhibitory properties, \\n\\toverview <392>; #222# strongest inhibitors of enzyme CA are aromatic or \\n\\theteroaromatic sulfonamides <377>; #127# structure-activity \\n\\trelationships of benzenesulfonamide-based inhibitors towards carbonic \\n\\tanhydrase isoform specificity, inhibition of different human isozymes, \\n\\tin silico modeling of inhibitors in CA I, oveview <365>; #119,120,124# \\n\\tstructure-activity relationships of benzenesulfonamide-based inhibitors \\n\\ttowards carbonic anhydrase isoform specificity, inhibition of different \\n\\thuman isozymes, overview <365>; #91# sulfate, sulfide, azide, nitrate, \\n\\tnitrite and iodide exhibit strong inhibitory activity in the micromolar \\n\\trange (Ki values of 5.5-15.5 mM). Cyanide, bromide, chloride, and \\n\\tcarbonate are moderate inhibitors, whereas other anions show only weak \\n\\tactivities. The anions inhibit enzyme HmCA in a similar manner to other \\n\\talpha-CAs from mammals, but the susceptibility to various anions \\n\\tdiffers significantly between the Halomonas sp. and other organism CAs, \\n\\toverview <385>; #195# sulfonamides CA inhibitors generally show much \\n\\tweaker inhibitory activity against PfCAdom compared to truncated PfCA \\n\\t<362>; #124# synthesis, X-ray structure, in silico calculation, and \\n\\tcarbonic anhydrase inhibitory properties of benzylimidazole metal \\n\\tcomplexes, i.e. three coordination compounds of formula [M(bmim)2Cl2], \\n\\tcrystal structures of metal complexes, overview. Each complex \\n\\tincorporates 1-benzyl-2-methylimidazole (bmim) as ligand. The \\n\\tcoordination polyhedron around the metal center for all complexes has a \\n\\tquasi-regular tetragonal geometry. In the 1-benzyl-2-methylimidazole \\n\\tligand, imidazole moiety is connected to phenyl cycle via a methylene \\n\\tlinker. Density functional theory calculations are carried out on the \\n\\ttitle compounds, with Co2+, Zn2+, and Hg2+, and as well on hypothetical \\n\\tcomplexes (with Cu2+, Ni2+) in order to elucidate their electronic and \\n\\tmolecular structure. All three complxes do not inhibit the enzyme \\n\\tsignificantly <393>; #127# synthesis, X-ray structure, in silico \\n\\tcalculation, and carbonic anhydrase inhibitory properties of \\n\\tbenzylimidazole metal complexes, i.e. three coordination compounds of \\n\\tformula [M(bmim)2Cl2], crystal structures of metal complexes, overview. \\n\\tEach complex incorporates 1-benzyl-2-methylimidazole (bmim) as ligand. \\n\\tThe coordination polyhedron around the metal center for all complexes \\n\\thas a quasi-regular tetragonal geometry. In the \\n\\t1-benzyl-2-methylimidazole ligand, imidazole moiety is connected to \\n\\tphenyl cycle via a methylene linker. Density functional theory \\n\\tcalculations are carried out on the title compounds, with Co2+, Zn2+, \\n\\tand Hg2+, and as well on hypothetical complexes (with Cu2+, Ni2+) in \\n\\torder to elucidate their electronic and molecular structure. Only \\n\\tcompound [Hg(bmim)2Cl2] exhibits a modest inhibitory effect against \\n\\tenzyme hCA I, probably due to the affinity of Hg(II) for His residues \\n\\tat the entrance of the active site cavity <393>; #203# the C-terminal \\n\\ttail appears to partly inhibit activity, possibly indicating a role in \\n\\tminimizing the activity of unencapsulated enzyme <355>; #28# fluoride, \\n\\tchloride, cyanide, azide, pyrodiphosphate, divanadate, perchlorate, \\n\\ttetrafluoroborate, sulfamic acid, hexafluorophosphate, and triflate do \\n\\tnot inhibit the enzyme activity <443>; #191# NO22- and SO42- anions \\n\\thave no inhibitory activity <441>; #132# not inhibited by \\n\\tciprofloxacin, levofloxacin, metronidazole, moxifloxacin, netilmicin, \\n\\tofloxacin, and ornidazole <418>; #238# not inhibited by iodide, azide, \\n\\tnitrate, bicarbonate, carbonate, sulphate, phenylarsonic acid, \\n\\tphenylboronic acid, perchlorate, selenate, pyrophosphate, tetraborate, \\n\\thexafluorophosphate and triflate <438>; #14# not inhibited by \\n\\tneostigmine <416>; #85# not inhibited by saccharin, \\n\\thydrochlorothiazide, sulpiride, indisulam, valdecoxib, and celecoxib \\n\\t<408>) \\n\\t<2,48,175,204,205,207,214,228,234,253,286,293,294,296,298,299,300,301,\\n\\t302,304,305,306,316,317,352,355,357,358,359,361,362,365,369,377,378,381,\\n\\t385,386,387,392,393,394,398,400,408,416,418,419,438,441,443>\\nIN\\t#12,14,17,20,32,53,99,118,119,120,124,125,127,128,129,130,131,132,133,\\n\\t134,135,147,162,172,228,230# topiramate (#99# isoenzyme gammaCA <169>; \\n\\t#127# isoenzyme hCA I <169>; #124# isoenzyme hCA II <169>; #125# \\n\\tisoenzyme hCA III <169>; #128# isoenzyme hCA IV <169>; #120# isoenzyme \\n\\thCA IX <169>; #129# isoenzyme hCA VA <169>; #130# isoenzyme hCA VB \\n\\t<169>; #131# isoenzyme hCA VI <169>; #132# isoenzyme hCA VII <169>; \\n\\t#119# isoenzyme hCA XII <169>; #118# isoenzyme hCA XIV <169>; #134# \\n\\tisoenzyme hpalphaCA <169>; #135# isoenzyme hpbetaCA <169>; #133# \\n\\tisoenzyme mCA XIII <169>; #14# powerful inhibitor of CA II <228>; #17# \\n\\tshows effective carbonic anhydrase inhibitory activity <210>) \\n\\t<131,167,169,184,202,210,228,230,231,255,258,259,261,275,276,277,278,\\n\\t294,318,436,440>\\nIN\\t#12,14,17,28,41,43,62,125,133,147,167,238# thiocyanate (#17# weak \\n\\tinhibition <207>; #125# best inhibitor <227>; #167# high inhibition \\n\\t<300>; #133# carbonic anhydrase XIII <175>; #12# shows low micromolar \\n\\tinhibition against CA XV <253>; #62# weak inhibitor of the \\n\\tZn(II)-substituted enzyme <316>; #28# low millimolar inhibitor <443>) \\n\\t<98,101,175,207,208,227,253,282,300,316,438,443>\\nIN\\t#12,14,17,88,147,167,178,179# sulfamate (#147# best inhibitor <208>) \\n\\t<131,207,208,253,300,334,337>\\nIN\\t#12,14,18,19,29,62# OCN- (#18,29# i.e. cyanate, , KOCN <3,15>) \\n\\t<3,15,41,51,52,64,68>\\nIN\\t#12,14,221# azetazolamide <215,366>\\nIN\\t#12,17,18,28,34,40,43,53,83,87,125,147,167,179# sulfate (#147# slight \\n\\tinhibition <208>; #28# less effective inhibitor <443>; #40# weak Nce103 \\n\\tinhibitor <204>; #12# shows low micromolar inhibition against CA XV \\n\\t<253>) <204,207,208,227,253,282,300,309,329,337,443>\\nIN\\t#12,17,18,34,40,43,53,83,125,147,167,178,179,238# chloride \\n\\t<204,207,208,227,253,282,300,309,337,438>\\nIN\\t#12,17,20,28,34,40,43,44,53,83,99,147,167,208# Iodide (#147# best \\n\\tinhibitor <208>; #17# strong inhibition <207>; #53# worst Can2 anion \\n\\tinhibitor <204>; #208# about 30% inhibition at 1 mM <363>; #28# low \\n\\tmillimolar inhibitor <443>) \\n\\t<112,160,204,207,208,253,272,282,300,305,309,363,443>\\nIN\\t#12,17,20,28,88,125,133,147,178,179# phenylboronic acid (#17# weak \\n\\tinhibition <207>; #125# weak inhibitor <227>; #133# carbonic anhydrase \\n\\tXIII <175>; #28# one of the most effective inhibitors <443>) \\n\\t<175,207,208,227,253,297,317,334,337,443>\\nIN\\t#12,17,20,28,88,125,133,147,178,179# phenylarsonic acid (#125# weak \\n\\tinhibitor <227>; #133# carbonic anhydrase XIII <175>; #28# one of the \\n\\tmost effective inhibitors <443>) \\n\\t<175,207,208,227,253,297,317,334,337,443>\\nIN\\t#12,17,28,34,40,43,53,83,125,147,167,178,179,238# bromide (#147# best \\n\\tinhibitor <208>; #17# strong inhibition <207>; #28# less effective \\n\\tinhibitor <443>) <204,207,208,227,253,282,300,305,309,337,438,443>\\nIN\\t#12,17,28,40,53,62,125,133,147,167# Carbonate (#125,147# best inhibitor \\n\\t<208,227>; #40# potent inhibitor <204>; #167# high inhibition <300>; \\n\\t#133# carbonic anhydrase XIII <175>; #62# weak inhibitor of the \\n\\tZn(II)-substituted enzyme, best inhibitor of the Co(II)-substituted \\n\\tenzyme <316>; #28# low millimolar inhibitor <443>) \\n\\t<175,204,207,208,227,253,300,316,443>\\nIN\\t#12,17,28,40,53,62,125,133,147,167,238# nitrite (#133# weak, carbonic \\n\\tanhydrase XIII <175>; #62# weak inhibitor of the Zn(II)-substituted \\n\\tenzyme <316>; #28# low millimolar inhibitor <443>) \\n\\t<175,204,207,208,227,253,300,316,438,443>\\nIN\\t#12,17,40,43,53,125,147,167,238# fluoride (#125# weak inhibitor <227>) \\n\\t<204,207,208,227,253,282,300,438>\\nIN\\t#12,17,40,53,62,88,125,133,147# hydrogen sulfide (#125# best inhibitor \\n\\t<227>; #133# carbonic anhydrase XIII <175>; #53# best Can2 anion \\n\\tinhibitor <204>; #12# shows low micromolar inhibition against CA XV \\n\\t<253>; #62# best inhibitor of the Zn(II)-substituted enzyme <316>) \\n\\t<175,204,207,208,227,253,316,334>\\nIN\\t#12,178,179# perchlorate <253,337>\\nIN\\t#12,30# NCO- (#30# anion inhibition of the esterase activity <107>) \\n\\t<106,107>\\nIN\\t#12,40,53,62# hydrogen sulfite (#12# shows low micromolar inhibition \\n\\tagainst CA XV <253>; #62# weak inhibitor of the Zn(II)-substituted \\n\\tenzyme <316>) <204,253,316>\\nIN\\t#120# 1,1,1-trifluoromethanesulfonamide <274>\\nIN\\t#120# 3-chloro-4H-[1,2,3]thiadiazolo[3,4-a]benzimidazole-7-sulfonamide \\n\\t<274>\\nIN\\t#120# \\n\\t3-morpholin-4-yl-4H-[1,2,3]thiadiazolo[3,\\n\\t4-a]benzimidazole-7-sulfonamide <274>\\nIN\\t#120# \\n\\t3-(phenylsulfanyl)-4H-[1,2,3]thiadiazolo[3,\\n\\t4-a]benzimidazole-7-sulfonamide <274>\\nIN\\t#120# \\n\\t3-(methylsulfanyl)-4H-[1,2,3]thiadiazolo[3,\\n\\t4-a]benzimidazole-7-sulfonamide <274>\\nIN\\t#120# 4H-[1,2,3]thiadiazolo[3,4-a]benzimidazole-7-sulfonamide <274>\\nIN\\t#120# \\n\\t3-(methylsulfonyl)-4H-[1,2,3]thiadiazolo[3,\\n\\t4-a]benzimidazole-7-sulfonamide <274>\\nIN\\t#120# \\n\\t3-(4-methylpiperazin-1-yl)-4H-[1,2,3]thiadiazolo[3,\\n\\t4-a]benzimidazole-7-sulfonamide <274>\\nIN\\t#120# \\n\\t1,1-dimethyl-4-(7-sulfamoyl-4H-[1,2,3]thiadiazolo[3,\\n\\t4-a]benzimidazol-3-yl)piperazin-1-ium iodide <274>\\nIN\\t#120# dobutamine <386>\\nIN\\t#120# \\n\\tN-2\\'-sulfamoylethyl-S-(2,3,4,\\n\\t6-tetra-O-acetyl-1-thio-beta-D-glucopyranosyl)sulfonamide <394>\\nIN\\t#120# \\n\\tN-3\\'-sulfamoylpropyl-S-(2,3,4,\\n\\t6-tetra-O-acetyl-1-thio-beta-D-glucopyranosyl)sulfonamide <394>\\nIN\\t#120# \\n\\tN-5\\'-sulfamoylpentyl-S-(2,3,4,\\n\\t6-tetra-O-acetyl-1-thio-beta-D-glucopyranosyl)sulfonamide <394>\\nIN\\t#120# \\n\\tN-4\\'-sulfamoylpiperidinyl-S-(2,3,4,\\n\\t6-tetra-O-acetyl-1-thio-beta-D-glucopyranosyl)sulfonamide <394>\\nIN\\t#120# \\n\\tN-3\\'-R-sulfamoylpyrrolidinyl-S-(2,3,4,\\n\\t6-tetra-O-acetyl-1-thio-beta-D-glucopyranosyl)sulfonamide <394>\\nIN\\t#120# methyl \\n\\tN-[(2,3,4,\\n\\t6-Tetra-O-acetyl-beta-D-glucosyl)sulfonyl]-L-4\\'-sulfamoylprolinate <394>\\nIN\\t#120# methyl \\n\\tN-[(2,3,4,\\n\\t6-tetra-O-acetyl-beta-D-glucosyl)sulfonyl]-L-sulfamoylserinate <394>\\nIN\\t#120# N-3\\'-sulfamoylpropyl-S-(1-thio-beta-D-glucopyranosyl)sulfonamide \\n\\t<394>\\nIN\\t#120# N-5\\'-sulfamoylpentyl-S-(1-thio-beta-D-glucopyranosyl)sulfonamide \\n\\t<394>\\nIN\\t#120# \\n\\tN-4\\'-sulfamoylpiperidinyl-S-(1-thio-beta-D-glucopyranosyl)sulfonamide \\n\\t<394>\\nIN\\t#120# \\n\\tN-3\\'-R-sulfamoylpyrrolidinyl-S-(1-thio-beta-D-\\n\\tglucopyranosyl)sulfonamide <394>\\nIN\\t#120,124,127# resorcinol (#124# inhibition of isozyme hCA II <392>) \\n\\t<386,392>\\nIN\\t#120,124,127# catechol (#124# inhibition of isozyme hCA II <392>) \\n\\t<386,392>\\nIN\\t#120,124,127# \\n\\tN-(1-(2-hydroxyphenylamino)-3-methyl-1-oxobutan-2-\\n\\tylcarbamothioyl)benzamide (#120,124,127# i.e. NK-154, binding \\n\\tstructure, overview <386>) <386>\\nIN\\t#120,124,127# \\n\\tN-(1-(2-hydroxyphenylamino)-4-methyl-1-oxopentan-2-ylcarbamothioyl) \\n\\tbenzamide (#120,124,127# i.e. NK-168, binding structure, overview \\n\\t<386>) <386>\\nIN\\t#120,124,127# thioxolone <386>\\nIN\\t#120,124,127# propofol <386>\\nIN\\t#120,124,127# 2-coumaric acid <386>\\nIN\\t#120,124,127# \\n\\t(2E)-2-[(4-hydroxyphenyl)methylidene]-N-(5-sulfanylidene-4,5-dihydro-1,\\n\\t3,4-thiadiazol-2-yl)hydrazine-1-carboxamide <386>\\nIN\\t#120,124,127# \\n\\t(2E)-2-[(4-hydroxy-3-methylphenyl)methylidene]-N-(5-sulfanylidene-4,\\n\\t5-dihydro-1,3,4-thiadiazol-2-yl)hydrazine-1-carboxamide <386>\\nIN\\t#120,124,127,128# \\n\\t(S)-4-(2,4-dibenzylpiperazine-1-carbonyl)benzenesulfonamide <369>\\nIN\\t#120,124,127,128# \\n\\t(R)-4-(2,4-dibenzylpiperazine-1-carbonyl)benzenesulfonamide <369>\\nIN\\t#120,124,127,128# \\n\\t4-[(2S)-2-benzylpiperazine-1-carbonyl]benzene-1-sulfonamide <369>\\nIN\\t#120,124,127,128# \\n\\t4-[(2R)-2-benzylpiperazine-1-carbonyl]benzene-1-sulfonamide <369>\\nIN\\t#120,124,127,128# \\n\\t(S)-1-[4-(benzenesulfonyl)-2-benzylpiperazin-1-yl]ethan-1-one <369>\\nIN\\t#120,124,127,128# \\n\\t(R)-1-[4-(benzenesulfonyl)-2-benzylpiperazin-1-yl]ethan-1-one <369>\\nIN\\t#120,124,127,128# \\n\\t(S)-4-[2-benzyl-4-(2-phenylacetyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide <369>\\nIN\\t#120,124,127,128# \\n\\t(R)-4-[2-benzyl-4-(2-phenylacetyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide <369>\\nIN\\t#120,124,127,128# \\n\\t(S)-4-(2-benzyl-4-methanesulfonylpiperazine-1-carbonyl)benzene-1-\\n\\tsulfonamide <369>\\nIN\\t#120,124,127,128# \\n\\t(R)-4-(2-benzyl-4-methanesulfonylpiperazine-1-carbonyl)benzene-1-\\n\\tsulfonamide <369>\\nIN\\t#120,124,127,128# \\n\\t(S)-4-[4-(benzenesulfonyl)-2-benzylpiperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide <369>\\nIN\\t#120,124,127,128# \\n\\t(R)-4-[4-(benzenesulfonyl)-2-benzylpiperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide <369>\\nIN\\t#120,124,127,128# \\n\\t(S)-4-(3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide <369>\\nIN\\t#120,124,127,128# \\n\\t(R)-4-(3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide <369>\\nIN\\t#120,124,127,128# \\n\\t(S)-4-(3,4-dibenzylpiperazine-1-carbonyl)benzene-1-sulfonamide <369>\\nIN\\t#120,124,127,128# \\n\\t(R)-4-(3,4-dibenzylpiperazine-1-carbonyl)benzene-1-sulfonamide <369>\\nIN\\t#120,124,127,128# \\n\\t(S)-4-(3-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide \\n\\t<369>\\nIN\\t#120,124,127,128# \\n\\t(R)-4-(3-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide \\n\\t<369>\\nIN\\t#120,124,127,128# \\n\\t(S)-4-(4-acetyl-3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide \\n\\t<369>\\nIN\\t#120,124,127,128# \\n\\t(R)-4-(4-acetyl-3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide \\n\\t<369>\\nIN\\t#120,124,127,128# \\n\\t(S)-4-(4-benzoyl-3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide \\n\\t<369>\\nIN\\t#120,124,127,128# \\n\\t(R)-4-(4-benzoyl-3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide \\n\\t<369>\\nIN\\t#120,124,127,128# \\n\\t(S)-4-[3-benzyl-4-(2-phenylacetyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide <369>\\nIN\\t#120,124,127,128# \\n\\t(R)-4-[3-benzyl-4-(2-phenylacetyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide <369>\\nIN\\t#120,124,127,128# \\n\\t(S)-4-(3-benzyl-4-methanesulfonylpiperazine-1-carbonyl)benzene-1-\\n\\tsulfonamide <369>\\nIN\\t#120,124,127,128# \\n\\t(R)-4-(3-benzyl-4-methanesulfonylpiperazine-1-carbonyl)benzene-1-\\n\\tsulfonamide <369>\\nIN\\t#120,124,127,128# \\n\\t(S)-4-[4-(benzenesulfonyl)-3-benzylpiperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide <369>\\nIN\\t#120,124,127,128# \\n\\t(R)-4-[4-(benzenesulfonyl)-3-benzylpiperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide <369>\\nIN\\t#120,124,127,128# \\n\\t(S)-4-[2-benzyl-4-(4-sulfamoylbenzoyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide <369>\\nIN\\t#120,124,127,128# \\n\\t(R)-17(R)-4-[2-benzyl-4-(4-sulfamoylbenzoyl)piperazine-1-\\n\\tcarbonyl]benzene-1-sulfonamide <369>\\nIN\\t#120,124,128# (S)- \\n\\t4-(2-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide <369>\\nIN\\t#120,124,128# (R)- \\n\\t4-(2-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide <369>\\nIN\\t#120,124,128# (S)- \\n\\t4-(4-benzoyl-2-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide <369>\\nIN\\t#120,124,128# (R)- \\n\\t4-(4-benzoyl-2-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide <369>\\nIN\\t#122# 2,4-Dichlorophenol <308>\\nIN\\t#122# maneb <308>\\nIN\\t#122# parathion <308>\\nIN\\t#122,126# sulphanilamide (#122# strong inhibition <308>; #126# \\n\\tcytosolic isoenzyme <176>; #126# inner peripheral isoenzyme <176>) \\n\\t<176,308>\\nIN\\t#122,234# propineb (#234# uncompetive inhibition <424>) <308,424>\\nIN\\t#123# \\n\\t(2Z)-2-(4-fluorobenzylidene)-N-(5-sulfanyl-1,3,\\n\\t4-thiadiazol-2-yl)hydrazinecarboxamide <343>\\nIN\\t#124# RWJ-37497 <80>\\nIN\\t#124# 4-fluorobenzenesulfonamide <130>\\nIN\\t#124# p-(aminomethyl)-benzene-sulfonamide (#124# a CAII inhibitor \\n\\t<224>) <224>\\nIN\\t#124# Chlorthalidone (#124# chlorthalidone is a medium potency CA I, \\n\\tII, and IV inhibitor, a very effective inhibitor of CA VB, CA VII, CA \\n\\tIX, CA XII, and CA XIII and an ineffective inhibitor of isozymes CA \\n\\tIII, VA, VI, and XIV <229>) <229>\\nIN\\t#124# indapamide (#124# indapamide is a quite ineffective inhibitor of \\n\\tisozymes CA I, II, III, VA, VI, and XIV, a medium potency CA IV and CA \\n\\tVB inhibitor, and a very effective inhibitor of isozymes CA VII, IX, \\n\\tXII, and XIII <229>) <229>\\nIN\\t#124# 6-((1S)-hydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one <279>\\nIN\\t#124# 7-ethoxy-2H-chromen-2-one <279>\\nIN\\t#124# 7-propoxy-2H-chromen-2-one <279>\\nIN\\t#124# 2H-chromen-2-one <279>\\nIN\\t#124# 7-methoxy-2H-chromen-2-one <279>\\nIN\\t#124# 7-butoxy-2H-chromen-2-one <279>\\nIN\\t#124# 7-(benzyloxy)-2H-chromen-2-one <279>\\nIN\\t#124# 7-(2-phenylethoxy)-2H-chromen-2-one <279>\\nIN\\t#124# 7-methoxy-2-oxo-2H-chromene-4-carboxylic acid <279>\\nIN\\t#124# 2-oxo-2H-chromene-3-carboxylic acid <279>\\nIN\\t#124# 6-methyl-2-oxo-2H-chromene-3-carboxylic acid <279>\\nIN\\t#124# 6-methoxy-2-oxo-2H-chromene-3-carboxylic acid <279>\\nIN\\t#124# 6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylic acid <279>\\nIN\\t#124# 8-methoxy-2-oxo-2H-chromene-3-carboxylic acid <279>\\nIN\\t#124# 2-oxo-2H-thiochromene-3-carboxylic acid <279>\\nIN\\t#124# methyl 6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylate <279>\\nIN\\t#124# ethyl 6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylate <279>\\nIN\\t#124# ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate <279>\\nIN\\t#124# 6-(hydroxymethyl)-2H-chromen-2-one <279>\\nIN\\t#124# 6-(aminomethyl)-2H-chromen-2-one <279>\\nIN\\t#124# \\n\\t1-[(2-oxo-2H-chromen-6-yl)methyl]-3,5,\\n\\t7-triaza-1-azoniatricyclo[3.3.1.13,7]decane <279>\\nIN\\t#124# \\n\\t1-[2-(1H-imidazol-5-yl)ethyl]-4-methyl-2,6-di(propan-2-yl)pyridin-1-ium \\n\\thexafluorophosphate <396>\\nIN\\t#124# N\\'\\',N\\'\\'\\'-bis[(E)-(4-chlorophenyl)methylidene]carbonic dihydrazide \\n\\t<396>\\nIN\\t#124# N\\'\\',N\\'\\'\\'-bis[(E)-(2-fluorophenyl)methylidene]carbonic dihydrazide \\n\\t<396>\\nIN\\t#124# N\\'\\',N\\'\\'\\'-bis[(E)-phenylmethylidene]carbonic dihydrazide <396>\\nIN\\t#124# N\\'\\',N\\'\\'\\'-bis[(E)-(2-hydroxyphenyl)methylidene]carbonic \\n\\tdihydrazide <396>\\nIN\\t#124# N\\'\\',N\\'\\'\\'-bis[(E)-(3-hydroxyphenyl)methylidene]carbonic \\n\\tdihydrazide <396>\\nIN\\t#124# N\\'\\',N\\'\\'\\'-bis[(E)-(4-hydroxyphenyl)methylidene]carbonic \\n\\tdihydrazide <396>\\nIN\\t#124# N\\'\\',N\\'\\'\\'-bis[(E)-(2,3-dihydroxyphenyl)methylidene]carbonic \\n\\tdihydrazide <396>\\nIN\\t#124# N\\'\\',N\\'\\'\\'-bis[(E)-(2,5-dihydroxyphenyl)methylidene]carbonic \\n\\tdihydrazide <396>\\nIN\\t#124# N\\'\\',N\\'\\'\\'-bis[(E)-(5-bromo-2-hydroxyphenyl)methylidene]carbonic \\n\\tdihydrazide <396>\\nIN\\t#124# N\\'\\',N\\'\\'\\'-bis[(E)-(2,4,6-trihydroxyphenyl)methylidene]carbonic \\n\\tdihydrazide <396>\\nIN\\t#124# N\\'\\',N\\'\\'\\'-bis[(E)-(2,3,4-trihydroxyphenyl)methylidene]carbonic \\n\\tdihydrazide <396>\\nIN\\t#124# N\\'\\',N\\'\\'\\'-bis[(E)-(2-methoxyphenyl)methylidene]carbonic \\n\\tdihydrazide <396>\\nIN\\t#124# N\\'\\',N\\'\\'\\'-bis[(E)-(3-methoxyphenyl)methylidene]carbonic \\n\\tdihydrazide <396>\\nIN\\t#124# N\\'\\',N\\'\\'\\'-bis[(E)-(4-methoxyphenyl)methylidene]carbonic \\n\\tdihydrazide <396>\\nIN\\t#124# N\\'\\',N\\'\\'\\'-bis[(E)-(2-hydroxy-5-methoxyphenyl)methylidene]carbonic \\n\\tdihydrazide <396>\\nIN\\t#124# N\\'\\',N\\'\\'\\'-bis[(E)-(2-hydroxy-3-methoxyphenyl)methylidene]carbonic \\n\\tdihydrazide <396>\\nIN\\t#124# N\\'\\',N\\'\\'\\'-bis[(E)-(3-ethoxy-2-hydroxyphenyl)methylidene]carbonic \\n\\tdihydrazide <396>\\nIN\\t#124# N\\'\\',N\\'\\'\\'-bis[(E)-(3,4-dimethoxyphenyl)methylidene]carbonic \\n\\tdihydrazide <396>\\nIN\\t#124,127# [Co(1-benzyl-2-methylimidazole)2Cl2] <393>\\nIN\\t#124,127# [Zn(1-benzyl-2-methylimidazole)2Cl2] <393>\\nIN\\t#124,127# [Hg(1-benzyl-2-methylimidazole)2Cl2] <393>\\nIN\\t#124,127# 6-amino-5-chlorouracil <392>\\nIN\\t#124,127# 6-amino-5-bromouracil <392>\\nIN\\t#124,127# 5-bromo-1-(methanesulfonyl)pyrimidine-2,4(1H,3H)-dione (#127# \\n\\tinhibition of isozyme hCA I <392>; #124# inhibition of isozyme hCA II \\n\\t<392>) <392>\\nIN\\t#124,127# \\n\\t5-bromo-1-(4-methylbenzene-1-sulfonyl)pyrimidine-2,4(1H,3H)-dione \\n\\t(#127# inhibition of isozyme hCA I <392>; #124# inhibition of isozyme \\n\\thCA II <392>) <392>\\nIN\\t#124,127# 6-methylpyrimidine-2,4(1H,3H)-dione (#127# inhibition of \\n\\tisozyme hCA I <392>) <392>\\nIN\\t#124,127# 5-(hydroxymethyl)pyrimidine-2,4(1H,3H)-dione (#127# \\n\\tinhibition of isozyme hCA I <392>) <392>\\nIN\\t#124,127# 1,3-dimethylpyrimidine-2,4(1H,3H)-dione (#127# inhibition of \\n\\tisozyme hCA I <392>; #124# inhibition of isozyme hCA II <392>) <392>\\nIN\\t#124,127# Orotic acid (#127# inhibition of isozyme hCA I <392>; #124# \\n\\tinhibition of isozyme hCA II <392>) <392>\\nIN\\t#124,127# Isoorotic acid (#127# inhibition of isozyme hCA I <392>; \\n\\t#124# inhibition of isozyme hCA II <392>) <392>\\nIN\\t#124,127# 6-amino-1,3-dimethyluracil (#127# inhibition of isozyme hCA I \\n\\t<392>; #124# inhibition of isozyme hCA II <392>) <392>\\nIN\\t#124,127# 5,6-diamino-1,3-dimethyluracil (#127# inhibition of isozyme \\n\\thCA I <392>; #124# inhibition of isozyme hCA II <392>) <392>\\nIN\\t#124,127# Benzyl \\n\\t(2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate \\n\\t<387>\\nIN\\t#124,127# tert-butyl \\n\\t(2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-oxoethyl)carbamate \\n\\t<387>\\nIN\\t#124,127# (S)-benzyl \\n\\t(1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxopropan-2-\\n\\tyl)carbamate <387>\\nIN\\t#124,127# pyrogallol <386>\\nIN\\t#124,127# malvin <378>\\nIN\\t#124,127# callistephin <378>\\nIN\\t#124,127# oenin <378>\\nIN\\t#124,127# silychristin <378>\\nIN\\t#124,127# 1-(4-methoxyphenyl)-2-methyl-3-nitro-1-H-indol-6-ol \\n\\t(#124,127# ID-8 <378>) <378>\\nIN\\t#124,127# 1-(3-cyanobenzyl)-3-(2-methylbenzyl)-3H-benzoimidazol-1-ium \\n\\tbromide (#124,127# inhibitory to carbonic anhydrase, alpha-glycosidase, \\n\\tbutyrylcholinesterase, and acetylcholinesterase <409>) <409>\\nIN\\t#124,127# 1-(3-cyanobenzyl)-3-(4-methylbenzyl)-3H-benzoimidazol-1-ium \\n\\tbromide (#124,127# inhibitory to carbonic anhydrase, alpha-glycosidase, \\n\\tbutyrylcholinesterase, and acetylcholinesterase <409>) <409>\\nIN\\t#124,127# \\n\\t1-(3-cyanobenzyl)-3-(2,4,6-trimethyl-benzyl)-3H-benzoimidazol-1-ium \\n\\tbromide (#124,127# inhibitory to carbonic anhydrase, alpha-glycosidase, \\n\\tbutyrylcholinesterase, and acetylcholinesterase <409>) <409>\\nIN\\t#124,127# \\n\\t1-(3-cyanobenzyl)-3-(2,3,5,6-tetramethyl-benzyl)-3H-benzoimidazol-1-ium \\n\\tbromide (#124,127# inhibitory to carbonic anhydrase, alpha-glycosidase, \\n\\tbutyrylcholinesterase, and acetylcholinesterase <409>) <409>\\nIN\\t#124,127# \\n\\t1-(3-cyanobenzyl)-3-(2,3,4,5,\\n\\t6-pentamethyl-benzyl)-3H-benzoimidazol-1-ium bromide (#124,127# \\n\\tinhibitory to carbonic anhydrase, alpha-glycosidase, \\n\\tbutyrylcholinesterase, and acetylcholinesterase <409>) <409>\\nIN\\t#124,127# \\n\\t2,2\\'-(1-(4-methoxyphenyl)ethane-1,1-diyl)bis(sulfanediyl)diacetic acid \\n\\t(#124,127# inhibits acetylcholinesterase, butyrylcholinesterase, and \\n\\tcarbonic anhydrase <431>) <431>\\nIN\\t#124,127# \\n\\t2,2\\'-(1-(4-bromophenyl)ethane-1,1-diyl)bis(sulfanediyl)diacetic acid \\n\\t(#124,127# inhibits acetylcholinesterase, butyrylcholinesterase, and \\n\\tcarbonic anhydrase <431>) <431>\\nIN\\t#124,127# \\n\\t2,2\\'-(1-(4-methoxyphenyl)ethane-1,\\n\\t1-diyl)bis(sulfanediyl)bis(N-(pyridin-2-yl)acetamide) (#124,127# \\n\\tinhibits acetylcholinesterase, butyrylcholinesterase, and carbonic \\n\\tanhydrase <431>) <431>\\nIN\\t#124,127# \\n\\t2,2\\'-(1-(4-nitrophenyl)ethane-1,\\n\\t1-diyl)bis(sulfanediyl)bis(N-(pyridin-2-yl)acetamide) (#124,127# \\n\\tinhibits acetylcholinesterase, butyrylcholinesterase, and carbonic \\n\\tanhydrase <431>) <431>\\nIN\\t#124,127# \\n\\t2,2\\'-(1-phenylethane-1,1-diyl)bis(sulfanediyl)bis(N-p-tolylacetamide) \\n\\t(#124,127# inhibits acetylcholinesterase, butyrylcholinesterase, and \\n\\tcarbonic anhydrase <431>) <431>\\nIN\\t#124,127# \\n\\t2,2\\'-(1-phenylethane-1,1-diyl)bis(sulfanediyl)bis(N-benzylacetamide) \\n\\t(#124,127# inhibits acetylcholinesterase, butyrylcholinesterase, and \\n\\tcarbonic anhydrase <431>) <431>\\nIN\\t#124,127# 1-anilino-4,4,5,5-tetrafluoropentane-2-thiol (#124,127# \\n\\tinhibits carbonic anhydrase, acetylcholinesterase and alpha-glycosidase \\n\\t<433>) <433>\\nIN\\t#124,127# 1-anilino-3-[(oxolan-2-yl)methoxy]propane-2-thiol (#124,127# \\n\\tinhibits carbonic anhydrase, acetylcholinesterase and alpha-glycosidase \\n\\t<433>) <433>\\nIN\\t#124,127# 1-methoxy-3-(3-methylanilino)propane-2-thiol (#124,127# \\n\\tinhibits carbonic anhydrase, acetylcholinesterase and alpha-glycosidase \\n\\t<433>) <433>\\nIN\\t#124,127# ethyl 5-phenyl-1H-pyrrole-2-carbodithioate (#124,127# \\n\\tinhibits carbonic anhydrase, acetylcholinesterase, \\n\\tbutyrylcholinesterase and alpha-glycosidase <412>) <412>\\nIN\\t#124,127# \\n\\t2-[(ethylsulfanyl)(4,5,6,\\n\\t7-tetrahydro-1H-indol-2-yl)methylene]malononitrile (#124,127# inhibits \\n\\tcarbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and \\n\\talpha-glycosidase <412>) <412>\\nIN\\t#124,127# \\n\\t3-imino-1-ethylsulfanyl-5,6,7,8-tetrahydro-3H-pyrrolo[1,\\n\\t2-a]indole-2-carboxamide (#124,127# inhibits carbonic anhydrase, \\n\\tacetylcholinesterase, butyrylcholinesterase and alpha-glycosidase \\n\\t<412>) <412>\\nIN\\t#124,127# tris(2-pyridyl)phosphine sulfide (#124,127# inhibits carbonic \\n\\tanhydrase, acetylcholinesterase, butyrylcholinesterase and \\n\\talpha-glycosidase <412>) <412>\\nIN\\t#124,127# tris(2-pyridyl)phosphine selenide (#124,127# inhibits \\n\\tcarbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and \\n\\talpha-glycosidase <412>) <412>\\nIN\\t#124,127# 4-benzyl-6-(thiophen-2-yl)pyrimidin-2-amine (#124,127# \\n\\tinhibits carbonic anhydrase, acetylcholinesterase, \\n\\tbutyrylcholinesterase and alpha-glycosidase <412>) <412>\\nIN\\t#124,127# 1-benzyl-3-[2-(4-hydroxyphenyl)ethyl]-2-methylimidazolium \\n\\tbromide <417>\\nIN\\t#124,127# 1-benzyl-3-(N-methyphthalimide)-2-methylimidazolium bromide \\n\\t<417>\\nIN\\t#124,127# 1-benzyl-3-(2,4,6-trimethoxybenzyl)-2-methylimidazolium \\n\\tchloride <417>\\nIN\\t#124,127# 1-decyl-3-[2-(4-hydroxyphenyl)ethyl]-2-methylimidazolium \\n\\tbromide <417>\\nIN\\t#124,127# 1-decyl-3-(N-methyphthalimide)-2-methylimidazolium bromide \\n\\t<417>\\nIN\\t#124,127# 1-decyl-3-(2,4,6-trimethoxybenzyl)-2-methylimidazolium \\n\\tchloride <417>\\nIN\\t#124,127# N\\'-[(Z)-(1H-indol-3-yl)methylidene]butane-1-sulfonohydrazide \\n\\t(#124,127# good inhibitor of alpha-glycosidase, human carbonic \\n\\tanhydrase I and II isoforms and acetylcholinesterase enzyme <432>) <432>\\nIN\\t#124,127# N\\'-[(1Z)-1-(furan-3-yl)ethylidene]butane-1-sulfonohydrazide \\n\\t(#124,127# good inhibitor of alpha-glycosidase, human carbonic \\n\\tanhydrase I and II isoforms and acetylcholinesterase enzyme <432>) <432>\\nIN\\t#124,127# \\n\\tN\\'-[(1Z)-1-(thiophen-3-yl)ethylidene]butane-1-sulfonohydrazide \\n\\t(#124,127# good inhibitor of alpha-glycosidase, human carbonic \\n\\tanhydrase I and II isoforms and acetylcholinesterase enzyme <432>) <432>\\nIN\\t#124,127# \\n\\tN\\'-[(1Z)-1-(5-chlorothiophen-3-yl)ethylidene]butane-1-sulfonohydrazide \\n\\t(#124,127# good inhibitor of alpha-glycosidase, human carbonic \\n\\tanhydrase I and II isoforms and acetylcholinesterase enzyme <432>) <432>\\nIN\\t#124,127# 1-benzyl-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine \\n\\t(#124,127# inhibitor of acetylcholinesterase and the human carbonic \\n\\tanhydrase isoforms I and II <410>) <410>\\nIN\\t#124,127# 1,3-bis(4-bromobenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine \\n\\t(#124,127# inhibitor of acetylcholinesterase and the human carbonic \\n\\tanhydrase isoforms I and II <410>) <410>\\nIN\\t#124,127# (E)-3-iodo-1-styryl-1H-pyrazolo[3,4-d]pyrimidin-4-amine \\n\\t(#124,127# inhibitor of acetylcholinesterase and the human carbonic \\n\\tanhydrase isoforms I and II <410>) <410>\\nIN\\t#124,127# methyl \\n\\t2-[(4-amino-3-iodo-1H-pyrazolo[3,\\n\\t4-d]pyrimidin-1-yl)methyl]-3-nitrobenzoate (#124,127# inhibitor of \\n\\tacetylcholinesterase and the human carbonic anhydrase isoforms I and II \\n\\t<410>) <410>\\nIN\\t#124,127# 1-butyl-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine (#124,127# \\n\\tinhibitor of acetylcholinesterase and the human carbonic anhydrase \\n\\tisoforms I and II <410>) <410>\\nIN\\t#124,127# 3-iodo-1-propyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine \\n\\t(#124,127# inhibitor of acetylcholinesterase and the human carbonic \\n\\tanhydrase isoforms I and II <410>) <410>\\nIN\\t#124,127# 3-iodo-1-phenethyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine \\n\\t(#124,127# inhibitor of acetylcholinesterase and the human carbonic \\n\\tanhydrase isoforms I and II <410>) <410>\\nIN\\t#124,127# 1-(3-fluorobenzyl)-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine \\n\\t(#124,127# inhibitor of acetylcholinesterase and the human carbonic \\n\\tanhydrase isoforms I and II <410>) <410>\\nIN\\t#124,127# 3-iodo-1-(prop-2-yn-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine \\n\\t(#124,127# inhibitor of acetylcholinesterase and the human carbonic \\n\\tanhydrase isoforms I and II <410>) <410>\\nIN\\t#124,127# 1-(4-chlorobenzyl)-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine \\n\\t(#124,127# inhibitor of acetylcholinesterase and the human carbonic \\n\\tanhydrase isoforms I and II <410>) <410>\\nIN\\t#124,127# \\n\\t3-iodo-1-(4-methoxybenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine \\n\\t(#124,127# inhibitor of acetylcholinesterase and the human carbonic \\n\\tanhydrase isoforms I and II <410>) <410>\\nIN\\t#124,127# \\n\\t4-[(4-amino-3-iodo-1H-pyrazolo[3,\\n\\t4-d]pyrimidin-1-yl)methyl]phenylmethanesulfonate (#124,127# inhibitor \\n\\tof acetylcholinesterase and the human carbonic anhydrase isoforms I and \\n\\tII <410>) <410>\\nIN\\t#124,127# \\n\\t4-[(4-amino-3-iodo-1H-pyrazolo[3,\\n\\t4-d]pyrimidin-1-yl)methyl]-2-methoxyphenyl methanesulfonate (#124,127# \\n\\tinhibitor of acetylcholinesterase and the human carbonic anhydrase \\n\\tisoforms I and II <410>) <410>\\nIN\\t#124,127# \\n\\t2-((2-chloro-6-fluorobenzyl)thio)-6-phenylimidazo[2,1-b][1,3,4] \\n\\tthiadiazole (#124,127# competitive. Potent acetylcholinesterase and \\n\\tnon-classical carbonic anhydrase inhibitor <413>) <413>\\nIN\\t#124,127# \\n\\t2-((2-chloro-6-fluorobenzyl)thio)-6-(4-fluorophenyl)imidazo[2,1-b][1,3,\\n\\t4]thiadiazole (#124,127# competitive. competitive. Potent \\n\\tacetylcholinesterase and non-classical carbonic anhydrase inhibitor \\n\\t<413>) <413>\\nIN\\t#124,127# \\n\\t2-((2-chloro-6-fluorobenzyl)thio)-6-(4-chlorophenyl)imidazo[2,1-b][1,3,\\n\\t4]thiadiazole (#124# competitive. Potent acetylcholinesterase and \\n\\tnon-classical carbonic anhydrase inhibitor <413>; #127# noncompetitive. \\n\\tPotent acetylcholinesterase and non-classical carbonic anhydrase \\n\\tinhibitor <413>) <413>\\nIN\\t#124,127# \\n\\t6-(4-bromophenyl)-2-((2-chloro-6-fluorobenzyl)thio)imidazo[2,1-b][1,3,\\n\\t4]thiadiazole (#124# competitive. Potent acetylcholinesterase and \\n\\tnon-classical carbonic anhydrase inhibitor <413>; #127# noncompetitive. \\n\\tPotent acetylcholinesterase and non-classical carbonic anhydrase \\n\\tinhibitor <413>) <413>\\nIN\\t#124,127# 2-((2-chloro-6-fluorobenzyl)thio)-6-(4-methoxyphenyl)imidazo \\n\\t[2,1-b][1,3,4]thiadiazole (#124# competitive. Potent \\n\\tacetylcholinesterase and non-classical carbonic anhydrase inhibitor \\n\\t<413>; #127# noncompetitive. Potent acetylcholinesterase and \\n\\tnon-classical carbonic anhydrase inhibitor <413>) <413>\\nIN\\t#124,127# 4-(2-((2-chloro-6-fluorobenzyl)thio)imidazo[2,1-b][1,3,4] \\n\\tthiadiazol-6-yl)benzonitrile (#124# competitive. Potent \\n\\tacetylcholinesterase and non-classical carbonic anhydrase inhibitor \\n\\t<413>; #127# noncompetitive. Potent acetylcholinesterase and \\n\\tnon-classical carbonic anhydrase inhibitor <413>) <413>\\nIN\\t#124,127# \\n\\t6-([1,1\\'-biphenyl]-4-yl)-2-((2-chloro-6-fluorobenzyl)thio)imidazo \\n\\t[2,1-b][1,3,4]thiadiazole (#124,127# competitive. Potent \\n\\tacetylcholinesterase and non-classical carbonic anhydrase inhibitor \\n\\t<413>) <413>\\nIN\\t#124,127# \\n\\t2-((2-chloro-6-fluorobenzyl)thio)-6-(3,4-dichlorophenyl)imidazo \\n\\t[2,1-b][1,3,4]thiadiazole (#124,127# competitive. Potent \\n\\tacetylcholinesterase and non-classical carbonic anhydrase inhibitor \\n\\t<413>) <413>\\nIN\\t#124,127# 2-((2,6-difluorobenzyl)thio)-6-phenylimidazo[2,1-b][1,3,4] \\n\\tthiadiazole (#124,127# competitive. Potent acetylcholinesterase and \\n\\tnon-classical carbonic anhydrase inhibitor <413>) <413>\\nIN\\t#124,127# 2-((2,6-dichlorobenzyl)thio)-6-phenylimidazo[2,1-b][1,3,4] \\n\\tthiadiazole (#124,127# competitive. Potent acetylcholinesterase and \\n\\tnon-classical carbonic anhydrase inhibitor <413>) <413>\\nIN\\t#124,127# 4-((2-((2-chloro-6-fluorobenzyl)thio)-6-phenylimidazo[2,1-b] \\n\\t[1,3,4]thiadiazol-5-yl)methyl)morpholine (#124,127# competitive. Potent \\n\\tacetylcholinesterase and non-classical carbonic anhydrase inhibitor \\n\\t<413>) <413>\\nIN\\t#124,127# \\n\\t4-((2-((2,6-difluorobenzyl)thio)-6-phenylimidazo[2,1-b][1,3,4] \\n\\tthiadiazol-5-yl)methyl)-morpholine (#124,127# competitive. Potent \\n\\tacetylcholinesterase and non-classical carbonic anhydrase inhibitor \\n\\t<413>) <413>\\nIN\\t#124,127# \\n\\t4-((2-((2,6-dichlorobenzyl)thio)-6-phenylimidazo[2,1-b][1,3,4] \\n\\tthiadiazol-5-yl)methyl)-morpholine (#124,127# competitive. Potent \\n\\tacetylcholinesterase and non-classical carbonic anhydrase inhibitor \\n\\t<413>) <413>\\nIN\\t#124,127# \\n\\t2-((2,6-dichlorobenzyl)thio)-6-phenyl-5-(piperidin-1-ylmethyl) \\n\\timidazo[2,1-b][1,3,4]-thiadiazole (#124,127# competitive. Potent \\n\\tacetylcholinesterase and non-classical carbonic anhydrase inhibitor \\n\\t<413>) <413>\\nIN\\t#124,127# \\n\\t2-((2,6-dichlorobenzyl)thio)-6-phenyl-5-(pyrrolidin-1-ylmethyl) \\n\\timidazo[2,1-b][1,3,4]-thiadiazole <413>\\nIN\\t#124,193# N\\'\\',N\\'\\'\\'-bis[(E)-(4-nitrophenyl)methylidene]carbonic \\n\\tdihydrazide (#124# mixed-type inhibition <396>) <357,396>\\nIN\\t#124,193# N\\'\\',N\\'\\'\\'-bis[(E)-(2-nitrophenyl)methylidene]carbonic \\n\\tdihydrazide (#124# mixed-type inhibition <396>) <357,396>\\nIN\\t#124,193# N\\'\\',N\\'\\'\\'-bis[(E)-(2-chloro-5-nitrophenyl)methylidene]carbonic \\n\\tdihydrazide (#124# mixed-type inhibition <396>) <357,396>\\nIN\\t#124,193# N\\'\\',N\\'\\'\\'-bis[(E)-(4-bromophenyl)methylidene]carbonic \\n\\tdihydrazide (#124# mixed-type inhibition <396>) <357,396>\\nIN\\t#124,193# N\\'\\',N\\'\\'\\'-bis[(E)-(2-bromophenyl)methylidene]carbonic \\n\\tdihydrazide <357,396>\\nIN\\t#124,193# N\\'\\',N\\'\\'\\'-bis[(E)-(2-chlorophenyl)methylidene]carbonic \\n\\tdihydrazide (#124# mixed-type inhibition <396>) <357,396>\\nIN\\t#124,193# N\\'\\',N\\'\\'\\'-Bis[(E)-(2,4-dichlorophenyl)methylidene]carbonic \\n\\tdihydrazide <357,396>\\nIN\\t#124,193# N\\'\\',N\\'\\'\\'-bis[(E)-(2,6-dichlorophenyl)methylidene]carbonic \\n\\tdihydrazide (#124# mixed-type inhibition <396>) <357,396>\\nIN\\t#124,193# N\\'\\',N\\'\\'\\'-bis[(E)-(4-fluorophenyl)methylidene]carbonic \\n\\tdihydrazide <357,396>\\nIN\\t#125# prontosil <167>\\nIN\\t#125# 4-(aminosulfonyl)-N-{2-[4-(aminosulfonyl)phenyl]ethyl}benzamide \\n\\t<167>\\nIN\\t#125# 4-amino-3-fluoro-5-iodobenzenesulfonamide <167>\\nIN\\t#125# \\n\\t5-{[(4-amino-3-chloro-5-fluorophenyl)sulfonyl]amino}-1,3,\\n\\t4-thiadiazole-2-sulfonamide <167>\\nIN\\t#125,131# \\n\\t5-{[(4-aminophenyl)sulfonyl]amino}-1,3,4-thiadiazole-2-sulfonamide \\n\\t<167,184>\\nIN\\t#125,131# 4-amino-N-[4-(aminosulfonyl)benzyl]benzenesulfonamide \\n\\t<167,184>\\nIN\\t#125,131# \\n\\t4-amino-N-{2-[4-(aminosulfonyl)phenyl]ethyl}benzenesulfonamide <167,184>\\nIN\\t#125,131# 4-(aminosulfonyl)benzoic acid <167,184>\\nIN\\t#125,131,172# 2-hydrazinobenzenesulfonamide <167,184,230>\\nIN\\t#125,147,162,180# 4-amino-3,5-dibromobenzenesulfonamide \\n\\t<167,277,297,298,331>\\nIN\\t#125,238# hydrosulfide <227,438>\\nIN\\t#127# Cu-GGHSLN (#127# time-dependent inactivation of carbonic \\n\\tanhydrase I activity, within 3 h carbonic anhydrase I activity is \\n\\teliminated at 0.005 mM Cu-GGHSLN <220>) <220>\\nIN\\t#127# Benzene <392>\\nIN\\t#127# benzyl \\n\\t(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate \\n\\t<387>\\nIN\\t#127# (S)-tert-butyl \\n\\t(1-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-\\n\\t2-yl)carbamate <387>\\nIN\\t#127# (S)-tert-butyl \\n\\t(1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxo-3-phenylpropan-\\n\\t2-yl)carbamate <387>\\nIN\\t#127# benzyl \\n\\t(2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate <387>\\nIN\\t#127# tert-butyl \\n\\t(2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-carbamate <387>\\nIN\\t#127# (S)-benzyl \\n\\t(1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate \\n\\t<387>\\nIN\\t#127# (S)-tert-butyl \\n\\t(1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate \\n\\t<387>\\nIN\\t#127# (S)-tert-butyl \\n\\t(1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-\\n\\tyl)carbamate <387>\\nIN\\t#127# (S)-2-(2-ammoniopropanamido)-4-methylbenzo[d]thiazol-3-ium \\n\\tdi-2,2,2-trifluoroacetate <387>\\nIN\\t#127# \\n\\t(S)-4-(2-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide \\n\\t<369>\\nIN\\t#127# \\n\\t(R)-4-(2-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide \\n\\t<369>\\nIN\\t#127# \\n\\t(S)-4-(4-benzoyl-2-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide \\n\\t<369>\\nIN\\t#127# \\n\\t(R)-4-(4-benzoyl-2-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide \\n\\t<369>\\nIN\\t#127# tacrine <417>\\nIN\\t#131# 2,3,4,5,6-pentafluorobenzene-1-sulfonamide (#131# VD10-9 <446>) \\n\\t<446>\\nIN\\t#131# 2,3,5,6-tetrafluoro-4-(morpholin-4-yl)benzene-1-sulfonamide \\n\\t(#131# VD10-12 <446>) <446>\\nIN\\t#131# \\n\\t2,3,5,6-tetrafluoro-4-[(2-hydroxyethyl)sulfanyl]benzene-1-sulfonamide \\n\\t(#131# VD10-13 <446>) <446>\\nIN\\t#131# 2,3,5,6-tetrafluoro-4-hydrazinylbenzene-1-sulfonamide (#131# \\n\\tVD10-14 <446>) <446>\\nIN\\t#131# 4-(benzylamino)-2,3,5,6-tetrafluorobenzene-1-sulfonamide (#131# \\n\\tVD10-16 <446>) <446>\\nIN\\t#131# 2,3,5,6-tetrafluoro-4-(phenylsulfanyl)benzene-1-sulfonamide \\n\\t(#131# VD10-18 <446>) <446>\\nIN\\t#131# \\n\\t2,3,5,6-tetrafluoro-4-(2-hydroxyethanesulfonyl)benzene-1-sulfonamide \\n\\t(#131# VD10-35 <446>) <446>\\nIN\\t#131# \\n\\t2-(benzylamino)-3,5,\\n\\t6-trifluoro-4-(2-hydroxyethanesulfonyl)benzene-1-sulfonamide (#131# \\n\\tVD10-39b <446>) <446>\\nIN\\t#131# \\n\\t4-[(4,5-diphenyl-1H-imidazol-2-yl)sulfanyl]-2,3,5,\\n\\t6-tetrafluorobenzene-1-sulfonamide (#131# VD10-45 <446>) <446>\\nIN\\t#131# \\n\\t4-[(1,3-benzothiazol-2-yl)sulfanyl]-2,3,5,\\n\\t6-tetrafluorobenzene-1-sulfonamide (#131# VD10-49 <446>) <446>\\nIN\\t#131# \\n\\t4-[(4,6-dimethylpyrimidin-2-yl)sulfanyl]-2,3,5,\\n\\t6-tetrafluorobenzene-1-sulfonamide (#131# VD10-50 <446>) <446>\\nIN\\t#131# \\n\\t2,3,5,6-tetrafluoro-4-[(2-phenylethyl)sulfanyl]benzene-1-sulfonamide \\n\\t(#131# VD11-09 <446>) <446>\\nIN\\t#131# 4-[(2-phenylethyl)sulfanyl]benzene-1-sulfonamide (#131# VD11-36 \\n\\t<446>) <446>\\nIN\\t#131# \\n\\t2,3,\\n\\t5-trifluoro-6-(morpholin-4-yl)-4-[(2-phenylethyl)sulfanyl]benzene-1-\\n\\tsulfonamide (#131# VD11-67 <446>) <446>\\nIN\\t#131# 4-(benzenesulfonyl)-2,3,5,6-tetrafluorobenzene-1-sulfonamide \\n\\t(#131# VD11-51 <446>) <446>\\nIN\\t#131# 3-[(2,3,5,6-tetrafluoro-4-sulfamoylphenyl)sulfanyl]propanoic acid \\n\\t(#131# VD11-56 <446>) <446>\\nIN\\t#131# \\n\\t2,3,\\n\\t5-trifluoro-4-[(2-phenylethyl)sulfanyl]-6-[(propan-2-yl)amino]benzene-1-\\n\\tsulfonamide (#131# VD11-71 <446>) <446>\\nIN\\t#131# \\n\\t2-[[(3,4-dimethoxyphenyl)methyl]amino]-3,5,\\n\\t6-trifluoro-4-[(2-phenylethyl)sulfanyl]benzene-1-sulfonamide (#131# \\n\\tVD12-04 <446>) <446>\\nIN\\t#131# 2,3,5,6-tetrafluoro-4-(propylsulfanyl)benzene-1-sulfonamide \\n\\t(#131# VD12-05 <446>) <446>\\nIN\\t#131# 4-(propylsulfanyl)benzene-1-sulfonamide (#131# VD12-10 <446>) \\n\\t<446>\\nIN\\t#131# \\n\\t2-[[(3,4-dimethoxyphenyl)methyl]amino]-3,5,\\n\\t6-trifluoro-4-[(2-hydroxyethyl)sulfanyl]benzene-1-sulfonamide (#131# \\n\\tVD12-17 <446>) <446>\\nIN\\t#131# \\n\\t3-(cyclooctylamino)-2,5,\\n\\t6-trifluoro-4-(2-hydroxyethanesulfonyl)benzene-1-sulfonamide (#131# \\n\\tVD11-4-2 <446>) <446>\\nIN\\t#131# \\n\\t3-[(2,3-dihydro-1H-inden-2-yl)amino]-2,5,\\n\\t6-trifluoro-4-(2-phenylethanesulfonyl)benzene-1-sulfonamide (#131# \\n\\tVD11-16 <446>) <446>\\nIN\\t#131# \\n\\t3-[(adamantan-2-yl)amino]-2,5,\\n\\t6-trifluoro-4-(2-phenylethanesulfonyl)benzene-1-sulfonamide (#131# \\n\\tVD11-17 <446>) <446>\\nIN\\t#131# \\n\\t3-(benzylamino)-2,5,\\n\\t6-trifluoro-4-(2-phenylethanesulfonyl)benzene-1-sulfonamide (#131# \\n\\tVD11-28 <446>) <446>\\nIN\\t#131# 4-[(2-hydroxyethyl)sulfanyl]benzene-1-sulfonamide (#131# VD11-31 \\n\\t<446>) <446>\\nIN\\t#131# \\n\\t2,3,6-trifluoro-5-[[(1R,2R)-2-hydroxy-1,\\n\\t2-diphenylethyl]amino]-4-(2-phenylethanesulfonyl)benzene-1-sulfonamide \\n\\t(#131# VD11-39 <446>) <446>\\nIN\\t#131# 4-(benzylsulfanyl)-2,3,5,6-tetrafluorobenzene-1-sulfonamide \\n\\t(#131# VD11-61 <446>) <446>\\nIN\\t#131# ethyl \\n\\t2-[[2-(4-chloro-3-sulfamoylphenyl)-2-oxoethyl]sulfanyl]-6-oxo-1,\\n\\t6-dihydropyrimidine-5-carboxylate (#131# E46 <446>) <446>\\nIN\\t#131# 2-chloro-4-[(phenylsulfanyl)acetyl]benzene-1-sulfonamide (#131# \\n\\tE11-6 <446>) <446>\\nIN\\t#131# \\n\\t3-[[(4,6-dimethylpyrimidin-2-yl)sulfanyl]acetyl]benzene-1-sulfonamide \\n\\t(#131# E11-11 <446>) <446>\\nIN\\t#131# \\n\\t2-chloro-3-[[(5-ethylpyrimidin-2-yl)sulfanyl]acetyl]benzene-1-\\n\\tsulfonamide (#131# E11-12 <446>) <446>\\nIN\\t#131# \\n\\t2-chloro-3-[[(5-propylpyrimidin-2-yl)sulfanyl]acetyl]benzene-1-\\n\\tsulfonamide (#131# E11-14 <446>) <446>\\nIN\\t#131# 3-[[(5-propylpyrimidin-2-yl)sulfanyl]acetyl]benzene-1-sulfonamide \\n\\t(#131# E11-15 <446>) <446>\\nIN\\t#131# \\n\\t2-chloro-3-[[(4-methyl-6-oxo-1,\\n\\t6-dihydropyrimidin-2-yl)sulfanyl]acetyl]benzene-1-sulfonamide (#131# \\n\\tE11-18 <446>) <446>\\nIN\\t#131# 3-[(1H-benzimidazol-1-yl)acetyl]benzene-1-sulfonamide (#131# \\n\\tE11-37 <446>) <446>\\nIN\\t#131# 3-[(1H-benzimidazol-1-yl)acetyl]-2-chlorobenzene-1-sulfonamide \\n\\t(#131# E11-36 <446>) <446>\\nIN\\t#131# \\n\\t3-[(2-benzyl-1H-benzimidazol-1-yl)acetyl]-2-chlorobenzene-1-sulfonamide \\n\\t(#131# E11-52 <446>) <446>\\nIN\\t#131# 3-[(2-benzyl-1H-benzimidazol-1-yl)acetyl]benzene-1-sulfonamide \\n\\t(#131# E11-53 <446>) <446>\\nIN\\t#131# 3-[[(1,3-benzothiazol-2-yl)sulfanyl]acetyl]benzene-1-sulfonamide \\n\\t(#131# E11-57 <446>) <446>\\nIN\\t#131# \\n\\t2-chloro-4-[2-[(prop-2-en-1-yl)amino]-1,\\n\\t3-thiazol-4-yl]benzene-1-sulfonamide (#131# E11-64 <446>) <446>\\nIN\\t#131,172# 4-hydrazinobenzenesulfonamide <184,230>\\nIN\\t#132# rifamycin (#132# strongest competitive inhibition <418>) <418>\\nIN\\t#132# Vancomycin (#132# noncompetitive inhibition <418>) <418>\\nIN\\t#132# tobramycin (#132# uncompetitive inhibition <418>) <418>\\nIN\\t#132# amoxicillin (#132# uncompetitive inhibition <418>) <418>\\nIN\\t#132# kanamycin sulfate (#132# competitive inhibition <418>) <418>\\nIN\\t#132# teicoplanin (#132# noncompetitive inhibition <418>) <418>\\nIN\\t#132# gentamicin sulfate (#132# uncompetitive inhibition <418>) <418>\\nIN\\t#132# amikacin sulfate (#132# noncompetitive inhibition <418>) <418>\\nIN\\t#132# piperacillin (#132# noncompetitive inhibition <418>) <418>\\nIN\\t#132# cefuroxime (#132# uncompetitive inhibition <418>) <418>\\nIN\\t#132# clindamycin phosphate (#132# uncompetitive inhibition <418>) <418>\\nIN\\t#132# Lincomycin (#132# competitive inhibition <418>) <418>\\nIN\\t#132# ampicillin (#132# uncompetitive inhibition <418>) <418>\\nIN\\t#132# cefazolin (#132# uncompetitive inhibition <418>) <418>\\nIN\\t#132# ceftriaxone (#132# noncompetitive inhibition <418>) <418>\\nIN\\t#132# cefoperazone (#132# uncompetitive inhibition <418>) <418>\\nIN\\t#133# orthanilamide (#133# carbonic anhydrase XIII <175>) <175>\\nIN\\t#133# bisulfate (#133# weak, carbonic anhydrase XIII <175>) <175>\\nIN\\t#14# Sulfonamides (#14# affinity of carbonic anhydrase IV for \\n\\tsulfonamides is decreased up to 65fold compared to carbonic anhydrase \\n\\tII <70>) <70>\\nIN\\t#14# \\n\\t4-S-isobutylamino-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide \\n\\t7,7-dioxide (#14# binds 800 times more strongly to carbonic anhydrase \\n\\tII than to carbonic anhydrase I <44>) <44>\\nIN\\t#14# 2-Nitrophenol (#14# product inhibition <105>) <105>\\nIN\\t#14# 4-nitrobenzenesulfonamide <103>\\nIN\\t#14# 2-nitrobenzenesulfonamide <103>\\nIN\\t#14# 1,2-bis[(4-sulfonamidobenzamide)ethoxy]ethane <96>\\nIN\\t#14# 1,2-bis[(2,4-dichloro-5-sulfonamidobenzamide)ethoxy]ethane <96>\\nIN\\t#14# 1,2-bis[(4-sulfonamidobenzoate)ethoxy]ethane <96>\\nIN\\t#14# 1,2-bis[(2,4-dichloro-5-sulfonamidobenzoate)-ethoxy]ethane <96>\\nIN\\t#14# EMATE <131>\\nIN\\t#14# phenylsulfamate (#14# best CA I inhibitor <131>) <131>\\nIN\\t#14# n-octyl sulfamate (#14# inhibition of hCA I, hCA II, and hCA IX \\n\\t<132>) <131,132>\\nIN\\t#14# estradiol 3,17 beta-disulfamate (#14# CA II inhibitor <131>) <131>\\nIN\\t#14# 4-methylphenyl sulfamate <131>\\nIN\\t#14# 4-phenylphenyl sulfamate <131>\\nIN\\t#14# 4-iodophenyl sulfamate <131>\\nIN\\t#14# 4-methoxyphenyl sulfamate <131>\\nIN\\t#14# 4-phenoxyphenyl sulfamate <131>\\nIN\\t#14# 4-acetylamidophenyl sulfamate <131>\\nIN\\t#14# 4-nitrophenyl sulfamate <131>\\nIN\\t#14# 4-cyanophenyl sulfamate <131>\\nIN\\t#14# 4-t-butylphenyl sulfamate <131>\\nIN\\t#14# 4-trichloromethylphenyl sulfamate <131>\\nIN\\t#14# pentafluorophenyl sulfamate <131>\\nIN\\t#14# pentachlorophenyl sulfamate <131>\\nIN\\t#14# 2,4,6-trichlorophenyl sulfamate <131>\\nIN\\t#14# 2-naphthyl sulfamate <131>\\nIN\\t#14# 3-methylphenylsulfamate <131>\\nIN\\t#14# 5-pentylresorcinylsulfamate <131>\\nIN\\t#14# estrone sulfamate <131>\\nIN\\t#14# estradiol 17 beta-sulfamate <131>\\nIN\\t#14# dehydroepiandrosterone sulfamate (#14# CA II inhibitor <132>) \\n\\t<131,132>\\nIN\\t#14# 1,2:5,6-di-O-isopropylidene-alpha-D-glucofuranose 3-sulfamate <131>\\nIN\\t#14# 1,2:3,4-di-O-isopropylidene-alpha-D-galactopyranose 6-sulfamate \\n\\t<131>\\nIN\\t#14# n-tetradecyl sulfamate (#14# most potent CA I inhibitor <132>) \\n\\t<132>\\nIN\\t#14# n-decyl sulfamate (#14# CA II inhibitor <132>) <132>\\nIN\\t#14# methyl sulfamate <132>\\nIN\\t#14# ethyl sulfamate <132>\\nIN\\t#14# n-propyl sulfamate <132>\\nIN\\t#14# isopropyl sulfamate <132>\\nIN\\t#14# n-butyl sulfamate <132>\\nIN\\t#14# n-pentyl sulfamate <132>\\nIN\\t#14# n-undecyl sulfamate <132>\\nIN\\t#14# n-dodecyl sulfamate <132>\\nIN\\t#14# n-hexadecyl sulfamate <132>\\nIN\\t#14# n-octadecyl sulfamate <132>\\nIN\\t#14# 1H,1H-perfluoroethyl sulfamate <132>\\nIN\\t#14# 1H,1H,2H,2H-perfluorooctyl sulfamate <132>\\nIN\\t#14# 1H,1H,2H,2H-perfluorodecyl sulfamate <132>\\nIN\\t#14# 1H-perfluoroisopropyl sulfamate <132>\\nIN\\t#14# but-3-enyl sulfamate <132>\\nIN\\t#14# 3-chloropropyl sulfamate <132>\\nIN\\t#14# cyclopentyl sulfamate <132>\\nIN\\t#14# cyclohexyl sulfamate <132>\\nIN\\t#14# benzyl sulfamate <132>\\nIN\\t#14# 2-phenylethyl sulfamate <132>\\nIN\\t#14# p-methylbenzyl sulfamate <132>\\nIN\\t#14# p-biphenylmethyl sulfamate <132>\\nIN\\t#14# fluorenylmethyl sulfamate <132>\\nIN\\t#14# cholesteryl sulfamate <132>\\nIN\\t#14# 7-alpha-hydroxydehydroepiandrosterone sulfamate <132>\\nIN\\t#14# 7-oxodehydroepiandrosterone sulfamate <132>\\nIN\\t#14# \\n\\t5-(3alpha-hydroxy-5beta-cholanamido)-1,3,4-thiadiazole-2-sulfonamide \\n\\t<100>\\nIN\\t#14# \\n\\t5-(3alpha,12alpha-dihydroxy-5beta-cholanamido)-1,3,\\n\\t4-thiadiazole-2-sulfonamide <100>\\nIN\\t#14# \\n\\t5-(3alpha,7alpha,12alpha-trihydroxy-5beta-cholanamido)-1,3,\\n\\t4-thiadiazole-2-sulfonamide <100>\\nIN\\t#14# 3alpha-acetoxy-5beta-cholan-24-oic acid <100>\\nIN\\t#14# \\n\\t5-(3alpha-acetoxy-5beta-cholanamido)-1,3,4-thiadiazole-2-sulfonamide \\n\\t<100>\\nIN\\t#14# 3alpha,12alpha-diacetoxy-5beta-cholan-24-oic acid <100>\\nIN\\t#14# 3alpha,7alpha,12alpha-triacetoxy-5beta-cholan-24-oic acid <100>\\nIN\\t#14# \\n\\t5-(3alpha,7alpha,12alpha-triacetoxy-5beta-cholanamido)-1,3,\\n\\t4-thiadiazole-2-sulfonamide <100>\\nIN\\t#14# \\n\\t5-(3,7,12-trioxo-5beta-cholanamido)-1,3,4-thiadiazole-2-sulfonamide \\n\\t<100>\\nIN\\t#14# Hydroxyurea <101>\\nIN\\t#14# Urea <101>\\nIN\\t#14# cyanamide <101>\\nIN\\t#14# methylbenzolamide <102>\\nIN\\t#14# \\n\\t2-[2-(acetoxy)ethyl]-N-(1,1-dimethylethyl)-4-hydroxy-2H-thieno[3,\\n\\t2-e-]-1,2-thiazine-6-sulfonamide 1,1-dioxide <102>\\nIN\\t#14# \\n\\t2-(2-hydroxyethyl)-N-(1,1-dimethylethyl)-2H-thieno[3,2-e-]-1,\\n\\t2-thiazine-6-sulfonamide 1,1-dioxide <102>\\nIN\\t#14# \\n\\tN-(1,1-dimethylethyl)-2-[4-(4-morpholinyl)-2-butenyl]-2H-thieno[3,\\n\\t2-e-]-1,2-thiazine-6-sulfonamide 1,1-dioxide <102>\\nIN\\t#14# \\n\\t2-[2-[bis(2-methoxyethyl)amino]ethyl]-2H-thieno[3,2-e-]-1,\\n\\t2-thiazine-6-sulfonamide 1,1-dioxide hydrochloride <102>\\nIN\\t#14# \\n\\t2-[2-(4-morpholinyl)ethyl]-2H-thieno[3,2-e-]-1,2-thiazine-6-sulfonamide \\n\\t1,1-dioxide hydrochloride <102>\\nIN\\t#14# \\n\\t2-[2-[4-acetyl-(1-piperazinyl)]ethyl]-2H-thieno[3,2-e-]-1,\\n\\t2-thiazine-6-sulfonamide 1,1-dioxide <102>\\nIN\\t#14# \\n\\t2-[2-(propylamino)ethyl]-2H-thieno[3,2-e-]-1,2-thiazine-6-sulfonamide \\n\\t1,1-dioxide hydrochloride <102>\\nIN\\t#14# \\n\\t2-[4-(4-morpholinyl)-2-butenyl]-2H-thieno[3,2-e-]-1,\\n\\t2-thiazine-6-sulfonamide 1,1-dioxide hydrochloride <102>\\nIN\\t#14# N-[[3-(1,3-dioxolan-2-yl)-2-thienyl]sulfonyl]-glycine ethyl ester \\n\\t<102>\\nIN\\t#14# N-[(3-formyl-2-thienyl)sulfonyl]-glycine ethyl ester <102>\\nIN\\t#14# ethyl \\n\\t3,4-dihydro-4-hydroxy-2H-thieno[3,2-e]-1,2-thiazine-3-carboxylate \\n\\t1,1-dioxide <102>\\nIN\\t#14# 3-3-(1,3-dioxolan-2-yl)-N-(1-methylethyl)-2-thiophene-sulfonamide \\n\\t<102>\\nIN\\t#14# 1,3-dioxolan-2-yl-N-(2-propenyl)-2-thiophene-sulfonamide <102>\\nIN\\t#14# N-cyclopropylmethyl-3-(1,3-dioxolan-2-yl)-2-thiophenesulfonamide \\n\\t<102>\\nIN\\t#14# 3-(1,3-dioxolan-2-yl)-N-cyclohexyl-2-thiophenesulfonamide <102>\\nIN\\t#14# 3-(1,3-dioxolan-2-yl)-N-(2-methoxyethyl)-2-thiophenesulfonamide \\n\\t<102>\\nIN\\t#14# 3-(1,3-dioxolan-2-yl)-N-(3-methoxyphenyl)-2-thiophenesulfonamide \\n\\t<102>\\nIN\\t#14# \\n\\t3-(1,3-dioxolan-2-yl)-N-(3,4-dimethoxyphenyl)-2-thiophenesulfonamide \\n\\t<102>\\nIN\\t#14# \\n\\t3-(1,\\n\\t3-dioxolan-2-yl)-N-(4-(4-morpholinyl)phenyl)-2-thiophenesulfonamide \\n\\t<102>\\nIN\\t#14# N-(cyclopropylmethyl)-3-(1,3-dioxolan-2-yl)thiophene-2-sulfonamide \\n\\t<102>\\nIN\\t#14# 3-[1,3-dioxolan-2-yl]-N-(2-methoxyethyl)-2-thiophenesulfonamide \\n\\t<102>\\nIN\\t#14# \\n\\t3-[1,3-dioxolan-2-yl]-N-(3,4-dimethoxyphenyl)-2-thiophenesulfonamide \\n\\t<102>\\nIN\\t#14# \\n\\t3-(1,\\n\\t3-dioxolan-2-yl)-N-[4-(4-morpholinyl)phenyl]-2-thiophenesulfonamide \\n\\t<102>\\nIN\\t#14# N-[[3-(1,3-dioxolan-2-yl)thien-2-yl]sulfonyl]-N-methylglycine \\n\\tethyl ester <102>\\nIN\\t#14# N-[[3-(1,3-dioxolan-2-yl)thien-2-yl]sulfonyl]-N-ethylglycine ethyl \\n\\tester <102>\\nIN\\t#14# N-[[3-(1,3-dioxolan-2-yl)thien-2-yl]sulfonyl]-N-propylglycine \\n\\tethyl ester <102>\\nIN\\t#14# \\n\\tN-[[3-(1,3-dioxolan-2-yl)thien-2-yl]sulfonyl]-N-(1-methylethyl)-glycine \\n\\tethyl ester <102>\\nIN\\t#14# \\n\\tN-[[3-(1,3-dioxolan-2-yl)thien-2-yl]sulfonyl]-N-(2-propenyl)-glycine \\n\\tethyl ester <102>\\nIN\\t#14# \\n\\tN-[[3-(1,\\n\\t3-dioxolan-2-yl)thien-2-yl]sulfonyl]-N-methylcyclopropyl-glycine ethyl \\n\\tester <102>\\nIN\\t#14# N-cyclohexyl-N-[(3-formyl-thien-2-yl)sulfonyl]-glycine methyl \\n\\tester <102>\\nIN\\t#14# N-[(3-formyl-thien-2-yl)sulfonyl]-N-(2-methoxyethyl)-glycine ethyl \\n\\tester <102>\\nIN\\t#14# \\n\\tN-[[3-(1,\\n\\t3-dioxolan-2-yl)thien-2-yl]sulfonyl]-N-(3-methoxyethyl)-glycine ethyl \\n\\tester <102>\\nIN\\t#14# \\n\\tN-[[3-(1,\\n\\t3-dioxolan-2-yl)thien-2-yl]sulfonyl]-N-[(4-methoxyphenyl)methyl]-\\n\\tglycine ethyl ester <102>\\nIN\\t#14# \\n\\tN-[[3-(1,\\n\\t3-dioxolan-2-yl)thien-2-yl]sulfonyl]-N-[(3-methoxyphenyl)methyl]-\\n\\tglycine ethyl ester <102>\\nIN\\t#14# \\n\\tN-[[3-(1,3-dioxolan-2-yl)thien-2-yl]sulfonyl]-N-[(3,\\n\\t4-dimethoxyphenyl)methyl]-glycine ethyl ester <102>\\nIN\\t#14# \\n\\tN-[[3-(1,\\n\\t3-dioxolan-2-yl)thien-2-yl]sulfonyl]-N-[4-(morpholin-4-yl)phenyl]-\\n\\tglycine methyl ester <102>\\nIN\\t#14# ethyl 2-methyl-2H-thieno[3,2-e]-1,2-thiazine-3-carboxylate \\n\\t1,1-dioxide <102>\\nIN\\t#14# 2-methyl-2H-thieno[3,2-e]-1,2-thiazine-3-methanol 1,1-dioxide <102>\\nIN\\t#14# \\n\\t3-hydroxymethyl-2-methyl-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide \\n\\t1,1-dioxide <102>\\nIN\\t#14# 2-methyl-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,2-thiazine \\n\\t1,1-dioxide <102>\\nIN\\t#14# \\n\\t2-methyl-3-[[N-(2-methoxyethyl)-N-(3-methoxypropyl)-amino]methyl]-2H-\\n\\tthieno[3,2-e]-1,2-thiazine 1,1-dioxide <102>\\nIN\\t#14# \\n\\t2-methyl-3-[[N-(2-methoxyethyl)-N-(2-propenyl)amino]methyl]-2H-thieno[3,\\n\\t2-e]-1,2-thiazine 1,1-dioxide <102>\\nIN\\t#14# \\n\\t2-(3-methoxypropyl)-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,\\n\\t2-thiazine 1,1-dioxide <102>\\nIN\\t#14# \\n\\t2-[(4-methoxyphenyl)methyl]-3-[(4-morpholinyl)methyl]-2H-thieno[3,\\n\\t2-e]-1,2-thiazine 1,1-dioxide <102>\\nIN\\t#14# 2-methyl-3-(4-morpholinylmethyl)-2H-thieno[3,2-e]-1,2-thiazine \\n\\t1,1-dioxide hydrochloride <102>\\nIN\\t#14# \\n\\t3-[[N-(2-methoxyethyl)-N-(3-methoxypropyl)amino]methyl]-2-methyl-2H-\\n\\tthieno[3,2-e]-1,2-thiazine 1,1-dioxide hydrochloride <102>\\nIN\\t#14# \\n\\t3-[[N-(2-methoxyethyl)-N-methylamino]methyl]-2-methyl-2H-thieno[3,\\n\\t2-e]-1,2-thiazine 1,1-dioxide <102>\\nIN\\t#14# \\n\\t3-[[N-(2-methoxyethyl)-N-(2-propenyl)amino]methyl]-2-methyl-2H-thieno[3,\\n\\t2-e]-1,2-thiazine 1,1-dioxide hydrochloride <102>\\nIN\\t#14# 2-ethyl-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,2-thiazine \\n\\t1,1-dioxide hydrochloride <102>\\nIN\\t#14# \\n\\t2-ethyl-3-[[bis(2-methoxyethyl)amino]methyl]-2H-thieno[3,2-e]-1,\\n\\t2-thiazine 1,1-dioxide hydrochloride <102>\\nIN\\t#14# \\n\\t2-ethyl-3-[[bis(2-hydroxyethyl)amino]methyl]-2H-thieno[3,2-e]-1,\\n\\t2-thiazine 1,1-dioxide hydrochloride <102>\\nIN\\t#14# 3-[(4-morpholinyl)methyl]-2-propyl-2H-thieno[3,2-e]-1,2-thiazine \\n\\t1,1-dioxide hydrochloride <102>\\nIN\\t#14# \\n\\t3-[[bis(2-methoxyethyl)amino]methyl]-2-propyl-2H-thieno[3,2-e]-1,\\n\\t2-thiazine 1,1-dioxide hydrochloride <102>\\nIN\\t#14# 2-propyl-3-[(2-propynylamino)methyl]-2H-thieno[3,2-e]-1,2-thiazine \\n\\t1,1-dioxide <102>\\nIN\\t#14# \\n\\t2-(1-methylethyl)-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,\\n\\t2-thiazine 1,1-dioxide <102>\\nIN\\t#14# \\n\\t2-(1-methylethyl)-3-[(2-propynylamino)methyl]-2H-thieno[3,2-e]-1,\\n\\t2-thiazine 1,1-dioxide <102>\\nIN\\t#14# \\n\\t3-[(4-morpholinyl)methyl]-2-(2-propenyl)-2H-thieno[3,2-e]-1,2-thiazine \\n\\t1,1-dioxide <102>\\nIN\\t#14# \\n\\t2-cyclopropylmethyl-3-[(4-morpholinyl)methyl]-2-(2-propenyl)-2H-\\n\\tthieno[3,2-e]-1,2-thiazine 1,1-dioxide <102>\\nIN\\t#14# \\n\\t2-cyclohexyl-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,2-thiazine \\n\\t1,1-dioxide <102>\\nIN\\t#14# \\n\\t2-(2-methoxyethyl)-3-[(4-morpholinyl)methyl]-2-(2-propenyl)-2H-thieno[3,\\n\\t2-e]-1,2-thiazine 1,1-dioxide <102>\\nIN\\t#14# \\n\\t2-(2-methoxyethyl)-3-[[bis(2-methoxyethyl)amino]methyl]-2H-thieno[3,\\n\\t2-e]-1,2-thiazine 1,1-dioxide hydrochloride <102>\\nIN\\t#14# \\n\\t2-(3-methoxypropyl)-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,\\n\\t2-thiazine 1,1-dioxide hydrochloride <102>\\nIN\\t#14# \\n\\t3-[(cyclopropylamino)methyl]-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,\\n\\t2-thiazine 1,1-dioxide hydrochloride <102>\\nIN\\t#14# \\n\\t3-[(1-imidazolyl)methyl]-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,\\n\\t2-thiazine 1,1-dioxide <102>\\nIN\\t#14# \\n\\t2-[(4-methoxyphenyl)methyl]-3-[(4-morpholinyl)methyl]-2H-thieno[3,\\n\\t2-e]-1,2-thiazine 1,1-dioxide hydrochloride <102>\\nIN\\t#14# \\n\\t2-(3-methoxyphenyl)-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,\\n\\t2-thiazine 1,1-dioxide hydrochloride <102>\\nIN\\t#14# \\n\\t2-(3-methoxyphenyl)-3-[(2-hydroxyethylamino)methyl]-2H-thieno[3,2-e]-1,\\n\\t2-thiazine 1,1-dioxide hydrochloride <102>\\nIN\\t#14# \\n\\t2-(3,4-dimethoxyphenyl)-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,\\n\\t2-thiazine 1,1-dioxide hydrochloride <102>\\nIN\\t#14# \\n\\t2-[(4-morpholinyl)phenyl]-3-[(4-morpholinyl)methyl]-2H-thieno[3,2-e]-1,\\n\\t2-thiazine 1,1-dioxide hydrochloride <102>\\nIN\\t#14# \\n\\t2-(3-hydroxypropyl)-3-(4-morpholinylmethyl)-2H-thieno[3,2-e]-1,\\n\\t2-thiazine 1,1-dioxide <102>\\nIN\\t#14# \\n\\t2-(3-hydroxyphenyl)-3-(4-morpholinylmethyl)-2H-thieno[3,2-e]-1,\\n\\t2-thiazine 1,1-dioxide <102>\\nIN\\t#14# \\n\\t2-(3-hydroxyphenyl)-3-[(2-propynylamino)methyl]-2H-thieno[3,2-e]-1,\\n\\t2-thiazine 1,1-dioxide hydrochloride <102>\\nIN\\t#14# \\n\\t3-chloromethyl-N-(1,1-dimethylethyl)-2-(3-methoxyphenyl)-2H-thieno[3,\\n\\t2-e]-1,2-thiazine 1,1-dioxide <102>\\nIN\\t#14# \\n\\tN-(1,\\n\\t1-dimethylethyl)-2-(3-methoxyphenyl)-3-[(4-morpholinyl)methyl]-2H-\\n\\tthieno[3,2-e]-1,2-thiazine 1,1-dioxide <102>\\nIN\\t#14# \\n\\tN-(1,\\n\\t1-dimethylethyl)-2-(3-methoxyphenyl)-3-[(2-propylaminol)methyl]-2H-\\n\\tthieno[3,2-e]-1,2-thiazine 1,1-dioxide <102>\\nIN\\t#14# 3,5-dibromo-2-(1,3-dioxalan-2-yl)-thiophene <102>\\nIN\\t#14# N-[[2-(1,3-dioxalan-2-yl)-3-thienyl]sulfonyl]-N-methylglycine \\n\\tethyl ester <102>\\nIN\\t#14# ethyl 2-methyl-2H-thieno[2,3-e]-1,2-thiazine-3-carboxylate \\n\\t1,1-dioxide <102>\\nIN\\t#14# 2-methyl-2H-thieno[2,3-e]-1,2-thiazine-3-methanol 1,1-dioxide <102>\\nIN\\t#14# 3-hydroxymethyl \\n\\t2-methyl-2H-thieno[2,3-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide <102>\\nIN\\t#14# \\n\\t2-methyl-3-(4-morpholinylmethyl)-2H-thieno[2,3-e]-1,\\n\\t2-thiazine-6-sulfonamide 1,1-dioxide <102>\\nIN\\t#14# \\n\\t4-bromo-5-(1,3-dioxalan-2-yl)-N-(1,\\n\\t1-dimethylethyl)-thiophene-2-sulfonamide <102>\\nIN\\t#14# \\n\\tN-[[5-(aminosulfonyl)-2-formyl-thiophen-3-yl]sulfonyl]-N-methyl-glycine \\n\\tethyl ester <102>\\nIN\\t#14# PH2BOH <124>\\nIN\\t#14# dimethylsilylfluoroborane <124>\\nIN\\t#14# dimethylsilylaminoborane <124>\\nIN\\t#14# dimethylsilyl-diphenylaminoborane <124>\\nIN\\t#14# dimethylsilyl-N-methyl-N-phenylaminoborane <124>\\nIN\\t#14# dimethylsilyl para-toluenesulfonamidoborane <124>\\nIN\\t#14# dimethylsilylsulfonamidoborane <124>\\nIN\\t#14# dimethylsilylboronic acid <124>\\nIN\\t#14# 4-toluenesulfonamide <124>\\nIN\\t#14# allylamine hydrochloride <125>\\nIN\\t#14# allylsulfonamide hydrochloride <125>\\nIN\\t#14# allylsulfonyl chloride <125>\\nIN\\t#14# allylsulfonamide <125>\\nIN\\t#14# prop-2-ene-1-sulfonamide <125>\\nIN\\t#14# 3-phenylprop-2-ene-1-sulfonamide <125>\\nIN\\t#14# N-allyl-1-phenylmethanesulfonamide <125>\\nIN\\t#14# N-(benzylsulfonyl)allylamine <125>\\nIN\\t#14# N-(trans-styrenesulfonyl)allylamine <125>\\nIN\\t#14# N-(allylsulfonyl)allylamine <125>\\nIN\\t#14# N,N\\'-bis(benzylsulfonyl)allylamine <125>\\nIN\\t#14# N,N\\'-bis(styrenesulfonyl)allylamine <125>\\nIN\\t#14# 3-triethylsilylpropanamine <125>\\nIN\\t#14# 3-triethylgermylpropanamine <125>\\nIN\\t#14# 3-tributylgermylpropanamine <125>\\nIN\\t#14# 3-triphenylgermylpropanamine <125>\\nIN\\t#14# N-trimethylsilylallylsulfonamide <125>\\nIN\\t#14# N-(benzylsulfonyl)-3-triethylsilylpropanamine <125>\\nIN\\t#14# N-(styrenesulfonyl)-3-triethylsilylpropanamine <125>\\nIN\\t#14# N-(allysulfonyl)-3-triethylsilylpropanamine <125>\\nIN\\t#14# N-(benzylsulfonyl)-3-tributylgermylpropanamine <125>\\nIN\\t#14# 3-[9-borabicyclo[1.3.3.]nonane]-1-bromopropane <125>\\nIN\\t#14# 3-[9-borabicyclo[1.3.3.]nonane]-1-propylsulfonic acid sodium salt \\n\\t<125>\\nIN\\t#14# N-(dimesilylboro)allylsulfonamide <125>\\nIN\\t#14# N-allylsulfonyl-3-[9-borabicyclo[1.3.3.]nonane]propanamine <125>\\nIN\\t#14# ArSO2-NHPO3H2 <121>\\nIN\\t#14# N-phosphoryl-4-carboxy-benzenesulfonamide <121>\\nIN\\t#14# N,N\\'-biphosphoryl-4,5-dichloro-1,3-benzenesulfonamide <121>\\nIN\\t#14# N-phosphoryl-benzothiazole -2-sulfonamide <121>\\nIN\\t#14# N-phosphoryl-6-nitro-benzothiazole-2-sulfonamide <121>\\nIN\\t#14# 2-N-(4-sulfamoylphenyl)-thioformyl-L-Ala <153>\\nIN\\t#14# 2-N-(4-sulfamoylphenyl)-thioformyl-L-Asn <153>\\nIN\\t#14# 2-N-(4-sulfamoylphenyl)-thioformyl-L-Gln <153>\\nIN\\t#14# 2-N-(4-sulfamoylphenyl)-thioformyl-L-Ile <153>\\nIN\\t#14# 2-N-(4-sulfamoylphenyl)-thioformyl-L-Leu <153>\\nIN\\t#14# 2-N-(4-sulfamoylphenyl)-thioformyl-L-Met <153>\\nIN\\t#14# 2-N-(4-sulfamoylphenyl)-thioformyl-L-Phe <153>\\nIN\\t#14# 2-N-(4-sulfamoylphenyl)-thioformyl-L-Pro <153>\\nIN\\t#14# 2-N-(4-sulfamoylphenyl)-thioformyl-L-Trp <153>\\nIN\\t#14# 2-N-(4-sulfamoylphenyl)-thioformyl-L-Val <153>\\nIN\\t#14# N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-alanine <153>\\nIN\\t#14# N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-asparagine <153>\\nIN\\t#14# N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-glutamine <153>\\nIN\\t#14# N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-isoleucine <153>\\nIN\\t#14# N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-leucine <153>\\nIN\\t#14# N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-methionine <153>\\nIN\\t#14# N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-phenylalanine \\n\\t<153>\\nIN\\t#14# N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-proline <153>\\nIN\\t#14# N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-tryptophan <153>\\nIN\\t#14# N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-valine <153>\\nIN\\t#14# acetaldehyde (#14# modification of carbonic anhydrase II with \\n\\tacetaldehyde leads to decreased enzyme activity, acetaldehyde (100 mM) \\n\\tin the presence of NaBH3(CN) causes 23.7% reduction in CA II activity, \\n\\tin the absence of NaBH3(CN) the activity is only slightly reduced \\n\\t<211>) <211>\\nIN\\t#14# ethoxazolamide (#14# systemic carbonic anhydrase inhibitor <228>) \\n\\t<228>\\nIN\\t#14# 4-ethynylbenzenesulfonamide <228>\\nIN\\t#14# \\n\\t4-[4-(aminosulfonyl)phenyl]-1-(2\\',3\\',4\\',\\n\\t6\\'-tetra-O-acetyl-beta-D-glucopyranosyl)-1H-1,2,3-triazole <228>\\nIN\\t#14# \\n\\t4-[4-(aminosulfonyl)phenyl]-1-(2\\',3\\',4\\',\\n\\t6\\'-tetra-O-acetyl-beta-D-galactopyranosyl)-1H-1,2,3-triazole <228>\\nIN\\t#14# \\n\\t4-[4-(aminosulfonyl)phenyl]-1-(hepta-O-acetyl-beta-D-maltopyranosyl)-1H-\\n\\t1,2,3-triazole <228>\\nIN\\t#14# \\n\\t4-[4-(aminosulfonyl)phenyl]-1-(2\\'-acetamido-2\\'-deoxy\\'-3\\',4\\',\\n\\t6\\'-tri-O-acetyl-beta-D-glucopyranosyl)-1H-1,2,3-triazole <228>\\nIN\\t#14# \\n\\t4-[4-(aminosulfonyl)phenyl]-1-(2\\',3\\',4\\'-tri-O-acetyl-beta-D-glucuronic \\n\\tacid methyl ester)-1H-1,2,3-triazole <228>\\nIN\\t#14# \\n\\t4-[4-(aminosulfonyl)phenyl]-1-(2\\',3\\',\\n\\t5\\'-tri-O-benzoyl-beta-D-ribofuranosyl)-1H-1,2,3-triazole <228>\\nIN\\t#14# \\n\\t4-[4-(aminosulfonyl)phenyl]-1-(2\\',3\\',4\\',\\n\\t6\\'-tetra-O-acetyl-alpha-D-mannopyranosyl)-1H-1,2,3-triazole <228>\\nIN\\t#14# \\n\\t4-[4-(aminosulfonyl)phenyl]-1-(2\\',3\\',\\n\\t4\\'-tri-O-acetyl-alpha-D-arabinopyranosyl)-1H-1,2,3-triazole <228>\\nIN\\t#14# \\n\\t4-[4-(aminosulfonyl)phenyl]-1-(beta-D-glucopyranosyl)-1H-1,2,3-triazole \\n\\t<228>\\nIN\\t#14# \\n\\t4-[4-(aminosulfonyl)phenyl]-1-(beta-D-galactopyranosyl)-1H-1,2,\\n\\t3-triazole <228>\\nIN\\t#14# \\n\\t4-[4-(aminosulfonyl)phenyl]-1-(beta-D-maltopyranosyl)-1H-1,2,3-triazole \\n\\t<228>\\nIN\\t#14# \\n\\t4-[4-(aminosulfonyl)phenyl]-1-(2\\'-acetamido-2\\'-deoxy-beta-D-\\n\\tglucopyranosyl)-1H-1,2,3-triazole <228>\\nIN\\t#14# 4-[4-(aminosulfonyl)phenyl]-1-(beta-D-glucuronic acid methyl \\n\\tester)-1H-1,2,3-triazole <228>\\nIN\\t#14# \\n\\t4-[4-(aminosulfonyl)phenyl]-1-(beta-D-ribofuranosyl)-1H-1,2,3-triazole \\n\\t<228>\\nIN\\t#14# \\n\\t4-[4-(aminosulfonyl)phenyl]-1-(alpha-D-mannopyranosyl)-1H-1,2,\\n\\t3-triazole <228>\\nIN\\t#14# \\n\\t4-[4-(aminosulfonyl)phenyl]-1-(alpha-D-arabinopyranosyl)-1H-1,2,\\n\\t3-triazole <228>\\nIN\\t#14# 4-aminosalicylic acid (#14# noncompetitive inhibition of isozymes \\n\\tcarbonic anhydrase I and II <209>) <209>\\nIN\\t#14# 4-sulfosalicylic acid (#14# uncompetitive inhibition of isozyme \\n\\tcarbonic anhydrase I and competitive inhibition of isozyme carbonic \\n\\tanhydrase II <209>) <209>\\nIN\\t#14# 5-sulfosalicylic acid (#14# competitive inhibition of isozyme \\n\\tcarbonic anhydrase I and noncompetitive inhibition of isozyme carbonic \\n\\tanhydrase II <209>) <209>\\nIN\\t#14# 5-chlorosalicylic acid (#14# uncompetitive inhibition of isozymes \\n\\tcarbonic anhydrase I and II <209>) <209>\\nIN\\t#14# 4,6-dinitrosalicylic acid (#14# noncompetitive inhibition of \\n\\tisozymes carbonic anhydrase I and II <209>) <209>\\nIN\\t#14# 3-methylsalicylic acid (#14# noncompetitive inhibition of isozyme \\n\\tcarbonic anhydrase I and uncompetitive inhibition of isozyme carbonic \\n\\tanhydrase II <209>) <209>\\nIN\\t#14# diflunisal (#14# noncompetitive inhibition of isozymes carbonic \\n\\tanhydrase I and II <209>) <209>\\nIN\\t#14# sulfasalazine (#14# noncompetitive inhibition of isozymes carbonic \\n\\tanhydrase I and II <209>) <209>\\nIN\\t#14# Acetylsalicylic acid (#14# noncompetitive inhibition of isozymes \\n\\tcarbonic anhydrase I and II <209>) <209>\\nIN\\t#14# coumarin <263,293,299>\\nIN\\t#14# 2-hydroxycinnamic acid <263>\\nIN\\t#14# L-adrenaline <263>\\nIN\\t#14# histamine <263>\\nIN\\t#14# 4-(2-hydroxyethyl)phenol <261>\\nIN\\t#14# (4-hydroxyphenyl)acetic acid <261>\\nIN\\t#14# 2-(4-hydroxyphenyl)acetamide <261>\\nIN\\t#14# (3-chloro-4-hydroxyphenyl)acetic acid <261>\\nIN\\t#14# 2-(3-chloro-4-hydroxyphenyl)acetamide <261>\\nIN\\t#14# methyl (3-chloro-4-hydroxyphenyl)acetate <261>\\nIN\\t#14# N-benzyl-2-(3-chloro-4-hydroxyphenyl)acetamide <261>\\nIN\\t#14# 2-(3-chloro-4-hydroxyphenyl)-N-(2-phenylethyl)acetamide <261>\\nIN\\t#14# 2-(3-chloro-4-hydroxyphenyl)-N-[2-(3-methoxyphenyl)ethyl]acetamide \\n\\t<261>\\nIN\\t#14# \\n\\t2-(3-chloro-4-hydroxyphenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]acetamide \\n\\t<261>\\nIN\\t#14# \\n\\t2-(3-chloro-4-hydroxyphenyl)-N-[2-(4-sulfamoylphenyl)ethyl]acetamide \\n\\t<261>\\nIN\\t#14# 2-(3-chloro-4-hydroxyphenyl)-N-(2-methoxyethyl)acetamide <261>\\nIN\\t#14# N-tert-butyl-2-(3-chloro-4-hydroxyphenyl)acetamide <261>\\nIN\\t#14# N-butyl-2-(3-chloro-4-hydroxyphenyl)acetamide <261>\\nIN\\t#14# \\n\\t(2R)-3-(3-chloro-4-hydroxyphenyl)-2-[[(2E)-4-methoxy-4-oxobut-2-\\n\\tenoyl]amino]propanoic acid <261>\\nIN\\t#14# \\n\\t(2S)-3-(3-chloro-4-hydroxyphenyl)-2-[[(2E)-4-methoxy-4-oxobut-2-\\n\\tenoyl]amino]propanoic acid <261>\\nIN\\t#14# \\n\\t(5Z)-2-amino-5-(4-hydroxy-3-methoxybenzylidene)-3,\\n\\t5-dihydro-4H-imidazol-4-one <261>\\nIN\\t#14# \\n\\t(5Z)-2-amino-5-(3,4-dihydroxybenzylidene)-3,5-dihydro-4H-imidazol-4-one \\n\\t<261>\\nIN\\t#14# \\n\\t7-hydroxy-1-methoxy-3-methyl-9-oxo-9,\\n\\t9a-dihydro-4aH-xanthene-8-carboxylic acid <261>\\nIN\\t#14# \\n\\t7-hydroxy-3-(hydroxymethyl)-1-methoxy-9-oxo-9,\\n\\t9a-dihydro-4aH-xanthene-8-carboxylic acid <261>\\nIN\\t#14# \\n\\t4,4\\'-[(1R,2R,3S,4S)-3,4-dimethylcyclobutane-1,\\n\\t2-diyl]bis(2-methoxyphenol) <261>\\nIN\\t#14# \\n\\t4,4\\'-[(1R,2S,3R,4S)-3,4-dimethylcyclobutane-1,\\n\\t2-diyl]bis(2-methoxyphenol) <261>\\nIN\\t#14# 4,4\\'-[(2R,3R)-2,3-dimethylbutane-1,4-diyl]bis(2-methoxyphenol) \\n\\t<261>\\nIN\\t#14# (3-chlorophenyl)acetic acid <261>\\nIN\\t#14# (2E)-but-2-enedioic acid <261>\\nIN\\t#14# (2E)-4-methoxy-4-oxobut-2-enoic acid <261>\\nIN\\t#14# 4-chlorobenzenesulfonamide <268>\\nIN\\t#14# 4-(4\\'-dimethylaminophenyl)diazenylbenzenesulfonamide <268>\\nIN\\t#14# 4-(4\\'-hydroxyphenyl)diazenylbenzenesulfonamide <268>\\nIN\\t#14# 4-(4\\'-methoxyphenyl)diazenylbenzene-N,N-dimethylsulfonamide <268>\\nIN\\t#14# 4-(4\\'-hydroxyphenyl)diazenylbenzene-N,N-dimethylsulfonamide <268>\\nIN\\t#14# 4-(4\\'-hydroxyphenyl)diazenylbenzene-N-methylsulfonamide <268>\\nIN\\t#14# 4-methoxy-3-pyridinesulfonamide <271>\\nIN\\t#14# 4-ethoxy-3-pyridinesulfonamide <271>\\nIN\\t#14# 4-(4-cyanophenoxy)-3-pyridinesulfonamide <271>\\nIN\\t#14# 4-(4-fluorophenoxy)-3-pyridinesulfonamide <271>\\nIN\\t#14# 4-(quinolinoxy)-3-pyridinesulfonamide <271>\\nIN\\t#14# 4-(2-methyl-8-quinolinoxy)-3-pyridinesulfonamide <271>\\nIN\\t#14# 4-(N-oxide-2-pyridylthio)pyridine-3-sulfonamide <271>\\nIN\\t#14# 4-(1-methyl-5-tetrazolylthio)pyridine-3-sulfonamide <271>\\nIN\\t#14# 4-(1,3,4-thiadiazol-2-ylthio)pyridine-3-sulfonamide <271>\\nIN\\t#14# 4-(6-nitrobenzothiazol-2-ylthio)pyridine-3-sulfonamide <271>\\nIN\\t#14# 4,4\\'-thiodipyridine-3-sulfonamide <271>\\nIN\\t#14# 4-methylthiopyridine-3-sulfonamide <271>\\nIN\\t#14# 4-(cyanomethylthio)pyridine-3-sulfonamide <271>\\nIN\\t#14# 4-(2-propynylthio)pyridine-3-sulfonamide <271>\\nIN\\t#14# 4-benzythiopyridine-3-sulfonamide <271>\\nIN\\t#14# 4-(carbamoylmethylthio)pyridine-3-sulfonamide <271>\\nIN\\t#14# 4-(allylamino)-3-pyridinesulfonamide <271>\\nIN\\t#14# 4-(5-methyl-2-pyrazolino)-3-pyridinesulfonamide <271>\\nIN\\t#14# 4-(methylhydrazino)-3-pyridinesulfonamide <271>\\nIN\\t#14# 4-hydrazino-3-pyridinesulfonamide <271>\\nIN\\t#14# 4-[2-(4-sulfamoylphenyl)ethylamino]-3-pyridinosulfonamide <271>\\nIN\\t#14# \\n\\t4-[N\\'-(6-chloro-7-cyano-1,1-dioxo-1,4,\\n\\t2-benzodithiazin-3-yl)hydrazino]-3-pyridinesulfonamide <271>\\nIN\\t#14# \\n\\t4-[N\\'-(6-chloro-7-methyl-1,1-dioxo-1,4,\\n\\t2-benzodithiazin-3-yl)hydrazino]-3-pyridinesulfonamide <271>\\nIN\\t#14# \\n\\t4-[N\\'-(1,1-dioxopyrido[4,3-e]-1,4,\\n\\t2-dithiazin-3-yl)hydrazino]-3-pyridinesulfonamide <271>\\nIN\\t#14# 1,1,2,2,3,3,4,4 octafluoro-n-butane-1-4-bissulfonamide <270>\\nIN\\t#14# octane-1-sulfonamide <270>\\nIN\\t#14# sodium (butylsulfonyl)azanide <270>\\nIN\\t#14# sodium (hexylsulfonyl)azanide <270>\\nIN\\t#14# sodium (octylsulfonyl)azanide <270>\\nIN\\t#14# 3,4-dimethoxybenzoic acid <299>\\nIN\\t#14# 3,4-dihydroxybenzoic acid <299>\\nIN\\t#14# 1,2-dimethoxybenzene <299>\\nIN\\t#14# 1,4-dimethoxybenzene <299>\\nIN\\t#14# 1,2,4-trimethoxybenzene <299>\\nIN\\t#14# 3,5-Dihydroxybenzoic acid <299>\\nIN\\t#14# 3-Hydroxybenzoic acid <299>\\nIN\\t#14# 2,6-dimethoxybenzoic acid <299>\\nIN\\t#14# spermine <299>\\nIN\\t#14# N-(4-sulfamoylphenyl)-2-(thiophen-2-yl)acetamide <302>\\nIN\\t#14# N-(2-fluoro-4-sulfamoylphenyl)-2-(thiophen-2-yl)acetamide <302>\\nIN\\t#14# 2-(p-toluenesulfonamido)-l,3,4-thiadiazole-5-sulfonamide <301>\\nIN\\t#14# 2-benzene-sulfonamido-l,3,4-thiadiazole-5-sulfonamide <301>\\nIN\\t#14# \\n\\t5-{butyl[(4-methylphenyl)sulfonyl]amino}-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# \\n\\t5-{benzyl[(4-methylphenyl)sulfonyl]amino}-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# \\n\\t5-{[(4-methylphenyl)sulfonyl](propyl)amino}-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# \\n\\t5-{methyl[(4-methylphenyl)sulfonyl]amino}-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# \\n\\t5-{ethyl[(4-methylphenyl)sulfonyl]amino}-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# \\n\\t5-{dodecyl[(4-methylphenyl)sulfonyl]amino}-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# \\n\\t5-{[(4-methylphenyl)sulfonyl](propan-2-yl)amino}-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# \\n\\t5-{[(4-methylphenyl)sulfonyl](2-methylpropyl)amino}-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# \\n\\t5-{[(4-methylphenyl)sulfonyl](pentyl)amino}-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# \\n\\t5-{(4-chlorobenzyl)[(4-methylphenyl)sulfonyl]amino}-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# \\n\\t5-{(2,4-dichlorobenzyl)[(4-methylphenyl)sulfonyl]amino}-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# \\n\\t5-{[(4-methylphenyl)sulfonyl](2-phenylethyl)amino}-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# \\n\\t5-{(4-bromobenzyl)[(4-methylphenyl)sulfonyl]amino}-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# \\n\\t5-{(4-methoxybenzyl)[(4-methylphenyl)sulfonyl]amino}-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# \\n\\t5-{[2-(4-bromophenyl)ethyl][(4-methylphenyl)sulfonyl]amino}-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# \\n\\t5-{[(4-methylphenyl)sulfonyl](3,4,5-trimethoxybenzyl)amino}-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# \\n\\t5-{(4-methylbenzyl)[(4-methylphenyl)sulfonyl]amino}-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# \\n\\t5-{(4-fluorobenzyl)[(4-methylphenyl)sulfonyl]amino}-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# \\n\\t5-{[3-(2-methoxyphenyl)propyl][(4-methylphenyl)sulfonyl]amino}-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# 5-[ethyl(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide \\n\\t<301>\\nIN\\t#14# 5-[(benzylsulfonyl)(butyl)amino]-1,3,4-thiadiazole-2-sulfonamide \\n\\t<301>\\nIN\\t#14# \\n\\t2-[benzenesulfonamido-N-(n-propyl)]-l,3,4-thiadiazole-5-sulfonamide \\n\\t<301>\\nIN\\t#14# \\n\\t5-[(2-phenylethyl)(phenylsulfonyl)amino]-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# \\n\\t5-[(benzylsulfonyl)(4-chlorobenzyl)amino]-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# \\n\\t5-[(benzylsulfonyl)(2,4-dichlorobenzyl)amino]-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# 5-[methyl(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide \\n\\t<301>\\nIN\\t#14# 5-[(benzylsulfonyl)(pentyl)amino]-1,3,4-thiadiazole-2-sulfonamide \\n\\t<301>\\nIN\\t#14# \\n\\t5-[(benzylsulfonyl)(2-methylpropyl)amino]-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# 5-[(benzylsulfonyl)(dodecyl)amino]-1,3,4-thiadiazole-2-sulfonamide \\n\\t<301>\\nIN\\t#14# 5-[benzyl(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide \\n\\t<301>\\nIN\\t#14# \\n\\t5-[(benzylsulfonyl)(4-methoxybenzyl)amino]-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# \\n\\t5-[(benzylsulfonyl)(propan-2-yl)amino]-1,3,4-thiadiazole-2-sulfonamide \\n\\t<301>\\nIN\\t#14# \\n\\t5-{(benzylsulfonyl)[2-(4-bromophenyl)ethyl]amino}-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# \\n\\t5-[(benzylsulfonyl)(3,4,5-trimethoxybenzyl)amino]-1,3,\\n\\t4-thiadiazole-2-sulfonamide <301>\\nIN\\t#14# \\n\\t2-[(p-toluenesulfonamido)-N-methyl]-5-[N,N-dimethylsulfonamide]-l,3,\\n\\t4-thiadiazole <301>\\nIN\\t#14# \\n\\t2-(benzenesulfonamido-N-benzyl)-5-[N,Ndibenzylsulfonamido]-l,3,\\n\\t4-thiadiazole <301>\\nIN\\t#14# umbelliferone <293>\\nIN\\t#14# 6-acetyl-7-hydroxy-2H-chromen-2-one <293>\\nIN\\t#14# 7-hydroxy-6-propanoyl-2H-chromen-2-one <293>\\nIN\\t#14# 8-acetyl-7-hydroxy-2H-chromen-2-one <293>\\nIN\\t#14# 7-hydroxy-8-propanoyl-2H-chromen-2-one <293>\\nIN\\t#14# 6-acetyl-7-methoxy-2H-chromen-2-one <293>\\nIN\\t#14# 6-acetyl-7-ethoxy-2H-chromen-2-one <293>\\nIN\\t#14# 6-acetyl-7-propoxy-2H-chromen-2-one <293>\\nIN\\t#14# 6-acetyl-7-butoxy-2H-chromen-2-one <293>\\nIN\\t#14# 6-acetyl-7-(benzyloxy)-2H-chromen-2-one <293>\\nIN\\t#14# 8-acetyl-7-methoxy-2H-chromen-2-one <293>\\nIN\\t#14# 8-acetyl-7-ethoxy-2H-chromen-2-one <293>\\nIN\\t#14# 8-acetyl-7-propoxy-2H-chromen-2-one <293>\\nIN\\t#14# 8-acetyl-7-butoxy-2H-chromen-2-one <293>\\nIN\\t#14# 8-acetyl-7-(benzyloxy)-2H-chromen-2-one <293>\\nIN\\t#14# 2-adamantylethyl 7-methoxy-2-oxo-2H-chromene-8-carboxylate <293>\\nIN\\t#14# 7-methoxy-8-propanoyl-2H-chromen-2-one <293>\\nIN\\t#14# 7-ethoxy-8-propanoyl-2H-chromen-2-one <293>\\nIN\\t#14# 8-propanoyl-7-propoxy-2H-chromen-2-one <293>\\nIN\\t#14# 6-acetyl-7-adamantylethoxy-2H-chromen-2-one <293>\\nIN\\t#14# 6-(1-hydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one <293>\\nIN\\t#14# \\n\\t(3aR,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,\\n\\t5-b:4\\',5\\'-d]pyran-3a-yl sulfamate <294>\\nIN\\t#14# \\n\\tN-[(3aR,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,\\n\\t3]dioxolo[4,5-b:4\\',5\\'-d]pyran-3a-yl]sulfamic amide <294>\\nIN\\t#14# 2,3,4,6-tetra-O-acetyl-N-sulfamoyl-beta-D-glucopyranosylamine <294>\\nIN\\t#14# 2,3,4,6-tetra-O-acetyl-N-sulfamoyl-beta-D-galactopyranosylamine \\n\\t<294>\\nIN\\t#14# 2,3,4,6-tetra-O-acetyl-N-sulfamoyl-beta-D-mannopyranosylamine <294>\\nIN\\t#14# 2,3,4-tri-O-acetyl-6-deoxy-N-sulfamoyl-alpha-L-glucopyranosylamine \\n\\t<294>\\nIN\\t#14# N-sulfamoyl-beta-D-glucopyranosylamine <294>\\nIN\\t#14# N-sulfamoyl-beta-D-galactopyranosylamine <294>\\nIN\\t#14# N-sulfamoyl-beta-D-mannopyranosylamine <294>\\nIN\\t#14# 6-deoxy-N-sulfamoyl-alpha-L-glucopyranosylamine <294>\\nIN\\t#14# \\n\\t3,4,\\n\\t6-tri-O-acetyl-2-deoxy-N-sulfamoyl-beta-D-arabino-hexopyranosylamine \\n\\t<294>\\nIN\\t#14# \\n\\t3,4,6-tri-O-acetyl-2-deoxy-N-sulfamoyl-beta-D-lyxo-hexopyranosylamine \\n\\t<294>\\nIN\\t#14# catechin (#14# a competitive inhibitor with 4-nitrophenylacetate \\n\\tas substrate <304>) <304>\\nIN\\t#14# silymarin (#14# a competitive inhibitor with 4-nitrophenylacetate \\n\\tas substrate <304>) <304>\\nIN\\t#14# 4-(phenylethynyl)benzenesulfonamide <296>\\nIN\\t#14# 4-[(4-methylphenyl)ethynyl]benzenesulfonamide <296>\\nIN\\t#14# 4-[(3-methoxyphenyl)ethynyl]benzenesulfonamide <296>\\nIN\\t#14# 4-[(3-hydroxyphenyl)ethynyl]benzenesulfonamide <296>\\nIN\\t#14# 4-[(3-fluorophenyl)ethynyl]benzenesulfonamide <296>\\nIN\\t#14# 3-(phenylethynyl)benzenesulfonamide <296>\\nIN\\t#14# 3-[(4-methylphenyl)ethynyl]benzenesulfonamide <296>\\nIN\\t#14# 3-[(3-methoxyphenyl)ethynyl]benzenesulfonamide <296>\\nIN\\t#14# 3-[(3-fluorophenyl)ethynyl]benzenesulfonamide <296>\\nIN\\t#14# 2-(phenylethynyl)benzenesulfonamide <296>\\nIN\\t#14# phenylacetonitrile <296>\\nIN\\t#14# 3-phenylpropanenitrile <296>\\nIN\\t#14# 4-[4-(methylsulfonyl)phenyl]-3-phenyldihydrofuran-2(3H)-one <296>\\nIN\\t#14# rofecoxib <296>\\nIN\\t#14# dinitrosalicylic acid <209>\\nIN\\t#14# 7alpha-hydroxyepiandrosterone sulfamate <132>\\nIN\\t#14# but-3-ynyl sulfamate <132>\\nIN\\t#14# 2-naphthylsulfamate <131>\\nIN\\t#14# 5-(formylamino)-1,3,4-thiadiazole-2-sulfonamide <332>\\nIN\\t#14# 2-amino-1-benzothiophen-3(2H)-one 1,1-dioxide <332>\\nIN\\t#14# \\n\\t4-(1-[2-[2-benzylidenehydrazino]-2-oxoethyl]-3-methyl-5-oxo-1,\\n\\t5-dihydro-4H-1,2,4-triazol-4-yl)-N\\'-[phenylmethylene]benzohydrazide \\n\\t<416>\\nIN\\t#14# \\n\\t4-(1-[2-[2-(4-chlorobenzylidene)hydrazino]-2-oxoethyl]-3-methyl-5-oxo-1,\\n\\t5-dihydro-4H-1,2,\\n\\t4-triazol-4-yl)-N\\'-[(4-chlorophenyl)methylene]benzohydrazide <416>\\nIN\\t#14# \\n\\t4-(1-[2-[2-(4-bromobenzylidene)hydrazino]-2-oxoethyl]-3-methyl-5-oxo-1,\\n\\t5-dihydro-4H-1,2,\\n\\t4-triazol-4-yl)-N\\'-[(4-bromophenyl)methylene]benzohydrazide <416>\\nIN\\t#14# \\n\\t4-(1-[2-[2-(3-bromobenzylidene)hydrazino]-2-oxoethyl]-3-methyl-5-oxo-1,\\n\\t5-dihydro-4H-1,2,\\n\\t4-triazol-4-yl)-N\\'-[(3-bromophenyl)methylene]benzohydrazide <416>\\nIN\\t#14# \\n\\t4-(1-[2-[2-(4-methoxybenzylidene)hydrazino]-2-oxoethyl]-3-methyl-5-oxo-\\n\\t1,5-dihydro-4H-1,2,\\n\\t4-triazol-4-yl)-N\\'-[(4-methoxyphenyl)methylene]benzohydrazide <416>\\nIN\\t#14# \\n\\t4-(1-[2-[2-(4-bromo-2-hydroxybenzylidene)hydrazino]-2-oxoethyl]-3-\\n\\tmethyl-5-oxo-1,5-dihydro-4H-1,2,\\n\\t4-triazol-4-yl)-N\\'-[(4-bromo-2-ydroxyphenyl)methylene]benzohydrazide \\n\\t<416>\\nIN\\t#14# melphalan <414>\\nIN\\t#14# 2-(4-hydroxybenzylidene)-2H-indene-1,3-dione <414>\\nIN\\t#14# 4-(4-hydroxyphenyl)-2-phenyl-5H-indeno[1,2-b]pyridin-5-one <414>\\nIN\\t#14# 4-(4-hydroxyphenyl)-2-p-tolyl-5H-indeno[1,2-b]pyridin-5-one <414>\\nIN\\t#14# \\n\\t4-(4-hydroxyphenyl)-2-(4-methoxyphenyl)-5H-indeno[1,2-b]pyridin-5-one \\n\\t<414>\\nIN\\t#14# \\n\\t4-(4-hydroxyphenyl)-2-(4-fluorophenyl)-5H-indeno[1,2-b]pyridin-5-one \\n\\t<414>\\nIN\\t#14# \\n\\t4-(4-hydroxyphenyl)-2-(4-bromophenyl)-5H-indeno[1,2-b]pyridin-5-one \\n\\t<414>\\nIN\\t#14# \\n\\t4-(4-hydroxyphenyl)-2-(4-chlorophenyl)-5H-indeno[1,2-b]pyridin-5-one \\n\\t<414>\\nIN\\t#14# \\n\\t4-(4-hydroxyphenyl)-2-(3-hydroxyphenyl)-5H-indeno[1,2-b]pyridin-5-one \\n\\t<414>\\nIN\\t#14# 2,4-bis(4-hydroxyphenyl)-5H-indeno[1,2-b]pyridin-5-one <414>\\nIN\\t#14# \\n\\tN-[(benzyloxy)carbonyl]glycyl-N-[2-(4-sulfamoylphenyl)ethyl]glycinamide \\n\\t<415>\\nIN\\t#14# \\n\\tN-[(benzyloxy)carbonyl]glycyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tmethioninamide <415>\\nIN\\t#14# \\n\\tN-[(benzyloxy)carbonyl]-D-alanyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]glycinamide <415>\\nIN\\t#14# \\n\\tN-[(benzyloxy)carbonyl]-D-alanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\talaninamide <415>\\nIN\\t#14# \\n\\tN-[(benzyloxy)carbonyl]-D-alanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tphenylalaninamide <415>\\nIN\\t#14# \\n\\tN-[(benzyloxy)carbonyl]-D-alanyl-S-benzyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]-D-cysteinamide <415>\\nIN\\t#14# \\n\\tN-[(benzyloxy)carbonyl]-D-alanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tvalinamide <415>\\nIN\\t#14# \\n\\tN-[(benzyloxy)carbonyl]-D-alanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tmethioninamide <415>\\nIN\\t#14# \\n\\tN-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]glycinamide <415>\\nIN\\t#14# \\n\\tN-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\talaninamide <415>\\nIN\\t#14# \\n\\tN-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tphenylalaninamide <415>\\nIN\\t#14# \\n\\tN-[(benzyloxy)carbonyl]-D-phenylalanyl-S-benzyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]-D-cysteinamide <415>\\nIN\\t#14# \\n\\tN-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tleucinamide <415>\\nIN\\t#14# \\n\\tN-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tisoleucinamide <415>\\nIN\\t#14# \\n\\tN-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tvalinamide <415>\\nIN\\t#14# \\n\\tN-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tmethioninamide <415>\\nIN\\t#14# \\n\\tN-[(benzyloxy)carbonyl]-D-methionyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]glycinamide <415>\\nIN\\t#14# \\n\\tN-[(benzyloxy)carbonyl]-D-methionyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\talaninamide <415>\\nIN\\t#14# \\n\\tN-[(benzyloxy)carbonyl]-D-methionyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tphenylalaninamide <415>\\nIN\\t#14# \\n\\tN-[(benzyloxy)carbonyl]-D-methionyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tmethioninamide <415>\\nIN\\t#14# \\n\\tN-(tert-butoxycarbonyl)-D-phenylalanyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]glycinamide <415>\\nIN\\t#14# \\n\\tN-(tert-butoxycarbonyl)-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tphenylalaninamide <415>\\nIN\\t#14# \\n\\tN-(tert-butoxycarbonyl)-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tleucinamide <415>\\nIN\\t#14# \\n\\tN-(tert-butoxycarbonyl)-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\talloisoleucinamide <415>\\nIN\\t#14# \\n\\tN-(tert-butoxycarbonyl)-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tmethioninamide <415>\\nIN\\t#14# D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-methioninamide \\n\\t<415>\\nIN\\t#14# D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-alloisoleucinamide \\n\\t<415>\\nIN\\t#14# D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-leucinamide <415>\\nIN\\t#14# D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-phenylalaninamide \\n\\t<415>\\nIN\\t#14,120,124,127# resveratrol (#14# a competitive inhibitor with \\n\\t4-nitrophenylacetate as substrate <304>) <304,386>\\nIN\\t#14,120,124,127# curcumin (#14# a competitive inhibitor with \\n\\t4-nitrophenylacetate as substrate <304>) <304,386>\\nIN\\t#14,124# 3,4-dihydroisoquinoline-2(1H)-sulfonamide <278>\\nIN\\t#14,124# \\n\\t6,7-dimethoxy-1-methyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide <278>\\nIN\\t#14,124# \\n\\t6,7-dimethoxy-1-ethyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide <278>\\nIN\\t#14,124# \\n\\t6,7-dimethoxy-1-propyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide <278>\\nIN\\t#14,124# \\n\\t6,7-dimethoxy-1-isopropyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide \\n\\t<278>\\nIN\\t#14,124# \\n\\t1-cyclopropyl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide \\n\\t<278>\\nIN\\t#14,124# \\n\\t1-n-butyl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide <278>\\nIN\\t#14,124# \\n\\t1-cyclopentyl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide \\n\\t<278>\\nIN\\t#14,124# \\n\\t1-cyclohexyl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide \\n\\t<278>\\nIN\\t#14,124# \\n\\t6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide <278>\\nIN\\t#14,124,127# dobutamin (#14# a competitive inhibitor with \\n\\t4-nitrophenylacetate as substrate <304>) <304,386>\\nIN\\t#14,124,127# 5-fluorouracil <392,414>\\nIN\\t#14,129,130# 4-[2-(2-thienyl)acetamido]benzenesulfonamide <255,258>\\nIN\\t#14,129,130# 4-[2-(2-thienyl)acetamido]-3-fluorobenzenesulfonamide \\n\\t<255,258>\\nIN\\t#14,129,130# 4-[2-(2-thienyl)acetamido]-3-chlorobenzenesulfonamide \\n\\t<255,258>\\nIN\\t#14,129,130# 4-[2-(2-thienyl)acetamido]-3-bromobenzenesulfonamide \\n\\t<255,258>\\nIN\\t#14,129,130# 4-[2-(2-thienyl)acetamidomethyl]benzenesulfonamide \\n\\t<255,258>\\nIN\\t#14,129,130# 4-[2-(2-thienyl)acetamidoethyl]benzenesulfonamide <255,258>\\nIN\\t#14,129,130# 5-[2-(2-thienyl)acetamido]-1,3,4-thiadiazole-2-sulfonamide \\n\\t<255,258>\\nIN\\t#14,129,130# 4-(2-phenylacetamido)benzenesulfonamide <255,258>\\nIN\\t#14,129,130# 4-(2-phenylacetamidomethyl)benzenesulfonamide <255,258>\\nIN\\t#14,129,130# 4-(2-phenylacetamidoethyl)benzenesulfonamide <255,258>\\nIN\\t#14,129,130# 4-(2-phenylacetamido)-3-fluorobenzenesulfonamide <255,258>\\nIN\\t#14,129,130# 4-(2-phenylacetamido)-3-chlorobenzenesulfonamide <255,258>\\nIN\\t#14,129,130# 4-(2-phenylacetamido)-3-bromobenzenesulfonamide <255,258>\\nIN\\t#14,129,130# 4-(2-pyridin-2-ylacetamido)benzenesulfonamide <255,258>\\nIN\\t#14,129,130# 4-(2-pyridin-4-ylacetamido)benzenesulfonamide <255,258>\\nIN\\t#14,129,130# 4-(2-pyridin-4-ylacetamidoethyl)benzenesulfonamide \\n\\t<255,258>\\nIN\\t#14,129,130# 5-(2-phenylacetamido)-1,3,4-thiadiazole-2-sulfonamide \\n\\t<255,258>\\nIN\\t#14,15# ethanol (#15# carbonic anhydrase activity is significantly \\n\\tinhibited by 2ml/kg ethanol for up to 3 h following intraperitoneally \\n\\tadministration <225>) <225>\\nIN\\t#14,15,17,18,19,20,29,32,39,53,99,120,124,125,131,133,147,162,167,172,\\n\\t195,228,230# methazolamide (#133# carbonic anhydrase XIII <175>; #172# \\n\\tbest isozyme CA XV inhibitor <230>; #124# promiscuous inhibitor of all \\n\\tisozymes except CA III <229>; #17# shows effective carbonic anhydrase \\n\\tinhibitory activity <210>; #14# systemic carbonic anhydrase inhibitor \\n\\t<228>; #32# effective, submicromolar inhibition <276>) \\n\\t<2,7,15,68,79,102,120,131,132,143,153,165,167,175,184,196,210,228,229,\\n\\t230,231,259,268,271,274,275,276,277,300,302,318,362,436,440,446>\\nIN\\t#14,162# 4-chlorophenyl sulfamate (#14# best CA IX inhibitor <131>) \\n\\t<131,298>\\nIN\\t#14,17,18,20,32,39,53,74,99,110,118,119,120,124,125,127,128,129,130,131,\\n\\t132,133,134,135,147,162,172,228,230# ethoxzolamide (#99# isoenzyme \\n\\tgammaCA <169>; #127# isoenzyme hCA I <169,171>; #124# isoenzyme hCA II \\n\\t<169,171>; #125# isoenzyme hCA III <169,171>; #128# isoenzyme hCA IV \\n\\t<169,171>; #120# isoenzyme hCA IX <169,171>; #129# isoenzyme hCA VA \\n\\t<169,171>; #130# isoenzyme hCA VB <169,171>; #131# isoenzyme hCA VI \\n\\t<169,171>; #132# isoenzyme hCA VII <169,171>; #110,119# isoenzyme hCA \\n\\tXII <169,171>; #118# isoenzyme hCA XIV <169>; #118# isoenzyme hCA XIV \\n\\tcatalytic domain <171>; #134# isoenzyme hpalphaCA <169>; #135# \\n\\tisoenzyme hpbetaCA <169>; #133# isoenzyme mCA XIII <169,171>; #172# \\n\\tbest isozyme CA XV inhibitor <230>; #124# promiscuous inhibitor of all \\n\\tisozymes except CA III <229>; #17# shows effective carbonic anhydrase \\n\\tinhibitory activity <210>; #162# best CA 1 inhibitor <277>; #32# \\n\\teffective, submicromolar inhibition <276>; #118# strong binding, \\n\\tU-shaped pH-dependence of the Gibbs energy of binding, the affinity is \\n\\tgreatest in the near neutral pH region and diminished towards both the \\n\\tacidic and alkaline regions <381>) \\n\\t<79,120,131,132,133,141,148,153,165,167,169,171,184,196,208,210,229,230,\\n\\t231,255,259,271,275,276,277,318,381,436,440,446>\\nIN\\t#14,17,18,20,32,53,99,110,118,120,124,125,127,128,129,130,131,132,133,\\n\\t147,162,167,172,222,228# dorzolamide (#133# carbonic anhydrase XIII \\n\\t<175>; #127# isoenzyme hCA I <171>; #124# isoenzyme hCA II <171>; #125# \\n\\tisoenzyme hCA III <171>; #128# isoenzyme hCA IV <171>; #120# isoenzyme \\n\\thCA IX <171>; #129# isoenzyme hCA VA <171>; #130# isoenzyme hCA VB \\n\\t<171>; #131# isoenzyme hCA VI <171>; #132# isoenzyme hCA VII <171>; \\n\\t#110# isoenzyme hCA XII <171>; #118# isoenzyme hCA XIV catalytic domain \\n\\t<171>; #133# isoenzyme mCA XIII <171>; #172# best isozyme CA XV \\n\\tinhibitor <230>; #14# potent inhibitor of isozymes CA II <228>; #17# \\n\\tshows effective carbonic anhydrase inhibitory activity <210>; #162# \\n\\tbest CA 1 inhibitor <277>; #32# effective, submicromolar inhibition \\n\\t<276>) \\n\\t<102,120,123,153,167,171,175,184,210,228,230,231,259,275,276,277,300,\\n\\t318,377,436>\\nIN\\t#14,17,18,32,53,110,118,120,124,125,127,128,129,130,131,132,133,147,162,\\n\\t167,172,222,228# brinzolamide (#127# isoenzyme hCA I <171>; #124# \\n\\tisoenzyme hCA II <171>; #125# isoenzyme hCA III <171>; #128# isoenzyme \\n\\thCA IV <171>; #120# isoenzyme hCA IX <171>; #129# isoenzyme hCA VA \\n\\t<171>; #130# isoenzyme hCA VB <171>; #131# isoenzyme hCA VI <171>; \\n\\t#132# isoenzyme hCA VII <171>; #110# isoenzyme hCA XII <171>; #118# \\n\\tisoenzyme hCA XIV catalytic domain <171>; #133# isoenzyme mCA XIII \\n\\t<171>; #172# best isozyme CA XV inhibitor <230>; #14# potent inhibitor \\n\\tof isozymes CA II <228>; #17# shows effective carbonic anhydrase \\n\\tinhibitory activity <210>; #32# effective, submicromolar inhibition \\n\\t<276>) <102,123,167,171,184,210,228,230,231,259,275,276,277,300,377,436>\\nIN\\t#14,17,20,32,53,99,125,133,147,162,172,228,230# valdecoxib (#133# \\n\\tcarbonic anhydrase XIII <175>; #17# shows effective carbonic anhydrase \\n\\tinhibitory activity <210>; #162# best CA 1 inhibitor <277>) \\n\\t<167,175,210,230,231,259,275,276,277,296,297,318,436,440>\\nIN\\t#14,17,20,32,53,99,125,147,162,172,195,228,230# celecoxib (#172# best \\n\\tisozyme CA XV inhibitor <230>; #17# shows effective carbonic anhydrase \\n\\tinhibitory activity <210>; #162# best CA 1 inhibitor <277>) \\n\\t<167,210,230,231,259,275,276,277,296,297,318,362,436,440>\\nIN\\t#14,17,28,62,99,133,147,167,238# Cyanate (#17# weak inhibition <207>; \\n\\t#99# IC50: 0.28 mM <160>; #167# high inhibition <300>; #133# carbonic \\n\\tanhydrase XIII <175>; #62# best inhibitor of the Zn(II)-substituted \\n\\tenzyme <316>; #28# sub-millimolar inhibitor <443>) \\n\\t<79,111,118,160,175,207,208,300,316,438,443>\\nIN\\t#14,17,32,53,110,118,120,124,125,127,128,129,130,131,132,133,147,162,\\n\\t167,172,193,228,230# zonisamide (#127# isoenzyme hCA I <171>; #124# \\n\\tisoenzyme hCA II <171>; #125# isoenzyme hCA III <171>; #128# isoenzyme \\n\\thCA IV <171>; #120# isoenzyme hCA IX <171>; #129# isoenzyme hCA VA \\n\\t<171>; #130# isoenzyme hCA VB <171>; #131# isoenzyme hCA VI <171>; \\n\\t#132# isoenzyme hCA VII <171>; #110# isoenzyme hCA XII <171>; #118# \\n\\tisoenzyme hCA XIV catalytic domain <171>; #133# isoenzyme mCA XIII \\n\\t<171>; #17# shows effective carbonic anhydrase inhibitory activity \\n\\t<210>; #32# effective, submicromolar inhibition <276>) \\n\\t<167,171,210,230,231,255,258,259,261,268,275,276,277,278,300,357,436,\\n\\t440>\\nIN\\t#14,17,32,53,131,147,162,172,228,230# indisulam (#14# potent inhibitor \\n\\tof CA IX <228>; #17# shows effective carbonic anhydrase inhibitory \\n\\tactivity <210>) <184,210,228,230,231,259,271,275,276,277,436,440>\\nIN\\t#14,18# N-hydroxysulfonamide <129>\\nIN\\t#14,18# N-pentafluorophenylsulfonyl-glycine <129>\\nIN\\t#14,18# N-pentafluorophenylsulfonyl-glycine hydroxamate <129>\\nIN\\t#14,18# N-n-perfluorobutylsulfonyl-alanine hydroxamate <129>\\nIN\\t#14,18# N-4-methoxyphenylsulfonyl-N-benzyl-L-valine hydroxamate <129>\\nIN\\t#14,18# N-pentafluorophenylsulfonyl-N-4-nitrobenzyl-glycine hydroxamate \\n\\t<129>\\nIN\\t#14,18# N-4-methoxyphenylsulfonyl-N-2-nitrobenzyl-L-alanine hydroxamate \\n\\t<129>\\nIN\\t#14,18# N-(aminosulfonyl)methanesulfonamide <122>\\nIN\\t#14,18# methylsulfonylsulfamic acid <122>\\nIN\\t#14,18# (trifluoromethyl)sulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(aminosulfonyl)-1,1,1-trifluoromethanesulfonamide <122>\\nIN\\t#14,18# N-(aminosulfonyl)-1,1,1-trichloromethanesulfonamide <122>\\nIN\\t#14,18# (trichloromethyl)sulfonylsulfamic acid <122>\\nIN\\t#14,18# (nonafluorobutyl)sulfonylsulfamic acid <122>\\nIN\\t#14,18# \\n\\tN-(aminosulfonyl)-1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonamide <122>\\nIN\\t#14,18# (heptadecafluorooctyl)sulfonylsulfamic acid <122>\\nIN\\t#14,18# \\n\\tN-(aminosulfonyl)-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,\\n\\t8-heptadecafluorooctane-1-sulfonamide <122>\\nIN\\t#14,18# N,N-dimethylamidimidodisulfuric acid <122>\\nIN\\t#14,18# N,N-dimethylimidodisulfuric diamide <122>\\nIN\\t#14,18# phenylsulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(aminosulfonyl)benzenesulfonamide <122>\\nIN\\t#14,18# benzylsulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(aminosulfonyl)-1-phenylmethanesulfonamide <122>\\nIN\\t#14,18# (4-fluorophenyl)sulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(aminosulfonyl)-4-fluorobenzenesulfonamide <122>\\nIN\\t#14,18# (4-chlorophenyl)sulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(aminosulfonyl)-4-chlorobenzenesulfonamide <122>\\nIN\\t#14,18# (4-bromophenyl)sulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(aminosulfonyl)-4-bromobenzenesulfonamide <122>\\nIN\\t#14,18# (4-iodophenyl)sulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(aminosulfonyl)-4-iodobenzenesulfonamide <122>\\nIN\\t#14,18# (4-methylphenyl)sulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(aminosulfonyl)-4-methylbenzenesulfonamide <122>\\nIN\\t#14,18# (4-nitrophenyl)sulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(aminosulfonyl)-4-nitrobenzenesulfonamide <122>\\nIN\\t#14,18# (3-nitrophenyl)sulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(aminosulfonyl)-3-nitrobenzenesulfonamide <122>\\nIN\\t#14,18# (2-nitrophenyl)sulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(aminosulfonyl)-2-nitrobenzenesulfonamide <122>\\nIN\\t#14,18# (3-chloro-4-nitrophenyl)sulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(aminosulfonyl)-3-chloro-4-nitrobenzenesulfonamide <122>\\nIN\\t#14,18# [4-(acetylamino)phenyl]sulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(4-[[(aminosulfonyl)amino]sulfonyl]phenyl)acetamide <122>\\nIN\\t#14,18# [4-[(tert-butoxycarbonyl)amino]phenyl]sulfonylsulfamic acid \\n\\t<122>\\nIN\\t#14,18# tert-butyl 4-[[(aminosulfonyl)amino]sulfonyl]phenylcarbamate \\n\\t<122>\\nIN\\t#14,18# [3-[(tert-butoxycarbonyl)amino]phenyl]sulfonylsulfamic acid \\n\\t<122>\\nIN\\t#14,18# (pentafluorophenyl)sulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(aminosulfonyl)-2,3,4,5,6-pentafluorobenzenesulfonamide <122>\\nIN\\t#14,18# [3-(trifluoromethyl)phenyl]sulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(aminosulfonyl)-3-(trifluoromethyl)benzenesulfonamide <122>\\nIN\\t#14,18# (2,5-dichlorophenyl)sulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(aminosulfonyl)-2,5-dichlorobenzenesulfonamide <122>\\nIN\\t#14,18# (4-methoxyphenyl)sulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(aminosulfonyl)-4-methoxybenzenesulfonamide <122>\\nIN\\t#14,18# tert-butyl 3-[[(aminosulfonyl)amino]sulfonyl]phenylcarbamate \\n\\t<122>\\nIN\\t#14,18# (2,4,6-tripropylphenyl)sulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(aminosulfonyl)-2,4,6-tripropylbenzenesulfonamide <122>\\nIN\\t#14,18# (2,4,6-triisopropylphenyl)sulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(aminosulfonyl)-2,4,6-triisopropylbenzenesulfonamide <122>\\nIN\\t#14,18# \\n\\t[3-[(tert-butoxycarbonyl)amino]-4-hydroperoxyphenyl]sulfonylsulfamic \\n\\tacid <122>\\nIN\\t#14,18# tert-butyl \\n\\t5-[[(aminosulfonyl)amino]sulfonyl]-2-hydroperoxyphenylcarbamate <122>\\nIN\\t#14,18# isopropylsulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(aminosulfonyl)propane-2-sulfonamide <122>\\nIN\\t#14,18# (3,5-dichloro-2-hydroxyphenyl)sulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(aminosulfonyl)-3,5-dichloro-2-hydroxybenzenesulfonamide <122>\\nIN\\t#14,18# 3-[(sulfoamino)sulfonyl]benzoic acid <122>\\nIN\\t#14,18# 3-[[(aminosulfonyl)amino]sulfonyl]benzoic acid <122>\\nIN\\t#14,18# 4-[(sulfoamino)sulfonyl]benzoic acid <122>\\nIN\\t#14,18# 4-[[(aminosulfonyl)amino]sulfonyl]benzoic acid <122>\\nIN\\t#14,18# (4-acetylphenyl)sulfonylsulfamic acid <122>\\nIN\\t#14,18# 4-acetyl-N-(aminosulfonyl)benzenesulfonamide <122>\\nIN\\t#14,18# 1-naphthylsulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(aminosulfonyl)naphthalene-1-sulfonamide <122>\\nIN\\t#14,18# 2-naphthylsulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(aminosulfonyl)naphthalene-2-sulfonamide <122>\\nIN\\t#14,18# [5-(dimethylamino)-1-naphthyl]sulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(aminosulfonyl)-5-(dimethylamino)naphthalene-1-sulfonamide \\n\\t<122>\\nIN\\t#14,18# thien-2-ylsulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(aminosulfonyl)thiophene-2-sulfonamide <122>\\nIN\\t#14,18# quinolin-8-ylsulfonylsulfamic acid <122>\\nIN\\t#14,18# N-(aminosulfonyl)quinoline-8-sulfonamide <122>\\nIN\\t#14,18# [(7,7-dimethylbicyclo[2.2.1]hept-1-yl)methyl]sulfonylsulfamic \\n\\tacid <122>\\nIN\\t#14,18# \\n\\tN-(aminosulfonyl)-1-(7,\\n\\t7-dimethylbicyclo[2.2.1]hept-1-yl)methanesulfonamide <122>\\nIN\\t#14,18# [[(4-fluorophenyl)sulfonyl]amino]carbonylsulfamic acid <122>\\nIN\\t#14,18# [[(4-fluorophenyl)sulfonyl]amino]carbonylsulfamic amide <122>\\nIN\\t#14,18# [[(4-chlorophenyl)sulfonyl]amino]carbonylsulfamic acid <122>\\nIN\\t#14,18# [[(4-chlorophenyl)sulfonyl]amino]carbonylsulfamic amide <122>\\nIN\\t#14,18# [[(4-methylphenyl)sulfonyl]amino]carbonylsulfamic acid <122>\\nIN\\t#14,18# [[(4-methylphenyl)sulfonyl]amino]carbonylsulfamic amide <122>\\nIN\\t#14,18# [[(2-methylphenyl)sulfonyl]amino]carbonylsulfamic acid <122>\\nIN\\t#14,18# [[(2-methylphenyl)sulfonyl]amino]carbonylsulfamic amide <122>\\nIN\\t#14,18# N-[(1E)-thien-2-ylmethylene]sulfamide <122>\\nIN\\t#14,18# N-[(1E)-(5-methylthien-2-yl)methylene]sulfamide <122>\\nIN\\t#14,18# N-[(1E)-(1-methyl-1H-pyrrol-2-yl)methylene]sulfamide <122>\\nIN\\t#14,18# N-[(1E)-phenylmethylene]sulfamide <122>\\nIN\\t#14,18# N-[(1E)-(4-methylphenyl)methylene]sulfamide <122>\\nIN\\t#14,18# N-[(1E)-(4-methoxyphenyl)methylene]sulfamide <122>\\nIN\\t#14,18# N-[(1E)-(3,4,5-trimethoxyphenyl)methylene]sulfamide <122>\\nIN\\t#14,18# N-[(1E)-[4-(dimethylamino)phenyl]methylene]sulfamide <122>\\nIN\\t#14,18# N-(4-[(E)-[(aminosulfonyl)imino]methyl]phenyl)acetamide <122>\\nIN\\t#14,18# N-[(1E)-(4-nitrophenyl)methylene]sulfamide <122>\\nIN\\t#14,18# N-[(1E)-(3-nitrophenyl)methylene]sulfamide <122>\\nIN\\t#14,18# N-salicylidene-sulfanilic acid amide <126>\\nIN\\t#14,18# N-salicylidene-sulfanilic acid amide cobalt chloride complex \\n\\t<126>\\nIN\\t#14,18# N-salicylidene-sulfanilic acid amide cobalt nitrate complex \\n\\t<126>\\nIN\\t#14,18# N-salicylidene-sulfanilic acid amide cobalt acetate complex \\n\\t<126>\\nIN\\t#14,18# N-salicylidene-sulfanilic acid amide cobalt sulfate complex \\n\\t<126>\\nIN\\t#14,18# N-salicylidene-sulfanilic acid amide nickel chloride complex \\n\\t<126>\\nIN\\t#14,18# N-salicylidene-sulfanilic acid amide nickel nitrate complex \\n\\t<126>\\nIN\\t#14,18# N-salicylidene-sulfanilic acid amide nickel acetate complex \\n\\t<126>\\nIN\\t#14,18# N-salicylidene-sulfanilic acid amide nickel sulfate complex \\n\\t<126>\\nIN\\t#14,18# N-salicylidene-sulfanilic acid amide copper chloride complex \\n\\t<126>\\nIN\\t#14,18# N-salicylidene-sulfanilic acid amide copper nitrate complex \\n\\t<126>\\nIN\\t#14,18# CF3SO2NH2 <270>\\nIN\\t#14,18# perfluorobutanesulfonamide <270>\\nIN\\t#14,18# 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-n-hexane-1-sulfonamide \\n\\t<270>\\nIN\\t#14,18# \\n\\t1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-n-heptane-1-sulfonamide \\n\\t<270>\\nIN\\t#14,18# 3,3,4,4,5,5,6,6,6-nonafluoro-n-hexanesulfonamide <270>\\nIN\\t#14,18# 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-n-octanesulfonamide \\n\\t<270>\\nIN\\t#14,18# \\n\\t3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,\\n\\t10-heptadecafluoro-n-decanesulfonamide <270>\\nIN\\t#14,18# n-hexanesulfonamide <270>\\nIN\\t#14,18# n-octanesulfonamide <270>\\nIN\\t#14,18,21,35,65,123,180,182# benzenesulfonamide \\n\\t<103,331,333,341,342,343>\\nIN\\t#14,18,29,55,64# NaCl (#14# weak <2>; #55# 0.5 M, 60% inhibition <55>; \\n\\t#64# 0.5 M, no effect <66>) <2,3,15,55,66>\\nIN\\t#14,18,32,125,131,147,162,172,180# \\n\\t5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide \\n\\t<120,167,184,230,275,276,277,297,298,331>\\nIN\\t#14,18,32,35,59,65,123,125,131,147,162,172,180,182# \\n\\t4-Aminobenzenesulfonamide \\n\\t<126,167,184,230,259,275,276,277,296,297,298,331,332,339,341,342,343>\\nIN\\t#14,18,44,133# sulfonamide <79,118,129,272>\\nIN\\t#14,18,53# chlorazolamide <120,231>\\nIN\\t#14,182# 4-bromophenyl sulfamate <131,342>\\nIN\\t#14,182# phenyl sulfamate <132,342>\\nIN\\t#14,182# 4-bromobenzenesulfonamide <268,342>\\nIN\\t#14,20,40,53,99,124,125,133,147,238# sulfamic acid (#53# weak inhibitor \\n\\t<204>; #133# weak, carbonic anhydrase XIII <175>) \\n\\t<130,131,175,204,208,227,297,317,318,438>\\nIN\\t#14,21,32,35,65,85,123,125,131,147,162,172,180,182,195,222,228# \\n\\t4-amino-6-chlorobenzene-1,3-disulfonamide \\n\\t<167,184,230,259,275,276,277,297,298,331,332,333,341,342,343,362,377,\\n\\t408,436>\\nIN\\t#14,32,35,53,65,85,123,125,131,147,162,172,180,182,195,228# \\n\\t5-amino-1,3,4-thiadiazole-2-sulfonamide \\n\\t<100,167,184,226,230,231,259,275,276,277,297,298,299,331,332,341,342,\\n\\t343,362,408,436>\\nIN\\t#14,32,35,65,123,125,131,147,162,172,180,182# \\n\\t4-(2-aminoethyl)benzenesulfonamide \\n\\t<167,184,230,259,275,276,277,297,298,331,332,341,342,343>\\nIN\\t#14,32,35,65,123,125,131,147,162,172,180,182# \\n\\t4-amino-3-fluorobenzenesulfonamide \\n\\t<167,184,230,259,275,276,277,297,298,331,332,341,342,343>\\nIN\\t#14,32,35,65,123,125,131,147,162,172,180,182# \\n\\t4-(2-hydroxyethyl)benzenesulfonamide \\n\\t<167,184,230,259,275,276,277,298,331,332,341,342,343>\\nIN\\t#14,32,53,71,125,131,133,147,167,172# dichlorophenamide (#133# carbonic \\n\\tanhydrase XIII <175>; #14# systemic carbonic anhydrase inhibitor <228>; \\n\\t#32# effective, submicromolar inhibition <276>) \\n\\t<35,153,167,175,184,228,230,231,259,268,271,276,296,297,300,302>\\nIN\\t#14,35,123# 4-hydroxybenzenesulfonamide <268,342,343>\\nIN\\t#14,35,59,65,123,147,180,182,195# \\n\\t6-ethoxy-1,3-benzothiazole-2-sulfonamide \\n\\t<297,331,332,339,341,342,343,362>\\nIN\\t#14,35,65,123,147,180,182,195# 4,5-dichlorobenzene-1,3-disulfonamide \\n\\t<296,297,331,341,342,343,362>\\nIN\\t#14,35,65,123,147,180,182,195# \\n\\t1-(1,2-benzoxazol-3-yl)methanesulfonamide <297,331,332,341,342,343,362>\\nIN\\t#14,35,65,123,180,182# N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide \\n\\t<296,331,341,342,343>\\nIN\\t#14,35,65,123,180,182# \\n\\t4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-\\n\\tyl]benzenesulfonamide <331,332,341,342,343>\\nIN\\t#14,35,65,123,180,182# \\n\\t[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,\\n\\t5-b:4\\',5\\'-d]pyran-3a-yl]methyl sulfamate <331,332,341,342,343>\\nIN\\t#14,53,148# N-(5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl)acetamide (#148# \\n\\tspecific inhibitor <213>) <101,213,231>\\nIN\\t#14,71# 4-iodobenzenesulfonamide <35,268>\\nIN\\t#144,181,197# Ni2+ (#197# inhibitits by 80-100% at 5 mM <367>; #197# \\n\\tinhibits by 84% at 5 mM, 80% inhibition at 1 mM <374>) <367,374,421,426>\\nIN\\t#147# phenyl-boronic acid <297>\\nIN\\t#147# \\n\\t(6S)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,\\n\\t3-b]thiopyran-2-sulfonamide 7,7-dioxide <297>\\nIN\\t#147# \\n\\t4-(ethylamino)-6-(3-methoxypropyl)-5,6-dihydro-4H-thieno[2,\\n\\t3-b]thiopyran-2-sulfonamide 7,7-dioxide <297>\\nIN\\t#147# \\n\\t((3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis([1,\\n\\t3]dioxolo)[4,5-b:4\\',5\\'-d]pyran-3a-yl)methyl sulfamate <297>\\nIN\\t#147,162# \\n\\t5-[[(4-amino-3-chloro-5-fluorophenyl)sulfonyl]amino]-4,5-dihydro-1,3,\\n\\t4-thiadiazole-2-sulfonamide <297,298>\\nIN\\t#147,162,180# 4-amino-3,5-diiodobenzenesulfonamide <277,297,298,331>\\nIN\\t#15# 6-ethoxyzolamide <154>\\nIN\\t#162# \\n\\t4-[[3,4,\\n\\t5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-\\n\\tyl]amino]benzenesulfonamide <257>\\nIN\\t#162# \\n\\t4-[[(5R)-3,4,\\n\\t5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-\\n\\tyl]amino]benzenesulfonamide <257>\\nIN\\t#162# \\n\\t4-[[(3R)-3,4,\\n\\t5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-\\n\\tyl]amino]benzenesulfonamide <257>\\nIN\\t#162# \\n\\t4-[[(4R)-3,4,\\n\\t5-trihydroxytetrahydro-2H-pyran-2-yl]amino]benzenesulfonamide <257>\\nIN\\t#162# \\n\\t4-[[(3R,4R)-3,4,\\n\\t5-trihydroxytetrahydro-2H-pyran-2-yl]amino]benzenesulfonamide <257>\\nIN\\t#162# \\n\\t4-[(3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)amino]benzenesulfonamide \\n\\t<257>\\nIN\\t#162# \\n\\t4-[[(2R,3R)-3,4,\\n\\t5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl]amino]benzenesulfonamide \\n\\t<257>\\nIN\\t#162# \\n\\t4-[[(2R,5S)-3,4,\\n\\t5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl]amino]benzenesulfonamide \\n\\t<257>\\nIN\\t#162# \\n\\t5-[[(4-amino-3-chloro-5-fluorophenyl)sulfonyl]amino]-1,3,\\n\\t4-thiadiazole-2-sulfonamide <277>\\nIN\\t#162# N-(4-sulfamoylphenyl)-beta-D-galactopyranosylamine <298>\\nIN\\t#162# N-(4-sulfamoylphenyl)-beta-D-idopyranosylamine <298>\\nIN\\t#162# 6-deoxy-N-(4-sulfamoylphenyl)-alpha-L-mannopyranosylamine <298>\\nIN\\t#162# heptane-1,7-diyl disulfamate <298>\\nIN\\t#167# Sulfide <300>\\nIN\\t#167# PhB(OH)2 <300>\\nIN\\t#167# PhAsO3H2 <300>\\nIN\\t#17# 2-[(aminooxy)sulfinyl]aniline <210>\\nIN\\t#17# 4-[(aminooxy)sulfinyl]aniline <210>\\nIN\\t#17# 3-[4-[(aminooxy)sulfinyl]phenyl]propanoic acid <210>\\nIN\\t#17# 1-[(aminooxy)sulfinyl]-4-methylbenzene <210>\\nIN\\t#17# 1-[4-[(aminooxy)sulfinyl]phenyl]methanamine <210>\\nIN\\t#17# 2-[4-[(aminooxy)sulfinyl]phenyl]ethanamine <210>\\nIN\\t#17# 4-[(aminooxy)sulfinyl]-2-fluoroaniline <210>\\nIN\\t#17# 4-[(aminooxy)sulfinyl]-2-chloroaniline <210>\\nIN\\t#17# 4-[(aminooxy)sulfinyl]-2-bromoaniline <210>\\nIN\\t#17# 4-[(aminooxy)sulfinyl]-2-iodoaniline <210>\\nIN\\t#17# 2,4-bis[(aminooxy)sulfinyl]-5-(trifluoromethyl)aniline <210>\\nIN\\t#17# 2,4-bis[(aminooxy)sulfinyl]-5-chloroaniline <210>\\nIN\\t#17# 5-[(aminooxy)sulfinyl]-1,3,4-thiadiazol-2-amine <210>\\nIN\\t#17# 5-[(aminooxy)sulfinyl]-3-methyl-1,3,4-thiadiazol-2(3H)-imine <210>\\nIN\\t#17# 4-amino-N-[4-[(aminooxy)sulfinyl]benzyl]benzenesulfonamide <210>\\nIN\\t#17# 2-[(aminooxy)sulfinyl]-5-(2-chlorophenyl)-1,3,4-thiadiazole <210>\\nIN\\t#17# [4-[(aminooxy)sulfinyl]phenyl]methanol <210>\\nIN\\t#17# 2-[4-[(aminooxy)sulfinyl]phenyl]ethanol <210>\\nIN\\t#17# 4-[(aminooxy)sulfinyl]benzoic acid <210>\\nIN\\t#17,21,32,53,125,147,167,228,230# saccharin (#17# shows effective \\n\\tcarbonic anhydrase inhibitory activity <210>; #147# effective STPCA \\n\\tinhibitor <259>) <167,210,231,259,275,276,300,333,436,440>\\nIN\\t#17,28,147,238# bisulfite (#28# less effective inhibitor <443>) \\n\\t<207,208,438,443>\\nIN\\t#17,32,147,162,172# \\n\\t5-[[(4-aminophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide \\n\\t<210,230,259,275,276,277,297,298>\\nIN\\t#17,32,35,65,123,147,162,172,180,182# \\n\\t4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide \\n\\t<210,230,259,275,276,277,297,298,331,341,342,343>\\nIN\\t#17,32,53,118,120,124,125,127,128,129,130,131,132,133,147,172,230# \\n\\tsulthiame (#127# isoenzyme hCA I <170>; #124# isoenzyme hCA II <170>; \\n\\t#125# isoenzyme hCA III <170>; #128# isoenzyme hCA IV <170>; #120# \\n\\tisoenzyme hCA IX <170>; #129# isoenzyme hCA VA <170>; #130# isoenzyme \\n\\thCA VB <170>; #131# isoenzyme hCA VI <170>; #132# isoenzyme hCA VII \\n\\t<170>; #118# isoenzyme hCA XIV <170>; #133# isoenzyme mCA XIII <170>; \\n\\t#172# best isozyme CA XV inhibitor <230>; #17# shows effective carbonic \\n\\tanhydrase inhibitory activity <210>) <170,210,230,231,259,275,276,440>\\nIN\\t#17,32,53,125,131,147,162,172,228# sulpiride (#17# shows effective \\n\\tcarbonic anhydrase inhibitory activity <210>; #162# best CA 1 inhibitor \\n\\t<277>) <167,184,210,230,231,259,275,276,277,436>\\nIN\\t#17,32,99,118,119,120,124,125,127,128,129,130,131,132,133,134,135,162# \\n\\t4,5-dichloro-benzene-1,3-disulfonamide (#99# isoenzyme gammaCA, i.e. \\n\\tdaranide <169>; #127# isoenzyme hCA I, i.e. daranide <169>; #124# \\n\\tisoenzyme hCA II, i.e. daranide <169>; #125# isoenzyme hCA III, i.e. \\n\\tdaranide <169>; #128# isoenzyme hCA IV, i.e. daranide <169>; #120# \\n\\tisoenzyme hCA IX, i.e. daranide <169>; #129# isoenzyme hCA VA, i.e. \\n\\tdaranide <169>; #130# isoenzyme hCA VB, i.e. daranide <169>; #131# \\n\\tisoenzyme hCA VI, i.e. daranide <169>; #132# isoenzyme hCA VII, i.e. \\n\\tdaranide <169>; #119# isoenzyme hCA XII, i.e. daranide <169>; #118# \\n\\tisoenzyme hCA XIV, i.e. daranide <169>; #134# isoenzyme hpalphaCA, i.e. \\n\\tdaranide <169>; #135# isoenzyme hpbetaCA, i.e. daranide <169>; #133# \\n\\tisoenzyme mCA XIII, i.e. daranide <169>; #17# shows effective carbonic \\n\\tanhydrase inhibitory activity <210>) <169,210,275,277>\\nIN\\t#17,53,230# 4-(2-amino-pyrimidin-4-yl)-benzenesulfonamide (#17# best \\n\\tinhibitor <210>) <210,231,305,440>\\nIN\\t#178,179# tetrafluoroborate <337>\\nIN\\t#18# Na2S <3>\\nIN\\t#18# 2-(3-chloropropionylamino)-1,3,4-thiadiazole-5-sulfonamide (#18# \\n\\tnoncompetitive inhibition <95>) <95>\\nIN\\t#18# 2-(2,2-dichloroacetylamino)-1,3,4-thiadiazole-5-sulfonamide (#18# \\n\\tnoncompetitive inhibition <95>) <95>\\nIN\\t#18# 2-(3-phenylpropionylamino)-1,3,4-thiadiazole-5-sulfonamide (#18# \\n\\tnoncompetitive inhibition <95>) <95>\\nIN\\t#18# \\n\\t4-[cis-5-norbornene-endo-3-carboxy-2-carboxamido]-benzenesulfonamide \\n\\t<123>\\nIN\\t#18# \\n\\t4-[cis-5-norbornene-endo-3-carboxy-2-carboxamidomethyl]-\\n\\tbenzenesulfonamide <123>\\nIN\\t#18# \\n\\t4-[cis-5-norbornene-endo-3-carboxy-2-carboxamidoethyl]-\\n\\tbenzenesulfonamide <123>\\nIN\\t#18# \\n\\t5-[cis-5-norbornene-endo-3-carboxy-2-carboxamido]-1,3,\\n\\t4-thiadiazole-2-sulfonamide <123>\\nIN\\t#18# 4-[cis-5-norbornene-endo-2,3-dicarboximido]-benzenesulfonamide \\n\\t<123>\\nIN\\t#18# \\n\\t4-[cis-5-norbornene-endo-2,3-dicarboximidomethyl]-benzenesulfonamide \\n\\t<123>\\nIN\\t#18# \\n\\t4-[cis-5-norbornene-endo-2,3-dicarboximidoethyl]-benzenesulfonamide \\n\\t<123>\\nIN\\t#18# \\n\\t5-[cis-5-norbornene-endo-2,3-dicarboximido]-1,3,\\n\\t4-thiadiazole-2-sulfonamide <123>\\nIN\\t#18# COS (#18# 3 mM, slightly inhibitory <143>) <143>\\nIN\\t#18# 1,1,2,2,3,3,4,4-octafluoro-n-butane-1-4-bissulfonamide <270>\\nIN\\t#18,100# p-aminomethylbenzenesulfonamide (#100# IC50: 0.0058 mM <161>) \\n\\t<109,161>\\nIN\\t#18,118,119,120,124,125,127,128,129,130,131,132,133# Furosemide (#127# \\n\\tisoenzyme hCA I <169>; #124# isoenzyme hCA II <169>; #125# isoenzyme \\n\\thCA III <169>; #128# isoenzyme hCA IV <169>; #120# isoenzyme hCA IX \\n\\t<169>; #129# isoenzyme hCA VA <169>; #130# isoenzyme hCA VB <169>; \\n\\t#131# isoenzyme hCA VI <169>; #132# isoenzyme hCA VII <169>; #119# \\n\\tisoenzyme hCA XII <169>; #118# isoenzyme hCA XIV <169>; #133# isoenzyme \\n\\tmCA XIII <169>) <169,324>\\nIN\\t#18,126# KSCN (#18# uncompetitive inhibitor <248>; #18# uncompetitive \\n\\tinhibition of outer peripheral, cytosolic, inner peripheral and \\n\\tintegral isoenzyme <149>; #126# cytosolic isoenzyme <176>; #126# inner \\n\\tperipheral isoenzyme <176>; #126# integral isoenzyme <176>; #126# outer \\n\\tperipheral isoenzyme <176>) <149,176,248>\\nIN\\t#18,126# NaN3 (#18# uncompetitive inhibitor <248>; #18# uncompetitive \\n\\tinhibition of outer peripheral, cytosolic, inner peripheral and \\n\\tintegral isoenzyme <149>; #126# cytosolic isoenzyme <176>; #126# inner \\n\\tperipheral isoenzyme <176>; #126# integral isoenzyme <176>; #126# outer \\n\\tperipheral isoenzyme <176>) <149,176,248>\\nIN\\t#18,34,43,83# Mg2+ (#18,34,43,83# 25% inhibition at 0.2 mM <309>) <309>\\nIN\\t#18,34,43,83,234# As3+ (#43# 37.1% residual activity at 1 mM <282>; \\n\\t#234# uncompetive inhibition <424>) <282,309,424>\\nIN\\t#18,34,43,83,94# K+ (#18,34,43,83# 25% inhibition at 0.2 mM <309>) \\n\\t<309,425>\\nIN\\t#18,34,43,83,94,197# Na+ (#18,34,43,83# 25% inhibition at 0.2 mM <309>; \\n\\t#197# inhibits by 25% at 2 mM <374>) <309,374,425>\\nIN\\t#18,48# imidazole <6,41>\\nIN\\t#18,53# acetate <41,60,231>\\nIN\\t#180# \\n\\t5-([(4-amino-3-chloro-5-fluorophenyl)sulfonyl]amino)-1,3,\\n\\t4-thiadiazole-2-sulfonamide <331>\\nIN\\t#182# N-phenylsulfuric diamide <342>\\nIN\\t#182# N-(4-bromophenyl)sulfuric diamide <342>\\nIN\\t#19,29,124# chlorzolamide (#124# potent inhibitor <196>) <15,68,196>\\nIN\\t#191,197# Fe3+ (#197# inhibits completely at 5 mM, 75% inhibition at 1 \\n\\tmM <374>) <374,404>\\nIN\\t#193# dibenzyl \\n\\tN\\',N\\'\\'\\'-(tribromo-lambda5-stibanediyl)biscarbamimidothioate (#193# \\n\\t36.0% inhibition of CO2 hydration reaction after 30 min <400>) <400>\\nIN\\t#193# \\n\\t3-amino-1,1,1-tribromo-4,5-dihydro-1H-1lambda5-[1,3,5,\\n\\t2]triazastibinino[1,6-a]benzimidazol-10-ium (#193# 35% inhibition of \\n\\tCO2 hydration reaction after 30 min <400>) <400>\\nIN\\t#193,213# \\n\\t2-[[(5-chlorothiophen-2-yl)(hydroxy)methyl]amino]-1-(trichloro[2-[2-(5-\\n\\tchlorothiophen-2-yl)-2-oxoethyl]pyrimidin-1-ium-1-yl]-lambda5-\\n\\tstibanyl)pyrimidin-1-ium (#193# 18.7% inhibition of CO2 hydration \\n\\treaction after 30 min <400>; #213# 62.5% inhibition of CO2 hydration \\n\\treaction after 30 min <400>) <400>\\nIN\\t#193,213# \\n\\t6-chloro-6,6-dimethyl-12-oxo-6,8,9,10,11,11a,12,\\n\\t13-octahydro-6lambda5-pyrido[2,1-g]pyrimido[1,2-c][1,3,5,\\n\\t2]triazastibepin-5-ium (#213# 22.9% inhibition of CO2 hydration \\n\\treaction after 30 min <400>; #193# 99.3% inhibition of CO2 hydration \\n\\treaction after 30 min <400>) <400>\\nIN\\t#193,213# \\n\\t5,5,5-tribromo-1,2,3,7,8,9,9a,11,16,\\n\\t17a-decahydro-5H-5lambda5-dipyrrolo[2,1-c:1\\',2\\'-f][1,4,6,9,\\n\\t5]benzotetraazastibacycloundecine-10,17-dione (#193# 83.9% inhibition \\n\\tof CO2 hydration reaction after 30 min <400>; #213# 9.9% inhibition of \\n\\tCO2 hydration reaction after 30 min <400>) <400>\\nIN\\t#193,213# \\n\\t6,6,6-trichloro-11-oxo-8,9,10,10a,11,\\n\\t12-hexahydro-6H-6lambda5-pyrimido[1,2-c]pyrrolo[2,1-g][1,3,5,\\n\\t2]triazastibepin-5-ium (#213# 25.1% inhibition of CO2 hydration \\n\\treaction after 30 min <400>; #193# 31.0% inhibition of CO2 hydration \\n\\treaction after 30 min <400>) <400>\\nIN\\t#193,213# \\n\\t12,12,12-tribromo-7-oxo-6,7a,8,9,10,\\n\\t12-hexahydro-7H-12lambda5-pyrrolo[1\\',2\\':1,7][1,3,5,2]triazastibepino[4,\\n\\t3-b][1,3]benzothiazol-13-ium (#213# 11.1% inhibition of CO2 hydration \\n\\treaction after 30 min <400>; #213# 18.4% inhibition of CO2 hydration \\n\\treaction after 30 min <400>; #193# 92.3% inhibition of CO2 hydration \\n\\treaction after 30 min <400>) <400>\\nIN\\t#193,213# 1,1\\'-(trichloro-lambda5-stibanediyl)bis(2-aminopyridin-1-ium) \\n\\t(#193# 49.2% inhibition of CO2 hydration reaction after 30 min <400>; \\n\\t#213# 9.4% inhibition of CO2 hydration reaction after 30 min <400>) \\n\\t<400>\\nIN\\t#193,213# 1,1\\'-(tribromo-lambda5-stibanediyl)bis(2-aminopyridin-1-ium) \\n\\t(#193# 29.9% inhibition of CO2 hydration reaction after 30 min <400>; \\n\\t#213# 31.6% inhibition of CO2 hydration reaction after 30 min <400>) \\n\\t<400>\\nIN\\t#193,213# \\n\\t1,1\\'-(trichloro-lambda5-stibanediyl)bis(2-aminopyrimidin-1-ium) (#213# \\n\\t90.2% inhibition of CO2 hydration reaction after 30 min <400>; #193# \\n\\t98.4% inhibition of CO2 hydration reaction after 30 min <400>) <400>\\nIN\\t#193,213# \\n\\t1,1\\'-(tribromo-lambda5-stibanediyl)bis(2-aminopyrimidin-1-ium) (#213# \\n\\t16.3% inhibition of CO2 hydration reaction after 30 min <400>; #193# \\n\\t57.6% inhibition of CO2 hydration reaction after 30 min <400>) <400>\\nIN\\t#193,213# dibenzyl \\n\\tN\\',N\\'\\'\\'-(trichloro-lambda5-stibanediyl)biscarbamimidothioate (#193# \\n\\t26.7% inhibition of CO2 hydration reaction after 30 min <400>; #213# \\n\\t54.4% inhibition of CO2 hydration reaction after 30 min <400>) <400>\\nIN\\t#193,213# \\n\\t1,1\\'-(trichloro-lambda5-stibanediyl)bis(2-amino-4,\\n\\t6-dimethoxy-5-sulfanylpyrimidin-1-ium) (#213# 64.8% inhibition of CO2 \\n\\thydration reaction after 30 min <400>; #193# 99.3% inhibition of CO2 \\n\\thydration reaction after 30 min <400>) <400>\\nIN\\t#195# \\n\\t4-amino-N-(4-sulfamoylcyclopenta-1,3-dien-1-yl)benzene-1-sulfonamide \\n\\t<362>\\nIN\\t#195# \\n\\t(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-4,5,6,\\n\\t7-tetrahydro-7lambda~6~-thieno[2,3-b]thiopyran-2-sulfonamide <362>\\nIN\\t#195# \\n\\t(4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-1,2,3,\\n\\t4-tetrahydro-1lambda~6~-thieno[3,2-e][1,2]thiazine-6-sulfonamide <362>\\nIN\\t#195# 5-[(benzenesulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide <362>\\nIN\\t#195# \\n\\t[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-2H,3aH,7H-bis[1,\\n\\t3]dioxolo[4,5-b:4\\',5\\'-d]pyran-3a-yl]methyl sulfamate <362>\\nIN\\t#195# N~1~-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide <362>\\nIN\\t#195# 4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzene-1-sulfonamide <362>\\nIN\\t#195# 4-(1,1-dioxo-1lambda6,2-thiazinan-2-yl)benzene-1-sulfonamide <362>\\nIN\\t#195# \\n\\t6-chloro-1,1-dioxo-1,2,3,4-tetrahydro-1lambda~6~,2,\\n\\t4-benzothiadiazine-7-sulfonamide <362>\\nIN\\t#195,222# \\n\\t6-chloro-1,1-dioxo-1,2,3,4-tetrahydro-1lambda6,2,\\n\\t4-benzothiadiazine-7-sulfonamide <362,377>\\nIN\\t#197# ethyl 3-(3-dimethylaminopropyl)-carbodiimide (#197# 80% \\n\\tinhibition at 5 mM, via irreversible modification of carboxyl groups or \\n\\tthepresence of catalytically active tyrosine in the enzyme molecule \\n\\t<374>) <374>\\nIN\\t#197# PMSF (#197# 80% inhibition at 5 mM <374>) <374>\\nIN\\t#197# iodoacetic acid <374>\\nIN\\t#197# Triton X-100 <374>\\nIN\\t#197# Tween 80 <374>\\nIN\\t#197# 2,6-PDCA <374>\\nIN\\t#197# diethyl dicarbonate (#197# strong inhibition at 5 mM <374>) <374>\\nIN\\t#197# Woodward\\'s reagent K (#197# WRK <374>) <374>\\nIN\\t#197# N-bromosuccinimide (#197# strong inhibition at 5 mM <374>) <374>\\nIN\\t#197# N-ethylmaleimide (#197# strong inhibition at 5 mM <374>) <374>\\nIN\\t#197,218# DTT (#197# 60% inhibition at 5 mM <374>; #218# 50% inhibition \\n\\tat 0.5 mM, complete inhibition at above 2.5 mM <403>) <374,403>\\nIN\\t#20,32,35,65,99,123,147,162,172,180,182# \\n\\t4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide \\n\\t<230,259,275,276,277,297,298,318,331,341,342,343>\\nIN\\t#20,63,91,99,147,205,206,220# CO32- <297,316,317,330,358,359,361,385>\\nIN\\t#20,99# 1-[4-[amino(dihydroxy)-lambda4-sulfanyl]phenyl]methanamine <318>\\nIN\\t#20,99# 1-[4-[amino(dihydroxy)-lambda4-sulfanyl]phenyl]ethanamine <318>\\nIN\\t#20,99# 4-[amino(dihydroxy)-lambda4-sulfanyl]-2-fluoroaniline <318>\\nIN\\t#20,99# 4-[amino(dihydroxy)-lambda4-sulfanyl]-2-chloroaniline <318>\\nIN\\t#20,99# 4-[amino(dihydroxy)-lambda4-sulfanyl]-2-bromoaniline <318>\\nIN\\t#20,99# 4-[amino(dihydroxy)-lambda4-sulfanyl]-2-iodoaniline <318>\\nIN\\t#20,99# \\n\\t2,4-bis[amino(dihydroxy)-lamba4-sulfanyl]-5-(trifluoromethyl)aniline \\n\\t<318>\\nIN\\t#20,99# 2,4-bis[amino(dihydroxy)-lambda4-sulfanyl]-5-chloroaniline <318>\\nIN\\t#20,99# 1,5-bis[amino(dihydroxy)-lambda4-sulfanyl]-2,3-dichlorobenzene \\n\\t<318>\\nIN\\t#20,99# [4-[amino(dihydroxy)-lambda4-sulfanyl]phenyl]hydrazine <318>\\nIN\\t#20,99# 3-[amino(dihydroxy)-lambda4-sulfanyl]aniline <318>\\nIN\\t#202# p-(aminomethyl)-benzenesulfonamide (#202# p-AMBS <350>) <350>\\nIN\\t#205,206,220# SnO32- <358,359,361>\\nIN\\t#205,206,220# SeO42- <358,359,361>\\nIN\\t#205,206,220# TeO42- <358,359,361>\\nIN\\t#205,206,220# B4O72- <358,359,361>\\nIN\\t#205,206,220# RuO4- <358,359,361>\\nIN\\t#205,206,220# S2O82- <358,359,361>\\nIN\\t#205,206,220# NH(SO3)22- <358,359,361>\\nIN\\t#205,220# P2O74- <359,361>\\nIN\\t#205,220# V2O74- <359,361>\\nIN\\t#205,220# PF6- <359,361>\\nIN\\t#205,220# CF3SO3- <359,361>\\nIN\\t#21# 2-sulfonamido-1,3,4-thiadiazole-5-benzene sulfonamide <17>\\nIN\\t#21# 4-(2-aminoethyl) benzenesulfonamide <333>\\nIN\\t#21# 2-bromo-benzenesulfonamide <333>\\nIN\\t#21# naphthalene-2-sulfonamide <333>\\nIN\\t#21# dexamethasone <379>\\nIN\\t#21# Caffeine <379>\\nIN\\t#21# metamizole sodium <379>\\nIN\\t#21# tetramisol <379>\\nIN\\t#21# ivermectin <379>\\nIN\\t#21# tavilin 50 <379>\\nIN\\t#21# sulfamezathine <379>\\nIN\\t#21# \\n\\t(2S,5R,6R)-3,\\n\\t3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-\\n\\tazabicyclo[3.2.0]heptane-2-carboxylic acid (#21# i.e. penokain G <379>) \\n\\t<379>\\nIN\\t#21# \\n\\t(1R,2S,3S,4S)-4,6-diamino-2-([3-O-[(1S,2S,3S,4S,\\n\\t5S)-2-amino-5-(aminomethyl)-3,\\n\\t4-dihydroxycyclohexyl]-alpha-L-arabinofuranosyl]oxy)-3-\\n\\thydroxycyclohexyl 2,6-diamino-2,6-dideoxy-beta-L-glucopyranoside (#21# \\n\\ti.e. neosym <379>) <379>\\nIN\\t#21# \\n\\t(7S)-7-[[(2Z)-2-(2-amino-1,\\n\\t3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino]-3-[[(furan-2-\\n\\tcarbonyl)sulfanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-\\n\\tcarboxylic acid (#21# i.e. ceftiofur <379>) <379>\\nIN\\t#21,197,219,234# Fe2+ (#21# uncompetitive inhibition <380>; #197# \\n\\tinhibitits by 80-100% at 5 mM <367>; #197# inhibits completely at 5 mM, \\n\\t74% inhibition at 1 mM <374>; #234# competive inhibition <424>) \\n\\t<367,368,374,380,424>\\nIN\\t#21,22,58,122,197,219,234# Co2+ (#122# weak inhibition <308>; #58# \\n\\tcompetitive inhibition <246>; #21# uncompetitive inhibition <380>; #58# \\n\\tcobalt inhibits competitively <199>; #197# inhibitits by 80-100% at 5 \\n\\tmM <367>; #197# inhibits by 74% at 5 mM <374>; #234# competive \\n\\tinhibition <424>) <69,199,246,308,367,368,374,380,424>\\nIN\\t#21,222# mafenide <333,377>\\nIN\\t#21,32,125,131,147,162,172# 4-methylbenzenesulfonamide \\n\\t<167,184,230,259,275,276,277,297,298,333>\\nIN\\t#21,58,80,122,144,191,197,219# Ag+ (#122# weak inhibition <308>; \\n\\t#21,58# uncompetitive inhibition <246,380>; #58# silver inhibits \\n\\tcompetitively <199>; #80# competitive, strong inhibition of carbonic \\n\\tanhydrase esterase activity <306>; #197# inhibits by 17% at 5 mM, no \\n\\tinhibition at 1 mM <374>) <199,246,306,308,368,374,380,404,426>\\nIN\\t#212# (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid <398>\\nIN\\t#212# (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid <398>\\nIN\\t#212# 4-coumaric acid <398>\\nIN\\t#212# 2-[4-[2-(4-hydroxyphenyl)ethoxy]phenyl]ethyl \\n\\t(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate <398>\\nIN\\t#212# 2-[3-[2-(3-hydroxyphenyl)ethoxy]phenyl]ethyl \\n\\t(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate <398>\\nIN\\t#212# benzyl (2E)-3-(3-hydroperoxy-4-hydroxyphenyl)prop-2-enoate <398>\\nIN\\t#212# 2-(4-hydroxyphenyl)ethyl \\n\\t(2E)-3-(3-hydroperoxy-4-hydroxyphenyl)prop-2-enoate <398>\\nIN\\t#212# 2-(3-hydroxyphenyl)ethyl \\n\\t(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate <398>\\nIN\\t#212# benzyl 4-coumarate <398>\\nIN\\t#212# 2-(4-hydroxyphenyl)ethyl (2E)-3-(4-hydroxyphenyl)prop-2-enoate \\n\\t<398>\\nIN\\t#212# 2-(3-hydroxyphenyl)ethyl (2E)-3-(4-hydroxyphenyl)prop-2-enoate \\n\\t<398>\\nIN\\t#213# \\n\\t3-amino-1,1,1-trichloro-4,5-dihydro-1H-1lambda5-[1,3,5,\\n\\t2]triazastibinino[1,6-a]benzimidazol-10-ium (#213# 10.0% inhibition of \\n\\tCO2 hydration reaction after 30 min <400>) <400>\\nIN\\t#213# \\n\\t1,1\\'-(trichloro-lambda5-stibanediyl)bis[2-amino-4,\\n\\t6-dimethoxy-5-[(1H-tetrazol-5-yl)sulfanyl]pyrimidin-1-ium] (#213# 14.3% \\n\\tinhibition of CO2 hydration reaction after 30 min <400>) <400>\\nIN\\t#218# phosphate (#218# binding structure analysis, overview. Phosphate \\n\\tbinds to the catalytic zinc cofactor, each unit cell is comprised of \\n\\tfour dimers of CrCAH3 <403>) <403>\\nIN\\t#22# ethylsulfonamide <69>\\nIN\\t#22# methylsulfonamide <69>\\nIN\\t#22# n-hexylsulfonamide <69>\\nIN\\t#220# diethyldithiocarbamate <361>\\nIN\\t#222# 2-bromo-benzene sulfonamide <377>\\nIN\\t#222# 4-chlorobenzene sulfonamide <377>\\nIN\\t#222# 4-amino-6-chloro-1-3 benzenedisulfonamide <377>\\nIN\\t#222# sulfamethazine <377>\\nIN\\t#222# Sulfaguanidine <377>\\nIN\\t#222# Sulfadiazine <377>\\nIN\\t#222# metazolamide <377>\\nIN\\t#222# diclofenamide <377>\\nIN\\t#222# 2-bromobenzene-1-sulfonamide <377>\\nIN\\t#222# 4-chlorobenzene-1-sulfonamide <377>\\nIN\\t#222# 4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzene-1-sulfonamide <377>\\nIN\\t#222# 4-amino-N-carbamimidoylbenzene-1-sulfonamide <377>\\nIN\\t#222# 4-amino-N-(pyrimidin-2-yl)benzene-1-sulfonamide <377>\\nIN\\t#228# acetolamide <436>\\nIN\\t#228# dichlorphenamide <436>\\nIN\\t#228# sultiame <436>\\nIN\\t#23# acetic acid <104>\\nIN\\t#23,48# o-Iodosobenzoate <6,39>\\nIN\\t#230# 4-amino-6-chloro-1,3-benzenedisulfonamide <440>\\nIN\\t#230# sulpride <440>\\nIN\\t#230# 1,3-dibenzenesulfonamide <440>\\nIN\\t#230# \\n\\t4-(2-hydroxymethyl-4-nitrophenyl-sulfonamido)ethylbenzene-sulfonamide \\n\\t<440>\\nIN\\t#230# 1,3-disulfamoyl benzene <440>\\nIN\\t#234# azoxystrobin (#234# competive inhibition <424>) <424>\\nIN\\t#234# clofentezine (#234# competive inhibition <424>) <424>\\nIN\\t#234# deltamethrin (#234# uncompetive inhibition <424>) <424>\\nIN\\t#234# thiophanate (#234# uncompetive inhibition <424>) <424>\\nIN\\t#234# thiram (#234# uncompetive inhibition <424>) <424>\\nIN\\t#238# divanadate <438>\\nIN\\t#238# peroxodisulfate <438>\\nIN\\t#238# perosmate <438>\\nIN\\t#24,49,197# 2-mercaptoethanol (#197# 15% inhibition at 5 mM <374>) \\n\\t<56,178,374>\\nIN\\t#28# fluorosulfonate (#28# one of the most effective inhibitors <443>) \\n\\t<443>\\nIN\\t#28# hydrogensulfide (#28# low millimolar inhibitor <443>) <443>\\nIN\\t#28# Selenite (#28# low millimolar inhibitor <443>) <443>\\nIN\\t#28# peroxydisulfate (#28# low millimolar inhibitor <443>) <443>\\nIN\\t#28# trithiocarbonate (#28# low millimolar inhibitor <443>) <443>\\nIN\\t#28,238# fulminate <438,443>\\nIN\\t#28,238# stannate (#28# sub-millimolar inhibitor <443>) <438,443>\\nIN\\t#28,238# tellurate (#28# sub-millimolar inhibitor <443>) <438,443>\\nIN\\t#28,238# perrhenate (#28# low millimolar inhibitor <443>) <438,443>\\nIN\\t#28,238# perruthenate (#28# low millimolar inhibitor <443>) <438,443>\\nIN\\t#28,238# selenocyanate (#28# sub-millimolar inhibitor <443>) <438,443>\\nIN\\t#28,238# imidosulfonate (#28# low millimolar inhibitor <443>) <438,443>\\nIN\\t#28,238# N,N-diethyldithiocarbamate (#28# sub-millimolar inhibitor \\n\\t<443>) <438,443>\\nIN\\t#30# 6-ethoxy-2-benzo-thiazolesulfonamide <107>\\nIN\\t#30# guanidine hydrochloride <107>\\nIN\\t#32# 3-bromosulfanilamide <275>\\nIN\\t#32# 2-amino-pyrimidin-4-yl-sulfanilamide (#32# best inhibitor <276>) \\n\\t<276>\\nIN\\t#32,147,182# 3-(4-sulfamoylphenyl)propanoic acid <259,275,276,342>\\nIN\\t#32,35,65,123,125,131,147,162,172,180,182# \\n\\t4-(aminomethyl)benzenesulfonamide \\n\\t<167,184,230,259,275,276,277,297,298,331,341,342,343>\\nIN\\t#32,35,65,123,125,131,147,162,172,180,182# \\n\\t4-amino-3-chlorobenzenesulfonamide \\n\\t<167,184,230,259,275,276,277,297,298,331,341,342,343>\\nIN\\t#32,35,65,123,125,131,147,162,172,180,182# \\n\\t4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide \\n\\t<167,184,230,259,275,276,277,297,298,331,341,342,343>\\nIN\\t#32,35,65,123,125,131,147,162,172,180,182# \\n\\t4-(hydroxymethyl)benzenesulfonamide \\n\\t<167,184,230,259,275,276,277,298,331,341,342,343>\\nIN\\t#32,35,65,85,123,125,131,147,162,172,180,182,195,228# \\n\\t4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide \\n\\t<167,184,230,259,275,276,277,297,298,331,341,342,343,362,408,436>\\nIN\\t#32,35,65,85,123,125,131,147,162,172,180,182,195,228# \\n\\t5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide \\n\\t<167,184,230,259,275,276,277,297,298,331,341,342,343,362,408,436>\\nIN\\t#32,35,65,85,123,147,162,172,180,182,195,228# 4-sulfamoylbenzoic acid \\n\\t<230,259,275,276,277,298,331,341,342,343,362,408,436>\\nIN\\t#32,65,123,131,147,172,182# 4-amino-3-bromobenzenesulfonamide \\n\\t<184,230,259,275,276,341,342,343>\\nIN\\t#32,65,125,131,147,162,172,180,182# 2-aminobenzenesulfonamide \\n\\t<167,184,230,259,275,276,277,297,298,331,341,342>\\nIN\\t#32,65,131,147,172,182# 4-amino-3-iodobenzenesulfonamide \\n\\t<184,230,259,275,276,341,342>\\nIN\\t#35# 4-amino-3,bromobenzenesulfonamide <342>\\nIN\\t#35,123# 3-aminobenzenesulfonamide <342,343>\\nIN\\t#35,123# 3,5-dichloro-2-hydroxybenzenesulfonamide <342,343>\\nIN\\t#35,123# \\n\\t2-(hydroxymethyl)-4-nitro-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]benzenesulfonamide <342,343>\\nIN\\t#35,123# N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide \\n\\t<342,343>\\nIN\\t#35,123# \\n\\t(2Z)-2-benzylidene-N-(5-sulfanyl-1,3,\\n\\t4-thiadiazol-2-yl)hydrazinecarboxamide <342,343>\\nIN\\t#35,123# \\n\\t(2Z)-2-(4-chlorobenzylidene)-N-(5-sulfanyl-1,3,\\n\\t4-thiadiazol-2-yl)hydrazinecarboxamide <342,343>\\nIN\\t#35,123# \\n\\t(2Z)-2-(3-methoxybenzylidene)-N-(5-sulfanyl-1,3,\\n\\t4-thiadiazol-2-yl)hydrazinecarboxamide <342,343>\\nIN\\t#35,123# \\n\\t(2Z)-2-(3-bromobenzylidene)-N-(5-sulfanyl-1,3,\\n\\t4-thiadiazol-2-yl)hydrazinecarboxamide <342,343>\\nIN\\t#35,123# \\n\\t(2Z)-2-(4-methylpentan-2-ylidene)-N-(5-sulfanyl-1,3,\\n\\t4-thiadiazol-2-yl)hydrazinecarboxamide <342,343>\\nIN\\t#35,123# \\n\\t(2Z)-2-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)-N-(5-sulfanyl-1,3,\\n\\t4-thiadiazol-2-yl)hydrazinecarboxamide <342,343>\\nIN\\t#35,123# \\n\\t(2Z)-2-(5-bromo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-N-(5-sulfanyl-1,3,\\n\\t4-thiadiazol-2-yl)hydrazinecarboxamide <342,343>\\nIN\\t#35,123,180# \\n\\t5-([(4-aminophenyl)sulfonyl]amino)-1,3,4-thiadiazole-2-sulfonamide \\n\\t<331,342,343>\\nIN\\t#35,65,123,147,180# \\n\\t4-(1,1-dioxido-1,2-thiazinan-2-yl)benzenesulfonamide \\n\\t<297,331,341,342,343>\\nIN\\t#35,65,123,147,180# 1,2-benzothiazol-3(2H)-one 1,1-dioxide \\n\\t<297,331,341,342,343>\\nIN\\t#35,65,123,147,180,182# \\n\\tN-[(2E)-3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide \\n\\t<297,331,341,342,343>\\nIN\\t#35,65,123,147,180,182# \\n\\t5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide \\n\\t<297,331,341,342,343>\\nIN\\t#35,65,123,147,180,182# \\n\\tN-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide \\n\\t<297,331,341,342,343>\\nIN\\t#35,65,123,180# \\n\\t6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide \\n\\t1,1-dioxide <331,341,342,343>\\nIN\\t#35,65,123,180,182# \\n\\t(4S,6S)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,\\n\\t3-b]thiopyran-2-sulfonamide 7,7-dioxide <331,341,342,343>\\nIN\\t#35,65,123,180,182# \\n\\t(4R)-4-(ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,\\n\\t2]thiazine-6-sulfonamide 1,1-dioxide <331,341,342,343>\\nIN\\t#35,65,123,180,182# \\n\\t4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide \\n\\t<331,341,342,343>\\nIN\\t#35,65,123,180,182,195# \\n\\t2-methoxy-N-[(1-methylpyrrolidin-2-yl)methyl]-5-sulfamoylbenzamide \\n\\t<331,341,342,343,362>\\nIN\\t#35,65,123,182# 4-amino-N-(4-sulfamoylphenyl)benzenesulfonamide \\n\\t<341,342,343>\\nIN\\t#35,85,123,195,228# benzene-1,3-disulfonamide <342,343,362,408,436>\\nIN\\t#38# tebuconazole <390>\\nIN\\t#38# propoxur <390>\\nIN\\t#38# carbofuran <390>\\nIN\\t#38# simazine <390>\\nIN\\t#38# Atrazine <390>\\nIN\\t#38,122# Carbaryl <308,390>\\nIN\\t#40,53# hydrogen carbonate <204>\\nIN\\t#40,53# Thiocyanide <204>\\nIN\\t#40,53# phenyl boronic acid (#40# weak Nce103 inhibitor <204>) <204>\\nIN\\t#40,53# phenyl arsonic acid (#40# weak Nce103 inhibitor <204>) <204>\\nIN\\t#40,53,147# isocyanide <204,208>\\nIN\\t#41# 2-acetylamido-1,3,4-thiadiazole-5-sulfonamide (#41# acetazolamide \\n\\t<98>) <98>\\nIN\\t#43# Chlorate <282>\\nIN\\t#45# 4-(3,4-dichlorophenylureido)thioureido-benzenesulfonamide (#45# \\n\\teffective in vitro carbonic anhydrase inhibitor <205>) <205>\\nIN\\t#45# \\n\\t5-[[(pentafluorophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide \\n\\t<205>\\nIN\\t#45# \\n\\t2,3,4,5,6-pentafluoro-N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)benzamide \\n\\t<205>\\nIN\\t#45# \\n\\t2,3,4,5,6-pentafluoro-N-[(2E)-3-methyl-5-sulfamoyl-1,3,\\n\\t4-thiadiazol-2(3H)-ylidene]benzamide <205>\\nIN\\t#45# \\n\\tN-[5-[(aminooxy)sulfinyl]-1,3,4-thiadiazol-2-yl]-1,1,2,2,3,3,4,4,5,5,6,\\n\\t6,7,7,8,8,8-heptadecafluorooctane-1-sulfonamide <205>\\nIN\\t#45# 4-[[(3,4-dichlorophenyl)carbamoyl]amino]benzenesulfonamide <205>\\nIN\\t#45# 2,3,4,5,6-pentafluoro-N-(2-sulfamoylphenyl)benzenesulfonamide <205>\\nIN\\t#45# 2-[(diphenylcarbamoyl)amino]benzenesulfonamide <205>\\nIN\\t#45# \\n\\tN-[4-[(aminooxy)sulfinyl]phenyl]-4-\\n\\t[(diphenylcarbamoyl)amino]benzenesulfonamide <205>\\nIN\\t#45# 4-[[(diphenylcarbamoyl)amino]methyl]benzenesulfonamide <205>\\nIN\\t#45# \\n\\tN-[(4-[[(4-\\n\\tsulfamoylphenyl)carbamothioyl]amino]phenyl)sulfonyl]acetamide <205>\\nIN\\t#45# 4-(carbamothioylamino)benzenesulfonamide <205>\\nIN\\t#45# 4-sulfamoyl-N-(4-sulfamoylphenyl)benzamide <205>\\nIN\\t#45# \\n\\t4-([[(diethyl-l5-azanylidyne)methyl]disulfanyl]amino)benzenesulfonamide \\n\\t<205>\\nIN\\t#45# \\n\\t4-[([[(diethyl-l5-\\n\\tazanylidyne)methyl]disulfanyl]amino)methyl]benzenesulfonamide <205>\\nIN\\t#45# \\n\\t4-([[(1Z)-(2-chlorophenyl)methylidene]amino]methyl)benzenesulfonamide \\n\\t<205>\\nIN\\t#45# \\n\\t4-(3-[[(1E)-(1-methyl-1H-imidazol-2-\\n\\tyl)methylidene]amino]propyl)benzenesulfonamide <205>\\nIN\\t#45# \\n\\t4-[([(1Z)-[4-\\n\\t(dimethylamino)phenyl]methylidene]amino)methyl]benzenesulfonamide <205>\\nIN\\t#45# \\n\\t4-[3-([(1E)-[4-\\n\\t(dimethylamino)phenyl]methylidene]amino)propyl]benzenesulfonamide <205>\\nIN\\t#45# \\n\\t4-([(1E)-[4-(dimethylamino)phenyl]methylidene]amino)benzenesulfonamide \\n\\t<205>\\nIN\\t#45# 2-oxo-N-[2-(4-sulfamoylphenyl)ethyl]-2H-chromene-3-carboxamide \\n\\t<205>\\nIN\\t#45# 2-oxo-N-(4-sulfamoylbenzyl)-2H-chromene-3-carboxamide <205>\\nIN\\t#45# 2-oxo-N-(4-sulfamoylphenyl)-2H-chromene-3-carboxamide <205>\\nIN\\t#45# 2-oxo-N-(2-sulfamoylphenyl)-2H-chromene-3-carboxamide <205>\\nIN\\t#45# 4-[2-[(2-oxo-2H-chromen-3-yl)carbonyl]hydrazino]benzenesulfonamide \\n\\t<205>\\nIN\\t#45# 2-oxo-N-(3-sulfamoylphenyl)-2H-chromene-3-carboxamide <205>\\nIN\\t#45# \\n\\tN-[2,\\n\\t4-disulfamoyl-5-(trifluoromethyl)phenyl]-2-oxo-2H-chromene-3-\\n\\tcarboxamide <205>\\nIN\\t#45# 2-(7-methoxy-2-oxo-2H-chromen-4-yl)-N-(2-sulfamoylphenyl)acetamide \\n\\t<205>\\nIN\\t#45# 2-(7-methoxy-2-oxo-2H-chromen-4-yl)-N-(3-sulfamoylphenyl)acetamide \\n\\t<205>\\nIN\\t#45# \\n\\t4-[2-[(7-methoxy-2-oxo-2H-chromen-4-\\n\\tyl)acetyl]hydrazino]benzenesulfonamide <205>\\nIN\\t#45# 2-(7-methoxy-2-oxo-2H-chromen-4-yl)-N-(4-sulfamoylphenyl)acetamide \\n\\t<205>\\nIN\\t#45# \\n\\tN-[2,\\n\\t4-disulfamoyl-5-(trifluoromethyl)phenyl]-2-(7-methoxy-2-oxo-2H-chromen-\\n\\t4-yl)acetamide <205>\\nIN\\t#45# \\n\\t4-[[(1Z)-(1-bromonaphthalen-2-yl)methylidene]amino]benzenesulfonamide \\n\\t<205>\\nIN\\t#45# \\n\\t5-[[(phenylcarbamoyl)carbamothioyl]amino]-1,3,\\n\\t4-thiadiazole-2-sulfonamide <205>\\nIN\\t#47# K3[Fe(CN)6] (#47# isoenzyme I <26>) <26>\\nIN\\t#47# K4[Fe(CN)6] (#47# isoenzyme I <26>) <26>\\nIN\\t#48# DTNB <6>\\nIN\\t#48# iodoacetate <6>\\nIN\\t#48# phenyl methyl sulfonyl fluoride <6>\\nIN\\t#48# pyridoxal 5\\'-phosphate <6>\\nIN\\t#48# Rose bengal <6>\\nIN\\t#49,55,66# dithiothreitol (#55# 10 mM. 22C, 50% inactivation <55>) \\n\\t<9,55,178>\\nIN\\t#5,124,197# SDS (#124# the wild-type enzyme is inactivated at 0.4% w/v, \\n\\tthe mutant enzymes are more stable showing residual activity at that \\n\\tconcentration <397>) <152,374,397>\\nIN\\t#53# 4-amino-benzenesulfonamide <231>\\nIN\\t#53# 4-(carboxyethyl)-benzenesulfonamide <231>\\nIN\\t#53# 4-methyl-benzenesulfonamide <231>\\nIN\\t#53# 4-aminomethyl-benzenesulfonamide <231>\\nIN\\t#53# 3-fluoro-4-amino-benzenesulfonamide <231>\\nIN\\t#53# 3-chloro-4-amino-benzenesulfonamide <231>\\nIN\\t#53# 3-iodo-4-amino-benzenesulfonamide <231>\\nIN\\t#53# 4-amino-6-chloro-benzene-1,3-disulfonamide <231>\\nIN\\t#53# 4-methyl-5-imino-1,3,4-thiadiazoline-2-sulfonamide <231>\\nIN\\t#53# aminobenzolamide <231>\\nIN\\t#53# 4-(4-sulfanilyl-aminomethyl)-benzenesulfonamide <231>\\nIN\\t#53# 4-(4-sulfanilyl-aminoethyl)-benzenesulfonamide <231>\\nIN\\t#53# 4-hydroxymethyl-benzenesulfonamide <231>\\nIN\\t#53# 4-hydroxyethyl-benzenesulfonamide <231>\\nIN\\t#53# 4-carboxy-benzenesulfonamide <231>\\nIN\\t#53,133# 4-aminoethyl-benzenesulfonamide (#133# carbonic anhydrase XIII \\n\\t<175>) <175,231>\\nIN\\t#53,230# 3-bromo-4-amino-benzenesulfonamide <231,440>\\nIN\\t#53,230# 4-amino-6-trifluoromethyl-benzene-1,3-disulfonamide <231,440>\\nIN\\t#58# \\n\\t5-(3alpha,12alpha-dihydroxy-5-beta-cholanamido)-1,3,\\n\\t4-thiadiazole-2-sulfonamide <127>\\nIN\\t#58# \\n\\t5-(3alpha,7alpha,12alpha-trihydroxy-5-beta-cholanamido)-1,3,\\n\\t4-thiadiazole-2-sulfonamide <127>\\nIN\\t#58# \\n\\t5-(3alpha,7alpha,12alpha-triacetoxy-5-beta-cholanamido)-1,3,\\n\\t4-thiadiazole-2-sulfonamide <127>\\nIN\\t#58,144# Cd2+ (#58# cadmium inhibits competitively <199>) <199,426>\\nIN\\t#59# N-(4-sulfamoylphenyl)acetamide <339>\\nIN\\t#59# 2,2,2-trifluoro-N-(4-sulfamoylphenyl)acetamide <339>\\nIN\\t#59# N-(4-sulfamoylphenyl)propanamide <339>\\nIN\\t#59# N-(4-sulfamoylphenyl)butanamide <339>\\nIN\\t#59# 2-methyl-N-(4-sulfamoylphenyl)propanamide <339>\\nIN\\t#59# N-(4-sulfamoylphenyl)pentanamide <339>\\nIN\\t#59# 3,3-dimethyl-N-(4-sulfamoylphenyl)butanamide <339>\\nIN\\t#59# N-(4-sulfamoylphenyl)benzamide <339>\\nIN\\t#59# N-(4-[(4-sulfamoylphenyl)sulfamoyl]phenyl)acetamide <339>\\nIN\\t#59# N-(4-sulfamoylbenzyl)benzenesulfonamide <339>\\nIN\\t#59# 4-([(phenylcarbamothioyl)amino]methyl)benzenesulfonamide <339>\\nIN\\t#59# 4-(2-[(phenylcarbamothioyl)amino]ethyl)benzenesulfonamide <339>\\nIN\\t#59# 4-(2-[(phenylcarbamoyl)amino]ethyl)benzenesulfonamide <339>\\nIN\\t#59# \\n\\t4-(2-([(4-sulfamoylphenyl)carbamothioyl]amino)ethyl)benzenesulfonamide \\n\\t<339>\\nIN\\t#59# 3-[(phenylcarbamoyl)amino]benzenesulfonamide <339>\\nIN\\t#59# 4-chloro-6-[(phenylcarbamoyl)amino]benzene-1,3-disulfonamide <339>\\nIN\\t#59# 5-([(4-bromophenyl)sulfonyl]amino)-1,3,4-thiadiazole-2-sulfonamide \\n\\t<339>\\nIN\\t#59# 5-([(4-nitrophenyl)sulfonyl]amino)-1,3,4-thiadiazole-2-sulfonamide \\n\\t<339>\\nIN\\t#59# \\n\\tN-[(2E)-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene]furan-2-carboxamide \\n\\t<339>\\nIN\\t#59,147,162,180# 4-sulfamoyl-N-[2-(4-sulfamoylphenyl)ethyl]benzamide \\n\\t<277,297,298,331,339>\\nIN\\t#59,74,118,119,120# 4-[(methylsulfonyl)amino]benzenesulfonamide \\n\\t<141,148,339>\\nIN\\t#59,74,118,119,120# 4-[(phenylsulfonyl)amino]benzenesulfonamide \\n\\t<141,148,339>\\nIN\\t#6,100# ClO4- (#6# poor inhibition <303>; #100# IC50: 2.2 mM <161>) \\n\\t<161,303>\\nIN\\t#6,11,12,14,18,22,23,24,51,63,91,111,112,147,205,220# Cl- (#18# 100 mM, \\n\\tthe firmly-membrane-associated activity is less sensitive to inhibition \\n\\tthan the loosely-membrane associated enzyme <60>; #14# relatively \\n\\tresistant to <53>; #24# no significant inhibition at physiological \\n\\tconcentrations <56>; #11# 10% residual activity at 1 mM <264>) \\n\\t<41,53,56,60,69,75,106,150,190,264,297,303,330,359,361,385>\\nIN\\t#6,11,12,18,20,22,24,47,51,91,99,147,191,205,206,220,231# NO3- (#47# \\n\\tisoenzyme I <26>; #11# 36% residual activity at 1 mM <264>; #231# about \\n\\t10% residual activity at 0.1 mM <442>; #191# weak inhibitor, the enzyme \\n\\tactivity is stable in the presence of NO3- up to 0.0001 mM <441>) \\n\\t<26,41,56,60,69,106,190,264,297,303,316,317,358,359,361,385,441,442>\\nIN\\t#6,11,18,20,23,63,99,147,205,206,220# HCO3- (#11# 7% residual activity \\n\\tat 1 mM <264>; #23# substrate inhibition above 0.1 M <39>) \\n\\t<39,41,264,297,303,316,317,330,358,359,361>\\nIN\\t#6,11,20,91,99,147,205,206,220,231# NO2- (#11# 41% residual activity at \\n\\t1 mM <264>; #231# about 85% residual activity at 0.1 mM <442>) \\n\\t<264,297,303,316,317,358,359,361,385,442>\\nIN\\t#6,12,14,17,20,28,40,53,88,99,124,125,147,167,178,179,238# sulfamide \\n\\t(#17# strong inhibition <207>; #167# high inhibition <300>; #28# one of \\n\\tthe most effective inhibitors <443>) \\n\\t<101,130,204,207,227,253,297,300,303,305,317,318,334,337,438,443>\\nIN\\t#6,12,14,18,20,22,23,29,30,63,91,99,147,205,206,220# SCN- (#18# KSCN, \\n\\tweak <3>; #14# inhibits 4-nitrophenyl acetate hydrolase activity <44>; \\n\\t#30# anion inhibition of the esterase activity <107>) \\n\\t<3,15,41,44,69,75,106,107,297,303,316,317,330,358,359,361,385>\\nIN\\t#6,12,14,18,20,29,36,48,51,62,91,99,100,133,147,205,220# I- (#14,18# \\n\\tweak <2,3>; #18# 100 mM, the firmly-membrane-associated activity is \\n\\tless sensitive to inhibition than the loosely-membrane associated \\n\\tenzyme <60>; #14# inhibits 4-nitrophenyl acetate hydrolase activity \\n\\t<44>; #14# relatively resistant to <53>; #36# uncompetitive at pH 6.0, \\n\\tmixed type at higher pH-values <5>; #14,48# NaI <2,6>; #18,29# KI \\n\\t<3,15>; #100# IC50: 100 mM <161>; #133# carbonic anhydrase XIII <175>) \\n\\t<2,3,5,6,15,44,53,60,106,161,175,190,297,303,316,317,359,361,385>\\nIN\\t#6,12,18,20,21,22,24,30,36,47,48,51,62,63,73,91,99,100,147,220# N3- \\n\\t(#47# NaN3, isoenzyme 1 <26>; #36# NaN3, uncompetitive at pH 6.0, mixed \\n\\ttype at higher pH-values <5>; #30# anion inhibition of the esterase \\n\\tactivity <107>; #100# IC50: about 50 mM <161>) \\n\\t<3,5,6,17,26,33,48,51,54,56,69,106,107,161,190,297,303,316,317,330,361,\\n\\t385>\\nIN\\t#6,12,18,20,30,47,48,62,63,99,147,205,206,220# CN- (#18# KCN <3>; #47# \\n\\ti.e. cyanide, , isoenzyme I <26>; #30# anion inhibition of the esterase \\n\\tactivity <107>; #99# best anion inhibitors for Zn2+-substituted enzyme \\n\\tare cyanate and hydrogen sulfide <316>) \\n\\t<3,6,26,41,47,51,106,107,297,303,316,317,330,358,359,361>\\nIN\\t#6,14,22,88,125# 5-acetamido-1,3,4-thiadiazole-2-sulfonamide \\n\\t<33,167,251,303,334>\\nIN\\t#6,18,20,51,62,63,91,99,133,147,206,220# Br- (#133# weak, carbonic \\n\\tanhydrase XIII <175>) <60,175,190,297,303,316,317,330,358,361,385>\\nIN\\t#6,18,22,23,91,119,127,147,205# SO42- (#127# isoenzyme hCA I <168>; \\n\\t#119# isoenzyme hCA XII <168>) <48,69,75,168,297,303,359,385>\\nIN\\t#6,20,63,99,147,205,206,220# HS- (#99# best anion inhibitors for \\n\\tZn2+-substituted enzyme are cyanate and hydrogen sulfide <316>) \\n\\t<297,303,316,317,330,358,359,361>\\nIN\\t#6,20,63,99,147,205,206,220,221# CNO- \\n\\t<297,303,316,317,330,358,359,361,366>\\nIN\\t#6,20,99,147,167,205,206,220# HSO3- <297,300,303,316,317,358,359,361>\\nIN\\t#6,63,133,147# F- (#133# carbonic anhydrase XIII <175>) \\n\\t<175,297,303,330>\\nIN\\t#6,63,87,119,120,124,127,147,167,205,206,220# H2NSO3H (#127# isoenzyme \\n\\thCA I <168>; #124# isoenzyme hCA II <168>; #120# isoenzyme hCA IX \\n\\t<168>; #119# isoenzyme hCA XII <168>) \\n\\t<168,297,300,303,329,330,358,359,361>\\nIN\\t#6,63,87,119,120,124,127,147,167,205,206,220# H2NSO2NH2 (#127# \\n\\tisoenzyme hCA I <168>; #124# isoenzyme hCA II <168>; #120# isoenzyme \\n\\thCA IX <168>; #119# isoenzyme hCA XII <168>) \\n\\t<168,297,300,303,329,330,358,359,361>\\nIN\\t#6,63,87,147,205,206,220# Ph-AsO3H2 <297,303,329,330,358,359,361>\\nIN\\t#6,63,87,205,206,220# Ph-B(OH)2 <303,329,330,358,359,361>\\nIN\\t#61# tris(hydroxymethyl)phosphine <346>\\nIN\\t#62# hydrogencarbonate (#62# good inhibitor of the Co(II)-substituted \\n\\tenzyme <316>) <316>\\nIN\\t#63,205,220# ReO4- <330,359,361>\\nIN\\t#63,87,205,206,220# SeCN- <329,330,358,359,361>\\nIN\\t#63,87,205,206,220# Et2NCS2- <329,330,358,359,361>\\nIN\\t#63,87,205,206,220,238# CS32- <329,330,358,359,361,438>\\nIN\\t#65,131,147,162,172,180# 6-hydroxy-1,3-benzothiazole-2-sulfonamide \\n\\t<184,230,277,297,298,331,341>\\nIN\\t#65,147,162,180# 2-hydrazinylbenzenesulfonamide <259,277,298,331,341>\\nIN\\t#65,147,162,180# 4-hydrazinylbenzenesulfonamide <277,297,298,331,341>\\nIN\\t#65,182# 5-(3-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide <341,342>\\nIN\\t#66# p-hydroxymercuribenzoate <9>\\nIN\\t#71# chlorothiazide <35>\\nIN\\t#71,222# p-toluenesulfonamide <35,377>\\nIN\\t#74,118,119,120# N-[4-(aminosulfonyl)phenyl]acetamide <141,148>\\nIN\\t#74,118,119,120# N-[4-(aminosulfonyl)phenyl]-2,2,2-trifluoroacetamide \\n\\t<141,148>\\nIN\\t#74,118,119,120# N-[4-(aminosulfonyl)phenyl]propanamide <141,148>\\nIN\\t#74,118,119,120# N-[4-(aminosulfonyl)phenyl]butanamide <141,148>\\nIN\\t#74,118,119,120# N-[4-(aminosulfonyl)phenyl]-2-methylpropanamide \\n\\t<141,148>\\nIN\\t#74,118,119,120# N-[4-(aminosulfonyl)phenyl]pentanamide <141,148>\\nIN\\t#74,118,119,120# N-[4-(aminosulfonyl)phenyl]-2,2-dimethylpropanamide \\n\\t<141,148>\\nIN\\t#74,118,119,120# N-[4-(aminosulfonyl)phenyl]benzamide <141,148>\\nIN\\t#74,118,119,120# \\n\\t4-[(acetyloxy)amino]-N-[4-(aminosulfonyl)phenyl]benzenesulfonamide \\n\\t<141,148>\\nIN\\t#74,118,119,120# 4-[[(phenylsulfonyl)amino]methyl]benzenesulfonamide \\n\\t<141,148>\\nIN\\t#74,118,119,120# \\n\\t4-[[(anilinocarbonothioyl)amino]methyl]benzenesulfonamide <141,148>\\nIN\\t#74,118,119,120# \\n\\t4-[2-[(anilinocarbonothioyl)amino]ethyl]benzenesulfonamide <141,148>\\nIN\\t#74,118,119,120# 4-[2-[(anilinocarbonyl)amino]ethyl]benzenesulfonamide \\n\\t<141,148>\\nIN\\t#74,118,119,120# \\n\\t4-[2-[([[4-\\n\\t(aminosulfonyl)phenyl]amino]carbonothioyl)\\n\\tamino]ethyl]benzenesulfonamide <141,148>\\nIN\\t#74,118,119,120# \\n\\t4-(aminosulfonyl)-N-[2-[4-(aminosulfonyl)phenyl]ethyl]benzamide \\n\\t<141,148>\\nIN\\t#74,118,119,120# 3-[(anilinocarbonyl)amino]benzenesulfonamide <141,148>\\nIN\\t#74,118,119,120# \\n\\t4-[(anilinocarbonyl)amino]-6-chlorobenzene-1,3-disulfonamide <141,148>\\nIN\\t#74,118,119,120# \\n\\t5-[[(4-bromophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide \\n\\t<141,148>\\nIN\\t#74,118,119,120# \\n\\t5-[[(4-nitrophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide \\n\\t<141,148>\\nIN\\t#74,118,119,120# \\n\\tN-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)furan-2-carboxamide <141,148>\\nIN\\t#80# Co3+ (#80# competitive, strong inhibition of carbonic anhydrase \\n\\testerase activity <306>) <306>\\nIN\\t#80,94,191,197# Al3+ (#80# competitive, very strong inhibition of \\n\\tcarbonic anhydrase esterase activity <306>; #197# inhibits by 12% at 5 \\n\\tmM, no inhibition at 1 mM <374>) <306,374,404,425>\\nIN\\t#85# 5-((4-aminophenyl)sulfonamido)-1,3,4-thiadiazole-2-sulfonamide \\n\\t<408>\\nIN\\t#85# \\n\\t4-(2-hydroxymethyl-4-nitrophenyl-sulfonamidoethyl)-benzenesulfonamide \\n\\t<408>\\nIN\\t#85,195,222,228# 4-methylbenzene-1-sulfonamide <362,377,408,436>\\nIN\\t#85,195,228# 3-aminobenzene-1-sulfonamide <362,408,436>\\nIN\\t#85,195,228# 4-aminobenzene-1-sulfonamide <362,408,436>\\nIN\\t#85,195,228# 4-(aminomethyl)benzene-1-sulfonamide <362,408,436>\\nIN\\t#85,195,228# 4-(2-aminoethyl)benzene-1-sulfonamide <362,408,436>\\nIN\\t#85,195,228# 4-amino-3-fluorobenzene-1-sulfonamide <362,408,436>\\nIN\\t#85,195,228# 4-amino-3-chlorobenzene-1-sulfonamide <362,408,436>\\nIN\\t#85,195,228# 4-amino-3-bromobenzene-1-sulfonamide <362,408,436>\\nIN\\t#85,195,228# 3,5-dichloro-2-hydroxybenzene-1-sulfonamide <362,408,436>\\nIN\\t#85,195,228# 4-hydroxybenzene-1-sulfonamide <362,408,436>\\nIN\\t#85,195,228# 4-(hydroxymethyl)benzene-1-sulfonamide <362,408,436>\\nIN\\t#85,195,228# 4-(2-hydroxyethyl)benzene-1-sulfonamide <362,408,436>\\nIN\\t#85,195,228# 4-[(2-aminopyrimidin-4-yl)amino]benzene-1-sulfonamide \\n\\t<362,408,436>\\nIN\\t#85,195,228# \\n\\t2-(hydroxymethyl)-4-nitro-N-[2-(4-sulfamoylphenyl)ethyl]benzene-1-\\n\\tsulfonamide <362,408,436>\\nIN\\t#85,195,228# 4-amino-N-(4-sulfamoylphenyl)benzene-1-sulfonamide \\n\\t<362,408,436>\\nIN\\t#85,195,228# 4-amino-N-[(4-sulfamoylphenyl)methyl]benzene-1-sulfonamide \\n\\t<362,408,436>\\nIN\\t#85,195,228# \\n\\t4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzene-1-sulfonamide \\n\\t<362,408,436>\\nIN\\t#85,228# \\n\\t5-[(4-aminobenzene-1-sulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide \\n\\t<408,436>\\nIN\\t#87# [S2O8]2- <329>\\nIN\\t#87,205,206,220,238# FSO3- <329,358,359,361,438>\\nIN\\t#88,90# dextran-bound acetazolamide (#90# at very low CO2 \\n\\tconcentrations enzyme inhibition reduces photosynthesis <347>; #88# at \\n\\tvery low CO2 concentrations enzyme inhibition reduces photosynthesis. \\n\\tInhibition of enzyme reduces growth by about 10% at pH 8.4 <347>) <347>\\nIN\\t#9,12,17,18,28,34,43,50,83,124,125,147,167# bicarbonate (#167# high \\n\\tinhibition <300>; #12# shows low micromolar inhibition against CA XV \\n\\t<253>; #9# is hypothesized to be an allosteric inhibitor of HICA <288>; \\n\\t#28# sub-millimolar inhibitor <443>) \\n\\t<207,208,227,250,253,288,300,309,313,443>\\nIN\\t#91# SO32- <385>\\nIN\\t#99,118,119,120,124,125,127,128,129,130,131,132,133,134,135# \\n\\t6-chloro-4-amino-benzene-1,3-disulfonamide (#99# isoenzyme gammaCA \\n\\t<169>; #127# isoenzyme hCA I <169>; #124# isoenzyme hCA II <169>; #125# \\n\\tisoenzyme hCA III <169>; #128# isoenzyme hCA IV <169>; #120# isoenzyme \\n\\thCA IX <169>; #129# isoenzyme hCA VA <169>; #130# isoenzyme hCA VB \\n\\t<169>; #131# isoenzyme hCA VI <169>; #132# isoenzyme hCA VII <169>; \\n\\t#119# isoenzyme hCA XII <169>; #118# isoenzyme hCA XIV <169>; #134# \\n\\tisoenzyme hpalphaCA <169>; #135# isoenzyme hpbetaCA <169>; #133# \\n\\tisoenzyme mCA XIII <169>) <169>\\nIN\\t#99,118,119,120,124,125,127,128,129,130,131,132,133,134,135# \\n\\t6-trifluoromethyl-4-aminobenzene-1,3-disulfonamide (#99# isoenzyme \\n\\tgammaCA <169>; #127# isoenzyme hCA I <169>; #124# isoenzyme hCA II \\n\\t<169>; #125# isoenzyme hCA III <169>; #128# isoenzyme hCA IV <169>; \\n\\t#120# isoenzyme hCA IX <169>; #129# isoenzyme hCA VA <169>; #130# \\n\\tisoenzyme hCA VB <169>; #131# isoenzyme hCA VI <169>; #132# isoenzyme \\n\\thCA VII <169>; #119# isoenzyme hCA XII <169>; #118# isoenzyme hCA XIV \\n\\t<169>; #134# isoenzyme hpalphaCA <169>; #135# isoenzyme hpbetaCA <169>; \\n\\t#133# isoenzyme mCA XIII <169>) <169>\\nIN\\t#99,118,119,120,124,125,127,128,129,130,131,132,133,134,135# \\n\\tN-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide \\n\\t(#99# isoenzyme gammaCA <169>; #125# isoenzyme hCA III <169>; #120# \\n\\tisoenzyme hCA IX <169>; #129# isoenzyme hCA VA <169>; #130# isoenzyme \\n\\thCA VB <169>; #131# isoenzyme hCA VI <169>; #119# isoenzyme hCA XII \\n\\t<169>; #118# isoenzyme hCA XIV <169>; #134# isoenzyme hpalphaCA <169>; \\n\\t#135# isoenzyme hpbetaCA <169>; #133# isoenzyme mCA XIII <169>) <169>\\nIN\\t#99,118,119,120,124,125,127,128,129,130,131,132,133,134,135# \\n\\t6-methyl-4-(methylamino)-5,6-dihydro-4H-thieno[2,\\n\\t3-b]thiopyran-2-sulfonamide 7,7-dioxide (#99# isoenzyme gammaCA <169>; \\n\\t#125# isoenzyme hCA III <169>; #120# isoenzyme hCA IX <169>; #129# \\n\\tisoenzyme hCA VA <169>; #130# isoenzyme hCA VB <169>; #131# isoenzyme \\n\\thCA VI <169>; #119# isoenzyme hCA XII <169>; #118# isoenzyme hCA XIV \\n\\t<169>; #134# isoenzyme hpalphaCA <169>; #135# isoenzyme hpbetaCA <169>; \\n\\t#133# isoenzyme mCA XIII <169>) <169>\\nIN\\t#99,118,119,120,124,127,129,130,131,132,134,135# \\n\\t2-(3-methoxypropyl)-4-(methylamino)-3,4-dihydro-2H-thieno[3,2-e][1,\\n\\t2]thiazine-6-sulfonamide 1,1-dioxide (#99# isoenzyme gammaCA <169>; \\n\\t#120# isoenzyme hCA IX <169>; #129# isoenzyme hCA VA <169>; #130# \\n\\tisoenzyme hCA VB <169>; #131# isoenzyme hCA VI <169>; #119# isoenzyme \\n\\thCA XII <169>; #118# isoenzyme hCA XIV <169>; #134# isoenzyme hpalphaCA \\n\\t<169>; #135# isoenzyme hpbetaCA <169>) <169>\\n\\nMETALS_IONS\\nME\\t#1,10,15,18,21,22,23,47,48,62,66,67,70,71,143# Zinc (#67# essential for \\n\\tactivity <16>; #62# contains 1 Zn per subunit <51>; #1# contains 1 \\n\\tgatom of tightly bound zinc per molecule <34>; #47# contains 5-6 gatom \\n\\tof zinc per mol of hexamer <26>; #23# contains 6 mol of zinc per mol of \\n\\tenzyme <39>; #66# Zn2+, when added back to the apoenzyme in a 1:1 molar \\n\\tratio or greater, the activity immediately returns to control level \\n\\t<9>; #22# total coordination number 4-6 <69>; #70# the major enzyme \\n\\tform contains 1 gatom of zinc per 30000 Da enzyme, the minor enzyme \\n\\tform contains 1.09 gatom of zinc per 30000 Da enzyme <32>; #18# the \\n\\tZn2+ enzyme remains essentially fourcoordinate in all its forms, \\n\\talthough alterations in the K-edge shape imply differences in \\n\\tcoordination geometry <41>; #71# contains 0.92 zinc ions per protein \\n\\tmolecule with 28600 Da <35>; #48# required for activity and stability \\n\\t<6>; #21# 0.8 gatom of zinc per protein subunit <1>; #10# enzyme \\n\\tcontains 1 gatom of zinc per 27000 MW monomer <14>; #22# contains 1 \\n\\tgatom of zinc per subunit <21>; #21# contains 0.81 gatom of zinc per \\n\\tmol of enzyme, carbonic anhydrase A <22>; #143# zinc metalloenzymes \\n\\t<173>) <1,6,9,13,14,16,21,22,26,32,34,35,39,41,51,69,173>\\nME\\t#100# NaCl (#100# enzyme retains activity at salt concentrations \\n\\tranging from low salt to at least 1.5 M NaCl or KCl for CO2 hydration, \\n\\t2.0 M NaCl for esterase activity and 0.5 M for bicarbonate dehydration \\n\\t<161>) <161>\\nME\\t#100# KCl (#100# enzyme retains activity at salt concentrations ranging \\n\\tfrom low salt to at least 1.5 M NaCl or KCl for CO2 hydration, 2.0 M \\n\\tNaCl for esterase activity and 0.5 M for bicarbonate dehydration <161>) \\n\\t<161>\\nME\\t#100# Zn (#100# Zn metalloenzyme <161>) <161>\\nME\\t#11# Fe3+ (#11# 281% activity at 1 mM <264>) <264>\\nME\\t#11,120,232# Mg2+ (#120# strongly activating effect, Mg2+ induces an \\n\\tincrease in the kcat/Km value <223>; #11# 107% activity at 1 mM <264>; \\n\\t#232# either Mg or Zn can occupy the active site <411>) <223,264,411>\\nME\\t#11,14# Cu2+ (#14# binds copper about 50fold more tightly than zinc \\n\\t<82>; #14# CAII binds 2 copper ions <88>; #11# 165% activity at 1 mM \\n\\t<264>) <82,88,264>\\nME\\t#11,197,207# SO42- (#11# 126% activity at 1 mM <264>; #197# the \\n\\trecombinant enzyme displays the unique property of stimulation in \\n\\tpresence of SO42- <367>; #207# SO42- ions have a stimulatory effect on \\n\\tthe enzymes CO2 hydration activity <444>) <264,367,444>\\nME\\t#124# Na+ (#124# a key role for sodium ions in increasing halotolerant \\n\\tenzyme stability largely through interactions with the highly ordered \\n\\tfirst Na+ hydration shell, molecular dynamics calculations, overview. \\n\\tVery strong activation by Na2SO4 of all enzymes, especially of mutant \\n\\tM4, slight activation by NaCl, overview <397>) <397>\\nME\\t#14,66# Ni2+ (#66# slight activation of the apoenzyme <9>) <9,82>\\nME\\t#166# sulfate (#166# the sulfate ion competes with the bicarbonate ion \\n\\tfor the binding site near the active site affecting the allosteric \\n\\tregulation of the enzyme, binding structure in wild-type an dmutant \\n\\tenzymes, overview <289>) <289>\\nME\\t#183# Hg2+ (#183# inhibit activity <325>) <325>\\nME\\t#183# Pb2+ (#183# inhibit activity <325>) <325>\\nME\\t#183# CN- (#183# inhibit activity <325>) <325>\\nME\\t#183# F- (#183# inhibit activity <325>) <325>\\nME\\t#183# SCN- (#183# inhibit activity <325>) <325>\\nME\\t#183# As3+ (#183# inhibit activity <325>) <325>\\nME\\t#183,231# NO2- (#183# inhibit activity <325>; #231# about 108% activity \\n\\tat 0.01 mM <442>) <325,442>\\nME\\t#184,191# Ca2+ (#184# the native enzyme contains four Ca2+ ions <194>; \\n\\t#191# contains calcium ions <441>) <194,441>\\nME\\t#197# Sn2+ (#197# stimulates at 5 mM <367>; #197# activates about 40% \\n\\tat 5 mM <374>) <367,374>\\nME\\t#23,120,197# Mn2+ (#23# required <155>; #120# strongly activating \\n\\teffect, Mn2+ induces an increase in the kcat/Km value <223>; #197# BhCA \\n\\talso functions as an efficient virtual peroxidase when Zn2+ is \\n\\tsubstituted with Mn2+ <374>) <155,223,374>\\nME\\t#231# NO3- (#231# about 120% activity at 0.001 mM <442>) <442>\\nME\\t#43,62,80,91,99,106,124,191,195,197,231,233# more (#43# not influenced \\n\\tby Cu2+, K+, Na+, Ca2+, and Mg2+ <282>; #80# the enzyme shows an \\n\\toptimum ionic strength at 10mM <306>; #99# reconstitution of the \\n\\tapoenzyme with Cu2+, Mn2+, Ni2+, or Cd2+ yields enzymes with effective \\n\\tkcat values that are 10% or less than the value for the \\n\\tZn2+-reconstituted apoenzyme <321>; #62# the metal ion in the enzyme \\n\\tisolated directly from Methanosarcina thermophila is not been \\n\\tdetermined since only enzyme overproduced in Escherichia coli is \\n\\tcharacterized <316>; #62# analysis of three-dimensional structures of \\n\\tMtCam, in both Zn- and Co-bound forms, overview. Structure comparisons \\n\\t<376>; #124# distribution of cations and anions within 3 A of the \\n\\tenzyme surface, overview <397>; #195# homology modeling analysis shows \\n\\tthat the metal ion coordination pattern of the eta-CA involves two His \\n\\tand one Gln residues in addition to the water molecule/hydroxide ion \\n\\tacting as nucleophile in the catalytic cycle <362>; #197# no effect on \\n\\tenzyme activity at 5 mM by Ca2+, NH4+, Mg2+, Ba2+, and Mn2+ <374>; \\n\\t#197# rBhCA activity is unaffected by Na+ and Cl- up to 1.0 M or by \\n\\tPb2+ at 1 mM. rBhCA is able to tolerate high concentration of NO32- and \\n\\tSO32- up to 1 M without losing activity <367>; #91# the enzyme has an \\n\\toptimum ionic strength at 20 mM. Sulfate, sulfide, azide, nitrate, \\n\\tnitrite and iodide exhibit strong inhibitory activity in the micromolar \\n\\trange (Ki values of 5.5-15.5 mM). Cyanide, bromide, chloride, and \\n\\tcarbonate are moderate inhibitors, whereas other anions show only weak \\n\\tactivities <385>; #191# the recombinant enzyme activity is not affected \\n\\tsignificantly by the presence of Ca2+, Mg2+, or K+ ions <404>; #231# \\n\\tnot affected by SO42- <442>; #106,233# the enzyme exhibits its activity \\n\\tunder metal-free conditions. The enzyme activity is not affected by 2 \\n\\tmM Mg2+,Ca2+, Mn2+, Fe2+, Co2+, Ni2+, or Cd2+ <419>) \\n\\t<282,306,316,321,362,367,374,376,385,397,404,419,442>\\nME\\t#43,62,88,183# Cd2+ (#88# the enzyme uses cadmium as a catalytic metal \\n\\tatom <235>; #43# 106.6% relative activity at 1 mM <282>; #62,88# \\n\\treplacement of zinc ion with cadmium does not entail significant \\n\\tdifferences in the catalytic performance of the enzyme <312>; #183# \\n\\tstimulate activity <325>) <235,282,312,325>\\nME\\t#43,62,94,99,176# Fe2+ (#94# slight enhancement of activity <425>; #62# \\n\\tcontains one iron ion per monomer when synthesized in Methanosarcina \\n\\tacetivorans <197>; #43# 102.6% relative activity at 1 mM <282>; #99# \\n\\tanaerobic reconstitution of apoenzyme with Fe2+, which yields an enzyme \\n\\twith an effective kcat that exceeds that for the Zn2+-reconstituted \\n\\tenzyme. The Fe2+-reconstituted enzyme contains high spin Fe2+ that, \\n\\twhen oxidized to Fe3+, inactivates the enzyme. Reconstitution with Fe3+ \\n\\tis unsuccessful <321>; #62# the Fe2+-reconstituted enzyme produced in \\n\\tEscherichia coli and purified anaerobically contains iron with \\n\\teffective kcat and kcat/Km values exceeding the values for \\n\\tZn2+-reconstituted enzyme. The Fe2+-reconstituted enzyme contains high \\n\\tspin Fe2+ that, when oxidized to Fe3+, inactivates the enzyme. \\n\\tReconstitution with Fe3+ is unsuccessful <321>; #176# the homotrimer \\n\\tpurified from Escherichia coli cultured with supplemental zinc contains \\n\\t0.71 zinc and 0.15 iron per monomer. Enzyme purified from Escheria coli \\n\\tcultured with supplemental iron contains 0.15 iron per monomer and only \\n\\ta trace amount of zinc <320>; #62# when overproduced in Escherichia \\n\\tcoli or in Methanosarcina acetivorans and subsequently anaerobically \\n\\tpurified, the enzyme contains Fe2+ in the active site and is 4fold more \\n\\tactive. In these conditions, catalytic activity is rapidly lost after \\n\\texposure to air, as a consequence of the oxidation of Fe2+ to Fe3+ and \\n\\tloss of the metal from the active site, thus convincing evidence is \\n\\tthat iron is the physiologically relevant metal for this enzyme <376>) \\n\\t<197,282,320,321,376,425>\\nME\\t#9,10,11,12,14,15,18,20,21,23,26,28,30,31,38,41,43,49,50,51,52,53,56,58,\\n\\t62,81,88,91,92,94,96,99,101,102,103,104,105,118,119,120,124,127,128,131,\\n\\t133,145,147,162,163,164,166,167,168,169,173,176,181,183,184,185,186,187,\\n\\t188,189,190,191,192,193,194,195,196,197,198,199,200,201,202,203,204,205,\\n\\t207,208,209,210,211,212,213,214,215,216,217,218,219,220,221,222,223,224,\\n\\t225,226,227,228,229,231,232,235,236# Zn2+ (#14,120,124,147,208# \\n\\trequired <286,293,294,295,297,299,363,364>; #10,30,124# zinc \\n\\tmetalloenzyme <107,195,239>; #14,18,20,99,119,124# zinc enzyme \\n\\t<94,96,112,126,129,130,131,132,135>; #96,124,131,224,225,226,227,229# \\n\\tcontains zinc <219,237,407,422,423,434,446>; #12,14,18,164# \\n\\tzinc-containing metalloenzyme <97,273>; #21# metalloenzyme <379,380>; \\n\\t#20# active site zinc <116>; #23# active site zinc ion <104>; #103# \\n\\tactive-site zinc <138>; #14# thermodynamics of metal-binding <89>; #14# \\n\\tzinc bound water molecule of the enzyme <77>; #101,105# zinc hydroxide \\n\\tmechanism <113>; #14# zinc is bound with a 1:1 stoichiometry <88>; \\n\\t#127# zinc-activated variant <93>; #12,14,18,23,30,56,99# \\n\\tzinc-containing enzyme <74,75,85,115,119,251,265>; #20# zinc-hydroxide \\n\\tmechanism of catalysis <114>; #14,58,103,124# zinc-metalloenzyme \\n\\t<71,73,100,124,127,249>; #14,62# Zn2+ containing <110>; #81# monomer \\n\\tcontains a single Zn2+ <158>; #49# addition of 1 mM ZnCl2 to the \\n\\tmetal-depleted enzyme restores the ctivity to nearly the level observed \\n\\tfor nondialyzed samples, while neither CoCl2 nor MgCl2 is able to \\n\\treverse the inactivation of the enzyme. Zn2+ contents of 0.9 mol of \\n\\tZn2+ per mol of monomer <178>; #51# addition of zinc improves the CO2 \\n\\thydration activity of the rice CA produced by Escherichia coli <190>; \\n\\t#14,231# a zinc metalloenzyme <291,442>; #88# Cd2+ can be substituted \\n\\tby Zn2+, yielding an even more efficient enzyme <235>; #62# contains \\n\\tone zinc ion per monomer when overproduced in Escherichia coli <197>; \\n\\t#53# contains one Zn2+ per monomer <231>; #14# contains Zn2+ <247>; \\n\\t#120# strongly activating effect, the recombinant extracellular domain \\n\\tof CA IX, which includes both the proteoglycan and catalytic domains, \\n\\tshows 2166% increase of activity in the presence of 0.05 mM Zn2+ <223>; \\n\\t#124# the holoenzyme contains Zn2+ <224>; #184# zinc-containing \\n\\tmetalloenzyme, the asymmetric unit contains a catalytic Zn2+ ion <194>; \\n\\t#43# 109.25% relative activity at 1 mM <282>; #11# 473% activity at 1 \\n\\tmM <264>; #163# a zinc ion is coordinated by the three highly conserved \\n\\tresidues Cys57, His112 and Cys115 <266>; #166,192,236# a \\n\\tzinc-metalloenzyme <289,429>; #14# active site bound and essential for \\n\\tcatalysis, metalloenzyme <311>; #162# beta class CAs contain four \\n\\tprotein zinc ligands, one His, two Cys, and one Asp coordinated to \\n\\tZn(II). At pH 8.0, no water is coordinated to the metal ion <298>; \\n\\t#167# catalytically crucial <300>; #62,88# required for activity. \\n\\tReplacement of zinc ion with cadmium does not entail significant \\n\\tdifferences in the catalytic performance of the enzyme <312>; #14# \\n\\trequired for catalysis, the side chain of His64 occupies two \\n\\tconformations in wild-type HCA II, pointing inward toward the zinc or \\n\\toutward toward bulk solvent <290>; #168,169# required, binding \\n\\tstructure modelling, overview <292>; #9# required, can be substituted \\n\\tby Co2+ <288>; #50# required, increases the growth rate of the cells \\n\\tand the enzyme activity <313>; #31# required, isozymes CAH-3, CAH-4 and \\n\\tCAH-5 contain the three zinc-binding histidines that are important for \\n\\tenzyme activity, His94, His96, and His119, and also two ligands that \\n\\tprovide a hydrogen bond to stabilize the zinc ion during catalysis, \\n\\tGln-92 and Glu-117 <310>; #14# required. The side chain of Tyr7 in HCA \\n\\tII extends into the active-site cavity about 7 A from the catalytic \\n\\tzinc atom <287>; #10# two Zn atoms in the alphaCA1 crystal asymmetric \\n\\tunit <284>; #99# the enzyme contains contains catalytic zinc <321>; \\n\\t#176# the homotrimer purified from Escherichia coli cultured with \\n\\tsupplemental zinc contains 0.71 zinc and 0.15 iron per monomer. Enzyme \\n\\tpurified from Escherichia coli cultured with supplemental iron contains \\n\\t0.15 iron per monomer and only a trace amount of zinc <320>; #62# the \\n\\tindividual subunits are only weakly folded and fractionally associated \\n\\tin the absence of Zn2+. The crucial thermodynamic step in the assembly \\n\\tof the trimeric holo-Cam is the incorporation of the three Zn2+ ions, \\n\\tevents which must occur after the monomer is resident on the surface \\n\\tand has access to other monomers <322>; #52# enzyme contains one active \\n\\tsite zinc per subunit <338>; #183# stimulate activity <325>; \\n\\t#38,91,118,119,120,124,127,128,145,193,196,197,199,200,202,204,210,212,\\n\\t213,214,215,216,217,218,221,222# required, metalloenzyme \\n\\t<350,352,354,355,357,365,366,373,374,375,377,378,381,382,383,385,386,\\n\\t387,390,392,394,396,397,398,399,400,402,403,405>; #219# a \\n\\tzinc-containing metalloenzyme <368>; #201# essential for the catalytic \\n\\tactivity, metalloenzyme <401>; #220# metal ion ligands are His81, \\n\\tHist117 and His122 <361>; #185# metalloenzyme, the metal ion is \\n\\trequired for catalytic activity, coordinated by three histidine \\n\\tresidues: His89, His91 and His108, zinc cordination site structure, PDB \\n\\tID 4G7A <376>; #62,124,181,184,186,187,189,190,191,192,193# \\n\\tmetalloenzyme, the metal ion is required for catalytic activity, \\n\\tcoordinated by three residues <376>; #188# metalloenzyme, the metal ion \\n\\tis required for catalytic activity, coordinated by three residues. Each \\n\\tmonomer of the enzyme dimer contains a zinc ion tetrahedrally \\n\\tcoordinated by two cysteines (Cys32 and Cys90), one histidine (His87) \\n\\tand a water molecule/hydroxide ion <376>; #195# required for activity, \\n\\tmetalloenzyme <388>; #193# required, carbonic anhydrase is a \\n\\tmetalloenzyme, that binds a single zinc atom in its active site using \\n\\tthree histidine ligands. The enzyme binds zinc relatively strongly with \\n\\tan apparent stability constant (log(KF)) of approximately 11.4 at pH \\n\\t7.0. Following de novo protein synthesis, apocarbonic anhydrase must \\n\\tacquire and insert the enzymatically necessary zinc atom into the \\n\\tactive site. The enzyme accepts donation of a single zinc atom from \\n\\tzinc-saturated metallothioneins at rates and concentrations that \\n\\tsupports in vivo zinc donation by metallothionein (MT), fully saturated \\n\\tZn-MT is capable of donating zinc to the apoenzyme. Competitive zinc \\n\\ttitration to a solution containing equal concentrations of apo-rhMT1A \\n\\tand apoCA, formation of the fully metalated Zn7MT and holo-ZnCA, \\n\\tkinetics, simulation and modelling, overview <356>; #191# required, \\n\\tmetalloenzyme, activates the recombinant enzyme lacking the signal \\n\\tpeptide <404>; #124# required, metalloenzyme, molecular dynamics \\n\\tsimulations in catalysis. Active site residues correspond to His94, \\n\\tHis96, His119 belonging to the inner coordination shell of the metal \\n\\tion and Glu106, Thr199, Thr200 belonging to the outer one <351>; #207# \\n\\trequired, metalloenzyme, on the bottom of a central cavity, the \\n\\tcatalytic zinc ion is tetrahedrally coordinated by the three histidine \\n\\tresidues (His89, His91 and His108) <360>; #209# required, \\n\\tmetalloenzyme, residues His130, His132, and His155 are zinc iron \\n\\tbinding sites <372>; #198# required, metalloenzyme, the catalytic \\n\\tresidues Asp44 and Arg46 are involved in activation of the \\n\\tzinc-coordinated water molecule/hydroxide ion for catalysis <384>; \\n\\t#203# required, metalloenzyme, the zinc ion bound to Cys39, His98, and \\n\\tCys101 in the catalytic site, water forms the fourth zinc ligand <355>; \\n\\t#211# required, metalloenzyme, three histidine residues predicted to \\n\\tform the Zn2+ coordination center, H233, H235, and H258, are conserved \\n\\tin Pl-CAN <395>; #205# required, metalloenzyme. The three amino acid \\n\\tresidues Asn73, Gln75 and Asn202, which constitute the triad involved \\n\\tin the network of hydrogen bonds with the zinc-coordinated water \\n\\tmolecule, are conserved in all the sequences of gamma-CA enzymes. The \\n\\tenzyme CpsCA trimer contains 3 active sites and each monomer \\n\\tcontributes His residues located on the surface to coordinate the \\n\\tZn(II) ion crucial for catalysis <359>; #195# required, metalloenzyme. \\n\\tThe zinc ion is coordinated by residues His299, His301 and Gln320 \\n\\t<362>; #201# required, zinc enzyme, one of the Zn2+-containing active \\n\\tsites might be located externally and the other one inside the cell. \\n\\tConserved histidine residues (His116, His118, His141) coordinate the \\n\\tZn2+-containing catalytic site <371>; #194# the conserved three \\n\\thistidines, His94, His96, and His119 (hCA I numbering system) \\n\\tcoordinate the Zn(II) ion that is crucial for catalysis <389>; #194# \\n\\tthe metalloenzyme, the Zn(II) ion is crucial for catalysis, the enzyme \\n\\tsequence contains the three His residues acting as zinc ligands <391>; \\n\\t#191# contains zinc ions <441>; #94# contains zinc. Zn2+ produces \\n\\tslight enhancement of activity <425>; #223# each subunit contains a \\n\\tzinc atom in the active site <420>; #232# either Mg or Zn can occupy \\n\\tthe active site <411>; #235# enhances the enzyme activity <427>; #28# \\n\\tthe enzyme contains one zinc ion per polypeptide chain <443>; #228# the \\n\\tenzyme contains three zinc-containing active sites <436>) \\n\\t<71,72,73,74,75,77,79,80,81,82,83,84,85,86,87,88,89,90,91,93,94,96,97,\\n\\t98,99,100,101,102,104,107,110,111,112,113,114,115,116,117,118,119,120,\\n\\t121,122,124,126,127,128,129,130,131,132,133,134,135,136,138,158,178,190,\\n\\t194,195,197,219,223,224,231,235,237,239,247,249,251,264,265,266,273,282,\\n\\t284,286,287,288,289,290,291,292,293,294,295,297,298,299,300,310,311,312,\\n\\t313,320,321,322,325,338,350,351,352,354,355,356,357,359,360,361,362,363,\\n\\t364,365,366,368,371,372,373,374,375,376,377,378,379,380,381,382,383,384,\\n\\t385,386,387,388,389,390,391,392,394,395,396,397,398,399,400,401,402,403,\\n\\t404,405,407,411,420,422,423,425,427,429,434,436,441,442,443,446>\\nME\\t#9,11,14,18,30,62,66,99,120,124,183,191# Co2+ (#66# when added back to \\n\\tthe apoenzyme in a 1:1 molar ratio or greater, the activity immediately \\n\\treturns to control level <9>; #18# the Co2+-enzyme shows a definite \\n\\tpropensity for five-coordination <41>; #30,99# can substitute for Zn2+ \\n\\t<85,107>; #14# Co2+ containing <110>; #14# cobalt is bound with a 1:1 \\n\\tstoichiometry <88>; #62# isomorphously replaces zinc <81>; #120# \\n\\tstrongly activating effect, Co2+ induces an increase in the kcat/Km \\n\\tvalue <223>; #11# 305% activity at 1 mM <264>; #9# preparation of a \\n\\tCo(II)-substituted HICA, Co-HICA. Co(II)-substituted HICA, Co-HICA, has \\n\\tcomparable, 20% enhanced kcat and 2.3fold increased Km/kcat compared to \\n\\tthat of the wild-type enzyme <288>; #124# removal of Zn2+ and \\n\\tpreparation of Co(II)-substituted carbonic anhydrase II, Co(II)-HCA II. \\n\\tChange in metal coordination from tetrahedral at pH 11.0 to a \\n\\tcoordination consistent with a mixed population of both tetrahedral and \\n\\tpenta-coordinate at pH 8.5 to an octahedral geometry characteristic of \\n\\tthe oxidized enzyme Co(III)-HCA II at pH 6.0 <286>; #183# stimulate \\n\\tactivity <325>; #191# activates the recombinant enzyme lacking the \\n\\tsignal peptide <404>; #62# activates to a 2fold activity compared to \\n\\tthe activity with Zn2+ <376>) \\n\\t<9,41,81,82,85,88,101,107,110,223,264,286,288,325,376,404>\\n\\nMOLECULAR_WEIGHT\\nMW\\t#1,30,77# 28000 (#1# equilibrium sedimentation <34>; #77# apparent \\n\\tmolecular mass, SDS-PAGE <269>; #30# x * 28000, SDS-PAGE <49>) \\n\\t<34,49,269>\\nMW\\t#1,5,12,14,16,18,21,22,23,24,48,59,71,72,81,119,124,133,167,173# 30000 \\n\\t(#5,48,71,72# gel filtration <6,24,35,61>; #59# SDS-PAGE <339>; #173# \\n\\tamino acid sequence <136>; #21# kidney, brain, liver, stomach, gel \\n\\tfiltration <17>; #14,133# Western blotting <118>; #1# 1 * 30000, \\n\\tSDS-PAGE <34>; #18,124# 1 * 30000 <73,74>; #1# x * 30000, carbonic \\n\\tanhydrase A, B and C, SDS-PAGE <22>; #5,16,18# x * 30000, SDS-PAGE \\n\\t<3,4,152>; #22,23# 6 * 30000, SDS-PAGE <33,39>; #24# 8 * 30000, \\n\\tcytosolic isoenzyme, SDS-PAGE <56>; #119# 2 * 30000, CA XII, SDS-PAGE \\n\\t<135>; #167# x * 30000, about, SDS-PAGE <300>) \\n\\t<3,4,6,17,22,24,33,34,35,39,56,61,72,73,74,97,118,135,136,152,300,339>\\nMW\\t#10# 38000 (#10# 2 * 4243 + 2 * 38000, carbonic anhydrase 2, SDS-PAGE \\n\\t<62>) <62>\\nMW\\t#10# 165000 (#10# native PAGE <14>) <14>\\nMW\\t#10# 40000 (#10# 2 * 40000, mature isozyme CAH8 <239>) <239>\\nMW\\t#10# 76000 (#10# carbonic anhydrase 1 <62>) <62>\\nMW\\t#10# 84500-87900 (#10# carbonic anhydrase 2, gel filtration <62>) <62>\\nMW\\t#10# 20700 (#10# x * 20700, calculation from nucleotide sequence <43>) \\n\\t<43>\\nMW\\t#10,62,99# 84000 (#99# gel filtration <160>; #62# authentic enzyme, gel \\n\\tfiltration <51>; #10# isoform CAH7, SDS-PAGE <239>) <51,160,239>\\nMW\\t#10,99# 80000 (#99# gel filtration <94>; #10# isoform CAH8, SDS-PAGE \\n\\t<239>) <94,239>\\nMW\\t#100,119# 60000 (#119# CA XII, gel filtration <135>; #100# Western blot \\n\\tanalysis, SDS-PAGE <137>) <135,137>\\nMW\\t#102# 28900 (#102# SDS-PAGE <128>) <128>\\nMW\\t#102# 284500 (#102# x * 284500, calculation from sequence <191>) <191>\\nMW\\t#102# 287600 (#102# x * 287600, SDS-PAGE <191>) <191>\\nMW\\t#103,178# 25100 (#103# mass spectrometry <71>; #178# calculated from \\n\\tcDNA <337>) <71,337>\\nMW\\t#104# 29900 (#104# SDS-PAGE <128>) <128>\\nMW\\t#11,126# 37000 (#11# SDS-PAGE <264>; #126# outer peripheral isoenzyme, \\n\\tgel filtration <176>) <176,264>\\nMW\\t#119# 30000-31000 (#119# CA XII, amino acid sequence, SDS-PAGE <135>) \\n\\t<135>\\nMW\\t#12# 29500 (#12# calculated from amino acid sequence, CA14x <119>) <119>\\nMW\\t#12,14# 44000 (#14# SDS-PAGE <133>; #12# SDS-PAGE, CA14x <119>) \\n\\t<119,133>\\nMW\\t#12,44# 120000 (#12# gel filtration, CA14x <119>; #44# apparent \\n\\tmolecular mass of the purified protein, gel filtration <272>) <119,272>\\nMW\\t#124# 29300 (#124# determined spectrophotometrically <84>; #124# 1 * \\n\\t29300 <80>) <80,84>\\nMW\\t#131# 202000 (#131# milk isoform CA VI, gel filtration <445>) <445>\\nMW\\t#131# 214000 (#131# saliva isoform CA VI, gel filtration <445>) <445>\\nMW\\t#14# 54000 (#14# isozyme CAIX migrates as a doublet of 54000 Da and \\n\\t58000 Da, SDS-PAGE <267>) <267>\\nMW\\t#14# 58000 (#14# isozyme CAIX migrates as a doublet of 54000 Da and \\n\\t58000 Da, SDS-PAGE <267>) <267>\\nMW\\t#14,123,126# 35000 (#123# SDS-PAGE <343>; #126# inner peripheral \\n\\tisoenzyme, gel filtration <176>; #14# x * 35000, calculation from amino \\n\\tacid composition <53>) <53,176,343>\\nMW\\t#14,126# 39000 (#126# integral isoenzyme, gel filtration <176>; #14# x \\n\\t* 39000, SDS-PAGE after partial digestion with glucosidase <2>) <2,176>\\nMW\\t#14,15# 42000 (#14# Western blot <134>; #15# plus additional minor \\n\\t36000 Da band, Western blot <134>; #14# x * 42000, SDS-PAGE <2>) <2,134>\\nMW\\t#15# 46000 (#15# x * 46000, SDS-PAGE <7>) <7>\\nMW\\t#15# 25700 (#15# kidney enzyme, equilibrium sedimentation <23>) <23>\\nMW\\t#15,18,21,41,44,51,58,122,127# 29000 (#21,41# SDS-PAGE <98,333>; #18# \\n\\tamino acid sequence <99>; #15# erythrocyte enzyme forms, gel filtration \\n\\t<23>; #58# subunit, SDS-PAGE <199>; #51,122# x * 29000, SDS-PAGE \\n\\t<190,308>; #127# 1 * 29000 <93>; #44# 4 * 29000, SDS-PAGE, the native \\n\\trecombinant enzyme is a homotetramer <272>) \\n\\t<23,93,98,99,190,199,272,308,333>\\nMW\\t#150# 36600 (#150# calculated from amino acid sequence <222>) <222>\\nMW\\t#164# 27200 (#164# calculated from amino acid sequence <273>) <273>\\nMW\\t#176# 62000 (#176# gel filtration <320>) <320>\\nMW\\t#176# 20000 (#176# 2 * 20000, SDS-PAGE <320>) <320>\\nMW\\t#179# 25900 (#179# calculated from cDNA <337>) <337>\\nMW\\t#18# 53000 (#18# x * 53000, SDS-PAGE <11>) <11>\\nMW\\t#18,21,126# 36000 (#18# gel filtration <248>; #126# cytosolic \\n\\tisoenzyme, gel filtration <176>; #21# x * 36000, SDS-PAGE after \\n\\tdeglycosylation with N-glycanase <1>) <1,176,248>\\nMW\\t#180# 33200 (#180# calculated from cDNA <331>) <331>\\nMW\\t#183,227# 59000 (#183# SDS-PAGE <325>; #227# truncated isoform LCIB3-C, \\n\\tcalculated from amino acid sequence <407>) <325,407>\\nMW\\t#197# 75000 (#197# about <374>) <374>\\nMW\\t#197# 79500 (#197# about, recombinant enzyme, gel filtration and native \\n\\tPAGE <367>) <367>\\nMW\\t#20# 90000 (#20# gel filtration <112>) <112>\\nMW\\t#20# 21000 (#20# 4 * 21000, SDS-PAGE, 4 * 18900, calculated on the \\n\\tbasis of the amino acid composition deduced from the nucleotide \\n\\tsequence <112>) <112>\\nMW\\t#20# 18900 (#20# 4 * 21000, SDS-PAGE, 4 * 18900, calculated on the \\n\\tbasis of the amino acid composition deduced from the nucleotide \\n\\tsequence <112>) <112>\\nMW\\t#200# 280000 (#200# recombinant enzyme CA VI-PTX, gel filtration, light \\n\\tscattering, and dynamic light scattering <399>) <399>\\nMW\\t#202# 66000 (#202# about, recombinant enzyme, ge filtration <350>) <350>\\nMW\\t#205# 55000 (#205# recombinant enzyme, native PAGE <359>) <359>\\nMW\\t#21# 540000 (#21# gel filtration <1>) <1>\\nMW\\t#21# 45000 (#21# x * 45000, SDS-PAGE <1>) <1>\\nMW\\t#21# 238000 (#21# gel filtration <17>) <17>\\nMW\\t#21,35,47,88,182# 34000 (#35,182# SDS-PAGE <342>; #21# carbonic \\n\\tanhydrase A, gel filtration <22>; #88# peptide sequence <83>; #47# 6 * \\n\\t34000, isoenzyme I, SDS-PAGE <26>) <22,26,83,342>\\nMW\\t#22# 212000 (#22# gel filtration <21>) <21>\\nMW\\t#22,65,177# 26000 (#65,177# SDS-PAGE <340,341>; #22# 8 * 26000, \\n\\tSDS-PAGE <21>) <21,340,341>\\nMW\\t#227# 380000 (#227# isoform LCIB3, calculated from amino acid sequence \\n\\t<407>) <407>\\nMW\\t#229# 39700 (#229# light scattering <434>) <434>\\nMW\\t#23# 160000 (#23# native PAGE <212>) <212>\\nMW\\t#23# 194000 (#23# gel filtration, meniscus depletion equilibrium \\n\\tsedimentation, analytical ultracentrifugation <39>) <39>\\nMW\\t#23# 24200 (#23# SDS-PAGE <75>) <75>\\nMW\\t#23,30,90,103,162,164# 25000 (#23,30,90,103,164# SDS-PAGE \\n\\t<71,212,241,265,273>; #162# 2 * 25000, SDS-PAGE <277>; #23# 8 * 25000, \\n\\tassembled as a dimer of dimers of dimers, crystallography <104>; #162# \\n\\tx * 25000, recombinant bsCA II, SDS-PAGE <298>) \\n\\t<71,104,212,241,265,273,277,298>\\nMW\\t#230# 44300 (#230# gel filtration <440>) <440>\\nMW\\t#231# 92000 (#231# gel filtration <442>) <442>\\nMW\\t#24# 255000 (#24# cytosolic isoenzyme, native PAGE <56>) <56>\\nMW\\t#24,173# 220000 (#173# gel filtration <136>; #24# chloroplastic \\n\\tisoenzyme, native PAGE <56>) <56,136>\\nMW\\t#24,46,48,58# 27000 (#58# gel filtration <177>; #48# sucrose density \\n\\tgradient centrifugation <6>; #46# x * 27000, SDS-PAGE <12>; #24# x * \\n\\t27000 + x * 27500, chloroplastic isoenzyme, the two subunits are \\n\\tidentical, except that the 27000 Da subunit is three amino acids \\n\\tshorter than the 27500 Da subunit, SDS-PAGE <56>) <6,12,56,177>\\nMW\\t#24,58,70# 27500 (#70# gel filtration <32>; #24# x * 27000 + x * 27500, \\n\\tchloroplastic isoenzyme, the two subunits are identical, except that \\n\\tthe 27000 Da subunit is three amino acids shorter than the 27500 Da \\n\\tsubunit, SDS-PAGE <56>; #58# 1 * 27500, SDS-PAGE <177>) <32,56,177>\\nMW\\t#29,67# 28500 (#29,67# gel filtration <16,30>) <16,30>\\nMW\\t#30# 28085 (#30# x * 28085, a 26-residue signal peptide is cleaved off \\n\\tby the Escherichia coli processing machinery, thus the recombinant \\n\\tenzyme has a MW of 26314 Da, calculation from nucleotide sequence <49>) \\n\\t<49>\\nMW\\t#41# 28280 (#41# amino acid sequence <98>) <98>\\nMW\\t#43# 94000 (#43# gel filtration <282>) <282>\\nMW\\t#43,58# 31000 (#58# native enzyme, gel filtration <246>; #43# 3 * \\n\\t31000, calculated from the log plot obtained from the relative mobility \\n\\tof the standard proteins in SDS-PAGE <282>) <246,282>\\nMW\\t#47# 195000 (#47# isoenzyme I, gel filtration <26>) <26>\\nMW\\t#48# 14000 (#48# 2 * 14000, SDS-PAGE <6>) <6>\\nMW\\t#52# 88000 (#52# gel filtration, tetramer <338>) <338>\\nMW\\t#52# 23000 (#52# SDS-PAGE <338>) <338>\\nMW\\t#55,120,194# 50000 (#194# native enzyme, native PAGE <391>; #55# 2 * \\n\\t50000, SDS-PAGE <55>; #120# isolated recombinant detagged PG domain \\n\\t(PG(38-136)), gel filtration, the high retention volume observed is a \\n\\tconsequence of a non-globular structure, PG(38-136) has an hydrodynamic \\n\\tdimension typical of IDPs <364>) <55,364,391>\\nMW\\t#58# 27300 (#58# native enzyme, estimated by gel filtration <199>) <199>\\nMW\\t#58# 29400 (#58# SDS-PAGE <246>) <246>\\nMW\\t#62# 70000 (#62# gel filtration <86>; #62# apo-Cam and Co-Cam, gel \\n\\tfiltration <81>) <81,86>\\nMW\\t#62# 74000 (#62# recombinant enzyme, gel filtration <51>; #62# Cam and \\n\\tZn-Cam, gel filtration <81>) <51,81>\\nMW\\t#62,99# 22900 (#62# or tetramer, 3 * or 4 * 22900, calculation from \\n\\tnucleotide sequence <51>; #62# or trimer, 3 * or 4 * 22900, calculation \\n\\tfrom nucleotide sequence <51>; #99# 4 * 22900, calculation from \\n\\tnucleotide sequence <160>) <51,160>\\nMW\\t#62,99# 22873 (#62# 3 * 22873, determined by measuring A280S of protein \\n\\tsolution <86>; #99# 3 * 22873, measuring A280 value of protein solution \\n\\t<94>) <86,94>\\nMW\\t#63,88# 32300 (#63,88# calculated from cDNA <330,334>) <330,334>\\nMW\\t#64# 32119 (#64# x * 32119, calculation from amino acid composition \\n\\t<66>) <66>\\nMW\\t#66# 30700 (#66# gel filtration <9>) <9>\\nMW\\t#66# 28200 (#66# 1 * 28200, carbonic anhydrase A, SDS-PAGE <9>) <9>\\nMW\\t#68# 205000 (#68# gel filtration <63>) <63>\\nMW\\t#68# 24800 (#68# 8 * 24800, calculation from nucleotide sequence <63>) \\n\\t<63>\\nMW\\t#71# 28600 (#71# equilibrium sedimentation <35>) <35>\\nMW\\t#73# 80500 (#73# native PAGE <54>) <54>\\nMW\\t#80# 30200 (#80# x * 30200, SDS-PAGE <306>) <306>\\nMW\\t#9,55# 100000 (#55# native PAGE <55>; #9# about, recombinant Co-HICA, \\n\\tgel filtration <288>) <55,288>\\nMW\\t#92# 31200 (#92# SDS-PAGE <128>) <128>\\n\\nPOSTTRANSLATIONAL_MODIFICATION\\nPM\\t#12,14,15,118,131,172,197,200,209,210# glycoprotein (#12# \\n\\tN-glycosylated <175>; #14# CAIX exists predominantly as a dimeric, \\n\\thigh-mannose N-linked glycoprotein <291>; #118# CA XIV is a \\n\\tmembrane-associated glycoprotein <381>; #200# four potentially \\n\\tN-glycosylated Asn residues (in the motif Asn-X-Ser/Thr) are all on the \\n\\tsurface of the monomer <399>; #210# isozyme CA VI contains three \\n\\tpotential N-linked glycosylation sites <373>; #209# the HcCA3 isozyme \\n\\tcontains four N-glycosylation sites: Asn37, Asn44, Asn195, and Asn253 \\n\\t<372>; #197# the recombinant enzyme BhCA expressed in Pichia pastoris \\n\\tstrain GS115 is a glycosylated protein. rBhCA possesses two potential \\n\\tN-glycosylation sites and many O-glycosylation sites. Enzyme \\n\\tdeglycosylation by endoglycosylase H <367>; #131# the enzyme has two \\n\\tputative N-glycosylation sites at Asn67 and Asn256. The attached \\n\\tglycans in milk isoform CA VI are di- and triantennary complex-type \\n\\tglycans, carrying both a core fucose and 1 to 2 additional fucose \\n\\tunits, whereas the glycans in salivary isoform CA VI are smaller <445>) \\n\\t<79,119,133,134,139,175,291,367,372,373,381,399,435,445>\\nPM\\t#14# acetylation <435>\\nPM\\t#14# glutathionylation <435>\\nPM\\t#14# methylation <435>\\nPM\\t#14# ubiquitination <435>\\nPM\\t#14# S-nitrosylation <435>\\nPM\\t#14,15,18,21,55,64,102# side-chain modification (#14,21,55# \\n\\tglycoprotein <1,2,55>; #15# high mannose oligosaccharides <7>; #18# at \\n\\tleast 20% carbohydrate, contains glucosamine, galactose and sialic acid \\n\\t<11>; #55# glycosylated in an Asn-linked manner <55>; #14# N-linked \\n\\toligosaccharides of the complex type <2>; #64# glycoprotein with one \\n\\tN-linked oligosaccharide chains, the enzyme is anchored to membrane \\n\\tsurface by a phosphatidylinositol-glycan linkage <66>; #14# \\n\\tphospholipid anchor may be acting both as an extracellular tether and \\n\\tas a protein activator <70>; #102# glutathione binding to Cys residues \\n\\tmay have a role in the defence against oxidative damage. \\n\\tS-glutathionylation does not have any effect on the anhydrase activity \\n\\tof Ice-CA <191>) <1,2,7,11,45,55,66,70,191>\\nPM\\t#14,209# phosphoprotein (#14# CAIX tyrosine phosphorylation in the \\n\\tcytoplasmic domain. EGF induces CAIX translocation to lipid rafts but \\n\\tnot its phosphorylation <291>; #209# the HcCA3 isozyme contains five \\n\\tKinasePhos sites: Tyr24, Ser25, Ser220, Thr236, Thr249 and Ser343 \\n\\t<372>) <291,372,435>\\nPM\\t#14,210# more (#14# contains no N-linked or O-linked oligosaccharides \\n\\t<53>; #14# carbonic anhydrase IV lacks carbohydrate <45>; #210# two \\n\\tcysteine residues, Cys28 and Cys209, that are likely to form one \\n\\tdisulfide bond, are present in pufferfish CA VI <373>; #14# disulfide \\n\\tformation <435>) <45,53,373,435>\\nPM\\t#23,30,62,79,211# proteolytic modification (#62# the discrepancy in \\n\\tmolecular weight between the recombinant and the authentic enzyme \\n\\tsuggests that the carbonic anhydrase is posttranslationally modified in \\n\\teither E. coli or Methanobacterium thermophilum <51>; #30# a 26-residue \\n\\tsignal peptide is cleaved off by the E. coli processing machinery <49>; \\n\\t#23# precursor OEC33 has a MW of 41000 Da, mature enzyme has a MW of \\n\\t33000 Da <155>; #79# ptca1 cDNA possesses a presequence of 138 bp \\n\\t(pre138), which encodes 46 N-terminal amino acids (Pre46AA) that does \\n\\tnot occur in the mature PtCA1. Pre46AA is relatively rich in \\n\\thydrophobic amino acids and functions as a sorting signal for PtCA1 \\n\\t<156>; #211# a signal peptide of 21 amino acids is identified at the \\n\\tN-terminal of the protein (MNAYILLSLTTLTVLYQECLG), followed by a \\n\\tcleavage site between the G21 and A22 residues, suggesting that Pl-CAN \\n\\tis a secreted protein <395>) <49,51,155,156,395>\\n\\nSUBUNITS\\nSU\\t#1,18,21,58,66,81,124,127,194# monomer (#1# 1 * 30000, SDS-PAGE <34>; \\n\\t#18,124# 1 * 30000 <73,74>; #21# 1 * 34000, SDS-PAGE <22>; #66# 1 * \\n\\t28200, carbonic anhydrase A, SDS-PAGE <9>; #58# 1 * 27500, SDS-PAGE \\n\\t<177>; #127# 1 * 29000 <93>; #124# 1 * 29300 <80>; #194# 1 * 32000, \\n\\trecombinant enzyme, SDS-PAGE <389>) <9,22,34,73,74,80,93,158,177,389>\\nSU\\t#1,5,10,14,15,16,18,21,30,38,46,51,64,80,85,94,96,97,102,118,120,122,\\n\\t124,129,132,144,162,167,168,169,192,195,198,201,207,208,209,211,219,222,\\n\\t227,232,234,235,236,237,238# ? (#96,234# x * 35000, SDS-PAGE <423,424>; \\n\\t#18# x * 53000, SDS-PAGE <11>; #46,192,237# x * 27000, SDS-PAGE \\n\\t<12,428,429>; #14# x * 42000, SDS-PAGE <2>; #207# x * 70000, SDS-PAGE \\n\\t<444>; #21,132# x * 45000, SDS-PAGE <1,418>; #30# x * 28000, SDS-PAGE \\n\\t<49>; #238# x * 26000, SDS-PAGE <438>; #15# x * 46000, SDS-PAGE <7>; \\n\\t#38# x * 32000, SDS-PAGE <390>; #21# x * 36000, SDS-PAGE after \\n\\tdeglycosylation with N-glycanase <1>; #14# x * 39000, SDS-PAGE after \\n\\tpartial digestion with glucosidase <2>; #10# x * 20700, calculation \\n\\tfrom nucleotide sequence <43>; #1# x * 30000, carbonic anhydrase A, B \\n\\tand C, SDS-PAGE <22>; #30# x * 28085, a 26-residue signal peptide is \\n\\tcleaved off by the Escherichia coli processing machinery, thus the \\n\\trecombinant enzyme has a MW of 26314 Da, calculation from nucleotide \\n\\tsequence <49>; #14# x * 35000, calculation from amino acid composition \\n\\t<53>; #64# x * 32119, calculation from amino acid composition <66>; \\n\\t#5,16,18,97# x * 30000, SDS-PAGE <3,4,152,439>; #232# x * 20000, \\n\\tSDS-PAGE <411>; #51,94,122# x * 29000, SDS-PAGE <190,308,425>; #85# x * \\n\\t24300, SDS-PAGE <408>; #236# x * 27200, SDS-PAGE <429>; #124# x * \\n\\t29000, recombinant enzyme, SDS-PAGE <375>; #102# x * 284500, \\n\\tcalculation from sequence <191>; #102# x * 287600, SDS-PAGE <191>; \\n\\t#167# x * 30000, about, SDS-PAGE <300>; #162# x * 25000, recombinant \\n\\tbsCA II, SDS-PAGE <298>; #80# x * 30200, SDS-PAGE <306>; #168# x * \\n\\t30294.62, isozyme LjCAA1, sequence calculation <292>; #169# x * \\n\\t30740.77, isozyme LjCAA2, sequence calculation <292>; #120# x * 20000, \\n\\tabout, isolated recombinant detagged PG domain (PG(38-136)), SDS-PAGE \\n\\t<364>; #198# x * 24950, sequence calculation, x * 25000, recombinant \\n\\tHis-tagged enzyme, SDS-PAGE <384>; #208# x * 26000, about, recombinant \\n\\toptimized enzyme without signal peptide, SDS-PAGE, x * 25715, sequence \\n\\tcalculation <363>; #21# x * 28890, SDS-PAGE <380>; #201# x * 29600, \\n\\tabout, sequence calculation <401>; #219# x * 29710, SDS-PAGE <368>; \\n\\t#222# x * 29900, SDS-PAGE <377>; #129# x * 30000, recombinant enzyme \\n\\tincuding signal peptide, SDS-PAGE <349>; #209# x * 36690, isozyme CA3, \\n\\tsequence calculation, x * 40000, SDS-PAGE <372>; #118# x * 37670, \\n\\trecombinant His-tagged enzyme, SDS-PAGE, x * 31998, sequence \\n\\tcalculation  <381>; #195# x * 42300, about, enzyme PfCAdom, sequence \\n\\tcalculation <388>; #211# x * 48500, recombinant premature enzyme, \\n\\tSDS-PAGE, x * 46200, recombinant mature enzyme, SDS-PAGE <395>; #201# x \\n\\t* 66700, about, sequence calculation <371>; #235# x * 25000, isoform \\n\\tgamma-CA, SDS-PAGE <427>; #96# x * 25700, premature protein, calculated \\n\\tfrom amino acid sequence <423>; #235# x * 27000, isoform beta-CA, \\n\\tSDS-PAGE <427>; #144# x * 27800, isoform CA II, calculated from \\n\\tSDS-PAGE <426>; #227# x * 28000, isoform LCIB4, SDS-PAGE <407>; #144# x \\n\\t* 28400, isoform CA I, calculated from SDS-PAGE <426>; #227# x * 28800, \\n\\tisoform LCIB4, calculated from amino acid sequence <407>; #132# x * \\n\\t46770, calculated from amino acid sequence <418>) \\n\\t<1,2,3,4,7,11,12,22,43,49,53,66,152,190,191,292,298,300,306,308,349,363,\\n\\t364,368,371,372,375,377,380,381,384,388,390,395,401,407,408,411,418,423,\\n\\t424,425,426,427,428,429,438,439,444>\\nSU\\t#10,56,162,163,191,197,207,227,229,230,233# homodimer (#229# 2 * 20000, \\n\\tSDS-PAGE <434>; #162# 2 * 25000, SDS-PAGE <277>; #163,191,233# x-ray \\n\\tcrystallography <266,419,441>; #10# 2 * 40000, mature isozyme CAH8 \\n\\t<239>; #197# 2 * 39500, recombinant glycosylated enzyme, SDS-PAGE, 2 * \\n\\t37500, recombinant deglycosylated enzyme, SDS-PAGE <367>; #207# SazCA \\n\\tenzyme three-dimensional structure determination and analysis, \\n\\tstructure comparison with the enzyme from Sulfurihydrogenibium \\n\\tyellowstonensis, PDB ID 4G7A. The SazCA monomer adopts the canonical \\n\\tfold of the alpha-CA family members consisting of a central \\n\\tten-stranded beta-sheet surrounded by alpha- and 310-helices as well as \\n\\tsmall additional beta-sheets. The active site of each monomer within \\n\\tthe dimer is completely accessible to the solvent and, as observed for \\n\\tother alpha-CAs, is located in a cavity which extends from the surface \\n\\tto the center of the protein <360>; #230# 2 * 20300, gel filtration \\n\\twith light scattering analysis <440>; #227# 2 * 27000, truncated \\n\\tisoform LCIB3-C, calculated from amino acid sequence <407>) \\n\\t<115,239,266,277,360,367,374,404,407,419,434,440,441>\\nSU\\t#12# multimer (#12# x * 29500, amino acid sequence, CA14x, x * 44000, \\n\\tSDS-PAGE, CA14x <119>) <119>\\nSU\\t#173# oligomer (#173# 6-8 * 30000, SDS-PAGE <136>) <136>\\nSU\\t#176# heterotrimer (#176# 2 * 20000, SDS-PAGE <320>) <320>\\nSU\\t#194# monomer or dimer (#194# x * 50000, native enzyme, SDS-PAGE <389>; \\n\\t#194# x * 50000, native enzyme, SDS-PAGE, x * 26000, about, sequence \\n\\tcalculation <391>) <389,391>\\nSU\\t#200# pentamer (#200# 5 * 58600, recombinant enzyme CA VI-PTX, \\n\\tSDS-PAGE, 5 * 58107, enzyme sequence without glycans and signal peptide \\n\\texcluded, sequence calculation <399>) <399>\\nSU\\t#22,23,24,68,105# octamer (#22# 8 * 26000, SDS-PAGE <21>; #68# 8 * \\n\\t24800, calculation from nucleotide sequence <63>; #24# x * 27000 + x * \\n\\t27500, chloroplastic isoenzyme, the two subunits are identical, except \\n\\tthat the 27000 Da subunit is three amino acids shorter than the 27500 \\n\\tDa subunit, SDS-PAGE <56>; #24# 8 * 30000, cytosolic isoenzyme, \\n\\tSDS-PAGE <56>; #23# 8 * 25000, assembled as a dimer of dimers of \\n\\tdimers, crystallography <104>) <21,56,63,104,113>\\nSU\\t#22,23,47,48,131,203# hexamer (#131# 6 * 37000, SDS-PAGE <445>; #48# 6 \\n\\t* 27000, SDS-PAGE <6>; #47# 6 * 34000, isoenzyme I, SDS-PAGE <26>; \\n\\t#22,23# 6 * 30000, SDS-PAGE <33,39>; #203# enzyme CcaA shows a \\n\\twellpacked trimer-of-dimers organization. The proximal part of the \\n\\tcharacteristic C-terminal extension is ordered by binding at a site \\n\\tthat passes through the two-fold symmetry axis shared with an adjacent \\n\\tdimer, as a result, only one of a pair of converging termini can be \\n\\tordered at any given time. beta-CA structures are organized around a \\n\\ttight, catalytic dimer. The catalytic site of CcaA is located at the \\n\\tinterface between two protomers, with the zinc ion bound to Cys39, \\n\\tHis98, and Cys101. A water molecule forms the fourth zinc ligand at pH \\n\\t4.5 <355>; #131# 6 * 33570, calculated from amino acid sequence <445>) \\n\\t<6,26,33,39,355,445>\\nSU\\t#227# homooctamer (#227# 8 * 48100, isoform LCIB3, calculated from \\n\\tamino acid sequence <407>; #227# 8 * 50000, isoform LCIB3, SDS-PAGE \\n\\t<407>) <407>\\nSU\\t#43,62,205,228# homotrimer (#43# 3 * 31000, calculated from the log \\n\\tplot obtained from the relative mobility of the standard proteins in \\n\\tSDS-PAGE <282>; #205# 3 * 20000, recombinant enzyme, SDS-PAGE <359>; \\n\\t#228# 3 * 32400, His-tagged enzyme, calculated from amino acid sequence \\n\\t<436>; #228# 3 * 33000, His-tagged enzyme, SDS-PAGE <436>) \\n\\t<282,322,359,436>\\nSU\\t#44,106,223,231# homotetramer (#44# 4 * 29000, SDS-PAGE, the native \\n\\trecombinant enzyme is a homotetramer <272>; #231# 4 * 23000, calculated \\n\\tfrom amino acid sequence <442>; #106# 4 * 55000-59000, SDS-PAGE <419>) \\n\\t<272,419,420,442>\\nSU\\t#6,10,14,20,48,53,55,119,185,188,202,212,218# dimer (#55# 2 * 50000, \\n\\tSDS-PAGE <55>; #48# 2 * 14000, SDS-PAGE <6>; #53# x-ray crystallography \\n\\t<231>; #119# 2 * 30000, CA XII, SDS-PAGE <135>; #14# two catalytic \\n\\tdomains of CA IX associate to form a dimer, which is stabilized by the \\n\\tformation of an intermolecular disulfide bond <251>; #14# 2 * \\n\\t54000-58000, SDS-PAGE <291>; #6# dynamic light scattering analysis and \\n\\tgel filtration <303>; #10# most alphaCA enzymes are monomeric, but \\n\\talphaCA1 from Chlamydomonas reinhardtii is a dimer that is uniquely \\n\\tstabilized by disulfide bonds, crystal structure determination and \\n\\tanalysis <284>; #202# 2 * 33000, recombinant enzyme, SDS-PAGE <350>; \\n\\t#212# beta-CAs act as dimeric structures <398>; #188# enzyme Cab is a \\n\\tdimer with the typical alpha/beta fold of beta-CAs. The two monomers \\n\\twithin the dimer are related by a 2fold axis and their structure \\n\\tconsists of a central beta-sheet core composed of five strands. Upon \\n\\tdimer formation, an extended beta-sheet core encompassing the entire \\n\\tdimer is formed. Several alpha-helices pack onto this beta-structural \\n\\tmotif, resulting in a large interface area between the two enzyme \\n\\tsubunits <376>; #218# enzyme CrCAH3 is a dimer at pH 4.1 that is \\n\\tstabilized by swapping of the N-terminal arms, a feature not previously \\n\\tobserved in alpha-type carbonic anhydrases <403>; #185# enzyme SspCA \\n\\tforms a dimer characterized by a large interface area and stabilized by \\n\\tseveral polar and hydrophobic interactions <376>) \\n\\t<6,55,116,135,231,251,284,291,303,350,376,398,403>\\nSU\\t#62,73,99# trimer (#62# or tetramer, 3 * or 4 * 22900, calculation from \\n\\tnucleotide sequence <51>; #62# 3 * 22873, determined by measuring A280S \\n\\tof protein solution <86>; #99# 3 * 22873, measuring A280 value of \\n\\tprotein solution <94>) <51,54,86,94>\\nSU\\t#9,10,20,52,62,99,101,103,178,179# tetramer (#178,179# crystal \\n\\tstructure <337>; #10# 2 * 4243 + 2 * 38000, carbonic anhydrase 2, \\n\\tSDS-PAGE <62>; #10# 2 * 4144 + 2 * 35000-36500, carbonic anhydrase 1 \\n\\t<62>; #62# or trimer, 3 * or 4 * 22900, calculation from nucleotide \\n\\tsequence <51>; #20# 4 * 21000, SDS-PAGE, 4 * 18900, calculated on the \\n\\tbasis of the amino acid composition deduced from the nucleotide \\n\\tsequence <112>; #99# 4 * 22900, calculation from nucleotide sequence \\n\\t<160>; #9# recombinant Co-HICA, the crystal structure shows a \\n\\tfour-coordinate geometry for Co-HICA with pH-dependent changes in the \\n\\tabsorption spectrum of Co-HICA, overview <288>; #52# 4 * 23000, gel \\n\\tfiltration <338>) <51,62,112,113,138,160,288,337,338>\\nSU\\t#9,14,118,120,124,129,162,166,168,169,172,185,188,194,197,202,204,205,\\n\\t210,211,218# More (#172# in SDS-PAGE the enzyme migrates as a 66000 Da \\n\\tdisulfide-linked dimer, which turnes into a 31000 Da monomer upon \\n\\treduction with DTT <139>; #168,169# molecular modeling, overview <292>; \\n\\t#162# bsCA II shows pH-dependent closed or open conformation, overview \\n\\t<298>; #9# overall secondary and tertiary structure of Co-HICA differ \\n\\tfrom wild-type Zn-enzyme structure, active R-state and inactive T-state \\n\\tconformations, overview <288>; #14# the active form of CAIX in the \\n\\tMDA-MB-231 breast cancer cell line is dimeric but that neither lipid \\n\\traft localization nor phosphorylation are likely required for its \\n\\tdimerization or activity <291>; #166# the studied anion binding site \\n\\talong the dimerization interface of HICA is an escort site that \\n\\trepresents an intermediate along the ingress/egress route of \\n\\tbicarbonate ion to/from the allosteric binding site, overview. Type II \\n\\tbeta-CAs can also adopt an active, R-state conformation in which Asp44 \\n\\tpairs with Arg46, allowing the coordination of the catalytically \\n\\tessential water molecule to the active site zinc ion. The noncatalytic \\n\\tbicarbonate ion stabilizes the inactive T state <289>; #118# CA XIV is \\n\\ta membrane-associated glycoprotein composed of an extracellular \\n\\tcatalytic domain, a single transmembrane helix, and a short \\n\\tintracellular polypeptide chain. The protein has two cysteine residues \\n\\tthat form a disulfide bond for the stabilization of CA XIV structure \\n\\tand one N-glycosylation site <381>; #204# CcmM is built as two distinct \\n\\tregions, the C-terminal region of CcmM consists of three to five \\n\\trepeats of a RubisCO small subunit-like domain, separated by flexible \\n\\tlinker regions. This region binds RubisCO. The N-terminal domain is \\n\\tclearly homologous to gamma-CAs, but in at least some strains, \\n\\tincluding Synechocystis sp. PCC 6803 and Synechococcus sp. PCC 7942, \\n\\tthis domain lacks measurable CA activity. CcmMs N-terminal domain is \\n\\ttrimeric. The C-terminal end of the eta-helix is dominated by the \\n\\tprotruding alphaA helix and the alphaA-alphaB loop <355>; #205# \\n\\tcross-sectional profiles of the gamma-CA trimer reveal that each \\n\\tmonomer resembles an equilateral triangle, which is stabilized by \\n\\thydrogen bonds, salt bridges and hydrophobic interactions. The trimer \\n\\tcontains 3 active sites and each monomer contributes His residues \\n\\tlocated on the surface to coordinate the Zn(II) ion crucial for \\n\\tcatalysis <359>; #218# each unit cell is comprised of four dimers of \\n\\tCrCAH3 <403>; #188# enzyme Cab shows significant structural differences \\n\\twith respect to the other enzymes of beta-class in the N-terminus, \\n\\tC-terminus and in the region encompassing residues 90-125. Moreover, it \\n\\tpresents a less extended C-terminal region, being the smallest beta-CA \\n\\tso far characterized <376>; #211# in addition to the alpha-type \\n\\tCA-specific domain, the enzyme has a glycine-rich region at the \\n\\tN-terminal of the molecule functional domains <395>; #124# isozyme \\n\\tHCAII is a beta-sheet dominated monomeric protein of 259 aminoacid \\n\\tresidues. The far-UV CD is used to characterize the intermediate states \\n\\t(XI and XII) for secondary structural content, near-UV CD for tertiary \\n\\tstructure, dynamic light scatteringfor hydrodynamic radius and ANS \\n\\tfluorescence spectroscopy for the presence of exposed hydrophobic \\n\\tpatches. Stable intermediates XI and XII populations of intermediates \\n\\tare prepared by urea-derived protein denaturation at around 2 and 4 M \\n\\turea, respectively. Urea-induced XI state has characteristics ofmolten \\n\\tglobule state while XII state bears characteristics features of \\n\\tpre-molten globule state, overview <375>; #129# peptide mass finger \\n\\tprints by tryptic digestion and mass spectrometry. Secondary structure \\n\\tof enzyme CAVA is measured using circular dichroism. The secondary \\n\\tstructural contents for the native CAVA include 20.2% alpha-helix, \\n\\t29.1% beta-sheet and 50.7% random coil, while the renatured CAVA has \\n\\t21.7% alpha-helix, 27.2% beta-sheet, and 51.3% random coil, and the \\n\\tdenatured CAVA has 15.3% alpha-helix, 21.7% beta-sheet, and 63% random \\n\\tcoil <349>; #194# primary structure analysis <391>; #124# secondary \\n\\tstructure stability of wild-type and mutant enzymes in SDS, overview \\n\\t<397>; #197# structural secondary composition of rBhCA at different pH \\n\\tvalues, overview <374>; #185# the alpha-CA presents a fold \\n\\tcharacterized by a central ten-stranded beta-sheet surrounded by \\n\\tseveral helices and additional beta-strands. The active site is found \\n\\tin a deep conical cavity which extends from the protein surface to the \\n\\tcenter of the molecule, with the catalytic zinc ion positioned at the \\n\\tbottom of this cavity <376>; #202# the dimeric enzyme TcruCA has a \\n\\thighly conserved yet compact structure compared with other alpha-CAs, \\n\\tinterface structure, structure comparisons, detailed overview. The \\n\\tTcruCA monomer has the signature secondary structure typical of an \\n\\talpha-CA fold, with helical and loop structures present towards the \\n\\tsurface and a conical active-site cavity comprised of mostly \\n\\tbeta-structure <350>; #120# the extracellular region of the isozyme \\n\\tconsists of the catalytic CA domain and the proteoglycan-like (PG) \\n\\tdomain, PG domain structure determination and analysis, overview. The \\n\\tisolated PG domain belongs to the family of intrinsically disordered \\n\\tproteins, being globally unfolded with only some local residual \\n\\tpolyproline II secondary structure, it shows conformational \\n\\tflexibility. Primary sequence analysis of the PG(38-136) protein, \\n\\tpeptide analysis by gel filtration, NMR spectroscopy, and dynamic light \\n\\tscattering, modelling and molecular dynamics studies, overview <364>; \\n\\t#210# three-dimensional homology structure modeling of carbonic \\n\\tanhydrase VI, overview <373>) \\n\\t<139,288,289,291,292,298,349,350,355,359,364,373,374,375,376,381,391,\\n\\t395,397,403>\\n\\nPI_VALUE\\nPI\\t#102# -999 (#102# isoelectric focusing of native Ice-CA shows three \\n\\tbands in correspondence to pI 5.5, 5.1 and 4.8 <191>) <191>\\nPI\\t#11# 6.1 (#11# isoelectric focusing <264>) <264>\\nPI\\t#14# 7.9 (#14# untreated enzyme, isoelectric focusing <211>) <211>\\nPI\\t#168# 9.05 (#168# isozyme LjCAA1, sequence calculation <292>) <292>\\nPI\\t#169# 6.63 (#169# isozyme LjCAA2, sequence calculation <292>) <292>\\nPI\\t#209# 5.92 (#209# sequence calculation <372>) <372>\\nPI\\t#211# 6.83 (#211# sequence calculation <395>) <395>\\nPI\\t#41# 8.8 (#41# calculated from amino acid composition <98>) <98>\\nPI\\t#41# 9 (#41# isoelectric focusing <98>) <98>\\nPI\\t#51# 8.41 <190>\\nPI\\t#96# 5.7 (#96# calculated from amino acid sequence <423>) <423>\\nPI\\t#99# 4 (#99# calculation from nucleotide sequence <160>) <160>\\n\\nAPPLICATION\\nAP\\t#127,197# more (#197# carbonic anhydrase is a biocatalyst that \\n\\tcatalyzes the hydration of CO2 to bicarbonate and protons, thus useful \\n\\tin mitigating green house effect by sequestering CO2 from various point \\n\\tsources <374>; #127# immobilized hCA I on the magnetic nanoparticles \\n\\thas high operational stability and magnetic recovery which is desirable \\n\\tfor biotechnological applications <405>) <374,405>\\nAP\\t#14# pharmacology (#14# extensively investigated enzyme as a target for \\n\\tdrug design <121>) <121>\\nAP\\t#14# diagnostics (#14# activity of carbonic anhydrase is significantly \\n\\tlower in patients with renal cell carcinoma than in controls. The \\n\\tmarker carbonic anhydrase might be potentially important as an \\n\\tadditional biochemical tool for diagnosing renal cell carcinoma <406>) \\n\\t<406>\\nAP\\t#14,39,120,124# medicine (#14# design of novel antitumor properties, \\n\\tmainly for hypoxic tumors that overexpress CA IX <131>; #14# \\n\\toverexpressed on cell surfaces of certain cancers, potential target for \\n\\tchemotherapeutic agents <133>; #124# relevance for the drug design of \\n\\tnovel CA inhibitors, intersting pharmacological applications <130>; \\n\\t#39# there are amino acid differences in the active site of AaCA1 of \\n\\tAedes aegypti and human carbonic anhydrases. Terefore this enzyme could \\n\\tbe a potential drug target of selective carbonic anhydrase inhibitors \\n\\tfor the control of mosquito populations and the pathogens they carry \\n\\t<165>; #120# CA IX is a marker of tumor hypoxia and a prognostic factor \\n\\tin several human cancers, inhibition of this enzyme shows antitumor \\n\\tactivity both in vitro and in vivo <280>; #14# isoform CA IX is used as \\n\\ta marker of tumor hypoxia and as a prognostic factor for many human \\n\\tcancers <251>; #14# isozyme CAIX is a marker for hypoxic tumors and is \\n\\tcorrelated with poor prognosis in breast cancer patients <267>; #14# \\n\\tcarbonic anhydrase inhibitors are clinically used to treat epilepsy, \\n\\tschizophrenia, and bipolar disorder <430>) \\n\\t<130,131,133,165,251,267,280,430>\\nAP\\t#18,34,43,62,83,124,145,181,184,185,186,187,188,189,190,191,192,193,\\n\\t208# environmental protection (#18,34,43,83# the enzyme can be useful \\n\\tin biomimetic sequestration of CO2 into CaCO3 as a biological catalyst \\n\\t<309>; #145# carbon dioxide absorption into carbonate solutions, \\n\\tpromoted by the enzyme carbonic anhydrase, is proposed as potential \\n\\ttechnology for CO2 capture. The use of solid CA-based biocat-alysts \\n\\tallows the enzyme recovery and reuse under continuous operating \\n\\tconditions typical of industrial applications <354>; #208# recombinant \\n\\tengineered mASCA enzyme exhibits high production yield and sufficient \\n\\tstabilities against relatively high temperature and alkaline pH, which \\n\\tare required conditions for the development of more efficient enzymatic \\n\\tCCS systems. Carbon capture and storage (CCS) is a technology that can \\n\\tcapture up to 90% of the carbon dioxide (CO2) emissions produced from \\n\\tthe use of fossil fuels in electricity generation and industrial \\n\\tprocesses, preventing the carbon dioxide from entering the atmosphere. \\n\\tmASCA has the potential to play an important role in CCS systems, \\n\\tparticularly in an enzyme-based CO2 capture system that requires large \\n\\tamounts of CA enzyme <363>; \\n\\t#62,124,181,184,185,186,187,188,189,190,191,192,193# the enzyme is \\n\\tuseful to capture CO2 from flue gas in bio-mimetic CO2 capture systems \\n\\tto reduce the concentration of CO2 in the atmosphere, method \\n\\ttechnology, overview <376>) <309,354,363,376>\\nAP\\t#181# industry (#181# a green and low-cost removal method for cyanate, \\n\\ta toxic byproduct from the treatment of cyanide. Cyanase converts \\n\\tcyanate to CO2 and NH3, but its industrial practicality is limited \\n\\tbecause the reaction requires HCO3- as a substrate. Carbonic anhydrase \\n\\tfrom Sulfurihydrogenibium azorense and cyanase from Thermomyces \\n\\tlanuginosus are purified by one-step heating without prior cell lysis. \\n\\tThe heat treatment results in higher activities of both enzymes than \\n\\tthe conventional two-step process <421>) <421>\\nAP\\t#22,136# analysis (#22# carbonic anhydrase assay based on membrane \\n\\tinlet mass spectrometry. A quantitative assessment of the carbonic \\n\\tanhydrase activity in photosystem II <164>; #136# carbonic anhydrase \\n\\tmay serve as a biochemical marker for photosynthetic capacity in teak \\n\\tgenotypes <193>) <164,193>\\nAP\\t#6,118,193,195# drug development (#6# Drosophila beta-CA represents a \\n\\thighly active mitochondrial enzyme that is a potential model enzyme for \\n\\tanti-parasitic drug development <303>; #193# discovery and development \\n\\tof carbonic anhydrase inhibitors is crucial for their clinical use as \\n\\tantiepileptic, diurectic, and antiglaucoma agents <357>; #195# \\n\\tsuperfamily of metalloenzymes carbonic anhydrases (CAs) has a potential \\n\\tas druggable enzymes to limit the development of Plasmodium falciparum \\n\\tgametocytes <388>; #118# the isozymes CA IVX is a possible drug target \\n\\tfor the treatment of epilepsy, some retinopathies, and skin tumors \\n\\t<381>) <303,357,381,388>\\n\\nENGINEERING\\nEN\\t#106# S586A (#106# the mutation causes an 8fold decrease in the enzyme \\n\\tactivity compared to the wild type enzyme <419>) <419>\\nEN\\t#106# H584A (#106# the mutation causes a 4fold decrease in the enzyme \\n\\tactivity compared to the wild type enzyme <419>) <419>\\nEN\\t#106# Y503A (#106# inactive <419>) <419>\\nEN\\t#106# T486A (#106# inactive <419>) <419>\\nEN\\t#106# Y552A (#106# the substitution has minimal effect on the activity \\n\\t<419>) <419>\\nEN\\t#12# Y64H (#12# the values of kcat/Km are very similar to those for the \\n\\twild type enzyme <47>) <47>\\nEN\\t#12# His64Ala (#12# 100fold lower activity compared to the wild type \\n\\tenzyme <52>) <52>\\nEN\\t#12# R117H (#12# site-directed mutagenesis, replacement reconstructs a \\n\\tzinc-binding site and changes a catalytically inactive murine carbonic \\n\\tanhydrase-related protein to an active carbonic anhydrase <106>) <106>\\nEN\\t#12# R94H (#12# site-directed mutagenesis, replacement reconstructs a \\n\\tzinc-binding site and changes a catalytically inactive murine carbonic \\n\\tanhydrase-related protein to an active carbonic anhydrase <106>) <106>\\nEN\\t#12# E115Q (#12# site-directed mutagenesis, results in increased \\n\\tactivity <106>) <106>\\nEN\\t#12# E92Q (#12# site-directed mutagenesis, results in increased \\n\\tactivity <106>) <106>\\nEN\\t#12# R94H/E92Q (#12# site-directed mutagenesis <106>) <106>\\nEN\\t#12# R94H/E92Q/I121V (#12# site-directed mutagenesis <106>) <106>\\nEN\\t#12# R94H/E92Q/I200T (#12# site-directed mutagenesis <106>) <106>\\nEN\\t#12# R94H/E92Q/I143V/I200T (#12# site-directed mutagenesis <106>) <106>\\nEN\\t#12# R94H/E92Q/I121V/I143V/I200T (#12# site-directed mutagenesis <106>) \\n\\t<106>\\nEN\\t#12# F65A/Y131C (#12# covalently modified at cysteine residues with \\n\\t4-chloromethylimidazole, exhibits an up to 3fold enhancement of \\n\\tcatalytic activity over that of wild-type <91>) <91>\\nEN\\t#12# Y64H/F65A (#12# CAV variant, double mutation, transforms \\n\\tCAVeffectively into an anlogue of CAII, the prototypical carbonic \\n\\tanhydrase isozyme <91>) <91>\\nEN\\t#124# Y7H (#124# site-specific mutagenesis, HCA II <117>; #124# \\n\\tsite-specific mutagenesis, HCA III <117>) <117>\\nEN\\t#124# Y7H/H64A (#124# site-specific mutagenesisHCA II <117>) <117>\\nEN\\t#124# K64H/R67H (#124# site-specific mutagenesis, HCA III <117>) <117>\\nEN\\t#124# F198L (#124# site-specific mutagenesis, HCA III <117>) <117>\\nEN\\t#124# K64H/F198L (#124# site-specific mutagenesis, HCA III <117>) <117>\\nEN\\t#124# Y7H/F198L (#124# site-specific mutagenesis, HCA III <117>) <117>\\nEN\\t#124# Y7H/K64H/F198L (#124# site-specific mutagenesis, HCA III <117>) \\n\\t<117>\\nEN\\t#124# Y7H/K64H (#124# site-specific mutagenesis, HCA III <117>) <117>\\nEN\\t#124# N62D (#124# site-directed mutagenesis <397>; #124# the mutant \\n\\tshows a predominantly outward orientation of the side chain of His64 \\n\\t<195>) <195,397>\\nEN\\t#124# N67L (#124# turnover-number for hydration is 1.4fold lower than \\n\\twild-type value. Turnover-number for dehydration is 5.8fold lower than \\n\\twild-type value <162>; #124# the hydrogen-bonding network is \\n\\tdisruptedin the active site of the N67L mutant, shows inability to \\n\\tstabilize water clusters when His64 is in the inward orientation, \\n\\tthereby favoring proton transfer when His64 is in the outward \\n\\torientation <249>) <162,249>\\nEN\\t#124# A65S (#124# the mutation can cause variations in binding affinity \\n\\tof small molecule inhibitors <196>) <196>\\nEN\\t#124# N67Q (#124# the mutation can cause variations in binding affinity \\n\\tof small molecule inhibitors <196>) <196>\\nEN\\t#124# N62T (#124# the mutant shows both inward and outward orientation \\n\\tof the side chain of His64 like the wild type enzyme <195>) <195>\\nEN\\t#124# N62A (#124# the mutant shows a predominantly inward orientation \\n\\tof the side chain of His64 <195>) <195>\\nEN\\t#124# N62V (#124# the mutant shows a predominantly inward orientation \\n\\tof the side chain of His64 <195>) <195>\\nEN\\t#124# N62L (#124# the mutant shows a predominantly inward orientation \\n\\tof the side chain of His64 <195>) <195>\\nEN\\t#124# A23C/L203C/C206S (#124# mutant retains high catalytic efficiency, \\n\\tand differential scanning calorimetry shows acid stability and thermal \\n\\tstability that is enhanced compared with native enzyme <323>) <323>\\nEN\\t#124# L100H/L224S/L240P (#124# kcat/Km (CO2) decreased compared to \\n\\twild-type, T(M): 65C compared to wild-type: 58C, T (inactivation): \\n\\t65C compared to wild-type: 60C <348>) <348>\\nEN\\t#124# L100H/L224S/L240P/Y7F (#124# kcat/Km (CO2) slightly decreased \\n\\tcompared to wild-type, T(M): 61.1C compared to wild-type: 58C, T \\n\\t(inactivation): 65C compared to wild-type: 60C <348>) <348>\\nEN\\t#124# L100H/L224S/L240P/Y7F/N62L (#124# kcat/Km (CO2) decreased \\n\\tcompared to wild-type, T(M): 58.1C compared to wild-type: 58C, T \\n\\t(inactivation): 60C compared to wild-type: 60C <348>) <348>\\nEN\\t#124# L100H/L224S/L240P/Y7F/N67Q (#124# kcat/Km (CO2) decreased \\n\\tcompared to wild-type, T(M): 62.7C compared to wild-type: 58C, T \\n\\t(inactivation): 65C compared to wild-type: 60C <348>) <348>\\nEN\\t#124# L100H/L224S/L240P/Y7F/N62L/N67Q (#124# kcat/Km (CO2) slightly \\n\\tdecreased compared to wild-type, T(M): 59.2C compared to wild-type: \\n\\t58C, T (inactivation): 60C compared to wild-type: 60C <348>) <348>\\nEN\\t#124# E234P (#124# site-directed mutagenesis, residue Glu234, which is \\n\\tpositioned in a surface loop, is substituted with a proline residue. \\n\\tThermal stability analysis of this variant indicates an enhanced \\n\\tmelting temperature of about 3C compared to the wild-type enzyme \\n\\t<376>) <376>\\nEN\\t#124# G8D/K36D/V50D/N62D/Q136E/L238E (#124# site-directed mutagenesis, \\n\\tmutant M2, shows reduced activity but increased thermostability and \\n\\thalostability compared to wild-type enzyme <397>) <397>\\nEN\\t#124# N24D/V39D/R57D/Q74E/K169E/N252D (#124# site-directed mutagenesis, \\n\\tmutant M3, shows reduced activity but increased thermostability and \\n\\thalostability compared to wild-type enzyme <397>) <397>\\nEN\\t#124# G8D/N24D/K36D/V39D/V50D/R57D/N62D/Q74E/Q136E/K169E/L238E/N252D \\n\\t(#124# site-directed mutagenesis, mutant M3, shows reduced activity but \\n\\tincreased thermostability compared to wild-type enzyme <397>) <397>\\nEN\\t#124# \\n\\tG8D/K18E/N24D/K36D/V39D/V50D/R57D/N62D/Q74E/T85D/Q136E/K169E/N177D/\\n\\tN186E/Q220E/L238E/N252D/Q254E (#124# site-directed mutagenesis, mutant \\n\\tM4, shows reduced activity but increased thermostability and \\n\\thalostability compared to wild-type enzyme. The successful redesign of \\n\\ta mesohalophile enzyme to an extremely halotolerant orthologue, that \\n\\tis, one that is active at 3M NaCl and above. Role of Na+ in stabilizing \\n\\tM4 structure, molecular dynamics simulations, overview <397>) <397>\\nEN\\t#124# A65S/N67Q/E69T/I91L/F131V/K170E/L204A (#124# site-directed \\n\\tmutagenesis, active site mutant <365>) <365>\\nEN\\t#124# A65T/N67Q/F130Y/V134Q/L203T (#124# the mutations do not influence \\n\\tcatalytic properties of isoform CA II, but inhibitor affinities \\n\\tresemble isoform CA VI <446>) <446>\\nEN\\t#124,125# R67H (#124# site-specific mutagenesis, HCA III <117>; #125# \\n\\tmutant has enhanced proton transfer in catalysis compared with \\n\\twild-type HCA III <192>) <117,192>\\nEN\\t#125# C183S/C188S (#125# mutations at positions 183 and 188 are to \\n\\tenhance crystallization by removing oxidizable cysteine residues. The \\n\\tpositions of residues 183 and 188 are solvent exposed on the side of \\n\\tthe enzyme opposite to the active site. The mutations C183S and C188S \\n\\tdo not affect catalysis <140>) <140>\\nEN\\t#125# F198L/C183S/C188S (#125# the ratio of turnover-number to Km-value \\n\\tfor hydration of CO2 of mutant enzyme F198L/C183S/C188S is 25fold \\n\\thigher than the ratio of wild-type enzyme and mutant enzyme C183S/C188S \\n\\t<140>) <140>\\nEN\\t#125# K64H/R67N (#125# mutant has enhanced proton transfer in catalysis \\n\\tcompared with wild-type HCA III <192>) <192>\\nEN\\t#127# H67R (#127# site-directed mutagenesis, single point mutation in a \\n\\tcritical region of the active site <93>) <93>\\nEN\\t#13,14,124,232# H64A (#14# site-directed mutagenesis <133>; #124# \\n\\tactive-site mutant, reduction in proton transfer activity <73>; #124# \\n\\tcatalytic activity decreases more than 10fold <87>; #14# HCA III \\n\\tsite-specific mutant <92>; #14# removes the prominent histidine proton \\n\\tshuttle <97>; #14# site-directed mutant <77>; #124# site-specific \\n\\tmutagenesis, HCA II <117>; #14# site-specific mutant <110>; #13# \\n\\tshuttling mutant CAII-H64A shows lower catalytic activity compared to \\n\\twild-type. Mutant displays catalytic activity in intact oocytes, also \\n\\treduces the SNAT3-associated membrane conductance, when glutamine, but \\n\\tnot when asparagine is the substrate <335>; #232# the mutant shows \\n\\tdecreased enzyme activity in comparison with native enzyme <411>) \\n\\t<73,77,87,92,97,110,117,133,335,411>\\nEN\\t#14# H94Q (#14# oligonucleotide-directed mutagenesis <89>) <89>\\nEN\\t#14# V62N (#14# complex effect on the catalytic and inhibitor-binding \\n\\tproperties <44>) <44>\\nEN\\t#14# H67N (#14# complex effect on the catalytic and inhibitor-binding \\n\\tproperties <44>) <44>\\nEN\\t#14# H200T (#14# complex effect on the catalytic and inhibitor-binding \\n\\tproperties <44>) <44>\\nEN\\t#14# V62N/H67N (#14# complex effect on the catalytic and \\n\\tinhibitor-binding properties <44>) <44>\\nEN\\t#14# V62H/H67N/H200T (#14# complex effect on the catalytic and \\n\\tinhibitor-binding properties <44>) <44>\\nEN\\t#14# R67N (#14# mutant of carbonic anhydrase III, pH-dependent behavior \\n\\tand enhanced CO2 hydration activity compared to the wild-type enzyme, \\n\\tno enhanced hydrolysis rate <67>) <67>\\nEN\\t#14# K170A (#14# site-directed mutagenesis, the active site residue \\n\\tK170 is located near the side chain of His64, but over 15 A away from \\n\\tthe active site zinc. The mutation leads to His64 inward conformation \\n\\tassociated with a decrease in the pKa of His64 and an increase in the \\n\\trate constant for proton transfer compared to the wild-type HCA II \\n\\t<290>) <290>\\nEN\\t#14# Y7W (#14# site-directed mutagenesis <287>) <287>\\nEN\\t#14# T199A (#14# oligonucleotide-directed mutagenesis <89>) <89>\\nEN\\t#14# A65L (#14# site-specific mutagenesis, enhancement of activity with \\n\\tall substrates, about 5fold increase in activity with 4-nitrophenyl \\n\\tacetate <105>) <105>\\nEN\\t#14# T200G (#14# site-specific mutagenesis, 3fold increase in activity \\n\\twith 4-nitrophenyl acetate <105>) <105>\\nEN\\t#14# T200A (#14# site-specific mutagenesis, enhancement of activity \\n\\twith all substrates, about 2fold increase in activity with \\n\\t4-nitrophenyl acetate <105>) <105>\\nEN\\t#14# T200D (#14# site-specific mutagenesis, 93fold decrease in activity \\n\\twith 4-nitrophenylacetate <105>) <105>\\nEN\\t#14# T200H (#14# site-specific mutagenesis, enhancement of activity \\n\\twith all substrates, 2fold increase in activity with 4-nitrophenyl \\n\\tacetate <105>) <105>\\nEN\\t#14# T200I (#14# site-specific mutagenesis, enhancement of activity \\n\\twith all substrates, 1.5fold increase in activity with 4-nitrophenyl \\n\\tacetate <105>) <105>\\nEN\\t#14# T200K (#14# site-specific mutagenesis, enhancement of activity \\n\\twith all substrates, 1.3fold increase in activity with 4-nitrophenyl \\n\\tacetate <105>) <105>\\nEN\\t#14# T200N (#14# site-specific mutagenesis, enhancement of activity \\n\\twith all substrates <105>) <105>\\nEN\\t#14# T200R (#14# site-specific mutagenesis, enhancement of activity \\n\\twith all substrates, 7fold increase in activity with 4-nitrophenyl \\n\\tacetate <105>) <105>\\nEN\\t#14# T200S (#14# site-specific mutagenesis, 3fold increase in activity \\n\\twith 4-nitrophenyl acetate, decrease in activity with all other \\n\\tsubstrates <105>) <105>\\nEN\\t#14# T200V (#14# site-specific mutagenesis, decrease in activity with \\n\\tall substrates <105>) <105>\\nEN\\t#14# V143G (#14# site-specific mutagenesis, 6fold decrease in activity \\n\\twith 4-nitrophenylacetate <105>) <105>\\nEN\\t#14# V143A (#14# site-specific mutagenesis, 2fold decrease in activity \\n\\twith 4-nitrophenylacetate <105>; #14# mutant shows 20fold decreased \\n\\tcatalytic activity compared to wild-type <327>) <105,327>\\nEN\\t#14# V121A (#14# site-specific mutagenesis, 4fold decrease in activity \\n\\twith 4-nitrophenylacetate <105>) <105>\\nEN\\t#14# L198A (#14# site-specific mutagenesis, 5fold decrease in activity \\n\\twith 4-nitrophenylacetate <105>) <105>\\nEN\\t#14# V207A (#14# site-specific mutagenesis, 1.5fold decrease in \\n\\tactivity with 4-nitrophenylacetate <105>) <105>\\nEN\\t#14# Y7F/T200G (#14# site-specific mutagenesis, 1.5fold increase in \\n\\tactivity with 4-nitrophenylacetate <105>) <105>\\nEN\\t#14# Y7F/T200R (#14# site-specific mutagenesis, 7.5fold increase in \\n\\tactivity with 4-nitrophenylacetate <105>) <105>\\nEN\\t#14# A65L/T200R (#14# site-specific mutagenesis, 4fold increase in \\n\\tactivity with 4-nitrophenylacetate <105>) <105>\\nEN\\t#14# A65L/T200G (#14# site-specific mutagenesis, 5fold increase in \\n\\tactivity with 4-nitrophenylacetate <105>) <105>\\nEN\\t#14# Q92A (#14# oligonucleotide-directed mutagenesis <89>) <89>\\nEN\\t#14# E117A (#14# oligonucleotide-directed mutagenesis <89>) <89>\\nEN\\t#14# H94N (#14# oligonucleotide-directed mutagenesis <89>) <89>\\nEN\\t#14# W5C (#14# site-directed mutant <77>) <77>\\nEN\\t#14# N62C (#14# site-directed mutant <77>) <77>\\nEN\\t#14# I91C (#14# site-directed mutant <77>) <77>\\nEN\\t#14# F131C (#14# site-directed mutant <77>) <77>\\nEN\\t#14# H64R (#14# site-directed mutagenesis <133>) <133>\\nEN\\t#14# W5A (#14# HCA III site-specific mutant <92>) <92>\\nEN\\t#14# W5L (#14# HCA III site-specific mutant <92>) <92>\\nEN\\t#14# W5F (#14# HCA III site-specific mutant <92>) <92>\\nEN\\t#14# Y7I (#14# site-directed mutagenesis, replacement of Tyr7 with Ile \\n\\thas no effect on the interconversion of bicarbonate and CO2, but \\n\\tenhances intramolecular proton transfer approximately twofold. No \\n\\tchanges occur in the ordered solvent structure in the active-site \\n\\tcavity or in the conformation of the side chain of the proton shuttle \\n\\tHis64, while the first 11 residues of the amino-terminal chain in Y7I \\n\\tHCA II assume an alternate conformation compared to the wild-type \\n\\tenzyme <287>) <287>\\nEN\\t#14# Y7A (#14# site-directed mutagenesis <287>) <287>\\nEN\\t#14# Y7D (#14# site-directed mutagenesis <287>) <287>\\nEN\\t#14# Y7N (#14# site-directed mutagenesis <287>) <287>\\nEN\\t#14# Y7R (#14# site-directed mutagenesis <287>) <287>\\nEN\\t#14# Y7S (#14# site-directed mutagenesis <287>) <287>\\nEN\\t#14# K170D (#14# site-directed mutagenesis, the active site residue \\n\\tK170 is located near the side chain of His64, but over 15 A away from \\n\\tthe active site zinc. The mutation leads to His64 inward conformation \\n\\tassociated with a decrease in the pKa of His64 and an increase in the \\n\\trate constant for proton transfer compared to the wild-type HCA II \\n\\t<290>) <290>\\nEN\\t#14# K170E (#14# site-directed mutagenesis, the active site residue \\n\\tK170 is located near the side chain of His64, but over 15 A away from \\n\\tthe active site zinc. The mutation leads to His64 inward conformation \\n\\tassociated with a decrease in the pKa of His64 and an increase in the \\n\\trate constant for proton transfer compared to the wild-type HCA II \\n\\t<290>) <290>\\nEN\\t#14# K170H (#14# site-directed mutagenesis, the active site residue \\n\\tK170 is located near the side chain of His64, but over 15 A away from \\n\\tthe active site zinc. The mutation leads to His64 inward conformation \\n\\tassociated with a decrease in the pKa of His64 and an increase in the \\n\\trate constant for proton transfer compared to the wild-type HCA II \\n\\t<290>) <290>\\nEN\\t#14# V143Y (#14# inactive mutant <344>) <344>\\nEN\\t#14# N67I (#14# affinity for sulfonamides/sulfamate inhibitor is highly \\n\\tdecreased compared to wild-type. kcat and Km (CO2) comparable to \\n\\twild-type <332>) <332>\\nEN\\t#14# Q92V (#14# affinity for sulfonamides/sulfamate inhibitor is \\n\\tdecreased compared to wild-type. kcat and Km (CO2) comparable to \\n\\twild-type <332>) <332>\\nEN\\t#14# L204S (#14# affinity for sulfonamides/sulfamate inhibitor is \\n\\tmoderately decreased compared to wild-type. kcat and Km (CO2) \\n\\tcomparable to wild-type <332>) <332>\\nEN\\t#14# V143I (#14# mutant shows 20fold decreased catalytic activity \\n\\tcompared to wild-type <327>) <327>\\nEN\\t#14# V143L (#14# mutant shows 20fold decreased catalytic activity \\n\\tcompared to wild-type <327>) <327>\\nEN\\t#14,124# Y7F (#14# site-directed mutagenesis <287>; #14# site-specific \\n\\tmutagenesis, enhancement of activity with all substrates <105>; #124# \\n\\tturnover-number for hydration is identical to wild-type value. \\n\\tTurnover-number for dehydration is 5.8fold lower than wild-type value \\n\\t<162>; #124# the mutation has the effect of increasing the proton \\n\\ttransfer rate by 7fold in the dehydration direction of the enzyme \\n\\treaction compared to the wild type enzyme <219>; #124# kcat/Km (CO2) \\n\\tequal to wild-type, T(M): 53C compared to wild-type: 58C <348>) \\n\\t<105,162,219,287,348>\\nEN\\t#14,124,125# K64H (#14# mutant of carbonic anhydrase III, pH-dependent \\n\\tbehavior and enhanced CO2 hydration activity compared to the wild-type \\n\\tenzyme, no enhanced hydrolysis rate <67>; #124# site-specific \\n\\tmutagenesis, HCA III <117>; #125# mutant has enhanced proton transfer \\n\\tin catalysis compared with wild-type HCA III <192>) <67,117,192>\\nEN\\t#14,31,34,43,62,83,99,120,124,127,145,163,171,184,185,186,187,188,189,\\n\\t190,191,192,195,197,200,208,214,215,216,217,218# more (#163# the \\n\\ttruncated Nce103 without the sequence coding for the N-terminal 13 \\n\\tresidues Nce103DELTAN13 shows almost the same activity as the full \\n\\tlength Nce103, whereas the activity of the truncated Nce103 without the \\n\\tsequence coding for the N-terminal 50 residues Nce103DELTAN50 is \\n\\tcompletely abolished <266>; #34# immobilization of purified CA and \\n\\twhole cell on different biopolymer matrices, overview <307>; #83# \\n\\timmobilization of purified CA and whole cell on different biopolymer \\n\\tmatrices, overview. The highest enzyme immobilization of 75% is \\n\\tachieved on chitosan-NH4OH beads with maximum increase of 1.08-1.18 \\n\\tfold stability between 35C and 55C <307>; #43# immobilization of \\n\\tpurified CA and whole cell on different biopolymer matrices, overview. \\n\\tThe highest enzyme immobilization of 89% is achieved on chitosan-KOH \\n\\tbeads <307>; #14# replacement of Tyr7 with eight other amino acids has \\n\\tno effect on the interconversion of bicarbonate and CO2, but in some \\n\\tcases causes enhancements in the rate constant of proton transfer by \\n\\tnearly 10fold. Mutant variants at position 7 show a melting temperature \\n\\tapproximately 8C lower than that of the wild-type enzyme <287>; #31# \\n\\tRNAi by feeding is performed on wild-type worms for all genes, \\n\\tsilencing of genes cah-3 and cah-4 reduces the life-span of the worms \\n\\tat 22C, phenotypes, overview <310>; #99# although Trp19 and Y200 are \\n\\tnon-essential, they contribute to an extended active-site structure \\n\\tdistant from the catalytic metal that fine tunes catalysis. Trp19 is \\n\\timportant for both CO2/bicarbonate interconversion, and the proton \\n\\ttransfer step of catalysis <315>; #214,215,216,217# mutant phenotypes, \\n\\toverview <402>; #185,186,187,188,189,190,191,192# capture of CO2 from \\n\\tflue gas in bio-mimetic CO2 capture systems to reduce the concentration \\n\\tof CO2 in the atmosphere, method technology, overview <376>; #62,184# \\n\\tcapture of CO2 from flue gas in bio-mimetic CO2 capture systems to \\n\\treduce the concentration of CO2 in the atmosphere, method technology, \\n\\toverview. Immobilizing the enzyme within solid supports improves the \\n\\tmethod. Formation of gamma-CA nanoassemblies, where individual enzymes \\n\\tare connected to each other and make multiple linked interactions with \\n\\tthe reactor surface. This can be achieved by mutating specific enzyme \\n\\tresidues to cysteines, in order to introduce sites for biotinylation, \\n\\tthus allowing the subsequent formation of stable nanostructures by \\n\\tcross-linking of biotinylated-gamma-CAs with streptavidin tetramers. \\n\\tFurther addition of an immobilization sequence at amino- or \\n\\tcarboxy-terminus also allows for a controlled and reversible \\n\\timmobilization of the gamma-CA to a functionalized surface <376>; #195# \\n\\tcloning of the full domain of carbonic anhydrase from Plasmodium \\n\\tfalciparum, which incorporates 358 amino acid residues, from 181 to \\n\\t538, in the sequence of this 600 amino acid long protein, called \\n\\tPfCAdom. PfCAdom is 13.3times more effective as a catalyst compared to \\n\\tthe truncated form PfCA1. One of the highly conserved zinc coordinating \\n\\thistidines (His119 in hCA II) is not present in the truncated enzyme \\n\\tform PfCA1 since a Gln residue is found in the same, a tyrosine residue \\n\\tinstead of a histidine is present in position 64 <362>; #124# \\n\\tconstruction of a chimeric enzyme, the mimic is a chimeric protein of \\n\\tCA II containing seven active-site-residue mutations to resemble CA IX, \\n\\tallowing for ease of protein expression and crystallization. The \\n\\tactive-site mutations, A65S, N67Q, E69T, I91L, F131V, K170E, L204A, \\n\\tresult in approximately 90% sequence homology between the mimic and \\n\\twild-type CA IX active sites, such that drugs bound to the CA IXb mimic \\n\\tare representative of the interactions that occur with the wild type \\n\\tenzyme <365>; #208# design of a mature form ofASCA(mASCA) using a codon \\n\\toptimization of ASCA gene and removal of the ASCA signal peptide. mASCA \\n\\tis highly expressed and highly stable. The recombinant engineered \\n\\tenzyme ASCA can promote CO2 absorption in an alkaline solvent required \\n\\tfor efficient carbon capture <363>; #145# development and the kinetic \\n\\tcharacterization of a solid CA-based biocatalyst to be used in CO2 \\n\\tcapture processes based on reactive absorption. The commercially \\n\\tavailbale technical grade thermostable CA is immobilized by covalent \\n\\tbonding on aminated paramagnetic Fe3O4 nanoparticles via carbodiimide \\n\\tactivation of the enzyme. The effective covalent binding of the enzyme \\n\\ton the support is verified in the alkaline carbonate solution used as \\n\\tsolvent for CO2 absorption tests. The kinetics of the biocatalyst are \\n\\tassessed by means of CO2 absorption tests in a stirred cell reactor. \\n\\tThe liquid solvents used in the CO2 absorption tests are 0.5 M \\n\\tNa2CO3/NaHCO3 buffer, pH 9.6, at 25C and 40C and 10% w/w K2CO3 \\n\\tsolutions at different carbonate conversion degrees (0-40%). Intrinsic \\n\\tsecond order kinetic constant kcat/KM for the CO2 hydration reaction \\n\\tcatalyzed by the immobilized CA and method validation <354>; #127# \\n\\tenzyme immobilization on magnetic nanoparticles (MNPs) by \\n\\tco-precipitation method. Silica coating with tetraethyl orthosilicate \\n\\tand amine functionalization of silica coated MNPs by using \\n\\t3-aminopropyltriethoxysilane are performed. After activation with \\n\\tglutaraldehyde of silica coated MNPs, human carbonic anhydrase (hCA I) \\n\\tis immobilized on silica coated MNPs. Characterization of nanoparticles \\n\\tby transmission electron microscopy, fourier transform infrared \\n\\tspectroscopy, X-ray powder diffraction, and vibrating sample \\n\\tmagnetometer. Method evaluation and optimization with respecto to \\n\\tactivity, kinetic parameters (Km, Vmax, kcat, kcat/Km), thermal \\n\\tstability, storage stability and reusability of immobilized enzyme, \\n\\toverview. The immobilized hCA I possesses a better thermal stability \\n\\tthan free hCA I at 30-50C. After 40 days storage, the free hCA I \\n\\tsustains 50% and 0.11% of its original activity, whereas the \\n\\timmobilized hCA I retains 89% and 85% of its original activity at 4C \\n\\tand 25C, respectively. The immobilized hCA I retains 61% of its \\n\\tinitial activity after successively utilization for 13 cycles <405>; \\n\\t#218# generation of a CrCIA3 deletion mutant. Point mutations A399C, \\n\\tC499G, C525G, A570G, G732C, G888C, and C903G, none of these mutations \\n\\tintroduces changes in the CrCAH3 amino acid sequence <403>; #171# \\n\\tgeneration of Car3-knockout mice. Loss of CAIII in soleus and \\n\\ttibialanterior (TA) muscles in Car3-KO mice does not change muscle \\n\\tmass, sarcomere protein isoform contents, and the baseline twitch and \\n\\ttetanic contractility as compared with age-matched wild-type controls. \\n\\tCar3-KO TA muscle shows faster force reduction at the beginning but \\n\\thigher resistance at the end during a fatigue test, followed by slower \\n\\tpostfatigue recovery than that of wild-type TA muscle. Superfused \\n\\tCar3-KO soleus muscle also have faster total force reduction during \\n\\tfatigue test than that of wild-type soleus. It shows less elevation of \\n\\tresting tension followed by a better postfatigue recovery under \\n\\tacidotic stress <370>; #195# generation of truncated mutant PfCA1 \\n\\tcomprising 231 amino acids, the mutant shows 2.7fold lower kcat and a \\n\\t13fold lower catalytic efficiency than enzyme PfCAdom <388>; #124# \\n\\thalotolerance can be generated in an enzyme solely by modifying surface \\n\\tresidues. Rational design of carbonic anhydrase II is undertaken in \\n\\tthree stages replacing 18 residues in total, crystal structures confirm \\n\\tchanges are confined to surface residues. Catalytic activities and \\n\\tthermal unfolding temperatures of the designed enzymes increase at high \\n\\tsalt concentrations demonstrating their shift to halotolerance, whereas \\n\\tthe opposite response is found in the wild-type enzyme. Molecular \\n\\tdynamics calculations, overview <397>; #200# knockdown of gene ca6 via \\n\\ttwo different antisense gene ca6-morpholino oligonucleotides-injected \\n\\tlarvae. Zebrafish cannot swim properly in the ca6 knockdown model, in \\n\\tunderdeveloped or deflated swim bladder in ca6 morphant larvae is \\n\\tobserved, swimming pattern analysis of ca6 morphant and wild-type \\n\\tzebrafish, phenotype, overview <399>; #124# optimization of expression \\n\\tmedia and cell culture conditions to produce high levels of 3 different \\n\\tdeuterated human carbonic anhydrases (hCAs). The labeled hCAs are then \\n\\tcharacterized and tested for deuterium incorporation by mass \\n\\tspectrometry, temperature stability, and propensity to crystallize, \\n\\toverview. Deuteration highly reduces the enzyme yield <352>; #120# \\n\\toptimization of expression media and cell culture conditions to produce \\n\\thigh levels of 3 different deuterated human carbonic anhydrases (hCAs). \\n\\tThe labeled hCAs are then characterized and tested for deuterium \\n\\tincorporation by mass spectrometry, temperature stability, and \\n\\tpropensity to crystallize, overview. The protein appears to be more \\n\\ttemperature stable at pH 7.5-8.5 compared to pH 5.5 <352>; #14# \\n\\tpolyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase, \\n\\tpoly-[SFHb-SOD-CAT-CA], is a constructed type of blood substitute. The \\n\\tenzymes polyhemoglobin, superoxide dismutase, catalase, and carbonic \\n\\tanhydrase (SFHb, SOD, CAT, CA) are all cross-linked together to form a \\n\\tnano-sized soluble blood substitute. The enzymes activities of the \\n\\tfreeze-dried cross-linked enzyme complex poly-[SFHb-SOD-CAT-CA] are \\n\\tmore stable compared with the soluble poly-[SFHb-SOD-CAT-CA] and even \\n\\tmore so when compared to the uncrosslinked solution of free SFHb, SOD, \\n\\tCAT and CA enzymes <353>; #124# substitution in hCA II of residues 23 \\n\\tand 203 with two cysteines (dsHCA II) to reproduce a disulfide bridge \\n\\tconserved in many members of alpha-CA class. Thermal stability \\n\\tinvestigations of this variant shows that the melting temperature is \\n\\tenhanced by 14C compared to the wild-type enzyme, while the catalytic \\n\\tefficiency is similar to that of native enzyme <376>; #197# the \\n\\trecombinant enzyme expressed from Pichia pastoris has a higher \\n\\tthermostability, a higher molecular weight and is glycosylated, as \\n\\tcompared the unglycosylated recombinant enzyme expressed from \\n\\tEscherichia coli, overview <367>) \\n\\t<266,287,307,310,315,352,353,354,362,363,365,367,370,376,388,397,399,\\n\\t402,403,405>\\nEN\\t#166# G41A (#166# the mutant has kcat/Km values similar to wild-type \\n\\tenzyme, and exhibits a similar dramatic decrease in catalytic activity \\n\\tat pH values below pH 8.0, but HICA-G41A is serendipitously found to \\n\\tbind sulfate ion or bicarbonate ion near pairs of Glu50 and Arg64 \\n\\tresidues located on the dimerization interface, 2 of 12 chains in the \\n\\tasymmetric unit bind bicarbonate ion exclusively at the dimerization \\n\\tinterface, while the remaining 10 chains bind bicarbonate ion \\n\\texclusively at the allosteric site <289>) <289>\\nEN\\t#166# V47A (#166# the mutant has kcat/Km values similar to wild-type \\n\\tenzyme, and exhibits a similar dramatic decrease in catalytic activity \\n\\tat pH values below pH 8.0, but HICA-V47A is serendipitously found to \\n\\tbind sulfate ion or bicarbonate ion near pairs of Glu50 and Arg64 \\n\\tresidues located on the dimerization interface, bicarbonate ions \\n\\tsimultaneously bind to both the dimerization interface and the \\n\\tallosteric sites <289>) <289>\\nEN\\t#18# Q253C (#18# engineered protein <109>) <109>\\nEN\\t#20# R36A (#20# site-directed mutagenesis <114>) <114>\\nEN\\t#20# D34A (#20# site-directed mutagenesis <114>) <114>\\nEN\\t#20# D34E (#20# site-directed mutagenesis <114>) <114>\\nEN\\t#20# R36K (#20# site-directed mutagenesis <114>) <114>\\nEN\\t#20# D34A/R36A (#20# site-directed mutagenesis <114>) <114>\\nEN\\t#227# E310A (#227# the mutant of isoform LCIB3 does not show an evident \\n\\tdifference in activity from the wild type <407>) <407>\\nEN\\t#227# E310Q (#227# the mutant of isoform LCIB3 does not show an evident \\n\\tdifference in activity from the wild type <407>) <407>\\nEN\\t#227# K64E (#227# the kcat and kcat/Km of the mutant of isoform LCIB4 \\n\\tonly increase marginally compared with the wild type enzyme <407>) <407>\\nEN\\t#227# K64R (#227# in the mutant of isoform LCIB4, both the kcat and \\n\\tkcat/Km are reduced by approximately half compared with the wild type \\n\\tenzyme <407>) <407>\\nEN\\t#227# D325E (#227# in the mutant of isoform LCIB3, the kcat and kcat/Km \\n\\tare slightly reduced compared with the wild type enzyme <407>) <407>\\nEN\\t#227# D325N (#227# the kinetic parameters of the mutant of isoform \\n\\tLCIB3are nearly unaffected by the mutation <407>) <407>\\nEN\\t#227# H349A (#227# the mutation of isoform LCIB3 renders the enzyme \\n\\tlargely inactive, with the kcat and kcat/Km reduced by 30fold and \\n\\t479fold, respectively <407>) <407>\\nEN\\t#227# D325A (#227# the kinetic parameters of the mutant of isoform \\n\\tLCIB3are nearly unaffected by the mutation <407>) <407>\\nEN\\t#227# S308R (#227# the truncated isoform LCIB3-C S308R mutant exists in \\n\\ta monomeric state in solution. The kcat of the isoform LCIB3 S308R \\n\\tmutant is also reduced by approximately 10fold compared with the wild \\n\\ttype enzyme <407>) <407>\\nEN\\t#227# D325Q (#227# in the mutant of isoform LCIB3, the kcat is reduced \\n\\tby 23fold and kcat/Km is reduced by 248fold compared to the wild type \\n\\tenzyme <407>) <407>\\nEN\\t#227# D325K (#227# the kinetic parameters of the mutant of isoform \\n\\tLCIB3 are similar to those of the D325Q mutant <407>) <407>\\nEN\\t#227# D325R (#227# the kinetic parameters of the mutant of isoform \\n\\tLCIB3 are similar to those of the D325Q mutant <407>) <407>\\nEN\\t#227# K64D (#227# the kcat and kcat/Km of the mutant of isoform LCIB4 \\n\\tonly increase marginally compared with the wild type enzyme <407>) <407>\\nEN\\t#23# H169N (#23# little change in hydration activity <65>) <65>\\nEN\\t#23# C160S (#23# completely inactive <65>) <65>\\nEN\\t#23# E204A (#23# completely inactive <65>) <65>\\nEN\\t#23# C223S (#23# completely inactive <65>) <65>\\nEN\\t#23# H209N (#23# somewhat defective in catalytic activity, to varying \\n\\tdegrees in different buffers, 44% of wild-type activity in imidazole \\n\\tbuffer <65>) <65>\\nEN\\t#23# E276A (#23# somewhat defective in catalytic activity, to varying \\n\\tdegrees in different buffers. 40% of wild-type activity in HEPES/KOH \\n\\tbuffer, 77.5% of wild-type activity in imidazole buffer, 6% of \\n\\twild-type activity in HEPES/KOH buffer <65>) <65>\\nEN\\t#23# H208A (#23# site-directed mutagenesis, mutant is more easily \\n\\tinactivated by oxidation than the wild-type enzyme <75>) <75>\\nEN\\t#23# H208A/C272A (#23# site-directed mutagenesis <75>) <75>\\nEN\\t#232# Y158A (#232# the mutant shows decreased enzyme activity in \\n\\tcomparison with native enzyme <411>) <411>\\nEN\\t#232# R43A (#232# the mutant shows decreased enzyme activity in \\n\\tcomparison with native enzyme <411>) <411>\\nEN\\t#232# N56A (#232# the mutant shows decreased enzyme activity in \\n\\tcomparison with native enzyme <411>) <411>\\nEN\\t#232# Q58A (#232# the mutant shows decreased enzyme activity in \\n\\tcomparison with native enzyme <411>) <411>\\nEN\\t#233# H197A (#233# inactive <419>) <419>\\nEN\\t#233# K180A (#233# the mutation does not affect the enzyme activity \\n\\t<419>) <419>\\nEN\\t#233# T106A (#233# inactive <419>) <419>\\nEN\\t#233# Y124A (#233# inactive <419>) <419>\\nEN\\t#233# S199A (#233# inactive <419>) <419>\\nEN\\t#236# S82Y (#236# the mutant shows at least an 8.3fold higher \\n\\texpression level compared to that of wild type enzyme. The mutant does \\n\\tnot show any difference in both activity and stability compared to the \\n\\twild type enzyme <429>) <429>\\nEN\\t#26# H216N (#26# proton shuttle replaced with a residue that does not \\n\\ttransfer protons <90>; #26# site-directed variant <76>) <76,90>\\nEN\\t#26# Y212F (#26# site-directed variant <76>) <76>\\nEN\\t#26# Q158A (#26# site-directed variant <78>) <78>\\nEN\\t#30# H66A (#30# higher sensitivity to inhibitor \\n\\t6-ethoxy-2-benzo-thiazolesulfonamide <107>) <107>\\nEN\\t#62# C148S (#62# the mutation eliminate potential problems with the \\n\\toxidation of the single cysteine residue at position 148 <322>) <322>\\nEN\\t#62# E88A (#62# site-directed mutagenesis, large decrease in kcat <86>) \\n\\t<86>\\nEN\\t#62# E84 D (#62# site-directed mutagenesis, large decrease in kcat \\n\\tvalues in pH 7.5 MOPS buffer <86>) <86>\\nEN\\t#62# E84 H (#62# site-directed mutagenesis, large decrease in kcat \\n\\tvalues in pH 7.5 MOPS buffer <86>) <86>\\nEN\\t#62# E84 A (#62# site-directed mutagenesis, large decrease in kcat \\n\\tvalues in pH 7.5 MOPS buffer <86>) <86>\\nEN\\t#62# E84 Y (#62# site-directed mutagenesis, large decrease in kcat \\n\\tvalues in pH 7.5 MOPS buffer <86>) <86>\\nEN\\t#62# E84 C (#62# site-directed mutagenesis, large decrease in kcat \\n\\tvalues in pH 7.5 MOPS buffer <86>) <86>\\nEN\\t#62# E84 K (#62# site-directed mutagenesis, large decrease in kcat \\n\\tvalues in pH 7.5 MOPS buffer <86>) <86>\\nEN\\t#62# E84 Q (#62# site-directed mutagenesis, large decrease in kcat \\n\\tvalues in pH 7.5 MOPS buffer <86>) <86>\\nEN\\t#62# E84 S (#62# site-directed mutagenesis, large decrease in kcat \\n\\tvalues in pH 7.5 MOPS buffer <86>) <86>\\nEN\\t#62# E62D (#62# site-directed mutagenesis, 3fold decrease in kcat <86>) \\n\\t<86>\\nEN\\t#62# E62A (#62# site-directed mutagenesis, large decrease in kcat <86>) \\n\\t<86>\\nEN\\t#62# E62C (#62# site-directed mutagenesis, large decrease in kcat <86>) \\n\\t<86>\\nEN\\t#62# E62H (#62# site-directed mutagenesis, large decrease in kcat <86>) \\n\\t<86>\\nEN\\t#62# E62Q (#62# site-directed mutagenesis, large decrease in kcat <86>) \\n\\t<86>\\nEN\\t#62# E62T (#62# site-directed mutagenesis, large decrease in kcat <86>) \\n\\t<86>\\nEN\\t#62# E62Y (#62# site-directed mutagenesis, large decrease in kcat <86>) \\n\\t<86>\\nEN\\t#62# E89A (#62# site-directed mutagenesis, large decrease in kcat <86>) \\n\\t<86>\\nEN\\t#62# E62A/E84A (#62# site-directed mutagenesis, large decrease in kcat \\n\\t<86>) <86>\\nEN\\t#62# E62D/E84D (#62# site-directed mutagenesis, large decrease in kcat \\n\\t<86>) <86>\\nEN\\t#62# E84A (#62# proton shuttle replaced with a residue that does not \\n\\ttransfer protons <90>) <90>\\nEN\\t#99# Y200F (#99# kcat/km at pH 7.5 is 3.6fold higher than wild-type \\n\\tvalue, kcat/km at pH 8.8 is 2.5fold lower than wild-type value <315>) \\n\\t<315>\\nEN\\t#99# R59A (#99# site-directed mutagenesis <94>) <94>\\nEN\\t#99# R59C (#99# site-directed mutagenesis <94>) <94>\\nEN\\t#99# R59E (#99# site-directed mutagenesis <94>) <94>\\nEN\\t#99# R59H (#99# site-directed mutagenesis <94>) <94>\\nEN\\t#99# R59K (#99# site-directed mutagenesis <94>) <94>\\nEN\\t#99# R59M (#99# site-directed mutagenesis <94>) <94>\\nEN\\t#99# R59Q (#99# site-directed mutagenesis <94>) <94>\\nEN\\t#99# W19A (#99# kcat/km at pH 7.5 is 2.5fold lower than wild-type \\n\\tvalue, kcat/km at pH 8.8 is 2.2fold lower than wild-type value <315>) \\n\\t<315>\\nEN\\t#99# Y200A (#99# kcat/km at pH 7.5 is 3.5fold higher than wild-type \\n\\tvalue, kcat/km at pH 8.8 is 3.3fold higher than wild-type value <315>) \\n\\t<315>\\nEN\\t#99# W19N (#99# kcat/km at pH 7.5 is 3.2fold lower than wild-type \\n\\tvalue, kcat/km at pH 8.8 is 2.4fold lower than wild-type value <315>) \\n\\t<315>\\nEN\\t#99# W19F (#99# kcat/km at pH 7.5 is 5fold lower than wild-type value, \\n\\tkcat/km at pH 8.8 is 5.2fold lower than wild-type value <315>) <315>\\nEN\\t#99# Y200S (#99# kcat/km at pH 7.5 is 3fold higher than wild-type \\n\\tvalue, kcat/km at pH 8.8 is 3.3fold higher than wild-type value <315>) \\n\\t<315>\\n\\nCLONED\\nCL\\t#6# (gene DmBCA, phylogenetic analysis, expression in Spodoptera \\n\\tfrugiperda Sf9 cells using the baculovirus transfection system) <303>\\nCL\\t#9# (overexpression of HICA in Escherichia coli in minimal media \\n\\tsupplemented with CoCl2) <288>\\nCL\\t#10# (expressed in Escherichia coli) <239>\\nCL\\t#10# (carbonic anhydrase is encoded by at least two genes) <43>\\nCL\\t#12# <47>\\nCL\\t#12# (expression in Escherichia coli) <50,52>\\nCL\\t#12# (overexpressed in Escherichia coli) <91>\\nCL\\t#12# (expressed in Escherichia coli BL21(DE3)) <106>\\nCL\\t#12# (cDNA cloned and expressed in COS-7 cells) <119>\\nCL\\t#14# (expressed in Escherichia coli) <110,211,327>\\nCL\\t#14# (expressed in Escherichia coli BL21(DE3)) <82,89>\\nCL\\t#14# (CA I and CA II cDNA expressed in Escherichia coli BL21 (DE3)) \\n\\t<120,132>\\nCL\\t#14# (CA I and CA II cDNA expressed in Escherichia coli BL21 (DE3), \\n\\tcDNA hCA IX PCR amplified) <131>\\nCL\\t#14# (CA I and CA II cDNAs expressed in Escherichia coli BL21 (DE3)) \\n\\t<121,126>\\nCL\\t#14# (CA I and CAII cDNA expressed in Escherichia coli BL21 (DE3)) <122>\\nCL\\t#14# (CA II expressed in Escherichia coli BL21(DE3)pLysS) <97>\\nCL\\t#14# (CA13 gene cDNA) <118>\\nCL\\t#14# (CAII transformed into Escherichia coli BL21(DE3)) <88>\\nCL\\t#14# (cDNA expressed in CHO-K1 cells) <133>\\nCL\\t#14# (cDNA expressed in Escherichia coli BL21 (DE3)) <124>\\nCL\\t#14# (cDNA expressed in Escherichia coli BL21(DE3)pLysS) <79>\\nCL\\t#14# (cloned and overexpressed) <77,111>\\nCL\\t#14# (expressed in Escherichia coli BL21 (DE3)) <125>\\nCL\\t#14# (hCA I and hCA II cDNA expressed in escherichia coli BL21 (DE3)) \\n\\t<101>\\nCL\\t#14# (mutants expressed in Escherichia coli BL21(DE3)) <92>\\nCL\\t#14# (expressed in Mus musculus) <245>\\nCL\\t#14# (expressed in Escherichia coli BL21 (DE3) pLysS cells) <247>\\nCL\\t#14# (expressed in SK-Hep1 cells) <234>\\nCL\\t#14# (expressed in Escherichia coli BL21(DE3) cells and in insect \\n\\tcells) <251>\\nCL\\t#14# (expression of wild-type and mutant enzymes in Escherichia coli \\n\\tstrain BL21(DE3)pLysS) <290>\\nCL\\t#14# (isozyme hCAII, expression in Escherichia coli strain BL21(DE3) \\n\\tfrom the plasmids pET-28b/hCA II) <301>\\nCL\\t#14# (coexpressed in tsA201 cells expressing heterologous fluorescent \\n\\tfusion proteins CAII-CyPet and YPet-AE1) <344>\\nCL\\t#17# (expressed in Escherichia coli BL21 (DE3) cells) <210>\\nCL\\t#18# (CA I and CA II cDNA expressed in Escherichia coli BL21 (DE3)) \\n\\t<123>\\nCL\\t#18# (CA I and CA II cDNAs expressed in Escherichia coli BL21 (DE3)) \\n\\t<126>\\nCL\\t#18# (mutant genes expressed in Escherichia coli BL21 (DE3)) <109>\\nCL\\t#20# (overexpressed in Escherichia coli) <116>\\nCL\\t#20# (DELTAH cab gene hyperexpressed in Escherichia coli) <112>\\nCL\\t#20# (wild-type and variant carbonic anhydrases heterologously produced \\n\\tin Escherichia coli BL21(DE3)) <114>\\nCL\\t#23# (expression in Escherichia coli) <65>\\nCL\\t#23# (expressed in Escherichia coli BL21(DE3)) <75>\\nCL\\t#23# (precursor OEC33 expressed in Escherichia coli) <155>\\nCL\\t#26# (cloned and overexpressed) <76,78>\\nCL\\t#28# (expressed in Escherichia coli BL21 Star (DE3) cells) <443>\\nCL\\t#30# (overexpression in Escherichia coli) <49>\\nCL\\t#30# (cloned and expressed in Escherichia coli BL21(DE3)) <107>\\nCL\\t#30# (expressed in Escherichia coli BL21(DE3) cells) <265>\\nCL\\t#31# (genes cah-1, cah-2, cah-3, cah-4, cah-5, and cah-6, real-time \\n\\tRT-PCR expression analysis, overview. Gene cah-3 is able to complement \\n\\tthe function of Saccharomyces cerevisiae CA, NCE103, in vivo, \\n\\texpression in Saccharomyces cerevisiae wild-type strain CEN.PK2 and in \\n\\tmutant strain CEN.HE28-1A. Recombinant expression of His-tagged CAH-3, \\n\\tCAH-4a and CAH-5 in Escherichia coli strain BL21(DE3), but in vitro \\n\\tactivity is only detectable for CAH-4a) <310>\\nCL\\t#32# (expressed in Escherichia coli) <276>\\nCL\\t#32# (expressed in Escherichia coli BL21(DE3) cells) <275>\\nCL\\t#35# (using the baculovirus expression system as a His-tagged fusion \\n\\tprotein) <342>\\nCL\\t#39# (expression in Escherichia coli BL21) <165>\\nCL\\t#41# (alpha-carbonic anhydrase gene cloned and sequenced, truncated \\n\\tgene expressed in Escherichia coli BL21(DE3)) <98>\\nCL\\t#44# (expressed in Escherichia coli BL21(DE3) cells) <272>\\nCL\\t#49# <180>\\nCL\\t#49# (expression in Escherichia coli) <178>\\nCL\\t#51# (expression as a glutathione-S-transferase fusion protein in \\n\\tEscherichia coli) <190>\\nCL\\t#55# <55>\\nCL\\t#59# <339>\\nCL\\t#61# (expressed in Escherichia coli as a His-tagged fusion protein) \\n\\t<346>\\nCL\\t#62# (overexpression in Escherichia coli) <51>\\nCL\\t#62# (expression in Escherichia coli) <322>\\nCL\\t#62# (expressed in Escherichia coli) <110>\\nCL\\t#62# (cam gene expressed in Escherichia coli) <81>\\nCL\\t#62# (expressed in Escherichia coli BL21(DE3) or Bl21(DE3) Gold) <86>\\nCL\\t#62# (expressed in Escherichia coli and Methanosarcina acetivorans) \\n\\t<197>\\nCL\\t#62# (recombinant enzyme expression in Escherichia coli or in \\n\\tMethanosarcina acetivorans) <376>\\nCL\\t#65# (in Escherichia coli as a His-tagged-fusion protein) <341>\\nCL\\t#68# (expression in Escherichia coli) <63>\\nCL\\t#81# (cDNA cloning, functionally overexpressed in Escherichia coli) <72>\\nCL\\t#85# (expressed in Escherichia coli OneShot BL21 Star (DE3) cells) <408>\\nCL\\t#96# (expressed in Escherichia coli BL21 cells) <423>\\nCL\\t#97# (expressed in Escherichia coli BL21(DE3)pLysS cells) <439>\\nCL\\t#98# (cDNA sequenced) <108>\\nCL\\t#99# (expression in Escherichia coli) <160,321>\\nCL\\t#99# (produced in Escherichia coli) <85>\\nCL\\t#99# (wild-type and variants expressed in Escherichia coli BL21(DE3) or \\n\\tBL21(DE3) Gold) <94>\\nCL\\t#100# (expression in Escherichia coli) <161>\\nCL\\t#100# (functionally expressed in Escherichia coli Origami B(DE3)pLys) \\n\\t<137>\\nCL\\t#101# (heterologously produced in Escherichia coli) <113>\\nCL\\t#103# (CynT2 expressed in Escherichia coli BL21(DE3)) <71>\\nCL\\t#103# (overexpressed in transformed Escherichia coli cultures, \\n\\texpression in yeast, complements the growth defect in a yeast beta-CA \\n\\tknockout in Saccharomyces cerevisiae DELTA NCE103) <138>\\nCL\\t#106# (expressed in Escherichia coli Rosetta 2 (DE3) cells) <419>\\nCL\\t#107# <182>\\nCL\\t#108# (expressed in Escherichia coli Rosetta DE3 cells) <281>\\nCL\\t#118# (gene CA14, recombinant expression in Escherichia coli: effect of \\n\\tdifferent promoters, Escherichia coli strains (Rosetta 2(DE3), \\n\\tRosetta-gami 2 (DE3), Origami B (DE3), and BL21 trxB (DE3)), and the \\n\\tlength of recombinant CA XIV protein construct are analyzed for the \\n\\tproduction CA XIV in large scale by using affinity purification, method \\n\\tevaluation and optimization, overview. The most suitable Escherichia \\n\\tcoli strain is Origami B (DE3)) <381>\\nCL\\t#119# (CA XII expressed in Escherichia coli AD494(DE3)) <135>\\nCL\\t#120# (expressed in Escherichia coli and in a baculovirus-Sf9 insect \\n\\tcell expression system, the recombinant proteins consist of either the \\n\\tCA IX catalytic domain only or the extracellular domain, which includes \\n\\tboth the proteoglycan and catalytic domains, lacking the small \\n\\ttransmembrane and intracytoplasmic regions of CA IX) <223>\\nCL\\t#120# (expressed in Escherichia coli BL21(DE3) cells using the \\n\\tbaculovirus-insect cell expression system) <274>\\nCL\\t#120# (using the baculovirusinsect cell expression system) <280>\\nCL\\t#120# (gene CA9, recombinant expression in Escherichia coli strain \\n\\tBL21(DE3), optimization of expression media and cell culture conditions \\n\\tto produce high levels of 3 different deuterated human carbonic \\n\\tanhydrases (hCAs). The labeled hCAs are then characterized and tested \\n\\tfor deuterium incorporation by mass spectrometry, temperature \\n\\tstability, and propensity to crystallize, overview. Deuteration highly \\n\\treduces the enzyme yield) <352>\\nCL\\t#120# (isozyme CA IX, recombinant expression of wild-type isozyme in \\n\\tEscherichia coli strain BL21(DE3)) <365>\\nCL\\t#120# (recombinant expression of GST-tagged isozyme hCA IX in \\n\\tEscherichia coli strain BL21 Codon Plus) <386>\\nCL\\t#120# (recombinant expression of His-tagged PG domain of isozyme CA9 IX \\n\\tin Escherichia coli strain BL21(DE3)) <364>\\nCL\\t#123# (using the baculovirus expression system as a His-tagged fusion \\n\\tprotein) <343>\\nCL\\t#124# (expressed in Escherichia coli) <323>\\nCL\\t#124# (cDNA overexpressed in Escherichia coli BL21 (DE3)) <84>\\nCL\\t#124# (wild-type HCA II and H64A II expressed in Escherichia coli) <87>\\nCL\\t#124# (expressed in Escherichia coli BL21(DE3) cells) <249>\\nCL\\t#124# (expressed in Escherichia coli BL21(DE3)pLysS cells) <196,224>\\nCL\\t#124# (expression of mutant enzymes Y7F, N62L, and N67L in Escherichia \\n\\tcoli) <162>\\nCL\\t#124# (mutants are expressed in Escherichia coli BL21(DE3)pLysS cells) \\n\\t<195>\\nCL\\t#124# (expression of HCA II in Escherichia coli strain BL21) <286>\\nCL\\t#124# (gene CA2, recombinant expression in Escherichia coli strain \\n\\tBL21(DE3), optimization of expression media and cell culture conditions \\n\\tto produce high levels of 3 different deuterated human carbonic \\n\\tanhydrases (hCAs). The labeled hCAs are then characterized and tested \\n\\tfor deuterium incorporation by mass spectrometry, temperature \\n\\tstability, and propensity to crystallize, overview) <352>\\nCL\\t#124# (gene CA2, recombinant expression of His-tagged isozyme HCAII) \\n\\t<375>\\nCL\\t#124# (gene CA2, recombinant expression of the enzyme in Escherichia \\n\\tcoli strain BL21(DE3)) <396>\\nCL\\t#124# (gene CA2, recombinant expression of wild-type and mutant enzymes \\n\\tin Escherichia coli) <397>\\nCL\\t#124# (isozyme CA II, recombinant expression of wild-type isozyme CA II \\n\\tand chimeric CA IX mimic mutant isozyme in Escherichia coli strain \\n\\tBL21(DE3)) <365>\\nCL\\t#125# (expression in Escherichia coli) <167>\\nCL\\t#127# (cDNA transformed into Escherichia coli JM109) <93>\\nCL\\t#129# (gene CA5A, localized to chromosome 16q24.3, an unprocessed \\n\\tpseudogene is assigned to 16p12, recombinant His-tagged enzyme \\n\\texpression in Escherichia coli strain BL21(DE3) from plasmid pENTR223 \\n\\tas soluble enzyme and in inclusion bodies) <349>\\nCL\\t#131# <184>\\nCL\\t#132# (expressed in Escherichia coli One Shot Mach1-T1R and BL21 (DE-3) \\n\\tcells) <418>\\nCL\\t#133# (expression in Escherichia coli) <175>\\nCL\\t#133# (CA13 gene cDNA cloned into Escherichia coli TOP 10) <118>\\nCL\\t#150# (expressed in Escherichia coli and in HEK-293 cells) <222>\\nCL\\t#162# (expressed in Escherichia coli BL21(DE3) cells) <277>\\nCL\\t#162# (beta class isozymes bsCA I and bsCA II, DNA and amino acid \\n\\tsequence determination and analysis, phylogenetic analysis, recombinant \\n\\texpression of His-tagged bsCA II in Escherichia coli) <298>\\nCL\\t#163# (expressed in Escherichia coli Rosetta (DE3) cells) <266>\\nCL\\t#164# (expressed in Escherichia coli) <273>\\nCL\\t#165# (expressed in Escherichia coli BL21(DE3) cells) <283>\\nCL\\t#166# (overexpression of wild-type enzyme and mutants V47A and G41A in \\n\\tEscherichia coli) <289>\\nCL\\t#168# (isozyme LjCAA1, DNA and amino acid sequence determination and \\n\\tanalysis, sequence comparisons and phylogenetic tree, expression \\n\\tanalysis by quantitative real-time RT-PCR, and spatial expression \\n\\tprofiling, recombinant expression of His-tagged isozyme in Escherichia \\n\\tcoli strain BL21(DE3)) <292>\\nCL\\t#169# (isozyme LjCAA2, DNA and amino acid sequence determination and \\n\\tanalysis, sequence comparisons and phylogenetic tree, expression \\n\\tanalysis by quantitative real-time RT-PCR, and spatial expression \\n\\tprofiling, recombinant expression of His-tagged isozymes in Escherichia \\n\\tcoli strain BL21(DE3)) <292>\\nCL\\t#170# (expression in COS 7 cells) <46>\\nCL\\t#172# (expression in COS-7 cells or in Escherichia coli) <139>\\nCL\\t#172# (expressed in a baculovirus-Sf9 insect cell expression system) \\n\\t<230>\\nCL\\t#173# (cDNA cloned and expressed in Saccharomyces cerevisiae, also \\n\\texpressed in Escherichia coli) <136>\\nCL\\t#176# (overproduced in Escherichia coli) <320>\\nCL\\t#177# (expressed in Escherichia coli) <340>\\nCL\\t#178# (expressed as a His-tagged fusion protein in Escherichia coli) \\n\\t<337>\\nCL\\t#179# (expressed as a His-tagged fusion protein in Escherichia coli) \\n\\t<337>\\nCL\\t#180# (expressed as a GST-fucion protein) <331>\\nCL\\t#182# (in Escherichia coli as a GST-fusion protein) <342>\\nCL\\t#183# (expressed in Escherichia coli as a His-tagged fusion protein) \\n\\t<325>\\nCL\\t#184# (expressed in Escherichia coli BL21-CodonPlus (DE3)-RIL cells) \\n\\t<194>\\nCL\\t#191# (expressed in Escherichia coli BL21(DE3) cells) <441>\\nCL\\t#191# (gene PERMA_1443, phylogenetic tree, recombinant expression of \\n\\tHis-tagged enzyme lacking the signal peptide from codon-optimized \\n\\tcarbonic anhydrase gene in Escherichia coli strain BL21(DE3), real-time \\n\\tPCR enzyme expression analysis) <404>\\nCL\\t#192# (expressed in Escherichia coli BL21(DE3) cells) <429>\\nCL\\t#194# (recombinant expression of soluble His-tagged enzyme in \\n\\tEscherichia coli strain ArcticExpress (DE3)RIL) <389>\\nCL\\t#195# (cloning of the full domain of carbonic anhydrase from Plasmodium \\n\\tfalciparum, which incorporates 358 amino acid residues, from 181 to \\n\\t538, in the sequence of this 600 amino acid long protein, called \\n\\tPfCAdom) <362>\\nCL\\t#195# (enzyme form PfCAdom comprising 358 amino acids (residue 181 to \\n\\tresidue 538), recombinant expression of His-tagged enzyme PfCAdom) <388>\\nCL\\t#196# (DNA and amino acid sequence determination and analysis of \\n\\tPgiCAb, sequence comparisons and phylogenetic tree, recombinant \\n\\texpression of His-tagged enzyme in Escherichia coli) <383>\\nCL\\t#197# (BhCA, recombinant constitutive extracellular expression of the \\n\\tenzyme in Pichia pastoris strain GS115 under methanol inducible (AOX1) \\n\\tas well as constitutive (GAP) promoters, the recombinant enzyme is \\n\\tsecreted. The double transformant of the strain GS115 harboring BhCA \\n\\tunder both AOX1 and GAP promoters possessed two copies of the gene) \\n\\t<367>\\nCL\\t#197# (recombinant expression of His-tagged wild-type and mutant \\n\\tenzymes in Escherichia coli strain BL21(DE3) achieving a 31.4fold \\n\\tenhancement in CA production for the wild-type, subcloning in \\n\\tEscherichia coli strain DH5alpha. About 50% of wild-type enzyme \\n\\tproduced is secreted when recombinant Escherichia coli harboring \\n\\tBhCA-pET22b is cultivated in a medium with EDTA and lysozyme because of \\n\\tthe efficient pelB leader sequence, cultvation parameters are optimized \\n\\tfor rBhCA secretion) <374>\\nCL\\t#198# (gene can, sequence comparisons and phylogenetic analysis, \\n\\trecombinant overexpression of N-terminally His-tagged enzyme in \\n\\tEscherichia coli strain BL21(DE3)pLysS) <384>\\nCL\\t#199# (gene ca1, encoding delta-CA, sequence comparisons, phylogenetic \\n\\tanalysis, recombinant His-tagged enzyme expression in Escherichia coli) \\n\\t<382>\\nCL\\t#200# (gene ca6, isolation and sequencing of Danio rerio CA VI cDNA, \\n\\tcomplete with the sequence coding for the PTX domain, DNA and amino \\n\\tacid sequence determination and analysis, sequence comparisons and \\n\\tphylogenetic analysis, expression of the recombinant CA VI-PTX protein \\n\\tin Spodoptera frugiperda Sf9 cells using the baculovirus expression \\n\\tsystem, quantitative real-time PCR) <399>\\nCL\\t#201# (DNA and amino acid sequence determination and analysis, sequence \\n\\tcomparisons and phylogenetic tree) <371>\\nCL\\t#201# (gene CA2, cloned from DNA of outer and inner mantle, DNA and \\n\\tamino acid sequence determination and analysis, no nucleotide \\n\\tpolymorphism is observed between the CA2-like cDNA sequences obtained \\n\\tfrom these two tissues, phylogenetic analysis, quantitative real-time \\n\\tPCR expression analysis of CA2-like) <401>\\nCL\\t#202# (gene Tcr_1545, sequence comparisons, recombinant enzyme \\n\\texpression in Escherichia coli strain BL21(DE3)) <350>\\nCL\\t#203# (gene icfA, CcaA sequence comparisons, recombinant expression of \\n\\tHis-tagged enzyme in Escherichia coli strain BL21(DE3)) <355>\\nCL\\t#204# (gene ccmM, CcmM sequence comparisons, recombinant expression of \\n\\tHis-tagged enzyme in Escherichia coli strain BL21(DE3)) <355>\\nCL\\t#205# (gene CpsCAgamma, sequence comparisons and phylogenetic analysis, \\n\\trecombinant expression of His-tagged enzyme in Escherichia coli strain \\n\\tBL21(DE3) (Arctic Express DE3 competent cells), subcloning in \\n\\tEscherichia coli strain DH5alpha) <359>\\nCL\\t#206# (gene PhaCAgamma, sequence comparisons and phylogenetic tree, \\n\\trecombinant expression of His-tagged enzyme in Escherichia coli strain \\n\\tBL21(DE3)(ArcticExpress DE3 competent cells), subcloning in Escherichia \\n\\tcoli strain DH5alpha) <358>\\nCL\\t#207# (recombinant expression of His-tagged enzyme in Escherichia coli \\n\\tstrain BL21(DE3)) <360>\\nCL\\t#207# (enzyme fused to the 60-amino acid-long ectodomain (M-domain) of \\n\\tthe human receptor-type tyrosine-protein phosphatase C and to the \\n\\tcellulose-binding module 3 from Clostridium thermocellum is expressed \\n\\tin Nicotiana benthamiana and Escherichia coli BL21 (DE3) pLysS cells) \\n\\t<444>\\nCL\\t#208# (recombinant overexpression of His-tagged enzyme in Escherichia \\n\\tcoli strain BL21(DE3)) <363>\\nCL\\t#209# (gene CA3, DNA and amino acid sequence determination and \\n\\tanalysis, sequence comparisons, quantitative RT-PCR expression \\n\\tanalysis) <372>\\nCL\\t#210# (isozyme carbonic anhydrase 6, DNA and amino acid sequence \\n\\tdetermination and analysis, sequence comparisons and phylogenetic \\n\\tanalysis and tree, quantitative real-time PCR and \\n\\tquantitative/semiquantitative RT-PCR expression analysis) <373>\\nCL\\t#211# (gene Ca, DNA and amino acid sequence determination and analysis, \\n\\tphylogenetic analysis and tree, comparative real-time quantitative PCR, \\n\\trecombinant expression of His6-tagged enzyme in Escherichia coli strain \\n\\tBL21(DE3)) <395>\\nCL\\t#214# (Arabidopsis thaliana plant transformation for expression of \\n\\tmutant enzymes via Agrobacterium tumefaciens strain GV3101) <402>\\nCL\\t#215# (Arabidopsis thaliana plant transformation for expression of \\n\\tmutant enzymes via Agrobacterium tumefaciens strain GV3101) <402>\\nCL\\t#216# (Arabidopsis thaliana plant transformation for expression of \\n\\tmutant enzymes via Agrobacterium tumefaciens strain GV3101) <402>\\nCL\\t#217# (Arabidopsis thaliana plant transformation for expression of \\n\\tmutant enzymes via Agrobacterium tumefaciens strain GV3101) <402>\\nCL\\t#218# (recombinant expression of His-tagged wild-type and mutant \\n\\tenzymes in Escherichia coli strain BL21 (DE3)pLysS) <403>\\nCL\\t#220# (DNA and amino acid sequence comparisons, phylogenetic tree of \\n\\tgamma-CAs) <361>\\nCL\\t#221# (cloning of isozyme CA XIII, phylogenetic analysis, quantitative \\n\\treal-time PCR expression analysis) <366>\\nCL\\t#223# (expressed in Escherichia coli BL21(DE3) cells) <420>\\nCL\\t#227# (expressed in Escherichia coli BL21(DE3) Rosetta cells) <407>\\nCL\\t#228# (expressed in Escherichia coli BL21(DE3) cells) <436>\\nCL\\t#229# (expressed in Escherichia coli One Shot BL21 Star (DE3) cells) \\n\\t<434>\\nCL\\t#230# (expressed in Escherichia coli OneShot BL21 Star (DE3) cells) \\n\\t<440>\\nCL\\t#231# (expressed in Escherichia coli BL21(DE3) cells) <442>\\nCL\\t#233# (expressed in Escherichia coli Rosetta 2 (DE3) cells) <419>\\nCL\\t#235# (expressed in Escherichia coli BL21(DE3) cells) <427>\\nCL\\t#236# (expressed in Escherichia coli BL21(DE3) cells) <429>\\nCL\\t#237# (expressed in Escherichia coli BL21(DE3) cells) <428>\\nCL\\t#238# (expressed in Escherichia coli BL21 Star (DE3) cells) <438>\\n\\nCRYSTALLIZATION\\nCR\\t#9# (purified recombinant Co-HICA by hanging drop vapor diffusion, 10 \\n\\tmg/ml protein crystallized in 0.2 M sodium acetate, 0.1 M Tris-HCl, pH \\n\\t8.5, 0.1 M (NH4)2SO4, and 27% PEG 4000, 22C, several days, X-ray \\n\\tdiffraction structure determination and analysis at 2.5 A resolution) \\n\\t<288>\\nCR\\t#10# (purified native isozyme alphaCA1, 0.002 ml of 20 mg/ml protein in \\n\\t25 mM Tris-HCl, pH 7.5, is mixed with 0.002 ml of reservoir solution, \\n\\tcontaining 1.0 M ammonium sulfate and 100 mM Tris-HCl, pH 8.5, and \\n\\tequilibrated against 0.7 ml of reservoir solution, 20C, X-ray \\n\\tdiffraction structure determination and analysis at 1.88 A resolution, \\n\\tMAD method) <284>\\nCR\\t#12# (crystallized by hanging drop vapor diffusion method, crystals \\n\\tbelong to space group P2(1) with unit cell dimesions a : 59.0 A, b : \\n\\t75.6 A, c : 73.2 A) <119>\\nCR\\t#12# (crystallized by the vapor diffusion method, hanging drop, space \\n\\tgroup C2, unit cell parameters a : 99.3 A, b : 66.7 A, c : 92.6 A) <91>\\nCR\\t#12# (wild-type CA IV and CA V) <97>\\nCR\\t#12# (structure of the extracellular domain of murine CA XIV solved at \\n\\t2.8 A resolution, and the enzyme-acetazolamide complex at 2.9 A \\n\\tresolution) <175>\\nCR\\t#14# <38,88,92,101,110,111>\\nCR\\t#14# (carbonic anhydrase II inhibited by CN- or OCN-) <64>\\nCR\\t#14# (wild-type CA II) <97>\\nCR\\t#14# (isozyme CA XIII in the unbound state and in complex with \\n\\tacetazolamide, hanging drop vapour diffusion method, in 20 mM Tris-HCl, \\n\\tpH 7.5, 150 mM NaCl, 1 mM dithiothreitol with 30% (w/v) polyethylene \\n\\tglycol 4000, 0.2 M ammonium acetate, 0.1 M sodium acetate, pH 4.6) <247>\\nCR\\t#14# (carbonic anhydrase II complexed with two aromatic sulfonamide \\n\\tinhibitors N-(4-sulfamoylphenyl)-2-(thiophen-2-yl)acetamide and \\n\\tN-(2-fluoro-4-sulfamoylphenyl)-2-(thiophen-2-yl)acetamide incorporating \\n\\t2-thienylacetamido moieties, hanging drop vapor diffusion method, drops \\n\\tof 0.005 ml containing 0.5 mM hCA II, 1 mM inhibitor, 0.1% DMSO, 0.8 M \\n\\tsodium citrate, 50 mM Tris-HCl, pH 8.0,are equilibrated against 1 ml \\n\\tprecipitant solution containing 1.6 M sodium citrate and 50 mM \\n\\tTris-HCl, pH 8.0, at room temperature, X-ray diffraction structure \\n\\tdetermination and analysis at 1.6-1.7 A resolution) <302>\\nCR\\t#14# (purified recombinant K170 HCA II variants, hanging drop vapour \\n\\tdiffusion method, 2-3days, X-ray diffraction structure determination at \\n\\troom temperature and analysis) <290>\\nCR\\t#14# (X-ray crystallography is determined at 1.7-1.5 A resolution) <327>\\nCR\\t#18# (crystals belong to hexagonal space group P6(1), with unit-cell \\n\\tparameters a : b : 66.7 A, c : 240.0 A) <74>\\nCR\\t#18# (wild-type CA III) <97>\\nCR\\t#20# (crystals grown by hanging drop method, orthorhombic space group \\n\\tP2(1)2(1)2(1) with unit cell dimensions a : 54.9 A, b : 113.2 A, c : \\n\\t156.2 A) <116>\\nCR\\t#23# (in complex with the inhibitor acetic acid, crystals of the \\n\\torthorhombic space group C222 with cell parameters a : 136.9 A, b : \\n\\t143.3 A, c : 202.1 A) <104>\\nCR\\t#46# <12,37>\\nCR\\t#46# (carboxamidomethyl derivative) <25>\\nCR\\t#49# (hanging drop vapor diffusion method. 2.2 A crystal structure of \\n\\tCsoSCA) <180>\\nCR\\t#53# (Can2 in complex with acetate, hanging drop vapour diffusion \\n\\tmethod) <231>\\nCR\\t#56# (hanging-drop vapor diffusion method) <115>\\nCR\\t#62# (purified enzyme in complex with Zn2+ and Co2+, X-ray diffraction \\n\\tstructure determination and analysis, PDB ID 1QRG) <376>\\nCR\\t#81# (crystal structure of dCA II at 1.86 A resolution, vapour \\n\\tdiffusion method) <158>\\nCR\\t#88# <83>\\nCR\\t#88# (Cd2+-bound CDCA1 in the presence of acetate) <235>\\nCR\\t#98# (space group P2(1), a: 41.25 A, b: 44.73 A, c : 66.91 A) <108>\\nCR\\t#99# <81>\\nCR\\t#99# (cubic crystals, space group P2(1)3, Zn-Cam, unit cell a : b : c: \\n\\t82.64 A, Zn-Cam-HCO3-, unit cell a : b : c: 82.51 A, Zn-Cam-SO42-, unit \\n\\tcell a : b : c: 82.68 A, Co-Cam, unit cell a : b : c: 82.34 A, \\n\\tCo-Cam-HCO3-, unit cell a : b : c: 82.58 A, Co-Cam-SO42-, unit cell a : \\n\\tb : c: 82.61 A) <85>\\nCR\\t#99# (hanging-drop vapor diffusion technique) <315>\\nCR\\t#99# (the crystal structure of the enzyme is determined at 2.8 A \\n\\tresolution using the method of multiple isomorphous replacement in \\n\\tcombination with 3fold non-crystallographic symmetry averaging and \\n\\tphase extension) <319>\\nCR\\t#100# (crystallized by the hanging drop vapour-diffusion method, \\n\\tmonoclinic crystal system, crystals belong to space group P2(1), with \\n\\tunit-cell parameters a : 47.0 A, b : 119.9 A, c : 58.5 A) <72>\\nCR\\t#101# <113>\\nCR\\t#103# (2 different tetragonal crystal forms, form 1 space group \\n\\tP4(2)2(1)2, unit cell dimensions a : b : 68.54 A, c : 85.88A, form 2 \\n\\tspace group P4(3)22, a : : b : 81.24 A, c : 162.14 A) <138>\\nCR\\t#103# (CynT2, form 1, space group P4(2)212, unit-cell parameters a : b \\n\\t: 68.54 A, c : 85.88 A, form 2, space group P4(3)22, a : b : 81.00 A, c \\n\\t: 161.98 A, form 3, space group P2(1), a : 48.21, b : 140.73, c : \\n\\t72.57, selenomethionine-substituted crystals, space group P4(3)22, a : \\n\\tb : 81.24 A, c : 162.14 A) <71>\\nCR\\t#106# (in complex with bicarbonate or iodide, hanging drop vapor \\n\\tdiffusion method, using 20% (w/v) PEG4000, 20% (v/v) 2-propanol, and \\n\\t0.1 M sodium citrate, pH 5.6) <419>\\nCR\\t#108# (vapor diffusion method, using 1.0 M ammonium sulfate, 0.1 M \\n\\t[bis(2-hydroxyethyl)amino]tris(hydroxymethyl)methane, 1% (w/v) PEG \\n\\t3350, pH 5.5) <281>\\nCR\\t#119# (CA XII crystallized by the hanging drop vapor diffusion method, \\n\\tspace group C2 with unit cell dimensions a : 146.7 A, b : 44.6 A, c : \\n\\t85.2 A) <135>\\nCR\\t#120# (hanging drop vapor diffusion method, using 0.4 M NH4H2PO4, 0.1 M \\n\\tsodium citrate, pH 5.0) <280>\\nCR\\t#120# (isoform CA II, sitting drop vapor diffusion method, using 0.1 M \\n\\tsodium bicine, 0.2 M ammonium sulfate and 2 M sodium malonate) <274>\\nCR\\t#120# (purified isozyme CA IX in complex with inhibitors \\n\\t4-phenylbenzene-1-sulfonamide, 4-(2-methylphenyl)benzene-1-sulfonamide, \\n\\t4-(3-formylphenyl)benzene-1-sulfonamide, and \\n\\t4-(3-quinolinyl)benzene-1-sulfonamide, X-ray diffraction structure \\n\\tdetermination and analysis at 1.15-1.78 A resolution (PDB IDS 5SZ4, \\n\\t5SZ5, 5SZ6, and 5SZ7), molecular replacement using the enzyme structure \\n\\tPBD ID 3KS3 without zinc and solvent as search model) <365>\\nCR\\t#120# (purified recombinant differently isotope-labeled isozyme hCAIX, \\n\\t17 mg/ml protein, both vapour diffusion and microbatch under-oil \\n\\ttechniques are valuated, hanging and sitting drop set-ups with 0.01 ml \\n\\tdrops, microseeding, room temperature, deuteration of hCA XI does not \\n\\taffect the crystal structure, but for D-hCA IX mimic no crystals appear \\n\\tin any of the under-oil batch trays at all pHs tested, while H-hCA IX \\n\\tSV gives several good crystals per drop at pH 8.5. X-ray diffraction \\n\\tstructure determination and analysis) <352>\\nCR\\t#124# (crystals obtained by hanging drop technique, hCA II-sulfamate, \\n\\tspace group P2(1), a : 42.32 A, b : 41.48 A, c : 72.44 A, hCA \\n\\tII-sulfamide, space group P2(1), a : 42.70 A, b : 41.70 A, c : 73.00 A) \\n\\t<130>\\nCR\\t#124# (crystals obtained by hanging drop technique, space group P2(1), \\n\\tcell parameters a: 42.01 A, b : 41.43 A, c: 71.99 A) <84>\\nCR\\t#124# (in complex with inhibitor RWJ-37497, crystals obtained by the \\n\\thanging-drop vapour-diffusion method, space group P2(1) with unit cell \\n\\tparameters a : 42.28 A, b : 41.39 A, c : 72.51 A) <80>\\nCR\\t#124# (mutant H64A complexed with 4-methylimidazole) <73>\\nCR\\t#124# (mutant H64A, crystals produced by the hanging drop method, space \\n\\tgroup P2(1) with unit cell parameters of a : 42.5 A, b : 41.6 A, c : \\n\\t72.7 A) <87>\\nCR\\t#124# (site-specific mutant Y7H, crystals produced by the hanging drop \\n\\tmethod, space group P2(1) with unit cell dimensions a : 42.9 A, b: 41.6 \\n\\tA, c : 73.0 A) <117>\\nCR\\t#124# (crystal structure of the hCA \\n\\tII/2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide adduct) \\n\\t<172>\\nCR\\t#124# (crystal structure of the \\n\\thCA/2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide adduct) <171>\\nCR\\t#124# (crystals of the HCA II single-site mutants Y7F, N62L, and N67L \\n\\tare obtained using the hanging-drop vapor diffusion method. All \\n\\tcrystals are isomorphous and belong to space group P2(1) with mean unit \\n\\tcell dimensions: a = 42.7 A, b = 41.6 A, c = 72.9 A and beta = 104.6) \\n\\t<162>\\nCR\\t#124# (the hCA II-sulthiame complex is crystallized by \\n\\tcocrystallization procedures. High resolution crystal structure of the \\n\\thCA II-sulthiame adduct) <170>\\nCR\\t#124# (the hCA IIN-hydroxysulfamide complex is cocrystallized at 4C \\n\\tby the hanging drop vapor diffusion method. X-ray crystal structure of \\n\\tthe human hCA II-N-hydroxysulfamide adduct) <168>\\nCR\\t#124# (X-ray absorption nearedge spectroscopy (XANES)/MXAN analysis of \\n\\tthe reaction center) <173>\\nCR\\t#124# (crystals of carbonic anhydrase II and carbonic anhydrase IX \\n\\tmimic are grown at room temperature using the hanging drop vapour \\n\\tdiffusion method) <196>\\nCR\\t#124# (holoenzyme and apoenzyme are crystallized by hanging drop vapour \\n\\tdiffusion method, using 1.3 M sodium citrate, 100 mM Tris-HCl, pH 7.8) \\n\\t<224>\\nCR\\t#124# (in complex with the inhibitor chlorthalidone) <229>\\nCR\\t#124# (isozyme carbonic anhydrase II complexed with inhibitor EMD \\n\\t486019) <202>\\nCR\\t#124# (mutants are crystallized by hanging drop vapour diffusion \\n\\tmethod, with 50 mM Tris-HCl (pH 9.0) and 1.3 M sodium citrate at 20C) \\n\\t<195>\\nCR\\t#124# (isoform CA II in complex with 4b, hanging drop vapor diffusion \\n\\tmethod) <279>\\nCR\\t#124# (isoform CA II in complex with \\n\\t6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide, hanging drop \\n\\tvapor diffusion method, using 2.5 M (NH4)2SO4, 0.3 M NaCl, 100 mM \\n\\tTris-Cl, pH 8.2) <278>\\nCR\\t#124# (purified recombinant HCA II, crystals are prepared at pH 6.0, pH \\n\\t8.5, and pH 11.0, hanging drop vapor diffusion method, crystal \\n\\tpreparation from apo-Co(II)-HCA II by mixing 0.005 ml of protein \\n\\tsolution with 0.005 ml of precipitant solution, containing 1.4 M sodium \\n\\tcitrate, and 100 mM Tris-HCl, pH 9.0, at room temperature, and soaking \\n\\tof the crystals in 100 mM CoCl2, 1.4 M sodium citrate, 50 mM Tris-Cl, \\n\\t50 mM 3-(cyclohexylamino)propanesulfonic acid with pH values of 6.0, \\n\\t8.5 and 11.0, respectively, 2-3days, X-ray diffraction structure \\n\\tdetermination and analysis at 1.5-1.6 A resolution) <286>\\nCR\\t#124# (all variants crystallized in the orthorhombic P2(1) 2(1) 2 (1) \\n\\tspace group and are highly isomorphous with approximate unit cell \\n\\tdimensions a=42, b=72 and c=75 A and diffract between 1.56 and 2.0 A \\n\\tresolution) <348>\\nCR\\t#124# (X-ray crystallographic structure of the disulfide-containing \\n\\tHCAII (dsHCAII) is solved to 1.77 A resolution) <323>\\nCR\\t#124# (purified isozyme CA II (chimeric CA IX mimic) mutant in complex \\n\\twith inhibitors 4-phenylbenzene-1-sulfonamide, \\n\\t4-(2-methylphenyl)benzene-1-sulfonamide, \\n\\t4-(3-formylphenyl)benzene-1-sulfonamide, and \\n\\t4-(3-quinolinyl)benzene-1-sulfonamide, sitting drop vapor diffusion \\n\\tmethod, mixing of 300-500 nl of 20 mg/mL of CA II and 41 mg/ml of the \\n\\tCA IX mimic solution with crystallization solution containing 1.6 M \\n\\tsodium citrate, 50 mM Tris-HCl, pH 7.8, in a ratio of 3:5 or 1:1, 25C, \\n\\t1 week, X-ray diffraction structure determination and analysis at \\n\\t1.55-1.69 A resolution (PDB IDS 5SZ0, 5SZ1, 5SZ2, and 5SZ3), molecular \\n\\treplacement using the enzyme structure PBD ID 3KS3 without zinc and \\n\\tsolvent as search model) <365>\\nCR\\t#124# (purified recombinant differently isotope-labeled isozyme hCAII, \\n\\t14 mg/ml protein, both vapour diffusion and microbatch under-oil \\n\\ttechniques are valuated, hanging and sitting drop set-ups with 0.01 ml \\n\\tdrops, microseeding, deuteration of hCA II does not affect the crystal \\n\\tstructure. Large, single crystals grow for both H and D enzyme versions \\n\\tin microbatch under-oil experiments at pH 8.5, room temperature, X-ray \\n\\tdiffraction structure determination and analysis) <352>\\nCR\\t#124# (purified recombinant human CA II in complex with imidazole-based \\n\\tactivator CAA12i, hanging drop vapor diffusion method, mixing of 10 \\n\\tmg/ml protein and 0.2 mM ligand in 50 mM Tris-HCl, pH 7.8, with \\n\\treservoir solution, containing 50 mM Tris HCl and 1.3 M sodium citrate, \\n\\tpH 7.4, in a 1:1 ratio, 23C, 7 days without agitation, X-ray \\n\\tdiffraction structure determination and analysis at 1.6 A resolution) \\n\\t<396>\\nCR\\t#124# (purified recombinant wild-type enzyme and mutants M1-M4, X-ray \\n\\tdiffraction structure determination and analysis at resolutions of \\n\\t1.62-2.29 A) <397>\\nCR\\t#124# (mutant enzyme A65T/N67Q/F130Y/V134Q/L203T, using 0.1 M sodium \\n\\tbicine (pH 9.0), 0.2 M ammonium sulfate and 2 M sodium malonate (pH \\n\\t7.0)) <446>\\nCR\\t#125# (crystal structures of C-terminal hexahistidine-tagged carbonic \\n\\tanhydrase III and F198L carbonic anhydrase III, hanging-drop vapour \\n\\tdiffusion method, 2.1 A resolution) <140>\\nCR\\t#125# (crystals of K64H, R67H, and K64H/R67N HCA III are grown by \\n\\thanging drop vapor diffusion method. X-ray crystal structures of \\n\\tsite-specific mutants of human carbonic anhydrase III (HCA III): K64H, \\n\\tR67H, and K64H/R67N HCA III) <192>\\nCR\\t#127# (crystals obtained using the hanging drop vapor diffusion method, \\n\\tisozyme CA I Michigan I, space group P2(1)2(1)2(1), with unit cell \\n\\tdimensions parameters a : 62.50 A, b : 72.13 A, c : 121.54 A, isozyme \\n\\tCA I Michigan 1-Zn(II)2, space group P2(1)2(1)2(1), with unit cell \\n\\tdimensions parameters a : 62.68 A, b : 71.36 A, c : 120.91A) <93>\\nCR\\t#127# (purified enzyme in complex with inhibitors \\n\\t(S)-4-(4-acetyl-3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide and \\n\\t(S)-4-[2-benzyl-4-(4-sulfamoylbenzoyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide, sitting drop vapor diffusion method, mixing of 0.002 ml of \\n\\t10 mg/ml protein in 20 mM Tris-HCl, pH 9.0, with 0.002 ml of a solution \\n\\tof 28-31% PEG 4000, 0.2 M sodium acetate, 0.1 M Tris, pH 8.5-9.0 and \\n\\tequilibration against the same solution at 23C, fifteen days, \\n\\tafterwards the crystals are soaked in 5 mM inhibitor solutions for 3 \\n\\tdays, X-ray diffraction structure determination and analysis at 1.5-1.6 \\n\\tA resolution) <369>\\nCR\\t#143# (X-ray absorption near edge spectroscopy (XANES)/MXAN analysis of \\n\\tthe reaction center) <173>\\nCR\\t#163# (Nce103 in complex with a substrate analog at 2.04 A resolution, \\n\\thanging drop vapor diffusion method, using 20% (w/v) PEG4000, 0.1 M \\n\\tsodium citrate, pH 5.6, 0.1 M sodium acetate, 20% (v/v) ethylene \\n\\tglycol, at 16C) <266>\\nCR\\t#165# (sitting drop vapor diffusion method, using 10% (w/v) PEG 6000, \\n\\t0.3 M NH4Cl pH 6.3, and 10% (v/v) ethylene glycol) <283>\\nCR\\t#166# (purified wild-type and mutant enzymes, 12 mg/ml protein mixed \\n\\twith 0.7 M sodium potassium tartrate, 0.10 M HEPES, pH 7.5, for \\n\\ttetragonal crystals and with 1.8 M ammonium sulfate, 4% PEG 400, 0.10 M \\n\\tHEPES, pH 7.5, for monoclinic crystals, 22C, 2-3 days, crystals are \\n\\tsoaked for 1-2 min in artificial mother liquor plus either 30% glucose \\n\\tor 30% glucose and 100 mM NaHCO3, X-ray diffraction structure \\n\\tdetermination and analysis) <289>\\nCR\\t#175# (complex with the inhibitor acetazolamide) <59>\\nCR\\t#178# (determined to a resolution of 2.7A) <337>\\nCR\\t#179# (determined to a resolution of 2.7A) <337>\\nCR\\t#181# (crystal structure determination and analysis, PDB ID 4X5S) <376>\\nCR\\t#184# (in complex with Ca2+, sitting drop vapour diffusion method, with \\n\\t22.5% PEG 4000 in MES-NaOH pH 5.8 and 0.1 M lithium chloride as the \\n\\tprecipitating agent) <194>\\nCR\\t#185# (purified enzyme in complex with inhibitor acetazolamide, X-ray \\n\\tdiffraction structure determination and analysis, PDB ID 4G7A) <376>\\nCR\\t#188# (enzyme crystal structure determination and analysis, Cab dimer, \\n\\tPDB ID 1G5C) <376>\\nCR\\t#191# (in the absence and presence of acetazolamide, sitting drop vapor \\n\\tdiffusion method, using 100 mM sodium HEPES pH 7.5 (or glycine pH 9.5), \\n\\t28-32% (w/v) polyethylene glycol 400, and 200-400 mM calcium chloride \\n\\tdehydrate) <441>\\nCR\\t#192# (crystal structure determination and analysis, PDB ID 4C3T) <376>\\nCR\\t#202# (purified recombinant enzyme, sitting drop vapour diffusion, \\n\\tusing a precipitant solution consisting of 2% v/v Tacsimate, pH 4.0, \\n\\t0.1 M sodium acetate trihydrate, pH 4.6, and 16% w/v PEG 3350, 10 days \\n\\tat 17C, X-ray diffraction structure determination and analysis at 2.6 \\n\\tA resolution) <350>\\nCR\\t#203# (purified recombinant truncated enzyme CcaA220, by sitting drop \\n\\tvapor diffusion method, mixing of 0.001 ml of 7 mg/ml protein solution \\n\\twith 0.001 ml of well solution containing 2.0 M Na formate and 0.1 M Na \\n\\tacetate, pH 4.6, X-ray diffraction structure determination and analysis \\n\\tat 1.45 A resolution, molecular replacement using the structure of a \\n\\tcatalytic dimer (residues 121-318) from Pisum sativum beta-CA (PDB ID \\n\\t1ekj) as a search model) <355>\\nCR\\t#207# (purified recombinant His-tagged enzyme incomplex with inhibitor \\n\\tacetazolamide, hanging drop vapor diffusion method, mixing of 0.001 ml \\n\\tof 8 mg/ml protein in 20 mM Tris, pH 8.3, and a 10-molar excess of the \\n\\tinhibitor with 0.001 m of reservoir solution containing 30% w/v PEG \\n\\tmonomethyl ether 550, 0.05 M MgCl2, and 0.1 M HEPES, pH 7.5, and \\n\\tequilibration against 0.5 ml of reservoir solution, 1 week, room \\n\\ttemperature, X-ray diffraction structure determination and analysis at \\n\\t1.95 A resolution, molecular replacement using the structure of enzyme \\n\\tSspCA from Sulfurihydrogenibium yellowstonensis (PDB ID 4G7A) as a \\n\\tsearch model) <360>\\nCR\\t#218# (purified recombinant detagged enzyme CrCAH3 with inhibitors \\n\\tphosphate and acetazolamide, hanging drop vapor diffusion method, \\n\\tmixing of 0.001 ml of 3.6 mg/l protein in mM Tris-HCl, pH 8.0, and 150 \\n\\tmM NaCl, and 1 mM ligand, with 0.001 ml of reservoir solution \\n\\tcontaining 2.5 M NH4H2PO4 and 0.1 M Tris-HCl, pH 8.0, to a final pH of \\n\\tpH 4.1, and equilibration over 1 ml reservoir solution, at 18C, method \\n\\toptimization, X-ray diffraction structure determination and analysis at \\n\\t2.6-2.7 A resolution) <403>\\nCR\\t#223# (enzyme variant truncated by 29 residues, hanging drop vapor \\n\\tdiffusion method, using 0.1 M ammonium acetate, pH 5.5, 25% (w/v) PEG \\n\\t3350) <420>\\nCR\\t#227# (truncated isoform LCIB3-C, hanging drop vapor diffusion method, \\n\\tusing 0.2 M ammonium sulfate, 0.1 M bis-Tris pH 5.3, 26% (w/v) PEG \\n\\t3350) <407>\\nCR\\t#229# (hanging drop vapor diffusion method, using 30% (w/v) PEG 4000, \\n\\t0.2M sodium acetate, 0.1M Tris-HCl, pH 8.5) <434>\\nCR\\t#231# (apoenzyme and enzyme bound to acetazolamide, sitting drop vapor \\n\\tdiffusion method, using 0.1 M MES (or Tris-HCl) pH 6.0-7.5, 24-30% \\n\\t(w/v) polyethylene glycol 2000 monomethyl ether, and 0.2-0.4 M sodium \\n\\tacetate) <442>\\nCR\\t#233# (in complex with bicarbonate or iodide, hanging drop vapor \\n\\tdiffusion method, using 2.4 M sodium malonate, pH 7.0) <419>\\n\\nPURIFICATION\\nPU\\t#1# <34>\\nPU\\t#1# (native enzyme from erythrocytes by gel filtration and \\n\\telectrofocusing) <285>\\nPU\\t#5# <24,152>\\nPU\\t#9# (recombinant Co-HICA from Escherichia coli by gel filtration) <288>\\nPU\\t#10# <14>\\nPU\\t#10# (carbonic anhydrase 2) <62>\\nPU\\t#10# (amylose resin chromatography) <239>\\nPU\\t#10# (native enzyme by anion exchange and hydrophobic interaction \\n\\tchromatography, followed by gel filtration) <284>\\nPU\\t#11# (Sephadex G-75 gel filtration, DEAE cellulose column \\n\\tchromatography, and Sepharose-4B-L tyrosine sulfanilamide column \\n\\tchromatography) <264>\\nPU\\t#12# <91,106,119>\\nPU\\t#12# (recombinant enzyme) <50>\\nPU\\t#14# <2,28,53,92,96,100,120,131,133,134,226,416>\\nPU\\t#14# (recombinant enzyme) <82,88,101,110>\\nPU\\t#14# (improved method for the purification of the carbonic anhydrase \\n\\tisozymes by affinity chromatography) <29>\\nPU\\t#14# (recombinant enzymes) <132>\\nPU\\t#14# (carbonic anhydrase inhibitor affinity chromatography) <211>\\nPU\\t#14# (GSTrap resin chromatography and NHS-activated Sepharose 4 Fast \\n\\tFlow resin chromatography) <247>\\nPU\\t#14# (Sepharose 4B-L-tyrosine-sulfanilamide affinity chromatography) \\n\\t<225>\\nPU\\t#14# (Sepharose-6B-aniline-sulfanilamide affinity column \\n\\tchromatography) <209>\\nPU\\t#14# (native hCA I and hCA II from erythrocytes by \\n\\taniline-sulfanylamide affinity chromatography) <304>\\nPU\\t#14# (recombinant wild-type and mutant enzymes from Escherichia coli \\n\\tstrain BL21(DE3)pLysS by affinity chromatography on a \\n\\t4-(aminomethyl)-benzene-sulfonamide resin) <290>\\nPU\\t#14# (Sepharose-4B-L-tyrosine-sulfanilamide column chromatography, and \\n\\tSuperdex 200 gel filtration) <414>\\nPU\\t#15# <7,23,45,134>\\nPU\\t#16# <4>\\nPU\\t#17# (ammonium sulfate precipitation and Sephadex G-100 gel filtration) \\n\\t<210>\\nPU\\t#18# <3,11,74,120,149>\\nPU\\t#18# (His-tagged recombinant protein) <109>\\nPU\\t#18# (Sepharose 4B-L-tyrosine sulfanilamide column chromatography) <248>\\nPU\\t#20# <114>\\nPU\\t#20# (recombinant protein) <112>\\nPU\\t#21# <1,40>\\nPU\\t#21# (affinity chromatography) <333>\\nPU\\t#21# (native enzynme from erythrocytes, 203fold by L-tyrosine \\n\\tsulfanilamide affinity chromatography) <380>\\nPU\\t#21# (native enzynme from erythrocytes, 243fold by L-tyrosine \\n\\tsulfanilamide affinity chromatography, to homogeneity) <379>\\nPU\\t#23# <39,75,104,155>\\nPU\\t#24# <56>\\nPU\\t#26# <90>\\nPU\\t#28# (Ni-NTA resin column chromatography, TALON cobalt resin column \\n\\tchromatography, and Superdex 200 gel filtration) <443>\\nPU\\t#30# <49,107>\\nPU\\t#30# (Ni-NTA column chromatography) <265>\\nPU\\t#31# (recombinant isozymes CAH-3, CAH-4a and CAH-5 from Escherichia \\n\\tcoli strain BL21(DE3) by nickel affinity chromatography) <310>\\nPU\\t#32# <276>\\nPU\\t#32# (glutathione Sepharose 4B column chromatography and sulfonamide \\n\\taffinity chromatography) <275>\\nPU\\t#38# (native enzyme 35fold from spermatheca by L-tyrosine-sulfanylamide \\n\\taffinity chromatography, elution with 1 M NaCl/25 mM Na2HPO4, pH 6.3) \\n\\t<390>\\nPU\\t#39# <165>\\nPU\\t#41# <98>\\nPU\\t#43# (ammonium sulfate fractionation and \\n\\t4-aminomethylbenzenesulfonamide agarose column chromatography) <282>\\nPU\\t#44# (Ni-NTA resin column chromatography) <272>\\nPU\\t#46# <25>\\nPU\\t#48# <6>\\nPU\\t#49# <180>\\nPU\\t#49# (recombinant) <178>\\nPU\\t#51# (recombinant) <190>\\nPU\\t#55# <55>\\nPU\\t#56# <115>\\nPU\\t#58# <127,177>\\nPU\\t#58# (Sepharose-4B-L-tyrosine-sulfanilamide affinity chromatography) \\n\\t<199>\\nPU\\t#58# (Sepharose-4B-L-tyrosine-sulfanilamide affinity column \\n\\tchromatography) <246>\\nPU\\t#59# (affinity chromatography) <339>\\nPU\\t#62# <51,86,90,322>\\nPU\\t#62# (recombinant enzyme) <81,110>\\nPU\\t#62# (recombinant enzyme from Escherichia coli anaerobically or \\n\\taerobically, recombinant enzyme from Methanosarcina acetivorans \\n\\tanaerobically) <376>\\nPU\\t#63# (affinity chromatography) <330>\\nPU\\t#64# <66>\\nPU\\t#65# (using Ni-NTA chromatography) <341>\\nPU\\t#66# <9>\\nPU\\t#67# <16>\\nPU\\t#68# <63>\\nPU\\t#70# <32>\\nPU\\t#71# <35>\\nPU\\t#72# <61>\\nPU\\t#73# <54>\\nPU\\t#77# (protein A Sepharose CL-4B column chromatography) <269>\\nPU\\t#80# (native enzyme 78.8fold from liver by single step tyrosine \\n\\tsulfanilamide affinity chromatography) <306>\\nPU\\t#81# (recombinant enzyme) <72>\\nPU\\t#85# (Ni2+-NTA agarose column chromatography) <408>\\nPU\\t#88# <83>\\nPU\\t#88# (affinity chromatography) <334>\\nPU\\t#91# (native enzyme 91fold by L-tyrosine-sulfanilamide affinity \\n\\tchromatography, elution with 1 M NaCl/25 mM Na2HPO4, pH 6.3) <385>\\nPU\\t#92# <128>\\nPU\\t#94# (acetone precipitation and Sephadex G-100 gel filtration) <425>\\nPU\\t#97# (His-Select nickel affinity column chromatography) <439>\\nPU\\t#98# <108>\\nPU\\t#99# <94,160>\\nPU\\t#99# (recombinant enzyme) <85>\\nPU\\t#99# (the recombinant enzyme is purified anaerobically) <321>\\nPU\\t#100# <161>\\nPU\\t#100# (recombinant enzyme) <137>\\nPU\\t#101# (recombinant enzyme) <113>\\nPU\\t#102# <128>\\nPU\\t#103# <138>\\nPU\\t#103# (recombinant enzyme) <71>\\nPU\\t#104# <128>\\nPU\\t#106# (His GraviTrap column chromatography) <419>\\nPU\\t#108# (His-Select column chromatography, gel filtration) <281>\\nPU\\t#118# (recombinant His-tagged isozyme CA XIV from Escherichia coli \\n\\tstrains to 96% purity by nickel affinity chromatography, dialysis, and \\n\\t4-aminomethylbenzenesulfonamide affinity chromatography (elution by a \\n\\tlinear gradient of 0.5 M sodium perchlorate using 0.1 M sodium acetate \\n\\tand 0-0.5 M sodium perchlorate, pH 5.6)) <381>\\nPU\\t#120# (Sepharose-IDA-Ni+2 column chromatography, S-Sepharose column \\n\\tchromatography, gel filtration) <274>\\nPU\\t#120# (Superdex 200 gel filtration and Superdex 75 gel filtration) <280>\\nPU\\t#120# (isozyme CA IX, recombinant wild-type isozyme from Escherichia \\n\\tcoli strain BL21(DE3) by p-aminomethylbenzenesulfonamide affinity \\n\\tchromatography) <365>\\nPU\\t#120# (recombinant enzyme from Escherichia coli strain BL21(DE3) by \\n\\tp-amino-methyl-benzenesulfonamide affinity chromatography and gel \\n\\tfiltration, followed by ultrafiltration) <352>\\nPU\\t#120# (recombinant GST-tagged isozyme hCA IX from Escherichia coli \\n\\tstrain BL21 Codon Plus by glutathione affinity chromatography and \\n\\tsulfonamide affinity chromatography) <386>\\nPU\\t#120# (recombinant His-tagged PG domain of isozyme CA9 IX from \\n\\tEscherichia coli strain BL21(DE3) by nickel affinity chromatography, \\n\\ttag cleavage by protease enzyme SenP2, and another step of nickel \\n\\taffinity chromatography to remove the tag) <364>\\nPU\\t#122# (native enzyme 539fold by one-step affinity chromatography on \\n\\tL-tyrosine sulphonamide) <308>\\nPU\\t#124# <80,117,173>\\nPU\\t#124# (recombinant enzymes) <87>\\nPU\\t#124# (mutant H64A) <73>\\nPU\\t#124# (recombinant wild-type and mutant enzymes from Escherichia coli) \\n\\t<397>\\nPU\\t#124# (agarose resin column chromatography) <224>\\nPU\\t#124# (mutant enzyme N67L is purified by affinity chromatography using \\n\\t4-(aminomethyl)benzenesulfonamide coupled to agarose beads) <249>\\nPU\\t#124# (recombinant HCA II from Escherichia coli strain BL21) <286>\\nPU\\t#124# (isozyme CA II, recombinant wild-type isozyme CA II and chimeric \\n\\tCA IX mimic mutant isozyme from Escherichia coli strain BL21(DE3) by \\n\\tp-aminomethylbenzenesulfonamide affinity chromatography) <365>\\nPU\\t#124# (native isozyme hCA II from erythrocytes isolated from human \\n\\tblood by cellulose-benzyl-sulfanilamide affinity chromatography, \\n\\telution with 0.1 M CH3COONa/0.5 M NaClO4, pH 5.6) <386>\\nPU\\t#124# (native isozyme hCA II from human blood erythrocytes by \\n\\tL-tyrosine-sulfanilamide affinity chromatography and elution with 0.1 M \\n\\tNaCH3COO/0.5 M NaClO4, pH 5.6) <378>\\nPU\\t#124# (recombinant enzyme from Escherichia coli strain BL21(DE3) by \\n\\t4-aminomethylbenzenesulfonamide agarose affinity chromatography and \\n\\tultrafiltration) <396>\\nPU\\t#124# (recombinant enzyme from Escherichia coli strain BL21(DE3) by \\n\\tp-amino-methyl-benzenesulfonamide affinity chromatography and gel \\n\\tfiltration, followed by ultrafiltration) <352>\\nPU\\t#124# (recombinant His-tagged isozyme HCAII by nickel affinity \\n\\tchromatography, ultrafiltration, and gel filtration, to homogeneity) \\n\\t<375>\\nPU\\t#125# <167>\\nPU\\t#126# (cytosolic isoenzyme) <176>\\nPU\\t#126# (inner peripheral isoenzyme) <176>\\nPU\\t#126# (integral isoenzyme) <176>\\nPU\\t#126# (outer peripheral isoenzyme) <176>\\nPU\\t#127# <93>\\nPU\\t#127# (native isozyme hCA I from erythrocytes isolated from human blood \\n\\tby cellulose-benzyl-sulfanilamide affinity chromatography, elution with \\n\\t1 M NaCl/25 mM Na2HPO4, pH 6.3) <386>\\nPU\\t#127# (native isozyme hCA I from human blood erythrocytes by \\n\\tL-tyrosine-p-aminobenzene sulfonamide affinity chromatography) <405>\\nPU\\t#127# (native isozyme hCA I from human blood erythrocytes by \\n\\tL-tyrosine-sulfanilamide affinity chromatography and elution with 1.0 M \\n\\tNaCl/25 mM Na2HPO4, pH 6.3) <378>\\nPU\\t#129# (recombinant soluble His-tagged enzyme from Escherichia coli \\n\\tstrain BL21(DE3) by nickel affinity and anion exchange chromatography \\n\\tfrom the supernatant, and recombinant renatured His-tagged enzyme from \\n\\tinclusion bodies by nickel affinity chromatography, both enzyme forms \\n\\tare active) <349>\\nPU\\t#131# (p-aminomethylbenzenesulfonamide-agarose column chromatography) \\n\\t<445>\\nPU\\t#132# (Probond nickel chelating resin affinity column chromatography, \\n\\tand Superdex 200 gel filtration) <418>\\nPU\\t#133# (recombinant His-tagged enzyme) <118>\\nPU\\t#143# <173>\\nPU\\t#144# (Sepharose-4B-L-tyrosine-sulfanilamide column chromatography, and \\n\\tSuperdex 200 gel filtration) <426>\\nPU\\t#162# (Talon Co2+-affinity resin column chromatography, gel filtration) \\n\\t<277>\\nPU\\t#162# (recombinant His-tagged bsCA II from Escherichia coli by cobalt \\n\\taffinityy chromatography) <298>\\nPU\\t#163# (Ni2+ affinity column chromatography and Superdex 75 gel \\n\\tfiltration) <266>\\nPU\\t#164# (nickel affinity column chromatography) <273>\\nPU\\t#165# (Ni-Sepharose column chromatography and Superdex S75 gel \\n\\tfiltration) <283>\\nPU\\t#166# (recombinant mutants V47A and G41A to homogeneity from \\n\\tEscherichia coli by ion exchange and hydrophobic interaction \\n\\tchromatography, and gel filtration) <289>\\nPU\\t#168# (recombinant His-tagged isozyme from Escherichia coli strain \\n\\tBL21(DE3) by nickel affinity chromatography) <292>\\nPU\\t#169# (recombinant His-tagged isozyme from Escherichia coli strain \\n\\tBL21(DE3) by nickel affinity chromatography) <292>\\nPU\\t#172# <230>\\nPU\\t#173# <136>\\nPU\\t#176# <320>\\nPU\\t#177# (affinity chromatography) <340>\\nPU\\t#181# (carbonic anhydrase from Sulfurihydrogenibium azorense and \\n\\tcyanase from Thermomyces lanuginosus are purified by one-step heating \\n\\twithout prior cell lysis. The heat treatment results in higher \\n\\tactivities of both enzymes than the conventional two-step process) <421>\\nPU\\t#184# (Super Q Toyopearl 650M column chromatography, Resource Q column \\n\\tchromatography, Bio-Scale CHT-20-I column chromatography, and Superdex \\n\\t200pg gel filtration) <194>\\nPU\\t#191# (recombinant His-tagged enzyme from Escherichia coli strain \\n\\tBL21(DE3) by nickel affinity chromatography, dialysis, and \\n\\tultrafiltration) <404>\\nPU\\t#191# (nickel affinity resin column chromatography, HiTrap column \\n\\tchromatography, and Superdex 200 gel filtration) <441>\\nPU\\t#192# (Ni-NTA column chromatography) <429>\\nPU\\t#193# (the enzyme from a commercial preparation is further purified by \\n\\tgel filtration and ultrafiltration) <356>\\nPU\\t#194# (native soluble enzyme from mantle by ammonium sulfate \\n\\tfractionation, anion exchange chromatography, and pAMBS affinity \\n\\tchromatography, to homogeneity) <391>\\nPU\\t#197# (recombinant extracellular enzyme from Pichia pastoris strain \\n\\tGS115 culture supernatant by ultrafiltration, acetone precipitation, \\n\\tand pAMBS affinity chromatography) <367>\\nPU\\t#197# (recombinant His-tagged enzyme from Escherichia coli strain \\n\\tBL21(DE3) medium by nickel affinity chromatography) <374>\\nPU\\t#198# (recombinant His-tagged enzyme from Escherichia coli strain \\n\\tBL21(DE3)pLysS by cobalt affinity chromatography and dialysis) <384>\\nPU\\t#199# (recombinant His-tagged enzyme from Escherichia coli by nickel \\n\\taffinity chromatagraphy) <382>\\nPU\\t#200# (recombinant enzyme CA VI-PTX from Spodoptera frugiperda Sf9 \\n\\tcells) <399>\\nPU\\t#202# (recombinant enzyme from Escherichia coli strain BL21(DE3) by \\n\\tp-(aminomethyl)-benzenesulfonamide affinity chromatography) <350>\\nPU\\t#203# (recombinant His-tagged enzyme from Escherichia coli strain \\n\\tBL21(DE3) by nickel affinity chromatography) <355>\\nPU\\t#204# (recombinant His-tagged enzyme from Escherichia coli strain \\n\\tBL21(DE3) by nickel affinity chromatography) <355>\\nPU\\t#205# (recombinant His-tagged enzyme from Escherichia coli strain \\n\\tBL21(DE3)/ArcticExpress DE3 cells by nickel affinity chromatography) \\n\\t<359>\\nPU\\t#206# (recombinant His-tagged enzyme from Escherichia coli strain \\n\\tBL21(DE3)/ArcticExpress DE3 cells by nickel affinity chromatography) \\n\\t<358>\\nPU\\t#207# (Ni-NTA column chromatography) <444>\\nPU\\t#207# (recombinant His-tagged enzyme from Escherichia coli strain \\n\\tBL21(DE3) by nickel affinity chromatography, dialysis, and gel \\n\\tfiltration, followed by pAMBS affinity chromatography) <360>\\nPU\\t#208# (recombinant His-tagged enzyme from Escherichia coli strain \\n\\tBL21(DE3) by nickel affinity chromatography and dialysis) <363>\\nPU\\t#211# (recombinant His6-tagged enzyme from Escherichia coli strain \\n\\tBL21(DE3) by nickel affinity chromatography, ultrafiltration, and \\n\\tdialysis) <395>\\nPU\\t#218# (recombinant is-tagged wild-type and mutant enzymes from \\n\\tEscherichia coli strain BL21 (DE3)pLysS by nickel affinity \\n\\tchromatography, gel filtration, and tag cleavage by TEV protease, \\n\\tfollowed by dialysis, another step of nickel affinity chromatography, \\n\\tanion exchange chromatography, gel filtration, and ultrafiltration) \\n\\t<403>\\nPU\\t#219# (native enzyme 349fold by L-tyrosine-sulfanilamide affinity \\n\\tchromatography) <368>\\nPU\\t#222# (native enzyme 303.9fold from gills by L-tyrosine-sulfanilamide \\n\\taffinity chromatography) <377>\\nPU\\t#223# (Ni-NTA column chromatography and MonoQ column chromatography) \\n\\t<420>\\nPU\\t#227# (HisTrap column chromatography and Superdex 200 gel filtration) \\n\\t<407>\\nPU\\t#228# (His-Trap column chromatography) <436>\\nPU\\t#229# (Ni-NTA agarose column chromatography) <434>\\nPU\\t#230# (Ni-NTA column chromatography) <440>\\nPU\\t#231# (glutathione agarose bead chromatography, HiTrap Q anion exchange \\n\\tcolumn chromatography, and Superdex 200 gel filtration) <442>\\nPU\\t#232# (Ni-NTA column chromatography and Superdex 75 gel filtration) \\n\\t<411>\\nPU\\t#233# (His GraviTrap column chromatography) <419>\\nPU\\t#234# (Sepharose-4B-L-sulfanilamide affinity column chromatography) \\n\\t<424>\\nPU\\t#235# (Ni-NTA column chromatography) <427>\\nPU\\t#236# (Ni-NTA column chromatography) <429>\\nPU\\t#237# (His-Select nickel affinity column chromatography) <428>\\nPU\\t#238# (Ni-NTA resin column chromatography) <438>\\n\\nRENATURED\\nREN\\t#96# (the enzyme is refolded through stepwise dialysis with decreasing \\n\\tconcentrations of urea (2, 1, and 0 mM) for 12 h each for renaturation) \\n\\t<423>\\nREN\\t#129# (recombinant enzyme from Escherichia coli inclusion bodies by \\n\\tsolubilization of the purified inclusion bodies in 50 mM phosphate \\n\\tbuffer, pH 7.0, 300 mM NaCl, and 1% N-lauroylsarcosine, and incubation \\n\\ton rocker for 30 min, or by dialyzing the solution against 50 mM \\n\\tphosphate buffer, pH 7.0, and 150 mM NaCl for 24 h at 4C, and then \\n\\tfollowed by centrifugation of the solubilized inclusion bodies for 30 \\n\\tmin at 12000 rpm) <349>\\n\\nGENERAL_STABILITY\\nGS\\t#100# (presence of salt, 0-4 M NaCl, during Dca storage has no effect \\n\\ton the enzyme stability and activity) <137>\\nGS\\t#12# (guanidine hydrochloride causes denaturation) <106>\\nGS\\t#124# (a key role for sodium ions in increasing halotolerant enzyme \\n\\tstability largely through interactions with the highly ordered first \\n\\tNa+ hydration shell, molecular dynamics calculations, overview) <397>\\nGS\\t#14# (noncovalent complexes with benzenesulfonamide inhibitors are \\n\\thighly stable) <103>\\nGS\\t#14# (the enzymes polyhemoglobin, superoxide dismutase, catalase, and \\n\\tcarbonic anhydrase (SFHb, SOD, CAT, CA) are all cross-linked together \\n\\tto form a nano-sized soluble blood substitute. The enzymes activities \\n\\tof the freeze-dried cross-linked enzyme complex poly-[SFHb-SOD-CAT-CA] \\n\\tare more stable compared with the soluble poly-[SFHb-SOD-CAT-CA] and \\n\\teven more so when compared to the uncrosslinked solution of free SFHb, \\n\\tSOD, CAT and CA enzymes) <353>\\nGS\\t#15# (relatively resistant to SDS) <45>\\nGS\\t#18# (denaturation with guanidinium chloride) <10>\\nGS\\t#18# (4C, 1% SDS, stable for several weeks) <11>\\nGS\\t#207# (after 10 cycles, the immobilized enzyme shows approximately 90% \\n\\tof the activity of freshly prepared immobilized enzyme) <444>\\nGS\\t#30# (guanidine hydrochloride causes denaturation and inactivation) \\n\\t<107>\\nGS\\t#41# (enzyme appears to denature with a midpoint of a structural \\n\\ttransition near 2.1 M denaturant guanidine hydrochloride) <98>\\nGS\\t#44# (the purified protein is unstable in the absence of glycerol and \\n\\taggregates irreversibly) <272>\\nGS\\t#66# (dialysis against pyridine dicarboxylate, at 15C, 98% loss of \\n\\tactivity after 24 h) <9>\\nGS\\t#67# (0.8 M guanidinium chloride, 24 h, 50% inactivation) <16>\\nGS\\t#81# (enzyme retains conformational stability in low and high salt \\n\\tconcentrations) <158>\\nGS\\t#99# (freezing and thawing results in formation of aggregates, unfolded \\n\\tat 1.5 M guanidine hydrochloride) <94>\\n\\nOXIDATION_STABILITY\\nOS\\t#176# (the enzyme loses activity when it is exposed to air or 3% H2O2) \\n\\t<320>\\nOS\\t#62# (the enzyme produced in vivo is sensitive to oxygen, losing 90% of \\n\\tactivity in 5 min after exposure to air) <197>\\n\\nPH_STABILITY\\nPHS\\t#1# 5-8 (#1# stable for about 1 week, in presence of dithiothreitol or \\n\\tmercaptoethanol <34>) <34>\\nPHS\\t#1,208# 10 (#1# half-life: 50 h <34>; #208# purified recombinant enzyme \\n\\tmASCA, over 90% activity remaining after 48 h, 70% after 72 h <363>) \\n\\t<34,363>\\nPHS\\t#1,208# 4 (#1# half-life: less than 5 h <34>; #208# purified \\n\\trecombinant enzyme mASCA, about 30% activity remaining after 15 min \\n\\t<363>) <34,363>\\nPHS\\t#11# 4-13 (#11# activity is completely lost at a moderately acidic pH \\n\\tof 4.0 and a highly basic pH of 13.0 <264>) <264>\\nPHS\\t#18# 4.8-11.4 (#18# 20C, 30 min, stable <3>) <3>\\nPHS\\t#18,34,83# -999 (#18# 42%, 39% and 36% stability is observed at pH 8.0, \\n\\tpH 8.5, and pH 9.0, respectively for commercial bovine carbonic \\n\\tanhydrase following 6 h of incubation. After 3 h incubation at pH 7.0 \\n\\tand pH 7.5, bovin retains 81% and 75% residual activity, while 79%, \\n\\t69%, 61%, stability is observed at pH 8.0, pH 8.5, and pH 9.0, \\n\\trespectively. Effect of pH and temperature as function of time on \\n\\tstability of carbonic anhydrases from different species, overview \\n\\t<309>; #83# effect of pH and temperature as function of time on \\n\\tstability of CAs from different species, overview <309>; #34# the \\n\\tenzyme shows 78% stability along with 71% and 73% residual activity at \\n\\tpH 8.0 and pH 9.0, respectively, following 6 h of incubation, after 3 h \\n\\tof incubation 80% stability is observed between pH 7.5-9.0, effect of \\n\\tpH and temperature as function of time on stability of CAs from \\n\\tdifferent species, overview <309>) <309>\\nPHS\\t#183# 7.6-10 (#183# enzyme shows high stable activity at the two ranges \\n\\twhich are around pH 7.6 and pH 10 <325>) <325>\\nPHS\\t#19# 5-11 (#19# carbonic anhydrase II holoenzyme is stable <18>) <18>\\nPHS\\t#197# 1-2 (#197# purified recombinant enzyme, stable for 2 h, complete \\n\\tloss of activity after 12 h <367>) <367>\\nPHS\\t#197,208# 6-11 (#208# purified recombinant enzyme mASCA, over 90% \\n\\tactivity remaining after 15 min within this range <363>; #197# purified \\n\\trecombinant enzyme, 100% activity remaining after 48 h <367>; #197# \\n\\tpurified recombinant enzyme, completely stable within this range for 48 \\n\\th <374>) <363,367,374>\\nPHS\\t#208# 5 (#208# purified recombinant enzyme mASCA, about 70% activity \\n\\tremaining after 15 min <363>) <363>\\nPHS\\t#43# 7-9 (#43# the enzyme retains 88% residual activity at pH 8.0, 72% \\n\\tresidual activity at pH 8.5, and 66% residual activity at pH 9.0 \\n\\tfollowing 6 h of incubation, stable at 80% of maximal activity in the \\n\\tpH range pH 7.0-9.0 following 3 h of incubation, effect of pH and \\n\\ttemperature as function of time on stability of carbonic anhydrases \\n\\tfrom different species, overview <309>) <309>\\nPHS\\t#43# 5-10 (#43# the enzyme retains 100% activity at pH 8.0 while more \\n\\tthan 80% enzyme activity is retained in the pH range 7.0-8.5 after 24 h \\n\\tincubation at room temperature, 45% and 65% enzyme activity at pH 5.0 \\n\\tand 10.0 respectively <282>) <282>\\nPHS\\t#58# 8.5-9 (#58# in 1 M Tris-SO4 buffer <246>) <246>\\nPHS\\t#58# 7.2 (#58# maximal stability in 0.025 M Tris-SO4 buffer <177>) <177>\\nPHS\\t#58# 9 (#58# stable at pH 9.0 in 1 M Tris-SO4 at 4C <199>) <199>\\nPHS\\t#71# 5.5-8.5 (#71# 8-10C, moderate ionic strength, stable <36>) <36>\\nPHS\\t#80,219# 8.5 (#219# stable at <368>; #80# purified native enzyme, \\n\\toptimally stable, 93% of maximum activity remaining after 14 days in 10 \\n\\tmM Tris-HCl buffer, pH 8.5 <306>) <306,368>\\n\\nSTORAGE_STABILITY\\nSS\\t#100# (4C, Tris-SO4, pH 8.8, purified enzyme, solution remains fully \\n\\tsoluble and active for at least 2 months) <137>\\nSS\\t#100# (-20C, Tris-SO4, pH 8.8, purified enzyme, solution remains fully \\n\\tsoluble and active for at least 2 months) <137>\\nSS\\t#100# (-80C, recombinant bacterial cell pellets can be stored for \\n\\tseveral months without apparent loss in enzyme activity) <137>\\nSS\\t#12# (4C, -20C or -70C stable) <50>\\nSS\\t#127# (after 40 days storage, the free hCA I sustains 50% and 0.11% of \\n\\tits original activity, whereas the immobilized hCA I retains 89% and \\n\\t85% of its original activity at 4C and 25C, respectively) <405>\\nSS\\t#136# (0C, activity remains stable during the first months in storage \\n\\tbut gradually declines to 25% of the initial value after 1 year \\n\\tstorage) <193>\\nSS\\t#14# (4C, stable for at least 1 year) <53>\\nSS\\t#207# (25C, enzyme immobilized on microcrystalline cellulose beads in \\n\\tPBS buffer (pH 7.4) containing 10% glycerol, 28 days, the enzymatic \\n\\tactivity is 70% compared to that of fresh enzyme) <444>\\nSS\\t#207# (4C, enzyme immobilized on microcrystalline cellulose beads in \\n\\tPBS buffer (pH 7.4) containing 10% glycerol, 28 days, the enzymatic \\n\\tactivity is 90% compared to that of fresh enzyme) <444>\\nSS\\t#21# (20 mM Tris-HCl (pH 8.5) buffer, 14 days, 97 activity maintained) \\n\\t<333>\\nSS\\t#22# (-14C, enzyme as a suspension in saturated (NH4)2SO4 containing \\n\\t0.02 M sodium phosphate buffer, 0.1 M NaCl and 0.001 M EDTA, pH 6.8, \\n\\tstable for 2 months) <21>\\nSS\\t#48# (-70C, in presence of Zn2+ and 50% glycerol, stable for 3 months) \\n\\t<6>\\nSS\\t#66# (4C, stable for up to 1 year) <9>\\n\\nTEMPERATURE_STABILITY\\nTS\\t#105# 85 (#105# most thermostable carbonic anhydrase, retains 90% \\n\\tactivity after incubation for 15 min <113>) <113>\\nTS\\t#11,124,191,192# 60 (#11# the enzyme is not stable at temperatures of \\n\\t60C and above <264>; #124# inactivation temperature wild-type <348>; \\n\\t#191# half-life of the enzyme is 29 days <376>; #192# half-life of the \\n\\tenzyme is 77 days <376>) <264,348,376>\\nTS\\t#120# 55-60 (#120# the melting temperature is around 55C without the \\n\\taddition of ligand, and shifts to 60C or higher when the added ligand \\n\\tbinds and stabilizes the protein <274>) <274>\\nTS\\t#120,124# 40-60 (#120# thermal unfolding of recombinant isotope-labeled \\n\\tisozyme at different pH values of pH 5.5-8.5, overview <352>; #124# \\n\\tthermal unfolding of recombinant isotope-labeled isozyme at different \\n\\tpH values of pH 5.5-8.5, overview. The protein appears to be more \\n\\ttemperature stable at pH 7.5-8.5 compared to pH 5.5 <352>) <352>\\nTS\\t#124# 58 (#124# T(M), wild-type <348>) <348>\\nTS\\t#124# 45.5 (#124# Tm, wild-type, pH 5.6 <323>) <323>\\nTS\\t#124# 71.1 (#124# Tm, mutant A23C/L203C/C206S, pH 7.8 <323>) <323>\\nTS\\t#124# 57.7 (#124# Tm, wild-type, pH 7.8 <323>) <323>\\nTS\\t#124# 59.7 (#124# Tm, mutant A23C/L203C/C206S, pH 5.6 <323>) <323>\\nTS\\t#14,177,185,193# 70 (#177# half-life: 8 days <336>; #14# at the \\n\\tpasteurization temperature of 70C, the enzyme activity of carbonic \\n\\tanhydrase is 100% after 1 h, 97% after 2 h, and 94% after 3 h, \\n\\tfreeze-dried enzyme. For the enzyme in solution, 87.6% activity remains \\n\\tafter 30 min, 81.5% after 1 h, 62% after 2 h, and 50% activity remains \\n\\tafter 3 h <353>; #185# half-life of the enzyme is 8 days <376>; #193# \\n\\thalf-life of the enzyme is less than one day <376>) <336,353,376>\\nTS\\t#177,181,192# 100 (#177# enzyme is active and stable for up to 50 h \\n\\t<340>; #181# purified enzyme SazCA is able to retain CO2 hydration \\n\\tactivity after incubation for 3 h <376>; #192# the enzyme shows about \\n\\t90, 75 and 45% activity after 15 min at 70, 80 and 90C, respectively. \\n\\tAt 100C, the enzyme completely loses its activity after 15 min \\n\\tincubation. After the boiling of soluble enzyme for 1 h, no soluble \\n\\tprotein is observed <429>) <340,376,429>\\nTS\\t#18,102,104# 30 (#102,104# stable up to <128>; #18# the enzyme \\n\\tpossesses two stable folded conformers with the conformational \\n\\ttransition occurring at about 30C. The methodology yields a stability \\n\\tcurve for the complete unfolding of the enzyme below this temperature \\n\\tbut only the partial unfolding, to the molten globule state, above it. \\n\\tThe transition state thermodynamics for the low-term to \\n\\tphysiological-temperature conformational change are calculated from \\n\\tslow-scan-rate differential scanning calorimetry measurements where it \\n\\tis found that the free energy barrier for the conversion is 90 kJ/mole \\n\\tand the transition state possesses a substantial unfolding quality \\n\\t<179>) <128,179>\\nTS\\t#18,34,43,83# 35-45 (#18# the purifed enzyme retains 38-54% after 6 h \\n\\t<309>; #83# the purifed enzyme retains 40-51% after 6 h <309>; #43# the \\n\\tpurifed enzyme retains 65-50% after 6 h <309>; #34# the purifed enzyme \\n\\tretains 71-83% after 6 h <309>) <309>\\nTS\\t#18,34,43,83,124,197# -999 (#18,34# effect of pH and temperature as \\n\\tfunction of time on stability of carbonic anhydrases from different \\n\\tspecies, overview <309>; #43# effect of pH and temperature as function \\n\\tof time on stability of CAs from different species, overview <309>; \\n\\t#83# the enzyme exhibits more than 80% stability between pH 7.0 and pH \\n\\t8.0, while 68% and 57% are retained at pH 8.5 and pH 9.0 after 3 h of \\n\\tincubation. The enzyme retains 63%, 54% and 45% residual activity at pH \\n\\t8.0, pH 8.5, and pH 9.0, respectively, following 6 h of incubation. \\n\\tEffect of pH and temperature as function of time on stability of CAs \\n\\tfrom different species, overview <309>; #197# the thermal unfolding of \\n\\trecombinant BhCA is studied by using circular dichroism <367>; #124# \\n\\tthermal stability and thermal unfolding analyses of wild-type enzyme \\n\\tand mutants M1-M4, overview <397>) <309,367,397>\\nTS\\t#18,61# 50 (#18# pH 7.0, stable for at least 30 min <3>; #61# enzyme \\n\\tgets irreversibly denaturated above 50C <346>) <3,346>\\nTS\\t#183# 47 (#183# half-denaturation temperature <325>) <325>\\nTS\\t#188# 75-90 (#188# enzyme Cab retains its activity after incubation at \\n\\ttemperatures up to 75C for 15 min, whereas poor activity is recovered \\n\\twhen the enzyme is incubated at temperatures of 90C or higher <376>) \\n\\t<376>\\nTS\\t#191# 30-100 (#191# purified recombinant His-tagged enzyme lacking the \\n\\tsignal peptide, pH 7.6, 15 min, slow decrease in the enzyme activity at \\n\\ttemperatures up to 50C and almost no effect beyond 50C up to 100C. \\n\\tThe enzyme retains over 80% of its activity between 60C and 100C, the \\n\\tTm is 84.5C  <404>) <404>\\nTS\\t#197# 50-80 (#197# the T1/2 values at 50C, 60C, 70C, and 80 C are \\n\\t72, 32, 7.0, and 2.0 min <367>) <367>\\nTS\\t#197# 50-72 (#197# Tm of BhCA is 72C, T1/2 values at 50C and 60C are \\n\\t66 min and 24 min, respectively <374>) <374>\\nTS\\t#199# 80 (#199# purified recombinant His-tagged enzyme, pH 8.3, 40% \\n\\tactivity remaining after 30 min, complete inactivation after 60 min \\n\\t<382>) <382>\\nTS\\t#20,197# 75 (#20# thermostable up to 75C <112>; #197# purified \\n\\trecombinant enzyme, Tm value <367>) <112,367>\\nTS\\t#202# 71.9 (#202# the enzyme has a melting temperature of 71.9C at pH \\n\\t8.0. TcruCA presents two transition peaks: one between 58C and 62C \\n\\tand the other between 68C and 72C, dependent on the pH <350>) <350>\\nTS\\t#207# 25-90 (#207# both the free and immobilized forms of the enzyme \\n\\tshow a 50% increase in activity after heat treatment at 70C for 24 h. \\n\\tMicrocrystalline cellulose-immobilized enzyme retains 70% of its \\n\\toriginal activity after 24 h at 90C, but the free form retains 45% of \\n\\tits original activity <444>) <444>\\nTS\\t#208# 65 (#208# purified recombinant enzyme mASCA, retains over 90% \\n\\tactivity after 15 min <363>) <363>\\nTS\\t#23# 90 (#23# activity of OEC33 remains after treatment for 15 min \\n\\t<155>) <155>\\nTS\\t#232# 20-80 (#232# structurally the enzyme remains stable when \\n\\tincubated at higher temperatures (60-80C) for 1 h as the protein \\n\\texhibits the activity at these temperatures, however the values are \\n\\tlesser in comparison with the activity at 20C <411>) <411>\\nTS\\t#236# 70-100 (#236# the enzyme shows about 50% activity after 15 min at \\n\\t70-90C. exhibiting 0.5% of the initial activity exhibiting 0.5% of the \\n\\tinitial activity. At 100C, the enzyme exhibits 18% residual activity \\n\\tafter 15 min incubation. After the boiling of soluble enzyme for 1 h, a \\n\\tsignificant fraction of the enzyme still remains soluble exhibiting \\n\\t0.5% of the initial activity <429>) <429>\\nTS\\t#43# 35-55 (#43# stable at 35-45C, there is a progressive decline in \\n\\tthe stability of enzyme following increase in temperature from 35C to \\n\\t55C, the enzyme retains 100% activity at 35C while 89% and 86% \\n\\tactivity is retained at 40C and 45C respectively. In contrast, 21.0% \\n\\tresidual activity is observed at 55C following 1 h incubation at the \\n\\trespective temperatures <282>) <282>\\nTS\\t#62# 55-75 (#62# the purified enzyme retains catalytic activity if \\n\\tincubated for 15 min at 55C, but only a little activity is recovered \\n\\twhen the enzyme is incubated above 75C <376>) <376>\\nTS\\t#66# 55 (#66# t1/2: more than 120 min <9>) <9>\\nTS\\t#92,177,185,191,192,193,197# 40 (#92# stable up to <128>; #197# \\n\\tpurified recombinant enzyme, stable at <367>; #177# half-life: 53 days \\n\\t<336>; #192# half-life of the enzyme is 152 days <376>; #185# half-life \\n\\tof the enzyme is 53 days <376>; #193# half-life of the enzyme is 6 days \\n\\t<376>; #191# half-life of the enzyme is 75 days <376>) <128,336,367,376>\\n\\nREFERENCE\\nRF\\t<1> Fernley, R.T.; Coghlan, J.P.; Wright, R.D.: Purification and \\n\\tcharacterization of a high-Mr carbonic anhydrase from sheep parotid \\n\\tgland:: Biochem. J. (1988) 249, 201-207. {Pubmed:3124821} (c)\\nRF\\t<2> Murakami, H.; Sly, W.S.: Purification and characterization of human \\n\\tsalivary carbonic anhydrase:: J. Biol. Chem. (1987) 262, 1382-1388. \\n\\t{Pubmed:2433278} (c)\\nRF\\t<3> Engberg, P.; Millqvist, E.; Pohl, G.; Lindskog, S.: Purification \\n\\tand some properties of carbonic anhydrase from bovine skeletal muscle:: \\n\\tArch. Biochem. Biophys. (1985) 241, 628-638. {Pubmed:3929690} (c)\\nRF\\t<4> Pullan, L.M.; Noltmann, E.A.: Purification and properties of pig \\n\\tmuscle carbonic anhydrase III:: Biochim. Biophys. Acta (1985) 839, \\n\\t147-154. {Pubmed:3921058} (c)\\nRF\\t<5> Kararli, T.; Silverman, D.N.: Inhibition of the hydration of CO2 \\n\\tcatalyzed by carbonic anhydrase III from cat muscle:: J. Biol. Chem. \\n\\t(1985) 260, 3484-3489. {Pubmed:3919025} (c)\\nRF\\t<6> Gill, S.R.; Fedorka-Cray, P.J.; Tweten, R.K.; Sleeper, B.P.: \\n\\tPurification and properties of the carbonic anhydrase of \\n\\tRhodospirillum:: Arch. Microbiol. (1984) 138, 113-118. {Pubmed:} (c)\\nRF\\t<7> Breiner Feldstein, J.; Silverman, D.N.: Purification and \\n\\tcharacterization of carbonic anhydrase from the saliva of the rat:: J. \\n\\tBiol. Chem. (1984) 259, 5447-5453. {Pubmed:6425289} (c)\\nRF\\t<8> Siffert, W.; Gros, G.: Carbonic anhydrase in human platelets:: \\n\\tBiochem. J. (1984) 217, 727-730. {Pubmed:6424649} (c)\\nRF\\t<9> Jones, G.L.; Shaw, D.C.: Purification, properties, partial sequence \\n\\tand evolutionary relationships of marsupial erythrocyte carbonic \\n\\tanhydrase:: Biochim. Biophys. Acta (1982) 709, 284-303. \\n\\t{Pubmed:6817802} (c)\\nRF\\t<10> Henkens, R.W.; Kitchell, B.B.; Lottich, S.C.; Stein, P.J.; \\n\\tWilliams, T.J.: Detection and characterization using circular dichroism \\n\\tand fluorescence spectroscopy of a stable intermediate conformation \\n\\tformed in the denaturation of bovine carbonic anhydrase with \\n\\tguanidinium chloride:: Biochemistry (1982) 21, 5918-5923. \\n\\t{Pubmed:6817784} (c)\\nRF\\t<11> Whitney, P.L.; Briggle, T.V.: Membrane-associated carbonic \\n\\tanhydrase purified from bovine lung:: J. Biol. Chem. (1982) 257, \\n\\t12056-12059. {Pubmed:6811592} (c)\\nRF\\t<12> Nishita, T.; Deutsch, H.F.: Isolation of equine muscle carbonic \\n\\tanhydrase in crystalline form:: Biochem. Biophys. Res. Commun. (1981) \\n\\t103, 573-580. {Pubmed:6800366} (c)\\nRF\\t<13> Carter, N.; Batten, J.; Jackson, M.; Jeffery, S.; Moyle, S.: The \\n\\tinitial stage in the dehydrogenation of dihydrodiols:: Biochem. Soc. \\n\\tTrans. (1981) 9, 73. {Pubmed:7011879} (c)\\nRF\\t<14> Bundy, H.F.; Cote, S.: Purification and properties of carbonic \\n\\tanhydrase from Chlamydomonas reinhardii:: Phytochemistry (1980) 19, \\n\\t2531-2534. {Pubmed:} (c)\\nRF\\t<15> Sanyal, G.; Pessah, N.I.; Maren, T.H.: Kinetics and inhibition of \\n\\tmembrane-bound carbonic anhydrase from canine renal cortex:: Biochim. \\n\\tBiophys. Acta (1981) 657, 128-137. {Pubmed:7213743} (c)\\nRF\\t<16> Carlsson, U.; Kjellstrm, B.; Antonsson, B.: Purification and \\n\\tproperties of cyclostome carbonic anhydrase from erythrocytes of \\n\\thagfish:: Biochim. Biophys. Acta (1980) 612, 160-170. {Pubmed:6767497} \\n\\t(c)\\nRF\\t<17> Fernley, R.T.; Wright, R.D.; Coghlan, J.P.: A novel carbonic \\n\\tanhydrase from the ovine parotid gland:: FEBS Lett. (1979) 105, \\n\\t299-302. {Pubmed:114424} (c)\\nRF\\t<18> Koester, M.K.; Noltmann, E.A.: Unique conformational properties of \\n\\tmuscle carbonic anhydrase III as demonstrated by circular dichroism \\n\\tspectrometry:: Biochemistry (1979) 18, 343-348. {Pubmed:105751} (c)\\nRF\\t<19> Carter, M.J.: Carbonic anhydrase: isoenzymes, properties, \\n\\tdistribution, and functional significance:: Biol. Rev. (1972) 47, \\n\\t465-513. {Pubmed:4631687} (c,review)\\nRF\\t<20> Pocker, Y.; Miksch, R.R.: Plant carbonic anhydrase. Properties and \\n\\tbicarbonate dehydration kinetics:: Biochemistry (1978) 17, 1119-1125. \\n\\t{Pubmed:415758} (c)\\nRF\\t<21> Kandel, M.; Gornall, A.G.; Cybulsky, D.L.; Kandel, S.I.: Carbonic \\n\\tanhydrase from spinach leaves. Isolation and some chemical properties:: \\n\\tJ. Biol. Chem. (1978) 253, 679-685. {Pubmed:413832} (c)\\nRF\\t<22> Holmes, R.S.: Purification, molecular properties and ontogeny of \\n\\tcarbonic anhydrase isozymes. Evidence for A, B and C isozymes in avian \\n\\tand mammalian tissues:: Eur. J. Biochem. (1977) 78, 511-520. \\n\\t{Pubmed:410641} (c)\\nRF\\t<23> Wistrand, P.J.; Whlstrand, T.: Rat renal and erythrocyte carbonic \\n\\tanhydrases. Purification and properties:: Biochim. Biophys. Acta (1977) \\n\\t481, 712-721. {Pubmed:403951} (c)\\nRF\\t<24> Drescher, D.G.: Purification of a carbonic anhydrase from the \\n\\tinner ear of the guinea pig:: Proc. Natl. Acad. Sci. USA (1977) 74, \\n\\t892-896. {Pubmed:403527} (c)\\nRF\\t<25> Deutsch, H.F.; Jabusch, J.R.; Lin, K.T.D.: Purification and \\n\\tproperties of a polymorphic high activity equine erythrocyte carbonic \\n\\tanhydrase:: J. Biol. Chem. (1977) 252, 555-559. {Pubmed:401815} (c)\\nRF\\t<26> Walk, R.A.; Metzner, H.: [Purification and characterization of \\n\\tchloroplast carbonate dehydratase from leaves of Lactuca sativa (author \\n\\ts transl):: Hoppe-Seyler\\'s Z. Physiol. Chem. (1975) 356, 1733-1741. \\n\\t{Pubmed:812792} (c)\\nRF\\t<27> Carter, N.; Auton, J.: Characterisation of carbonic anhydrases \\n\\tfrom tissues of the cat:: Biochim. Biophys. Acta (1975) 410, 220-228. \\n\\t{Pubmed:811260} (c)\\nRF\\t<28> Wistrand, P.J.; Lindahl, S.; Whlstrand, T.: Human renal carbonic \\n\\tanhydrase. Purification and properties:: Eur. J. Biochem. (1975) 57, \\n\\t189-195. {Pubmed:809281} (C)\\nRF\\t<29> Osborne, W.R.A.; Tashian, R.E.: An improved method for the \\n\\tpurification of carbonic anhydrase isozymes by affinity \\n\\tchromatography:: Anal. Biochem. (1975) 64, 297-303. {Pubmed:806235} (c)\\nRF\\t<30> Soliman, M.H.; Kluh, I.: Isolation of carbonic anhydrase from dog \\n\\terythrocytes and determination of its N-terminal amino-acid sequence:: \\n\\tEur. J. Biochem. (1974) 44, 611-615. {Pubmed:4209623} (c)\\nRF\\t<31> Atkins, C.A.: Occurence and some properties of carbonic anhydrases \\n\\tfrom legume root nodules:: Phytochemistry (1974) 13, 93-98. {Pubmed:} \\n\\t(c)\\nRF\\t<32> Carlsson, U.; Hannestad, U.; Lindskog, S.: Purification and some \\n\\tproperties or erythrocyte carbonic anhydrase from the European moose:: \\n\\tBiochim. Biophys. Acta (1973) 327, 515-527. {Pubmed:4205073} (c)\\nRF\\t<33> Pocker, Y.; Ng, J.S.Y.: Plant carbonic anhydrase. Properties and \\n\\tcarbon dioxide hydration kinetics:: Biochemistry (1973) 12, 5127-5134. \\n\\t{Pubmed:4210017} (c)\\nRF\\t<34> Bernstein, R.S.; Schraer, R.: Purification and properties of an \\n\\tavian carbonic anhydrase from the erythrocytes of Gallus domesticus:: \\n\\tJ. Biol. Chem. (1972) 247, 1306-1322. {Pubmed:4621976} (c)\\nRF\\t<35> Brundell, J.; Falkbring, S.O.; Nyman, P.O.: Carbonic anhydrase \\n\\tfrom Neisseria sicca, strain 6021. II. Properties of the purified \\n\\tenzyme:: Biochim. Biophys. Acta (1972) 284, 311-323. {Pubmed:4627453} \\n\\t(c)\\nRF\\t<36> Brundell, L.A.; Falkbring, S.O.; Nyman, P.O.: Carbonic anhydrase \\n\\tfrom Neisseria sicca, strain 6021. I. Bacterial growth and purification \\n\\tof the enzyme:: Biochim. Biophys. Acta (1972) 284, 298-310. \\n\\t{Pubmed:4627452} (c)\\nRF\\t<37> Deutsch, H.F.: Isolation in crystalline form and properties of six \\n\\thorse erythrocyte carbonic anhydrases:: J. Biol. Chem. (1972) 247, \\n\\t4499-4502. {Pubmed:4625482} (c)\\nRF\\t<38> Lin, K.T.D.; Deutsch, H.F.: Human carbonic anhydrases. 8. \\n\\tIsolation and characterization of polymorphic form of a C type \\n\\tisozyme:: J. Biol. Chem. (1972) 247, 3761-3766. {Pubmed:4624444} (c)\\nRF\\t<39> Kisiel, W.; Graf, G.: Purification and characterization of \\n\\tcarbonic anhydrase from Pisum sativum:: Phytochemistry (1972) 11, \\n\\t113-117. {Pubmed:} (C)\\nRF\\t<40> Tanis, R.J.; Tashian, R.E.: Purification and properties of \\n\\tcarbonic anhydrase from sheep erythrocytes:: Biochemistry (1971) 10, \\n\\t4852-4858. {Pubmed:5002597} (c)\\nRF\\t<41> Yachandra, V.; Powers, L.; Spiro, T.G.: X-ray absorption spectra \\n\\tand the coordination number of Zn and Co carbonic anhydrase as a \\n\\tfunction of pH and inhibitor binding:: J. Am. Chem. Soc. (1983) 105, \\n\\t6596-6604. {Pubmed:} (c)\\nRF\\t<42> Ren, X.; Jonsson, B.H.; Millqvist, E.; Lindskog, S.: A comparison \\n\\tof the kinetic properties of native bovine muscle carbonic anhydrase \\n\\tand an activated derivative with modified thiol groups:: Biochim. \\n\\tBiophys. Acta (1988) 953, 79-85. {Pubmed:3124879} (c)\\nRF\\t<43> Eriksson, M.; Karlsson, J.; Ramazanov, Z.; Gardstrm, P.; \\n\\tSamuelsson, G.: Discovery of an algal mitochondrial carbonic anhydrase: \\n\\tmolecular cloning and characterization of a low-CO2-induced polypeptide \\n\\tin Chlamydomonas reinhardtii:: Proc. Natl. Acad. Sci. USA (1996) 93, \\n\\t12031-12034. {Pubmed:8876257} (c)\\nRF\\t<44> Engstrand, C.; Jonsson, B.H.; Lindskog, S.: Catalytic and \\n\\tinhibitor-binding properties of some active-site mutants of human \\n\\tcarbonic anhydrase I:: Eur. J. Biochem. (1995) 229, 696-702. \\n\\t{Pubmed:7758465} (c)\\nRF\\t<45> Waheed, A.; Zhu, X.L.; Sly, W.S.: Membrane-associated carbonic \\n\\tanhydrase from rat lung. Purification, characterization, tissue \\n\\tdistribution, and comparison with carbonic anhydrase IVs of other \\n\\tmammals:: J. Biol. Chem. (1992) 267, 3308-3311. {Pubmed:1737787} (c)\\nRF\\t<46> Mori, K.; Ogawa, Y.; Ebihara, K.; Tamura, N.; Tashiro, K.; \\n\\tKuwahara, T.; Mukoyama, M.; Sugawara, A.; Ozaki, S.; Tanaka, I.; Nakao, \\n\\tK.: Isolation and characterization of CA XIV, a novel membrane-bound \\n\\tcarbonic anhydrase from mouse kidney:: J. Biol. Chem. (1999) 274, \\n\\t15701-15705. {Pubmed:10336468} (c)\\nRF\\t<47> Heck, R.W.; Tanhauser, S.M.; Manda, R.; Tu, C.; Laipis, P.J.; \\n\\tSilverman, D.N.: Catalytic properties of mouse carbonic anhydrase V:: \\n\\tJ. Biol. Chem. (1994) 269, 24742-24746. {Pubmed:7929150} (c)\\nRF\\t<48> Rowlett, R.S.; Gargiulo III, N.J.; Santoli, F.A.; Jackson, J.M.; \\n\\tCorbett, A.H.: Activation and inhibition of bovine carbonic anhydrase \\n\\tIII by dianions:: J. Biol. Chem. (1961) 266, 93s-941. {Pubmed:} (c)\\nRF\\t<49> Chirica, L.C.; Elleby, B.; Jonsson, B.H.; Lindskog, S.: The \\n\\tcomplete sequence, expression in Escherichia coli, purification and \\n\\tsome properties of carbonic anhydrase from Neisseria gonorrhoeae:: Eur. \\n\\tJ. Biochem. (1997) 244, 755-760. {Pubmed:9108244} (c)\\nRF\\t<50> Earnhardt, J.N.; Qian, M.; Tu, C.; Lakkis, M.M.; Bergenhem, \\n\\tN.C.H.; Laipis, P.J.; Tashian, R.E.; Silverman, D.N.: The catalytic \\n\\tproperties of murine carbonic anhydrase VII:: Biochemistry (1998) 37, \\n\\t10837-10845. {Pubmed:9692974} (c)\\nRF\\t<51> Alber, B.E.; Ferry, J.G.: Characterization of heterologously \\n\\tproduced carbonic anhydrase from Methanosarcina thermophila:: J. \\n\\tBacteriol. (1996) 178, 3270-3274. {Pubmed:8655508} (c)\\nRF\\t<52> Hurt, J.D.; Tu, C.; Laipis, P.J.; Silverman, D.N.: Catalytic \\n\\tproperties of murine carbonic anhydrase IV:: J. Biol. Chem. (1997) 272, \\n\\t13512-13518. {Pubmed:9153196} (c)\\nRF\\t<53> Zhu, X.L.; Sly, W.S.: Carbonic anhydrase IV from human lung. \\n\\tPurification, characterization, and comparison with membrane carbonic \\n\\tanhydrase from human kidney:: J. Biol. Chem. (1990) 265, 8795-8801. \\n\\t{Pubmed:2111324} (c)\\nRF\\t<54> Hiltonen, T.; Karlsson, J.; Palmqvist, K.; Clarke, A.K.; \\n\\tSamuelsson, G.: Purification and characterisation of an intracellular \\n\\tcarbonic anhydrase from the unicellular green alga Coccomyxa:: Planta \\n\\t(1995) 195, 345-351. {Pubmed:7766041} (c)\\nRF\\t<55> Satoh, A.; Iwasaki, T.; Odani, S.; Shiraiwa, Y.: Purification, \\n\\tcharacterization and cDNA cloning of soluble carbonic anhydrase from \\n\\tChlorella sorokiniana grown under ordinary air:: Planta (1998) 206, \\n\\t657-665. {Pubmed:9821693} (c)\\nRF\\t<56> Rumeau, D.; Cuine, S.; Fina, L.; Gault, N.; Nicole, M.; Peltier, \\n\\tG.: Subcellular distribution of carbonic anhydrase in Solanum tuberosum \\n\\tL. leaves: characterization of two compartment-specific isoforms:: \\n\\tPlanta (1996) 199, 79-88. {Pubmed:8680307} (c)\\nRF\\t<57> Mahieu, I.; Saggar-Malik, A.; Hollande, E.; Carter, N.: \\n\\tLocalisation and characterisation of carbonic anhydrase isozymes (CA I, \\n\\tCA II, CA III and CA IV) in an umbilical vein endothelial cell line \\n\\t(EA-hy926):: Biochem. Soc. Trans. (1995) 23, 308S. {Pubmed:7672337} (c)\\nRF\\t<58> Mahieu, I.; Carter, N.; Hollande, E: Characterization of a human \\n\\tductal pancreatic Capan-1 clone (IMEH): carbonic anhydrases II and IV \\n\\t(CA II and CA IV) expression and targetting:: Biochem. Soc. Trans. \\n\\t(1995) 23, 309S. {Pubmed:7672338} (c)\\nRF\\t<59> Huang, S.; Xue, Y.; Sauer-Eriksson, E.; Chirica, L.; Lindskog, S.; \\n\\tJonsson, B.H.: Crystal structure of carbonic anhydrase from Neisseria \\n\\tgonorrhoeae and its complex with the inhibitor acetazolamide:: J. Mol. \\n\\tBiol. (1998) 283, 301-310. {Pubmed:9761692} (c)\\nRF\\t<60> Mananes, A.A.L.; Daleo, G.R.; Vega, F.V.: pH-dependent association \\n\\tof carbonic anhydrase (CA) with gastric light microsomal membranes \\n\\tisolated from bovine abomasum. Partial characterization of \\n\\tmembrane-associated activity:: Comp. Biochem. Physiol. B (1993) 105, \\n\\t175-182. {Pubmed:8504640} (c)\\nRF\\t<61> Sender, S.; Bttcher, K.; Cetin, Y.; Gros, G.: Carbonic anhydrase \\n\\tin the gills of seawater- and freshwater-acclimated flounders \\n\\tPlatichthys flesus: purification, characterization, and \\n\\timmunohistochemical localization:: J. Histochem. Cytochem. (1999) 47, \\n\\t43-50. {Pubmed:9857211} (c)\\nRF\\t<62> Tachiki, A.; Fukuzawa, H.; Miyachi, S.: Characterization of \\n\\tcarbonic anhydrase isozyme CA2, which is the CAH2 gene product, in \\n\\tChlamydomonas reinhardtii:: Biosci. Biotechnol. Biochem. (1992) 56, \\n\\t794-798. {Pubmed:1368343} (c)\\nRF\\t<63> Larsson, S.; Bjorkbacka, H.; Forsman, C.; Samuelsson, G.; Olsson, \\n\\tO.: Molecular cloning and biochemical characterization of carbonic \\n\\tanhydrase from Populus tremula x tremuloides:: Plant Mol. Biol. (1997) \\n\\t34, 583-592. {Pubmed:9247540} (c)\\nRF\\t<64> Lindahl, M.; Svensson, L.A.; Liljas, A.: Metal poison inhibition \\n\\tof carbonic anhydrase:: Proteins Struct. Funct. Genet. (1993) 15, \\n\\t177-182. {Pubmed:8441752} (c)\\nRF\\t<65> Provart, N.J.; Majeau, N.; Coleman, J.R.: Characterization of pea \\n\\tchloroplastic carbonic anhydrase. Expression in Escherichia coli and \\n\\tsite-directed mutagenesis:: Plant Mol. Biol. (1993) 22, 937-943. \\n\\t{Pubmed:8400138} (c)\\nRF\\t<66> Bttcher, K.; Waheed, A.; Sly, W.S.: Membrane-associated carbonic \\n\\tanhydrase from the crab gill: purification, characterization, and \\n\\tcomparison with mammalian CAs:: Arch. Biochem. Biophys. (1994) 312, \\n\\t429-435. {Pubmed:8037456} (c)\\nRF\\t<67> Jewell, D.A.; Tu, C.; Paranawithana, S.R.; Tanhauser, S.M.; \\n\\tLoGrasso, P.V.; Laipis, P.J.; Silverman, D.N.: Enhancement of the \\n\\tcatalytic properties of human carbonic anhydrase III by site-directed \\n\\tmutagenesis:: Biochemistry (1991) 30, 1484-1490. {Pubmed:1899618} (c)\\nRF\\t<68> Wetzel, P.; Gros, G.: Inhibition and kinetic properties of \\n\\tmembrane-bound carbonic anhydrases in rabbit skeletal muscles:: Arch. \\n\\tBiochem. Biophys. (1998) 356, 151-158. {Pubmed:9705205} (c)\\nRF\\t<69> Rowlett, R.S.; Chance, M.R.; Wirt, M.D.; Sidelinger, D.E.; Royal, \\n\\tJ.R.; Woodroffe, M.; Wang, Y.F.A.; Saha, R.P.; Lam, M.G.: Kinetic and \\n\\tstructural characterization of spinach carbonic anhydrase:: \\n\\tBiochemistry (1994) 33, 13967-13976. {Pubmed:7947805} (c)\\nRF\\t<70> Baird, T.T.; Waheed, A.; Okuyama, T.; Sly, W.S.; Fierke, C.A.: \\n\\tCatalysis and inhibition of human carbonic anhydrase IV:: Biochemistry \\n\\t(1997) 36, 2669-2678. {Pubmed:9054574} (c)\\nRF\\t<71> Cronk, J.D.; O\\'Neill, J.W.; Cronk, M.R.; Endrizzi, J.A.; Zhang, \\n\\tK.Y.J.: Cloning, crystallization and preliminary characterization of a \\n\\tbeta-carbonic anhydrase from Escherichia coli:: Acta Crystallogr. Sect. \\n\\tD (2000) 56, 1176-1179. {Pubmed:}\\nRF\\t<72> Premkumar, L.; Greenblatt, H.M.; Bageshwar, U.K.; Savchenko, T.; \\n\\tGokhman, I.; Zamir, A.; Sussman, J.L.: Identification, cDNA cloning, \\n\\texpression, crystallization and preliminary X-ray analysis of an \\n\\texceptionally halotolerant carbonic anhydrase from Dunaliella saline:: \\n\\tActa Crystallogr. Sect. D (2003) 59, 1084-1086. {Pubmed:12777782}\\nRF\\t<73> Duda, D.; Govindasamy, L.; Agbandje-Mckenna, M.; Tu, C.; \\n\\tSilverman, D.N.; McKenna, R.: The refined atomic structure of carbonic \\n\\tanhydrase II at 1.05 A resolution: implications of chemical rescue of \\n\\tproton transfer:: Acta Crystallogr. Sect. D (2003) 59, 93-104. \\n\\t{Pubmed:12499545}\\nRF\\t<74> Saito, R.; Sato, T.; Ikai, A.; Tanaka, N.: Structure of bovine \\n\\tcarbonic anhydrase II at 1.95 A resolution:: Acta Crystallogr. Sect. D \\n\\t(2004) 60, 792-795. {Pubmed:15039588}\\nRF\\t<75> Bjoerkbacka, H.; Johansson, I.M.; Forsman, C.: Possible roles for \\n\\tHis 208 in the active-site region of chloroplast carbonic anhydrase \\n\\tfrom Pisum sativum:: Arch. Biochem. Biophys. (1999) 361, 17-24. \\n\\t{Pubmed:9882424}\\nRF\\t<76> Rowlett, R.S.; Tu, C.; McKay, M.M.; Preiss, J.R.; Loomis, R.J.; \\n\\tHicks, K.A.; Marchione, R.J.; Strong, J.A.; Donovan jr., G.S.; \\n\\tChamberlin, J.E.: Kinetic characterization of wild-type and proton \\n\\ttransfer-impaired variants of beta-carbonic anhydrase from Arabidopsis \\n\\tthaliana:: Arch. Biochem. Biophys. (2002) 404, 197-209. \\n\\t{Pubmed:12147257}\\nRF\\t<77> Elder, I.; Han, S.; Tu, C.; Steele, H.; Laipis, P.J.; Viola, R.E.; \\n\\tSilverman, D.N.: Activation of carbonic anhydrase II by active-site \\n\\tincorporation of histidine analogs:: Arch. Biochem. Biophys. (2004) \\n\\t412, 283-289. {Pubmed:}\\nRF\\t<78> Rowlett, R.S.; Tu, C.; Murray, P.S.; Chamberlin, J.E.: Examination \\n\\tof the role of Gln-158 in the mechanism of CO2 hydration catalyzed by \\n\\tbeta-carbonic anhydrase from Arabidopsis thaliana:: Arch. Biochem. \\n\\tBiophys. (2004) 425, 25-32. {Pubmed:15081890}\\nRF\\t<79> Wingo, T.; Tu, C.; Laipis, P.J.; Silverman, D.N.: The catalytic \\n\\tproperties of human carbonic anhydrase IX:: Biochem. Biophys. Res. \\n\\tCommun. (2001) 288, 666-669. {Pubmed:11676494}\\nRF\\t<80> Recacha, R.; Constanzo, M.J.; Maryanhoff, B.E.; Chattopadhyay, D.: \\n\\tCrystal structure of human carbonic anhydrase II complexed with an \\n\\tanti-convulsant sugar sulphamate:: Biochem. J. (2002) 361, 437-441. \\n\\t{Pubmed:11802772}\\nRF\\t<81> Alber, B.E.; Colangelo, C.M.; Dong, J.; Stalhandske, C.M.V.; \\n\\tBaird, T.T.; Tu, C.; Fierke, C.A.; Silverman, D.N.; Scott, R.A.; Ferry, \\n\\tJ.G.: Kinetic and spectroscopic characterization of the gamma-carbonic \\n\\tanhydrase from the methanoarcheon Methanosarcina thermophila:: \\n\\tBiochemistry (1999) 38, 13119-13128. {Pubmed:10529183}\\nRF\\t<82> Hunt, J.A.; Ahmed, M.; Fierke, C.A.: Metal binding specificity in \\n\\tcarbonic anhydrase is influenced by conserved hydrophobic core \\n\\tresidues:: Biochemistry (1999) 38, 9054-9062. {Pubmed:10413479}\\nRF\\t<83> Cox, E.H.; McLendon, G.L.; Morel, F.M.M.; Lane, T.W.; Prince, \\n\\tR.C.; Pickering, I.J.; George, G.N.: The active site structure of \\n\\tThalassiosira weissflogii carbonic anhydrase 1:: Biochemistry (2000) \\n\\t39, 12128-12130. {Pubmed:11015190}\\nRF\\t<84> Guerri, A.; Briganti, F.; Scozzafava, A.; Supuran, C.T.; Mangani, \\n\\tS.: Mechanism of cyanamide hydration catalyzed by carbonic anhydrase II \\n\\tsuggested by cryogenic X-ray diffraction:: Biochemistry (2000) 39, \\n\\t12391-12397. {Pubmed:11015219}\\nRF\\t<85> Iverson, T.M.; Alber, B.E.; Kisker, C.; Ferry, J.G.; Rees, D.C.: A \\n\\tcloser look at the active site of gamma-class carbonic anhydrases: High \\n\\tresolution crystallographic studies of the carbonic anhydrase from \\n\\tMethanosarcina thermophila:: Biochemistry (2000) 39, 9222-9231. \\n\\t{Pubmed:10924115}\\nRF\\t<86> Tripp, B.C.; Ferry, J.G.: A structure-function study of a proton \\n\\ttransport pathway in teh gamma-class carbonic anhydrase from \\n\\tMethanosarcina thermophila:: Biochemistry (2000) 39, 9232-9240. \\n\\t{Pubmed:10924116}\\nRF\\t<87> Duda, D.; Tu, C.; Qian, M.; Laipis, P.; Agbandje-McKenna, M.; \\n\\tSilverman, D.N.; McKenna, R.: Structural and kinetic analysis of the \\n\\tchemical rescue of the proton transfer function of carbonic anhydrase \\n\\tII:: Biochemistry (2001) 40, 1741-1748. {Pubmed:11327835}\\nRF\\t<88> DiTusa, C.A.; Christensen, T.; McCall, K.A.; Fierke, C.A.; Toone, \\n\\tE.J.: Thermodynamics of metal ion binding. 1. Metal ion binding by \\n\\twild-type carbonic anhydrase:: Biochemistry (2001) 40, 5338-5344. \\n\\t{Pubmed:11330996}\\nRF\\t<89> DiTusa, C.A.; McCall, K.A.; Christensen, T.; Mahapatro, M.; \\n\\tFierke, C.A.; Toone, E.J.: Thermodynamics of metal ion binding by \\n\\tcarbonic anhydrase variants:: Biochemistry (2001) 40, 5345-5351. \\n\\t{Pubmed:11330997}\\nRF\\t<90> Tu, C.; Rowlett, R.S.; Tripp, B.C.; Ferry, J.G.; Silverman, D.N.: \\n\\tChemical rescue of proton transfer in catalysis by carbonic anhydrases \\n\\tin the beta- and gamma-class:: Biochemistry (2002) 41, 15429-15435. \\n\\t{Pubmed:12484784}\\nRF\\t<91> Jude, K.M.; Wright, S.K.; Tu, C.; Silverman, D.N.; Viola, R.E.; \\n\\tChristianson, D.W.: Crystal structure of F65/Y131C-methylimidazole \\n\\tcarbonic anhydrase V reveals architectural features of an engineered \\n\\tproton shuttle:: Biochemistry (2002) 41, 2485-2491. {Pubmed:11851394}\\nRF\\t<92> An, H.; Tu, C.; Duda, D.; Montanez-Clemente, I.; Math, K.; Laipis, \\n\\tP.J.; McKenna, R.; Silverman, D.N.: Chemical rescue in catalysis by \\n\\thuman carbonic anhydrases II and III:: Biochemistry (2002) 41, \\n\\t3235-3242. {Pubmed:11863462}\\nRF\\t<93> Ferraroni, M.; Tilli, S.; Briganti, F.; Chegwidden, W.R.; Supuran, \\n\\tC.T.; Wiebauer, K.E.; Tashian, R.E.; Scozzafava, A.: Crystal structure \\n\\tof a zinc-activated variant of human carbonic anhydrase I, CA I \\n\\tMichigan 1: Evidence for a second zinc binding site involving arginine \\n\\tcoordination:: Biochemistry (2002) 41, 6237-6244. {Pubmed:12009884}\\nRF\\t<94> Tripp, B.C.; Tu, C.; Ferry, J.G.: Role of the arginine 59 in the \\n\\tgamma-class carbonic anhydrases:: Biochemistry (2002) 41, 669-678. \\n\\t{Pubmed:11781108}\\nRF\\t<95> Arslan, O.: Inhibition of bovine carbonic anhydrase by new \\n\\tsulfonamide compounds:: Biochemistry (Moscow) (2001) 66, 982-983. \\n\\t{Pubmed:11703179}\\nRF\\t<96> Arslan, O.; Cakir, Ue.; Ugras, H.I.: Synthesis of new sulfonamide \\n\\tinhibitors of carbonic anhydrase:: Biochemistry (Moscow) (2002) 67, \\n\\t1273-1276. {Pubmed:}\\nRF\\t<97> Qian, M.; Earnhardt, J.N.; Wadhwa, N.R.; Tu, C.; Laipis, P.J.; \\n\\tSilverman, D.N.: Proton transfer to residues of basic pKa during \\n\\tcatalysis by carbonic anhydrase:: Biochim. Biophys. Acta (1999) 1434, \\n\\t1-5. {Pubmed:10556554}\\nRF\\t<98> Chirica, L.C.; Elleby, B.; Lindskog, S.: Cloning, expression and \\n\\tsome properties of alpha-carbonic anhydrase from Helicobacter pylori:: \\n\\tBiochim. Biophys. Acta (2001) 1544, 55-63. {Pubmed:11341916}\\nRF\\t<99> Sandor,M.; Riechel, A.; Kaplan, I.; Mathiowitz, E.: Effect of \\n\\tlecithin and MgCO3 as additives on the enzymatic activity of carbonic \\n\\tanhydrase encapsulated in poly(lactide-co-glycolide) (PLGA) \\n\\tmicrospheres:: Biochim. Biophys. Acta (2002) 1570, 63-74. \\n\\t{Pubmed:11960690}\\nRF\\t<100> Buelbuel, M.; Saracoglu, N.; Kuevrevioglu, Oe.I.; Ciftci, M.: \\n\\tBile acid derivatives of 5-amino-1,3,4-thiadiazole-2-sulfonamide as new \\n\\tcarbonic anhydrase inhibitors: Synthesis and investigation of \\n\\tinhibition effects:: Bioorg. Med. Chem. (2002) 10, 2561-2567. \\n\\t{Pubmed:12057645}\\nRF\\t<101> Scozzafava, A.; Supuran, C.T.: Hydroxyurea is a carbonic \\n\\tanhydrase inhibitor:: Bioorg. Med. Chem. (2003) 11, 2241-2246. \\n\\t{Pubmed:12713833}\\nRF\\t<102> Chen, H.H.; Gross, S.; Liao, J.; MaLaughlin, M.; Dean, T.; Sly, \\n\\tW.S.; May, J.A.: 2H-thieno[3,2-e]- and \\n\\t[2,3-e-]-1,2-thiazine-6-sulfonamide 1,1-dioxides as ocular hypotensive \\n\\tagents: Synthesis, carbonic anhydrase inhibition and evaluation in the \\n\\trabbit:: Bioorg. Med. Chem. (2000) 8, 957-975. {Pubmed:10882008}\\nRF\\t<103> Gao, J.; Wu, Q.; Carbeck, J.; Lei, Q.P.; Smith, R.D.; Whitesides, \\n\\tG.M.: Probing the energetics of dissociation of carbonic \\n\\tanhydrase-ligand complexes in the gas phase:: Biophys. J. (1999) 76, \\n\\t3253-3260. {Pubmed:10354450}\\nRF\\t<104> Kimber, M.S.; Pai, E.F.: The active site architecture of Pisum \\n\\tsativum beta-carbonic anhydrase is a mirror image of that of \\n\\talpha-carbonic anhydrases:: EMBO J. (2000) 19, 1407-1418. \\n\\t{Pubmed:10747009}\\nRF\\t<105> Elleby, B.; Sjoeblom, B.; Lindskog, S.: Changing the efficiency \\n\\tand specificity of the esterase activity of human carbonic anhydrase II \\n\\tby site-specific mutagenesis:: Eur. J. Biochem. (1999) 262, 516-521. \\n\\t{Pubmed:10336637}\\nRF\\t<106> Elleby, B.; Sjoeblom, B.; Tu, C.; Silverman, D.N.; Lindskog, S.: \\n\\tEnhancement of catalytic efficiency by the combination of site-specific \\n\\tmutations in a carbonic anhydrase-related protein:: Eur. J. Biochem. \\n\\t(2000) 267, 5908-5915. {Pubmed:10998050}\\nRF\\t<107> Elleby, B.; Chirica, L.C.; Tu, C.; Zeppezauer, M.; Lindskog, S.: \\n\\tCharacterization of carbonic anhydrase from Neisseria gonorrhoeae:: \\n\\tEur. J. Biochem. (2001) 268, 1613-1619. {Pubmed:11248679}\\nRF\\t<108> Mallis, R.J.; Poland, B.W.; Chatterjee, T.K.; Fisher, R.A.; \\n\\tDarmawan, S.; Honzatko, R.B.; Thomas, J.A.: Crystal structure of \\n\\tS-glutathiolated carbonic anhydrase III:: FEBS Lett. (2000) 482, \\n\\t237-241. {Pubmed:11024467}\\nRF\\t<109> Alam, M.T.; Yamada, T.; Carlsson, U.; Ikai, A.: The importance of \\n\\tbeing knotted: effects of the C-terminal knot structure on enzymatic \\n\\tand mechanical properties of bovine carbonic anhydrase II:: FEBS Lett. \\n\\t(2002) 519, 35-40. {Pubmed:12023014}\\nRF\\t<110> Tu, C.; Tripp, B.C.; Ferry, J.G.; Silverman, D.N.: Bicarbonate as \\n\\ta proton donor in catalysis by Zn(II)- and Co(II)-containing carbonic \\n\\tanhydrases:: J. Am. Chem. Soc. (2001) 123, 5861-5866. {Pubmed:11414818}\\nRF\\t<111> Loferer, M.J.; Tautermann, C.S.; Loeffler, H.H.; Liedl, K.R.: \\n\\tInfluence of backbone conformations of human carbonic anhydrase II on \\n\\tcarbon dioxide hydration: Hydration pathways and binding of \\n\\tbicarbonate:: J. Am. Chem. Soc. (2003) 125, 8921-8927. {Pubmed:12862489}\\nRF\\t<112> Smith, K.S.; Ferry, J.G.: A plant-type (beta-class) carbonic \\n\\tanhydrase in the thermophilic methanoarchaeon Methanobacterium \\n\\tthermoautotrophicum:: J. Bacteriol. (1999) 181, 6247-6253. \\n\\t{Pubmed:10515911}\\nRF\\t<113> Smith, K.S.; Cosper, N.J.; Stalhandske, C.; Scott, R.A.; Ferry, \\n\\tJ.G.: Structural and kinetic characterization of an archaeal beta-class \\n\\tcarbonic anhydrase:: J. Bacteriol. (2000) 182, 6605-6613. \\n\\t{Pubmed:11073902}\\nRF\\t<114> Smith, K.S.; Ingram-Smith, C.; Ferry, J.G.: Roles of the \\n\\tconserved aspartate and arginine in the catalytic mechanism of an \\n\\tarchaeal beta-class carbonic anhydrase:: J. Bacteriol. (2002) 184, \\n\\t4240-4245. {Pubmed:12107142}\\nRF\\t<115> Mitsuhashi, S.; Mizushima, T.; Yamashita, E.; Yamamoto, M.; \\n\\tKumasaka, T.; Moriyama, H.; Ueki, T.; Miyachi, S.; Tsukihara, T.: X-ray \\n\\tstructure of beta-carbonic anhydrase from the red alga, Porphyridium \\n\\tpurpureum, reveals a novel catalytic site for CO2 hydration:: J. Biol. \\n\\tChem. (2000) 275, 5521-5526. {Pubmed:10681531}\\nRF\\t<116> Strop, P.; Smith, K.S.; Iverson, T.M.; Ferry, J.G.; Rees, D.C.: \\n\\tCrystal structure of the \"cab\"-type beta class carbonic anhydrase from \\n\\tthe archaeon Methanobacterium thermoautotrophicum:: J. Biol. Chem. \\n\\t(2001) 276, 10299-10305. {Pubmed:11096105}\\nRF\\t<117> Tu, C.; Qian, M.; An, H.; Wadhwa, N.R.; Duda, D.; Yoshioka, C.; \\n\\tPathak, Y.; McKenna, R.; Laipis, P.J.; Silverman, D.N.: Kinetic \\n\\tanalysis of multiple proton shulttles in the active site of human \\n\\tcarbonic anhydrase:: J. Biol. Chem. (2002) 277, 38870-38876. \\n\\t{Pubmed:12171926}\\nRF\\t<118> Lehtonen, J.; Shen, B.; Vihinen, M.; Casini, A.; Scozzafava, A.; \\n\\tSupuran, C.T.; Parkkila, A.K.; Saarnio, J.; Kivelae, A.J.; Waheed, A.; \\n\\tSly, W.S.; Parkkila, S.: Characterization of CA XIII, a novel member of \\n\\tthe carbonic anhydrase isozyme family:: J. Biol. Chem. (2004) 279, \\n\\t2719-2727. {Pubmed:14600151}\\nRF\\t<119> Whittington, D.A.; Grubb, J.H.; Waheed, A.; Shah, G.N.; Sly, \\n\\tW.S.; Christianson, D.W.: Expression, assay, and structure of the \\n\\textracellular domain of murine carbonic anhydrase XIV:: J. Biol. Chem. \\n\\t(2004) 279, 7223-7228. {Pubmed:14660577}\\nRF\\t<120> Briganti, F.; Tilli, S.; Mincione, G.; Mincione, F.; Menabuoni, \\n\\tL.; Supuran, C.T.: Carbonic anhydrase inhibitors. Metal complexes of \\n\\t5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide with topical \\n\\tintraocular pressure lowering properties: The influence of metal ions \\n\\tupon the pharmacological activity:: J. Enzyme Inhib. (2000) 15, \\n\\t185-200. {Pubmed:10938543}\\nRF\\t<121> Fenesan, I.; Popescu, R.; Scozzafava, A.; Crucin, V.; Mateiciuc, \\n\\tE.; Bauer, R.; Ilies, M.A.; Supuran, C.T.: Carbonic anhydrase \\n\\tinhibitors; phosphoryl-sulfonamides-a new class of high affinity \\n\\tinhibitors of isozymes I and II:: J. Enzyme Inhib. (2000) 15, 297-310. \\n\\t{Pubmed:10811034}\\nRF\\t<122> Scozzafava, A.; Banciu, M.D.; Popescu, A.; Supuran, C.T.: \\n\\tCarbonic anhydrase inhibitors: Inhibition of isozymes I, II and IV by \\n\\tsulfamide and sulfamic acid derivatives:: J. Enzyme Inhib. (2000) 15, \\n\\t443-453. {Pubmed:11030084}\\nRF\\t<123> Casini, A.; Minicione, F.; Ilies, M.A.; Menabuoni, L.; \\n\\tScozzafava, A.; Supuran, C.T.: Carbonic anhydrase inhibitors: Synthesis \\n\\tand inhibition against isozymes I, II and IV of topically acting \\n\\tantiglaucoma sulfonamides incorporating \\n\\tcis-5-norbornene-endo-3-carboxy-2-carbxamido moieties:: J. Enzyme \\n\\tInhib. (2001) 16, 113-123. {Pubmed:11342280}\\nRF\\t<124> Chazalette, C.; Riviere-Baudet, M.; Scozzafava, A.; Abate, F.; \\n\\tMaarouf, Z.B.; Supuran, C.T.;: Carbonic anhydrase inhibitors, \\n\\tinteraction of boron derivatives with isozymes I and II: A new binding \\n\\tsite for hydrophobic inhibitors at the entrance of the active site as \\n\\tshown by docking studies:: J. Enzyme Inhib. (2001) 16, 125-133. \\n\\t{Pubmed:11342281}\\nRF\\t<125> Chazalette, C.; Riviere-Baudet, M.; Supuran, C.T.; Scozzafava, \\n\\tA.: Carbonic anhydrase inhibitors: Allylsulfonamide, styrene \\n\\tsulfonamide, N-allyl sulfonamides and some of their Si, Ge and B \\n\\tderivatives:: J. Enzyme Inhib. (2001) 16, 475-489. {Pubmed:12164387}\\nRF\\t<126> Ul-Hassan, M.; Scozzafava, A.; Chohan, Z.H.; Supuran, C.T.: \\n\\tCarbonic anhydrase inhibitors: Metal complexes of a sulfanilamide \\n\\tderived schiff base and their interaction with isozymes I, II and IV:: \\n\\tJ. Enzyme Inhib. (2001) 16, 499-505. {Pubmed:12164389}\\nRF\\t<127> Buelbuel, M.; Hisar, O.; Beydemir, S.; Ciftci, M.; Kuefrevioglu, \\n\\tOe.I.: The in vitro and in vivo inhibitory effects of some sulfonamide \\n\\tderivatives on rainbow trout (Oncorhynchus mykiss) erythrocyte carbonic \\n\\tanhydrase activity:: J. Enzyme Inhib. Med. Chem. (2003) 18, 371-375. \\n\\t{Pubmed:14567552}\\nRF\\t<128> Maffia, M.; Rizzello, A.; Acierno, R.; Rollo, M.; Chiloiro, R.; \\n\\tStorelli, C.: Carbonic anhydrase activity in tissues of the icefish \\n\\tChionodraco hamatus and of the red-blooded teleosts Trematomus \\n\\tbernacchii and Anguilla anguilla:: J. Exp. Biol. (2001) 204, 3983-3992. \\n\\t{Pubmed:11807116}\\nRF\\t<129> Scozzafava, A.; Supuran, C.T.: Carbonic anhydrase and matrix \\n\\tmetalloproteinase inhibitors: Sulfonylated amino acid hydroxamates with \\n\\tMMP inhibitory properties act as efficient inhibitors of CA isozymes I, \\n\\tII, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes:: \\n\\tJ. Med. Chem. (2000) 43, 3677-3687. {Pubmed:11020282}\\nRF\\t<130> Abbate, F.; Supuran, C.T.; Scozzafava, A.; Orioloi, P.; Stubbs, \\n\\tM.T.; Klebe, G.: Nonaromatic sulfonamide group as an ideal anchor or \\n\\tpotent human carbonic anhydrase inhibitors: Role of hydrogen-bonding \\n\\tnetworks in ligand binding and drug design:: J. Med. Chem. (2002) 45, \\n\\t3583-3587. {Pubmed:12166931}\\nRF\\t<131> Winum, J.Y.; Vullo, D.; Casini, A.; Montero, J.L.; Scozzafava, \\n\\tA.; Supuran, C.T.: Carbonic anhydrase inhibitors. Inhibition of \\n\\tcytosolic isozymes I and II and transmembrane, tumor-associated isozyme \\n\\tIX with sulfamates including EMATE also acting as steroid sulfatase \\n\\tinhibitors:: J. Med. Chem. (2003) 46, 2197-2204. {Pubmed:12747791}\\nRF\\t<132> Winum, J.Y.; Vullo, D.; Casini, A.; Montero, J.L.; Scozzafava, \\n\\tA.; Supuran, C.T.: Carbonic anhydrase inhibitors: Inhibition of \\n\\ttransmembrane, tumor-associated isozyme IX, and cytosolic isozymes I \\n\\tand II with aliphatic sulfamates:: J. Med. Chem. (2003) 46, 5471-5477. \\n\\t{Pubmed:14640555}\\nRF\\t<133> Ulmasov, B.; Waheed, A.; Shah, G.N.; Grubb, J.H.; Sly, W.S.; Tu, \\n\\tC.; Silverman, D.N.: Purification and kinetic analysis of recombinant \\n\\tCA XII, a membrane carbonic anhydrase overexpressed in certain \\n\\tcancers:: Proc. Natl. Acad. Sci. USA (2000) 97, 14212-14217. \\n\\t{Pubmed:11121027}\\nRF\\t<134> Karhumaa, P.; Leinonen, J.; Parkkila, S.; Kaunisto, K.; \\n\\tTapanainen, J.; Rajaniemi, H.: The identification of secreted carbonic \\n\\tanhydrase VI as a constitutive glycoprotein of human and rat milk:: \\n\\tProc. Natl. Acad. Sci. USA (2001) 98, 11604-11608. {Pubmed:11553764}\\nRF\\t<135> Whittington, D.A.; Waheed, A.; Ulmasov, B.; Shah, G.N.; Grubb, \\n\\tJ.H.; Sly, W.S.; Christianson, D.W.: Crystal structure of the dimeric \\n\\textracellular domain of human carbonic anhydrase XII, a bitopic \\n\\tmembrane protein overexpressed in certain cancer tumor cells:: Proc. \\n\\tNatl. Acad. Sci. USA (2001) 98, 9545-9550. {Pubmed:11493685}\\nRF\\t<136> Slaymaker, D.H.; Navarre, D.A.; Clark, D.; del Pozo, O.; Martin, \\n\\tG.B.; Klessig, D.F.: The tobacco salicylic acid-binding protein 3 \\n\\t(SABP3) is the chloroplast carbonic anhydrase, which exhibits \\n\\tantioxidant activity and plays a role in the hypersensitive defense \\n\\tresponse:: Proc. Natl. Acad. Sci. USA (2002) 99, 11640-11645. \\n\\t{Pubmed:12185253}\\nRF\\t<137> Premkumar, L.; Bageshwar, U.K.; Gokhman, I.; Zamir, A.; Sussman, \\n\\tJ.L.: An unusual halotolerant alpha-type carbonic anhydrase from the \\n\\talga Dunaliella salina functionally expressed in Escherichia coli:: \\n\\tProtein Expr. Purif. (2003) 28, 151-157. {Pubmed:12651119}\\nRF\\t<138> Cronk, J.D.; Endrizzi, J.A.; Cronk, M.R.; O\\'Neill, J.W.; Zhang, \\n\\tK.Y.J.: Crystal structure of E. coli beta-carbonic anhydrase, an enzyme \\n\\twith a n unusual pH-dependent activity:: Protein Sci. (2001) 10, \\n\\t911-922. {Pubmed:11316870}\\nRF\\t<139> Hilvo, M.; Tolvanen, M.; Clark, A.; Shen, B.; Shah, G.N.; Waheed, \\n\\tA.; Halmi, P.; Hanninen, M.; Hamalainen, J.M.; Vihinen, M.; Sly, W.S.; \\n\\tParkkila, S.: Characterization of CA XV, a new GPI-anchored form of \\n\\tcarbonic anhydrase:: Biochem. J. (2005) 392, 83-92. {Pubmed:16083424} \\n\\t(c)\\nRF\\t<140> Duda, D.M.; Tu, C.; Fisher, S.Z.; An, H.; Yoshioka, C.; \\n\\tGovindasamy, L.; Laipis, P.J.; Agbandje-McKenna, M.; Silverman, D.N.; \\n\\tMcKenna, R.: Human carbonic anhydrase III: structural and kinetic study \\n\\tof catalysis and proton transfer:: Biochemistry (2005) 44, 10046-10053. \\n\\t{Pubmed:16042381} (c)\\nRF\\t<141> zensoy, O.; Nishimori, I.; Vullo, D.; Puccetti, L.; Scozzafava, \\n\\tA.; Supuran, C.T.: Carbonic anhydrase inhibitors: inhibition of the \\n\\thuman transmembrane isozyme XIV with a library of aromatic/heterocyclic \\n\\tsulfonamides:: Bioorg. Med. Chem. (2005) 13, 6089-6093. \\n\\t{Pubmed:16006130} (c)\\nRF\\t<142> Wang, B.; Liu, C.Q.; Wu, Y.: Effect of heavy metals on the \\n\\tactivity of external carbonic anhydrase of microalga Chlamydomonas \\n\\treinhardtii and microalgae from karst lakes:: Bull. Environ. Contam. \\n\\tToxicol. (2005) 74, 227-233. {Pubmed:15841961} (c)\\nRF\\t<143> Haritos, V.S.; Dojchinov, G.: Carbonic anhydrase metabolism is a \\n\\tkey factor in the toxicity of CO2 and COS but not CS2 toward the flour \\n\\tbeetle Tribolium castaneum [Coleoptera: Tenebrionidae]:: Comp. Biochem. \\n\\tPhysiol. C (2005) 140, 139-147. {Pubmed:15792633} (c)\\nRF\\t<144> Wroblewski, K.; Spalthoff, S.; Zimmerman, U.J.; Post, R.L.; \\n\\tSanger, J.W.; Forster, R.E.: The role of carbonic anhydrase in the \\n\\trecovery of skeletal muscle from anoxia:: J. Appl. Physiol. (2005) 99, \\n\\t488-498. {Pubmed:15802363} (c)\\nRF\\t<145> Marcus, E.A.; Moshfegh, A.P.; Sachs, G.; Scott, D.R.: The \\n\\tperiplasmic alpha-carbonic anhydrase activity of Helicobacter pylori is \\n\\tessential for acid acclimation:: J. Bacteriol. (2005) 187, 729-738. \\n\\t{Pubmed:15629943} (c)\\nRF\\t<146> Esbaugh, A.J.; Tufts, B.L.: Evidence for a membrane-bound \\n\\tcarbonic anhydrase in the heart of an ancient vertebrate, the sea \\n\\tlamprey (Petromyzon marinus):: J. Comp. Physiol. B (2004) 174, 399-406. \\n\\t{Pubmed:15088117} (c)\\nRF\\t<147> Esbaugh, A.J.; Lund, S.G.; Tufts, B.L.: Comparative physiology \\n\\tand molecular analysis of carbonic anhydrase from the red blood cells \\n\\tof teleost fish:: J. Comp. Physiol. B (2004) 174, 429-438. \\n\\t{Pubmed:15146348} (c)\\nRF\\t<148> zensoy, .; Isik, S.; Arslan, O.; Arslan, M.; Scozzafava, A.; \\n\\tSupuran, C.T.: Carbonic anhydrase inhibitors. Inhibition of red blood \\n\\tcell ostrich (Struthio camelus) carbonic anhydrase with a series of \\n\\taromatic and heterocyclic sulfonamides:: J. Enzyme Inhib. Med. Chem. \\n\\t(2005) 20, 383-387. {Pubmed:16206834} (c)\\nRF\\t<149> Demir, Y.; Nadaroglu, H.; Demir, N.: Purification and \\n\\tcharacterization of carbonic anhydrase from bovine stomach and effects \\n\\tof some known inhibitors on enzyme activity:: J. Enzyme Inhib. Med. \\n\\tChem. (2005) 20, 75-80. {Pubmed:15895688} (c)\\nRF\\t<150> Esbaugh, A.J.; Perry, S.F.; Bayaa, M.; Georgalis, T.; Nickerson, \\n\\tJ.; Tufts, B.L.; Gilmour, K.M.: Cytoplasmic carbonic anhydrase isozymes \\n\\tin rainbow trout Oncorhynchus mykiss: comparative physiology and \\n\\tmolecular evolution:: J. Exp. Biol. (2005) 208, 1951-1961. \\n\\t{Pubmed:15879075} (c)\\nRF\\t<151> del Pilar Corena, M.; VanEkeris, L.; Salazar, M.I.; Bowers, D.; \\n\\tFiedler, M.M.; Silverman, D.; Tu, C.; Linser, P.J.: Carbonic anhydrase \\n\\tin the adult mosquito midgut:: J. Exp. Biol. (2005) 208, 3263-3273. \\n\\t{Pubmed:16109888} (c)\\nRF\\t<152> Kleinke, T.; Wagner, S.; John, H.; Hewett-Emmett, D.; Parkkila, \\n\\tS.; Forssmann, W.G.; Gros, G.: A distinct carbonic anhydrase in the \\n\\tmucus of the colon of humans and other mammals:: J. Exp. Biol. (2005) \\n\\t208, 487-496. {Pubmed:15671337} (c)\\nRF\\t<153> Innocenti, A.; Casini, A.; Alcaro, M.C.; Papini, A.M.; \\n\\tScozzafava, A.; Supuran, C.T.: Carbonic anhydrase inhibitors: the first \\n\\ton-resin screening of a 4-sulfamoylphenylthiourea library:: J. Med. \\n\\tChem. (2004) 47, 5224-5229. {Pubmed:15456265} (c)\\nRF\\t<154> Andrade, F.H.; Hatala, D.A.; McMullen, C.A.: Carbonic anhydrase \\n\\tisoform expression and functional role in rodent extraocular muscle:: \\n\\tPflugers Arch. (2004) 448, 547-551. {Pubmed:15112082} (c)\\nRF\\t<155> Lu, Y.K.; Theg, S.M.; Stemler, A.J.: Carbonic anhydrase activity \\n\\tof the photosystem II OEC33 protein from pea:: Plant Cell Physiol. \\n\\t(2005) 46, 1944-1953. {Pubmed:16223737} (c)\\nRF\\t<156> Tanaka, Y.; Nakatsuma, D.; Harada, H.; Ishida, M.; Matsuda, Y.: \\n\\tLocalization of soluble beta-carbonic anhydrase in the marine diatom \\n\\tPhaeodactylum tricornutum. Sorting to the chloroplast and cluster \\n\\tformation on the girdle lamellae:: Plant Physiol. (2005) 138, 207-217. \\n\\t{Pubmed:15849303} (c)\\nRF\\t<157> Shah, G.N.; Ulmasov, B.; Waheed, A.; Becker, T.; Makani, S.; \\n\\tSvichar, N.; Chesler, M.; Sly, W.S.: Carbonic anhydrase IV and XIV \\n\\tknockout mice: roles of the respective carbonic anhydrases in buffering \\n\\tthe extracellular space in brain:: Proc. Natl. Acad. Sci. USA (2005) \\n\\t102, 16771-16776. {Pubmed:16260723} (c)\\nRF\\t<158> Premkumar, L.; Greenblatt, H.M.; Bageshwar, U.K.; Savchenko, T.; \\n\\tGokhman, I.; Sussman, J.L.; Zamir, A.: Three-dimensional structure of a \\n\\thalotolerant algal carbonic anhydrase predicts halotolerance of a \\n\\tmammalian homolog:: Proc. Natl. Acad. Sci. USA (2005) 102, 7493-7498. \\n\\t{Pubmed:15894606} (c)\\nRF\\t<159> Nagelhus, E.A.; Mathiisen, T.M.; Bateman, A.C.; Haug, F.M.; \\n\\tOttersen, O.P.; Grubb, J.H.; Waheed, A.; Sly, W.S.: Carbonic anhydrase \\n\\tXIV is enriched in specific membrane domains of retinal pigment \\n\\tepithelium, Muller cells, and astrocytes:: Proc. Natl. Acad. Sci. USA \\n\\t(2005) 102, 8030-8035. {Pubmed:15901897} (c)\\nRF\\t<160> Alber, B.E.; Ferry, J.G.: A carbonic anhydrase from the archaeon \\n\\tMethanosarcina thermophila:: Proc. Natl. Acad. Sci. USA (1994) 91, \\n\\t6909-6913. {Pubmed:8041719} (c)\\nRF\\t<161> Bageshwar, U.K.; Premkumar, L.; Gokhman, I.; Savchenko, T.; \\n\\tSussman, J.L.; Zamir, A.: Natural protein engineering: a uniquely \\n\\tsalt-tolerant, but not halophilic, alpha-type carbonic anhydrase from \\n\\talgae proliferating in low- to hyper-saline environments:: Protein Eng. \\n\\tDes. Sel. (2004) 17, 191-200. {Pubmed:15047915} (c)\\nRF\\t<162> Fisher, S.Z.; Tu, C.; Bhatt, D.; Govindasamy, L.; \\n\\tAgbandje-McKenna, M.; McKenna, R.; Silvermann, D.N.: Speeding up \\n\\tproteon transfer in a fast enzyme: kinetic and crystallographic studies \\n\\ton the effect of hydrophobic amino acid substitutions in the active \\n\\tsite of human carbonic anhydrase II:: Biochemistry (2007) 46, \\n\\t3803-3813. {Pubmed:17330962}\\nRF\\t<163> Ignatova, L.K.; Rudenko, N.N.; Khristin, M.S.; Ivanov, B.N.: \\n\\tHeterogeneous origin of carbonic anhydrase activity of thylakoid \\n\\tmembranes:: Biochemistry (2006) 71, 525-532. {Pubmed:16732731}\\nRF\\t<164> McConnell, I.L.; Badger, M.R.; Wydrzynski, T.; Hillier, W.: A \\n\\tquantitative assessment of the carbonic anhydrase activity in \\n\\tphotosystem II:: Biochim. Biophys. Acta (2007) 1767, 639-647. \\n\\t{Pubmed:17467655}\\nRF\\t<165> Fisher, S.Z.; Tariku, I.; Case, N.M.; Tu, C.; Seron, T.; \\n\\tSilverman, D.N.; Linser, P.J.; McKenna, R.: Expression, purification, \\n\\tkinetic, and structural characterization of an alpha-class carbonic \\n\\tanhydrase from Aedes aegypti (AaCA1):: Biochim. Biophys. Acta (2006) \\n\\t764, 1413-1419. {Pubmed:16920039}\\nRF\\t<166> Wu, Y.; Zhao, X.; Li, P.; Huang, H.: Impact of Zn, Cu, and Fe on \\n\\tthe activity of carbonic anhydrase of erythrocytes in ducks:: Biol. \\n\\tTrace Elem. Res. (2007) 118, 227-232. {Pubmed:17916925}\\nRF\\t<167> Nishimori, I.; Minakuchi, T.; Onishi, S.; Vullo, D.; Cecchi, A.; \\n\\tScozzafava, A.; Supuran, C.T.: Carbonic anhydrase inhibitors: cloning, \\n\\tcharacterization, and inhibition studies of the cytosolic isozyme III \\n\\twith sulfonamides:: Bioorg. Med. Chem. (2007) 15, 7229-7236. \\n\\t{Pubmed:17826101}\\nRF\\t<168> Temperini, C.; Winum, J.Y.; Montero, J.L.; Scozzafava, A.; \\n\\tSupuran, C.T.: Carbonic anhydrase inhibitors: the X-ray crystal \\n\\tstructure of the adduct of N-hydroxysulfamide with isozyme II explains \\n\\twhy this new zinc binding function is effective in the design of potent \\n\\tinhibitors:: Bioorg. Med. Chem. Lett. (2007) 17, 2795-2801. \\n\\t{Pubmed:17346964}\\nRF\\t<169> Alterio, V.; De Simone, G.; Monti, S.M.; Scozzafava, A.; Supuran, \\n\\tC.T.: Carbonic anhydrase inhibitors: inhibition of human, bacterial, \\n\\tand archaeal isozymes with benzene-1,3-disulfonamides - solution and \\n\\tcrystallographic studies:: Bioorg. Med. Chem. Lett. (2007) 17, \\n\\t4201-4207. {Pubmed:17540563}\\nRF\\t<170> Temperini, C.; Innocenti, A.; Mastrolorenzo, A.; Scozzafava, A.; \\n\\tSupuran, C.T.: Carbonic anhydrase inhibitors. Interaction of the \\n\\tantiepileptic drug sulthiame with twelve mammalian isoforms: kinetic \\n\\tand X-ray crystallographic studies:: Bioorg. Med. Chem. Lett. (2007) \\n\\t17, 4866-4872. {Pubmed:17588751}\\nRF\\t<171> Guezel, O.; Temperini, C.; Innocenti, A.; Scozzafava, A.; Salman, \\n\\tA.; Supuran, C.T.: Carbonic anhydrase inhibitors. Interaction of \\n\\t2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 \\n\\tmammalian isoforms: kinetic and X-ray crystallographic studies:: \\n\\tBioorg. Med. Chem. Lett. (2008) 18, 152-158. {Pubmed:18024029}\\nRF\\t<172> Temperini, C.; Cecchi, A.; Boyle, N.A.; Scozzafava, A.; Cabeza, \\n\\tJ.E.; Wentworth, P.; Blackburn, G.M.; Supuran, C.T.: Carbonic anhydrase \\n\\tinhibitors. Interaction of \\n\\t2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide with 12 \\n\\tmammalian isoforms: Kinetic and X-ray crystallographic studies:: \\n\\tBioorg. Med. Chem. Lett. (2007) 18, 999-1005. {Pubmed:18162396}\\nRF\\t<173> Marino, S.; Hayakawa, K.; Hatada, K.; Benfatto, M.; Rizzello, A.; \\n\\tMaffia, M.; Bubacco, L.: Structural features that govern enzymatic \\n\\tactivity in carbonic anhydrase from a low-temperature adapted fish, \\n\\tChionodraco hamatus:: Biophys. J. (2007) 93, 2781-2790. \\n\\t{Pubmed:17573429}\\nRF\\t<174> Roy, L.A.; Davis, D.A.; Saoud, I.P.; Henry, R.P.: Branchial \\n\\tcarbonic anhydrase activity and ninhydrin positive substances in the \\n\\tPacific white shrimp, Litopenaeus vannamei, acclimated to low and high \\n\\tsalinities:: Comp. Biochem. Physiol. A (2007) 147, 404-411. \\n\\t{Pubmed:17350299}\\nRF\\t<175> Hilvo, M.; Supuran, C.T.; Parkkila, S.: Characterization and \\n\\tinhibition of the recently discovered carbonic anhydrase isoforms CA \\n\\tXIII, XIV and XV:: Curr. Top. Med. Chem. (2007) 7, 893-899. \\n\\t{Pubmed:17504134} (review)\\nRF\\t<176> Demir, Y.; Nadaroglu, H.; Demir, N.: Purification and some \\n\\tproperties of carbonic anhydrase from Elephas trogontherii (Steppe \\n\\telephant) bone:: Indian J. Biochem. Biophys. (2007) 44, 252-256. \\n\\t{Pubmed:17970284}\\nRF\\t<177> Beydemir, S.; Bulbul, M.; Hisar, O.; Soyut, H.; Yanik, T.: \\n\\tCarbonic anhydrase: affinity purification and kinetic properties from \\n\\trainbow trout lens:: Int. J. Appl. Chem. (2006) 2, 45-55. {Pubmed:}\\nRF\\t<178> Heinhorst, S.; Williams, E.B.; Cai, F.; Murin, C.D.; Shively, \\n\\tJ.M.; Cannon, G.C.: Characterization of the carboxysomal carbonic \\n\\tanhydrase CsoSCA from Halothiobacillus neapolitanus:: J. Bacteriol. \\n\\t(2006) 188, 8087-8094. {Pubmed:17012396}\\nRF\\t<179> Hollowell, H.N.; Younvanich, S.S.; McNevin, S.L.; Britt, B.M.: \\n\\tThermodynamic analysis of the low- to physiological-temperature \\n\\tnondenaturational conformational change of bovine carbonic anhydrase:: \\n\\tJ. Biochem. Mol. Biol. (2007) 40, 205-211. {Pubmed:17394770}\\nRF\\t<180> Sawaya, M.R.; Cannon, G.C.; Heinhorst, S.; Tanaka, S.; Williams, \\n\\tE.B.; Yeates, T.O.; Kerfeld, C.A.: The structure of beta-carbonic \\n\\tanhydrase from the carboxysomal shell reveals a distinct subclass with \\n\\tone active site for the price of two:: J. Biol. Chem. (2006) 281, \\n\\t7546-7555. {Pubmed:16407248}\\nRF\\t<181> Becker, H.M.; Deitmer, J.W.: Carbonic anhydrase II increases the \\n\\tactivity of the human electrogenic Na+/HCO3- cotransporter:: J. Biol. \\n\\tChem. (2007) 282, 13508-13521. {Pubmed:17353189}\\nRF\\t<182> Esbaugh, A.J.; Tufts, B.L.: Tribute to R. G. Boutilier: evidence \\n\\tof a high activity carbonic anhydrase isozyme in the red blood cells of \\n\\tan ancient vertebrate, the sea lamprey Petromyzon marinus:: J. Exp. \\n\\tBiol. (2006) 209, 1169-1178. {Pubmed:16547289}\\nRF\\t<183> Serrano, L.; Halanych, K.M.; Henry, R.P.: Salinity-stimulated \\n\\tchanges in expression and activity of two carbonic anhydrase isoforms \\n\\tin the blue crab Callinectes sapidus:: J. Exp. Biol. (2007) 210, \\n\\t2320-2332. {Pubmed:17575037}\\nRF\\t<184> Nishimori, I.; Minakuchi, T.; Onishi, S.; Vullo, D.; Scozzafava, \\n\\tA.; Supuran, C.T.: Carbonic anhydrase inhibitors. DNA cloning, \\n\\tcharacterization, and inhibition studies of the human secretory isoform \\n\\tVI, a new target for sulfonamide and sulfamate inhibitors:: J. Med. \\n\\tChem. (2007) 50, 381-388. {Pubmed:17228881}\\nRF\\t<185> Rahman, M.A.; Oomori, T.; Uehara, T.: Carbonic anhydrase in \\n\\tcalcified endoskeleton: novel activity in biocalcification in \\n\\tAlcyonarian:: Mar. Biotechnol. (2007) 10, 31-38. {Pubmed:17896136}\\nRF\\t<186> Gao, B.B.; Clermont, A.; Rook, S.; Fonda, S.J.; Srinivasan, V.J.; \\n\\tWojtkowski, M.; Fujimoto, J.G.; Avery, R.L.; Arrigg, P.G.; Bursell, \\n\\tS.E.; Aiello, L.P.; Feener, E.P.: Extracellular carbonic anhydrase \\n\\tmediates hemorrhagic retinal and cerebral vascular permeability through \\n\\tprekallikrein activation:: Nat. Med. (2007) 13, 181-188. \\n\\t{Pubmed:17259996}\\nRF\\t<187> Rudenko, N.N.; Ignatova, L.K.; Ivanov, B.N.: Multiple sources of \\n\\tcarbonic anhydrase activity in pea thylakoids: soluble and \\n\\tmembrane-bound forms:: Photosynth. Res. (2007) 91, 81-89. \\n\\t{Pubmed:17347907}\\nRF\\t<188> Fabre, N.; Reiter, I.M.; Becuwe-Linka, N.; Genty, B.; Rumeau, D.: \\n\\tCharacterization and expression analysis of genes encoding alpha and \\n\\tbeta carbonic anhydrases in Arabidopsis:: Plant Cell Environ. (2007) \\n\\t30, 617-629. {Pubmed:17407539}\\nRF\\t<189> Tetu, S.G.; Tanz, S.K.; Vella, N.; Burnell, J.N.; Ludwig, M.: The \\n\\tFlaveria bidentis beta-carbonic anhydrase gene family encodes cytosolic \\n\\tand chloroplastic isoforms demonstrating distinct organ-specific \\n\\texpression patterns:: Plant Physiol. (2007) 144, 1316-1327. \\n\\t{Pubmed:17496111}\\nRF\\t<190> Yu, S.; Xia, D.; Luo, Q.; Cheng, Y.; Takano, T.; Liu, S.: \\n\\tPurification and characterization of carbonic anhydrase of rice (Oryza \\n\\tsativa L.) expressed in Escherichia coli:: Protein Expr. Purif. (2007) \\n\\t52, 379-383. {Pubmed:17208453}\\nRF\\t<191> Rizzello, A.; Ciardiello, M.A.; Acierno, R.; Carratore, V.; \\n\\tVerri, T.; di Prisco, G.; Storelli, C.; Maffia, M.: Biochemical \\n\\tcharacterization of a S-glutathionylated carbonic anhydrase isolated \\n\\tfrom gills of the Antarctic icefish Chionodraco hamatus:: Protein J. \\n\\t(2007) 26, 335-348. {Pubmed:17510781}\\nRF\\t<192> Elder, I.; Fisher, Z.; Laipis, P.J.; Tu, C.; McKenna, R.; \\n\\tSilverman, D.N.: Structural and kinetic analysis of proton shuttle \\n\\tresidues in the active site of human carbonic anhydrase III:: Proteins \\n\\t(2007) 68, 337-343. {Pubmed:17427958}\\nRF\\t<193> Tiwari, A.; Kumar, P.; Chawhaan, P.H.; Singh, S.; Ansari, S.A.: \\n\\tCarbonic anhydrase in Tectona grandis: kinetics, stability, isozyme \\n\\tanalysis and relationship with photosynthesis:: Tree Physiol. (2006) \\n\\t26, 1067-1073. {Pubmed:16651256}\\nRF\\t<194> Jeyakanthan, J.; Rangarajan, S.; Mridula, P.; Kanaujia, S.P.; \\n\\tShiro, Y.; Kuramitsu, S.; Yokoyama, S.; Sekar, K.: Observation of a \\n\\tcalcium-binding site in the gamma-class carbonic anhydrase from \\n\\tPyrococcus horikoshii:: Acta Crystallogr. Sect. D (2008) 64, 1012-1019. \\n\\t{Pubmed:18931408}\\nRF\\t<195> Zheng, J.; Avvaru, B.S.; Tu, C.; McKenna, R.; Silverman, D.N.: \\n\\tRole of hydrophilic residues in proton transfer during catalysis by \\n\\thuman carbonic anhydrase II:: Biochemistry (2008) 47, 12028-12036. \\n\\t{Pubmed:18942852}\\nRF\\t<196> Genis, C.; Sippel, K.H.; Case, N.; Cao, W.; Avvaru, B.S.; \\n\\tTartaglia, L.J.; Govindasamy, L.; Tu, C.; Agbandje-McKenna, M.; \\n\\tSilverman, D.N.; Rosser, C.J.; McKenna, R.: Design of a carbonic \\n\\tanhydrase IX active-site mimic to screen inhibitors for possible \\n\\tanticancer properties:: Biochemistry (2009) 48, 1322-1331. \\n\\t{Pubmed:19170619}\\nRF\\t<197> Macauley, S.R.; Zimmerman, S.A.; Apolinario, E.E.; Evilia, C.; \\n\\tHou, Y.M.; Ferry, J.G.; Sowers, K.R.: The archetype gamma-class \\n\\tcarbonic anhydrase (Cam) contains iron when synthesized in vivo:: \\n\\tBiochemistry (2009) 48, 817-819. {Pubmed:19187031}\\nRF\\t<198> Rana, A.; Gupta, T.P.; Bansal, S.; Kundu, B.: Formation of \\n\\tamyloid fibrils by bovine carbonic anhydrase:: Biochim. Biophys. Acta \\n\\t(2008) 1784, 930-935. {Pubmed:18395531}\\nRF\\t<199> Soyut, H.; Beydemir, S.; Hisar, O.: Effects of some metals on \\n\\tcarbonic anhydrase from brains of rainbow trout:: Biol. Trace Elem. \\n\\tRes. (2008) 123, 179-190. {Pubmed:18288451}\\nRF\\t<200> Innocenti, A.; Scozzafava, A.; Parkkila, S.; Puccetti, L.; De \\n\\tSimone, G.; Supuran, C.T.: Investigations of the esterase, phosphatase, \\n\\tand sulfatase activities of the cytosolic mammalian carbonic anhydrase \\n\\tisoforms I, II, and XIII with 4-nitrophenyl esters as substrates:: \\n\\tBioorg. Med. Chem. Lett. (2008) 18, 2267-2271. {Pubmed:18353640}\\nRF\\t<201> Innocenti, A.; Hilvo, M.; Scozzafava, A.; Parkkila, S.; Supuran, \\n\\tC.T.: Carbonic anhydrase inhibitors: Inhibition of the new \\n\\tmembrane-associated isoform XV with phenols:: Bioorg. Med. Chem. Lett. \\n\\t(2008) 18, 3593-3596. {Pubmed:18501600}\\nRF\\t<202> Temperini, C.; Innocenti, A.; Scozzafava, A.; Supuran, C.T.: \\n\\tCarbonic anhydrase inhibitors. Interaction of the antitumor sulfamate \\n\\tEMD 486019 with twelve mammalian carbonic anhydrase isoforms: Kinetic \\n\\tand X-ray crystallographic studies:: Bioorg. Med. Chem. Lett. (2008) \\n\\t18, 4282-4286. {Pubmed:18640037}\\nRF\\t<203> Vullo, D.; Nishimori, I.; Scozzafava, A.; Supuran, C.T.: Carbonic \\n\\tanhydrase activators: Activation of the human cytosolic isozyme III and \\n\\tmembrane-associated isoform IV with amino acids and amines:: Bioorg. \\n\\tMed. Chem. Lett. (2008) 18, 4303-4307. {Pubmed:18627905}\\nRF\\t<204> Innocenti, A.; Muehlschlegel, F.A.; Hall, R.A.; Steegborn, C.; \\n\\tScozzafava, A.; Supuran, C.T.: Carbonic anhydrase inhibitors: \\n\\tinhibition of the beta-class enzymes from the fungal pathogens Candida \\n\\talbicans and Cryptococcus neoformans with simple anions:: Bioorg. Med. \\n\\tChem. Lett. (2008) 18, 5066-5070. {Pubmed:18723348}\\nRF\\t<205> Krungkrai, J.; Krungkrai, S.R.; Supuran, C.T.: Carbonic anhydrase \\n\\tinhibitors: inhibition of Plasmodium falciparum carbonic anhydrase with \\n\\taromatic/heterocyclic sulfonamides-in vitro and in vivo studies:: \\n\\tBioorg. Med. Chem. Lett. (2008) 18, 5466-5471. {Pubmed:18805693}\\nRF\\t<206> Innocenti, A.; Zimmerman, S.A.; Scozzafava, A.; Ferry, J.G.; \\n\\tSupuran, C.T.: Carbonic anhydrase activators: activation of the \\n\\tarchaeal beta-class (Cab) and gamma-class (Cam) carbonic anhydrases \\n\\twith amino acids and amines:: Bioorg. Med. Chem. Lett. (2008) 18, \\n\\t6194-6198. {Pubmed:18930395}\\nRF\\t<207> Isik, S.; Kockar, F.; Arslan, O.; Guler, O.O.; Innocenti, A.; \\n\\tSupuran, C.T.: Carbonic anhydrase inhibitors. Inhibition of the \\n\\tbeta-class enzyme from the yeast Saccharomyces cerevisiae with anions:: \\n\\tBioorg. Med. Chem. Lett. (2008) 18, 6327-6331. {Pubmed:18993072}\\nRF\\t<208> Bertucci, A.; Innocenti, A.; Zoccola, D.; Scozzafava, A.; \\n\\tAllemand, D.; Tambutte, S.; Supuran, C.T.: Carbonic anhydrase \\n\\tinhibitors: inhibition studies of a coral secretory isoform with \\n\\tinorganic anions:: Bioorg. Med. Chem. Lett. (2009) 19, 650-653. \\n\\t{Pubmed:19121582}\\nRF\\t<209> Bayram, E.; Senturk, M.; Kufrevioglu, O.I.; Supuran, C.T.: In \\n\\tvitro inhibition of salicylic acid derivatives on human cytosolic \\n\\tcarbonic anhydrase isozymes I and II:: Bioorg. Med. Chem. (2008) 16, \\n\\t9101-9105. {Pubmed:18819808}\\nRF\\t<210> Isik, S.; Kockar, F.; Aydin, M.; Arslan, O.; Guler, O.O.; \\n\\tInnocenti, A.; Scozzafava, A.; Supuran, C.T.: Carbonic anhydrase \\n\\tinhibitors: inhibition of the beta-class enzyme from the yeast \\n\\tSaccharomyces cerevisiae with sulfonamides and sulfamates:: Bioorg. \\n\\tMed. Chem. (2009) 17, 1158-1163. {Pubmed:19124253}\\nRF\\t<211> Bootorabi, F.; Jaenis, J.; Valjakka, J.; Isoniemi, S.; \\n\\tVainiotalo, P.; Vullo, D.; Supuran, C.T.; Waheed, A.; Sly, W.S.; \\n\\tNiemelae, O.; Parkkila, S.: Modification of carbonic anhydrase II with \\n\\tacetaldehyde, the first metabolite of ethanol, leads to decreased \\n\\tenzyme activity:: BMC Biochem. (2008) 9, 32. {Pubmed:19036170}\\nRF\\t<212> Lazova, G.N.; Stemler, A.J.: A 160 kDa protein with carbonic \\n\\tanhydrase activity is complexed with rubisco on the outer surface of \\n\\tthylakoids:: Cell Biol. Int. (2008) 32, 646-653. {Pubmed:18342550}\\nRF\\t<213> Marie, B.; Luquet, G.; Bedouet, L.; Milet, C.; Guichard, N.; \\n\\tMedakovic, D.; Marin, F.: Nacre calcification in the freshwater mussel \\n\\tUnio pictorum: carbonic anhydrase activity and purification of a 95 kDa \\n\\tcalcium-binding glycoprotein:: ChemBioChem (2008) 9, 2515-2523. \\n\\t{Pubmed:18810748}\\nRF\\t<214> Pongsomboon, S.; Udomlertpreecha, S.; Amparyup, P.; \\n\\tWuthisuthimethavee, S.; Tassanakajon, A.: Gene expression and activity \\n\\tof carbonic anhydrase in salinity stressed Penaeus monodon:: Comp. \\n\\tBiochem. Physiol. A (2009) 152, 225-233. {Pubmed:18950726}\\nRF\\t<215> Hilvo, M.; Innocenti, A.; Monti, S.M.; De Simone, G.; Supuran, \\n\\tC.T.; Parkkila, S.: Recent advances in research on the most novel \\n\\tcarbonic anhydrases, CA XIII and XV:: Curr. Pharm. Des. (2008) 14, \\n\\t672-678. {Pubmed:18336313}\\nRF\\t<216> Ye, C.; Gao, K.; Giordano, M.: The odd behaviour of carbonic \\n\\tanhydrase in the terrestrial cyanobacterium Nostoc flagelliforme during \\n\\thydration-dehydration cycles:: Environ. Microbiol. (2008) 10, \\n\\t1018-1023. {Pubmed:18177372}\\nRF\\t<217> Choi, S.W.; Kim, J.Y.; Park, J.Y.; Cha, I.H.; Kim, J.; Lee, S.: \\n\\tExpression of carbonic anhydrase IX is associated with postoperative \\n\\trecurrence and poor prognosis in surgically treated oral squamous cell \\n\\tcarcinoma:: Hum. Pathol. (2008) 39, 1317-1322. {Pubmed:18440050}\\nRF\\t<218> Sun, X.C.; Li, J.; Cui, M.; Bonanno, J.A.: Role of carbonic \\n\\tanhydrase IV in corneal endothelial HCO3- transport:: Invest. \\n\\tOphthalmol. Vis. Sci. (2008) 49, 1048-1055. {Pubmed:18326729}\\nRF\\t<219> Maupin, C.M.; Saunders, M.G.; Thorpe, I.F.; McKenna, R.; \\n\\tSilverman, D.N.; Voth, G.A.: Origins of enhanced proton transport in \\n\\tthe Y7F mutant of human carbonic anhydrase II:: J. Am. Chem. Soc. \\n\\t(2008) 130, 11399-11408. {Pubmed:18671353}\\nRF\\t<220> Gokhale, N.H.; Bradford, S.; Cowan, J.A.: Catalytic inactivation \\n\\tof human carbonic anhydrase I by a metallopeptide-sulfonamide conjugate \\n\\tis mediated by oxidation of active site residues:: J. Am. Chem. Soc. \\n\\t(2008) 130, 2388-2389. {Pubmed:18251475}\\nRF\\t<221> Swingley, W.D.; Sadekar, S.; Mastrian, S.D.; Matthies, H.J.; Hao \\n\\tJ.; Ramos, H.; Acharya, C.R.; Conrad, A.L.; Taylor, H.L.; Dejesa, L.C.; \\n\\tShah, M.K.; O\\'huallachain, M.E.; Lince, M.T.; Blankenship, R.E.; \\n\\tBeatty, J.T.; Touchman, J.W.: The complete genome sequence of \\n\\tRoseobacter denitrificans reveals a mixotrophic rather than \\n\\tphotosynthetic metabolism:: J. Bacteriol. (2007) 189, 683-690. \\n\\t{Pubmed:17098896}\\nRF\\t<222> Moya, A.; Tambutte, S.; Bertucci, A.; Tambutte, E.; Lotto, S.; \\n\\tVullo, D.; Supuran, C.T.; Allemand, D.; Zoccola, D.: Carbonic anhydrase \\n\\tin the scleractinian coral Stylophora pistillata: characterization, \\n\\tlocalization, and role in biomineralization:: J. Biol. Chem. (2008) \\n\\t283, 25475-25484. {Pubmed:18617510}\\nRF\\t<223> Hilvo, M.; Baranauskiene, L.; Salzano, A.M.; Scaloni, A.; \\n\\tMatulis, D.; Innocenti, A.; Scozzafava, A.; Monti, S.M.; Di Fiore, A.; \\n\\tDe Simone, G.; Lindfors, M.; Jaenis, J.; Valjakka, J.; Pastorekova, S.; \\n\\tPastorek, J.; Kulomaa, M.S.; Nordlund, H.R.; Supuran, C.T.; Parkkila, \\n\\tS.: Biochemical characterization of CA IX, one of the most active \\n\\tcarbonic anhydrase isozymes:: J. Biol. Chem. (2008) 283, 27799-27809. \\n\\t{Pubmed:18703501}\\nRF\\t<224> Domsic, J.F.; Avvaru, B.S.; Kim, C.U.; Gruner, S.M.; \\n\\tAgbandje-McKenna, M.; Silverman, D.N.; McKenna, R.: Entrapment of \\n\\tcarbon dioxide in the active site of carbonic anhydrase II:: J. Biol. \\n\\tChem. (2008) 283, 30766-30771. {Pubmed:18768466}\\nRF\\t<225> Coban, T.A.; Beydemir, S.; Guelcin, I.; Ekinci, D.: The effect of \\n\\tethanol on erythrocyte carbonic anhydrase isoenzymes activity: an in \\n\\tvitro and in vivo study:: J. Enzyme Inhib. Med. Chem. (2008) 23, \\n\\t266-270. {Pubmed:18343914}\\nRF\\t<226> Buelbuel, M.; Kasimogullari, R.; Kuefrevioglu, O.I.: Amide \\n\\tderivatives with pyrazole carboxylic acids of 5-amino-1,3,4-thiadiazole \\n\\t2-sulfonamide as new carbonic anhydrase inhibitors: synthesis and \\n\\tinvestigation of inhibitory effects:: J. Enzyme Inhib. Med. Chem. \\n\\t(2008) 23, 895-900. {Pubmed:18618324}\\nRF\\t<227> Nishimori, I.; Minakuchi, T.; Onishi, S.; Vullo, D.; Cecchi, A.; \\n\\tScozzafava, A.; Supuran, C.T.: Carbonic anhydrase inhibitors. Cloning, \\n\\tcharacterization and inhibition studies of the cytosolic isozyme III \\n\\twith anions:: J. Enzyme Inhib. Med. Chem. (2009) 24, 70-76. \\n\\t{Pubmed:18618322}\\nRF\\t<228> Wilkinson, B.L.; Innocenti, A.; Vullo, D.; Supuran, C.T.; \\n\\tPoulsen, S.A.: Inhibition of carbonic anhydrases with glycosyltriazole \\n\\tbenzene sulfonamides:: J. Med. Chem. (2008) 51, 1945-1953. \\n\\t{Pubmed:18307288}\\nRF\\t<229> Temperini, C.; Cecchi, A.; Scozzafava, A.; Supuran, C.T.: \\n\\tCarbonic anhydrase inhibitors. Comparison of chlorthalidone and \\n\\tindapamide X-ray crystal structures in adducts with isozyme II: when \\n\\tthree water molecules and the keto-enol tautomerism make the \\n\\tdifference:: J. Med. Chem. (2009) 52, 322-328. {Pubmed:19115843}\\nRF\\t<230> Hilvo, M.; Salzano, A.M.; Innocenti, A.; Kulomaa, M.S.; \\n\\tScozzafava, A.; Scaloni, A.; Parkkila, S.; Supuran, C.T.: Cloning, \\n\\texpression, post-Translational modifications and inhibition Studies on \\n\\tthe latest mammalian carbonic anhydrase isoform, CA XV:: J. Med. Chem. \\n\\t(2009) 52, 646-654. {Pubmed:19193158}\\nRF\\t<231> Schlicker, C.; Hall, R.A.; Vullo, D.; Middelhaufe, S.; Gertz, M.; \\n\\tSupuran, C.T.; Muehlschlegel, F.A.; Steegborn, C.: Structure and \\n\\tinhibition of the CO2-sensing carbonic anhydrase Can2 from the \\n\\tpathogenic fungus Cryptococcus neoformans:: J. Mol. Biol. (2009) 385, \\n\\t1207-1220. {Pubmed:19071134}\\nRF\\t<232> Gailly, P.; Jouret, F.; Martin, D.; Debaix, H.; Parreira, K.S.; \\n\\tNishita, T.; Blanchard, A.; Antignac, C.; Willnow, T.E.; Courtoy, P.J.; \\n\\tScheinman, S.J.; Christensen, E.I.; Devuyst, O.: A novel renal carbonic \\n\\tanhydrase type III plays a role in proximal tubule dysfunction:: Kidney \\n\\tInt. (2008) 74, 52-61. {Pubmed:18322545}\\nRF\\t<233> Malentacchi, F.; Simi, L.; Nannelli, C.; Andreani, M.; Janni, A.; \\n\\tPastorekova, S.; Orlando, C.: Alternative splicing variants of carbonic \\n\\tanhydrase IX in human non-small cell lung cancer:: Lung Cancer (2009) \\n\\t64, 271-276. {Pubmed:19022520}\\nRF\\t<234> Dai, H.Y.; Hong, C.C.; Liang, S.C.; Yan, M.D.; Lai, G.M.; Cheng, \\n\\tA.L.; Chuang, S.E.: Carbonic anhydrase III promotes transformation and \\n\\tinvasion capability in hepatoma cells through FAK signaling pathway:: \\n\\tMol. Carcinog. (2008) 47, 956-963. {Pubmed:18444244}\\nRF\\t<235> Xu, Y.; Feng, L.; Jeffrey, P.D.; Shi, Y.; Morel, F.M.: Structure \\n\\tand metal exchange in the cadmium carbonic anhydrase of marine \\n\\tdiatoms:: Nature (2008) 452, 56-61. {Pubmed:18322527}\\nRF\\t<236> Haapasalo, J.; Hilvo, M.; Nordfors, K.; Haapasalo, H.; Parkkila, \\n\\tS.; Hyrskyluoto, A.; Rantala, I.; Waheed, A.; Sly, W.S.; Pastorekova, \\n\\tS.; Pastorek, J.; Parkkila, A.K.: Identification of an alternatively \\n\\tspliced isoform of carbonic anhydrase XII in diffusely infiltrating \\n\\tastrocytic gliomas:: Neuro-oncology (2008) 10, 131-138. \\n\\t{Pubmed:18322268}\\nRF\\t<237> Frison, G.; Ohanessian, G.: Metal-histidine-glutamate as a \\n\\tregulator of enzymatic cycles: a case study of carbonic anhydrase:: \\n\\tPhys. Chem. Chem. Phys. (2009) 11, 374-383. {Pubmed:19088994}\\nRF\\t<238> Martin, C.L.; Tortell, P.D.: Bicarbonate transport and \\n\\textracellular carbonic anhydrase in marine diatoms:: Physiol. Plant. \\n\\t(2008) 133, 106-116. {Pubmed:18298417}\\nRF\\t<239> Ynalvez, R.A.; Xiao, Y.; Ward, A.S.; Cunnusamy, K.; Moroney, \\n\\tJ.V.: Identification and characterization of two closely related \\n\\tbeta-carbonic anhydrases from Chlamydomonas reinhardtii:: Physiol. \\n\\tPlant. (2008) 133, 15-26. {Pubmed:18405332}\\nRF\\t<240> Kitao, Y.; Harada, H.; Matsuda, Y.: Localization and targeting \\n\\tmechanisms of two chloroplastic beta-carbonic anhydrases in the marine \\n\\tdiatom Phaeodactylum tricornutum:: Physiol. Plant. (2008) 133, 68-77. \\n\\t{Pubmed:18298418}\\nRF\\t<241> McGinn, P.J.; Morel, F.M.: Expression and regulation of carbonic \\n\\tanhydrases in the marine diatom Thalassiosira pseudonana and in natural \\n\\tphytoplankton assemblages from Great Bay, New Jersey:: Physiol. Plant. \\n\\t(2008) 133, 78-91. {Pubmed:18405334}\\nRF\\t<242> Lapointe, M.; Mackenzie, T.D.; Morse, D.: An external \\n\\tdelta-carbonic anhydrase in a free-living marine dinoflagellate may \\n\\tcircumvent diffusion-limited carbon acquisition:: Plant Physiol. (2008) \\n\\t147, 1427-1436. {Pubmed:18467453}\\nRF\\t<243> Ferreira, F.J.; Guo, C.; Coleman, J.R.: Reduction of \\n\\tplastid-localized carbonic anhydrase activity results in reduced \\n\\tArabidopsis seedling survivorship:: Plant Physiol. (2008) 147, 585-594. \\n\\t{Pubmed:18434607}\\nRF\\t<244> Duanmu, D.; Wang, Y.; Spalding, M.H.: Thylakoid lumen carbonic \\n\\tanhydrase (CAH3) mutation suppresses air-dier phenotype of LCIB mutant \\n\\tin Chlamydomonas reinhardtii:: Plant Physiol. (2008) 149, 929-937. \\n\\t{Pubmed:19074623}\\nRF\\t<245> Inada, A.; Nienaber, C.; Katsuta, H.; Fujitani, Y.; Levine, J.; \\n\\tMorita, R.; Sharma, A.; Bonner-Weir, S.: Carbonic anhydrase II-positive \\n\\tpancreatic cells are progenitors for both endocrine and exocrine \\n\\tpancreas after birth:: Proc. Natl. Acad. Sci. USA (2008) 105, \\n\\t19915-19919. {Pubmed:19052237}\\nRF\\t<246> Soyut, H.; Beydemir, S.: Purification and some kinetic properties \\n\\tof carbonic anhydrase from rainbow trout (Oncorhynchus mykiss) liver \\n\\tand metal inhibition:: Protein Pept. Lett. (2008) 15, 528-535. \\n\\t{Pubmed:18537745}\\nRF\\t<247> Di Fiore, A.; Monti, S.M.; Hilvo, M.; Parkkila, S.; Romano, V.; \\n\\tScaloni, A.; Pedone, C.; Scozzafava, A.; Supuran, C.T.; De Simone, G.: \\n\\tCrystal structure of human carbonic anhydrase XIII and its complex with \\n\\tthe inhibitor acetazolamide:: Proteins (2009) 74, 164-175. \\n\\t{Pubmed:18618712}\\nRF\\t<248> Tasgin, E.; Nadaroglu, H.; Demir, Y.; Demir, N.: Purification and \\n\\tproperties of carbonic anhydrase from bone marrow:: Asian J. Chem. \\n\\t(2009) 21, 5117-5122. {Pubmed:}\\nRF\\t<249> Maupin, C.M.; Zheng, J.; Tu, C.; McKenna, R.; Silverman, D.N.; \\n\\tVoth, G.A.: Effect of active-site mutation at Asn67 on the proton \\n\\ttransfer mechanism of human carbonic anhydrase II:: Biochemistry (2009) \\n\\t48, 7996-8005. {Pubmed:19634894}\\nRF\\t<250> Avvaru, B.S.; Kim, C.U.; Sippel, K.H.; Gruner, S.M.; \\n\\tAgbandje-McKenna, M.; Silverman, D.N.; McKenna, R.: A short, strong \\n\\thydrogen bond in the active site of human carbonic anhydrase II:: \\n\\tBiochemistry (2010) 49, 249-251. {Pubmed:20000378}\\nRF\\t<251> De Simone, G.; Supuran, C.T.: Carbonic anhydrase IX: Biochemical \\n\\tand crystallographic characterization of a novel antitumor target:: \\n\\tBiochim. Biophys. Acta (2010) 1804, 404-409. {Pubmed:19679200}\\nRF\\t<252> Sugimoto, A.; Ikeda, H.; Tsukamoto, H.; Kihira, K.; Ishioka, M.; \\n\\tHirose, J.; Hata, T.; Fujioka, H.; Ono, Y.: Timolol activates the \\n\\tenzyme activities of human carbonic anhydrase I and II:: Biol. Pharm. \\n\\tBull. (2010) 33, 301-306. {Pubmed:20118557}\\nRF\\t<253> Innocenti, A.; Hilvo, M.; Parkkila, S.; Scozzafava, A.; Supuran, \\n\\tC.: Carbonic anhydrase inhibitors: The membrane-associated isoform XV \\n\\tis highly inhibited by inorganic anions:: Bioorg. Med. Chem. Lett. \\n\\t(2009) 19, 1155-1158. {Pubmed:19128966}\\nRF\\t<254> Abdo, M.R.; Vullo, D.; Saada, M.C.; Montero, J.L.; Scozzafava, \\n\\tA.; Winum, J.Y.; Supuran, C.T.: Carbonic anhydrase activators: \\n\\tactivation of human isozymes I, II and IX with phenylsulfonylhydrazido \\n\\tL-histidine derivatives:: Bioorg. Med. Chem. Lett. (2009) 19, \\n\\t2440-2443. {Pubmed:19345095}\\nRF\\t<255> Guezel, O.; Innocenti, A.; Scozzafava, A.; Salman, A.; Supuran, \\n\\tC.T.: Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl- and \\n\\tthienylacetyl-substituted aromatic sulfonamides act as potent and \\n\\tselective isoform VII inhibitors:: Bioorg. Med. Chem. Lett. (2009) 19, \\n\\t3170-3173. {Pubmed:19435663}\\nRF\\t<256> Innocenti, A.; Leewattanapasuk, W.; Manole, G.; Scozzafava, A.; \\n\\tMuehlschlegel, F.A.; Supuran, C.T.: Carbonic anhydrase activators: \\n\\tActivation of the beta-carbonic anhydrase from the pathogenic yeast \\n\\tCandida glabrata with amines and amino acids:: Bioorg. Med. Chem. Lett. \\n\\t(2010) 20, 1701-1704. {Pubmed:20129782}\\nRF\\t<257> Vullo, D.; Nishimori, I.; Scozzafava, A.; Koehler, S.; Winum, \\n\\tJ.Y.; Supuran, C.T.: Inhibition studies of a beta-carbonic anhydrase \\n\\tfrom Brucella suis with a series of water soluble glycosyl \\n\\tsulfanilamides:: Bioorg. Med. Chem. Lett. (2010) 20, 2178-2182. \\n\\t{Pubmed:20211561}\\nRF\\t<258> Guezel, O.; Innocenti, A.; Scozzafava, A.; Salman, A.; Supuran, \\n\\tC.T.: Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides \\n\\tincorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as \\n\\tpotent inhibitors of human mitochondrial isoforms VA and VB:: Bioorg. \\n\\tMed. Chem. (2009) 17, 4894-4899. {Pubmed:19539481}\\nRF\\t<259> Bertucci, A.; Innocenti, A.; Zoccola, D.; Scozzafava, A.; \\n\\tTambutte, S.; Supuran, C.T.: Carbonic anhydrase inhibitors. Inhibition \\n\\tstudies of a coral secretory isoform by sulfonamides:: Bioorg. Med. \\n\\tChem. (2009) 17, 5054-5058. {Pubmed:19520577}\\nRF\\t<260> Innocenti, A.; Hall, R.A.; Scozzafava, A.; Muehlschlegel, F.A.; \\n\\tSupuran, C.T.: Carbonic anhydrase activators: activation of the \\n\\tbeta-carbonic anhydrases from the pathogenic fungi Candida albicans and \\n\\tCryptococcus neoformans with amines and amino acids:: Bioorg. Med. \\n\\tChem. (2010) 18, 1034-1037. {Pubmed:20061162}\\nRF\\t<261> Davis, R.A.; Innocenti, A.; Poulsen, S.A.; Supuran, C.T.: \\n\\tCarbonic anhydrase inhibitors. Identification of selective inhibitors \\n\\tof the human mitochondrial isozymes VA and VB over the cytosolic \\n\\tisozymes I and II from a natural product-based phenolic library:: \\n\\tBioorg. Med. Chem. (2010) 18, 14-18. {Pubmed:19962903}\\nRF\\t<262> Bertucci, A.; Zoccola, D.; Tambutte, S.; Vullo, D.; Supuran, \\n\\tC.T.: Carbonic anhydrase activators. The first activation study of a \\n\\tcoral secretory isoform with amino acids and amines:: Bioorg. Med. \\n\\tChem. (2010) 18, 2300-2303. {Pubmed:20176489}\\nRF\\t<263> Innocenti, A.; Durdagi, S.; Doostdar, N.; Strom, T.A.; Barron, \\n\\tA.R.; Supuran, C.T.: Nanoscale enzyme inhibitors: fullerenes inhibit \\n\\tcarbonic anhydrase by occluding the active site entrance:: Bioorg. Med. \\n\\tChem. (2010) 18, 2822-2828. {Pubmed:20363143}\\nRF\\t<264> Ramanan, R.; Kannan, K.; Vinayagamoorthy, N.; Ramkumar, K.; \\n\\tSivanesan, S.; Chakrabarti, T.: Purification and characterization of a \\n\\tnovel plant-type carbonic anhydrase from Bacillus subtilis:: \\n\\tBiotechnol. Bioprocess Eng. (2009) 14, 32-37. {Pubmed:}\\nRF\\t<265> Liu, Z.; Bartlow, P.; Dilmore, R.M.; Soong, Y.; Pan, Z.; Koepsel, \\n\\tR.; Ataai, M.: Production, purification, and characterization of a \\n\\tfusion protein of carbonic anhydrase from Neisseria gonorrhoeae and \\n\\tcellulose binding domain from Clostridium thermocellum:: Biotechnol. \\n\\tProg. (2009) 25, 68-74. {Pubmed:19224556}\\nRF\\t<266> Teng, Y.B.; Jiang, Y.L.; He, Y.X.; He, W.W.; Lian, F.M.; Chen, \\n\\tY.; Zhou, C.Z.: Structural insights into the substrate tunnel of \\n\\tSaccharomyces cerevisiae carbonic anhydrase Nce103:: BMC Struct. Biol. \\n\\t(2009) 9, 67. {Pubmed:19852838}\\nRF\\t<267> Li, Y.; Wang, H.; Oosterwijk, E.; Tu, C.; Shiverick, K.T.; \\n\\tSilverman, D.N.; Frost, S.C.: Expression and activity of carbonic \\n\\tanhydrase IX is associated with metabolic dysfunction in MDA-MB-231 \\n\\tbreast cancer cells:: Cancer Invest. (2009) 27, 613-623. \\n\\t{Pubmed:19367501}\\nRF\\t<268> Carta, F.; Pothen, B.; Maresca, A.; Tiwari, M.; Singh, V.; \\n\\tSupuran, C.T.: Carbonic anhydrase inhibitors: inhibition of cytosolic \\n\\tcarbonic anhydrase isozymes II and VII with simple aromatic \\n\\tsulfonamides and some azo dyes:: Chem. Biol. Drug Des. (2009) 74, \\n\\t196-202. {Pubmed:19549076}\\nRF\\t<269> Roberto, C.; Giulia, L.M.; Francesco, D.; Aldo, V.; Trifone, S.: \\n\\tCarbonic anhydrase activity in Mytilus galloprovincialis digestive \\n\\tgland: Sensitivity to heavy metal exposure:: Comp. Biochem. Physiol. C \\n\\t(2010) 152, 241-247. {Pubmed:20462499}\\nRF\\t<270> Benfodda, Z.; Guillen, F.; Romestand, B.; Dahmani, A.; Blancou, \\n\\tH.: Synthesis and investigation of inhibition effect of fluorinated \\n\\tsulfonamide derivatives on carbonic anhydrase:: Eur. J. Med. Chem. \\n\\t(2010) 45, 1225-1229. {Pubmed:20036446}\\nRF\\t<271> Brzozowski, Z.; Slawinski, J.; Saczewski, F.; Innocenti, A.; \\n\\tSupuran, C.T.: Carbonic anhydrase inhibitors: synthesis and inhibition \\n\\tof the human cytosolic isozymes I and II and transmembrane isozymes IX, \\n\\tXII (cancer-associated) and XIV with 4-substituted \\n\\t3-pyridinesulfonamides:: Eur. J. Med. Chem. (2010) 45, 2396-2404. \\n\\t{Pubmed:20202722}\\nRF\\t<272> Kaur, S.; Mishra, M.N.; Tripathi, A.K.: Regulation of expression \\n\\tand biochemical characterization of a beta-class carbonic anhydrase \\n\\tfrom the plant growth-promoting rhizobacterium, Azospirillum brasilense \\n\\tSp7:: FEMS Microbiol. Lett. (2009) 299, 149-158. {Pubmed:19694814}\\nRF\\t<273> Kalloniati, C.; Tsikou, D.; Lampiri, V.; Fotelli, M.N.; \\n\\tRennenberg, H.; Chatzipavlidis, I.; Fasseas, C.; Katinakis, P.; \\n\\tFlemetakis, E.: Characterization of a Mesorhizobium loti alpha-type \\n\\tcarbonic anhydrase and its role in symbiotic nitrogen fixation:: J. \\n\\tBacteriol. (2009) 191, 2593-2600. {Pubmed:19218391}\\nRF\\t<274> Baranauskiene, L.; Hilvo, M.; Matuliene, J.; Golovenko, D.; \\n\\tManakova, E.; Dudutiene, V.; Michailoviene, V.; Torresan, J.; Jachno, \\n\\tJ.; Parkkila, S.; Maresca, A.; Supuran, C.T.; Grazulis, S.; Matulis, \\n\\tD.: Inhibition and binding studies of carbonic anhydrase isozymes I, II \\n\\tand IX with benzimidazo[1,2-c][1,2,3]thiadiazole-7-sulphonamides:: J. \\n\\tEnzyme Inhib. Med. Chem. (2010) 25, 863-870. {Pubmed:20166809}\\nRF\\t<275> Minakuchi, T.; Nishimori, I.; Vullo, D.; Scozzafava, A.; Supuran, \\n\\tC.T.: Molecular cloning, characterization, and inhibition studies of \\n\\tthe Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with \\n\\tsulfonamides and a sulfamate:: J. Med. Chem. (2009) 52, 2226-2232. \\n\\t{Pubmed:19317447}\\nRF\\t<276> Nishimori, I.; Minakuchi, T.; Vullo, D.; Scozzafava, A.; \\n\\tInnocenti, A.; Supuran, C.T.: Carbonic anhydrase inhibitors. Cloning, \\n\\tcharacterization, and inhibition studies of a new beta-carbonic \\n\\tanhydrase from Mycobacterium tuberculosis:: J. Med. Chem. (2009) 52, \\n\\t3116-3120. {Pubmed:19338333}\\nRF\\t<277> Joseph, P.; Turtaut, F.; Ouahrani-Bettache, S.; Montero, J.L.; \\n\\tNishimori, I.; Minakuchi, T.; Vullo, D.; Scozzafava, A.; Koehler, S.; \\n\\tWinum, J.Y.; Supuran, C.T.: Cloning, characterization, and inhibition \\n\\tstudies of a beta-carbonic anhydrase from Brucella suis:: J. Med. Chem. \\n\\t(2010) 53, 2277-2285. {Pubmed:20158185}\\nRF\\t<278> Gitto, R.; Agnello, S.; Ferro, S.; De Luca, L.; Vullo, D.; \\n\\tBrynda, J.; Mader, P.; Supuran, C.T.; Chimirri, A.: Identification of \\n\\t3,4-dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase \\n\\tinhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray \\n\\tstudies:: J. Med. Chem. (2010) 53, 2401-2408. {Pubmed:20170095}\\nRF\\t<279> Maresca, A.; Temperini, C.; Pochet, L.; Masereel, B.; Scozzafava, \\n\\tA.; Supuran, C.T.: Deciphering the mechanism of carbonic anhydrase \\n\\tinhibition with coumarins and thiocoumarins:: J. Med. Chem. (2010) 53, \\n\\t335-344. {Pubmed:19911821}\\nRF\\t<280> Alterio, V.; Hilvo, M.; Di Fiore, A.; Supuran, C.T.; Pan, P.; \\n\\tParkkila, S.; Scaloni, A.; Pastorek, J.; Pastorekova, S.; Pedone, C.; \\n\\tScozzafava, A.; Monti, S.M.; De Simone, G.: Crystal structure of the \\n\\tcatalytic domain of the tumor-associated human carbonic anhydrase IX:: \\n\\tProc. Natl. Acad. Sci. USA (2009) 106, 16233-16238. {Pubmed:19805286}\\nRF\\t<281> Pena, K.L.; Castel, S.E.; de Araujo, C.; Espie, G.S.; Kimber, \\n\\tM.S.: Structural basis of the oxidative activation of the carboxysomal \\n\\tgamma-carbonic anhydrase, CcmM:: Proc. Natl. Acad. Sci. USA (2010) 107, \\n\\t2455-2460. {Pubmed:20133749}\\nRF\\t<282> Sharma, A.; Bhattacharya, A.; Singh, S.: Purification and \\n\\tcharacterization of an extracellular carbonic anhydrase from \\n\\tPseudomonas fragi:: Process Biochem. (2009) 44, 1293-1297. {Pubmed:}\\nRF\\t<283> Picaud, S.; Muniz, J.; Kramm, A.; Pilka, E.; Kochan, G.; \\n\\tOppermann, U.; Yue, W.: Crystal structure of human carbonic \\n\\tanhydrase-related protein VIII reveals the basis for catalytic \\n\\tsilencing:: Proteins (2009) 76, 507-511. {Pubmed:19360879}\\nRF\\t<284> Suzuki, K.; Shimizu, S.; Juan, E.C.; Miyamoto, T.; Fang, Z.; \\n\\tHoque, M.M.; Sato, Y.; Tsunoda, M.; Sekiguchi, T.; Takenaka, A.; Yang, \\n\\tS.Y.: Crystallographic study of wild-type carbonic anhydrase alpha CA1 \\n\\tfrom Chlamydomonas reinhardtii:: Acta Crystallogr. Sect. F (2010) 66, \\n\\t1082-1085. {Pubmed:20823532}\\nRF\\t<285> Nishita, T.; Tomita, Y.; Imanari, T.; Ichihara, N.; Orito, K.; \\n\\tArishima, K.: Biochemical and developmental characterization of \\n\\tcarbonic anhydrase II from chicken erythrocytes:: Acta Vet. Scand. \\n\\t(2011) 53, 16. {Pubmed:21375785}\\nRF\\t<286> Avvaru, B.S.; Arenas, D.J.; Tu, C.; Tanner, D.B.; McKenna, R.; \\n\\tSilverman, D.N.: Comparison of solution and crystal properties of \\n\\tCo(II)-substituted human carbonic anhydrase II:: Arch. Biochem. \\n\\tBiophys. (2010) 502, 53-59. {Pubmed:20637176}\\nRF\\t<287> Mikulski, R.; Avvaru, B.S.; Tu, C.; Case, N.; McKenna, R.; \\n\\tSilverman, D.N.: Kinetic and crystallographic studies of the role of \\n\\ttyrosine 7 in the active site of human carbonic anhydrase II:: Arch. \\n\\tBiochem. Biophys. (2011) 506, 181-187. {Pubmed:21145876}\\nRF\\t<288> Hoffmann, K.M.; Samardzic, D.; Heever, K.; Rowlett, R.S.: \\n\\tCo(II)-substituted Haemophilus influenzae beta-carbonic anhydrase: \\n\\tspectral evidence for allosteric regulation by pH and bicarbonate ion:: \\n\\tArch. Biochem. Biophys. (2011) 511, 80-87. {Pubmed:21531201}\\nRF\\t<289> Rowlett, R.S.; Hoffmann, K.M.; Failing, H.; Mysliwiec, M.M.; \\n\\tSamardzic, D.: Evidence for a bicarbonate escort site in Haemophilus \\n\\tinfluenzae beta-carbonic anhydrase:: Biochemistry (2010) 49, 3640-3647. \\n\\t{Pubmed:20359198}\\nRF\\t<290> Domsic, J.F.; Williams, W.; Fisher, S.Z.; Tu, C.; \\n\\tAgbandje-McKenna, M.; Silverman, D.N.; McKenna, R.: Structural and \\n\\tkinetic study of the extended active site for proton transfer in human \\n\\tcarbonic anhydrase II:: Biochemistry (2010) 49, 6394-6399. \\n\\t{Pubmed:20578724}\\nRF\\t<291> Li, Y.; Wang, H.; Tu, C.; Shiverick, K.T.; Silverman, D.N.; \\n\\tFrost, S.C.: Role of hypoxia and EGF on expression, activity, \\n\\tlocalization and phosphorylation of carbonic anhydrase IX in MDA-MB-231 \\n\\tbreast cancer cells:: Biochim. Biophys. Acta (2011) 1813, 159-167. \\n\\t{Pubmed:20920536}\\nRF\\t<292> Tsikou, D.; Stedel, C.; Kouri, E.D.; Udvardi, M.K.; Wang, T.L.; \\n\\tKatinakis, P.; Labrou, N.E.; Flemetakis, E.: Characterization of two \\n\\tnovel nodule-enhanced alpha-type carbonic anhydrases from Lotus \\n\\tjaponicus:: Biochim. Biophys. Acta (2011) 1814, 496-504. \\n\\t{Pubmed:21256984}\\nRF\\t<293> Maresca, A.; Scozzafava, A.; Supuran, C.T.: 7,8-disubstituted- \\n\\tbut not 6,7-disubstituted coumarins selectively inhibit the \\n\\ttransmembrane, tumor-associated carbonic anhydrase isoforms IX and XII \\n\\tover the cytosolic ones I and II in the low nanomolar/subnanomolar \\n\\trange:: Bioorg. Med. Chem. Lett. (2010) 20, 7255-7258. {Pubmed:21067924}\\nRF\\t<294> Rodriguez, O.M.; Maresca, A.; Tempera, C.A.; Bravo, R.D.; \\n\\tColinas, P.A.; Supuran, C.T.: N-beta-Glycosyl sulfamides are selective \\n\\tinhibitors of the cancer associated carbonic anhydrase isoforms IX and \\n\\tXII:: Bioorg. Med. Chem. Lett. (2011) 21, 4447-4450. {Pubmed:21723123}\\nRF\\t<295> Saada, M.C.; Vullo, D.; Montero, J.L.; Scozzafava, A.; Winum, \\n\\tJ.Y.; Supuran, C.T.: Carbonic anhydrase I and II activation with mono- \\n\\tand dihalogenated histamine derivatives:: Bioorg. Med. Chem. Lett. \\n\\t(2011) 21, 4884-4887. {Pubmed:21742491}\\nRF\\t<296> Knaus, E.E.; Innocenti, A.; Scozzafava, A.; Supuran, C.T.: \\n\\tPhenylethynylbenzenesulfonamide regioisomers strongly and selectively \\n\\tinhibit the transmembrane, tumor-associated carbonic anhydrase isoforms \\n\\tIX and XII over the cytosolic isoforms I and II:: Bioorg. Med. Chem. \\n\\tLett. (2011) 21, 5892-5896. {Pubmed:21852133}\\nRF\\t<297> Bertucci, A.; Innocenti, A.; Scozzafava, A.; Tambutte, S.; \\n\\tZoccola, D.; Supuran, C.T.: Carbonic anhydrase inhibitors. Inhibition \\n\\tstudies with anions and sulfonamides of a new cytosolic enzyme from the \\n\\tscleractinian coral Stylophora pistillata:: Bioorg. Med. Chem. Lett. \\n\\t(2011) 21, 710-714. {Pubmed:21208801}\\nRF\\t<298> Joseph, P.; Ouahrani-Bettache, S.; Montero, J.L.; Nishimori, I.; \\n\\tMinakuchi, T.; Vullo, D.; Scozzafava, A.; Winum, J.Y.; Koehler, S.; \\n\\tSupuran, C.T.: A new beta-carbonic anhydrase from Brucella suis, its \\n\\tcloning, characterization, and inhibition with sulfonamides and \\n\\tsulfamates, leading to impaired pathogen growth:: Bioorg. Med. Chem. \\n\\t(2011) 19, 1172-1178. {Pubmed:21251841}\\nRF\\t<299> Durdagi, S.; Sentuerk, M.; Ekinci, D.; Balaydin, H.T.; Goeksu, \\n\\tS.; Kuefrevioglu, .I.; Innocenti, A.; Scozzafava, A.; Supuran, C.T.: \\n\\tKinetic and docking studies of phenol-based inhibitors of carbonic \\n\\tanhydrase isoforms I, II, IX and XII evidence a new binding mode within \\n\\tthe enzyme active site:: Bioorg. Med. Chem. (2011) 19, 1381-1389. \\n\\t{Pubmed:21282059}\\nRF\\t<300> Cincinelli, A.; Martellini, T.; Innocenti, A.; Scozzafava, A.; \\n\\tSupuran, C.T.: Purification and inhibition studies with anions and \\n\\tsulfonamides of an alpha-carbonic anhydrase from the Antarctic seal \\n\\tLeptonychotes weddellii:: Bioorg. Med. Chem. (2011) 19, 1847-1851. \\n\\t{Pubmed:21377369}\\nRF\\t<301> Xiao, Z.; Duan, R.; Cui, W.; Zhang, Y.; Zhang, S.; Chen, F.; \\n\\tZhang, Y.; Liu, J.; Zhang, D.; Meng, Y.; Wang, L.; Wang, H.: Synthesis \\n\\tand evaluation of new carbonic anhydrase inhibitors:: Bioorg. Med. \\n\\tChem. (2011) 19, 3221-3228. {Pubmed:21524585}\\nRF\\t<302> Biswas, S.; Aggarwal, M.; Guezel, O.e.; Scozzafava, A.; McKenna, \\n\\tR.; Supuran, C.T.: Conformational variability of different sulfonamide \\n\\tinhibitors with thienyl-acetamido moieties attributes to differential \\n\\tbinding in the active site of cytosolic human carbonic anhydrase \\n\\tisoforms:: Bioorg. Med. Chem. (2011) 19, 3732-3738. {Pubmed:21620713}\\nRF\\t<303> Syrjaenen, L.; Tolvanen, M.; Hilvo, M.; Olatubosun, A.; \\n\\tInnocenti, A.; Scozzafava, A.; Leppiniemi, J.; Niederhauser, B.; \\n\\tHytoenen, V.P.; Gorr, T.A.; Parkkila, S.; Supuran, C.T.: \\n\\tCharacterization of the first beta-class carbonic anhydrase from an \\n\\tarthropod (Drosophila melanogaster) and phylogenetic analysis of \\n\\tbeta-class carbonic anhydrases in invertebrates:: BMC Biochem. (2010) \\n\\t11, 28. {Pubmed:20659325}\\nRF\\t<304> Sentuerk, M.; Guelcin, I.; Beydemir, S.; Kuefrevioglu, O.I.; \\n\\tSupuran, C.T.: In vitro inhibition of human carbonic anhydrase I and II \\n\\tisozymes with natural phenolic compounds:: Chem. Biol. Drug Des. (2011) \\n\\t77, 494-499. {Pubmed:21332948}\\nRF\\t<305> Isik, S.; Guler, O.O.; Kockar, F.; Aydin, M.; Arslan, O.; \\n\\tSupuran, C.T.: Saccharomyces cerevisiae beta-carbonic anhydrase: \\n\\tinhibition and activation studies:: Curr. Pharm. Des. (2010) 16, \\n\\t3327-3336. {Pubmed:20819061}\\nRF\\t<306> Ceyhun, S.B.; Sentuerk, M.; Yerlikaya, E.; Erdogan, O.; \\n\\tKuefrevioglu, O.I.; Ekinci, D.: Purification and characterization of \\n\\tcarbonic anhydrase from the teleost fish Dicentrarchus labrax (European \\n\\tseabass) liver and toxicological effects of metals on enzyme activity:: \\n\\tEnviron. Toxicol. Pharmacol. (2011) 32, 69-74. {Pubmed:21787732}\\nRF\\t<307> Sharma, A.; Bhattacharya, A.; Shrivastava, A.: Biomimetic CO2 \\n\\tsequestration using purified carbonic anhydrase from indigenous \\n\\tbacterial strains immobilized on biopolymeric materials:: Enzyme \\n\\tMicrob. Technol. (2011) 48, 416-426. {Pubmed:22112959}\\nRF\\t<308> Kolayli, S.; Karahalil, F.; Sahin, H.; Dincer, B.; Supuran, C.T.: \\n\\tCharacterization and inhibition studies of an alpha-carbonic anhydrase \\n\\tfrom the endangered sturgeon species Acipenser gueldenstaedti:: J. \\n\\tEnzyme Inhib. Med. Chem. (2011) 26, 895-900. {Pubmed:21381885}\\nRF\\t<309> Sharma, A.; Bhattacharya, A.: Enhanced biomimetic sequestration \\n\\tof CO2 into CaCO3 using purified carbonic anhydrase from indigenous \\n\\tbacterial strains:: J. Mol. Catal. B (2010) 67, 122-128. {Pubmed:}\\nRF\\t<310> Fasseas, M.K.; Tsikou, D.; Flemetakis, E.; Katinakis, P.: \\n\\tMolecular and biochemical analysis of the alpha class carbonic \\n\\tanhydrases in Caenorhabditis elegans:: Mol. Biol. Rep. (2011) 38, \\n\\t1777-1785. {Pubmed:20842438}\\nRF\\t<311> Dave, K.; Scozzafava, A.; Vullo, D.; Supuran, C.T.; Ilies, M.A.: \\n\\tPyridinium derivatives of histamine are potent activators of cytosolic \\n\\tcarbonic anhydrase isoforms I, II and VII:: Org. Biomol. Chem. (2011) \\n\\t9, 2790-2800. {Pubmed:21369613}\\nRF\\t<312> Amata, O.; Marino, T.; Russo, N.; Toscano, M.: Catalytic activity \\n\\tof a zeta-class zinc and cadmium containing carbonic anhydrase. \\n\\tCompared work mechanisms:: Phys. Chem. Chem. Phys. (2011) 13, \\n\\t3468-3477. {Pubmed:21212893}\\nRF\\t<313> Wang, M.; Sang, M.; Li, A.; Zhang, C.; Yang, Y.: Effects of \\n\\tphysical and chemical factors on carbonic anhydrase activity of \\n\\tHaematococcus pluvialis CG-11:: Plant Physiol. Commun. (2010) 46, \\n\\t701-706. {Pubmed:}\\nRF\\t<314> Wandernoth, P.M.; Raubuch, M.; Mannowetz, N.; Becker, H.M.; \\n\\tDeitmer, J.W.; Sly, W.S.; Wennemuth, G.: Role of carbonic anhydrase IV \\n\\tin the bicarbonate-mediated activation of murine and human sperm:: PLoS \\n\\tONE (2010) 5, e15061. {Pubmed:21124840}\\nRF\\t<315> Zimmerman, S.; Domsic, J.F.; Tu, C.; Robbins, A.H.; McKenna, R.; \\n\\tSilverman, D.N.; Ferry, J.G.: Role of Trp19 and Tyr200 in catalysis by \\n\\tthe gamma-class carbonic anhydrase from Methanosarcina thermophila:: \\n\\tArch. Biochem. Biophys. (2013) 529, 11-17. {Pubmed:23111186}\\nRF\\t<316> Innocenti, A.; Zimmerman. S.; Ferry, J.G.; Scozzafava, A.; \\n\\tSupuran, C.T.: Carbonic anhydrase inhibitors. Inhibition of the zinc \\n\\tand cobalt gamma-class enzyme from the archaeon Methanosarcina \\n\\tthermophila with anions:: Bioorg. Med. Chem. Lett. (2004) 14, \\n\\t3327-3331. {Pubmed:15149700}\\nRF\\t<317> Innocenti, A.; Zimmerman, S.; Ferry, J.G.; Scozzafava, A.; \\n\\tSupuran, C.T.: Carbonic anhydrase inhibitors. Inhibition of the \\n\\tbeta-class enzyme from the methanoarchaeon Methanobacterium \\n\\tthermoautotrophicum (Cab) with anions:: Bioorg. Med. Chem. Lett. (2004) \\n\\t14, 4563-4567. {Pubmed:15357993}\\nRF\\t<318> Zimmerman, S.; Innocenti, A.; Casini, A.; Ferry, J.G.; \\n\\tScozzafava, A.; Supuran, C.T.: Carbonic anhydrase inhibitors. \\n\\tInhibition of the prokariotic beta and gamma-class enzymes from Archaea \\n\\twith sulfonamides:: Bioorg. Med. Chem. Lett. (2004) 14, 6001-6006. \\n\\t{Pubmed:15546717}\\nRF\\t<319> Kisker, C.; Schindelin, H.; Alber, B.E.; Ferry, J.G.; Rees, D.C.: \\n\\tA left-hand beta-helix revealed by the crystal structure of a carbonic \\n\\tanhydrase from the archaeon Methanosarcina thermophila:: EMBO J. (1996) \\n\\t15, 2323-2330. {Pubmed:8665839}\\nRF\\t<320> Zimmerman, S.A.; Tomb, J.F.; Ferry, J.G.: Characterization of \\n\\tCamH from Methanosarcina thermophila, founding member of a subclass of \\n\\tthe gamma class of carbonic anhydrases:: J. Bacteriol. (2010) 192, \\n\\t1353-1360. {Pubmed:20023030}\\nRF\\t<321> Tripp, B.C.; Bell, C.B.; Cruz, F.; Krebs, C.; Ferry, J.G.: A role \\n\\tfor iron in an ancient carbonic anhydrase:: J. Biol. Chem. (2004) 279, \\n\\t6683-6687. {Pubmed:14662760}\\nRF\\t<322> Simler, B.R.; Doyle, B.L.; Matthews, C.R.: Zinc binding drives \\n\\tthe folding and association of the homo-trimeric gamma-carbonic \\n\\tanhydrase from Methanosarcina thermophila:: Protein Eng. Des. Sel. \\n\\t(2004) 17, 285-291. {Pubmed:15051865}\\nRF\\t<323> Boone, C.D.; Habibzadegan, A.; Tu, C.; Silverman, D.N.; McKenna, \\n\\tR.: Structural and catalytic characterization of a thermally stable and \\n\\tacid-stable variant of human carbonic anhydrase II containing an \\n\\tengineered disulfide bond:: Acta Crystallogr. Sect. D (2013) 69, \\n\\t1414-1422. {Pubmed:23897465}\\nRF\\t<324> Iqbal, S.; Nisar-ur-Rahman, S.; Iqbal, J.: A capillary \\n\\telectrophoresis-based enzyme assay for kinetics and inhibition studies \\n\\tof carbonic anhydrase:: Anal. Biochem. (2014) 444, 16-21. \\n\\t{Pubmed:24064297}\\nRF\\t<325> Kanth, B.K.; Min, K.; Kumari, S.; Jeon, H.; Jin, E.S.; Lee, J.; \\n\\tPack, S.P.: Expression and characterization of codon-optimized carbonic \\n\\tanhydrase from Dunaliella species for CO(2) sequestration application:: \\n\\tAppl. Biochem. Biotechnol. (2012) 167, 2341-2356. {Pubmed:22715026}\\nRF\\t<326> Tu, C.; Foster, L.; Alvarado, A.; McKenna, R.; Silverman, D.N.; \\n\\tFrost, S.C.: Role of zinc in catalytic activity of carbonic anhydrase \\n\\tIX:: Arch. Biochem. Biophys. (2012) 521, 90-94. {Pubmed:22465027}\\nRF\\t<327> West, D.; Kim, C.U.; Tu, C.; Robbins, A.H.; Gruner, S.M.; \\n\\tSilverman, D.N.; McKenna, R.: Structural and kinetic effects on changes \\n\\tin the CO(2) binding pocket of human carbonic anhydrase II:: \\n\\tBiochemistry (2012) 51, 9156-9163. {Pubmed:23098192}\\nRF\\t<328> Akdemir, A.; Vullo, D.; De Luca, V.; Scozzafava, A.; Carginale, \\n\\tV.; Rossi, M.; Supuran, C.T.; Capasso, C.: The extremo-alpha-carbonic \\n\\tanhydrase (CA) from Sulfurihydrogenibium azorense, the fastest CA \\n\\tknown, is highly activated by amino acids and amines:: Bioorg. Med. \\n\\tChem. Lett. (2013) 23, 1087-1090. {Pubmed:23294703}\\nRF\\t<329> Monti, S.M.; De Simone, G.; Dathan, N.A.; Ludwig, M.; Vullo, D.; \\n\\tScozzafava, A.; Capasso, C.; Supuran, C.T.: Kinetic and anion \\n\\tinhibition studies of a beta-carbonic anhydrase (FbiCA 1) from the C4 \\n\\tplant Flaveria bidentis:: Bioorg. Med. Chem. Lett. (2013) 23, \\n\\t1626-1630. {Pubmed:23414801}\\nRF\\t<330> Del Prete, S.; Vullo, D.; De Luca, V.; Carginale, V.; Scozzafava, \\n\\tA.; Supuran, C.T.; Capasso, C.: A highly catalytically active \\n\\talpha-carbonic anhydrase from the pathogenic anaerobe Porphyromonas \\n\\tgingivalis and its inhibition profile with anions and small molecules:: \\n\\tBioorg. Med. Chem. Lett. (2013) 23, 4067-4071. {Pubmed:23769640}\\nRF\\t<331> Ohradanova, A.; Vullo, D.; Pastorekova, S.; Pastorek, J.; \\n\\tJackson, D.J.; Woerheide, G.; Supuran, C.T.: Cloning, characterization \\n\\tand sulfonamide inhibition studies of an alpha-carbonic anhydrase from \\n\\tthe living fossil sponge Astrosclera willeyana:: Bioorg. Med. Chem. \\n\\t(2012) 20, 1403-1410. {Pubmed:22285172}\\nRF\\t<332> Turkoglu, S.; Maresca, A.; Alper, M.; Kockar, F.; Isik, S.; \\n\\tSinan, S.; Ozensoy, O.; Arslan, O.; Supuran, C.T.: Mutation of active \\n\\tsite residues Asn67 to Ile, Gln92 to Val and Leu204 to Ser in human \\n\\tcarbonic anhydrase II: influences on the catalytic activity and \\n\\taffinity for inhibitors:: Bioorg. Med. Chem. (2012) 20, 2208-2213. \\n\\t{Pubmed:22386980}\\nRF\\t<333> Demirdag, R.; Comakli, V.; Sentuerk, M.; Ekinci, D.;Irfan \\n\\tKuefrevioglu, O.e.; Supuran, C.T.: Purification and characterization of \\n\\tcarbonic anhydrase from sheep kidney and effects of sulfonamides on \\n\\tenzyme activity:: Bioorg. Med. Chem. (2013) 21, 1522-1525. \\n\\t{Pubmed:22974493}\\nRF\\t<334> Del Prete, S.; Vullo, D.; Scozzafava, A.; Capasso, C.; Supuran, \\n\\tC.T.: Cloning, characterization and anion inhibition study of the \\n\\tdelta-class carbonic anhydrase (TweCA) from the marine diatom \\n\\tThalassiosira weissflogii:: Bioorg. Med. Chem. (2014) 22, 531-537. \\n\\t{Pubmed:24268544}\\nRF\\t<335> Weise, A.; Schneider, H.P.; McKenna, R.; Deitmer, J.W.: \\n\\tSubstrate-dependent interference of carbonic anhydrases with the \\n\\tglutamine transporter SNAT3-induced conductance:: Cell. Physiol. \\n\\tBiochem. (2011) 27, 79-90. {Pubmed:21325825}\\nRF\\t<336> Russo, M.E.; Olivieri, G.; Capasso, C.; De Luca, V.; \\n\\tMarzocchella, A.; Salatino, P.; Rossi, M.: Kinetic study of a novel \\n\\tthermo-stable alpha-carbonic anhydrase for biomimetic CO2 capture:: \\n\\tEnzyme Microb. Technol. (2013) 53, 271-277. {Pubmed:23931693}\\nRF\\t<337> Lehneck, R.; Neumann, P.; Vullo, D.; Elleuche, S.; Supuran, C.T.; \\n\\tFicner, R.; Poeggeler, S.: Crystal structures of two tetrameric \\n\\tbeta-carbonic anhydrases from the filamentous ascomycete Sordaria \\n\\tmacrospora:: FEBS J. (2014) 281, 1759-1772. {Pubmed:24506675}\\nRF\\t<338> Kumar, R.S.; Hendrick, W.; Correll, J.B.; Patterson, A.D.; \\n\\tMelville, S.B.; Ferry, J.G.: Biochemistry and physiology of the beta \\n\\tclass carbonic anhydrase (Cpb) from Clostridium perfringens strain 13:: \\n\\tJ. Bacteriol. (2013) 195, 2262-2269. {Pubmed:23475974}\\nRF\\t<339> Ozensoy, O.; Arslan, M.; Supuran, C.T.: Carbonic anhydrase \\n\\tinhibitors: purification and inhibition studies of pigeon (Columba \\n\\tlivia var. domestica) red blood cell carbonic anhydrase with \\n\\tsulfonamides:: J. Enzyme Inhib. Med. Chem. (2011) 26, 749-753. \\n\\t{Pubmed:21476925}\\nRF\\t<340> Capasso, C.; De Luca, V.; Carginale, V.; Cannio, R.; Rossi, M.: \\n\\tBiochemical properties of a novel and highly thermostable bacterial \\n\\talpha-carbonic anhydrase from Sulfurihydrogenibium yellowstonense \\n\\tYO3AOP1:: J. Enzyme Inhib. Med. Chem. (2012) 27, 892-897. \\n\\t{Pubmed:22803664}\\nRF\\t<341> Del Prete, S.; Isik, S.; Vullo, D.; De Luca, V.; Carginale, V.; \\n\\tScozzafava, A.; Supuran, C.T.; Capasso, C.: DNA cloning, \\n\\tcharacterization, and inhibition studies of an alpha-carbonic anhydrase \\n\\tfrom the pathogenic bacterium Vibrio cholerae:: J. Med. Chem. (2012) \\n\\t55, 10742-10748. {Pubmed:23181552}\\nRF\\t<342> Pan, P.; Vermelho, A.B.; Capaci Rodrigues, G.; Scozzafava, A.; \\n\\tTolvanen, M.E.; Parkkila, S.; Capasso, C.; Supuran, C.T.: Cloning, \\n\\tcharacterization, and sulfonamide and thiol inhibition studies of an \\n\\talpha-carbonic anhydrase from Trypanosoma cruzi, the causative agent of \\n\\tChagas disease:: J. Med. Chem. (2013) 56, 1761-1771. {Pubmed:23391336}\\nRF\\t<343> Syrjaenen, L.; Vermelho, A.B.; Rodrigues, I.d.e..A.; Corte-Real, \\n\\tS.; Salonen, T.; Pan, P.; Vullo, D.; Parkkila, S.; Capasso, C.; \\n\\tSupuran, C.T.: Cloning, characterization, and inhibition studies of a \\n\\tbeta-carbonic anhydrase from Leishmania donovani chagasi, the protozoan \\n\\tparasite responsible for leishmaniasis:: J. Med. Chem. (2013) 56, \\n\\t7372-7381. {Pubmed:23977960}\\nRF\\t<344> Al-Samir, S.; Papadopoulos, S.; Scheibe, R.J.; Meissner, J.D.; \\n\\tCartron, J.P.; Sly, W.S.; Alper, S.L.; Gros, G.; Endeward, V.: Activity \\n\\tand distribution of intracellular carbonic anhydrase II and their \\n\\teffects on the transport activity of anion exchanger AE1/SLC4A1:: J. \\n\\tPhysiol. (2013) 591, 4963-4982. {Pubmed:23878365}\\nRF\\t<345> Ignatova, L.K.; Rudenko, N.N.; Mudrik, V.A.; Fedorchuk, T.P.; \\n\\tIvanov, B.N.: Carbonic anhydrase activity in Arabidopsis thaliana \\n\\tthylakoid membrane and fragments enriched with PSI or PSII:: \\n\\tPhotosynth. Res. (2011) 110, 89-98. {Pubmed:22006267}\\nRF\\t<346> de Araujo, C.; Arefeen, D.; Tadesse, Y.; Long, B.M.; Price, G.D.; \\n\\tRowlett, R.S.; Kimber, M.S.; Espie, G.S.: Identification and \\n\\tcharacterization of a carboxysomal gamma-carbonic anhydrase from the \\n\\tcyanobacterium Nostoc sp. PCC 7120:: Photosynth. Res. (2014) 121, \\n\\t135-150. {Pubmed:24907906}\\nRF\\t<347> Hopkinson, B.M.; Meile, C.; Shen, C.: Quantification of \\n\\textracellular carbonic anhydrase activity in two marine diatoms and \\n\\tinvestigation of its role:: Plant Physiol. (2013) 162, 1142-1152. \\n\\t{Pubmed:23656892}\\nRF\\t<348> Fisher, Z.; Boone, C.D.; Biswas, S.M.; Venkatakrishnan, B.; \\n\\tAggarwal, M.; Tu, C.; Agbandje-McKenna, M.; Silverman, D.; McKenna, R.: \\n\\tKinetic and structural characterization of thermostabilized mutants of \\n\\thuman carbonic anhydrase II:: Protein Eng. Des. Sel. (2012) 25, \\n\\t347-355. {Pubmed:22691706}\\nRF\\t<349> Idrees, D.; Kumar, S.; Rehman, S.A.A.; Gourinath, S.; Islam, A.; \\n\\tAhmad, F.; Imtaiyaz Hassan, M.: Cloning, expression, purification and \\n\\tcharacterization of human mitochondrial carbonic anhydrase VA:: 3 \\n\\tBiotech (2016) 6, 16. {Pubmed:28330086}\\nRF\\t<350> Diaz-Torres, N.A.; Mahon, B.P.; Boone, C.D.; Pinard, M.A.; Tu, \\n\\tC.; Ng, R.; Agbandje-McKenna, M.; Silverman, D.; Scott, K.; McKenna, \\n\\tR.: Structural and biophysical characterization of the alpha-carbonic \\n\\tanhydrase from the gammaproteobacterium Thiomicrospira crunogena XCL-2\\t \\n\\tinsights into engineering thermostable enzymes for CO2 sequestration:: \\n\\tActa Crystallogr. Sect. D (2015) 71, 1745-1756. {Pubmed:26249355}\\nRF\\t<351> Piazzetta, P.; Marino, T.; Russo, N.: Theoretical investigation \\n\\ton the restoring step of the carbonic anhydrase catalytic cycle for \\n\\tnatural and promiscuous substrates:: Arch. Biochem. Biophys. (2015) \\n\\t582, 101-106. {Pubmed:25849760}\\nRF\\t<352> Koruza, K.; Lafumat, B.; Vegvari, A.; Knecht, W.; Fisher, S.Z.: \\n\\tDeuteration of human carbonic anhydrase for neutron crystallography\\t \\n\\tCell culture media, protein thermostability, and crystallization \\n\\tbehavior:: Arch. Biochem. Biophys. (2018) 645, 26-33. {Pubmed:29524429}\\nRF\\t<353> Bian, Y.; Guo, C.; Chang, T.: Temperature stability of \\n\\tpoly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] in \\n\\tthe form of a solution or in the lyophilized form during storage at \\n\\t-80C, 4C, 25C and 37C or pasteurization at 70C:: Artif. Cells \\n\\tNanomed. Biotechnol. (2016) 44, 41-47. {Pubmed:26613265}\\nRF\\t<354> Peirce, S.; Russo, M.; Perfetto, R.; Capasso, C.; Rossi, M.; \\n\\tFernandez-Lafuente, R.; Salatino, P.; Marzocchella, A.: Kinetic \\n\\tcharacterization of carbonic anhydrase immobilized on magnetic \\n\\tnanoparticles as biocatalyst for CO2 capture:: Biochem. Eng. J. (2018) \\n\\t138, 1-11. {Pubmed:28709922}\\nRF\\t<355> McGurn, L.D.; Moazami-Goudarzi, M.; White, S.A.; Suwal, T.; Brar, \\n\\tB.; Tang, J.Q.; Espie, G.S.; Kimber, M.S.: The structure, kinetics and \\n\\tinteractions of the beta-carboxysomal beta-carbonic anhydrase, CcaA:: \\n\\tBiochem. J. (2016) 473, 4559-4572. {Pubmed:27729545}\\nRF\\t<356> Pinter, T.B.; Stillman, M.J.: Kinetics of zinc and cadmium \\n\\texchanges between metallothionein and carbonic anhydrase:: Biochemistry \\n\\t(2015) 54, 6284-6293. {Pubmed:26401817}\\nRF\\t<357> Iqbal, S.; Saleem, M.; Azim, M.K.; Taha, M.; Salar, U.; Khan, \\n\\tK.M.; Perveen, S.; Choudhary, M.I.: Carbohydrazones as new class of \\n\\tcarbonic anhydrase inhibitors\\t synthesis, kinetics, and ligand docking \\n\\tstudies:: Bioorg. Chem. (2017) 72, 89-101. {Pubmed:28390994}\\nRF\\t<358> De Luca, V.; Vullo, D.; Del Prete, S.; Carginale, V.; Scozzafava, \\n\\tA.; Osman, S.M.; AlOthman, Z.; Supuran, C.T.; Capasso, C.: Cloning, \\n\\tcharacterization and anion inhibition studies of a new gamma-carbonic \\n\\tanhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis:: \\n\\tBioorg. Med. Chem. (2015) 23, 4405-4409. {Pubmed:26145820}\\nRF\\t<359> De Luca, V.; Vullo, D.; Del Prete, S.; Carginale, V.; Osman, \\n\\tS.M.; AlOthman, Z.; Supuran, C.T.; Capasso, C.: Cloning, \\n\\tcharacterization and anion inhibition studies of a gamma-carbonic \\n\\tanhydrase from the Antarctic bacterium Colwellia psychrerythraea:: \\n\\tBioorg. Med. Chem. (2016) 24, 835-840. {Pubmed:26778292}\\nRF\\t<360> De Simone, G.; Monti, S.M.; Alterio, V.; Buonanno, M.; De Luca, \\n\\tV.; Rossi, M.; Carginale, V.; Supuran, C.T.; Capasso, C.; Di Fiore, A.: \\n\\tCrystal structure of the most catalytically effective carbonic \\n\\tanhydrase enzyme known, SazCA from the thermophilic bacterium \\n\\tSulfurihydrogenibium azorense:: Bioorg. Med. Chem. Lett. (2015) 25, \\n\\t2002-2006. {Pubmed:25817590}\\nRF\\t<361> De Luca, V.; Del Prete, S.; Carginale, V.; Vullo, D.; Supuran, \\n\\tC.T.; Capasso, C.: Cloning, characterization and anion inhibition \\n\\tstudies of a gamma-carbonic anhydrase from the Antarctic cyanobacterium \\n\\tNostoc commune:: Bioorg. Med. Chem. Lett. (2015) 25, 4970-4975. \\n\\t{Pubmed:25804721}\\nRF\\t<362> Del Prete, S.; Vullo, D.; De Luca, V.; Carginale, V.; Osman, \\n\\tS.M.; AlOthman, Z.; Supuran, C.T.; Capasso, C.: Cloning, expression, \\n\\tpurification and sulfonamide inhibition profile of the complete domain \\n\\tof the eta-carbonic anhydrase from Plasmodium falciparum:: Bioorg. Med. \\n\\tChem. Lett. (2016) 26, 4184-4190. {Pubmed:27485387}\\nRF\\t<363> Jun, S.Y.; Kim, S.H.; Kanth, B.K.; Lee, J.; Pack, S.P.: \\n\\tExpression and characterization of a codon-optimized alkaline-stable \\n\\tcarbonic anhydrase from Aliivibrio salmonicida for CO2 sequestration \\n\\tapplications:: Bioprocess Biosyst. Eng. (2017) 40, 413-421. \\n\\t{Pubmed:27896426}\\nRF\\t<364> Langella, E.; Buonanno, M.; Vullo, D.; Dathan, N.; Leone, M.; \\n\\tSupuran, C.T.; De Simone, G.; Monti, S.M.: Biochemical, biophysical and \\n\\tmolecular dynamics studies on the proteoglycan-like domain of carbonic \\n\\tanhydrase IX:: Cell. Mol. Life Sci. (2018) 75, 3283-3296. \\n\\t{Pubmed:29564477}\\nRF\\t<365> Bhatt, A.; Mahon, B.P.; Cruzeiro, V.W.; Cornelio, B.; \\n\\tLaronze-Cochard, M.; Ceruso, M.; Sapi, J.; Rance, G.A.; Khlobystov, \\n\\tA.N.; Fontana, A.; Roitberg, A.; Supuran, C.T.; McKenna, R.: \\n\\tStructure-activity relationships of benzenesulfonamide-based inhibitors \\n\\ttowards carbonic anhydrase isoform specificity:: ChemBioChem (2017) 18, \\n\\t213-222. {Pubmed:27860128}\\nRF\\t<366> Esbaugh, A.J.; Secor, S.M.; Grosell, M.: Characterization of \\n\\tcarbonic anhydrase XIII in the erythrocytes of the Burmese python, \\n\\tPython molurus bivittatus:: Comp. Biochem. Physiol. B (2015) 187, \\n\\t71-77. {Pubmed:26005204}\\nRF\\t<367> Faridi, S.; Satyanarayana, T.: Novel alkalistable alpha-carbonic \\n\\tanhydrase from the polyextremophilic bacterium Bacillus halodurans\\t \\n\\tcharacteristics and applicability in flue gas CO2 sequestration:: \\n\\tEnviron. Sci. Pollut. Res. Int. (2016) 23, 15236-15249. \\n\\t{Pubmed:27102616}\\nRF\\t<368> Kucuk, M.; Gulcin, I.: Purification and characterization of the \\n\\tcarbonic anhydrase enzyme from Black Sea trout (Salmo trutta Labrax \\n\\tCoruhensis) kidney and inhibition effects of some metal ions on enzyme \\n\\tactivity:: Environ. Toxicol. Pharmacol. (2016) 44, 134-139. \\n\\t{Pubmed:27175889}\\nRF\\t<369> Chiaramonte, N.; Bua, S.; Ferraroni, M.; Nocentini, A.; Bonardi, \\n\\tA.; Bartolucci, G.; Durante, M.; Lucarini, L.; Chiapponi, D.; Dei, S.; \\n\\tManetti, D.; Teodori, E.; Gratteri, P.; Masini, E.; Supuran, C.T.; \\n\\tRomanelli, M.N.: 2-Benzylpiperazine\\t a new scaffold for potent human \\n\\tcarbonic anhydrase inhibitors. Synthesis, enzyme inhibition, \\n\\tenantioselectivity, computational and crystallographic studies and in \\n\\tvivo activity for a new class of intraocular pressure lowering agents:: \\n\\tEur. J. Med. Chem. (2018) 151, 363-375. {Pubmed:29635168}\\nRF\\t<370> Feng, H.Z.; Jin, J.P.: Carbonic anhydrase III is expressed in \\n\\tmouse skeletal muscles independent of fiber type-specific myofilament \\n\\tprotein isoforms and plays a role in fatigue resistance:: Front. \\n\\tPhysiol. (2016) 7, 597. {Pubmed:28018233}\\nRF\\t<371> Koh, C.Z.Y.; Hiong, K.C.; Choo, C.Y.L.; Boo, M.V.; Wong, W.P.; \\n\\tChew, S.F.; Neo, M.L.; Ip, Y.K.: Molecular characterization of a dual \\n\\tdomain carbonic anhydrase from the ctenidium of the giant clam, \\n\\tTridacna squamosa, and its expression levels after light exposure, \\n\\tcellular localization, and possible role in the uptake of exogenous \\n\\tinorganic carbon:: Front. Physiol. (2018) 9, 281. {Pubmed:29632495}\\nRF\\t<372> Wang, G.L.; Wang, Q.; Xu, Z.C.; Wang, Y.Y.; Li, J.L.: \\n\\tIdentification, structural characterization and expression analysis of \\n\\ta novel carbonic anhydrase from freshwater mussel Hyriopsis cumingii:: \\n\\tGene (2017) 636, 78-86. {Pubmed:28866087}\\nRF\\t<373> Sumi, K.R.; Kim, S.C.; Natarajan, S.; Choi, K.S.; Choi, M.R.; \\n\\tKim, H.T.; Park, J.I.; Nou, I.S.; Gilmour, K.M.; Kho, K.H.: Molecular \\n\\tcloning and characterization of secretory carbonic anhydrase VI in \\n\\tpufferfish (Takifugu rubripes):: Gene (2018) 640, 57-65. \\n\\t{Pubmed:29030255}\\nRF\\t<374> Faridi, S.; Satyanarayana, T.: Characteristics of recombinant \\n\\talpha-carbonic anhydrase of polyextremophilic bacterium Bacillus \\n\\thalodurans TSLV1:: Int. J. Biol. Macromol. (2016) 89, 659-668. \\n\\t{Pubmed:27174908}\\nRF\\t<375> Wahiduzzaman, C.T.; Dar, M.A.; Haque, M.A.; Idrees, D.; Hassan, \\n\\tM.I.; Islam, A.; Ahmad, F.: Characterization of folding intermediates \\n\\tduring urea-induced denaturation of human carbonic anhydrase II:: Int. \\n\\tJ. Biol. Macromol. (2017) 95, 881-887. {Pubmed:27789330}\\nRF\\t<376> Di Fiore, A.; Alterio, V.; Monti, S.M.; De Simone, G.; \\n\\tD\\'Ambrosio, K.: Thermostable carbonic anhydrases in biotechnological \\n\\tapplications:: Int. J. Mol. Sci. (2015) 16, 15456-15480. \\n\\t{Pubmed:26184158}\\nRF\\t<377> Demirdag, R.; Comakli, V.; Kuzu, M.; Yerlikaya, E.; Sentuerk, M.: \\n\\tPurification and characterization of carbonic anhydrase from Agri Balik \\n\\tLake trout gill (Salmo trutta labrax) and effects of sulfonamides on \\n\\tenzyme activity:: J. Biochem. Mol. Toxicol. (2015) 29, 123-128. \\n\\t{Pubmed:25345690}\\nRF\\t<378> Huyut, Z.; Beydemir, S.; Guelcin, I.: Inhibition properties of \\n\\tsome flavonoids on carbonic anhydrase I and II isoenzymes purified from \\n\\thuman erythrocytes:: J. Biochem. Mol. Toxicol. (2017) 31, e21930. \\n\\t{Pubmed:28445001}\\nRF\\t<379> Kocyigit, U.M.; Dastan, S.D.; Taslimi, P.; Dastan, T.; Gulcin, \\n\\tI.: Inhibitory effects of some drugs on carbonic anhydrase enzyme \\n\\tpurified from Kangal Akkaraman sheep in Sivas, Turkey:: J. Biochem. \\n\\tMol. Toxicol. (2017) 32, e22000. {Pubmed:28960668}\\nRF\\t<380> Kocyigit, U.M.; Taslimi, P.; Gulcin, I.: Characterization and \\n\\tinhibition effects of some metal ions on carbonic anhydrase enzyme from \\n\\tKangal Akkaraman sheep:: J. Biochem. Mol. Toxicol. (2018) 32, e22172. \\n\\t{Pubmed:29984873}\\nRF\\t<381> Juozapaitiene, V.; Bartkute, B.; Michailoviene, V.; Zaksauskas, \\n\\tA.; Baranauskiene, L.; Satkune, S.; Matulis, D.: Purification, \\n\\tenzymatic activity and inhibitor discovery for recombinant human \\n\\tcarbonic anhydrase XIV:: J. Biotechnol. (2016) 240, 31-42. \\n\\t{Pubmed:27773757}\\nRF\\t<382> Del Prete, S.; Vullo, D.; De Luca, V.; Supuran, C.T.; Capasso, \\n\\tC.: Biochemical characterization of the delta-carbonic anhydrase from \\n\\tthe marine diatom Thalassiosira weissflogii, TweCA:: J. Enzyme Inhib. \\n\\tMed. Chem. (2014) 29, 906-911. {Pubmed:24456295}\\nRF\\t<383> Del Prete, S.; Vullo, D.; De Luca, V.; AlOthman, Z.; Osman, S.M.; \\n\\tSupuran, C.T.; Capasso, C.: Biochemical characterization of recombinant \\n\\tbeta-carbonic anhydrase (PgiCAb) identified in the genome of the oral \\n\\tpathogenic bacterium Porphyromonas gingivalis:: J. Enzyme Inhib. Med. \\n\\tChem. (2015) 30, 366-370. {Pubmed:25032746}\\nRF\\t<384> Eminoglu, A.; Vullo, D.; Asik, A.; Colak, D.N.; Supuran, C.T.; \\n\\tCanakci, S.; Osman Belduez, A.: Cloning, expression and biochemical \\n\\tcharacterization of a beta-carbonic anhydrase from the soil bacterium \\n\\tEnterobacter sp. B13:: J. Enzyme Inhib. Med. Chem. (2016) 31, \\n\\t1111-1118. {Pubmed:26497870}\\nRF\\t<385> Orhan, F.; Sentuerk, M.; Supuran, C.T.: Interaction of anions \\n\\twith a newly characterized alpha carbonic anhydrase from Halomonas \\n\\tsp.:: J. Enzyme Inhib. Med. Chem. (2016) 31, 1119-1123. \\n\\t{Pubmed:26528918}\\nRF\\t<386> Durdagi, S.; Korkmaz, N.; Isik, S.; Vullo, D.; Astley, D.; \\n\\tEkinci, D.; Salmas, R.E.; Senturk, M.; Supuran, C.T.: Kinetic and \\n\\tdocking studies of cytosolic/tumor-associated carbonic anhydrase \\n\\tisozymes I, II and IX with some hydroxylic compounds:: J. Enzyme Inhib. \\n\\tMed. Chem. (2016) 31, 1214-1220. {Pubmed:26634620}\\nRF\\t<387> Kuecuekbay, F.Z.; Bugday, N.; Kuecuekbay, H.; Tanc, M.; Supuran, \\n\\tC.T.: Synthesis, characterization and carbonic anhydrase inhibitory \\n\\tactivity of novel benzothiazole derivatives:: J. Enzyme Inhib. Med. \\n\\tChem. (2016) 31, 1221-1225. {Pubmed:26598927}\\nRF\\t<388> Del Prete, S.; De Luca, V.; De Simone, G.; Supuran, C.T.; \\n\\tCapasso, C.: Cloning, expression and purification of the complete \\n\\tdomain of the eta-carbonic anhydrase from Plasmodium falciparum:: J. \\n\\tEnzyme Inhib. Med. Chem. (2016) 31, 54-59. {Pubmed:27615265}\\nRF\\t<389> Perfetto, R.; Del Prete, S.; Vullo, D.; Carginale, V.; Sansone, \\n\\tG.; Barone, C.M.A.; Rossi, M.; Alasmary, F.A.S.; Osman, S.M.; AlOthman, \\n\\tZ.; Supuran, C.T.; Capasso, C.: Cloning, expression and purification of \\n\\tthe alpha-carbonic anhydrase from the mantle of the Mediterranean \\n\\tmussel, Mytilus galloprovincialis:: J. Enzyme Inhib. Med. Chem. (2017) \\n\\t32, 1029-1035. {Pubmed:28741386}\\nRF\\t<390> Soydan, E.; Gueler, A.; Biyik, S.; Sentuerk, M.; Supuran, C.T.; \\n\\tEkinci, D.: Carbonic anhydrase from Apis mellifera\\t purification and \\n\\tinhibition by pesticides:: J. Enzyme Inhib. Med. Chem. (2017) 32, \\n\\t47-50. {Pubmed:28090787}\\nRF\\t<391> Perfetto, R.; Del Prete, S.; Vullo, D.; Sansone, G.; Barone, C.; \\n\\tRossi, M.; Supuran, C.T.; Capasso, C.: Biochemical characterization of \\n\\tthe native alpha-carbonic anhydrase purified from the mantle of the \\n\\tMediterranean mussel, Mytilus galloprovincialis:: J. Enzyme Inhib. Med. \\n\\tChem. (2017) 32, 632-639. {Pubmed:28229634}\\nRF\\t<392> Alper Tuerkoglu, E.; Sentuerk, M.; Supuran, C.T.; Ekinci, D.: \\n\\tCarbonic anhydrase inhibitory properties of some uracil derivatives:: \\n\\tJ. Enzyme Inhib. Med. Chem. (2017) 32, 74-77. {Pubmed:28097897}\\nRF\\t<393> Bouchouit, M.; Bouacida, S.; Zouchoune, B.; Merazig, H.; Bua, S.; \\n\\tBouaziz, Z.; Le Borgne, M.; Supuran, C.T.; Bouraiou, A.: Synthesis, \\n\\tX-ray structure, in silico calculation, and carbonic anhydrase \\n\\tinhibitory properties of benzylimidazole metal complexes:: J. Enzyme \\n\\tInhib. Med. Chem. (2018) 33, 1150-1159. {Pubmed:30001665}\\nRF\\t<394> Moeker, J.; Mahon, B.P.; Bornaghi, L.F.; Vullo, D.; Supuran, \\n\\tC.T.; McKenna, R.; Poulsen, S.A.: Structural insights into carbonic \\n\\tanhydrase IX isoform specificity of carbohydrate-based sulfamates:: J. \\n\\tMed. Chem. (2014) 57, 8635-8645. {Pubmed:25254302}\\nRF\\t<395> Karakostis, K.; Costa, C.; Zito, F.; Bruemmer, F.; Matranga, V.: \\n\\tCharacterization of an alpha type carbonic anhydrase from Paracentrotus \\n\\tlividus sea urchin embryos:: Mar. Biotechnol. (2016) 18, 384-395. \\n\\t{Pubmed:27230618}\\nRF\\t<396> Bhatt, A.; Mondal, U.K.; Supuran, C.T.; Ilies, M.A.; McKenna, R.: \\n\\tCrystal structure of carbonic anhydrase II in complex with an \\n\\tactivating ligand\\t implications in neuronal function:: Mol. Neurobiol. \\n\\t(2018) 55, 7431-7437. {Pubmed:29423818}\\nRF\\t<397> Warden, A.C.; Williams, M.; Peat, T.S.; Seabrook, S.A.; Newman, \\n\\tJ.; Dojchinov, G.; Haritos, V.S.: Rational engineering of a \\n\\tmesohalophilic carbonic anhydrase to an extreme halotolerant \\n\\tbiocatalyst:: Nat. Commun. (2015) 6, 10278. {Pubmed:26687908}\\nRF\\t<398> Cau, Y.; Mori, M.; Supuran, C.T.; Botta, M.: Mycobacterial \\n\\tcarbonic anhydrase inhibition with phenolic acids and esters\\t kinetic \\n\\tand computational investigations:: Org. Biomol. Chem. (2016) 14, \\n\\t8322-8330. {Pubmed:27530867}\\nRF\\t<399> Patrikainen, M.S.; Tolvanen, M.E.E.; Aspatwar, A.; Barker, H.R.; \\n\\tOrtutay, C.; Jaenis, J.; Laitaoja, M.; Hytoenen, V.P.; Azizi, L.; \\n\\tManandhar, P.; Jager, E.; Vullo, D.; Kukkurainen, S.; Hilvo, M.; \\n\\tSupuran, C.T.; Parkkila, S.: Identification and characterization of a \\n\\tnovel zebrafish (Danio rerio) pentraxin-carbonic anhydrase:: PeerJ \\n\\t(2017) 5, e4128. {Pubmed:29230365}\\nRF\\t<400> Karacan, M.S.; Rodionova, M.V.; Tunc, T.; Venedik, K.B.; Mamas, \\n\\tS.; Shitov, A.V.; Zharmukhamedov, S.K.; Klimov, V.V.; Karacan, N.; \\n\\tAllakhverdiev, S.I.: Characterization of nineteen antimony(III) \\n\\tcomplexes as potent inhibitors of photosystem II, carbonic anhydrase, \\n\\tand glutathione reductase:: Photosynth. Res. (2016) 130, 167-182. \\n\\t{Pubmed:26932934}\\nRF\\t<401> Ip, Y.K.; Koh, C.Z.Y.; Hiong, K.C.; Choo, C.Y.L.; Boo, M.V.; \\n\\tWong, W.P.; Neo, M.L.; Chew, S.F.: Carbonic anhydrase 2-like in the \\n\\tgiant clam, Tridacna squamosa\\t characterization, localization, response \\n\\tto light, and possible role in the transport of inorganic carbon from \\n\\tthe host to its symbionts:: Physiol. Rep. (2017) 5, e13494. \\n\\t{Pubmed:29199178}\\nRF\\t<402> Soto, D.; Cordoba, J.P.; Villarreal, F.; Bartoli, C.; Schmitz, \\n\\tJ.; Maurino, V.G.; Braun, H.P.; Pagnussat, G.C.; Zabaleta, E.: \\n\\tFunctional characterization of mutants affected in the carbonic \\n\\tanhydrase domain of the respiratory complex I in Arabidopsis thaliana:: \\n\\tPlant J. (2015) 83, 831-844. {Pubmed:26148112}\\nRF\\t<403> Benlloch, R.; Shevela, D.; Hainzl, T.; Grundstroem, C.; Shutova, \\n\\tT.; Messinger, J.; Samuelsson, G.; Sauer-Eriksson, A.E.: Crystal \\n\\tstructure and functional characterization of photosystem II-associated \\n\\tcarbonic anhydrase CAH3 in Chlamydomonas reinhardtii:: Plant Physiol. \\n\\t(2015) 167, 950-962. {Pubmed:25617045}\\nRF\\t<404> Kanth, B.; Jun, S.; Kumari, S.; Pack, S.: Highly thermostable \\n\\tcarbonic anhydrase from Persephonella marina EX-H1\\t its expression and \\n\\tcharacterization for CO2-sequestration applications:: Process Biochem. \\n\\t(2014) 49, 2114-2121. {Pubmed:}\\nRF\\t<405> Al-Dhrub, A.; Sahin, S.; Ozmen, I.; Tunca, E.; Bulbul, M.: \\n\\tImmobilization and characterization of human carbonic anhydrase I on \\n\\tamine functionalized magnetic nanoparticles:: Process Biochem. (2017) \\n\\t57, 95-104. {Pubmed:}\\nRF\\t<406> Pirincci, N.; Kaya, T.Y.; Kaba, M.; Ozan, T.; Gecit, I.; \\n\\tOezveren, H.; Eren, H.; Ceylan, K.: Serum adenosine deaminase, \\n\\tcatalase, and carbonic anhydrase activities in patients with renal cell \\n\\tcarcinoma:: Redox Rep. (2017) 22, 252-256. {Pubmed:27414070}\\nRF\\t<407> Jin, S.; Vullo, D.; Bua, S.; Nocentini, A.; Supuran, C.T.; Gao, \\n\\tY.G.: Structural and biochemical characterization of novel carbonic \\n\\tanhydrases from Phaeodactylum tricornutum:: Acta Crystallogr. Sect. D \\n\\t(2020) 76, 676-686. {Pubmed:32627740}\\nRF\\t<408> Urbanski, L.J.; Bua, S.; Angeli, A.; Emameh, R.Z.; Barker, H.R.; \\n\\tKuuslahti, M.; Hytoenen, V.P.; Parkkila, S.; Supuran, C.T.: The \\n\\tproduction and biochemical characterization of alpha-carbonic anhydrase \\n\\tfrom Lactobacillus rhamnosus GG:: Appl. Microbiol. Biotechnol. (2022) \\n\\t106, 4065-4074. {Pubmed:35612631}\\nRF\\t<409> Tuerker, F.; Barut Celepci, D.; Aktas, A.; Taslimi, P.; Goek, Y.; \\n\\tAyguen, M.; Guelcin, I.: meta-cyanobenzyl substituted benzimidazolium \\n\\tsalts\\t Synthesis, characterization, crystal structure and carbonic \\n\\tanhydrase, alpha-glycosidase, butyrylcholinesterase, and \\n\\tacetylcholinesterase inhibitory properties:: Arch. Pharm. (2018) 351, \\n\\te1800029. {Pubmed:29963738}\\nRF\\t<410> Aydin, B.O.; Anil, D.; Demir, Y.: Synthesis of N-alkylated \\n\\tpyrazolo[3,4-d]pyrimidine analogs and evaluation of \\n\\tacetylcholinesterase and carbonic anhydrase inhibition properties:: \\n\\tArch. Pharm. (2021) 354, e2000330. {Pubmed:33502038}\\nRF\\t<411> Sridharan, U.; Ragunathan, P.; Kuramitsu, S.; Yokoyama, S.; \\n\\tKumarevel, T.; Ponnuraj, K.: Structural and functional characterization \\n\\tof a putative carbonic anhydrase from Geobacillus kaustophilus reveals \\n\\tits cambialistic function:: Biochem. Biophys. Res. Commun. (2021) 547, \\n\\t96-101. {Pubmed:33610046}\\nRF\\t<412> Guelcin, I.; Trofimov, B.; Kaya, R.; Taslimi, P.; Sobenina, L.; \\n\\tSchmidt, E.; Petrova, O.; Malysheva, S.; Gusarova, N.; Farzaliyev, V.; \\n\\tSujayev, A.; Alwasel, S.; Supuran, C.T.: Synthesis of nitrogen, \\n\\tphosphorus, selenium and sulfur-containing heterocyclic compounds - \\n\\tdetermination of their carbonic anhydrase, acetylcholinesterase, \\n\\tbutyrylcholinesterase and alpha-glycosidase inhibition properties:: \\n\\tBioorg. Chem. (2020) 103, 104171. {Pubmed:32891857}\\nRF\\t<413> Askin, S.; Tahtaci, H.; Tuerkes, C.; Demir, Y.; Ece, A.; Akalin \\n\\tCiftci, G.; Beydemir, S.: Design, synthesis, characterization, in vitro \\n\\tand in silico evaluation of novel imidazo[2,1-b][1,3,4]thiadiazoles as \\n\\thighly competitive. Potent acetylcholinesterase and non-classical \\n\\tcarbonic anhydrase inhibitors:: Bioorg. Chem. (2021) 113, 105009. \\n\\t{Pubmed:34052739}\\nRF\\t<414> Tugrak, M.; Inci Gul, H.; Sakagami, H.; Gulcin, I.; Supuran, C.: \\n\\tNew azafluorenones with cytotoxic and carbonic anhydrase inhibitory \\n\\tproperties\\t 2-aryl-4-(4-hydroxyphenyl)-5H-indeno[1,2-b]pyridin-5-ones:: \\n\\tBioorg. Chem. (2018) 81, 433-439. {Pubmed:30223148}\\nRF\\t<415> Kuecuekbay, H.; Bugday, N.; Kuecuekbay, F.; Berrino, E.; \\n\\tBartolucci, G.; Del Prete, S.; Capasso, C.; Supuran, C.: Synthesis and \\n\\tcarbonic anhydrase inhibitory properties of novel \\n\\t4-(2-aminoethyl)benzenesulfonamide-dipeptide conjugates:: Bioorg. Chem. \\n\\t(2019) 83, 414-423. {Pubmed:30419497}\\nRF\\t<416> Oezil, M.; Balaydin, H.; Sentuerk, M.: Synthesis of \\n\\t5-methyl-2,4-dihydro-3H-1,2,4-triazole-3-ones aryl Schiff base \\n\\tderivatives and investigation of carbonic anhydrase and cholinesterase \\n\\t(AChE, BuChE) inhibitory properties:: Bioorg. Chem. (2019) 86, 705-713. \\n\\t{Pubmed:30836234}\\nRF\\t<417> Bal, S.; Kaya, R.; Goek, Y.; Taslimi, P.; Aktas, A.; Karaman, M.; \\n\\tGuelcin, I.: Novel 2-methylimidazolium salts\\t Synthesis, \\n\\tcharacterization, molecular docking, and carbonic anhydrase and \\n\\tacetylcholinesterase inhibitory properties:: Bioorg. Chem. (2020) 94, \\n\\t103468. {Pubmed:31791684}\\nRF\\t<418> Duran, H.E.; Beydemir, S.: Recombinant human carbonic anhydrase \\n\\tVII\\t Purification, characterization, inhibition, and molecular docking \\n\\tstudies:: Biotechnol. Appl. Biochem. (2023) 70, 415-428. \\n\\t{Pubmed:35638720}\\nRF\\t<419> Hirakawa, Y.; Senda, M.; Fukuda, K.; Yu, H.Y.; Ishida, M.; Taira, \\n\\tM.; Kinbara, K.; Senda, T.: Characterization of a novel type of \\n\\tcarbonic anhydrase that acts without metal cofactors:: BMC Biol. (2021) \\n\\t19, 105. {Pubmed:34006275}\\nRF\\t<420> Dostal, J.; Brynda, J.; Blaha, J.; Machacek, S.; Heidingsfeld, \\n\\tO.; Pichova, I.: Crystal structure of carbonic anhydrase CaNce103p \\n\\tfrom the pathogenic yeast Candida albicans:: BMC Struct. Biol. (2018) \\n\\t18, 14. {Pubmed:30367660}\\nRF\\t<421> Hsieh, C.; Yu, C.: Cyanate degradation in different matrices \\n\\tusing heat-purified enzymes:: Catalysts (2023) 13, 76. {Pubmed:}\\nRF\\t<422> Ge, Q.; Li, J.; Wang, J.; Li, Z.; Li, J.: Characterization, \\n\\tfunctional analysis, and expression levels of three carbonic anhydrases \\n\\tin response to pH and saline-alkaline stresses in the ridgetail white \\n\\tprawn Exopalaemon carinicauda:: Cell Stress Chaperones (2019) 24, \\n\\t503-515. {Pubmed:30915722}\\nRF\\t<423> Bi, Y.H.; Du, A.Y.; Li, J.L.; Zhou, Z.G.: Isolation and \\n\\tcharacterization of a gamma-carbonic anhydrase localized in the \\n\\tmitochondria of Saccharina japonica:: Chemosphere (2021) 266, 129162. \\n\\t{Pubmed:33310361}\\nRF\\t<424> Caglayan, C.; Taslimi, P.; Tuerk, C.; Kandemir, F.M.; Demir, Y.; \\n\\tGulcin, ?.: Purification and characterization of the carbonic anhydrase \\n\\tenzyme from horse mackerel (Trachurus trachurus) muscle and the impact \\n\\tof some metal ions and pesticides on enzyme activity:: Comp. Biochem. \\n\\tPhysiol. C (2019) 226, 108605. {Pubmed:31422160}\\nRF\\t<425> Sharma, T.; Sharma, A.; Xia, C.L.; Lam, S.S.; Khan, A.A.; \\n\\tTripathi, S.; Kumar, R.; Gupta, V.K.; Nadda, A.K.: Enzyme mediated \\n\\ttransformation of CO2 into calcium carbonate using purified microbial \\n\\tcarbonic anhydrase:: Environ. Res. (2022) 212, 113538. {Pubmed:35640707}\\nRF\\t<426> Kuzu, M.; Comakh, V.; Akkemik, E.; Ciftci, M.; Kuefrevioglu, O.: \\n\\tInhibitory properties of some heavy metals on carbonic anhydrase I and \\n\\tII isozymes activities purified from Van Lake fish (Chalcalburnus \\n\\ttarichi) gill:: Fish Physiol. Biochem. (2018) 44, 1119-1125. \\n\\t{Pubmed:29629489}\\nRF\\t<427> Maheshwari, N.; Kumar, M.; Thakur, I.; Srivastava, S.: Cloning, \\n\\texpression and characterization of beta- and gamma-carbonic anhydrase \\n\\tfrom Bacillus sp. SS105 for biomimetic sequestration of CO2:: Int. J. \\n\\tBiol. Macromol. (2019) 131, 445-452. {Pubmed:30876900}\\nRF\\t<428> Del Prete, S.; Vullo, D.; Ghobril, C.; Hitce, J.; Clavaud, C.; \\n\\tMarat, X.; Capasso, C.; Supuran, C.T.: Cloning, purification, and \\n\\tcharacterization of a beta-carbonic anhydrase from Malassezia \\n\\trestricta, an opportunistic pathogen involved in dandruff and \\n\\tseborrheic dermatitis:: Int. J. Mol. Sci. (2019) 20, 2447. \\n\\t{Pubmed:31108925}\\nRF\\t<429> Jo, B.H.; Hwang, I.S.: Characterization and high-level \\n\\tperiplasmic expression of thermostable alpha-carbonic anhydrase from \\n\\tThermosulfurimonas dismutans in Escherichia coli for CO2 capture and \\n\\tutilization:: Int. J. Mol. Sci. (2019) 21, 103. {Pubmed:31877855}\\nRF\\t<430> Tomar, J.S.; Shen, J.: Characterization of carbonic anhydrase in \\n\\tvivo using magnetic resonance spectroscopy:: Int. J. Mol. Sci. (2020) \\n\\t21, 2442. {Pubmed:32244610}\\nRF\\t<431> Taslimi, P.; Osmanova, S.; Caglayan, C.; Turkan, F.; Sardarova, \\n\\tS.; Farzaliyev, V.; Sujayev, A.; Sadeghian, N.; Gulcin, I.: Novel \\n\\tamides of 1,1-bis-(carboxymethylthio)-1-arylethanes\\t Synthesis, \\n\\tcharacterization, acetylcholinesterase, butyrylcholinesterase, and \\n\\tcarbonic anhydrase inhibitory properties:: J. Biochem. Mol. Toxicol. \\n\\t(2018) 32, e22191. {Pubmed:29992664}\\nRF\\t<432> Celebioglu, H.U.; Erden, Y.; Hamurcu, F.; Taslimi, P.; Sentuerk, \\n\\tO.S.; Oezmen, U.e.O.e.; Tuzun, B.; Gulcin, I.: Cytotoxic effects, \\n\\tcarbonic anhydrase isoenzymes, alpha-glycosidase and \\n\\tacetylcholinesterase inhibitory properties, and molecular docking \\n\\tstudies of heteroatom-containing sulfonyl hydrazone derivatives:: J. \\n\\tBiomol. Struct. Dyn. (2021) 39, 5539-5550. {Pubmed:32691677}\\nRF\\t<433> Huseynova, A.; Kaya, R.; Taslimi, P.; Farzaliyev, V.; \\n\\tMammadyarova, X.; Sujayev, A.; Tuezuen, B.; Kocyigit, U.M.; Alwasel, \\n\\tS.; Gulcin, I.: Design, synthesis, characterization, biological \\n\\tevaluation, and molecular docking studies of novel \\n\\t1,2-aminopropanthiols substituted derivatives as selective carbonic \\n\\tanhydrase, acetylcholinesterase and alpha-glycosidase enzymes \\n\\tinhibitors:: J. Biomol. Struct. Dyn. (2022) 40, 236-248. \\n\\t{Pubmed:32851915}\\nRF\\t<434> Urba?ski, L.J.; Di Fiore, A.; Azizi, L.; Hytoenen, V.P.; \\n\\tKuuslahti, M.; Buonanno, M.; Monti, S.M.; Angeli, A.; Zolfaghari \\n\\tEmameh, R.; Supuran, C.T.; De Simone, G.; Parkkila, S.: Biochemical and \\n\\tstructural characterisation of a protozoan beta-carbonic anhydrase from \\n\\tTrichomonas vaginalis:: J. Enzyme Inhib. Med. Chem. (2020) 35, \\n\\t1292-1299. {Pubmed:32515610}\\nRF\\t<435> Di Fiore, A.; Supuran, C.T.; Scaloni, A.; De Simone, G.: Human \\n\\tcarbonic anhydrases and post-translational modifications\\t a hidden \\n\\tworld possibly affecting protein properties and functions:: J. Enzyme \\n\\tInhib. Med. Chem. (2020) 35, 1450-1461. {Pubmed:32648529}\\nRF\\t<436> Del Prete, S.; Bua, S.; Supuran, C.T.; Capasso, C.: Escherichia \\n\\tcoli gamma-carbonic anhydrase\\t characterisation and effects of simple \\n\\taromatic/heterocyclic sulphonamide inhibitors:: J. Enzyme Inhib. Med. \\n\\tChem. (2020) 35, 1545-1554. {Pubmed:32746656}\\nRF\\t<437> Brichet, J.; Arancibia, R.; Berrino, E.; Supuran, C.T.: \\n\\tBioorganometallic derivatives of 4-hydrazino-benzenesulphonamide as \\n\\tcarbonic anhydrase inhibitors\\t synthesis, characterisation and \\n\\tbiological evaluation:: J. Enzyme Inhib. Med. Chem. (2020) 35, 622-628. \\n\\t{Pubmed:32037900}\\nRF\\t<438> Aspatwar, A.; Barker, H.; Aisala, H.; Zueva, K.; Kuuslahti, M.; \\n\\tTolvanen, M.; Primmer, C.R.; Lumme, J.; Bonardi, A.; Tripathi, A.; \\n\\tParkkila, S.; Supuran, C.T.: Cloning, purification, kinetic and anion \\n\\tinhibition studies of a recombinant beta-carbonic anhydrase from the \\n\\tAtlantic salmon parasite platyhelminth Gyrodactylus salaris:: J. Enzyme \\n\\tInhib. Med. Chem. (2022) 37, 1577-1586. {Pubmed:35637617}\\nRF\\t<439> De Luca, V.; Angeli, A.; Mazzone, V.; Adelfio, C.; Carginale, V.; \\n\\tScaloni, A.; Carta, F.; Selleri, S.; Supuran, C.T.; Capasso, C.: \\n\\tHeterologous expression and biochemical characterisation of the \\n\\trecombinant beta-carbonic anhydrase (MpaCA) from the warm-blooded \\n\\tvertebrate pathogen Malassezia pachydermatis:: J. Enzyme Inhib. Med. \\n\\tChem. (2022) 37, 62-68. {Pubmed:34894958}\\nRF\\t<440> Urbanski, L.J.; Angeli, A.; Mykuliak, V.V.; Azizi, L.; Kuuslahti, \\n\\tM.; Hytoenen, V.P.; Supuran, C.T.; Parkkila, S.: Biochemical and \\n\\tstructural characterization of beta-carbonic anhydrase from the \\n\\tparasite Trichomonas vaginalis:: J. Mol. Med. (2022) 100, 115-124. \\n\\t{Pubmed:34652457}\\nRF\\t<441> Kim, S.; Sung, J.; Yeon, J.; Choi, S.H.; Jin, M.S.: Crystal \\n\\tstructure of a highly thermostable alpha-carbonic anhydrase from \\n\\tPersephonella marina EX-H1:: Mol. Cells (2019) 42, 460-469. \\n\\t{Pubmed:31250619}\\nRF\\t<442> Kim, S.; Yeon, J.; Sung, J.; Jin, M.S.: Crystal structure of \\n\\tbeta-carbonic anhydrase CafA from the fungal pathogen Aspergillus \\n\\tfumigatus:: Mol. Cells (2020) 43, 831-840. {Pubmed:32975213}\\nRF\\t<443> Haapanen, S.; Bua, S.; Kuuslahti, M.; Parkkila, S.; Supuran, C.: \\n\\tCloning, characterization and anion inhibition studies of a \\n\\tbeta-carbonic anhydrase from the pathogenic protozoan Entamoeba \\n\\thistolytica:: Molecules (2018) 23, 3112. {Pubmed:30486513}\\nRF\\t<444> Kumari, M.; Lee, J.; Lee, D.W.; Hwang, I.: High-level production \\n\\tin a plant system of a thermostable carbonic anhydrase and its \\n\\timmobilization on microcrystalline cellulose beads for CO2 capture:: \\n\\tPlant Cell Rep. (2020) 39, 1317-1329. {Pubmed:32651706}\\nRF\\t<445> Yrjaenaeinen, A.; Patrikainen, M.S.; Azizi, L.; Tolvanen, M.E.E.; \\n\\tLaitaoja, M.; Jaenis, J.; Hytoenen, V.P.; Nocentini, A.; Supuran, C.T.; \\n\\tParkkila, S.: Biochemical and biophysical characterization of carbonic \\n\\tanhydrase VI from human milk and saliva:: Protein J. (2022) 41, \\n\\t489-503. {Pubmed:35947329}\\nRF\\t<446> Kazokaite, J.; Kairys, V.; Smirnoviene, J.; Smirnov, A.; \\n\\tManakova, E.; Tolvanen, M.; Parkkila, S.; Matulis, D.: Engineered \\n\\tcarbonic anhydrase VI-mimic enzyme switched the structure and \\n\\taffinities of inhibitors:: Sci. Rep. (2019) 9, 12710. {Pubmed:31481705}\\n\\nKI_VALUE\\nKI\\t#102# 0.0004 {sulfanilamide}  (#102# pH 8.5, 0C <128>) <128>\\nKI\\t#102# 0.0000003 {acetazolamide}  (#102# pH 8.5, 0C <128>) <128>\\nKI\\t#104# 0.0016 {sulfanilamide}  (#104# pH 8.5, 0C <128>) <128>\\nKI\\t#104# 0.00000035 {acetazolamide}  (#104# pH 8.5, 0C <128>) <128>\\nKI\\t#107# 0.0043 {Cu2+}  (#107# enzyme from heart membrane <146>) <146>\\nKI\\t#107# 0.0000044 {acetazolamide}  (#107# enzyme from heart membrane \\n\\t<146>) <146>\\nKI\\t#107# 0.0000021 {acetazolamide}  (#107# enzyme from heart membrane \\n\\t<146>) <146>\\nKI\\t#107# 0.0147 {Cu2+}  (#107# enzyme from heart membrane <146>) <146>\\nKI\\t#11# 0.22 {acetazolamide}  (#11# in 0.1 M Tris-HCl buffer, pH 8.3, and \\n\\t37C <264>) <264>\\nKI\\t#11# 0.099 {sulfanilamide}  (#11# in 0.1 M Tris-HCl buffer, pH 8.3, and \\n\\t37C <264>) <264>\\nKI\\t#110# 0.011 {zonisamide}  (#110# isoenzyme hCA XII catalytic domain \\n\\t<171>) <171>\\nKI\\t#110,124# 0.00011 \\n\\t{2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide}  (#110# \\n\\tisoenzyme hCA XII <171>; #124# isozyme CA XII, in 10 mM HEPES (pH 7.5) \\n\\tand 0.1 M Na2SO4 <229>) <171,229>\\nKI\\t#110,132# 0.0000035 {dorzolamide}  (#132# isoenzyme hCA VII <171>; \\n\\t#110# isoenzyme hCA XII <171>) <171>\\nKI\\t#111# 0.00000121 {acetazolamide}  <150>\\nKI\\t#111# 0.00006203 {Cl-}  <150>\\nKI\\t#112# 0.00000134 {acetazolamide}  <150>\\nKI\\t#112# 0.00006134 {Cl-}  <150>\\nKI\\t#118# 0.000345 {4,5-dichloro-benzene-1,3-disulfonamide}  (#118# \\n\\tisoenzyme hCA XIV, i.e. daranide <169>) <169>\\nKI\\t#118# 0.00001 \\n\\t{5-[[(4-nitrophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#118# pH 7.5, full-length recombinant enzyme <141>) <141>\\nKI\\t#118# 0.0029 {4-aminoethylbenzenesulfonamide}  (#118# pH 7.5, \\n\\tfull-length recombinant enzyme <141>) <141>\\nKI\\t#118# 0.0029 \\n\\t{2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide}  (#118# \\n\\tisoenzyme hCA XIV <172>) <172>\\nKI\\t#118# 0.00057 {6-chloro-4-amino-benzene-1,3-disulfonamide}  (#118# \\n\\tisoenzyme hCA XIV <169>) <169>\\nKI\\t#118# 0.0054 {sulfanilamide}  (#118# pH 7.5, full-length recombinant \\n\\tenzyme <141>) <141>\\nKI\\t#118# 0.000024 \\n\\t{2-(3-methoxypropyl)-4-(methylamino)-3,4-dihydro-2H-thieno[3,2-e][1,\\n\\t2]thiazine-6-sulfonamide 1,1-dioxide}  (#118# isoenzyme hCA XIV <169>) \\n\\t<169>\\nKI\\t#118# 0.000024 {brinzolamide}  (#118# isoenzyme hCA XIV catalytic \\n\\tdomain catalytic domain <171>) <171>\\nKI\\t#118# 0.0024 {N-[4-(aminosulfonyl)phenyl]-2-methylpropanamide}  (#118# \\n\\tpH 7.5, full-length recombinant enzyme <141>) <141>\\nKI\\t#118# 0.000023 \\n\\t{N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)furan-2-carboxamide}  (#118# pH \\n\\t7.5, full-length recombinant enzyme <141>) <141>\\nKI\\t#118# 0.0032 {homosulfanilamide}  (#118# pH 7.5, full-length \\n\\trecombinant enzyme <141>) <141>\\nKI\\t#118# 0.0023 {N-[4-(aminosulfonyl)phenyl]pentanamide}  (#118# pH 7.5, \\n\\tfull-length recombinant enzyme <141>) <141>\\nKI\\t#118# 0.000085 \\n\\t{4-[2-[([[4-\\n\\t(aminosulfonyl)phenyl]amino]carbonothioyl)\\n\\tamino]ethyl]benzenesulfonamide}  (#118# pH 7.5, full-length recombinant \\n\\tenzyme <141>) <141>\\nKI\\t#118# 0.0042 {N-[4-(aminosulfonyl)phenyl]acetamide}  (#118# pH 7.5, \\n\\tfull-length recombinant enzyme <141>) <141>\\nKI\\t#118# 0.000013 \\n\\t{5-[[(4-bromophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#118# pH 7.5, full-length recombinant enzyme <141>) <141>\\nKI\\t#118# 0.0037 {N-[4-(aminosulfonyl)phenyl]propanamide}  (#118# pH 7.5, \\n\\tfull-length recombinant enzyme <141>) <141>\\nKI\\t#118# 0.00125 {4-[(methylsulfonyl)amino]benzenesulfonamide}  (#118# pH \\n\\t7.5, full-length recombinant enzyme <141>) <141>\\nKI\\t#118# 0.000027 \\n\\t{6-methyl-4-(methylamino)-5,6-dihydro-4H-thieno[2,\\n\\t3-b]thiopyran-2-sulfonamide 7,7-dioxide}  (#118# isoenzyme hCA XIV \\n\\t<169>) <169>\\nKI\\t#118# 0.000027 {dorzolamide}  (#118# isoenzyme hCA XIV catalytic domain \\n\\t<171>) <171>\\nKI\\t#118# 0.00043 \\n\\t{4-[(anilinocarbonyl)amino]-6-chlorobenzene-1,3-disulfonamide}  (#118# \\n\\tpH 7.5, full-length recombinant enzyme <141>) <141>\\nKI\\t#118# 0.00026 {4-[2-[(anilinocarbonyl)amino]ethyl]benzenesulfonamide}  \\n\\t(#118# pH 7.5, full-length recombinant enzyme <141>) <141>\\nKI\\t#118# 0.000043 \\n\\t{N-[5-(aminosulfonyl)-3-methyl-1,3,\\n\\t4-thiadiazol-2(3H)-ylidene]acetamide}  (#118# isoenzyme hCA XIV <169>) \\n\\t<169>\\nKI\\t#118# 0.000052 {Furosemide}  (#118# isoenzyme hCA XIV <169>) <169>\\nKI\\t#118# 0.00143 {N-[4-(aminosulfonyl)phenyl]-2,2,2-trifluoroacetamide}  \\n\\t(#118# pH 7.5, full-length recombinant enzyme <141>) <141>\\nKI\\t#118# 0.000203 \\n\\t{4-[2-[(anilinocarbonothioyl)amino]ethyl]benzenesulfonamide}  (#118# pH \\n\\t7.5, full-length recombinant enzyme <141>) <141>\\nKI\\t#118# 0.00235 {N-[4-(aminosulfonyl)phenyl]butanamide}  (#118# pH 7.5, \\n\\tfull-length recombinant enzyme <141>) <141>\\nKI\\t#118# 0.000079 \\n\\t{4-(aminosulfonyl)-N-[2-[4-(aminosulfonyl)phenyl]ethyl]benzamide}  \\n\\t(#118# pH 7.5, full-length recombinant enzyme <141>) <141>\\nKI\\t#118# 0.00068 {6-trifluoromethyl-4-aminobenzene-1,3-disulfonamide}  \\n\\t(#118# isoenzyme hCA XIV <169>) <169>\\nKI\\t#118# 0.000237 \\n\\t{4-[[(anilinocarbonothioyl)amino]methyl]benzenesulfonamide}  (#118# pH \\n\\t7.5, full-length recombinant enzyme <141>) <141>\\nKI\\t#118# 0.00525 {sulthiame}  (#118# isoenzyme hCA XIV <170>) <170>\\nKI\\t#118# 0.00088 \\n\\t{4-[(acetyloxy)amino]-N-[4-(aminosulfonyl)phenyl]benzenesulfonamide}  \\n\\t(#118# pH 7.5, full-length recombinant enzyme <141>) <141>\\nKI\\t#118# 0.00265 {N-[4-(aminosulfonyl)phenyl]-2,2-dimethylpropanamide}  \\n\\t(#118# pH 7.5, full-length recombinant enzyme <141>) <141>\\nKI\\t#118# 0.001345 {N-[4-(aminosulfonyl)phenyl]benzamide}  (#118# pH 7.5, \\n\\tfull-length recombinant enzyme <141>) <141>\\nKI\\t#118# 0.000935 {4-[(phenylsulfonyl)amino]benzenesulfonamide}  (#118# pH \\n\\t7.5, full-length recombinant enzyme <141>) <141>\\nKI\\t#118# 0.000465 {4-[[(phenylsulfonyl)amino]methyl]benzenesulfonamide}  \\n\\t(#118# pH 7.5, full-length recombinant enzyme <141>) <141>\\nKI\\t#118# 0.00145 {3-[(anilinocarbonyl)amino]benzenesulfonamide}  (#118# pH \\n\\t7.5, full-length recombinant enzyme <141>) <141>\\nKI\\t#118# 0.004105 {hydrochlorothiazide}  (#118# isoenzyme hCA XIV <169>) \\n\\t<169>\\nKI\\t#118,124# 0.000048 \\n\\t{2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide}  (#118# \\n\\tisoenzyme hCA XIV catalytic domain <171>; #124# isozyme CA XIV, in 10 \\n\\tmM HEPES (pH 7.5) and 0.1 M Na2SO4 <229>) <171,229>\\nKI\\t#119# 0.00001 {3-[(anilinocarbonyl)amino]benzenesulfonamide}  (#119# pH \\n\\t7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#119# 0.000024 \\n\\t{4-[2-[(anilinocarbonothioyl)amino]ethyl]benzenesulfonamide}  (#119# pH \\n\\t7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#119# 0.77 {SO42-}  (#119# isoenzyme hCA XII <168>) <168>\\nKI\\t#119# 0.0000019 \\n\\t{5-[[(4-nitrophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#119# pH 7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#119# 0.0000019 {[[(eta5-C5H4)-C(CH3)=N-N(H)-C6H4-4-SO2NH2]]FeCp}  \\n\\t(#119# isoform CA I, at pH 7.5 and 25C <437>) <437>\\nKI\\t#119# 0.000085 {N-[4-(aminosulfonyl)phenyl]butanamide}  (#119# pH 7.5, \\n\\tcatalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#119# 0.000033 {4-[(methylsulfonyl)amino]benzenesulfonamide}  (#119# pH \\n\\t7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#119# 0.000013 {4-[2-[(anilinocarbonyl)amino]ethyl]benzenesulfonamide}  \\n\\t(#119# pH 7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#119# 0.000013 \\n\\t{4-(aminosulfonyl)-N-[2-[4-(aminosulfonyl)phenyl]ethyl]benzamide}  \\n\\t(#119# pH 7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#119# 0.0000003 {homosulfanilamide}  (#119# pH 7.5, catalytic domain of \\n\\tcloned isoenzyme <141>) <141>\\nKI\\t#119# 0.000018 \\n\\t{4-[[(anilinocarbonothioyl)amino]methyl]benzenesulfonamide}  (#119# pH \\n\\t7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#119# 0.000068 {4-[(phenylsulfonyl)amino]benzenesulfonamide}  (#119# pH \\n\\t7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#119# 0.000006 {acetazolamide}  (#119# pH 7.5, 22C <387>) <387>\\nKI\\t#119# 0.000021 {N-[4-(aminosulfonyl)phenyl]benzamide}  (#119# pH 7.5, \\n\\tcatalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#119# 0.0084 {tert-butyl \\n\\t(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-\\n\\toxoethyl)carbamate}  (#119# pH 7.5, 22C <387>) <387>\\nKI\\t#119# 0.000045 {6-trifluoromethyl-4-aminobenzene-1,3-disulfonamide}  \\n\\t(#119# isoenzyme hCA XII <169>) <169>\\nKI\\t#119# 0.00076 {4-(3-quinolinyl)benzene-1-sulfonamide}  (#119# pH and \\n\\ttemperature not specified in the publication <365>) <365>\\nKI\\t#119# 0.0000024 \\n\\t{N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)furan-2-carboxamide}  (#119# pH \\n\\t7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#119# 0.0132 {H2NSO2NH2}  (#119# isoenzyme hCA XII <168>) <168>\\nKI\\t#119# 0.0107 {H2NSO3H}  (#119# isoenzyme hCA XII <168>) <168>\\nKI\\t#119# 0.000031 {N-[4-(aminosulfonyl)phenyl]-2,2,2-trifluoroacetamide}  \\n\\t(#119# pH 7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#119# 0.0000032 {4-aminoethylbenzenesulfonamide}  (#119# pH 7.5, \\n\\tcatalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#119# 0.0000033 \\n\\t{5-[[(4-bromophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#119# pH 7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#119# 0.0000033 {[[(eta5-C5H4)-C(CH3)=N-N(H)-C6H4-4-SO2NH2]]Mn(CO)3}  \\n\\t(#119# isoform CA I, at pH 7.5 and 25C <437>) <437>\\nKI\\t#119# 0.0000031 {[[(eta5-C5H4)-CH=N-N(H)-C6H4-4-SO2NH2]]Mn(CO)3}  \\n\\t(#119# isoform CA I, at pH 7.5 and 25C <437>) <437>\\nKI\\t#119# 0.0000038 {[[(eta5-C5H4)-C(CH3)=N-N(H)-C6H4-4-SO2NH2]]re(CO)3}  \\n\\t(#119# isoform CA I, at pH 7.5 and 25C <437>) <437>\\nKI\\t#119# 0.0000049 {[[(eta5-C5H4)-CH=N-N(H)-C6H4-4-SO2NH2]]FeCp}  (#119# \\n\\tisoform CA I, at pH 7.5 and 25C <437>) <437>\\nKI\\t#119# 0.0000077 \\n\\t{2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide}  (#119# \\n\\tisoenzyme hCA XII <172>) <172>\\nKI\\t#119# 0.000044 {6-chloro-4-amino-benzene-1,3-disulfonamide}  (#119# \\n\\tisoenzyme hCA XII <169>) <169>\\nKI\\t#119# 0.000138 {N-[4-(aminosulfonyl)phenyl]-2-methylpropanamide}  \\n\\t(#119# pH 7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#119# 0.000034 \\n\\t{N-[5-(aminosulfonyl)-3-methyl-1,3,\\n\\t4-thiadiazol-2(3H)-ylidene]acetamide}  (#119# isoenzyme hCA XII <169>) \\n\\t<169>\\nKI\\t#119# 0.0000006 {4-(3-formylphenyl)benzene-1-sulfonamide}  (#119# pH \\n\\tand temperature not specified in the publication <365>) <365>\\nKI\\t#119# 0.000037 {sulfanilamide}  (#119# pH 7.5, catalytic domain of \\n\\tcloned isoenzyme <141>) <141>\\nKI\\t#119# 0.000047 {4-(2-methylphenyl)benzene-1-sulfonamide}  (#119# pH and \\n\\ttemperature not specified in the publication <365>) <365>\\nKI\\t#119# 0.000056 {N-[4-(aminosulfonyl)phenyl]propanamide}  (#119# pH 7.5, \\n\\tcatalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#119# 0.000049 {N-[4-(aminosulfonyl)phenyl]acetamide}  (#119# pH 7.5, \\n\\tcatalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#119# 0.000038 {topiramate}  (#119# isoenzyme hCA XII <169>) <169>\\nKI\\t#119# 0.000261 {Furosemide}  (#119# isoenzyme hCA XII <169>) <169>\\nKI\\t#119# 0.000079 \\n\\t{4-[2-[([[4-\\n\\t(aminosulfonyl)phenyl]amino]carbonothioyl)\\n\\tamino]ethyl]benzenesulfonamide}  (#119# pH 7.5, catalytic domain of \\n\\tcloned isoenzyme <141>) <141>\\nKI\\t#119# 0.000093 {4-phenylbenzene-1-sulfonamide}  (#119# pH and \\n\\ttemperature not specified in the publication <365>) <365>\\nKI\\t#119# 0.000076 \\n\\t{4-[(acetyloxy)amino]-N-[4-(aminosulfonyl)phenyl]benzenesulfonamide}  \\n\\t(#119# pH 7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#119# 0.000083 {4-[[(phenylsulfonyl)amino]methyl]benzenesulfonamide}  \\n\\t(#119# pH 7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#119# 0.00134 {N-hydroxysulfamide}  (#119# isoenzyme hCA XII <168>) \\n\\t<168>\\nKI\\t#119# 0.000147 {N-[4-(aminosulfonyl)phenyl]pentanamide}  (#119# pH 7.5, \\n\\tcatalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#119# 0.000249 {N-[4-(aminosulfonyl)phenyl]-2,2-dimethylpropanamide}  \\n\\t(#119# pH 7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#119# 0.000348 \\n\\t{4-[(anilinocarbonyl)amino]-6-chlorobenzene-1,3-disulfonamide}  (#119# \\n\\tpH 7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#119# 0.000355 {hydrochlorothiazide}  (#119# isoenzyme hCA XII <169>) \\n\\t<169>\\nKI\\t#119# 0.0000244 {[[(eta5-C5H4)-CH=N-N(H)-C6H4-4-SO2NH2]]re(CO)3}  \\n\\t(#119# isoform CA I, at pH 7.5 and 25C <437>) <437>\\nKI\\t#119,120# 0.00005 {4,5-dichloro-benzene-1,3-disulfonamide}  (#120# \\n\\tisoenzyme hCA IX, i.e. daranide <169>; #119# isoenzyme hCA XII, i.e. \\n\\tdaranide <169>) <169>\\nKI\\t#119,124# 0.000003 \\n\\t{2-(3-methoxypropyl)-4-(methylamino)-3,4-dihydro-2H-thieno[3,2-e][1,\\n\\t2]thiazine-6-sulfonamide 1,1-dioxide}  (#124# isoenzyme hCA II <169>; \\n\\t#119# isoenzyme hCA XII <169>) <169>\\nKI\\t#119,132# 0.0000035 \\n\\t{6-methyl-4-(methylamino)-5,6-dihydro-4H-thieno[2,\\n\\t3-b]thiopyran-2-sulfonamide 7,7-dioxide}  (#132# isoenzyme hCA VII \\n\\t<169>; #119# isoenzyme hCA XII <169>) <169>\\nKI\\t#12# 0.12 {SCN-}  (#12# pH 7.0, 10C, double mutant R94H/E92Q <106>) \\n\\t<106>\\nKI\\t#12# 0.0002 {benzolamide}  <157>\\nKI\\t#12# 0.27 {N3-}  (#12# pH 7.0, 10C, double mutant R94H/E92Q <106>) \\n\\t<106>\\nKI\\t#12# 0.0082 {bicarbonate}  (#12# isozyme CA XV <253>) <253>\\nKI\\t#12# 0.0101 {thiocyanate}  (#12# isozyme CA XV <253>) <253>\\nKI\\t#12# 0.0003 {benzolamide}  <157>\\nKI\\t#12# 0.0085 {azide}  (#12# isozyme CA XV <253>) <253>\\nKI\\t#12# 0.0092 {hydrogen sulfide}  (#12# isozyme CA XV <253>) <253>\\nKI\\t#12# 0.0102 {benzene-1,2-diol}  (#12# at pH 7.5 and 20C <201>) <201>\\nKI\\t#12# 0.0065 {CN-}  (#12# pH 7.0, 10C, double mutant R94H/E92Q <106>) \\n\\t<106>\\nKI\\t#12# 0.106 {Carbonate}  (#12# isozyme CA XV <253>) <253>\\nKI\\t#12# 0.0097 {hydrogen sulfite}  (#12# isozyme CA XV <253>) <253>\\nKI\\t#12# 0.0095 {sulfate}  (#12# isozyme CA XV <253>) <253>\\nKI\\t#12# 0.0106 {benzene-1,4-diol}  (#12# at pH 7.5 and 20C <201>) <201>\\nKI\\t#12# 0.0072 {salicylic acid}  (#12# at pH 7.5 and 20C <201>) <201>\\nKI\\t#12# 0.0113 {3,5-difluorophenol}  (#12# at pH 7.5 and 20C <201>) <201>\\nKI\\t#12# 0.0071 {NCO-}  (#12# pH 7.0, 10C, double mutant R94H/E92Q <106>) \\n\\t<106>\\nKI\\t#12# 0.0094 {cyanide}  (#12# isozyme CA XV <253>) <253>\\nKI\\t#12# 0.0853 {chloride}  (#12# isozyme CA XV <253>) <253>\\nKI\\t#12# 0.104 {bromide}  (#12# isozyme CA XV <253>) <253>\\nKI\\t#12# 0.385 {benzene-1,3-diol}  (#12# at pH 7.5 and 20C <201>) <201>\\nKI\\t#12# 0.000072 {azetazolamide}  <215>\\nKI\\t#12# 0.000066 {EMD 486019}  (#12# isozyme carbonic anhydrase XIII \\n\\t<202>) <202>\\nKI\\t#12# 0.0105 {phenol}  (#12# at pH 7.5 and 20C <201>) <201>\\nKI\\t#12# 12.1 {NO3-}  (#12# pH 7.0, 10C, double mutant R94H/E92Q <106>) \\n\\t<106>\\nKI\\t#12# 21.4 {I-}  (#12# pH 7.0, 10C, double mutant R94H/E92Q <106>) <106>\\nKI\\t#12# 222 {Cl-}  (#12# pH 7.0, 10C, double mutant R94H/E92Q <106>) <106>\\nKI\\t#12# 0.212 {2,5-difluorophenol}  (#12# at pH 7.5 and 20C <201>) <201>\\nKI\\t#12# 0.00105 {667-coumate}  (#12# isozyme carbonic anhydrase XIII \\n\\t<202>) <202>\\nKI\\t#12# 0.00233 {clioquinol}  (#12# at pH 7.5 and 20C <201>) <201>\\nKI\\t#12# 0.434 {4-Hydroxybenzonitrile}  (#12# at pH 7.5 and 20C <201>) \\n\\t<201>\\nKI\\t#12# 0.335 {4-Aminophenol}  (#12# at pH 7.5 and 20C <201>) <201>\\nKI\\t#12# 0.0678 {phenylboronic acid}  (#12# isozyme CA XV <253>) <253>\\nKI\\t#12# 0.0374 {sulfamide}  (#12# isozyme CA XV <253>) <253>\\nKI\\t#12# 0.00923 {paracetamol}  (#12# at pH 7.5 and 20C <201>) <201>\\nKI\\t#12# 0.00932 {4-hydroxybenzoic acid}  (#12# at pH 7.5 and 20C <201>) \\n\\t<201>\\nKI\\t#12# 0.0544 {fluoride}  (#12# isozyme CA XV <253>) <253>\\nKI\\t#12# 0.288 {Iodide}  (#12# isozyme CA XV <253>) <253>\\nKI\\t#12# 0.0276 {cyanide}  (#12# isozyme CA XV <253>) <253>\\nKI\\t#12# 0.0687 {nitrate}  (#12# isozyme CA XV <253>) <253>\\nKI\\t#12# 0.0612 {nitrite}  (#12# isozyme CA XV <253>) <253>\\nKI\\t#12# 0.0986 {sulfamate}  (#12# isozyme CA XV <253>) <253>\\nKI\\t#12# 0.0682 {phenylarsonic acid}  (#12# isozyme CA XV <253>) <253>\\nKI\\t#12,133# 0.000017 {acetazolamide}  (#133# pH 7.5, 25C, mCA XIII <118>; \\n\\t#133# isoenzyme mCA XIII <169>; #12# isozyme carbonic anhydrase XIII \\n\\t<202>) <118,169,202>\\nKI\\t#12,133# 0.000047 {topiramate}  (#133# isoenzyme mCA XIII <169>; #12# \\n\\tisozyme carbonic anhydrase XIII <202>) <169,202>\\nKI\\t#12,172# 0.000072 {acetazolamide}  (#172# at 20C and pH 7.5 <230>; \\n\\t#12# at pH 7.5 and 20C <201>) <201,230>\\nKI\\t#120# 0.00025 \\n\\t{(S)-4-(3,4-dibenzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#120# inhibition of isozyme hCA IX, pH 9.0, 40C <369>) <369>\\nKI\\t#120# 0.001 \\n\\t{3-chloro-4H-[1,2,3]thiadiazolo[3,4-a]benzimidazole-7-sulfonamide}  \\n\\t(#120# isoform CA IX, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4 <274>) <274>\\nKI\\t#120# 1 {2-coumaric acid}  (#120# above, pH 8.3, 22C <386>) <386>\\nKI\\t#120# 0.000003 \\n\\t{4-[2-[([[4-\\n\\t(aminosulfonyl)phenyl]amino]carbonothioyl)\\n\\tamino]ethyl]benzenesulfonamide}  (#120# pH 7.5, catalytic domain of \\n\\tcloned isoenzyme <141>) <141>\\nKI\\t#120# 0.0021 {4H-[1,2,3]thiadiazolo[3,4-a]benzimidazole-7-sulfonamide}  \\n\\t(#120# isoform CA I, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4 <274>) <274>\\nKI\\t#120# 0.00004 {4-[[(phenylsulfonyl)amino]methyl]benzenesulfonamide}  \\n\\t(#120# pH 7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#120# 0.000024 {6-trifluoromethyl-4-aminobenzene-1,3-disulfonamide}  \\n\\t(#120# isoenzyme hCA IX <169>) <169>\\nKI\\t#120# 0.000024 {acetazolamide}  (#120# recombinant CA IX catalytic \\n\\tdomain expressed in Sf9 cells, in the absence of Zn2+ <223>) <223>\\nKI\\t#120# 0.00017 \\n\\t{(S)-1-[4-(benzenesulfonyl)-2-benzylpiperazin-1-yl]ethan-1-one}  (#120# \\n\\tinhibition of isozyme hCA IX, pH 9.0, 40C <369>) <369>\\nKI\\t#120# 0.0096 {H2NSO2NH2}  (#120# isoenzyme hCA IX <168>) <168>\\nKI\\t#120# 0.000033 {4-aminoethylbenzenesulfonamide}  (#120# pH 7.5, \\n\\tcatalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#120# 0.000033 \\n\\t{3-chloro-4H-[1,2,3]thiadiazolo[3,4-a]benzimidazole-7-sulfonamide}  \\n\\t(#120# isoform CA II, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4 <274>) <274>\\nKI\\t#120# 0.0092 {H2NSO3H}  (#120# isoenzyme hCA IX <168>) <168>\\nKI\\t#120# 0.021 \\n\\t{(2E)-2-[(4-hydroxy-3-methylphenyl)methylidene]-N-(5-sulfanylidene-4,\\n\\t5-dihydro-1,3,4-thiadiazol-2-yl)hydrazine-1-carboxamide}  (#120# pH \\n\\t8.3, 22C <386>) <386>\\nKI\\t#120# 0.115 {catechol}  (#120# pH 8.3, 22C <386>) <386>\\nKI\\t#120# 0.00036 \\n\\t{(R)-4-[4-(benzenesulfonyl)-3-benzylpiperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#120# inhibition of isozyme hCA IX, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#120# 0.000013 \\n\\t{N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)furan-2-carboxamide}  (#120# pH \\n\\t7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#120# 0.0000002 {4-phenylbenzene-1-sulfonamide}  (#120# pH and \\n\\ttemperature not specified in the publication <365>) <365>\\nKI\\t#120# 0.0000002 {4-(3-quinolinyl)benzene-1-sulfonamide}  (#120# pH and \\n\\ttemperature not specified in the publication <365>) <365>\\nKI\\t#120# 0.000018 {4-[2-[(anilinocarbonyl)amino]ethyl]benzenesulfonamide}  \\n\\t(#120# pH 7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#120# 0.00002 {4-(2-methylphenyl)benzene-1-sulfonamide}  (#120# pH and \\n\\ttemperature not specified in the publication <365>) <365>\\nKI\\t#120# 0.000014 {3-[(anilinocarbonyl)amino]benzenesulfonamide}  (#120# \\n\\tpH 7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#120# 0.000021 \\n\\t{4-[2-[(anilinocarbonothioyl)amino]ethyl]benzenesulfonamide}  (#120# pH \\n\\t7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#120# 0.000021 \\n\\t{5-[[(4-bromophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#120# pH 7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#120# 0.00072 {4H-[1,2,3]thiadiazolo[3,4-a]benzimidazole-7-sulfonamide} \\n\\t (#120# isoform CA IX, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4 <274>) \\n\\t<274>\\nKI\\t#120# 0.000026 \\n\\t{4-[[(anilinocarbonothioyl)amino]methyl]benzenesulfonamide}  (#120# pH \\n\\t7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#120# 0.00015 \\n\\t{3-(methylsulfanyl)-4H-[1,2,3]thiadiazolo[3,\\n\\t4-a]benzimidazole-7-sulfonamide}  (#120# isoform CA I, in 10 mM HEPES \\n\\t(pH 7.5), 0.1 M Na2SO4 <274>) <274>\\nKI\\t#120# 0.00046 {4H-[1,2,3]thiadiazolo[3,4-a]benzimidazole-7-sulfonamide} \\n\\t (#120# isoform CA II, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4 <274>) \\n\\t<274>\\nKI\\t#120# 0.000025 {[[(eta5-C5H4)-C(CH3)=N-N(H)-C6H4-4-SO2NH2]]re(CO)3}  \\n\\t(#120# isoform CA IX, at pH 7.5 and 25C <437>) <437>\\nKI\\t#120# 0.00042 {Furosemide}  (#120# isoenzyme hCA IX <169>) <169>\\nKI\\t#120# 0.000016 \\n\\t{5-[[(4-nitrophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#120# pH 7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#120# 0.000012 \\n\\t{4-(aminosulfonyl)-N-[2-[4-(aminosulfonyl)phenyl]ethyl]benzamide}  \\n\\t(#120# pH 7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#120# 0.000039 {6-chloro-4-amino-benzene-1,3-disulfonamide}  (#120# \\n\\tisoenzyme hCA IX <169>) <169>\\nKI\\t#120# 0.000039 \\n\\t{2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide}  (#120# \\n\\tisoenzyme hCA IX <172>) <172>\\nKI\\t#120# 0.00049 \\n\\t{N-(1-(2-hydroxyphenylamino)-4-methyl-1-oxopentan-2-ylcarbamothioyl) \\n\\tbenzamide}  (#120# above, pH 8.3, 22C <386>) <386>\\nKI\\t#120# 0.000027 \\n\\t{N-[5-(aminosulfonyl)-3-methyl-1,3,\\n\\t4-thiadiazol-2(3H)-ylidene]acetamide}  (#120# isoenzyme hCA IX <169>) \\n\\t<169>\\nKI\\t#120# 0.00066 \\n\\t{3-chloro-4H-[1,2,3]thiadiazolo[3,4-a]benzimidazole-7-sulfonamide}  \\n\\t(#120# isoform CA I, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4 <274>) <274>\\nKI\\t#120# 0.000009 {acetazolamide}  (#120# recombinant CA IX catalytic \\n\\tdomain expressed in Sf9 cells, in the presence of 0.05 mM Zn2+ <223>) \\n\\t<223>\\nKI\\t#120# 0.000009 \\n\\t{3-morpholin-4-yl-4H-[1,2,3]thiadiazolo[3,\\n\\t4-a]benzimidazole-7-sulfonamide}  (#120# isoform CA II, in 10 mM HEPES \\n\\t(pH 7.5), 0.1 M Na2SO4 <274>) <274>\\nKI\\t#120# 0.000055 {acetazolamide}  (#120# recombinant extracellular domain \\n\\tof CA IX expressed in Sf9 cells, in the presence of 0.05 mM Mg2+ <223>) \\n\\t<223>\\nKI\\t#120# 0.00021 \\n\\t{3-morpholin-4-yl-4H-[1,2,3]thiadiazolo[3,\\n\\t4-a]benzimidazole-7-sulfonamide}  (#120# isoform CA I, in 10 mM HEPES \\n\\t(pH 7.5), 0.1 M Na2SO4 <274>; #120# isoform CA IX, in 10 mM HEPES (pH \\n\\t7.5), 0.1 M Na2SO4 <274>) <274>\\nKI\\t#120# 0.000073 {N-[4-(aminosulfonyl)phenyl]benzamide}  (#120# pH 7.5, \\n\\tcatalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#120# 0.000057 \\n\\t{3-(methylsulfanyl)-4H-[1,2,3]thiadiazolo[3,\\n\\t4-a]benzimidazole-7-sulfonamide}  (#120# isoform CA II, in 10 mM HEPES \\n\\t(pH 7.5), 0.1 M Na2SO4 <274>) <274>\\nKI\\t#120# 0.000043 {sulthiame}  (#120# isoenzyme hCA IX <170>) <170>\\nKI\\t#120# 0.000052 {4-[(phenylsulfonyl)amino]benzenesulfonamide}  (#120# pH \\n\\t7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#120# 0.000052 \\n\\t{6-methyl-4-(methylamino)-5,6-dihydro-4H-thieno[2,\\n\\t3-b]thiopyran-2-sulfonamide 7,7-dioxide}  (#120# isoenzyme hCA IX \\n\\t<169>) <169>\\nKI\\t#120# 0.00051 \\n\\t{3-(methylsulfanyl)-4H-[1,2,3]thiadiazolo[3,\\n\\t4-a]benzimidazole-7-sulfonamide}  (#120# isoform CA IX, in 10 mM HEPES \\n\\t(pH 7.5), 0.1 M Na2SO4 <274>) <274>\\nKI\\t#120# 0.000139 {N-[4-(aminosulfonyl)phenyl]-2-methylpropanamide}  \\n\\t(#120# pH 7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#120# 0.000205 {(R)- \\n\\t4-(4-benzoyl-2-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#120# inhibition of isozyme hCA IX, pH 9.0, 40C <369>) <369>\\nKI\\t#120# 0.0000279 \\n\\t{(S)-4-(2,4-dibenzylpiperazine-1-carbonyl)benzenesulfonamide}  (#120# \\n\\tinhibition of isozyme hCA IX, pH 9.0, 40C <369>) <369>\\nKI\\t#120# 0.000146 \\n\\t{4-[(anilinocarbonyl)amino]-6-chlorobenzene-1,3-disulfonamide}  (#120# \\n\\tpH 7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#120# 0.0000837 \\n\\t{(S)-4-(4-acetyl-3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#120# inhibition of isozyme hCA IX, pH 9.0, 40C <369>) <369>\\nKI\\t#120# 0.000037 \\n\\t{4-[(acetyloxy)amino]-N-[4-(aminosulfonyl)phenyl]benzenesulfonamide}  \\n\\t(#120# pH 7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#120# 0.000037 \\n\\t{2-(3-methoxypropyl)-4-(methylamino)-3,4-dihydro-2H-thieno[3,2-e][1,\\n\\t2]thiazine-6-sulfonamide 1,1-dioxide}  (#120# isoenzyme hCA IX <169>) \\n\\t<169>\\nKI\\t#120# 0.000037 {brinzolamide}  (#120# isoenzyme hCA IX catalytic domain \\n\\t<171>) <171>\\nKI\\t#120# 0.000181 \\n\\t{(R)-4-(3-benzyl-4-methanesulfonylpiperazine-1-carbonyl)benzene-1-\\n\\tsulfonamide}  (#120# inhibition of isozyme hCA IX, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#120# 0.000191 \\n\\t{(S)-4-[2-benzyl-4-(2-phenylacetyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#120# inhibition of isozyme hCA IX, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#120# 0.0000021 {[[(eta5-C5H4)-CH=N-N(H)-C6H4-4-SO2NH2]]Mn(CO)3}  \\n\\t(#120# isoform CA IX, at pH 7.5 and 25C <437>) <437>\\nKI\\t#120# 0.000056 {acetazolamide}  (#120# recombinant extracellular domain \\n\\tof CA IX expressed in Sf9 cells, in the presence of 0.05 mM Co2+ <223>) \\n\\t<223>\\nKI\\t#120# 0.00152 \\n\\t{(R)-4-[3-benzyl-4-(2-phenylacetyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#120# inhibition of isozyme hCA IX, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#120# 0.000106 {N-[4-(aminosulfonyl)phenyl]propanamide}  (#120# pH 7.5, \\n\\tcatalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#120# 0.000177 \\n\\t{(S)-4-[3-benzyl-4-(2-phenylacetyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#120# inhibition of isozyme hCA IX, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#120# 0.000079 {N-[4-(aminosulfonyl)phenyl]pentanamide}  (#120# pH 7.5, \\n\\tcatalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#120# 0.000099 {4-(3-formylphenyl)benzene-1-sulfonamide}  (#120# pH and \\n\\ttemperature not specified in the publication <365>) <365>\\nKI\\t#120# 0.000093 \\n\\t{4-[(2S)-2-benzylpiperazine-1-carbonyl]benzene-1-sulfonamide}  (#120# \\n\\tinhibition of isozyme hCA IX, pH 9.0, 40C <369>) <369>\\nKI\\t#120# 0.000103 {homosulfanilamide}  (#120# pH 7.5, catalytic domain of \\n\\tcloned isoenzyme <141>) <141>\\nKI\\t#120# 0.000113 {4-[(methylsulfonyl)amino]benzenesulfonamide}  (#120# pH \\n\\t7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#120# 0.000083 {N-[4-(aminosulfonyl)phenyl]butanamide}  (#120# pH 7.5, \\n\\tcatalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#120# 0.000083 \\n\\t{(S)-4-[4-(benzenesulfonyl)-2-benzylpiperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#120# inhibition of isozyme hCA IX, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#120# 0.000232 \\n\\t{(R)-4-(2-benzyl-4-methanesulfonylpiperazine-1-carbonyl)benzene-1-\\n\\tsulfonamide}  (#120# inhibition of isozyme hCA IX, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#120# 0.000104 \\n\\t{(S)-4-[2-benzyl-4-(4-sulfamoylbenzoyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#120# inhibition of isozyme hCA IX, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#120# 0.000135 {N-[4-(aminosulfonyl)phenyl]acetamide}  (#120# pH 7.5, \\n\\tcatalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#120# 0.000225 \\n\\t{(S)-4-(3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  (#120# \\n\\tinhibition of isozyme hCA IX, pH 9.0, 40C <369>) <369>\\nKI\\t#120# 0.000112 {N-[4-(aminosulfonyl)phenyl]-2,2,2-trifluoroacetamide}  \\n\\t(#120# pH 7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#120# 0.000166 \\n\\t{(R)-4-[2-benzyl-4-(2-phenylacetyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#120# inhibition of isozyme hCA IX, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#120# 0.000136 {N-[4-(aminosulfonyl)phenyl]-2,2-dimethylpropanamide}  \\n\\t(#120# pH 7.5, catalytic domain of cloned isoenzyme <141>) <141>\\nKI\\t#120# 0.000294 {sulfanilamide}  (#120# pH 7.5, catalytic domain of \\n\\tcloned isoenzyme <141>) <141>\\nKI\\t#120# 0.000481 \\n\\t{N-(1-(2-hydroxyphenylamino)-3-methyl-1-oxobutan-2-\\n\\tylcarbamothioyl)benzamide}  (#120# above, pH 8.3, 22C <386>) <386>\\nKI\\t#120# 0.000245 \\n\\t{(S)-4-(4-benzoyl-3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#120# inhibition of isozyme hCA IX, pH 9.0, 40C <369>) <369>\\nKI\\t#120# 0.000367 {hydrochlorothiazide}  (#120# isoenzyme hCA IX <169>) \\n\\t<169>\\nKI\\t#120# 0.000198 \\n\\t{(R)-1-[4-(benzenesulfonyl)-2-benzylpiperazin-1-yl]ethan-1-one}  (#120# \\n\\tinhibition of isozyme hCA IX, pH 9.0, 40C <369>) <369>\\nKI\\t#120# 0.00405 {curcumin}  (#120# pH 8.3, 22C <386>) <386>\\nKI\\t#120# 0.000865 {N-hydroxysulfamide}  (#120# isoenzyme hCA IX <168>) \\n\\t<168>\\nKI\\t#120# 0.002325 {acetazolamide}  (#120# recombinant extracellular domain \\n\\tof CA IX expressed in Sf9 cells, in the presence of 0.05 mM Zn2+ <223>) \\n\\t<223>\\nKI\\t#120# 0.00715 \\n\\t{(2E)-2-[(4-hydroxyphenyl)methylidene]-N-(5-sulfanylidene-4,5-dihydro-1,\\n\\t3,4-thiadiazol-2-yl)hydrazine-1-carboxamide}  (#120# pH 8.3, 22C \\n\\t<386>) <386>\\nKI\\t#120# 0.000227 {(S)- \\n\\t4-(4-benzoyl-2-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#120# inhibition of isozyme hCA IX, pH 9.0, 40C <369>) <369>\\nKI\\t#120# 0.0000419 {[[(eta5-C5H4)-C(CH3)=N-N(H)-C6H4-4-SO2NH2]]FeCp}  \\n\\t(#120# isoform CA IX, at pH 7.5 and 25C <437>) <437>\\nKI\\t#120# 0.0697 {resorcinol}  (#120# pH 8.3, 22C <386>) <386>\\nKI\\t#120# 0.00787 {salicylic acid}  (#120# pH 8.3, 22C <386>) <386>\\nKI\\t#120# 0.00982 {dobutamine}  (#120# pH 8.3, 22C <386>) <386>\\nKI\\t#120# 0.002639 \\n\\t{(R)-4-(2,4-dibenzylpiperazine-1-carbonyl)benzenesulfonamide}  (#120# \\n\\tinhibition of isozyme hCA IX, pH 9.0, 40C <369>) <369>\\nKI\\t#120# 0.001442 \\n\\t{4-[(2R)-2-benzylpiperazine-1-carbonyl]benzene-1-sulfonamide}  (#120# \\n\\tinhibition of isozyme hCA IX, pH 9.0, 40C <369>) <369>\\nKI\\t#120# 0.001432 {(S)- \\n\\t4-(2-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#120# inhibition of isozyme hCA IX, pH 9.0, 40C <369>) <369>\\nKI\\t#120# 0.001207 {(R)- \\n\\t4-(2-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#120# inhibition of isozyme hCA IX, pH 9.0, 40C <369>) <369>\\nKI\\t#120# 0.001207 \\n\\t{(R)-4-[4-(benzenesulfonyl)-2-benzylpiperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#120# inhibition of isozyme hCA IX, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#120# 0.0000316 \\n\\t{(S)-4-(2-benzyl-4-methanesulfonylpiperazine-1-carbonyl)benzene-1-\\n\\tsulfonamide}  (#120# inhibition of isozyme hCA IX, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#120# 0.001718 \\n\\t{(R)-4-(3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  (#120# \\n\\tinhibition of isozyme hCA IX, pH 9.0, 40C <369>) <369>\\nKI\\t#120# 0.0004185 \\n\\t{(R)-4-(3,4-dibenzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#120# inhibition of isozyme hCA IX, pH 9.0, 40C <369>) <369>\\nKI\\t#120# 0.001716 \\n\\t{(S)-4-(3-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#120# inhibition of isozyme hCA IX, pH 9.0, 40C <369>) <369>\\nKI\\t#120# 0.001811 \\n\\t{(R)-4-(3-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#120# inhibition of isozyme hCA IX, pH 9.0, 40C <369>) <369>\\nKI\\t#120# 0.0002273 \\n\\t{(R)-4-(4-acetyl-3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#120# inhibition of isozyme hCA IX, pH 9.0, 40C <369>) <369>\\nKI\\t#120# 0.001659 \\n\\t{(R)-4-(4-benzoyl-3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#120# inhibition of isozyme hCA IX, pH 9.0, 40C <369>) <369>\\nKI\\t#120# 0.0000744 \\n\\t{(S)-4-(3-benzyl-4-methanesulfonylpiperazine-1-carbonyl)benzene-1-\\n\\tsulfonamide}  (#120# inhibition of isozyme hCA IX, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#120# 0.001589 \\n\\t{(S)-4-[4-(benzenesulfonyl)-3-benzylpiperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#120# inhibition of isozyme hCA IX, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#120# 0.002626 \\n\\t{(R)-17(R)-4-[2-benzyl-4-(4-sulfamoylbenzoyl)piperazine-1-\\n\\tcarbonyl]benzene-1-sulfonamide}  (#120# inhibition of isozyme hCA IX, \\n\\tpH 9.0, 40C <369>) <369>\\nKI\\t#120# 0.0005798 {[[(eta5-C5H4)-CH=N-N(H)-C6H4-4-SO2NH2]]re(CO)3}  \\n\\t(#120# isoform CA IX, at pH 7.5 and 25C <437>) <437>\\nKI\\t#120# 0.0000499 {[[(eta5-C5H4)-CH=N-N(H)-C6H4-4-SO2NH2]]FeCp}  (#120# \\n\\tisoform CA IX, at pH 7.5 and 25C <437>) <437>\\nKI\\t#120# 0.0002213 {[[(eta5-C5H4)-C(CH3)=N-N(H)-C6H4-4-SO2NH2]]Mn(CO)3}  \\n\\t(#120# isoform CA IX, at pH 7.5 and 25C <437>) <437>\\nKI\\t#120# 0.0000258 {acetazolamide}  (#120# isoform CA I, at pH 7.5 and \\n\\t25C <437>) <437>\\nKI\\t#120,124# 0.000102 \\n\\t{2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide}  (#120# \\n\\tisoenzyme hCA IX <171>; #124# isozyme CA IX, in 10 mM HEPES (pH 7.5) \\n\\tand 0.1 M Na2SO4 <229>) <171,229>\\nKI\\t#120,133# 0.00005 {ethoxzolamide}  (#120# pH 7.5, catalytic domain of \\n\\tcloned isoenzyme <141>; #133# isoenzyme mCA XIII <171>) <141,171>\\nKI\\t#122# 0.00005 {acetazolamide}  (#122# pH 9.0, 30C, inhibition of \\n\\testerase activity with 4-nitrophenyl acetate <308>) <308>\\nKI\\t#122# 0.000026 {acetazolamide}  (#122# pH 7.4, 30C, inhibition of CO2 \\n\\thydration activity <308>) <308>\\nKI\\t#123# 0.1 {benzenesulfonamide}  (#123# pH 7.5, 20C <343>) <343>\\nKI\\t#123# 0.1 {4-(aminomethyl)benzenesulfonamide}  (#123# pH 7.5, 20C \\n\\t<343>) <343>\\nKI\\t#123# 0.1 {4-(2-aminoethyl)benzenesulfonamide}  (#123# pH 7.5, 20C \\n\\t<343>) <343>\\nKI\\t#123# 0.1 {4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide}  (#123# \\n\\tpH 7.5, 20C <343>) <343>\\nKI\\t#123# 0.1 \\n\\t{[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,\\n\\t5-b:4\\',5\\'-d]pyran-3a-yl]methyl sulfamate}  (#123# pH 7.5, 20C <343>) \\n\\t<343>\\nKI\\t#123# 0.1 {1-(1,2-benzoxazol-3-yl)methanesulfonamide}  (#123# pH 7.5, \\n\\t20C <343>) <343>\\nKI\\t#123# 0.1 \\n\\t{2-methoxy-N-[(1-methylpyrrolidin-2-yl)methyl]-5-sulfamoylbenzamide}  \\n\\t(#123# pH 7.5, 20C <343>) <343>\\nKI\\t#123# 0.1 {1,2-benzothiazol-3(2H)-one 1,1-dioxide}  (#123# pH 7.5, 20C \\n\\t<343>) <343>\\nKI\\t#123# 0.0000279 \\n\\t{(2Z)-2-benzylidene-N-(5-sulfanyl-1,3,\\n\\t4-thiadiazol-2-yl)hydrazinecarboxamide}  (#123# pH 7.5, 20C <343>) \\n\\t<343>\\nKI\\t#123# 0.000074 \\n\\t{N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide}  (#123# pH \\n\\t7.5, 20C <343>) <343>\\nKI\\t#123# 0.0000951 \\n\\t{5-([(4-aminophenyl)sulfonyl]amino)-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#123# pH 7.5, 20C <343>) <343>\\nKI\\t#123# 0.0156 {4-amino-3-fluorobenzenesulfonamide}  (#123# pH 7.5, 20C \\n\\t<343>) <343>\\nKI\\t#123# 0.0000953 \\n\\t{(2Z)-2-(4-chlorobenzylidene)-N-(5-sulfanyl-1,3,\\n\\t4-thiadiazol-2-yl)hydrazinecarboxamide}  (#123# pH 7.5, 20C <343>) \\n\\t<343>\\nKI\\t#123# 0.000389 {4-(hydroxymethyl)benzenesulfonamide}  (#123# pH 7.5, \\n\\t20C <343>) <343>\\nKI\\t#123# 0.000189 {4,5-dichlorobenzene-1,3-disulfonamide}  (#123# pH 7.5, \\n\\t20C <343>) <343>\\nKI\\t#123# 0.000764 \\n\\t{(4R)-4-(ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,\\n\\t2]thiazine-6-sulfonamide 1,1-dioxide}  (#123# pH 7.5, 20C <343>) <343>\\nKI\\t#123# 0.000152 \\n\\t{(2Z)-2-(5-bromo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-N-(5-sulfanyl-1,\\n\\t3,4-thiadiazol-2-yl)hydrazinecarboxamide}  (#123# pH 7.5, 20C <343>) \\n\\t<343>\\nKI\\t#123# 0.000136 {4-amino-N-(4-sulfamoylphenyl)benzenesulfonamide}  \\n\\t(#123# pH 7.5, 20C <343>) <343>\\nKI\\t#123# 0.000236 \\n\\t{5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide}  (#123# pH \\n\\t7.5, 20C <343>) <343>\\nKI\\t#123# 0.0000184 \\n\\t{(2Z)-2-(4-chlorobenzylidene)-N-(5-sulfanyl-1,3,\\n\\t4-thiadiazol-2-yl)hydrazinecarboxamide}  (#123# pH 7.5, 20C <343>) \\n\\t<343>\\nKI\\t#123# 0.0000195 \\n\\t{(2Z)-2-(4-methylpentan-2-ylidene)-N-(5-sulfanyl-1,3,\\n\\t4-thiadiazol-2-yl)hydrazinecarboxamide}  (#123# pH 7.5, 20C <343>) \\n\\t<343>\\nKI\\t#123# 0.0000734 \\n\\t{4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide}  (#123# pH \\n\\t7.5, 20C <343>) <343>\\nKI\\t#123# 0.0000331 \\n\\t{(2Z)-2-(4-fluorobenzylidene)-N-(5-sulfanyl-1,3,\\n\\t4-thiadiazol-2-yl)hydrazinecarboxamide}  (#123# pH 7.5, 20C <343>) \\n\\t<343>\\nKI\\t#123# 0.000705 \\n\\t{4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide}  (#123# pH \\n\\t7.5, 20C <343>) <343>\\nKI\\t#123# 0.0000401 \\n\\t{(2Z)-2-(3-methoxybenzylidene)-N-(5-sulfanyl-1,3,\\n\\t4-thiadiazol-2-yl)hydrazinecarboxamide}  (#123# pH 7.5, 20C <343>) \\n\\t<343>\\nKI\\t#123# 0.000338 \\n\\t{4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-\\n\\tyl]benzenesulfonamide}  (#123# pH 7.5, 20C <343>) <343>\\nKI\\t#123# 0.000227 {4-(2-hydroxyethyl)benzenesulfonamide}  (#123# pH 7.5, \\n\\t20C <343>) <343>\\nKI\\t#123# 0.00596 {3-aminobenzenesulfonamide}  (#123# pH 7.5, 20C <343>) \\n\\t<343>\\nKI\\t#123# 0.0000502 \\n\\t{2-(hydroxymethyl)-4-nitro-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]benzenesulfonamide}  (#123# pH 7.5, 20C <343>) \\n\\t<343>\\nKI\\t#123# 0.0000502 \\n\\t{6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide \\n\\t1,1-dioxide}  (#123# pH 7.5, 20C <343>) <343>\\nKI\\t#123# 0.000834 {4-(1,1-dioxido-1,2-thiazinan-2-yl)benzenesulfonamide}  \\n\\t(#123# pH 7.5, 20C <343>) <343>\\nKI\\t#123# 0.00891 {benzene-1,3-disulfonamide}  (#123# pH 7.5, 20C <343>) \\n\\t<343>\\nKI\\t#123# 0.0000134 \\n\\t{(2Z)-2-(3-bromobenzylidene)-N-(5-sulfanyl-1,3,\\n\\t4-thiadiazol-2-yl)hydrazinecarboxamide}  (#123# pH 7.5, 20C <343>) \\n\\t<343>\\nKI\\t#123# 0.0000917 {acetazolamide}  (#123# pH 7.5, 20C <343>) <343>\\nKI\\t#123# 0.0000917 {N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide}  \\n\\t(#123# pH 7.5, 20C <343>) <343>\\nKI\\t#123# 0.009251 {4-Aminobenzenesulfonamide}  (#123# pH 7.5, 20C <343>) \\n\\t<343>\\nKI\\t#123# 0.009058 {4-amino-3-chlorobenzenesulfonamide}  (#123# pH 7.5, \\n\\t20C <343>) <343>\\nKI\\t#123# 0.00842 {4-amino-3-bromobenzenesulfonamide}  (#123# pH 7.5, 20C \\n\\t<343>) <343>\\nKI\\t#123# 0.009135 {3,5-dichloro-2-hydroxybenzenesulfonamide}  (#123# pH \\n\\t7.5, 20C <343>) <343>\\nKI\\t#123# 0.009083 {4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide}  \\n\\t(#123# pH 7.5, 20C <343>) <343>\\nKI\\t#123# 0.004819 {4-amino-6-chlorobenzene-1,3-disulfonamide}  (#123# pH \\n\\t7.5, 20C <343>) <343>\\nKI\\t#123# 0.000584 {5-amino-1,3,4-thiadiazole-2-sulfonamide}  (#123# pH \\n\\t7.5, 20C <343>) <343>\\nKI\\t#123# 0.000433 \\n\\t{5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide}  (#123# \\n\\tpH 7.5, 20C <343>) <343>\\nKI\\t#123# 0.000927 {4-hydroxybenzenesulfonamide}  (#123# pH 7.5, 20C \\n\\t<343>) <343>\\nKI\\t#123# 0.0000596 {4-sulfamoylbenzoic acid}  (#123# pH 7.5, 20C <343>) \\n\\t<343>\\nKI\\t#123# 0.0000871 {4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide}  \\n\\t(#123# pH 7.5, 20C <343>) <343>\\nKI\\t#123# 0.0000871 \\n\\t{N-[(2E)-3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide} \\n\\t (#123# pH 7.5, 20C <343>) <343>\\nKI\\t#123# 0.0000515 {6-ethoxy-1,3-benzothiazole-2-sulfonamide}  (#123# pH \\n\\t7.5, 20C <343>) <343>\\nKI\\t#123# 0.000806 \\n\\t{(4S,6S)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,\\n\\t3-b]thiopyran-2-sulfonamide 7,7-dioxide}  (#123# pH 7.5, 20C <343>) \\n\\t<343>\\nKI\\t#123# 0.000316 {N-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide}  \\n\\t(#123# pH 7.5, 20C <343>) <343>\\nKI\\t#123# 0.000144 \\n\\t{(2Z)-2-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)-N-(5-sulfanyl-1,3,\\n\\t4-thiadiazol-2-yl)hydrazinecarboxamide}  (#123# pH 7.5, 20C <343>) \\n\\t<343>\\nKI\\t#124# 0.2 {acetazolamide}  (#124# isozyme CA III, in 10 mM HEPES (pH \\n\\t7.5) and 0.1 M Na2SO4 <229>; #124# isozyme carbonic anhydrase III \\n\\t<202>) <202,229>\\nKI\\t#124# 0.0093 {2-oxo-2H-chromene-3-carboxylic acid}  (#124# isoform CA \\n\\tI, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0093 {6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylic acid}  \\n\\t(#124# isoform CA I, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.0087 {6-methoxy-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA VA, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0087 {2-oxo-2H-thiochromene-3-carboxylic acid}  (#124# isoform \\n\\tCA XII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.015 {7-butoxy-2H-chromen-2-one}  (#124# isoform CA VII, in 20 m \\n\\tM HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0045 {7-butoxy-2H-chromen-2-one}  (#124# isoform CA IX, in 20 m \\n\\tM HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.011 {ethoxzolamide}  (#124# isozyme CA III, in 10 mM HEPES (pH \\n\\t7.5) and 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.000002 {chlorzolamide}  (#124# wild type carbonic anhydrase II \\n\\t<196>) <196>\\nKI\\t#124# 0.000002 {4-(3-formylphenyl)benzene-1-sulfonamide}  (#124# pH and \\n\\ttemperature not specified in the publication <365>) <365>\\nKI\\t#124# 0.000002 \\n\\t{(S)-4-[2-benzyl-4-(4-sulfamoylbenzoyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#124# inhibition of isozyme hCA II, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#124# 0.0013 {8-methoxy-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA I, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.000075 {6-chloro-4-amino-benzene-1,3-disulfonamide}  (#124# \\n\\tisoenzyme hCA II <169>) <169>\\nKI\\t#124# 0.00001 {topiramate}  (#124# isoenzyme hCA II <169>; #124# \\n\\tisozyme carbonic anhydrase II <202>; #124# isoform CA II, in 10-20 mM \\n\\tHEPES (pH 7.5) or Tris (pH 8.3) as buffers and 20 mM Na2SO4 or 20 mM \\n\\tNaClO4, at 22C <278>) <169,202,278>\\nKI\\t#124# 0.00001 {indapamide}  (#124# isozyme CA XII, in 10 mM HEPES (pH \\n\\t7.5) and 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.0031 {2H-chromen-2-one}  (#124# isoform CA I, in 20 m M HEPES \\n\\t(pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0031 \\n\\t{1-[(2-oxo-2H-chromen-6-yl)methyl]-3,5,\\n\\t7-triaza-1-azoniatricyclo[3.3.1.13,7]decane}  (#124# isoform CA VII, in \\n\\t20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0029 {ethyl 6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylate}  \\n\\t(#124# isoform CA VB, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.001 {8-methoxy-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA XIV, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.003 {ethyl 6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylate}  \\n\\t(#124# isoform CA VA, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.0075 {2-oxo-2H-thiochromene-3-carboxylic acid}  (#124# isoform \\n\\tCA VB, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.5 {6-((1S)-hydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one}  \\n\\t(#124# Ki above 0.5 mM, isoform CA III, in 20m M HEPES (pH 7.5), and 20 \\n\\tmM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.5 {2H-chromen-2-one}  (#124# IC50 above 0.5 mM, isoform CA III, \\n\\tin 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>; #124# IC50 \\n\\tabove 0.5 mM, isoform CA IX, in 20 m M HEPES (pH 7.5), and 20 mM \\n\\tNa2SO4, at 22C <279>; #124# IC50 above 0.5 mM, isoform CA VA, in 20 m \\n\\tM HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>; #124# IC50 above 0.5 \\n\\tmM, isoform CA VB, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>; #124# IC50 above 0.5 mM, isoform CA VI, in 20 m M HEPES (pH \\n\\t7.5), and 20 mM Na2SO4, at 22C <279>; #124# IC50 above 0.5 mM, isoform \\n\\tCA VII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>; \\n\\t#124# IC50 above 0.5 mM, isoform CA XII, in 20 m M HEPES (pH 7.5), and \\n\\t20 mM Na2SO4, at 22C <279>; #124# IC50 above 0.5 mM, isoform CA XIV, \\n\\tin 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.5 {7-methoxy-2-oxo-2H-chromene-4-carboxylic acid}  (#124# IC50 \\n\\tabove 0.5 mM, isoform CA IX, in 20 m M HEPES (pH 7.5), and 20 mM \\n\\tNa2SO4, at 22C <279>; #124# IC50 above 0.5 mM, isoform CA VA, in 20 m \\n\\tM HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>; #124# IC50 above 0.5 \\n\\tmM, isoform CA VB, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>; #124# IC50 above 0.5 mM, isoform CA VI, in 20 m M HEPES (pH \\n\\t7.5), and 20 mM Na2SO4, at 22C <279>; #124# IC50 above 0.5 mM, isoform \\n\\tCA XII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>; \\n\\t#124# isoform CA III, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.5 {7-methoxy-2H-chromen-2-one}  (#124# IC50 above 0.5 mM, \\n\\tisoform CA IX, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>; #124# IC50 above 0.5 mM, isoform CA VA, in 20 m M HEPES (pH \\n\\t7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.7 {667-coumate}  (#124# isozyme carbonic anhydrase III <202>) \\n\\t<202>\\nKI\\t#124# 0.7 {methazolamide}  (#124# isozyme CA III, in 10 mM HEPES (pH \\n\\t7.5) and 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.009 {2-oxo-2H-thiochromene-3-carboxylic acid}  (#124# isoform \\n\\tCA III, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.009 {7-butoxy-2H-chromen-2-one}  (#124# isoform CA VA, in 20 m \\n\\tM HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.009 {2-oxo-2H-chromene-3-carboxylic acid}  (#124# isoform CA \\n\\tVA, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>; #124# \\n\\tisoform CA XII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.009 {6-methoxy-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA XII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0000048 \\n\\t{(R)-4-[2-benzyl-4-(2-phenylacetyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#124# inhibition of isozyme hCA II, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#124# 1 \\n\\t{N-(1-(2-hydroxyphenylamino)-3-methyl-1-oxobutan-2-\\n\\tylcarbamothioyl)benzamide}  (#124# above, pH 8.3, 22C <386>) <386>\\nKI\\t#124# 1 \\n\\t{N-(1-(2-hydroxyphenylamino)-4-methyl-1-oxopentan-2-ylcarbamothioyl) \\n\\tbenzamide}  (#124# above, pH 8.3, 22C <386>) <386>\\nKI\\t#124# 0.0082 \\n\\t{1-[(2-oxo-2H-chromen-6-yl)methyl]-3,5,\\n\\t7-triaza-1-azoniatricyclo[3.3.1.13,7]decane}  (#124# isoform CA VA, in \\n\\t20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0082 {6-(hydroxymethyl)-2H-chromen-2-one}  (#124# isoform CA \\n\\tXII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0177 \\n\\t{6-((1S)-hydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one}  (#124# \\n\\tisoform CA VB, in 20m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0038 \\n\\t{6-((1S)-hydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one}  (#124# \\n\\tisoform CA IV, in 20m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0038 {2-oxo-2H-chromene-3-carboxylic acid}  (#124# isoform CA \\n\\tIV, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0054 {6-(aminomethyl)-2H-chromen-2-one}  (#124# isoform CA IV, \\n\\tin 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0066 {6-methoxy-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA I, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>; #124# isoform CA IX, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, \\n\\tat 22C <279>) <279>\\nKI\\t#124# 0.0066 {7-(2-phenylethoxy)-2H-chromen-2-one}  (#124# isoform CA \\n\\tVA, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0066 {6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylic acid}  \\n\\t(#124# isoform CA VII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.0066 {tert-butyl \\n\\t(2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-\\n\\toxoethyl)carbamate}  (#124# pH 7.5, 22C <387>) <387>\\nKI\\t#124# 0.00008 {ethoxzolamide}  (#124# isoenzyme hCA II <171>) <171>\\nKI\\t#124# 0.002 {7-(benzyloxy)-2H-chromen-2-one}  (#124# isoform CA XIV, in \\n\\t20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0062 {methazolamide}  (#124# isozyme CA IV, in 10 mM HEPES (pH \\n\\t7.5) and 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.0062 {2-oxo-2H-thiochromene-3-carboxylic acid}  (#124# isoform \\n\\tCA II, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0062 \\n\\t{1-[(2-oxo-2H-chromen-6-yl)methyl]-3,5,\\n\\t7-triaza-1-azoniatricyclo[3.3.1.13,7]decane}  (#124# isoform CA IV, in \\n\\t20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0062 {6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylic acid}  \\n\\t(#124# isoform CA VA, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.0062 {6-(aminomethyl)-2H-chromen-2-one}  (#124# isoform CA VB, \\n\\tin 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.029 {7-ethoxy-2H-chromen-2-one}  (#124# Ki above 0.5 mM, \\n\\tisoform CA III, in 20m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0145 {6-methoxy-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA III, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0001 {2-oxo-2H-thiochromene-3-carboxylic acid}  (#124# isoform \\n\\tCA I, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0015 {ethyl 6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylate}  \\n\\t(#124# isoform CA VI, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.000024 {667-coumate}  (#124# isozyme carbonic anhydrase IV \\n\\t<202>) <202>\\nKI\\t#124# 1.11 {Chlorthalidone}  (#124# isozyme CA III, in 10 mM HEPES (pH \\n\\t7.5) and 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.0088 {2-oxo-2H-thiochromene-3-carboxylic acid}  (#124# isoform \\n\\tCA VI, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0088 {ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate}  (#124# \\n\\tisoform CA XII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0088 {6-(aminomethyl)-2H-chromen-2-one}  (#124# isoform CA XIV, \\n\\tin 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0055 {7-(2-phenylethoxy)-2H-chromen-2-one}  (#124# isoform CA \\n\\tXIV, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.000001 {chlorzolamide}  (#124# wild type carbonic anhydrase IX \\n\\t<196>) <196>\\nKI\\t#124# 0.000001 {ethoxzolamide}  (#124# Ki less than 0.000001 mM wild \\n\\ttype carbonic anhydrase II <196>) <196>\\nKI\\t#124# 0.39 {H2NSO3H}  (#124# isoenzyme hCA II <168>) <168>\\nKI\\t#124# 0.042 {ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate}  (#124# \\n\\tisoform CA VI, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.00054 {pyrogallol}  (#124# pH 8.3, 22C <386>) <386>\\nKI\\t#124# 0.0024 {ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate}  (#124# \\n\\tisoform CA I, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.008 {ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate}  (#124# \\n\\tisoform CA VB, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0051 {6-(hydroxymethyl)-2H-chromen-2-one}  (#124# isoform CA \\n\\tIV, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0051 {2-oxo-2H-chromene-3-carboxylic acid}  (#124# isoform CA \\n\\tVII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.74 {EMD 486019}  (#124# isozyme carbonic anhydrase III <202>) \\n\\t<202>\\nKI\\t#124# 0.0085 {7-(2-phenylethoxy)-2H-chromen-2-one}  (#124# isoform CA \\n\\tVI, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0085 {7-butoxy-2H-chromen-2-one}  (#124# isoform CA XII, in 20 \\n\\tm M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.005 {7-propoxy-2H-chromen-2-one}  (#124# isoform CA XIV, in 20m \\n\\tM HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.005 {(S)-benzyl \\n\\t(1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxopropan-2-\\n\\tyl)carbamate}  (#124# pH 7.5, 22C <387>) <387>\\nKI\\t#124# 0.0033 {7-propoxy-2H-chromen-2-one}  (#124# isoform CA IX, in 20m \\n\\tM HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0033 {ethyl 6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylate}  \\n\\t(#124# isoform CA I, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.35 \\n\\t{1-cyclopentyl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide} \\n\\t (#124# isoform CA II, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#124# 0.35 \\n\\t{(2E)-2-[(4-hydroxy-3-methylphenyl)methylidene]-N-(5-sulfanylidene-4,\\n\\t5-dihydro-1,3,4-thiadiazol-2-yl)hydrazine-1-carboxamide}  (#124# pH \\n\\t8.3, 22C <386>) <386>\\nKI\\t#124# 0.0016 {7-ethoxy-2H-chromen-2-one}  (#124# isoform CA IX, in 20m \\n\\tM HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.000023 {667-coumate}  (#124# isozyme carbonic anhydrase VII \\n\\t<202>) <202>\\nKI\\t#124# 0.000023 {Chlorthalidone}  (#124# isozyme CA IX, in 10 mM HEPES \\n\\t(pH 7.5) and 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.0000012 {4-(2-methylphenyl)benzene-1-sulfonamide}  (#124# pH \\n\\tand temperature not specified in the publication <365>) <365>\\nKI\\t#124# 0.0096 {ethyl 6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylate}  \\n\\t(#124# isoform CA III, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.0096 {6-(aminomethyl)-2H-chromen-2-one}  (#124# isoform CA III, \\n\\tin 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0096 {ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate}  (#124# \\n\\tisoform CA XIV, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0032 \\n\\t{1-[(2-oxo-2H-chromen-6-yl)methyl]-3,5,\\n\\t7-triaza-1-azoniatricyclo[3.3.1.13,7]decane}  (#124# isoform CA II, in \\n\\t20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>; #124# isoform \\n\\tCA XII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0000062 \\n\\t{(R)-4-[4-(benzenesulfonyl)-3-benzylpiperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#124# inhibition of isozyme hCA II, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#124# 0.0000118 {methazolamide}  (#124# wild type carbonic anhydrase II \\n\\t<196>) <196>\\nKI\\t#124# 0.0043 {6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylic acid}  \\n\\t(#124# isoform CA IV, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.0043 {7-butoxy-2H-chromen-2-one}  (#124# isoform CA XIV, in 20 \\n\\tm M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0092 {2H-chromen-2-one}  (#124# isoform CA II, in 20 m M HEPES \\n\\t(pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0092 {6-(aminomethyl)-2H-chromen-2-one}  (#124# isoform CA VI, \\n\\tin 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0092 {2-coumaric acid}  (#124# pH 8.3, 22C <386>) <386>\\nKI\\t#124# 0.23 {indapamide}  (#124# isozyme CA III, in 10 mM HEPES (pH 7.5) \\n\\tand 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.0000125 \\n\\t{2-((2-chloro-6-fluorobenzyl)thio)-6-(3,4-dichlorophenyl)imidazo \\n\\t[2,1-b][1,3,4]thiadiazole}  (#124# pH not specified in the publication, \\n\\ttemperature not specified in the publication <413>) <413>\\nKI\\t#124# 0.0134 {6-methyl-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA III, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0102 {Benzyl \\n\\t(2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-\\n\\toxoethyl)carbamate}  (#124# pH 7.5, 22C <387>) <387>\\nKI\\t#124# 0.0076 {7-(benzyloxy)-2H-chromen-2-one}  (#124# isoform CA VA, in \\n\\t20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0076 {6-methoxy-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA VB, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0246 {7-propoxy-2H-chromen-2-one}  (#124# isoform CA IV, in 20m \\n\\tM HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.013 {6-methyl-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA XIV, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.037 {7-butoxy-2H-chromen-2-one}  (#124# isoform CA I, in 20 m M \\n\\tHEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0065 {methyl 6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylate} \\n\\t (#124# isoform CA IV, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.0065 {8-methoxy-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA VB, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0065 {ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate}  (#124# \\n\\tisoform CA IX, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0074 {8-methoxy-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA IX, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0074 {2-oxo-2H-chromene-3-carboxylic acid}  (#124# isoform CA \\n\\tXIV, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0074 {2-oxo-2H-thiochromene-3-carboxylic acid}  (#124# isoform \\n\\tCA XIV, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 1.13 {H2NSO2NH2}  (#124# isoenzyme hCA II <168>) <168>\\nKI\\t#124# 0.0227 {7-ethoxy-2H-chromen-2-one}  (#124# isoform CA IV, in 20m \\n\\tM HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0058 {7-ethoxy-2H-chromen-2-one}  (#124# isoform CA VI, in 20m \\n\\tM HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0058 {8-methoxy-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA IV, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0059 {7-methoxy-2H-chromen-2-one}  (#124# isoform CA I, in 20 m \\n\\tM HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0036 {EMD 486019}  (#124# isozyme carbonic anhydrase I <202>) \\n\\t<202>\\nKI\\t#124# 0.0017 {7-(benzyloxy)-2H-chromen-2-one}  (#124# isoform CA IX, in \\n\\t20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.000013 {EMD 486019}  (#124# isozyme carbonic anhydrase XII \\n\\t<202>; #124# isozyme carbonic anhydrase XIV <202>) <202>\\nKI\\t#124# 0.000015 \\n\\t{(S)-4-(4-benzoyl-3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#124# inhibition of isozyme hCA II, pH 9.0, 40C <369>) <369>\\nKI\\t#124# 0.0097 {6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylic acid}  \\n\\t(#124# isoform CA III, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.0097 {6-(aminomethyl)-2H-chromen-2-one}  (#124# isoform CA VA, \\n\\tin 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0097 {7-(benzyloxy)-2H-chromen-2-one}  (#124# isoform CA VI, in \\n\\t20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0097 {7-methoxy-2H-chromen-2-one}  (#124# isoform CA XIV, in 20 \\n\\tm M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.78 {topiramate}  (#124# isozyme carbonic anhydrase III <202>) \\n\\t<202>\\nKI\\t#124# 0.0037 {6-(aminomethyl)-2H-chromen-2-one}  (#124# isoform CA II, \\n\\tin 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.00000023 {indapamide}  (#124# isozyme CA VII, in 10 mM HEPES \\n\\t(pH 7.5) and 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.000018 {EMD 486019}  (#124# isozyme carbonic anhydrase IX \\n\\t<202>; #124# isozyme carbonic anhydrase VB <202>) <202>\\nKI\\t#124# 0.000019 {EMD 486019}  (#124# isozyme carbonic anhydrase VII \\n\\t<202>) <202>\\nKI\\t#124# 0.000098 {methyl \\n\\t6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylate}  (#124# isoform CA \\n\\tI, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.000006 \\n\\t{(S)-4-(3-benzyl-4-methanesulfonylpiperazine-1-carbonyl)benzene-1-\\n\\tsulfonamide}  (#124# inhibition of isozyme hCA II, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#124# 0.000007 {sulthiame}  (#124# isoenzyme hCA II <170>) <170>\\nKI\\t#124# 0.000007 {benzolamide}  (#124# wild type carbonic anhydrase II \\n\\t<196>) <196>\\nKI\\t#124# 0.000007 \\n\\t{(R)-4-[3-benzyl-4-(2-phenylacetyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#124# inhibition of isozyme hCA II, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#124# 0.000014 \\n\\t{N-[5-(aminosulfonyl)-3-methyl-1,3,\\n\\t4-thiadiazol-2(3H)-ylidene]acetamide}  (#124# isoenzyme hCA II <169>) \\n\\t<169>\\nKI\\t#124# 0.000014 {EMD 486019}  (#124# isozyme carbonic anhydrase II \\n\\t<202>) <202>\\nKI\\t#124# 0.000021 {667-coumate}  (#124# isozyme carbonic anhydrase II \\n\\t<202>) <202>\\nKI\\t#124# 0.000065 {Furosemide}  (#124# isoenzyme hCA II <169>) <169>\\nKI\\t#124# 0.000065 \\n\\t{2,2\\'-(1-(4-nitrophenyl)ethane-1,\\n\\t1-diyl)bis(sulfanediyl)bis(N-(pyridin-2-yl)acetamide)}  (#124# pH 8, \\n\\t25C <431>) <431>\\nKI\\t#124# 0.00072 {667-coumate}  (#124# isozyme carbonic anhydrase VB \\n\\t<202>) <202>\\nKI\\t#124# 0.0000075 \\n\\t{(R)-4-(2-benzyl-4-methanesulfonylpiperazine-1-carbonyl)benzene-1-\\n\\tsulfonamide}  (#124# inhibition of isozyme hCA II, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#124# 0.0083 {6-methyl-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tIC50 above 0.5 mM, isoform CA VB, in 20 m M HEPES (pH 7.5), and 20 mM \\n\\tNa2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0083 {7-(benzyloxy)-2H-chromen-2-one}  (#124# isoform CA XII, \\n\\tin 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.000032 {methyl \\n\\t6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylate}  (#124# isoform CA \\n\\tII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.000032 \\n\\t{(R)-4-(4-acetyl-3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#124# inhibition of isozyme hCA II, pH 9.0, 40C <369>) <369>\\nKI\\t#124# 0.0095 {ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate}  (#124# \\n\\tisoform CA VA, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0095 {methyl 6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylate} \\n\\t (#124# isoform CA VI, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.0095 {6-(hydroxymethyl)-2H-chromen-2-one}  (#124# isoform CA \\n\\tXIV, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0118 {7-(benzyloxy)-2H-chromen-2-one}  (#124# isoform CA VII, \\n\\tin 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0124 {7-ethoxy-2H-chromen-2-one}  (#124# isoform CA II, in 20m \\n\\tM HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0402 {7-(benzyloxy)-2H-chromen-2-one}  (#124# isoform CA III, \\n\\tin 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0084 {2-oxo-2H-thiochromene-3-carboxylic acid}  (#124# isoform \\n\\tCA VA, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0084 {methyl 6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylate} \\n\\t (#124# isoform CA VA, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.0084 {ethyl 6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylate}  \\n\\t(#124# isoform CA XII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.0084 {6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylic acid}  \\n\\t(#124# isoform CA XIV, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.00412 {N\\'\\',N\\'\\'\\'-bis[(E)-(2-chlorophenyl)methylidene]carbonic \\n\\tdihydrazide}  (#124# pH 7.4, 25C <396>) <396>\\nKI\\t#124# 0.000045 {ethyl \\n\\t6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylate}  (#124# isoform CA \\n\\tVII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.000045 {methyl \\n\\t6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylate}  (#124# isoform CA \\n\\tIX, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0072 {7-ethoxy-2H-chromen-2-one}  (#124# isoform CA VII, in 20m \\n\\tM HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0091 {2-oxo-2H-chromene-3-carboxylic acid}  (#124# isoform CA \\n\\tIII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0091 {ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate}  (#124# \\n\\tisoform CA III, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0091 {7-methoxy-2H-chromen-2-one}  (#124# isoform CA VII, in 20 \\n\\tm M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0086 {7-propoxy-2H-chromen-2-one}  (#124# isoform CA XII, in \\n\\t20m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0086 {6-methyl-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA VA, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>; #124# isoform CA XII, in 20 m M HEPES (pH 7.5), and 20 mM \\n\\tNa2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0086 {6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylic acid}  \\n\\t(#124# isoform CA VB, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.0086 {8-methoxy-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA XII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0086 {6-(aminomethyl)-2H-chromen-2-one}  (#124# isoform CA XII, \\n\\tin 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0185 {7-(2-phenylethoxy)-2H-chromen-2-one}  (#124# isoform CA \\n\\tIV, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0049 {6-methoxy-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA IV, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>; #124# isoform CA VII, in 20 m M HEPES (pH 7.5), and 20 mM \\n\\tNa2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0098 {6-(hydroxymethyl)-2H-chromen-2-one}  (#124# isoform CA \\n\\tIII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0000084 {methyl \\n\\t2-[(4-amino-3-iodo-1H-pyrazolo[3,\\n\\t4-d]pyrimidin-1-yl)methyl]-3-nitrobenzoate}  (#124# pH not specified in \\n\\tthe publication, temperature not specified in the publication <410>) \\n\\t<410>\\nKI\\t#124# 0.0041 \\n\\t{1-[(2-oxo-2H-chromen-6-yl)methyl]-3,5,\\n\\t7-triaza-1-azoniatricyclo[3.3.1.13,7]decane}  (#124# isoform CA I, in \\n\\t20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0041 {2-oxo-2H-thiochromene-3-carboxylic acid}  (#124# isoform \\n\\tCA IV, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0077 {7-propoxy-2H-chromen-2-one}  (#124# isoform CA VII, in \\n\\t20m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0077 {6-methyl-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA IX, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0077 \\n\\t{1-[(2-oxo-2H-chromen-6-yl)methyl]-3,5,\\n\\t7-triaza-1-azoniatricyclo[3.3.1.13,7]decane}  (#124# isoform CA XIV, in \\n\\t20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0077 {resorcinol}  (#124# pH 7.4, temperature not specified in \\n\\tthe publication <392>; #124# pH 8.3, 22C <386>) <386,392>\\nKI\\t#124# 0.0078 \\n\\t{6-((1S)-hydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one}  (#124# \\n\\tisoform CA XIV, in 20m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0078 {6-(hydroxymethyl)-2H-chromen-2-one}  (#124# isoform CA I, \\n\\tin 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0078 {7-methoxy-2H-chromen-2-one}  (#124# isoform CA IV, in 20 \\n\\tm M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0099 {6-(hydroxymethyl)-2H-chromen-2-one}  (#124# isoform CA \\n\\tVI, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0099 {catechol}  (#124# pH 7.4, temperature not specified in \\n\\tthe publication <392>; #124# pH 8.3, 22C <386>) <386,392>\\nKI\\t#124# 0.0057 {ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate}  (#124# \\n\\tisoform CA IV, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.00082 \\n\\t{1-n-butyl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#124# isoform CA II, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#124# 0.161 {7-methoxy-2H-chromen-2-one}  (#124# isoform CA III, in 20 \\n\\tm M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.00065 \\n\\t{1-cyclohexyl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#124# isoform CA II, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#124# 0.0073 {7-ethoxy-2H-chromen-2-one}  (#124# isoform CA VA, in 20m \\n\\tM HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0073 {2-oxo-2H-thiochromene-3-carboxylic acid}  (#124# isoform \\n\\tCA VII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0073 {methyl 6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylate} \\n\\t (#124# isoform CA VII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>; #124# isoform CA XIV, in 20 m M HEPES (pH 7.5), and 20 mM \\n\\tNa2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0068 {6-methyl-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA I, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0068 {2-oxo-2H-chromene-3-carboxylic acid}  (#124# isoform CA \\n\\tVB, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0068 {6-(hydroxymethyl)-2H-chromen-2-one}  (#124# isoform CA \\n\\tVB, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0081 {7-propoxy-2H-chromen-2-one}  (#124# isoform CA VA, in 20m \\n\\tM HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0081 \\n\\t{1-[(2-oxo-2H-chromen-6-yl)methyl]-3,5,\\n\\t7-triaza-1-azoniatricyclo[3.3.1.13,7]decane}  (#124# isoform CA III, in \\n\\t20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0081 {6-(aminomethyl)-2H-chromen-2-one}  (#124# isoform CA VII, \\n\\tin 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0039 {7-(2-phenylethoxy)-2H-chromen-2-one}  (#124# isoform CA \\n\\tIX, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0046 {ethyl 6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylate}  \\n\\t(#124# isoform CA XIV, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.00413 {Chlorthalidone}  (#124# isozyme CA XIV, in 10 mM HEPES \\n\\t(pH 7.5) and 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.0067 {6-(aminomethyl)-2H-chromen-2-one}  (#124# isoform CA IX, \\n\\tin 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0000017 {[[(eta5-C5H4)-CH=N-N(H)-C6H4-4-SO2NH2]]FeCp}  (#124# \\n\\tisoform CA II, at pH 7.5 and 25C <437>) <437>\\nKI\\t#124# 0.000048 {ethyl \\n\\t6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylate}  (#124# isoform CA \\n\\tIV, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.000048 \\n\\t{1-[(2-oxo-2H-chromen-6-yl)methyl]-3,5,\\n\\t7-triaza-1-azoniatricyclo[3.3.1.13,7]decane}  (#124# isoform CA IX, in \\n\\t20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0000028 {Chlorthalidone}  (#124# isozyme CA VII, in 10 mM HEPES \\n\\t(pH 7.5) and 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.000012 {667-coumate}  (#124# isozyme carbonic anhydrase XII \\n\\t<202>) <202>\\nKI\\t#124# 0.00178 \\n\\t{N\\'\\',N\\'\\'\\'-bis[(E)-(2,6-dichlorophenyl)methylidene]carbonic dihydrazide} \\n\\t (#124# pH 7.4, 25C <396>) <396>\\nKI\\t#124# 0.0069 {6-(hydroxymethyl)-2H-chromen-2-one}  (#124# isoform CA \\n\\tVII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0089 {methyl 6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylate} \\n\\t (#124# isoform CA III, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.0089 {6-(hydroxymethyl)-2H-chromen-2-one}  (#124# isoform CA \\n\\tVA, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0089 \\n\\t{1-[(2-oxo-2H-chromen-6-yl)methyl]-3,5,\\n\\t7-triaza-1-azoniatricyclo[3.3.1.13,7]decane}  (#124# isoform CA VI, in \\n\\t20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0089 {6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylic acid}  \\n\\t(#124# isoform CA XII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.096 {6-((1S)-hydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one} \\n\\t (#124# isoform CA VA, in 20m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.0056 {6-methyl-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA IV, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0056 \\n\\t{1-[(2-oxo-2H-chromen-6-yl)methyl]-3,5,\\n\\t7-triaza-1-azoniatricyclo[3.3.1.13,7]decane}  (#124# isoform CA VB, in \\n\\t20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0056 {6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylic acid}  \\n\\t(#124# isoform CA IX, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.0056 {methyl 6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylate} \\n\\t (#124# isoform CA XII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.00089 {indapamide}  (#124# isozyme CA VA, in 10 mM HEPES (pH \\n\\t7.5) and 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.000009 \\n\\t{6-methyl-4-(methylamino)-5,6-dihydro-4H-thieno[2,\\n\\t3-b]thiopyran-2-sulfonamide 7,7-dioxide}  (#124# isoenzyme hCA II \\n\\t<169>) <169>\\nKI\\t#124# 0.000009 {Chlorthalidone}  (#124# isozyme CA VB, in 10 mM HEPES \\n\\t(pH 7.5) and 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.0071 {6-(aminomethyl)-2H-chromen-2-one}  (#124# isoform CA I, \\n\\tin 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0071 {methyl 6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylate} \\n\\t (#124# isoform CA VB, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.0071 {salicylic acid}  (#124# pH 8.3, 22C <386>) <386>\\nKI\\t#124# 0.0094 {8-methoxy-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA VA, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0094 {7-methoxy-2-oxo-2H-chromene-4-carboxylic acid}  (#124# \\n\\tisoform CA VII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.235 \\n\\t{6,7-dimethoxy-1-isopropyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#124# isoform CA II, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#124# 0.0313 {2-oxo-2H-chromene-3-carboxylic acid}  (#124# isoform CA \\n\\tVI, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.196 {Chlorthalidone}  (#124# isozyme CA IV, in 10 mM HEPES (pH \\n\\t7.5) and 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.0047 {7-ethoxy-2H-chromen-2-one}  (#124# isoform CA XII, in 20m \\n\\tM HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>; #124# isoform CA \\n\\tXIV, in 20m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0047 {2-oxo-2H-chromene-3-carboxylic acid}  (#124# isoform CA \\n\\tIX, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0000097 {[[(eta5-C5H4)-C(CH3)=N-N(H)-C6H4-4-SO2NH2]]re(CO)3}  \\n\\t(#124# isoform CA II, at pH 7.5 and 25C <437>) <437>\\nKI\\t#124# 0.000036 {indapamide}  (#124# isozyme CA IX, in 10 mM HEPES (pH \\n\\t7.5) and 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.000105 \\n\\t{1-cyclopropyl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide} \\n\\t (#124# isoform CA II, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#124# 0.145 {7-propoxy-2H-chromen-2-one}  (#124# isoform CA II, in 20m \\n\\tM HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.00029 {hydrochlorothiazide}  (#124# isoenzyme hCA II <169>) \\n\\t<169>\\nKI\\t#124# 0.00048 {dobutamin}  (#124# pH 8.3, 22C <386>) <386>\\nKI\\t#124# 0.0052 {7-(2-phenylethoxy)-2H-chromen-2-one}  (#124# isoform CA \\n\\tXII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.00038 {curcumin}  (#124# pH 8.3, 22C <386>) <386>\\nKI\\t#124# 0.000063 {6-trifluoromethyl-4-aminobenzene-1,3-disulfonamide}  \\n\\t(#124# isoenzyme hCA II <169>) <169>\\nKI\\t#124# 0.0061 {8-methoxy-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA VII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0000079 \\n\\t{(R)-17(R)-4-[2-benzyl-4-(4-sulfamoylbenzoyl)piperazine-1-\\n\\tcarbonyl]benzene-1-sulfonamide}  (#124# inhibition of isozyme hCA II, \\n\\tpH 9.0, 40C <369>) <369>\\nKI\\t#124# 0.0296 {6-methyl-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA VII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.00000038 {topiramate}  (#124# isozyme carbonic anhydrase XII \\n\\t<202>) <202>\\nKI\\t#124# 0.0000008 {4-phenylbenzene-1-sulfonamide}  (#124# pH and \\n\\ttemperature not specified in the publication <365>) <365>\\nKI\\t#124# 0.0000077 \\n\\t{(S)-1-[4-(benzenesulfonyl)-2-benzylpiperazin-1-yl]ethan-1-one}  (#124# \\n\\tinhibition of isozyme hCA II, pH 9.0, 40C <369>) <369>\\nKI\\t#124# 0.0000081 \\n\\t{4-[(2R)-2-benzylpiperazine-1-carbonyl]benzene-1-sulfonamide}  (#124# \\n\\tinhibition of isozyme hCA II, pH 9.0, 40C <369>) <369>\\nKI\\t#124# 0.0000082 {[[(eta5-C5H4)-CH=N-N(H)-C6H4-4-SO2NH2]]Mn(CO)3}  \\n\\t(#124# isoform CA II, at pH 7.5 and 25C <437>) <437>\\nKI\\t#124# 0.000195 \\n\\t{1-(3-cyanobenzyl)-3-(2,4,6-trimethyl-benzyl)-3H-benzoimidazol-1-ium \\n\\tbromide}  (#124# pH not specified in the publication, temperature not \\n\\tspecified in the publication <409>) <409>\\nKI\\t#124# 0.000078 \\n\\t{6-((1S)-hydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one}  (#124# \\n\\tisoform CA I, in 20m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) \\n\\t<279>\\nKI\\t#124# 0.0000279 {1-benzyl-3-(N-methyphthalimide)-2-methylimidazolium \\n\\tbromide}  (#124# pH not specified in the publication, temperature not \\n\\tspecified in the publication <417>) <417>\\nKI\\t#124# 0.0000072 \\n\\t{2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide}  (#124# \\n\\tisoenzyme hCA II <171>; #124# isozyme CA II, in 10 mM HEPES (pH 7.5) \\n\\tand 0.1 M Na2SO4 <229>) <171,229>\\nKI\\t#124# 0.000138 {Chlorthalidone}  (#124# isozyme CA II, in 10 mM HEPES \\n\\t(pH 7.5) and 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.000138 {indapamide}  (#124# isozyme CA I, in 10 mM HEPES (pH \\n\\t7.5) and 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.0000076 {(R)- \\n\\t4-(2-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#124# inhibition of isozyme hCA II, pH 9.0, 40C <369>) <369>\\nKI\\t#124# 0.0000076 \\n\\t{(R)-4-[4-(benzenesulfonyl)-2-benzylpiperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#124# inhibition of isozyme hCA II, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#124# 0.0000076 \\n\\t{(S)-4-(4-acetyl-3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#124# inhibition of isozyme hCA II, pH 9.0, 40C <369>) <369>\\nKI\\t#124# 0.000034 {667-coumate}  (#124# isozyme carbonic anhydrase IX \\n\\t<202>) <202>\\nKI\\t#124# 0.000066 {7-methoxy-2H-chromen-2-one}  (#124# isoform CA II, in \\n\\t20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0000045 {Chlorthalidone}  (#124# isozyme CA XII, in 10 mM HEPES \\n\\t(pH 7.5) and 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.0000025 {4-(3-quinolinyl)benzene-1-sulfonamide}  (#124# pH and \\n\\ttemperature not specified in the publication <365>) <365>\\nKI\\t#124# 0.000047 {2-oxo-2H-thiochromene-3-carboxylic acid}  (#124# \\n\\tisoform CA IX, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.000047 {ethyl \\n\\t6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylate}  (#124# isoform CA \\n\\tIX, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.000059 \\n\\t{6-((1S)-hydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one}  (#124# \\n\\tisoform CA II, in 20m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.000096 {acetazolamide}  (#124# pH not specified in the \\n\\tpublication, temperature not specified in the publication <417>) <417>\\nKI\\t#124# 0.000062 {methazolamide}  (#124# isozyme CA VB, in 10 mM HEPES \\n\\t(pH 7.5) and 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.0159 {7-(2-phenylethoxy)-2H-chromen-2-one}  (#124# isoform CA \\n\\tVII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0153 {6-methoxy-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA II, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.00495 {indapamide}  (#124# isozyme CA XIV, in 10 mM HEPES (pH \\n\\t7.5) and 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.00235 {N\\'\\',N\\'\\'\\'-bis[(E)-(4-nitrophenyl)methylidene]carbonic \\n\\tdihydrazide}  (#124# pH 7.4, 25C <396>) <396>\\nKI\\t#124# 0.0256 {8-methoxy-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA VI, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0445 {6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylic acid}  \\n\\t(#124# isoform CA II, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.0000951 \\n\\t{(S)-4-[4-(benzenesulfonyl)-3-benzylpiperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#124# inhibition of isozyme hCA II, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#124# 0.0000267 \\n\\t{(E)-3-iodo-1-styryl-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  (#124# pH \\n\\tnot specified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nKI\\t#124# 0.000038 {4,5-dichloro-benzene-1,3-disulfonamide}  (#124# \\n\\tisoenzyme hCA II, i.e. daranide <169>) <169>\\nKI\\t#124# 0.000099 {7-methoxy-2-oxo-2H-chromene-4-carboxylic acid}  (#124# \\n\\tisoform CA II, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.000093 {6-(hydroxymethyl)-2H-chromen-2-one}  (#124# isoform CA \\n\\tIX, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0105 {6-methoxy-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA VI, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0000093 {[[(eta5-C5H4)-C(CH3)=N-N(H)-C6H4-4-SO2NH2]]FeCp}  \\n\\t(#124# isoform CA II, at pH 7.5 and 25C <437>) <437>\\nKI\\t#124# 0.0000083 \\n\\t{(S)-4-(3,4-dibenzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#124# inhibition of isozyme hCA II, pH 9.0, 40C <369>) <369>\\nKI\\t#124# 0.0000099 {1-butyl-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  \\n\\t(#124# pH not specified in the publication, temperature not specified \\n\\tin the publication <410>) <410>\\nKI\\t#124# 0.0156 {6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylic acid}  \\n\\t(#124# isoform CA VI, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.00000057 {acetazolamide}  (#124# isozyme carbonic anhydrase XII \\n\\t<202>) <202>\\nKI\\t#124# 0.0000169 \\n\\t{2-((2,6-dichlorobenzyl)thio)-6-phenyl-5-(pyrrolidin-1-ylmethyl) \\n\\timidazo[2,1-b][1,3,4]-thiadiazole}  (#124# pH not specified in the \\n\\tpublication, temperature not specified in the publication <413>) <413>\\nKI\\t#124# 0.0000656 \\n\\t{2,2\\'-(1-phenylethane-1,1-diyl)bis(sulfanediyl)bis(N-benzylacetamide)}  \\n\\t(#124# pH 8, 25C <431>) <431>\\nKI\\t#124# 0.000174 \\n\\t{1-(3-cyanobenzyl)-3-(2,3,5,\\n\\t6-tetramethyl-benzyl)-3H-benzoimidazol-1-ium bromide}  (#124# pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <409>) <409>\\nKI\\t#124# 0.000153 {acetazolamide}  (#124# pH 8, 25C <431>) <431>\\nKI\\t#124# 0.000225 \\n\\t{1-(3-cyanobenzyl)-3-(2-methylbenzyl)-3H-benzoimidazol-1-ium bromide}  \\n\\t(#124# pH not specified in the publication, temperature not specified \\n\\tin the publication <409>) <409>\\nKI\\t#124# 0.0694 {7-(2-phenylethoxy)-2H-chromen-2-one}  (#124# isoform CA \\n\\tVB, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0157 \\n\\t{6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#124# isoform CA II, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#124# 0.0231 {7-propoxy-2H-chromen-2-one}  (#124# isoform CA I, in 20m \\n\\tM HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.000112 \\n\\t{1-(3-cyanobenzyl)-3-(2,3,4,5,\\n\\t6-pentamethyl-benzyl)-3H-benzoimidazol-1-ium bromide}  (#124# pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <409>) <409>\\nKI\\t#124# 0.0000356 \\n\\t{4-((2-((2,6-dichlorobenzyl)thio)-6-phenylimidazo[2,1-b][1,3,4] \\n\\tthiadiazol-5-yl)methyl)-morpholine}  (#124# pH not specified in the \\n\\tpublication, temperature not specified in the publication <413>) <413>\\nKI\\t#124# 0.0000068 \\n\\t{(S)-4-[2-benzyl-4-(2-phenylacetyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#124# inhibition of isozyme hCA II, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#124# 0.0171 {8-methoxy-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA III, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0317 {6-methyl-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA VI, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.000348 {Chlorthalidone}  (#124# isozyme CA I, in 10 mM HEPES \\n\\t(pH 7.5) and 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.0269 {7-(benzyloxy)-2H-chromen-2-one}  (#124# isoform CA I, in \\n\\t20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0447 {2-oxo-2H-chromene-3-carboxylic acid}  (#124# isoform CA \\n\\tII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0203 {ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate}  (#124# \\n\\tisoform CA VII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0000245 \\n\\t{3-iodo-1-(4-methoxybenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  \\n\\t(#124# pH not specified in the publication, temperature not specified \\n\\tin the publication <410>) <410>\\nKI\\t#124# 0.000176 \\n\\t{(R)-4-(2,4-dibenzylpiperazine-1-carbonyl)benzenesulfonamide}  (#124# \\n\\tinhibition of isozyme hCA II, pH 9.0, 40C <369>) <369>\\nKI\\t#124# 0.00345 {667-coumate}  (#124# isozyme carbonic anhydrase I <202>) \\n\\t<202>\\nKI\\t#124# 0.0000054 \\n\\t{(R)-4-(3-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#124# inhibition of isozyme hCA II, pH 9.0, 40C <369>) <369>\\nKI\\t#124# 0.0000112 {[[(eta5-C5H4)-C(CH3)=N-N(H)-C6H4-4-SO2NH2]]Mn(CO)3}  \\n\\t(#124# isoform CA II, at pH 7.5 and 25C <437>) <437>\\nKI\\t#124# 0.0622 {2H-chromen-2-one}  (#124# isoform CA IV, in 20 m M HEPES \\n\\t(pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0486 \\n\\t{6-((1S)-hydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one}  (#124# \\n\\tisoform CA XII, in 20m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0486 {7-methoxy-2H-chromen-2-one}  (#124# isoform CA VB, in 20 \\n\\tm M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.000161 \\n\\t{(S)-4-(2-benzyl-4-methanesulfonylpiperazine-1-carbonyl)benzene-1-\\n\\tsulfonamide}  (#124# inhibition of isozyme hCA II, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#124# 0.000682 {EMD 486019}  (#124# isozyme carbonic anhydrase VA \\n\\t<202>) <202>\\nKI\\t#124# 0.000236 {5,6-diamino-1,3-dimethyluracil}  (#124# pH 7.4, \\n\\ttemperature not specified in the publication <392>) <392>\\nKI\\t#124# 0.0000257 \\n\\t{2-((2-chloro-6-fluorobenzyl)thio)-6-(4-fluorophenyl)imidazo[2,1-b][1,3,\\n\\t4]thiadiazole}  (#124# pH not specified in the publication, temperature \\n\\tnot specified in the publication <413>) <413>\\nKI\\t#124# 0.0000151 \\n\\t{6-(4-bromophenyl)-2-((2-chloro-6-fluorobenzyl)thio)imidazo[2,1-b][1,3,\\n\\t4]thiadiazole}  (#124# pH not specified in the publication, temperature \\n\\tnot specified in the publication <413>) <413>\\nKI\\t#124# 0.0545 \\n\\t{6-((1S)-hydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one}  (#124# \\n\\tisoform CA IX, in 20m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0000328 {3,4-dihydroisoquinoline-2(1H)-sulfonamide}  (#124# \\n\\tisoform CA II, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as buffers \\n\\tand 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#124# 0.0000154 \\n\\t{(R)-4-(3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  (#124# \\n\\tinhibition of isozyme hCA II, pH 9.0, 40C <369>) <369>\\nKI\\t#124# 0.000765 {667-coumate}  (#124# isozyme carbonic anhydrase VA \\n\\t<202>) <202>\\nKI\\t#124# 0.000566 {N-hydroxysulfamide}  (#124# isoenzyme hCA II <168>) \\n\\t<168>\\nKI\\t#124# 0.0000171 \\n\\t{2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide}  (#124# \\n\\tisoenzyme hCA II <172>) <172>\\nKI\\t#124# 0.645 {5-bromo-1-(methanesulfonyl)pyrimidine-2,4(1H,3H)-dione}  \\n\\t(#124# pH 7.4, temperature not specified in the publication <392>) <392>\\nKI\\t#124# 0.0192 {7-(benzyloxy)-2H-chromen-2-one}  (#124# isoform CA IV, in \\n\\t20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0000378 \\n\\t{1-benzyl-3-[2-(4-hydroxyphenyl)ethyl]-2-methylimidazolium bromide}  \\n\\t(#124# pH not specified in the publication, temperature not specified \\n\\tin the publication <417>) <417>\\nKI\\t#124# 0.0314 {7-ethoxy-2H-chromen-2-one}  (#124# isoform CA I, in 20m M \\n\\tHEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0314 {7-(2-phenylethoxy)-2H-chromen-2-one}  (#124# isoform CA \\n\\tI, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0314 {ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate}  (#124# \\n\\tisoform CA II, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0374 {7-propoxy-2H-chromen-2-one}  (#124# isoform CA VI, in 20m \\n\\tM HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0000155 \\n\\t{3-iodo-1-(prop-2-yn-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  (#124# \\n\\tpH not specified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nKI\\t#124# 0.0723 {7-methoxy-2-oxo-2H-chromene-4-carboxylic acid}  (#124# \\n\\tisoform CA IV, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0495 {7-(2-phenylethoxy)-2H-chromen-2-one}  (#124# isoform CA \\n\\tIII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0386 {7-propoxy-2H-chromen-2-one}  (#124# Ki above 0.5 mM, \\n\\tisoform CA III, in 20m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0000164 \\n\\t{1-(3-fluorobenzyl)-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  (#124# \\n\\tpH not specified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nKI\\t#124# 0.0000106 \\n\\t{4-[(4-amino-3-iodo-1H-pyrazolo[3,\\n\\t4-d]pyrimidin-1-yl)methyl]phenylmethanesulfonate}  (#124# pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nKI\\t#124# 0.0000198 \\n\\t{2-((2-chloro-6-fluorobenzyl)thio)-6-phenylimidazo[2,1-b][1,3,4] \\n\\tthiadiazole}  (#124# pH not specified in the publication, temperature \\n\\tnot specified in the publication <413>) <413>\\nKI\\t#124# 0.0000182 \\n\\t{1,3-bis(4-bromobenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  (#124# pH \\n\\tnot specified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nKI\\t#124# 0.000274 {indapamide}  (#124# isozyme CA VB, in 10 mM HEPES (pH \\n\\t7.5) and 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.000842 {EMD 486019}  (#124# isozyme carbonic anhydrase IV \\n\\t<202>) <202>\\nKI\\t#124# 0.000653 {667-coumate}  (#124# isozyme carbonic anhydrase VI \\n\\t<202>) <202>\\nKI\\t#124# 0.000654 {EMD 486019}  (#124# isozyme carbonic anhydrase VI \\n\\t<202>) <202>\\nKI\\t#124# 0.000755 {667-coumate}  (#124# isozyme carbonic anhydrase XIV \\n\\t<202>) <202>\\nKI\\t#124# 0.0000101 {acetazolamide}  (#124# wild type carbonic anhydrase II \\n\\t<196>) <196>\\nKI\\t#124# 0.00252 {indapamide}  (#124# isozyme CA II, in 10 mM HEPES (pH \\n\\t7.5) and 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.00252 {N\\'\\',N\\'\\'\\'-bis[(E)-(4-bromophenyl)methylidene]carbonic \\n\\tdihydrazide}  (#124# pH 7.4, 25C <396>) <396>\\nKI\\t#124# 0.000213 {indapamide}  (#124# isozyme CA IV, in 10 mM HEPES (pH \\n\\t7.5) and 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.000213 {7-butoxy-2H-chromen-2-one}  (#124# isoform CA II, in 20 \\n\\tm M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.000213 \\n\\t{1-(3-cyanobenzyl)-3-(4-methylbenzyl)-3H-benzoimidazol-1-ium bromide}  \\n\\t(#124# pH not specified in the publication, temperature not specified \\n\\tin the publication <409>) <409>\\nKI\\t#124# 0.000917 {Chlorthalidone}  (#124# isozyme CA VA, in 10 mM HEPES \\n\\t(pH 7.5) and 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.001357 {Chlorthalidone}  (#124# isozyme CA VI, in 10 mM HEPES \\n\\t(pH 7.5) and 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.001606 {indapamide}  (#124# isozyme CA VI, in 10 mM HEPES (pH \\n\\t7.5) and 0.1 M Na2SO4 <229>) <229>\\nKI\\t#124# 0.000382 {acetazolamide}  (#124# pH not specified in the \\n\\tpublication, temperature not specified in the publication <409>) <409>\\nKI\\t#124# 0.00383 \\n\\t{(2E)-2-[(4-hydroxyphenyl)methylidene]-N-(5-sulfanylidene-4,5-dihydro-1,\\n\\t3,4-thiadiazol-2-yl)hydrazine-1-carboxamide}  (#124# pH 8.3, 22C \\n\\t<386>) <386>\\nKI\\t#124# 0.0000291 \\n\\t{2-((2,6-dichlorobenzyl)thio)-6-phenylimidazo[2,1-b][1,3,4] \\n\\tthiadiazole}  (#124# pH not specified in the publication, temperature \\n\\tnot specified in the publication <413>) <413>\\nKI\\t#124# 0.0612 {7-methoxy-2H-chromen-2-one}  (#124# isoform CA VI, in 20 \\n\\tm M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0000945 \\n\\t{6,7-dimethoxy-1-methyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#124# isoform CA II, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#124# 0.0000804 \\n\\t{1-benzyl-3-(2,4,6-trimethoxybenzyl)-2-methylimidazolium chloride}  \\n\\t(#124# pH not specified in the publication, temperature not specified \\n\\tin the publication <417>) <417>\\nKI\\t#124# 0.0000156 \\n\\t{3-iodo-1-phenethyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  (#124# pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nKI\\t#124# 0.000243 {7-(2-phenylethoxy)-2H-chromen-2-one}  (#124# isoform CA \\n\\tII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0357 \\n\\t{6-((1S)-hydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one}  (#124# \\n\\tisoform CA VI, in 20m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0279 \\n\\t{6-((1S)-hydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one}  (#124# \\n\\tisoform CA VII, in 20m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0609 {7-ethoxy-2H-chromen-2-one}  (#124# isoform CA VB, in 20m \\n\\tM HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0717 {7-propoxy-2H-chromen-2-one}  (#124# isoform CA VB, in 20m \\n\\tM HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.00372 {7-methoxy-2-oxo-2H-chromene-4-carboxylic acid}  (#124# \\n\\tisoform CA I, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.000224 {7-(benzyloxy)-2H-chromen-2-one}  (#124# isoform CA II, \\n\\tin 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0425 {6-methyl-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA II, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0301 {8-methoxy-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA II, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0505 {ethyl 6-(hydroxymethyl)-2-oxo-2H-chromene-3-carboxylate}  \\n\\t(#124# isoform CA II, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at \\n\\t22C <279>) <279>\\nKI\\t#124# 0.0324 {6-(hydroxymethyl)-2H-chromen-2-one}  (#124# isoform CA \\n\\tII, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0503 {7-butoxy-2H-chromen-2-one}  (#124# isoform CA III, in 20 \\n\\tm M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0249 {7-butoxy-2H-chromen-2-one}  (#124# isoform CA IV, in 20 m \\n\\tM HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0764 {7-butoxy-2H-chromen-2-one}  (#124# isoform CA VB, in 20 m \\n\\tM HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0651 {7-(benzyloxy)-2H-chromen-2-one}  (#124# isoform CA VB, in \\n\\t20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0268 {7-butoxy-2H-chromen-2-one}  (#124# isoform CA VI, in 20 m \\n\\tM HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.1674 {7-methoxy-2H-chromen-2-one}  (#124# isoform CA XII, in 20 \\n\\tm M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C <279>) <279>\\nKI\\t#124# 0.0823 {7-methoxy-2-oxo-2H-chromene-4-carboxylic acid}  (#124# \\n\\tisoform CA XIV, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0396 {6-methoxy-2-oxo-2H-chromene-3-carboxylic acid}  (#124# \\n\\tisoform CA XIV, in 20 m M HEPES (pH 7.5), and 20 mM Na2SO4, at 22C \\n\\t<279>) <279>\\nKI\\t#124# 0.0000873 \\n\\t{6,7-dimethoxy-1-ethyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#124# isoform CA II, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#124# 0.001975 \\n\\t{6,7-dimethoxy-1-propyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#124# isoform CA II, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#124# 0.0000227 \\n\\t{4-(2-((2-chloro-6-fluorobenzyl)thio)imidazo[2,1-b][1,3,4] \\n\\tthiadiazol-6-yl)benzonitrile}  (#124# pH not specified in the \\n\\tpublication, temperature not specified in the publication <413>) <413>\\nKI\\t#124# 0.0000286 \\n\\t{1-(4-chlorobenzyl)-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  (#124# \\n\\tpH not specified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nKI\\t#124# 0.0000224 {[[(eta5-C5H4)-CH=N-N(H)-C6H4-4-SO2NH2]]re(CO)3}  \\n\\t(#124# isoform CA II, at pH 7.5 and 25C <437>) <437>\\nKI\\t#124# 0.0000384 {1-decyl-3-(2,4,6-trimethoxybenzyl)-2-methylimidazolium \\n\\tchloride}  (#124# pH not specified in the publication, temperature not \\n\\tspecified in the publication <417>) <417>\\nKI\\t#124# 0.0000172 {3-iodo-1-propyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  \\n\\t(#124# pH not specified in the publication, temperature not specified \\n\\tin the publication <410>) <410>\\nKI\\t#124# 0.00181 {N\\'\\',N\\'\\'\\'-bis[(E)-(2-nitrophenyl)methylidene]carbonic \\n\\tdihydrazide}  (#124# pH 7.4, 25C <396>) <396>\\nKI\\t#124# 0.0000524 \\n\\t{2,2\\'-(1-phenylethane-1,1-diyl)bis(sulfanediyl)bis(N-p-tolylacetamide)} \\n\\t (#124# pH 8, 25C <431>) <431>\\nKI\\t#124# 0.0000103 \\n\\t{2-((2,6-difluorobenzyl)thio)-6-phenylimidazo[2,1-b][1,3,4] \\n\\tthiadiazole}  (#124# pH not specified in the publication, temperature \\n\\tnot specified in the publication <413>) <413>\\nKI\\t#124# 0.02888 \\n\\t{5-bromo-1-(4-methylbenzene-1-sulfonyl)pyrimidine-2,4(1H,3H)-dione}  \\n\\t(#124# pH 7.4, temperature not specified in the publication <392>) <392>\\nKI\\t#124# 0.1664 {1,3-dimethylpyrimidine-2,4(1H,3H)-dione}  (#124# pH 7.4, \\n\\ttemperature not specified in the publication <392>) <392>\\nKI\\t#124# 1.682 {Orotic acid}  (#124# pH 7.4, temperature not specified in \\n\\tthe publication <392>) <392>\\nKI\\t#124# 1.432 {Isoorotic acid}  (#124# pH 7.4, temperature not specified \\n\\tin the publication <392>) <392>\\nKI\\t#124# 0.0001715 {6-amino-1,3-dimethyluracil}  (#124# pH 7.4, \\n\\ttemperature not specified in the publication <392>) <392>\\nKI\\t#124# 0.0000789 {1-decyl-3-(N-methyphthalimide)-2-methylimidazolium \\n\\tbromide}  (#124# pH not specified in the publication, temperature not \\n\\tspecified in the publication <417>) <417>\\nKI\\t#124# 0.00358 \\n\\t{N\\'\\',N\\'\\'\\'-bis[(E)-(2-chloro-5-nitrophenyl)methylidene]carbonic \\n\\tdihydrazide}  (#124# pH 7.4, 25C <396>) <396>\\nKI\\t#124# 0.0000607 \\n\\t{(R)-4-(3,4-dibenzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#124# inhibition of isozyme hCA II, pH 9.0, 40C <369>) <369>\\nKI\\t#124# 0.0002645 \\n\\t{4-[(2S)-2-benzylpiperazine-1-carbonyl]benzene-1-sulfonamide}  (#124# \\n\\tinhibition of isozyme hCA II, pH 9.0, 40C <369>) <369>\\nKI\\t#124# 0.0003586 {(S)- \\n\\t4-(2-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#124# inhibition of isozyme hCA II, pH 9.0, 40C <369>) <369>\\nKI\\t#124# 0.0000389 \\n\\t{(R)-1-[4-(benzenesulfonyl)-2-benzylpiperazin-1-yl]ethan-1-one}  (#124# \\n\\tinhibition of isozyme hCA II, pH 9.0, 40C <369>) <369>\\nKI\\t#124# 0.0000613 {(S)- \\n\\t4-(4-benzoyl-2-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#124# inhibition of isozyme hCA II, pH 9.0, 40C <369>) <369>\\nKI\\t#124# 0.0000334 {(R)- \\n\\t4-(4-benzoyl-2-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#124# inhibition of isozyme hCA II, pH 9.0, 40C <369>) <369>\\nKI\\t#124# 0.0000593 \\n\\t{(S)-4-[4-(benzenesulfonyl)-2-benzylpiperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#124# inhibition of isozyme hCA II, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#124# 0.0000834 \\n\\t{(S)-4-(3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  (#124# \\n\\tinhibition of isozyme hCA II, pH 9.0, 40C <369>) <369>\\nKI\\t#124# 0.0003278 \\n\\t{(S)-4-(3-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#124# inhibition of isozyme hCA II, pH 9.0, 40C <369>) <369>\\nKI\\t#124# 0.0000525 \\n\\t{(R)-4-(4-benzoyl-3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#124# inhibition of isozyme hCA II, pH 9.0, 40C <369>) <369>\\nKI\\t#124# 0.0000927 \\n\\t{(S)-4-[3-benzyl-4-(2-phenylacetyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#124# inhibition of isozyme hCA II, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#124# 0.0000323 \\n\\t{(R)-4-(3-benzyl-4-methanesulfonylpiperazine-1-carbonyl)benzene-1-\\n\\tsulfonamide}  (#124# inhibition of isozyme hCA II, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#124# 0.0000323 \\n\\t{4-((2-((2,6-difluorobenzyl)thio)-6-phenylimidazo[2,1-b][1,3,4] \\n\\tthiadiazol-5-yl)methyl)-morpholine}  (#124# pH not specified in the \\n\\tpublication, temperature not specified in the publication <413>) <413>\\nKI\\t#124# 0.0000214 \\n\\t{2-((2-chloro-6-fluorobenzyl)thio)-6-(4-methoxyphenyl)imidazo \\n\\t[2,1-b][1,3,4]thiadiazole}  (#124# pH not specified in the publication, \\n\\ttemperature not specified in the publication <413>) <413>\\nKI\\t#124# 0.0000216 \\n\\t{6-([1,1\\'-biphenyl]-4-yl)-2-((2-chloro-6-fluorobenzyl)thio)imidazo \\n\\t[2,1-b][1,3,4]thiadiazole}  (#124# pH not specified in the publication, \\n\\ttemperature not specified in the publication <413>) <413>\\nKI\\t#124# 0.0000262 {1-benzyl-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  \\n\\t(#124# pH not specified in the publication, temperature not specified \\n\\tin the publication <410>) <410>\\nKI\\t#124# 0.0000363 \\n\\t{2,2\\'-(1-(4-methoxyphenyl)ethane-1,1-diyl)bis(sulfanediyl)diacetic \\n\\tacid}  (#124# pH 8, 25C <431>) <431>\\nKI\\t#124# 0.0000547 \\n\\t{2,2\\'-(1-(4-bromophenyl)ethane-1,1-diyl)bis(sulfanediyl)diacetic acid}  \\n\\t(#124# pH 8, 25C <431>) <431>\\nKI\\t#124# 0.0000296 \\n\\t{2,2\\'-(1-(4-methoxyphenyl)ethane-1,\\n\\t1-diyl)bis(sulfanediyl)bis(N-(pyridin-2-yl)acetamide)}  (#124# pH 8, \\n\\t25C <431>) <431>\\nKI\\t#124# 0.0000659 \\n\\t{1-decyl-3-[2-(4-hydroxyphenyl)ethyl]-2-methylimidazolium bromide}  \\n\\t(#124# pH not specified in the publication, temperature not specified \\n\\tin the publication <417>) <417>\\nKI\\t#124# 0.0000116 \\n\\t{4-[(4-amino-3-iodo-1H-pyrazolo[3,\\n\\t4-d]pyrimidin-1-yl)methyl]-2-methoxyphenyl methanesulfonate}  (#124# pH \\n\\tnot specified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nKI\\t#124# 0.0000977 {acetazolamide}  (#124# pH not specified in the \\n\\tpublication, temperature not specified in the publication <410>) <410>\\nKI\\t#124# 0.0000203 \\n\\t{2-((2-chloro-6-fluorobenzyl)thio)-6-(4-chlorophenyl)imidazo[2,1-b][1,3,\\n\\t4]thiadiazole}  (#124# pH not specified in the publication, temperature \\n\\tnot specified in the publication <413>) <413>\\nKI\\t#124# 0.0000203 \\n\\t{4-((2-((2-chloro-6-fluorobenzyl)thio)-6-phenylimidazo[2,1-b] \\n\\t[1,3,4]thiadiazol-5-yl)methyl)morpholine}  (#124# pH not specified in \\n\\tthe publication, temperature not specified in the publication <413>) \\n\\t<413>\\nKI\\t#124# 0.0000628 \\n\\t{2-((2,6-dichlorobenzyl)thio)-6-phenyl-5-(piperidin-1-ylmethyl) \\n\\timidazo[2,1-b][1,3,4]-thiadiazole}  (#124# pH not specified in the \\n\\tpublication, temperature not specified in the publication <413>) <413>\\nKI\\t#124,125# 1.4 {2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide}  \\n\\t(#125# isoenzyme hCA III <171>; #124# isozyme CA III, in 10 mM HEPES \\n\\t(pH 7.5) and 0.1 M Na2SO4 <229>) <171,229>\\nKI\\t#124,127# 0.0001 \\n\\t{N\\'-[(1Z)-1-(furan-3-yl)ethylidene]butane-1-sulfonohydrazide}  \\n\\t(#124,127# pH not specified in the publication, temperature not \\n\\tspecified in the publication <432>) <432>\\nKI\\t#124,127# 0.0000075 \\n\\t{2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide}  (#127# \\n\\tisoenzyme hCA I <171>; #124# isozyme CA I, in 10 mM HEPES (pH 7.5) and \\n\\t0.1 M Na2SO4 <229>) <171,229>\\nKI\\t#124,127# 0.000125 \\n\\t{N\\'-[(Z)-(1H-indol-3-yl)methylidene]butane-1-sulfonohydrazide}  \\n\\t(#124,127# pH not specified in the publication, temperature not \\n\\tspecified in the publication <432>) <432>\\nKI\\t#124,127# 0.000046 \\n\\t{(S)-4-(2,4-dibenzylpiperazine-1-carbonyl)benzenesulfonamide}  \\n\\t(#124,127# inhibition of isozyme hCA II, pH 9.0, 40C <369>) <369>\\nKI\\t#124,127# 0.000066 \\n\\t{N\\'-[(1Z)-1-(5-chlorothiophen-3-yl)ethylidene]butane-1-\\n\\tsulfonohydrazide}  (#124,127# pH not specified in the publication, \\n\\ttemperature not specified in the publication <432>) <432>\\nKI\\t#124,127# 0.000161 {acetazolamide}  (#124,127# pH not specified in the \\n\\tpublication, temperature not specified in the publication <432>) <432>\\nKI\\t#124,127# 0.000118 \\n\\t{N\\'-[(1Z)-1-(thiophen-3-yl)ethylidene]butane-1-sulfonohydrazide}  \\n\\t(#124,127# pH not specified in the publication, temperature not \\n\\tspecified in the publication <432>) <432>\\nKI\\t#124,128# 0.009 \\n\\t{2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide}  (#128# \\n\\tisoenzyme hCA IV <171>; #124# isozyme CA IV, in 10 mM HEPES (pH 7.5) \\n\\tand 0.1 M Na2SO4 <229>) <171,229>\\nKI\\t#124,128# 0.0049 {topiramate}  (#128# isoenzyme hCA IV <169>; #124# \\n\\tisozyme carbonic anhydrase IV <202>) <169,202>\\nKI\\t#124,128# 0.000093 {ethoxzolamide}  (#128# isoenzyme hCA IV <169,171>; \\n\\t#124# isozyme CA IV, in 10 mM HEPES (pH 7.5) and 0.1 M Na2SO4 <229>) \\n\\t<169,171,229>\\nKI\\t#124,128,147# 0.000074 {acetazolamide}  (#128# pH 7.5, 22C <387>; \\n\\t#128# isoenzyme hCA IV <169>; #124# isozyme CA IV, in 10 mM HEPES (pH \\n\\t7.5) and 0.1 M Na2SO4 <229>; #124# isozyme carbonic anhydrase IV <202>; \\n\\t#147# isozyme STPCA-2, pH 7.5, 20C <297>) <169,202,229,297,387>\\nKI\\t#124,129# 0.000063 {topiramate}  (#129# isoenzyme hCA VA <169>; #124# \\n\\tisozyme carbonic anhydrase VA <202>) <169,202>\\nKI\\t#124,129,130# 0.0011 \\n\\t{2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide}  (#129# \\n\\tisoenzyme hCA VA <171>; #130# isoenzyme hCA VB <171>; #124# isozyme CA \\n\\tVA, in 10 mM HEPES (pH 7.5) and 0.1 M Na2SO4 <229>; #124# isozyme CA \\n\\tVB, in 10 mM HEPES (pH 7.5) and 0.1 M Na2SO4 <229>) <171,229>\\nKI\\t#124,130# 0.00003 {topiramate}  (#130# isoenzyme hCA VB <169>; #124# \\n\\tisozyme carbonic anhydrase VB <202>) <169,202>\\nKI\\t#124,130# 0.000019 {ethoxzolamide}  (#130# isoenzyme hCA VB <169,171>; \\n\\t#124# isozyme CA VB, in 10 mM HEPES (pH 7.5) and 0.1 M Na2SO4 <229>) \\n\\t<169,171,229>\\nKI\\t#124,130# 0.000054 {acetazolamide}  (#130# isoenzyme hCA VB <169>; \\n\\t#124# isozyme CA VB, in 10 mM HEPES (pH 7.5) and 0.1 M Na2SO4 <229>; \\n\\t#124# isozyme carbonic anhydrase VB <202>) <169,202,229>\\nKI\\t#124,131# 0.00001 {methazolamide}  (#131# 20C, pH 7.5, full-length \\n\\trecombinant hCA VI <184>; #124# isozyme CA VI, in 10 mM HEPES (pH 7.5) \\n\\tand 0.1 M Na2SO4 <229>) <184,229>\\nKI\\t#124,131# 0.000011 {acetazolamide}  (#131# 20C, pH 7.5, full-length \\n\\trecombinant hCA VI <184>; #131# isoenzyme hCA VI <169>; #124# isozyme \\n\\tCA VI, in 10 mM HEPES (pH 7.5) and 0.1 M Na2SO4 <229>; #124# isozyme \\n\\tcarbonic anhydrase VI <202>) <169,184,202,229>\\nKI\\t#124,131# 0.000045 {topiramate}  (#131# 20C, pH 7.5, full-length \\n\\trecombinant hCA VI <184>; #131# isoenzyme hCA VI <169>; #124# isozyme \\n\\tcarbonic anhydrase VI <202>) <169,184,202>\\nKI\\t#124,131# 0.000043 {ethoxzolamide}  (#131# 20C, pH 7.5, full-length \\n\\trecombinant hCA VI <184>; #131# isoenzyme hCA VI <169,171>; #124# \\n\\tisozyme CA VI, in 10 mM HEPES (pH 7.5) and 0.1 M Na2SO4 <229>) \\n\\t<169,171,184,229>\\nKI\\t#124,131# 0.00265 \\n\\t{2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide}  (#131# \\n\\tisoenzyme hCA VI <171>; #124# isozyme CA VI, in 10 mM HEPES (pH 7.5) \\n\\tand 0.1 M Na2SO4 <229>) <171,229>\\nKI\\t#124,132# 0.000089 \\n\\t{2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide}  (#132# \\n\\tisoenzyme hCA VII <171>; #124# isozyme CA VII, in 10 mM HEPES (pH 7.5) \\n\\tand 0.1 M Na2SO4 <229>) <171,229>\\nKI\\t#124,172# 0.000065 {methazolamide}  (#172# at 20C and pH 7.5 <230>; \\n\\t#124# isozyme CA VA, in 10 mM HEPES (pH 7.5) and 0.1 M Na2SO4 <229>) \\n\\t<229,230>\\nKI\\t#125# 0.14 \\n\\t{4-amino-N-[2-[4-(aminosulfonyl)phenyl]ethyl]benzenesulfonamide}  \\n\\t(#125# 20C, pH 7.5 <167>) <167>\\nKI\\t#125# 2.2 {saccharin}  (#125# 20C, pH 7.5 <167>) <167>\\nKI\\t#125# 2.2 {zonisamide}  (#125# isoenzyme hCA III <171>) <171>\\nKI\\t#125# 0.1 \\n\\t{N-[5-(aminosulfonyl)-3-methyl-1,3,\\n\\t4-thiadiazol-2(3H)-ylidene]acetamide}  (#125# isoenzyme hCA III <169>) \\n\\t<169>\\nKI\\t#125# 1 {celecoxib}  (#125# 20C, pH 7.5 <167>) <167>\\nKI\\t#125# 12 {bicarbonate}  (#125# isozyme CA II <227>) <227>\\nKI\\t#125# 0.11 {brinzolamide}  (#125# 20C, pH 7.5 <167>; #125# isoenzyme \\n\\thCA III <171>) <167,171>\\nKI\\t#125# 1.1 {ethoxzolamide}  (#125# isoenzyme hCA III <171>) <171>\\nKI\\t#125# 1.6 {4-(2-aminoethyl)benzenesulfonamide}  (#125# 20C, pH 7.5 \\n\\t<167>) <167>\\nKI\\t#125# 8 \\n\\t{6-methyl-4-(methylamino)-5,6-dihydro-4H-thieno[2,\\n\\t3-b]thiopyran-2-sulfonamide 7,7-dioxide}  (#125# isoenzyme hCA III \\n\\t<169>) <169>\\nKI\\t#125# 0.019 {4-amino-3-fluoro-5-iodobenzenesulfonamide}  (#125# 20C, \\n\\tpH 7.5 <167>) <167>\\nKI\\t#125# 0.71 {4-amino-3-chlorobenzenesulfonamide}  (#125# 20C, pH 7.5 \\n\\t<167>) <167>\\nKI\\t#125# 0.74 {bicarbonate}  (#125# isozyme CA III <227>) <227>\\nKI\\t#125# 0.005 {ethoxzolamide}  (#125# isoenzyme hCA III <169>) <169>\\nKI\\t#125# 0.0104 {sulpiride}  (#125# 20C, pH 7.5 <167>) <167>\\nKI\\t#125# 0.77 {methazolamide}  (#125# 20C, pH 7.5 <167>) <167>\\nKI\\t#125# 0.77 {dorzolamide}  (#125# 20C, pH 7.5 <167>; #125# isoenzyme \\n\\thCA III <171>) <167,171>\\nKI\\t#125# 0.0181 \\n\\t{5-[[(4-aminophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#125# 20C, pH 7.5 <167>) <167>\\nKI\\t#125# 0.198 \\n\\t{5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide}  (#125# \\n\\t20C, pH 7.5 <167>) <167>\\nKI\\t#125# 0.36 {2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide} \\n\\t (#125# isoenzyme hCA III <172>) <172>\\nKI\\t#125# 0.0063 {4,5-dichloro-benzene-1,3-disulfonamide}  (#125# isoenzyme \\n\\thCA III, i.e. daranide <169>) <169>\\nKI\\t#125# 0.0097 {4-amino-6-chlorobenzene-1,3-disulfonamide}  (#125# 20C, \\n\\tpH 7.5 <167>) <167>\\nKI\\t#125# 0.78 {zonisamide}  (#125# 20C, pH 7.5 <167>) <167>\\nKI\\t#125# 0.0106 {topiramate}  (#125# 20C, pH 7.5 <167>) <167>\\nKI\\t#125# 0.0072 {6-trifluoromethyl-4-aminobenzene-1,3-disulfonamide}  \\n\\t(#125# isoenzyme hCA III <169>) <169>\\nKI\\t#125# 0.0079 {4-methylbenzenesulfonamide}  (#125# 20C, pH 7.5 <167>) \\n\\t<167>\\nKI\\t#125# 0.0143 {benzolamide}  (#125# 20C, pH 7.5 <167>) <167>\\nKI\\t#125# 0.0068 {6-chloro-4-amino-benzene-1,3-disulfonamide}  (#125# \\n\\tisoenzyme hCA III <169>) <169>\\nKI\\t#125# 0.0107 {4-amino-3,5-dibromobenzenesulfonamide}  (#125# 20C, pH \\n\\t7.5 <167>) <167>\\nKI\\t#125# 0.0113 {4-(aminosulfonyl)benzoic acid}  (#125# 20C, pH 7.5 \\n\\t<167>) <167>\\nKI\\t#125# 0.114 {4-amino-N-[4-(aminosulfonyl)benzyl]benzenesulfonamide}  \\n\\t(#125# 20C, pH 7.5 <167>) <167>\\nKI\\t#125# 0.63 {sulthiame}  (#125# isoenzyme hCA III <170>) <170>\\nKI\\t#125# 1.06 \\n\\t{4-(aminosulfonyl)-N-[2-[4-(aminosulfonyl)phenyl]ethyl]benzamide}  \\n\\t(#125# 20C, pH 7.5 <167>) <167>\\nKI\\t#125# 85 {bicarbonate}  (#125# isozyme CA I <227>) <227>\\nKI\\t#125# 0.154 {valdecoxib}  (#125# 20C, pH 7.5 <167>) <167>\\nKI\\t#125# 0.236 {5-acetamido-1,3,4-thiadiazole-2-sulfonamide}  (#125# 20C, \\n\\tpH 7.5 <167>) <167>\\nKI\\t#125# 0.148 {5-amino-1,3,4-thiadiazole-2-sulfonamide}  (#125# 20C, pH \\n\\t7.5 <167>) <167>\\nKI\\t#125# 0.0146 {5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#125# 20C, pH 7.5 <167>) <167>\\nKI\\t#125# 1.113 {ethoxzolamide}  (#125# 20C, pH 7.5 <167>) <167>\\nKI\\t#125# 0.684 {dichlorophenamide}  (#125# 20C, pH 7.5 <167>) <167>\\nKI\\t#125# 0.788 {prontosil}  (#125# 20C, pH 7.5 <167>) <167>\\nKI\\t#125# 0.887 {2-aminobenzenesulfonamide}  (#125# 20C, pH 7.5 <167>) \\n\\t<167>\\nKI\\t#125# 0.988 {4-Aminobenzenesulfonamide}  (#125# 20C, pH 7.5 <167>) \\n\\t<167>\\nKI\\t#125# 0.681 {4-(aminomethyl)benzenesulfonamide}  (#125# 20C, pH 7.5 \\n\\t<167>) <167>\\nKI\\t#125# 2.075 {4-amino-3-fluorobenzenesulfonamide}  (#125# 20C, pH 7.5 \\n\\t<167>) <167>\\nKI\\t#125# 1.276 {4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide}  \\n\\t(#125# 20C, pH 7.5 <167>) <167>\\nKI\\t#125# 2.633 {4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide}  \\n\\t(#125# 20C, pH 7.5 <167>) <167>\\nKI\\t#125# 0.0805 \\n\\t{5-[[(4-amino-3-chloro-5-fluorophenyl)sulfonyl]amino]-1,3,\\n\\t4-thiadiazole-2-sulfonamide}  (#125# 20C, pH 7.5 <167>) <167>\\nKI\\t#125# 4.89 {4-(hydroxymethyl)benzenesulfonamide}  (#125# 20C, pH 7.5 \\n\\t<167>) <167>\\nKI\\t#125# 1.187 {4-(2-hydroxyethyl)benzenesulfonamide}  (#125# 20C, pH 7.5 \\n\\t<167>) <167>\\nKI\\t#125# 1.995 {2-hydrazinobenzenesulfonamide}  (#125# 20C, pH 7.5 <167>) \\n\\t<167>\\nKI\\t#127# 0.05 \\n\\t{6-methyl-4-(methylamino)-5,6-dihydro-4H-thieno[2,\\n\\t3-b]thiopyran-2-sulfonamide 7,7-dioxide}  (#127# isoenzyme hCA I <169>) \\n\\t<169>\\nKI\\t#127# 0.00025 {ethoxzolamide}  (#127# isoenzyme hCA I <169>) <169>\\nKI\\t#127# 0.0031 {2-coumaric acid}  (#127# pH 8.3, 22C <386>) <386>\\nKI\\t#127# 45 \\n\\t{2-(3-methoxypropyl)-4-(methylamino)-3,4-dihydro-2H-thieno[3,2-e][1,\\n\\t2]thiazine-6-sulfonamide 1,1-dioxide}  (#127# isoenzyme hCA I <169>) \\n\\t<169>\\nKI\\t#127# 0.00005 \\n\\t{N-[5-(aminosulfonyl)-3-methyl-1,3,\\n\\t4-thiadiazol-2(3H)-ylidene]acetamide}  (#127# isoenzyme hCA I <169>) \\n\\t<169>\\nKI\\t#127# 0.000029 \\n\\t{(R)-4-(2-benzyl-4-methanesulfonylpiperazine-1-carbonyl)benzene-1-\\n\\tsulfonamide}  (#127# inhibition of isozyme, pH 9.0, 40C <369>) <369>\\nKI\\t#127# 4.1 {Benzyl \\n\\t(2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-\\n\\toxoethyl)carbamate}  (#127# pH 7.5, 22C <387>) <387>\\nKI\\t#127# 4.1 {(S)-tert-butyl \\n\\t(1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-2-\\n\\tyl)carbamate}  (#127# pH 7.5, 22C <387>) <387>\\nKI\\t#127# 4.1 {(S)-2-(2-ammoniopropanamido)-4-methylbenzo[d]thiazol-3-ium \\n\\tdi-2,2,2-trifluoroacetate}  (#127# pH 7.5, 22C <387>) <387>\\nKI\\t#127# 0.31 {H2NSO2NH2}  (#127# isoenzyme hCA I <168>) <168>\\nKI\\t#127# 0.0012 {4,5-dichloro-benzene-1,3-disulfonamide}  (#127# isoenzyme \\n\\thCA I, i.e. daranide <169>) <169>\\nKI\\t#127# 0.0012 {4-(3-formylphenyl)benzene-1-sulfonamide}  (#127# pH and \\n\\ttemperature not specified in the publication <365>) <365>\\nKI\\t#127# 0.0035 {4-(2-methylphenyl)benzene-1-sulfonamide}  (#127# pH and \\n\\ttemperature not specified in the publication <365>) <365>\\nKI\\t#127# 0.000085 {6-amino-1,3-dimethyluracil}  (#127# pH 7.4, temperature \\n\\tnot specified in the publication <392>) <392>\\nKI\\t#127# 0.045 {brinzolamide}  (#127# isoenzyme hCA I <171>) <171>\\nKI\\t#127# 0.021 {H2NSO3H}  (#127# isoenzyme hCA I <168>) <168>\\nKI\\t#127# 0.0058 {6-trifluoromethyl-4-aminobenzene-1,3-disulfonamide}  \\n\\t(#127# isoenzyme hCA I <169>) <169>\\nKI\\t#127# 0.000042 {4-phenylbenzene-1-sulfonamide}  (#127# pH and \\n\\ttemperature not specified in the publication <365>) <365>\\nKI\\t#127# 0.0000037 {[[(eta5-C5H4)-C(CH3)=N-N(H)-C6H4-4-SO2NH2]]re(CO)3}  \\n\\t(#127# isoform CA I, at pH 7.5 and 25C <437>) <437>\\nKI\\t#127# 0.000068 \\n\\t{N-(1-(2-hydroxyphenylamino)-4-methyl-1-oxopentan-2-ylcarbamothioyl) \\n\\tbenzamide}  (#127# pH 8.3, 22C <386>) <386>\\nKI\\t#127# 0.0000039 \\n\\t{(R)-4-(3-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#127# inhibition of isozyme hCA I, pH 9.0, 40C <369>) <369>\\nKI\\t#127# 0.0000075 {[[(eta5-C5H4)-CH=N-N(H)-C6H4-4-SO2NH2]]re(CO)3}  \\n\\t(#127# isoform CA I, at pH 7.5 and 25C <437>) <437>\\nKI\\t#127# 0.0084 {6-chloro-4-amino-benzene-1,3-disulfonamide}  (#127# \\n\\tisoenzyme hCA I <169>) <169>\\nKI\\t#127# 0.000025 \\n\\t{2,2\\'-(1-phenylethane-1,1-diyl)bis(sulfanediyl)bis(N-p-tolylacetamide)} \\n\\t (#127# pH 8, 25C <431>) <431>\\nKI\\t#127# 0.000035 {4-(3-quinolinyl)benzene-1-sulfonamide}  (#127# pH and \\n\\ttemperature not specified in the publication <365>) <365>\\nKI\\t#127# 0.0099 {salicylic acid}  (#127# pH 8.3, 22C <386>) <386>\\nKI\\t#127# 0.086 {(S)-tert-butyl \\n\\t(1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate}  \\n\\t(#127# pH 7.5, 22C <387>) <387>\\nKI\\t#127# 63 {SO42-}  (#127# isoenzyme hCA I <168>) <168>\\nKI\\t#127# 0.000105 \\n\\t{4-(2-((2-chloro-6-fluorobenzyl)thio)imidazo[2,1-b][1,3,4] \\n\\tthiadiazol-6-yl)benzonitrile}  (#127# pH not specified in the \\n\\tpublication, temperature not specified in the publication <413>) <413>\\nKI\\t#127# 0.00334 \\n\\t{(2E)-2-[(4-hydroxy-3-methylphenyl)methylidene]-N-(5-sulfanylidene-4,\\n\\t5-dihydro-1,3,4-thiadiazol-2-yl)hydrazine-1-carboxamide}  (#127# pH \\n\\t8.3, 22C <386>) <386>\\nKI\\t#127# 0.0000029 \\n\\t{(R)-4-[2-benzyl-4-(2-phenylacetyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#127# inhibition of isozyme, pH 9.0, 40C <369>) <369>\\nKI\\t#127# 0.0000059 {[[(eta5-C5H4)-CH=N-N(H)-C6H4-4-SO2NH2]]Mn(CO)3}  \\n\\t(#127# isoform CA I, at pH 7.5 and 25C <437>) <437>\\nKI\\t#127# 0.0000036 {[[(eta5-C5H4)-C(CH3)=N-N(H)-C6H4-4-SO2NH2]]FeCp}  \\n\\t(#127# isoform CA I, at pH 7.5 and 25C <437>) <437>\\nKI\\t#127# 0.0000079 \\n\\t{(S)-4-(3-benzyl-4-methanesulfonylpiperazine-1-carbonyl)benzene-1-\\n\\tsulfonamide}  (#127# inhibition of isozyme hCA I, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#127# 0.000352 \\n\\t{1-(3-cyanobenzyl)-3-(2,4,6-trimethyl-benzyl)-3H-benzoimidazol-1-ium \\n\\tbromide}  (#127# pH not specified in the publication, temperature not \\n\\tspecified in the publication <409>) <409>\\nKI\\t#127# 0.0000066 \\n\\t{(R)-4-[3-benzyl-4-(2-phenylacetyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#127# inhibition of isozyme hCA I, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#127# 0.0000132 {[[(eta5-C5H4)-CH=N-N(H)-C6H4-4-SO2NH2]]FeCp}  (#127# \\n\\tisoform CA I, at pH 7.5 and 25C <437>) <437>\\nKI\\t#127# 0.000186 \\n\\t{(S)-4-(2-benzyl-4-methanesulfonylpiperazine-1-carbonyl)benzene-1-\\n\\tsulfonamide}  (#127# inhibition of isozyme, pH 9.0, 40C <369>) <369>\\nKI\\t#127# 0.000121 \\n\\t{2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide}  (#127# \\n\\tisoenzyme hCA I <172>) <172>\\nKI\\t#127# 0.000062 {Furosemide}  (#127# isoenzyme hCA I <169>) <169>\\nKI\\t#127# 0.000074 \\n\\t{N-(1-(2-hydroxyphenylamino)-3-methyl-1-oxobutan-2-\\n\\tylcarbamothioyl)benzamide}  (#127# pH 8.3, 22C <386>) <386>\\nKI\\t#127# 0.0000088 \\n\\t{(S)-4-(4-acetyl-3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#127# inhibition of isozyme hCA I, pH 9.0, 40C <369>) <369>\\nKI\\t#127# 0.795 {benzene-1,3-diol}  (#127# pH 7.4, temperature not \\n\\tspecified in the publication <392>) <392>\\nKI\\t#127# 0.795 {resorcinol}  (#127# pH 8.3, 22C <386>) <386>\\nKI\\t#127# 0.000189 \\n\\t{1-(3-cyanobenzyl)-3-(2,3,5,\\n\\t6-tetramethyl-benzyl)-3H-benzoimidazol-1-ium bromide}  (#127# pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <409>) <409>\\nKI\\t#127# 0.0000202 \\n\\t{2,2\\'-(1-phenylethane-1,1-diyl)bis(sulfanediyl)bis(N-benzylacetamide)}  \\n\\t(#127# pH 8, 25C <431>) <431>\\nKI\\t#127# 0.000478 {acetazolamide}  (#127# pH not specified in the \\n\\tpublication, temperature not specified in the publication <410>) <410>\\nKI\\t#127# 0.0000061 \\n\\t{(S)-4-[2-benzyl-4-(4-sulfamoylbenzoyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#127# inhibition of isozyme hCA I, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#127# 0.0000087 \\n\\t{4-[(2R)-2-benzylpiperazine-1-carbonyl]benzene-1-sulfonamide}  (#127# \\n\\tinhibition of isozyme, pH 9.0, 40C <369>) <369>\\nKI\\t#127# 0.000707 \\n\\t{(S)-4-(2-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#127# inhibition of isozyme, pH 9.0, 40C <369>) <369>\\nKI\\t#127# 0.0454 {(S)-tert-butyl \\n\\t(1-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-1-oxo-3-phenylpropan-\\n\\t2-yl)carbamate}  (#127# pH 7.5, 22C <387>) <387>\\nKI\\t#127# 0.000245 \\n\\t{(S)-4-[4-(benzenesulfonyl)-3-benzylpiperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#127# inhibition of isozyme hCA I, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#127# 0.0000539 \\n\\t{(R)-4-(4-benzoyl-3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#127# inhibition of isozyme hCA I, pH 9.0, 40C <369>) <369>\\nKI\\t#127# 0.0000443 \\n\\t{(R)-4-(4-benzoyl-2-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#127# inhibition of isozyme, pH 9.0, 40C <369>) <369>\\nKI\\t#127# 0.0000443 {1-butyl-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  \\n\\t(#127# pH not specified in the publication, temperature not specified \\n\\tin the publication <410>) <410>\\nKI\\t#127# 0.0000494 \\n\\t{(R)-4-(3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  (#127# \\n\\tinhibition of isozyme hCA I, pH 9.0, 40C <369>) <369>\\nKI\\t#127# 0.0000306 \\n\\t{(R)-4-(3-benzyl-4-methanesulfonylpiperazine-1-carbonyl)benzene-1-\\n\\tsulfonamide}  (#127# inhibition of isozyme hCA I, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#127# 0.00803 \\n\\t{(2E)-2-[(4-hydroxyphenyl)methylidene]-N-(5-sulfanylidene-4,5-dihydro-1,\\n\\t3,4-thiadiazol-2-yl)hydrazine-1-carboxamide}  (#127# pH 8.3, 22C \\n\\t<386>) <386>\\nKI\\t#127# 0.0000096 \\n\\t{(S)-1-[4-(benzenesulfonyl)-2-benzylpiperazin-1-yl]ethan-1-one}  (#127# \\n\\tinhibition of isozyme, pH 9.0, 40C <369>) <369>\\nKI\\t#127# 0.0000091 \\n\\t{2,2\\'-(1-(4-bromophenyl)ethane-1,1-diyl)bis(sulfanediyl)diacetic acid}  \\n\\t(#127# pH 8, 25C <431>) <431>\\nKI\\t#127# 0.0000195 {3-iodo-1-propyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  \\n\\t(#127# pH not specified in the publication, temperature not specified \\n\\tin the publication <410>) <410>\\nKI\\t#127# 0.00405 {N-hydroxysulfamide}  (#127# isoenzyme hCA I <168>) <168>\\nKI\\t#127# 0.000374 {sulthiame}  (#127# isoenzyme hCA I <170>) <170>\\nKI\\t#127# 0.000328 {hydrochlorothiazide}  (#127# isoenzyme hCA I <169>) \\n\\t<169>\\nKI\\t#127# 0.0000177 \\n\\t{1,3-bis(4-bromobenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  (#127# pH \\n\\tnot specified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nKI\\t#127# 0.0000889 \\n\\t{(S)-4-(2,4-dibenzylpiperazine-1-carbonyl)benzenesulfonamide}  (#127# \\n\\tinhibition of isozyme, pH 9.0, 40C <369>) <369>\\nKI\\t#127# 0.0711 {(S)-benzyl \\n\\t(1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxopropan-2-\\n\\tyl)carbamate}  (#127# pH 7.5, 22C <387>) <387>\\nKI\\t#127# 0.0000198 {methyl \\n\\t2-[(4-amino-3-iodo-1H-pyrazolo[3,\\n\\t4-d]pyrimidin-1-yl)methyl]-3-nitrobenzoate}  (#127# pH not specified in \\n\\tthe publication, temperature not specified in the publication <410>) \\n\\t<410>\\nKI\\t#127# 0.0000577 {acetazolamide}  (#127# pH 8, 25C <431>) <431>\\nKI\\t#127# 0.0000342 \\n\\t{2-((2-chloro-6-fluorobenzyl)thio)-6-phenylimidazo[2,1-b][1,3,4] \\n\\tthiadiazole}  (#127# pH not specified in the publication, temperature \\n\\tnot specified in the publication <413>) <413>\\nKI\\t#127# 0.000277 \\n\\t{1-(3-cyanobenzyl)-3-(2-methylbenzyl)-3H-benzoimidazol-1-ium bromide}  \\n\\t(#127# pH not specified in the publication, temperature not specified \\n\\tin the publication <409>) <409>\\nKI\\t#127# 0.428 {5-bromo-1-(methanesulfonyl)pyrimidine-2,4(1H,3H)-dione}  \\n\\t(#127# pH 7.4, temperature not specified in the publication <392>) <392>\\nKI\\t#127# 0.0000221 \\n\\t{(S)-4-(3,4-dibenzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#127# inhibition of isozyme hCA I, pH 9.0, 40C <369>) <369>\\nKI\\t#127# 0.0675 {benzyl \\n\\t(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-\\n\\toxoethyl)carbamate}  (#127# pH 7.5, 22C <387>) <387>\\nKI\\t#127# 0.0000205 \\n\\t{1-(3-fluorobenzyl)-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  (#127# \\n\\tpH not specified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nKI\\t#127# 0.00241 {curcumin}  (#127# pH 8.3, 22C <386>) <386>\\nKI\\t#127# 0.0000456 \\n\\t{2-((2-chloro-6-fluorobenzyl)thio)-6-(4-chlorophenyl)imidazo[2,1-b][1,3,\\n\\t4]thiadiazole}  (#127# pH not specified in the publication, temperature \\n\\tnot specified in the publication <413>) <413>\\nKI\\t#127# 0.000273 \\n\\t{1-(3-cyanobenzyl)-3-(2,3,4,5,\\n\\t6-pentamethyl-benzyl)-3H-benzoimidazol-1-ium bromide}  (#127# pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <409>) <409>\\nKI\\t#127# 0.0859 {tert-butyl \\n\\t(2-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-2-\\n\\toxoethyl)carbamate}  (#127# pH 7.5, 22C <387>) <387>\\nKI\\t#127# 0.0000515 \\n\\t{2-((2,6-difluorobenzyl)thio)-6-phenylimidazo[2,1-b][1,3,4] \\n\\tthiadiazole}  (#127# pH not specified in the publication, temperature \\n\\tnot specified in the publication <413>) <413>\\nKI\\t#127# 0.000402 \\n\\t{1-(3-cyanobenzyl)-3-(4-methylbenzyl)-3H-benzoimidazol-1-ium bromide}  \\n\\t(#127# pH not specified in the publication, temperature not specified \\n\\tin the publication <409>) <409>\\nKI\\t#127# 0.0000234 \\n\\t{2-((2-chloro-6-fluorobenzyl)thio)-6-(4-fluorophenyl)imidazo[2,1-b][1,3,\\n\\t4]thiadiazole}  (#127# pH not specified in the publication, temperature \\n\\tnot specified in the publication <413>) <413>\\nKI\\t#127# 0.01083 \\n\\t{5-bromo-1-(4-methylbenzene-1-sulfonyl)pyrimidine-2,4(1H,3H)-dione}  \\n\\t(#127# pH 7.4, temperature not specified in the publication <392>) <392>\\nKI\\t#127# 0.05776 {6-methylpyrimidine-2,4(1H,3H)-dione}  (#127# pH 7.4, \\n\\ttemperature not specified in the publication <392>) <392>\\nKI\\t#127# 0.04951 {5-(hydroxymethyl)pyrimidine-2,4(1H,3H)-dione}  (#127# pH \\n\\t7.4, temperature not specified in the publication <392>) <392>\\nKI\\t#127# 0.3162 {1,3-dimethylpyrimidine-2,4(1H,3H)-dione}  (#127# pH 7.4, \\n\\ttemperature not specified in the publication <392>) <392>\\nKI\\t#127# 0.0007325 {Orotic acid}  (#127# pH 7.4, temperature not specified \\n\\tin the publication <392>) <392>\\nKI\\t#127# 0.0004585 {Isoorotic acid}  (#127# pH 7.4, temperature not \\n\\tspecified in the publication <392>) <392>\\nKI\\t#127# 0.0001035 {5,6-diamino-1,3-dimethyluracil}  (#127# pH 7.4, \\n\\ttemperature not specified in the publication <392>) <392>\\nKI\\t#127# 4.003 {benzene-1,2-diol}  (#127# pH 7.4, temperature not \\n\\tspecified in the publication <392>) <392>\\nKI\\t#127# 4.003 {catechol}  (#127# pH 8.3, 22C <386>) <386>\\nKI\\t#127# 0.0782 {tert-butyl \\n\\t(2-((6-(methylsulfonyl)benzo[d]thiazol-2-yl)amino)-2-\\n\\toxoethyl)carbamate}  (#127# pH 7.5, 22C <387>) <387>\\nKI\\t#127# 0.0847 {(S)-tert-butyl \\n\\t(1-((4-(6-methylbenzo[d]thiazol-2-yl)phenyl)amino)-1-oxo-3-phenylpropan-\\n\\t2-yl)carbamate}  (#127# pH 7.5, 22C <387>) <387>\\nKI\\t#127# 0.0868 {benzyl \\n\\t(2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)carbamate}  (#127# \\n\\tpH 7.5, 22C <387>) <387>\\nKI\\t#127# 0.0888 {tert-butyl \\n\\t(2-((4-methylbenzo[d]thiazol-2-yl)amino)-2-oxoethyl)-carbamate}  (#127# \\n\\tpH 7.5, 22C <387>) <387>\\nKI\\t#127# 0.0726 {(S)-benzyl \\n\\t(1-((4-methylbenzo[d]thiazol-2-yl)amino)-1-oxopropan-2-yl)carbamate}  \\n\\t(#127# pH 7.5, 22C <387>) <387>\\nKI\\t#127# 0.00741 {pyrogallol}  (#127# pH 8.3, 22C <386>) <386>\\nKI\\t#127# 0.00192 {dobutamin}  (#127# pH 8.3, 22C <386>) <386>\\nKI\\t#127# 0.0004557 \\n\\t{(R)-4-(2,4-dibenzylpiperazine-1-carbonyl)benzenesulfonamide}  (#127# \\n\\tinhibition of isozyme, pH 9.0, 40C <369>) <369>\\nKI\\t#127# 0.0004219 \\n\\t{4-[(2S)-2-benzylpiperazine-1-carbonyl]benzene-1-sulfonamide}  (#127# \\n\\tinhibition of isozyme, pH 9.0, 40C <369>) <369>\\nKI\\t#127# 0.0000377 \\n\\t{(R)-4-(2-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#127# inhibition of isozyme, pH 9.0, 40C <369>) <369>\\nKI\\t#127# 0.0000218 \\n\\t{(R)-1-[4-(benzenesulfonyl)-2-benzylpiperazin-1-yl]ethan-1-one}  (#127# \\n\\tinhibition of isozyme, pH 9.0, 40C <369>) <369>\\nKI\\t#127# 0.0000828 \\n\\t{(S)-4-(4-benzoyl-2-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#127# inhibition of isozyme, pH 9.0, 40C <369>) <369>\\nKI\\t#127# 0.0000295 \\n\\t{(S)-4-[2-benzyl-4-(2-phenylacetyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#127# inhibition of isozyme, pH 9.0, 40C <369>) <369>\\nKI\\t#127# 0.0003303 \\n\\t{(S)-4-[4-(benzenesulfonyl)-2-benzylpiperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#127# inhibition of isozyme, pH 9.0, 40C <369>) <369>\\nKI\\t#127# 0.0000607 \\n\\t{(S)-4-(3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  (#127# \\n\\tinhibition of isozyme hCA I, pH 9.0, 40C <369>) <369>\\nKI\\t#127# 0.0003802 \\n\\t{(R)-4-(3,4-dibenzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#127# inhibition of isozyme hCA I, pH 9.0, 40C <369>) <369>\\nKI\\t#127# 0.0005686 \\n\\t{(S)-4-(3-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#127# inhibition of isozyme hCA I, pH 9.0, 40C <369>) <369>\\nKI\\t#127# 0.0000556 \\n\\t{(R)-4-(4-acetyl-3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#127# inhibition of isozyme hCA I, pH 9.0, 40C <369>) <369>\\nKI\\t#127# 0.0000307 \\n\\t{(S)-4-(4-benzoyl-3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#127# inhibition of isozyme hCA I, pH 9.0, 40C <369>) <369>\\nKI\\t#127# 0.0005426 \\n\\t{(S)-4-[3-benzyl-4-(2-phenylacetyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#127# inhibition of isozyme hCA I, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#127# 0.0000516 \\n\\t{(R)-4-[4-(benzenesulfonyl)-3-benzylpiperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#127# inhibition of isozyme hCA I, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#127# 0.0000572 \\n\\t{(R)-17(R)-4-[2-benzyl-4-(4-sulfamoylbenzoyl)piperazine-1-\\n\\tcarbonyl]benzene-1-sulfonamide}  (#127# inhibition of isozyme hCA I, pH \\n\\t9.0, 40C <369>) <369>\\nKI\\t#127# 0.0000316 \\n\\t{1-(4-chlorobenzyl)-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  (#127# \\n\\tpH not specified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nKI\\t#127# 0.0000199 \\n\\t{2,2\\'-(1-(4-methoxyphenyl)ethane-1,1-diyl)bis(sulfanediyl)diacetic \\n\\tacid}  (#127# pH 8, 25C <431>) <431>\\nKI\\t#127# 0.0000199 \\n\\t{2,2\\'-(1-(4-methoxyphenyl)ethane-1,\\n\\t1-diyl)bis(sulfanediyl)bis(N-(pyridin-2-yl)acetamide)}  (#127# pH 8, \\n\\t25C <431>) <431>\\nKI\\t#127# 0.0000385 \\n\\t{6-([1,1\\'-biphenyl]-4-yl)-2-((2-chloro-6-fluorobenzyl)thio)imidazo \\n\\t[2,1-b][1,3,4]thiadiazole}  (#127# pH not specified in the publication, \\n\\ttemperature not specified in the publication <413>) <413>\\nKI\\t#127# 0.0000248 \\n\\t{2,2\\'-(1-(4-nitrophenyl)ethane-1,\\n\\t1-diyl)bis(sulfanediyl)bis(N-(pyridin-2-yl)acetamide)}  (#127# pH 8, \\n\\t25C <431>) <431>\\nKI\\t#127# 0.0000248 \\n\\t{4-((2-((2,6-difluorobenzyl)thio)-6-phenylimidazo[2,1-b][1,3,4] \\n\\tthiadiazol-5-yl)methyl)-morpholine}  (#127# pH not specified in the \\n\\tpublication, temperature not specified in the publication <413>) <413>\\nKI\\t#127# 0.0000355 \\n\\t{2-((2,6-dichlorobenzyl)thio)-6-phenyl-5-(piperidin-1-ylmethyl) \\n\\timidazo[2,1-b][1,3,4]-thiadiazole}  (#127# pH not specified in the \\n\\tpublication, temperature not specified in the publication <413>) <413>\\nKI\\t#127# 0.0000514 \\n\\t{3-iodo-1-(prop-2-yn-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  (#127# \\n\\tpH not specified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nKI\\t#127# 0.0000352 \\n\\t{3-iodo-1-(4-methoxybenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  \\n\\t(#127# pH not specified in the publication, temperature not specified \\n\\tin the publication <410>) <410>\\nKI\\t#127# 0.0002686 {[[(eta5-C5H4)-C(CH3)=N-N(H)-C6H4-4-SO2NH2]]Mn(CO)3}  \\n\\t(#127# isoform CA I, at pH 7.5 and 25C <437>) <437>\\nKI\\t#127# 0.0000337 {1-benzyl-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  \\n\\t(#127# pH not specified in the publication, temperature not specified \\n\\tin the publication <410>) <410>\\nKI\\t#127# 0.0000308 \\n\\t{(E)-3-iodo-1-styryl-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  (#127# pH \\n\\tnot specified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nKI\\t#127# 0.0000308 \\n\\t{2-((2,6-dichlorobenzyl)thio)-6-phenylimidazo[2,1-b][1,3,4] \\n\\tthiadiazole}  (#127# pH not specified in the publication, temperature \\n\\tnot specified in the publication <413>) <413>\\nKI\\t#127# 0.0000231 \\n\\t{3-iodo-1-phenethyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  (#127# pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nKI\\t#127# 0.0000604 \\n\\t{4-[(4-amino-3-iodo-1H-pyrazolo[3,\\n\\t4-d]pyrimidin-1-yl)methyl]phenylmethanesulfonate}  (#127# pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nKI\\t#127# 0.0000663 \\n\\t{4-[(4-amino-3-iodo-1H-pyrazolo[3,\\n\\t4-d]pyrimidin-1-yl)methyl]-2-methoxyphenyl methanesulfonate}  (#127# pH \\n\\tnot specified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nKI\\t#127# 0.0000625 \\n\\t{6-(4-bromophenyl)-2-((2-chloro-6-fluorobenzyl)thio)imidazo[2,1-b][1,3,\\n\\t4]thiadiazole}  (#127# pH not specified in the publication, temperature \\n\\tnot specified in the publication <413>) <413>\\nKI\\t#127# 0.0000636 \\n\\t{2-((2-chloro-6-fluorobenzyl)thio)-6-(4-methoxyphenyl)imidazo \\n\\t[2,1-b][1,3,4]thiadiazole}  (#127# pH not specified in the publication, \\n\\ttemperature not specified in the publication <413>) <413>\\nKI\\t#127# 0.0000238 \\n\\t{2-((2-chloro-6-fluorobenzyl)thio)-6-(3,4-dichlorophenyl)imidazo \\n\\t[2,1-b][1,3,4]thiadiazole}  (#127# pH not specified in the publication, \\n\\ttemperature not specified in the publication <413>) <413>\\nKI\\t#127# 0.0000288 \\n\\t{4-((2-((2-chloro-6-fluorobenzyl)thio)-6-phenylimidazo[2,1-b] \\n\\t[1,3,4]thiadiazol-5-yl)methyl)morpholine}  (#127# pH not specified in \\n\\tthe publication, temperature not specified in the publication <413>) \\n\\t<413>\\nKI\\t#127# 0.0000288 \\n\\t{4-((2-((2,6-dichlorobenzyl)thio)-6-phenylimidazo[2,1-b][1,3,4] \\n\\tthiadiazol-5-yl)methyl)-morpholine}  (#127# pH not specified in the \\n\\tpublication, temperature not specified in the publication <413>) <413>\\nKI\\t#127# 0.0000433 \\n\\t{2-((2,6-dichlorobenzyl)thio)-6-phenyl-5-(pyrrolidin-1-ylmethyl) \\n\\timidazo[2,1-b][1,3,4]-thiadiazole}  (#127# pH not specified in the \\n\\tpublication, temperature not specified in the publication <413>) <413>\\nKI\\t#127# 0.000501 {acetazolamide}  (#127# pH not specified in the \\n\\tpublication, temperature not specified in the publication <409>) <409>\\nKI\\t#127,128# 0.0000036 \\n\\t{(R)-4-[4-(benzenesulfonyl)-2-benzylpiperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#127# inhibition of isozyme hCA I, pH 9.0, 40C <369>; \\n\\t#128# inhibition of isozyme hCA IV, pH 9.0, 40C <369>) <369>\\nKI\\t#128# 0.015 {4,5-dichloro-benzene-1,3-disulfonamide}  (#128# isoenzyme \\n\\thCA IV, i.e. daranide <169>) <169>\\nKI\\t#128# 0.000002 \\n\\t{(R)-4-(2-benzyl-4-methanesulfonylpiperazine-1-carbonyl)benzene-1-\\n\\tsulfonamide}  (#128# inhibition of isozyme hCA IV, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#128# 0.000095 {sulthiame}  (#128# isoenzyme hCA IV <170>) <170>\\nKI\\t#128# 0.0048 {6-trifluoromethyl-4-aminobenzene-1,3-disulfonamide}  \\n\\t(#128# isoenzyme hCA IV <169>) <169>\\nKI\\t#128# 0.0062 \\n\\t{N-[5-(aminosulfonyl)-3-methyl-1,3,\\n\\t4-thiadiazol-2(3H)-ylidene]acetamide}  (#128# isoenzyme hCA IV <169>) \\n\\t<169>\\nKI\\t#128# 0.0085 \\n\\t{6-methyl-4-(methylamino)-5,6-dihydro-4H-thieno[2,\\n\\t3-b]thiopyran-2-sulfonamide 7,7-dioxide}  (#128# isoenzyme hCA IV \\n\\t<169>) <169>\\nKI\\t#128# 0.0085 {dorzolamide}  (#128# isoenzyme hCA IV <171>) <171>\\nKI\\t#128# 0.000004 \\n\\t{(R)-4-(4-benzoyl-3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#128# inhibition of isozyme hCA IV, pH 9.0, 40C <369>) <369>\\nKI\\t#128# 0.000019 \\n\\t{(R)-4-(3-benzyl-4-methanesulfonylpiperazine-1-carbonyl)benzene-1-\\n\\tsulfonamide}  (#128# inhibition of isozyme hCA IV, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#128# 0.000068 \\n\\t{(S)-4-(4-benzoyl-3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#128# inhibition of isozyme hCA IV, pH 9.0, 40C <369>) <369>\\nKI\\t#128# 0.000006 \\n\\t{(S)-1-[4-(benzenesulfonyl)-2-benzylpiperazin-1-yl]ethan-1-one}  (#128# \\n\\tinhibition of isozyme hCA IV, pH 9.0, 40C <369>) <369>\\nKI\\t#128# 0.0000026 \\n\\t{(R)-4-[3-benzyl-4-(2-phenylacetyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#128# inhibition of isozyme hCA IV, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#128# 0.0000017 \\n\\t{(R)-4-(3-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#128# inhibition of isozyme hCA IV, pH 9.0, 40C <369>) <369>\\nKI\\t#128# 0.0000023 \\n\\t{(R)-4-[2-benzyl-4-(2-phenylacetyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#128# inhibition of isozyme hCA IV, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#128# 0.0000023 \\n\\t{(R)-4-(3,4-dibenzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#128# inhibition of isozyme hCA IV, pH 9.0, 40C <369>) <369>\\nKI\\t#128# 0.0000046 \\n\\t{(R)-4-(3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  (#128# \\n\\tinhibition of isozyme hCA IV, pH 9.0, 40C <369>) <369>\\nKI\\t#128# 0.0000235 \\n\\t{2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide}  (#128# \\n\\tisoenzyme hCA IV <172>) <172>\\nKI\\t#128# 0.00038 {6-chloro-4-amino-benzene-1,3-disulfonamide}  (#128# \\n\\tisoenzyme hCA IV <169>) <169>\\nKI\\t#128# 0.0000029 \\n\\t{(R)-1-[4-(benzenesulfonyl)-2-benzylpiperazin-1-yl]ethan-1-one}  (#128# \\n\\tinhibition of isozyme hCA IV, pH 9.0, 40C <369>) <369>\\nKI\\t#128# 0.0000033 \\n\\t{(R)-4-(4-acetyl-3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#128# inhibition of isozyme hCA IV, pH 9.0, 40C <369>) <369>\\nKI\\t#128# 0.0000036 {(R)- \\n\\t4-(2-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#128# inhibition of isozyme hCA IV, pH 9.0, 40C <369>) <369>\\nKI\\t#128# 0.0000056 \\n\\t{4-[(2R)-2-benzylpiperazine-1-carbonyl]benzene-1-sulfonamide}  (#128# \\n\\tinhibition of isozyme hCA IV, pH 9.0, 40C <369>) <369>\\nKI\\t#128# 0.000139 \\n\\t{(S)-4-[2-benzyl-4-(4-sulfamoylbenzoyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#128# inhibition of isozyme hCA IV, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#128# 0.000146 \\n\\t{(S)-4-(3-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#128# inhibition of isozyme hCA IV, pH 9.0, 40C <369>) <369>\\nKI\\t#128# 0.0000078 {(S)- \\n\\t4-(4-benzoyl-2-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#128# inhibition of isozyme hCA IV, pH 9.0, 40C <369>) <369>\\nKI\\t#128# 0.0000078 \\n\\t{(S)-4-[4-(benzenesulfonyl)-2-benzylpiperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#128# inhibition of isozyme hCA IV, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#128# 0.0000733 \\n\\t{(S)-4-(3,4-dibenzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#128# inhibition of isozyme hCA IV, pH 9.0, 40C <369>) <369>\\nKI\\t#128# 0.0000054 \\n\\t{(S)-4-[2-benzyl-4-(2-phenylacetyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#128# inhibition of isozyme hCA IV, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#128# 0.0000087 \\n\\t{(R)-4-[4-(benzenesulfonyl)-3-benzylpiperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#128# inhibition of isozyme hCA IV, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#128# 0.000427 {hydrochlorothiazide}  (#128# isoenzyme hCA IV <169>) \\n\\t<169>\\nKI\\t#128# 0.000564 {Furosemide}  (#128# isoenzyme hCA IV <169>) <169>\\nKI\\t#128# 0.00395 {brinzolamide}  (#128# isoenzyme hCA IV catalytic domain \\n\\t<171>) <171>\\nKI\\t#128# 0.00859 {zonisamide}  (#128# isoenzyme hCA IV catalytic domain \\n\\t<171>) <171>\\nKI\\t#128# 0.0000051 \\n\\t{(R)-17(R)-4-[2-benzyl-4-(4-sulfamoylbenzoyl)piperazine-1-\\n\\tcarbonyl]benzene-1-sulfonamide}  (#128# inhibition of isozyme hCA IV, \\n\\tpH 9.0, 40C <369>) <369>\\nKI\\t#128# 0.000371 \\n\\t{(S)-4-[3-benzyl-4-(2-phenylacetyl)piperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#128# inhibition of isozyme hCA IV, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#128# 0.0000725 \\n\\t{(S)-4-(2-benzyl-4-methanesulfonylpiperazine-1-carbonyl)benzene-1-\\n\\tsulfonamide}  (#128# inhibition of isozyme hCA IV, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#128# 0.0000668 \\n\\t{(S)-4-(4-acetyl-3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#128# inhibition of isozyme hCA IV, pH 9.0, 40C <369>) <369>\\nKI\\t#128# 0.0000793 \\n\\t{(S)-4-(2,4-dibenzylpiperazine-1-carbonyl)benzenesulfonamide}  (#128# \\n\\tinhibition of isozyme hCA IV, pH 9.0, 40C <369>) <369>\\nKI\\t#128# 0.0000669 \\n\\t{(R)-4-(2,4-dibenzylpiperazine-1-carbonyl)benzenesulfonamide}  (#128# \\n\\tinhibition of isozyme hCA IV, pH 9.0, 40C <369>) <369>\\nKI\\t#128# 0.0000754 \\n\\t{4-[(2S)-2-benzylpiperazine-1-carbonyl]benzene-1-sulfonamide}  (#128# \\n\\tinhibition of isozyme hCA IV, pH 9.0, 40C <369>) <369>\\nKI\\t#128# 0.0003425 {(S)- \\n\\t4-(2-benzyl-4-methylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#128# inhibition of isozyme hCA IV, pH 9.0, 40C <369>) <369>\\nKI\\t#128# 0.0001334 {(R)- \\n\\t4-(4-benzoyl-2-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  \\n\\t(#128# inhibition of isozyme hCA IV, pH 9.0, 40C <369>) <369>\\nKI\\t#128# 0.0000293 \\n\\t{(S)-4-(3-benzylpiperazine-1-carbonyl)benzene-1-sulfonamide}  (#128# \\n\\tinhibition of isozyme hCA IV, pH 9.0, 40C <369>) <369>\\nKI\\t#128# 0.0000797 \\n\\t{(S)-4-(3-benzyl-4-methanesulfonylpiperazine-1-carbonyl)benzene-1-\\n\\tsulfonamide}  (#128# inhibition of isozyme hCA IV, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#128# 0.0000622 \\n\\t{(S)-4-[4-(benzenesulfonyl)-3-benzylpiperazine-1-carbonyl]benzene-1-\\n\\tsulfonamide}  (#128# inhibition of isozyme hCA IV, pH 9.0, 40C <369>) \\n\\t<369>\\nKI\\t#129# 0.00005 \\n\\t{2-(3-methoxypropyl)-4-(methylamino)-3,4-dihydro-2H-thieno[3,2-e][1,\\n\\t2]thiazine-6-sulfonamide 1,1-dioxide}  (#129# isoenzyme hCA VA <169>) \\n\\t<169>\\nKI\\t#129# 0.00005 {brinzolamide}  (#129# isoenzyme hCA VA catalytic domain \\n\\t<171>) <171>\\nKI\\t#129# 0.000042 \\n\\t{6-methyl-4-(methylamino)-5,6-dihydro-4H-thieno[2,\\n\\t3-b]thiopyran-2-sulfonamide 7,7-dioxide}  (#129# isoenzyme hCA VA \\n\\t<169>) <169>\\nKI\\t#129# 0.000042 {dorzolamide}  (#129# isoenzyme hCA VA <171>) <171>\\nKI\\t#129# 0.00002 {zonisamide}  (#129# isoenzyme hCA VA catalytic domain \\n\\t<171>) <171>\\nKI\\t#129# 0.000065 \\n\\t{N-[5-(aminosulfonyl)-3-methyl-1,3,\\n\\t4-thiadiazol-2(3H)-ylidene]acetamide}  (#129# isoenzyme hCA VA <169>) \\n\\t<169>\\nKI\\t#129# 0.0094 {6-trifluoromethyl-4-aminobenzene-1,3-disulfonamide}  \\n\\t(#129# isoenzyme hCA VA <169>) <169>\\nKI\\t#129# 0.000438 \\n\\t{2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide}  (#129# \\n\\tisoenzyme hCA VA <172>) <172>\\nKI\\t#129# 0.00063 {4,5-dichloro-benzene-1,3-disulfonamide}  (#129# \\n\\tisoenzyme hCA VA, i.e. daranide <169>) <169>\\nKI\\t#129# 0.000081 {sulthiame}  (#129# isoenzyme hCA VA <170>) <170>\\nKI\\t#129# 0.00415 {6-chloro-4-amino-benzene-1,3-disulfonamide}  (#129# \\n\\tisoenzyme hCA VA <169>) <169>\\nKI\\t#129# 0.004225 {hydrochlorothiazide}  (#129# isoenzyme hCA VA <169>) \\n\\t<169>\\nKI\\t#129# 0.000499 {Furosemide}  (#129# isoenzyme hCA VA <169>) <169>\\nKI\\t#130# 0.0062 {6-chloro-4-amino-benzene-1,3-disulfonamide}  (#130# \\n\\tisoenzyme hCA VB <169>) <169>\\nKI\\t#130# 0.00003 \\n\\t{2-(3-methoxypropyl)-4-(methylamino)-3,4-dihydro-2H-thieno[3,2-e][1,\\n\\t2]thiazine-6-sulfonamide 1,1-dioxide}  (#130# isoenzyme hCA VB <169>) \\n\\t<169>\\nKI\\t#130# 0.00003 {brinzolamide}  (#130# isoenzyme hCA VB catalytic domain \\n\\t<171>) <171>\\nKI\\t#130# 0.000033 \\n\\t{6-methyl-4-(methylamino)-5,6-dihydro-4H-thieno[2,\\n\\t3-b]thiopyran-2-sulfonamide 7,7-dioxide}  (#130# isoenzyme hCA VB \\n\\t<169>) <169>\\nKI\\t#130# 0.000033 {dorzolamide}  (#130# isoenzyme hCA VB <171>) <171>\\nKI\\t#130# 0.0065 {6-trifluoromethyl-4-aminobenzene-1,3-disulfonamide}  \\n\\t(#130# isoenzyme hCA VB <169>) <169>\\nKI\\t#130# 0.000021 {4,5-dichloro-benzene-1,3-disulfonamide}  (#130# \\n\\tisoenzyme hCA VB, i.e. daranide <169>) <169>\\nKI\\t#130# 0.000091 {sulthiame}  (#130# isoenzyme hCA VB <170>) <170>\\nKI\\t#130# 0.000062 \\n\\t{N-[5-(aminosulfonyl)-3-methyl-1,3,\\n\\t4-thiadiazol-2(3H)-ylidene]acetamide}  (#130# isoenzyme hCA VB <169>) \\n\\t<169>\\nKI\\t#130# 0.000603 {hydrochlorothiazide}  (#130# isoenzyme hCA VB <169>) \\n\\t<169>\\nKI\\t#130# 0.000322 {Furosemide}  (#130# isoenzyme hCA VB <169>) <169>\\nKI\\t#130# 0.006033 {zonisamide}  (#130# isoenzyme hCA VB catalytic domain \\n\\t<171>) <171>\\nKI\\t#130# 0.001422 \\n\\t{2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide}  (#130# \\n\\tisoenzyme hCA VB <172>) <172>\\nKI\\t#131# 0.00001 \\n\\t{N-[5-(aminosulfonyl)-3-methyl-1,3,\\n\\t4-thiadiazol-2(3H)-ylidene]acetamide}  (#131# isoenzyme hCA VI <169>) \\n\\t<169>\\nKI\\t#131# 0.00001 \\n\\t{6-methyl-4-(methylamino)-5,6-dihydro-4H-thieno[2,\\n\\t3-b]thiopyran-2-sulfonamide 7,7-dioxide}  (#131# isoenzyme hCA VI \\n\\t<169>) <169>\\nKI\\t#131# 0.00001 {dorzolamide}  (#131# 20C, pH 7.5, full-length \\n\\trecombinant hCA VI <184>; #131# isoenzyme hCA VI <171>) <171,184>\\nKI\\t#131# 0.0048 {4-(aminomethyl)benzenesulfonamide}  (#131# 20C, pH 7.5, \\n\\tfull-length recombinant hCA VI <184>) <184>\\nKI\\t#131# 0.000024 \\n\\t{4-amino-N-[2-[4-(aminosulfonyl)phenyl]ethyl]benzenesulfonamide}  \\n\\t(#131# 20C, pH 7.5, full-length recombinant hCA VI <184>) <184>\\nKI\\t#131# 0.000023 {acetazolamide}  (#131# milk isoform CA VI, at pH 7.5, \\n\\ttemperature not specified in the publication <445>) <445>\\nKI\\t#131# 0.00074 \\n\\t{5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide}  (#131# \\n\\t20C, pH 7.5, full-length recombinant hCA VI <184>) <184>\\nKI\\t#131# 0.00109 {2-hydrazinobenzenesulfonamide}  (#131# 20C, pH 7.5, \\n\\tfull-length recombinant hCA VI <184>) <184>\\nKI\\t#131# 0.000009 {brinzolamide}  (#131# isoenzyme hCA VI catalytic domain \\n\\t<171>) <171>\\nKI\\t#131# 0.000055 {4-amino-N-[4-(aminosulfonyl)benzyl]benzenesulfonamide}  \\n\\t(#131# 20C, pH 7.5, full-length recombinant hCA VI <184>) <184>\\nKI\\t#131# 0.0000009 \\n\\t{2-(3-methoxypropyl)-4-(methylamino)-3,4-dihydro-2H-thieno[3,2-e][1,\\n\\t2]thiazine-6-sulfonamide 1,1-dioxide}  (#131# isoenzyme hCA VI <169>) \\n\\t<169>\\nKI\\t#131# 0.0000009 {brinzolamide}  (#131# 20C, pH 7.5, full-length \\n\\trecombinant hCA VI <184>) <184>\\nKI\\t#131# 0.000073 \\n\\t{5-[[(4-aminophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#131# 20C, pH 7.5, full-length recombinant hCA VI <184>) <184>\\nKI\\t#131# 0.0000008 {sulpiride}  (#131# 20C, pH 7.5, full-length \\n\\trecombinant hCA VI <184>) <184>\\nKI\\t#131# 0.000047 {indisulam}  (#131# 20C, pH 7.5, full-length \\n\\trecombinant hCA VI <184>) <184>\\nKI\\t#131# 0.000096 {4-amino-3-fluorobenzenesulfonamide}  (#131# 20C, pH \\n\\t7.5, full-length recombinant hCA VI <184>) <184>\\nKI\\t#131# 0.000134 {sulthiame}  (#131# isoenzyme hCA VI <170>) <170>\\nKI\\t#131# 0.000089 {zonisamide}  (#131# isoenzyme hCA VI catalytic domain \\n\\t<171>) <171>\\nKI\\t#131# 0.000114 {5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#131# 20C, pH 7.5, full-length recombinant hCA VI <184>) <184>\\nKI\\t#131# 0.001024 {4-amino-3-iodobenzenesulfonamide}  (#131# 20C, pH 7.5, \\n\\tfull-length recombinant hCA VI <184>) <184>\\nKI\\t#131# 0.000079 {4,5-dichloro-benzene-1,3-disulfonamide}  (#131# \\n\\tisoenzyme hCA VI, i.e. daranide <169>) <169>\\nKI\\t#131# 0.000079 {dichlorophenamide}  (#131# 20C, pH 7.5, full-length \\n\\trecombinant hCA VI <184>) <184>\\nKI\\t#131# 0.000093 {benzolamide}  (#131# 20C, pH 7.5, full-length \\n\\trecombinant hCA VI <184>) <184>\\nKI\\t#131# 0.000103 {6-hydroxy-1,3-benzothiazole-2-sulfonamide}  (#131# \\n\\t20C, pH 7.5, full-length recombinant hCA VI <184>) <184>\\nKI\\t#131# 0.000086 {4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide}  \\n\\t(#131# 20C, pH 7.5, full-length recombinant hCA VI <184>) <184>\\nKI\\t#131# 0.00415 {4-(2-hydroxyethyl)benzenesulfonamide}  (#131# 20C, pH \\n\\t7.5, full-length recombinant hCA VI <184>) <184>\\nKI\\t#131# 0.00215 \\n\\t{2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide}  (#131# \\n\\tisoenzyme hCA VI <172>) <172>\\nKI\\t#131# 0.000245 {Furosemide}  (#131# isoenzyme hCA VI <169>) <169>\\nKI\\t#131# 0.000798 {5-amino-1,3,4-thiadiazole-2-sulfonamide}  (#131# 20C, \\n\\tpH 7.5, full-length recombinant hCA VI <184>) <184>\\nKI\\t#131# 0.000608 {6-chloro-4-amino-benzene-1,3-disulfonamide}  (#131# \\n\\tisoenzyme hCA VI <169>) <169>\\nKI\\t#131# 0.000608 {4-amino-6-chlorobenzene-1,3-disulfonamide}  (#131# \\n\\t20C, pH 7.5, full-length recombinant hCA VI <184>) <184>\\nKI\\t#131# 0.000955 {6-trifluoromethyl-4-aminobenzene-1,3-disulfonamide}  \\n\\t(#131# isoenzyme hCA VI <169>) <169>\\nKI\\t#131# 0.000955 {4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide}  \\n\\t(#131# 20C, pH 7.5, full-length recombinant hCA VI <184>) <184>\\nKI\\t#131# 0.003655 {hydrochlorothiazide}  (#131# isoenzyme hCA VI <169>) \\n\\t<169>\\nKI\\t#131# 0.000772 {2-aminobenzenesulfonamide}  (#131# 20C, pH 7.5, \\n\\tfull-length recombinant hCA VI <184>) <184>\\nKI\\t#131# 0.000941 {4-Aminobenzenesulfonamide}  (#131# 20C, pH 7.5, \\n\\tfull-length recombinant hCA VI <184>) <184>\\nKI\\t#131# 0.001275 {4-hydrazinobenzenesulfonamide}  (#131# 20C, pH 7.5, \\n\\tfull-length recombinant hCA VI <184>) <184>\\nKI\\t#131# 0.001582 {4-methylbenzenesulfonamide}  (#131# 20C, pH 7.5, \\n\\tfull-length recombinant hCA VI <184>) <184>\\nKI\\t#131# 0.000813 {4-(2-aminoethyl)benzenesulfonamide}  (#131# 20C, pH \\n\\t7.5, full-length recombinant hCA VI <184>) <184>\\nKI\\t#131# 0.001097 {4-amino-3-chlorobenzenesulfonamide}  (#131# 20C, pH \\n\\t7.5, full-length recombinant hCA VI <184>) <184>\\nKI\\t#131# 0.00468 {4-amino-3-bromobenzenesulfonamide}  (#131# 20C, pH 7.5, \\n\\tfull-length recombinant hCA VI <184>) <184>\\nKI\\t#131# 0.00668 {4-(hydroxymethyl)benzenesulfonamide}  (#131# 20C, pH \\n\\t7.5, full-length recombinant hCA VI <184>) <184>\\nKI\\t#131# 0.000887 {4-(aminosulfonyl)benzoic acid}  (#131# 20C, pH 7.5, \\n\\tfull-length recombinant hCA VI <184>) <184>\\nKI\\t#132# 0.01 {tobramycin}  (#132# at pH 8.0, temperature not specified in \\n\\tthe publication <418>) <418>\\nKI\\t#132# 0.0006 {amoxicillin}  (#132# at pH 8.0, temperature not specified \\n\\tin the publication <418>) <418>\\nKI\\t#132# 0.0003 {cefoperazone}  (#132# at pH 8.0, temperature not \\n\\tspecified in the publication <418>) <418>\\nKI\\t#132# 0.0001 {6-trifluoromethyl-4-aminobenzene-1,3-disulfonamide}  \\n\\t(#132# isoenzyme hCA VII <169>) <169>\\nKI\\t#132# 0.00003 {kanamycin sulfate}  (#132# at pH 8.0, temperature not \\n\\tspecified in the publication <418>) <418>\\nKI\\t#132# 0.08 {Vancomycin}  (#132# at pH 8.0, temperature not specified in \\n\\tthe publication <418>) <418>\\nKI\\t#132# 0.00073 {gentamicin sulfate}  (#132# at pH 8.0, temperature not \\n\\tspecified in the publication <418>) <418>\\nKI\\t#132# 0.0018 {clindamycin phosphate}  (#132# at pH 8.0, temperature not \\n\\tspecified in the publication <418>) <418>\\nKI\\t#132# 0.00000061 \\n\\t{2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide}  (#132# \\n\\tisoenzyme hCA VII <172>) <172>\\nKI\\t#132# 0.000006 {sulthiame}  (#132# isoenzyme hCA VII <170>) <170>\\nKI\\t#132# 0.000026 {4,5-dichloro-benzene-1,3-disulfonamide}  (#132# \\n\\tisoenzyme hCA VII, i.e. daranide <169>) <169>\\nKI\\t#132# 0.0000028 \\n\\t{2-(3-methoxypropyl)-4-(methylamino)-3,4-dihydro-2H-thieno[3,2-e][1,\\n\\t2]thiazine-6-sulfonamide 1,1-dioxide}  (#132# isoenzyme hCA VII <169>) \\n\\t<169>\\nKI\\t#132# 0.0000028 {brinzolamide}  (#132# isoenzyme hCA VII catalytic \\n\\tdomain <171>) <171>\\nKI\\t#132# 0.00089 {teicoplanin}  (#132# at pH 8.0, temperature not \\n\\tspecified in the publication <418>) <418>\\nKI\\t#132# 0.00021 {6-chloro-4-amino-benzene-1,3-disulfonamide}  (#132# \\n\\tisoenzyme hCA VII <169>) <169>\\nKI\\t#132# 0.00029 {rifamycin}  (#132# at pH 8.0, temperature not specified \\n\\tin the publication <418>) <418>\\nKI\\t#132# 0.00495 {cefazolin}  (#132# at pH 8.0, temperature not specified \\n\\tin the publication <418>) <418>\\nKI\\t#132# 0.0000021 \\n\\t{N-[5-(aminosulfonyl)-3-methyl-1,3,\\n\\t4-thiadiazol-2(3H)-ylidene]acetamide}  (#132# isoenzyme hCA VII <169>) \\n\\t<169>\\nKI\\t#132# 0.000513 {Furosemide}  (#132# isoenzyme hCA VII <169>) <169>\\nKI\\t#132# 0.00501 {hydrochlorothiazide}  (#132# isoenzyme hCA VII <169>) \\n\\t<169>\\nKI\\t#132# 0.00827 {amikacin sulfate}  (#132# at pH 8.0, temperature not \\n\\tspecified in the publication <418>) <418>\\nKI\\t#132# 0.00534 {cefuroxime}  (#132# at pH 8.0, temperature not specified \\n\\tin the publication <418>) <418>\\nKI\\t#132# 0.00846 {ampicillin}  (#132# at pH 8.0, temperature not specified \\n\\tin the publication <418>) <418>\\nKI\\t#132# 0.00778 {piperacillin}  (#132# at pH 8.0, temperature not \\n\\tspecified in the publication <418>) <418>\\nKI\\t#132# 0.00952 {Lincomycin}  (#132# at pH 8.0, temperature not specified \\n\\tin the publication <418>) <418>\\nKI\\t#132# 0.1576 {ceftriaxone}  (#132# at pH 8.0, temperature not specified \\n\\tin the publication <418>) <418>\\nKI\\t#133# 0.031 {Cyanate}  (#133# pH 7.5, 25C, mCA V <118>) <118>\\nKI\\t#133# 0.00006 {acetazolamide}  (#133# pH 7.5, 25C, mCA V <118>) <118>\\nKI\\t#133# 0.00025 {Cyanate}  (#133# pH 7.5, 25C, mCA XIII <118>) <118>\\nKI\\t#133# 0.00001 {brinzolamide}  (#133# isoenzyme mCA XIII catalytic \\n\\tdomain <171>) <171>\\nKI\\t#133# 0.000023 {4,5-dichloro-benzene-1,3-disulfonamide}  (#133# \\n\\tisoenzyme mCA XIII, i.e. daranide <169>) <169>\\nKI\\t#133# 0.000018 \\n\\t{6-methyl-4-(methylamino)-5,6-dihydro-4H-thieno[2,\\n\\t3-b]thiopyran-2-sulfonamide 7,7-dioxide}  (#133# isoenzyme mCA XIII \\n\\t<169>) <169>\\nKI\\t#133# 0.000018 {dorzolamide}  (#133# isoenzyme mCA XIII <171>) <171>\\nKI\\t#133# 0.000019 \\n\\t{N-[5-(aminosulfonyl)-3-methyl-1,3,\\n\\t4-thiadiazol-2(3H)-ylidene]acetamide}  (#133# isoenzyme mCA XIII <169>) \\n\\t<169>\\nKI\\t#133# 0.00002 {6-trifluoromethyl-4-aminobenzene-1,3-disulfonamide}  \\n\\t(#133# isoenzyme mCA XIII <169>) <169>\\nKI\\t#133# 0.00002 \\n\\t{2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide}  (#133# \\n\\tisoenzyme mCA XIII <172>) <172>\\nKI\\t#133# 0.000021 {6-chloro-4-amino-benzene-1,3-disulfonamide}  (#133# \\n\\tisoenzyme mCA XIII <169>) <169>\\nKI\\t#133# 0.00043 {zonisamide}  (#133# isoenzyme mCA XIII catalytic domain \\n\\t<171>) <171>\\nKI\\t#133# 0.000425 {valdecoxib}  (#133# carbonic anhydrase XIII <175>) <175>\\nKI\\t#133# 0.00055 {Furosemide}  (#133# isoenzyme mCA XIII <169>) <169>\\nKI\\t#133# 0.00145 {sulthiame}  (#133# isoenzyme mCA XIII <170>) <170>\\nKI\\t#133# 0.003885 {hydrochlorothiazide}  (#133# isoenzyme mCA XIII <169>) \\n\\t<169>\\nKI\\t#133# 0.002633 {2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide} \\n\\t (#133# isoenzyme mCA XIII <171>) <171>\\nKI\\t#134# 0.000021 {acetazolamide}  (#134# isoenzyme hpalphaCA <169>) <169>\\nKI\\t#134# 0.00021 \\n\\t{2-(3-methoxypropyl)-4-(methylamino)-3,4-dihydro-2H-thieno[3,2-e][1,\\n\\t2]thiazine-6-sulfonamide 1,1-dioxide}  (#134# isoenzyme hpalphaCA \\n\\t<169>) <169>\\nKI\\t#134# 0.000172 {topiramate}  (#134# isoenzyme hpalphaCA <169>) <169>\\nKI\\t#134# 0.00436 \\n\\t{6-methyl-4-(methylamino)-5,6-dihydro-4H-thieno[2,\\n\\t3-b]thiopyran-2-sulfonamide 7,7-dioxide}  (#134# isoenzyme hpalphaCA \\n\\t<169>) <169>\\nKI\\t#134# 0.000049 {6-chloro-4-amino-benzene-1,3-disulfonamide}  (#134# \\n\\tisoenzyme hpalphaCA <169>) <169>\\nKI\\t#134# 0.000225 \\n\\t{N-[5-(aminosulfonyl)-3-methyl-1,3,\\n\\t4-thiadiazol-2(3H)-ylidene]acetamide}  (#134# isoenzyme hpalphaCA \\n\\t<169>) <169>\\nKI\\t#134# 0.000193 {ethoxzolamide}  (#134# isoenzyme hpalphaCA <169>) <169>\\nKI\\t#134# 0.000378 {4,5-dichloro-benzene-1,3-disulfonamide}  (#134# \\n\\tisoenzyme hpalphaCA, i.e. daranide <169>) <169>\\nKI\\t#134# 0.000412 {6-trifluoromethyl-4-aminobenzene-1,3-disulfonamide}  \\n\\t(#134# isoenzyme hpalphaCA <169>) <169>\\nKI\\t#135# 0.000033 {ethoxzolamide}  (#135# isoenzyme hpbetaCA <169>) <169>\\nKI\\t#135# 0.000032 {topiramate}  (#135# isoenzyme hpbetaCA <169>) <169>\\nKI\\t#135# 0.00064 {6-chloro-4-amino-benzene-1,3-disulfonamide}  (#135# \\n\\tisoenzyme hpbetaCA <169>) <169>\\nKI\\t#135# 0.000128 \\n\\t{2-(3-methoxypropyl)-4-(methylamino)-3,4-dihydro-2H-thieno[3,2-e][1,\\n\\t2]thiazine-6-sulfonamide 1,1-dioxide}  (#135# isoenzyme hpbetaCA <169>) \\n\\t<169>\\nKI\\t#135# 0.000105 {4,5-dichloro-benzene-1,3-disulfonamide}  (#135# \\n\\tisoenzyme hpbetaCA, i.e. daranide <169>) <169>\\nKI\\t#135# 0.000073 \\n\\t{6-methyl-4-(methylamino)-5,6-dihydro-4H-thieno[2,\\n\\t3-b]thiopyran-2-sulfonamide 7,7-dioxide}  (#135# isoenzyme hpbetaCA \\n\\t<169>) <169>\\nKI\\t#135# 0.000176 \\n\\t{N-[5-(aminosulfonyl)-3-methyl-1,3,\\n\\t4-thiadiazol-2(3H)-ylidene]acetamide}  (#135# isoenzyme hpbetaCA <169>) \\n\\t<169>\\nKI\\t#135# 0.000973 {6-trifluoromethyl-4-aminobenzene-1,3-disulfonamide}  \\n\\t(#135# isoenzyme hpbetaCA <169>) <169>\\nKI\\t#14# 0.0087 {4-(2-hydroxyethyl)phenol}  (#14# isoform CA II <261>) <261>\\nKI\\t#14# 0.12 {Hydroxyurea}  (#14# pH 7.8, 25C, hCA II <101>) <101>\\nKI\\t#14# 0.12 {N-(2-fluoro-4-sulfamoylphenyl)-2-(thiophen-2-yl)acetamide}  \\n\\t(#14# inhibition of CO2 hydration by isozyme hCAIII, pH 7.5, \\n\\ttemperature not specified in the publication <302>) <302>\\nKI\\t#14# 0.4 {1H,1H,2H,2H-perfluorooctyl sulfamate}  (#14# pH 7.5, 20C, \\n\\tHCA I <132>) <132>\\nKI\\t#14# 0.02 {N-(aminosulfonyl)methanesulfonamide}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA I <122>) <122>\\nKI\\t#14# 0.02 {methylsulfonylsulfamic acid}  (#14# pH 7.4, 25C, isozyme \\n\\thCA I <122>) <122>\\nKI\\t#14# 0.02 {isopropylsulfonylsulfamic acid}  (#14# pH 7.4, 25C, isozyme \\n\\thCA I <122>) <122>\\nKI\\t#14# 0.02 {N-(aminosulfonyl)propane-2-sulfonamide}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA I <122>) <122>\\nKI\\t#14# 0.02 {N-[(1E)-phenylmethylene]sulfamide}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA I <122>) <122>\\nKI\\t#14# 0.02 {N-[(1E)-(4-methylphenyl)methylene]sulfamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.02 {(trifluoromethyl)sulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA II <122>) <122>\\nKI\\t#14# 0.02 {N-(aminosulfonyl)-1,1,1-trifluoromethanesulfonamide}  (#14# \\n\\tpH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.02 {N-(aminosulfonyl)-1,1,1-trichloromethanesulfonamide}  (#14# \\n\\tpH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.02 {(trichloromethyl)sulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA II <122>) <122>\\nKI\\t#14# 0.02 {phenylsulfonylsulfamic acid}  (#14# pH 7.4, 25C, isozyme \\n\\thCA II <122>) <122>\\nKI\\t#14# 0.02 {benzylsulfonylsulfamic acid}  (#14# pH 7.4, 25C, isozyme \\n\\thCA II <122>) <122>\\nKI\\t#14# 0.02 {N-(aminosulfonyl)-4-bromobenzenesulfonamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.02 {N-(aminosulfonyl)-4-iodobenzenesulfonamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.02 {N-(aminosulfonyl)-4-methylbenzenesulfonamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.02 {4-Aminobenzenesulfonamide}  (#14# pH 7.4, 25C, isozyme hCA \\n\\tI <126>) <126>\\nKI\\t#14# 0.007 {N-(4-[(E)-[(aminosulfonyl)imino]methyl]phenyl)acetamide}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.007 {(heptadecafluorooctyl)sulfonylsulfamic acid}  (#14# pH 7.4, \\n\\t25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.007 {N-(aminosulfonyl)quinoline-8-sulfonamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.007 \\n\\t{N-(aminosulfonyl)-1-(7,\\n\\t7-dimethylbicyclo[2.2.1]hept-1-yl)methanesulfonamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0002 {(3-nitrophenyl)sulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA I <122>) <122>\\nKI\\t#14# 0.0002 {[4-(acetylamino)phenyl]sulfonylsulfamic acid}  (#14# pH \\n\\t7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0002 {[3-(trifluoromethyl)phenyl]sulfonylsulfamic acid}  (#14# \\n\\tpH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0002 {acetazolamide}  (#14# pH 7.5, 25C, hCA I <118>) <118>\\nKI\\t#14# 0.0045 {fluorenylmethylsulfamate}  (#14# pH 7.5, 20C, HCA II \\n\\t<132>) <132>\\nKI\\t#14# 0.00006 {cyclohexyl sulfamate}  (#14# pH 7.5, 20C, HCA II <132>) \\n\\t<132>\\nKI\\t#14# 0.00006 {[3-(trifluoromethyl)phenyl]sulfonylsulfamic acid}  (#14# \\n\\tpH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.00006 {4-[[(aminosulfonyl)amino]sulfonyl]benzoic acid}  (#14# pH \\n\\t7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.00006 {[[(4-methylphenyl)sulfonyl]amino]carbonylsulfamic amide}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.00006 {N-[(1E)-phenylmethylene]sulfamide}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA II <122>) <122>\\nKI\\t#14# 0.00006 {5-amino-1,3,4-thiadiazole-2-sulfonamide}  (#14# isozyme \\n\\thCAII, pH 7.5, 22C <299>; #14# wild-type, pH 7.5, 20C <332>) <299,332>\\nKI\\t#14# 0.00006 {4-amino-3-fluorobenzenesulfonamide}  (#14# wild-type, pH \\n\\t7.5, 20C <332>) <332>\\nKI\\t#14# 0.03 {N,N-dimethylamidimidodisulfuric acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA I <122>) <122>\\nKI\\t#14# 0.03 {N-(aminosulfonyl)methanesulfonamide}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA II <122>) <122>\\nKI\\t#14# 0.03 {N-(aminosulfonyl)-1-phenylmethanesulfonamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.03 {N-(aminosulfonyl)-4-chlorobenzenesulfonamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.03 {isopropylsulfonylsulfamic acid}  (#14# pH 7.4, 25C, isozyme \\n\\thCA II <122>) <122>\\nKI\\t#14# 0.03 {N-salicylidene-sulfanilic acid amide}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA I <126>) <126>\\nKI\\t#14# 0.03 {Cyanate}  (#14# pH 7.5, 25C, hCA II and hCA IV <118>) <118>\\nKI\\t#14# 0.05 {methylsulfonylsulfamic acid}  (#14# pH 7.4, 25C, isozyme \\n\\thCA II <122>) <122>\\nKI\\t#14# 0.05 {N-(aminosulfonyl)propane-2-sulfonamide}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA II <122>) <122>\\nKI\\t#14# 0.05 {celecoxib}  (#14# isozyme CA I, pH not specified in the \\n\\tpublication, temperature not specified in the publication <296>) <296>\\nKI\\t#14# 0.0025 {4-acetyl-N-(aminosulfonyl)benzenesulfonamide}  (#14# pH \\n\\t7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.0025 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(hepta-O-acetyl-beta-D-maltopyranosyl)-\\n\\t1H-1,2,3-triazole}  (#14# isozyme CA I, in 10 mM HEPES (pH 7.5), 0.1 M \\n\\tNaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.1 {Hydroxyurea}  (#14# pH 7.8, 25C, hCA I <101>) <101>\\nKI\\t#14# 0.1 {umbelliferone}  (#14# inhibition of isozyme hCA IX, pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <293>) <293>\\nKI\\t#14# 0.000345 {dichlorophenamide}  (#14# isoform CA XIV, in 10 mM HEPES \\n\\t(pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.000071 \\n\\t{4,4\\'-[(2R,3R)-2,3-dimethylbutane-1,4-diyl]bis(2-methoxyphenol)}  (#14# \\n\\tisoform CA VB <261>) <261>\\nKI\\t#14# 0.000178 \\n\\t{1-cyclohexyl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#14# isoform CA XIV, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.000008 {4-[(sulfoamino)sulfonyl]benzoic acid}  (#14# pH 7.4, \\n\\t25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.000008 {[[(2-methylphenyl)sulfonyl]amino]carbonylsulfamic acid}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.000008 \\n\\t{N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-phenylalanine}  \\n\\t(#14# NovaSyn TGA-resin bound, pH 7.5, carbonic anhydrase II <153>) \\n\\t<153>\\nKI\\t#14# 0.000008 {ethoxazolamide}  (#14# isozyme CA II, in 10 mM HEPES (pH \\n\\t7.5), 0.1 M NaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.000008 {6-ethoxy-1,3-benzothiazole-2-sulfonamide}  (#14# \\n\\twild-type, pH 7.5, 20C <332>) <332>\\nKI\\t#14# 0.000008 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-isoleucinamide}  (#14# isoform CA XII, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.000002 {N-phosphoryl-6-nitro-benzothiazole-2-sulfonamide}  (#14# \\n\\tpH 7.4, 25C, hCA II <121>) <121>\\nKI\\t#14# 0.000002 {ethoxzolamide}  (#14# pH 7.5, 25C, wild-type CA XII \\n\\t<133>) <133>\\nKI\\t#14# 0.0008 {[3-[(tert-butoxycarbonyl)amino]phenyl]sulfonylsulfamic \\n\\tacid}  (#14# pH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.0008 {tert-butyl \\n\\t3-[[(aminosulfonyl)amino]sulfonyl]phenylcarbamate}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA I <122>) <122>\\nKI\\t#14# 0.0008 {(2,4,6-tripropylphenyl)sulfonylsulfamic acid}  (#14# pH \\n\\t7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.0008 \\n\\t{N-(aminosulfonyl)-3,5-dichloro-2-hydroxybenzenesulfonamide}  (#14# pH \\n\\t7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.0008 {tert-butyl \\n\\t5-[[(aminosulfonyl)amino]sulfonyl]-2-hydroperoxyphenylcarbamate}  (#14# \\n\\tpH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0008 {3-[[(aminosulfonyl)amino]sulfonyl]benzoic acid}  (#14# pH \\n\\t7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0008 {[[(4-chlorophenyl)sulfonyl]amino]carbonylsulfamic amide}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.00025 \\n\\t{(3aR,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,\\n\\t5-b:4\\',5\\'-d]pyran-3a-yl sulfamate}  (#14# isozyme hCA I, pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <294>) <294>\\nKI\\t#14# 0.000075 {4-amino-6-chlorobenzene-1,3-disulfonamide}  (#14# \\n\\twild-type, pH 7.5, 20C <332>) <332>\\nKI\\t#14# 0.06 {N,N-dimethylimidodisulfuric diamide}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA II <122>) <122>\\nKI\\t#14# 0.00001 {estrone sulfamate}  (#14# pH 7.4, 25C, hCA II <131>) \\n\\t<131>\\nKI\\t#14# 0.00001 {n-dodecyl sulfamate}  (#14# pH 7.5, 20C, HCA II <132>) \\n\\t<132>\\nKI\\t#14# 0.00001 {(2,5-dichlorophenyl)sulfonylsulfamic acid}  (#14# pH 7.4, \\n\\t25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.00001 {[[(4-methylphenyl)sulfonyl]amino]carbonylsulfamic acid}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.00001 {(pentafluorophenyl)sulfonylsulfamic acid}  (#14# pH 7.4, \\n\\t25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.00001 {3-[(sulfoamino)sulfonyl]benzoic acid}  (#14# pH 7.4, \\n\\t25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.00001 {4-[(sulfoamino)sulfonyl]benzoic acid}  (#14# pH 7.4, \\n\\t25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.00001 {N-phosphoryl-benzothiazole-2-sulfonamide}  (#14# pH 7.4, \\n\\t25C, hCA I <121>) <121>\\nKI\\t#14# 0.00001 {2-(phenylethynyl)benzenesulfonamide}  (#14# isozyme CA \\n\\tXII, pH not specified in the publication, temperature not specified in \\n\\tthe publication <296>) <296>\\nKI\\t#14# 0.00001 \\n\\t{[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,\\n\\t5-b:4\\',5\\'-d]pyran-3a-yl]methyl sulfamate}  (#14# wild-type, pH 7.5, \\n\\t20C <332>) <332>\\nKI\\t#14# 0.0005 {(3-nitrophenyl)sulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA II <122>) <122>\\nKI\\t#14# 0.0005 {(3,5-dichloro-2-hydroxyphenyl)sulfonylsulfamic acid}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0005 {dorzolamide}  (#14# isozyme CA I, in 10 mM HEPES (pH 7.5), \\n\\t0.1 M NaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.0005 {1,2-dimethoxybenzene}  (#14# isozyme hCAII, pH 7.5, 22C \\n\\t<299>) <299>\\nKI\\t#14# 0.0031 {n-butyl sulfamate}  (#14# pH 7.5, 20C, HCA I <132>) <132>\\nKI\\t#14# 0.0031 {coumarin}  (#14# inhibition of isozyme hCA XII, pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <293>; #14# isozyme hCAI, pH 7.5, 22C <299>) <293,299>\\nKI\\t#14# 0.00057 {3-chloropropyl sulfamate}  (#14# pH 7.5, 20C, HCA II \\n\\t<132>) <132>\\nKI\\t#14# 0.001 {n-propyl sulfamate}  (#14# pH 7.5, 20C, HCA IX <132>) <132>\\nKI\\t#14# 0.001 {isopropyl sulfamate}  (#14# pH 7.5, 20C, HCA IX <132>) \\n\\t<132>\\nKI\\t#14# 0.001 {ethyl sulfamate}  (#14# pH 7.5, 20C, HCA IX <132>) <132>\\nKI\\t#14# 0.001 {n-butyl sulfamate}  (#14# pH 7.5, 20C, HCA IX <132>) <132>\\nKI\\t#14# 0.001 {methyl sulfamate}  (#14# pH 7.5, 20C, HCA IX <132>) <132>\\nKI\\t#14# 0.001 {p-methylbenzyl sulfamate}  (#14# pH 7.5, 20C, HCA I <132>) \\n\\t<132>\\nKI\\t#14# 0.001 {N-(4-[[(aminosulfonyl)amino]sulfonyl]phenyl)acetamide}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.001 {N-(aminosulfonyl)-2,4,6-triisopropylbenzenesulfonamide}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.001 {[3-[(tert-butoxycarbonyl)amino]phenyl]sulfonylsulfamic \\n\\tacid}  (#14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.001 {tert-butyl \\n\\t3-[[(aminosulfonyl)amino]sulfonyl]phenylcarbamate}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA II <122>) <122>\\nKI\\t#14# 0.006 {methyl sulfamate}  (#14# pH 7.5, 20C, HCA II <132>) <132>\\nKI\\t#14# 0.006 {N-(aminosulfonyl)thiophene-2-sulfonamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.003 {(nonafluorobutyl)sulfonylsulfamic acid}  (#14# pH 7.4, \\n\\t25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.003 {(4-methoxyphenyl)sulfonylsulfamic acid}  (#14# pH 7.4, \\n\\t25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.003 {N-(aminosulfonyl)naphthalene-1-sulfonamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.003 \\n\\t{N-(aminosulfonyl)-5-(dimethylamino)naphthalene-1-sulfonamide}  (#14# \\n\\tpH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.01 {isopropyl sulfamate}  (#14# pH 7.5, 20C, HCA II <132>) <132>\\nKI\\t#14# 0.01 {(trifluoromethyl)sulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA I <122>) <122>\\nKI\\t#14# 0.01 {N-(aminosulfonyl)-1,1,1-trifluoromethanesulfonamide}  (#14# \\n\\tpH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.01 {N-(aminosulfonyl)-1,1,1-trichloromethanesulfonamide}  (#14# \\n\\tpH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.01 {(trichloromethyl)sulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA I <122>) <122>\\nKI\\t#14# 0.01 {N,N-dimethylimidodisulfuric diamide}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA I <122>) <122>\\nKI\\t#14# 0.01 {phenylsulfonylsulfamic acid}  (#14# pH 7.4, 25C, isozyme \\n\\thCA I <122>) <122>\\nKI\\t#14# 0.01 {N-(aminosulfonyl)benzenesulfonamide}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA I <122>) <122>\\nKI\\t#14# 0.01 {benzylsulfonylsulfamic acid}  (#14# pH 7.4, 25C, isozyme \\n\\thCA I <122>) <122>\\nKI\\t#14# 0.01 {N-(aminosulfonyl)-1-phenylmethanesulfonamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.01 {(4-fluorophenyl)sulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA I <122>; #14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.01 {N-(aminosulfonyl)-4-fluorobenzenesulfonamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.01 {(4-chlorophenyl)sulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA I <122>; #14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.01 {N-(aminosulfonyl)-4-chlorobenzenesulfonamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.01 {(4-bromophenyl)sulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA I <122>; #14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.01 {N-(aminosulfonyl)-4-bromobenzenesulfonamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.01 {N-(aminosulfonyl)-4-iodobenzenesulfonamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.01 {(4-methylphenyl)sulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA I <122>; #14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.01 {N-(aminosulfonyl)-4-methylbenzenesulfonamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.01 {(nonafluorobutyl)sulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA II <122>) <122>\\nKI\\t#14# 0.01 \\n\\t{N-(aminosulfonyl)-1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonamide}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.01 {(4-iodophenyl)sulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA II <122>) <122>\\nKI\\t#14# 0.01 {(4-methoxyphenyl)sulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA II <122>) <122>\\nKI\\t#14# 0.01 {N-(aminosulfonyl)-4-methoxybenzenesulfonamide}  (#14# pH \\n\\t7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.01 \\n\\t{N-[(benzyloxy)carbonyl]-D-methionyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tphenylalaninamide}  (#14# isoform CA IV, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.0075 {(2E)-4-methoxy-4-oxobut-2-enoic acid}  (#14# isoform CA II \\n\\t<261>) <261>\\nKI\\t#14# 0.5 {6-deoxy-N-sulfamoyl-alpha-L-glucopyranosylamine}  (#14# \\n\\tabove, isozyme hCA I, pH not specified in the publication, temperature \\n\\tnot specified in the publication <294>) <294>\\nKI\\t#14# 0.0014 {N-(aminosulfonyl)-4-nitrobenzenesulfonamide}  (#14# pH \\n\\t7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.0014 {N-[(1E)-(3-nitrophenyl)methylene]sulfamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.009 {1H,1H,2H,2H-perfluorodecyl sulfamate}  (#14# pH 7.5, 20C, \\n\\tHCA II <132>) <132>\\nKI\\t#14# 0.009 {(4-iodophenyl)sulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA I <122>) <122>\\nKI\\t#14# 0.009 {N-[(1E)-(5-methylthien-2-yl)methylene]sulfamide}  (#14# pH \\n\\t7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.009 {N-[(1E)-(3,4,5-trimethoxyphenyl)methylene]sulfamide}  (#14# \\n\\tpH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.009 {N-(aminosulfonyl)naphthalene-2-sulfonamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0000048 \\n\\t{3,4,\\n\\t6-tri-O-acetyl-2-deoxy-N-sulfamoyl-beta-D-arabino-hexopyranosylamine}  \\n\\t(#14# isozyme hCA XII, pH not specified in the publication, temperature \\n\\tnot specified in the publication <294>) <294>\\nKI\\t#14# 0.0000048 {2-(4-hydroxybenzylidene)-2H-indene-1,3-dione}  (#14# \\n\\tisoform CA I, at 25C, pH not specified in the publication <414>) <414>\\nKI\\t#14# 0.000095 {4-biphenyl sulfamate}  (#14# pH 7.4, 25C, hCA II <131>) \\n\\t<131>\\nKI\\t#14# 0.000095 \\n\\t{(2R)-3-(3-chloro-4-hydroxyphenyl)-2-[[(2E)-4-methoxy-4-oxobut-2-\\n\\tenoyl]amino]propanoic acid}  (#14# isoform CA VA <261>) <261>\\nKI\\t#14# 1 {1H,1H,2H,2H-perfluorodecyl sulfamate}  (#14# pH 7.5, 20C, HCA \\n\\tI <132>) <132>\\nKI\\t#14# 1 {coumarin}  (#14# above, isozyme hCAIX, pH 7.5, 22C <299>; #14# \\n\\tabove, isozyme hCAXII, pH 7.5, 22C <299>) <299>\\nKI\\t#14# 0.0006 {3-Hydroxybenzoic acid}  (#14# isozyme hCAII, pH 7.5, 22C \\n\\t<299>) <299>\\nKI\\t#14# 0.000064 \\n\\t{N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-tryptophan}  (#14# \\n\\tNovaSyn TGA-resin bound, pH 7.5, carbonic anhydrase I <153>) <153>\\nKI\\t#14# 0.000003 {(pentafluorophenyl)sulfonylsulfamic acid}  (#14# pH 7.4, \\n\\t25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.000003 {chlorazolamide}  (#14# pH 7.4, 25C, hCA II <120>) <120>\\nKI\\t#14# 0.000003 {N-phosphoryl-benzothiazole-2-sulfonamide}  (#14# pH 7.4, \\n\\t25C, hCA II <121>) <121>\\nKI\\t#14# 0.0000737 \\n\\t{4-(4-hydroxyphenyl)-2-(4-fluorophenyl)-5H-indeno[1,2-b]pyridin-5-one}  \\n\\t(#14# isoform CA II, at 25C, pH not specified in the publication \\n\\t<414>) <414>\\nKI\\t#14# 0.004 {7alpha-hydroxyepiandrosterone sulfamate}  (#14# pH 7.5, \\n\\t20C, HCA I <132>) <132>\\nKI\\t#14# 0.004 {N-(aminosulfonyl)-4-methoxybenzenesulfonamide}  (#14# pH \\n\\t7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.004 {N-(aminosulfonyl)naphthalene-2-sulfonamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.004 {N-(aminosulfonyl)thiophene-2-sulfonamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.0101 {(3-chlorophenyl)acetic acid}  (#14# isoform CA II <261>) \\n\\t<261>\\nKI\\t#14# 0.0021 {(2,4,6-tripropylphenyl)sulfonylsulfamic acid}  (#14# pH \\n\\t7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0034 {2-naphthylsulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA II <122>) <122>\\nKI\\t#14# 0.00004 {4-nitrophenylsulfamate}  (#14# pH 7.4, 25C, hCA I <131>) \\n\\t<131>\\nKI\\t#14# 0.00004 {2-naphthyl sulfamate}  (#14# pH 7.4, 25C, hCA IX <131>) \\n\\t<131>\\nKI\\t#14# 0.00004 {N-[(1E)-(5-methylthien-2-yl)methylene]sulfamide}  (#14# \\n\\tpH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.00004 {N-[(1E)-(4-methoxyphenyl)methylene]sulfamide}  (#14# pH \\n\\t7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.00004 {2-N-(4-sulfamoylphenyl)-thioformyl-L-Gln}  (#14# pH 7.5, \\n\\tcarbonic anhydrase I <153>) <153>\\nKI\\t#14# 0.00008 {[[(4-fluorophenyl)sulfonyl]amino]carbonylsulfamic amide}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.00009 {(3-chloro-4-nitrophenyl)sulfonylsulfamic acid}  (#14# pH \\n\\t7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.00009 {(2E)-but-2-enedioic acid}  (#14# isoform CA VB <261>) \\n\\t<261>\\nKI\\t#14# 0.0003 {(3,5-dichloro-2-hydroxyphenyl)sulfonylsulfamic acid}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.0003 {(3-chloro-4-nitrophenyl)sulfonylsulfamic acid}  (#14# pH \\n\\t7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0003 {4-ethoxy-3-pyridinesulfonamide}  (#14# isoform CA IX, in \\n\\t10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0011 \\n\\t{N-(aminosulfonyl)-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,\\n\\t8-heptadecafluorooctane-1-sulfonamide}  (#14# pH 7.4, 25C, isozyme hCA \\n\\tI <122>) <122>\\nKI\\t#14# 0.0011 {N-(aminosulfonyl)-3-chloro-4-nitrobenzenesulfonamide}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.0011 {N-(4-[[(aminosulfonyl)amino]sulfonyl]phenyl)acetamide}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0011 {[[(4-methylphenyl)sulfonyl]amino]carbonylsulfamic amide}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.00005 {4-biphenyl sulfamate}  (#14# pH 7.4, 25C, hCA IX <131>) \\n\\t<131>\\nKI\\t#14# 0.00005 {[4-[(tert-butoxycarbonyl)amino]phenyl]sulfonylsulfamic \\n\\tacid}  (#14# pH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.00005 \\n\\t{N-(aminosulfonyl)-2,3,4,5,6-pentafluorobenzenesulfonamide}  (#14# pH \\n\\t7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.00005 {[[(4-chlorophenyl)sulfonyl]amino]carbonylsulfamic amide}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.00005 {[[(2-methylphenyl)sulfonyl]amino]carbonylsulfamic amide}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.00005 {N-[(1E)-thien-2-ylmethylene]sulfamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.00005 {N-[(1E)-(4-methylphenyl)methylene]sulfamide}  (#14# pH \\n\\t7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.00005 {dichlorophenamide}  (#14# isozyme CA IX, in 10 mM HEPES \\n\\t(pH 7.5), 0.1 M NaClO4, at 20C <228>; #14# isoform CA IX, in 10 mM \\n\\tHEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>; #14# isoform CA XII, in 10 \\n\\tmM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <228,271>\\nKI\\t#14# 0.00005 {N-(4-sulfamoylphenyl)-2-(thiophen-2-yl)acetamide}  (#14# \\n\\tinhibition of CO2 hydration by isozyme hCAII, pH 7.5, temperature not \\n\\tspecified in the publication <302>) <302>\\nKI\\t#14# 0.00005 {4,5-dichlorobenzene-1,3-disulfonamide}  (#14# isozyme CA \\n\\tIX, pH not specified in the publication, temperature not specified in \\n\\tthe publication <296>; #14# isozyme CA XII, pH not specified in the \\n\\tpublication, temperature not specified in the publication <296>) <296>\\nKI\\t#14# 0.00007 {n-butyl sulfamate}  (#14# pH 7.5, 20C, HCA II <132>) \\n\\t<132>\\nKI\\t#14# 0.00007 {[4-(acetylamino)phenyl]sulfonylsulfamic acid}  (#14# pH \\n\\t7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.00007 {3-[[(aminosulfonyl)amino]sulfonyl]benzoic acid}  (#14# pH \\n\\t7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.00007 {N-[(1E)-(1-methyl-1H-pyrrol-2-yl)methylene]sulfamide}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.00007 \\n\\t{(5Z)-2-amino-5-(4-hydroxy-3-methoxybenzylidene)-3,\\n\\t5-dihydro-4H-imidazol-4-one}  (#14# isoform CA VB <261>) <261>\\nKI\\t#14# 0.00007 {4-iodobenzenesulfonamide}  (#14# isozyme CA VII, at 25C, \\n\\tpH 7.4 <268>) <268>\\nKI\\t#14# 0.00007 {4-(2-methyl-8-quinolinoxy)-3-pyridinesulfonamide}  (#14# \\n\\tisoform CA XIV, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.000109 {methyl (3-chloro-4-hydroxyphenyl)acetate}  (#14# isoform \\n\\tCA VA <261>) <261>\\nKI\\t#14# 0.002 \\n\\t{N-(aminosulfonyl)-1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonamide}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.002 {[5-(dimethylamino)-1-naphthyl]sulfonylsulfamic acid}  (#14# \\n\\tpH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.002 {quinolin-8-ylsulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA I <122>) <122>\\nKI\\t#14# 0.002 {N-(aminosulfonyl)-2-nitrobenzenesulfonamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.002 {N-(aminosulfonyl)-3-chloro-4-nitrobenzenesulfonamide}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.025 {5-acetamido-1,3,4-thiadiazole-2-sulfonamide}  (#14# \\n\\tEscherichia coli recombinant enzyme <251>) <251>\\nKI\\t#14# 0.025 {sulfanilamide}  (#14# isozyme CA I, pH not specified in the \\n\\tpublication, temperature not specified in the publication <296>) <296>\\nKI\\t#14# 0.046 {Cyanate}  (#14# pH 7.6, 4C <79>) <79>\\nKI\\t#14# 0.0001 {(4-nitrophenyl)sulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA I <122>) <122>\\nKI\\t#14# 0.0001 {[4-[(tert-butoxycarbonyl)amino]phenyl]sulfonylsulfamic \\n\\tacid}  (#14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0001 {(2,5-dichlorophenyl)sulfonylsulfamic acid}  (#14# pH 7.4, \\n\\t25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0001 \\n\\t{[3-[(tert-butoxycarbonyl)amino]-4-hydroperoxyphenyl]sulfonylsulfamic \\n\\tacid}  (#14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0001 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(2\\',3\\',\\n\\t5\\'-tri-O-benzoyl-beta-D-ribofuranosyl)-1H-1,2,3-triazole}  (#14# \\n\\tisozyme CA IX, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, at 20C <228>) \\n\\t<228>\\nKI\\t#14# 0.0001 {(3-chloro-4-hydroxyphenyl)acetic acid}  (#14# isoform CA \\n\\tVA <261>) <261>\\nKI\\t#14# 0.0001 \\n\\t{1-cyclohexyl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#14# isoform CA I, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.0001 {coumarin}  (#14# inhibition of isozyme hCA I, pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <293>; #14# inhibition of isozyme hCA II, pH not specified \\n\\tin the publication, temperature not specified in the publication <293>) \\n\\t<293>\\nKI\\t#14# 0.04 {methyl sulfamate}  (#14# pH 7.5, 20C, HCA I <132>) <132>\\nKI\\t#14# 0.04 {N-(aminosulfonyl)benzenesulfonamide}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA II <122>) <122>\\nKI\\t#14# 0.0004 {(2,4,6-triisopropylphenyl)sulfonylsulfamic acid}  (#14# pH \\n\\t7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.0004 {(4-nitrophenyl)sulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA II <122>) <122>\\nKI\\t#14# 0.0004 \\n\\t{1-cyclopentyl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide} \\n\\t (#14# isoform CA IX, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.00045 {brinzolamide}  (#14# isozyme CA I, in 10 mM HEPES (pH \\n\\t7.5), 0.1 M NaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.00013 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(2\\',3\\',4\\'-tri-O-acetyl-beta-D-glucuronic \\n\\tacid methyl ester)-1H-1,2,3-triazole}  (#14# isozyme CA II, in 10 mM \\n\\tHEPES (pH 7.5), 0.1 M NaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.00013 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(beta-D-maltopyranosyl)-1H-1,2,\\n\\t3-triazole}  (#14# isozyme CA IX, in 10 mM HEPES (pH 7.5), 0.1 M \\n\\tNaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.00024 {N-salicylidene-sulfanilic acid amide copper nitrate \\n\\tcomplex}  (#14# pH 7.4, 25C, isozyme hCA I <126>) <126>\\nKI\\t#14# 0.00024 {4-Aminobenzenesulfonamide}  (#14# isozyme CA II, pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <296>; #14# wild-type, pH 7.5, 20C <332>) <296,332>\\nKI\\t#14# 0.0015 {1-naphthylsulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA I <122>) <122>\\nKI\\t#14# 0.0015 {N-(aminosulfonyl)-4-nitrobenzenesulfonamide}  (#14# pH \\n\\t7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0015 {N-(aminosulfonyl)-2,5-dichlorobenzenesulfonamide}  (#14# \\n\\tpH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0015 {(2,4,6-triisopropylphenyl)sulfonylsulfamic acid}  (#14# pH \\n\\t7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0015 {N-[(1E)-(4-nitrophenyl)methylene]sulfamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.00003 {estrone sulfamate}  (#14# pH 7.4, 25C, hCA IX <131>) \\n\\t<131>\\nKI\\t#14# 0.00003 \\n\\t{[3-[(tert-butoxycarbonyl)amino]-4-hydroperoxyphenyl]sulfonylsulfamic \\n\\tacid}  (#14# pH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.00003 {[[(4-methylphenyl)sulfonyl]amino]carbonylsulfamic acid}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.00003 {[[(2-methylphenyl)sulfonyl]amino]carbonylsulfamic acid}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.00003 {N-(4-[(E)-[(aminosulfonyl)imino]methyl]phenyl)acetamide}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.00003 {2-N-(4-sulfamoylphenyl)-thioformyl-L-Phe}  (#14# pH 7.5, \\n\\tcarbonic anhydrase I <153>) <153>\\nKI\\t#14# 0.00003 {4-(4\\'-dimethylaminophenyl)diazenylbenzenesulfonamide}  \\n\\t(#14# isozyme CA VII, at 25C, pH 7.4 <268>) <268>\\nKI\\t#14# 0.000024 {N-salicylidene-sulfanilic acid amide cobalt chloride \\n\\tcomplex}  (#14# pH 7.4, 25C, isozyme hCA II <126>) <126>\\nKI\\t#14# 0.000024 {indisulam}  (#14# isoform CA IX, in 10 mM HEPES (pH \\n\\t7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.000005 {topiramate}  (#14# pH 7.4, 25C, hCA II <131>) <131>\\nKI\\t#14# 0.000005 {estradiol 3,17beta-disulfamate}  (#14# pH 7.4, 25C, hCA \\n\\tII <131>) <131>\\nKI\\t#14# 0.000005 {2-N-(4-sulfamoylphenyl)-thioformyl-L-Leu}  (#14# pH 7.5, \\n\\tcarbonic anhydrase II <153>) <153>\\nKI\\t#14# 0.000005 {2-N-(4-sulfamoylphenyl)-thioformyl-L-Val}  (#14# pH 7.5, \\n\\tcarbonic anhydrase II <153>) <153>\\nKI\\t#14# 0.000005 \\n\\t{N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-isoleucine}  (#14# \\n\\tNovaSyn TGA-resin bound, pH 7.5, carbonic anhydrase II <153>) <153>\\nKI\\t#14# 0.000005 \\n\\t{N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-methionine}  (#14# \\n\\tNovaSyn TGA-resin bound, pH 7.5, carbonic anhydrase II <153>) <153>\\nKI\\t#14# 0.000005 \\n\\t{N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-valine}  (#14# \\n\\tNovaSyn TGA-resin bound, pH 7.5, carbonic anhydrase II <153>) <153>\\nKI\\t#14# 0.000005 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(2\\',3\\',4\\',\\n\\t6\\'-tetra-O-acetyl-alpha-D-mannopyranosyl)-1H-1,2,3-triazole}  (#14# \\n\\tisozyme CA IX, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, at 20C <228>) \\n\\t<228>\\nKI\\t#14# 0.000005 \\n\\t{(3aR,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,\\n\\t5-b:4\\',5\\'-d]pyran-3a-yl sulfamate}  (#14# isozyme hCA II, pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <294>) <294>\\nKI\\t#14# 0.000005 \\n\\t{2,3,4,6-tetra-O-acetyl-N-sulfamoyl-beta-D-mannopyranosylamine}  (#14# \\n\\tisozyme hCA IX, pH not specified in the publication, temperature not \\n\\tspecified in the publication <294>) <294>\\nKI\\t#14# 0.000005 \\n\\t{4-(4-hydroxyphenyl)-2-(4-chlorophenyl)-5H-indeno[1,2-b]pyridin-5-one}  \\n\\t(#14# isoform CA I, at 25C, pH not specified in the publication <414>) \\n\\t<414>\\nKI\\t#14# 0.0022 \\n\\t{[(7,7-dimethylbicyclo[2.2.1]hept-1-yl)methyl]sulfonylsulfamic acid}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.000058 {estradiol 3,17beta-disulfamate}  (#14# pH 7.4, 25C, hCA \\n\\tIX <131>) <131>\\nKI\\t#14# 0.000058 {n-pentyl sulfamate}  (#14# pH 7.5, 20C, HCA II <132>) \\n\\t<132>\\nKI\\t#14# 0.000058 \\n\\t{N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-alanine}  (#14# \\n\\tNovaSyn TGA-resin bound, pH 7.5, carbonic anhydrase I <153>) <153>\\nKI\\t#14# 0.000058 \\n\\t{(3aR,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,\\n\\t5-b:4\\',5\\'-d]pyran-3a-yl sulfamate}  (#14# isozyme hCA IX, pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <294>) <294>\\nKI\\t#14# 0.0055 {ethyl sulfamate}  (#14# pH 7.5, 20C, HCA II <132>) <132>\\nKI\\t#14# 0.000011 {2-N-(4-sulfamoylphenyl)-thioformyl-L-Trp}  (#14# pH 7.5, \\n\\tcarbonic anhydrase II <153>) <153>\\nKI\\t#14# 0.000011 \\n\\t{N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-glutamine}  (#14# \\n\\tNovaSyn TGA-resin bound, pH 7.5, carbonic anhydrase II <153>) <153>\\nKI\\t#14# 0.000011 \\n\\t{3,4,6-tri-O-acetyl-2-deoxy-N-sulfamoyl-beta-D-lyxo-hexopyranosylamine} \\n\\t (#14# isozyme hCA II, pH not specified in the publication, temperature \\n\\tnot specified in the publication <294>) <294>\\nKI\\t#14# 0.000001 {8-acetyl-7-ethoxy-2H-chromen-2-one}  (#14# inhibition of \\n\\tisozyme hCA XII, pH not specified in the publication, temperature not \\n\\tspecified in the publication <293>) <293>\\nKI\\t#14# 0.000001 {3-[(3-fluorophenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA IX, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.000107 {(4-hydroxyphenyl)acetic acid}  (#14# isoform CA VB \\n\\t<261>) <261>\\nKI\\t#14# 0.058 {n-hexadecyl sulfamate}  (#14# pH 7.5, 20C, HCA I <132>) \\n\\t<132>\\nKI\\t#14# 0.00031 {acetazolamide}  (#14# isoform CA I, in 10 mM HEPES (pH \\n\\t7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.00054 {N-salicylidene-sulfanilic acid amide nickel chloride \\n\\tcomplex}  (#14# pH 7.4, 25C, isozyme hCA I <126>) <126>\\nKI\\t#14# 0.00075 {n-propyl sulfamate}  (#14# pH 7.5, 20C, HCA II <132>) \\n\\t<132>\\nKI\\t#14# 0.0024 {thien-2-ylsulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA I <122>) <122>\\nKI\\t#14# 0.008 {1H,1H,2H,2H-perfluorooctyl sulfamate}  (#14# pH 7.5, 20C, \\n\\tHCA II <132>) <132>\\nKI\\t#14# 0.008 {N-[(1E)-thien-2-ylmethylene]sulfamide}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA I <122>) <122>\\nKI\\t#14# 0.008 \\n\\t{N-(aminosulfonyl)-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,\\n\\t8-heptadecafluorooctane-1-sulfonamide}  (#14# pH 7.4, 25C, isozyme hCA \\n\\tII <122>) <122>\\nKI\\t#14# 0.008 {N-(aminosulfonyl)naphthalene-1-sulfonamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.008 \\n\\t{(2S)-3-(3-chloro-4-hydroxyphenyl)-2-[[(2E)-4-methoxy-4-oxobut-2-\\n\\tenoyl]amino]propanoic acid}  (#14# isoform CA II <261>) <261>\\nKI\\t#14# 0.00035 {N-salicylidene-sulfanilic acid amide cobalt sulfate \\n\\tcomplex}  (#14# pH 7.4, 25C, isozyme hCA I <126>) <126>\\nKI\\t#14# 0.000029 {1,2:3,4-di-O-isopropylidene-alpha-D-galactopyranose \\n\\t6-sulfamate}  (#14# pH 7.4, 25C, hCA II <131>) <131>\\nKI\\t#14# 0.000029 \\n\\t{N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-asparagine}  (#14# \\n\\tNovaSyn TGA-resin bound, pH 7.5, carbonic anhydrase I <153>) <153>\\nKI\\t#14# 0.0000089 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(beta-D-glucopyranosyl)-1H-1,2,\\n\\t3-triazole}  (#14# isozyme CA IX, in 10 mM HEPES (pH 7.5), 0.1 M \\n\\tNaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.0000089 {4-(methylhydrazino)-3-pyridinesulfonamide}  (#14# \\n\\tisoform CA XII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.0000089 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-phenylalaninamide}  (#14# isoform CA XII, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.0000089 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-leucinamide}  (#14# isoform CA XII, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.8 {but-3-enyl sulfamate}  (#14# pH 7.5, 20C, HCA I <132>) <132>\\nKI\\t#14# 0.74 {salicylic acid}  (#14# isozyme carbonic anhydrase II <209>) \\n\\t<209>\\nKI\\t#14# 0.0012 {N-(aminosulfonyl)-2,4,6-tripropylbenzenesulfonamide}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.0012 {2-naphthylsulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA I <122>) <122>\\nKI\\t#14# 0.0012 {(2-nitrophenyl)sulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA II <122>) <122>\\nKI\\t#14# 0.0012 {tert-butyl \\n\\t4-[[(aminosulfonyl)amino]sulfonyl]phenylcarbamate}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA II <122>) <122>\\nKI\\t#14# 0.0012 {N-(aminosulfonyl)-2,3,4,5,6-pentafluorobenzenesulfonamide} \\n\\t (#14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0012 {N-(aminosulfonyl)-2,4,6-triisopropylbenzenesulfonamide}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0012 {2-N-(4-sulfamoylphenyl)-thioformyl-L-Ala}  (#14# pH 7.5, \\n\\tcarbonic anhydrase I <153>) <153>\\nKI\\t#14# 0.0012 {dichlorophenamide}  (#14# isozyme CA I, in 10 mM HEPES (pH \\n\\t7.5), 0.1 M NaClO4, at 20C <228>; #14# isoform CA I, in 10 mM HEPES \\n\\t(pH 7.5), 0.1 M Na2SO4, at 22C <271>; #14# isozyme CA I, pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <296>) <228,271,296>\\nKI\\t#14# 0.48 {4-sulfosalicylic acid}  (#14# isozyme carbonic anhydrase I \\n\\t<209>) <209>\\nKI\\t#14# 0.0000013 {phenylsulfamate}  (#14# pH 7.4, 25C, hCA II <131>) \\n\\t<131>\\nKI\\t#14# 0.0000013 {3-(phenylethynyl)benzenesulfonamide}  (#14# isozyme CA \\n\\tXII, pH not specified in the publication, temperature not specified in \\n\\tthe publication <296>) <296>\\nKI\\t#14# 0.0035 {quinolin-8-ylsulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA II <122>) <122>\\nKI\\t#14# 0.005 {N-(aminosulfonyl)quinoline-8-sulfonamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.005 \\n\\t{N-(aminosulfonyl)-1-(7,\\n\\t7-dimethylbicyclo[2.2.1]hept-1-yl)methanesulfonamide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.005 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(2\\'-acetamido-2\\'-deoxy\\'-3\\',4\\',\\n\\t6\\'-tri-O-acetyl-beta-D-glucopyranosyl)-1H-1,2,3-triazole}  (#14# \\n\\tisozyme CA I, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, at 20C <228>) \\n\\t<228>\\nKI\\t#14# 0.005 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(beta-D-maltopyranosyl)-1H-1,2,\\n\\t3-triazole}  (#14# isozyme CA I, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, \\n\\tat 20C <228>) <228>\\nKI\\t#14# 0.0033 \\n\\t{[(7,7-dimethylbicyclo[2.2.1]hept-1-yl)methyl]sulfonylsulfamic acid}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.08 {N-(4-sulfamoylphenyl)-2-(thiophen-2-yl)acetamide}  (#14# \\n\\tinhibition of CO2 hydration by isozyme hCAIII, pH 7.5, temperature not \\n\\tspecified in the publication <302>) <302>\\nKI\\t#14# 0.084 {spermine}  (#14# isozyme hCAII, pH 7.5, 22C <299>) <299>\\nKI\\t#14# 0.0104 {2-(3-chloro-4-hydroxyphenyl)-N-(2-methoxyethyl)acetamide}  \\n\\t(#14# isoform CA II <261>) <261>\\nKI\\t#14# 0.0104 {1,2-dimethoxybenzene}  (#14# isozyme hCAI, pH 7.5, 22C \\n\\t<299>) <299>\\nKI\\t#14# 0.0016 {N-(aminosulfonyl)-3-nitrobenzenesulfonamide}  (#14# pH \\n\\t7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.0016 {N-(aminosulfonyl)-3-(trifluoromethyl)benzenesulfonamide}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.77 {5-sulfosalicylic acid}  (#14# isozyme carbonic anhydrase I \\n\\t<209>) <209>\\nKI\\t#14# 0.038 {ethyl sulfamate}  (#14# pH 7.5, 20C, HCA I <132>) <132>\\nKI\\t#14# 0.038 {fluorenylmethyl sulfamate}  (#14# pH 7.5, 20C, HCA I \\n\\t<132>) <132>\\nKI\\t#14# 0.043 {Cyanate}  (#14# pH 7.5, 25C, hCA IX <118>) <118>\\nKI\\t#14# 0.0007 {tert-butyl \\n\\t5-[[(aminosulfonyl)amino]sulfonyl]-2-hydroperoxyphenylcarbamate}  (#14# \\n\\tpH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.0007 {4-[[(aminosulfonyl)amino]sulfonyl]benzoic acid}  (#14# pH \\n\\t7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0007 {[[(2-methylphenyl)sulfonyl]amino]carbonylsulfamic amide}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0007 {Cyanate}  (#14# pH 7.5, 25C, hCA I <118>) <118>\\nKI\\t#14# 0.0007 \\n\\t{2-(3-chloro-4-hydroxyphenyl)-N-[2-(4-sulfamoylphenyl)ethyl]acetamide}  \\n\\t(#14# isoform CA I <261>) <261>\\nKI\\t#14# 0.000023 {4-iodophenyl sulfamate}  (#14# pH 7.4, 25C, hCA IX \\n\\t<131>) <131>\\nKI\\t#14# 0.000023 {sulfamate}  (#14# pH 7.4, 25C, hCA II <131>) <131>\\nKI\\t#14# 0.000023 {n-decyl sulfamate}  (#14# pH 7.5, 20C, HCA IX <132>) \\n\\t<132>\\nKI\\t#14# 0.000023 {7-oxodehydroepiandrosterone sulfamate}  (#14# pH 7.5, \\n\\t20C, HCA II <132>) <132>\\nKI\\t#14# 0.000023 {N-salicylidene-sulfanilic acid amide cobalt acetate \\n\\tcomplex}  (#14# pH 7.4, 25C, isozyme hCA II <126>) <126>\\nKI\\t#14# 0.000023 {2-N-(4-sulfamoylphenyl)-thioformyl-L-Val}  (#14# pH 7.5, \\n\\tcarbonic anhydrase I <153>) <153>\\nKI\\t#14# 0.000023 \\n\\t{N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-leucine}  (#14# \\n\\tNovaSyn TGA-resin bound, pH 7.5, carbonic anhydrase I <153>) <153>\\nKI\\t#14# 0.0000012 {4-[(3-methoxyphenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA XII, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.000041 {4-cyanophenyl sulfamate}  (#14# pH 7.4, 25C, hCA IX \\n\\t<131>) <131>\\nKI\\t#14# 0.000041 {5-amino-1,3,4-thiadiazole-2-sulfonamide}  (#14# isozyme \\n\\thCAIX, pH 7.5, 22C <299>) <299>\\nKI\\t#14# 0.0000019 {3-methylphenyl sulfamate}  (#14# pH 7.4, 25C, hCA II \\n\\t<131>) <131>\\nKI\\t#14# 0.0096 {2-(3-chloro-4-hydroxyphenyl)-N-(2-phenylethyl)acetamide}  \\n\\t(#14# isoform CA I <261>) <261>\\nKI\\t#14# 0.0096 \\n\\t{(5Z)-2-amino-5-(4-hydroxy-3-methoxybenzylidene)-3,\\n\\t5-dihydro-4H-imidazol-4-one}  (#14# isoform CA II <261>) <261>\\nKI\\t#14# 0.0032 {1-naphthylsulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA II <122>) <122>\\nKI\\t#14# 0.0044 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(2\\',3\\',4\\',\\n\\t6\\'-tetra-O-acetyl-beta-D-glucopyranosyl)-1H-1,2,3-triazole}  (#14# \\n\\tisozyme CA I, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, at 20C <228>) \\n\\t<228>\\nKI\\t#14# 0.0044 \\n\\t{1-[2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl]-4-(4-\\n\\tsulfamoylphenyl)-1H-1,2,3-triazole}  (#14# isozyme CA I, in 10 mM HEPES \\n\\t(pH 7.5), 0.1 M NaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.035 {sulfamide}  (#14# pH 7.8, 25C, hCA I <101>) <101>\\nKI\\t#14# 0.0000062 {4-[2-(2-thienyl)acetamido]benzenesulfonamide}  (#14# \\n\\tisoform CA VII <255>) <255>\\nKI\\t#14# 0.0000062 {N-(4-sulfamoylphenyl)-2-(thiophen-2-yl)acetamide}  \\n\\t(#14# inhibition of CO2 hydration by isozyme hCAVII, pH 7.5, \\n\\ttemperature not specified in the publication <302>) <302>\\nKI\\t#14# 0.0000118 {4-(carbamoylmethylthio)pyridine-3-sulfonamide}  (#14# \\n\\tisoform CA IX, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.0043 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(2\\',3\\',4\\',\\n\\t6\\'-tetra-O-acetyl-beta-D-galactopyranosyl)-1H-1,2,3-triazole}  (#14# \\n\\tisozyme CA I, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, at 20C <228>) \\n\\t<228>\\nKI\\t#14# 0.0043 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(beta-D-ribofuranosyl)-1H-1,2,\\n\\t3-triazole}  (#14# isozyme CA I, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, \\n\\tat 20C <228>) <228>\\nKI\\t#14# 0.000085 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(2\\'-acetamido-2\\'-deoxy-beta-D-\\n\\tglucopyranosyl)-1H-1,2,3-triazole}  (#14# isozyme CA IX, in 10 mM HEPES \\n\\t(pH 7.5), 0.1 M NaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.000085 \\n\\t{4,4\\'-[(2R,3R)-2,3-dimethylbutane-1,4-diyl]bis(2-methoxyphenol)}  (#14# \\n\\tisoform CA VA <261>) <261>\\nKI\\t#14# 0.000085 {N-benzyl-2-(3-chloro-4-hydroxyphenyl)acetamide}  (#14# \\n\\tisoform CA VB <261>) <261>\\nKI\\t#14# 0.000085 {(3-chlorophenyl)acetic acid}  (#14# isoform CA VB <261>) \\n\\t<261>\\nKI\\t#14# 0.000085 \\n\\t{2,3,4,6-tetra-O-acetyl-N-sulfamoyl-beta-D-mannopyranosylamine}  (#14# \\n\\tisozyme hCA II, pH not specified in the publication, temperature not \\n\\tspecified in the publication <294>) <294>\\nKI\\t#14# 0.000033 {4-methoxyphenyl sulfamate}  (#14# pH 7.4, 25C, hCA I \\n\\t<131>) <131>\\nKI\\t#14# 0.000033 {4-t-butylphenyl sulfamate}  (#14# pH 7.4, 25C, hCA IX \\n\\t<131>) <131>\\nKI\\t#14# 0.000033 {5-amino-1,3,4-thiadiazole-2-sulfonamide}  (#14# isozyme \\n\\thCAXII, pH 7.5, 22C <299>) <299>\\nKI\\t#14# 0.0042 \\n\\t{4-(4\\'-methoxyphenyl)diazenylbenzene-N,N-dimethylsulfonamide}  (#14# \\n\\tisozyme CA VII, at 25C, pH 7.4 <268>) <268>\\nKI\\t#14# 0.0092 \\n\\t{7-hydroxy-3-(hydroxymethyl)-1-methoxy-9-oxo-9,\\n\\t9a-dihydro-4aH-xanthene-8-carboxylic acid}  (#14# isoform CA II <261>) \\n\\t<261>\\nKI\\t#14# 0.0092 {coumarin}  (#14# inhibition of isozyme hCA IX, pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <293>; #14# isozyme hCAII, pH 7.5, 22C <299>) <293,299>\\nKI\\t#14# 0.0092 {phenol}  (#14# isozyme hCAXII, pH 7.5, 22C <299>) <299>\\nKI\\t#14# 0.23 \\n\\t{4,4\\'-[(2R,3R)-2,3-dimethylbutane-1,4-diyl]bis(2-methoxyphenol)}  (#14# \\n\\tisoform CA II <261>) <261>\\nKI\\t#14# 0.021 {sulfamic acid}  (#14# pH 7.4, 25C, hCA I <131>) <131>\\nKI\\t#14# 0.0000265 {dichlorophenamide}  (#14# isozyme CA VII, at 25C, pH \\n\\t7.4 <268>) <268>\\nKI\\t#14# 0.0076 {benzyl sulfamate}  (#14# pH 7.5, 20C, HCA I <132>) <132>\\nKI\\t#14# 0.00047 {3,4-dihydroxybenzoic acid}  (#14# isozyme hCAII, pH 7.5, \\n\\t22C <299>) <299>\\nKI\\t#14# 0.000061 {N-(4-sulfamoylphenyl)-2-(thiophen-2-yl)acetamide}  (#14# \\n\\tinhibition of CO2 hydration by isozyme hCAI, pH 7.5, temperature not \\n\\tspecified in the publication <302>) <302>\\nKI\\t#14# 0.000061 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-isoleucinamide}  (#14# isoform CA I, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.00012 {n-octadecyl sulfamate}  (#14# pH 7.5, 20C, HCA IX <132>) \\n\\t<132>\\nKI\\t#14# 0.00012 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(2\\',3\\',4\\',\\n\\t6\\'-tetra-O-acetyl-beta-D-glucopyranosyl)-1H-1,2,3-triazole}  (#14# \\n\\tisozyme CA IX, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, at 20C <228>) \\n\\t<228>\\nKI\\t#14# 0.00012 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(hepta-O-acetyl-beta-D-maltopyranosyl)-\\n\\t1H-1,2,3-triazole}  (#14# isozyme CA IX, in 10 mM HEPES (pH 7.5), 0.1 M \\n\\tNaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.00012 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(beta-D-galactopyranosyl)-1H-1,2,\\n\\t3-triazole}  (#14# isozyme CA IX, in 10 mM HEPES (pH 7.5), 0.1 M \\n\\tNaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.0074 {6-acetyl-7-ethoxy-2H-chromen-2-one}  (#14# inhibition of \\n\\tisozyme hCA IX, pH not specified in the publication, temperature not \\n\\tspecified in the publication <293>) <293>\\nKI\\t#14# 0.69 {isopropyl sulfamate}  (#14# pH 7.5, 20C, HCA I <132>) <132>\\nKI\\t#14# 0.0112 \\n\\t{2-(3-chloro-4-hydroxyphenyl)-N-[2-(3-methoxyphenyl)ethyl]acetamide}  \\n\\t(#14# isoform CA I <261>) <261>\\nKI\\t#14# 0.0112 {2-(4-hydroxyphenyl)acetamide}  (#14# isoform CA II <261>) \\n\\t<261>\\nKI\\t#14# 0.0028 \\n\\t{6,7-dimethoxy-1-ethyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#14# isoform CA I, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.0059 {but-3-ynyl sulfamate}  (#14# pH 7.5, 20C, HCA II <132>) \\n\\t<132>\\nKI\\t#14# 0.0036 {(4-acetylphenyl)sulfonylsulfamic acid}  (#14# pH 7.4, \\n\\t25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0036 {4-acetyl-N-(aminosulfonyl)benzenesulfonamide}  (#14# pH \\n\\t7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0036 {thien-2-ylsulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA II <122>) <122>\\nKI\\t#14# 0.24 {4-aminosalicylic acid}  (#14# isozyme carbonic anhydrase I \\n\\t<209>) <209>\\nKI\\t#14# 0.000042 \\n\\t{N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-phenylalanine}  \\n\\t(#14# NovaSyn TGA-resin bound, pH 7.5, carbonic anhydrase I <153>) <153>\\nKI\\t#14# 0.0017 {N-(aminosulfonyl)-2-nitrobenzenesulfonamide}  (#14# pH \\n\\t7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.0017 {N-(aminosulfonyl)-2,4,6-tripropylbenzenesulfonamide}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.000013 {estradiol 17beta-sulfamate}  (#14# pH 7.4, 25C, hCA II \\n\\t<131>) <131>\\nKI\\t#14# 0.000013 {7alpha-hydroxyepiandrosterone sulfamate}  (#14# pH 7.5, \\n\\t20C, HCA II <132>) <132>\\nKI\\t#14# 0.000013 {p-methylbenzyl sulfamate}  (#14# pH 7.5, 20C, HCA IX \\n\\t<132>) <132>\\nKI\\t#14# 0.000013 {N-salicylidene-sulfanilic acid amide copper chloride \\n\\tcomplex}  (#14# pH 7.4, 25C, isozyme hCA II <126>) <126>\\nKI\\t#14# 0.000013 {4-[4-(aminosulfonyl)phenyl]-1-(beta-D-glucuronic acid \\n\\tmethyl ester)-1H-1,2,3-triazole}  (#14# isozyme CA II, in 10 mM HEPES \\n\\t(pH 7.5), 0.1 M NaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.000013 \\n\\t{3,4,\\n\\t6-tri-O-acetyl-2-deoxy-N-sulfamoyl-beta-D-arabino-hexopyranosylamine}  \\n\\t(#14# isozyme hCA IX, pH not specified in the publication, temperature \\n\\tnot specified in the publication <294>) <294>\\nKI\\t#14# 0.000013 {valdecoxib}  (#14# isozyme CA XII, pH not specified in \\n\\tthe publication, temperature not specified in the publication <296>) \\n\\t<296>\\nKI\\t#14# 0.000013 \\n\\t{N-(tert-butoxycarbonyl)-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-leucinamide}  (#14# isoform CA II, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.000015 {estradiol 17beta-sulfamate}  (#14# pH 7.4, 25C, hCA I \\n\\t<131>) <131>\\nKI\\t#14# 0.000015 {1,2:5,6-di-O-isopropylidene-alpha-D-glucofuranose \\n\\t3-sulfamate}  (#14# pH 7.4, 25C, hCA II <131>) <131>\\nKI\\t#14# 0.000015 {n-tetradecyl sulfamate}  (#14# pH 7.5, 20C, HCA IX \\n\\t<132>) <132>\\nKI\\t#14# 0.000015 {N-salicylidene-sulfanilic acid amide copper nitrate \\n\\tcomplex}  (#14# pH 7.4, 25C, isozyme hCA II <126>) <126>\\nKI\\t#14# 0.000015 {N,N\\'-biphosphoryl-4,5-dichloro-1,3-benzenesulfonamide}  \\n\\t(#14# pH 7.4, 25C, hCA II <121>) <121>\\nKI\\t#14# 0.000015 {indisulam}  (#14# isoform CA II, in 10 mM HEPES (pH \\n\\t7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.000015 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-isoleucinamide}  (#14# isoform CA IV, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.0018 {(heptadecafluorooctyl)sulfonylsulfamic acid}  (#14# pH \\n\\t7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.0018 {(4-acetylphenyl)sulfonylsulfamic acid}  (#14# pH 7.4, \\n\\t25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.0018 {3,4-dihydroxybenzoic acid}  (#14# isozyme hCAI, pH 7.5, \\n\\t22C <299>) <299>\\nKI\\t#14# 0.0000015 \\n\\t{D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-alloisoleucinamide}  \\n\\t(#14# isoform CA II, pH and temperature not specified in the \\n\\tpublication <415>) <415>\\nKI\\t#14# 0.0000015 \\n\\t{D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-phenylalaninamide}  \\n\\t(#14# isoform CA XII, pH and temperature not specified in the \\n\\tpublication <415>) <415>\\nKI\\t#14# 0.43 {4-(2-hydroxyethyl)phenol}  (#14# isoform CA I <261>) <261>\\nKI\\t#14# 0.00014 {4-(5-methyl-2-pyrazolino)-3-pyridinesulfonamide}  (#14# \\n\\tisoform CA II, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.00014 {4-(cyanomethylthio)pyridine-3-sulfonamide}  (#14# isoform \\n\\tCA XIV, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.00016 {4,4\\'-thiodipyridine-3-sulfonamide}  (#14# isoform CA XIV, \\n\\tin 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.00016 {4-(2-aminoethyl)benzenesulfonamide}  (#14# wild-type, pH \\n\\t7.5, 20C <332>) <332>\\nKI\\t#14# 0.0037 {n-propyl sulfamate}  (#14# pH 7.5, 20C, HCA I <132>) <132>\\nKI\\t#14# 0.0000052 \\n\\t{4-(4-hydroxyphenyl)-2-(4-bromophenyl)-5H-indeno[1,2-b]pyridin-5-one}  \\n\\t(#14# isoform CA I, at 25C, pH not specified in the publication <414>) \\n\\t<414>\\nKI\\t#14# 0.0000069 {4-[2-(2-thienyl)acetamido]-3-chlorobenzenesulfonamide}  \\n\\t(#14# isoform CA VII <255>) <255>\\nKI\\t#14# 0.0000069 \\n\\t{5-[2-(2-thienyl)acetamido]-1,3,4-thiadiazole-2-sulfonamide}  (#14# \\n\\tisoform CA VII <255>) <255>\\nKI\\t#14# 0.0000069 {4-(2-phenylacetamido)-3-chlorobenzenesulfonamide}  \\n\\t(#14# isoform CA VII <255>) <255>\\nKI\\t#14# 0.0000069 {4-(4-fluorophenoxy)-3-pyridinesulfonamide}  (#14# \\n\\tisoform CA XII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.0000069 {3-(phenylethynyl)benzenesulfonamide}  (#14# isozyme CA \\n\\tIX, pH not specified in the publication, temperature not specified in \\n\\tthe publication <296>) <296>\\nKI\\t#14# 0.0000069 \\n\\t{D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-methioninamide}  (#14# \\n\\tisoform CA XII, pH and temperature not specified in the publication \\n\\t<415>) <415>\\nKI\\t#14# 0.000018 {4-acetylamidophenyl sulfamate}  (#14# pH 7.4, 25C, hCA \\n\\tII <131>) <131>\\nKI\\t#14# 0.000018 {4-chlorophenyl sulfamate}  (#14# pH 7.4, 25C, hCA IX \\n\\t<131>) <131>\\nKI\\t#14# 0.000018 {benzolamide}  (#14# pH 7.4, 25C, hCA I <120>) <120>\\nKI\\t#14# 0.000018 \\n\\t{2-(3-chloro-4-hydroxyphenyl)-N-[2-(4-sulfamoylphenyl)ethyl]acetamide}  \\n\\t(#14# isoform CA II <261>) <261>\\nKI\\t#14# 0.000004 {[[(4-chlorophenyl)sulfonyl]amino]carbonylsulfamic acid}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.000004 {2-N-(4-sulfamoylphenyl)-thioformyl-L-Ile}  (#14# pH 7.5, \\n\\tcarbonic anhydrase II <153>) <153>\\nKI\\t#14# 0.000004 {2-N-(4-sulfamoylphenyl)-thioformyl-L-Met}  (#14# pH 7.5, \\n\\tcarbonic anhydrase II <153>) <153>\\nKI\\t#14# 0.000004 \\n\\t{N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-asparagine}  (#14# \\n\\tNovaSyn TGA-resin bound, pH 7.5, carbonic anhydrase II <153>) <153>\\nKI\\t#14# 0.000004 \\n\\t{D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-alloisoleucinamide}  \\n\\t(#14# isoform CA XII, pH and temperature not specified in the \\n\\tpublication <415>) <415>\\nKI\\t#14# 0.0000071 {4-[2-(2-thienyl)acetamidomethyl]benzenesulfonamide}  \\n\\t(#14# isoform CA VII <255>) <255>\\nKI\\t#14# 0.0000071 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-valinamide}  (#14# isoform CA XII, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.0000071 \\n\\t{N-(tert-butoxycarbonyl)-D-phenylalanyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]glycinamide}  (#14# isoform CA XII, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.000019 {4-bromophenyl sulfamate}  (#14# pH 7.4, 25C, hCA IX \\n\\t<131>) <131>\\nKI\\t#14# 0.00002 {[[(4-fluorophenyl)sulfonyl]amino]carbonylsulfamic acid}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.00002 {[[(4-chlorophenyl)sulfonyl]amino]carbonylsulfamic acid}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.00002 {N-[(1E)-(3,4,5-trimethoxyphenyl)methylene]sulfamide}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.00002 {N-[(1E)-[4-(dimethylamino)phenyl]methylene]sulfamide}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.00002 \\n\\t{N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-tryptophan}  (#14# \\n\\tNovaSyn TGA-resin bound, pH 7.5, carbonic anhydrase II <153>) <153>\\nKI\\t#14# 0.000068 {4-bromobenzenesulfonamide}  (#14# isozyme CA VII, at \\n\\t25C, pH 7.4 <268>) <268>\\nKI\\t#14# 0.000068 {4-[(4-methylphenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA IX, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.000098 {p-phenoxyphenylsulfamate}  (#14# pH 7.4, 25C, hCA II \\n\\t<131>) <131>\\nKI\\t#14# 0.000098 \\n\\t{4,4\\'-[(1R,2S,3R,4S)-3,4-dimethylcyclobutane-1,\\n\\t2-diyl]bis(2-methoxyphenol)}  (#14# isoform CA VA <261>) <261>\\nKI\\t#14# 0.000098 {(2E)-4-methoxy-4-oxobut-2-enoic acid}  (#14# isoform CA \\n\\tVB <261>) <261>\\nKI\\t#14# 0.000143 {4-(allylamino)-3-pyridinesulfonamide}  (#14# isoform CA \\n\\tXIV, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.000006 {estradiol 3,17beta-disulfamate}  (#14# pH 7.4, 25C, hCA \\n\\tI <131>) <131>\\nKI\\t#14# 0.000006 {3-[(sulfoamino)sulfonyl]benzoic acid}  (#14# pH 7.4, \\n\\t25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.000006 {[[(4-fluorophenyl)sulfonyl]amino]carbonylsulfamic acid}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.000006 {2-N-(4-sulfamoylphenyl)-thioformyl-L-Asn}  (#14# pH 7.5, \\n\\tcarbonic anhydrase II <153>) <153>\\nKI\\t#14# 0.000006 {2-N-(4-sulfamoylphenyl)-thioformyl-L-Phe}  (#14# pH 7.5, \\n\\tcarbonic anhydrase II <153>) <153>\\nKI\\t#14# 0.000006 {3,4-dihydroisoquinoline-2(1H)-sulfonamide}  (#14# \\n\\tisoform CA XIV, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as buffers \\n\\tand 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.000006 \\n\\t{N-[(benzyloxy)carbonyl]-D-methionyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]glycinamide}  (#14# isoform CA II, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.000007 {N-phosphoryl-6-nitro-benzothiazole-2-sulfonamide}  (#14# \\n\\tpH 7.4, 25C, hCA I <121>) <121>\\nKI\\t#14# 0.000007 \\n\\t{N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-leucine}  (#14# \\n\\tNovaSyn TGA-resin bound, pH 7.5, carbonic anhydrase II <153>) <153>\\nKI\\t#14# 0.000007 {4-[2-(2-thienyl)acetamido]-3-fluorobenzenesulfonamide}  \\n\\t(#14# isoform CA VII <255>) <255>\\nKI\\t#14# 0.000007 \\n\\t{N-(2-fluoro-4-sulfamoylphenyl)-2-(thiophen-2-yl)acetamide}  (#14# \\n\\tinhibition of CO2 hydration by isozyme hCAVII, pH 7.5, temperature not \\n\\tspecified in the publication <302>) <302>\\nKI\\t#14# 0.000014 {benzyl sulfamate}  (#14# pH 7.5, 20C, HCA IX <132>) \\n\\t<132>\\nKI\\t#14# 0.000014 \\n\\t{D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-phenylalaninamide}  \\n\\t(#14# isoform CA IV, pH and temperature not specified in the \\n\\tpublication <415>) <415>\\nKI\\t#14# 0.000021 {2-N-(4-sulfamoylphenyl)-thioformyl-L-Leu}  (#14# pH 7.5, \\n\\tcarbonic anhydrase I <153>) <153>\\nKI\\t#14# 0.000021 {celecoxib}  (#14# isozyme CA II, pH not specified in the \\n\\tpublication, temperature not specified in the publication <296>) <296>\\nKI\\t#14# 0.000021 \\n\\t{4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-\\n\\tyl]benzenesulfonamide}  (#14# wild-type, pH 7.5, 20C <332>) <332>\\nKI\\t#14# 0.000065 {7alpha-hydroxyepiandrosterone sulfamate}  (#14# pH 7.5, \\n\\t20C, HCA IX <132>) <132>\\nKI\\t#14# 0.000065 {4,4\\'-thiodipyridine-3-sulfonamide}  (#14# isoform CA II, \\n\\tin 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.000026 {sulfamate}  (#14# pH 7.4, 25C, hCA IX <131>) <131>\\nKI\\t#14# 0.0000016 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(2\\',3\\',4\\',\\n\\t6\\'-tetra-O-acetyl-alpha-D-mannopyranosyl)-1H-1,2,3-triazole}  (#14# \\n\\tisozyme CA I, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, at 20C <228>) \\n\\t<228>\\nKI\\t#14# 0.0000016 {4-[(3-hydroxyphenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA IX, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.000017 {n-undecyl sulfamate}  (#14# pH 7.5, 20C, HCA IX <132>) \\n\\t<132>\\nKI\\t#14# 0.0000075 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(beta-D-ribofuranosyl)-1H-1,2,\\n\\t3-triazole}  (#14# isozyme CA II, in 10 mM HEPES (pH 7.5), 0.1 M \\n\\tNaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.0000075 {4-(N-oxide-2-pyridylthio)pyridine-3-sulfonamide}  (#14# \\n\\tisoform CA IX, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.0000075 \\n\\t{4-[2-(4-sulfamoylphenyl)ethylamino]-3-pyridinosulfonamide}  (#14# \\n\\tisoform CA IX, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.0000075 \\n\\t{4-(4-hydroxyphenyl)-2-(3-hydroxyphenyl)-5H-indeno[1,2-b]pyridin-5-one} \\n\\t (#14# isoform CA I, at 25C, pH not specified in the publication \\n\\t<414>) <414>\\nKI\\t#14# 0.00015 {n-tetradecyl sulfamate}  (#14# pH 7.5, 20C, HCA I <132>) \\n\\t<132>\\nKI\\t#14# 0.0083 \\n\\t{(2R)-3-(3-chloro-4-hydroxyphenyl)-2-[[(2E)-4-methoxy-4-oxobut-2-\\n\\tenoyl]amino]propanoic acid}  (#14# isoform CA II <261>) <261>\\nKI\\t#14# 0.000032 {1,2:3,4-di-O-isopropylidene-alpha-D-galactopyranose \\n\\t6-sulfamate}  (#14# pH 7.4, 25C, hCA IX <131>) <131>\\nKI\\t#14# 0.000032 {estradiol 17beta-sulfamate}  (#14# pH 7.4, 25C, hCA IX \\n\\t<131>) <131>\\nKI\\t#14# 0.0084 \\n\\t{7-hydroxy-1-methoxy-3-methyl-9-oxo-9,\\n\\t9a-dihydro-4aH-xanthene-8-carboxylic acid}  (#14# isoform CA II <261>) \\n\\t<261>\\nKI\\t#14# 0.00011 {2-N-(4-sulfamoylphenyl)-thioformyl-L-Pro}  (#14# pH 7.5, \\n\\tcarbonic anhydrase I <153>) <153>\\nKI\\t#14# 0.00011 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(2\\',3\\',4\\',\\n\\t6\\'-tetra-O-acetyl-beta-D-galactopyranosyl)-1H-1,2,3-triazole}  (#14# \\n\\tisozyme CA IX, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, at 20C <228>) \\n\\t<228>\\nKI\\t#14# 0.00011 {2-(3-chloro-4-hydroxyphenyl)acetamide}  (#14# isoform CA \\n\\tVA <261>) <261>\\nKI\\t#14# 0.00046 \\n\\t{1-[2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl]-4-(4-\\n\\tsulfamoylphenyl)-1H-1,2,3-triazole}  (#14# isozyme CA II, in 10 mM \\n\\tHEPES (pH 7.5), 0.1 M NaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.000022 {n-hexadecyl sulfamate}  (#14# pH 7.5, 20C, HCA IX \\n\\t<132>) <132>\\nKI\\t#14# 0.000022 {N-salicylidene-sulfanilic acid amide cobalt sulfate \\n\\tcomplex}  (#14# pH 7.4, 25C, isozyme hCA II <126>) <126>\\nKI\\t#14# 0.000022 {2-N-(4-sulfamoylphenyl)-thioformyl-L-Ile}  (#14# pH 7.5, \\n\\tcarbonic anhydrase I <153>) <153>\\nKI\\t#14# 0.000028 {sulfamate}  (#14# pH 7.4, 25C, hCA I <131>) <131>\\nKI\\t#14# 0.000028 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(alpha-D-arabinopyranosyl)-1H-1,2,\\n\\t3-triazole}  (#14# isozyme CA IX, in 10 mM HEPES (pH 7.5), 0.1 M \\n\\tNaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.000028 \\n\\t{N-[(benzyloxy)carbonyl]glycyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]glycinamide}  (#14# isoform CA II, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.000131 {4-(carbamoylmethylthio)pyridine-3-sulfonamide}  (#14# \\n\\tisoform CA II, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.000025 {n-octylsulfamate}  (#14# pH 7.4, 25C, hCA IX <131>) \\n\\t<131>\\nKI\\t#14# 0.000025 {N-salicylidene-sulfanilic acid amide cobalt nitrate \\n\\tcomplex}  (#14# pH 7.4, 25C, isozyme hCA II <126>) <126>\\nKI\\t#14# 0.000025 \\n\\t{N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-isoleucine}  (#14# \\n\\tNovaSyn TGA-resin bound, pH 7.5, carbonic anhydrase I <153>) <153>\\nKI\\t#14# 0.000025 {2-N-(4-sulfamoylphenyl)-thioformyl-L-Pro}  (#14# pH 7.5, \\n\\tcarbonic anhydrase II <153>) <153>\\nKI\\t#14# 0.000025 {ethoxazolamide}  (#14# isozyme CA I, in 10 mM HEPES (pH \\n\\t7.5), 0.1 M NaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.000025 {N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide}  (#14# \\n\\tisozyme CA IX, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.000045 {4-acetylamidophenyl sulfamate}  (#14# pH 7.4, 25C, hCA \\n\\tIX <131>) <131>\\nKI\\t#14# 0.000045 {N-phosphoryl-4-carboxy-benzenesulfonamide}  (#14# pH \\n\\t7.4, 25C, hCA II <121>) <121>\\nKI\\t#14# 0.00033 {N-salicylidene-sulfanilic acid amide cobalt chloride \\n\\tcomplex}  (#14# pH 7.4, 25C, isozyme hCA I <126>) <126>\\nKI\\t#14# 0.00033 {N-salicylidene-sulfanilic acid amide cobalt acetate \\n\\tcomplex}  (#14# pH 7.4, 25C, isozyme hCA I <126>) <126>\\nKI\\t#14# 0.00033 \\n\\t{6,7-dimethoxy-1-isopropyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#14# isoform CA IX, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.0086 {(3-chloro-4-hydroxyphenyl)acetic acid}  (#14# isoform CA \\n\\tII <261>) <261>\\nKI\\t#14# 0.0086 {5-amino-1,3,4-thiadiazole-2-sulfonamide}  (#14# isozyme \\n\\thCAI, pH 7.5, 22C <299>) <299>\\nKI\\t#14# 0.0086 {phenylacetonitrile}  (#14# isozyme CA IX, pH not specified \\n\\tin the publication, temperature not specified in the publication <296>) \\n\\t<296>\\nKI\\t#14# 0.0098 {2-(3-chloro-4-hydroxyphenyl)-N-(2-phenylethyl)acetamide}  \\n\\t(#14# isoform CA II <261>) <261>\\nKI\\t#14# 0.0000098 \\n\\t{6,7-dimethoxy-1-methyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#14# isoform CA XIV, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.62 {salicylic acid}  (#14# isozyme carbonic anhydrase I <209>) \\n\\t<209>\\nKI\\t#14# 0.000051 {4-phenoxyphenyl sulfamate}  (#14# pH 7.4, 25C, hCA IX \\n\\t<131>) <131>\\nKI\\t#14# 0.065 {n-octadecyl sulfamate}  (#14# pH 7.5, 20C, HCA I <132>) \\n\\t<132>\\nKI\\t#14# 0.000035 {1-(1,2-benzoxazol-3-yl)methanesulfonamide}  (#14# \\n\\twild-type, pH 7.5, 20C <332>) <332>\\nKI\\t#14# 0.0000084 {4-[4-(aminosulfonyl)phenyl]-1-(beta-D-glucuronic acid \\n\\tmethyl ester)-1H-1,2,3-triazole}  (#14# isozyme CA IX, in 10 mM HEPES \\n\\t(pH 7.5), 0.1 M NaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.0041 {7-oxodehydroepiandrosterone sulfamate}  (#14# pH 7.5, \\n\\t20C, HCA I <132>) <132>\\nKI\\t#14# 0.0041 {2-phenylethyl sulfamate}  (#14# pH 7.5, 20C, HCA I <132>) \\n\\t<132>\\nKI\\t#14# 0.0041 {[5-(dimethylamino)-1-naphthyl]sulfonylsulfamic acid}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0041 \\n\\t{1-cyclopentyl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide} \\n\\t (#14# isoform CA I, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.0117 \\n\\t{4,4\\'-[(1R,2R,3S,4S)-3,4-dimethylcyclobutane-1,\\n\\t2-diyl]bis(2-methoxyphenol)}  (#14# isoform CA II <261>) <261>\\nKI\\t#14# 0.0019 {N-(aminosulfonyl)-3-nitrobenzenesulfonamide}  (#14# pH \\n\\t7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0009 {acetazolamide}  (#14# pH 7.4, 25C, hCA I <120,131>; #14# \\n\\tpH 7.5, 20C, HCA I <132>; #14# pH 7.5, carbonic anhydrase I <153>) \\n\\t<120,131,132,153>\\nKI\\t#14# 0.0009 {(2-nitrophenyl)sulfonylsulfamic acid}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA I <122>) <122>\\nKI\\t#14# 0.0009 {tert-butyl \\n\\t4-[[(aminosulfonyl)amino]sulfonyl]phenylcarbamate}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA I <122>) <122>\\nKI\\t#14# 0.0009 {N-(aminosulfonyl)-3-(trifluoromethyl)benzenesulfonamide}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.0009 {N-(aminosulfonyl)-2,5-dichlorobenzenesulfonamide}  (#14# \\n\\tpH 7.4, 25C, isozyme hCA I <122>) <122>\\nKI\\t#14# 0.0009 \\n\\t{N-(aminosulfonyl)-3,5-dichloro-2-hydroxybenzenesulfonamide}  (#14# pH \\n\\t7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0009 {[[(4-fluorophenyl)sulfonyl]amino]carbonylsulfamic amide}  \\n\\t(#14# pH 7.4, 25C, isozyme hCA II <122>) <122>\\nKI\\t#14# 0.0078 {1H,1H-perfluoroethyl sulfamate}  (#14# pH 7.5, 20C, HCA I \\n\\t<132>) <132>\\nKI\\t#14# 0.0078 {1,2,4-trimethoxybenzene}  (#14# isozyme hCAXII, pH 7.5, \\n\\t22C <299>) <299>\\nKI\\t#14# 0.0078 {6-acetyl-7-methoxy-2H-chromen-2-one}  (#14# inhibition of \\n\\tisozyme hCA IX, pH not specified in the publication, temperature not \\n\\tspecified in the publication <293>) <293>\\nKI\\t#14# 0.0099 {6-deoxy-N-sulfamoyl-alpha-L-glucopyranosylamine}  (#14# \\n\\tisozyme hCA XII, pH not specified in the publication, temperature not \\n\\tspecified in the publication <294>) <294>\\nKI\\t#14# 0.0133 {spermine}  (#14# isozyme hCAIX, pH 7.5, 22C <299>) <299>\\nKI\\t#14# 0.000082 \\n\\t{2,3,4-tri-O-acetyl-6-deoxy-N-sulfamoyl-alpha-L-glucopyranosylamine}  \\n\\t(#14# isozyme hCA II, pH not specified in the publication, temperature \\n\\tnot specified in the publication <294>) <294>\\nKI\\t#14# 0.00027 {n-dodecyl sulfamate}  (#14# pH 7.5, 20C, HCA I <132>) \\n\\t<132>\\nKI\\t#14# 0.059 {cyclohexyl sulfamate}  (#14# pH 7.5, 20C, HCA I <132>) \\n\\t<132>\\nKI\\t#14# 0.0103 {4-(5-methyl-2-pyrazolino)-3-pyridinesulfonamide}  (#14# \\n\\tisoform CA I, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.00083 \\n\\t{3,4,\\n\\t6-tri-O-acetyl-2-deoxy-N-sulfamoyl-beta-D-arabino-hexopyranosylamine}  \\n\\t(#14# isozyme hCA I, pH not specified in the publication, temperature \\n\\tnot specified in the publication <294>) <294>\\nKI\\t#14# 0.00083 \\n\\t{3,4,6-tri-O-acetyl-2-deoxy-N-sulfamoyl-beta-D-lyxo-hexopyranosylamine} \\n\\t (#14# isozyme hCA I, pH not specified in the publication, temperature \\n\\tnot specified in the publication <294>) <294>\\nKI\\t#14# 0.00056 {N-salicylidene-sulfanilic acid amide nickel nitrate \\n\\tcomplex}  (#14# pH 7.4, 25C, isozyme hCA I <126>) <126>\\nKI\\t#14# 0.00056 {4-[4-(aminosulfonyl)phenyl]-1-(beta-D-glucuronic acid \\n\\tmethyl ester)-1H-1,2,3-triazole}  (#14# isozyme CA I, in 10 mM HEPES \\n\\t(pH 7.5), 0.1 M NaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.00032 {N-salicylidene-sulfanilic acid amide cobalt nitrate \\n\\tcomplex}  (#14# pH 7.4, 25C, isozyme hCA I <126>) <126>\\nKI\\t#14# 0.0053 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(2\\',3\\',\\n\\t5\\'-tri-O-benzoyl-beta-D-ribofuranosyl)-1H-1,2,3-triazole}  (#14# \\n\\tisozyme CA I, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, at 20C <228>) \\n\\t<228>\\nKI\\t#14# 0.0115 \\n\\t{2-(3-chloro-4-hydroxyphenyl)-N-[2-(3,\\n\\t4-dimethoxyphenyl)ethyl]acetamide}  (#14# isoform CA II <261>) <261>\\nKI\\t#14# 0.0067 {3,4-dimethoxybenzoic acid}  (#14# isozyme hCAXII, pH 7.5, \\n\\t22C <299>) <299>\\nKI\\t#14# 0.0000011 {2-phenylethyl sulfamate}  (#14# pH 7.5, 20C, HCA II \\n\\t<132>) <132>\\nKI\\t#14# 0.0000011 {3-[(4-methylphenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA IX, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.0000017 {3-[(3-methoxyphenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA IX, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.0000017 \\n\\t{N-(tert-butoxycarbonyl)-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-phenylalaninamide}  (#14# isoform CA II, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.0000017 \\n\\t{D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-phenylalaninamide}  \\n\\t(#14# isoform CA II, pH and temperature not specified in the \\n\\tpublication <415>) <415>\\nKI\\t#14# 0.0000023 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(alpha-D-arabinopyranosyl)-1H-1,2,\\n\\t3-triazole}  (#14# isozyme CA II, in 10 mM HEPES (pH 7.5), 0.1 M \\n\\tNaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.0000046 {4-chlorophenyl sulfamate}  (#14# pH 7.4, 25C, hCA I \\n\\t<131>) <131>\\nKI\\t#14# 0.0000046 {4-(1-methyl-5-tetrazolylthio)pyridine-3-sulfonamide}  \\n\\t(#14# isoform CA IX, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C \\n\\t<271>) <271>\\nKI\\t#14# 0.0000046 \\n\\t{4-[N\\'-(1,1-dioxopyrido[4,3-e]-1,4,\\n\\t2-dithiazin-3-yl)hydrazino]-3-pyridinesulfonamide}  (#14# isoform CA \\n\\tXII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.000016 \\n\\t{N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-alanine}  (#14# \\n\\tNovaSyn TGA-resin bound, pH 7.5, carbonic anhydrase II <153>) <153>\\nKI\\t#14# 0.000016 {azetazolamide}  <215>\\nKI\\t#14# 0.000016 \\n\\t{3,4,6-tri-O-acetyl-2-deoxy-N-sulfamoyl-beta-D-lyxo-hexopyranosylamine} \\n\\t (#14# isozyme hCA IX, pH not specified in the publication, temperature \\n\\tnot specified in the publication <294>) <294>\\nKI\\t#14# 0.000016 {celecoxib}  (#14# isozyme CA IX, pH not specified in the \\n\\tpublication, temperature not specified in the publication <296>) <296>\\nKI\\t#14# 0.000048 \\n\\t{N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-proline}  (#14# \\n\\tNovaSyn TGA-resin bound, pH 7.5, carbonic anhydrase II <153>) <153>\\nKI\\t#14# 0.000048 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(2\\',3\\',4\\'-tri-O-acetyl-beta-D-glucuronic \\n\\tacid methyl ester)-1H-1,2,3-triazole}  (#14# isozyme CA I, in 10 mM \\n\\tHEPES (pH 7.5), 0.1 M NaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.0000028 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(alpha-D-mannopyranosyl)-1H-1,2,\\n\\t3-triazole}  (#14# isozyme CA I, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, \\n\\tat 20C <228>) <228>\\nKI\\t#14# 0.0000028 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-methioninamide}  (#14# isoform CA II, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.000012 {2-phenylethyl sulfamate}  (#14# pH 7.5, 20C, HCA IX \\n\\t<132>) <132>\\nKI\\t#14# 0.000012 {2-N-(4-sulfamoylphenyl)-thioformyl-L-Ala}  (#14# pH 7.5, \\n\\tcarbonic anhydrase II <153>) <153>\\nKI\\t#14# 0.000012 {4-(allylamino)-3-pyridinesulfonamide}  (#14# isoform CA \\n\\tIX, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.000012 \\n\\t{3,4,\\n\\t6-tri-O-acetyl-2-deoxy-N-sulfamoyl-beta-D-arabino-hexopyranosylamine}  \\n\\t(#14# isozyme hCA II, pH not specified in the publication, temperature \\n\\tnot specified in the publication <294>) <294>\\nKI\\t#14# 0.000012 {N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide}  (#14# \\n\\tisozyme CA II, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.000012 {3-phenylpropanenitrile}  (#14# isozyme CA XII, pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <296>) <296>\\nKI\\t#14# 0.000012 {5-(formylamino)-1,3,4-thiadiazole-2-sulfonamide}  (#14# \\n\\twild-type, pH 7.5, 20C <332>) <332>\\nKI\\t#14# 0.000039 {pentachlorophenyl sulfamate}  (#14# pH 7.4, 25C, hCA IX \\n\\t<131>) <131>\\nKI\\t#14# 0.000039 {1,2:5,6-di-O-isopropylidene-alpha-D-glucofuranose \\n\\t3-sulfamate}  (#14# pH 7.4, 25C, hCA IX <131>) <131>\\nKI\\t#14# 0.000039 {N-salicylidene-sulfanilic acid amide nickel chloride \\n\\tcomplex}  (#14# pH 7.4, 25C, isozyme hCA II <126>) <126>\\nKI\\t#14# 0.000039 {N-salicylidene-sulfanilic acid amide nickel nitrate \\n\\tcomplex}  (#14# pH 7.4, 25C, isozyme hCA II <126>) <126>\\nKI\\t#14# 0.103 {(4-hydroxyphenyl)acetic acid}  (#14# isoform CA II <261>) \\n\\t<261>\\nKI\\t#14# 0.00053 {n-decyl sulfamate}  (#14# pH 7.5, 20C, HCA I <132>) <132>\\nKI\\t#14# 0.0107 {N-butyl-2-(3-chloro-4-hydroxyphenyl)acetamide}  (#14# \\n\\tisoform CA I <261>) <261>\\nKI\\t#14# 0.0107 {methyl (3-chloro-4-hydroxyphenyl)acetate}  (#14# isoform \\n\\tCA II <261>) <261>\\nKI\\t#14# 0.00044 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(2\\'-acetamido-2\\'-deoxy\\'-3\\',4\\',\\n\\t6\\'-tri-O-acetyl-beta-D-glucopyranosyl)-1H-1,2,3-triazole}  (#14# \\n\\tisozyme CA II, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, at 20C <228>) \\n\\t<228>\\nKI\\t#14# 0.054 {valdecoxib}  (#14# isozyme CA I, pH not specified in the \\n\\tpublication, temperature not specified in the publication <296>) <296>\\nKI\\t#14# 0.00315 \\n\\t{6,7-dimethoxy-1-isopropyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#14# isoform CA I, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.0089 \\n\\t{4-[N\\'-(1,1-dioxopyrido[4,3-e]-1,4,\\n\\t2-dithiazin-3-yl)hydrazino]-3-pyridinesulfonamide}  (#14# isoform CA I, \\n\\tin 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.000027 {dehydroepiandrosterone sulfamate}  (#14# pH 7.4, 25C, \\n\\thCA II <131>) <131>\\nKI\\t#14# 0.000027 {2-N-(4-sulfamoylphenyl)-thioformyl-L-Asn}  (#14# pH 7.5, \\n\\tcarbonic anhydrase I <153>) <153>\\nKI\\t#14# 0.000027 {2-N-(4-sulfamoylphenyl)-thioformyl-L-Met}  (#14# pH 7.5, \\n\\tcarbonic anhydrase I <153>) <153>\\nKI\\t#14# 0.000027 {valdecoxib}  (#14# isozyme CA IX, pH not specified in \\n\\tthe publication, temperature not specified in the publication <296>) \\n\\t<296>\\nKI\\t#14# 0.0000047 {n-undecyl sulfamate}  (#14# pH 7.5, 20C, HCA II <132>) \\n\\t<132>\\nKI\\t#14# 0.0000047 {4-(2-phenylacetamido)benzenesulfonamide}  (#14# isoform \\n\\tCA VII <255>) <255>\\nKI\\t#14# 0.0000047 {4,4\\'-thiodipyridine-3-sulfonamide}  (#14# isoform CA \\n\\tXII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000047 \\n\\t{1-cyclopropyl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide} \\n\\t (#14# isoform CA XIV, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.0000047 \\n\\t{4-(4-hydroxyphenyl)-2-p-tolyl-5H-indeno[1,2-b]pyridin-5-one}  (#14# \\n\\tisoform CA I, at 25C, pH not specified in the publication <414>) <414>\\nKI\\t#14# 0.00071 {n-pentyl sulfamate}  (#14# pH 7.5, 20C, HCA I <132>) \\n\\t<132>\\nKI\\t#14# 0.082 {sulfamide}  (#14# pH 7.8, 25C, hCA II <101>) <101>\\nKI\\t#14# 0.0108 \\n\\t{2-(3-chloro-4-hydroxyphenyl)-N-[2-(3-methoxyphenyl)ethyl]acetamide}  \\n\\t(#14# isoform CA II <261>) <261>\\nKI\\t#14# 0.0108 {N-tert-butyl-2-(3-chloro-4-hydroxyphenyl)acetamide}  (#14# \\n\\tisoform CA II <261>) <261>\\nKI\\t#14# 0.0119 \\n\\t{2-(3-chloro-4-hydroxyphenyl)-N-[2-(3,\\n\\t4-dimethoxyphenyl)ethyl]acetamide}  (#14# isoform CA I <261>) <261>\\nKI\\t#14# 0.99 {but-3-ynyl sulfamate}  (#14# pH 7.5, 20C, HCA I <132>) <132>\\nKI\\t#14# 0.000009 {n-dodecyl sulfamate}  (#14# pH 7.5, 20C, HCA IX <132>) \\n\\t<132>\\nKI\\t#14# 0.000009 {2-N-(4-sulfamoylphenyl)-thioformyl-L-Gln}  (#14# pH 7.5, \\n\\tcarbonic anhydrase II <153>) <153>\\nKI\\t#14# 0.0094 {N-butyl-2-(3-chloro-4-hydroxyphenyl)acetamide}  (#14# \\n\\tisoform CA II <261>) <261>\\nKI\\t#14# 0.00039 \\n\\t{N-(2-fluoro-4-sulfamoylphenyl)-2-(thiophen-2-yl)acetamide}  (#14# \\n\\tinhibition of CO2 hydration by isozyme hCAII, pH 7.5, temperature not \\n\\tspecified in the publication <302>) <302>\\nKI\\t#14# 0.097 {sulfamic acid}  (#14# pH 7.4, 25C, hCA II <131>) <131>\\nKI\\t#14# 0.131 {2-(3-chloro-4-hydroxyphenyl)acetamide}  (#14# isoform CA II \\n\\t<261>) <261>\\nKI\\t#14# 0.284 {(2E)-4-methoxy-4-oxobut-2-enoic acid}  (#14# isoform CA I \\n\\t<261>) <261>\\nKI\\t#14# 0.00647 {N-sulfamoyl-beta-D-glucopyranosylamine}  (#14# isozyme \\n\\thCA IX, pH not specified in the publication, temperature not specified \\n\\tin the publication <294>) <294>\\nKI\\t#14# 0.000054 {dehydroepiandrosterone sulfamate}  (#14# pH 7.4, 25C, \\n\\thCA IX <131>) <131>\\nKI\\t#14# 0.000054 {4-trifluoromethylphenyl sulfamate}  (#14# pH 7.4, 25C, \\n\\thCA IX <131>) <131>\\nKI\\t#14# 0.00043 {n-undecyl sulfamate}  (#14# pH 7.5, 20C, HCA I <132>) \\n\\t<132>\\nKI\\t#14# 0.231 \\n\\t{(2S)-3-(3-chloro-4-hydroxyphenyl)-2-[[(2E)-4-methoxy-4-oxobut-2-\\n\\tenoyl]amino]propanoic acid}  (#14# isoform CA I <261>) <261>\\nKI\\t#14# 0.231 {spermine}  (#14# isozyme hCAI, pH 7.5, 22C <299>) <299>\\nKI\\t#14# 1.06 {4-sulfosalicylic acid}  (#14# isozyme carbonic anhydrase II \\n\\t<209>) <209>\\nKI\\t#14# 0.265 {(3-chloro-4-hydroxyphenyl)acetic acid}  (#14# isoform CA I \\n\\t<261>) <261>\\nKI\\t#14# 0.00489 {4-[(3-methoxyphenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA II, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.00565 {4-(phenylethynyl)benzenesulfonamide}  (#14# isozyme CA I, \\n\\tpH not specified in the publication, temperature not specified in the \\n\\tpublication <296>) <296>\\nKI\\t#14# 0.158 {2-(3-chloro-4-hydroxyphenyl)-N-(2-methoxyethyl)acetamide}  \\n\\t(#14# isoform CA I <261>) <261>\\nKI\\t#14# 0.000036 {4-nitrophenyl sulfamate}  (#14# pH 7.4, 25C, hCA IX \\n\\t<131>) <131>\\nKI\\t#14# 0.000036 {N-salicylidene-sulfanilic acid amide nickel sulfate \\n\\tcomplex}  (#14# pH 7.4, 25C, isozyme hCA II <126>) <126>\\nKI\\t#14# 0.000105 {5-pentylresorcinyl sulfamate}  (#14# pH 7.4, 25C, hCA I \\n\\t<131>) <131>\\nKI\\t#14# 0.000105 {N-tert-butyl-2-(3-chloro-4-hydroxyphenyl)acetamide}  \\n\\t(#14# isoform CA VA <261>) <261>\\nKI\\t#14# 0.000105 {4-(2-hydroxyethyl)phenol}  (#14# isoform CA VB <261>) \\n\\t<261>\\nKI\\t#14# 0.000105 {4-(quinolinoxy)-3-pyridinesulfonamide}  (#14# isoform CA \\n\\tII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.00021 {N-salicylidene-sulfanilic acid amide copper chloride \\n\\tcomplex}  (#14# pH 7.4, 25C, isozyme hCA I <126>) <126>\\nKI\\t#14# 0.0212 {N-sulfamoyl-beta-D-mannopyranosylamine}  (#14# isozyme hCA \\n\\tII, pH not specified in the publication, temperature not specified in \\n\\tthe publication <294>) <294>\\nKI\\t#14# 1.23 {4-aminosalicylic acid}  (#14# isozyme carbonic anhydrase II \\n\\t<209>) <209>\\nKI\\t#14# 0.000031 {dehydroepiandrosterone sulfamate}  (#14# pH 7.4, 25C, \\n\\thCA I <131>) <131>\\nKI\\t#14# 0.000031 \\n\\t{N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-methionine}  (#14# \\n\\tNovaSyn TGA-resin bound, pH 7.5, carbonic anhydrase I <153>) <153>\\nKI\\t#14# 0.000031 \\n\\t{N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-valine}  (#14# \\n\\tNovaSyn TGA-resin bound, pH 7.5, carbonic anhydrase I <153>) <153>\\nKI\\t#14# 0.000031 {indisulam}  (#14# isoform CA I, in 10 mM HEPES (pH 7.5), \\n\\t0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.000125 {pentachlorophenylsulfamate}  (#14# pH 7.4, 25C, hCA II \\n\\t<131>) <131>\\nKI\\t#14# 0.000125 {N-phosphoryl-4-carboxy-benzenesulfonamide}  (#14# pH \\n\\t7.4, 25C, hCA I <121>) <121>\\nKI\\t#14# 0.000125 {methyl (3-chloro-4-hydroxyphenyl)acetate}  (#14# isoform \\n\\tCA VB <261>) <261>\\nKI\\t#14# 0.000125 {N-(4-sulfamoylphenyl)-2-(thiophen-2-yl)acetamide}  (#14# \\n\\tinhibition of CO2 hydration by isozyme hCAXIII, pH 7.5, temperature not \\n\\tspecified in the publication <302>) <302>\\nKI\\t#14# 0.000125 {4-(2-hydroxyethyl)benzenesulfonamide}  (#14# wild-type, \\n\\tpH 7.5, 20C <332>) <332>\\nKI\\t#14# 0.00048 {4-cyanophenyl sulfamate}  (#14# pH 7.4, 25C, hCA I \\n\\t<131>) <131>\\nKI\\t#14# 0.000073 {8-acetyl-7-hydroxy-2H-chromen-2-one}  (#14# inhibition \\n\\tof isozyme hCA IX, pH not specified in the publication, temperature not \\n\\tspecified in the publication <293>) <293>\\nKI\\t#14# 0.0052 {4-(phenylethynyl)benzenesulfonamide}  (#14# isozyme CA II, \\n\\tpH not specified in the publication, temperature not specified in the \\n\\tpublication <296>) <296>\\nKI\\t#14# 0.00038 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(beta-D-glucopyranosyl)-1H-1,2,\\n\\t3-triazole}  (#14# isozyme CA II, in 10 mM HEPES (pH 7.5), 0.1 M \\n\\tNaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.000057 {4-[(3-fluorophenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA II, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.000057 {3-[(3-fluorophenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA XII, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.000063 {phenylsulfamate}  (#14# pH 7.4, 25C, hCA IX <131>) <131>\\nKI\\t#14# 0.000063 {2-naphthyl sulfamate}  (#14# pH 7.4, 25C, hCA II <131>) \\n\\t<131>\\nKI\\t#14# 0.0000029 {4-t-butylphenyl sulfamate}  (#14# pH 7.4, 25C, hCA II \\n\\t<131>) <131>\\nKI\\t#14# 0.0000059 {4-ethoxy-3-pyridinesulfonamide}  (#14# isoform CA XII, \\n\\tin 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000063 {4-(2-propynylthio)pyridine-3-sulfonamide}  (#14# \\n\\tisoform CA IX, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.0000063 {4-(4-cyanophenoxy)-3-pyridinesulfonamide}  (#14# \\n\\tisoform CA XII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.0000063 \\n\\t{N-[(benzyloxy)carbonyl]-D-alanyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]glycinamide}  (#14# isoform CA II, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.00653 {4-(1-methyl-5-tetrazolylthio)pyridine-3-sulfonamide}  \\n\\t(#14# isoform CA I, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C \\n\\t<271>) <271>\\nKI\\t#14# 0.0061 {4-ethoxy-3-pyridinesulfonamide}  (#14# isoform CA I, in 10 \\n\\tmM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000043 \\n\\t{N-(tert-butoxycarbonyl)-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-alloisoleucinamide}  (#14# isoform CA II, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.0000043 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-methioninamide}  (#14# isoform CA XII, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.0000079 {4-(2-pyridin-4-ylacetamido)benzenesulfonamide}  (#14# \\n\\tisoform CA VII <255>) <255>\\nKI\\t#14# 0.0000079 {4-(4-fluorophenoxy)-3-pyridinesulfonamide}  (#14# \\n\\tisoform CA IX, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.000043 {4-t-butylphenyl sulfamate}  (#14# pH 7.4, 25C, hCA I \\n\\t<131>) <131>\\nKI\\t#14# 0.000043 {5-pentylresorcinylsulfamate}  (#14# pH 7.4, 25C, hCA IX \\n\\t<131>) <131>\\nKI\\t#14# 0.000043 {valdecoxib}  (#14# isozyme CA II, pH not specified in \\n\\tthe publication, temperature not specified in the publication <296>) \\n\\t<296>\\nKI\\t#14# 0.000091 \\n\\t{4,4\\'-[(1R,2R,3S,4S)-3,4-dimethylcyclobutane-1,\\n\\t2-diyl]bis(2-methoxyphenol)}  (#14# isoform CA VA <261>) <261>\\nKI\\t#14# 0.000091 {2-(3-chloro-4-hydroxyphenyl)-N-(2-phenylethyl)acetamide} \\n\\t (#14# isoform CA VB <261>) <261>\\nKI\\t#14# 0.00094 {N-sulfamoyl-beta-D-galactopyranosylamine}  (#14# isozyme \\n\\thCA IX, pH not specified in the publication, temperature not specified \\n\\tin the publication <294>) <294>\\nKI\\t#14# 0.0000105 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(2\\',3\\',\\n\\t4\\'-tri-O-acetyl-alpha-D-arabinopyranosyl)-1H-1,2,3-triazole}  (#14# \\n\\tisozyme CA I, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, at 20C <228>) \\n\\t<228>\\nKI\\t#14# 0.000108 {N-butyl-2-(3-chloro-4-hydroxyphenyl)acetamide}  (#14# \\n\\tisoform CA VA <261>) <261>\\nKI\\t#14# 0.000108 \\n\\t{(2S)-3-(3-chloro-4-hydroxyphenyl)-2-[[(2E)-4-methoxy-4-oxobut-2-\\n\\tenoyl]amino]propanoic acid}  (#14# isoform CA VA <261>) <261>\\nKI\\t#14# 0.000108 {4-(2-propynylthio)pyridine-3-sulfonamide}  (#14# isoform \\n\\tCA II, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000211 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-leucinamide}  (#14# isoform CA II, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.0000056 \\n\\t{2,3,4,6-tetra-O-acetyl-N-sulfamoyl-beta-D-mannopyranosylamine}  (#14# \\n\\tisozyme hCA XII, pH not specified in the publication, temperature not \\n\\tspecified in the publication <294>) <294>\\nKI\\t#14# 0.0000056 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-alaninamide}  (#14# isoform CA XII, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.000052 {N,N\\'-biphosphoryl-4,5-dichloro-1,3-benzenesulfonamide}  \\n\\t(#14# pH 7.4, 25C, hCA I <121>) <121>\\nKI\\t#14# 0.000052 \\n\\t{4-[2-(4-sulfamoylphenyl)ethylamino]-3-pyridinosulfonamide}  (#14# \\n\\tisoform CA II, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.00051 {3,5-Dihydroxybenzoic acid}  (#14# isozyme hCAII, pH 7.5, \\n\\t22C <299>) <299>\\nKI\\t#14# 0.0000034 {benzyl sulfamate}  (#14# pH 7.5, 20C, HCA II <132>) \\n\\t<132>\\nKI\\t#14# 0.0000034 {indisulam}  (#14# isoform CA XII, in 10 mM HEPES (pH \\n\\t7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000034 \\n\\t{4-[N\\'-(6-chloro-7-cyano-1,1-dioxo-1,4,\\n\\t2-benzodithiazin-3-yl)hydrazino]-3-pyridinesulfonamide}  (#14# isoform \\n\\tCA XII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000038 {3-methylphenylsulfamate}  (#14# pH 7.4, 25C, hCA I \\n\\t<131>) <131>\\nKI\\t#14# 0.0000038 {4-iodophenyl sulfamate}  (#14# pH 7.4, 25C, hCA II \\n\\t<131>) <131>\\nKI\\t#14# 0.0000038 \\n\\t{(3aR,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,\\n\\t5-b:4\\',5\\'-d]pyran-3a-yl sulfamate}  (#14# isozyme hCA XII, pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <294>) <294>\\nKI\\t#14# 0.0000049 {4-hydrazino-3-pyridinesulfonamide}  (#14# isoform CA \\n\\tIX, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000064 \\n\\t{1-n-butyl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#14# isoform CA XIV, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.0000067 {4-(2-methyl-8-quinolinoxy)-3-pyridinesulfonamide}  \\n\\t(#14# isoform CA XII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C \\n\\t<271>) <271>\\nKI\\t#14# 0.0000067 {4-methylthiopyridine-3-sulfonamide}  (#14# isoform CA \\n\\tXII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000067 {2,4-bis(4-hydroxyphenyl)-5H-indeno[1,2-b]pyridin-5-one} \\n\\t (#14# isoform CA I, at 25C, pH not specified in the publication \\n\\t<414>) <414>\\nKI\\t#14# 0.0000077 {4-(2-pyridin-2-ylacetamido)benzenesulfonamide}  (#14# \\n\\tisoform CA VII <255>) <255>\\nKI\\t#14# 0.0000077 {4-(1,3,4-thiadiazol-2-ylthio)pyridine-3-sulfonamide}  \\n\\t(#14# isoform CA IX, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C \\n\\t<271>) <271>\\nKI\\t#14# 0.0000077 \\n\\t{2,3,4,6-tetra-O-acetyl-N-sulfamoyl-beta-D-glucopyranosylamine}  (#14# \\n\\tisozyme hCA IX, pH not specified in the publication, temperature not \\n\\tspecified in the publication <294>) <294>\\nKI\\t#14# 0.0000077 \\n\\t{N-[(benzyloxy)carbonyl]-D-methionyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]glycinamide}  (#14# isoform CA XII, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.0000077 \\n\\t{N-(tert-butoxycarbonyl)-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-methioninamide}  (#14# isoform CA XII, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.0000081 {4-ethynylbenzenesulfonamide}  <228>\\nKI\\t#14# 0.0000081 \\n\\t{4-[N\\'-(6-chloro-7-methyl-1,1-dioxo-1,4,\\n\\t2-benzodithiazin-3-yl)hydrazino]-3-pyridinesulfonamide}  (#14# isoform \\n\\tCA XII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000082 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(2\\',3\\',\\n\\t4\\'-tri-O-acetyl-alpha-D-arabinopyranosyl)-1H-1,2,3-triazole}  (#14# \\n\\tisozyme CA II, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, at 20C <228>) \\n\\t<228>\\nKI\\t#14# 0.000046 {4-(4\\'-hydroxyphenyl)diazenylbenzenesulfonamide}  (#14# \\n\\tisozyme CA VII, at 25C, pH 7.4 <268>) <268>\\nKI\\t#14# 0.000094 \\n\\t{2-(3-chloro-4-hydroxyphenyl)-N-[2-(3,\\n\\t4-dimethoxyphenyl)ethyl]acetamide}  (#14# isoform CA VA <261>) <261>\\nKI\\t#14# 0.000094 \\n\\t{7-hydroxy-3-(hydroxymethyl)-1-methoxy-9-oxo-9,\\n\\t9a-dihydro-4aH-xanthene-8-carboxylic acid}  (#14# isoform CA VA <261>) \\n\\t<261>\\nKI\\t#14# 0.000101 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(2\\'-acetamido-2\\'-deoxy\\'-3\\',4\\',\\n\\t6\\'-tri-O-acetyl-beta-D-glucopyranosyl)-1H-1,2,3-triazole}  (#14# \\n\\tisozyme CA IX, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, at 20C <228>) \\n\\t<228>\\nKI\\t#14# 0.000101 {4-(2-hydroxyethyl)phenol}  (#14# isoform CA VA <261>) \\n\\t<261>\\nKI\\t#14# 0.000101 {2-(3-chloro-4-hydroxyphenyl)-N-(2-phenylethyl)acetamide} \\n\\t (#14# isoform CA VA <261>) <261>\\nKI\\t#14# 0.000101 \\n\\t{(5Z)-2-amino-5-(3,4-dihydroxybenzylidene)-3,\\n\\t5-dihydro-4H-imidazol-4-one}  (#14# isoform CA VA <261>) <261>\\nKI\\t#14# 0.000101 \\n\\t{4-[N\\'-(6-chloro-7-methyl-1,1-dioxo-1,4,\\n\\t2-benzodithiazin-3-yl)hydrazyno]-3-pyridinesulfonamide}  (#14# isoform \\n\\tCA I, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.00138 {sodium (hexylsulfonyl)azanide}  <270>\\nKI\\t#14# 0.000078 \\n\\t{4-[N\\'-(6-chloro-7-cyano-1,1-dioxo-1,4,\\n\\t2-benzodithiazin-3-yl)hydrazino]-3-pyridinesulfonamide}  (#14# isoform \\n\\tCA I, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.000078 {6-(1-hydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one}  \\n\\t(#14# inhibition of isozyme hCA I, pH not specified in the publication, \\n\\ttemperature not specified in the publication <293>) <293>\\nKI\\t#14# 0.000078 {4-[(3-methoxyphenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA I, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.000078 {3-[(3-fluorophenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA I, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.00055 {N-salicylidene-sulfanilic acid amide nickel acetate \\n\\tcomplex}  (#14# pH 7.4, 25C, isozyme hCA I <126>) <126>\\nKI\\t#14# 0.00055 {N-salicylidene-sulfanilic acid amide nickel sulfate \\n\\tcomplex}  (#14# pH 7.4, 25C, isozyme hCA I <126>) <126>\\nKI\\t#14# 0.00055 {3,5-Dihydroxybenzoic acid}  (#14# isozyme hCAI, pH 7.5, \\n\\t22C <299>) <299>\\nKI\\t#14# 0.000097 {n-hexadecyl sulfamate}  (#14# pH 7.5, 20C, HCA II \\n\\t<132>) <132>\\nKI\\t#14# 0.000097 {(2E)-but-2-enedioic acid}  (#14# isoform CA VA <261>) \\n\\t<261>\\nKI\\t#14# 0.00171 {3-[(4-methylphenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA II, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.0000072 {4-[2-(2-thienyl)acetamido]-3-bromobenzenesulfonamide}  \\n\\t(#14# isoform CA VII <255>) <255>\\nKI\\t#14# 0.0000072 {4-(4-cyanophenoxy)-3-pyridinesulfonamide}  (#14# \\n\\tisoform CA IX, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.0000072 \\n\\t{4-[N\\'-(6-chloro-7-cyano-1,1-dioxo-1,4,\\n\\t2-benzodithiazin-3-yl)hydrazino]-3-pyridinesulfonamide}  (#14# isoform \\n\\tCA IX, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000072 \\n\\t{2,3,4,6-tetra-O-acetyl-N-sulfamoyl-beta-D-galactopyranosylamine}  \\n\\t(#14# isozyme hCA IX, pH not specified in the publication, temperature \\n\\tnot specified in the publication <294>) <294>\\nKI\\t#14# 0.000138 {2,4,6-trichlorophenyl sulfamate}  (#14# pH 7.4, 25C, \\n\\thCA II <131>) <131>\\nKI\\t#14# 0.000138 {4-trifluoromethylphenyl sulfamate}  (#14# pH 7.4, 25C, \\n\\thCA II <131>) <131>\\nKI\\t#14# 0.000142 {1H,1H,2H,2H-perfluorodecyl sulfamate}  (#14# pH 7.5, \\n\\t20C, HCA IX <132>) <132>\\nKI\\t#14# 0.000142 {4-(carbamoylmethylthio)pyridine-3-sulfonamide}  (#14# \\n\\tisoform CA XIV, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.0000076 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(alpha-D-mannopyranosyl)-1H-1,2,\\n\\t3-triazole}  (#14# isozyme CA II, in 10 mM HEPES (pH 7.5), 0.1 M \\n\\tNaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.0000076 {4-[2-(2-thienyl)acetamidoethyl]benzenesulfonamide}  \\n\\t(#14# isoform CA VII <255>) <255>\\nKI\\t#14# 0.000034 {4-methoxyphenyl sulfamate}  (#14# pH 7.4, 25C, hCA IX \\n\\t<131>) <131>\\nKI\\t#14# 0.000034 {ethoxazolamide}  (#14# isozyme CA IX, in 10 mM HEPES (pH \\n\\t7.5), 0.1 M NaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.0000027 {n-octyl sulfamate}  (#14# pH 7.4, 25C, hCA II <131>) \\n\\t<131>\\nKI\\t#14# 0.0000027 {p-methylbenzyl sulfamate}  (#14# pH 7.5, 20C, HCA II \\n\\t<132>) <132>\\nKI\\t#14# 0.0000837 \\n\\t{4-[N\\'-(1,1-dioxopyrido[4,3-e]-1,4,\\n\\t2-dithiazin-3-yl)hydrazino]-3-pyridinesulfonamide}  (#14# isoform CA \\n\\tXIV, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000007 {n-decyl sulfamate}  (#14# pH 7.5, 20C, HCA II <132>) \\n\\t<132>\\nKI\\t#14# 0.0000025 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(alpha-D-arabinopyranosyl)-1H-1,2,\\n\\t3-triazole}  (#14# isozyme CA I, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, \\n\\tat 20C <228>) <228>\\nKI\\t#14# 0.0000058 \\n\\t{4-[N\\'-(6-chloro-7-methyl-1,1-dioxo-1,4,\\n\\t2-benzodithiazin-3-yl)hydrazyno]-3-pyridinesulfonamide}  (#14# isoform \\n\\tCA IX, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000058 {4-methoxy-3-pyridinesulfonamide}  (#14# isoform CA XII, \\n\\tin 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000058 \\n\\t{2,3,4-tri-O-acetyl-6-deoxy-N-sulfamoyl-alpha-L-glucopyranosylamine}  \\n\\t(#14# isozyme hCA XII, pH not specified in the publication, temperature \\n\\tnot specified in the publication <294>) <294>\\nKI\\t#14# 0.0000058 {4-[(3-fluorophenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA IX, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.000037 {4-acetylamidophenyl sulfamate}  (#14# pH 7.4, 25C, hCA \\n\\tI <131>) <131>\\nKI\\t#14# 0.000037 {estrone sulfamate}  (#14# pH 7.4, 25C, hCA I <131>) \\n\\t<131>\\nKI\\t#14# 0.000037 {2,4,6-trichlorophenyl sulfamate}  (#14# pH 7.4, 25C, \\n\\thCA IX <131>) <131>\\nKI\\t#14# 0.000037 {N-salicylidene-sulfanilic acid amide nickel acetate \\n\\tcomplex}  (#14# pH 7.4, 25C, isozyme hCA II <126>) <126>\\nKI\\t#14# 0.000037 {3,4-dihydroisoquinoline-2(1H)-sulfonamide}  (#14# \\n\\tisoform CA IX, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as buffers \\n\\tand 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.000037 {4-Aminobenzenesulfonamide}  (#14# isozyme CA XII, pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <296>) <296>\\nKI\\t#14# 0.000115 {4-phenoxyphenyl sulfamate}  (#14# pH 7.4, 25C, hCA I \\n\\t<131>) <131>\\nKI\\t#14# 0.000047 {pentafluorophenyl sulfamate}  (#14# pH 7.4, 25C, hCA IX \\n\\t<131>) <131>\\nKI\\t#14# 0.000047 {2-N-(4-sulfamoylphenyl)-thioformyl-L-Trp}  (#14# pH 7.5, \\n\\tcarbonic anhydrase I <153>) <153>\\nKI\\t#14# 0.000047 {brinzolamide}  (#14# isozyme CA IX, in 10 mM HEPES (pH \\n\\t7.5), 0.1 M NaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.000047 {4-methylthiopyridine-3-sulfonamide}  (#14# isoform CA \\n\\tIX, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.000059 {4-methylphenyl sulfamate}  (#14# pH 7.4, 25C, hCA IX \\n\\t<131>) <131>\\nKI\\t#14# 0.000059 {6-(1-hydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one}  \\n\\t(#14# inhibition of isozyme hCA II, pH not specified in the \\n\\tpublication, temperature not specified in the publication <293>) <293>\\nKI\\t#14# 0.000059 {3-(phenylethynyl)benzenesulfonamide}  (#14# isozyme CA \\n\\tI, pH not specified in the publication, temperature not specified in \\n\\tthe publication <296>) <296>\\nKI\\t#14# 0.000059 {4-[(3-hydroxyphenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA XII, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.000096 {N-benzyl-2-(3-chloro-4-hydroxyphenyl)acetamide}  (#14# \\n\\tisoform CA VA <261>) <261>\\nKI\\t#14# 0.000096 {(3-chlorophenyl)acetic acid}  (#14# isoform CA VA <261>) \\n\\t<261>\\nKI\\t#14# 0.000117 \\n\\t{4-[N\\'-(1,1-dioxopyrido[4,3-e]-1,4,\\n\\t2-dithiazin-3-yl)hydrazino]-3-pyridinesulfonamide}  (#14# isoform CA \\n\\tII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.000121 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(beta-D-ribofuranosyl)-1H-1,2,\\n\\t3-triazole}  (#14# isozyme CA IX, in 10 mM HEPES (pH 7.5), 0.1 M \\n\\tNaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.000129 {n-octadecyl sulfamate}  (#14# pH 7.5, 20C, HCA II \\n\\t<132>) <132>\\nKI\\t#14# 0.00143 {1,2,4-trimethoxybenzene}  (#14# isozyme hCAII, pH 7.5, \\n\\t22C <299>) <299>\\nKI\\t#14# 1.92 {5-sulfosalicylic acid}  (#14# isozyme carbonic anhydrase II \\n\\t<209>) <209>\\nKI\\t#14# 0.237 {2-(3-chloro-4-hydroxyphenyl)acetamide}  (#14# isoform CA I \\n\\t<261>) <261>\\nKI\\t#14# 0.000062 {4-[(3-fluorophenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA I, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.00078 {methazolamide}  (#14# pH 7.4, 25C, hCA I <120,131>; #14# \\n\\tpH 7.5, 20C, HCA I <132>; #14# pH 7.5, carbonic anhydrase I <153>; \\n\\t#14# isoform CA I, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C \\n\\t<271>) <120,131,132,153,271>\\nKI\\t#14# 0.00102 {2,6-dimethoxybenzoic acid}  (#14# isozyme hCAII, pH 7.5, \\n\\t22C <299>) <299>\\nKI\\t#14# 0.000092 {2-(4-hydroxyphenyl)acetamide}  (#14# isoform CA VA \\n\\t<261>) <261>\\nKI\\t#14# 0.00495 {2-(phenylethynyl)benzenesulfonamide}  (#14# isozyme CA \\n\\tII, pH not specified in the publication, temperature not specified in \\n\\tthe publication <296>) <296>\\nKI\\t#14# 0.00529 {4-[(3-hydroxyphenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA II, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.0000021 {phenylsulfamate}  (#14# pH 7.4, 25C, hCA I <131>) <131>\\nKI\\t#14# 0.0000021 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(2\\',3\\',4\\',\\n\\t6\\'-tetra-O-acetyl-alpha-D-mannopyranosyl)-1H-1,2,3-triazole}  (#14# \\n\\tisozyme CA II, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, at 20C <228>) \\n\\t<228>\\nKI\\t#14# 0.0000021 \\n\\t{D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-methioninamide}  (#14# \\n\\tisoform CA II, pH and temperature not specified in the publication \\n\\t<415>) <415>\\nKI\\t#14# 0.0000021 \\n\\t{D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-leucinamide}  (#14# \\n\\tisoform CA II, pH and temperature not specified in the publication \\n\\t<415>) <415>\\nKI\\t#14# 0.000415 {pentafluorophenyl sulfamate}  (#14# pH 7.4, 25C, hCA I \\n\\t<131>) <131>\\nKI\\t#14# 0.0000094 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(beta-D-glucopyranosyl)-1H-1,2,\\n\\t3-triazole}  (#14# isozyme CA I, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, \\n\\tat 20C <228>) <228>\\nKI\\t#14# 0.0000094 \\n\\t{6,7-dimethoxy-1-ethyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#14# isoform CA IX, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.0000094 {4-(phenylethynyl)benzenesulfonamide}  (#14# isozyme CA \\n\\tXII, pH not specified in the publication, temperature not specified in \\n\\tthe publication <296>) <296>\\nKI\\t#14# 0.000122 {sodium (hexylsulfonyl)azanide}  <270>\\nKI\\t#14# 0.00152 \\n\\t{4-[2-(4-sulfamoylphenyl)ethylamino]-3-pyridinosulfonamide}  (#14# \\n\\tisoform CA I, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.00041 {N-salicylidene-sulfanilic acid amide}  (#14# pH 7.4, \\n\\t25C, isozyme hCA II <126>) <126>\\nKI\\t#14# 0.00041 {3-[(4-methylphenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA XII, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.369 {methyl (3-chloro-4-hydroxyphenyl)acetate}  (#14# isoform CA \\n\\tI <261>) <261>\\nKI\\t#14# 0.000134 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(2\\',3\\',\\n\\t4\\'-tri-O-acetyl-alpha-D-arabinopyranosyl)-1H-1,2,3-triazole}  (#14# \\n\\tisozyme CA IX, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, at 20C <228>) \\n\\t<228>\\nKI\\t#14# 0.000089 {N-tert-butyl-2-(3-chloro-4-hydroxyphenyl)acetamide}  \\n\\t(#14# isoform CA VB <261>) <261>\\nKI\\t#14# 0.000089 {4-hydroxybenzenesulfonamide}  (#14# isozyme CA II, at \\n\\t25C, pH 7.4 <268>) <268>\\nKI\\t#14# 0.000454 {2,4,6-trichlorophenyl sulfamate}  (#14# pH 7.4, 25C, \\n\\thCA I <131>) <131>\\nKI\\t#14# 0.000038 {dichlorophenamide}  (#14# pH 7.5, carbonic anhydrase II \\n\\t<153>; #14# isozyme CA II, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, at \\n\\t20C <228>; #14# isoform CA II, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, \\n\\tat 22C <271>; #14# isozyme CA II, at 25C, pH 7.4 <268>) \\n\\t<153,228,268,271>\\nKI\\t#14# 0.000038 {4,5-dichlorobenzene-1,3-disulfonamide}  (#14# isozyme CA \\n\\tII, pH not specified in the publication, temperature not specified in \\n\\tthe publication <296>) <296>\\nKI\\t#14# 0.0000078 {4-(5-methyl-2-pyrazolino)-3-pyridinesulfonamide}  (#14# \\n\\tisoform CA IX, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.0000078 \\n\\t{3,4,6-tri-O-acetyl-2-deoxy-N-sulfamoyl-beta-D-lyxo-hexopyranosylamine} \\n\\t (#14# isozyme hCA XII, pH not specified in the publication, \\n\\ttemperature not specified in the publication <294>) <294>\\nKI\\t#14# 0.0000078 \\n\\t{N-(tert-butoxycarbonyl)-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-alloisoleucinamide}  (#14# isoform CA XII, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.000106 {2-(3-chloro-4-hydroxyphenyl)acetamide}  (#14# isoform CA \\n\\tVB <261>) <261>\\nKI\\t#14# 0.000114 \\n\\t{(2R)-3-(3-chloro-4-hydroxyphenyl)-2-[[(2E)-4-methoxy-4-oxobut-2-\\n\\tenoyl]amino]propanoic acid}  (#14# isoform CA VB <261>) <261>\\nKI\\t#14# 0.0000074 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-leucinamide}  (#14# isoform CA II, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.000079 \\n\\t{2-(3-chloro-4-hydroxyphenyl)-N-[2-(3,\\n\\t4-dimethoxyphenyl)ethyl]acetamide}  (#14# isoform CA VB <261>) <261>\\nKI\\t#14# 0.000079 \\n\\t{4,4\\'-[(1R,2S,3R,4S)-3,4-dimethylcyclobutane-1,\\n\\t2-diyl]bis(2-methoxyphenol)}  (#14# isoform CA VB <261>) <261>\\nKI\\t#14# 0.000099 {(4-hydroxyphenyl)acetic acid}  (#14# isoform CA VA \\n\\t<261>) <261>\\nKI\\t#14# 0.000099 \\n\\t{(5Z)-2-amino-5-(4-hydroxy-3-methoxybenzylidene)-3,\\n\\t5-dihydro-4H-imidazol-4-one}  (#14# isoform CA VA <261>) <261>\\nKI\\t#14# 0.000313 {4-(2-methyl-8-quinolinoxy)-3-pyridinesulfonamide}  (#14# \\n\\tisoform CA IX, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.0000088 {8-acetyl-7-butoxy-2H-chromen-2-one}  (#14# inhibition \\n\\tof isozyme hCA XII, pH not specified in the publication, temperature \\n\\tnot specified in the publication <293>) <293>\\nKI\\t#14# 0.0000035 {n-octylsulfamate}  (#14# pH 7.4, 25C, hCA I <131>) \\n\\t<131>\\nKI\\t#14# 0.0000175 {4-chlorobenzenesulfonamide}  (#14# isozyme CA II, at \\n\\t25C, pH 7.4 <268>) <268>\\nKI\\t#14# 0.000093 \\n\\t{2-(3-chloro-4-hydroxyphenyl)-N-[2-(4-sulfamoylphenyl)ethyl]acetamide}  \\n\\t(#14# isoform CA VA <261>) <261>\\nKI\\t#14# 0.000093 \\n\\t{7-hydroxy-1-methoxy-3-methyl-9-oxo-9,\\n\\t9a-dihydro-4aH-xanthene-8-carboxylic acid}  (#14# isoform CA VA <261>) \\n\\t<261>\\nKI\\t#14# 0.00165 \\n\\t{1-cyclopentyl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide} \\n\\t (#14# isoform CA XIV, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.0105 {N-benzyl-2-(3-chloro-4-hydroxyphenyl)acetamide}  (#14# \\n\\tisoform CA I <261>) <261>\\nKI\\t#14# 0.0105 \\n\\t{(5Z)-2-amino-5-(4-hydroxy-3-methoxybenzylidene)-3,\\n\\t5-dihydro-4H-imidazol-4-one}  (#14# isoform CA I <261>) <261>\\nKI\\t#14# 0.0105 {(2E)-but-2-enedioic acid}  (#14# isoform CA II <261>) <261>\\nKI\\t#14# 0.000081 {2-(4-hydroxyphenyl)acetamide}  (#14# isoform CA VB \\n\\t<261>) <261>\\nKI\\t#14# 0.000081 {N-butyl-2-(3-chloro-4-hydroxyphenyl)acetamide}  (#14# \\n\\tisoform CA VB <261>) <261>\\nKI\\t#14# 0.000081 {4-bromobenzenesulfonamide}  (#14# isozyme CA II, at \\n\\t25C, pH 7.4 <268>) <268>\\nKI\\t#14# 0.000081 {4-iodobenzenesulfonamide}  (#14# isozyme CA II, at 25C, \\n\\tpH 7.4 <268>) <268>\\nKI\\t#14# 0.000081 \\n\\t{2,3,4,6-tetra-O-acetyl-N-sulfamoyl-beta-D-glucopyranosylamine}  (#14# \\n\\tisozyme hCA II, pH not specified in the publication, temperature not \\n\\tspecified in the publication <294>) <294>\\nKI\\t#14# 0.000081 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-alaninamide}  (#14# isoform CA I, pH and temperature not specified in \\n\\tthe publication <415>) <415>\\nKI\\t#14# 0.000084 \\n\\t{2-(3-chloro-4-hydroxyphenyl)-N-(2-methoxyethyl)acetamide}  (#14# \\n\\tisoform CA VB <261>) <261>\\nKI\\t#14# 0.0000073 {4-bromophenyl sulfamate}  (#14# pH 7.4, 25C, hCA I \\n\\t<131>) <131>\\nKI\\t#14# 0.0000073 \\n\\t{4-(4-hydroxyphenyl)-2-(4-methoxyphenyl)-5H-indeno[1,2-b]pyridin-5-one} \\n\\t (#14# isoform CA I, at 25C, pH not specified in the publication \\n\\t<414>) <414>\\nKI\\t#14# 0.0000095 {4-iodophenyl sulfamate}  (#14# pH 7.4, 25C, hCA I \\n\\t<131>) <131>\\nKI\\t#14# 0.0000095 \\n\\t{6,7-dimethoxy-1-methyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#14# isoform CA IX, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.000076 {5-pentylresorcinylsulfamate}  (#14# pH 7.4, 25C, hCA II \\n\\t<131>) <131>\\nKI\\t#14# 0.000076 {7-oxodehydroepiandrosterone sulfamate}  (#14# pH 7.5, \\n\\t20C, HCA IX <132>) <132>\\nKI\\t#14# 0.000076 \\n\\t{(5Z)-2-amino-5-(3,4-dihydroxybenzylidene)-3,\\n\\t5-dihydro-4H-imidazol-4-one}  (#14# isoform CA VB <261>) <261>\\nKI\\t#14# 0.000076 \\n\\t{2,3,4,6-tetra-O-acetyl-N-sulfamoyl-beta-D-galactopyranosylamine}  \\n\\t(#14# isozyme hCA II, pH not specified in the publication, temperature \\n\\tnot specified in the publication <294>) <294>\\nKI\\t#14# 0.000076 {3-[(3-methoxyphenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA I, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.000076 {4-[(3-fluorophenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA XII, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.000103 {2-naphthylsulfamate}  (#14# pH 7.4, 25C, hCA I <131>) \\n\\t<131>\\nKI\\t#14# 0.000103 \\n\\t{2-(3-chloro-4-hydroxyphenyl)-N-[2-(3-methoxyphenyl)ethyl]acetamide}  \\n\\t(#14# isoform CA VA <261>) <261>\\nKI\\t#14# 0.000103 {(2E)-4-methoxy-4-oxobut-2-enoic acid}  (#14# isoform CA \\n\\tVA <261>) <261>\\nKI\\t#14# 0.000103 \\n\\t{7-hydroxy-1-methoxy-3-methyl-9-oxo-9,\\n\\t9a-dihydro-4aH-xanthene-8-carboxylic acid}  (#14# isoform CA VB <261>) \\n\\t<261>\\nKI\\t#14# 0.000113 {pentafluorophenyl sulfamate}  (#14# pH 7.4, 25C, hCA II \\n\\t<131>) <131>\\nKI\\t#14# 0.000113 {4-biphenyl sulfamate}  (#14# pH 7.4, 25C, hCA I <131>) \\n\\t<131>\\nKI\\t#14# 0.000149 {4-cyanophenylsulfamate}  (#14# pH 7.4, 25C, hCA II \\n\\t<131>) <131>\\nKI\\t#14# 0.000149 \\n\\t{4-[2-(4-sulfamoylphenyl)ethylamino]-3-pyridinosulfonamide}  (#14# \\n\\tisoform CA XIV, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.000278 {1,2:5,6-di-O-isopropylidene-alpha-D-glucofuranose \\n\\t3-sulfamate}  (#14# pH 7.4, 25C, hCA I <131>) <131>\\nKI\\t#14# 0.000315 {1,2:3,4-di-O-isopropylidene-alpha-D-galactopyranose \\n\\t6-sulfamate}  (#14# pH 7.4, 25C, hCA I <131>) <131>\\nKI\\t#14# 0.000369 {p-trifluoromethylphenylsulfamate}  (#14# pH 7.4, 25C, \\n\\thCA I <131>) <131>\\nKI\\t#14# 0.000432 {pentachlorophenyl sulfamate}  (#14# pH 7.4, 25C, hCA I \\n\\t<131>) <131>\\nKI\\t#14# 0.000432 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(beta-D-maltopyranosyl)-1H-1,2,\\n\\t3-triazole}  (#14# isozyme CA II, in 10 mM HEPES (pH 7.5), 0.1 M \\n\\tNaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.000087 {n-tetradecyl sulfamate}  (#14# pH 7.5, 20C, HCA II \\n\\t<132>) <132>\\nKI\\t#14# 0.000087 \\n\\t{2-(3-chloro-4-hydroxyphenyl)-N-[2-(3-methoxyphenyl)ethyl]acetamide}  \\n\\t(#14# isoform CA VB <261>) <261>\\nKI\\t#14# 0.000087 {4-[(3-hydroxyphenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA I, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.000087 {3-(phenylethynyl)benzenesulfonamide}  (#14# isozyme CA \\n\\tII, pH not specified in the publication, temperature not specified in \\n\\tthe publication <296>) <296>\\nKI\\t#14# 0.000126 {n-pentyl sulfamate}  (#14# pH 7.5, 20C, HCA IX <132>) \\n\\t<132>\\nKI\\t#14# 0.000335 {1H,1H,2H,2H-perfluorooctyl sulfamate}  (#14# pH 7.5, \\n\\t20C, HCA IX <132>) <132>\\nKI\\t#14# 0.000458 {1H,1H-perfluoroethyl sulfamate}  (#14# pH 7.5, 20C, HCA \\n\\tIX <132>) <132>\\nKI\\t#14# 0.000845 {1H,1H-perfluoroethyl sulfamate}  (#14# pH 7.5, 20C, HCA \\n\\tII <132>) <132>\\nKI\\t#14# 0.000279 {1H-perfluoroisopropyl sulfamate}  (#14# pH 7.5, 20C, \\n\\tHCA IX <132>) <132>\\nKI\\t#14# 0.000386 {but-3-enyl sulfamate}  (#14# pH 7.5, 20C, HCA IX <132>) \\n\\t<132>\\nKI\\t#14# 0.000633 {but-3-ynyl sulfamate}  (#14# pH 7.5, 20C, HCA IX <132>) \\n\\t<132>\\nKI\\t#14# 0.000883 {but-3-enyl sulfamate}  (#14# pH 7.5, 20C, HCA II <132>) \\n\\t<132>\\nKI\\t#14# 0.00158 {1H-perfluoroisopropyl sulfamate}  (#14# pH 7.5, 20C, HCA \\n\\tII <132>) <132>\\nKI\\t#14# 0.00354 {1H-perfluoroisopropyl sulfamate}  (#14# pH 7.5, 20C, HCA \\n\\tI <132>) <132>\\nKI\\t#14# 0.00462 {3-chloropropyl sulfamate}  (#14# pH 7.5, 20C, HCA I \\n\\t<132>) <132>\\nKI\\t#14# 445 {Urea}  (#14# pH 7.8, 25C, hCA I <101>) <101>\\nKI\\t#14# 460 {Urea}  (#14# pH 7.8, 25C, hCA II <101>) <101>\\nKI\\t#14# 0.000102 \\n\\t{2-(3-chloro-4-hydroxyphenyl)-N-(2-methoxyethyl)acetamide}  (#14# \\n\\tisoform CA VA <261>) <261>\\nKI\\t#14# 0.000102 \\n\\t{(2S)-3-(3-chloro-4-hydroxyphenyl)-2-[[(2E)-4-methoxy-4-oxobut-2-\\n\\tenoyl]amino]propanoic acid}  (#14# isoform CA VB <261>) <261>\\nKI\\t#14# 0.000102 \\n\\t{7-hydroxy-3-(hydroxymethyl)-1-methoxy-9-oxo-9,\\n\\t9a-dihydro-4aH-xanthene-8-carboxylic acid}  (#14# isoform CA VB <261>) \\n\\t<261>\\nKI\\t#14# 0.000102 {3-[(4-methylphenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA I, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.0000085 {4-(2-pyridin-4-ylacetamidoethyl)benzenesulfonamide}  \\n\\t(#14# isoform CA VII <255>) <255>\\nKI\\t#14# 0.0000085 \\n\\t{1-n-butyl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#14# isoform CA IX, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.0000085 \\n\\t{4-(4-hydroxyphenyl)-2-(4-fluorophenyl)-5H-indeno[1,2-b]pyridin-5-one}  \\n\\t(#14# isoform CA I, at 25C, pH not specified in the publication <414>) \\n\\t<414>\\nKI\\t#14# 0.0000093 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(beta-D-galactopyranosyl)-1H-1,2,\\n\\t3-triazole}  (#14# isozyme CA I, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, \\n\\tat 20C <228>) <228>\\nKI\\t#14# 0.0000099 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(2\\',3\\',4\\'-tri-O-acetyl-beta-D-glucuronic \\n\\tacid methyl ester)-1H-1,2,3-triazole}  (#14# isozyme CA IX, in 10 mM \\n\\tHEPES (pH 7.5), 0.1 M NaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.0000099 {4-benzythiopyridine-3-sulfonamide}  (#14# isoform CA \\n\\tII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.307 \\n\\t{4,4\\'-[(2R,3R)-2,3-dimethylbutane-1,4-diyl]bis(2-methoxyphenol)}  (#14# \\n\\tisoform CA I <261>) <261>\\nKI\\t#14# 0.000086 {phenylacetonitrile}  (#14# isozyme CA XII, pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <296>) <296>\\nKI\\t#14# 0.000086 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-phenylalaninamide}  (#14# isoform CA I, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.0000065 {4-benzythiopyridine-3-sulfonamide}  (#14# isoform CA \\n\\tXII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000065 \\n\\t{2,3,4,6-tetra-O-acetyl-N-sulfamoyl-beta-D-galactopyranosylamine}  \\n\\t(#14# isozyme hCA XII, pH not specified in the publication, temperature \\n\\tnot specified in the publication <294>) <294>\\nKI\\t#14# 0.0000065 {4-[(3-methoxyphenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA IX, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.00415 {1,4-dimethoxybenzene}  (#14# isozyme hCAIX, pH 7.5, 22C \\n\\t<299>) <299>\\nKI\\t#14# 0.000053 \\n\\t{N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-glutamine}  (#14# \\n\\tNovaSyn TGA-resin bound, pH 7.5, carbonic anhydrase I <153>) <153>\\nKI\\t#14# 0.000053 {4-chlorobenzenesulfonamide}  (#14# isozyme CA VII, at \\n\\t25C, pH 7.4 <268>) <268>\\nKI\\t#14# 0.00167 {sodium (butylsulfonyl)azanide}  <270>\\nKI\\t#14# 0.0000057 {4-methoxy-3-pyridinesulfonamide}  (#14# isoform CA IX, \\n\\tin 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000057 {N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide}  (#14# \\n\\tisozyme CA XII, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.000104 {indisulam}  (#14# isoform CA XIV, in 10 mM HEPES (pH \\n\\t7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.000104 {4-[(4-methylphenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA XII, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.0000144 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-valinamide}  (#14# isoform CA IV, pH and temperature not specified in \\n\\tthe publication <415>) <415>\\nKI\\t#14# 0.0000053 {4-(2-phenylacetamido)-3-bromobenzenesulfonamide}  (#14# \\n\\tisoform CA VII <255>) <255>\\nKI\\t#14# 0.0000053 \\n\\t{2,3,4-tri-O-acetyl-6-deoxy-N-sulfamoyl-alpha-L-glucopyranosylamine}  \\n\\t(#14# isozyme hCA IX, pH not specified in the publication, temperature \\n\\tnot specified in the publication <294>) <294>\\nKI\\t#14# 0.0000169 {4-(allylamino)-3-pyridinesulfonamide}  (#14# isoform CA \\n\\tXII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000157 {4-(5-methyl-2-pyrazolino)-3-pyridinesulfonamide}  (#14# \\n\\tisoform CA XII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.0000138 {4-(N-oxide-2-pyridylthio)pyridine-3-sulfonamide}  (#14# \\n\\tisoform CA XII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.0000686 \\n\\t{4-(4-hydroxyphenyl)-2-(3-hydroxyphenyl)-5H-indeno[1,2-b]pyridin-5-one} \\n\\t (#14# isoform CA II, at 25C, pH not specified in the publication \\n\\t<414>) <414>\\nKI\\t#14# 0.0000143 \\n\\t{N-[(benzyloxy)carbonyl]-D-alanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tvalinamide}  (#14# isoform CA II, pH and temperature not specified in \\n\\tthe publication <415>) <415>\\nKI\\t#14# 0.0000485 \\n\\t{N-[(benzyloxy)carbonyl]-D-alanyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]glycinamide}  (#14# isoform CA XII, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.0000418 \\n\\t{N-[(benzyloxy)carbonyl]-D-alanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tmethioninamide}  (#14# isoform CA II, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.0000639 {2-adamantylethyl \\n\\t7-methoxy-2-oxo-2H-chromene-8-carboxylate}  (#14# inhibition of isozyme \\n\\thCA IX, pH not specified in the publication, temperature not specified \\n\\tin the publication <293>) <293>\\nKI\\t#14# 0.000133 {4-(allylamino)-3-pyridinesulfonamide}  (#14# isoform CA \\n\\tII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.000069 \\n\\t{2-(3-chloro-4-hydroxyphenyl)-N-[2-(4-sulfamoylphenyl)ethyl]acetamide}  \\n\\t(#14# isoform CA VB <261>) <261>\\nKI\\t#14# 0.000069 \\n\\t{4,4\\'-[(1R,2R,3S,4S)-3,4-dimethylcyclobutane-1,\\n\\t2-diyl]bis(2-methoxyphenol)}  (#14# isoform CA VB <261>) <261>\\nKI\\t#14# 0.000069 {4-(phenylethynyl)benzenesulfonamide}  (#14# isozyme CA \\n\\tIX, pH not specified in the publication, temperature not specified in \\n\\tthe publication <296>) <296>\\nKI\\t#14# 0.00667 {4-(1,3,4-thiadiazol-2-ylthio)pyridine-3-sulfonamide}  \\n\\t(#14# isoform CA I, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C \\n\\t<271>) <271>\\nKI\\t#14# 0.309 {(4-hydroxyphenyl)acetic acid}  (#14# isoform CA I <261>) \\n\\t<261>\\nKI\\t#14# 0.309 {2-(4-hydroxyphenyl)acetamide}  (#14# isoform CA I <261>) \\n\\t<261>\\nKI\\t#14# 0.000437 \\n\\t{N-(2-fluoro-4-sulfamoylphenyl)-2-(thiophen-2-yl)acetamide}  (#14# \\n\\tinhibition of CO2 hydration by isozyme hCAXIII, pH 7.5, temperature not \\n\\tspecified in the publication <302>) <302>\\nKI\\t#14# 0.0000092 {3-[(3-methoxyphenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA XII, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.0000092 \\n\\t{D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-leucinamide}  (#14# \\n\\tisoform CA XII, pH and temperature not specified in the publication \\n\\t<415>) <415>\\nKI\\t#14# 0.0114 {N-tert-butyl-2-(3-chloro-4-hydroxyphenyl)acetamide}  (#14# \\n\\tisoform CA I <261>) <261>\\nKI\\t#14# 0.0114 {N-benzyl-2-(3-chloro-4-hydroxyphenyl)acetamide}  (#14# \\n\\tisoform CA II <261>) <261>\\nKI\\t#14# 0.00406 {1,2,4-trimethoxybenzene}  (#14# isozyme hCAIX, pH 7.5, \\n\\t22C <299>) <299>\\nKI\\t#14# 0.00637 {2-(phenylethynyl)benzenesulfonamide}  (#14# isozyme CA \\n\\tIX, pH not specified in the publication, temperature not specified in \\n\\tthe publication <296>) <296>\\nKI\\t#14# 0.0131 \\n\\t{(5Z)-2-amino-5-(3,4-dihydroxybenzylidene)-3,\\n\\t5-dihydro-4H-imidazol-4-one}  (#14# isoform CA II <261>) <261>\\nKI\\t#14# 0.0000068 {4-(2-phenylacetamidomethyl)benzenesulfonamide}  (#14# \\n\\tisoform CA VII <255>) <255>\\nKI\\t#14# 0.0000068 {4-(quinolinoxy)-3-pyridinesulfonamide}  (#14# isoform \\n\\tCA XII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000068 \\n\\t{4-(4-hydroxyphenyl)-2-phenyl-5H-indeno[1,2-b]pyridin-5-one}  (#14# \\n\\tisoform CA I, at 25C, pH not specified in the publication <414>) <414>\\nKI\\t#14# 0.0000189 \\n\\t{N-(tert-butoxycarbonyl)-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-phenylalaninamide}  (#14# isoform CA XII, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.000197 \\n\\t{N-[[[4-(aminosulfonyl)phenyl]amino]thioxomethyl]-L-proline}  (#14# \\n\\tNovaSyn TGA-resin bound, pH 7.5, carbonic anhydrase I <153>) <153>\\nKI\\t#14# 0.000152 {4-(5-methyl-2-pyrazolino)-3-pyridinesulfonamide}  (#14# \\n\\tisoform CA XIV, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.000294 {4-Aminobenzenesulfonamide}  (#14# isozyme CA IX, pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <296>) <296>\\nKI\\t#14# 0.0000245 \\n\\t{D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-leucinamide}  (#14# \\n\\tisoform CA IV, pH and temperature not specified in the publication \\n\\t<415>) <415>\\nKI\\t#14# 0.0000343 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]glycinamide}  (#14# isoform CA IV, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.0000042 {4-(1-methyl-5-tetrazolylthio)pyridine-3-sulfonamide}  \\n\\t(#14# isoform CA XII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C \\n\\t<271>) <271>\\nKI\\t#14# 0.00127 {5-chlorosalicylic acid}  (#14# isozyme carbonic anhydrase \\n\\tII <209>) <209>\\nKI\\t#14# 0.00345 \\n\\t{N-[(3aR,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,\\n\\t3]dioxolo[4,5-b:4\\',5\\'-d]pyran-3a-yl]sulfamic amide}  (#14# isozyme hCA \\n\\tI, pH not specified in the publication, temperature not specified in \\n\\tthe publication <294>) <294>\\nKI\\t#14# 0.0000054 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(alpha-D-mannopyranosyl)-1H-1,2,\\n\\t3-triazole}  (#14# isozyme CA IX, in 10 mM HEPES (pH 7.5), 0.1 M \\n\\tNaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.0000054 {4-(2-phenylacetamido)-3-fluorobenzenesulfonamide}  \\n\\t(#14# isoform CA VII <255>) <255>\\nKI\\t#14# 0.0000054 \\n\\t{2,3,4,6-tetra-O-acetyl-N-sulfamoyl-beta-D-glucopyranosylamine}  (#14# \\n\\tisozyme hCA XII, pH not specified in the publication, temperature not \\n\\tspecified in the publication <294>) <294>\\nKI\\t#14# 0.0121 \\n\\t{4,4\\'-[(1R,2S,3R,4S)-3,4-dimethylcyclobutane-1,\\n\\t2-diyl]bis(2-methoxyphenol)}  (#14# isoform CA II <261>) <261>\\nKI\\t#14# 0.0223 {6-deoxy-N-sulfamoyl-alpha-L-glucopyranosylamine}  (#14# \\n\\tisozyme hCA II, pH not specified in the publication, temperature not \\n\\tspecified in the publication <294>) <294>\\nKI\\t#14# 0.0000061 {5-(2-phenylacetamido)-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#14# isoform CA VII <255>) <255>\\nKI\\t#14# 0.0000061 \\n\\t{1-cyclopropyl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide} \\n\\t (#14# isoform CA IX, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.0000061 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-valinamide}  (#14# isoform CA II, pH and temperature not specified in \\n\\tthe publication <415>) <415>\\nKI\\t#14# 0.0000061 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]glycinamide}  (#14# isoform CA XII, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.0000087 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(2\\',3\\',4\\',\\n\\t6\\'-tetra-O-acetyl-beta-D-galactopyranosyl)-1H-1,2,3-triazole}  (#14# \\n\\tisozyme CA II, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, at 20C <228>) \\n\\t<228>\\nKI\\t#14# 0.0000055 {4-(2-phenylacetamidoethyl)benzenesulfonamide}  (#14# \\n\\tisoform CA VII <255>) <255>\\nKI\\t#14# 0.0000055 \\n\\t{1-cyclohexyl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#14# isoform CA IX, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.0000055 \\n\\t{N-(tert-butoxycarbonyl)-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-methioninamide}  (#14# isoform CA II, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.000367 {3,5-Dihydroxybenzoic acid}  (#14# isozyme hCAXII, pH \\n\\t7.5, 22C <299>) <299>\\nKI\\t#14# 0.395 {(2E)-but-2-enedioic acid}  (#14# isoform CA I <261>) <261>\\nKI\\t#14# 0.000161 \\n\\t{N-(2-fluoro-4-sulfamoylphenyl)-2-(thiophen-2-yl)acetamide}  (#14# \\n\\tinhibition of CO2 hydration by isozyme hCAI, pH 7.5, temperature not \\n\\tspecified in the publication <302>) <302>\\nKI\\t#14# 0.00214 {3-[(3-fluorophenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA II, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.239 \\n\\t{(2R)-3-(3-chloro-4-hydroxyphenyl)-2-[[(2E)-4-methoxy-4-oxobut-2-\\n\\tenoyl]amino]propanoic acid}  (#14# isoform CA I <261>) <261>\\nKI\\t#14# 0.00803 {6-acetyl-7-hydroxy-2H-chromen-2-one}  (#14# inhibition of \\n\\tisozyme hCA IX, pH not specified in the publication, temperature not \\n\\tspecified in the publication <293>) <293>\\nKI\\t#14# 0.806 {2-(phenylethynyl)benzenesulfonamide}  (#14# isozyme CA I, \\n\\tpH not specified in the publication, temperature not specified in the \\n\\tpublication <296>) <296>\\nKI\\t#14# 0.0000151 \\n\\t{4-[2-(4-sulfamoylphenyl)ethylamino]-3-pyridinosulfonamide}  (#14# \\n\\tisoform CA XII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.000665 {4-(4\\'-hydroxyphenyl)diazenylbenzenesulfonamide}  (#14# \\n\\tisozyme CA II, at 25C, pH 7.4 <268>) <268>\\nKI\\t#14# 0.000088 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(beta-D-galactopyranosyl)-1H-1,2,\\n\\t3-triazole}  (#14# isozyme CA II, in 10 mM HEPES (pH 7.5), 0.1 M \\n\\tNaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.000088 {4-hydroxybenzenesulfonamide}  (#14# isozyme CA VII, at \\n\\t25C, pH 7.4 <268>) <268>\\nKI\\t#14# 0.0000217 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-S-benzyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]-D-cysteinamide}  (#14# isoform CA IV, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.00108 {4-ethynylbenzenesulfonamide}  <228>\\nKI\\t#14# 0.0000117 {4-(cyanomethylthio)pyridine-3-sulfonamide}  (#14# \\n\\tisoform CA IX, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.0000096 {4-(6-nitrobenzothiazol-2-ylthio)pyridine-3-sulfonamide} \\n\\t (#14# isoform CA IX, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C \\n\\t<271>) <271>\\nKI\\t#14# 0.0000096 \\n\\t{6,7-dimethoxy-1-ethyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#14# isoform CA XIV, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.0000096 \\n\\t{N-(tert-butoxycarbonyl)-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-leucinamide}  (#14# isoform CA XII, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.0000091 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(2\\',3\\',4\\',\\n\\t6\\'-tetra-O-acetyl-beta-D-glucopyranosyl)-1H-1,2,3-triazole}  (#14# \\n\\tisozyme CA II, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, at 20C <228>) \\n\\t<228>\\nKI\\t#14# 0.0000091 {4-(quinolinoxy)-3-pyridinesulfonamide}  (#14# isoform \\n\\tCA IX, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000091 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-isoleucinamide}  (#14# isoform CA II, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.000312 \\n\\t{4-(4\\'-hydroxyphenyl)diazenylbenzene-N,N-dimethylsulfonamide}  (#14# \\n\\tisozyme CA II, at 25C, pH 7.4 <268>) <268>\\nKI\\t#14# 0.001875 \\n\\t{N-[(3aR,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,\\n\\t3]dioxolo[4,5-b:4\\',5\\'-d]pyran-3a-yl]sulfamic amide}  (#14# isozyme hCA \\n\\tXII, pH not specified in the publication, temperature not specified in \\n\\tthe publication <294>) <294>\\nKI\\t#14# 0.0000154 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-leucinamide}  (#14# isoform CA IV, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.0000161 \\n\\t{4-[N\\'-(1,1-dioxopyrido[4,3-e]-1,4,\\n\\t2-dithiazin-3-yl)hydrazino]-3-pyridinesulfonamide}  (#14# isoform CA \\n\\tIX, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000263 {7-methoxy-8-propanoyl-2H-chromen-2-one}  (#14# \\n\\tinhibition of isozyme hCA XII, pH not specified in the publication, \\n\\ttemperature not specified in the publication <293>) <293>\\nKI\\t#14# 0.000427 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(2\\',3\\',\\n\\t5\\'-tri-O-benzoyl-beta-D-ribofuranosyl)-1H-1,2,3-triazole}  (#14# \\n\\tisozyme CA II, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, at 20C <228>) \\n\\t<228>\\nKI\\t#14# 0.00395 \\n\\t{1-n-butyl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#14# isoform CA I, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.0000051 {4-ethynylbenzenesulfonamide}  <228>\\nKI\\t#14# 0.0000051 {4-(1,3,4-thiadiazol-2-ylthio)pyridine-3-sulfonamide}  \\n\\t(#14# isoform CA XII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C \\n\\t<271>) <271>\\nKI\\t#14# 0.00468 {N-sulfamoyl-beta-D-glucopyranosylamine}  (#14# isozyme \\n\\thCA II, pH not specified in the publication, temperature not specified \\n\\tin the publication <294>) <294>\\nKI\\t#14# 0.000441 \\n\\t{D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-alloisoleucinamide}  \\n\\t(#14# isoform CA I, pH and temperature not specified in the publication \\n\\t<415>) <415>\\nKI\\t#14# 0.000118 {(3-chloro-4-hydroxyphenyl)acetic acid}  (#14# isoform CA \\n\\tVB <261>) <261>\\nKI\\t#14# 0.0000378 {7-methoxy-8-propanoyl-2H-chromen-2-one}  (#14# \\n\\tinhibition of isozyme hCA IX, pH not specified in the publication, \\n\\ttemperature not specified in the publication <293>) <293>\\nKI\\t#14# 0.00179 {N-sulfamoyl-beta-D-mannopyranosylamine}  (#14# isozyme \\n\\thCA IX, pH not specified in the publication, temperature not specified \\n\\tin the publication <294>) <294>\\nKI\\t#14# 0.0000155 {4-(cyanomethylthio)pyridine-3-sulfonamide}  (#14# \\n\\tisoform CA XII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.00314 {6-deoxy-N-sulfamoyl-alpha-L-glucopyranosylamine}  (#14# \\n\\tisozyme hCA IX, pH not specified in the publication, temperature not \\n\\tspecified in the publication <294>) <294>\\nKI\\t#14# 0.00402 {1,4-dimethoxybenzene}  (#14# isozyme hCAXII, pH 7.5, 22C \\n\\t<299>) <299>\\nKI\\t#14# 0.00845 {diflunisal}  (#14# isozyme carbonic anhydrase I <209>) \\n\\t<209>\\nKI\\t#14# 0.00845 {3-phenylpropanenitrile}  (#14# isozyme CA IX, pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <296>) <296>\\nKI\\t#14# 0.00618 {3,4-dimethoxybenzoic acid}  (#14# isozyme hCAII, pH 7.5, \\n\\t22C <299>) <299>\\nKI\\t#14# 0.00182 \\n\\t{6,7-dimethoxy-1-propyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#14# isoform CA I, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.00000721 \\n\\t{N-[(benzyloxy)carbonyl]glycyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]glycinamide}  (#14# isoform CA XII, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.0000467 {7-ethoxy-8-propanoyl-2H-chromen-2-one}  (#14# \\n\\tinhibition of isozyme hCA IX, pH not specified in the publication, \\n\\ttemperature not specified in the publication <293>) <293>\\nKI\\t#14# 0.0000467 \\n\\t{D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-alloisoleucinamide}  \\n\\t(#14# isoform CA IV, pH and temperature not specified in the \\n\\tpublication <415>) <415>\\nKI\\t#14# 0.00836 {1,2-dimethoxybenzene}  (#14# isozyme hCAXII, pH 7.5, 22C \\n\\t<299>) <299>\\nKI\\t#14# 0.00197 {N-sulfamoyl-beta-D-glucopyranosylamine}  (#14# isozyme \\n\\thCA XII, pH not specified in the publication, temperature not specified \\n\\tin the publication <294>) <294>\\nKI\\t#14# 0.0000542 \\n\\t{N-(tert-butoxycarbonyl)-D-phenylalanyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]glycinamide}  (#14# isoform CA II, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.00844 \\n\\t{6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#14# isoform CA IX, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.0000182 \\n\\t{N-[(benzyloxy)carbonyl]-D-methionyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\talaninamide}  (#14# isoform CA XII, pH and temperature not specified in \\n\\tthe publication <415>) <415>\\nKI\\t#14# 0.0000101 {4-hydrazino-3-pyridinesulfonamide}  (#14# isoform CA \\n\\tXII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.000235 \\n\\t{4-[4-(aminosulfonyl)phenyl]-1-(hepta-O-acetyl-beta-D-maltopyranosyl)-\\n\\t1H-1,2,3-triazole}  (#14# isozyme CA II, in 10 mM HEPES (pH 7.5), 0.1 M \\n\\tNaClO4, at 20C <228>) <228>\\nKI\\t#14# 0.00416 {5-chlorosalicylic acid}  (#14# isozyme carbonic anhydrase \\n\\tI <209>) <209>\\nKI\\t#14# 0.01485 {4,6-dinitrosalicylic acid}  (#14# isozyme carbonic \\n\\tanhydrase I <209>) <209>\\nKI\\t#14# 11.42 {3-methylsalicylic acid}  (#14# isozyme carbonic anhydrase I \\n\\t<209>) <209>\\nKI\\t#14# 0.00687 {sulfasalazine}  (#14# isozyme carbonic anhydrase I <209>) \\n\\t<209>\\nKI\\t#14# 7.53 {Acetylsalicylic acid}  (#14# isozyme carbonic anhydrase I \\n\\t<209>) <209>\\nKI\\t#14# 0.00545 {4,6-dinitrosalicylic acid}  (#14# isozyme carbonic \\n\\tanhydrase II <209>) <209>\\nKI\\t#14# 10.57 {3-methylsalicylic acid}  (#14# isozyme carbonic anhydrase \\n\\tII <209>) <209>\\nKI\\t#14# 0.00937 {diflunisal}  (#14# isozyme carbonic anhydrase II <209>) \\n\\t<209>\\nKI\\t#14# 0.00872 {sulfasalazine}  (#14# isozyme carbonic anhydrase II \\n\\t<209>) <209>\\nKI\\t#14# 3.66 {Acetylsalicylic acid}  (#14# isozyme carbonic anhydrase II \\n\\t<209>) <209>\\nKI\\t#14# 0.00409 {3,4-dihydroxybenzoic acid}  (#14# isozyme hCAXII, pH 7.5, \\n\\t22C <299>) <299>\\nKI\\t#14# 0.00378 \\n\\t{1-cyclopropyl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide} \\n\\t (#14# isoform CA I, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.0000482 \\n\\t{D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-methioninamide}  (#14# \\n\\tisoform CA IV, pH and temperature not specified in the publication \\n\\t<415>) <415>\\nKI\\t#14# 0.0000342 \\n\\t{N-[(benzyloxy)carbonyl]glycyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tmethioninamide}  (#14# isoform CA II, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.0000883 \\n\\t{4-[N\\'-(6-chloro-7-cyano-1,1-dioxo-1,4,\\n\\t2-benzodithiazin-3-yl)hydrazino]-3-pyridinesulfonamide}  (#14# isoform \\n\\tCA II, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.355 \\n\\t{(5Z)-2-amino-5-(3,4-dihydroxybenzylidene)-3,\\n\\t5-dihydro-4H-imidazol-4-one}  (#14# isoform CA I <261>) <261>\\nKI\\t#14# 0.201 \\n\\t{7-hydroxy-1-methoxy-3-methyl-9-oxo-9,\\n\\t9a-dihydro-4aH-xanthene-8-carboxylic acid}  (#14# isoform CA I <261>) \\n\\t<261>\\nKI\\t#14# 0.374 \\n\\t{7-hydroxy-3-(hydroxymethyl)-1-methoxy-9-oxo-9,\\n\\t9a-dihydro-4aH-xanthene-8-carboxylic acid}  (#14# isoform CA I <261>) \\n\\t<261>\\nKI\\t#14# 0.368 \\n\\t{4,4\\'-[(1R,2R,3S,4S)-3,4-dimethylcyclobutane-1,\\n\\t2-diyl]bis(2-methoxyphenol)}  (#14# isoform CA I <261>) <261>\\nKI\\t#14# 0.354 \\n\\t{4,4\\'-[(1R,2S,3R,4S)-3,4-dimethylcyclobutane-1,\\n\\t2-diyl]bis(2-methoxyphenol)}  (#14# isoform CA I <261>) <261>\\nKI\\t#14# 0.244 {(3-chlorophenyl)acetic acid}  (#14# isoform CA I <261>) \\n\\t<261>\\nKI\\t#14# 0.0276 {spermine}  (#14# isozyme hCAXII, pH 7.5, 22C <299>) <299>\\nKI\\t#14# 0.000638 {4-(4\\'-dimethylaminophenyl)diazenylbenzenesulfonamide}  \\n\\t(#14# isozyme CA II, at 25C, pH 7.4 <268>) <268>\\nKI\\t#14# 0.000863 \\n\\t{4-(4\\'-methoxyphenyl)diazenylbenzene-N,N-dimethylsulfonamide}  (#14# \\n\\tisozyme CA II, at 25C, pH 7.4 <268>) <268>\\nKI\\t#14# 0.000277 {4-(4\\'-hydroxyphenyl)diazenylbenzene-N-methylsulfonamide} \\n\\t (#14# isozyme CA II, at 25C, pH 7.4 <268>) <268>\\nKI\\t#14# 0.000752 \\n\\t{4-(4\\'-hydroxyphenyl)diazenylbenzene-N,N-dimethylsulfonamide}  (#14# \\n\\tisozyme CA VII, at 25C, pH 7.4 <268>) <268>\\nKI\\t#14# 0.000706 {4-(4\\'-hydroxyphenyl)diazenylbenzene-N-methylsulfonamide} \\n\\t (#14# isozyme CA VII, at 25C, pH 7.4 <268>) <268>\\nKI\\t#14# 0.00734 {4-methoxy-3-pyridinesulfonamide}  (#14# isoform CA I, in \\n\\t10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.00664 {4-(4-cyanophenoxy)-3-pyridinesulfonamide}  (#14# isoform \\n\\tCA I, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.00916 {4-(4-fluorophenoxy)-3-pyridinesulfonamide}  (#14# isoform \\n\\tCA I, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.01032 {4-(quinolinoxy)-3-pyridinesulfonamide}  (#14# isoform CA \\n\\tI, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.01032 {4-(2-methyl-8-quinolinoxy)-3-pyridinesulfonamide}  (#14# \\n\\tisoform CA I, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.00762 {4-(N-oxide-2-pyridylthio)pyridine-3-sulfonamide}  (#14# \\n\\tisoform CA I, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.00884 {4-(6-nitrobenzothiazol-2-ylthio)pyridine-3-sulfonamide}  \\n\\t(#14# isoform CA I, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C \\n\\t<271>) <271>\\nKI\\t#14# 0.01117 {4,4\\'-thiodipyridine-3-sulfonamide}  (#14# isoform CA I, \\n\\tin 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.00903 {4-methylthiopyridine-3-sulfonamide}  (#14# isoform CA I, \\n\\tin 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.01171 {4-(cyanomethylthio)pyridine-3-sulfonamide}  (#14# isoform \\n\\tCA I, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.00832 {4-(2-propynylthio)pyridine-3-sulfonamide}  (#14# isoform \\n\\tCA I, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.00909 {4-benzythiopyridine-3-sulfonamide}  (#14# isoform CA I, \\n\\tin 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.00951 {4-(carbamoylmethylthio)pyridine-3-sulfonamide}  (#14# \\n\\tisoform CA I, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.00886 {4-(allylamino)-3-pyridinesulfonamide}  (#14# isoform CA \\n\\tI, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.000562 {4-(methylhydrazino)-3-pyridinesulfonamide}  (#14# \\n\\tisoform CA I, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.00791 {4-hydrazino-3-pyridinesulfonamide}  (#14# isoform CA I, \\n\\tin 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.00009384 {4-methoxy-3-pyridinesulfonamide}  (#14# isoform CA II, \\n\\tin 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000767 {4-ethoxy-3-pyridinesulfonamide}  (#14# isoform CA II, \\n\\tin 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000945 {4-(4-cyanophenoxy)-3-pyridinesulfonamide}  (#14# \\n\\tisoform CA II, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.0000944 {4-(4-fluorophenoxy)-3-pyridinesulfonamide}  (#14# \\n\\tisoform CA II, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.0000804 {4-(2-methyl-8-quinolinoxy)-3-pyridinesulfonamide}  \\n\\t(#14# isoform CA II, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C \\n\\t<271>) <271>\\nKI\\t#14# 0.0000845 {4-(N-oxide-2-pyridylthio)pyridine-3-sulfonamide}  (#14# \\n\\tisoform CA II, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.0000458 {4-(1-methyl-5-tetrazolylthio)pyridine-3-sulfonamide}  \\n\\t(#14# isoform CA II, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C \\n\\t<271>) <271>\\nKI\\t#14# 0.0000569 {4-(1,3,4-thiadiazol-2-ylthio)pyridine-3-sulfonamide}  \\n\\t(#14# isoform CA II, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C \\n\\t<271>) <271>\\nKI\\t#14# 0.0000948 {4-(6-nitrobenzothiazol-2-ylthio)pyridine-3-sulfonamide} \\n\\t (#14# isoform CA II, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C \\n\\t<271>) <271>\\nKI\\t#14# 0.0000401 {4-methylthiopyridine-3-sulfonamide}  (#14# isoform CA \\n\\tII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000911 {4-(cyanomethylthio)pyridine-3-sulfonamide}  (#14# \\n\\tisoform CA II, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.0000872 {4-(methylhydrazino)-3-pyridinesulfonamide}  (#14# \\n\\tisoform CA II, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.0000856 {4-hydrazino-3-pyridinesulfonamide}  (#14# isoform CA \\n\\tII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000461 \\n\\t{4-[N\\'-(6-chloro-7-methyl-1,1-dioxo-1,4,\\n\\t2-benzodithiazin-3-yl)hydrazyno]-3-pyridinesulfonamide}  (#14# isoform \\n\\tCA II, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000473 {4,4\\'-thiodipyridine-3-sulfonamide}  (#14# isoform CA \\n\\tIX, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000304 {4-benzythiopyridine-3-sulfonamide}  (#14# isoform CA \\n\\tIX, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000158 {4-(methylhydrazino)-3-pyridinesulfonamide}  (#14# \\n\\tisoform CA IX, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.00000216 \\n\\t{4-(6-nitrobenzothiazol-2-ylthio)pyridine-3-sulfonamide}  (#14# isoform \\n\\tCA XII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000156 {4-(2-propynylthio)pyridine-3-sulfonamide}  (#14# \\n\\tisoform CA XII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.0000159 {4-(carbamoylmethylthio)pyridine-3-sulfonamide}  (#14# \\n\\tisoform CA XII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.0000522 {4-ethoxy-3-pyridinesulfonamide}  (#14# isoform CA XIV, \\n\\tin 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000522 \\n\\t{N-[(benzyloxy)carbonyl]-D-alanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tvalinamide}  (#14# isoform CA IV, pH and temperature not specified in \\n\\tthe publication <415>) <415>\\nKI\\t#14# 0.0000597 {4-(quinolinoxy)-3-pyridinesulfonamide}  (#14# isoform \\n\\tCA XIV, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000597 \\n\\t{4-(4-hydroxyphenyl)-2-(4-bromophenyl)-5H-indeno[1,2-b]pyridin-5-one}  \\n\\t(#14# isoform CA II, at 25C, pH not specified in the publication \\n\\t<414>) <414>\\nKI\\t#14# 0.00983 {4-methylthiopyridine-3-sulfonamide}  (#14# isoform CA \\n\\tXIV, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000564 {4-(2-propynylthio)pyridine-3-sulfonamide}  (#14# \\n\\tisoform CA XIV, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.0000682 {4-benzythiopyridine-3-sulfonamide}  (#14# isoform CA \\n\\tXIV, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000957 {4-(methylhydrazino)-3-pyridinesulfonamide}  (#14# \\n\\tisoform CA XIV, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<271>\\nKI\\t#14# 0.0000934 {4-hydrazino-3-pyridinesulfonamide}  (#14# isoform CA \\n\\tXIV, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000923 \\n\\t{4-[N\\'-(6-chloro-7-cyano-1,1-dioxo-1,4,\\n\\t2-benzodithiazin-3-yl)hydrazino]-3-pyridinesulfonamide}  (#14# isoform \\n\\tCA XIV, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.0000509 \\n\\t{4-[N\\'-(6-chloro-7-methyl-1,1-dioxo-1,4,\\n\\t2-benzodithiazin-3-yl)hydrazyno]-3-pyridinesulfonamide}  (#14# isoform \\n\\tCA XIV, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <271>\\nKI\\t#14# 0.001858 {octane-1-sulfonamide}  <270>\\nKI\\t#14# 0.001789 {sodium (octylsulfonyl)azanide}  <270>\\nKI\\t#14# 0.000754 {umbelliferone}  (#14# inhibition of isozyme hCA I, pH \\n\\tnot specified in the publication, temperature not specified in the \\n\\tpublication <293>) <293>\\nKI\\t#14# 0.00821 {1,4-dimethoxybenzene}  (#14# isozyme hCAI, pH 7.5, 22C \\n\\t<299>) <299>\\nKI\\t#14# 0.00151 {3,4-dihydroisoquinoline-2(1H)-sulfonamide}  (#14# isoform \\n\\tCA I, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as buffers and 20 mM \\n\\tNa2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.00641 \\n\\t{6,7-dimethoxy-1-methyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#14# isoform CA I, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.00898 \\n\\t{6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#14# isoform CA I, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.0000763 \\n\\t{6,7-dimethoxy-1-propyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#14# isoform CA IX, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.002754 \\n\\t{6,7-dimethoxy-1-propyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#14# isoform CA XIV, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.000302 \\n\\t{6,7-dimethoxy-1-isopropyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#14# isoform CA XIV, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.00386 \\n\\t{6,7-dimethoxy-1-phenyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide}  \\n\\t(#14# isoform CA XIV, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <278>\\nKI\\t#14# 0.0000873 \\n\\t{N-(tert-butoxycarbonyl)-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-methioninamide}  (#14# isoform CA IV, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.0754 {N-sulfamoyl-beta-D-glucopyranosylamine}  (#14# isozyme hCA \\n\\tI, pH not specified in the publication, temperature not specified in \\n\\tthe publication <294>) <294>\\nKI\\t#14# 0.00967 {2,6-dimethoxybenzoic acid}  (#14# isozyme hCAI, pH 7.5, \\n\\t22C <299>) <299>\\nKI\\t#14# 0.0485 {N-sulfamoyl-beta-D-galactopyranosylamine}  (#14# isozyme \\n\\thCA II, pH not specified in the publication, temperature not specified \\n\\tin the publication <294>) <294>\\nKI\\t#14# 0.00544 {N-sulfamoyl-beta-D-mannopyranosylamine}  (#14# isozyme \\n\\thCA XII, pH not specified in the publication, temperature not specified \\n\\tin the publication <294>) <294>\\nKI\\t#14# 0.00683 {3,4-dimethoxybenzoic acid}  (#14# isozyme hCAI, pH 7.5, \\n\\t22C <299>) <299>\\nKI\\t#14# 0.00596 {1,2,4-trimethoxybenzene}  (#14# isozyme hCAI, pH 7.5, \\n\\t22C <299>) <299>\\nKI\\t#14# 0.00237 {3-Hydroxybenzoic acid}  (#14# isozyme hCAI, pH 7.5, 22C \\n\\t<299>) <299>\\nKI\\t#14# 0.00335 {1,4-dimethoxybenzene}  (#14# isozyme hCAII, pH 7.5, 22C \\n\\t<299>) <299>\\nKI\\t#14# 0.00825 {3,4-dimethoxybenzoic acid}  (#14# isozyme hCAIX, pH 7.5, \\n\\t22C <299>) <299>\\nKI\\t#14# 0.00445 {3,4-dihydroxybenzoic acid}  (#14# isozyme hCAIX, pH 7.5, \\n\\t22C <299>) <299>\\nKI\\t#14# 0.00863 {1,2-dimethoxybenzene}  (#14# isozyme hCAIX, pH 7.5, 22C \\n\\t<299>) <299>\\nKI\\t#14# 0.00441 {3,5-Dihydroxybenzoic acid}  (#14# isozyme hCAIX, pH 7.5, \\n\\t22C <299>) <299>\\nKI\\t#14# 0.00453 {3-Hydroxybenzoic acid}  (#14# isozyme hCAIX, pH 7.5, 22C \\n\\t<299>) <299>\\nKI\\t#14# 0.00907 {2,6-dimethoxybenzoic acid}  (#14# isozyme hCAIX, pH 7.5, \\n\\t22C <299>) <299>\\nKI\\t#14# 0.000353 {3-Hydroxybenzoic acid}  (#14# isozyme hCAXII, pH 7.5, \\n\\t22C <299>) <299>\\nKI\\t#14# 0.000823 {2,6-dimethoxybenzoic acid}  (#14# isozyme hCAXII, pH \\n\\t7.5, 22C <299>) <299>\\nKI\\t#14# 0.008015 {7-hydroxy-6-propanoyl-2H-chromen-2-one}  (#14# \\n\\tinhibition of isozyme hCA IX, pH not specified in the publication, \\n\\ttemperature not specified in the publication <293>) <293>\\nKI\\t#14# 0.0000582 {7-hydroxy-8-propanoyl-2H-chromen-2-one}  (#14# \\n\\tinhibition of isozyme hCA IX, pH not specified in the publication, \\n\\ttemperature not specified in the publication <293>) <293>\\nKI\\t#14# 0.00758 {6-acetyl-7-propoxy-2H-chromen-2-one}  (#14# inhibition of \\n\\tisozyme hCA IX, pH not specified in the publication, temperature not \\n\\tspecified in the publication <293>) <293>\\nKI\\t#14# 0.0000783 {8-acetyl-7-methoxy-2H-chromen-2-one}  (#14# inhibition \\n\\tof isozyme hCA IX, pH not specified in the publication, temperature not \\n\\tspecified in the publication <293>) <293>\\nKI\\t#14# 0.0000708 {8-acetyl-7-ethoxy-2H-chromen-2-one}  (#14# inhibition \\n\\tof isozyme hCA IX, pH not specified in the publication, temperature not \\n\\tspecified in the publication <293>) <293>\\nKI\\t#14# 0.0000567 {8-acetyl-7-propoxy-2H-chromen-2-one}  (#14# inhibition \\n\\tof isozyme hCA IX, pH not specified in the publication, temperature not \\n\\tspecified in the publication <293>) <293>\\nKI\\t#14# 0.0000612 {8-acetyl-7-butoxy-2H-chromen-2-one}  (#14# inhibition \\n\\tof isozyme hCA IX, pH not specified in the publication, temperature not \\n\\tspecified in the publication <293>) <293>\\nKI\\t#14# 0.0000723 {8-acetyl-7-(benzyloxy)-2H-chromen-2-one}  (#14# \\n\\tinhibition of isozyme hCA IX, pH not specified in the publication, \\n\\ttemperature not specified in the publication <293>) <293>\\nKI\\t#14# 0.0000502 {8-propanoyl-7-propoxy-2H-chromen-2-one}  (#14# \\n\\tinhibition of isozyme hCA IX, pH not specified in the publication, \\n\\ttemperature not specified in the publication <293>) <293>\\nKI\\t#14# 0.0000619 {8-acetyl-7-hydroxy-2H-chromen-2-one}  (#14# inhibition \\n\\tof isozyme hCA XII, pH not specified in the publication, temperature \\n\\tnot specified in the publication <293>) <293>\\nKI\\t#14# 0.0000617 {7-hydroxy-8-propanoyl-2H-chromen-2-one}  (#14# \\n\\tinhibition of isozyme hCA XII, pH not specified in the publication, \\n\\ttemperature not specified in the publication <293>) <293>\\nKI\\t#14# 0.00654 {6-acetyl-7-methoxy-2H-chromen-2-one}  (#14# inhibition of \\n\\tisozyme hCA XII, pH not specified in the publication, temperature not \\n\\tspecified in the publication <293>) <293>\\nKI\\t#14# 0.0777 {6-acetyl-7-adamantylethoxy-2H-chromen-2-one}  (#14# \\n\\tinhibition of isozyme hCA XII, pH not specified in the publication, \\n\\ttemperature not specified in the publication <293>) <293>\\nKI\\t#14# 0.0000609 {8-acetyl-7-methoxy-2H-chromen-2-one}  (#14# inhibition \\n\\tof isozyme hCA XII, pH not specified in the publication, temperature \\n\\tnot specified in the publication <293>) <293>\\nKI\\t#14# 0.00000098 {8-acetyl-7-propoxy-2H-chromen-2-one}  (#14# inhibition \\n\\tof isozyme hCA XII, pH not specified in the publication, temperature \\n\\tnot specified in the publication <293>) <293>\\nKI\\t#14# 0.0000224 {8-acetyl-7-(benzyloxy)-2H-chromen-2-one}  (#14# \\n\\tinhibition of isozyme hCA XII, pH not specified in the publication, \\n\\ttemperature not specified in the publication <293>) <293>\\nKI\\t#14# 0.0000315 {2-adamantylethyl \\n\\t7-methoxy-2-oxo-2H-chromene-8-carboxylate}  (#14# inhibition of isozyme \\n\\thCA XII, pH not specified in the publication, temperature not specified \\n\\tin the publication <293>) <293>\\nKI\\t#14# 0.0000332 {7-ethoxy-8-propanoyl-2H-chromen-2-one}  (#14# \\n\\tinhibition of isozyme hCA XII, pH not specified in the publication, \\n\\ttemperature not specified in the publication <293>) <293>\\nKI\\t#14# 0.0000384 {8-propanoyl-7-propoxy-2H-chromen-2-one}  (#14# \\n\\tinhibition of isozyme hCA XII, pH not specified in the publication, \\n\\ttemperature not specified in the publication <293>) <293>\\nKI\\t#14# 0.0000486 {6-(1-hydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one} \\n\\t (#14# inhibition of isozyme hCA XII, pH not specified in the \\n\\tpublication, temperature not specified in the publication <293>) <293>\\nKI\\t#14# 0.0000545 {6-(1-hydroxy-3-methylbutyl)-7-methoxy-2H-chromen-2-one} \\n\\t (#14# inhibition of isozyme hCA IX, pH not specified in the \\n\\tpublication, temperature not specified in the publication <293>) <293>\\nKI\\t#14# 0.0584 {umbelliferone}  (#14# inhibition of isozyme hCA XII, pH \\n\\tnot specified in the publication, temperature not specified in the \\n\\tpublication <293>) <293>\\nKI\\t#14# 0.000482 {umbelliferone}  (#14# inhibition of isozyme hCA II, pH \\n\\tnot specified in the publication, temperature not specified in the \\n\\tpublication <293>) <293>\\nKI\\t#14# 0.003714 \\n\\t{2,3,4,6-tetra-O-acetyl-N-sulfamoyl-beta-D-glucopyranosylamine}  (#14# \\n\\tisozyme hCA I, pH not specified in the publication, temperature not \\n\\tspecified in the publication <294>) <294>\\nKI\\t#14# 0.008637 \\n\\t{2,3,4,6-tetra-O-acetyl-N-sulfamoyl-beta-D-galactopyranosylamine}  \\n\\t(#14# isozyme hCA I, pH not specified in the publication, temperature \\n\\tnot specified in the publication <294>) <294>\\nKI\\t#14# 0.009703 \\n\\t{2,3,4,6-tetra-O-acetyl-N-sulfamoyl-beta-D-mannopyranosylamine}  (#14# \\n\\tisozyme hCA I, pH not specified in the publication, temperature not \\n\\tspecified in the publication <294>) <294>\\nKI\\t#14# 0.00953 \\n\\t{2,3,4-tri-O-acetyl-6-deoxy-N-sulfamoyl-alpha-L-glucopyranosylamine}  \\n\\t(#14# isozyme hCA I, pH not specified in the publication, temperature \\n\\tnot specified in the publication <294>) <294>\\nKI\\t#14# 0.0658 {N-sulfamoyl-beta-D-galactopyranosylamine}  (#14# isozyme \\n\\thCA I, pH not specified in the publication, temperature not specified \\n\\tin the publication <294>) <294>\\nKI\\t#14# 0.0919 {N-sulfamoyl-beta-D-mannopyranosylamine}  (#14# isozyme hCA \\n\\tI, pH not specified in the publication, temperature not specified in \\n\\tthe publication <294>) <294>\\nKI\\t#14# 0.002135 \\n\\t{N-[(3aR,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,\\n\\t3]dioxolo[4,5-b:4\\',5\\'-d]pyran-3a-yl]sulfamic amide}  (#14# isozyme hCA \\n\\tII, pH not specified in the publication, temperature not specified in \\n\\tthe publication <294>) <294>\\nKI\\t#14# 0.00458 \\n\\t{N-[(3aR,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,\\n\\t3]dioxolo[4,5-b:4\\',5\\'-d]pyran-3a-yl]sulfamic amide}  (#14# isozyme hCA \\n\\tIX, pH not specified in the publication, temperature not specified in \\n\\tthe publication <294>) <294>\\nKI\\t#14# 0.00823 {N-sulfamoyl-beta-D-galactopyranosylamine}  (#14# isozyme \\n\\thCA XII, pH not specified in the publication, temperature not specified \\n\\tin the publication <294>) <294>\\nKI\\t#14# 0.00559 {4-[(4-methylphenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA I, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.674 {phenylacetonitrile}  (#14# isozyme CA I, pH not specified \\n\\tin the publication, temperature not specified in the publication <296>) \\n\\t<296>\\nKI\\t#14# 0.416 {3-phenylpropanenitrile}  (#14# isozyme CA I, pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <296>) <296>\\nKI\\t#14# 0.00522 {4-[(4-methylphenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA II, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.006315 {3-[(3-methoxyphenyl)ethynyl]benzenesulfonamide}  (#14# \\n\\tisozyme CA II, pH not specified in the publication, temperature not \\n\\tspecified in the publication <296>) <296>\\nKI\\t#14# 0.00461 {phenylacetonitrile}  (#14# isozyme CA II, pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <296>) <296>\\nKI\\t#14# 0.004125 {3-phenylpropanenitrile}  (#14# isozyme CA II, pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <296>) <296>\\nKI\\t#14# 0.0000107 {2-(4-hydroxybenzylidene)-2H-indene-1,3-dione}  (#14# \\n\\tisoform CA II, at 25C, pH not specified in the publication <414>) <414>\\nKI\\t#14# 0.0000714 \\n\\t{4-(4-hydroxyphenyl)-2-p-tolyl-5H-indeno[1,2-b]pyridin-5-one}  (#14# \\n\\tisoform CA II, at 25C, pH not specified in the publication <414>) <414>\\nKI\\t#14# 0.0000383 \\n\\t{N-[(benzyloxy)carbonyl]-D-alanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tmethioninamide}  (#14# isoform CA IV, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.00595 {2-amino-1-benzothiophen-3(2H)-one 1,1-dioxide}  (#14# \\n\\twild-type, pH 7.5, 20C <332>) <332>\\nKI\\t#14# 0.000325 \\n\\t{N-(tert-butoxycarbonyl)-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-leucinamide}  (#14# isoform CA I, pH and temperature not specified in \\n\\tthe publication <415>) <415>\\nKI\\t#14# 0.0000736 \\n\\t{N-(tert-butoxycarbonyl)-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-alloisoleucinamide}  (#14# isoform CA IV, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.0000178 \\n\\t{N-[(benzyloxy)carbonyl]-D-alanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tvalinamide}  (#14# isoform CA XII, pH and temperature not specified in \\n\\tthe publication <415>) <415>\\nKI\\t#14# 0.0000258 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-S-benzyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]-D-cysteinamide}  (#14# isoform CA II, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.0001834 {acetazolamide}  (#14# isoform CA I, at 25C, pH not \\n\\tspecified in the publication <414>) <414>\\nKI\\t#14# 0.0001046 {acetazolamide}  (#14# isoform CA II, at 25C, pH not \\n\\tspecified in the publication <414>) <414>\\nKI\\t#14# 0.0000673 \\n\\t{4-(4-hydroxyphenyl)-2-phenyl-5H-indeno[1,2-b]pyridin-5-one}  (#14# \\n\\tisoform CA II, at 25C, pH not specified in the publication <414>) <414>\\nKI\\t#14# 0.0000673 \\n\\t{4-(4-hydroxyphenyl)-2-(4-chlorophenyl)-5H-indeno[1,2-b]pyridin-5-one}  \\n\\t(#14# isoform CA II, at 25C, pH not specified in the publication \\n\\t<414>) <414>\\nKI\\t#14# 0.0000745 \\n\\t{4-(4-hydroxyphenyl)-2-(4-methoxyphenyl)-5H-indeno[1,2-b]pyridin-5-one} \\n\\t (#14# isoform CA II, at 25C, pH not specified in the publication \\n\\t<414>) <414>\\nKI\\t#14# 0.0000762 {2,4-bis(4-hydroxyphenyl)-5H-indeno[1,2-b]pyridin-5-one} \\n\\t (#14# isoform CA II, at 25C, pH not specified in the publication \\n\\t<414>) <414>\\nKI\\t#14# 0.0000742 {acetazolamide}  (#14# isoform CA IV, pH and temperature \\n\\tnot specified in the publication <415>) <415>\\nKI\\t#14# 0.0000742 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-valinamide}  (#14# isoform CA I, pH and temperature not specified in \\n\\tthe publication <415>) <415>\\nKI\\t#14# 0.0004358 \\n\\t{N-[(benzyloxy)carbonyl]glycyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]glycinamide}  (#14# isoform CA I, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.0008316 \\n\\t{N-[(benzyloxy)carbonyl]glycyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tmethioninamide}  (#14# isoform CA I, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.0000915 \\n\\t{N-[(benzyloxy)carbonyl]-D-alanyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]glycinamide}  (#14# isoform CA I, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.0000823 \\n\\t{N-[(benzyloxy)carbonyl]-D-alanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\talaninamide}  (#14# isoform CA I, pH and temperature not specified in \\n\\tthe publication <415>) <415>\\nKI\\t#14# 0.0000704 \\n\\t{N-[(benzyloxy)carbonyl]-D-alanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tphenylalaninamide}  (#14# isoform CA I, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.0000721 \\n\\t{N-[(benzyloxy)carbonyl]-D-alanyl-S-benzyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]-D-cysteinamide}  (#14# isoform CA I, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.0000645 \\n\\t{N-[(benzyloxy)carbonyl]-D-alanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tvalinamide}  (#14# isoform CA I, pH and temperature not specified in \\n\\tthe publication <415>) <415>\\nKI\\t#14# 0.0008248 \\n\\t{N-[(benzyloxy)carbonyl]-D-alanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tmethioninamide}  (#14# isoform CA I, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.0000646 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]glycinamide}  (#14# isoform CA I, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.0000732 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-S-benzyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]-D-cysteinamide}  (#14# isoform CA I, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.0000732 \\n\\t{D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-phenylalaninamide}  \\n\\t(#14# isoform CA I, pH and temperature not specified in the publication \\n\\t<415>) <415>\\nKI\\t#14# 0.0000787 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-leucinamide}  (#14# isoform CA I, pH and temperature not specified in \\n\\tthe publication <415>) <415>\\nKI\\t#14# 0.0003986 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-methioninamide}  (#14# isoform CA I, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.0002076 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-leucinamide}  (#14# isoform CA I, pH and temperature not specified in \\n\\tthe publication <415>) <415>\\nKI\\t#14# 0.0002563 \\n\\t{N-[(benzyloxy)carbonyl]-D-methionyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]glycinamide}  (#14# isoform CA I, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.007015 \\n\\t{N-[(benzyloxy)carbonyl]-D-methionyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\talaninamide}  (#14# isoform CA I, pH and temperature not specified in \\n\\tthe publication <415>) <415>\\nKI\\t#14# 0.004281 \\n\\t{N-[(benzyloxy)carbonyl]-D-methionyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tphenylalaninamide}  (#14# isoform CA I, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.004191 \\n\\t{N-[(benzyloxy)carbonyl]-D-methionyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tmethioninamide}  (#14# isoform CA I, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.005336 \\n\\t{N-(tert-butoxycarbonyl)-D-phenylalanyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]glycinamide}  (#14# isoform CA I, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.0004619 \\n\\t{N-(tert-butoxycarbonyl)-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-phenylalaninamide}  (#14# isoform CA I, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.0006346 \\n\\t{N-(tert-butoxycarbonyl)-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-alloisoleucinamide}  (#14# isoform CA I, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.0003109 \\n\\t{N-(tert-butoxycarbonyl)-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-methioninamide}  (#14# isoform CA I, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.0001889 \\n\\t{D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-methioninamide}  (#14# \\n\\tisoform CA I, pH and temperature not specified in the publication \\n\\t<415>) <415>\\nKI\\t#14# 0.0002985 \\n\\t{D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-leucinamide}  (#14# \\n\\tisoform CA I, pH and temperature not specified in the publication \\n\\t<415>) <415>\\nKI\\t#14# 0.0000707 \\n\\t{N-[(benzyloxy)carbonyl]-D-alanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\talaninamide}  (#14# isoform CA II, pH and temperature not specified in \\n\\tthe publication <415>) <415>\\nKI\\t#14# 0.0003746 \\n\\t{N-[(benzyloxy)carbonyl]-D-alanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tphenylalaninamide}  (#14# isoform CA II, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.0006597 \\n\\t{N-[(benzyloxy)carbonyl]-D-alanyl-S-benzyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]-D-cysteinamide}  (#14# isoform CA II, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.0000415 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]glycinamide}  (#14# isoform CA II, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.0000538 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-alaninamide}  (#14# isoform CA II, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.0000421 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-phenylalaninamide}  (#14# isoform CA II, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.0000203 \\n\\t{N-[(benzyloxy)carbonyl]-D-methionyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\talaninamide}  (#14# isoform CA II, pH and temperature not specified in \\n\\tthe publication <415>) <415>\\nKI\\t#14# 0.0000512 \\n\\t{N-[(benzyloxy)carbonyl]-D-methionyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tphenylalaninamide}  (#14# isoform CA II, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.0000955 \\n\\t{N-[(benzyloxy)carbonyl]-D-methionyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tmethioninamide}  (#14# isoform CA II, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.0024678 \\n\\t{N-[(benzyloxy)carbonyl]glycyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]glycinamide}  (#14# isoform CA IV, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.0006269 \\n\\t{N-[(benzyloxy)carbonyl]glycyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tmethioninamide}  (#14# isoform CA IV, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.0007021 \\n\\t{N-[(benzyloxy)carbonyl]-D-alanyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]glycinamide}  (#14# isoform CA IV, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.0003981 \\n\\t{N-[(benzyloxy)carbonyl]-D-alanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\talaninamide}  (#14# isoform CA IV, pH and temperature not specified in \\n\\tthe publication <415>) <415>\\nKI\\t#14# 0.0021877 \\n\\t{N-[(benzyloxy)carbonyl]-D-alanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tphenylalaninamide}  (#14# isoform CA IV, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.0045046 \\n\\t{N-[(benzyloxy)carbonyl]-D-alanyl-S-benzyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]-D-cysteinamide}  (#14# isoform CA IV, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.0002257 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-alaninamide}  (#14# isoform CA IV, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.0000354 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-phenylalaninamide}  (#14# isoform CA IV, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.0077364 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-methioninamide}  (#14# isoform CA IV, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.0078938 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-leucinamide}  (#14# isoform CA IV, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.0005185 \\n\\t{N-[(benzyloxy)carbonyl]-D-methionyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]glycinamide}  (#14# isoform CA IV, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.0008979 \\n\\t{N-[(benzyloxy)carbonyl]-D-methionyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\talaninamide}  (#14# isoform CA IV, pH and temperature not specified in \\n\\tthe publication <415>) <415>\\nKI\\t#14# 0.0054235 \\n\\t{N-[(benzyloxy)carbonyl]-D-methionyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tmethioninamide}  (#14# isoform CA IV, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.0005124 \\n\\t{N-(tert-butoxycarbonyl)-D-phenylalanyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]glycinamide}  (#14# isoform CA IV, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.0005656 \\n\\t{N-(tert-butoxycarbonyl)-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-phenylalaninamide}  (#14# isoform CA IV, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.0002189 \\n\\t{N-(tert-butoxycarbonyl)-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-leucinamide}  (#14# isoform CA IV, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.0000511 \\n\\t{N-[(benzyloxy)carbonyl]glycyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tmethioninamide}  (#14# isoform CA XII, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.0000526 \\n\\t{N-[(benzyloxy)carbonyl]-D-alanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\talaninamide}  (#14# isoform CA XII, pH and temperature not specified in \\n\\tthe publication <415>) <415>\\nKI\\t#14# 0.0000899 \\n\\t{N-[(benzyloxy)carbonyl]-D-alanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tphenylalaninamide}  (#14# isoform CA XII, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.0007611 \\n\\t{N-[(benzyloxy)carbonyl]-D-alanyl-S-benzyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]-D-cysteinamide}  (#14# isoform CA XII, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.0000498 \\n\\t{N-[(benzyloxy)carbonyl]-D-alanyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tmethioninamide}  (#14# isoform CA XII, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.0000531 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-S-benzyl-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]-D-cysteinamide}  (#14# isoform CA XII, pH and \\n\\ttemperature not specified in the publication <415>) <415>\\nKI\\t#14# 0.0003622 \\n\\t{N-[(benzyloxy)carbonyl]-D-phenylalanyl-N-[2-(4-sulfamoylphenyl)ethyl]-\\n\\tD-leucinamide}  (#14# isoform CA XII, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14# 0.0000676 \\n\\t{N-[(benzyloxy)carbonyl]-D-methionyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tphenylalaninamide}  (#14# isoform CA XII, pH and temperature not \\n\\tspecified in the publication <415>) <415>\\nKI\\t#14# 0.0000689 \\n\\t{N-[(benzyloxy)carbonyl]-D-methionyl-N-[2-(4-sulfamoylphenyl)ethyl]-D-\\n\\tmethioninamide}  (#14# isoform CA XII, pH and temperature not specified \\n\\tin the publication <415>) <415>\\nKI\\t#14,110,119,124# 0.000022 {ethoxzolamide}  (#119# pH 7.5, catalytic \\n\\tdomain of cloned isoenzyme <141>; #110,119# isoenzyme hCA XII \\n\\t<169,171>; #124# isozyme CA XII, in 10 mM HEPES (pH 7.5) and 0.1 M \\n\\tNa2SO4 <229>; #14# isoform CA XII, in 10 mM HEPES (pH 7.5), 0.1 M \\n\\tNa2SO4, at 22C <271>) <141,169,171,229,271>\\nKI\\t#14,110,124# 0.000003 {brinzolamide}  (#124# isoenzyme hCA II <171>; \\n\\t#110# isoenzyme hCA XII catalytic domain <171>; #14# isozyme CA II, in \\n\\t10 mM HEPES (pH 7.5), 0.1 M NaClO4, at 20C <228>) <171,228>\\nKI\\t#14,118# 0.00525 {zonisamide}  (#118# isoenzyme hCA XIV catalytic \\n\\tdomain catalytic domain <171>; #14# isoform CA XIV, in 10-20 mM HEPES \\n\\t(pH 7.5) or Tris (pH 8.3) as buffers and 20 mM Na2SO4 or 20 mM NaClO4, \\n\\tat 22C <278>) <171,278>\\nKI\\t#14,118,120,124# 0.000041 {acetazolamide}  (#118# pH 7.5, full-length \\n\\trecombinant enzyme <141>; #118# isoenzyme hCA XIV <169>; #124# isozyme \\n\\tCA XIV, in 10 mM HEPES (pH 7.5) and 0.1 M Na2SO4 <229>; #124# isozyme \\n\\tcarbonic anhydrase XIV <202>; #120# recombinant extracellular domain of \\n\\tCA IX expressed in Sf9 cells, in the presence of 0.05 mM Mn2+ <223>; \\n\\t#14# isoform CA XIV, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C \\n\\t<271>; #14# isoform CA XIV, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) \\n\\tas buffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) \\n\\t<141,169,202,223,229,271,278>\\nKI\\t#14,118,124# 0.00146 {topiramate}  (#118# isoenzyme hCA XIV <169>; \\n\\t#124# isozyme carbonic anhydrase XIV <202>; #14# isoform CA XIV, in \\n\\t10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as buffers and 20 mM Na2SO4 or \\n\\t20 mM NaClO4, at 22C <278>) <169,202,278>\\nKI\\t#14,118,124,127,129# 0.000025 {ethoxzolamide}  (#14# pH 7.4, 25C, hCA \\n\\tI <120,131>; #14# pH 7.5, 20C, HCA I <132>; #14# pH 7.5, carbonic \\n\\tanhydrase I <153>; #118# pH 7.5, full-length recombinant enzyme <141>; \\n\\t#127# isoenzyme hCA I <171>; #129# isoenzyme hCA VA <169,171>; #118# \\n\\tisoenzyme hCA XIV <169>; #118# isoenzyme hCA XIV catalytic domain \\n\\t<171>; #124# isozyme CA I, in 10 mM HEPES (pH 7.5) and 0.1 M Na2SO4 \\n\\t<229>; #124# isozyme CA VA, in 10 mM HEPES (pH 7.5) and 0.1 M Na2SO4 \\n\\t<229>; #124# isozyme CA XIV, in 10 mM HEPES (pH 7.5) and 0.1 M Na2SO4 \\n\\t<229>; #14# isoform CA I, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at \\n\\t22C <271>; #14# isoform CA XIV, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, \\n\\tat 22C <271>) <120,131,132,141,153,169,171,229,271>\\nKI\\t#14,119,124# 0.0000057 {acetazolamide}  (#119# pH 7.5, catalytic domain \\n\\tof cloned isoenzyme <141>; #119# isoenzyme hCA XII <169>; #124# isozyme \\n\\tCA XII, in 10 mM HEPES (pH 7.5) and 0.1 M Na2SO4 <229>; #14# isoform CA \\n\\tXII, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>; #119# pH and \\n\\ttemperature not specified in the publication <365>; #119# isoform CA I, \\n\\tat pH 7.5 and 25C <437>; #14# isoform CA XII, pH and temperature not \\n\\tspecified in the publication <415>) <141,169,229,271,365,415,437>\\nKI\\t#14,120# 0.0088 {phenol}  (#14# isozyme hCAIX, pH 7.5, 22C <299>; \\n\\t#120# pH 8.3, 22C <386>) <299,386>\\nKI\\t#14,120# 0.000052 {dorzolamide}  (#120# isoenzyme hCA IX <171>; #14# \\n\\tisozyme CA IX, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, at 20C <228>) \\n\\t<171,228>\\nKI\\t#14,120# 0.0000051 {zonisamide}  (#120# isoenzyme hCA IX catalytic \\n\\tdomain <171>; #14# isoform CA IX, in 10-20 mM HEPES (pH 7.5) or Tris \\n\\t(pH 8.3) as buffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) \\n\\t<171,278>\\nKI\\t#14,120,124# 0.000058 {topiramate}  (#120# isoenzyme hCA IX <169>; \\n\\t#124# isozyme carbonic anhydrase IX <202>; #14# isoform CA IX, in 10-20 \\n\\tmM HEPES (pH 7.5) or Tris (pH 8.3) as buffers and 20 mM Na2SO4 or 20 mM \\n\\tNaClO4, at 22C <278>) <169,202,278>\\nKI\\t#14,120,124# 0.000025 {acetazolamide}  (#14# pH 7.4, 25C, hCA IX \\n\\t<131>; #14# pH 7.5, 20C, HCA IX <132>; #14# pH 7.5, 25C, hCA IX \\n\\t<118>; #120# pH 7.5, catalytic domain of cloned isoenzyme <141>; #120# \\n\\tisoenzyme hCA IX <169>; #124# isozyme CA IX, in 10 mM HEPES (pH 7.5) \\n\\tand 0.1 M Na2SO4 <229>; #14# isozyme CA IX, in 10 mM HEPES (pH 7.5), \\n\\t0.1 M NaClO4, at 20C <228>; #124# isozyme carbonic anhydrase IX <202>; \\n\\t#120# recombinant CA IX catalytic domain expressed in Escherichia coli \\n\\t<223>; #14# isoform CA IX, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at \\n\\t22C <271>; #14# isoform CA IX, in 10-20 mM HEPES (pH 7.5) or Tris (pH \\n\\t8.3) as buffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>; #120# \\n\\tpH and temperature not specified in the publication <365>; #120# pH \\n\\t8.3, 22C <386>) <118,131,132,141,169,202,223,228,229,271,278,365,386>\\nKI\\t#14,120,124# 0.000034 {ethoxzolamide}  (#14# pH 7.4, 25C, hCA IX \\n\\t<131>; #14# pH 7.5, 20C, HCA IX <132>; #120# isoenzyme hCA IX \\n\\t<169,171>; #124# isozyme CA IX, in 10 mM HEPES (pH 7.5) and 0.1 M \\n\\tNa2SO4 <229>; #14# isoform CA IX, in 10 mM HEPES (pH 7.5), 0.1 M \\n\\tNa2SO4, at 22C <271>) <131,132,169,171,229,271>\\nKI\\t#14,120,131,147,150# 0.000016 {acetazolamide}  (#147,150# at 20C and \\n\\tpH 7.5 in 10 mM HEPES buffer <208,222>; #120# recombinant extracellular \\n\\tdomain of CA IX expressed in Sf9 cells, in the absence of Zn2+ <223>; \\n\\t#147# in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, at 25C <259>; \\n\\t#147# isozyme STPCA, pH 7.5, 20C <297>; #131# saliva isoform CA VI, at \\n\\tpH 7.5, temperature not specified in the publication <445>) \\n\\t<208,222,223,247,259,297,445>\\nKI\\t#14,124# 0.000008 {ethoxzolamide}  (#14# pH 7.4, 25C, hCA II \\n\\t<120,131>; #14# pH 7.5, 20C, HCA II <132>; #14# pH 7.5, carbonic \\n\\tanhydrase II <153>; #124# isoenzyme hCA II <169>; #124# isozyme CA II, \\n\\tin 10 mM HEPES (pH 7.5) and 0.1 M Na2SO4 <229>; #14# isoform CA II, in \\n\\t10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) \\n\\t<120,131,132,153,169,229,271>\\nKI\\t#14,124# 0.000003 {acetazolamide}  (#14# pH 7.6, 4C <79>; #124# wild \\n\\ttype carbonic anhydrase IX <196>) <79,196>\\nKI\\t#14,124# 0.00005 {methazolamide}  (#124# isozyme CA I, in 10 mM HEPES \\n\\t(pH 7.5) and 0.1 M Na2SO4 <229>; #14# isozyme CA I, in 10 mM HEPES (pH \\n\\t7.5), 0.1 M NaClO4, at 20C <228>) <228,229>\\nKI\\t#14,124# 0.0055 {phenol}  (#124# pH 7.4, temperature not specified in \\n\\tthe publication <392>; #14# isozyme hCAII, pH 7.5, 22C <299>; #124# pH \\n\\t8.3, 22C <386>) <299,386,392>\\nKI\\t#14,124# 0.000014 {methazolamide}  (#14# pH 7.4, 25C, hCA II \\n\\t<120,131>; #14# pH 7.5, 20C, HCA II <132>; #14# pH 7.5, carbonic \\n\\tanhydrase II <153>; #124# isozyme CA II, in 10 mM HEPES (pH 7.5) and \\n\\t0.1 M Na2SO4 <229>; #14# isozyme CA II, in 10 mM HEPES (pH 7.5), 0.1 M \\n\\tNaClO4, at 20C <228>; #14# isoform CA II, in 10 mM HEPES (pH 7.5), 0.1 \\n\\tM Na2SO4, at 22C <271>; #14# isozyme CA II, at 25C, pH 7.4 <268>) \\n\\t<120,131,132,153,228,229,268,271>\\nKI\\t#14,124# 0.000035 {zonisamide}  (#124# isoenzyme hCA II <171>; #124# \\n\\tisoform CA II, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as buffers \\n\\tand 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>; #14# isozyme CA II, at \\n\\t25C, pH 7.4 <268>) <171,268,278>\\nKI\\t#14,124# 0.000012 {acetazolamide}  (#124# pH 7.5, 22C <387>; #14# pH \\n\\t7.4, 25C, hCA II <120,131>; #14# pH 7.5, 20C, HCA II <132>; #14# pH \\n\\t7.5, 25C, hCA II <118>; #14# pH 7.5, carbonic anhydrase II <153>; \\n\\t#124# isoenzyme hCA II <169>; #124# isozyme CA II, in 10 mM HEPES (pH \\n\\t7.5) and 0.1 M Na2SO4 <229>; #14# isozyme CA II, in 10 mM HEPES (pH \\n\\t7.5), 0.1 M NaClO4, at 20C <228>; #124# isozyme carbonic anhydrase II \\n\\t<202>; #14# isoform CA II, in 10 mM HEPES (pH 7.5), 0.1 M Na2SO4, at \\n\\t22C <271>; #124# isoform CA II, in 10-20 mM HEPES (pH 7.5) or Tris (pH \\n\\t8.3) as buffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>; #14# \\n\\tisozyme CA II, at 25C, pH 7.4 <268>; #124# pH and temperature not \\n\\tspecified in the publication <365>; #124# pH 8.3, 22C <386>; #124# \\n\\tisoform CA II, at pH 7.5 and 25C <437>; #14# isoform CA II, pH and \\n\\ttemperature not specified in the publication <415>) \\n\\t<118,120,131,132,153,169,202,211,228,229,268,271,278,365,386,387,415,\\n\\t437>\\nKI\\t#14,124# 0.000027 {methazolamide}  (#14# pH 7.4, 25C, hCA IX <131>; \\n\\t#14# pH 7.5, 20C, HCA IX <132>; #124# isozyme CA IX, in 10 mM HEPES \\n\\t(pH 7.5) and 0.1 M Na2SO4 <229>; #14# isozyme CA IX, in 10 mM HEPES (pH \\n\\t7.5), 0.1 M NaClO4, at 20C <228>; #14# isoform CA IX, in 10 mM HEPES \\n\\t(pH 7.5), 0.1 M Na2SO4, at 22C <271>) <131,132,228,229,271>\\nKI\\t#14,124# 0.000009 {methazolamide}  (#14# pH 7.6, 4C <79>; #124# wild \\n\\ttype carbonic anhydrase IX <196>) <79,196>\\nKI\\t#14,124# 0.000009 {benzolamide}  (#14# pH 7.4, 25C, hCA II <120>; \\n\\t#124# wild type carbonic anhydrase IX <196>) <120,196>\\nKI\\t#14,124# 0.000009 {dorzolamide}  (#14# pH 7.4, 25C, hCA II <120>; #14# \\n\\tpH 7.5, carbonic anhydrase II <153>; #124# isoenzyme hCA II <171>; #14# \\n\\tisozyme CA II, in 10 mM HEPES (pH 7.5), 0.1 M NaClO4, at 20C <228>) \\n\\t<120,153,171,228>\\nKI\\t#14,124# 0.000043 {methazolamide}  (#124# isozyme CA XIV, in 10 mM \\n\\tHEPES (pH 7.5) and 0.1 M Na2SO4 <229>; #14# isoform CA XIV, in 10 mM \\n\\tHEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <229,271>\\nKI\\t#14,124# 0.0000034 {methazolamide}  (#124# isozyme CA XII, in 10 mM \\n\\tHEPES (pH 7.5) and 0.1 M Na2SO4 <229>; #14# isoform CA XII, in 10 mM \\n\\tHEPES (pH 7.5), 0.1 M Na2SO4, at 22C <271>) <229,271>\\nKI\\t#14,124# 0.0000021 {methazolamide}  (#124# isozyme CA VII, in 10 mM \\n\\tHEPES (pH 7.5) and 0.1 M Na2SO4 <229>; #14# isozyme CA VII, at 25C, pH \\n\\t7.4 <268>) <229,268>\\nKI\\t#14,124,127# 0.00025 {topiramate}  (#14# pH 7.4, 25C, hCA I <131>; \\n\\t#127# isoenzyme hCA I <169>; #124# isozyme carbonic anhydrase I <202>; \\n\\t#14# isoform CA I, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as \\n\\tbuffers and 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) \\n\\t<131,169,202,278>\\nKI\\t#14,124,127# 0.00025 {acetazolamide}  (#127# pH 7.5, 22C <387>; #127# \\n\\tisoenzyme hCA I <169>; #124# isozyme CA I, in 10 mM HEPES (pH 7.5) and \\n\\t0.1 M Na2SO4 <229>; #14# isozyme CA I, in 10 mM HEPES (pH 7.5), 0.1 M \\n\\tNaClO4, at 20C <228>; #124# isozyme carbonic anhydrase I <202>; #14# \\n\\tisoform CA I, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as buffers \\n\\tand 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>; #127# pH and \\n\\ttemperature not specified in the publication <365>; #14# isozyme CA I, \\n\\tpH not specified in the publication, temperature not specified in the \\n\\tpublication <296>; #127# pH 8.3, 22C <386>; #127# isoform CA I, at pH \\n\\t7.5 and 25C <437>; #14# isoform CA I, pH and temperature not \\n\\tspecified in the publication <415>) \\n\\t<169,202,228,229,278,296,365,386,387,415,437>\\nKI\\t#14,124,132# 0.0000009 {topiramate}  (#132# isoenzyme hCA VII <169>; \\n\\t#124# isozyme carbonic anhydrase VII <202>; #14# isoform CA VII <255>) \\n\\t<169,202,255>\\nKI\\t#14,124,132# 0.0000008 {ethoxzolamide}  (#132# isoenzyme hCA VII \\n\\t<169,171>; #124# isozyme CA VII, in 10 mM HEPES (pH 7.5) and 0.1 M \\n\\tNa2SO4 <229>; #14# isoform CA VII <255>) <169,171,229,255>\\nKI\\t#14,124,132# 0.0000025 {acetazolamide}  (#132# isoenzyme hCA VII <169>; \\n\\t#124# isozyme CA VII, in 10 mM HEPES (pH 7.5) and 0.1 M Na2SO4 <229>; \\n\\t#124# isozyme carbonic anhydrase VII <202>; #14# isoform CA VII <255>; \\n\\t#14# isozyme CA VII, at 25C, pH 7.4 <268>) <169,202,229,255,268>\\nKI\\t#14,125# 0.3 {acetazolamide}  (#14# pH 7.5, 25C, hCA III <118>; #125# \\n\\tisoenzyme hCA III <169>) <118,169>\\nKI\\t#14,127# 0.05 {dorzolamide}  (#14# pH 7.4, 25C, hCA I <120>; #14# pH \\n\\t7.5, carbonic anhydrase I <153>; #127# isoenzyme hCA I <171>) \\n\\t<120,153,171>\\nKI\\t#14,127# 0.0102 {phenol}  (#127# pH 7.4, temperature not specified in \\n\\tthe publication <392>; #14# isozyme hCAI, pH 7.5, 22C <299>; #127# pH \\n\\t8.3, 22C <386>) <299,386,392>\\nKI\\t#14,127# 0.000056 {zonisamide}  (#127# isoenzyme hCA I <171>; #14# \\n\\tisoform CA I, in 10-20 mM HEPES (pH 7.5) or Tris (pH 8.3) as buffers \\n\\tand 20 mM Na2SO4 or 20 mM NaClO4, at 22C <278>) <171,278>\\nKI\\t#14,132# 0.000117 {zonisamide}  (#132# isoenzyme hCA VII catalytic \\n\\tdomain <171>; #14# isoform CA VII <255>; #14# isozyme CA VII, at 25C, \\n\\tpH 7.4 <268>) <171,255,268>\\nKI\\t#14,135# 0.00004 {acetazolamide}  (#14# pH 7.5, 25C, hCA IV <118>; \\n\\t#135# isoenzyme hpbetaCA <169>) <118,169>\\nKI\\t#14,147# 0.0003 {4-Aminobenzenesulfonamide}  (#14# pH 7.4, 25C, \\n\\tisozyme hCA II <126>; #147# isozyme STPCA, pH 7.5, 20C <297>) <126,297>\\nKI\\t#14,162# 0.000018 {celecoxib}  (#162# in 10-20 mM Tris, pH 8.3, 10-20 \\n\\tmM NaCl <277>; #14# isozyme CA XII, pH not specified in the \\n\\tpublication, temperature not specified in the publication <296>) \\n\\t<277,296>\\nKI\\t#14,18# 0.07 {N,N-dimethylamidimidodisulfuric acid}  (#18# pH 7.4, \\n\\t25C, isozyme bCA IV <122>; #14# pH 7.4, 25C, isozyme hCA II <122>) \\n\\t<122>\\nKI\\t#14,18# 0.03 {N-(aminosulfonyl)-4-fluorobenzenesulfonamide}  (#18# pH \\n\\t7.4, 25C, isozyme bCA IV <122>; #14# pH 7.4, 25C, isozyme hCA II \\n\\t<122>) <122>\\nKI\\t#14,18# 0.01 {N-[(1E)-(1-methyl-1H-pyrrol-2-yl)methylene]sulfamide}  \\n\\t(#18# pH 7.4, 25C, isozyme bCA IV <122>; #14# pH 7.4, 25C, isozyme \\n\\thCA I <122>) <122>\\nKI\\t#14,18# 0.01 {N-[(1E)-(4-methoxyphenyl)methylene]sulfamide}  (#18# pH \\n\\t7.4, 25C, isozyme bCA IV <122>; #14# pH 7.4, 25C, isozyme hCA I \\n\\t<122>) <122>\\nKI\\t#14,18# 0.01 {N-[(1E)-(4-nitrophenyl)methylene]sulfamide}  (#18# pH \\n\\t7.4, 25C, isozyme bCA IV <122>; #14# pH 7.4, 25C, isozyme hCA I \\n\\t<122>) <122>\\nKI\\t#14,18# 0.01 {N-[(1E)-(3-nitrophenyl)methylene]sulfamide}  (#18# pH \\n\\t7.4, 25C, isozyme bCA IV <122>; #14# pH 7.4, 25C, isozyme hCA I \\n\\t<122>) <122>\\nKI\\t#14,18# 0.01 \\n\\t{N-(aminosulfonyl)-5-(dimethylamino)naphthalene-1-sulfonamide}  (#18# \\n\\tpH 7.4, 25C, isozyme bCA IV <122>; #14# pH 7.4, 25C, isozyme hCA II \\n\\t<122>) <122>\\nKI\\t#14,18# 0.008 {N-[(1E)-[4-(dimethylamino)phenyl]methylene]sulfamide}  \\n\\t(#18# pH 7.4, 25C, isozyme bCA IV <122>; #14# pH 7.4, 25C, isozyme \\n\\thCA I <122>) <122>\\nKI\\t#14,18# 0.000015 {chlorazolamide}  (#18# pH 7.4, 25C, bCA IV <120>; \\n\\t#14# pH 7.4, 25C, hCA I <120>) <120>\\nKI\\t#14,80,118,119,124,127,128,222# -999 {more}  (#14# Ki values for \\n\\tnatural phenols with isozymes hCA I and hCA II in the esterase activity \\n\\tassay, overview <304>; #80# Ki values of esterase activity with \\n\\t4-nitrophenylacetate as substrate <306>; #119,124,127,128# inhibition \\n\\tassay using the CO2 hydration activity measurement <387>; #222# \\n\\tinhibition kinetics of CA isozymes, overview <377>; #118# inhibition \\n\\tkinetics, dissociation constants of compounds \\n\\t2,3,5,6-tetrafluoro-4-(2-phenylethanesulfonyl)benzene-1-sulfonamide, \\n\\t3-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]-2,5,\\n\\t6-trifluoro-4-(2-phenylethanesulfonyl)benzene-1-sulfonamide, \\n\\t3-(benzylamino)-2,5,\\n\\t6-trifluoro-4-(2-hydroxyethanesulfonyl)benzene-1-sulfonamide, \\n\\t3-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]-2,5,\\n\\t6-trifluoro-4-(2-hydroxyethanesulfonyl)benzene-1-sulfonamide and \\n\\t2,3,6-trifluoro-4-(2-hydroxyethanesulfonyl)-5-[[(1S)-1,2,3,\\n\\t4-tetrahydronaphthalen-1-yl]amino]benzene-1-sulfonamide binding to \\n\\thuman recombinant CA XIV at 37C, sodium phosphate buffer, pH 7.0 \\n\\t<381>) <304,306,377,381,387>\\nKI\\t#147# 0.45 {Carbonate}  (#147# at 20C and pH 7.5 in 10 mM HEPES buffer \\n\\t<208>) <208>\\nKI\\t#147# 0.45 {bicarbonate}  (#147# at 20C and pH 7.5 in 10 mM HEPES \\n\\tbuffer <208>) <208>\\nKI\\t#147# 0.53 {Cl-}  (#147# isozyme STPCA-2, pH not specified in the \\n\\tpublication, temperature not specified in the publication <297>) <297>\\nKI\\t#147# 0.01 {bisulfite}  (#147# at 20C and pH 7.5 in 10 mM HEPES buffer \\n\\t<208>) <208>\\nKI\\t#147# 0.5 {chloride}  (#147# at 20C and pH 7.5 in 10 mM HEPES buffer \\n\\t<208>) <208>\\nKI\\t#147# 0.009 {Iodide}  (#147# at 20C and pH 7.5 in 10 mM HEPES buffer \\n\\t<208>) <208>\\nKI\\t#147# 0.56 {nitrate}  (#147# at 20C and pH 7.5 in 10 mM HEPES buffer \\n\\t<208>) <208>\\nKI\\t#147# 0.51 {SCN-}  (#147# isozyme STPCA-2, pH not specified in the \\n\\tpublication, temperature not specified in the publication <297>) <297>\\nKI\\t#147# 33 {I-}  (#147# isozyme STPCA-2, pH not specified in the \\n\\tpublication, temperature not specified in the publication <297>) <297>\\nKI\\t#147# 0.91 {sulfate}  (#147# at 20C and pH 7.5 in 10 mM HEPES buffer \\n\\t<208>) <208>\\nKI\\t#147# 0.33 {SO42-}  (#147# isozyme STPCA-2, pH not specified in the \\n\\tpublication, temperature not specified in the publication <297>) <297>\\nKI\\t#147# 0.00054 {4-amino-3,5-dibromobenzenesulfonamide}  (#147# isozyme \\n\\tSTPCA, pH 7.5, 20C <297>) <297>\\nKI\\t#147# 0.0085 {H2NSO3H}  (#147# isozyme STPCA-2, pH not specified in the \\n\\tpublication, temperature not specified in the publication <297>) <297>\\nKI\\t#147# 3.15 {NO2-}  (#147# isozyme STPCA-2, pH not specified in the \\n\\tpublication, temperature not specified in the publication <297>) <297>\\nKI\\t#147# 0.77 {nitrite}  (#147# at 20C and pH 7.5 in 10 mM HEPES buffer \\n\\t<208>) <208>\\nKI\\t#147# 0.69 {CNO-}  (#147# isozyme STPCA-2, pH not specified in the \\n\\tpublication, temperature not specified in the publication <297>) <297>\\nKI\\t#147# 0.86 {CN-}  (#147# isozyme STPCA-2, pH not specified in the \\n\\tpublication, temperature not specified in the publication <297>) <297>\\nKI\\t#147# 0.24 {CO32-}  (#147# isozyme STPCA-2, pH not specified in the \\n\\tpublication, temperature not specified in the publication <297>) <297>\\nKI\\t#147# 0.43 {HSO3-}  (#147# isozyme STPCA-2, pH not specified in the \\n\\tpublication, temperature not specified in the publication <297>) <297>\\nKI\\t#147# 0.0097 {bromide}  (#147# at 20C and pH 7.5 in 10 mM HEPES buffer \\n\\t<208>) <208>\\nKI\\t#147# 0.78 {phenylarsonic acid}  (#147# at 20C and pH 7.5 in 10 mM \\n\\tHEPES buffer <208>) <208>\\nKI\\t#147# 0.68 {thiocyanate}  (#147# at 20C and pH 7.5 in 10 mM HEPES \\n\\tbuffer <208>) <208>\\nKI\\t#147# 0.68 {phenylboronic acid}  (#147# at 20C and pH 7.5 in 10 mM \\n\\tHEPES buffer <208>) <208>\\nKI\\t#147# 0.59 {isocyanide}  (#147# at 20C and pH 7.5 in 10 mM HEPES \\n\\tbuffer <208>) <208>\\nKI\\t#147# 0.62 {fluoride}  (#147# at 20C and pH 7.5 in 10 mM HEPES buffer \\n\\t<208>) <208>\\nKI\\t#147# 0.58 {Cyanate}  (#147# at 20C and pH 7.5 in 10 mM HEPES buffer \\n\\t<208>) <208>\\nKI\\t#147# 0.0057 {H2NSO2NH2}  (#147# isozyme STPCA-2, pH not specified in \\n\\tthe publication, temperature not specified in the publication <297>) \\n\\t<297>\\nKI\\t#147# 0.41 {sulfamate}  (#147# at 20C and pH 7.5 in 10 mM HEPES buffer \\n\\t<208>) <208>\\nKI\\t#147# 0.41 {hydrogen sulfide}  (#147# at 20C and pH 7.5 in 10 mM HEPES \\n\\tbuffer <208>) <208>\\nKI\\t#147# 0.00065 \\n\\t{4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide}  (#147# \\n\\tisozyme STPCA, pH 7.5, 20C <297>) <297>\\nKI\\t#147# 0.96 {Br-}  (#147# isozyme STPCA-2, pH not specified in the \\n\\tpublication, temperature not specified in the publication <297>) <297>\\nKI\\t#147# 0.0081 {phenyl-boronic acid}  (#147# isozyme STPCA-2, pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <297>) <297>\\nKI\\t#147# 0.99 {NO3-}  (#147# isozyme STPCA-2, pH not specified in the \\n\\tpublication, temperature not specified in the publication <297>) <297>\\nKI\\t#147# 0.81 {sulfamic acid}  (#147# at 20C and pH 7.5 in 10 mM HEPES \\n\\tbuffer <208>) <208>\\nKI\\t#147# 0.92 {F-}  (#147# isozyme STPCA-2, pH not specified in the \\n\\tpublication, temperature not specified in the publication <297>) <297>\\nKI\\t#147# 0.00043 {sulpiride}  (#147# in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 \\n\\tor NaClO4, at 25C <259>) <259>\\nKI\\t#147# 0.000105 {5-amino-1,3,4-thiadiazole-2-sulfonamide}  (#147# in 10 \\n\\tmM HEPES (pH 7.4), at 25C <259>) <259>\\nKI\\t#147# 0.000508 {4-(aminomethyl)benzenesulfonamide}  (#147# isozyme \\n\\tSTPCA, pH 7.5, 20C <297>) <297>\\nKI\\t#147# 0.000163 {indisulam}  (#147# in 10 mM HEPES (pH 7.4), 0.1 M \\n\\tNa2SO4 or NaClO4, at 25C <259>) <259>\\nKI\\t#147# 0.00084 {4-amino-6-chlorobenzene-1,3-disulfonamide}  (#147# \\n\\tisozyme STPCA, pH 7.5, 20C <297>) <297>\\nKI\\t#147# 0.0000298 {4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide}  \\n\\t(#147# in 10 mM HEPES (pH 7.4), at 25C <259>) <259>\\nKI\\t#147# 0.00251 {2-hydrazinylbenzenesulfonamide}  (#147# in 10 mM HEPES \\n\\t(pH 7.4), at 25C <259>) <259>\\nKI\\t#147# 0.000435 {4-sulfamoylbenzoic acid}  (#147# in 10 mM HEPES (pH \\n\\t7.4), at 25C <259>) <259>\\nKI\\t#147# 0.00077 {4-(2-hydroxyethyl)benzenesulfonamide}  (#147# in 10 mM \\n\\tHEPES (pH 7.4), at 25C <259>) <259>\\nKI\\t#147# 0.000104 {4-amino-3-bromobenzenesulfonamide}  (#147# in 10 mM \\n\\tHEPES (pH 7.4), at 25C <259>) <259>\\nKI\\t#147# 0.000259 {zonisamide}  (#147# in 10 mM HEPES (pH 7.4), 0.1 M \\n\\tNa2SO4 or NaClO4, at 25C <259>) <259>\\nKI\\t#147# 0.000768 {4-(hydroxymethyl)benzenesulfonamide}  (#147# in 10 mM \\n\\tHEPES (pH 7.4), at 25C <259>) <259>\\nKI\\t#147# 0.000294 {4-hydrazinylbenzenesulfonamide}  (#147# isozyme STPCA, \\n\\tpH 7.5, 20C <297>) <297>\\nKI\\t#147# 0.000256 {3-(4-sulfamoylphenyl)propanoic acid}  (#147# in 10 mM \\n\\tHEPES (pH 7.4), at 25C <259>) <259>\\nKI\\t#147# 0.0000287 {valdecoxib}  (#147# in 10 mM HEPES (pH 7.4), 0.1 M \\n\\tNa2SO4 or NaClO4, at 25C <259>) <259>\\nKI\\t#147# 0.000481 {4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide}  \\n\\t(#147# isozyme STPCA, pH 7.5, 20C <297>) <297>\\nKI\\t#147# 0.000367 {4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide}  \\n\\t(#147# in 10 mM HEPES (pH 7.4), at 25C <259>) <259>\\nKI\\t#147# 7.81 {HCO3-}  (#147# isozyme STPCA-2, pH not specified in the \\n\\tpublication, temperature not specified in the publication <297>) <297>\\nKI\\t#147# 0.0000197 \\n\\t{4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide}  (#147# in \\n\\t10 mM HEPES (pH 7.4), at 25C <259>) <259>\\nKI\\t#147# 0.0000212 {methazolamide}  (#147# in 10 mM HEPES (pH 7.4), 0.1 M \\n\\tNa2SO4 or NaClO4, at 25C <259>) <259>\\nKI\\t#147# 0.000902 {4-sulfamoyl-N-[2-(4-sulfamoylphenyl)ethyl]benzamide}  \\n\\t(#147# isozyme STPCA, pH 7.5, 20C <297>) <297>\\nKI\\t#147# 0.0000394 {ethoxzolamide}  (#147# in 10 mM HEPES (pH 7.4), 0.1 M \\n\\tNa2SO4 or NaClO4, at 25C <259>) <259>\\nKI\\t#147# 0.000431 {dichlorophenamide}  (#147# in 10 mM HEPES (pH 7.4), 0.1 \\n\\tM Na2SO4 or NaClO4, at 25C <259>) <259>\\nKI\\t#147# 0.0000181 {dorzolamide}  (#147# in 10 mM HEPES (pH 7.4), 0.1 M \\n\\tNa2SO4 or NaClO4, at 25C <259>) <259>\\nKI\\t#147# 0.0000482 {brinzolamide}  (#147# in 10 mM HEPES (pH 7.4), 0.1 M \\n\\tNa2SO4 or NaClO4, at 25C <259>) <259>\\nKI\\t#147# 0.0000204 {benzolamide}  (#147# in 10 mM HEPES (pH 7.4), 0.1 M \\n\\tNa2SO4 or NaClO4, at 25C <259>) <259>\\nKI\\t#147# 0.0000291 {topiramate}  (#147# in 10 mM HEPES (pH 7.4), 0.1 M \\n\\tNa2SO4 or NaClO4, at 25C <259>) <259>\\nKI\\t#147# 0.0000342 {celecoxib}  (#147# in 10 mM HEPES (pH 7.4), 0.1 M \\n\\tNa2SO4 or NaClO4, at 25C <259>) <259>\\nKI\\t#147# 0.0000452 {sulthiame}  (#147# in 10 mM HEPES (pH 7.4), 0.1 M \\n\\tNa2SO4 or NaClO4, at 25C <259>) <259>\\nKI\\t#147# 0.0000403 {saccharin}  (#147# in 10 mM HEPES (pH 7.4), 0.1 M \\n\\tNa2SO4 or NaClO4, at 25C <259>) <259>\\nKI\\t#147# 0.000553 {2-aminobenzenesulfonamide}  (#147# in 10 mM HEPES (pH \\n\\t7.4), at 25C <259>) <259>\\nKI\\t#147# 0.000364 {4-Aminobenzenesulfonamide}  (#147# in 10 mM HEPES (pH \\n\\t7.4), at 25C <259>) <259>\\nKI\\t#147# 0.000614 {4-methylbenzenesulfonamide}  (#147# in 10 mM HEPES (pH \\n\\t7.4), at 25C <259>) <259>\\nKI\\t#147# 0.0000825 {4-(aminomethyl)benzenesulfonamide}  (#147# in 10 mM \\n\\tHEPES (pH 7.4), at 25C <259>) <259>\\nKI\\t#147# 0.0000943 {4-(2-aminoethyl)benzenesulfonamide}  (#147# in 10 mM \\n\\tHEPES (pH 7.4), at 25C <259>) <259>\\nKI\\t#147# 0.0000751 {4-amino-3-fluorobenzenesulfonamide}  (#147# in 10 mM \\n\\tHEPES (pH 7.4), at 25C <259>) <259>\\nKI\\t#147# 0.0000875 {4-amino-3-chlorobenzenesulfonamide}  (#147# in 10 mM \\n\\tHEPES (pH 7.4), at 25C <259>) <259>\\nKI\\t#147# 0.0000883 {4-amino-3-iodobenzenesulfonamide}  (#147# in 10 mM \\n\\tHEPES (pH 7.4), at 25C <259>) <259>\\nKI\\t#147# 0.000295 {4-amino-6-chlorobenzene-1,3-disulfonamide}  (#147# in \\n\\t10 mM HEPES (pH 7.4), at 25C <259>) <259>\\nKI\\t#147# 0.0000919 \\n\\t{5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide}  (#147# \\n\\tin 10 mM HEPES (pH 7.4), at 25C <259>) <259>\\nKI\\t#147# 0.0000276 \\n\\t{5-[[(4-aminophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#147# in 10 mM HEPES (pH 7.4), at 25C <259>) <259>\\nKI\\t#147# 0.0000254 {4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide}  \\n\\t(#147# in 10 mM HEPES (pH 7.4), at 25C <259>) <259>\\nKI\\t#147# 0.000333 \\n\\t{5-[[(4-aminophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#147# isozyme STPCA, pH 7.5, 20C <297>) <297>\\nKI\\t#147# 4.68 {N3-}  (#147# isozyme STPCA-2, pH not specified in the \\n\\tpublication, temperature not specified in the publication <297>) <297>\\nKI\\t#147# 3.94 {HS-}  (#147# isozyme STPCA-2, pH not specified in the \\n\\tpublication, temperature not specified in the publication <297>) <297>\\nKI\\t#147# 0.0672 {Ph-AsO3H2}  (#147# isozyme STPCA-2, pH not specified in \\n\\tthe publication, temperature not specified in the publication <297>) \\n\\t<297>\\nKI\\t#147# 0.000675 {2-aminobenzenesulfonamide}  (#147# isozyme STPCA, pH \\n\\t7.5, 20C <297>) <297>\\nKI\\t#147# 0.000516 {4-methylbenzenesulfonamide}  (#147# isozyme STPCA, pH \\n\\t7.5, 20C <297>) <297>\\nKI\\t#147# 0.000577 {4-(2-aminoethyl)benzenesulfonamide}  (#147# isozyme \\n\\tSTPCA, pH 7.5, 20C <297>) <297>\\nKI\\t#147# 0.000493 {4-amino-3-fluorobenzenesulfonamide}  (#147# isozyme \\n\\tSTPCA, pH 7.5, 20C <297>) <297>\\nKI\\t#147# 0.000551 {4-amino-3-chlorobenzenesulfonamide}  (#147# isozyme \\n\\tSTPCA, pH 7.5, 20C <297>) <297>\\nKI\\t#147# 0.000695 {4-amino-3,5-diiodobenzenesulfonamide}  (#147# isozyme \\n\\tSTPCA, pH 7.5, 20C <297>) <297>\\nKI\\t#147# 0.000361 {5-amino-1,3,4-thiadiazole-2-sulfonamide}  (#147# \\n\\tisozyme STPCA, pH 7.5, 20C <297>) <297>\\nKI\\t#147# 0.000357 \\n\\t{5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide}  (#147# \\n\\tisozyme STPCA, pH 7.5, 20C <297>) <297>\\nKI\\t#147# 0.000661 \\n\\t{5-[[(4-amino-3-chloro-5-fluorophenyl)sulfonyl]amino]-4,5-dihydro-1,3,\\n\\t4-thiadiazole-2-sulfonamide}  (#147# isozyme STPCA, pH 7.5, 20C <297>) \\n\\t<297>\\nKI\\t#147# 0.000868 {4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide}  \\n\\t(#147# isozyme STPCA, pH 7.5, 20C <297>) <297>\\nKI\\t#147# 0.000642 {4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide}  \\n\\t(#147# isozyme STPCA, pH 7.5, 20C <297>) <297>\\nKI\\t#147# 0.000701 {6-hydroxy-1,3-benzothiazole-2-sulfonamide}  (#147# \\n\\tisozyme STPCA, pH 7.5, 20C <297>) <297>\\nKI\\t#147# 0.000607 {5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#147# isozyme STPCA, pH 7.5, 20C <297>) <297>\\nKI\\t#162# 0.00006 {4-amino-3,5-dibromobenzenesulfonamide}  (#162# pH 8.3, \\n\\ttemperature not specified in the publication, isozyme bsCA II <298>) \\n\\t<298>\\nKI\\t#162# 0.0025 {sulfanilamide}  (#162# at 20C, pH 8.3 in 20 mM Tris-HCl \\n\\tbuffer and 20 mM NaCl <257>) <257>\\nKI\\t#162# 0.0025 {4-Aminobenzenesulfonamide}  (#162# isoform CA I, in 10-20 \\n\\tmM Tris, pH 8.3, 10-20 mM NaCl <277>; #162# pH 8.3, temperature not \\n\\tspecified in the publication, isozyme bsCA I <298>) <277,298>\\nKI\\t#162# 0.000345 {4-amino-3,5-diiodobenzenesulfonamide}  (#162# isoform \\n\\tCA I, in 10-20 mM Tris, pH 8.3, 10-20 mM NaCl <277>; #162# pH 8.3, \\n\\ttemperature not specified in the publication, isozyme bsCA I <298>) \\n\\t<277,298>\\nKI\\t#162# 0.0008 {4-amino-3-chlorobenzenesulfonamide}  (#162# isoform CA I, \\n\\tin 10-20 mM Tris, pH 8.3, 10-20 mM NaCl <277>; #162# pH 8.3, \\n\\ttemperature not specified in the publication, isozyme bsCA I <298>) \\n\\t<277,298>\\nKI\\t#162# 0.000075 {heptane-1,7-diyl disulfamate}  (#162# pH 8.3, \\n\\ttemperature not specified in the publication, isozyme bsCA I <298>) \\n\\t<298>\\nKI\\t#162# 0.00009 {4-sulfamoyl-N-[2-(4-sulfamoylphenyl)ethyl]benzamide}  \\n\\t(#162# pH 8.3, temperature not specified in the publication, isozyme \\n\\tbsCA II <298>) <298>\\nKI\\t#162# 0.00007 \\n\\t{5-[[(4-aminophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#162# isoform CA I, in 10-20 mM Tris, pH 8.3, 10-20 mM NaCl <277>; \\n\\t#162# pH 8.3, temperature not specified in the publication, isozyme \\n\\tbsCA I <298>) <277,298>\\nKI\\t#162# 0.0024 {4-hydrazinylbenzenesulfonamide}  (#162# isoform CA I, in \\n\\t10-20 mM Tris, pH 8.3, 10-20 mM NaCl <277>; #162# pH 8.3, temperature \\n\\tnot specified in the publication, isozyme bsCA I <298>) <277,298>\\nKI\\t#162# 0.0000089 \\n\\t{4-[[(4R)-3,4,\\n\\t5-trihydroxytetrahydro-2H-pyran-2-yl]amino]benzenesulfonamide}  (#162# \\n\\tat 20C, pH 8.3 in 20 mM Tris-HCl buffer and 20 mM NaCl <257>) <257>\\nKI\\t#162# 0.0000089 {N-(4-sulfamoylphenyl)-beta-D-idopyranosylamine}  \\n\\t(#162# pH 8.3, temperature not specified in the publication, isozyme \\n\\tbsCA I <298>) <298>\\nKI\\t#162# 0.000033 {5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#162# isoform CA I, in 10-20 mM Tris, pH 8.3, 10-20 mM NaCl <277>; \\n\\t#162# pH 8.3, temperature not specified in the publication, isozyme \\n\\tbsCA I <298>) <277,298>\\nKI\\t#162# 0.00034 {4-sulfamoylbenzoic acid}  (#162# isoform CA I, in 10-20 \\n\\tmM Tris, pH 8.3, 10-20 mM NaCl <277>; #162# pH 8.3, temperature not \\n\\tspecified in the publication, isozyme bsCA I <298>) <277,298>\\nKI\\t#162# 0.000067 \\n\\t{4-[(3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)amino]benzenesulfonamide} \\n\\t (#162# at 20C, pH 8.3 in 20 mM Tris-HCl buffer and 20 mM NaCl <257>) \\n\\t<257>\\nKI\\t#162# 0.000019 \\n\\t{4-[[(2R,3R)-3,4,\\n\\t5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl]amino]benzenesulfonamide} \\n\\t (#162# at 20C, pH 8.3 in 20 mM Tris-HCl buffer and 20 mM NaCl <257>) \\n\\t<257>\\nKI\\t#162# 0.000019 {sulpiride}  (#162# in 10-20 mM Tris, pH 8.3, 10-20 mM \\n\\tNaCl <277>) <277>\\nKI\\t#162# 0.000019 {valdecoxib}  (#162# in 10-20 mM Tris, pH 8.3, 10-20 mM \\n\\tNaCl <277>) <277>\\nKI\\t#162# 0.000019 \\n\\t{6-deoxy-N-(4-sulfamoylphenyl)-alpha-L-mannopyranosylamine}  (#162# pH \\n\\t8.3, temperature not specified in the publication, isozyme bsCA I \\n\\t<298>) <298>\\nKI\\t#162# 0.000068 \\n\\t{4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide}  (#162# pH \\n\\t8.3, temperature not specified in the publication, isozyme bsCA II \\n\\t<298>) <298>\\nKI\\t#162# 0.000021 {dorzolamide}  (#162# in 10-20 mM Tris, pH 8.3, 10-20 mM \\n\\tNaCl <277>) <277>\\nKI\\t#162# 0.000021 {4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide}  \\n\\t(#162# isoform CA I, in 10-20 mM Tris, pH 8.3, 10-20 mM NaCl <277>; \\n\\t#162# pH 8.3, temperature not specified in the publication, isozyme \\n\\tbsCA I <298>) <277,298>\\nKI\\t#162# 0.000065 \\n\\t{4-[[(3R,4R)-3,4,\\n\\t5-trihydroxytetrahydro-2H-pyran-2-yl]amino]benzenesulfonamide}  (#162# \\n\\tat 20C, pH 8.3 in 20 mM Tris-HCl buffer and 20 mM NaCl <257>) <257>\\nKI\\t#162# 0.000017 {ethoxzolamide}  (#162# in 10-20 mM Tris, pH 8.3, 10-20 \\n\\tmM NaCl <277>) <277>\\nKI\\t#162# 0.00011 \\n\\t{4-[[3,4,\\n\\t5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-\\n\\tyl]amino]benzenesulfonamide}  (#162# at 20C, pH 8.3 in 20 mM Tris-HCl \\n\\tbuffer and 20 mM NaCl <257>) <257>\\nKI\\t#162# 0.000028 \\n\\t{4-[[(2R,5S)-3,4,\\n\\t5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl]amino]benzenesulfonamide} \\n\\t (#162# at 20C, pH 8.3 in 20 mM Tris-HCl buffer and 20 mM NaCl <257>) \\n\\t<257>\\nKI\\t#162# 0.00107 {4-amino-3-fluorobenzenesulfonamide}  (#162# isoform CA \\n\\tI, in 10-20 mM Tris, pH 8.3, 10-20 mM NaCl <277>; #162# pH 8.3, \\n\\ttemperature not specified in the publication, isozyme bsCA I <298>) \\n\\t<277,298>\\nKI\\t#162# 0.000048 {6-hydroxy-1,3-benzothiazole-2-sulfonamide}  (#162# \\n\\tisoform CA I, in 10-20 mM Tris, pH 8.3, 10-20 mM NaCl <277>; #162# pH \\n\\t8.3, temperature not specified in the publication, isozyme bsCA I \\n\\t<298>) <277,298>\\nKI\\t#162# 0.000027 {4-sulfamoyl-N-[2-(4-sulfamoylphenyl)ethyl]benzamide}  \\n\\t(#162# isoform CA I, in 10-20 mM Tris, pH 8.3, 10-20 mM NaCl <277>; \\n\\t#162# pH 8.3, temperature not specified in the publication, isozyme \\n\\tbsCA I <298>) <277,298>\\nKI\\t#162# 0.00094 {4-amino-6-chlorobenzene-1,3-disulfonamide}  (#162# \\n\\tisoform CA I, in 10-20 mM Tris, pH 8.3, 10-20 mM NaCl <277>; #162# pH \\n\\t8.3, temperature not specified in the publication, isozyme bsCA I \\n\\t<298>) <277,298>\\nKI\\t#162# 0.00121 {5-amino-1,3,4-thiadiazole-2-sulfonamide}  (#162# isoform \\n\\tCA I, in 10-20 mM Tris, pH 8.3, 10-20 mM NaCl <277>; #162# pH 8.3, \\n\\ttemperature not specified in the publication, isozyme bsCA I <298>) \\n\\t<277,298>\\nKI\\t#162# 0.000108 \\n\\t{5-[[(4-aminophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#162# pH 8.3, temperature not specified in the publication, isozyme \\n\\tbsCA II <298>) <298>\\nKI\\t#162# 0.000094 {4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide}  \\n\\t(#162# pH 8.3, temperature not specified in the publication, isozyme \\n\\tbsCA II <298>) <298>\\nKI\\t#162# 0.000186 \\n\\t{5-[[(4-amino-3-chloro-5-fluorophenyl)sulfonyl]amino]-1,3,\\n\\t4-thiadiazole-2-sulfonamide}  (#162# isoform CA I, in 10-20 mM Tris, pH \\n\\t8.3, 10-20 mM NaCl <277>) <277>\\nKI\\t#162# 0.000186 \\n\\t{5-[[(4-amino-3-chloro-5-fluorophenyl)sulfonyl]amino]-4,5-dihydro-1,3,\\n\\t4-thiadiazole-2-sulfonamide}  (#162# pH 8.3, temperature not specified \\n\\tin the publication, isozyme bsCA I <298>) <298>\\nKI\\t#162# 0.00143 \\n\\t{5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide}  (#162# \\n\\tisoform CA I, in 10-20 mM Tris, pH 8.3, 10-20 mM NaCl <277>; #162# pH \\n\\t8.3, temperature not specified in the publication, isozyme bsCA I \\n\\t<298>) <277,298>\\nKI\\t#162# 0.000663 \\n\\t{5-[[(4-amino-3-chloro-5-fluorophenyl)sulfonyl]amino]-4,5-dihydro-1,3,\\n\\t4-thiadiazole-2-sulfonamide}  (#162# pH 8.3, temperature not specified \\n\\tin the publication, isozyme bsCA II <298>) <298>\\nKI\\t#162# 0.000079 {4-chlorophenyl sulfamate}  (#162# pH 8.3, temperature \\n\\tnot specified in the publication, isozyme bsCA I <298>) <298>\\nKI\\t#162# 0.000079 {4-amino-3-chlorobenzenesulfonamide}  (#162# pH 8.3, \\n\\ttemperature not specified in the publication, isozyme bsCA II <298>) \\n\\t<298>\\nKI\\t#162# 0.000084 {4-amino-3,5-diiodobenzenesulfonamide}  (#162# pH 8.3, \\n\\ttemperature not specified in the publication, isozyme bsCA II <298>) \\n\\t<298>\\nKI\\t#162# 0.0000073 \\n\\t{6-deoxy-N-(4-sulfamoylphenyl)-alpha-L-mannopyranosylamine}  (#162# pH \\n\\t8.3, temperature not specified in the publication, isozyme bsCA II \\n\\t<298>) <298>\\nKI\\t#162# 0.000103 \\n\\t{4-[[(3R)-3,4,\\n\\t5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-\\n\\tyl]amino]benzenesulfonamide}  (#162# at 20C, pH 8.3 in 20 mM Tris-HCl \\n\\tbuffer and 20 mM NaCl <257>) <257>\\nKI\\t#162# 0.000087 {4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide}  \\n\\t(#162# pH 8.3, temperature not specified in the publication, isozyme \\n\\tbsCA II <298>) <298>\\nKI\\t#162# 0.00158 {4-methylbenzenesulfonamide}  (#162# isoform CA I, in \\n\\t10-20 mM Tris, pH 8.3, 10-20 mM NaCl <277>; #162# pH 8.3, temperature \\n\\tnot specified in the publication, isozyme bsCA I <298>) <277,298>\\nKI\\t#162# 0.000083 {4-amino-3-fluorobenzenesulfonamide}  (#162# pH 8.3, \\n\\ttemperature not specified in the publication, isozyme bsCA II <298>) \\n\\t<298>\\nKI\\t#162# 0.000083 {6-hydroxy-1,3-benzothiazole-2-sulfonamide}  (#162# pH \\n\\t8.3, temperature not specified in the publication, isozyme bsCA II \\n\\t<298>) <298>\\nKI\\t#162# 0.0000092 \\n\\t{4-[[(5R)-3,4,\\n\\t5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-\\n\\tyl]amino]benzenesulfonamide}  (#162# at 20C, pH 8.3 in 20 mM Tris-HCl \\n\\tbuffer and 20 mM NaCl <257>) <257>\\nKI\\t#162# 0.0000092 {N-(4-sulfamoylphenyl)-beta-D-galactopyranosylamine}  \\n\\t(#162# pH 8.3, temperature not specified in the publication, isozyme \\n\\tbsCA I <298>) <298>\\nKI\\t#162# 0.00591 {4-(aminomethyl)benzenesulfonamide}  (#162# pH 8.3, \\n\\ttemperature not specified in the publication, isozyme bsCA II <298>) \\n\\t<298>\\nKI\\t#162# 0.000166 {5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#162# pH 8.3, temperature not specified in the publication, isozyme \\n\\tbsCA II <298>) <298>\\nKI\\t#162# 0.00088 {4-(2-aminoethyl)benzenesulfonamide}  (#162# isoform CA \\n\\tI, in 10-20 mM Tris, pH 8.3, 10-20 mM NaCl <277>; #162# pH 8.3, \\n\\ttemperature not specified in the publication, isozyme bsCA I <298>) \\n\\t<277,298>\\nKI\\t#162# 0.000768 {4-(aminomethyl)benzenesulfonamide}  (#162# isoform CA \\n\\tI, in 10-20 mM Tris, pH 8.3, 10-20 mM NaCl <277>; #162# pH 8.3, \\n\\ttemperature not specified in the publication, isozyme bsCA I <298>) \\n\\t<277,298>\\nKI\\t#162# 0.00105 {4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide}  (#162# \\n\\tisoform CA I, in 10-20 mM Tris, pH 8.3, 10-20 mM NaCl <277>; #162# pH \\n\\t8.3, temperature not specified in the publication, isozyme bsCA I \\n\\t<298>) <277,298>\\nKI\\t#162# 0.0000112 \\n\\t{5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide}  (#162# \\n\\tpH 8.3, temperature not specified in the publication, isozyme bsCA II \\n\\t<298>) <298>\\nKI\\t#162# 0.000865 {4-(2-hydroxyethyl)benzenesulfonamide}  (#162# isoform \\n\\tCA I, in 10-20 mM Tris, pH 8.3, 10-20 mM NaCl <277>; #162# pH 8.3, \\n\\ttemperature not specified in the publication, isozyme bsCA I <298>) \\n\\t<277,298>\\nKI\\t#162# 0.000193 {heptane-1,7-diyl disulfamate}  (#162# pH 8.3, \\n\\ttemperature not specified in the publication, isozyme bsCA II <298>) \\n\\t<298>\\nKI\\t#162# 0.000745 \\n\\t{4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide}  (#162# \\n\\tisoform CA I, in 10-20 mM Tris, pH 8.3, 10-20 mM NaCl <277>; #162# pH \\n\\t8.3, temperature not specified in the publication, isozyme bsCA I \\n\\t<298>) <277,298>\\nKI\\t#162# 0.0000146 {N-(4-sulfamoylphenyl)-beta-D-idopyranosylamine}  \\n\\t(#162# pH 8.3, temperature not specified in the publication, isozyme \\n\\tbsCA II <298>) <298>\\nKI\\t#162# 0.000758 {4-(hydroxymethyl)benzenesulfonamide}  (#162# pH 8.3, \\n\\ttemperature not specified in the publication, isozyme bsCA II <298>) \\n\\t<298>\\nKI\\t#162# 0.005048 {2-aminobenzenesulfonamide}  (#162# pH 8.3, temperature \\n\\tnot specified in the publication, isozyme bsCA II <298>) <298>\\nKI\\t#162# 0.0000101 {N-(4-sulfamoylphenyl)-beta-D-galactopyranosylamine}  \\n\\t(#162# pH 8.3, temperature not specified in the publication, isozyme \\n\\tbsCA II <298>) <298>\\nKI\\t#162# 0.00587 {2-aminobenzenesulfonamide}  (#162# isoform CA I, in \\n\\t10-20 mM Tris, pH 8.3, 10-20 mM NaCl <277>; #162# pH 8.3, temperature \\n\\tnot specified in the publication, isozyme bsCA I <298>) <277,298>\\nKI\\t#162# 0.000243 {4-amino-3,5-dibromobenzenesulfonamide}  (#162# isoform \\n\\tCA I, in 10-20 mM Tris, pH 8.3, 10-20 mM NaCl <277>; #162# pH 8.3, \\n\\ttemperature not specified in the publication, isozyme bsCA I <298>) \\n\\t<277,298>\\nKI\\t#162# 0.00483 {4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide}  \\n\\t(#162# isoform CA I, in 10-20 mM Tris, pH 8.3, 10-20 mM NaCl <277>; \\n\\t#162# pH 8.3, temperature not specified in the publication, isozyme \\n\\tbsCA I <298>) <277,298>\\nKI\\t#162# 0.000754 {4-(hydroxymethyl)benzenesulfonamide}  (#162# isoform CA \\n\\tI, in 10-20 mM Tris, pH 8.3, 10-20 mM NaCl <277>; #162# pH 8.3, \\n\\ttemperature not specified in the publication, isozyme bsCA I <298>) \\n\\t<277,298>\\nKI\\t#162# 0.001035 {2-hydrazinylbenzenesulfonamide}  (#162# isoform CA I, \\n\\tin 10-20 mM Tris, pH 8.3, 10-20 mM NaCl <277>; #162# pH 8.3, \\n\\ttemperature not specified in the publication, isozyme bsCA I <298>) \\n\\t<277,298>\\nKI\\t#162# 0.000215 {4-chlorophenyl sulfamate}  (#162# pH 8.3, temperature \\n\\tnot specified in the publication, isozyme bsCA II <298>) <298>\\nKI\\t#162# 0.00856 {4-(2-aminoethyl)benzenesulfonamide}  (#162# pH 8.3, \\n\\ttemperature not specified in the publication, isozyme bsCA II <298>) \\n\\t<298>\\nKI\\t#162# 0.00508 {4-Aminobenzenesulfonamide}  (#162# pH 8.3, temperature \\n\\tnot specified in the publication, isozyme bsCA II <298>) <298>\\nKI\\t#162# 0.004763 {4-hydrazinylbenzenesulfonamide}  (#162# pH 8.3, \\n\\ttemperature not specified in the publication, isozyme bsCA II <298>) \\n\\t<298>\\nKI\\t#162# 0.00556 {4-methylbenzenesulfonamide}  (#162# pH 8.3, temperature \\n\\tnot specified in the publication, isozyme bsCA II <298>) <298>\\nKI\\t#162# 0.000691 {4-amino-6-chlorobenzene-1,3-disulfonamide}  (#162# pH \\n\\t8.3, temperature not specified in the publication, isozyme bsCA II \\n\\t<298>) <298>\\nKI\\t#162# 0.000847 {5-amino-1,3,4-thiadiazole-2-sulfonamide}  (#162# pH \\n\\t8.3, temperature not specified in the publication, isozyme bsCA II \\n\\t<298>) <298>\\nKI\\t#162# 0.000769 {4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide}  \\n\\t(#162# pH 8.3, temperature not specified in the publication, isozyme \\n\\tbsCA II <298>) <298>\\nKI\\t#162# 0.00513 {4-(2-hydroxyethyl)benzenesulfonamide}  (#162# pH 8.3, \\n\\ttemperature not specified in the publication, isozyme bsCA II <298>) \\n\\t<298>\\nKI\\t#162# 0.000697 {4-sulfamoylbenzoic acid}  (#162# pH 8.3, temperature \\n\\tnot specified in the publication, isozyme bsCA II <298>) <298>\\nKI\\t#162# 0.005639 {2-hydrazinylbenzenesulfonamide}  (#162# pH 8.3, \\n\\ttemperature not specified in the publication, isozyme bsCA II <298>) \\n\\t<298>\\nKI\\t#17# 0.0087 {sulfamide}  (#17# at 20C, pH 8.3 in 20 mM Tris buffer and \\n\\t20 mM NaClO4- <207>) <207>\\nKI\\t#17# 0.4 {phenylarsonic acid}  (#17# at 20C, pH 8.3 in 20 mM Tris \\n\\tbuffer and 20 mM NaClO4- <207>) <207>\\nKI\\t#17# 0.33 {hydrogen sulfide}  (#17# at 20C, pH 8.3 in 20 mM Tris \\n\\tbuffer and 20 mM NaClO4- <207>) <207>\\nKI\\t#17# 0.33 {bisulfite}  (#17# at 20C, pH 8.3 in 20 mM Tris buffer and \\n\\t20 mM NaClO4- <207>) <207>\\nKI\\t#17# 0.33 {sulfamate}  (#17# at 20C, pH 8.3 in 20 mM Tris buffer and \\n\\t20 mM NaClO4- <207>) <207>\\nKI\\t#17# 0.46 {nitrate}  (#17# at 20C, pH 8.3 in 20 mM Tris buffer and 20 \\n\\tmM NaClO4- <207>) <207>\\nKI\\t#17# 0.76 {Carbonate}  (#17# at 20C, pH 8.3 in 20 mM Tris buffer and \\n\\t20 mM NaClO4- <207>) <207>\\nKI\\t#17# 0.78 {bicarbonate}  (#17# at 20C, pH 8.3 in 20 mM Tris buffer and \\n\\t20 mM NaClO4- <207>) <207>\\nKI\\t#17# 0.00011 {dorzolamide}  <210>\\nKI\\t#17# 0.00011 {topiramate}  <210>\\nKI\\t#17# 0.000082 {acetazolamide}  (#17# at 20C, pH 8.3 in 20 mM Tris \\n\\tbuffer and 20 mM NaClO4- <207>) <207>\\nKI\\t#17# 0.58 {sulfate}  (#17# at 20C, pH 8.3 in 20 mM Tris buffer and 20 \\n\\tmM NaClO4- <207>) <207>\\nKI\\t#17# 12.5 {saccharin}  <210>\\nKI\\t#17# 0.0103 {Iodide}  (#17# at 20C, pH 8.3 in 20 mM Tris buffer and 20 \\n\\tmM NaClO4- <207>) <207>\\nKI\\t#17# 0.0108 {bromide}  (#17# at 20C, pH 8.3 in 20 mM Tris buffer and \\n\\t20 mM NaClO4- <207>) <207>\\nKI\\t#17# 0.000108 {celecoxib}  <210>\\nKI\\t#17# 0.000124 {sulpiride}  <210>\\nKI\\t#17# 0.00102 {sulthiame}  <210>\\nKI\\t#17# 0.000106 {zonisamide}  <210>\\nKI\\t#17# 0.000114 {brinzolamide}  <210>\\nKI\\t#17# 0.000119 {methazolamide}  <210>\\nKI\\t#17# 0.000103 {4,5-dichloro-benzene-1,3-disulfonamide}  <210>\\nKI\\t#17# 2.85 {fluoride}  (#17# at 20C, pH 8.3 in 20 mM Tris buffer and 20 \\n\\tmM NaClO4- <207>) <207>\\nKI\\t#17# 16.8 {cyanide}  (#17# at 20C, pH 8.3 in 20 mM Tris buffer and 20 \\n\\tmM NaClO4- <207>) <207>\\nKI\\t#17# 0.000133 {indisulam}  <210>\\nKI\\t#17# 0.0000984 {ethoxzolamide}  <210>\\nKI\\t#17# 0.000111 {benzolamide}  <210>\\nKI\\t#17# 0.0000151 {4-(2-amino-pyrimidin-4-yl)-benzenesulfonamide}  (#17# \\n\\tpH not specified in the publication, temperature not specified in the \\n\\tpublication <305>) <210,305>\\nKI\\t#17# 27.9 {azide}  (#17# at 20C, pH 8.3 in 20 mM Tris buffer and 20 mM \\n\\tNaClO4- <207>) <207>\\nKI\\t#17# 31.7 {Cyanate}  (#17# at 20C, pH 8.3 in 20 mM Tris buffer and 20 \\n\\tmM NaClO4- <207>) <207>\\nKI\\t#17# 55.6 {thiocyanate}  (#17# at 20C, pH 8.3 in 20 mM Tris buffer and \\n\\t20 mM NaClO4- <207>) <207>\\nKI\\t#17# 38.2 {phenylboronic acid}  (#17# at 20C, pH 8.3 in 20 mM Tris \\n\\tbuffer and 20 mM NaClO4- <207>) <207>\\nKI\\t#17# 0.000654 {valdecoxib}  <210>\\nKI\\t#17# 0.0000826 {acetazolamide}  <210>\\nKI\\t#17,40# 0.85 {chloride}  (#40# at 20C, pH 8.3 in 20 mM Tris buffer and \\n\\t20 mM NaClO4 <204>; #17# at 20C, pH 8.3 in 20 mM Tris buffer and 20 mM \\n\\tNaClO4- <207>) <204,207>\\nKI\\t#172# 0.00006 {5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#172# at 20C and pH 7.5 <230>) <230>\\nKI\\t#172# 0.000095 {dichlorophenamide}  (#172# at 20C and pH 7.5 <230>) \\n\\t<230>\\nKI\\t#172# 0.000064 {6-hydroxy-1,3-benzothiazole-2-sulfonamide}  (#172# at \\n\\t20C and pH 7.5 <230>) <230>\\nKI\\t#172# 0.00007 {benzolamide}  (#172# at 20C and pH 7.5 <230>) <230>\\nKI\\t#172# 0.000058 {ethoxzolamide}  (#172# at 20C and pH 7.5 <230>) <230>\\nKI\\t#172# 0.000067 {4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide}  \\n\\t(#172# at 20C and pH 7.5 <230>) <230>\\nKI\\t#172# 0.000061 {dorzolamide}  (#172# at 20C and pH 7.5 <230>) <230>\\nKI\\t#172# 0.000061 {brinzolamide}  (#172# at 20C and pH 7.5 <230>) <230>\\nKI\\t#172# 0.000065 {sulthiame}  (#172# at 20C and pH 7.5 <230>) <230>\\nKI\\t#172# 0.000045 {celecoxib}  (#172# at 20C and pH 7.5 <230>) <230>\\nKI\\t#172# 0.000048 {5-amino-1,3,4-thiadiazole-2-sulfonamide}  (#172# at \\n\\t20C and pH 7.5 <230>) <230>\\nKI\\t#172# 0.000048 \\n\\t{5-[[(4-aminophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#172# at 20C and pH 7.5 <230>) <230>\\nKI\\t#172# 0.000073 {sulpiride}  (#172# at 20C and pH 7.5 <230>) <230>\\nKI\\t#172# 0.00097 {4-(aminomethyl)benzenesulfonamide}  (#172# at 20C and \\n\\tpH 7.5 <230>) <230>\\nKI\\t#172# 0.000072 {indisulam}  (#172# at 20C and pH 7.5 <230>) <230>\\nKI\\t#172# 0.000072 {4-amino-3-iodobenzenesulfonamide}  (#172# at 20C and \\n\\tpH 7.5 <230>) <230>\\nKI\\t#172# 0.000078 {topiramate}  (#172# at 20C and pH 7.5 <230>) <230>\\nKI\\t#172# 0.000066 {valdecoxib}  (#172# at 20C and pH 7.5 <230>) <230>\\nKI\\t#172# 0.000062 {4-amino-3-chlorobenzenesulfonamide}  (#172# at 20C and \\n\\tpH 7.5 <230>) <230>\\nKI\\t#172# 0.00456 {4-(hydroxymethyl)benzenesulfonamide}  (#172# at 20C and \\n\\tpH 7.5 <230>) <230>\\nKI\\t#172# 0.000049 \\n\\t{5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide}  (#172# \\n\\tat 20C and pH 7.5 <230>) <230>\\nKI\\t#172# 0.000049 {4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide}  \\n\\t(#172# at 20C and pH 7.5 <230>) <230>\\nKI\\t#172# 0.000079 {4-amino-3-fluorobenzenesulfonamide}  (#172# at 20C and \\n\\tpH 7.5 <230>) <230>\\nKI\\t#172# 0.00466 {4-(2-hydroxyethyl)benzenesulfonamide}  (#172# at 20C \\n\\tand pH 7.5 <230>) <230>\\nKI\\t#172# 0.000083 {4-amino-3-bromobenzenesulfonamide}  (#172# at 20C and \\n\\tpH 7.5 <230>) <230>\\nKI\\t#172# 0.00799 {4-methylbenzenesulfonamide}  (#172# at 20C and pH 7.5 \\n\\t<230>) <230>\\nKI\\t#172# 0.00465 {4-sulfamoylbenzoic acid}  (#172# at 20C and pH 7.5 \\n\\t<230>) <230>\\nKI\\t#172# 0.000634 {zonisamide}  (#172# at 20C and pH 7.5 <230>) <230>\\nKI\\t#172# 0.008805 {2-aminobenzenesulfonamide}  (#172# at 20C and pH 7.5 \\n\\t<230>) <230>\\nKI\\t#172# 0.00961 {4-Aminobenzenesulfonamide}  (#172# at 20C and pH 7.5 \\n\\t<230>) <230>\\nKI\\t#172# 0.00954 {4-hydrazinobenzenesulfonamide}  (#172# at 20C and pH \\n\\t7.5 <230>) <230>\\nKI\\t#172# 0.000783 {4-(2-aminoethyl)benzenesulfonamide}  (#172# at 20C and \\n\\tpH 7.5 <230>) <230>\\nKI\\t#172# 0.000926 {4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide}  \\n\\t(#172# at 20C and pH 7.5 <230>) <230>\\nKI\\t#172# 0.000757 {4-amino-6-chlorobenzene-1,3-disulfonamide}  (#172# at \\n\\t20C and pH 7.5 <230>) <230>\\nKI\\t#172# 0.006895 {2-hydrazinobenzenesulfonamide}  (#172# at 20C and pH \\n\\t7.5 <230>) <230>\\nKI\\t#172,182# 0.000063 \\n\\t{4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide}  (#172# at \\n\\t20C and pH 7.5 <230>; #182# pH 8.3, 20C <342>) <230,342>\\nKI\\t#178# 0.009 {phenylboronic acid}  (#178# 20C, pH 8.3 <337>) <337>\\nKI\\t#178# 0.069 {sulfamate}  (#178# 20C, pH 8.3 <337>) <337>\\nKI\\t#178# 0.084 {sulfamide}  (#178# 20C, pH 8.3 <337>) <337>\\nKI\\t#178# 9.2 {chloride}  (#178# 20C, pH 8.3 <337>) <337>\\nKI\\t#178# 0.035 {phenylarsonic acid}  (#178# 20C, pH 8.3 <337>) <337>\\nKI\\t#178# 9.3 {bromide}  (#178# 20C, pH 8.3 <337>) <337>\\nKI\\t#178# 0.000445 {acetazolamide}  (#178# 20C, pH 8.3 <337>) <337>\\nKI\\t#179# 0.072 {sulfamate}  (#179# 20C, pH 8.3 <337>) <337>\\nKI\\t#179# 100 {bromide}  (#179# value above, 20C, pH 8.3 <337>) <337>\\nKI\\t#179# 100 {chloride}  (#179# value above, 20C, pH 8.3 <337>) <337>\\nKI\\t#179# 0.056 {phenylboronic acid}  (#179# 20C, pH 8.3 <337>) <337>\\nKI\\t#179# 0.048 {sulfamide}  (#179# 20C, pH 8.3 <337>) <337>\\nKI\\t#179# 4.8 {sulfamide}  (#179# 20C, pH 8.3 <337>) <337>\\nKI\\t#179# 0.054 {phenylarsonic acid}  (#179# 20C, pH 8.3 <337>) <337>\\nKI\\t#179# 0.000816 {acetazolamide}  (#179# 20C, pH 8.3 <337>) <337>\\nKI\\t#18# 0.07 {N-(aminosulfonyl)-1,1,1-trifluoromethanesulfonamide}  (#18# \\n\\tpH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.07 {N-(aminosulfonyl)-1,1,1-trichloromethanesulfonamide}  (#18# \\n\\tpH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.07 {N,N-dimethylimidodisulfuric diamide}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.07 {N-(aminosulfonyl)benzenesulfonamide}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.07 {isopropylsulfonylsulfamic acid}  (#18# pH 7.4, 25C, isozyme \\n\\tbCA IV <122>) <122>\\nKI\\t#18# 0.02 {(4-methoxyphenyl)sulfonylsulfamic acid}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.02 {N-(aminosulfonyl)-4-methoxybenzenesulfonamide}  (#18# pH \\n\\t7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.09 {N-(aminosulfonyl)methanesulfonamide}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.007 {thien-2-ylsulfonylsulfamic acid}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.03 {(heptadecafluorooctyl)sulfonylsulfamic acid}  (#18# pH 7.4, \\n\\t25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.03 \\n\\t{N-(aminosulfonyl)-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,\\n\\t8-heptadecafluorooctane-1-sulfonamide}  (#18# pH 7.4, 25C, isozyme bCA \\n\\tIV <122>) <122>\\nKI\\t#18# 0.03 {(4-chlorophenyl)sulfonylsulfamic acid}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.03 {(4-bromophenyl)sulfonylsulfamic acid}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.03 {(4-iodophenyl)sulfonylsulfamic acid}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.03 {N-(aminosulfonyl)-4-iodobenzenesulfonamide}  (#18# pH 7.4, \\n\\t25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.03 {(4-methylphenyl)sulfonylsulfamic acid}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.05 {(trifluoromethyl)sulfonylsulfamic acid}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.05 {(trichloromethyl)sulfonylsulfamic acid}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.05 {benzylsulfonylsulfamic acid}  (#18# pH 7.4, 25C, isozyme \\n\\tbCA IV <122>) <122>\\nKI\\t#18# 0.05 {N-(aminosulfonyl)-1-phenylmethanesulfonamide}  (#18# pH 7.4, \\n\\t25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.1 {methylsulfonylsulfamic acid}  (#18# pH 7.4, 25C, isozyme bCA \\n\\tIV <122>) <122>\\nKI\\t#18# 0.1 {N-(aminosulfonyl)propane-2-sulfonamide}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.0008 {(pentafluorophenyl)sulfonylsulfamic acid}  (#18# pH 7.4, \\n\\t25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.06 {phenylsulfonylsulfamic acid}  (#18# pH 7.4, 25C, isozyme \\n\\tbCA IV <122>) <122>\\nKI\\t#18# 0.0005 {4-[(sulfoamino)sulfonyl]benzoic acid}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.001 {3-[[(aminosulfonyl)amino]sulfonyl]benzoic acid}  (#18# pH \\n\\t7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.006 {N-(aminosulfonyl)-4-nitrobenzenesulfonamide}  (#18# pH 7.4, \\n\\t25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.006 {N-(aminosulfonyl)-2-nitrobenzenesulfonamide}  (#18# pH 7.4, \\n\\t25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.006 \\n\\t{[(7,7-dimethylbicyclo[2.2.1]hept-1-yl)methyl]sulfonylsulfamic acid}  \\n\\t(#18# pH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.003 {4-Aminobenzenesulfonamide}  (#18# pH 7.4, 25C, isozyme bCA \\n\\tIV <126>) <126>\\nKI\\t#18# 0.003 {(4-nitrophenyl)sulfonylsulfamic acid}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.003 {N-(aminosulfonyl)-3-chloro-4-nitrobenzenesulfonamide}  \\n\\t(#18# pH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.003 {(2,4,6-triisopropylphenyl)sulfonylsulfamic acid}  (#18# pH \\n\\t7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.01 {[3-[(tert-butoxycarbonyl)amino]phenyl]sulfonylsulfamic acid} \\n\\t (#18# pH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.01 {(4-acetylphenyl)sulfonylsulfamic acid}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.01 {4-acetyl-N-(aminosulfonyl)benzenesulfonamide}  (#18# pH 7.4, \\n\\t25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.01 {N-(aminosulfonyl)naphthalene-1-sulfonamide}  (#18# pH 7.4, \\n\\t25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.01 {N-(aminosulfonyl)naphthalene-2-sulfonamide}  (#18# pH 7.4, \\n\\t25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.01 {N-(aminosulfonyl)thiophene-2-sulfonamide}  (#18# pH 7.4, \\n\\t25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.01 {N-(aminosulfonyl)quinoline-8-sulfonamide}  (#18# pH 7.4, \\n\\t25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.01 {N-[(1E)-thien-2-ylmethylene]sulfamide}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.01 {N-[(1E)-(5-methylthien-2-yl)methylene]sulfamide}  (#18# pH \\n\\t7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.01 {N-[(1E)-phenylmethylene]sulfamide}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.01 {N-[(1E)-(4-methylphenyl)methylene]sulfamide}  (#18# pH 7.4, \\n\\t25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.01 {N-[(1E)-(3,4,5-trimethoxyphenyl)methylene]sulfamide}  (#18# \\n\\tpH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.01 {N-(4-[(E)-[(aminosulfonyl)imino]methyl]phenyl)acetamide}  \\n\\t(#18# pH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.0014 {[[(4-methylphenyl)sulfonyl]amino]carbonylsulfamic amide}  \\n\\t(#18# pH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.0026 {N-(aminosulfonyl)-3-(trifluoromethyl)benzenesulfonamide}  \\n\\t(#18# pH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.009 {1-naphthylsulfonylsulfamic acid}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.009 {2-naphthylsulfonylsulfamic acid}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.009 \\n\\t{N-(aminosulfonyl)-1-(7,\\n\\t7-dimethylbicyclo[2.2.1]hept-1-yl)methanesulfonamide}  (#18# pH 7.4, \\n\\t25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.0006 {[[(4-methylphenyl)sulfonyl]amino]carbonylsulfamic acid}  \\n\\t(#18# pH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.004 {(3-nitrophenyl)sulfonylsulfamic acid}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.004 {(2-nitrophenyl)sulfonylsulfamic acid}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.0021 {(3,5-dichloro-2-hydroxyphenyl)sulfonylsulfamic acid}  \\n\\t(#18# pH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.0021 \\n\\t{N-(aminosulfonyl)-3,5-dichloro-2-hydroxybenzenesulfonamide}  (#18# pH \\n\\t7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.00008 {N-salicylidene-sulfanilic acid amide copper nitrate \\n\\tcomplex}  (#18# pH 7.4, 25C, isozyme bCA IV <126>) <126>\\nKI\\t#18# 0.0003 {[[(4-fluorophenyl)sulfonyl]amino]carbonylsulfamic acid}  \\n\\t(#18# pH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.0003 {[[(2-methylphenyl)sulfonyl]amino]carbonylsulfamic acid}  \\n\\t(#18# pH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.0011 {[[(4-chlorophenyl)sulfonyl]amino]carbonylsulfamic amide}  \\n\\t(#18# pH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.002 {(3-chloro-4-nitrophenyl)sulfonylsulfamic acid}  (#18# pH \\n\\t7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.002 {N-(4-[[(aminosulfonyl)amino]sulfonyl]phenyl)acetamide}  \\n\\t(#18# pH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.002 {tert-butyl \\n\\t4-[[(aminosulfonyl)amino]sulfonyl]phenylcarbamate}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.04 {(nonafluorobutyl)sulfonylsulfamic acid}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.04 \\n\\t{N-(aminosulfonyl)-1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonamide}  \\n\\t(#18# pH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.04 {(4-fluorophenyl)sulfonylsulfamic acid}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.04 {N-(aminosulfonyl)-4-chlorobenzenesulfonamide}  (#18# pH 7.4, \\n\\t25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.04 {N-(aminosulfonyl)-4-bromobenzenesulfonamide}  (#18# pH 7.4, \\n\\t25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.04 {N-(aminosulfonyl)-4-methylbenzenesulfonamide}  (#18# pH 7.4, \\n\\t25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.0004 {[[(4-chlorophenyl)sulfonyl]amino]carbonylsulfamic acid}  \\n\\t(#18# pH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.00013 {sulfanilamide}  (#18# pH 7.4, 20C, cytosolic isoenzyme \\n\\t<149>) <149>\\nKI\\t#18# 0.00024 {methazolamide}  (#18# pH 7.4, 25C, bCA IV <120>) <120>\\nKI\\t#18# 0.0015 {[4-(acetylamino)phenyl]sulfonylsulfamic acid}  (#18# pH \\n\\t7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.0015 {[3-(trifluoromethyl)phenyl]sulfonylsulfamic acid}  (#18# \\n\\tpH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.00022 {acetazolamide}  (#18# pH 7.4, 25C, bCA IV <120>) <120>\\nKI\\t#18# 0.0024 {tert-butyl \\n\\t5-[[(aminosulfonyl)amino]sulfonyl]-2-hydroperoxyphenylcarbamate}  (#18# \\n\\tpH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.008 {[5-(dimethylamino)-1-naphthyl]sulfonylsulfamic acid}  (#18# \\n\\tpH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.008 {quinolin-8-ylsulfonylsulfamic acid}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.0012 {[4-[(tert-butoxycarbonyl)amino]phenyl]sulfonylsulfamic \\n\\tacid}  (#18# pH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.0012 \\n\\t{[3-[(tert-butoxycarbonyl)amino]-4-hydroperoxyphenyl]sulfonylsulfamic \\n\\tacid}  (#18# pH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.0012 {[[(4-fluorophenyl)sulfonyl]amino]carbonylsulfamic amide}  \\n\\t(#18# pH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.0035 {N-(aminosulfonyl)-2,4,6-triisopropylbenzenesulfonamide}  \\n\\t(#18# pH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.005 {N-(aminosulfonyl)-3-nitrobenzenesulfonamide}  (#18# pH 7.4, \\n\\t25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.005 {(2,4,6-tripropylphenyl)sulfonylsulfamic acid}  (#18# pH \\n\\t7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.0016 {tert-butyl \\n\\t3-[[(aminosulfonyl)amino]sulfonyl]phenylcarbamate}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.0007 {3-[(sulfoamino)sulfonyl]benzoic acid}  (#18# pH 7.4, 25C, \\n\\tisozyme bCA IV <122>) <122>\\nKI\\t#18# 0.0032 {N-(aminosulfonyl)-2,5-dichlorobenzenesulfonamide}  (#18# \\n\\tpH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.00023 {sulfanilamide}  (#18# pH 7.4, 20C, inner peripheral \\n\\tisoenzyme <149>) <149>\\nKI\\t#18# 0.000013 {ethoxzolamide}  (#18# pH 7.4, 25C, bCA IV <120>) <120>\\nKI\\t#18# 0.0018 {N-(aminosulfonyl)-2,3,4,5,6-pentafluorobenzenesulfonamide} \\n\\t (#18# pH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.00015 {NaN3}  (#18# pH 7.4, 20C, integral isoenzyme <149>) <149>\\nKI\\t#18# 0.00033 {NaN3}  (#18# pH 7.4, 20C, cytosolic isoenzyme <149>) \\n\\t<149>\\nKI\\t#18# 0.0009 {(2,5-dichlorophenyl)sulfonylsulfamic acid}  (#18# pH 7.4, \\n\\t25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.0009 {4-[[(aminosulfonyl)amino]sulfonyl]benzoic acid}  (#18# pH \\n\\t7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.0009 {[[(2-methylphenyl)sulfonyl]amino]carbonylsulfamic amide}  \\n\\t(#18# pH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.00042 {N-salicylidene-sulfanilic acid amide}  (#18# pH 7.4, \\n\\t25C, isozyme bCA IV <126>) <126>\\nKI\\t#18# 0.0039 {N-(aminosulfonyl)-2,4,6-tripropylbenzenesulfonamide}  \\n\\t(#18# pH 7.4, 25C, isozyme bCA IV <122>) <122>\\nKI\\t#18# 0.000012 {benzolamide}  (#18# pH 7.4, 25C, bCA IV <120>) <120>\\nKI\\t#18# 0.000165 {KSCN}  (#18# pH 7.4, 20C, integral isoenzyme <149>) \\n\\t<149>\\nKI\\t#18# 0.000105 {N-salicylidene-sulfanilic acid amide nickel chloride \\n\\tcomplex}  (#18# pH 7.4, 25C, isozyme bCA IV <126>) <126>\\nKI\\t#18# 0.000073 {N-salicylidene-sulfanilic acid amide cobalt nitrate \\n\\tcomplex}  (#18# pH 7.4, 25C, isozyme bCA IV <126>) <126>\\nKI\\t#18# 0.000073 {N-salicylidene-sulfanilic acid amide cobalt acetate \\n\\tcomplex}  (#18# pH 7.4, 25C, isozyme bCA IV <126>) <126>\\nKI\\t#18# 0.000043 {dorzolamide}  (#18# pH 7.4, 25C, bCA IV <120>) <120>\\nKI\\t#18# 0.000108 {N-salicylidene-sulfanilic acid amide nickel acetate \\n\\tcomplex}  (#18# pH 7.4, 25C, isozyme bCA IV <126>) <126>\\nKI\\t#18# 0.000072 {N-salicylidene-sulfanilic acid amide cobalt sulfate \\n\\tcomplex}  (#18# pH 7.4, 25C, isozyme bCA IV <126>) <126>\\nKI\\t#18# 0.000094 {KSCN}  (#18# pH 7.4, 20C, inner peripheral isoenzyme \\n\\t<149>) <149>\\nKI\\t#18# 0.000078 {N-salicylidene-sulfanilic acid amide cobalt chloride \\n\\tcomplex}  (#18# pH 7.4, 25C, isozyme bCA IV <126>) <126>\\nKI\\t#18# 0.00139 {Furosemide}  (#18# pH 9, 25C <324>) <324>\\nKI\\t#18# 0.000134 {KSCN}  (#18# pH 7.4, 20C, cytosolic isoenzyme <149>) \\n\\t<149>\\nKI\\t#18# 0.000106 {N-salicylidene-sulfanilic acid amide nickel sulfate \\n\\tcomplex}  (#18# pH 7.4, 25C, isozyme bCA IV <126>) <126>\\nKI\\t#18# 0.000119 {sulfanilamide}  (#18# pH 7.4, 20C, outer peripheral \\n\\tisoenzyme <149>) <149>\\nKI\\t#18# 0.000102 {N-salicylidene-sulfanilic acid amide nickel nitrate \\n\\tcomplex}  (#18# pH 7.4, 25C, isozyme bCA IV <126>) <126>\\nKI\\t#18# 0.000083 {N-salicylidene-sulfanilic acid amide copper chloride \\n\\tcomplex}  (#18# pH 7.4, 25C, isozyme bCA IV <126>) <126>\\nKI\\t#18# 0.000152 {KSCN}  (#18# pH 7.4, 20C, outer peripheral isoenzyme \\n\\t<149>) <149>\\nKI\\t#18# 0.000668 {NaN3}  (#18# pH 7.4, 20C, outer peripheral isoenzyme \\n\\t<149>) <149>\\nKI\\t#18# 0.000596 {NaN3}  (#18# pH 7.4, 20C, inner peripheral isoenzyme \\n\\t<149>) <149>\\nKI\\t#18# 0.000285 {sulfanilamide}  (#18# pH 7.4, 20C, integral isoenzyme \\n\\t<149>) <149>\\nKI\\t#18# 0.0000343 {NaN3}  (#18# at pH 7.0 and 20C <248>) <248>\\nKI\\t#18# 0.0000212 {acetazolamide}  (#18# at pH 7.0 and 20C <248>) <248>\\nKI\\t#18# 0.0000521 {sulfanilamide}  (#18# at pH 7.0 and 20C <248>) <248>\\nKI\\t#18# 0.00000718 {KSCN}  (#18# at pH 7.0 and 20C <248>) <248>\\nKI\\t#180# 0.00037 {5-amino-1,3,4-thiadiazole-2-sulfonamide}  (#180# pH 7.5, \\n\\t20C <331>) <331>\\nKI\\t#180# 0.004-26 {4-(hydroxymethyl)benzenesulfonamide}  (#180# pH 7.5, \\n\\t20C <331>) <331>\\nKI\\t#180# 0.00028 \\n\\t{(4S,6S)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,\\n\\t3-b]thiopyran-2-sulfonamide 7,7-dioxide}  (#180# pH 7.5, 20C <331>) \\n\\t<331>\\nKI\\t#180# 0.000032 \\n\\t{5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide}  (#180# pH \\n\\t7.5, 20C <331>) <331>\\nKI\\t#180# 0.000051 {N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide}  (#180# \\n\\tpH 7.5, 20C <331>) <331>\\nKI\\t#180# 0.0077 {4-Aminobenzenesulfonamide}  (#180# pH 7.5, 20C <331>) \\n\\t<331>\\nKI\\t#180# 0.000016 \\n\\t{4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide}  (#180# pH \\n\\t7.5, 20C <331>) <331>\\nKI\\t#180# 0.000048 {4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide}  \\n\\t(#180# pH 7.5, 20C <331>) <331>\\nKI\\t#180# 0.00089 {4-amino-3-fluorobenzenesulfonamide}  (#180# pH 7.5, 20C \\n\\t<331>) <331>\\nKI\\t#180# 0.000054 {4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide}  \\n\\t(#180# pH 7.5, 20C <331>) <331>\\nKI\\t#180# 0.000165 {1-(1,2-benzoxazol-3-yl)methanesulfonamide}  (#180# pH \\n\\t7.5, 20C <331>) <331>\\nKI\\t#180# 0.00138 {4-(2-hydroxyethyl)benzenesulfonamide}  (#180# pH 7.5, \\n\\t20C <331>) <331>\\nKI\\t#180# 0.000034 {4-sulfamoyl-N-[2-(4-sulfamoylphenyl)ethyl]benzamide}  \\n\\t(#180# pH 7.5, 20C <331>) <331>\\nKI\\t#180# 0.000062 {4,5-dichlorobenzene-1,3-disulfonamide}  (#180# pH 7.5, \\n\\t20C <331>) <331>\\nKI\\t#180# 0.000276 {4-(1,1-dioxido-1,2-thiazinan-2-yl)benzenesulfonamide}  \\n\\t(#180# pH 7.5, 20C <331>) <331>\\nKI\\t#180# 0.000038 \\n\\t{[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,\\n\\t5-b:4\\',5\\'-d]pyran-3a-yl]methyl sulfamate}  (#180# pH 7.5, 20C <331>) \\n\\t<331>\\nKI\\t#180# 0.000278 \\n\\t{(4R)-4-(ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,\\n\\t2]thiazine-6-sulfonamide 1,1-dioxide}  (#180# pH 7.5, 20C <331>) <331>\\nKI\\t#180# 0.000751 {1,2-benzothiazol-3(2H)-one 1,1-dioxide}  (#180# pH 7.5, \\n\\t20C <331>) <331>\\nKI\\t#180# 0.000378 \\n\\t{2-methoxy-N-[(1-methylpyrrolidin-2-yl)methyl]-5-sulfamoylbenzamide}  \\n\\t(#180# pH 7.5, 20C <331>) <331>\\nKI\\t#180# 0.000973 {4-(aminomethyl)benzenesulfonamide}  (#180# pH 7.5, 20C \\n\\t<331>) <331>\\nKI\\t#180# 0.000423 {N-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide}  \\n\\t(#180# pH 7.5, 20C <331>) <331>\\nKI\\t#180# 0.000552 {4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide}  \\n\\t(#180# pH 7.5, 20C <331>) <331>\\nKI\\t#180# 0.000393 \\n\\t{5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide}  (#180# \\n\\tpH 7.5, 20C <331>) <331>\\nKI\\t#180# 0.000965 {4-amino-3,5-dibromobenzenesulfonamide}  (#180# pH 7.5, \\n\\t20C <331>) <331>\\nKI\\t#180# 0.000387 {6-ethoxy-1,3-benzothiazole-2-sulfonamide}  (#180# pH \\n\\t7.5, 20C <331>) <331>\\nKI\\t#180# 0.000326 \\n\\t{N-[(2E)-3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide} \\n\\t (#180# pH 7.5, 20C <331>) <331>\\nKI\\t#180# 0.000675 {benzenesulfonamide}  (#180# pH 7.5, 20C <331>) <331>\\nKI\\t#180# 0.00775 {2-aminobenzenesulfonamide}  (#180# pH 7.5, 20C <331>) \\n\\t<331>\\nKI\\t#180# 0.006081 {4-hydrazinylbenzenesulfonamide}  (#180# pH 7.5, 20C \\n\\t<331>) <331>\\nKI\\t#180# 0.000715 {4-(2-aminoethyl)benzenesulfonamide}  (#180# pH 7.5, \\n\\t20C <331>) <331>\\nKI\\t#180# 0.000884 {4-amino-3-chlorobenzenesulfonamide}  (#180# pH 7.5, \\n\\t20C <331>) <331>\\nKI\\t#180# 0.000879 {4-amino-3,5-diiodobenzenesulfonamide}  (#180# pH 7.5, \\n\\t20C <331>) <331>\\nKI\\t#180# 0.04188 \\n\\t{5-([(4-aminophenyl)sulfonyl]amino)-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#180# pH 7.5, 20C <331>) <331>\\nKI\\t#180# 0.04185 \\n\\t{5-([(4-amino-3-chloro-5-fluorophenyl)sulfonyl]amino)-1,3,\\n\\t4-thiadiazole-2-sulfonamide}  (#180# pH 7.5, 20C <331>) <331>\\nKI\\t#180# 0.000866 {6-hydroxy-1,3-benzothiazole-2-sulfonamide}  (#180# pH \\n\\t7.5, 20C <331>) <331>\\nKI\\t#180# 0.000792 {5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#180# pH 7.5, 20C <331>) <331>\\nKI\\t#180# 0.001215 {4-sulfamoylbenzoic acid}  (#180# pH 7.5, 20C <331>) \\n\\t<331>\\nKI\\t#180# 0.00885 {2-hydrazinylbenzenesulfonamide}  (#180# pH 7.5, 20C \\n\\t<331>) <331>\\nKI\\t#180# 0.000732 \\n\\t{4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-\\n\\tyl]benzenesulfonamide}  (#180# pH 7.5, 20C <331>) <331>\\nKI\\t#180# 0.000517 \\n\\t{4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide}  (#180# pH \\n\\t7.5, 20C <331>) <331>\\nKI\\t#180# 0.000394 \\n\\t{6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide \\n\\t1,1-dioxide}  (#180# pH 7.5, 20C <331>) <331>\\nKI\\t#182# 0.085 \\n\\t{5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide}  (#182# \\n\\tpH 8.3, 20C <342>) <342>\\nKI\\t#182# 0.0031 {N-phenylsulfuric diamide}  (#182# pH 8.3, 20C <342>) \\n\\t<342>\\nKI\\t#182# 0.00009 {4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide}  \\n\\t(#182# pH 8.3, 20C <342>) <342>\\nKI\\t#182# 0.076 {N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide}  (#182# pH \\n\\t8.3, 20C <342>) <342>\\nKI\\t#182# 0.084 \\n\\t{(4R)-4-(ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,\\n\\t2]thiazine-6-sulfonamide 1,1-dioxide}  (#182# pH 8.3, 20C <342>) <342>\\nKI\\t#182# 0.038 {6-ethoxy-1,3-benzothiazole-2-sulfonamide}  (#182# pH 8.3, \\n\\t20C <342>) <342>\\nKI\\t#182# 0.035 {5-(3-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#182# pH 8.3, 20C <342>) <342>\\nKI\\t#182# 0.079 {5-amino-1,3,4-thiadiazole-2-sulfonamide}  (#182# pH 8.3, \\n\\t20C <342>) <342>\\nKI\\t#182# 0.079 \\n\\t{(4S,6S)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,\\n\\t3-b]thiopyran-2-sulfonamide 7,7-dioxide}  (#182# pH 8.3, 20C <342>) \\n\\t<342>\\nKI\\t#182# 0.000068 {4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide}  \\n\\t(#182# pH 8.3, 20C <342>) <342>\\nKI\\t#182# 0.0098 {2-aminobenzenesulfonamide}  (#182# pH 8.3, 20C <342>) \\n\\t<342>\\nKI\\t#182# 0.00065 {4-bromobenzenesulfonamide}  (#182# pH 8.3, 20C <342>) \\n\\t<342>\\nKI\\t#182# 0.00032 \\n\\t{2-methoxy-N-[(1-methylpyrrolidin-2-yl)methyl]-5-sulfamoylbenzamide}  \\n\\t(#182# pH 8.3, 20C <342>) <342>\\nKI\\t#182# 0.00146 \\n\\t{[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,\\n\\t5-b:4\\',5\\'-d]pyran-3a-yl]methyl sulfamate}  (#182# pH 8.3, 20C <342>) \\n\\t<342>\\nKI\\t#182# 0.000094 {4-sulfamoylbenzoic acid}  (#182# pH 8.3, 20C <342>) \\n\\t<342>\\nKI\\t#182# 0.000121 {4-amino-3-chlorobenzenesulfonamide}  (#182# pH 8.3, \\n\\t20C <342>) <342>\\nKI\\t#182# 0.000092 {4-amino-6-chlorobenzene-1,3-disulfonamide}  (#182# pH \\n\\t8.3, 20C <342>) <342>\\nKI\\t#182# 0.000079 {4-(2-aminoethyl)benzenesulfonamide}  (#182# pH 8.3, \\n\\t20C <342>) <342>\\nKI\\t#182# 0.00256 {phenyl sulfamate}  (#182# pH 8.3, 20C <342>) <342>\\nKI\\t#182# 0.000113 {N-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide}  \\n\\t(#182# pH 8.3, 20C <342>) <342>\\nKI\\t#182# 0.000104 {4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide}  \\n\\t(#182# pH 8.3, 20C <342>) <342>\\nKI\\t#182# 0.000174 {4-(aminomethyl)benzenesulfonamide}  (#182# pH 8.3, 20C \\n\\t<342>) <342>\\nKI\\t#182# 0.000116 {4-amino-3-fluorobenzenesulfonamide}  (#182# pH 8.3, \\n\\t20C <342>) <342>\\nKI\\t#182# 0.000152 {3-(4-sulfamoylphenyl)propanoic acid}  (#182# pH 8.3, \\n\\t20C <342>) <342>\\nKI\\t#182# 0.000245 {4-Aminobenzenesulfonamide}  (#182# pH 8.3, 20C <342>) \\n\\t<342>\\nKI\\t#182# 0.000346 {4,5-dichlorobenzene-1,3-disulfonamide}  (#182# pH 8.3, \\n\\t20C <342>) <342>\\nKI\\t#182# 0.000236 {4-amino-N-(4-sulfamoylphenyl)benzenesulfonamide}  \\n\\t(#182# pH 8.3, 20C <342>) <342>\\nKI\\t#182# 0.0315 {4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide}  \\n\\t(#182# pH 8.3, 20C <342>) <342>\\nKI\\t#182# 0.000413 {N-(4-bromophenyl)sulfuric diamide}  (#182# pH 8.3, 20C \\n\\t<342>) <342>\\nKI\\t#182# 0.000374 {4-bromophenyl sulfamate}  (#182# pH 8.3, 20C <342>) \\n\\t<342>\\nKI\\t#182# 0.000234 {4-(hydroxymethyl)benzenesulfonamide}  (#182# pH 8.3, \\n\\t20C <342>) <342>\\nKI\\t#182# 0.000118 {4-(2-hydroxyethyl)benzenesulfonamide}  (#182# pH 8.3, \\n\\t20C <342>) <342>\\nKI\\t#182# 0.00453 {benzenesulfonamide}  (#182# pH 8.3, 20C <342>) <342>\\nKI\\t#182# 0.000482 \\n\\t{5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide}  (#182# pH \\n\\t8.3, 20C <342>) <342>\\nKI\\t#182# 0.0348 \\n\\t{4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-\\n\\tyl]benzenesulfonamide}  (#182# pH 8.3, 20C <342>) <342>\\nKI\\t#182# 0.00674 {benzenesulfonamide}  (#182# pH 8.3, 20C <342>) <342>\\nKI\\t#182# 0.000349 {4-amino-3-bromobenzenesulfonamide}  (#182# pH 8.3, 20C \\n\\t<342>) <342>\\nKI\\t#182# 0.000543 {4-amino-3-iodobenzenesulfonamide}  (#182# pH 8.3, 20C \\n\\t<342>) <342>\\nKI\\t#182# 0.07455 \\n\\t{N-[(2E)-3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide} \\n\\t (#182# pH 8.3, 20C <342>) <342>\\nKI\\t#182# 0.00765 {1-(1,2-benzoxazol-3-yl)methanesulfonamide}  (#182# pH \\n\\t8.3, 20C <342>) <342>\\nKI\\t#194# 0.00038 {acetazolamide}  (#194# CO2 hydration, pH 8.3, 22C, \\n\\tnative enzyme <389,391>) <389,391>\\nKI\\t#194# 0.000361 {acetazolamide}  (#194# CO2 hydration, pH 8.3, 22C, \\n\\trecombinant enzyme <389>) <389>\\nKI\\t#195# 0.015 {4-amino-N-(4-sulfamoylphenyl)benzene-1-sulfonamide}  \\n\\t(#195# pH 7.5, 22C, inhibition of CO2 hydration activity of PfCA22 \\n\\t<362>) <362>\\nKI\\t#195# 0.0025 {4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide}  \\n\\t(#195# pH 7.5, 22C, inhibition of CO2 hydration activity of PfCAdom \\n\\t<362>) <362>\\nKI\\t#195# 0.000226 \\n\\t{4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzene-1-sulfonamide}  (#195# pH \\n\\t7.5, 22C, inhibition of CO2 hydration activity of PfCA35 <362>) <362>\\nKI\\t#195# 0.0054 {4-amino-6-chlorobenzene-1,3-disulfonamide}  (#195# pH \\n\\t7.5, 22C, inhibition of CO2 hydration activity of PfCAdom <362>) <362>\\nKI\\t#195# 0.00075 {6-ethoxy-1,3-benzothiazole-2-sulfonamide}  (#195# pH \\n\\t7.5, 22C, inhibition of CO2 hydration activity of PfCAdom <362>) <362>\\nKI\\t#195# 0.00017 {acetazolamide}  (#195# pH 7.5, 22C, truncated form \\n\\tPfCA1, CO2 hydration reaction <362>; #195# truncated mutant PfCA1, pH \\n\\t8.3, 22C <388>) <362,388>\\nKI\\t#195# 0.0102 {4-amino-3-fluorobenzene-1-sulfonamide}  (#195# pH 7.5, \\n\\t22C, inhibition of CO2 hydration activity of PfCAdom <362>) <362>\\nKI\\t#195# 0.000618 {5-amino-1,3,4-thiadiazole-2-sulfonamide}  (#195# pH \\n\\t7.5, 22C, inhibition of CO2 hydration activity of PfCA13 <362>) <362>\\nKI\\t#195# 0.0112 \\n\\t{5-[(benzenesulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide}  (#195# pH \\n\\t7.5, 22C, inhibition of CO2 hydration activity of PfCAdom <362>) <362>\\nKI\\t#195# 0.0058 {4-aminobenzene-1-sulfonamide}  (#195# pH 7.5, 22C, \\n\\tinhibition of CO2 hydration activity of PfCA2 <362>) <362>\\nKI\\t#195# 0.0063 {4-(hydroxymethyl)benzene-1-sulfonamide}  (#195# pH 7.5, \\n\\t22C, inhibition of CO2 hydration activity of PfCAdom <362>) <362>\\nKI\\t#195# 0.0064 {4-(2-aminoethyl)benzene-1-sulfonamide}  (#195# pH 7.5, \\n\\t22C, inhibition of CO2 hydration activity of PfCAdom <362>) <362>\\nKI\\t#195# 0.0124 \\n\\t{4-amino-N-(4-sulfamoylcyclopenta-1,3-dien-1-yl)benzene-1-sulfonamide}  \\n\\t(#195# pH 7.5, 22C, inhibition of CO2 hydration activity of PfCAdom \\n\\t<362>) <362>\\nKI\\t#195# 0.0084 \\n\\t{4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzene-1-sulfonamide}  (#195# \\n\\tpH 7.5, 22C, inhibition of CO2 hydration activity of PfCA24 <362>) \\n\\t<362>\\nKI\\t#195# 0.000131 {6-ethoxy-1,3-benzothiazole-2-sulfonamide}  (#195# pH \\n\\t7.5, 22C, inhibition of CO2 hydration activity of PfCA26 <362>) <362>\\nKI\\t#195# 0.0077 {4-sulfamoylbenzoic acid}  (#195# pH 7.5, 22C, inhibition \\n\\tof CO2 hydration activity of PfCAdom <362>) <362>\\nKI\\t#195# 0.0128 \\n\\t{2-(hydroxymethyl)-4-nitro-N-[2-(4-sulfamoylphenyl)ethyl]benzene-1-\\n\\tsulfonamide}  (#195# pH 7.5, 22C, inhibition of CO2 hydration activity \\n\\tof PfCA21 <362>) <362>\\nKI\\t#195# 0.0189 \\n\\t{4-(1,1-dioxo-1lambda6,2-thiazinan-2-yl)benzene-1-sulfonamide}  (#195# \\n\\tpH 7.5, 22C, inhibition of CO2 hydration activity of PfCAdom <362>) \\n\\t<362>\\nKI\\t#195# 0.0113 {4-amino-3-chlorobenzene-1-sulfonamide}  (#195# pH 7.5, \\n\\t22C, inhibition of CO2 hydration activity of PfCAdom <362>) <362>\\nKI\\t#195# 0.00089 {4,5-dichlorobenzene-1,3-disulfonamide}  (#195# pH 7.5, \\n\\t22C, inhibition of CO2 hydration activity of PfCAdom <362>) <362>\\nKI\\t#195# 0.0212 \\n\\t{4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzene-1-sulfonamide}  (#195# \\n\\tpH 7.5, 22C, inhibition of CO2 hydration activity of PfCAdom <362>) \\n\\t<362>\\nKI\\t#195# 0.00026 \\n\\t{(4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-1,2,3,\\n\\t4-tetrahydro-1lambda~6~-thieno[3,2-e][1,2]thiazine-6-sulfonamide}  \\n\\t(#195# pH 7.5, 22C, inhibition of CO2 hydration activity of PfCA29 \\n\\t<362>) <362>\\nKI\\t#195# 0.000132 \\n\\t{4-(1,1-dioxo-1lambda6,2-thiazinan-2-yl)benzene-1-sulfonamide}  (#195# \\n\\tpH 7.5, 22C, inhibition of CO2 hydration activity of PfCA37 <362>) \\n\\t<362>\\nKI\\t#195# 0.00312 {4-methylbenzene-1-sulfonamide}  (#195# pH 7.5, 22C, \\n\\tinhibition of CO2 hydration activity of PfCAdom <362>) <362>\\nKI\\t#195# 0.000704 {4-(hydroxymethyl)benzene-1-sulfonamide}  (#195# pH 7.5, \\n\\t22C, inhibition of CO2 hydration activity of PfCA16 <362>) <362>\\nKI\\t#195# 0.00063 {3-aminobenzene-1-sulfonamide}  (#195# pH 7.5, 22C, \\n\\tinhibition of CO2 hydration activity of PfCAdom <362>) <362>\\nKI\\t#195# 0.0164 \\n\\t{4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzene-1-sulfonamide}  (#195# pH \\n\\t7.5, 22C, inhibition of CO2 hydration activity of PfCAdom <362>) <362>\\nKI\\t#195# 0.000723 {N~1~-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide} \\n\\t (#195# pH 7.5, 22C, inhibition of CO2 hydration activity of PfCAdom \\n\\t<362>) <362>\\nKI\\t#195# 0.0196 \\n\\t{6-chloro-1,1-dioxo-1,2,3,4-tetrahydro-1lambda6,2,\\n\\t4-benzothiadiazine-7-sulfonamide}  (#195# pH 7.5, 22C, inhibition of \\n\\tCO2 hydration activity of PfCAdom <362>) <362>\\nKI\\t#195# 0.0148 \\n\\t{[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-2H,3aH,7H-bis[1,\\n\\t3]dioxolo[4,5-b:4\\',5\\'-d]pyran-3a-yl]methyl sulfamate}  (#195# pH 7.5, \\n\\t22C, inhibition of CO2 hydration activity of PfCAdom <362>) <362>\\nKI\\t#195# 0.0146 \\n\\t{4-amino-N-[(4-sulfamoylphenyl)methyl]benzene-1-sulfonamide}  (#195# pH \\n\\t7.5, 22C, inhibition of CO2 hydration activity of PfCA23 <362>) <362>\\nKI\\t#195# 0.000153 \\n\\t{6-chloro-1,1-dioxo-1,2,3,4-tetrahydro-1lambda~6~,2,\\n\\t4-benzothiadiazine-7-sulfonamide}  (#195# pH 7.5, 22C, inhibition of \\n\\tCO2 hydration activity of PfCA38 <362>) <362>\\nKI\\t#195# 0.00525 {4-[(2-aminopyrimidin-4-yl)amino]benzene-1-sulfonamide}  \\n\\t(#195# pH 7.5, 22C, inhibition of CO2 hydration activity of PfCA19 \\n\\t<362>) <362>\\nKI\\t#195# 0.00117 \\n\\t{2-methoxy-N-[(1-methylpyrrolidin-2-yl)methyl]-5-sulfamoylbenzamide}  \\n\\t(#195# pH 7.5, 22C, inhibition of CO2 hydration activity of PfCA33 \\n\\t<362>) <362>\\nKI\\t#195# 0.00414 {4-amino-6-chlorobenzene-1,3-disulfonamide}  (#195# pH \\n\\t7.5, 22C, inhibition of CO2 hydration activity of PfCA12 <362>) <362>\\nKI\\t#195# 0.000655 {methazolamide}  (#195# pH 7.5, 22C, inhibition of CO2 \\n\\thydration activity of PfCAdom <362>) <362>\\nKI\\t#195# 0.00365 {4-(aminomethyl)benzene-1-sulfonamide}  (#195# pH 7.5, \\n\\t22C, inhibition of CO2 hydration activity of PfCA5 <362>) <362>\\nKI\\t#195# 0.000308 {N~1~-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide} \\n\\t (#195# pH 7.5, 22C, inhibition of CO2 hydration activity of PfCA34 \\n\\t<362>) <362>\\nKI\\t#195# 0.00133 \\n\\t{5-[(benzenesulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide}  (#195# pH \\n\\t7.5, 22C, inhibition of CO2 hydration activity of PfCA30 <362>) <362>\\nKI\\t#195# 0.000246 {1-(1,2-benzoxazol-3-yl)methanesulfonamide}  (#195# pH \\n\\t7.5, 22C, inhibition of CO2 hydration activity of PfCA32 <362>) <362>\\nKI\\t#195# 0.0187 \\n\\t{4-amino-N-[(4-sulfamoylphenyl)methyl]benzene-1-sulfonamide}  (#195# pH \\n\\t7.5, 22C, inhibition of CO2 hydration activity of PfCAdom <362>) <362>\\nKI\\t#195# 0.000198 {methazolamide}  (#195# pH 7.5, 22C, inhibition of CO2 \\n\\thydration activity of PfCA25 <362>) <362>\\nKI\\t#195# 0.000217 {celecoxib}  (#195# pH 7.5, 22C, inhibition of CO2 \\n\\thydration activity of PfCA36 <362>) <362>\\nKI\\t#195# 0.000758 {4-(2-aminoethyl)benzene-1-sulfonamide}  (#195# pH 7.5, \\n\\t22C, inhibition of CO2 hydration activity of PfCA6 <362>) <362>\\nKI\\t#195# 0.00558 {4-methylbenzene-1-sulfonamide}  (#195# pH 7.5, 22C, \\n\\tinhibition of CO2 hydration activity of PfCA4 <362>) <362>\\nKI\\t#195# 0.000963 \\n\\t{(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-4,5,6,\\n\\t7-tetrahydro-7lambda~6~-thieno[2,3-b]thiopyran-2-sulfonamide}  (#195# \\n\\tpH 7.5, 22C, inhibition of CO2 hydration activity of PfCA28 <362>) \\n\\t<362>\\nKI\\t#195# 0.000295 \\n\\t{[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-2H,3aH,7H-bis[1,\\n\\t3]dioxolo[4,5-b:4\\',5\\'-d]pyran-3a-yl]methyl sulfamate}  (#195# pH 7.5, \\n\\t22C, inhibition of CO2 hydration activity of PfCA31 <362>) <362>\\nKI\\t#195# 0.000744 \\n\\t{5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide}  (#195# \\n\\tpH 7.5, 22C, inhibition of CO2 hydration activity of PfCA14 <362>) \\n\\t<362>\\nKI\\t#195# 0.00814 {4-amino-N-(4-sulfamoylphenyl)benzene-1-sulfonamide}  \\n\\t(#195# pH 7.5, 22C, inhibition of CO2 hydration activity of PfCAdom \\n\\t<362>) <362>\\nKI\\t#195# 0.00289 {4-hydroxybenzene-1-sulfonamide}  (#195# pH 7.5, 22C, \\n\\tinhibition of CO2 hydration activity of PfCAdom <362>) <362>\\nKI\\t#195# 0.00544 {4-amino-3-bromobenzene-1-sulfonamide}  (#195# pH 7.5, \\n\\t22C, inhibition of CO2 hydration activity of PfCA9 <362>) <362>\\nKI\\t#195# 0.000675 {5-amino-1,3,4-thiadiazole-2-sulfonamide}  (#195# pH \\n\\t7.5, 22C, inhibition of CO2 hydration activity of PfCAdom <362>) <362>\\nKI\\t#195# 0.00502 {4-amino-3-bromobenzene-1-sulfonamide}  (#195# pH 7.5, \\n\\t22C, inhibition of CO2 hydration activity of PfCAdom <362>) <362>\\nKI\\t#195# 0.00789 {1-(1,2-benzoxazol-3-yl)methanesulfonamide}  (#195# pH \\n\\t7.5, 22C, inhibition of CO2 hydration activity of PfCAdom <362>) <362>\\nKI\\t#195# 0.00794 \\n\\t{(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-4,5,6,\\n\\t7-tetrahydro-7lambda~6~-thieno[2,3-b]thiopyran-2-sulfonamide}  (#195# \\n\\tpH 7.5, 22C, inhibition of CO2 hydration activity of PfCAdom <362>) \\n\\t<362>\\nKI\\t#195# 0.00514 {benzene-1,3-disulfonamide}  (#195# pH 7.5, 22C, \\n\\tinhibition of CO2 hydration activity of PfCAdom <362>) <362>\\nKI\\t#195# 0.000366 {acetazolamide}  (#195# enzyme PfCAdom, pH 8.3, 22C \\n\\t<388>; #195# pH 7.5, 22C, long enzyme form PfCAdom, CO2 hydration \\n\\treaction <362>) <362,388>\\nKI\\t#195# 0.000581 {3-aminobenzene-1-sulfonamide}  (#195# pH 7.5, 22C, \\n\\tinhibition of CO2 hydration activity of PfCA1 <362>) <362>\\nKI\\t#195# 0.005885 {benzene-1,3-disulfonamide}  (#195# pH 7.5, 22C, \\n\\tinhibition of CO2 hydration activity of PfCA3 <362>) <362>\\nKI\\t#195# 0.005545 {4-amino-3-fluorobenzene-1-sulfonamide}  (#195# pH 7.5, \\n\\t22C, inhibition of CO2 hydration activity of PfCA7 <362>) <362>\\nKI\\t#195# 0.006175 {4-amino-3-chlorobenzene-1-sulfonamide}  (#195# pH 7.5, \\n\\t22C, inhibition of CO2 hydration activity of PfCA8 <362>) <362>\\nKI\\t#195# 0.00631 {3,5-dichloro-2-hydroxybenzene-1-sulfonamide}  (#195# pH \\n\\t7.5, 22C, inhibition of CO2 hydration activity of PfCA10 <362>) <362>\\nKI\\t#195# 0.01245 {4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide}  \\n\\t(#195# pH 7.5, 22C, inhibition of CO2 hydration activity of PfCA11 \\n\\t<362>) <362>\\nKI\\t#195# 0.00449 {4-hydroxybenzene-1-sulfonamide}  (#195# pH 7.5, 22C, \\n\\tinhibition of CO2 hydration activity of PfCA15 <362>) <362>\\nKI\\t#195# 0.000726 {4-(2-hydroxyethyl)benzene-1-sulfonamide}  (#195# pH \\n\\t7.5, 22C, inhibition of CO2 hydration activity of PfCA17 <362>) <362>\\nKI\\t#195# 0.00678 {4-sulfamoylbenzoic acid}  (#195# pH 7.5, 22C, \\n\\tinhibition of CO2 hydration activity of PfCA18 <362>) <362>\\nKI\\t#195# 0.006705 \\n\\t{4-amino-N-(4-sulfamoylcyclopenta-1,3-dien-1-yl)benzene-1-sulfonamide}  \\n\\t(#195# pH 7.5, 22C, inhibition of CO2 hydration activity of PfCA20 \\n\\t<362>) <362>\\nKI\\t#195# 0.000542 {4,5-dichlorobenzene-1,3-disulfonamide}  (#195# pH 7.5, \\n\\t22C, inhibition of CO2 hydration activity of PfCA27 <362>) <362>\\nKI\\t#195# 0.000808 {4-aminobenzene-1-sulfonamide}  (#195# pH 7.5, 22C, \\n\\tinhibition of CO2 hydration activity of PfCAdom <362>) <362>\\nKI\\t#195# 0.000904 {4-(aminomethyl)benzene-1-sulfonamide}  (#195# pH 7.5, \\n\\t22C, inhibition of CO2 hydration activity of PfCAdom <362>) <362>\\nKI\\t#195# 0.000904 {4-(2-hydroxyethyl)benzene-1-sulfonamide}  (#195# pH \\n\\t7.5, 22C, inhibition of CO2 hydration activity of PfCAdom <362>) <362>\\nKI\\t#195# 0.000957 {3,5-dichloro-2-hydroxybenzene-1-sulfonamide}  (#195# pH \\n\\t7.5, 22C, inhibition of CO2 hydration activity of PfCAdom <362>) <362>\\nKI\\t#195# 0.000912 \\n\\t{5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide}  (#195# \\n\\tpH 7.5, 22C, inhibition of CO2 hydration activity of PfCAdom <362>) \\n\\t<362>\\nKI\\t#195# 0.006225 {4-[(2-aminopyrimidin-4-yl)amino]benzene-1-sulfonamide}  \\n\\t(#195# pH 7.5, 22C, inhibition of CO2 hydration activity of PfCAdom \\n\\t<362>) <362>\\nKI\\t#195# 0.000893 \\n\\t{2-(hydroxymethyl)-4-nitro-N-[2-(4-sulfamoylphenyl)ethyl]benzene-1-\\n\\tsulfonamide}  (#195# pH 7.5, 22C, inhibition of CO2 hydration activity \\n\\tof PfCAdom <362>) <362>\\nKI\\t#195# 0.007835 \\n\\t{(4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-1,2,3,\\n\\t4-tetrahydro-1lambda~6~-thieno[3,2-e][1,2]thiazine-6-sulfonamide}  \\n\\t(#195# pH 7.5, 22C, inhibition of CO2 hydration activity of PfCAdom \\n\\t<362>) <362>\\nKI\\t#195# 0.00835 \\n\\t{2-methoxy-N-[(1-methylpyrrolidin-2-yl)methyl]-5-sulfamoylbenzamide}  \\n\\t(#195# pH 7.5, 22C, inhibition of CO2 hydration activity of PfCAdom \\n\\t<362>) <362>\\nKI\\t#195# 0.00838 {celecoxib}  (#195# pH 7.5, 22C, inhibition of CO2 \\n\\thydration activity of PfCAdom <362>) <362>\\nKI\\t#196# 0.000214 {acetazolamide}  (#196# pH 8.3, 22C, recombinant \\n\\tHis-tagged enzyme <383>) <383>\\nKI\\t#198# 0.0000789 {acetazolamide}  (#198# pH 8.3, 20C, recombinant \\n\\tHis-tagged enzyme <384>) <384>\\nKI\\t#20# 0.2 {phenylboronic acid}  (#20# 20C, pH not specified in the \\n\\tpublication <317>) <317>\\nKI\\t#20# 0.098 {4-[amino(dihydroxy)-lambda4-sulfanyl]-2-iodoaniline}  (#20# \\n\\t20C, pH not specified in the publication <318>) <318>\\nKI\\t#20# 0.05 \\n\\t{2,4-bis[amino(dihydroxy)-lamba4-sulfanyl]-5-(trifluoromethyl)aniline}  \\n\\t(#20# 20C, pH not specified in the publication <318>) <318>\\nKI\\t#20# 0.012 {acetazolamide}  (#20# 20C, pH not specified in the \\n\\tpublication <318>) <318>\\nKI\\t#20# 0.7 {HS-}  (#20# 20C, pH not specified in the publication <317>) \\n\\t<317>\\nKI\\t#20# 0.33 {phenylarsonic acid}  (#20# 20C, pH not specified in the \\n\\tpublication <317>) <317>\\nKI\\t#20# 0.077 {4-[amino(dihydroxy)-lambda4-sulfanyl]-2-bromoaniline}  \\n\\t(#20# 20C, pH not specified in the publication <318>) <318>\\nKI\\t#20# 0.061 {valdecoxib}  (#20# 20C, pH not specified in the \\n\\tpublication <318>) <318>\\nKI\\t#20# 0.52 {SCN-}  (#20# 20C, pH not specified in the publication \\n\\t<317>) <317>\\nKI\\t#20# 0.032 {methazolamide}  (#20# 20C, pH not specified in the \\n\\tpublication <318>) <318>\\nKI\\t#20# 0.105 \\n\\t{1,5-bis[amino(dihydroxy)-lambda4-sulfanyl]-2,3-dichlorobenzene}  (#20# \\n\\t20C, pH not specified in the publication <318>) <318>\\nKI\\t#20# 0.0235 {topiramate}  (#20# 20C, pH not specified in the \\n\\tpublication <318>) <318>\\nKI\\t#20# 0.0143 {3-[amino(dihydroxy)-lambda4-sulfanyl]aniline}  (#20# 20C, \\n\\tpH not specified in the publication <318>) <318>\\nKI\\t#20# 0.111 {4-[amino(dihydroxy)-lambda4-sulfanyl]-2-chloroaniline}  \\n\\t(#20# 20C, pH not specified in the publication <318>) <318>\\nKI\\t#20# 11.2 {CNO-}  (#20# 20C, pH not specified in the publication \\n\\t<317>) <317>\\nKI\\t#20# 44 {sulfamide}  (#20# 20C, pH not specified in the publication \\n\\t<318>) <318>\\nKI\\t#20# 44 {sulfamic acid}  (#20# 20C, pH not specified in the \\n\\tpublication <317>) <317>\\nKI\\t#20# 7.8 {NO3-}  (#20# 20C, pH not specified in the publication <317>) \\n\\t<317>\\nKI\\t#20# 0.127 {[4-[amino(dihydroxy)-lambda4-sulfanyl]phenyl]hydrazine}  \\n\\t(#20# 20C, pH not specified in the publication <318>) <318>\\nKI\\t#20# 9.6 {CO32-}  (#20# 20C, pH not specified in the publication \\n\\t<317>) <317>\\nKI\\t#20# 0.00535 {ethoxzolamide}  (#20# 20C, pH not specified in the \\n\\tpublication <318>) <318>\\nKI\\t#20# 13.2 {I-}  (#20# 20C, pH not specified in the publication <317>) \\n\\t<317>\\nKI\\t#20# 27.8 {CN-}  (#20# 20C, pH not specified in the publication <317>) \\n\\t<317>\\nKI\\t#20# 0.0307 {dorzolamide}  (#20# 20C, pH not specified in the \\n\\tpublication <318>) <318>\\nKI\\t#20# 0.0257 {1-[4-[amino(dihydroxy)-lambda4-sulfanyl]phenyl]ethanamine} \\n\\t (#20# 20C, pH not specified in the publication <318>) <318>\\nKI\\t#20# 0.0578 {sulfanilamide}  (#20# 20C, pH not specified in the \\n\\tpublication <318>) <318>\\nKI\\t#20# 44.9 {HCO3-}  (#20# 20C, pH not specified in the publication \\n\\t<317>) <317>\\nKI\\t#20# 0.0285 \\n\\t{1-[4-[amino(dihydroxy)-lambda4-sulfanyl]phenyl]methanamine}  (#20# \\n\\t20C, pH not specified in the publication <318>) <318>\\nKI\\t#20# 103 {sulfamic acid}  (#20# 20C, pH not specified in the \\n\\tpublication <318>) <318>\\nKI\\t#20# 103 {sulfamide}  (#20# 20C, pH not specified in the publication \\n\\t<317>) <317>\\nKI\\t#20# 0.0385 {celecoxib}  (#20# 20C, pH not specified in the \\n\\tpublication <318>) <318>\\nKI\\t#20# 0.0534 {4-[amino(dihydroxy)-lambda4-sulfanyl]-2-fluoroaniline}  \\n\\t(#20# 20C, pH not specified in the publication <318>) <318>\\nKI\\t#20# 0.0621 \\n\\t{2,4-bis[amino(dihydroxy)-lambda4-sulfanyl]-5-chloroaniline}  (#20# \\n\\t20C, pH not specified in the publication <318>) <318>\\nKI\\t#20# 0.0524 {4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide}  (#20# \\n\\t20C, pH not specified in the publication <318>) <318>\\nKI\\t#20# 42.1 {Br-}  (#20# 20C, pH not specified in the publication <317>) \\n\\t<317>\\nKI\\t#20# 55.7 {N3-}  (#20# 20C, pH not specified in the publication <317>) \\n\\t<317>\\nKI\\t#20# 44.8 {NO2-}  (#20# 20C, pH not specified in the publication \\n\\t<317>) <317>\\nKI\\t#20# 45.1 {HSO3-}  (#20# 20C, pH not specified in the publication \\n\\t<317>) <317>\\nKI\\t#200# 0.000005 {acetazolamide}  (#200# recombinant enzyme, pH and \\n\\ttemperature not specified in the publication <399>) <399>\\nKI\\t#205# 5.1 {TeO42-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 3.3 {SCN-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 0.026 {Ph-B(OH)2}  (#205# pH 8.3, 22C, inhibition of CO2 \\n\\thydration activity <359>) <359>\\nKI\\t#205# 4.7 {B4O72-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 6 {SeCN-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 1.4 {CO32-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 8.3 {SeO42-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 1.8 {SnO32-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 1.7 {HCO3-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 7.9 {RuO4-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 7.9 {NH(SO3)22-}  (#205# pH 8.3, 22C, inhibition of CO2 \\n\\thydration activity <359>) <359>\\nKI\\t#205# 9.4 {SO42-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 2.5 {CNO-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 0.008 {H2NSO2NH2}  (#205# pH 8.3, 22C, inhibition of CO2 \\n\\thydration activity <359>) <359>\\nKI\\t#205# 4.4 {CN-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 3.8 {CS32-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 9 {Cl-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 0.038 {Ph-AsO3H2}  (#205# pH 8.3, 22C, inhibition of CO2 \\n\\thydration activity <359>) <359>\\nKI\\t#205# 4.5 {S2O82-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 0.037 {H2NSO3H}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 5.6 {PF6-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 4.8 {HS-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 0.58 {Et2NCS2-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 5.8 {V2O74-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 7.3 {P2O74-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 7.8 {ReO4-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 4.3 {FSO3-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 7.7 {CF3SO3-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 8.7 {I-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 21.7 {NO3-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205# 0.000502 {acetazolamide}  (#205# pH 8.3, 22C <359>) <359>\\nKI\\t#205# 37.5 {HSO3-}  (#205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359>\\nKI\\t#205,220# 8.8 {NO2-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>; #205# pH 8.3, 22C, inhibition of CO2 hydration \\n\\tactivity <359>) <359,361>\\nKI\\t#206# 6.1 {SeO42-}  (#206# pH 8.3, 20C, inhibition of CO2 hydration \\n\\tactivity <358>) <358>\\nKI\\t#206# 1.7 {CNO-}  (#206# pH 8.3, 20C, inhibition of CO2 hydration \\n\\tactivity <358>) <358>\\nKI\\t#206# 8 {B4O72-}  (#206# pH 8.3, 20C, inhibition of CO2 hydration \\n\\tactivity <358>) <358>\\nKI\\t#206# 2.5 {CO32-}  (#206# pH 8.3, 20C, inhibition of CO2 hydration \\n\\tactivity <358>) <358>\\nKI\\t#206# 5.9 {CN-}  (#206# pH 8.3, 20C, inhibition of CO2 hydration \\n\\tactivity <358>) <358>\\nKI\\t#206# 0.088 {Ph-B(OH)2}  (#206# pH 8.3, 20C, inhibition of CO2 \\n\\thydration activity <358>) <358>\\nKI\\t#206# 6.2 {HCO3-}  (#206# pH 8.3, 20C, inhibition of CO2 hydration \\n\\tactivity <358>) <358>\\nKI\\t#206# 8.5 {TeO42-}  (#206# pH 8.3, 20C, inhibition of CO2 hydration \\n\\tactivity <358>) <358>\\nKI\\t#206# 9.3 {SCN-}  (#206# pH 8.3, 20C, inhibition of CO2 hydration \\n\\tactivity <358>) <358>\\nKI\\t#206# 5.6 {NO3-}  (#206# pH 8.3, 20C, inhibition of CO2 hydration \\n\\tactivity <358>) <358>\\nKI\\t#206# 6.5 {NH(SO3)22-}  (#206# pH 8.3, 20C, inhibition of CO2 \\n\\thydration activity <358>) <358>\\nKI\\t#206# 0.091 {H2NSO3H}  (#206# pH 8.3, 20C, inhibition of CO2 hydration \\n\\tactivity <358>) <358>\\nKI\\t#206# 0.087 {Ph-AsO3H2}  (#206# pH 8.3, 20C, inhibition of CO2 \\n\\thydration activity <358>) <358>\\nKI\\t#206# 0.96 {Et2NCS2-}  (#206# pH 8.3, 20C, inhibition of CO2 hydration \\n\\tactivity <358>) <358>\\nKI\\t#206# 6.7 {NO2-}  (#206# pH 8.3, 20C, inhibition of CO2 hydration \\n\\tactivity <358>) <358>\\nKI\\t#206# 6.7 {SnO32-}  (#206# pH 8.3, 20C, inhibition of CO2 hydration \\n\\tactivity <358>) <358>\\nKI\\t#206# 0.082 {H2NSO2NH2}  (#206# pH 8.3, 20C, inhibition of CO2 \\n\\thydration activity <358>) <358>\\nKI\\t#206# 7.8 {SeCN-}  (#206# pH 8.3, 20C, inhibition of CO2 hydration \\n\\tactivity <358>) <358>\\nKI\\t#206# 7.7 {FSO3-}  (#206# pH 8.3, 20C, inhibition of CO2 hydration \\n\\tactivity <358>) <358>\\nKI\\t#206# 8.7 {Br-}  (#206# pH 8.3, 20C, inhibition of CO2 hydration \\n\\tactivity <358>) <358>\\nKI\\t#206# 8.7 {RuO4-}  (#206# pH 8.3, 20C, inhibition of CO2 hydration \\n\\tactivity <358>) <358>\\nKI\\t#206# 9.1 {S2O82-}  (#206# pH 8.3, 20C, inhibition of CO2 hydration \\n\\tactivity <358>) <358>\\nKI\\t#206# 8.4 {HS-}  (#206# pH 8.3, 20C, inhibition of CO2 hydration \\n\\tactivity <358>) <358>\\nKI\\t#206# 24.1 {HSO3-}  (#206# pH 8.3, 20C, inhibition of CO2 hydration \\n\\tactivity <358>) <358>\\nKI\\t#206# 0.000403 {acetazolamide}  (#206# pH 8.3, 20C <358>) <358>\\nKI\\t#206# 34.6 {CS32-}  (#206# pH 8.3, 20C, inhibition of CO2 hydration \\n\\tactivity <358>) <358>\\nKI\\t#21# 0.12 {Pb2+}  (#21# pH 7.4, 25C, purified enzyme <380>) <380>\\nKI\\t#21# 0.0045 {4-amino-6-chlorobenzene-1,3-disulfonamide}  (#21# pH 8.5, \\n\\t35C <333>) <333>\\nKI\\t#21# 0.0038 {mafenide}  (#21# pH 8.5, 35C <333>) <333>\\nKI\\t#21# 0.0096 {4-(2-aminoethyl) benzenesulfonamide}  (#21# pH 8.5, 35C \\n\\t<333>) <333>\\nKI\\t#21# 1.36 {Ag+}  (#21# pH 7.4, 25C, purified enzyme <380>) <380>\\nKI\\t#21# 0.0315 {saccharin}  (#21# pH 8.5, 35C <333>) <333>\\nKI\\t#21# 0.401 {Co2+}  (#21# pH 7.4, 25C, purified enzyme <380>) <380>\\nKI\\t#21# 0.915 {Fe2+}  (#21# pH 7.4, 25C, purified enzyme <380>) <380>\\nKI\\t#21# 0.571 {Cu2+}  (#21# pH 7.4, 25C, purified enzyme <380>) <380>\\nKI\\t#21# 0.008664 {benzenesulfonamide}  (#21# pH 8.5, 35C <333>) <333>\\nKI\\t#21# 0.06931 {sulfanilamide}  (#21# pH 8.5, 35C <333>) <333>\\nKI\\t#21# 0.001348 {4-methylbenzenesulfonamide}  (#21# pH 8.5, 35C <333>) \\n\\t<333>\\nKI\\t#21# 0.005874 {2-bromo-benzenesulfonamide}  (#21# pH 8.5, 35C <333>) \\n\\t<333>\\nKI\\t#21# 0.002586 {naphthalene-2-sulfonamide}  (#21# pH 8.5, 35C <333>) \\n\\t<333>\\nKI\\t#21# 0.543 {Hg2+}  (#21# pH 7.4, 25C, purified enzyme <380>) <380>\\nKI\\t#212# 0.0054 {2-(3-hydroxyphenyl)ethyl \\n\\t(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate}  (#212# pH 8.3, 25C, \\n\\trecombinant enzyme <398>) <398>\\nKI\\t#212# 0.0024 {(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid}  \\n\\t(#212# pH 8.3, 25C, recombinant enzyme <398>) <398>\\nKI\\t#212# 0.0051 {2-[4-[2-(4-hydroxyphenyl)ethoxy]phenyl]ethyl \\n\\t(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate}  (#212# pH 8.3, 25C, \\n\\trecombinant enzyme <398>) <398>\\nKI\\t#212# 0.0032 {2-(4-hydroxyphenyl)ethyl \\n\\t(2E)-3-(3-hydroperoxy-4-hydroxyphenyl)prop-2-enoate}  (#212# pH 8.3, \\n\\t25C, recombinant enzyme <398>) <398>\\nKI\\t#212# 0.0023 {2-(3-hydroxyphenyl)ethyl \\n\\t(2E)-3-(4-hydroxyphenyl)prop-2-enoate}  (#212# pH 8.3, 25C, \\n\\trecombinant enzyme <398>) <398>\\nKI\\t#212# 0.00567 {2-(4-hydroxyphenyl)ethyl \\n\\t(2E)-3-(3-hydroperoxy-4-hydroxyphenyl)prop-2-enoate}  (#212# pH 8.3, \\n\\t25C, recombinant enzyme <398>) <398>\\nKI\\t#212# 0.00536 {(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid}  (#212# \\n\\tpH 8.3, 25C, recombinant enzyme <398>) <398>\\nKI\\t#212# 0.0067 {(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid}  (#212# pH \\n\\t8.3, 25C, recombinant enzyme <398>) <398>\\nKI\\t#212# 0.00187 {2-(4-hydroxyphenyl)ethyl \\n\\t(2E)-3-(4-hydroxyphenyl)prop-2-enoate}  (#212# pH 8.3, 25C, \\n\\trecombinant enzyme <398>) <398>\\nKI\\t#212# 0.00574 {2-(3-hydroxyphenyl)ethyl \\n\\t(2E)-3-(4-hydroxyphenyl)prop-2-enoate}  (#212# pH 8.3, 25C, \\n\\trecombinant enzyme <398>) <398>\\nKI\\t#212# 0.00605 {4-coumaric acid}  (#212# pH 8.3, 25C, recombinant \\n\\tenzyme <398>) <398>\\nKI\\t#212# 0.00184 {benzyl 4-coumarate}  (#212# pH 8.3, 25C, recombinant \\n\\tenzyme <398>) <398>\\nKI\\t#212# 0.00269 {4-coumaric acid}  (#212# pH 8.3, 25C, recombinant \\n\\tenzyme <398>) <398>\\nKI\\t#212# 0.00232 {2-(3-hydroxyphenyl)ethyl \\n\\t(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate}  (#212# pH 8.3, 25C, \\n\\trecombinant enzyme <398>) <398>\\nKI\\t#212# 0.00803 {2-[3-[2-(3-hydroxyphenyl)ethoxy]phenyl]ethyl \\n\\t(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate}  (#212# pH 8.3, 25C, \\n\\trecombinant enzyme <398>) <398>\\nKI\\t#212# 0.00395 {2-[3-[2-(3-hydroxyphenyl)ethoxy]phenyl]ethyl \\n\\t(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate}  (#212# pH 8.3, 25C, \\n\\trecombinant enzyme <398>) <398>\\nKI\\t#212# 0.00378 {benzyl 4-coumarate}  (#212# pH 8.3, 25C, recombinant \\n\\tenzyme <398>) <398>\\nKI\\t#212# 0.00705 {benzyl \\n\\t(2E)-3-(3-hydroperoxy-4-hydroxyphenyl)prop-2-enoate}  (#212# pH 8.3, \\n\\t25C, recombinant enzyme <398>) <398>\\nKI\\t#212# 0.00467 {2-(4-hydroxyphenyl)ethyl \\n\\t(2E)-3-(4-hydroxyphenyl)prop-2-enoate}  (#212# pH 8.3, 25C, \\n\\trecombinant enzyme <398>) <398>\\nKI\\t#212# 0.00683 {2-[3-[2-(3-hydroxyphenyl)ethoxy]phenyl]ethyl \\n\\t(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate}  (#212# pH 8.3, 25C, \\n\\trecombinant enzyme <398>) <398>\\nKI\\t#212# 0.00513 {2-(4-hydroxyphenyl)ethyl \\n\\t(2E)-3-(4-hydroxyphenyl)prop-2-enoate}  (#212# pH 8.3, 25C, \\n\\trecombinant enzyme <398>) <398>\\nKI\\t#212# 0.00451 {benzyl \\n\\t(2E)-3-(3-hydroperoxy-4-hydroxyphenyl)prop-2-enoate}  (#212# pH 8.3, \\n\\t25C, recombinant enzyme <398>) <398>\\nKI\\t#212# 0.00532 {2-[4-[2-(4-hydroxyphenyl)ethoxy]phenyl]ethyl \\n\\t(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate}  (#212# pH 8.3, 25C, \\n\\trecombinant enzyme <398>) <398>\\nKI\\t#212# 0.00319 {benzyl \\n\\t(2E)-3-(3-hydroperoxy-4-hydroxyphenyl)prop-2-enoate}  (#212# pH 8.3, \\n\\t25C, recombinant enzyme <398>) <398>\\nKI\\t#212# 0.00592 {(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid}  (#212# \\n\\tpH 8.3, 25C, recombinant enzyme <398>) <398>\\nKI\\t#212# 0.00713 {(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid}  \\n\\t(#212# pH 8.3, 25C, recombinant enzyme <398>) <398>\\nKI\\t#212# 0.00713 {2-[4-[2-(4-hydroxyphenyl)ethoxy]phenyl]ethyl \\n\\t(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate}  (#212# pH 8.3, 25C, \\n\\trecombinant enzyme <398>) <398>\\nKI\\t#212# 0.00469 {2-(3-hydroxyphenyl)ethyl \\n\\t(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate}  (#212# pH 8.3, 25C, \\n\\trecombinant enzyme <398>) <398>\\nKI\\t#212# 0.00564 {(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid}  \\n\\t(#212# pH 8.3, 25C, recombinant enzyme <398>) <398>\\nKI\\t#212# 0.00433 {4-coumaric acid}  (#212# pH 8.3, 25C, recombinant \\n\\tenzyme <398>) <398>\\nKI\\t#212# 0.00726 {2-(4-hydroxyphenyl)ethyl \\n\\t(2E)-3-(3-hydroperoxy-4-hydroxyphenyl)prop-2-enoate}  (#212# pH 8.3, \\n\\t25C, recombinant enzyme <398>) <398>\\nKI\\t#212# 0.00504 {benzyl 4-coumarate}  (#212# pH 8.3, 25C, recombinant \\n\\tenzyme <398>) <398>\\nKI\\t#212# 0.00609 {2-(3-hydroxyphenyl)ethyl \\n\\t(2E)-3-(4-hydroxyphenyl)prop-2-enoate}  (#212# pH 8.3, 25C, \\n\\trecombinant enzyme <398>) <398>\\nKI\\t#219# 0.185 {Pb2+}  (#219# pH 9.0, 40C <368>) <368>\\nKI\\t#219# 0.703 {Fe2+}  (#219# pH 9.0, 40C <368>) <368>\\nKI\\t#219# 1.679 {Co2+}  (#219# pH 9.0, 40C <368>) <368>\\nKI\\t#219# 48.81 {Cu2+}  (#219# pH 9.0, 40C <368>) <368>\\nKI\\t#219# 18.55 {Ag+}  (#219# pH 9.0, 40C <368>) <368>\\nKI\\t#220# 0.07 {Ph-B(OH)2}  (#220# pH 7.5, 20C, inhibition of CO2 \\n\\thydration activity <361>) <361>\\nKI\\t#220# 5.4 {SnO32-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 0.09 {H2NSO3H}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 6 {CNO-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 6.9 {NH(SO3)22-}  (#220# pH 7.5, 20C, inhibition of CO2 \\n\\thydration activity <361>) <361>\\nKI\\t#220# 8 {SeCN-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 0.8 {diethyldithiocarbamate}  (#220# pH 7.5, 20C <361>) <361>\\nKI\\t#220# 0.8 {Et2NCS2-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 2.4 {CO32-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 0.084 {Ph-AsO3H2}  (#220# pH 7.5, 20C, inhibition of CO2 \\n\\thydration activity <361>) <361>\\nKI\\t#220# 9.5 {S2O82-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 9.5 {FSO3-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 4.5 {HCO3-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 7.4 {PF6-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 8.5 {SeO42-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 9.3 {Br-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 7.6 {V2O74-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 7.6 {RuO4-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 7.3 {CF3SO3-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 6.7 {CN-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 6.4 {B4O72-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 7.7 {TeO42-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 0.081 {H2NSO2NH2}  (#220# pH 7.5, 20C, inhibition of CO2 \\n\\thydration activity <361>) <361>\\nKI\\t#220# 8.7 {Cl-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 9.1 {P2O74-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 8.1 {SCN-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 8.8 {ReO4-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 8.9 {I-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 8.9 {CS32-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 14.9 {HSO3-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 0.0758 {acetazolamide}  (#220# pH 7.5, 20C <361>) <361>\\nKI\\t#220# 30.5 {N3-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 27.6 {NO3-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#220# 20.4 {HS-}  (#220# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <361>) <361>\\nKI\\t#221# 0.0004 {Cu2+}  (#221# pH not specified in the publication, 4C, \\n\\tassay using the delta pH method <366>) <366>\\nKI\\t#221# 0.0024 {CNO-}  (#221# pH not specified in the publication, 4C, \\n\\tassay using the delta pH method <366>) <366>\\nKI\\t#221# 0.00000064 {azetazolamide}  (#221# pH not specified in the \\n\\tpublication, 4C, assay using the delta pH method <366>) <366>\\nKI\\t#221# 0.0309 {Cu2+}  (#221# pH not specified in the publication, 4C, \\n\\tassay using the delta pH method <366>) <366>\\nKI\\t#222# 0.0075 {4-methylbenzene-1-sulfonamide}  (#222# pH 7.4, 25C, \\n\\tinhibition of 4-nitrophenyl acetate hydrolysis activity <377>) <377>\\nKI\\t#222# 0.0216 {4-amino-N-(pyrimidin-2-yl)benzene-1-sulfonamide}  (#222# \\n\\tpH 7.4, 25C, inhibition of 4-nitrophenyl acetate hydrolysis activity \\n\\t<377>) <377>\\nKI\\t#222# 0.0736 {4-amino-6-chlorobenzene-1,3-disulfonamide}  (#222# pH \\n\\t7.4, 25C, inhibition of 4-nitrophenyl acetate hydrolysis activity \\n\\t<377>) <377>\\nKI\\t#222# 0.0683 \\n\\t{6-chloro-1,1-dioxo-1,2,3,4-tetrahydro-1lambda6,2,\\n\\t4-benzothiadiazine-7-sulfonamide}  (#222# pH 7.4, 25C, inhibition of \\n\\t4-nitrophenyl acetate hydrolysis activity <377>) <377>\\nKI\\t#222# 0.10875 {brinzolamide}  (#222# pH 7.4, 25C <377>) <377>\\nKI\\t#222# 0.0674 {2-bromobenzene-1-sulfonamide}  (#222# pH 7.4, 25C, \\n\\tinhibition of 4-nitrophenyl acetate hydrolysis activity <377>) <377>\\nKI\\t#222# 0.08275 {4-chlorobenzene-1-sulfonamide}  (#222# pH 7.4, 25C, \\n\\tinhibition of 4-nitrophenyl acetate hydrolysis activity <377>) <377>\\nKI\\t#222# 0.0303 \\n\\t{4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzene-1-sulfonamide}  (#222# \\n\\tpH 7.4, 25C, inhibition of 4-nitrophenyl acetate hydrolysis activity \\n\\t<377>) <377>\\nKI\\t#222# 0.09125 {4-amino-N-carbamimidoylbenzene-1-sulfonamide}  (#222# pH \\n\\t7.4, 25C, inhibition of 4-nitrophenyl acetate hydrolysis activity \\n\\t<377>) <377>\\nKI\\t#228# 0.000094 {benzolamide}  (#228# at pH 8.3 and 25C <436>) <436>\\nKI\\t#228# 0.000446 {sultiame}  (#228# at pH 8.3 and 25C <436>) <436>\\nKI\\t#228# 0.000248 {acetolamide}  (#228# at pH 8.3 and 25C <436>) <436>\\nKI\\t#228# 0.000755 {zonisamide}  (#228# at pH 8.3 and 25C <436>) <436>\\nKI\\t#228# 0.000387 {indisulam}  (#228# at pH 8.3 and 25C <436>) <436>\\nKI\\t#228# 0.000944 {celecoxib}  (#228# at pH 8.3 and 25C <436>) <436>\\nKI\\t#228# 0.000921 {methazolamide}  (#228# at pH 8.3 and 25C <436>) <436>\\nKI\\t#228# 0.005538 {ethoxzolamide}  (#228# at pH 8.3 and 25C <436>) <436>\\nKI\\t#228# 0.000889 {dichlorphenamide}  (#228# at pH 8.3 and 25C <436>) \\n\\t<436>\\nKI\\t#228# 0.002007 {dorzolamide}  (#228# at pH 8.3 and 25C <436>) <436>\\nKI\\t#228# 0.004842 {brinzolamide}  (#228# at pH 8.3 and 25C <436>) <436>\\nKI\\t#228# 0.000648 {topiramate}  (#228# at pH 8.3 and 25C <436>) <436>\\nKI\\t#228# 0.000914 {sulpiride}  (#228# at pH 8.3 and 25C <436>) <436>\\nKI\\t#228# 0.000891 {valdecoxib}  (#228# at pH 8.3 and 25C <436>) <436>\\nKI\\t#228# 0.004903 {saccharin}  (#228# at pH 8.3 and 25C <436>) <436>\\nKI\\t#228# 0.003643 {hydrochlorothiazide}  (#228# at pH 8.3 and 25C <436>) \\n\\t<436>\\nKI\\t#229# 0.000391 {acetazolamide}  (#229# at pH 7.5 and 25C <434>) <434>\\nKI\\t#230# 0.01 {topiramate}  (#230# Ki above 0.01 mM, at pH 7.5 and 20C \\n\\t<440>) <440>\\nKI\\t#230# 0.01 {indisulam}  (#230# Ki above 0.01 mM, at pH 7.5 and 20C \\n\\t<440>) <440>\\nKI\\t#230# 0.01 {zonisamide}  (#230# Ki above 0.01 mM, at pH 7.5 and 20C \\n\\t<440>) <440>\\nKI\\t#230# 0.01 {sulpride}  (#230# Ki above 0.01 mM, at pH 7.5 and 20C \\n\\t<440>) <440>\\nKI\\t#230# 0.01 {celecoxib}  (#230# Ki above 0.01 mM, at pH 7.5 and 20C \\n\\t<440>) <440>\\nKI\\t#230# 0.01 {valdecoxib}  (#230# Ki above 0.01 mM, at pH 7.5 and 20C \\n\\t<440>) <440>\\nKI\\t#230# 0.01 {sulthiame}  (#230# Ki above 0.01 mM, at pH 7.5 and 20C \\n\\t<440>) <440>\\nKI\\t#230# 0.01 {saccharin}  (#230# Ki above 0.01 mM, at pH 7.5 and 20C \\n\\t<440>) <440>\\nKI\\t#230# 0.01 {3-bromo-4-amino-benzenesulfonamide}  (#230# Ki above 0.01 \\n\\tmM, at pH 7.5 and 20C <440>) <440>\\nKI\\t#230# 0.01 {1,3-dibenzenesulfonamide}  (#230# Ki above 0.01 mM, at pH \\n\\t7.5 and 20C <440>) <440>\\nKI\\t#230# 0.01 {4-(2-amino-pyrimidin-4-yl)-benzenesulfonamide}  (#230# Ki \\n\\tabove 0.01 mM, at pH 7.5 and 20C <440>) <440>\\nKI\\t#230# 0.01 \\n\\t{4-(2-hydroxymethyl-4-nitrophenyl-sulfonamido)ethylbenzene-sulfonamide} \\n\\t (#230# Ki above 0.01 mM, at pH 7.5 and 20C <440>) <440>\\nKI\\t#230# 0.0002229 {acetazolamide}  (#230# at pH 7.5 and 20C <440>) <440>\\nKI\\t#230# 0.0003621 {ethoxzolamide}  (#230# at pH 7.5 and 20C <440>) <440>\\nKI\\t#230# 0.0003822 {4-amino-6-chloro-1,3-benzenedisulfonamide}  (#230# at \\n\\tpH 7.5 and 20C <440>) <440>\\nKI\\t#230# 0.0003898 {methazolamide}  (#230# at pH 7.5 and 20C <440>) <440>\\nKI\\t#230# 0.0004461 {1,3-disulfamoyl benzene}  (#230# at pH 7.5 and 20C \\n\\t<440>) <440>\\nKI\\t#230# 0.0004403 {4-amino-6-trifluoromethyl-benzene-1,3-disulfonamide}  \\n\\t(#230# at pH 7.5 and 20C <440>) <440>\\nKI\\t#234# 0.32 {Pb2+}  (#234# pH and temperature not specified in the \\n\\tpublication <424>) <424>\\nKI\\t#234# 0.36 {Fe2+}  (#234# pH and temperature not specified in the \\n\\tpublication <424>) <424>\\nKI\\t#234# 1.14 {Co2+}  (#234# pH and temperature not specified in the \\n\\tpublication <424>) <424>\\nKI\\t#234# 0.00000223 {clofentezine}  (#234# pH and temperature not \\n\\tspecified in the publication <424>) <424>\\nKI\\t#234# 12.8 {As3+}  (#234# pH and temperature not specified in the \\n\\tpublication <424>) <424>\\nKI\\t#234# 0.00000571 {thiram}  (#234# pH and temperature not specified in \\n\\tthe publication <424>) <424>\\nKI\\t#234# 0.00003074 {azoxystrobin}  (#234# pH and temperature not \\n\\tspecified in the publication <424>) <424>\\nKI\\t#234# 0.00000756 {deltamethrin}  (#234# pH and temperature not \\n\\tspecified in the publication <424>) <424>\\nKI\\t#234# 0.00000998 {propineb}  (#234# pH and temperature not specified in \\n\\tthe publication <424>) <424>\\nKI\\t#234# 0.00008976 {thiophanate}  (#234# pH and temperature not specified \\n\\tin the publication <424>) <424>\\nKI\\t#234# 17.83 {Cu2+}  (#234# pH and temperature not specified in the \\n\\tpublication <424>) <424>\\nKI\\t#234# 12.63 {Hg2+}  (#234# pH and temperature not specified in the \\n\\tpublication <424>) <424>\\nKI\\t#237# 0.0000507 {acetazolamide}  (#237# at pH 8.3 and 25C <428>) <428>\\nKI\\t#238# 3.5 {selenocyanate}  (#238# at pH 8.3 and 20C <438>) <438>\\nKI\\t#238# 3.3 {chloride}  (#238# at pH 8.3 and 20C <438>) <438>\\nKI\\t#238# 5.4 {CS32-}  (#238# at pH 8.3 and 20C <438>) <438>\\nKI\\t#238# 1.9 {fulminate}  (#238# at pH 8.3 and 20C <438>) <438>\\nKI\\t#238# 8.3 {bromide}  (#238# at pH 8.3 and 20C <438>) <438>\\nKI\\t#238# 6.9 {hydrosulfide}  (#238# at pH 8.3 and 20C <438>) <438>\\nKI\\t#238# 0.0062 {sulfamic acid}  (#238# at pH 8.3 and 20C <438>) <438>\\nKI\\t#238# 0.91 {peroxodisulfate}  (#238# at pH 8.3 and 20C <438>) <438>\\nKI\\t#238# 2.7 {thiocyanate}  (#238# at pH 8.3 and 20C <438>) <438>\\nKI\\t#238# 0.067 {N,N-diethyldithiocarbamate}  (#238# at pH 8.3 and 20C \\n\\t<438>) <438>\\nKI\\t#238# 2.5 {perosmate}  (#238# at pH 8.3 and 20C <438>) <438>\\nKI\\t#238# 3.8 {perrhenate}  (#238# at pH 8.3 and 20C <438>) <438>\\nKI\\t#238# 0.77 {stannate}  (#238# at pH 8.3 and 20C <438>) <438>\\nKI\\t#238# 3.1 {imidosulfonate}  (#238# at pH 8.3 and 20C <438>) <438>\\nKI\\t#238# 5.5 {fluoride}  (#238# at pH 8.3 and 20C <438>) <438>\\nKI\\t#238# 6.2 {bisulfite}  (#238# at pH 8.3 and 20C <438>) <438>\\nKI\\t#238# 0.86 {Cyanate}  (#238# at pH 8.3 and 20C <438>) <438>\\nKI\\t#238# 4.9 {divanadate}  (#238# at pH 8.3 and 20C <438>) <438>\\nKI\\t#238# 0.00046 {acetazolamide}  (#238# at pH 8.3 and 20C <438>) <438>\\nKI\\t#238# 7.1 {perruthenate}  (#238# at pH 8.3 and 20C <438>) <438>\\nKI\\t#238# 0.92 {FSO3-}  (#238# at pH 8.3 and 20C <438>) <438>\\nKI\\t#238# 4.3 {tellurate}  (#238# at pH 8.3 and 20C <438>) <438>\\nKI\\t#238# 0.081 {sulfamide}  (#238# at pH 8.3 and 20C <438>) <438>\\nKI\\t#238# 9.1 {nitrite}  (#238# at pH 8.3 and 20C <438>) <438>\\nKI\\t#28# 2.2 {sulfamide}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#28# 6 {Selenite}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#28# 6 {trithiocarbonate}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#28# 6.9 {hydrogensulfide}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#28# 0.51 {N,N-diethyldithiocarbamate}  (#28# at pH 8.3 and 25C <443>) \\n\\t<443>\\nKI\\t#28# 0.51 {stannate}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#28# 0.028 {imidosulfonate}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#28# 1.7 {nitrite}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#28# 7.9 {thiocyanate}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#28# 3.6 {nitrate}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#28# 7 {perruthenate}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#28# 2.4 {Carbonate}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#28# 0.77 {Cyanate}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#28# 0.047 {phenylboronic acid}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#28# 0.038 {phenylarsonic acid}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#28# 7.4 {Iodide}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#28# 0.28 {bicarbonate}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#28# 36.8 {bromide}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#28# 7.1 {perrhenate}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#28# 0.086 {fluorosulfonate}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#28# 1-1.5 {bisulfite}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#28# 0.87 {selenocyanate}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#28# 0.6-1 {tellurate}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#28# 8.4 {peroxydisulfate}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#28# 0.00077 {fulminate}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#28# 0.000509 {acetazolamide}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#28# 21.6 {sulfate}  (#28# at pH 8.3 and 25C <443>) <443>\\nKI\\t#30# 0.092 {CN-}  (#30# pH 6.7, 25C <107>) <107>\\nKI\\t#30# 0.56 {N3-}  (#30# pH 6.7, 25C <107>) <107>\\nKI\\t#30# 0.027 {NCO-}  (#30# pH 6.7, 25C <107>) <107>\\nKI\\t#30# 0.000025 {6-ethoxy-2-benzo-thiazolesulfonamide}  (#30# pH 7.0, \\n\\t10C, mutant H66A <107>) <107>\\nKI\\t#30# 0.000084 {6-ethoxy-2-benzo-thiazolesulfonamide}  (#30# pH 7.0, \\n\\t10C, wild-type enzyme <107>) <107>\\nKI\\t#30# 1.16 {SCN-}  (#30# pH 6.7, 25C <107>) <107>\\nKI\\t#32# 0.0031 \\n\\t{5-[[(4-aminophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#32# isoform CA 3, at 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 \\n\\tmM NaCl <276>) <276>\\nKI\\t#32# 0.00075 {4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide}  \\n\\t(#32# at 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl \\n\\t<275>; #32# isoform CA 1, at 20C and pH 8.3, in 20 mM Tris-HCl buffer \\n\\tand 20 mM NaCl <276>) <275,276>\\nKI\\t#32# 0.00017 {4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide} \\n\\t (#32# isoform CA 3, at 20C and pH 8.3, in 20 mM Tris-HCl buffer and \\n\\t20 mM NaCl <276>) <276>\\nKI\\t#32# 0.0023 {sulpiride}  (#32# at 20C and pH 8.3, in 20 mM Tris-HCl \\n\\tbuffer and 20 mM NaCl <275>) <275>\\nKI\\t#32# 0.0076 {5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide}  (#32# \\n\\tisoform CA 3, at 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM \\n\\tNaCl <276>) <276>\\nKI\\t#32# 0.0074 {4-sulfamoylbenzoic acid}  (#32# isoform CA 3, at 20C and \\n\\tpH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) <276>\\nKI\\t#32# 0.00081 {benzolamide}  (#32# at 20C and pH 8.3, in 20 mM Tris-HCl \\n\\tbuffer and 20 mM NaCl <275>) <275>\\nKI\\t#32# 0.0079 {4-amino-3-fluorobenzenesulfonamide}  (#32# isoform CA 3, \\n\\tat 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) <276>\\nKI\\t#32# 0.00956 {4-(2-aminoethyl)benzenesulfonamide}  (#32# at 20C and pH \\n\\t8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <275>; #32# isoform CA 1, \\n\\tat 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) \\n\\t<275,276>\\nKI\\t#32# 0.00956 {4-(hydroxymethyl)benzenesulfonamide}  (#32# at 20C and \\n\\tpH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <275>; #32# isoform CA \\n\\t1, at 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) \\n\\t<275,276>\\nKI\\t#32# 0.0081 {4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide}  \\n\\t(#32# at 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl \\n\\t<275>; #32# isoform CA 1, at 20C and pH 8.3, in 20 mM Tris-HCl buffer \\n\\tand 20 mM NaCl <276>) <275,276>\\nKI\\t#32# 0.00752 {4-amino-3-chlorobenzenesulfonamide}  (#32# at 20C and pH \\n\\t8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <275>; #32# isoform CA 1, \\n\\tat 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) \\n\\t<275,276>\\nKI\\t#32# 0.000091 {2-amino-pyrimidin-4-yl-sulfanilamide}  (#32# at 20C, pH \\n\\t8.3, in 20 mM Tris-HCl and 20 mM NaCl <276>) <276>\\nKI\\t#32# 0.000091 {4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide}  \\n\\t(#32# isoform CA 3, at 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 \\n\\tmM NaCl <276>) <276>\\nKI\\t#32# 0.000186 {4-amino-3-bromobenzenesulfonamide}  (#32# at 20C and pH \\n\\t8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <275>; #32# isoform CA 1, \\n\\tat 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) \\n\\t<275,276>\\nKI\\t#32# 0.000097 {indisulam}  (#32# at 20C and pH 8.3, in 20 mM Tris-HCl \\n\\tbuffer and 20 mM NaCl <275>) <275>\\nKI\\t#32# 0.00235 {4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide}  \\n\\t(#32# isoform CA 3, at 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 \\n\\tmM NaCl <276>) <276>\\nKI\\t#32# 0.00251 {4-(2-hydroxyethyl)benzenesulfonamide}  (#32# isoform CA \\n\\t3, at 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) \\n\\t<276>\\nKI\\t#32# 0.000104 {acetazolamide}  (#32# at 20C, pH 8.3, in 20 mM Tris-HCl \\n\\tand 20 mM NaCl <276>) <276>\\nKI\\t#32# 0.00103 {ethoxzolamide}  (#32# at 20C and pH 8.3, in 20 mM \\n\\tTris-HCl buffer and 20 mM NaCl <275>) <275>\\nKI\\t#32# 0.000137 {dorzolamide}  (#32# at 20C, pH 8.3, in 20 mM Tris-HCl \\n\\tand 20 mM NaCl <276>) <276>\\nKI\\t#32# 0.00342 {4-(2-aminoethyl)benzenesulfonamide}  (#32# isoform CA 3, \\n\\tat 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) <276>\\nKI\\t#32# 0.00172 {4-amino-6-chlorobenzene-1,3-disulfonamide}  (#32# at 20C \\n\\tand pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <275>; #32# isoform \\n\\tCA 1, at 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl \\n\\t<276>) <275,276>\\nKI\\t#32# 0.0217 {4-amino-6-chlorobenzene-1,3-disulfonamide}  (#32# isoform \\n\\tCA 3, at 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl \\n\\t<276>) <276>\\nKI\\t#32# 0.000481 {acetazolamide}  (#32# at 20C and pH 8.3, in 20 mM \\n\\tTris-HCl buffer and 20 mM NaCl <275>) <275>\\nKI\\t#32# 0.00302 {topiramate}  (#32# at 20C, pH 8.3, in 20 mM Tris-HCl and \\n\\t20 mM NaCl <276>) <276>\\nKI\\t#32# 0.00624 {2-aminobenzenesulfonamide}  (#32# isoform CA 3, at 20C \\n\\tand pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) <276>\\nKI\\t#32# 0.00581 {4-amino-3-iodobenzenesulfonamide}  (#32# isoform CA 3, at \\n\\t20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) <276>\\nKI\\t#32# 0.000208 {zonisamide}  (#32# at 20C, pH 8.3, in 20 mM Tris-HCl \\n\\tand 20 mM NaCl <276>) <276>\\nKI\\t#32# 0.00923 {2-aminobenzenesulfonamide}  (#32# at 20C and pH 8.3, in \\n\\t20 mM Tris-HCl buffer and 20 mM NaCl <275>; #32# isoform CA 1, at 20C \\n\\tand pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) <275,276>\\nKI\\t#32# 0.000562 {methazolamide}  (#32# at 20C, pH 8.3, in 20 mM Tris-HCl \\n\\tand 20 mM NaCl <276>) <276>\\nKI\\t#32# 0.000781 {methazolamide}  (#32# at 20C and pH 8.3, in 20 mM \\n\\tTris-HCl buffer and 20 mM NaCl <275>) <275>\\nKI\\t#32# 0.000872 {4,5-dichloro-benzene-1,3-disulfonamide}  (#32# at 20C \\n\\tand pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <275>) <275>\\nKI\\t#32# 0.000744 {dorzolamide}  (#32# at 20C and pH 8.3, in 20 mM \\n\\tTris-HCl buffer and 20 mM NaCl <275>) <275>\\nKI\\t#32# 0.000839 {brinzolamide}  (#32# at 20C and pH 8.3, in 20 mM \\n\\tTris-HCl buffer and 20 mM NaCl <275>) <275>\\nKI\\t#32# 0.000612 {topiramate}  (#32# at 20C and pH 8.3, in 20 mM Tris-HCl \\n\\tbuffer and 20 mM NaCl <275>) <275>\\nKI\\t#32# 0.000612 {4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide}  (#32# \\n\\tat 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <275>; #32# \\n\\tisoform CA 1, at 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM \\n\\tNaCl <276>) <275,276>\\nKI\\t#32# 0.02868 {zonisamide}  (#32# at 20C and pH 8.3, in 20 mM Tris-HCl \\n\\tbuffer and 20 mM NaCl <275>) <275>\\nKI\\t#32# 0.01035 {celecoxib}  (#32# at 20C and pH 8.3, in 20 mM Tris-HCl \\n\\tbuffer and 20 mM NaCl <275>) <275>\\nKI\\t#32# 0.01297 {valdecoxib}  (#32# at 20C and pH 8.3, in 20 mM Tris-HCl \\n\\tbuffer and 20 mM NaCl <275>) <275>\\nKI\\t#32# 0.00516 {sulthiame}  (#32# at 20C and pH 8.3, in 20 mM Tris-HCl \\n\\tbuffer and 20 mM NaCl <275>) <275>\\nKI\\t#32# 0.00796 {saccharin}  (#32# at 20C and pH 8.3, in 20 mM Tris-HCl \\n\\tbuffer and 20 mM NaCl <275>) <275>\\nKI\\t#32# 0.00984 {4-Aminobenzenesulfonamide}  (#32# at 20C and pH 8.3, in \\n\\t20 mM Tris-HCl buffer and 20 mM NaCl <275>; #32# isoform CA 1, at 20C \\n\\tand pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) <275,276>\\nKI\\t#32# 0.00793 {3-(4-sulfamoylphenyl)propanoic acid}  (#32# at 20C and \\n\\tpH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <275>; #32# isoform CA \\n\\t1, at 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) \\n\\t<275,276>\\nKI\\t#32# 0.00492 {4-methylbenzenesulfonamide}  (#32# at 20C and pH 8.3, in \\n\\t20 mM Tris-HCl buffer and 20 mM NaCl <275>; #32# isoform CA 1, at 20C \\n\\tand pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) <275,276>\\nKI\\t#32# 0.00869 {4-(aminomethyl)benzenesulfonamide}  (#32# at 20C and pH \\n\\t8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <275>; #32# isoform CA 1, \\n\\tat 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) \\n\\t<275,276>\\nKI\\t#32# 0.00874 {4-amino-3-fluorobenzenesulfonamide}  (#32# at 20C and pH \\n\\t8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <275>; #32# isoform CA 1, \\n\\tat 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) \\n\\t<275,276>\\nKI\\t#32# 0.00771 {4-amino-3-iodobenzenesulfonamide}  (#32# at 20C and pH \\n\\t8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <275>; #32# isoform CA 1, \\n\\tat 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) \\n\\t<275,276>\\nKI\\t#32# 0.01154 {5-amino-1,3,4-thiadiazole-2-sulfonamide}  (#32# at 20C \\n\\tand pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <275>; #32# isoform \\n\\tCA 1, at 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl \\n\\t<276>) <275,276>\\nKI\\t#32# 0.01265 \\n\\t{5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide}  (#32# \\n\\tat 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <275>; #32# \\n\\tisoform CA 1, at 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM \\n\\tNaCl <276>) <275,276>\\nKI\\t#32# 0.000905 \\n\\t{5-[[(4-aminophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#32# at 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl \\n\\t<275>; #32# isoform CA 1, at 20C and pH 8.3, in 20 mM Tris-HCl buffer \\n\\tand 20 mM NaCl <276>) <275,276>\\nKI\\t#32# 0.000853 \\n\\t{4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide}  (#32# at \\n\\t20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <275>; #32# \\n\\tisoform CA 1, at 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM \\n\\tNaCl <276>) <275,276>\\nKI\\t#32# 0.00748 {5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#32# at 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl \\n\\t<275>; #32# isoform CA 1, at 20C and pH 8.3, in 20 mM Tris-HCl buffer \\n\\tand 20 mM NaCl <276>) <275,276>\\nKI\\t#32# 0.00551 {4-(2-hydroxyethyl)benzenesulfonamide}  (#32# at 20C and \\n\\tpH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <275>; #32# isoform CA \\n\\t1, at 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) \\n\\t<275,276>\\nKI\\t#32# 0.00821 {4-sulfamoylbenzoic acid}  (#32# at 20C and pH 8.3, in 20 \\n\\tmM Tris-HCl buffer and 20 mM NaCl <275>; #32# isoform CA 1, at 20C and \\n\\tpH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) <275,276>\\nKI\\t#32# 0.000594 {ethoxzolamide}  (#32# at 20C, pH 8.3, in 20 mM Tris-HCl \\n\\tand 20 mM NaCl <276>) <276>\\nKI\\t#32# 0.000611 {dichlorophenamide}  (#32# at 20C, pH 8.3, in 20 mM \\n\\tTris-HCl and 20 mM NaCl <276>) <276>\\nKI\\t#32# 0.000201 {brinzolamide}  (#32# at 20C, pH 8.3, in 20 mM Tris-HCl \\n\\tand 20 mM NaCl <276>) <276>\\nKI\\t#32# 0.000338 {benzolamide}  (#32# at 20C, pH 8.3, in 20 mM Tris-HCl \\n\\tand 20 mM NaCl <276>) <276>\\nKI\\t#32# 0.00792 {sulpiride}  (#32# at 20C, pH 8.3, in 20 mM Tris-HCl and \\n\\t20 mM NaCl <276>) <276>\\nKI\\t#32# 0.00792 \\n\\t{5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide}  (#32# \\n\\tisoform CA 3, at 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM \\n\\tNaCl <276>) <276>\\nKI\\t#32# 0.00784 {indisulam}  (#32# at 20C, pH 8.3, in 20 mM Tris-HCl and \\n\\t20 mM NaCl <276>) <276>\\nKI\\t#32# 0.00776 {celecoxib}  (#32# at 20C, pH 8.3, in 20 mM Tris-HCl and \\n\\t20 mM NaCl <276>) <276>\\nKI\\t#32# 0.00781 {valdecoxib}  (#32# at 20C, pH 8.3, in 20 mM Tris-HCl and \\n\\t20 mM NaCl <276>) <276>\\nKI\\t#32# 0.00672 {sulthiame}  (#32# at 20C, pH 8.3, in 20 mM Tris-HCl and \\n\\t20 mM NaCl <276>) <276>\\nKI\\t#32# 0.00715 {saccharin}  (#32# at 20C, pH 8.3, in 20 mM Tris-HCl and \\n\\t20 mM NaCl <276>) <276>\\nKI\\t#32# 0.00711 {4-Aminobenzenesulfonamide}  (#32# isoform CA 3, at 20C \\n\\tand pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) <276>\\nKI\\t#32# 0.00783 {3-(4-sulfamoylphenyl)propanoic acid}  (#32# isoform CA 3, \\n\\tat 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) <276>\\nKI\\t#32# 0.00702 {4-methylbenzenesulfonamide}  (#32# isoform CA 3, at 20C \\n\\tand pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) <276>\\nKI\\t#32# 0.00733 {4-(aminomethyl)benzenesulfonamide}  (#32# isoform CA 3, \\n\\tat 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) <276>\\nKI\\t#32# 0.00151 {4-amino-3-chlorobenzenesulfonamide}  (#32# isoform CA 3, \\n\\tat 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) <276>\\nKI\\t#32# 0.00732 {4-amino-3-bromobenzenesulfonamide}  (#32# isoform CA 3, \\n\\tat 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) <276>\\nKI\\t#32# 0.00763 {5-amino-1,3,4-thiadiazole-2-sulfonamide}  (#32# isoform \\n\\tCA 3, at 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl \\n\\t<276>) <276>\\nKI\\t#32# 0.00221 {4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide}  (#32# \\n\\tisoform CA 3, at 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM \\n\\tNaCl <276>) <276>\\nKI\\t#32# 0.00782 {4-(hydroxymethyl)benzenesulfonamide}  (#32# isoform CA 3, \\n\\tat 20C and pH 8.3, in 20 mM Tris-HCl buffer and 20 mM NaCl <276>) <276>\\nKI\\t#35# 0.084 {4-sulfamoylbenzoic acid}  (#35# pH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.00081 {4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide}  \\n\\t(#35# pH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.000128 {4,5-dichlorobenzene-1,3-disulfonamide}  (#35# pH 7.5, \\n\\t20C <342>) <342>\\nKI\\t#35# 0.000125 \\n\\t{N-(5-sulfanyl-1,3,4-thiadiazol-2-yl)hydrazinecarboxamide}  (#35# pH \\n\\t7.5, 20C <342>) <342>\\nKI\\t#35# 0.0000211 \\n\\t{(2Z)-2-benzylidene-N-(5-sulfanyl-1,3,\\n\\t4-thiadiazol-2-yl)hydrazinecarboxamide}  (#35# pH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.000134 \\n\\t{2-(hydroxymethyl)-4-nitro-N-[2-(4-\\n\\tsulfamoylphenyl)ethyl]benzenesulfonamide}  (#35# pH 7.5, 20C <342>) \\n\\t<342>\\nKI\\t#35# 0.000134 \\n\\t{6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide \\n\\t1,1-dioxide}  (#35# pH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.000079 \\n\\t{(2Z)-2-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)-N-(5-sulfanyl-1,3,\\n\\t4-thiadiazol-2-yl)hydrazinecarboxamide}  (#35# pH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.0000345 \\n\\t{(2Z)-2-(3-methoxybenzylidene)-N-(5-sulfanyl-1,3,\\n\\t4-thiadiazol-2-yl)hydrazinecarboxamide}  (#35# pH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.000867 {1-(1,2-benzoxazol-3-yl)methanesulfonamide}  (#35# pH \\n\\t7.5, 20C <342>) <342>\\nKI\\t#35# 0.0000936 \\n\\t{5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide}  (#35# pH \\n\\t7.5, 20C <342>) <342>\\nKI\\t#35# 0.0573 {4-Aminobenzenesulfonamide}  (#35# pH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.0442 {benzenesulfonamide}  (#35# pH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.0000749 \\n\\t{N-[(2E)-3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide} \\n\\t (#35# pH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.000192 \\n\\t{4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide}  (#35# pH \\n\\t7.5, 20C <342>) <342>\\nKI\\t#35# 0.000842 {4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide}  \\n\\t(#35# pH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.0000845 {N-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide}  \\n\\t(#35# pH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.0000911 \\n\\t{4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide}  (#35# pH \\n\\t7.5, 20C <342>) <342>\\nKI\\t#35# 0.000243 {4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide}  (#35# \\n\\tpH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.00821 {1,2-benzothiazol-3(2H)-one 1,1-dioxide}  (#35# pH 7.5, \\n\\t20C <342>) <342>\\nKI\\t#35# 0.0000873 \\n\\t{(4R)-4-(ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,\\n\\t2]thiazine-6-sulfonamide 1,1-dioxide}  (#35# pH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.00813 {4-amino-3-fluorobenzenesulfonamide}  (#35# pH 7.5, 20C \\n\\t<342>) <342>\\nKI\\t#35# 0.0000616 {acetazolamide}  (#35# pH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.0000616 {N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide}  (#35# \\n\\tpH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.02546 {3-aminobenzenesulfonamide}  (#35# pH 7.5, 20C <342>) \\n\\t<342>\\nKI\\t#35# 0.0638 {benzene-1,3-disulfonamide}  (#35# pH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.007231 {4-(aminomethyl)benzenesulfonamide}  (#35# pH 7.5, 20C \\n\\t<342>) <342>\\nKI\\t#35# 0.009238 {4-(2-aminoethyl)benzenesulfonamide}  (#35# pH 7.5, 20C \\n\\t<342>) <342>\\nKI\\t#35# 0.006925 {4-amino-3-chlorobenzenesulfonamide}  (#35# pH 7.5, 20C \\n\\t<342>) <342>\\nKI\\t#35# 0.00852 {4-amino-3,bromobenzenesulfonamide}  (#35# pH 7.5, 20C \\n\\t<342>) <342>\\nKI\\t#35# 0.009433 {3,5-dichloro-2-hydroxybenzenesulfonamide}  (#35# pH 7.5, \\n\\t20C <342>) <342>\\nKI\\t#35# 0.000534 {5-amino-1,3,4-thiadiazole-2-sulfonamide}  (#35# pH 7.5, \\n\\t20C <342>) <342>\\nKI\\t#35# 0.000652 \\n\\t{5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide}  (#35# \\n\\tpH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.07388 {4-hydroxybenzenesulfonamide}  (#35# pH 7.5, 20C <342>) \\n\\t<342>\\nKI\\t#35# 0.07185 {4-(hydroxymethyl)benzenesulfonamide}  (#35# pH 7.5, 20C \\n\\t<342>) <342>\\nKI\\t#35# 0.06675 {4-(2-hydroxyethyl)benzenesulfonamide}  (#35# pH 7.5, 20C \\n\\t<342>) <342>\\nKI\\t#35# 0.0000885 \\n\\t{5-([(4-aminophenyl)sulfonyl]amino)-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#35# pH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.000365 {4-amino-N-(4-sulfamoylphenyl)benzenesulfonamide}  (#35# \\n\\tpH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.0000882 {6-ethoxy-1,3-benzothiazole-2-sulfonamide}  (#35# pH \\n\\t7.5, 20C <342>) <342>\\nKI\\t#35# 0.0000929 \\n\\t{(4S,6S)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,\\n\\t3-b]thiopyran-2-sulfonamide 7,7-dioxide}  (#35# pH 7.5, 20C <342>) \\n\\t<342>\\nKI\\t#35# 0.0000855 \\n\\t{[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,\\n\\t5-b:4\\',5\\'-d]pyran-3a-yl]methyl sulfamate}  (#35# pH 7.5, 20C <342>) \\n\\t<342>\\nKI\\t#35# 0.0000879 \\n\\t{2-methoxy-N-[(1-methylpyrrolidin-2-yl)methyl]-5-sulfamoylbenzamide}  \\n\\t(#35# pH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.0000827 \\n\\t{4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-\\n\\tyl]benzenesulfonamide}  (#35# pH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.0000719 {4-(1,1-dioxido-1,2-thiazinan-2-yl)benzenesulfonamide}  \\n\\t(#35# pH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.0000643 \\n\\t{(2Z)-2-(4-chlorobenzylidene)-N-(5-sulfanyl-1,3,\\n\\t4-thiadiazol-2-yl)hydrazinecarboxamide}  (#35# pH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.0000431 \\n\\t{(2Z)-2-(3-bromobenzylidene)-N-(5-sulfanyl-1,3,\\n\\t4-thiadiazol-2-yl)hydrazinecarboxamide}  (#35# pH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.0000947 \\n\\t{(2Z)-2-(4-chlorobenzylidene)-N-(5-sulfanyl-1,3,\\n\\t4-thiadiazol-2-yl)hydrazinecarboxamide}  (#35# pH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.0000524 \\n\\t{(2Z)-2-(4-methylpentan-2-ylidene)-N-(5-sulfanyl-1,3,\\n\\t4-thiadiazol-2-yl)hydrazinecarboxamide}  (#35# pH 7.5, 20C <342>) <342>\\nKI\\t#35# 0.0000725 \\n\\t{(2Z)-2-(5-bromo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-N-(5-sulfanyl-1,\\n\\t3,4-thiadiazol-2-yl)hydrazinecarboxamide}  (#35# pH 7.5, 20C <342>) \\n\\t<342>\\nKI\\t#35,180# 0.00082 {4-amino-6-chlorobenzene-1,3-disulfonamide}  (#35,180# \\n\\tpH 7.5, 20C <331,342>) <331,342>\\nKI\\t#39# 0.0000019 {ethoxzolamide}  <165>\\nKI\\t#39# 0.0000027 {methazolamide}  <165>\\nKI\\t#40# 0.65 {Thiocyanide}  (#40# at 20C, pH 8.3 in 20 mM Tris buffer and \\n\\t20 mM NaClO4 <204>) <204>\\nKI\\t#40# 0.3 {sulfamide}  (#40# at 20C, pH 8.3 in 20 mM Tris buffer and 20 \\n\\tmM NaClO4 <204>) <204>\\nKI\\t#40# 0.37 {hydrogen sulfide}  (#40# at 20C, pH 8.3 in 20 mM Tris \\n\\tbuffer and 20 mM NaClO4 <204>) <204>\\nKI\\t#40# 0.011 {cyanide}  (#40# at 20C, pH 8.3 in 20 mM Tris buffer and 20 \\n\\tmM NaClO4 <204>) <204>\\nKI\\t#40# 0.53 {nitrite}  (#40# at 20C, pH 8.3 in 20 mM Tris buffer and 20 \\n\\tmM NaClO4 <204>) <204>\\nKI\\t#40# 0.7 {sulfamic acid}  (#40# at 20C, pH 8.3 in 20 mM Tris buffer \\n\\tand 20 mM NaClO4 <204>) <204>\\nKI\\t#40# 1.4 {Iodide}  (#40# at 20C, pH 8.3 in 20 mM Tris buffer and 20 mM \\n\\tNaClO4 <204>) <204>\\nKI\\t#40# 0.54 {hydrogen sulfite}  (#40# at 20C, pH 8.3 in 20 mM Tris \\n\\tbuffer and 20 mM NaClO4 <204>) <204>\\nKI\\t#40# 0.94 {bromide}  (#40# at 20C, pH 8.3 in 20 mM Tris buffer and 20 \\n\\tmM NaClO4 <204>) <204>\\nKI\\t#40# 0.69 {nitrate}  (#40# at 20C, pH 8.3 in 20 mM Tris buffer and 20 \\n\\tmM NaClO4 <204>) <204>\\nKI\\t#40# 0.69 {fluoride}  (#40# at 20C, pH 8.3 in 20 mM Tris buffer and 20 \\n\\tmM NaClO4 <204>) <204>\\nKI\\t#40# 0.62 {hydrogen carbonate}  (#40# at 20C, pH 8.3 in 20 mM Tris \\n\\tbuffer and 20 mM NaClO4 <204>) <204>\\nKI\\t#40# 1.18 {isocyanide}  (#40# at 20C, pH 8.3 in 20 mM Tris buffer and \\n\\t20 mM NaClO4 <204>) <204>\\nKI\\t#40# 0.000132 {acetazolamide}  (#40# at 20C, pH 8.3 in 20 mM Tris \\n\\tbuffer and 20 mM NaClO4 <204>) <204>\\nKI\\t#40# 30.85 {phenyl boronic acid}  (#40# at 20C, pH 8.3 in 20 mM Tris \\n\\tbuffer and 20 mM NaClO4 <204>) <204>\\nKI\\t#40# 30.84 {phenyl arsonic acid}  (#40# at 20C, pH 8.3 in 20 mM Tris \\n\\tbuffer and 20 mM NaClO4 <204>) <204>\\nKI\\t#40# 14.15 {sulfate}  (#40# at 20C, pH 8.3 in 20 mM Tris buffer and 20 \\n\\tmM NaClO4 <204>) <204>\\nKI\\t#40,125# 0.01 {Carbonate}  (#40# at 20C, pH 8.3 in 20 mM Tris buffer \\n\\tand 20 mM NaClO4 <204>; #125# isozyme CA III <227>) <204,227>\\nKI\\t#40,147# 0.52 {azide}  (#147# at 20C and pH 7.5 in 10 mM HEPES buffer \\n\\t<208>; #40# at 20C, pH 8.3 in 20 mM Tris buffer and 20 mM NaClO4 \\n\\t<204>) <204,208>\\nKI\\t#41# 2.8 {thiocyanate}  (#41# pH 7.5, 25C <98>) <98>\\nKI\\t#45# 0.02 {acetazolamide}  <205>\\nKI\\t#45# 0.00025 \\n\\t{4-([[(1Z)-(2-chlorophenyl)methylidene]amino]methyl)benzenesulfonamide} \\n\\t <205>\\nKI\\t#45# 0.025 \\n\\t{4-(3-[[(1E)-(1-methyl-1H-imidazol-2-\\n\\tyl)methylidene]amino]propyl)benzenesulfonamide}  <205>\\nKI\\t#45# 0.025 \\n\\t{4-[([(1Z)-[4-\\n\\t(dimethylamino)phenyl]methylidene]amino)methyl]benzenesulfonamide}  \\n\\t<205>\\nKI\\t#45# 0.025 \\n\\t{4-[3-([(1E)-[4-\\n\\t(dimethylamino)phenyl]methylidene]amino)propyl]benzenesulfonamide}  \\n\\t<205>\\nKI\\t#45# 0.025 \\n\\t{4-([(1E)-[4-\\n\\t(dimethylamino)phenyl]methylidene]amino)benzenesulfonamide}  <205>\\nKI\\t#45# 0.025 {2-oxo-N-(3-sulfamoylphenyl)-2H-chromene-3-carboxamide}  \\n\\t<205>\\nKI\\t#45# 0.00018 \\n\\t{4-(3,4-dichlorophenylureido)thioureido-benzenesulfonamide}  <205>\\nKI\\t#45# 0.00097 \\n\\t{2-(7-methoxy-2-oxo-2H-chromen-4-yl)-N-(4-sulfamoylphenyl)acetamide}  \\n\\t<205>\\nKI\\t#45# 0.000315 \\n\\t{5-[[(phenylcarbamoyl)carbamothioyl]amino]-1,3,\\n\\t4-thiadiazole-2-sulfonamide}  <205>\\nKI\\t#45# 0.002583 \\n\\t{5-[[(pentafluorophenyl)sulfonyl]amino]-1,3,\\n\\t4-thiadiazole-2-sulfonamide}  <205>\\nKI\\t#45# 0.003441 \\n\\t{2,3,4,5,6-pentafluoro-N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)benzamide}  \\n\\t<205>\\nKI\\t#45# 0.006867 \\n\\t{2,3,4,5,6-pentafluoro-N-[(2E)-3-methyl-5-sulfamoyl-1,3,\\n\\t4-thiadiazol-2(3H)-ylidene]benzamide}  <205>\\nKI\\t#45# 0.000192 \\n\\t{N-[5-[(aminooxy)sulfinyl]-1,3,4-thiadiazol-2-yl]-1,1,2,2,3,3,4,4,5,5,6,\\n\\t6,7,7,8,8,8-heptadecafluorooctane-1-sulfonamide}  <205>\\nKI\\t#45# 0.00558 \\n\\t{4-[[(3,4-dichlorophenyl)carbamoyl]amino]benzenesulfonamide}  <205>\\nKI\\t#45# 0.003055 \\n\\t{2,3,4,5,6-pentafluoro-N-(2-sulfamoylphenyl)benzenesulfonamide}  <205>\\nKI\\t#45# 0.001992 {2-[(diphenylcarbamoyl)amino]benzenesulfonamide}  <205>\\nKI\\t#45# 0.01652 \\n\\t{N-[4-[(aminooxy)sulfinyl]phenyl]-4-\\n\\t[(diphenylcarbamoyl)amino]benzenesulfonamide}  <205>\\nKI\\t#45# 0.01604 {4-[[(diphenylcarbamoyl)amino]methyl]benzenesulfonamide}  \\n\\t<205>\\nKI\\t#45# 0.004622 \\n\\t{N-[(4-[[(4-\\n\\tsulfamoylphenyl)carbamothioyl]amino]phenyl)sulfonyl]acetamide}  <205>\\nKI\\t#45# 0.002102 {4-(carbamothioylamino)benzenesulfonamide}  <205>\\nKI\\t#45# 0.003053 {4-sulfamoyl-N-(4-sulfamoylphenyl)benzamide}  <205>\\nKI\\t#45# 0.002997 \\n\\t{4-([[(diethyl-l5-\\n\\tazanylidyne)methyl]disulfanyl]amino)benzenesulfonamide}  <205>\\nKI\\t#45# 0.008392 \\n\\t{4-[([[(diethyl-l5-\\n\\tazanylidyne)methyl]disulfanyl]amino)methyl]benzenesulfonamide}  <205>\\nKI\\t#45# 0.01317 \\n\\t{2-oxo-N-[2-(4-sulfamoylphenyl)ethyl]-2H-chromene-3-carboxamide}  <205>\\nKI\\t#45# 0.005048 {2-oxo-N-(4-sulfamoylbenzyl)-2H-chromene-3-carboxamide}  \\n\\t<205>\\nKI\\t#45# 0.005816 {2-oxo-N-(4-sulfamoylphenyl)-2H-chromene-3-carboxamide}  \\n\\t<205>\\nKI\\t#45# 0.01851 {2-oxo-N-(2-sulfamoylphenyl)-2H-chromene-3-carboxamide}  \\n\\t<205>\\nKI\\t#45# 0.004057 \\n\\t{4-[2-[(2-oxo-2H-chromen-3-yl)carbonyl]hydrazino]benzenesulfonamide}  \\n\\t<205>\\nKI\\t#45# 0.009034 \\n\\t{N-[2,\\n\\t4-disulfamoyl-5-(trifluoromethyl)phenyl]-2-oxo-2H-chromene-3-\\n\\tcarboxamide}  <205>\\nKI\\t#45# 0.001436 \\n\\t{2-(7-methoxy-2-oxo-2H-chromen-4-yl)-N-(2-sulfamoylphenyl)acetamide}  \\n\\t<205>\\nKI\\t#45# 0.004578 \\n\\t{2-(7-methoxy-2-oxo-2H-chromen-4-yl)-N-(3-sulfamoylphenyl)acetamide}  \\n\\t<205>\\nKI\\t#45# 0.003506 \\n\\t{4-[2-[(7-methoxy-2-oxo-2H-chromen-4-\\n\\tyl)acetyl]hydrazino]benzenesulfonamide}  <205>\\nKI\\t#45# 0.002519 \\n\\t{N-[2,\\n\\t4-disulfamoyl-5-(trifluoromethyl)phenyl]-2-(7-methoxy-2-oxo-2H-chromen-\\n\\t4-yl)acetamide}  <205>\\nKI\\t#45# 0.004162 \\n\\t{4-[[(1Z)-(1-bromonaphthalen-2-yl)methylidene]amino]benzenesulfonamide} \\n\\t <205>\\nKI\\t#51# 0.14 {I-}  (#51# 25C, pH 7.4 <190>) <190>\\nKI\\t#51# 0.0026 {acetazolamide}  (#51# 25C, pH 7.4 <190>) <190>\\nKI\\t#51# 0.04 {NO3-}  (#51# 25C, pH 7.4 <190>) <190>\\nKI\\t#51# 2.5 {Br-}  (#51# 25C, pH 7.4 <190>) <190>\\nKI\\t#51# 0.0037 {N3-}  (#51# 25C, pH 7.4 <190>) <190>\\nKI\\t#51# 38 {Cl-}  (#51# 25C, pH 7.4 <190>) <190>\\nKI\\t#53# 1 {bromide}  (#53# at 20C, pH 8.3 in 20 mM Tris buffer and 20 mM \\n\\tNaClO4 <204>) <204>\\nKI\\t#53# 0.0003 {4-amino-6-chloro-benzene-1,3-disulfonamide}  (#53# at \\n\\t20C, pH 8.3 <231>) <231>\\nKI\\t#53# 0.6 {hydrogen sulfide}  (#53# at 20C, pH 8.3 in 20 mM Tris buffer \\n\\tand 20 mM NaClO4 <204>) <204>\\nKI\\t#53# 0.6 {Carbonate}  (#53# at 20C, pH 8.3 in 20 mM Tris buffer and 20 \\n\\tmM NaClO4 <204>) <204>\\nKI\\t#53# 1.11 {Iodide}  (#53# at 20C, pH 8.3 in 20 mM Tris buffer and 20 \\n\\tmM NaClO4 <204>) <204>\\nKI\\t#53# 0.71 {hydrogen sulfite}  (#53# at 20C, pH 8.3 in 20 mM Tris \\n\\tbuffer and 20 mM NaClO4 <204>) <204>\\nKI\\t#53# 8.22 {sulfamic acid}  (#53# at 20C, pH 8.3 in 20 mM Tris buffer \\n\\tand 20 mM NaClO4 <204>) <204>\\nKI\\t#53# 0.94 {Thiocyanide}  (#53# at 20C, pH 8.3 in 20 mM Tris buffer and \\n\\t20 mM NaClO4 <204>) <204>\\nKI\\t#53# 0.000023 {benzolamide}  (#53# at 20C, pH 8.3 <231>) <231>\\nKI\\t#53# 0.75 {hydrogen carbonate}  (#53# at 20C, pH 8.3 in 20 mM Tris \\n\\tbuffer and 20 mM NaClO4 <204>) <204>\\nKI\\t#53# 0.032 {saccharin}  (#53# at 20C, pH 8.3 <231>) <231>\\nKI\\t#53# 0.00115 {4-methyl-benzenesulfonamide}  (#53# at 20C, pH 8.3 \\n\\t<231>) <231>\\nKI\\t#53# 0.86 {sulfate}  (#53# at 20C, pH 8.3 in 20 mM Tris buffer and 20 \\n\\tmM NaClO4 <204>) <204>\\nKI\\t#53# 0.86 {fluoride}  (#53# at 20C, pH 8.3 in 20 mM Tris buffer and 20 \\n\\tmM NaClO4 <204>) <204>\\nKI\\t#53# 0.000042 {aminobenzolamide}  (#53# at 20C, pH 8.3 <231>) <231>\\nKI\\t#53# 0.96 {nitrite}  (#53# at 20C, pH 8.3 in 20 mM Tris buffer and 20 \\n\\tmM NaClO4 <204>) <204>\\nKI\\t#53# 0.73 {azide}  (#53# at 20C, pH 8.3 in 20 mM Tris buffer and 20 mM \\n\\tNaClO4 <204>) <204>\\nKI\\t#53# 0.00044 {4-(carboxyethyl)-benzenesulfonamide}  (#53# at 20C, pH \\n\\t8.3 <231>) <231>\\nKI\\t#53# 13.56 {cyanide}  (#53# at 20C, pH 8.3 in 20 mM Tris buffer and 20 \\n\\tmM NaClO4 <204>) <204>\\nKI\\t#53# 0.00089 {sulthiame}  (#53# at 20C, pH 8.3 <231>) <231>\\nKI\\t#53# 0.99 {sulfamide}  (#53# at 20C, pH 8.3 in 20 mM Tris buffer and \\n\\t20 mM NaClO4 <204>) <204>\\nKI\\t#53# 0.81 {phenyl boronic acid}  (#53# at 20C, pH 8.3 in 20 mM Tris \\n\\tbuffer and 20 mM NaClO4 <204>) <204>\\nKI\\t#53# 0.92 {nitrate}  (#53# at 20C, pH 8.3 in 20 mM Tris buffer and 20 \\n\\tmM NaClO4 <204>) <204>\\nKI\\t#53# 0.92 {chloride}  (#53# at 20C, pH 8.3 in 20 mM Tris buffer and 20 \\n\\tmM NaClO4 <204>) <204>\\nKI\\t#53# 0.87 {phenyl arsonic acid}  (#53# at 20C, pH 8.3 in 20 mM Tris \\n\\tbuffer and 20 mM NaClO4 <204>) <204>\\nKI\\t#53# 0.000063 {methazolamide}  (#53# at 20C, pH 8.3 <231>) <231>\\nKI\\t#53# 0.0000105 {acetazolamide}  (#53# at 20C, pH 8.3 in 20 mM Tris \\n\\tbuffer and 20 mM NaClO4 <204>) <204>\\nKI\\t#53# 0.0000105 {N-(5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl)acetamide}  \\n\\t(#53# at 20C, pH 8.3 <231>) <231>\\nKI\\t#53# 0.000379 {chlorazolamide}  (#53# at 20C, pH 8.3 <231>) <231>\\nKI\\t#53# 0.000704 {valdecoxib}  (#53# at 20C, pH 8.3 <231>) <231>\\nKI\\t#53# 0.000791 {5-amino-1,3,4-thiadiazole-2-sulfonamide}  (#53# at 20C, \\n\\tpH 8.3 <231>) <231>\\nKI\\t#53# 0.000087 {ethoxzolamide}  (#53# at 20C, pH 8.3 <231>) <231>\\nKI\\t#53# 0.000087 {brinzolamide}  (#53# at 20C, pH 8.3 <231>) <231>\\nKI\\t#53# 1.01 {isocyanide}  (#53# at 20C, pH 8.3 in 20 mM Tris buffer and \\n\\t20 mM NaClO4 <204>) <204>\\nKI\\t#53# 0.000367 {topiramate}  (#53# at 20C, pH 8.3 <231>) <231>\\nKI\\t#53# 0.000765 {4-amino-benzenesulfonamide}  (#53# at 20C, pH 8.3 \\n\\t<231>) <231>\\nKI\\t#53# 0.000812 {sulpiride}  (#53# at 20C, pH 8.3 <231>) <231>\\nKI\\t#53# 0.000484 {4-carboxy-benzenesulfonamide}  (#53# at 20C, pH 8.3 \\n\\t<231>) <231>\\nKI\\t#53# 0.01849 {4-aminomethyl-benzenesulfonamide}  (#53# at 20C, pH 8.3 \\n\\t<231>) <231>\\nKI\\t#53# 0.001394 {4-aminoethyl-benzenesulfonamide}  (#53# at 20C, pH 8.3 \\n\\t<231>) <231>\\nKI\\t#53# 0.000809 {3-fluoro-4-amino-benzenesulfonamide}  (#53# at 20C, pH \\n\\t8.3 <231>) <231>\\nKI\\t#53# 0.000605 {3-chloro-4-amino-benzenesulfonamide}  (#53# at 20C, pH \\n\\t8.3 <231>) <231>\\nKI\\t#53# 0.000977 {3-bromo-4-amino-benzenesulfonamide}  (#53# at 20C, pH \\n\\t8.3 <231>) <231>\\nKI\\t#53# 0.000711 {3-iodo-4-amino-benzenesulfonamide}  (#53# at 20C, pH \\n\\t8.3 <231>) <231>\\nKI\\t#53# 0.000968 {4-amino-6-trifluoromethyl-benzene-1,3-disulfonamide}  \\n\\t(#53# at 20C, pH 8.3 <231>) <231>\\nKI\\t#53# 0.000815 {4-methyl-5-imino-1,3,4-thiadiazoline-2-sulfonamide}  \\n\\t(#53# at 20C, pH 8.3 <231>) <231>\\nKI\\t#53# 0.000971 {4-(4-sulfanilyl-aminomethyl)-benzenesulfonamide}  (#53# \\n\\tat 20C, pH 8.3 <231>) <231>\\nKI\\t#53# 0.000971 {zonisamide}  (#53# at 20C, pH 8.3 <231>) <231>\\nKI\\t#53# 0.000624 {4-(4-sulfanilyl-aminoethyl)-benzenesulfonamide}  (#53# \\n\\tat 20C, pH 8.3 <231>) <231>\\nKI\\t#53# 0.003887 {4-(2-amino-pyrimidin-4-yl)-benzenesulfonamide}  (#53# at \\n\\t20C, pH 8.3 <231>) <231>\\nKI\\t#53# 0.000623 {4-hydroxymethyl-benzenesulfonamide}  (#53# at 20C, pH \\n\\t8.3 <231>) <231>\\nKI\\t#53# 0.000878 {4-hydroxyethyl-benzenesulfonamide}  (#53# at 20C, pH \\n\\t8.3 <231>) <231>\\nKI\\t#53# 0.001203 {dichlorophenamide}  (#53# at 20C, pH 8.3 <231>) <231>\\nKI\\t#53# 0.008347 {dorzolamide}  (#53# at 20C, pH 8.3 <231>) <231>\\nKI\\t#53# 0.000963 {indisulam}  (#53# at 20C, pH 8.3 <231>) <231>\\nKI\\t#53# 0.003056 {celecoxib}  (#53# at 20C, pH 8.3 <231>) <231>\\nKI\\t#58# 0.05 {Co2+}  <246>\\nKI\\t#58# 0.014 {Co2+}  (#58# in 0.05 M Tris-SO4 buffer, at pH 9.0 and 25C \\n\\t<199>) <199>\\nKI\\t#58# 2.15 {Zn2+}  (#58# in 0.05 M Tris-SO4 buffer, at pH 9.0 and 25C \\n\\t<199>) <199>\\nKI\\t#58# 1.95 {Cu2+}  <246>\\nKI\\t#58# 0.00000757 {sulfanilamide}  <177>\\nKI\\t#58# 7.035 {Zn2+}  <246>\\nKI\\t#58# 2.19 {Ag+}  <246>\\nKI\\t#58# 27.68 {Cu2+}  (#58# in 0.05 M Tris-SO4 buffer, at pH 9.0 and 25C \\n\\t<199>) <199>\\nKI\\t#58# 193.9 {Ag+}  (#58# in 0.05 M Tris-SO4 buffer, at pH 9.0 and 25C \\n\\t<199>) <199>\\nKI\\t#58# 94.18 {Cd2+}  (#58# in 0.05 M Tris-SO4 buffer, at pH 9.0 and 25C \\n\\t<199>) <199>\\nKI\\t#59# 0.000071 {acetazolamide}  (#59# pH 7.5, 20C <339>) <339>\\nKI\\t#59# 0.000095 {N-(4-sulfamoylphenyl)benzamide}  (#59# pH 7.5, 20C \\n\\t<339>) <339>\\nKI\\t#59# 0.000041 {4-[(phenylsulfonyl)amino]benzenesulfonamide}  (#59# pH \\n\\t7.5, 20C <339>) <339>\\nKI\\t#59# 0.0000019 \\n\\t{5-([(4-bromophenyl)sulfonyl]amino)-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#59# pH 7.5, 20C <339>) <339>\\nKI\\t#59# 0.00036 {N-(4-sulfamoylphenyl)pentanamide}  (#59# pH 7.5, 20C \\n\\t<339>) <339>\\nKI\\t#59# 0.000015 {4-sulfamoyl-N-[2-(4-sulfamoylphenyl)ethyl]benzamide}  \\n\\t(#59# pH 7.5, 20C <339>) <339>\\nKI\\t#59# 0.000016 \\n\\t{4-(2-([(4-\\n\\tsulfamoylphenyl)carbamothioyl]amino)ethyl)benzenesulfonamide}  (#59# pH \\n\\t7.5, 20C <339>) <339>\\nKI\\t#59# 0.000012 {6-ethoxy-1,3-benzothiazole-2-sulfonamide}  (#59# pH 7.5, \\n\\t20C <339>) <339>\\nKI\\t#59# 0.000036 {N-(4-[(4-sulfamoylphenyl)sulfamoyl]phenyl)acetamide}  \\n\\t(#59# pH 7.5, 20C <339>) <339>\\nKI\\t#59# 0.000031 {N-(4-sulfamoylbenzyl)benzenesulfonamide}  (#59# pH 7.5, \\n\\t20C <339>) <339>\\nKI\\t#59# 0.0000036 \\n\\t{N-[(2E)-5-sulfamoyl-1,3,\\n\\t4-thiadiazol-2(3H)-ylidene]furan-2-carboxamide}  (#59# pH 7.5, 20C \\n\\t<339>) <339>\\nKI\\t#59# 0.000156 {3-[(phenylcarbamoyl)amino]benzenesulfonamide}  (#59# pH \\n\\t7.5, 20C <339>) <339>\\nKI\\t#59# 0.000079 \\n\\t{4-chloro-6-[(phenylcarbamoyl)amino]benzene-1,3-disulfonamide}  (#59# \\n\\tpH 7.5, 20C <339>) <339>\\nKI\\t#59# 0.0000035 \\n\\t{5-([(4-nitrophenyl)sulfonyl]amino)-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#59# pH 7.5, 20C <339>) <339>\\nKI\\t#59# 0.000369 {2-methyl-N-(4-sulfamoylphenyl)propanamide}  (#59# pH \\n\\t7.5, 20C <339>) <339>\\nKI\\t#59# 0.000147 {3,3-dimethyl-N-(4-sulfamoylphenyl)butanamide}  (#59# pH \\n\\t7.5, 20C <339>) <339>\\nKI\\t#59# 0.000137 {4-[(methylsulfonyl)amino]benzenesulfonamide}  (#59# pH \\n\\t7.5, 20C <339>) <339>\\nKI\\t#59# 0.000621 \\n\\t{4-(2-[(phenylcarbamothioyl)amino]ethyl)benzenesulfonamide}  (#59# pH \\n\\t7.5, 20C <339>) <339>\\nKI\\t#59# 0.000355 {N-(4-sulfamoylphenyl)butanamide}  (#59# pH 7.5, 20C \\n\\t<339>) <339>\\nKI\\t#59# 0.000679 \\n\\t{4-([(phenylcarbamothioyl)amino]methyl)benzenesulfonamide}  (#59# pH \\n\\t7.5, 20C <339>) <339>\\nKI\\t#59# 0.000382 {N-(4-sulfamoylphenyl)propanamide}  (#59# pH 7.5, 20C \\n\\t<339>) <339>\\nKI\\t#59# 0.00346 {4-Aminobenzenesulfonamide}  (#59# pH 7.5, 20C <339>) \\n\\t<339>\\nKI\\t#59# 0.000467 {N-(4-sulfamoylphenyl)acetamide}  (#59# pH 7.5, 20C \\n\\t<339>) <339>\\nKI\\t#59# 0.000325 {2,2,2-trifluoro-N-(4-sulfamoylphenyl)acetamide}  (#59# \\n\\tpH 7.5, 20C <339>) <339>\\nKI\\t#59# 0.000238 {4-(2-[(phenylcarbamoyl)amino]ethyl)benzenesulfonamide}  \\n\\t(#59# pH 7.5, 20C <339>) <339>\\nKI\\t#6# 0.15 {H2NSO2NH2}  (#6# pH 8.3, 20C <303>) <303>\\nKI\\t#6# 0.15 {sulfamide}  (#6# pH 8.3, 20C <303>) <303>\\nKI\\t#6# 0.67 {CN-}  (#6# pH 8.3, 20C <303>) <303>\\nKI\\t#6# 0.8 {F-}  (#6# pH 8.3, 20C <303>) <303>\\nKI\\t#6# 200 {ClO4-}  (#6# above, pH 8.3, 20C <303>) <303>\\nKI\\t#6# 1.04 {Br-}  (#6# pH 8.3, 20C <303>) <303>\\nKI\\t#6# 22.4 {Ph-B(OH)2}  (#6# pH 8.3, 20C <303>) <303>\\nKI\\t#6# 1.36 {SO42-}  (#6# pH 8.3, 20C <303>) <303>\\nKI\\t#6# 0.73 {CNO-}  (#6# pH 8.3, 20C <303>) <303>\\nKI\\t#6# 0.97 {Cl-}  (#6# pH 8.3, 20C <303>) <303>\\nKI\\t#6# 28.6 {NO2-}  (#6# pH 8.3, 20C <303>) <303>\\nKI\\t#6# 1.29 {HSO3-}  (#6# pH 8.3, 20C <303>) <303>\\nKI\\t#6# 1.28 {SCN-}  (#6# pH 8.3, 20C <303>) <303>\\nKI\\t#6# 1.18 {I-}  (#6# pH 8.3, 20C <303>) <303>\\nKI\\t#6# 0.000049 {5-acetamido-1,3,4-thiadiazole-2-sulfonamide}  (#6# pH \\n\\t8.3, 20C <303>) <303>\\nKI\\t#6# 1.01 {HS-}  (#6# pH 8.3, 20C <303>) <303>\\nKI\\t#6# 26.9 {HCO3-}  (#6# pH 8.3, 20C <303>) <303>\\nKI\\t#6# 1.12 {N3-}  (#6# pH 8.3, 20C <303>) <303>\\nKI\\t#6# 43.7 {NO3-}  (#6# pH 8.3, 20C <303>) <303>\\nKI\\t#6# 2.45 {H2NSO3H}  (#6# pH 8.3, 20C <303>) <303>\\nKI\\t#6# 32.6 {Ph-AsO3H2}  (#6# pH 8.3, 20C <303>) <303>\\nKI\\t#62# 0.09 {Cyanate}  (#62# Zn(II)-substituted enzyme, pH and \\n\\ttemperature not specified in the publication  <316>) <316>\\nKI\\t#62# 0.09 {nitrate}  (#62# Co(II)-substituted enzyme, pH and \\n\\ttemperature not specified in the publication <316>) <316>\\nKI\\t#62# 6.1 {thiocyanate}  (#62# Co(II)-substituted enzyme, pH and \\n\\ttemperature not specified in the publication <316>) <316>\\nKI\\t#62# 4.7 {Cyanate}  (#62# Co(II)-substituted enzyme, pH and temperature \\n\\tnot specified in the publication <316>) <316>\\nKI\\t#62# 0.05 {hydrogen sulfide}  (#62# Zn(II)-substituted enzyme, pH and \\n\\ttemperature not specified in the publication  <316>) <316>\\nKI\\t#62# 0.1 {hydrogencarbonate}  (#62# Co(II)-substituted enzyme, pH and \\n\\ttemperature not specified in the publication <316>) <316>\\nKI\\t#62# 0.009 {Carbonate}  (#62# Co(II)-substituted enzyme, pH and \\n\\ttemperature not specified in the publication <316>) <316>\\nKI\\t#62# 1.8 {hydrogen sulfite}  (#62# Co(II)-substituted enzyme, pH and \\n\\ttemperature not specified in the publication <316>) <316>\\nKI\\t#62# 2 {hydrogen sulfide}  (#62# Co(II)-substituted enzyme, pH and \\n\\ttemperature not specified in the publication <316>) <316>\\nKI\\t#62# 6.8 {nitrite}  (#62# Zn(II)-substituted enzyme, pH and temperature \\n\\tnot specified in the publication  <316>) <316>\\nKI\\t#62# 7 {thiocyanate}  (#62# Zn(II)-substituted enzyme, pH and \\n\\ttemperature not specified in the publication  <316>) <316>\\nKI\\t#62# 4.9 {azide}  (#62# Co(II)-substituted enzyme, pH and temperature \\n\\tnot specified in the publication <316>) <316>\\nKI\\t#62# 0.68 {cyanide}  (#62# Zn(II)-substituted enzyme, pH and \\n\\ttemperature not specified in the publication  <316>) <316>\\nKI\\t#62# 5.8 {azide}  (#62# Zn(II)-substituted enzyme, pH and temperature \\n\\tnot specified in the publication  <316>) <316>\\nKI\\t#62# 7.3 {nitrite}  (#62# Co(II)-substituted enzyme, pH and temperature \\n\\tnot specified in the publication <316>) <316>\\nKI\\t#62# 6.7 {Carbonate}  (#62# Zn(II)-substituted enzyme, pH and \\n\\ttemperature not specified in the publication  <316>) <316>\\nKI\\t#62# 42 {hydrogencarbonate}  (#62# Zn(II)-substituted enzyme, pH and \\n\\ttemperature not specified in the publication  <316>) <316>\\nKI\\t#62# 11.7 {hydrogen sulfite}  (#62# Zn(II)-substituted enzyme, pH and \\n\\ttemperature not specified in the publication  <316>) <316>\\nKI\\t#62# 36.5 {nitrate}  (#62# Zn(II)-substituted enzyme, pH and \\n\\ttemperature not specified in the publication  <316>) <316>\\nKI\\t#62# 51.5 {cyanide}  (#62# Co(II)-substituted enzyme, pH and \\n\\ttemperature not specified in the publication <316>) <316>\\nKI\\t#62,99# 5.3 {I-}  (#99# 20C, pH not specified in the publication, \\n\\tCo2+-substituted enzyme <316>; #62# Co(II)-substituted enzyme, pH and \\n\\ttemperature not specified in the publication <316>) <316>\\nKI\\t#62,99# 160 {Br-}  (#99# 20C, pH not specified in the publication, \\n\\tZn2+-substituted enzyme <316>; #62# Zn(II)-substituted enzyme, pH and \\n\\ttemperature not specified in the publication  <316>) <316>\\nKI\\t#62,99# 160 {I-}  (#99# 20C, pH not specified in the publication, \\n\\tZn2+-substituted enzyme <316>; #62# Zn(II)-substituted enzyme, pH and \\n\\ttemperature not specified in the publication  <316>) <316>\\nKI\\t#62,99# 22.2 {Br-}  (#99# 20C, pH not specified in the publication, \\n\\tCo2+-substituted enzyme <316>; #62# Co(II)-substituted enzyme, pH and \\n\\ttemperature not specified in the publication <316>) <316>\\nKI\\t#63# 0.95 {F-}  (#63# pH 8.3, 20C <330>) <330>\\nKI\\t#63# 0.09 {Ph-AsO3H2}  (#63# pH 8.3, 20C <330>) <330>\\nKI\\t#63# 0.092 {HS-}  (#63# pH 8.3, 20C <330>) <330>\\nKI\\t#63# 0.004 {Et2NCS2-}  (#63# pH 8.3, 20C <330>) <330>\\nKI\\t#63# 0.041 {CN-}  (#63# pH 8.3, 20C <330>) <330>\\nKI\\t#63# 0.91 {SeCN-}  (#63# pH 8.3, 20C <330>) <330>\\nKI\\t#63# 0.71 {CNO-}  (#63# pH 8.3, 20C <330>) <330>\\nKI\\t#63# 0.94 {Cl-}  (#63# pH 8.3, 20C <330>) <330>\\nKI\\t#63# 0.073 {N3-}  (#63# pH 8.3, 20C <330>) <330>\\nKI\\t#63# 0.0092 {H2NSO2NH2}  (#63# pH 8.3, 20C <330>) <330>\\nKI\\t#63# 0.093 {SCN-}  (#63# pH 8.3, 20C <330>) <330>\\nKI\\t#63# 0.093 {H2NSO3H}  (#63# pH 8.3, 20C <330>) <330>\\nKI\\t#63# 0.0098 {Ph-B(OH)2}  (#63# pH 8.3, 20C <330>) <330>\\nKI\\t#63# 0.93 {ReO4-}  (#63# pH 8.3, 20C <330>) <330>\\nKI\\t#63# 0.096 {HCO3-}  (#63# pH 8.3, 20C <330>) <330>\\nKI\\t#63# 0.89 {CO32-}  (#63# pH 8.3, 20C <330>) <330>\\nKI\\t#63# 0.92 {Br-}  (#63# pH 8.3, 20C <330>) <330>\\nKI\\t#63# 0.097 {CS32-}  (#63# pH 8.3, 20C <330>) <330>\\nKI\\t#63# 0.000324 {acetazolamide}  (#63# pH 8.3, 20C <330>) <330>\\nKI\\t#65# 0.000008 {N-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide}  \\n\\t(#65# pH 7.5, 20C <341>) <341>\\nKI\\t#65# 0.001 \\n\\t{[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,\\n\\t5-b:4\\',5\\'-d]pyran-3a-yl]methyl sulfamate}  (#65# pH 7.5, 20C <341>) \\n\\t<341>\\nKI\\t#65# 0.001 \\n\\t{2-methoxy-N-[(1-methylpyrrolidin-2-yl)methyl]-5-sulfamoylbenzamide}  \\n\\t(#65# pH 7.5, 20C <341>) <341>\\nKI\\t#65# 0.001 \\n\\t{4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-\\n\\tyl]benzenesulfonamide}  (#65# pH 7.5, 20C <341>) <341>\\nKI\\t#65# 0.001 {1,2-benzothiazol-3(2H)-one 1,1-dioxide}  (#65# pH 7.5, 20C \\n\\t<341>) <341>\\nKI\\t#65# 0.0000235 {5-amino-1,3,4-thiadiazole-2-sulfonamide}  (#65# pH 7.5, \\n\\t20C <341>) <341>\\nKI\\t#65# 0.00044 {2-aminobenzenesulfonamide}  (#65# pH 7.5, 20C <341>) \\n\\t<341>\\nKI\\t#65# 0.0000047 {6-hydroxy-1,3-benzothiazole-2-sulfonamide}  (#65# pH \\n\\t7.5, 20C <341>) <341>\\nKI\\t#65# 0.000125 {4-hydrazinylbenzenesulfonamide}  (#65# pH 7.5, 20C \\n\\t<341>) <341>\\nKI\\t#65# 0.0000063 \\n\\t{(4S,6S)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,\\n\\t3-b]thiopyran-2-sulfonamide 7,7-dioxide}  (#65# pH 7.5, 20C <341>) \\n\\t<341>\\nKI\\t#65# 0.0000036 \\n\\t{N-[(2E)-3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide} \\n\\t (#65# pH 7.5, 20C <341>) <341>\\nKI\\t#65# 0.000139 {4-amino-3-chlorobenzenesulfonamide}  (#65# pH 7.5, 20C \\n\\t<341>) <341>\\nKI\\t#65# 0.0000025 \\n\\t{(4R)-4-(ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,\\n\\t2]thiazine-6-sulfonamide 1,1-dioxide}  (#65# pH 7.5, 20C <341>) <341>\\nKI\\t#65# 0.00000069 {6-ethoxy-1,3-benzothiazole-2-sulfonamide}  (#65# pH \\n\\t7.5, 20C <341>) <341>\\nKI\\t#65# 0.000471 {4-Aminobenzenesulfonamide}  (#65# pH 7.5, 20C <341>) \\n\\t<341>\\nKI\\t#65# 0.000133 {4-amino-3-bromobenzenesulfonamide}  (#65# pH 7.5, 20C \\n\\t<341>) <341>\\nKI\\t#65# 0.000199 {4-amino-3-fluorobenzenesulfonamide}  (#65# pH 7.5, 20C \\n\\t<341>) <341>\\nKI\\t#65# 0.0000068 {N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide}  (#65# \\n\\tpH 7.5, 20C <341>) <341>\\nKI\\t#65# 0.0000042 {4-amino-N-(4-sulfamoylphenyl)benzenesulfonamide}  (#65# \\n\\tpH 7.5, 20C <341>) <341>\\nKI\\t#65# 0.0000042 \\n\\t{5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide}  (#65# pH \\n\\t7.5, 20C <341>) <341>\\nKI\\t#65# 0.00000059 {5-(3-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#65# pH 7.5, 20C <341>) <341>\\nKI\\t#65# 0.0000121 \\n\\t{5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide}  (#65# \\n\\tpH 7.5, 20C <341>) <341>\\nKI\\t#65# 0.000219 {benzenesulfonamide}  (#65# pH 7.5, 20C <341>) <341>\\nKI\\t#65# 0.0000521 {2-hydrazinylbenzenesulfonamide}  (#65# pH 7.5, 20C \\n\\t<341>) <341>\\nKI\\t#65# 0.0000567 {4-(2-hydroxyethyl)benzenesulfonamide}  (#65# pH 7.5, \\n\\t20C <341>) <341>\\nKI\\t#65# 0.0000545 {4-(hydroxymethyl)benzenesulfonamide}  (#65# pH 7.5, \\n\\t20C <341>) <341>\\nKI\\t#65# 0.000447 {4-(aminomethyl)benzenesulfonamide}  (#65# pH 7.5, 20C \\n\\t<341>) <341>\\nKI\\t#65# 0.000402 {4-(2-aminoethyl)benzenesulfonamide}  (#65# pH 7.5, 20C \\n\\t<341>) <341>\\nKI\\t#65# 0.0000991 {4-amino-3-iodobenzenesulfonamide}  (#65# pH 7.5, 20C \\n\\t<341>) <341>\\nKI\\t#65# 0.0000629 {4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide}  \\n\\t(#65# pH 7.5, 20C <341>) <341>\\nKI\\t#65# 0.0000453 {4-amino-6-chlorobenzene-1,3-disulfonamide}  (#65# pH \\n\\t7.5, 20C <341>) <341>\\nKI\\t#65# 0.0000427 {4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide}  (#65# \\n\\tpH 7.5, 20C <341>) <341>\\nKI\\t#65# 0.0000303 \\n\\t{4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzenesulfonamide}  (#65# pH \\n\\t7.5, 20C <341>) <341>\\nKI\\t#65# 0.0000598 {4-[(2-aminopyrimidin-4-yl)amino]benzenesulfonamide}  \\n\\t(#65# pH 7.5, 20C <341>) <341>\\nKI\\t#65# 0.0000715 {4-sulfamoylbenzoic acid}  (#65# pH 7.5, 20C <341>) \\n\\t<341>\\nKI\\t#65# 0.0000371 {4,5-dichlorobenzene-1,3-disulfonamide}  (#65# pH 7.5, \\n\\t20C <341>) <341>\\nKI\\t#65# 0.000982 {1-(1,2-benzoxazol-3-yl)methanesulfonamide}  (#65# pH \\n\\t7.5, 20C <341>) <341>\\nKI\\t#65# 0.0000897 \\n\\t{4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide}  (#65# pH \\n\\t7.5, 20C <341>) <341>\\nKI\\t#65# 0.0000884 {4-(1,1-dioxido-1,2-thiazinan-2-yl)benzenesulfonamide}  \\n\\t(#65# pH 7.5, 20C <341>) <341>\\nKI\\t#65# 0.0000795 \\n\\t{6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide \\n\\t1,1-dioxide}  (#65# pH 7.5, 20C <341>) <341>\\nKI\\t#73# 0.001 {acetazolamide}  <54>\\nKI\\t#74# 0.00057 {sulfanilamide}  (#74# pH 7.5, 20C <148>) <148>\\nKI\\t#74# 0.0026 \\n\\t{4-[(acetyloxy)amino]-N-[4-(aminosulfonyl)phenyl]benzenesulfonamide}  \\n\\t(#74# pH 7.5, 20C <148>) <148>\\nKI\\t#74# 0.00054 {N-[4-(aminosulfonyl)phenyl]-2,2-dimethylpropanamide}  \\n\\t(#74# pH 7.5, 20C <148>) <148>\\nKI\\t#74# 0.0036 {N-[4-(aminosulfonyl)phenyl]propanamide}  (#74# pH 7.5, \\n\\t20C <148>) <148>\\nKI\\t#74# 0.0000039 {ethoxzolamide}  (#74# pH 7.5, 20C <148>) <148>\\nKI\\t#74# 0.000025 \\n\\t{4-(aminosulfonyl)-N-[2-[4-(aminosulfonyl)phenyl]ethyl]benzamide}  \\n\\t(#74# pH 7.5, 20C <148>) <148>\\nKI\\t#74# 0.000318 {4-[[(phenylsulfonyl)amino]methyl]benzenesulfonamide}  \\n\\t(#74# pH 7.5, 20C <148>) <148>\\nKI\\t#74# 0.000039 {4-[2-[(anilinocarbonyl)amino]ethyl]benzenesulfonamide}  \\n\\t(#74# pH 7.5, 20C <148>) <148>\\nKI\\t#74# 0.00303 \\n\\t{4-[2-[([[4-\\n\\t(aminosulfonyl)phenyl]amino]carbonothioyl)\\n\\tamino]ethyl]benzenesulfonamide}  (#74# pH 7.5, 20C <148>) <148>\\nKI\\t#74# 0.0047 {N-[4-(aminosulfonyl)phenyl]-2,2,2-trifluoroacetamide}  \\n\\t(#74# pH 7.5, 20C <148>) <148>\\nKI\\t#74# 0.00026 {N-[4-(aminosulfonyl)phenyl]pentanamide}  (#74# pH 7.5, \\n\\t20C <148>) <148>\\nKI\\t#74# 0.000072 \\n\\t{5-[[(4-nitrophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#74# pH 7.5, 20C <148>) <148>\\nKI\\t#74# 0.00243 {4-[(phenylsulfonyl)amino]benzenesulfonamide}  (#74# pH \\n\\t7.5, 20C <148>) <148>\\nKI\\t#74# 0.000066 {4-[(methylsulfonyl)amino]benzenesulfonamide}  (#74# pH \\n\\t7.5, 20C <148>) <148>\\nKI\\t#74# 0.000062 \\n\\t{5-[[(4-bromophenyl)sulfonyl]amino]-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#74# pH 7.5, 20C <148>) <148>\\nKI\\t#74# 0.000069 \\n\\t{4-[(anilinocarbonyl)amino]-6-chlorobenzene-1,3-disulfonamide}  (#74# \\n\\tpH 7.5, 20C <148>) <148>\\nKI\\t#74# 0.00455 {N-[4-(aminosulfonyl)phenyl]acetamide}  (#74# pH 7.5, 20C \\n\\t<148>) <148>\\nKI\\t#74# 0.000397 {N-[4-(aminosulfonyl)phenyl]butanamide}  (#74# pH 7.5, \\n\\t20C <148>) <148>\\nKI\\t#74# 0.000573 {N-[4-(aminosulfonyl)phenyl]-2-methylpropanamide}  (#74# \\n\\tpH 7.5, 20C <148>) <148>\\nKI\\t#74# 0.003245 {N-[4-(aminosulfonyl)phenyl]benzamide}  (#74# pH 7.5, \\n\\t20C <148>) <148>\\nKI\\t#74# 0.00297 \\n\\t{4-[[(anilinocarbonothioyl)amino]methyl]benzenesulfonamide}  (#74# pH \\n\\t7.5, 20C <148>) <148>\\nKI\\t#74# 0.00298 \\n\\t{4-[2-[(anilinocarbonothioyl)amino]ethyl]benzenesulfonamide}  (#74# pH \\n\\t7.5, 20C <148>) <148>\\nKI\\t#74# 0.00365 {3-[(anilinocarbonyl)amino]benzenesulfonamide}  (#74# pH \\n\\t7.5, 20C <148>) <148>\\nKI\\t#74# 0.000768 \\n\\t{N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)furan-2-carboxamide}  (#74# pH \\n\\t7.5, 20C <148>) <148>\\nKI\\t#74,162# 0.000303 {acetazolamide}  (#74# pH 7.5, 20C <148>; #162# \\n\\tisozyme bsCAII, pH 8.3, temperature not specified in the publication \\n\\t<298>) <148,298>\\nKI\\t#85# 0.000378 \\n\\t{4-(2-hydroxymethyl-4-nitrophenyl-sulfonamidoethyl)-benzenesulfonamide} \\n\\t (#85# at pH 7.5 and 37C <408>) <408>\\nKI\\t#85# 0.000733 {acetazolamide}  (#85# at pH 7.5 and 37C <408>) <408>\\nKI\\t#85# 0.000387 {benzolamide}  (#85# at pH 7.5 and 37C <408>) <408>\\nKI\\t#85# 0.000319 \\n\\t{5-((4-aminophenyl)sulfonamido)-1,3,4-thiadiazole-2-sulfonamide}  (#85# \\n\\tat pH 7.5 and 37C <408>) <408>\\nKI\\t#87# 0.006 {CS32-}  (#87# pH 7.5, 20C <329>) <329>\\nKI\\t#87# 0.006 {Ph-AsO3H2}  (#87# pH 7.5, 20C <329>) <329>\\nKI\\t#87# 0.004 {H2NSO2NH2}  (#87# pH 7.5, 20C <329>) <329>\\nKI\\t#87# 0.008 {Et2NCS2-}  (#87# pH 7.5, 20C <329>) <329>\\nKI\\t#87# 0.008 {Ph-B(OH)2}  (#87# pH 7.5, 20C <329>) <329>\\nKI\\t#87# 0.005 {H2NSO3H}  (#87# pH 7.5, 20C <329>) <329>\\nKI\\t#87# 0.88 {SeCN-}  (#87# pH 7.5, 20C <329>) <329>\\nKI\\t#87# 0.69 {FSO3-}  (#87# pH 7.5, 20C <329>) <329>\\nKI\\t#87# 0.62 {sulfate}  (#87# pH 7.5, 20C <329>) <329>\\nKI\\t#87# 0.000027 {acetazolamide}  (#87# pH 7.5, 20C <329>) <329>\\nKI\\t#87# 0.87 {[S2O8]2-}  (#87# pH 7.5, 20C <329>) <329>\\nKI\\t#88# 0.00009 {hydrogen sulfide}  (#88# pH 7.5, 20C <334>) <334>\\nKI\\t#88# 0.000048 {sulfamide}  (#88# pH 7.5, 20C <334>) <334>\\nKI\\t#88# 0.000009 {phenylboronic acid}  (#88# pH 7.5, 20C <334>) <334>\\nKI\\t#88# 0.000079 {sulfamate}  (#88# pH 7.5, 20C <334>) <334>\\nKI\\t#88# 0.000076 {phenylarsonic acid}  (#88# pH 7.5, 20C <334>) <334>\\nKI\\t#88# 0.000083 {5-acetamido-1,3,4-thiadiazole-2-sulfonamide}  (#88# pH \\n\\t7.5, 20C <334>) <334>\\nKI\\t#91# 0.01 {N3-}  (#91# pH 7.5, 20C, inhibition of CO2 hydration \\n\\treaction <385>) <385>\\nKI\\t#91# 0.01 {NO3-}  (#91# pH 7.5, 20C, inhibition of CO2 hydration \\n\\treaction <385>) <385>\\nKI\\t#91# 0.0055 {SO42-}  (#91# pH 7.5, 20C, inhibition of CO2 hydration \\n\\treaction <385>) <385>\\nKI\\t#91# 0.039 {Cl-}  (#91# pH 7.5, 20C, inhibition of CO2 hydration \\n\\treaction <385>) <385>\\nKI\\t#91# 0.008 {SO32-}  (#91# pH 7.5, 20C, inhibition of CO2 hydration \\n\\treaction <385>) <385>\\nKI\\t#91# 0.0085 {I-}  (#91# pH 7.5, 20C, inhibition of CO2 hydration \\n\\treaction <385>) <385>\\nKI\\t#91# 0.0155 {NO2-}  (#91# pH 7.5, 20C, inhibition of CO2 hydration \\n\\treaction <385>) <385>\\nKI\\t#91# 0.121 {CO32-}  (#91# pH 7.5, 20C, inhibition of CO2 hydration \\n\\treaction <385>) <385>\\nKI\\t#91# 0.0275 {Br-}  (#91# pH 7.5, 20C, inhibition of CO2 hydration \\n\\treaction <385>) <385>\\nKI\\t#91# 0.0285 {SCN-}  (#91# pH 7.5, 20C, inhibition of CO2 hydration \\n\\treaction <385>) <385>\\nKI\\t#92# 0.0017 {sulfanilamide}  (#92# pH 8.5, 0C <128>) <128>\\nKI\\t#92# 0.00000081 {acetazolamide}  (#92# pH 8.5, 0C <128>) <128>\\nKI\\t#97# 0.000623 {acetazolamide}  (#97# at pH 8.3, temperature not \\n\\tspecified in the publication <439>) <439>\\nKI\\t#99# 0.09 {CNO-}  (#99# 20C, pH not specified in the publication, \\n\\tZn2+-substituted enzyme <316>) <316>\\nKI\\t#99# 0.09 {NO3-}  (#99# 20C, pH not specified in the publication, \\n\\tCo2+-substituted enzyme <316>) <316>\\nKI\\t#99# 0.0002 {ethoxzolamide}  (#99# isoenzyme gammaCA <169>; #99# 20C, \\n\\tpH not specified in the publication, Zn2+-containing enzyme <318>) \\n\\t<169,318>\\nKI\\t#99# 6.1 {SCN-}  (#99# 20C, pH not specified in the publication, \\n\\tCo2+-substituted enzyme <316>) <316>\\nKI\\t#99# 4.7 {CNO-}  (#99# 20C, pH not specified in the publication, \\n\\tCo2+-substituted enzyme <316>) <316>\\nKI\\t#99# 0.05 {HS-}  (#99# 20C, pH not specified in the publication, \\n\\tZn2+-substituted enzyme <316>) <316>\\nKI\\t#99# 0.1 {HCO3-}  (#99# 20C, pH not specified in the publication, \\n\\tCo2+-substituted enzyme <316>) <316>\\nKI\\t#99# 0.0013 {1-[4-[amino(dihydroxy)-lambda4-sulfanyl]phenyl]ethanamine} \\n\\t (#99# 20C, pH not specified in the publication, Co2+-containing \\n\\tenzyme <318>) <318>\\nKI\\t#99# 0.00025 {sulfanilamide}  (#99# 20C, pH not specified in the \\n\\tpublication, Zn2+-containing enzyme <318>) <318>\\nKI\\t#99# 0.009 {CO32-}  (#99# 20C, pH not specified in the publication, \\n\\tCo2+-substituted enzyme <316>) <316>\\nKI\\t#99# 1.8 {HSO3-}  (#99# 20C, pH not specified in the publication, \\n\\tCo2+-substituted enzyme <316>) <316>\\nKI\\t#99# 2 {HS-}  (#99# 20C, pH not specified in the publication, \\n\\tCo2+-substituted enzyme <316>) <316>\\nKI\\t#99# 6.8 {NO2-}  (#99# 20C, pH not specified in the publication, \\n\\tZn2+-substituted enzyme <316>) <316>\\nKI\\t#99# 0.069 {sulfamide}  (#99# 20C, pH not specified in the \\n\\tpublication, Zn2+-containing enzyme <318>) <318>\\nKI\\t#99# 0.00013 {valdecoxib}  (#99# 20C, pH not specified in the \\n\\tpublication, Zn2+-containing enzyme <318>) <318>\\nKI\\t#99# 0.00024 {valdecoxib}  (#99# 20C, pH not specified in the \\n\\tpublication, Co2+-containing enzyme <318>) <318>\\nKI\\t#99# 0.0022 {[4-[amino(dihydroxy)-lambda4-sulfanyl]phenyl]hydrazine}  \\n\\t(#99# 20C, pH not specified in the publication, Zn2+-containing enzyme \\n\\t<318>) <318>\\nKI\\t#99# 0.00022 {[4-[amino(dihydroxy)-lambda4-sulfanyl]phenyl]hydrazine}  \\n\\t(#99# 20C, pH not specified in the publication, Co2+-containing enzyme \\n\\t<318>) <318>\\nKI\\t#99# 0.00035 \\n\\t{1-[4-[amino(dihydroxy)-lambda4-sulfanyl]phenyl]methanamine}  (#99# \\n\\t20C, pH not specified in the publication, Zn2+-containing enzyme \\n\\t<318>) <318>\\nKI\\t#99# 7 {SCN-}  (#99# 20C, pH not specified in the publication, \\n\\tZn2+-substituted enzyme <316>) <316>\\nKI\\t#99# 0.0085 \\n\\t{1-[4-[amino(dihydroxy)-lambda4-sulfanyl]phenyl]methanamine}  (#99# \\n\\t20C, pH not specified in the publication, Co2+-containing enzyme \\n\\t<318>) <318>\\nKI\\t#99# 0.00017 {3-[amino(dihydroxy)-lambda4-sulfanyl]aniline}  (#99# \\n\\t20C, pH not specified in the publication, Zn2+-containing enzyme \\n\\t<318>) <318>\\nKI\\t#99# 0.00017 {methazolamide}  (#99# 20C, pH not specified in the \\n\\tpublication, Co2+-containing enzyme <318>) <318>\\nKI\\t#99# 0.00124 {3-[amino(dihydroxy)-lambda4-sulfanyl]aniline}  (#99# \\n\\t20C, pH not specified in the publication, Co2+-containing enzyme \\n\\t<318>) <318>\\nKI\\t#99# 0.0042 {4-[amino(dihydroxy)-lambda4-sulfanyl]-2-fluoroaniline}  \\n\\t(#99# 20C, pH not specified in the publication, Co2+-containing enzyme \\n\\t<318>) <318>\\nKI\\t#99# 0.00012 {6-chloro-4-amino-benzene-1,3-disulfonamide}  (#99# \\n\\tisoenzyme gammaCA <169>) <169>\\nKI\\t#99# 0.00012 \\n\\t{2,4-bis[amino(dihydroxy)-lambda4-sulfanyl]-5-chloroaniline}  (#99# \\n\\t20C, pH not specified in the publication, Zn2+-containing enzyme \\n\\t<318>) <318>\\nKI\\t#99# 0.00012 {topiramate}  (#99# 20C, pH not specified in the \\n\\tpublication, Co2+-containing enzyme <318>) <318>\\nKI\\t#99# 0.00028 {4-[amino(dihydroxy)-lambda4-sulfanyl]-2-iodoaniline}  \\n\\t(#99# 20C, pH not specified in the publication, Zn2+-containing enzyme \\n\\t<318>) <318>\\nKI\\t#99# 0.00028 {4-[amino(dihydroxy)-lambda4-sulfanyl]-2-bromoaniline}  \\n\\t(#99# 20C, pH not specified in the publication, Co2+-containing enzyme \\n\\t<318>) <318>\\nKI\\t#99# 0.00074 {ethoxzolamide}  (#99# 20C, pH not specified in the \\n\\tpublication, Co2+-containing enzyme <318>) <318>\\nKI\\t#99# 0.00074 {4-[amino(dihydroxy)-lambda4-sulfanyl]-2-chloroaniline}  \\n\\t(#99# 20C, pH not specified in the publication, Co2+-containing enzyme \\n\\t<318>) <318>\\nKI\\t#99# 0.00014 \\n\\t{N-[5-(aminosulfonyl)-3-methyl-1,3,\\n\\t4-thiadiazol-2(3H)-ylidene]acetamide}  (#99# isoenzyme gammaCA <169>) \\n\\t<169>\\nKI\\t#99# 0.00014 {methazolamide}  (#99# 20C, pH not specified in the \\n\\tpublication, Zn2+-containing enzyme <318>) <318>\\nKI\\t#99# 0.00014 {celecoxib}  (#99# 20C, pH not specified in the \\n\\tpublication, Zn2+-containing enzyme <318>) <318>\\nKI\\t#99# 0.00014 {4-[amino(dihydroxy)-lambda4-sulfanyl]-2-chloroaniline}  \\n\\t(#99# 20C, pH not specified in the publication, Zn2+-containing enzyme \\n\\t<318>) <318>\\nKI\\t#99# 4.9 {N3-}  (#99# 20C, pH not specified in the publication, \\n\\tCo2+-substituted enzyme <316>) <316>\\nKI\\t#99# 0.00018 {4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide}  (#99# \\n\\t20C, pH not specified in the publication, Zn2+-containing enzyme \\n\\t<318>) <318>\\nKI\\t#99# 0.00015 \\n\\t{1,5-bis[amino(dihydroxy)-lambda4-sulfanyl]-2,3-dichlorobenzene}  (#99# \\n\\t20C, pH not specified in the publication, Co2+-containing enzyme \\n\\t<318>) <318>\\nKI\\t#99# 0.68 {CN-}  (#99# 20C, pH not specified in the publication, \\n\\tZn2+-substituted enzyme <316>) <316>\\nKI\\t#99# 0.00046 \\n\\t{2-(3-methoxypropyl)-4-(methylamino)-3,4-dihydro-2H-thieno[3,2-e][1,\\n\\t2]thiazine-6-sulfonamide 1,1-dioxide}  (#99# isoenzyme gammaCA <169>) \\n\\t<169>\\nKI\\t#99# 0.00095 \\n\\t{2,4-bis[amino(dihydroxy)-lamba4-sulfanyl]-5-(trifluoromethyl)aniline}  \\n\\t(#99# 20C, pH not specified in the publication, Co2+-containing enzyme \\n\\t<318>) <318>\\nKI\\t#99# 0.00027 \\n\\t{1-[4-[amino(dihydroxy)-lambda4-sulfanyl]phenyl]ethanamine}  (#99# \\n\\t20C, pH not specified in the publication, Zn2+-containing enzyme \\n\\t<318>) <318>\\nKI\\t#99# 5.8 {N3-}  (#99# 20C, pH not specified in the publication, \\n\\tZn2+-substituted enzyme <316>) <316>\\nKI\\t#99# 0.00019 {4,5-dichloro-benzene-1,3-disulfonamide}  (#99# isoenzyme \\n\\tgammaCA, i.e. daranide <169>) <169>\\nKI\\t#99# 0.00019 \\n\\t{1,5-bis[amino(dihydroxy)-lambda4-sulfanyl]-2,3-dichlorobenzene}  (#99# \\n\\t20C, pH not specified in the publication, Zn2+-containing enzyme \\n\\t<318>) <318>\\nKI\\t#99# 7.3 {NO2-}  (#99# 20C, pH not specified in the publication, \\n\\tCo2+-substituted enzyme <316>) <316>\\nKI\\t#99# 0.00083 {6-trifluoromethyl-4-aminobenzene-1,3-disulfonamide}  \\n\\t(#99# isoenzyme gammaCA <169>) <169>\\nKI\\t#99# 0.00083 \\n\\t{2,4-bis[amino(dihydroxy)-lamba4-sulfanyl]-5-(trifluoromethyl)aniline}  \\n\\t(#99# 20C, pH not specified in the publication, Zn2+-containing enzyme \\n\\t<318>) <318>\\nKI\\t#99# 6.7 {CO32-}  (#99# 20C, pH not specified in the publication, \\n\\tZn2+-substituted enzyme <316>) <316>\\nKI\\t#99# 0.00066 {4-[amino(dihydroxy)-lambda4-sulfanyl]-2-iodoaniline}  \\n\\t(#99# 20C, pH not specified in the publication, Co2+-containing enzyme \\n\\t<318>) <318>\\nKI\\t#99# 0.00061 \\n\\t{2,4-bis[amino(dihydroxy)-lambda4-sulfanyl]-5-chloroaniline}  (#99# \\n\\t20C, pH not specified in the publication, Co2+-containing enzyme \\n\\t<318>) <318>\\nKI\\t#99# 0.00101 {celecoxib}  (#99# 20C, pH not specified in the \\n\\tpublication, Co2+-containing enzyme <318>) <318>\\nKI\\t#99# 42 {HCO3-}  (#99# 20C, pH not specified in the publication, \\n\\tZn2+-substituted enzyme <316>) <316>\\nKI\\t#99# 11.7 {HSO3-}  (#99# 20C, pH not specified in the publication, \\n\\tZn2+-substituted enzyme <316>) <316>\\nKI\\t#99# 0.00097 {4-[amino(dihydroxy)-lambda4-sulfanyl]-2-fluoroaniline}  \\n\\t(#99# 20C, pH not specified in the publication, Zn2+-containing enzyme \\n\\t<318>) <318>\\nKI\\t#99# 0.00171 {dorzolamide}  (#99# 20C, pH not specified in the \\n\\tpublication, Co2+-containing enzyme <318>) <318>\\nKI\\t#99# 0.000096 {sulfamic acid}  (#99# 20C, pH not specified in the \\n\\tpublication, Zn2+-containing enzyme <318>) <318>\\nKI\\t#99# 0.00143 {acetazolamide}  (#99# 20C, pH not specified in the \\n\\tpublication, Co2+-containing enzyme <318>) <318>\\nKI\\t#99# 0.00102 {topiramate}  (#99# isoenzyme gammaCA <169>; #99# 20C, pH \\n\\tnot specified in the publication, Zn2+-containing enzyme <318>) \\n\\t<169,318>\\nKI\\t#99# 0.00041 \\n\\t{6-methyl-4-(methylamino)-5,6-dihydro-4H-thieno[2,\\n\\t3-b]thiopyran-2-sulfonamide 7,7-dioxide}  (#99# isoenzyme gammaCA \\n\\t<169>) <169>\\nKI\\t#99# 0.00041 {dorzolamide}  (#99# 20C, pH not specified in the \\n\\tpublication, Zn2+-containing enzyme <318>) <318>\\nKI\\t#99# 0.00172 {4-[amino(dihydroxy)-lambda4-sulfanyl]-2-bromoaniline}  \\n\\t(#99# 20C, pH not specified in the publication, Zn2+-containing enzyme \\n\\t<318>) <318>\\nKI\\t#99# 0.00596 {sulfamide}  (#99# 20C, pH not specified in the \\n\\tpublication, Co2+-containing enzyme <318>) <318>\\nKI\\t#99# 0.00636 {4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide}  (#99# \\n\\t20C, pH not specified in the publication, Co2+-containing enzyme \\n\\t<318>) <318>\\nKI\\t#99# 36.5 {NO3-}  (#99# 20C, pH not specified in the publication, \\n\\tZn2+-substituted enzyme <316>) <316>\\nKI\\t#99# 0.00336 {sulfamic acid}  (#99# 20C, pH not specified in the \\n\\tpublication, Co2+-containing enzyme <318>) <318>\\nKI\\t#99# 0.00393 {sulfanilamide}  (#99# 20C, pH not specified in the \\n\\tpublication, Co2+-containing enzyme <318>) <318>\\nKI\\t#99# 51.5 {CN-}  (#99# 20C, pH not specified in the publication, \\n\\tCo2+-substituted enzyme <316>) <316>\\nKI\\t#99,124,129,162# 0.000063 {acetazolamide}  (#99# isoenzyme gammaCA \\n\\t<169>; #129# isoenzyme hCA VA <169>; #124# isozyme CA VA, in 10 mM \\n\\tHEPES (pH 7.5) and 0.1 M Na2SO4 <229>; #124# isozyme carbonic anhydrase \\n\\tVA <202>; #162# at 20C, pH 8.3 in 20 mM Tris-HCl buffer and 20 mM NaCl \\n\\t<257>; #162# in 10-20 mM Tris, pH 8.3, 10-20 mM NaCl <277>; #162# \\n\\tisozyme bsCAI, pH 8.3, temperature not specified in the publication \\n\\t<298>; #99# 20C, pH not specified in the publication, Zn2+-containing \\n\\tenzyme <318>) <169,202,229,257,277,298,318>\\n\\nIC50_VALUE\\nIC50\\t#1# 0.012 \\n\\t{1-(3-acetyl-1,2-dihydro-2-thioxobenzo[d]imidazol-1-yl)hexan-1-one}  \\n\\t(#1# pH 7.4, 37C <285>) <285>\\nIC50\\t#1# 0.005 {1,3-diacetylbenzimidazole-2-thione}  (#1# pH 7.4, 37C \\n\\t<285>) <285>\\nIC50\\t#1# 0.017 {1-(2-thioxo-1H-benzo[d]imidazol-1-yl)ethanone}  (#1# pH 7.4, \\n\\t37C <285>) <285>\\nIC50\\t#1# 0.017 {1-(2-thioxobenzo[d]oxazol-3(2H)-yl)hexadecan-1-one}  (#1# pH \\n\\t7.4, 37C <285>) <285>\\nIC50\\t#1# 0.021 \\n\\t{methyl-3-(3-phenylpropanoyl)-2,\\n\\t3-dihydro-2-thioxobenzo[d]oxazole-5-carboxylate}  (#1# pH 7.4, 37C \\n\\t<285>) <285>\\nIC50\\t#1# 0.0001 {1,3-diacetyl-1H-benzo[d]imidazol-2(3H)-one}  (#1# pH 7.4, \\n\\t37C <285>) <285>\\nIC50\\t#1# 0.019 \\n\\t{1-(3-ethyl-1,2-dihydro-2-thioxobenzo[d]imidazole-1-yl)ethanone}  (#1# \\n\\tpH 7.4, 37C <285>) <285>\\nIC50\\t#1# 0.019 {4-phenyl-1-(2-thioxobenzo[d]oxazol-3(2H)-yl)butan-1-one}  \\n\\t(#1# pH 7.4, 37C <285>) <285>\\nIC50\\t#1# 0.025 {1-(2-thioxobenzo[d]oxazol-3(2H)-yl)decan-1-one}  (#1# pH \\n\\t7.4, 37C <285>) <285>\\nIC50\\t#1# 0.029 {1-(2-thioxo-1H-benzo[d]imidazol-1-yl)-3-phenylpropan-1-one}  \\n\\t(#1# pH 7.4, 37C <285>) <285>\\nIC50\\t#1# 0.029 {1-(2-thioxobenzo[d]oxazol-3(2H)-yl)hexan-1-one}  (#1# pH \\n\\t7.4, 37C <285>) <285>\\nIC50\\t#1# 0.016 {1-(2-thioxo-1H-benzo[d]imidazol-1-yl)hexan-1-one}  (#1# pH \\n\\t7.4, 37C <285>) <285>\\nIC50\\t#1# 0.048 {1-(2-thioxobenzo[d]oxazol-3(2H)-yl)propan-1-one}  (#1# pH \\n\\t7.4, 37C <285>) <285>\\nIC50\\t#1# 0.026 {1-(2-thioxo-1H-benzo[d]imidazol-1-yl)propan-1one}  (#1# pH \\n\\t7.4, 37C <285>) <285>\\nIC50\\t#1# 0.062 {2-phenoxy-1-(2-thioxobenzo[d]oxazol-3(2H)-yl)ethanone}  (#1# \\n\\tpH 7.4, 37C <285>) <285>\\nIC50\\t#1# 0.02 {1-(2-Tthioxo-1H-benzo[d]imidazol-1-yl)butan-1-one}  (#1# pH \\n\\t7.4, 37C <285>) <285>\\nIC50\\t#1# 0.02 {3-cyclohexyl-1-(2-thioxobenzo[d]oxazol-3(2H)-yl)propan-1-one} \\n\\t (#1# pH 7.4, 37C <285>) <285>\\nIC50\\t#1# 0.07 {(3-chlorophenyl)(2-thioxo-1H-benzo[d]imidazol-1-yl)methanone} \\n\\t (#1# pH 7.4, 37C <285>) <285>\\nIC50\\t#1# 0.024 {3-phenyl-1-(2-thioxobenzo[d]oxazol-3(2H)-yl)propan-1-one}  \\n\\t(#1# pH 7.4, 37C <285>) <285>\\nIC50\\t#1# 0.069 {2-phenyl-1-(2-thioxobenzo[d]oxazol-3(2H)-yl)ethanone}  (#1# \\n\\tpH 7.4, 37C <285>) <285>\\nIC50\\t#1# 0.042 {1-(2-thioxobenzo[d]oxazol-3(2H)-yl)ethanone}  (#1# pH 7.4, \\n\\t37C <285>) <285>\\nIC50\\t#1# 0.556 {benzyl 2-thioxobenzo[d]oxazol-3(2H)-carboxylate}  (#1# pH \\n\\t7.4, 37C <285>) <285>\\nIC50\\t#10# 0.015 {cyanide}  (#10# isozyme CAH8, in 20 mM \\n\\t4-(2-hydroxyethyl)-1-piperazine propane sulfonic acid, pH 8.0, at 4C \\n\\t<239>) <239>\\nIC50\\t#10# 1.9 {azide}  (#10# isozyme CAH8, in 20 mM \\n\\t4-(2-hydroxyethyl)-1-piperazine propane sulfonic acid, pH 8.0, at 4C \\n\\t<239>) <239>\\nIC50\\t#10# 0.02 {ethoxyzolamide}  (#10# isozyme CAH8, in 20 mM \\n\\t4-(2-hydroxyethyl)-1-piperazine propane sulfonic acid, pH 8.0, at 4C \\n\\t<239>) <239>\\nIC50\\t#10# 0.044 {ethoxyzolamide}  (#10# isozyme CAH7, in 20 mM \\n\\t4-(2-hydroxyethyl)-1-piperazine propane sulfonic acid, pH 8.0, at 4C \\n\\t<239>) <239>\\nIC50\\t#10# 0.0044 {acetazolamide}  (#10# isozyme CAH7, in 20 mM \\n\\t4-(2-hydroxyethyl)-1-piperazine propane sulfonic acid, pH 8.0, at 4C \\n\\t<239>) <239>\\nIC50\\t#10# 0.041 {acetazolamide}  (#10# isozyme CAH8, in 20 mM \\n\\t4-(2-hydroxyethyl)-1-piperazine propane sulfonic acid, pH 8.0, at 4C \\n\\t<239>) <239>\\nIC50\\t#10# 0.061 {cyanide}  (#10# isozyme CAH7, in 20 mM \\n\\t4-(2-hydroxyethyl)-1-piperazine propane sulfonic acid, pH 8.0, at 4C \\n\\t<239>) <239>\\nIC50\\t#10,43# 0.003 {azide}  (#10# isozyme CAH7, in 20 mM \\n\\t4-(2-hydroxyethyl)-1-piperazine propane sulfonic acid, pH 8.0, at 4C \\n\\t<239>) <239>\\nIC50\\t#10,43# 0.003 {azide}  (#10# isozyme CAH7, in 20 mM \\n\\t4-(2-hydroxyethyl)-1-piperazine propane sulfonic acid, pH 8.0, at 4C \\n\\t<239>) <282>\\nIC50\\t#100# 0.0058 {p-aminomethylbenzenesulfonamide}  (#100# IC50: 0.0058 mM \\n\\t<161>) <161>\\nIC50\\t#100# 2.2 {ClO4-}  (#100# IC50: 2.2 mM <161>) <161>\\nIC50\\t#100# 50 {N3-}  (#100# IC50: about 50 mM <161>) <161>\\nIC50\\t#100# 100 {I-}  (#100# IC50: 100 mM <161>) <161>\\nIC50\\t#100,124# 0.000097 {acetazolamide}  (#100# IC50: 97 nM <161>; #124# pH \\n\\tnot specified in the publication, temperature not specified in the \\n\\tpublication <410>) <161>\\nIC50\\t#100,124# 0.000097 {acetazolamide}  (#100# IC50: 97 nM <161>; #124# pH \\n\\tnot specified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nIC50\\t#12# 0.00049 {acetazolamide}  (#12# isoform carbonic anhydrase XIII, \\n\\tusing 4-nitrophenyl acetate as substrate, at pH 7.4 and 25C <200>) \\n\\t<200>\\nIC50\\t#12# 0.00105 {acetazolamide}  (#12# isoform carbonic anhydrase XIII, \\n\\tusing 4-nitrophenyl phosphate as substrate, at pH 7.4 and 25C <200>) \\n\\t<200>\\nIC50\\t#122# 0.004 {sulphanilamide}  (#122# pH 7.4, 30C, inhibition of CO2 \\n\\thydration activity <308>) <308>\\nIC50\\t#122# 0.0001 {acetazolamide}  (#122# pH 7.4, 30C, inhibition of CO2 \\n\\thydration activity <308>) <308>\\nIC50\\t#122# 3 {Co2+}  (#122# pH 7.4, 30C, inhibition of CO2 hydration \\n\\tactivity <308>) <308>\\nIC50\\t#122# 0.016 {propineb}  (#122# pH 7.4, 30C, inhibition of CO2 \\n\\thydration activity <308>) <308>\\nIC50\\t#122# 1.7 {Ag+}  (#122# pH 7.4, 30C, inhibition of CO2 hydration \\n\\tactivity <308>) <308>\\nIC50\\t#122# 0.018 {maneb}  (#122# pH 7.4, 30C, inhibition of CO2 hydration \\n\\tactivity <308>) <308>\\nIC50\\t#122# 0.24 {2,4-Dichlorophenol}  (#122# pH 7.4, 30C, inhibition of CO2 \\n\\thydration activity <308>) <308>\\nIC50\\t#122# 5.2 {Cu2+}  (#122# pH 7.4, 30C, inhibition of CO2 hydration \\n\\tactivity <308>) <308>\\nIC50\\t#122# 2.8 {Zn2+}  (#122# pH 7.4, 30C, inhibition of CO2 hydration \\n\\tactivity <308>) <308>\\nIC50\\t#122# 0.398 {Carbaryl}  (#122# pH 7.4, 30C, inhibition of CO2 \\n\\thydration activity <308>) <308>\\nIC50\\t#122# 0.102 {parathion}  (#122# pH 7.4, 30C, inhibition of CO2 \\n\\thydration activity <308>) <308>\\nIC50\\t#124# 0.01 {nitrate}  (#124# pH 7.5, 20C, inhibition of CO2 hydration \\n\\treaction <397>) <397>\\nIC50\\t#124# 0.0001 \\n\\t{N\\'-[(1Z)-1-(furan-3-yl)ethylidene]butane-1-sulfonohydrazide}  (#124# \\n\\tpH not specified in the publication, temperature not specified in the \\n\\tpublication <432>) <432>\\nIC50\\t#124# 0.231 {malvin}  (#124# versus CO2 hydration activity, pH and \\n\\ttemperature not specified in the publication <378>) <378>\\nIC50\\t#124# 0.05 {[Co(1-benzyl-2-methylimidazole)2Cl2]}  (#124# above, pH \\n\\t7.5, 22C <393>) <393>\\nIC50\\t#124# 0.05 {[Zn(1-benzyl-2-methylimidazole)2Cl2]}  (#124# above, pH \\n\\t7.5, 22C <393>) <393>\\nIC50\\t#124# 0.000019 {acetazolamide}  (#124# pH 7.5, 22C <393>) <393>\\nIC50\\t#124# 0.0013 {silychristin}  (#124# versus CO2 hydration activity, pH \\n\\tand temperature not specified in the publication <378>) <378>\\nIC50\\t#124# 0.000197 \\n\\t{1-(3-cyanobenzyl)-3-(4-methylbenzyl)-3H-benzoimidazol-1-ium bromide}  \\n\\t(#124# pH not specified in the publication, temperature not specified \\n\\tin the publication <409>) <409>\\nIC50\\t#124# 0.000197 {acetazolamide}  (#124# pH not specified in the \\n\\tpublication, temperature not specified in the publication <432>) <432>\\nIC50\\t#124# 0.00017 \\n\\t{N\\'-[(1Z)-1-(thiophen-3-yl)ethylidene]butane-1-sulfonohydrazide}  \\n\\t(#124# pH not specified in the publication, temperature not specified \\n\\tin the publication <432>) <432>\\nIC50\\t#124# 0.00035 {oenin}  (#124# versus CO2 hydration activity, pH and \\n\\ttemperature not specified in the publication <378>) <378>\\nIC50\\t#124# 0.000121 {acetazolamide}  (#124# pH 8, 25C <431>) <431>\\nIC50\\t#124# 0.00025 \\n\\t{1-(3-cyanobenzyl)-3-(2-methylbenzyl)-3H-benzoimidazol-1-ium bromide}  \\n\\t(#124# pH not specified in the publication, temperature not specified \\n\\tin the publication <409>) <409>\\nIC50\\t#124# 0.00137 \\n\\t{N\\'\\',N\\'\\'\\'-bis[(E)-(2-chloro-5-nitrophenyl)methylidene]carbonic \\n\\tdihydrazide}  (#124# pH 7.4, 25C <396>) <396>\\nIC50\\t#124# 0.0000187 \\n\\t{1,3-bis(4-bromobenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  (#124# pH \\n\\tnot specified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nIC50\\t#124# 0.000033 {3-iodo-1-phenethyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine} \\n\\t (#124# pH not specified in the publication, temperature not specified \\n\\tin the publication <410>) <410>\\nIC50\\t#124# 0.00185 {N\\'\\',N\\'\\'\\'-bis[(E)-(2-nitrophenyl)methylidene]carbonic \\n\\tdihydrazide}  (#124# pH 7.4, 25C <396>) <396>\\nIC50\\t#124# 0.0168 {1-methoxy-3-(3-methylanilino)propane-2-thiol}  (#124# \\n\\t25C, pH not specified in the publication <433>) <433>\\nIC50\\t#124# 0.0264 {1-anilino-3-[(oxolan-2-yl)methoxy]propane-2-thiol}  \\n\\t(#124# 25C, pH not specified in the publication <433>) <433>\\nIC50\\t#124# 0.000204 \\n\\t{1-(3-cyanobenzyl)-3-(2,4,6-trimethyl-benzyl)-3H-benzoimidazol-1-ium \\n\\tbromide}  (#124# pH not specified in the publication, temperature not \\n\\tspecified in the publication <409>) <409>\\nIC50\\t#124# 0.0000405 {1-benzyl-3-(N-methyphthalimide)-2-methylimidazolium \\n\\tbromide}  (#124# pH not specified in the publication, temperature not \\n\\tspecified in the publication <417>) <417>\\nIC50\\t#124# 0.000089 \\n\\t{N\\'-[(1Z)-1-(5-chlorothiophen-3-yl)ethylidene]butane-1-\\n\\tsulfonohydrazide}  (#124# pH not specified in the publication, \\n\\ttemperature not specified in the publication <432>) <432>\\nIC50\\t#124# 0.00232 {N\\'\\',N\\'\\'\\'-bis[(E)-(4-bromophenyl)methylidene]carbonic \\n\\tdihydrazide}  (#124# pH 7.4, 25C <396>) <396>\\nIC50\\t#124# 0.0000537 {tris(2-pyridyl)phosphine selenide}  (#124# 25C, pH \\n\\tnot specified in the publication <412>) <412>\\nIC50\\t#124# 0.000158 \\n\\t{N\\'-[(Z)-(1H-indol-3-yl)methylidene]butane-1-sulfonohydrazide}  (#124# \\n\\tpH not specified in the publication, temperature not specified in the \\n\\tpublication <432>) <432>\\nIC50\\t#124# 0.0000277 \\n\\t{3-iodo-1-(4-methoxybenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  \\n\\t(#124# pH not specified in the publication, temperature not specified \\n\\tin the publication <410>) <410>\\nIC50\\t#124# 0.000261 \\n\\t{1-(3-cyanobenzyl)-3-(2,3,5,\\n\\t6-tetramethyl-benzyl)-3H-benzoimidazol-1-ium bromide}  (#124# pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <409>) <409>\\nIC50\\t#124# 0.00133 {N\\'\\',N\\'\\'\\'-bis[(E)-(4-nitrophenyl)methylidene]carbonic \\n\\tdihydrazide}  (#124# pH 7.4, 25C <396>) <396>\\nIC50\\t#124# 0.00267 \\n\\t{N\\'\\',N\\'\\'\\'-Bis[(E)-(2,4-dichlorophenyl)methylidene]carbonic dihydrazide} \\n\\t (#124# pH 7.4, 25C <396>) <396>\\nIC50\\t#124# 0.0000347 \\n\\t{1-(3-fluorobenzyl)-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  (#124# \\n\\tpH not specified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nIC50\\t#124# 0.0000881 {acetazolamide}  (#124# pH not specified in the \\n\\tpublication, temperature not specified in the publication <417>) <417>\\nIC50\\t#124# 0.0000415 {1-decyl-3-(2,4,6-trimethoxybenzyl)-2-methylimidazolium \\n\\tchloride}  (#124# pH not specified in the publication, temperature not \\n\\tspecified in the publication <417>) <417>\\nIC50\\t#124# 0.00146 \\n\\t{N\\'\\',N\\'\\'\\'-bis[(E)-(2,6-dichlorophenyl)methylidene]carbonic dihydrazide} \\n\\t (#124# pH 7.4, 25C <396>) <396>\\nIC50\\t#124# 0.00233 {N\\'\\',N\\'\\'\\'-bis[(E)-(2-chlorophenyl)methylidene]carbonic \\n\\tdihydrazide}  (#124# pH 7.4, 25C <396>) <396>\\nIC50\\t#124# 0.000418 {acetazolamide}  (#124# pH not specified in the \\n\\tpublication, temperature not specified in the publication <409>) <409>\\nIC50\\t#124# 0.00396 {N\\'\\',N\\'\\'\\'-bis[(E)-(2-bromophenyl)methylidene]carbonic \\n\\tdihydrazide}  (#124# pH 7.4, 25C <396>) <396>\\nIC50\\t#124# 0.0315 {1-anilino-4,4,5,5-tetrafluoropentane-2-thiol}  (#124# \\n\\t25C, pH not specified in the publication <433>) <433>\\nIC50\\t#124# 0.0000182 \\n\\t{4-[(4-amino-3-iodo-1H-pyrazolo[3,\\n\\t4-d]pyrimidin-1-yl)methyl]-2-methoxyphenyl methanesulfonate}  (#124# pH \\n\\tnot specified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nIC50\\t#124# 0.0000289 {1-benzyl-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  \\n\\t(#124# pH not specified in the publication, temperature not specified \\n\\tin the publication <410>) <410>\\nIC50\\t#124# 0.0000239 {1-butyl-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  \\n\\t(#124# pH not specified in the publication, temperature not specified \\n\\tin the publication <410>) <410>\\nIC50\\t#124# 0.0000301 \\n\\t{(E)-3-iodo-1-styryl-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  (#124# pH \\n\\tnot specified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nIC50\\t#124# 0.0533 {1-(4-methoxyphenyl)-2-methyl-3-nitro-1-H-indol-6-ol}  \\n\\t(#124# versus CO2 hydration activity, pH and temperature not specified \\n\\tin the publication <378>) <378>\\nIC50\\t#124# 0.0000161 {methyl \\n\\t2-[(4-amino-3-iodo-1H-pyrazolo[3,\\n\\t4-d]pyrimidin-1-yl)methyl]-3-nitrobenzoate}  (#124# pH not specified in \\n\\tthe publication, temperature not specified in the publication <410>) \\n\\t<410>\\nIC50\\t#124# 0.0000568 {1-decyl-3-(N-methyphthalimide)-2-methylimidazolium \\n\\tbromide}  (#124# pH not specified in the publication, temperature not \\n\\tspecified in the publication <417>) <417>\\nIC50\\t#124# 0.0000315 {3-iodo-1-propyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  \\n\\t(#124# pH not specified in the publication, temperature not specified \\n\\tin the publication <410>) <410>\\nIC50\\t#124# 0.0000315 \\n\\t{1-(4-chlorobenzyl)-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  (#124# \\n\\tpH not specified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nIC50\\t#124# 0.0000377 {tris(2-pyridyl)phosphine sulfide}  (#124# 25C, pH not \\n\\tspecified in the publication <412>) <412>\\nIC50\\t#124# 0.0000778 \\n\\t{2,2\\'-(1-phenylethane-1,1-diyl)bis(sulfanediyl)bis(N-benzylacetamide)}  \\n\\t(#124# pH 8, 25C <431>) <431>\\nIC50\\t#124# 0.0000488 \\n\\t{1-benzyl-3-(2,4,6-trimethoxybenzyl)-2-methylimidazolium chloride}  \\n\\t(#124# pH not specified in the publication, temperature not specified \\n\\tin the publication <417>) <417>\\nIC50\\t#124# 0.0000231 \\n\\t{4-[(4-amino-3-iodo-1H-pyrazolo[3,\\n\\t4-d]pyrimidin-1-yl)methyl]phenylmethanesulfonate}  (#124# pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nIC50\\t#124# 0.0000365 \\n\\t{3-iodo-1-(prop-2-yn-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  (#124# \\n\\tpH not specified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nIC50\\t#124# 0.0000237 {acetazolamide}  (#124# 25C, pH not specified in the \\n\\tpublication <412>) <412>\\nIC50\\t#124# 0.0000325 \\n\\t{1-benzyl-3-[2-(4-hydroxyphenyl)ethyl]-2-methylimidazolium bromide}  \\n\\t(#124# pH not specified in the publication, temperature not specified \\n\\tin the publication <417>) <417>\\nIC50\\t#124# 0.000179 \\n\\t{1-(3-cyanobenzyl)-3-(2,3,4,5,\\n\\t6-pentamethyl-benzyl)-3H-benzoimidazol-1-ium bromide}  (#124# pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <409>) <409>\\nIC50\\t#124# 0.3465 {callistephin}  (#124# versus CO2 hydration activity, pH \\n\\tand temperature not specified in the publication <378>) <378>\\nIC50\\t#124# 0.0000563 \\n\\t{1-decyl-3-[2-(4-hydroxyphenyl)ethyl]-2-methylimidazolium bromide}  \\n\\t(#124# pH not specified in the publication, temperature not specified \\n\\tin the publication <417>) <417>\\nIC50\\t#124# 0.0000385 \\n\\t{2-[(ethylsulfanyl)(4,5,6,\\n\\t7-tetrahydro-1H-indol-2-yl)methylene]malononitrile}  (#124# 25C, pH \\n\\tnot specified in the publication <412>) <412>\\nIC50\\t#124# 0.0000269 \\n\\t{2,2\\'-(1-(4-methoxyphenyl)ethane-1,\\n\\t1-diyl)bis(sulfanediyl)bis(N-(pyridin-2-yl)acetamide)}  (#124# pH 8, \\n\\t25C <431>) <431>\\nIC50\\t#124# 0.0000371 {ethyl 5-phenyl-1H-pyrrole-2-carbodithioate}  (#124# \\n\\t25C, pH not specified in the publication <412>) <412>\\nIC50\\t#124# 0.0000513 \\n\\t{2,2\\'-(1-(4-bromophenyl)ethane-1,1-diyl)bis(sulfanediyl)diacetic acid}  \\n\\t(#124# pH 8, 25C <431>) <431>\\nIC50\\t#124# 0.0000627 \\n\\t{2,2\\'-(1-(4-nitrophenyl)ethane-1,\\n\\t1-diyl)bis(sulfanediyl)bis(N-(pyridin-2-yl)acetamide)}  (#124# pH 8, \\n\\t25C <431>) <431>\\nIC50\\t#124# 0.00006375 \\n\\t{2,2\\'-(1-(4-methoxyphenyl)ethane-1,1-diyl)bis(sulfanediyl)diacetic \\n\\tacid}  (#124# pH 8, 25C <431>) <431>\\nIC50\\t#124# 0.0000638 \\n\\t{2,2\\'-(1-phenylethane-1,1-diyl)bis(sulfanediyl)bis(N-p-tolylacetamide)} \\n\\t (#124# pH 8, 25C <431>) <431>\\nIC50\\t#124# 0.1488 {acetazolamide}  (#124# 25C, pH not specified in the \\n\\tpublication <433>) <433>\\nIC50\\t#124# 0.0000517 \\n\\t{3-imino-1-ethylsulfanyl-5,6,7,8-tetrahydro-3H-pyrrolo[1,\\n\\t2-a]indole-2-carboxamide}  (#124# 25C, pH not specified in the \\n\\tpublication <412>) <412>\\nIC50\\t#124# 0.0000666 {4-benzyl-6-(thiophen-2-yl)pyrimidin-2-amine}  (#124# \\n\\t25C, pH not specified in the publication <412>) <412>\\nIC50\\t#124,127# 0.05 {[Hg(1-benzyl-2-methylimidazole)2Cl2]}  (#124,127# \\n\\tabove, pH 7.5, 22C <393>) <393>\\nIC50\\t#127# 0.00027 \\n\\t{1-(3-cyanobenzyl)-3-(2,3,4,5,\\n\\t6-pentamethyl-benzyl)-3H-benzoimidazol-1-ium bromide}  (#127# pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <409>) <409>\\nIC50\\t#127# 0.0187 {oenin}  (#127# versus CO2 hydration activity, pH and \\n\\ttemperature not specified in the publication <378>) <378>\\nIC50\\t#127# 0.00025 {acetazolamide}  (#127# pH 7.5, 22C <393>) <393>\\nIC50\\t#127# 0.00036 \\n\\t{1-(3-cyanobenzyl)-3-(2-methylbenzyl)-3H-benzoimidazol-1-ium bromide}  \\n\\t(#127# pH not specified in the publication, temperature not specified \\n\\tin the publication <409>) <409>\\nIC50\\t#127# 0.0000114 {tacrine}  (#127# pH not specified in the publication, \\n\\ttemperature not specified in the publication <417>) <417>\\nIC50\\t#127# 0.000065 \\n\\t{N\\'-[(1Z)-1-(5-chlorothiophen-3-yl)ethylidene]butane-1-\\n\\tsulfonohydrazide}  (#127# pH not specified in the publication, \\n\\ttemperature not specified in the publication <432>) <432>\\nIC50\\t#127# 0.000066 \\n\\t{4-[(4-amino-3-iodo-1H-pyrazolo[3,\\n\\t4-d]pyrimidin-1-yl)methyl]phenylmethanesulfonate}  (#127# pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nIC50\\t#127# 0.000125 \\n\\t{N\\'-[(1Z)-1-(thiophen-3-yl)ethylidene]butane-1-sulfonohydrazide}  \\n\\t(#127# pH not specified in the publication, temperature not specified \\n\\tin the publication <432>) <432>\\nIC50\\t#127# 0.0000333 {tris(2-pyridyl)phosphine sulfide}  (#127# 25C, pH not \\n\\tspecified in the publication <412>) <412>\\nIC50\\t#127# 0.000033 \\n\\t{(E)-3-iodo-1-styryl-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  (#127# pH \\n\\tnot specified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nIC50\\t#127# 0.000045 \\n\\t{2-[(ethylsulfanyl)(4,5,6,\\n\\t7-tetrahydro-1H-indol-2-yl)methylene]malononitrile}  (#127# 25C, pH \\n\\tnot specified in the publication <412>) <412>\\nIC50\\t#127# 0.693 {1-(4-methoxyphenyl)-2-methyl-3-nitro-1-H-indol-6-ol}  \\n\\t(#127# versus CO2 hydration activity, pH and temperature not specified \\n\\tin the publication <378>) <378>\\nIC50\\t#127# 0.000094 \\n\\t{N\\'-[(1Z)-1-(furan-3-yl)ethylidene]butane-1-sulfonohydrazide}  (#127# \\n\\tpH not specified in the publication, temperature not specified in the \\n\\tpublication <432>) <432>\\nIC50\\t#127# 0.0000198 {methyl \\n\\t2-[(4-amino-3-iodo-1H-pyrazolo[3,\\n\\t4-d]pyrimidin-1-yl)methyl]-3-nitrobenzoate}  (#127# pH not specified in \\n\\tthe publication, temperature not specified in the publication <410>) \\n\\t<410>\\nIC50\\t#127# 0.000275 \\n\\t{1-(3-cyanobenzyl)-3-(2,4,6-trimethyl-benzyl)-3H-benzoimidazol-1-ium \\n\\tbromide}  (#127# pH not specified in the publication, temperature not \\n\\tspecified in the publication <409>) <409>\\nIC50\\t#127# 0.000535 {acetazolamide}  (#127# pH not specified in the \\n\\tpublication, temperature not specified in the publication <409>) <409>\\nIC50\\t#127# 0.000107 \\n\\t{N\\'-[(Z)-(1H-indol-3-yl)methylidene]butane-1-sulfonohydrazide}  (#127# \\n\\tpH not specified in the publication, temperature not specified in the \\n\\tpublication <432>) <432>\\nIC50\\t#127# 0.000151 {acetazolamide}  (#127# pH not specified in the \\n\\tpublication, temperature not specified in the publication <432>) <432>\\nIC50\\t#127# 0.000224 {acetazolamide}  (#127# pH not specified in the \\n\\tpublication, temperature not specified in the publication <410>) <410>\\nIC50\\t#127# 0.000135 {acetazolamide}  (#127# pH 8, 25C <431>) <431>\\nIC50\\t#127# 0.0247 {1-methoxy-3-(3-methylanilino)propane-2-thiol}  (#127# \\n\\t25C, pH not specified in the publication <433>) <433>\\nIC50\\t#127# 0.0375 {1-anilino-3-[(oxolan-2-yl)methoxy]propane-2-thiol}  \\n\\t(#127# 25C, pH not specified in the publication <433>) <433>\\nIC50\\t#127# 0.000318 \\n\\t{1-(3-cyanobenzyl)-3-(2,3,5,\\n\\t6-tetramethyl-benzyl)-3H-benzoimidazol-1-ium bromide}  (#127# pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <409>) <409>\\nIC50\\t#127# 0.0000257 \\n\\t{1,3-bis(4-bromobenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  (#127# pH \\n\\tnot specified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nIC50\\t#127# 0.0000426 \\n\\t{1-benzyl-3-(2,4,6-trimethoxybenzyl)-2-methylimidazolium chloride}  \\n\\t(#127# pH not specified in the publication, temperature not specified \\n\\tin the publication <417>) <417>\\nIC50\\t#127# 0.0462 {callistephin}  (#127# versus CO2 hydration activity, pH \\n\\tand temperature not specified in the publication <378>) <378>\\nIC50\\t#127# 0.0000485 {ethyl 5-phenyl-1H-pyrrole-2-carbodithioate}  (#127# \\n\\t25C, pH not specified in the publication <412>) <412>\\nIC50\\t#127# 0.0000347 {3-iodo-1-propyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  \\n\\t(#127# pH not specified in the publication, temperature not specified \\n\\tin the publication <410>) <410>\\nIC50\\t#127# 0.0309 {[Zn(1-benzyl-2-methylimidazole)2Cl2]}  (#127# pH 7.5, \\n\\t22C <393>) <393>\\nIC50\\t#127# 0.0367 {1-anilino-4,4,5,5-tetrafluoropentane-2-thiol}  (#127# \\n\\t25C, pH not specified in the publication <433>) <433>\\nIC50\\t#127# 0.0000533 {1-decyl-3-(2,4,6-trimethoxybenzyl)-2-methylimidazolium \\n\\tchloride}  (#127# pH not specified in the publication, temperature not \\n\\tspecified in the publication <417>) <417>\\nIC50\\t#127# 0.0000533 \\n\\t{3-iodo-1-(prop-2-yn-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  (#127# \\n\\tpH not specified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nIC50\\t#127# 0.0000332 \\n\\t{1-decyl-3-[2-(4-hydroxyphenyl)ethyl]-2-methylimidazolium bromide}  \\n\\t(#127# pH not specified in the publication, temperature not specified \\n\\tin the publication <417>) <417>\\nIC50\\t#127# 0.000559 {[Co(1-benzyl-2-methylimidazole)2Cl2]}  (#127# pH 7.5, \\n\\t22C <393>) <393>\\nIC50\\t#127# 0.0000434 \\n\\t{1-(4-chlorobenzyl)-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  (#127# \\n\\tpH not specified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nIC50\\t#127# 0.000329 \\n\\t{1-(3-cyanobenzyl)-3-(4-methylbenzyl)-3H-benzoimidazol-1-ium bromide}  \\n\\t(#127# pH not specified in the publication, temperature not specified \\n\\tin the publication <409>) <409>\\nIC50\\t#127# 0.0000681 \\n\\t{2,2\\'-(1-phenylethane-1,1-diyl)bis(sulfanediyl)bis(N-p-tolylacetamide)} \\n\\t (#127# pH 8, 25C <431>) <431>\\nIC50\\t#127# 0.0000258 {acetazolamide}  (#127# 25C, pH not specified in the \\n\\tpublication <412>) <412>\\nIC50\\t#127# 0.0000514 {1-butyl-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  \\n\\t(#127# pH not specified in the publication, temperature not specified \\n\\tin the publication <410>) <410>\\nIC50\\t#127# 0.0433 {silychristin}  (#127# versus CO2 hydration activity, pH \\n\\tand temperature not specified in the publication <378>) <378>\\nIC50\\t#127# 0.0000365 \\n\\t{3-iodo-1-(4-methoxybenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  \\n\\t(#127# pH not specified in the publication, temperature not specified \\n\\tin the publication <410>) <410>\\nIC50\\t#127# 0.1125 {acetazolamide}  (#127# 25C, pH not specified in the \\n\\tpublication <433>) <433>\\nIC50\\t#127# 0.1155 {malvin}  (#127# versus CO2 hydration activity, pH and \\n\\ttemperature not specified in the publication <378>) <378>\\nIC50\\t#127# 0.0000563 {tris(2-pyridyl)phosphine selenide}  (#127# 25C, pH \\n\\tnot specified in the publication <412>) <412>\\nIC50\\t#127# 0.0000578 \\n\\t{2,2\\'-(1-(4-methoxyphenyl)ethane-1,\\n\\t1-diyl)bis(sulfanediyl)bis(N-(pyridin-2-yl)acetamide)}  (#127# pH 8, \\n\\t25C <431>) <431>\\nIC50\\t#127# 0.0000578 {1-decyl-3-(N-methyphthalimide)-2-methylimidazolium \\n\\tbromide}  (#127# pH not specified in the publication, temperature not \\n\\tspecified in the publication <417>) <417>\\nIC50\\t#127# 0.0000385 \\n\\t{1-(3-fluorobenzyl)-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  (#127# \\n\\tpH not specified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nIC50\\t#127# 0.0000607 \\n\\t{2,2\\'-(1-(4-methoxyphenyl)ethane-1,1-diyl)bis(sulfanediyl)diacetic \\n\\tacid}  (#127# pH 8, 25C <431>) <431>\\nIC50\\t#127# 0.0000513 \\n\\t{1-benzyl-3-[2-(4-hydroxyphenyl)ethyl]-2-methylimidazolium bromide}  \\n\\t(#127# pH not specified in the publication, temperature not specified \\n\\tin the publication <417>) <417>\\nIC50\\t#127# 0.0000408 \\n\\t{3-iodo-1-phenethyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  (#127# pH not \\n\\tspecified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nIC50\\t#127# 0.0000693 \\n\\t{4-[(4-amino-3-iodo-1H-pyrazolo[3,\\n\\t4-d]pyrimidin-1-yl)methyl]-2-methoxyphenyl methanesulfonate}  (#127# pH \\n\\tnot specified in the publication, temperature not specified in the \\n\\tpublication <410>) <410>\\nIC50\\t#127# 0.0000552 \\n\\t{2,2\\'-(1-(4-bromophenyl)ethane-1,1-diyl)bis(sulfanediyl)diacetic acid}  \\n\\t(#127# pH 8, 25C <431>) <431>\\nIC50\\t#127# 0.0000674 \\n\\t{2,2\\'-(1-(4-nitrophenyl)ethane-1,\\n\\t1-diyl)bis(sulfanediyl)bis(N-(pyridin-2-yl)acetamide)}  (#127# pH 8, \\n\\t25C <431>) <431>\\nIC50\\t#127# 0.0000858 \\n\\t{2,2\\'-(1-phenylethane-1,1-diyl)bis(sulfanediyl)bis(N-benzylacetamide)}  \\n\\t(#127# pH 8, 25C <431>) <431>\\nIC50\\t#127# 0.0000597 \\n\\t{3-imino-1-ethylsulfanyl-5,6,7,8-tetrahydro-3H-pyrrolo[1,\\n\\t2-a]indole-2-carboxamide}  (#127# 25C, pH not specified in the \\n\\tpublication <412>) <412>\\nIC50\\t#127# 0.0000608 {4-benzyl-6-(thiophen-2-yl)pyrimidin-2-amine}  (#127# \\n\\t25C, pH not specified in the publication <412>) <412>\\nIC50\\t#127# 0.0000338 {1-benzyl-3-(N-methyphthalimide)-2-methylimidazolium \\n\\tbromide}  (#127# pH not specified in the publication, temperature not \\n\\tspecified in the publication <417>) <417>\\nIC50\\t#127# 0.00003495 {1-benzyl-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine}  \\n\\t(#127# pH not specified in the publication, temperature not specified \\n\\tin the publication <410>) <410>\\nIC50\\t#129# 0.0076 \\n\\t{5-[2-(2-thienyl)acetamido]-1,3,4-thiadiazole-2-sulfonamide}  (#129# \\n\\tcarbonic anhydrase VA, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#129# 0.0076 {4-(2-pyridin-4-ylacetamidoethyl)benzenesulfonamide}  \\n\\t(#129# carbonic anhydrase VA, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or \\n\\tNaClO4, at 25C <258>) <258>\\nIC50\\t#129# 0.0075 {4-[2-(2-thienyl)acetamido]-3-bromobenzenesulfonamide}  \\n\\t(#129# carbonic anhydrase VA, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or \\n\\tNaClO4, at 25C <258>) <258>\\nIC50\\t#129# 0.0067 {4-(2-phenylacetamido)benzenesulfonamide}  (#129# carbonic \\n\\tanhydrase VA, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, at 25C \\n\\t<258>) <258>\\nIC50\\t#129# 0.0081 {4-(2-phenylacetamidoethyl)benzenesulfonamide}  (#129# \\n\\tcarbonic anhydrase VA, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#129# 0.0069 {4-[2-(2-thienyl)acetamido]-3-fluorobenzenesulfonamide}  \\n\\t(#129# carbonic anhydrase VA, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or \\n\\tNaClO4, at 25C <258>) <258>\\nIC50\\t#129# 0.0072 {4-[2-(2-thienyl)acetamido]benzenesulfonamide}  (#129# \\n\\tcarbonic anhydrase VA, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#129# 0.0082 {4-(2-phenylacetamido)-3-chlorobenzenesulfonamide}  (#129# \\n\\tcarbonic anhydrase VA, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#129# 0.02 {zonisamide}  (#129# carbonic anhydrase VA, in 10 mM HEPES \\n\\t(pH 7.4), 0.1 M Na2SO4 or NaClO4, at 25C <258>) <258>\\nIC50\\t#129# 0.0077 {4-[2-(2-thienyl)acetamido]-3-chlorobenzenesulfonamide}  \\n\\t(#129# carbonic anhydrase VA, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or \\n\\tNaClO4, at 25C <258>) <258>\\nIC50\\t#129# 0.0091 {4-[2-(2-thienyl)acetamidomethyl]benzenesulfonamide}  \\n\\t(#129# carbonic anhydrase VA, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or \\n\\tNaClO4, at 25C <258>) <258>\\nIC50\\t#129# 0.063 {acetazolamide}  (#129# carbonic anhydrase VA, in 10 mM \\n\\tHEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, at 25C <258>) <258>\\nIC50\\t#129# 0.063 {topiramate}  (#129# carbonic anhydrase VA, in 10 mM HEPES \\n\\t(pH 7.4), 0.1 M Na2SO4 or NaClO4, at 25C <258>) <258>\\nIC50\\t#129# 0.0102 {4-[2-(2-thienyl)acetamidoethyl]benzenesulfonamide}  \\n\\t(#129# carbonic anhydrase VA, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or \\n\\tNaClO4, at 25C <258>) <258>\\nIC50\\t#129# 0.0084 {5-(2-phenylacetamido)-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#129# carbonic anhydrase VA, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or \\n\\tNaClO4, at 25C <258>) <258>\\nIC50\\t#129# 0.0071 {4-(2-phenylacetamido)-3-bromobenzenesulfonamide}  (#129# \\n\\tcarbonic anhydrase VA, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#129# 0.0073 {4-(2-pyridin-4-ylacetamido)benzenesulfonamide}  (#129# \\n\\tcarbonic anhydrase VA, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#129# 0.0083 {4-(2-phenylacetamido)-3-fluorobenzenesulfonamide}  (#129# \\n\\tcarbonic anhydrase VA, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#129# 0.086 {4-(2-phenylacetamidomethyl)benzenesulfonamide}  (#129# \\n\\tcarbonic anhydrase VA, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#129,130# 0.0068 {4-(2-pyridin-2-ylacetamido)benzenesulfonamide}  \\n\\t(#129# carbonic anhydrase VA, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or \\n\\tNaClO4, at 25C <258>; #130# carbonic anhydrase VB, in 10 mM HEPES (pH \\n\\t7.4), 0.1 M Na2SO4 or NaClO4, at 25C <258>) <258>\\nIC50\\t#130# 0.03 {topiramate}  (#130# carbonic anhydrase VB, in 10 mM HEPES \\n\\t(pH 7.4), 0.1 M Na2SO4 or NaClO4, at 25C <258>) <258>\\nIC50\\t#130# 0.008 {4-[2-(2-thienyl)acetamidoethyl]benzenesulfonamide}  (#130# \\n\\tcarbonic anhydrase VB, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#130# 0.007 {4-[2-(2-thienyl)acetamido]benzenesulfonamide}  (#130# \\n\\tcarbonic anhydrase VB, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#130# 0.0059 {4-(2-phenylacetamido)-3-bromobenzenesulfonamide}  (#130# \\n\\tcarbonic anhydrase VB, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#130# 0.0081 {4-(2-phenylacetamido)-3-fluorobenzenesulfonamide}  (#130# \\n\\tcarbonic anhydrase VB, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#130# 0.0081 {4-(2-phenylacetamido)-3-chlorobenzenesulfonamide}  (#130# \\n\\tcarbonic anhydrase VB, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#130# 0.0054 {acetazolamide}  (#130# carbonic anhydrase VB, in 10 mM \\n\\tHEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, at 25C <258>) <258>\\nIC50\\t#130# 0.0061 {5-(2-phenylacetamido)-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#130# carbonic anhydrase VB, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or \\n\\tNaClO4, at 25C <258>) <258>\\nIC50\\t#130# 0.0086 {4-[2-(2-thienyl)acetamido]-3-chlorobenzenesulfonamide}  \\n\\t(#130# carbonic anhydrase VB, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or \\n\\tNaClO4, at 25C <258>) <258>\\nIC50\\t#130# 0.0072 {4-[2-(2-thienyl)acetamidomethyl]benzenesulfonamide}  \\n\\t(#130# carbonic anhydrase VB, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or \\n\\tNaClO4, at 25C <258>) <258>\\nIC50\\t#130# 0.0087 {4-[2-(2-thienyl)acetamido]-3-bromobenzenesulfonamide}  \\n\\t(#130# carbonic anhydrase VB, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or \\n\\tNaClO4, at 25C <258>) <258>\\nIC50\\t#130# 0.0082 {4-(2-phenylacetamidoethyl)benzenesulfonamide}  (#130# \\n\\tcarbonic anhydrase VB, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#130# 0.009 {4-(2-pyridin-4-ylacetamido)benzenesulfonamide}  (#130# \\n\\tcarbonic anhydrase VB, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#130# 0.0083 {4-(2-phenylacetamidomethyl)benzenesulfonamide}  (#130# \\n\\tcarbonic anhydrase VB, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#130# 0.0093 {4-(2-pyridin-4-ylacetamidoethyl)benzenesulfonamide}  \\n\\t(#130# carbonic anhydrase VB, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or \\n\\tNaClO4, at 25C <258>) <258>\\nIC50\\t#130# 0.0079 {4-[2-(2-thienyl)acetamido]-3-fluorobenzenesulfonamide}  \\n\\t(#130# carbonic anhydrase VB, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or \\n\\tNaClO4, at 25C <258>) <258>\\nIC50\\t#130# 0.0079 {4-(2-phenylacetamido)benzenesulfonamide}  (#130# carbonic \\n\\tanhydrase VB, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, at 25C \\n\\t<258>) <258>\\nIC50\\t#130# 0.0074 \\n\\t{5-[2-(2-thienyl)acetamido]-1,3,4-thiadiazole-2-sulfonamide}  (#130# \\n\\tcarbonic anhydrase VB, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#130# 6.033 {zonisamide}  (#130# carbonic anhydrase VB, in 10 mM HEPES \\n\\t(pH 7.4), 0.1 M Na2SO4 or NaClO4, at 25C <258>) <258>\\nIC50\\t#132# 0.00008 {kanamycin sulfate}  (#132# at pH 8.0, temperature not \\n\\tspecified in the publication <418>) <418>\\nIC50\\t#132# 0.00762 {clindamycin phosphate}  (#132# at pH 8.0, temperature \\n\\tnot specified in the publication <418>) <418>\\nIC50\\t#132# 0.06 {amoxicillin}  (#132# at pH 8.0, temperature not specified \\n\\tin the publication <418>) <418>\\nIC50\\t#132# 0.059 {tobramycin}  (#132# at pH 8.0, temperature not specified \\n\\tin the publication <418>) <418>\\nIC50\\t#132# 0.051 {Vancomycin}  (#132# at pH 8.0, temperature not specified \\n\\tin the publication <418>) <418>\\nIC50\\t#132# 0.00056 {rifamycin}  (#132# at pH 8.0, temperature not specified \\n\\tin the publication <418>) <418>\\nIC50\\t#132# 0.00048 {cefoperazone}  (#132# at pH 8.0, temperature not \\n\\tspecified in the publication <418>) <418>\\nIC50\\t#132# 0.00061 {teicoplanin}  (#132# at pH 8.0, temperature not \\n\\tspecified in the publication <418>) <418>\\nIC50\\t#132# 0.00778 {piperacillin}  (#132# at pH 8.0, temperature not \\n\\tspecified in the publication <418>) <418>\\nIC50\\t#132# 0.00825 {Lincomycin}  (#132# at pH 8.0, temperature not specified \\n\\tin the publication <418>) <418>\\nIC50\\t#132# 0.00396 {amikacin sulfate}  (#132# at pH 8.0, temperature not \\n\\tspecified in the publication <418>) <418>\\nIC50\\t#132# 0.00352 {gentamicin sulfate}  (#132# at pH 8.0, temperature not \\n\\tspecified in the publication <418>) <418>\\nIC50\\t#132# 0.01386 {ampicillin}  (#132# at pH 8.0, temperature not specified \\n\\tin the publication <418>) <418>\\nIC50\\t#132# 0.00506 {cefuroxime}  (#132# at pH 8.0, temperature not specified \\n\\tin the publication <418>) <418>\\nIC50\\t#132# 0.03465 {cefazolin}  (#132# at pH 8.0, temperature not specified \\n\\tin the publication <418>) <418>\\nIC50\\t#132# 0.05332 {ceftriaxone}  (#132# at pH 8.0, temperature not \\n\\tspecified in the publication <418>) <418>\\nIC50\\t#14# 0.012 {acetazolamide}  (#14# carbonic anhydrase II, in 10 mM HEPES \\n\\t(pH 7.4), 0.1 M Na2SO4 or NaClO4, at 25C <258>) <258>\\nIC50\\t#14# 0.01 {topiramate}  (#14# carbonic anhydrase II, in 10 mM HEPES (pH \\n\\t7.4), 0.1 M Na2SO4 or NaClO4, at 25C <258>) <258>\\nIC50\\t#14# 0.035 {zonisamide}  (#14# carbonic anhydrase II, in 10 mM HEPES \\n\\t(pH 7.4), 0.1 M Na2SO4 or NaClO4, at 25C <258>) <258>\\nIC50\\t#14# 0.395 {4-(2-phenylacetamido)-3-bromobenzenesulfonamide}  (#14# \\n\\tcarbonic anhydrase II, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#14# 0.056 {zonisamide}  (#14# carbonic anhydrase I, in 10 mM HEPES (pH \\n\\t7.4), 0.1 M Na2SO4 or NaClO4, at 25C <258>) <258>\\nIC50\\t#14# 0.25 {acetazolamide}  (#14# carbonic anhydrase I, in 10 mM HEPES \\n\\t(pH 7.4), 0.1 M Na2SO4 or NaClO4, at 25C <258>) <258>\\nIC50\\t#14# 0.25 {topiramate}  (#14# carbonic anhydrase I, in 10 mM HEPES (pH \\n\\t7.4), 0.1 M Na2SO4 or NaClO4, at 25C <258>) <258>\\nIC50\\t#14# 0.072 {5-[2-(2-thienyl)acetamido]-1,3,4-thiadiazole-2-sulfonamide} \\n\\t (#14# carbonic anhydrase I, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or \\n\\tNaClO4, at 25C <258>) <258>\\nIC50\\t#14# 0.05 {4-[2-(2-thienyl)acetamido]benzenesulfonamide}  (#14# \\n\\tcarbonic anhydrase II, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#14# 0.05 {4-[2-(2-thienyl)acetamido]-3-chlorobenzenesulfonamide}  \\n\\t(#14# carbonic anhydrase II, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or \\n\\tNaClO4, at 25C <258>) <258>\\nIC50\\t#14# 0.13 {4-aminosalicylic acid}  (#14# isozyme carbonic anhydrase I \\n\\t<209>) <209>\\nIC50\\t#14# 0.0027 {diflunisal}  (#14# isozyme carbonic anhydrase II <209>) \\n\\t<209>\\nIC50\\t#14# 0.00007 \\n\\t{4-(4-hydroxyphenyl)-2-p-tolyl-5H-indeno[1,2-b]pyridin-5-one}  (#14# \\n\\tisoform CA I, at 25C, pH not specified in the publication <414>) <414>\\nIC50\\t#14# 0.00033 {acetazolamide}  (#14# isoform carbonic anhydrase I, using \\n\\t4-nitrophenyl phosphate as substrate, at pH 7.4 and 25C <200>) <200>\\nIC50\\t#14# 0.053 {4-[2-(2-thienyl)acetamidoethyl]benzenesulfonamide}  (#14# \\n\\tcarbonic anhydrase II, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#14# 0.29 {4-sulfosalicylic acid}  (#14# isozyme carbonic anhydrase I \\n\\t<209>) <209>\\nIC50\\t#14# 0.29 {5-sulfosalicylic acid}  (#14# isozyme carbonic anhydrase II \\n\\t<209>) <209>\\nIC50\\t#14# 0.39 {4-[2-(2-thienyl)acetamido]-3-fluorobenzenesulfonamide}  \\n\\t(#14# carbonic anhydrase II, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or \\n\\tNaClO4, at 25C <258>) <258>\\nIC50\\t#14# 0.06 {4-[2-(2-thienyl)acetamidomethyl]benzenesulfonamide}  (#14# \\n\\tcarbonic anhydrase I, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#14# 0.06 {4-(2-phenylacetamidoethyl)benzenesulfonamide}  (#14# \\n\\tcarbonic anhydrase I, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#14# 0.56 {salicylic acid}  (#14# isozyme carbonic anhydrase I <209>) \\n\\t<209>\\nIC50\\t#14# 0.0000263 {acetazolamide}  (#14# isoform carbonic anhydrase II, \\n\\tusing 4-nitrophenyl phosphate as substrate, at pH 7.4 and 25C <200>) \\n\\t<200>\\nIC50\\t#14# 0.42 {5-sulfosalicylic acid}  (#14# isozyme carbonic anhydrase I \\n\\t<209>) <209>\\nIC50\\t#14# 0.075 {4-(2-phenylacetamidomethyl)benzenesulfonamide}  (#14# \\n\\tcarbonic anhydrase I, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#14# 0.075 {4-(2-pyridin-2-ylacetamido)benzenesulfonamide}  (#14# \\n\\tcarbonic anhydrase I, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#14# 0.074 {4-(2-pyridin-4-ylacetamido)benzenesulfonamide}  (#14# \\n\\tcarbonic anhydrase II, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#14# 0.0028 {dinitrosalicylic acid}  (#14# isozyme carbonic anhydrase \\n\\tII <209>) <209>\\nIC50\\t#14# 0.071 {4-(2-pyridin-4-ylacetamido)benzenesulfonamide}  (#14# \\n\\tcarbonic anhydrase I, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#14# 0.084 {4-[2-(2-thienyl)acetamido]-3-bromobenzenesulfonamide}  \\n\\t(#14# carbonic anhydrase I, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or \\n\\tNaClO4, at 25C <258>) <258>\\nIC50\\t#14# 0.72 {4-sulfosalicylic acid}  (#14# isozyme carbonic anhydrase II \\n\\t<209>) <209>\\nIC50\\t#14# 4.7 {3-methylsalicylic acid}  (#14# isozyme carbonic anhydrase II \\n\\t<209>) <209>\\nIC50\\t#14# 0.077 {4-[2-(2-thienyl)acetamido]-3-chlorobenzenesulfonamide}  \\n\\t(#14# carbonic anhydrase I, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or \\n\\tNaClO4, at 25C <258>) <258>\\nIC50\\t#14# 0.063 {5-(2-phenylacetamido)-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#14# carbonic anhydrase I, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or \\n\\tNaClO4, at 25C <258>) <258>\\nIC50\\t#14# 0.051 {5-[2-(2-thienyl)acetamido]-1,3,4-thiadiazole-2-sulfonamide} \\n\\t (#14# carbonic anhydrase II, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or \\n\\tNaClO4, at 25C <258>) <258>\\nIC50\\t#14# 0.051 {5-(2-phenylacetamido)-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#14# carbonic anhydrase II, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or \\n\\tNaClO4, at 25C <258>) <258>\\nIC50\\t#14# 0.069 {4-(2-pyridin-2-ylacetamido)benzenesulfonamide}  (#14# \\n\\tcarbonic anhydrase II, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#14# 0.067 {4-(2-phenylacetamido)-3-fluorobenzenesulfonamide}  (#14# \\n\\tcarbonic anhydrase I, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#14# 0.067 {4-(2-phenylacetamidoethyl)benzenesulfonamide}  (#14# \\n\\tcarbonic anhydrase II, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#14# 0.054 {4-(2-phenylacetamidomethyl)benzenesulfonamide}  (#14# \\n\\tcarbonic anhydrase II, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#14# 0.000117 \\n\\t{4-(1-[2-[2-(3-bromobenzylidene)hydrazino]-2-oxoethyl]-3-methyl-5-oxo-1,\\n\\t5-dihydro-4H-1,2,\\n\\t4-triazol-4-yl)-N\\'-[(3-bromophenyl)methylene]benzohydrazide}  (#14# \\n\\tisoform CA II, pH and temperature not specified in the publication \\n\\t<416>) <416>\\nIC50\\t#14# 0.097 {4-(2-pyridin-4-ylacetamidoethyl)benzenesulfonamide}  (#14# \\n\\tcarbonic anhydrase II, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#14# 0.107 {4-(2-phenylacetamido)benzenesulfonamide}  (#14# carbonic \\n\\tanhydrase II, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, at 25C \\n\\t<258>) <258>\\nIC50\\t#14# 0.000028 {acetazolamide}  (#14# isoform carbonic anhydrase II, \\n\\tusing 4-nitrophenyl acetate as substrate, at pH 7.4 and 25C <200>) \\n\\t<200>\\nIC50\\t#14# 0.068 {4-[2-(2-thienyl)acetamidoethyl]benzenesulfonamide}  (#14# \\n\\tcarbonic anhydrase I, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#14# 0.000111 \\n\\t{4-(1-[2-[2-benzylidenehydrazino]-2-oxoethyl]-3-methyl-5-oxo-1,\\n\\t5-dihydro-4H-1,2,4-triazol-4-yl)-N\\'-[phenylmethylene]benzohydrazide}  \\n\\t(#14# isoform CA I, pH and temperature not specified in the publication \\n\\t<416>) <416>\\nIC50\\t#14# 0.263 {4-(2-phenylacetamido)-3-bromobenzenesulfonamide}  (#14# \\n\\tcarbonic anhydrase I, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#14# 0.0000035 \\n\\t{4-(4-hydroxyphenyl)-2-phenyl-5H-indeno[1,2-b]pyridin-5-one}  (#14# \\n\\tisoform CA II, at 25C, pH not specified in the publication <414>) <414>\\nIC50\\t#14# 0.0000035 \\n\\t{4-(4-hydroxyphenyl)-2-(3-hydroxyphenyl)-5H-indeno[1,2-b]pyridin-5-one} \\n\\t (#14# isoform CA II, at 25C, pH not specified in the publication \\n\\t<414>) <414>\\nIC50\\t#14# 0.0000056 \\n\\t{4-(4-hydroxyphenyl)-2-(4-methoxyphenyl)-5H-indeno[1,2-b]pyridin-5-one} \\n\\t (#14# isoform CA II, at 25C, pH not specified in the publication \\n\\t<414>) <414>\\nIC50\\t#14# 0.0000062 {2,4-bis(4-hydroxyphenyl)-5H-indeno[1,2-b]pyridin-5-one} \\n\\t (#14# isoform CA II, at 25C, pH not specified in the publication \\n\\t<414>) <414>\\nIC50\\t#14# 0.0000068 \\n\\t{4-(4-hydroxyphenyl)-2-p-tolyl-5H-indeno[1,2-b]pyridin-5-one}  (#14# \\n\\tisoform CA II, at 25C, pH not specified in the publication <414>) <414>\\nIC50\\t#14# 0.0000079 \\n\\t{4-(4-hydroxyphenyl)-2-(4-fluorophenyl)-5H-indeno[1,2-b]pyridin-5-one}  \\n\\t(#14# isoform CA II, at 25C, pH not specified in the publication \\n\\t<414>) <414>\\nIC50\\t#14# 0.000078 \\n\\t{4-(1-[2-[2-benzylidenehydrazino]-2-oxoethyl]-3-methyl-5-oxo-1,\\n\\t5-dihydro-4H-1,2,4-triazol-4-yl)-N\\'-[phenylmethylene]benzohydrazide}  \\n\\t(#14# isoform CA II, pH and temperature not specified in the \\n\\tpublication <416>) <416>\\nIC50\\t#14# 0.108 {4-(2-phenylacetamido)benzenesulfonamide}  (#14# carbonic \\n\\tanhydrase I, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, at 25C \\n\\t<258>) <258>\\nIC50\\t#14# 0.0000038 \\n\\t{4-(4-hydroxyphenyl)-2-(4-bromophenyl)-5H-indeno[1,2-b]pyridin-5-one}  \\n\\t(#14# isoform CA II, at 25C, pH not specified in the publication \\n\\t<414>) <414>\\nIC50\\t#14# 0.00072 {5-chlorosalicylic acid}  (#14# isozyme carbonic anhydrase \\n\\tII <209>) <209>\\nIC50\\t#14# 0.058 {4-(2-phenylacetamido)-3-chlorobenzenesulfonamide}  (#14# \\n\\tcarbonic anhydrase II, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#14# 0.061 {4-[2-(2-thienyl)acetamido]benzenesulfonamide}  (#14# \\n\\tcarbonic anhydrase I, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#14# 0.061 {4-(2-phenylacetamido)-3-chlorobenzenesulfonamide}  (#14# \\n\\tcarbonic anhydrase I, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#14# 0.061 {4-(2-phenylacetamido)-3-fluorobenzenesulfonamide}  (#14# \\n\\tcarbonic anhydrase II, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#14# 0.073 {4-(2-pyridin-4-ylacetamidoethyl)benzenesulfonamide}  (#14# \\n\\tcarbonic anhydrase I, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#14# 0.68 {salicylic acid}  (#14# isozyme carbonic anhydrase II <209>) \\n\\t<209>\\nIC50\\t#14# 0.052 {4-[2-(2-thienyl)acetamido]-3-bromobenzenesulfonamide}  \\n\\t(#14# carbonic anhydrase II, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or \\n\\tNaClO4, at 25C <258>) <258>\\nIC50\\t#14# 0.052 {4-[2-(2-thienyl)acetamidomethyl]benzenesulfonamide}  (#14# \\n\\tcarbonic anhydrase II, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or NaClO4, \\n\\tat 25C <258>) <258>\\nIC50\\t#14# 0.75 {4-aminosalicylic acid}  (#14# isozyme carbonic anhydrase II \\n\\t<209>) <209>\\nIC50\\t#14# 0.161 {4-[2-(2-thienyl)acetamido]-3-fluorobenzenesulfonamide}  \\n\\t(#14# carbonic anhydrase I, in 10 mM HEPES (pH 7.4), 0.1 M Na2SO4 or \\n\\tNaClO4, at 25C <258>) <258>\\nIC50\\t#14# 0.0000613 \\n\\t{4-(4-hydroxyphenyl)-2-(4-chlorophenyl)-5H-indeno[1,2-b]pyridin-5-one}  \\n\\t(#14# isoform CA I, at 25C, pH not specified in the publication <414>) \\n\\t<414>\\nIC50\\t#14# 0.00338 {diflunisal}  (#14# isozyme carbonic anhydrase I <209>) \\n\\t<209>\\nIC50\\t#14# 0.0000072 \\n\\t{4-(4-hydroxyphenyl)-2-(4-chlorophenyl)-5H-indeno[1,2-b]pyridin-5-one}  \\n\\t(#14# isoform CA II, at 25C, pH not specified in the publication \\n\\t<414>) <414>\\nIC50\\t#14# 0.0000762 \\n\\t{4-(1-[2-[2-(4-chlorobenzylidene)hydrazino]-2-oxoethyl]-3-methyl-5-oxo-\\n\\t1,5-dihydro-4H-1,2,\\n\\t4-triazol-4-yl)-N\\'-[(4-chlorophenyl)methylene]benzohydrazide}  (#14# \\n\\tisoform CA II, pH and temperature not specified in the publication \\n\\t<416>) <416>\\nIC50\\t#14# 0.0000105 {2-(4-hydroxybenzylidene)-2H-indene-1,3-dione}  (#14# \\n\\tisoform CA II, at 25C, pH not specified in the publication <414>) <414>\\nIC50\\t#14# 0.00121 {acetazolamide}  (#14# isoform carbonic anhydrase I, using \\n\\t4-nitrophenyl acetate as substrate, at pH 7.4 and 25C <200>) <200>\\nIC50\\t#14# 0.0000538 \\n\\t{4-(1-[2-[2-(4-methoxybenzylidene)hydrazino]-2-oxoethyl]-3-methyl-5-oxo-\\n\\t1,5-dihydro-4H-1,2,\\n\\t4-triazol-4-yl)-N\\'-[(4-methoxyphenyl)methylene]benzohydrazide}  (#14# \\n\\tisoform CA I, pH and temperature not specified in the publication \\n\\t<416>) <416>\\nIC50\\t#14# 0.0000541 \\n\\t{4-(4-hydroxyphenyl)-2-(3-hydroxyphenyl)-5H-indeno[1,2-b]pyridin-5-one} \\n\\t (#14# isoform CA I, at 25C, pH not specified in the publication \\n\\t<414>) <414>\\nIC50\\t#14# 2090 {ethanol}  (#14# isozyme carbonic anhydrase-I <225>) <225>\\nIC50\\t#14# 1830 {ethanol}  (#14# isozyme carbonic anhydrase-II <225>) <225>\\nIC50\\t#14# 0.00304 {sulfasalazine}  (#14# isozyme carbonic anhydrase I <209>) \\n\\t<209>\\nIC50\\t#14# 0.00407 {5-chlorosalicylic acid}  (#14# isozyme carbonic anhydrase \\n\\tI <209>) <209>\\nIC50\\t#14# 0.00764 {dinitrosalicylic acid}  (#14# isozyme carbonic anhydrase \\n\\tI <209>) <209>\\nIC50\\t#14# 2.71 {Acetylsalicylic acid}  (#14# isozyme carbonic anhydrase I \\n\\t<209>) <209>\\nIC50\\t#14# 3.07 {3-methylsalicylic acid}  (#14# isozyme carbonic anhydrase I \\n\\t<209>) <209>\\nIC50\\t#14# 0.00449 {sulfasalazine}  (#14# isozyme carbonic anhydrase II \\n\\t<209>) <209>\\nIC50\\t#14# 1.16 {Acetylsalicylic acid}  (#14# isozyme carbonic anhydrase II \\n\\t<209>) <209>\\nIC50\\t#14# 0.0000686 \\n\\t{4-(4-hydroxyphenyl)-2-(4-fluorophenyl)-5H-indeno[1,2-b]pyridin-5-one}  \\n\\t(#14# isoform CA I, at 25C, pH not specified in the publication <414>) \\n\\t<414>\\nIC50\\t#14# 0.0000619 \\n\\t{4-(4-hydroxyphenyl)-2-phenyl-5H-indeno[1,2-b]pyridin-5-one}  (#14# \\n\\tisoform CA I, at 25C, pH not specified in the publication <414>) <414>\\nIC50\\t#14# 0.0000514 \\n\\t{4-(1-[2-[2-(4-methoxybenzylidene)hydrazino]-2-oxoethyl]-3-methyl-5-oxo-\\n\\t1,5-dihydro-4H-1,2,\\n\\t4-triazol-4-yl)-N\\'-[(4-methoxyphenyl)methylene]benzohydrazide}  (#14# \\n\\tisoform CA II, pH and temperature not specified in the publication \\n\\t<416>) <416>\\nIC50\\t#14# 0.0000877 {2-(4-hydroxybenzylidene)-2H-indene-1,3-dione}  (#14# \\n\\tisoform CA I, at 25C, pH not specified in the publication <414>) <414>\\nIC50\\t#14# 0.0001156 {acetazolamide}  (#14# isoform CA II, at 25C, pH not \\n\\tspecified in the publication <414>) <414>\\nIC50\\t#14# 0.0000592 \\n\\t{4-(4-hydroxyphenyl)-2-(4-bromophenyl)-5H-indeno[1,2-b]pyridin-5-one}  \\n\\t(#14# isoform CA I, at 25C, pH not specified in the publication <414>) \\n\\t<414>\\nIC50\\t#14# 0.0000737 {2,4-bis(4-hydroxyphenyl)-5H-indeno[1,2-b]pyridin-5-one} \\n\\t (#14# isoform CA I, at 25C, pH not specified in the publication \\n\\t<414>) <414>\\nIC50\\t#14# 0.0009857 {acetazolamide}  (#14# isoform CA I, pH and temperature \\n\\tnot specified in the publication <416>) <416>\\nIC50\\t#14# 0.0004894 {acetazolamide}  (#14# isoform CA II, pH and temperature \\n\\tnot specified in the publication <416>) <416>\\nIC50\\t#14# 0.0000769 \\n\\t{4-(1-[2-[2-(4-chlorobenzylidene)hydrazino]-2-oxoethyl]-3-methyl-5-oxo-\\n\\t1,5-dihydro-4H-1,2,\\n\\t4-triazol-4-yl)-N\\'-[(4-chlorophenyl)methylene]benzohydrazide}  (#14# \\n\\tisoform CA I, pH and temperature not specified in the publication \\n\\t<416>) <416>\\nIC50\\t#14# 0.0001361 \\n\\t{4-(1-[2-[2-(4-bromobenzylidene)hydrazino]-2-oxoethyl]-3-methyl-5-oxo-1,\\n\\t5-dihydro-4H-1,2,\\n\\t4-triazol-4-yl)-N\\'-[(4-bromophenyl)methylene]benzohydrazide}  (#14# \\n\\tisoform CA I, pH and temperature not specified in the publication \\n\\t<416>) <416>\\nIC50\\t#14# 0.0001401 \\n\\t{4-(1-[2-[2-(3-bromobenzylidene)hydrazino]-2-oxoethyl]-3-methyl-5-oxo-1,\\n\\t5-dihydro-4H-1,2,\\n\\t4-triazol-4-yl)-N\\'-[(3-bromophenyl)methylene]benzohydrazide}  (#14# \\n\\tisoform CA I, pH and temperature not specified in the publication \\n\\t<416>) <416>\\nIC50\\t#14# 0.0000774 \\n\\t{4-(1-[2-[2-(4-bromo-2-hydroxybenzylidene)hydrazino]-2-oxoethyl]-3-\\n\\tmethyl-5-oxo-1,5-dihydro-4H-1,2,\\n\\t4-triazol-4-yl)-N\\'-[(4-bromo-2-ydroxyphenyl)methylene]benzohydrazide}  \\n\\t(#14# isoform CA I, pH and temperature not specified in the publication \\n\\t<416>) <416>\\nIC50\\t#14# 0.0001243 \\n\\t{4-(1-[2-[2-(4-bromobenzylidene)hydrazino]-2-oxoethyl]-3-methyl-5-oxo-1,\\n\\t5-dihydro-4H-1,2,\\n\\t4-triazol-4-yl)-N\\'-[(4-bromophenyl)methylene]benzohydrazide}  (#14# \\n\\tisoform CA II, pH and temperature not specified in the publication \\n\\t<416>) <416>\\nIC50\\t#14# 0.0000717 \\n\\t{4-(1-[2-[2-(4-bromo-2-hydroxybenzylidene)hydrazino]-2-oxoethyl]-3-\\n\\tmethyl-5-oxo-1,5-dihydro-4H-1,2,\\n\\t4-triazol-4-yl)-N\\'-[(4-bromo-2-ydroxyphenyl)methylene]benzohydrazide}  \\n\\t(#14# isoform CA II, pH and temperature not specified in the \\n\\tpublication <416>) <416>\\nIC50\\t#14# 0.0001973 {acetazolamide}  (#14# isoform CA I, at 25C, pH not \\n\\tspecified in the publication <414>) <414>\\nIC50\\t#14# 0.0000587 \\n\\t{4-(4-hydroxyphenyl)-2-(4-methoxyphenyl)-5H-indeno[1,2-b]pyridin-5-one} \\n\\t (#14# isoform CA I, at 25C, pH not specified in the publication \\n\\t<414>) <414>\\nIC50\\t#14,38,80# -999 {more}  (#14# IC50 values for natural phenols with \\n\\tisozymes hCA I and hCA II in the esterase activity assay, overview \\n\\t<304>; #80# IC50 values of esterase activity with 4-nitrophenylacetate \\n\\tas substrate, competitive inhibition type <306>; #38# AmCA inhibition \\n\\tby the pesticides is also measured (IC50 values) using an esterase \\n\\tassay with 4-nitrophenylacetate as substrate <390>) <304>\\nIC50\\t#14,38,80# -999 {more}  (#14# IC50 values for natural phenols with \\n\\tisozymes hCA I and hCA II in the esterase activity assay, overview \\n\\t<304>; #80# IC50 values of esterase activity with 4-nitrophenylacetate \\n\\tas substrate, competitive inhibition type <306>; #38# AmCA inhibition \\n\\tby the pesticides is also measured (IC50 values) using an esterase \\n\\tassay with 4-nitrophenylacetate as substrate <390>) <306>\\nIC50\\t#14,38,80# -999 {more}  (#14# IC50 values for natural phenols with \\n\\tisozymes hCA I and hCA II in the esterase activity assay, overview \\n\\t<304>; #80# IC50 values of esterase activity with 4-nitrophenylacetate \\n\\tas substrate, competitive inhibition type <306>; #38# AmCA inhibition \\n\\tby the pesticides is also measured (IC50 values) using an esterase \\n\\tassay with 4-nitrophenylacetate as substrate <390>) <390>\\nIC50\\t#144# 0.0039 {Cu2+}  (#144# isoform CA I, pH and temperature not \\n\\tspecified in the publication <426>) <426>\\nIC50\\t#144# 0.00616 {Cu2+}  (#144# isoform CA II, pH and temperature not \\n\\tspecified in the publication <426>) <426>\\nIC50\\t#144# 0.046 {Cd2+}  (#144# isoform CA II, pH and temperature not \\n\\tspecified in the publication <426>) <426>\\nIC50\\t#144# 0.206 {Ni2+}  (#144# isoform CA I, pH and temperature not \\n\\tspecified in the publication <426>) <426>\\nIC50\\t#144# 0.00638 {Ag+}  (#144# isoform CA I, pH and temperature not \\n\\tspecified in the publication <426>) <426>\\nIC50\\t#144# 0.223 {Ni2+}  (#144# isoform CA II, pH and temperature not \\n\\tspecified in the publication <426>) <426>\\nIC50\\t#144# 0.01352 {Cd2+}  (#144# isoform CA I, pH and temperature not \\n\\tspecified in the publication <426>) <426>\\nIC50\\t#144# 0.02029 {Ag+}  (#144# isoform CA II, pH and temperature not \\n\\tspecified in the publication <426>) <426>\\nIC50\\t#167# 0.1 {bicarbonate}  (#167# pH 7.5, 20C, inhibition of CO2 \\n\\thydration activity <300>) <300>\\nIC50\\t#167# 0.055 {H2NSO3H}  (#167# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <300>) <300>\\nIC50\\t#167# 0.087 {Cyanate}  (#167# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <300>) <300>\\nIC50\\t#167# 1 {Sulfide}  (#167# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <300>) <300>\\nIC50\\t#167# 0.057 {PhAsO3H2}  (#167# pH 7.5, 20C, inhibition of CO2 \\n\\thydration activity <300>) <300>\\nIC50\\t#167# 0.06 {Carbonate}  (#167# pH 7.5, 20C, inhibition of CO2 \\n\\thydration activity <300>) <300>\\nIC50\\t#167# 0.82 {sulfate}  (#167# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <300>) <300>\\nIC50\\t#167# 0.07 {cyanide}  (#167# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <300>) <300>\\nIC50\\t#167# 0.07 {H2NSO2NH2}  (#167# pH 7.5, 20C, inhibition of CO2 \\n\\thydration activity <300>) <300>\\nIC50\\t#167# 0.9 {nitrite}  (#167# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <300>) <300>\\nIC50\\t#167# 0.046 {PhB(OH)2}  (#167# pH 7.5, 20C, inhibition of CO2 \\n\\thydration activity <300>) <300>\\nIC50\\t#167# 0.74 {fluoride}  (#167# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <300>) <300>\\nIC50\\t#167# 0.097 {thiocyanate}  (#167# pH 7.5, 20C, inhibition of CO2 \\n\\thydration activity <300>) <300>\\nIC50\\t#167# 0.59 {HSO3-}  (#167# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <300>) <300>\\nIC50\\t#167# 20 {Iodide}  (#167# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <300>) <300>\\nIC50\\t#167# 0.89 {chloride}  (#167# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <300>) <300>\\nIC50\\t#167# 1.01 {bromide}  (#167# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <300>) <300>\\nIC50\\t#167# 0.83 {azide}  (#167# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <300>) <300>\\nIC50\\t#167# 55.6 {nitrate}  (#167# pH 7.5, 20C, inhibition of CO2 hydration \\n\\tactivity <300>) <300>\\nIC50\\t#17# 0.0123 {2-[(aminooxy)sulfinyl]aniline}  <210>\\nIC50\\t#17# 0.000124 \\n\\t{4-amino-N-[5-[(aminooxy)sulfinyl]-1,3,\\n\\t4-thiadiazol-2-yl]benzenesulfonamide}  <210>\\nIC50\\t#17# 0.00036 \\n\\t{5-[(aminooxy)sulfinyl]-3-methyl-1,3,4-thiadiazol-2(3H)-imine}  <210>\\nIC50\\t#17# 0.000154 \\n\\t{4-amino-N-(2-[4-[(aminooxy)sulfinyl]phenyl]ethyl)benzenesulfonamide}  \\n\\t<210>\\nIC50\\t#17# 0.0185 {4-[(aminooxy)sulfinyl]aniline}  <210>\\nIC50\\t#17# 0.00754 {4-[(aminooxy)sulfinyl]benzoic acid}  <210>\\nIC50\\t#17# 0.000165 {3-[4-[(aminooxy)sulfinyl]phenyl]propanoic acid}  <210>\\nIC50\\t#17# 0.000166 \\n\\t{4-amino-N-[4-[(aminooxy)sulfinyl]benzyl]benzenesulfonamide}  <210>\\nIC50\\t#17# 0.000163 {2-[4-[(aminooxy)sulfinyl]phenyl]ethanamine}  <210>\\nIC50\\t#17# 0.000248 {4-[(aminooxy)sulfinyl]-2-bromoaniline}  <210>\\nIC50\\t#17# 0.0000151 \\n\\t{2-[(aminooxy)sulfinyl]-5-(2-chlorophenyl)-1,3,4-thiadiazole}  <210>\\nIC50\\t#17# 0.000447 {5-[(aminooxy)sulfinyl]-1,3,4-thiadiazol-2-amine}  <210>\\nIC50\\t#17# 0.0161 {1-[(aminooxy)sulfinyl]-4-methylbenzene}  <210>\\nIC50\\t#17# 0.000457 {4-[(aminooxy)sulfinyl]-2-chloroaniline}  <210>\\nIC50\\t#17# 0.000169 {2,4-bis[(aminooxy)sulfinyl]-5-chloroaniline}  <210>\\nIC50\\t#17# 0.000976 {4-[(aminooxy)sulfinyl]-2-iodoaniline}  <210>\\nIC50\\t#17# 0.000223 {2,4-bis[(aminooxy)sulfinyl]-5-(trifluoromethyl)aniline}  \\n\\t<210>\\nIC50\\t#17# 0.000433 {1-[4-[(aminooxy)sulfinyl]phenyl]methanamine}  <210>\\nIC50\\t#17# 0.000389 {4-[(aminooxy)sulfinyl]-2-fluoroaniline}  <210>\\nIC50\\t#17# 0.000565 {[4-[(aminooxy)sulfinyl]phenyl]methanol}  <210>\\nIC50\\t#17# 0.00897 {2-[4-[(aminooxy)sulfinyl]phenyl]ethanol}  <210>\\nIC50\\t#18# 0.824 {sulfanilamide}  (#18# at pH 7.0 and 20C <248>) <248>\\nIC50\\t#18# 1.151 {KSCN}  (#18# at pH 7.0 and 20C <248>) <248>\\nIC50\\t#18# 1.529 {NaN3}  (#18# at pH 7.0 and 20C <248>) <248>\\nIC50\\t#18# 1.145 {acetazolamide}  (#18# at pH 7.0 and 20C <248>) <248>\\nIC50\\t#193# 0.00186 {zonisamide}  (#193# pH 7.4, 25C <357>) <357>\\nIC50\\t#21# 0.11 {Pb2+}  (#21# pH 7.4, 25C, purified enzyme <380>) <380>\\nIC50\\t#21# 0.4 {Hg2+}  (#21# pH 7.4, 25C, purified enzyme <380>) <380>\\nIC50\\t#21# 0.42 {Co2+}  (#21# pH 7.4, 25C, purified enzyme <380>) <380>\\nIC50\\t#21# 0.00038 {dexamethasone}  (#21# pH 7.4, 25C, versus \\n\\t4-nitrophenylacetate as substrate <379>) <379>\\nIC50\\t#21# 1.15 {Ag+}  (#21# pH 7.4, 25C, purified enzyme <380>) <380>\\nIC50\\t#21# 0.63 {Cu2+}  (#21# pH 7.4, 25C, purified enzyme <380>) <380>\\nIC50\\t#21# 1.22 {Fe2+}  (#21# pH 7.4, 25C, purified enzyme <380>) <380>\\nIC50\\t#21# 0.00533 \\n\\t{(7S)-7-[[(2Z)-2-(2-amino-1,\\n\\t3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino]-3-[[(furan-2-\\n\\tcarbonyl)sulfanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-\\n\\tcarboxylic acid}  (#21# pH 7.4, 25C, versus 4-nitrophenylacetate as \\n\\tsubstrate <379>) <379>\\nIC50\\t#21# 0.0276 {tavilin 50}  (#21# pH 7.4, 25C, versus \\n\\t4-nitrophenylacetate as substrate <379>) <379>\\nIC50\\t#21# 0.0366 {sulfamezathine}  (#21# pH 7.4, 25C, versus \\n\\t4-nitrophenylacetate as substrate <379>) <379>\\nIC50\\t#21# 0.00824 {Caffeine}  (#21# pH 7.4, 25C, versus \\n\\t4-nitrophenylacetate as substrate <379>) <379>\\nIC50\\t#21# 0.00276 {ivermectin}  (#21# pH 7.4, 25C, versus \\n\\t4-nitrophenylacetate as substrate <379>) <379>\\nIC50\\t#21# 0.2855 {metamizole sodium}  (#21# pH 7.4, 25C, versus \\n\\t4-nitrophenylacetate as substrate <379>) <379>\\nIC50\\t#21# 0.1147 {tetramisol}  (#21# pH 7.4, 25C, versus \\n\\t4-nitrophenylacetate as substrate <379>) <379>\\nIC50\\t#21# 0.2135 \\n\\t{(2S,5R,6R)-3,\\n\\t3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-\\n\\tazabicyclo[3.2.0]heptane-2-carboxylic acid}  (#21# pH 7.4, 25C, versus \\n\\t4-nitrophenylacetate as substrate <379>) <379>\\nIC50\\t#21# 0.2083 \\n\\t{(1R,2S,3S,4S)-4,6-diamino-2-([3-O-[(1S,2S,3S,4S,\\n\\t5S)-2-amino-5-(aminomethyl)-3,\\n\\t4-dihydroxycyclohexyl]-alpha-L-arabinofuranosyl]oxy)-3-\\n\\thydroxycyclohexyl 2,6-diamino-2,6-dideoxy-beta-L-glucopyranoside}  \\n\\t(#21# pH 7.4, 25C, versus 4-nitrophenylacetate as substrate <379>) \\n\\t<379>\\nIC50\\t#219# 0.13 {Pb2+}  (#219# pH 9.0, 40C, uncompetitve inhibition <368>) \\n\\t<368>\\nIC50\\t#219# 0.78 {Fe2+}  (#219# pH 9.0, 40C, competitve inhibition <368>) \\n\\t<368>\\nIC50\\t#219# 2.07 {Co2+}  (#219# pH 9.0, 40C, competitve inhibition <368>) \\n\\t<368>\\nIC50\\t#219# 76.7 {Cu2+}  (#219# pH 9.0, 40C, competitve inhibition <368>) \\n\\t<368>\\nIC50\\t#219# 19.2 {Ag+}  (#219# pH 9.0, 40C, uncompetitve inhibition <368>) \\n\\t<368>\\nIC50\\t#228# 0.000197 {5-amino-1,3,4-thiadiazole-2-sulfonamide}  (#228# at pH \\n\\t8.3 and 25C <436>) <436>\\nIC50\\t#228# 0.00016 {4-(aminomethyl)benzene-1-sulfonamide}  (#228# at pH 8.3 \\n\\tand 25C <436>) <436>\\nIC50\\t#228# 0.000671 {4-amino-3-chlorobenzene-1-sulfonamide}  (#228# at pH \\n\\t8.3 and 25C <436>) <436>\\nIC50\\t#228# 0.000221 {4-methylbenzene-1-sulfonamide}  (#228# at pH 8.3 and \\n\\t25C <436>) <436>\\nIC50\\t#228# 0.000246 {benzene-1,3-disulfonamide}  (#228# at pH 8.3 and 25C \\n\\t<436>) <436>\\nIC50\\t#228# 0.000712 \\n\\t{5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide}  (#228# \\n\\tat pH 8.3 and 25C <436>) <436>\\nIC50\\t#228# 0.000314 {3-aminobenzene-1-sulfonamide}  (#228# at pH 8.3 and \\n\\t25C <436>) <436>\\nIC50\\t#228# 0.000193 {4-aminobenzene-1-sulfonamide}  (#228# at pH 8.3 and \\n\\t25C <436>) <436>\\nIC50\\t#228# 0.000718 {4-amino-3-bromobenzene-1-sulfonamide}  (#228# at pH 8.3 \\n\\tand 25C <436>) <436>\\nIC50\\t#228# 0.000605 {4-amino-3-fluorobenzene-1-sulfonamide}  (#228# at pH \\n\\t8.3 and 25C <436>) <436>\\nIC50\\t#228# 0.000883 \\n\\t{5-[(4-aminobenzene-1-sulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#228# at pH 8.3 and 25C <436>) <436>\\nIC50\\t#228# 0.000622 {4-(2-aminoethyl)benzene-1-sulfonamide}  (#228# at pH \\n\\t8.3 and 25C <436>) <436>\\nIC50\\t#228# 0.002577 {3,5-dichloro-2-hydroxybenzene-1-sulfonamide}  (#228# at \\n\\tpH 8.3 and 25C <436>) <436>\\nIC50\\t#228# 0.001779 {4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide}  \\n\\t(#228# at pH 8.3 and 25C <436>) <436>\\nIC50\\t#228# 0.001953 {4-amino-6-chlorobenzene-1,3-disulfonamide}  (#228# at \\n\\tpH 8.3 and 25C <436>) <436>\\nIC50\\t#228# 0.001013 {4-hydroxybenzene-1-sulfonamide}  (#228# at pH 8.3 and \\n\\t25C <436>) <436>\\nIC50\\t#228# 0.004238 {4-(hydroxymethyl)benzene-1-sulfonamide}  (#228# at pH \\n\\t8.3 and 25C <436>) <436>\\nIC50\\t#228# 0.001975 {4-(2-hydroxyethyl)benzene-1-sulfonamide}  (#228# at pH \\n\\t8.3 and 25C <436>) <436>\\nIC50\\t#228# 0.002064 {4-sulfamoylbenzoic acid}  (#228# at pH 8.3 and 25C \\n\\t<436>) <436>\\nIC50\\t#228# 0.001894 {4-[(2-aminopyrimidin-4-yl)amino]benzene-1-sulfonamide}  \\n\\t(#228# at pH 8.3 and 25C <436>) <436>\\nIC50\\t#228# 0.000819 \\n\\t{2-(hydroxymethyl)-4-nitro-N-[2-(4-sulfamoylphenyl)ethyl]benzene-1-\\n\\tsulfonamide}  (#228# at pH 8.3 and 25C <436>) <436>\\nIC50\\t#228# 0.003501 {4-amino-N-(4-sulfamoylphenyl)benzene-1-sulfonamide}  \\n\\t(#228# at pH 8.3 and 25C <436>) <436>\\nIC50\\t#228# 0.004045 \\n\\t{4-amino-N-[(4-sulfamoylphenyl)methyl]benzene-1-sulfonamide}  (#228# at \\n\\tpH 8.3 and 25C <436>) <436>\\nIC50\\t#228# 0.004262 \\n\\t{4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzene-1-sulfonamide}  (#228# \\n\\tat pH 8.3 and 25C <436>) <436>\\nIC50\\t#23# 0.001 {ethoxyzolamide}  (#23# carbonic anhydrase activity of \\n\\tphotosystem 1 membranes <163>) <163>\\nIC50\\t#23# 0.001 {acetazolamide}  (#23# carbonic anhydrase activity of \\n\\tphotosystem 1 membranes <163>) <163>\\nIC50\\t#23# 0.000001 {ethoxyzolamide}  (#23# carbonic anhydrase activity of \\n\\tphotosystem 2 membranes <163>) <163>\\nIC50\\t#234# 0.43 {Fe2+}  (#234# pH and temperature not specified in the \\n\\tpublication <424>) <424>\\nIC50\\t#234# 1.7 {Co2+}  (#234# pH and temperature not specified in the \\n\\tpublication <424>) <424>\\nIC50\\t#234# 0.21 {Pb2+}  (#234# pH and temperature not specified in the \\n\\tpublication <424>) <424>\\nIC50\\t#234# 0.00003001 {azoxystrobin}  (#234# pH and temperature not \\n\\tspecified in the publication <424>) <424>\\nIC50\\t#234# 0.00000378 {clofentezine}  (#234# pH and temperature not \\n\\tspecified in the publication <424>) <424>\\nIC50\\t#234# 0.00000855 {deltamethrin}  (#234# pH and temperature not \\n\\tspecified in the publication <424>) <424>\\nIC50\\t#234# 0.00000936 {propineb}  (#234# pH and temperature not specified in \\n\\tthe publication <424>) <424>\\nIC50\\t#234# 0.00007058 {thiophanate}  (#234# pH and temperature not specified \\n\\tin the publication <424>) <424>\\nIC50\\t#234# 0.00000577 {thiram}  (#234# pH and temperature not specified in \\n\\tthe publication <424>) <424>\\nIC50\\t#234# 13.84 {Cu2+}  (#234# pH and temperature not specified in the \\n\\tpublication <424>) <424>\\nIC50\\t#234# 8.63 {Hg2+}  (#234# pH and temperature not specified in the \\n\\tpublication <424>) <424>\\nIC50\\t#234# 11.04 {As3+}  (#234# pH and temperature not specified in the \\n\\tpublication <424>) <424>\\nIC50\\t#38# 0.003 {tebuconazole}  (#38# measured with hydration of CO2 \\n\\tactivity assay, pH and temperature not specified in the publication \\n\\t<390>) <390>\\nIC50\\t#38# 0.0031 {Carbaryl}  (#38# measured with hydration of CO2 activity \\n\\tassay, pH and temperature not specified in the publication <390>) <390>\\nIC50\\t#38# 0.0087 {carbofuran}  (#38# measured with hydration of CO2 activity \\n\\tassay, pH and temperature not specified in the publication <390>) <390>\\nIC50\\t#38# 0.0165 {Atrazine}  (#38# measured with hydration of CO2 activity \\n\\tassay, pH and temperature not specified in the publication <390>) <390>\\nIC50\\t#38# 0.0273 {simazine}  (#38# measured with hydration of CO2 activity \\n\\tassay, pH and temperature not specified in the publication <390>) <390>\\nIC50\\t#38# 0.0321 {propoxur}  (#38# measured with hydration of CO2 activity \\n\\tassay, pH and temperature not specified in the publication <390>) <390>\\nIC50\\t#43# 0.0008 {cyanide}  <282>\\nIC50\\t#43# 0.007 {sulfanilamide}  <282>\\nIC50\\t#43# 1.5 {thiocyanate}  <282>\\nIC50\\t#43# 0.00002 {acetazolamide}  <282>\\nIC50\\t#43# 200 {sulfate}  <282>\\nIC50\\t#43# 180 {chloride}  <282>\\nIC50\\t#43# 29 {Iodide}  <282>\\nIC50\\t#43# 69 {bromide}  <282>\\nIC50\\t#43# 35 {nitrate}  <282>\\nIC50\\t#43# 240 {Chlorate}  <282>\\nIC50\\t#43# 350 {fluoride}  <282>\\nIC50\\t#44# 0.008 {acetazolamide}  <272>\\nIC50\\t#44# 0.014 {azide}  <272>\\nIC50\\t#44# 0.15 {Iodide}  <272>\\nIC50\\t#44# 0.073 {nitrate}  <272>\\nIC50\\t#45# 0.05 \\n\\t{5-[[(pentafluorophenyl)sulfonyl]amino]-1,3,\\n\\t4-thiadiazole-2-sulfonamide}  (#45# IC50 above 0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 \\n\\t{2,3,4,5,6-pentafluoro-N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)benzamide}  \\n\\t(#45# IC50 above 0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 \\n\\t{2,3,4,5,6-pentafluoro-N-[(2E)-3-methyl-5-sulfamoyl-1,3,\\n\\t4-thiadiazol-2(3H)-ylidene]benzamide}  (#45# IC50 above 0.05 mM <205>) \\n\\t<205>\\nIC50\\t#45# 0.05 \\n\\t{N-[5-[(aminooxy)sulfinyl]-1,3,4-thiadiazol-2-yl]-1,1,2,2,3,3,4,4,5,5,6,\\n\\t6,7,7,8,8,8-heptadecafluorooctane-1-sulfonamide}  (#45# IC50 above 0.05 \\n\\tmM <205>) <205>\\nIC50\\t#45# 0.05 {4-[[(3,4-dichlorophenyl)carbamoyl]amino]benzenesulfonamide}  \\n\\t(#45# IC50 above 0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 \\n\\t{2,3,4,5,6-pentafluoro-N-(2-sulfamoylphenyl)benzenesulfonamide}  (#45# \\n\\tIC50 above 0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 {2-[(diphenylcarbamoyl)amino]benzenesulfonamide}  (#45# IC50 \\n\\tabove 0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 \\n\\t{N-[4-[(aminooxy)sulfinyl]phenyl]-4-\\n\\t[(diphenylcarbamoyl)amino]benzenesulfonamide}  (#45# IC50 above 0.05 mM \\n\\t<205>) <205>\\nIC50\\t#45# 0.05 {4-[[(diphenylcarbamoyl)amino]methyl]benzenesulfonamide}  \\n\\t(#45# IC50 above 0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 \\n\\t{N-[(4-[[(4-\\n\\tsulfamoylphenyl)carbamothioyl]amino]phenyl)sulfonyl]acetamide}  (#45# \\n\\tIC50 above 0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 {4-(carbamothioylamino)benzenesulfonamide}  (#45# IC50 above \\n\\t0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 {4-sulfamoyl-N-(4-sulfamoylphenyl)benzamide}  (#45# IC50 \\n\\tabove 0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 \\n\\t{4-([[(diethyl-l5-\\n\\tazanylidyne)methyl]disulfanyl]amino)benzenesulfonamide}  (#45# IC50 \\n\\tabove 0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 \\n\\t{4-[([[(diethyl-l5-\\n\\tazanylidyne)methyl]disulfanyl]amino)methyl]benzenesulfonamide}  (#45# \\n\\tIC50 above 0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 \\n\\t{4-(3-[[(1E)-(1-methyl-1H-imidazol-2-\\n\\tyl)methylidene]amino]propyl)benzenesulfonamide}  (#45# IC50 above 0.05 \\n\\tmM <205>) <205>\\nIC50\\t#45# 0.05 \\n\\t{4-[([(1Z)-[4-\\n\\t(dimethylamino)phenyl]methylidene]amino)methyl]benzenesulfonamide}  \\n\\t(#45# IC50 above 0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 \\n\\t{4-[3-([(1E)-[4-\\n\\t(dimethylamino)phenyl]methylidene]amino)propyl]benzenesulfonamide}  \\n\\t(#45# IC50 above 0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 \\n\\t{4-([(1E)-[4-\\n\\t(dimethylamino)phenyl]methylidene]amino)benzenesulfonamide}  (#45# IC50 \\n\\tabove 0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 \\n\\t{2-oxo-N-[2-(4-sulfamoylphenyl)ethyl]-2H-chromene-3-carboxamide}  (#45# \\n\\tIC50 above 0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 {2-oxo-N-(4-sulfamoylbenzyl)-2H-chromene-3-carboxamide}  \\n\\t(#45# IC50 above 0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 {2-oxo-N-(4-sulfamoylphenyl)-2H-chromene-3-carboxamide}  \\n\\t(#45# IC50 above 0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 {2-oxo-N-(2-sulfamoylphenyl)-2H-chromene-3-carboxamide}  \\n\\t(#45# IC50 above 0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 \\n\\t{4-[2-[(2-oxo-2H-chromen-3-yl)carbonyl]hydrazino]benzenesulfonamide}  \\n\\t(#45# IC50 above 0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 {2-oxo-N-(3-sulfamoylphenyl)-2H-chromene-3-carboxamide}  \\n\\t(#45# IC50 above 0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 \\n\\t{N-[2,\\n\\t4-disulfamoyl-5-(trifluoromethyl)phenyl]-2-oxo-2H-chromene-3-\\n\\tcarboxamide}  (#45# IC50 above 0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 \\n\\t{2-(7-methoxy-2-oxo-2H-chromen-4-yl)-N-(2-sulfamoylphenyl)acetamide}  \\n\\t(#45# IC50 above 0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 \\n\\t{2-(7-methoxy-2-oxo-2H-chromen-4-yl)-N-(3-sulfamoylphenyl)acetamide}  \\n\\t(#45# IC50 above 0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 \\n\\t{4-[2-[(7-methoxy-2-oxo-2H-chromen-4-\\n\\tyl)acetyl]hydrazino]benzenesulfonamide}  (#45# IC50 above 0.05 mM \\n\\t<205>) <205>\\nIC50\\t#45# 0.05 \\n\\t{2-(7-methoxy-2-oxo-2H-chromen-4-yl)-N-(4-sulfamoylphenyl)acetamide}  \\n\\t(#45# IC50 above 0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 \\n\\t{N-[2,\\n\\t4-disulfamoyl-5-(trifluoromethyl)phenyl]-2-(7-methoxy-2-oxo-2H-chromen-\\n\\t4-yl)acetamide}  (#45# IC50 above 0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 \\n\\t{4-[[(1Z)-(1-bromonaphthalen-2-yl)methylidene]amino]benzenesulfonamide} \\n\\t (#45# IC50 above 0.05 mM <205>) <205>\\nIC50\\t#45# 0.05 \\n\\t{5-[[(phenylcarbamoyl)carbamothioyl]amino]-1,3,\\n\\t4-thiadiazole-2-sulfonamide}  (#45# IC50 above 0.05 mM <205>) <205>\\nIC50\\t#45# 0.000315 {acetazolamide}  <205>\\nIC50\\t#45# 0.001002 \\n\\t{4-(3,4-dichlorophenylureido)thioureido-benzenesulfonamide}  <205>\\nIC50\\t#45# 0.003886 \\n\\t{4-([[(1Z)-(2-chlorophenyl)methylidene]amino]methyl)benzenesulfonamide} \\n\\t <205>\\nIC50\\t#49# 4.1 {azide}  <178>\\nIC50\\t#49# 0.26 {dithiothreitol}  <178>\\nIC50\\t#49# 3.4 {2-mercaptoethanol}  <178>\\nIC50\\t#58# 0.03 {Co2+}  <246>\\nIC50\\t#58# 0.01 {Ag+}  <246>\\nIC50\\t#58# 0.05 {Co2+}  (#58# in 0.05 M Tris-SO4 buffer, at pH 9.0 and 25C \\n\\t<199>) <199>\\nIC50\\t#58# 0.31 {Zn2+}  (#58# in 0.05 M Tris-SO4 buffer, at pH 9.0 and 25C \\n\\t<199>) <199>\\nIC50\\t#58# 30 {Cu2+}  (#58# in 0.05 M Tris-SO4 buffer, at pH 9.0 and 25C \\n\\t<199>) <199>\\nIC50\\t#58# 30 {Cu2+}  (#58# in 0.05 M Tris-SO4 buffer, at pH 9.0 and 25C \\n\\t<199>) <246>\\nIC50\\t#58# 47.1 {Zn2+}  <246>\\nIC50\\t#58# 159 {Ag+}  (#58# in 0.05 M Tris-SO4 buffer, at pH 9.0 and 25C \\n\\t<199>) <199>\\nIC50\\t#58# 82.5 {Cd2+}  (#58# in 0.05 M Tris-SO4 buffer, at pH 9.0 and 25C \\n\\t<199>) <199>\\nIC50\\t#85# 0.01 {4-(aminomethyl)benzene-1-sulfonamide}  (#85# IC50 above 0.01 \\n\\tmM, at pH 7.5 and 37C <408>) <408>\\nIC50\\t#85# 0.01 {4-(2-aminoethyl)benzene-1-sulfonamide}  (#85# IC50 above \\n\\t0.01 mM, at pH 7.5 and 37C <408>) <408>\\nIC50\\t#85# 0.01 {4-amino-3-fluorobenzene-1-sulfonamide}  (#85# IC50 above \\n\\t0.01 mM, at pH 7.5 and 37C <408>) <408>\\nIC50\\t#85# 0.01 {4-amino-3-bromobenzene-1-sulfonamide}  (#85# IC50 above 0.01 \\n\\tmM, at pH 7.5 and 37C <408>) <408>\\nIC50\\t#85# 0.01 {4-hydroxybenzene-1-sulfonamide}  (#85# IC50 above 0.01 mM, \\n\\tat pH 7.5 and 37C <408>) <408>\\nIC50\\t#85# 0.000691 \\n\\t{5-imino-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamide}  (#85# \\n\\tat pH 7.5 and 37C <408>) <408>\\nIC50\\t#85# 0.000403 \\n\\t{4-amino-N-[2-(4-sulfamoylphenyl)ethyl]benzene-1-sulfonamide}  (#85# at \\n\\tpH 7.5 and 37C <408>) <408>\\nIC50\\t#85# 0.000378 \\n\\t{2-(hydroxymethyl)-4-nitro-N-[2-(4-sulfamoylphenyl)ethyl]benzene-1-\\n\\tsulfonamide}  (#85# at pH 7.5 and 37C <408>) <408>\\nIC50\\t#85# 0.000559 {4-amino-N-(4-sulfamoylphenyl)benzene-1-sulfonamide}  \\n\\t(#85# at pH 7.5 and 37C <408>) <408>\\nIC50\\t#85# 0.000866 {5-amino-1,3,4-thiadiazole-2-sulfonamide}  (#85# at pH \\n\\t7.5 and 37C <408>) <408>\\nIC50\\t#85# 0.000319 \\n\\t{5-[(4-aminobenzene-1-sulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide}  \\n\\t(#85# at pH 7.5 and 37C <408>) <408>\\nIC50\\t#85# 0.000681 {4-(2-hydroxyethyl)benzene-1-sulfonamide}  (#85# at pH \\n\\t7.5 and 37C <408>) <408>\\nIC50\\t#85# 0.000487 \\n\\t{4-amino-N-[(4-sulfamoylphenyl)methyl]benzene-1-sulfonamide}  (#85# at \\n\\tpH 7.5 and 37C <408>) <408>\\nIC50\\t#85# 0.007611 {3-aminobenzene-1-sulfonamide}  (#85# at pH 7.5 and 37C \\n\\t<408>) <408>\\nIC50\\t#85# 0.007583 {4-aminobenzene-1-sulfonamide}  (#85# at pH 7.5 and 37C \\n\\t<408>) <408>\\nIC50\\t#85# 0.003019 {benzene-1,3-disulfonamide}  (#85# at pH 7.5 and 37C \\n\\t<408>) <408>\\nIC50\\t#85# 0.005603 {4-methylbenzene-1-sulfonamide}  (#85# at pH 7.5 and 37C \\n\\t<408>) <408>\\nIC50\\t#85# 0.008938 {4-amino-3-chlorobenzene-1-sulfonamide}  (#85# at pH 7.5 \\n\\tand 37C <408>) <408>\\nIC50\\t#85# 0.005029 {3,5-dichloro-2-hydroxybenzene-1-sulfonamide}  (#85# at \\n\\tpH 7.5 and 37C <408>) <408>\\nIC50\\t#85# 0.007556 {4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide}  \\n\\t(#85# at pH 7.5 and 37C <408>) <408>\\nIC50\\t#85# 0.007927 {4-amino-6-chlorobenzene-1,3-disulfonamide}  (#85# at pH \\n\\t7.5 and 37C <408>) <408>\\nIC50\\t#85# 0.006006 {4-(hydroxymethyl)benzene-1-sulfonamide}  (#85# at pH 7.5 \\n\\tand 37C <408>) <408>\\nIC50\\t#85# 0.002707 {4-sulfamoylbenzoic acid}  (#85# at pH 7.5 and 37C \\n\\t<408>) <408>\\nIC50\\t#85# 0.004407 {4-[(2-aminopyrimidin-4-yl)amino]benzene-1-sulfonamide}  \\n\\t(#85# at pH 7.5 and 37C <408>) <408>\\nIC50\\t#99# 0.4 {acetazolamide}  (#99# IC50: 0.4 mM <160>) <160>\\nIC50\\t#99# 0.28 {Cyanate}  (#99# IC50: 0.28 mM <160>) <160>\\nIC50\\t#99# 0.31 {cyanide}  (#99# IC50: 0.31 mM <160>) <160>\\nIC50\\t#99# 3.4 {azide}  (#99# IC50: 3.4 mM <160>) <160>\\n\\nKCAT_KM_VALUE\\nKKM\\t#123# 59000 {CO2}  (#123# pH 7.5, 20C <343>) <343>\\nKKM\\t#124# 88000 {CO2}  (#124# mutant L100H/L224S/L240P/Y7F/N62L, pH 7.6, \\n\\t25C <348>) <348>\\nKKM\\t#124# 85000 {CO2}  (#124# mutant L100H/L224S/L240P, pH 7.6, 25C <348>) \\n\\t<348>\\nKKM\\t#124# 130000 {CO2}  (#124# pH 7.6, temperature not specified in the \\n\\tpublication, mutant A23C/L203C/C206S <323>) <323>\\nKKM\\t#124# 150000 {H2CO3}  (#124# pH 7.5, 20C <376>) <376>\\nKKM\\t#124# 94000 {CO2}  (#124# mutant L100H/L224S/L240P/Y7F/N67Q, pH 7.6, \\n\\t25C <348>) <348>\\nKKM\\t#14# 55000 {CO2}  (#14# Escherichia coli recombinant enzyme <251>) <251>\\nKKM\\t#14# 5500 {CO2}  (#14# mutant V143L, pH 8.3, 25C <327>) <327>\\nKKM\\t#14# 9300 {CO2}  (#14# mutant V143I, pH 8.3, 25C <327>) <327>\\nKKM\\t#14# 42000 {CO2}  (#14# mutant V143A, pH 8.3, 25C <327>) <327>\\nKKM\\t#14# 150000 {CO2}  (#14# pH 7.5, 20C, wild-type <332>) <332>\\nKKM\\t#14# 155000 {CO2}  (#14# pH 7.5, 20C, mutant N67I <332>) <332>\\nKKM\\t#14# 108000 {CO2}  (#14# pH 7.5, 20C, mutant Q92V <332>) <332>\\nKKM\\t#14# 161000 {CO2}  (#14# pH 7.5, 20C, mutant L204S <332>) <332>\\nKKM\\t#14,124# 120000 {CO2}  (#124# mutant Y7F, pH 7.6, 25C <348>; #124# pH \\n\\t7.6, temperature not specified in the publication, wild-type <323>; \\n\\t#124# wild-type, pH 7.6, 25C <348>; #14# wild-type, pH 8.3, 25C \\n\\t<327>) <323>\\nKKM\\t#14,124# 120000 {CO2}  (#124# mutant Y7F, pH 7.6, 25C <348>; #124# pH \\n\\t7.6, temperature not specified in the publication, wild-type <323>; \\n\\t#124# wild-type, pH 7.6, 25C <348>; #14# wild-type, pH 8.3, 25C \\n\\t<327>) <327>\\nKKM\\t#14,124# 120000 {CO2}  (#124# mutant Y7F, pH 7.6, 25C <348>; #124# pH \\n\\t7.6, temperature not specified in the publication, wild-type <323>; \\n\\t#124# wild-type, pH 7.6, 25C <348>; #14# wild-type, pH 8.3, 25C \\n\\t<327>) <348>\\nKKM\\t#14,62,99# -999 {more}  (#14# Km/kcat values for 4-nitrophenylacetate \\n\\thydrolysis by wild-type and mutant enzymes, overview <287>; #99# \\n\\tkinetic constants of apoenzyme reconstituted with Zn2+, Co2+, Cu2+, \\n\\tMn2+, Ni2+, Cd2+, or Fe2+ <321>; #62# the Fe2+-reconstituted enzyme \\n\\tproduced in Escherichia coli and purified anaerobically contains iron \\n\\twith effective kcat and kcat/Km values exceeding the values for \\n\\tZn2+-reconstituted enzyme <321>) <287>\\nKKM\\t#14,62,99# -999 {more}  (#14# Km/kcat values for 4-nitrophenylacetate \\n\\thydrolysis by wild-type and mutant enzymes, overview <287>; #99# \\n\\tkinetic constants of apoenzyme reconstituted with Zn2+, Co2+, Cu2+, \\n\\tMn2+, Ni2+, Cd2+, or Fe2+ <321>; #62# the Fe2+-reconstituted enzyme \\n\\tproduced in Escherichia coli and purified anaerobically contains iron \\n\\twith effective kcat and kcat/Km values exceeding the values for \\n\\tZn2+-reconstituted enzyme <321>) <321>\\nKKM\\t#162# 39000 {CO2}  (#162# in 10-20 mM Tris, pH 8.3, 10-20 mM NaCl \\n\\t<277>) <257>\\nKKM\\t#162# 39000 {CO2}  (#162# in 10-20 mM Tris, pH 8.3, 10-20 mM NaCl \\n\\t<277>) <277>\\nKKM\\t#162# 3900 {CO2}  (#162# isozyme bsCAI, pH 8.3, temperature not \\n\\tspecified in the publication <298>) <298>\\nKKM\\t#162# 8900 {CO2}  (#162# isozyme bsCAII, pH 8.3, temperature not \\n\\tspecified in the publication <298>) <298>\\nKKM\\t#17# 98000 {CO2}  (#17# pH not specified in the publication, \\n\\ttemperature not specified in the publication <305>) <305>\\nKKM\\t#176# 0.0017 {CO2}  (#176# pH 7.5, 25C, enzyme cultured with \\n\\tsupplemental iron <320>) <320>\\nKKM\\t#176# 0.00016 {CO2}  (#176# pH 7.5, 25C, enzyme cultured with \\n\\tsupplemental zinc <320>) <320>\\nKKM\\t#179# 1210 {CO2}  (#179# 20C, pH 8.3 <337>) <337>\\nKKM\\t#181# 350000 {H2CO3}  (#181# pH 7.5, 20C <376>) <376>\\nKKM\\t#182# 69000 {CO2}  (#182# pH 8.3, 20C <342>) <342>\\nKKM\\t#185# 110000 {H2CO3}  (#185# pH 7.5, 20C <376>) <376>\\nKKM\\t#188# 5900 {H2CO3}  (#188# pH 8.5, 25C <376>) <376>\\nKKM\\t#191# 30000 {H2CO3}  (#191# pH 7.5, 20C <376>) <376>\\nKKM\\t#191# 30000 {CO2}  (#191# pH 7.8, 25C, recombinant enzyme <404>) <404>\\nKKM\\t#192# 160000 {H2CO3}  (#192# pH 7.5, 20C <376>) <376>\\nKKM\\t#194# 35000 {CO2}  (#194# CO2 hydration, pH 8.3, 22C, recombinant \\n\\tenzyme <389>) <389>\\nKKM\\t#194# 36000 {CO2}  (#194# CO2 hydration, pH 8.3, 22C, native enzyme \\n\\t<389>) <389>\\nKKM\\t#195# 5400 {CO2}  (#195# pH 7.5, 22C, truncated form PfCA1, CO2 \\n\\thydration reaction <362>) <362>\\nKKM\\t#195# 72000 {H2CO3}  (#195# enzyme PfCAdom, pH 8.3, 22C <388>) <388>\\nKKM\\t#195# 72000 {CO2}  (#195# pH 7.5, 22C, long enzyme form PfCAdom, CO2 \\n\\thydration reaction <362>) <362>\\nKKM\\t#196# 15000 {CO2}  (#196# pH 8.3, 22C, recombinant His-tagged enzyme \\n\\t<383>) <383>\\nKKM\\t#198# 56000 {CO2}  (#198# pH 8.3, 20C, recombinant His-tagged enzyme \\n\\t<384>) <384>\\nKKM\\t#200# 130000 {H2CO3}  (#200# carbonate dehydratase activity, \\n\\trecombinant enzyme, pH and temperature not specified in the publication \\n\\t<399>) <399>\\nKKM\\t#203# 1190 {CO2}  (#203# recombinant full-length CcaA274 enzyme, pH \\n\\t7.5, 25C, CO2 hydration reaction <355>) <355>\\nKKM\\t#203# 17300 {CO2}  (#203# full-length CcaA274 enzyme, pH 9.5, 25C, CO2 \\n\\thydration reaction <355>) <355>\\nKKM\\t#206# 1900 {CO2}  (#206# pH 8.3, 20C <358>) <358>\\nKKM\\t#207# 350000 {CO2}  (#207# pH 7.5, 20C, recombinant His-tagged enzyme \\n\\t<360>) <360>\\nKKM\\t#219# 1585 {H2CO3}  (#219# pH 9.0, 40C <368>) <368>\\nKKM\\t#220# 83000 {CO2}  (#220# pH 7.5, 20C <361>) <361>\\nKKM\\t#228# 6900 {CO2}  (#228# at pH 8.3 and 25C <436>) <436>\\nKKM\\t#229# 80000 {CO2}  (#229# at pH 7.5 and 25C <434>) <434>\\nKKM\\t#230# 44000 {CO2}  (#230# at pH 7.5 and 20C <440>) <440>\\nKKM\\t#237# 107000 {CO2}  (#237# at pH 8.3 and 25C <428>) <428>\\nKKM\\t#238# 7580 {CO2}  (#238# at pH 8.3 and 20C <438>) <438>\\nKKM\\t#28# 89000 {CO2}  (#28# at pH 8.3 and 25C <443>) <443>\\nKKM\\t#30# 3133 {CO2}  (#30# purified recombinant enzyme <265>) <265>\\nKKM\\t#31# 66.8 {CO2}  (#31# purified recombinant CAH-4a, pH 7.5, 4C <310>) \\n\\t<310>\\nKKM\\t#32# 37000 {CO2}  (#32# at 20C and pH 8.3, in 20 mM Tris-HCl buffer \\n\\tand 20 mM NaCl <275>) <275>\\nKKM\\t#32# 40000 {CO2}  (#32# at 20C, pH 8.3, in 20 mM Tris-HCl and 20 mM \\n\\tNaCl <276>) <276>\\nKKM\\t#35# 149000 {CO2}  (#35# pH 7.5, 20C <342>) <342>\\nKKM\\t#52# 4800 {CO2}  (#52# pH not specified in the publication, 25C <338>) \\n\\t<338>\\nKKM\\t#6,59,124,180# 110000 {CO2}  (#6# pH 8.3, 20C <303>; #59,180# pH 7.5, \\n\\t20C <331,339>; #124# mutant L100H/L224S/L240P/Y7F, pH 7.6, 25C <348>; \\n\\t#124# mutant L100H/L224S/L240P/Y7F/N62L/N67Q, pH 7.6, 25C <348>) <303>\\nKKM\\t#6,59,124,180# 110000 {CO2}  (#6# pH 8.3, 20C <303>; #59,180# pH 7.5, \\n\\t20C <331,339>; #124# mutant L100H/L224S/L240P/Y7F, pH 7.6, 25C <348>; \\n\\t#124# mutant L100H/L224S/L240P/Y7F/N62L/N67Q, pH 7.6, 25C <348>) <331>\\nKKM\\t#6,59,124,180# 110000 {CO2}  (#6# pH 8.3, 20C <303>; #59,180# pH 7.5, \\n\\t20C <331,339>; #124# mutant L100H/L224S/L240P/Y7F, pH 7.6, 25C <348>; \\n\\t#124# mutant L100H/L224S/L240P/Y7F/N62L/N67Q, pH 7.6, 25C <348>) <339>\\nKKM\\t#6,59,124,180# 110000 {CO2}  (#6# pH 8.3, 20C <303>; #59,180# pH 7.5, \\n\\t20C <331,339>; #124# mutant L100H/L224S/L240P/Y7F, pH 7.6, 25C <348>; \\n\\t#124# mutant L100H/L224S/L240P/Y7F/N62L/N67Q, pH 7.6, 25C <348>) <348>\\nKKM\\t#61# 4100 {CO2}  (#61# pH 8, 25C <346>) <346>\\nKKM\\t#62# 3100 {H2CO3}  (#62# pH 7.5, 25C, recombinant enzyme expressed \\n\\tfrom Escherichia coli and aerobically purified <376>) <376>\\nKKM\\t#62# 3900 {H2CO3}  (#62# pH 7.5, 25C, recombinant enzyme expressed \\n\\tfrom Methanosarcina acetivorans and anaerobically purified <376>) <376>\\nKKM\\t#62,195# 5400 {H2CO3}  (#62# pH 7.5, 25C, recombinant enzyme expressed \\n\\tfrom Escherichia coli and anaerobically purified <376>; #195# truncated \\n\\tmutant PfCA1, pH 8.3, 22C <388>) <376>\\nKKM\\t#62,195# 5400 {H2CO3}  (#62# pH 7.5, 25C, recombinant enzyme expressed \\n\\tfrom Escherichia coli and anaerobically purified <376>; #195# truncated \\n\\tmutant PfCA1, pH 8.3, 22C <388>) <388>\\nKKM\\t#63# 540000 {CO2}  (#63# pH 8.3, 20C <330>) <330>\\nKKM\\t#65# 70000 {CO2}  (#65# pH 7.5, 20C <341>) <341>\\nKKM\\t#85# 14100 {CO2}  (#85# at pH 7.5 and 37C <408>) <408>\\nKKM\\t#87# 7500000 {CO2}  (#87# pH 7.5, 20C <329>) <329>\\nKKM\\t#88,199# 33000 {CO2}  (#88# pH 7.5, 20C <334>; #199# measured with \\n\\thydration of CO2 activity assay, pH 7.5-8.3, 0C <382>) <334>\\nKKM\\t#88,199# 33000 {CO2}  (#88# pH 7.5, 20C <334>; #199# measured with \\n\\thydration of CO2 activity assay, pH 7.5-8.3, 0C <382>) <382>\\nKKM\\t#97# 9700 {CO2}  (#97# at pH 8.3, temperature not specified in the \\n\\tpublication <439>) <439>\\nKKM\\t#99# 1400 {CO2}  (#99# 25C, pH 8.8, mutant enzyme W19A <315>) <315>\\nKKM\\t#99# 10300 {CO2}  (#99# 25C, pH 8.8, mutant enzyme Y200A <315>) <315>\\nKKM\\t#99# 790 {CO2}  (#99# 25C, pH 7.5, mutant enzyme W19A <315>) <315>\\nKKM\\t#99# 600 {CO2}  (#99# 25C, pH 8.8, mutant enzyme W19F <315>) <315>\\nKKM\\t#99# 630 {CO2}  (#99# 25C, pH 7.5, mutant enzyme W19N <315>) <315>\\nKKM\\t#99# 3100 {CO2}  (#99# 25C, pH 8.8, wild-type enzyme <315>) <315>\\nKKM\\t#99# 2000 {CO2}  (#99# 25C, pH 7.5, wild-type enzyme <315>) <315>\\nKKM\\t#99# 400 {CO2}  (#99# 25C, pH 7.5, mutant enzyme W19F <315>) <315>\\nKKM\\t#99# 7000 {CO2}  (#99# 25C, pH 7.5, mutant enzyme Y200A <315>) <315>\\nKKM\\t#99# 7900 {CO2}  (#99# 25C, pH 8.8, mutant enzyme Y200F <315>) <315>\\nKKM\\t#99# 7100 {CO2}  (#99# 25C, pH 7.5, mutant enzyme Y200F <315>) <315>\\nKKM\\t#99# 5900 {CO2}  (#99# 25C, pH 7.5, mutant enzyme Y200S <315>) <315>\\nKKM\\t#99# 10200 {CO2}  (#99# 25C, pH 8.8, mutant enzyme Y200S <315>) <315>\\nKKM\\t#99,178# 1300 {CO2}  (#99# 25C, pH 8.8, mutant enzyme W19N <315>; \\n\\t#178# 20C, pH 8.3 <337>) <315>\\nKKM\\t#99,178# 1300 {CO2}  (#99# 25C, pH 8.8, mutant enzyme W19N <315>; \\n\\t#178# 20C, pH 8.3 <337>) <337>\\n\\nEXPRESSION\\nEXP\\t#14,43,77,90,96,164,176,201,207,225,226# up (#77# carbonic anhydrase \\n\\tactivity shows week sensitivity to in vitro cadmium exposure, while it \\n\\tis significantly increased (about 40%) following two weeks in vivo \\n\\texposure (0.001785 mM cadmium), additionally protein expression appears \\n\\tsignificantly enhanced. When exposed for 30 days to the \\n\\tcadmium-polluted site of Mar Grande of Taranto mussels show a very \\n\\tsignificant increase in the carbonic anhydrase activity (about 26% \\n\\tincrease) <269>; #14# expression of CA IX is strongly increased in many \\n\\ttypes of tumors, such as gliomas/ependymomas, mesotheliomas, and \\n\\tpapillary/follicular carcinomas, as well as carcinomas of the bladder, \\n\\tuterine cervix, kidneys, esophagus, lungs, head and neck, breast, \\n\\tbrain, vulva, and squamous/basal cell carcinomas <251>; #164# gene \\n\\texpression is induced by increased medium pH <273>; #43# the enzyme is \\n\\tinduced in presence of CaCO3 <282>; #14# CAIX expression is 5-7fold \\n\\tinduced by hypoxia and is significantly associated with tumor grade and \\n\\tpoor survival, overview <291>; #176# the expression of the gene \\n\\tencoding CamH is substantially greater in acetate-grown cells than in \\n\\tmethanol- or trimethylamine-grown cells <320>; #90# eCA expression is \\n\\tprimarily controlled by CO2 <347>; #201# exposure to light induces \\n\\tsignificant increases in the protein abundance of CA2-like in the outer \\n\\tmantle <401>; #201# the transcript and protein levels of DDCA/DDCA in \\n\\tthe ctenidium of Tridacna squamosa increase significantly after 6 and \\n\\t12 h of exposure to light, respectively <371>; #207# fusion of the \\n\\t60-amino acid-long ectodomain (M-domain) of the human receptor-type \\n\\ttyrosine-protein phosphatase C increased the levels of enzyme \\n\\taccumulation <444>; #225# the isoform CAc expression in gills is \\n\\tsignificantly upregulated during the early period of pH and \\n\\tsaline-alkaline stresses <422>; #226# the isoform CAg expression in \\n\\tgills is significantly upregulated during the early period of pH and \\n\\tsaline-alkaline stresses <422>; #96# the mRNA level of isoform gamma-CA \\n\\tgene is highly regulated by the low CO2 concentration <423>) \\n\\t<251,269,273,282,291,320,347,371,401,422,423,444>\\nEXP\\t#168,169,221# down (#168# the gene encoding isozyme LjCAA1 is slightly \\n\\tto moderately down-regulated in ineffective nodules formed by mutant \\n\\tMesorhizobium loti strains <292>; #169# the gene encoding isozyme \\n\\tLjCAA2 is slightly to moderately down-regulated in ineffective nodules \\n\\tformed by mutant Mesorhizobium loti strains <292>; #221# feeding stress \\n\\tis used to upregulate CO2 excretion pathways: significant upregulation \\n\\tof isozyme CA II is observed, while isozyme CA XIII is strongly \\n\\tdownregulated <366>) <292,366>\\nEXP\\t#214,215,216,217,224# more (#214,215,216,217# transcript levels of \\n\\tspecific CA subunits depend on the CO2 level in air <402>; #224# the \\n\\tisoform CAb expression shows no regular or large changes during the \\n\\tearly period of pH and saline-alkaline stresses <422>) <402,422>\\n\\nGENERAL_INFORMATION\\nGI\\t#1,12,13,14,44,62,120,124,129,132,168,169,171,184,194,197,199,201,203,\\n\\t204,209,210,214,215,216,217,218,220,221,225,226# physiological function \\n\\t(#44# beta carbonic anhydrase is required for scavenging CO2 from the \\n\\tambient air <272>; #120# CA IX is involved in solid tumor acidification \\n\\t<280>; #14# isoform CA IX is involved in tumorigenesis through many \\n\\tpathways, such as pH regulation and cell adhesion control <251>; #14# \\n\\tCAIX is a zinc metalloenzyme that catalyzes the reversible hydration of \\n\\tCO2. CAIX expression is strongly induced by hypoxia and is \\n\\tsignificantly associated with tumor grade and poor survival <291>; #14# \\n\\tisoyzme CAII is associated with the acute mountain sickness, a common \\n\\tdisease at high altitude <301>; #168# isozyme LjCAA1 is involved in \\n\\tnitrogen ficxation/assimilation, but may also be involved in \\n\\tbiochemical and physiological processes not directly linked to nitrogen \\n\\tfixation/assimilation <292>; #169# isozyme LjCAA2 is involved in \\n\\tnitrogen fixation/assimilation, but may also be involved in biochemical \\n\\tand physiological processes not directly linked to nitrogen \\n\\tfixation/assimilation <292>; #12,14# role of isozyme carbonic anhydrase \\n\\tIV in the bicarbonate-mediated activation of sperm, overview. Sperm \\n\\trespond to CO2 with an increase in beat frequency, an effect that can \\n\\tbe inhibited by ethoxyzolamide. CA IV supplies sperm with HCO3-, which \\n\\tis necessary for stimulation of atypical sperm adenylyl cyclase and \\n\\thence early activation of spermatozoa <314>; #1# the enzyme from \\n\\tchicken has an important role in eggshell formation <285>; #14# a \\n\\ttheoretical model predicts that homogeneous cytoplasmic distribution of \\n\\tCAII is more favourable for cellular transport of HCO3- and CO2 than is \\n\\tassociation of CAII with the cytoplasmic surface of the plasma \\n\\tmembrane. Physiological interference with anion exchanger AE1 could not \\n\\tbe demonstrated <344>; #13# carbonic anhydrase which displays \\n\\tsignificant catalytic activity in intact oocytes, also reduces the \\n\\tSNAT3-associated membrane conductance, when glutamine, but not when \\n\\tasparagine is the substrate <335>; #201# CA2-like can probably take \\n\\tpart in the increased supply of inorganic carbon (Ci) from the host \\n\\tclam to the symbiotic zooxanthellae when the latter conduct \\n\\tphotosynthesis to fix Ci during light exposure <401>; #221# carbonic \\n\\tanhydrase (CA) is a ubiquitously expressed metalloenzyme that catalyses \\n\\tthe hydration and dehydration reactions of carbon dioxide and \\n\\tbicarbonate, respectively. This basic reaction has innumerable \\n\\tphysiological and biochemical associations and consequently CA isoforms \\n\\tare found in virtually all living organisms <366>; #124# carbonic \\n\\tanhydrase (CA) plays a key role in neuronal signaling, providing \\n\\tbicarbonate and proton ions for GABAergic and glutamatergic neuronal \\n\\tfunction. Activation of CA isoforms expressed in neurons have been \\n\\tshown to have implications in the prognosis of Alzheimers disease and \\n\\tdementia, while inhibitors of CAs are clinically used in the treatment \\n\\tof epilepsy, emphasizing the importance of this family of enzymes in \\n\\tboth disease and normal neuronal function <396>; #197# carbonic \\n\\tanhydrase is a biocatalyst that catalyzes the hydration of CO2to \\n\\tbicarbonate and protons, and an alkalistable and moderately \\n\\tthermostable alpha-carbonic anhydrase <374>; #129# carbonic anhydrase \\n\\tVA (CAVA) is a mitochondrial enzyme that catalyzes the reversible \\n\\thydration of CO2 to produce HCO3- and proton. CAVA is primarily \\n\\tinvolved in several biosynthetic processes such as ureagenesis, \\n\\tgluconeogenesis and lipogenesis by providing bicarbonate ion <349>; \\n\\t#199# carbonic anhydrases are key enzymes involved in the acquisition \\n\\tof inorganic carbon for photosynthesis in phytoplankton, as they \\n\\tcatalyze efficiently the interconversion between carbon dioxide and \\n\\tbicarbonate <382>; #203# CcaA is a beta-carbonic anhydrase that is a \\n\\tcomponent of the carboxysomes of a subset of beta-cyanobacteria. It has \\n\\ta characteristic C-terminal extension and is recruited to the \\n\\tcarboxysome via interactions with CcmM, UniProt ID P72758, which is \\n\\titself a gamma-CA homologue with enzymatic activity in many, but not \\n\\tall cyanobacteria. Enzyme CcaA forms a complex with CcmM with \\n\\tsub-picomolar affinity, with contributions from residues in CcmMs \\n\\talphaA helix and CcaAs C-terminal tail. Enzyme Cca shows low activity \\n\\tcompared to other CAs, the C-terminal tail appears to partly inhibit \\n\\tactivity, possibly indicating a role in minimizing the activity of \\n\\tunencapsulated enzyme. The need for the HCO3- entering the carboxysome \\n\\tto be efficiently converted into CO2 requires that carbonic anhydrase \\n\\tis co-encapsulated within the carboxysome. On the other hand, the \\n\\tpresence of CA activity in the cytosol is highly deleterious as it \\n\\tconverts the accumulated HCO3- into its membrane-permeable CO2 \\n\\tcounterpart outside of the protective barrier afforded by the shell. \\n\\tIntracellular CAs in cyanobacteria are required to possess interaction \\n\\tdeterminants that target them to the carboxysome, as well as mechanisms \\n\\tthat minimize CA activity prior to the completion of the shell. CcmM is \\n\\tthe second potential beta-carboxysomal CA and is universally present in \\n\\tbeta-carboxysomes as it functions as a central nexus for organizing the \\n\\tcarboxysomes interior. Formation of the CcaA/CcmM complex probably \\n\\trequires significant backbone movements in at least one of the binding \\n\\tpartners. CcaA is among the least active beta-CAs characterized to \\n\\tdate, with activity comparable with the gamma-CA, CcmM <355>; #204# \\n\\tCcmM is itself a gamma-carbonic anhydrase homologue with enzymatic \\n\\tactivity. It has a characteristic C-terminal extension and is recruited \\n\\tto the carboxysome via interactions with CcmM, which is itself a \\n\\tgamma-CA homologue with enzymatic activity in many, but not all \\n\\tcyanobacteria. Enzyme CcaA forms a complex with CcmM with sub-picomolar \\n\\taffinity, with contributions from residues in CcmMs alphaA helix and \\n\\tCcaAs C-terminal tail. CcaA is recruited to the beta-carboxysome by \\n\\tbinding the N-terminal domain of CcmM. Enzyme Cca shows low activity \\n\\tcompared to other CAs, the C-terminal tail appears to partly inhibit \\n\\tactivity, possibly indicating a role in minimizing the activity of \\n\\tunencapsulated enzyme. The need for the HCO3- entering the carboxysome \\n\\tto be efficiently converted into CO2 requires that carbonic anhydrase \\n\\tis co-encapsulated within the carboxysome. On the other hand, the \\n\\tpresence of CA activity in the cytosol is highly deleterious as it \\n\\tconverts the accumulated HCO3- into its membrane-permeable CO2 \\n\\tcounterpart outside of the protective barrier afforded by the shell. \\n\\tIntracellular CAs in cyanobacteria are required to possess interaction \\n\\tdeterminants that target them to the carboxysome, as well as mechanisms \\n\\tthat minimize CA activity prior to the completion of the shell. CcmM is \\n\\tthe second potential beta-carboxysomal CA and is universally present in \\n\\tbeta-carboxysomes as it functions as a central nexus for organizing the \\n\\tcarboxysomes interior. Formation of the CcaA/CcmM complex probably \\n\\trequires significant backbone movements in at least one of the binding \\n\\tpartners. CcaA is among the least active beta-CAs characterized to \\n\\tdate, with activity comparable with the gamma-CA, CcmM. CcmM is the \\n\\tsecond potential beta-carboxysomal CA and is universally present in \\n\\tbeta-carboxysomes as it functions as a central nexus for organizing the \\n\\tcarboxysomes interior. CcmM is built as two distinct regions, the \\n\\tC-terminal region of CcmM consists of three to five repeats of a \\n\\tRubisCO small subunit-like domain, separated by flexible linker \\n\\tregions, this region binds RubisCO. The N-terminal domain is clearly \\n\\thomologous to gamma-CAs, but in Synechocystis sp. PCC 6803, this domain \\n\\tlacks measurable CA activity <355>; #171# expressing similar fast type \\n\\tof myofilament proteins, CAIII-positive tibial anterior muscle exhibits \\n\\thigher tolerance to fatigue than that of CAIII-negative fast twitch \\n\\textensor digitorum longus muscle in in situ contractility studies \\n\\t<370>; #220# gamma-CAs are present in carboxysomes, being involved in \\n\\tphotosynthesis <361>; #62,184# gamma-CAs are widely distributed in all \\n\\tthree phylogenetic domains of life, playing important roles in the \\n\\tglobal carbon cycle <376>; #120# human carbonic anhydrase IX (hCA IX) \\n\\tis a tumour-associated enzyme. The observed conformational flexibility \\n\\tof the enzymes extrcellular PG domain may have several important roles \\n\\tin tumour progression, facilitating interactions of hCA IX with partner \\n\\tproteins assisting tumour spreading and progression <364>; #209# \\n\\tHyriopsis cumingii isozyme HcCA3 play a role in the formation of shell \\n\\tand pearl sac formation. The mantle epithelial cell of acceptor mussels \\n\\tsharply divide and proliferate after being stimulated and wrap the \\n\\tstimulus to form pearl sac gradually. Pearl sac gradually secretes \\n\\tpearl essence layer by layer around stimulus and form pearl ultimately. \\n\\tHcCA3 expression in different parts of the mantle shows different \\n\\ttrends during pearl formation, which suggests that it plays different \\n\\troles in the process <372>; #194# in metazoans, the alpha-CA family is \\n\\tlargely represented and plays a pivotal role in the deposition of \\n\\tcalcium carbonate biominerals <389>; #218# in the green alga \\n\\tChlamydomonas reinhardtii, a luminal carbonic anhydrase, CrCAH3 \\n\\timproves proton removal from phorosystem PSII, possibly by rapid \\n\\treformation of HCO3- from CO2. It plays a direct role of CrCAH3 in the \\n\\tturnover efficiency of PSII, and a stimulating effect of CrCAH3 and \\n\\tCO2/HCO3- on PSII activity. Possible redox regulation of the enzyme, \\n\\toverview. Redox regulation in the chloroplast thylakoid lumen is a \\n\\tcommon way to regulate lumenal and photosynthetic proteins <403>; #14# \\n\\tpolyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase \\n\\t(poly-[Hb-SOD-CAT-CA]) contains all three major functions of red blood \\n\\tcells (RBCs) at an enhanced level. The crosslinked \\n\\tpoly-[SFHb-SOD-CAT-CA] enzyme complex does not activate the complement \\n\\tpathway in rat plasma <353>; #210# pufferfish CA VI is an extracellular \\n\\tsecretory protein <373>; #197# the carbonic anhydrase catalyzed \\n\\thydration of CO2 is fundamental to many vital physiological functions \\n\\tin living organisms such as pH homeostasis, ion transport, carbon \\n\\tconcentrating mechanism (plants and many microorganisms), and in \\n\\tbiosynthesis of physiologically important metabolites <367>; #201# the \\n\\tctenidial DDCA is positioned to dehydrate HCO3- to CO2 in seawater, and \\n\\tto hydrate the CO2 that has permeated the apical membrane back to HCO3- \\n\\tin the cytoplasm. During insolation, the host clam needs to increase \\n\\tthe uptake of inorganic carbon from the ambient seawater to benefit the \\n\\tsymbiotic zooxanthellae. Only then can the symbionts conduct \\n\\tphotosynthesis and share the photosynthates with the host. Enzyme DDCA \\n\\tmight participate in the light-enhanced uptake and assimilation of \\n\\texogenous inorganic carbon <371>; #194# the Mytilus galloprovincialis \\n\\talpha-CA is involved in pH regulation and/or in the delivery of \\n\\tbicarbonate helping the mussel during the formation of the shell <391>; \\n\\t#214,215,216,217# the NADH-ubiquinone oxidoreductase complex (complex \\n\\tI, EC 1.6.5.3) is the main entrance site of electrons into the \\n\\trespiratory chain. In a variety of eukaryotic organisms, except animals \\n\\tand fungi (Opisthokonta), it contains an extra domain comprising \\n\\ttrimers of putative gamma-carbonic anhydrases, named the CA domain, \\n\\twhich has been proposed to be essential for assembly of complex I. The \\n\\tCA domain of plant complex I contributes to sustaining efficient \\n\\tphotosynthesis under ambient (photorespiratory) conditions. The CA \\n\\tprotein domain contains at least two different gamma-CA proteins, CA1 \\n\\t(At1g19580) and CA2 (At1g47260), which show conserved active-site \\n\\tregions, and two less well-conserved gamma-CA-like proteins, CAL1 \\n\\t(At5g63510) and CAL2 (At3g48680), containing non-conservative \\n\\treplacements of putatively important amino acids <402>; #225# isoform \\n\\tCAc is important modulators in response to pH and saline-alkaline \\n\\tstresses in Exopalaemon carinicauda <422>; #226# isoform CAg is \\n\\timportant modulators in response to pH and saline-alkaline stresses in \\n\\tExopalaemon carinicauda <422>; #132# isoform VII defends against \\n\\toxidative stress by preventing reactive oxygen species from forming \\n\\t<418>; #14# the enzyme activity regulates pH and CO2 homeostasis, \\n\\telectrolyte secretion and transport, many biosynthetic reactions (e.g., \\n\\tgluconeogenesis, lipogenesis, and ureagenesis), bone resorption, \\n\\tcalcification, and tumorigenicity <430>) \\n\\t<251,272,280,285,291,292,301,314,335,344,349,353,355,361,364,366,367,\\n\\t370,371,372,373,374,376,382,389,391,396,401,402,403,418,422,430>\\nGI\\t#12,14,52,88,90,171,178,179,200,214,215,216,217,218,223,225,226# \\n\\tmalfunction (#14# isozyme CAIX expression and activity is associated \\n\\twith metabolic dysfunction in MDA-MB-231 cells <267>; #12# CA IV-/- \\n\\tmice show a 32.13% reduction in total carbonic anhydrase activity and \\n\\treduced beat frequency compared to the wild-type <314>; #52# analyses \\n\\tof a cpb deletion mutant shows that Cpb is strictly required for growth \\n\\twhen cultured in semi-defined medium and an atmosphere without CO2. \\n\\tGrowth of the mutant is the same as that of the parent wild-type strain \\n\\twhen cultured in nutrient-rich media with or without CO2 in the \\n\\tatmosphere, although elimination of glucose results in decreased \\n\\tproduction of acetate, propionate, and butyrate <338>; #90# at very low \\n\\tCO2 concentrations eCA inhibition reduces photosynthesis <347>; #88# at \\n\\tvery low CO2 concentrations enzyme inhibition reduces photosynthesis \\n\\t<347>; #178,179# enzyme complements Saccharomyces cerevisiae deletion \\n\\tmutant Nce103 <337>; #218# a CrCIA3 deletion mutant shows 50% reduction \\n\\tof the O2 evolution rate <403>; #215,216,217# Arabidopsis thaliana \\n\\tmutants defective in two CA subunits show an altered photorespiratory \\n\\tphenotype. Mutants grown in ambient air show growth retardation \\n\\tcompared to wild-type plants, a feature that is reversed by cultivating \\n\\tplants in a high-CO2 atmosphere. Under photorespiratory conditions, \\n\\tcarbon assimilation is diminished and glycine accumulates, suggesting \\n\\tan imbalance with respect to photorespiration. Additionally, transcript \\n\\tlevels of specific CA subunits are reduced in plants grown under \\n\\tnon-photorespiratory conditions, leaves of ca2cal1 and ca2cal2 double \\n\\tmutants exhibited increased ROS levels. Mutants ca2cal1 and ca2cal2 \\n\\tshow growth retardation in normal air. Mutant phenotypes, overview \\n\\t<402>; #214# Arabidopsis thaliana mutants defective in two CA subunits \\n\\tshow an altered photorespiratory phenotype. Mutants grown in ambient \\n\\tair show growth retardation compared to wild-type plants, a feature \\n\\tthat is reversed by cultivating plants in a high-CO2 atmosphere. Under \\n\\tphotorespiratory conditions, carbon assimilation is diminished and \\n\\tglycine accumulates, suggesting an imbalance with respect to \\n\\tphotorespiration. Additionally, transcript levels of specific CA \\n\\tsubunits are reduced in plants grown under non-photorespiratory \\n\\tconditions. Mutant phenotypes, overview <402>; #171# loss of CAIII in \\n\\tsoleus and tibialanterior (TA) muscles in Car3-KO mice does not change \\n\\tmuscle mass, sarcomere protein isoform contents, mitochondrial \\n\\tfunction, and the baseline twitch and tetanic contractility as compared \\n\\twith age-matched wild-type controls. Car3-KO TA muscle shows faster \\n\\tforce reduction at the beginning but higher resistance at the end \\n\\tduring a fatigue test, followed by slower postfatigue recovery than \\n\\tthat of wild-type TA muscle. Superfused Car3-KO soleus muscle also have \\n\\tfaster total force reduction during fatigue test than that of wild-type \\n\\tsoleus. It shows less elevation of resting tension followed by a better \\n\\tpostfatigue recovery under acidotic stress. Car3-KO increases the \\n\\tresistance of soleus muscle to acidosis <370>; #200# swimming pattern \\n\\tanalysis of ca6 morphant and wild-type zebrafish, mutant phenotype of \\n\\tca6 knockout fish, overview <399>; #225# isoform CAc-silenced prawns \\n\\tshow increased mortality under saline-alkaline stress. Isoform CAc \\n\\tknockdown reduces the expressions of Na+/H+ exchanger and sodium \\n\\tbicarbonate cotransporter <422>; #226# isoform CAg-silenced prawns show \\n\\tincreased mortality under saline-alkaline stress. Isoform CAg knockdown \\n\\treduces the expression of isoform CAc, Na+/H+ exchanger and sodium \\n\\tbicarbonate cotransporter, and V-type H+-ATPase <422>; #223# without \\n\\tfunctional enzyme, Candida albicans cannot survive in atmospheric air \\n\\t<420>) <267,314,337,338,347,370,399,402,403,420,422>\\nGI\\t#14,18,34,43,83,120,122,124,128,181,184,185,188,194,195,197,200,201,202,\\n\\t203,204,207,209,210,211,218# more (#14# EGF induces CAIX translocation \\n\\tto lipid rafts but not its phosphorylation <291>; #18,34# evaluation of \\n\\tefficiency of enzymes from Pseudomonas fragi, Micrococcus lylae, and \\n\\tMicrococcus luteus 2 compared to commercial Bos taurus carbonic \\n\\tanhydrase as biocatalysts in biomimetic sequestration of CO2 into \\n\\tCaCO3, the compared parameters are stability, inhibition rates by toxic \\n\\tmetals, and pH dependency, overview. Indigenous carbonic anhydrases and \\n\\ttheir consortia exhibit enhanced CO2 sequestration competence compared \\n\\tto commercial bovine carbonic anhydrase <309>; #43,83# Pseudomonas \\n\\tfragi, Micrococcus lylae and Micrococcus luteus 2 along with a \\n\\tcomparative evaluation of their efficiency compared to commercial Bis \\n\\ttaurus carbonic anhydrase as biocatalysts in biomimetic sequestration \\n\\tof CO2 into CaCO3, aparameters are stability, inhibition rates by toxic \\n\\tmetals, and pH dependency, overview. Indigenous CAs and their consortia \\n\\texhibit enhanced CO2 sequestration competence compared to commercial \\n\\tbovine CA <309>; #122# the wide use of dithiocarbamate pesticides may \\n\\tbe one of the factors enhancing the vulnerability of this sturgeon \\n\\tspecies to pollutants, since they act as effective carbonate \\n\\tdehydratase inhibitors <308>; #218# a disulfide bond between Cys90 and \\n\\tCys258 is essential for CrCAH3 activity <403>; #124# a key role for \\n\\tsodium ions in increasing halotolerant enzyme stability largely through \\n\\tinteractions with the highly ordered first Na+ hydration shell, \\n\\tmolecular dynamics calculations, overview <397>; #203# CcaA is \\n\\tcrystallized at pH 4.5 but remains in the active, type I conformation, \\n\\twhich is typified by a salt bridge between Asp41 and Arg43 that allows \\n\\tthe zinc ion to remain free for substrate binding. In addition, CcaA \\n\\tdoes not show the co-operative inactivation at low pH characteristic of \\n\\tthe type II bacterial enzymes (see below), and the residues that form \\n\\tthe non-catalytic (regulatory) bicarbonate-binding site (Arg-Trp-Tyr) \\n\\tare absent. CcaA is a structurally characterized bacterial beta-CA that \\n\\tdisplays type I active sites <355>; #124# enzyme structure, catalytic \\n\\tmechanism, and molecular dynamics simulations <351>; #200# homology \\n\\tmodeling of isozyme CA VI including PTX domain (residues 317-530) using \\n\\tthe structure of human isozyme CA IV as template, PDB ID 3FE4. \\n\\tStructure comparisons <399>; #210# homology modeling of puffer CA VI is \\n\\tperformed using the crystal structure of human carbonic anhydrase XIV \\n\\tas a template structure <373>; #204# homology modeling of Synechocystis \\n\\tCcmM <355>; #207# identification of the structural features responsible \\n\\tfor the high catalytic activity of the enzyme from Sulfurihydrogenibium \\n\\tazorense, structure comparison with the enzyme from \\n\\tSulfurihydrogenibium yellowstonensis. The active site of each monomer \\n\\twithin the dimer is completely accessible to the solvent and, as \\n\\tobserved for other alpha-CAs, is located in a cavity which extends from \\n\\tthe surface to the center of the protein. On the bottom of this cavity, \\n\\tthe catalytic zinc ion is tetrahedrally coordinated by the three \\n\\thistidine residues (His89, His91 and His108). Enzyme SazCA active site \\n\\tstructure and environment, important for catalytic activity, overview \\n\\t<360>; #120# isozyme modelling and molecular dynamics studies, overview \\n\\t<364>; #195# residue Thr477 in PfCAdom is crucial for its catalysis \\n\\t<388>; #197# residues H137, H139, H156, and H110 present in the active \\n\\tsite play an important role in catalysis, the active site of \\n\\trecombinant BhCA is also composed of conserved Glu and Asp acid \\n\\tresidues <374>; #188# structure analysis. Enzyme Cab shows significant \\n\\tstructural differences with respect to the other enzymes of beta-class \\n\\tin the N-terminus, C-terminus and in the region encompassing residues \\n\\t90-125. Moreover, it presents a less extended C-terminal region, being \\n\\tthe smallest beta-CA so far characterized <376>; #124,184# structure \\n\\tcomparisons <376>; #185# structure comparisons, residues His2 and \\n\\tHis207 in enzyme SazCA from Sulphurihydrogenibium azorense, as compared \\n\\tto Glu2 and Gln207 in enzyme SspCA from Sulfurihydrogenibium \\n\\tyellowstonense, are proposed to be responsible for the higher SazCA \\n\\tcatalytic activity <376>; #181# structure comparisons, residues His2 \\n\\tand His207 in SazCA, compared Glu2 and Gln207 in enzyme SspCA from \\n\\tSulfurihydrogenibium yellowstonense, are proposed to be responsible for \\n\\tthe higher SazCA catalytic activity <376>; #195# the 69 amino acid \\n\\tresidues insertion present in the active site of eta-CA PfCAdom seem to \\n\\tbe crucial for the active site architecture <362>; #209# the CA domain \\n\\tof the enzyme includes 7 active site residues: His93, Gln128, His130, \\n\\tHis132, Glu142, His155 and Thr248. Residues His130, His132, and His155 \\n\\tare zinc iron binding sites <372>; #201# the deduced enzyme DDCA \\n\\tsequence contains two distinct alpha-CA domains, each with a specific \\n\\tcatalytic site. Each alpha-CA domain of the DDCA has its own set of \\n\\tcatalytic and active sites. The first alpha-CA domain comprised the \\n\\tthree histidine residues (His116, His118, His141) which coordinate the \\n\\tZn2+-containing catalytic site, the hydrophobic residues (Val143, \\n\\tVal164, Leu224, Val233, Trp235) that form the CO2 binding pocket, and \\n\\tthe gatekeeper residues (Glu128, Thr226). In the first alpha-CA domain, \\n\\tthe active binding site for HCO3- and H+ constitutes five hydrophilic \\n\\tresidues (Asn85, His87, Gln114, Thr225, and Thr226), of which His87 \\n\\tacts as a proton shuttle for CO2 hydration. Similarly, the \\n\\tZn2+-containing catalytic site (His391, His393, His416), the \\n\\thydrophobic residues that form the CO2 binding pocket (Val418, Val439, \\n\\tLeu504, Val513, Trp515), and the gatekeeper residues (Glu403, Thr506) \\n\\tare conserved in the second alpha-CA domain. Unlike the first alpha-CA \\n\\tdomain, six hydrophilic residues (Asn361, His363, Gln366, Gln389, \\n\\tThr505, and Thr506) are found in the second alpha-CA domain, and His363 \\n\\tserves as a proton shuttle for CO2 hydration <371>; #194# the full \\n\\tnucleotide sequence encoding for the native MgaCA shows an open reading \\n\\tframe of 255 amino acid residues containing the conserved three \\n\\thistidines, His94, His96, and His119 (hCA I numbering system), which \\n\\tcoordinate the Zn(II) ion crucial for catalysis, and the two \\n\\tgate-keeper residues, the Glu106 and Thr199. The mussel enzyme has a \\n\\tresidue of lysine as substituent of the proton shuttle residue His64, \\n\\texplaining the relatively low catalytic activity of the native MgaCA, \\n\\twith the following kinetic parameters for the CO2 hydration reaction \\n\\t<389>; #194# the Mytilus galloprovincialis alpha-CA sequence contains \\n\\tthe three His residues (His94, His96, and His119) acting as zinc \\n\\tligands and the gate-keeper residues present in all alpha-CAs (Glu106 \\n\\tand Thr199), but has a Lys in position 64 and not a His as proton \\n\\tshuttling residue <391>; #128# the polypeptide segment Val131-Asp136 in \\n\\tCA IV arranges in an extended loop conformation rich of charged \\n\\tresidues extending to the outside <369>; #201# the residues essential \\n\\tfor CA2 catalytic activity are highly conserved, and also the \\n\\thydrophobic portion of the CA2 active site (Val129, Val150, Leu209, \\n\\tVal218 and Trp220) and responsible for binding the substrate CO2 are \\n\\tfully conserved, active site structure <401>; #202# the TcruCA monomer \\n\\thas the signature secondary structure typical of an alpha-CA fold, with \\n\\thelical and loop structures present towards the surface and a conical \\n\\tactive-site cavity comprised of mostly beta-structure, structure \\n\\tcomparisons, especially with human carbonic anhydrase 2, CA2, overview \\n\\t<350>; #211# three histidine residues predicted to form the Zn2+ \\n\\tcoordination center, H233, H235, and H258, are conserved in Pl-CAN, \\n\\ttogether with four additional sites, H206, Q231, E245, and T340 <395>) \\n\\t<291,308,309,350,351,355,360,362,364,369,371,372,373,374,376,388,389,\\n\\t391,395,397,399,401,403>\\nGI\\t#6,62,88,124,162,166,181,185,191,192,193,195,198,199,210,211,219,220# \\n\\tevolution (#62,88# carbonic anhydrase represents one of the most \\n\\tancient proteins <312>; #162# evolutionary tree of some bacterial \\n\\tbeta-CAs among which the two Brucella suis isozymes bsCA I and bsCA II, \\n\\tphylogenetic analysis, overview <298>; #166# HICA is a type II member \\n\\tof the beta-carbonic anhydrase family <289>; #6# phylogenetic analysis \\n\\tof beta-class carbonic anhydrases in invertebrates, overview <303>; \\n\\t#219# carbonic anhydrase is a member of zinc-containing metalloenzyme \\n\\tfamily <368>; #210# comparisons of putative active site residues \\n\\tbetween CA II and CA VI from humans and several fishes <373>; #198# \\n\\tevolutionary relationship analysis, phylogenetic tree, the enzyme \\n\\tbelongs to the beta class of carbonic anhydrases, subgroup of type II \\n\\tbeta-CAs. The enzyme B13-CA has all the features of a catalytically \\n\\teffective beta-CA: (i) the putative Zn(II) ligands, Cys42, Asp44, His \\n\\t98 and Cys101, (ii) the catalytic dyad involved in activation of the \\n\\tzinc-coordinated water molecule/hydroxide ion for catalysis, \\n\\trepresented by the Asp44-Arg46 residues, which resembles in a way the \\n\\tactivation of the water molecule in aspartic proteases <384>; #211# \\n\\tphylogenetic analysis indicates that Pl-CAN is evolutionarily closer to \\n\\thumans among chordates than to other species <395>; #220# phylogenetic \\n\\ttree of gamma-CAs <361>; #199# several genetically distinct classes of \\n\\tcarbonic anhydrase (CAs) exist, e.g. alpha-, beta-, gamma-, delta- and \\n\\tzeta-, and all of them are metalloenzymes. delta-CAs are closer to the \\n\\talpha-CAs than to the other classes of the enzymes, phylogenetic \\n\\tanalysis <382>; #124,181,185,191,192,193# the dimeric arrangement is a \\n\\tpeculiar feature of all bacterial alpha-CAs so far structurally \\n\\tcharacterized <376>; #195# the enzyme belongs to the eta-CA class. Six \\n\\tgenetically distinct CA families are known to date, the alpha-, beta-, \\n\\tgamma-, delta-, zeta- and eta-CAs. The alpha-, beta-, delta- and \\n\\tprobably eta-CAs use Zn(II) ions at the active site, the gamma-CAs are \\n\\tprobably Fe(II) enzymes, but they are active also with bound Zn(II) or \\n\\tCo(II) ions, whereas the zeta-class are cambialistic enzymes, active \\n\\tboth with Cd(II) or Zn(II) bound within the active site <362>; #195# \\n\\tthe enzyme belongs to the superfamily of metalloenzymes <388>) \\n\\t<289,298,303,312,361,362,368,373,376,382,384,388,395>\\nGI\\t#96,106# metabolism (#96# isoform gamma-CA is a possible component of \\n\\tthe carbon-concentrating mechanism in Saccharina japonica <423>; #106# \\n\\tthe enzyme is involved in CO2 metabolism in plastids and mitochondria \\n\\t<419>) <419,423>\\n']\n"
     ]
    },
    {
     "ename": "AttributeError",
     "evalue": "'list' object has no attribute 'replace'",
     "output_type": "error",
     "traceback": [
      "\u001b[31m---------------------------------------------------------------------------\u001b[39m",
      "\u001b[31mAttributeError\u001b[39m                            Traceback (most recent call last)",
      "\u001b[36mCell\u001b[39m\u001b[36m \u001b[39m\u001b[32mIn[31]\u001b[39m\u001b[32m, line 7\u001b[39m\n\u001b[32m      5\u001b[39m \u001b[38;5;28mprint\u001b[39m(\u001b[33m\"\u001b[39m\u001b[33mSystematic Name:\u001b[39m\u001b[33m\"\u001b[39m, rxn.systematic_name)\n\u001b[32m      6\u001b[39m \u001b[38;5;28mprint\u001b[39m(\u001b[33m\"\u001b[39m\u001b[33mReaction Type:\u001b[39m\u001b[33m\"\u001b[39m, rxn.reaction_type)\n\u001b[32m----> \u001b[39m\u001b[32m7\u001b[39m \u001b[38;5;28mprint\u001b[39m(\u001b[33m\"\u001b[39m\u001b[33mReaction:\u001b[39m\u001b[33m\"\u001b[39m, \u001b[43mrxn\u001b[49m\u001b[43m.\u001b[49m\u001b[43mreaction_str\u001b[49m)\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~/brenda-env/lib/python3.12/site-packages/brendapyrser/parser.py:503\u001b[39m, in \u001b[36mReaction.reaction_str\u001b[39m\u001b[34m(self)\u001b[39m\n\u001b[32m    501\u001b[39m \u001b[38;5;129m@property\u001b[39m\n\u001b[32m    502\u001b[39m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34mreaction_str\u001b[39m(\u001b[38;5;28mself\u001b[39m):\n\u001b[32m--> \u001b[39m\u001b[32m503\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43m__extractReactionMechanismInfo\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43m__mechanism_str\u001b[49m\u001b[43m)\u001b[49m[\u001b[32m0\u001b[39m]\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~/brenda-env/lib/python3.12/site-packages/brendapyrser/parser.py:386\u001b[39m, in \u001b[36mReaction.__extractReactionMechanismInfo\u001b[39m\u001b[34m(self, line)\u001b[39m\n\u001b[32m    382\u001b[39m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34m__extractReactionMechanismInfo\u001b[39m(\u001b[38;5;28mself\u001b[39m, line: \u001b[38;5;28mstr\u001b[39m):\n\u001b[32m    383\u001b[39m \u001b[38;5;250m    \u001b[39m\u001b[33;03m\"\"\"\u001b[39;00m\n\u001b[32m    384\u001b[39m \u001b[33;03m    Extracts reaction string and mechanism info\u001b[39;00m\n\u001b[32m    385\u001b[39m \u001b[33;03m    \"\"\"\u001b[39;00m\n\u001b[32m--> \u001b[39m\u001b[32m386\u001b[39m     line = \u001b[38;5;28;43mself\u001b[39;49m\u001b[43m.\u001b[49m\u001b[43m__removeTabs\u001b[49m\u001b[43m(\u001b[49m\u001b[43mline\u001b[49m\u001b[43m)\u001b[49m\n\u001b[32m    387\u001b[39m     line, meta = \u001b[38;5;28mself\u001b[39m.__extractDataField(line, (\u001b[33m\"\u001b[39m\u001b[33m\\\u001b[39m\u001b[33m(\u001b[39m\u001b[33m\"\u001b[39m, \u001b[33m\"\u001b[39m\u001b[33m.*\u001b[39m\u001b[33m\\\u001b[39m\u001b[33m)\u001b[39m\u001b[33m\"\u001b[39m))\n\u001b[32m    388\u001b[39m     rxn_str = line.strip()\n",
      "\u001b[36mFile \u001b[39m\u001b[32m~/brenda-env/lib/python3.12/site-packages/brendapyrser/parser.py:327\u001b[39m, in \u001b[36mReaction.__removeTabs\u001b[39m\u001b[34m(line)\u001b[39m\n\u001b[32m    325\u001b[39m \u001b[38;5;129m@staticmethod\u001b[39m\n\u001b[32m    326\u001b[39m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[34m__removeTabs\u001b[39m(line):\n\u001b[32m--> \u001b[39m\u001b[32m327\u001b[39m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mline\u001b[49m\u001b[43m.\u001b[49m\u001b[43mreplace\u001b[49m(\u001b[33m\"\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[33m\"\u001b[39m, \u001b[33m\"\u001b[39m\u001b[33m\"\u001b[39m).replace(\u001b[33m\"\u001b[39m\u001b[38;5;130;01m\\t\u001b[39;00m\u001b[33m\"\u001b[39m, \u001b[33m\"\u001b[39m\u001b[33m\"\u001b[39m).strip()\n",
      "\u001b[31mAttributeError\u001b[39m: 'list' object has no attribute 'replace'"
     ]
    }
   ],
   "source": [
    "rxn = [rxn for rxn in brenda.reactions if rxn.ec_number == \"4.2.1.1\"][0]\n",
    "\n",
    "print(\"EC:\", rxn.ec_number)\n",
    "print(\"Name:\", rxn.name)\n",
    "print(\"Systematic Name:\", rxn.systematic_name)\n",
    "print(\"Reaction Type:\", rxn.reaction_type)\n",
    "print(\"Reaction:\", rxn.reaction_str)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "5fccdc70-a300-4210-aa19-2463e5ca9fc8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "km_vals = [v for v in rxn.KMvalues.get_values() if isinstance(v, (float, int))]\n",
    "plt.hist(km_vals, bins=30)\n",
    "plt.title(\"Km values for EC 4.2.1.1\")\n",
    "plt.xlabel(\"Km (mM)\")\n",
    "plt.ylabel(\"Frequency\")\n",
    "plt.show()\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "f3d847b5-094e-4697-9fe0-58d2716cf193",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "ph_vals = [v for v in rxn.PH.get_values() if isinstance(v, (float, int)) and 1 <= v <= 14]\n",
    "plt.hist(ph_vals, bins=14)\n",
    "plt.title(\"pH values for EC 4.2.1.1\")\n",
    "plt.xlabel(\"pH\")\n",
    "plt.ylabel(\"Frequency\")\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "38ef29f4-1cc2-45f0-83b0-5ffd1d21a38b",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CABRENDA.ipynb                       pixi.toml\n",
      "\u001b[0m\u001b[01;34mDesktop\u001b[0m/                             \u001b[01;34mtreesapp_env\u001b[0m/\n",
      "\u001b[01;34mDownloads\u001b[0m/                           \u001b[01;34mtreesapp_output\u001b[0m/\n",
      "\u001b[01;32mENOG501XT7N\u001b[0m*                         \u001b[01;34mtreesapp_project\u001b[0m/\n",
      "Miniconda3-latest-Linux-x86_64.sh    \u001b[01;34mtreesapp_project2\u001b[0m/\n",
      "Miniconda3-latest-Linux-x86_64.sh.1  \u001b[01;34mtreesapp_project3\u001b[0m/\n",
      "\u001b[01;34mbrenda-env\u001b[0m/                          \u001b[01;34mtreesapp_project4\u001b[0m/\n",
      "\u001b[01;34mbrenda_data\u001b[0m/                         \u001b[01;34mtreesapp_references\u001b[0m/\n",
      "my_tree.nwk                          \u001b[01;32mtreesapp_sequences.fasta\u001b[0m*\n",
      "pixi.lock\n"
     ]
    }
   ],
   "source": [
    "ls\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7a68f160-aa3a-4ca5-b737-6478ec97d7fe",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
